Psyllid ID: psy14630

---

Local Sequence Feature Prediction

Residue Number Marker
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------
Protein Sequence
MCQSIQSSGKLKLSPDTVYDFTSEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQFYGALFKEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPLRARGYPSFKTKLGFKFNYRIP
Secondary Structure (PSIPRED)
ccccccccccEEEccccEEEcccccHHHHccccccccEEEEEEEEcccccEEEEEEEEccccHHHHHHHHHHHHHHHHccccccEEEEcccHHHHHHHHHHHHHHHHHHcccccccccccccEEEcccccEEEEccccHHHHHHHHHcccccccccccccccccccccccccccEEEcEEEEccccc
Secondary Structure Prediction (SSPRO)
ccccccccccccccccccccccccccEEEEEEccccHHHEEEEEEcccccEEEEEEEEccccccHHHHHHHHHHHHHHHcccccHHHHHHHHHHHHHHHHHHHHHHHHHHccEEcccccHHHEEEcccccEEEccccccEEccccccEccccccHHHccHHHHHHHHccccccEEEEHHHEHHHccc
Coil and Loop (DISEMBL)
mcqsiqssgklklspdtvydftsedlqdlgeigrggfgtVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVvmksnecpYIVQFYGALFKEVTVATVKALNYLKEELKIIhrdvkpsnilldrrgaiklcdfgisgqlvDSIAKTrdagcrpymaperidplrargypsfktklgfkfnyrip
Flexible Loop (DISEMBL)
mcqsiqssgklklspdtVYDFTSEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIrstvdekdqrqLLMDLDVVMKSNECPYIVQFYGALFKEVTVATVKALNYLKEelkiihrdvkpsnilldRRGAIKLCDfgisgqlvdSIAKtrdagcrpymaperidplrargypsfktklgfkfnyrip
Low Complexity Region (SEG)
MCQSIQSSGKLKLSPDTVYDFTSEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQFYGALFKEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPLRARGYPSFKTKLGFKFNYRIP
Disordered region (IsUnstruct)
*****************VYDFTSEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVD**DQRQLLMDLDVVMKSNECPYIVQFYGALFKEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPLRARGYPSFKTKLGFKFNY***
Disordered Region (DISOPRED)
******************YDFTSEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQFYGALFKEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPLRARGYPSFKTKLGFKFNYR**
Disordered Region (DISEMBL)
************LSPDTVYDFTSEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQFYGALFKEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPLRARGYPSFKTKLGFKFNYRIP
Disordered Region (DISPRO)
********************FTSEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQFYGALFKEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPLRARGYPSFKTKLGFKFNYRIP
Transmembrane Helix (TMHMM)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (HMMTOP)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (MEMSAT)
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiihhhhhhhhhhhhhhhhhhhhhoooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
TM Helix, Signal Peptide (MEMSAT_SVM)
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiihhhhhhhhhhhhhhhhooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
TM Helix, Signal Peptide (Phobius)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Signal Peptide (SignalP HMM Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Signal Peptide (SignalP NN Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Coiled Coils (COILS)
MCQSIQSSGKLKLSPDTVYDFTSEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQFYGALFKEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPLRARGYPSFKTKLGFKFNYRIP
Positional Conservation
no confident homologs detected

---

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST

Original result of BLAST against SWISS-PROT Database

ID	Length	Definition	RBH(Q2H)	RBH(H2Q)	Q cover	H cover	Identity	E-value
Query	187	2.2.26 [Sep-21-2011]
P47809	397	Dual specificity mitogen-	yes	N/A	0.903	0.425	0.655	3e-72
P45985	399	Dual specificity mitogen-	yes	N/A	0.903	0.423	0.655	3e-72
Q07192	446	Dual specificity mitogen-	N/A	N/A	0.903	0.378	0.655	1e-71
Q5E9X2	334	Dual specificity mitogen-	no	N/A	0.818	0.458	0.465	9e-46
Q9DGE0	361	Dual specificity mitogen-	no	N/A	0.796	0.412	0.481	1e-45
P70236	334	Dual specificity mitogen-	no	N/A	0.818	0.458	0.470	1e-45
P52564	334	Dual specificity mitogen-	no	N/A	0.818	0.458	0.465	2e-45
P46734	347	Dual specificity mitogen-	no	N/A	0.834	0.449	0.458	3e-45
O09110	347	Dual specificity mitogen-	no	N/A	0.834	0.449	0.458	5e-45
Q20347	363	MAP kinase kinase mkk-4 O	yes	N/A	0.839	0.432	0.492	2e-43

>sp|P47809|MP2K4_MOUSE Dual specificity mitogen-activated protein kinase kinase 4 OS=Mus musculus GN=Map2k4 PE=1 SV=2

 Score =  271 bits (692), Expect = 3e-72,   Method: Compositional matrix adjust.
 Identities = 135/206 (65%), Positives = 157/206 (76%), Gaps = 37/206 (17%)

Query: 3   QSIQSSGKLKLSPDTVYDFTSEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVD 62
            SI+SSGKLK+SP+  +DFT+EDL+DLGEIGRG +G+VNKM+H+ S  +MAVKRIRSTVD
Sbjct: 77  HSIESSGKLKISPEQHWDFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVD 136

Query: 63  EKDQRQLLMDLDVVMKSNECPYIVQFYGALFKE--------------------------- 95
           EK+Q+QLLMDLDVVM+S++CPYIVQFYGALF+E                           
Sbjct: 137 EKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICMELMSTSFDKFYKYVYSVLDD 196

Query: 96  ---------VTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSI 146
                    +T+ATVKALN+LKE LKIIHRD+KPSNILLDR G IKLCDFGISGQLVDSI
Sbjct: 197 VIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSI 256

Query: 147 AKTRDAGCRPYMAPERIDPLRAR-GY 171
           AKTRDAGCRPYMAPERIDP  +R GY
Sbjct: 257 AKTRDAGCRPYMAPERIDPSASRQGY 282

Dual specificity protein kinase which acts as an essential component of the MAP kinase signal transduction pathway. Essential component of the stress-activated protein kinase/c-Jun N-terminal kinase (SAP/JNK) signaling pathway. With MAP2K7/MKK7, is the one of the only known kinase to directly activate the stress-activated protein kinase/c-Jun N-terminal kinases MAPK8/JNK1, MAPK9/JNK2 and MAPK10/JNK3. MAP2K4/MKK4 and MAP2K7/MKK7 both activate the JNKs by phosphorylation, but they differ in their preference for the phosphorylation site in the Thr-Pro-Tyr motif. MAP2K4 shows preference for phosphorylation of the Tyr residue and MAP2K7/MKK7 for the Thr residue. The phosphorylation of the Thr residue by MAP2K7/MKK7 seems to be the prerequisite for JNK activation at least in response to proinflammatory cytokines, while other stimuli activate both MAP2K4/MKK4 and MAP2K7/MKK7 which synergistically phosphorylate JNKs. MAP2K4 is required for maintaining peripheral lymphoid homeostasis. The MKK/JNK signaling pathway is also involved in mitochondrial death signaling pathway, including the release cytochrome c, leading to apoptosis. Whereas MAP2K7/MKK7 exclusively activates JNKs, MAP2K4/MKK4 additionally activates the p38 MAPKs MAPK11, MAPK12, MAPK13 and MAPK14.
Mus musculus (taxid: 10090)
EC: 2EC: .EC: 7EC: .EC: 1EC: 2EC: .EC: 2

>sp|P45985|MP2K4_HUMAN Dual specificity mitogen-activated protein kinase kinase 4 OS=Homo sapiens GN=MAP2K4 PE=1 SV=1

 Score =  270 bits (691), Expect = 3e-72,   Method: Compositional matrix adjust.
 Identities = 135/206 (65%), Positives = 157/206 (76%), Gaps = 37/206 (17%)

Query: 3   QSIQSSGKLKLSPDTVYDFTSEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVD 62
            SI+SSGKLK+SP+  +DFT+EDL+DLGEIGRG +G+VNKM+H+ S  +MAVKRIRSTVD
Sbjct: 79  HSIESSGKLKISPEQHWDFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVD 138

Query: 63  EKDQRQLLMDLDVVMKSNECPYIVQFYGALFKE--------------------------- 95
           EK+Q+QLLMDLDVVM+S++CPYIVQFYGALF+E                           
Sbjct: 139 EKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICMELMSTSFDKFYKYVYSVLDD 198

Query: 96  ---------VTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSI 146
                    +T+ATVKALN+LKE LKIIHRD+KPSNILLDR G IKLCDFGISGQLVDSI
Sbjct: 199 VIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSI 258

Query: 147 AKTRDAGCRPYMAPERIDPLRAR-GY 171
           AKTRDAGCRPYMAPERIDP  +R GY
Sbjct: 259 AKTRDAGCRPYMAPERIDPSASRQGY 284

Dual specificity protein kinase which acts as an essential component of the MAP kinase signal transduction pathway. Essential component of the stress-activated protein kinase/c-Jun N-terminal kinase (SAP/JNK) signaling pathway. With MAP2K7/MKK7, is the one of the only known kinase to directly activate the stress-activated protein kinase/c-Jun N-terminal kinases MAPK8/JNK1, MAPK9/JNK2 and MAPK10/JNK3. MAP2K4/MKK4 and MAP2K7/MKK7 both activate the JNKs by phosphorylation, but they differ in their preference for the phosphorylation site in the Thr-Pro-Tyr motif. MAP2K4 shows preference for phosphorylation of the Tyr residue and MAP2K7/MKK7 for the Thr residue. The phosphorylation of the Thr residue by MAP2K7/MKK7 seems to be the prerequisite for JNK activation at least in response to proinflammatory cytokines, while other stimuli activate both MAP2K4/MKK4 and MAP2K7/MKK7 which synergistically phosphorylate JNKs. MAP2K4 is required for maintaining peripheral lymphoid homeostasis. The MKK/JNK signaling pathway is also involved in mitochondrial death signaling pathway, including the release cytochrome c, leading to apoptosis. Whereas MAP2K7/MKK7 exclusively activates JNKs, MAP2K4/MKK4 additionally activates the p38 MAPKs MAPK11, MAPK12, MAPK13 and MAPK14.

Homo sapiens (taxid: 9606)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 2

EC: .

EC: 2

>sp|Q07192|MP2K2_XENLA Dual specificity mitogen-activated protein kinase kinase 2 (Fragment) OS=Xenopus laevis GN=map2k2 PE=1 SV=1

 Score =  268 bits (686), Expect = 1e-71,   Method: Compositional matrix adjust.
 Identities = 135/206 (65%), Positives = 154/206 (74%), Gaps = 37/206 (17%)

Query: 3   QSIQSSGKLKLSPDTVYDFTSEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVD 62
            SI+SSGKLKLSP+  +DFT+EDL+DLGEIGRG +G+VNKM H  S  +MAVKRIRSTVD
Sbjct: 126 HSIESSGKLKLSPEQHWDFTAEDLKDLGEIGRGAYGSVNKMSHTPSGQIMAVKRIRSTVD 185

Query: 63  EKDQRQLLMDLDVVMKSNECPYIVQFYGALFKE--------------------------- 95
           EK+Q+QLLMDLDVVM+S++CPYIVQFYGALF+E                           
Sbjct: 186 EKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICMELMATSFDKFYKYVYSFLDD 245

Query: 96  ---------VTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSI 146
                    +T+ATVKALN+LKE LKIIHRD+KPSNILLD  G IKLCDFGISGQLVDSI
Sbjct: 246 VIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLDTNGNIKLCDFGISGQLVDSI 305

Query: 147 AKTRDAGCRPYMAPERIDPLRAR-GY 171
           AKTRDAGCRPYMAPERIDP  +R GY
Sbjct: 306 AKTRDAGCRPYMAPERIDPSASRQGY 331

Catalyzes the concomitant phosphorylation of a threonine and a tyrosine residue in a Thr-Glu-Tyr sequence located in MAP kinases.

Xenopus laevis (taxid: 8355)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 2

EC: .

EC: 2

>sp|Q5E9X2|MP2K6_BOVIN Dual specificity mitogen-activated protein kinase kinase 6 OS=Bos taurus GN=MAP2K6 PE=2 SV=1

 Score =  182 bits (463), Expect = 9e-46,   Method: Compositional matrix adjust.
 Identities = 88/189 (46%), Positives = 124/189 (65%), Gaps = 36/189 (19%)

Query: 19  YDFTSEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMK 78
           ++  ++DL+ + E+GRG +G V KM H  S+ +MAVKRIR+TV+ ++Q++LLMDLD+ M+
Sbjct: 46  FEVKADDLEPIVELGRGAYGVVEKMRHVPSEQIMAVKRIRATVNSQEQKRLLMDLDISMR 105

Query: 79  SNECPYIVQFYGALFKE-----------------------------------VTVATVKA 103
           + +CP+ V FYGALF+E                                   + V+ VKA
Sbjct: 106 TVDCPFTVTFYGALFREGDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKA 165

Query: 104 LNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERI 163
           L +L  +L +IHRDVKPSN+L++  G +K+CDFGISG LVDS+AKT DAGC+PYMAPERI
Sbjct: 166 LEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDSVAKTIDAGCKPYMAPERI 225

Query: 164 DP-LRARGY 171
           +P L  +GY
Sbjct: 226 NPELNQKGY 234

Dual specificity protein kinase which acts as an essential component of the MAP kinase signal transduction pathway. With MAP3K3/MKK3, catalyzes the concomitant phosphorylation of a threonine and a tyrosine residue in the MAP kinases p38 MAPK11, MAPK12, MAPK13 and MAPK14 and plays an important role in the regulation of cellular responses to cytokines and all kinds of stresses. Especially, MAP2K3/MKK3 and MAP2K6/MKK6 are both essential for the activation of MAPK11 and MAPK13 induced by environmental stress, whereas MAP2K6/MKK6 is the major MAPK11 activator in response to TNF. MAP2K6/MKK6 also phosphorylates and activates PAK6. The p38 MAP kinase signal transduction pathway leads to direct activation of transcription factors. Nuclear targets of p38 MAP kinase include the transcription factors ATF2 and ELK1. Within the p38 MAPK signal transduction pathway, MAP3K6/MKK6 mediates phosphorylation of STAT4 through MAPK14 activation, and is therefore required for STAT4 activation and STAT4-regulated gene expression in response to IL-12 stimulation. The pathway is also crucial for IL-6-induced SOCS3 expression and down-regulation of IL-6-mediated gene induction; and for IFNG-dependent gene transcription. Has a role in osteoclast differentiation through NF-kappa-B transactivation by TNFSF11, and in endochondral ossification and since SOX9 is another likely downstream target of the p38 MAPK pathway. MAP2K6/MKK6 mediates apoptotic cell death in thymocytes. Acts also as a regulator for melanocytes dendricity, through the modulation of Rho family GTPases.

Bos taurus (taxid: 9913)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 2

EC: .

EC: 2

>sp|Q9DGE0|MP2K6_DANRE Dual specificity mitogen-activated protein kinase kinase 6 OS=Danio rerio GN=map2k6 PE=1 SV=2

 Score =  182 bits (461), Expect = 1e-45,   Method: Compositional matrix adjust.
 Identities = 89/185 (48%), Positives = 122/185 (65%), Gaps = 36/185 (19%)

Query: 23  SEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNEC 82
           ++DL+ +GE+GRG +G V+KM H  S  +MAVKRIR+TV+ ++Q++LLMDLD+ M++ +C
Sbjct: 77  ADDLEQIGELGRGAYGVVDKMRHVPSGVIMAVKRIRATVNTQEQKRLLMDLDISMRTVDC 136

Query: 83  PYIVQFYGALFKE-----------------------------------VTVATVKALNYL 107
            Y V FYGALF+E                                   +TV+ VKAL +L
Sbjct: 137 FYTVTFYGALFREGDVWICMELMDTSLDKFYKQVHEKGKTIPEDILGKITVSIVKALEHL 196

Query: 108 KEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDP-L 166
              L +IHRDVKPSN+L++ +G +K+CDFGISG LVDS+AKT DAGC+PYMAPERI+P  
Sbjct: 197 HSNLSVIHRDVKPSNVLINMQGQVKMCDFGISGYLVDSVAKTMDAGCKPYMAPERINPET 256

Query: 167 RARGY 171
             +GY
Sbjct: 257 NQKGY 261

Dual specificity protein kinase which acts as an essential component of the MAP kinase signal transduction pathway. Catalyzes the concomitant phosphorylation of a threonine and a tyrosine residue in the MAP kinases p38 and plays an important role in the regulation of cellular responses to cytokines and all kinds of stresses. The p38 MAP kinase signal transduction pathway leads to direct activation of transcription factors. Phosphorylation by MAP2K6 asymmetrically activates p38 on one side of the blastodisc, an event which is necessary for blastomere cleavage.

Danio rerio (taxid: 7955)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 2

EC: .

EC: 2

>sp|P70236|MP2K6_MOUSE Dual specificity mitogen-activated protein kinase kinase 6 OS=Mus musculus GN=Map2k6 PE=1 SV=1

 Score =  182 bits (461), Expect = 1e-45,   Method: Compositional matrix adjust.
 Identities = 89/189 (47%), Positives = 123/189 (65%), Gaps = 36/189 (19%)

Query: 19  YDFTSEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMK 78
           ++  ++DL+ + E+GRG +G V KM H  S  +MAVKRIR+TV+ ++Q++LLMDLDV M+
Sbjct: 46  FEVKADDLEPIVELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDVSMR 105

Query: 79  SNECPYIVQFYGALFKE-----------------------------------VTVATVKA 103
           + +CP+ V FYGALF+E                                   + V+ VKA
Sbjct: 106 TVDCPFTVTFYGALFREGDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKA 165

Query: 104 LNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERI 163
           L +L  +L +IHRDVKPSN+L++  G +K+CDFGISG LVDS+AKT DAGC+PYMAPERI
Sbjct: 166 LEHLHSKLSVIHRDVKPSNVLINTLGQVKMCDFGISGYLVDSVAKTIDAGCKPYMAPERI 225

Query: 164 DP-LRARGY 171
           +P L  +GY
Sbjct: 226 NPELNQKGY 234

Dual specificity protein kinase which acts as an essential component of the MAP kinase signal transduction pathway. With MAP3K3/MKK3, catalyzes the concomitant phosphorylation of a threonine and a tyrosine residue in the MAP kinases p38 MAPK11, MAPK12, MAPK13 and MAPK14 and plays an important role in the regulation of cellular responses to cytokines and all kinds of stresses. Especially, MAP2K3/MKK3 and MAP2K6/MKK6 are both essential for the activation of MAPK11 and MAPK13 induced by environmental stress, whereas MAP2K6/MKK6 is the major MAPK11 activator in response to TNF. MAP2K6/MKK6 also phosphorylates and activates PAK6. The p38 MAP kinase signal transduction pathway leads to direct activation of transcription factors. Nuclear targets of p38 MAP kinase include the transcription factors ATF2 and ELK1. Within the p38 MAPK signal transduction pathway, MAP3K6/MKK6 mediates phosphorylation of STAT4 through MAPK14 activation, and is therefore required for STAT4 activation and STAT4-regulated gene expression in response to IL-12 stimulation. The pathway is also crucial for IL-6-induced SOCS3 expression and down-regulation of IL-6-mediated gene induction; and for IFNG-dependent gene transcription. Has a role in osteoclast differentiation through NF-kappa-B transactivation by TNFSF11, and in endochondral ossification and since SOX9 is another likely downstream target of the p38 MAPK pathway. MAP2K6/MKK6 mediates apoptotic cell death in thymocytes. Acts also as a regulator for melanocytes dendricity, through the modulation of Rho family GTPases.

Mus musculus (taxid: 10090)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 2

EC: .

EC: 2

>sp|P52564|MP2K6_HUMAN Dual specificity mitogen-activated protein kinase kinase 6 OS=Homo sapiens GN=MAP2K6 PE=1 SV=1

 Score =  181 bits (460), Expect = 2e-45,   Method: Compositional matrix adjust.
 Identities = 88/189 (46%), Positives = 123/189 (65%), Gaps = 36/189 (19%)

Query: 19  YDFTSEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMK 78
           ++  ++DL+ + E+GRG +G V KM H  S  +MAVKRIR+TV+ ++Q++LLMDLD+ M+
Sbjct: 46  FEVKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMR 105

Query: 79  SNECPYIVQFYGALFKE-----------------------------------VTVATVKA 103
           + +CP+ V FYGALF+E                                   + V+ VKA
Sbjct: 106 TVDCPFTVTFYGALFREGDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKA 165

Query: 104 LNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERI 163
           L +L  +L +IHRDVKPSN+L++  G +K+CDFGISG LVDS+AKT DAGC+PYMAPERI
Sbjct: 166 LEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDSVAKTIDAGCKPYMAPERI 225

Query: 164 DP-LRARGY 171
           +P L  +GY
Sbjct: 226 NPELNQKGY 234

Dual specificity protein kinase which acts as an essential component of the MAP kinase signal transduction pathway. With MAP3K3/MKK3, catalyzes the concomitant phosphorylation of a threonine and a tyrosine residue in the MAP kinases p38 MAPK11, MAPK12, MAPK13 and MAPK14 and plays an important role in the regulation of cellular responses to cytokines and all kinds of stresses. Especially, MAP2K3/MKK3 and MAP2K6/MKK6 are both essential for the activation of MAPK11 and MAPK13 induced by environmental stress, whereas MAP2K6/MKK6 is the major MAPK11 activator in response to TNF. MAP2K6/MKK6 also phosphorylates and activates PAK6. The p38 MAP kinase signal transduction pathway leads to direct activation of transcription factors. Nuclear targets of p38 MAP kinase include the transcription factors ATF2 and ELK1. Within the p38 MAPK signal transduction pathway, MAP3K6/MKK6 mediates phosphorylation of STAT4 through MAPK14 activation, and is therefore required for STAT4 activation and STAT4-regulated gene expression in response to IL-12 stimulation. The pathway is also crucial for IL-6-induced SOCS3 expression and down-regulation of IL-6-mediated gene induction; and for IFNG-dependent gene transcription. Has a role in osteoclast differentiation through NF-kappa-B transactivation by TNFSF11, and in endochondral ossification and since SOX9 is another likely downstream target of the p38 MAPK pathway. MAP2K6/MKK6 mediates apoptotic cell death in thymocytes. Acts also as a regulator for melanocytes dendricity, through the modulation of Rho family GTPases.

Homo sapiens (taxid: 9606)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 2

EC: .

EC: 2

>sp|P46734|MP2K3_HUMAN Dual specificity mitogen-activated protein kinase kinase 3 OS=Homo sapiens GN=MAP2K3 PE=1 SV=2

 Score =  181 bits (458), Expect = 3e-45,   Method: Compositional matrix adjust.
 Identities = 88/192 (45%), Positives = 124/192 (64%), Gaps = 36/192 (18%)

Query: 16  DTVYDFTSEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDV 75
           D  ++  ++DL  + E+GRG +G V K+ H  S T+MAVKRIR+TV+ ++Q++LLMDLD+
Sbjct: 54  DRNFEVEADDLVTISELGRGAYGVVEKVRHAQSGTIMAVKRIRATVNSQEQKRLLMDLDI 113

Query: 76  VMKSNECPYIVQFYGALFKE-----------------------------------VTVAT 100
            M++ +C Y V FYGALF+E                                   + V+ 
Sbjct: 114 NMRTVDCFYTVTFYGALFREGDVWICMELMDTSLDKFYRKVLDKNMTIPEDILGEIAVSI 173

Query: 101 VKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTRDAGCRPYMAP 160
           V+AL +L  +L +IHRDVKPSN+L+++ G +K+CDFGISG LVDS+AKT DAGC+PYMAP
Sbjct: 174 VRALEHLHSKLSVIHRDVKPSNVLINKEGHVKMCDFGISGYLVDSVAKTMDAGCKPYMAP 233

Query: 161 ERIDP-LRARGY 171
           ERI+P L  +GY
Sbjct: 234 ERINPELNQKGY 245

Dual specificity kinase. Is activated by cytokines and environmental stress in vivo. Catalyzes the concomitant phosphorylation of a threonine and a tyrosine residue in the MAP kinase p38.

Homo sapiens (taxid: 9606)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 2

EC: .

EC: 2

>sp|O09110|MP2K3_MOUSE Dual specificity mitogen-activated protein kinase kinase 3 OS=Mus musculus GN=Map2k3 PE=1 SV=2

 Score =  180 bits (457), Expect = 5e-45,   Method: Compositional matrix adjust.
 Identities = 88/192 (45%), Positives = 124/192 (64%), Gaps = 36/192 (18%)

Query: 16  DTVYDFTSEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDV 75
           D  ++  ++DL  + E+GRG +G V K+ H  S T+MAVKRIR+TV+ ++Q++LLMDLD+
Sbjct: 54  DRNFEVEADDLVTISELGRGAYGVVEKVRHAQSGTIMAVKRIRATVNTQEQKRLLMDLDI 113

Query: 76  VMKSNECPYIVQFYGALFKE-----------------------------------VTVAT 100
            M++ +C Y V FYGALF+E                                   + V+ 
Sbjct: 114 NMRTVDCFYTVTFYGALFREGDVWICMELMDTSLDKFYRKVLEKNMKIPEDILGEIAVSI 173

Query: 101 VKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTRDAGCRPYMAP 160
           V+AL +L  +L +IHRDVKPSN+L+++ G +K+CDFGISG LVDS+AKT DAGC+PYMAP
Sbjct: 174 VRALEHLHSKLSVIHRDVKPSNVLINKEGHVKMCDFGISGYLVDSVAKTMDAGCKPYMAP 233

Query: 161 ERIDP-LRARGY 171
           ERI+P L  +GY
Sbjct: 234 ERINPELNQKGY 245

Dual specificity kinase. Is activated by cytokines and environmental stress in vivo. Catalyzes the concomitant phosphorylation of a threonine and a tyrosine residue in the MAP kinase p38.

Mus musculus (taxid: 10090)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 2

EC: .

EC: 2

>sp|Q20347|MKK4_CAEEL MAP kinase kinase mkk-4 OS=Caenorhabditis elegans GN=mkk-4 PE=3 SV=3

 Score =  174 bits (442), Expect = 2e-43,   Method: Compositional matrix adjust.
 Identities = 96/195 (49%), Positives = 123/195 (63%), Gaps = 38/195 (19%)

Query: 7   SSGKLKLSPDT-VYDFTSEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIR-STVDEK 64
           S+G LK   D  +Y F+S +LQDLG IG G FGTV KM H+ +  ++AVKRIR + +  +
Sbjct: 46  STGTLKYPDDEHLYTFSSANLQDLGAIGNGNFGTVYKMRHKETGKLIAVKRIRCNNIGHR 105

Query: 65  DQRQLLMDLDVVMKSNECPYIVQFYGALFKE----------------------------- 95
           +Q +LL + D ++KS + P IV+FYGA+F E                             
Sbjct: 106 EQIRLLREHDTIVKSEKGPNIVKFYGAIFSEGDCWICMELMDISMDLLYKRVYMVKNSRL 165

Query: 96  -------VTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAK 148
                  +TV TV AL+YLK+ELKIIHRDVKPSNIL+D  GA+KLCDFGI GQL +S AK
Sbjct: 166 NENVVGHITVCTVDALDYLKKELKIIHRDVKPSNILVDGTGAVKLCDFGICGQLEESFAK 225

Query: 149 TRDAGCRPYMAPERI 163
           T DAGC+PY+APERI
Sbjct: 226 THDAGCQPYLAPERI 240

Activity is required in presynaptic neurons, in a dose-dependent manner, for normal presynaptic development and morphology.

Caenorhabditis elegans (taxid: 6239)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 2

EC: .

EC: 2

Close Homologs in the Non-Redundant Database Detected by BLAST

Original result of BLAST against Nonredundant Database

GI	Length	Definition	Q cover	H cover	Identity	E-value
Query	187
156554395	441	PREDICTED: dual specificity mitogen-acti	0.914	0.387	0.758	6e-83
328707315	424	PREDICTED: dual specificity mitogen-acti	0.909	0.400	0.742	2e-81
110763741	436	PREDICTED: dual specificity mitogen-acti	0.914	0.392	0.734	8e-81
307201888	436	Dual specificity mitogen-activated prote	0.914	0.392	0.739	9e-81
332030763	438	Dual specificity mitogen-activated prote	0.914	0.390	0.734	1e-80
380016274	436	PREDICTED: dual specificity mitogen-acti	0.914	0.392	0.734	2e-80
340722097	436	PREDICTED: dual specificity mitogen-acti	0.914	0.392	0.734	2e-80
322794514	330	hypothetical protein SINV_14274 [Solenop	0.914	0.518	0.739	3e-80
383862107	436	PREDICTED: dual specificity mitogen-acti	0.914	0.392	0.724	1e-79
307184441	445	Dual specificity mitogen-activated prote	0.914	0.384	0.734	2e-79

>gi|156554395|ref|XP_001603456.1| PREDICTED: dual specificity mitogen-activated protein kinase kinase 4-like [Nasonia vitripennis]

 Score =  311 bits (798), Expect = 6e-83,   Method: Compositional matrix adjust.
 Identities = 157/207 (75%), Positives = 167/207 (80%), Gaps = 36/207 (17%)

Query: 1   MCQSIQSSGKLKLSPDTVYDFTSEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRST 60
           MCQS+QSSGKL+LSPDTVYDFTSEDLQDLGEIGRGGFGTVNKMIHR S+TVMAVKRIRST
Sbjct: 117 MCQSMQSSGKLQLSPDTVYDFTSEDLQDLGEIGRGGFGTVNKMIHRISNTVMAVKRIRST 176

Query: 61  VDEKDQRQLLMDLDVVMKSNECPYIVQFYGALFKE------------------------- 95
           VDEK+Q+QLLMDL+VVMKSNECP IVQFYGALFKE                         
Sbjct: 177 VDEKEQKQLLMDLEVVMKSNECPCIVQFYGALFKEGDCWICMELMDTSLDKFYKFIYERL 236

Query: 96  -----------VTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVD 144
                      +TVATVKALNYLKE+L+IIHRDVKPSNILLDRRG IKLCDFGISGQLVD
Sbjct: 237 NERIPECILGKITVATVKALNYLKEKLRIIHRDVKPSNILLDRRGNIKLCDFGISGQLVD 296

Query: 145 SIAKTRDAGCRPYMAPERIDPLRARGY 171
           SIA+TRDAGCRPYMAPERIDP RARGY
Sbjct: 297 SIARTRDAGCRPYMAPERIDPQRARGY 323

Source: Nasonia vitripennis

Species: Nasonia vitripennis

Genus: Nasonia

Family: Pteromalidae

Order: Hymenoptera

Class: Insecta

Phylum: Arthropoda

Superkingdom: Eukaryota

>gi|328707315|ref|XP_001949896.2| PREDICTED: dual specificity mitogen-activated protein kinase kinase 2-like [Acyrthosiphon pisum]

 Score =  306 bits (784), Expect = 2e-81,   Method: Compositional matrix adjust.
 Identities = 153/206 (74%), Positives = 164/206 (79%), Gaps = 36/206 (17%)

Query: 1   MCQSIQSSGKLKLSPDTVYDFTSEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRST 60
           MCQ+IQS+GKL+LS + VYDFTS+DLQDLGEIGRGGFGTVNKM+HRSSDTVMAVKRIRST
Sbjct: 102 MCQTIQSTGKLQLSENKVYDFTSDDLQDLGEIGRGGFGTVNKMLHRSSDTVMAVKRIRST 161

Query: 61  VDEKDQRQLLMDLDVVMKSNECPYIVQFYGALFKE------------------------- 95
           VDE +Q+QLLMDLDVVMKSNECPYIVQFYGALFKE                         
Sbjct: 162 VDENEQKQLLMDLDVVMKSNECPYIVQFYGALFKEGDCWICMELMDTSLDKFYKYVYEKL 221

Query: 96  -----------VTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVD 144
                      +TVATVKALNYLKE+LKIIHRDVKPSNILLD RG IKLCDFGISGQLVD
Sbjct: 222 NQRIPENILGKITVATVKALNYLKEKLKIIHRDVKPSNILLDSRGNIKLCDFGISGQLVD 281

Query: 145 SIAKTRDAGCRPYMAPERIDPLRARG 170
           SIAKTRDAGCRPYMAPERIDP+R RG
Sbjct: 282 SIAKTRDAGCRPYMAPERIDPVRGRG 307

Source: Acyrthosiphon pisum

Species: Acyrthosiphon pisum

Genus: Acyrthosiphon

Family: Aphididae

Order: Hemiptera

Class: Insecta

Phylum: Arthropoda

Superkingdom: Eukaryota

>gi|110763741|ref|XP_394054.3| PREDICTED: dual specificity mitogen-activated protein kinase kinase 4 isoform 1 [Apis mellifera]

 Score =  304 bits (779), Expect = 8e-81,   Method: Compositional matrix adjust.
 Identities = 152/207 (73%), Positives = 165/207 (79%), Gaps = 36/207 (17%)

Query: 1   MCQSIQSSGKLKLSPDTVYDFTSEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRST 60
           MCQS+QS+GKL+LSP+ VYDFTSEDLQDLGEIGRGGFGTVNKMIHR SDTVMAVKRIRST
Sbjct: 112 MCQSMQSTGKLQLSPNAVYDFTSEDLQDLGEIGRGGFGTVNKMIHRISDTVMAVKRIRST 171

Query: 61  VDEKDQRQLLMDLDVVMKSNECPYIVQFYGALFKE------------------------- 95
           VDE++Q+QLLMDL+VVMKSNECP IVQFYGALFKE                         
Sbjct: 172 VDEREQKQLLMDLEVVMKSNECPCIVQFYGALFKEGDCWICMELMDTSLDIFYKFIHEVL 231

Query: 96  -----------VTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVD 144
                      +TVATVKALNYLKE+L+IIHRDVKPSNILLDR G IKLCDFGISGQLVD
Sbjct: 232 KERIPERILGKITVATVKALNYLKEKLRIIHRDVKPSNILLDRHGNIKLCDFGISGQLVD 291

Query: 145 SIAKTRDAGCRPYMAPERIDPLRARGY 171
           SIA+TRDAGCRPYMAPERIDP RA+GY
Sbjct: 292 SIARTRDAGCRPYMAPERIDPQRAKGY 318

Source: Apis mellifera

Species: Apis mellifera

Genus: Apis

Family: Apidae

Order: Hymenoptera

Class: Insecta

Phylum: Arthropoda

Superkingdom: Eukaryota

>gi|307201888|gb|EFN81517.1| Dual specificity mitogen-activated protein kinase kinase 4 [Harpegnathos saltator]

 Score =  304 bits (779), Expect = 9e-81,   Method: Compositional matrix adjust.
 Identities = 153/207 (73%), Positives = 165/207 (79%), Gaps = 36/207 (17%)

Query: 1   MCQSIQSSGKLKLSPDTVYDFTSEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRST 60
           MCQS+Q++GKL+LSPD VYDFTSEDLQDLGEIGRGGFGTVNKMIHR S+TVMAVKRIRST
Sbjct: 112 MCQSMQTTGKLQLSPDVVYDFTSEDLQDLGEIGRGGFGTVNKMIHRISNTVMAVKRIRST 171

Query: 61  VDEKDQRQLLMDLDVVMKSNECPYIVQFYGALFKE------------------------- 95
           VDE++Q+QLLMDL+VVMKSNECP IVQFYGALFKE                         
Sbjct: 172 VDEREQKQLLMDLEVVMKSNECPCIVQFYGALFKEGDCWICMELMDTSLDKFYKFIYERL 231

Query: 96  -----------VTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVD 144
                      +TVATVKALNYLKE+L IIHRDVKPSNILLDRRG IKLCDFGISGQLVD
Sbjct: 232 NERIPECILGKITVATVKALNYLKEKLMIIHRDVKPSNILLDRRGNIKLCDFGISGQLVD 291

Query: 145 SIAKTRDAGCRPYMAPERIDPLRARGY 171
           SIA+TRDAGCRPYMAPERIDP RARGY
Sbjct: 292 SIARTRDAGCRPYMAPERIDPQRARGY 318

Source: Harpegnathos saltator

Species: Harpegnathos saltator

Genus: Harpegnathos

Family: Formicidae

Order: Hymenoptera

Class: Insecta

Phylum: Arthropoda

Superkingdom: Eukaryota

>gi|332030763|gb|EGI70439.1| Dual specificity mitogen-activated protein kinase kinase 4 [Acromyrmex echinatior]

 Score =  304 bits (778), Expect = 1e-80,   Method: Compositional matrix adjust.
 Identities = 152/207 (73%), Positives = 165/207 (79%), Gaps = 36/207 (17%)

Query: 1   MCQSIQSSGKLKLSPDTVYDFTSEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRST 60
           MCQS+Q++GKL+LS D VYDFTSEDLQDLGEIGRGGFGTVNKMIHR S+TVMAVKRIRST
Sbjct: 114 MCQSMQTTGKLQLSSDVVYDFTSEDLQDLGEIGRGGFGTVNKMIHRISNTVMAVKRIRST 173

Query: 61  VDEKDQRQLLMDLDVVMKSNECPYIVQFYGALFKE------------------------- 95
           VDE++Q+QLLMDL+VVMKSNECP IVQFYGALFKE                         
Sbjct: 174 VDEREQKQLLMDLEVVMKSNECPCIVQFYGALFKEGDCWICMELMDTSLDKFYKFIYEKL 233

Query: 96  -----------VTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVD 144
                      +TVATVKALNYLKE+L+IIHRDVKPSNILLDRRG IKLCDFGISGQLVD
Sbjct: 234 NERIPECILGKITVATVKALNYLKEKLRIIHRDVKPSNILLDRRGNIKLCDFGISGQLVD 293

Query: 145 SIAKTRDAGCRPYMAPERIDPLRARGY 171
           SIA+TRDAGCRPYMAPERIDP RARGY
Sbjct: 294 SIARTRDAGCRPYMAPERIDPQRARGY 320

Source: Acromyrmex echinatior

Species: Acromyrmex echinatior

Genus: Acromyrmex

Family: Formicidae

Order: Hymenoptera

Class: Insecta

Phylum: Arthropoda

Superkingdom: Eukaryota

>gi|380016274|ref|XP_003692112.1| PREDICTED: dual specificity mitogen-activated protein kinase kinase 4-like [Apis florea]

 Score =  303 bits (777), Expect = 2e-80,   Method: Compositional matrix adjust.
 Identities = 152/207 (73%), Positives = 165/207 (79%), Gaps = 36/207 (17%)

Query: 1   MCQSIQSSGKLKLSPDTVYDFTSEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRST 60
           MCQS+QS+GKL+LSP+ VYDFTSEDLQDLGEIGRGGFGTVNKMIHR SDTVMAVKRIRST
Sbjct: 112 MCQSMQSTGKLQLSPNVVYDFTSEDLQDLGEIGRGGFGTVNKMIHRISDTVMAVKRIRST 171

Query: 61  VDEKDQRQLLMDLDVVMKSNECPYIVQFYGALFKE------------------------- 95
           VDE++Q+QLLMDL+VVMKSNECP IVQFYGALFKE                         
Sbjct: 172 VDEREQKQLLMDLEVVMKSNECPCIVQFYGALFKEGDCWICMELMDTSLDIFYKFIHEVL 231

Query: 96  -----------VTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVD 144
                      +TVATVKALNYLKE+L+IIHRDVKPSNILLDR G IKLCDFGISGQLVD
Sbjct: 232 KERIPERILGKITVATVKALNYLKEKLRIIHRDVKPSNILLDRHGNIKLCDFGISGQLVD 291

Query: 145 SIAKTRDAGCRPYMAPERIDPLRARGY 171
           SIA+TRDAGCRPYMAPERIDP RA+GY
Sbjct: 292 SIARTRDAGCRPYMAPERIDPQRAKGY 318

Source: Apis florea

Species: Apis florea

Genus: Apis

Family: Apidae

Order: Hymenoptera

Class: Insecta

Phylum: Arthropoda

Superkingdom: Eukaryota

>gi|340722097|ref|XP_003399446.1| PREDICTED: dual specificity mitogen-activated protein kinase kinase 4-like [Bombus terrestris] gi|350423787|ref|XP_003493591.1| PREDICTED: dual specificity mitogen-activated protein kinase kinase 4-like [Bombus impatiens]

 Score =  303 bits (775), Expect = 2e-80,   Method: Compositional matrix adjust.
 Identities = 152/207 (73%), Positives = 165/207 (79%), Gaps = 36/207 (17%)

Query: 1   MCQSIQSSGKLKLSPDTVYDFTSEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRST 60
           MCQS+QS+GKL+LSP+ VYDFTSEDLQDLGEIGRGGFGTVNKMIHR SDTVMAVKRIRST
Sbjct: 112 MCQSMQSTGKLQLSPNVVYDFTSEDLQDLGEIGRGGFGTVNKMIHRISDTVMAVKRIRST 171

Query: 61  VDEKDQRQLLMDLDVVMKSNECPYIVQFYGALFKE------------------------- 95
           VDE++Q+QLLMDL+VVMKSNECP IVQFYGALFKE                         
Sbjct: 172 VDEREQKQLLMDLEVVMKSNECPCIVQFYGALFKEGDCWICMELMDTSLDIFYKFIHEVL 231

Query: 96  -----------VTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVD 144
                      +TVATVKALNYLKE+L+IIHRDVKPSNILLDR G IKLCDFGISGQLVD
Sbjct: 232 KERIPERILGKITVATVKALNYLKEKLRIIHRDVKPSNILLDRHGNIKLCDFGISGQLVD 291

Query: 145 SIAKTRDAGCRPYMAPERIDPLRARGY 171
           SIA+TRDAGCRPYMAPERIDP RA+GY
Sbjct: 292 SIARTRDAGCRPYMAPERIDPQRAKGY 318

Source: Bombus terrestris

Species: Bombus terrestris

Genus: Bombus

Family: Apidae

Order: Hymenoptera

Class: Insecta

Phylum: Arthropoda

Superkingdom: Eukaryota

>gi|322794514|gb|EFZ17567.1| hypothetical protein SINV_14274 [Solenopsis invicta]

 Score =  302 bits (774), Expect = 3e-80,   Method: Compositional matrix adjust.
 Identities = 153/207 (73%), Positives = 165/207 (79%), Gaps = 36/207 (17%)

Query: 1   MCQSIQSSGKLKLSPDTVYDFTSEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRST 60
           MCQS+QS+GKL+LS D VYDFTSEDLQDLGEIGRGGFGTVNKMIHR S+TVMAVKRIRST
Sbjct: 6   MCQSMQSTGKLQLSTDVVYDFTSEDLQDLGEIGRGGFGTVNKMIHRLSNTVMAVKRIRST 65

Query: 61  VDEKDQRQLLMDLDVVMKSNECPYIVQFYGALFKE------------------------- 95
           VDE++Q+QLLMDL+VVMKSNECP IVQFYGALFKE                         
Sbjct: 66  VDEREQKQLLMDLEVVMKSNECPCIVQFYGALFKEGDCWICMELMDTSLDKFYKFIYERL 125

Query: 96  -----------VTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVD 144
                      +TVATVKALNYLKE+L+IIHRDVKPSNILLDRRG IKLCDFGISGQLVD
Sbjct: 126 NERIPECILGKITVATVKALNYLKEKLRIIHRDVKPSNILLDRRGNIKLCDFGISGQLVD 185

Query: 145 SIAKTRDAGCRPYMAPERIDPLRARGY 171
           SIA+TRDAGCRPYMAPERIDP RARGY
Sbjct: 186 SIARTRDAGCRPYMAPERIDPQRARGY 212

Source: Solenopsis invicta

Species: Solenopsis invicta

Genus: Solenopsis

Family: Formicidae

Order: Hymenoptera

Class: Insecta

Phylum: Arthropoda

Superkingdom: Eukaryota

>gi|383862107|ref|XP_003706525.1| PREDICTED: dual specificity mitogen-activated protein kinase kinase 2-like [Megachile rotundata]

 Score =  300 bits (769), Expect = 1e-79,   Method: Compositional matrix adjust.
 Identities = 150/207 (72%), Positives = 164/207 (79%), Gaps = 36/207 (17%)

Query: 1   MCQSIQSSGKLKLSPDTVYDFTSEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRST 60
           MCQS+QS+GKL+LSP+ +YDFTSEDL+DLGEIGRGGFGTVNKMIHR SDTVMAVKRIRST
Sbjct: 112 MCQSMQSTGKLQLSPNVIYDFTSEDLEDLGEIGRGGFGTVNKMIHRISDTVMAVKRIRST 171

Query: 61  VDEKDQRQLLMDLDVVMKSNECPYIVQFYGALFKE------------------------- 95
           VDE++Q+QLLMDL+VVMKSNECP IVQFYGALFKE                         
Sbjct: 172 VDEREQKQLLMDLEVVMKSNECPCIVQFYGALFKEGDCWICMELMDTSLDIFYKFIHEVL 231

Query: 96  -----------VTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVD 144
                      +TVATVKALNYLKE+L IIHRDVKPSNILLDR G IKLCDFGISGQLVD
Sbjct: 232 KERIPERILGKITVATVKALNYLKEKLTIIHRDVKPSNILLDRHGNIKLCDFGISGQLVD 291

Query: 145 SIAKTRDAGCRPYMAPERIDPLRARGY 171
           SIA+TRDAGCRPYMAPERIDP RA+GY
Sbjct: 292 SIARTRDAGCRPYMAPERIDPQRAKGY 318

Source: Megachile rotundata

Species: Megachile rotundata

Genus: Megachile

Family: Megachilidae

Order: Hymenoptera

Class: Insecta

Phylum: Arthropoda

Superkingdom: Eukaryota

>gi|307184441|gb|EFN70850.1| Dual specificity mitogen-activated protein kinase kinase 4 [Camponotus floridanus]

 Score =  300 bits (767), Expect = 2e-79,   Method: Compositional matrix adjust.
 Identities = 152/207 (73%), Positives = 164/207 (79%), Gaps = 36/207 (17%)

Query: 1   MCQSIQSSGKLKLSPDTVYDFTSEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRST 60
           MCQS+QS+GKL+LS D VYDFTSEDLQDLGEIGRGGFGTVNKMIHR S+TVMAVKRIRST
Sbjct: 121 MCQSMQSTGKLQLSSDMVYDFTSEDLQDLGEIGRGGFGTVNKMIHRISNTVMAVKRIRST 180

Query: 61  VDEKDQRQLLMDLDVVMKSNECPYIVQFYGALFKE------------------------- 95
           VDE++Q+QLLMDL+VVMKSNECP IVQFYGALFKE                         
Sbjct: 181 VDEREQKQLLMDLEVVMKSNECPCIVQFYGALFKEGDCWICMELMDTSLDKFYKFIYERL 240

Query: 96  -----------VTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVD 144
                      +TVATVKALNYLKE+L+IIHRDVKPSNILLDR G IKLCDFGISGQLVD
Sbjct: 241 NERIPECILGKITVATVKALNYLKEKLRIIHRDVKPSNILLDRGGNIKLCDFGISGQLVD 300

Query: 145 SIAKTRDAGCRPYMAPERIDPLRARGY 171
           SIA+TRDAGCRPYMAPERIDP RARGY
Sbjct: 301 SIARTRDAGCRPYMAPERIDPQRARGY 327

Source: Camponotus floridanus

Species: Camponotus floridanus

Genus: Camponotus

Family: Formicidae

Order: Hymenoptera

Class: Insecta

Phylum: Arthropoda

Superkingdom: Eukaryota

---

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST

Original result of BLAST against Gene Ontology (AMIGO)

ID	Length	Definition	Q cover	H cover	Identity	E-value
Query	187
UNIPROTKB|F1P3T1	366	MAP2K4 "Uncharacterized protei	0.491	0.251	0.75	8.7e-69
UNIPROTKB|A5PJP8	412	MAP2K4 "Uncharacterized protei	0.491	0.223	0.75	1.1e-68
UNIPROTKB|F1PBB6	377	MAP2K4 "Uncharacterized protei	0.491	0.244	0.75	1.1e-68
UNIPROTKB|P45985	399	MAP2K4 "Dual specificity mitog	0.491	0.230	0.75	1.1e-68
UNIPROTKB|F1SS51	376	MAP2K4 "Uncharacterized protei	0.491	0.244	0.75	1.1e-68
MGI|MGI:1346869	397	Map2k4 "mitogen-activated prot	0.491	0.231	0.75	1.1e-68
RGD|1307040	397	Map2k4 "mitogen activated prot	0.491	0.231	0.75	1.1e-68
ZFIN|ZDB-GENE-080721-13	417	map2k4b "mitogen-activated pro	0.491	0.220	0.739	7.7e-68
ZFIN|ZDB-GENE-060512-98	404	map2k4a "mitogen-activated pro	0.491	0.227	0.728	5.4e-67
FB|FBgn0024326	424	Mkk4 "MAP kinase kinase 4" [Dr	0.433	0.191	0.851	2.3e-64

UNIPROTKB|F1P3T1 MAP2K4 "Uncharacterized protein" [Gallus gallus (taxid:9031)]

 Score = 376 (137.4 bits), Expect = 8.7e-69, Sum P(2) = 8.7e-69
 Identities = 69/92 (75%), Positives = 86/92 (93%)

Query:     4 SIQSSGKLKLSPDTVYDFTSEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDE 63
             SI+SSGKLK+SP+  +DFT+EDL+DLGEIGRG +G+VNKM+H+ S  +MAVKRIRSTVDE
Sbjct:    47 SIESSGKLKISPEQHWDFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDE 106

Query:    64 KDQRQLLMDLDVVMKSNECPYIVQFYGALFKE 95
             K+Q+QLLMDLDVVM+S++CPYIVQFYGALF+E
Sbjct:   107 KEQKQLLMDLDVVMRSSDCPYIVQFYGALFRE 138

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0000165 "MAPK cascade" evidence=IEA

GO:0071260 "cellular response to mechanical stimulus" evidence=IEA

UNIPROTKB|A5PJP8 MAP2K4 "Uncharacterized protein" [Bos taurus (taxid:9913)]

 Score = 376 (137.4 bits), Expect = 1.1e-68, Sum P(2) = 1.1e-68
 Identities = 69/92 (75%), Positives = 86/92 (93%)

Query:     4 SIQSSGKLKLSPDTVYDFTSEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDE 63
             SI+SSGKLK+SP+  +DFT+EDL+DLGEIGRG +G+VNKM+H+ S  +MAVKRIRSTVDE
Sbjct:    93 SIESSGKLKISPEQHWDFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDE 152

Query:    64 KDQRQLLMDLDVVMKSNECPYIVQFYGALFKE 95
             K+Q+QLLMDLDVVM+S++CPYIVQFYGALF+E
Sbjct:   153 KEQKQLLMDLDVVMRSSDCPYIVQFYGALFRE 184

GO:0071260 "cellular response to mechanical stimulus" evidence=IEA

GO:0000165 "MAPK cascade" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

UNIPROTKB|F1PBB6 MAP2K4 "Uncharacterized protein" [Canis lupus familiaris (taxid:9615)]

 Score = 376 (137.4 bits), Expect = 1.1e-68, Sum P(2) = 1.1e-68
 Identities = 69/92 (75%), Positives = 86/92 (93%)

Query:     4 SIQSSGKLKLSPDTVYDFTSEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDE 63
             SI+SSGKLK+SP+  +DFT+EDL+DLGEIGRG +G+VNKM+H+ S  +MAVKRIRSTVDE
Sbjct:    58 SIESSGKLKISPEQHWDFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDE 117

Query:    64 KDQRQLLMDLDVVMKSNECPYIVQFYGALFKE 95
             K+Q+QLLMDLDVVM+S++CPYIVQFYGALF+E
Sbjct:   118 KEQKQLLMDLDVVMRSSDCPYIVQFYGALFRE 149

GO:0005524 "ATP binding" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

UNIPROTKB|P45985 MAP2K4 "Dual specificity mitogen-activated protein kinase kinase 4" [Homo sapiens (taxid:9606)]

 Score = 376 (137.4 bits), Expect = 1.1e-68, Sum P(2) = 1.1e-68
 Identities = 69/92 (75%), Positives = 86/92 (93%)

Query:     4 SIQSSGKLKLSPDTVYDFTSEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDE 63
             SI+SSGKLK+SP+  +DFT+EDL+DLGEIGRG +G+VNKM+H+ S  +MAVKRIRSTVDE
Sbjct:    80 SIESSGKLKISPEQHWDFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDE 139

Query:    64 KDQRQLLMDLDVVMKSNECPYIVQFYGALFKE 95
             K+Q+QLLMDLDVVM+S++CPYIVQFYGALF+E
Sbjct:   140 KEQKQLLMDLDVVMRSSDCPYIVQFYGALFRE 171

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0006915 "apoptotic process" evidence=IEA

GO:0005634 "nucleus" evidence=IEA

GO:0071260 "cellular response to mechanical stimulus" evidence=IEP

GO:0004672 "protein kinase activity" evidence=TAS

GO:0007165 "signal transduction" evidence=TAS

GO:0002224 "toll-like receptor signaling pathway" evidence=TAS

GO:0002755 "MyD88-dependent toll-like receptor signaling pathway" evidence=TAS

GO:0002756 "MyD88-independent toll-like receptor signaling pathway" evidence=TAS

GO:0005829 "cytosol" evidence=TAS

GO:0007254 "JNK cascade" evidence=TAS

GO:0008063 "Toll signaling pathway" evidence=TAS

GO:0034130 "toll-like receptor 1 signaling pathway" evidence=TAS

GO:0034134 "toll-like receptor 2 signaling pathway" evidence=TAS

GO:0034138 "toll-like receptor 3 signaling pathway" evidence=TAS

GO:0034142 "toll-like receptor 4 signaling pathway" evidence=TAS

GO:0035666 "TRIF-dependent toll-like receptor signaling pathway" evidence=TAS

GO:0045087 "innate immune response" evidence=TAS

GO:0051403 "stress-activated MAPK cascade" evidence=TAS

GO:0005515 "protein binding" evidence=IPI

UNIPROTKB|F1SS51 MAP2K4 "Uncharacterized protein" [Sus scrofa (taxid:9823)]

 Score = 376 (137.4 bits), Expect = 1.1e-68, Sum P(2) = 1.1e-68
 Identities = 69/92 (75%), Positives = 86/92 (93%)

Query:     4 SIQSSGKLKLSPDTVYDFTSEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDE 63
             SI+SSGKLK+SP+  +DFT+EDL+DLGEIGRG +G+VNKM+H+ S  +MAVKRIRSTVDE
Sbjct:    57 SIESSGKLKISPEQHWDFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDE 116

Query:    64 KDQRQLLMDLDVVMKSNECPYIVQFYGALFKE 95
             K+Q+QLLMDLDVVM+S++CPYIVQFYGALF+E
Sbjct:   117 KEQKQLLMDLDVVMRSSDCPYIVQFYGALFRE 148

GO:0071260 "cellular response to mechanical stimulus" evidence=IEA

GO:0000165 "MAPK cascade" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

MGI|MGI:1346869 Map2k4 "mitogen-activated protein kinase kinase 4" [Mus musculus (taxid:10090)]

 Score = 376 (137.4 bits), Expect = 1.1e-68, Sum P(2) = 1.1e-68
 Identities = 69/92 (75%), Positives = 86/92 (93%)

Query:     4 SIQSSGKLKLSPDTVYDFTSEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDE 63
             SI+SSGKLK+SP+  +DFT+EDL+DLGEIGRG +G+VNKM+H+ S  +MAVKRIRSTVDE
Sbjct:    78 SIESSGKLKISPEQHWDFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDE 137

Query:    64 KDQRQLLMDLDVVMKSNECPYIVQFYGALFKE 95
             K+Q+QLLMDLDVVM+S++CPYIVQFYGALF+E
Sbjct:   138 KEQKQLLMDLDVVMRSSDCPYIVQFYGALFRE 169

GO:0000165 "MAPK cascade" evidence=IPI

GO:0000166 "nucleotide binding" evidence=IEA

GO:0001934 "positive regulation of protein phosphorylation" evidence=ISO

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004708 "MAP kinase kinase activity" evidence=ISO

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005515 "protein binding" evidence=IPI

GO:0005524 "ATP binding" evidence=ISO

GO:0005634 "nucleus" evidence=ISO

GO:0005737 "cytoplasm" evidence=IEA

GO:0005829 "cytosol" evidence=ISO

GO:0006468 "protein phosphorylation" evidence=IEA;ISO

GO:0006915 "apoptotic process" evidence=IEA

GO:0006950 "response to stress" evidence=IEA

GO:0007254 "JNK cascade" evidence=ISO

GO:0007257 "activation of JUN kinase activity" evidence=ISO

GO:0008545 "JUN kinase kinase activity" evidence=ISO

GO:0016301 "kinase activity" evidence=IEA

GO:0016310 "phosphorylation" evidence=IEA

GO:0016740 "transferase activity" evidence=IEA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0031435 "mitogen-activated protein kinase kinase kinase binding" evidence=ISO

GO:0032839 "dendrite cytoplasm" evidence=ISO

GO:0033267 "axon part" evidence=ISO

GO:0043065 "positive regulation of apoptotic process" evidence=ISO

GO:0043204 "perikaryon" evidence=ISO

GO:0043525 "positive regulation of neuron apoptotic process" evidence=ISO

GO:0045740 "positive regulation of DNA replication" evidence=ISO

RGD|1307040 Map2k4 "mitogen activated protein kinase kinase 4" [Rattus norvegicus (taxid:10116)]

 Score = 376 (137.4 bits), Expect = 1.1e-68, Sum P(2) = 1.1e-68
 Identities = 69/92 (75%), Positives = 86/92 (93%)

Query:     4 SIQSSGKLKLSPDTVYDFTSEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDE 63
             SI+SSGKLK+SP+  +DFT+EDL+DLGEIGRG +G+VNKM+H+ S  +MAVKRIRSTVDE
Sbjct:    78 SIESSGKLKISPEQHWDFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDE 137

Query:    64 KDQRQLLMDLDVVMKSNECPYIVQFYGALFKE 95
             K+Q+QLLMDLDVVM+S++CPYIVQFYGALF+E
Sbjct:   138 KEQKQLLMDLDVVMRSSDCPYIVQFYGALFRE 169

GO:0000165 "MAPK cascade" evidence=ISO

GO:0001934 "positive regulation of protein phosphorylation" evidence=IDA

GO:0004708 "MAP kinase kinase activity" evidence=IDA

GO:0005515 "protein binding" evidence=IPI

GO:0005524 "ATP binding" evidence=IDA

GO:0005634 "nucleus" evidence=IDA

GO:0005829 "cytosol" evidence=IDA

GO:0006468 "protein phosphorylation" evidence=IDA

GO:0007254 "JNK cascade" evidence=IDA

GO:0007257 "activation of JUN kinase activity" evidence=IDA

GO:0008545 "JUN kinase kinase activity" evidence=IDA

GO:0031435 "mitogen-activated protein kinase kinase kinase binding" evidence=IPI

GO:0032839 "dendrite cytoplasm" evidence=IDA

GO:0033267 "axon part" evidence=IDA

GO:0043065 "positive regulation of apoptotic process" evidence=IMP

GO:0043204 "perikaryon" evidence=IDA

GO:0043525 "positive regulation of neuron apoptotic process" evidence=IMP

GO:0045740 "positive regulation of DNA replication" evidence=IMP

GO:0071260 "cellular response to mechanical stimulus" evidence=ISO

ZFIN|ZDB-GENE-080721-13 map2k4b "mitogen-activated protein kinase kinase 4b" [Danio rerio (taxid:7955)]

 Score = 367 (134.2 bits), Expect = 7.7e-68, Sum P(2) = 7.7e-68
 Identities = 68/92 (73%), Positives = 84/92 (91%)

Query:     4 SIQSSGKLKLSPDTVYDFTSEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDE 63
             SI+SSGKLK+SP+   DFT+EDL+DLGEIGRG +G+VN M+H+ S  +MAVKRIRSTVDE
Sbjct:    98 SIESSGKLKISPEQHCDFTAEDLKDLGEIGRGAYGSVNNMVHKPSGQIMAVKRIRSTVDE 157

Query:    64 KDQRQLLMDLDVVMKSNECPYIVQFYGALFKE 95
             K+Q+QLLMDLDVVM+S++CPYIVQFYGALF+E
Sbjct:   158 KEQKQLLMDLDVVMRSSDCPYIVQFYGALFRE 189

GO:0004672 "protein kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005575 "cellular_component" evidence=ND

GO:0060027 "convergent extension involved in gastrulation" evidence=IMP

GO:0016301 "kinase activity" evidence=IEA

GO:0016310 "phosphorylation" evidence=IEA

GO:0000166 "nucleotide binding" evidence=IEA

ZFIN|ZDB-GENE-060512-98 map2k4a "mitogen-activated protein kinase kinase 4a" [Danio rerio (taxid:7955)]

 Score = 357 (130.7 bits), Expect = 5.4e-67, Sum P(2) = 5.4e-67
 Identities = 67/92 (72%), Positives = 83/92 (90%)

Query:     4 SIQSSGKLKLSPDTVYDFTSEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDE 63
             SI+SSGKLK+S +   DFT+EDL+DLGEIGRG +G+VNKM H+ S  +MAVKRIRSTVDE
Sbjct:    85 SIESSGKLKISAEQHCDFTAEDLKDLGEIGRGAYGSVNKMAHKPSGQIMAVKRIRSTVDE 144

Query:    64 KDQRQLLMDLDVVMKSNECPYIVQFYGALFKE 95
             ++Q+QLLMDLDVVM+S++CPYIVQFYGALF+E
Sbjct:   145 REQKQLLMDLDVVMRSSDCPYIVQFYGALFRE 176

GO:0004672 "protein kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005575 "cellular_component" evidence=ND

GO:0048263 "determination of dorsal identity" evidence=IMP

GO:0016310 "phosphorylation" evidence=IEA

GO:0000166 "nucleotide binding" evidence=IEA

GO:0016301 "kinase activity" evidence=IEA

FB|FBgn0024326 Mkk4 "MAP kinase kinase 4" [Drosophila melanogaster (taxid:7227)]

 Score = 360 (131.8 bits), Expect = 2.3e-64, Sum P(2) = 2.3e-64
 Identities = 69/81 (85%), Positives = 75/81 (92%)

Query:    91 ALFKEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTR 150
             ++  ++TVATV ALNYLKEELKIIHRDVKPSNILL RRG IKLCDFGISGQLVDSIAKT+
Sbjct:   223 SILAKITVATVNALNYLKEELKIIHRDVKPSNILLHRRGDIKLCDFGISGQLVDSIAKTK 282

Query:   151 DAGCRPYMAPERIDPLRARGY 171
             DAGCRPYMAPERIDP RA+GY
Sbjct:   283 DAGCRPYMAPERIDPERAKGY 303

GO:0004708 "MAP kinase kinase activity" evidence=NAS;TAS

GO:0006468 "protein phosphorylation" evidence=IDA;NAS

GO:0008545 "JUN kinase kinase activity" evidence=NAS;IDA

GO:0007257 "activation of JUN kinase activity" evidence=IDA

GO:0004702 "receptor signaling protein serine/threonine kinase activity" evidence=NAS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0048812 "neuron projection morphogenesis" evidence=IMP

GO:0046330 "positive regulation of JNK cascade" evidence=IGI;IPI

GO:0048666 "neuron development" evidence=IMP

GO:0030424 "axon" evidence=IDA

GO:0048082 "regulation of adult chitin-containing cuticle pigmentation" evidence=IGI

---

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries

Original result of BLAST against SWISS-PROT

ID	Name	Annotated EC number	Identity	Query coverage	Hit coverage	RBH(Q2H)	RBH(H2Q)
P45985	MP2K4_HUMAN	2, ., 7, ., 1, 2, ., 2	0.6553	0.9037	0.4235	yes	N/A
P47809	MP2K4_MOUSE	2, ., 7, ., 1, 2, ., 2	0.6553	0.9037	0.4256	yes	N/A

EC Number Prediction by EFICAz Software

Prediction Level	EC number	Confidence of Prediction
3rd Layer	2.7.12	0.766
4th Layer	2.7.11.1	LOW CONFIDENCE prediction!
3rd Layer	2.7.11	LOW CONFIDENCE prediction!

---

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST

Original result of RPS-BLAST against CDD database

ID	Length	Definition	E-value
Query	187
cd06616	288	cd06616, PKc_MKK4, Catalytic domain of the dual-sp	1e-106
cd06617	283	cd06617, PKc_MKK3_6, Catalytic domain of the dual-	5e-78
cd06605	265	cd06605, PKc_MAPKK, Catalytic domain of the dual-s	3e-71
cd06618	296	cd06618, PKc_MKK7, Catalytic domain of the dual-sp	1e-69
cd06622	286	cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of	2e-49
cd06615	308	cd06615, PKc_MEK, Catalytic domain of the dual-spe	6e-44
cd06620	284	cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of	8e-42
cd06623	264	cd06623, PKc_MAPKK_plant_like, Catalytic domain of	2e-41
cd06619	279	cd06619, PKc_MKK5, Catalytic domain of the dual-sp	1e-37
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	4e-36
cd06621	287	cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of	2e-35
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	3e-35
cd06650	333	cd06650, PKc_MEK1, Catalytic domain of the dual-sp	4e-35
cd06649	331	cd06649, PKc_MEK2, Catalytic domain of the dual-sp	3e-34
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	1e-30
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	2e-29
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	8e-26
cd06613	262	cd06613, STKc_MAP4K3_like, Catalytic domain of Mit	8e-26
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	2e-24
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	3e-24
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	1e-23
cd06627	254	cd06627, STKc_Cdc7_like, Catalytic domain of Cell	3e-22
cd05578	258	cd05578, STKc_Yank1, Catalytic domain of the Prote	1e-21
cd08215	258	cd08215, STKc_Nek, Catalytic domain of the Protein	3e-21
cd06608	275	cd06608, STKc_myosinIII_like, Catalytic domain of	2e-19
cd06614	286	cd06614, STKc_PAK, Catalytic domain of the Protein	9e-19
cd06626	264	cd06626, STKc_MEKK4, Catalytic domain of the Prote	1e-18
cd06648	285	cd06648, STKc_PAK_II, Catalytic domain of the Prot	1e-18
cd06642	277	cd06642, STKc_STK25-YSK1, Catalytic domain of the	1e-17
cd06611	280	cd06611, STKc_SLK_like, Catalytic domain of Ste20-	1e-17
cd06641	277	cd06641, STKc_MST3, Catalytic domain of the Protei	1e-17
cd06640	277	cd06640, STKc_MST4, Catalytic domain of the Protei	2e-17
cd05579	265	cd05579, STKc_MAST_like, Catalytic domain of Micro	5e-17
cd06628	267	cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o	7e-17
cd05572	262	cd05572, STKc_cGK_PKG, Catalytic domain of the Pro	9e-17
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	1e-16
cd06917	277	cd06917, STKc_NAK1_like, Catalytic domain of Funga	1e-16
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	2e-16
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	3e-16
cd06632	258	cd06632, STKc_MEKK1_plant, Catalytic domain of the	5e-16
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	5e-16
cd05573	350	cd05573, STKc_ROCK_NDR_like, Catalytic domain of R	9e-16
cd06644	292	cd06644, STKc_STK10_LOK, Catalytic domain of the P	3e-15
cd06610	267	cd06610, STKc_OSR1_SPAK, Catalytic domain of the P	4e-15
pfam07714	258	pfam07714, Pkinase_Tyr, Protein tyrosine kinase	4e-15
cd08217	265	cd08217, STKc_Nek2, Catalytic domain of the Protei	5e-15
cd05582	318	cd05582, STKc_RSK_N, N-terminal catalytic domain o	5e-15
cd05599	364	cd05599, STKc_NDR_like, Catalytic domain of Nuclea	6e-15
cd05600	333	cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun	8e-15
cd00192	262	cd00192, PTKc, Catalytic domain of Protein Tyrosin	9e-15
cd06643	282	cd06643, STKc_SLK, Catalytic domain of the Protein	1e-14
PLN00034	353	PLN00034, PLN00034, mitogen-activated protein kina	1e-14
cd07833	288	cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep	3e-14
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	9e-14
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	1e-13
cd05612	291	cd05612, STKc_PRKX_like, Catalytic domain of PRKX-	2e-13
cd05611	260	cd05611, STKc_Rim15_like, Catalytic domain of fung	2e-13
cd05580	290	cd05580, STKc_PKA, Catalytic domain of the Protein	6e-13
cd06645	267	cd06645, STKc_MAP4K3, Catalytic domain of the Prot	7e-13
cd05581	280	cd05581, STKc_PDK1, Catalytic domain of the Protei	1e-12
cd06629	272	cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o	1e-12
cd05602	325	cd05602, STKc_SGK1, Catalytic domain of the Protei	3e-12
cd07847	286	cd07847, STKc_CDKL1_4, Catalytic domain of the Ser	5e-12
cd05596	370	cd05596, STKc_ROCK, Catalytic domain of the Protei	6e-12
cd05575	323	cd05575, STKc_SGK, Catalytic domain of the Protein	9e-12
cd08224	267	cd08224, STKc_Nek6_Nek7, Catalytic domain of the P	1e-11
cd06647	293	cd06647, STKc_PAK_I, Catalytic domain of the Prote	1e-11
cd05586	330	cd05586, STKc_Sck1_like, Catalytic domain of Suppr	1e-11
cd05585	312	cd05585, STKc_YPK1_like, Catalytic domain of Yeast	2e-11
cd05603	321	cd05603, STKc_SGK2, Catalytic domain of the Protei	2e-11
cd05621	370	cd05621, STKc_ROCK2, Catalytic domain of the Prote	3e-11
cd06639	291	cd06639, STKc_myosinIIIB, Catalytic domain of the	3e-11
cd07838	287	cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc	4e-11
cd07846	286	cd07846, STKc_CDKL2_3, Catalytic domain of the Ser	4e-11
cd08220	256	cd08220, STKc_Nek8, Catalytic domain of the Protei	4e-11
cd05604	325	cd05604, STKc_SGK3, Catalytic domain of the Protei	5e-11
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	5e-11
cd06658	292	cd06658, STKc_PAK5, Catalytic domain of the Protei	6e-11
cd05629	377	cd05629, STKc_NDR_like_fungal, Catalytic domain of	7e-11
cd07861	285	cd07861, STKc_CDK1_euk, Catalytic domain of the Se	9e-11
cd08221	256	cd08221, STKc_Nek9, Catalytic domain of the Protei	1e-10
PTZ00263	329	PTZ00263, PTZ00263, protein kinase A catalytic sub	1e-10
cd06657	292	cd06657, STKc_PAK4, Catalytic domain of the Protei	1e-10
cd06656	297	cd06656, STKc_PAK3, Catalytic domain of the Protei	1e-10
cd06638	286	cd06638, STKc_myosinIIIA, Catalytic domain of the	2e-10
cd06654	296	cd06654, STKc_PAK1, Catalytic domain of the Protei	2e-10
cd05601	330	cd05601, STKc_CRIK, Catalytic domain of the Protei	2e-10
cd06637	272	cd06637, STKc_TNIK, Catalytic domain of the Protei	3e-10
cd07866	311	cd07866, STKc_BUR1, Catalytic domain of the Serine	3e-10
cd06630	268	cd06630, STKc_MEKK1, Catalytic domain of the Prote	3e-10
cd07830	283	cd07830, STKc_MAK_like, Catalytic domain of Male g	3e-10
cd07835	283	cd07835, STKc_CDK1_like, Catalytic domain of Cycli	4e-10
cd05628	363	cd05628, STKc_NDR1, Catalytic domain of the Protei	4e-10
cd06625	263	cd06625, STKc_MEKK3_like, Catalytic domain of MAP/	5e-10
cd07860	284	cd07860, STKc_CDK2_3, Catalytic domain of the Seri	6e-10
cd05060	257	cd05060, PTKc_Syk_like, Catalytic domain of Spleen	7e-10
cd06636	282	cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr	8e-10
cd07843	293	cd07843, STKc_CDC2L1, Catalytic domain of the Seri	1e-09
cd05622	371	cd05622, STKc_ROCK1, Catalytic domain of the Prote	1e-09
cd06659	297	cd06659, STKc_PAK6, Catalytic domain of the Protei	1e-09
cd06607	307	cd06607, STKc_TAO, Catalytic domain of the Protein	1e-09
cd07845	309	cd07845, STKc_CDK10, Catalytic domain of the Serin	1e-09
cd05570	318	cd05570, STKc_PKC, Catalytic domain of the Protein	1e-09
cd05597	331	cd05597, STKc_DMPK_like, Catalytic domain of Myoto	2e-09
cd05607	277	cd05607, STKc_GRK7, Catalytic domain of the Protei	2e-09
cd05627	360	cd05627, STKc_NDR2, Catalytic domain of the Protei	2e-09
cd06646	267	cd06646, STKc_MAP4K5, Catalytic domain of the Prot	2e-09
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	4e-09
cd08529	256	cd08529, STKc_FA2-like, Catalytic domain of the Pr	4e-09
cd05583	288	cd05583, STKc_MSK_N, N-terminal catalytic domain o	4e-09
cd06655	296	cd06655, STKc_PAK2, Catalytic domain of the Protei	4e-09
cd07852	337	cd07852, STKc_MAPK15, Catalytic domain of the Seri	4e-09
cd07839	284	cd07839, STKc_CDK5, Catalytic domain of the Serine	6e-09
cd05115	257	cd05115, PTKc_Zap-70, Catalytic domain of the Prot	7e-09
cd05623	332	cd05623, STKc_MRCK_alpha, Catalytic domain of the	9e-09
cd07865	310	cd07865, STKc_CDK9, Catalytic domain of the Serine	1e-08
cd08528	269	cd08528, STKc_Nek10, Catalytic domain of the Prote	1e-08
cd05609	305	cd05609, STKc_MAST, Catalytic domain of the Protei	2e-08
cd07848	287	cd07848, STKc_CDKL5, Catalytic domain of the Serin	2e-08
cd05608	280	cd05608, STKc_GRK1, Catalytic domain of the Protei	2e-08
cd05584	323	cd05584, STKc_p70S6K, Catalytic domain of the Prot	2e-08
cd05057	279	cd05057, PTKc_EGFR_like, Catalytic domain of Epide	2e-08
cd08530	256	cd08530, STKc_CNK2-like, Catalytic domain of the P	3e-08
cd05056	270	cd05056, PTKc_FAK, Catalytic domain of the Protein	4e-08
cd05571	323	cd05571, STKc_PKB, Catalytic domain of the Protein	4e-08
cd05594	325	cd05594, STKc_PKB_alpha, Catalytic domain of the P	6e-08
cd06635	317	cd06635, STKc_TAO1, Catalytic domain of the Protei	7e-08
cd07849	336	cd07849, STKc_ERK1_2_like, Catalytic domain of Ext	7e-08
cd05577	277	cd05577, STKc_GRK, Catalytic domain of the Protein	8e-08
cd07834	330	cd07834, STKc_MAPK, Catalytic domain of the Serine	9e-08
cd05113	256	cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro	1e-07
cd06633	313	cd06633, STKc_TAO3, Catalytic domain of the Protei	1e-07
cd06624	268	cd06624, STKc_ASK, Catalytic domain of the Protein	1e-07
cd08218	256	cd08218, STKc_Nek1, Catalytic domain of the Protei	1e-07
cd08229	267	cd08229, STKc_Nek7, Catalytic domain of the Protei	2e-07
cd08219	255	cd08219, STKc_Nek3, Catalytic domain of the Protei	2e-07
cd05610	669	cd05610, STKc_MASTL, Catalytic domain of the Prote	3e-07
cd07857	332	cd07857, STKc_MPK1, Catalytic domain of the Serine	4e-07
cd05624	331	cd05624, STKc_MRCK_beta, Catalytic domain of the P	4e-07
cd05631	285	cd05631, STKc_GRK4, Catalytic domain of the Protei	4e-07
PLN00009	294	PLN00009, PLN00009, cyclin-dependent kinase A; Pro	5e-07
cd05605	285	cd05605, STKc_GRK4_like, Catalytic domain of G pro	5e-07
cd05598	376	cd05598, STKc_LATS, Catalytic domain of the Protei	6e-07
cd07836	284	cd07836, STKc_Pho85, Catalytic domain of the Serin	6e-07
cd07873	301	cd07873, STKc_PCTAIRE1, Catalytic domain of the Se	6e-07
cd05109	279	cd05109, PTKc_HER2, Catalytic domain of the Protei	8e-07
cd07831	282	cd07831, STKc_MOK, Catalytic domain of the Serine/	1e-06
cd05108	316	cd05108, PTKc_EGFR, Catalytic domain of the Protei	1e-06
cd05116	257	cd05116, PTKc_Syk, Catalytic domain of the Protein	1e-06
cd05574	316	cd05574, STKc_phototropin_like, Catalytic domain o	1e-06
cd06634	308	cd06634, STKc_TAO2, Catalytic domain of the Protei	1e-06
cd05032	277	cd05032, PTKc_InsR_like, Catalytic domain of Insul	1e-06
cd05593	328	cd05593, STKc_PKB_gamma, Catalytic domain of the P	1e-06
PTZ00426	340	PTZ00426, PTZ00426, cAMP-dependent protein kinase	1e-06
cd06651	266	cd06651, STKc_MEKK3, Catalytic domain of the Prote	2e-06
cd05595	323	cd05595, STKc_PKB_beta, Catalytic domain of the Pr	2e-06
cd05614	332	cd05614, STKc_MSK2_N, N-terminal catalytic domain	2e-06
cd05590	320	cd05590, STKc_nPKC_eta, Catalytic domain of the Pr	3e-06
cd05613	290	cd05613, STKc_MSK1_N, N-terminal catalytic domain	3e-06
cd07871	288	cd07871, STKc_PCTAIRE3, Catalytic domain of the Se	3e-06
cd05084	252	cd05084, PTKc_Fes, Catalytic domain of the Protein	3e-06
cd05059	256	cd05059, PTKc_Tec_like, Catalytic domain of Tec-li	3e-06
cd07864	302	cd07864, STKc_CDK12, Catalytic domain of the Serin	4e-06
cd05625	382	cd05625, STKc_LATS1, Catalytic domain of the Prote	4e-06
cd05592	316	cd05592, STKc_nPKC_theta_delta, Catalytic domain o	4e-06
cd07844	291	cd07844, STKc_PCTAIRE_like, Catalytic domain of PC	4e-06
cd07856	328	cd07856, STKc_Sty1_Hog1, Catalytic domain of the S	5e-06
cd05616	323	cd05616, STKc_cPKC_beta, Catalytic domain of the P	5e-06
cd08225	257	cd08225, STKc_Nek5, Catalytic domain of the Protei	5e-06
cd05589	324	cd05589, STKc_PKN, Catalytic domain of the Protein	6e-06
cd06653	264	cd06653, STKc_MEKK3_like_1, Catalytic domain of MA	6e-06
cd07872	309	cd07872, STKc_PCTAIRE2, Catalytic domain of the Se	6e-06
cd06652	265	cd06652, STKc_MEKK2, Catalytic domain of the Prote	7e-06
cd05039	256	cd05039, PTKc_Csk_like, Catalytic domain of C-term	7e-06
cd05040	257	cd05040, PTKc_Ack_like, Catalytic domain of the Pr	7e-06
cd05587	324	cd05587, STKc_cPKC, Catalytic domain of the Protei	7e-06
cd05591	321	cd05591, STKc_nPKC_epsilon, Catalytic domain of th	9e-06
PTZ00267	478	PTZ00267, PTZ00267, NIMA-related protein kinase; P	1e-05
cd07850	353	cd07850, STKc_JNK, Catalytic domain of the Serine/	1e-05
PTZ00036	440	PTZ00036, PTZ00036, glycogen synthase kinase; Prov	1e-05
PHA03207	392	PHA03207, PHA03207, serine/threonine kinase US3; P	1e-05
cd05630	285	cd05630, STKc_GRK6, Catalytic domain of the Protei	1e-05
cd08222	260	cd08222, STKc_Nek11, Catalytic domain of the Prote	1e-05
cd06631	265	cd06631, STKc_YSK4, Catalytic domain of the Protei	1e-05
cd07855	334	cd07855, STKc_ERK5, Catalytic domain of the Serine	1e-05
cd05588	329	cd05588, STKc_aPKC, Catalytic domain of the Protei	2e-05
cd07853	372	cd07853, STKc_NLK, Catalytic domain of the Serine/	2e-05
cd07837	295	cd07837, STKc_CdkB_plant, Catalytic domain of the	2e-05
cd05615	323	cd05615, STKc_cPKC_alpha, Catalytic domain of the	2e-05
cd05112	256	cd05112, PTKc_Itk, Catalytic domain of the Protein	2e-05
cd05576	237	cd05576, STKc_RPK118_like, Catalytic domain of the	2e-05
cd08228	267	cd08228, STKc_Nek6, Catalytic domain of the Protei	2e-05
cd05618	329	cd05618, STKc_aPKC_iota, Catalytic domain of the P	2e-05
PHA03390	267	PHA03390, pk1, serine/threonine-protein kinase 1;	2e-05
cd07870	291	cd07870, STKc_PFTAIRE2, Catalytic domain of the Se	3e-05
cd05632	285	cd05632, STKc_GRK5, Catalytic domain of the Protei	3e-05
cd07863	288	cd07863, STKc_CDK4, Catalytic domain of the Serine	3e-05
cd05054	337	cd05054, PTKc_VEGFR, Catalytic domain of the Prote	3e-05
cd07842	316	cd07842, STKc_CDK8_like, Catalytic domain of Cycli	3e-05
cd05619	316	cd05619, STKc_nPKC_theta, Catalytic domain of the	4e-05
cd08223	257	cd08223, STKc_Nek4, Catalytic domain of the Protei	4e-05
cd05626	381	cd05626, STKc_LATS2, Catalytic domain of the Prote	4e-05
cd05102	338	cd05102, PTKc_VEGFR3, Catalytic domain of the Prot	4e-05
cd07869	303	cd07869, STKc_PFTAIRE1, Catalytic domain of the Se	4e-05
cd05041	251	cd05041, PTKc_Fes_like, Catalytic domain of Fes-li	5e-05
cd07858	337	cd07858, STKc_TEY_MAPK_plant, Catalytic domain of	5e-05
cd07862	290	cd07862, STKc_CDK6, Catalytic domain of the Serine	5e-05
cd08216	314	cd08216, PK_STRAD, Pseudokinase domain of STE20-re	5e-05
cd07851	343	cd07851, STKc_p38, Catalytic domain of the Serine/	6e-05
cd05103	343	cd05103, PTKc_VEGFR2, Catalytic domain of the Prot	6e-05
cd05633	279	cd05633, STKc_GRK3, Catalytic domain of the Protei	7e-05
cd05617	327	cd05617, STKc_aPKC_zeta, Catalytic domain of the P	8e-05
cd05053	293	cd05053, PTKc_FGFR, Catalytic domain of the Protei	8e-05
cd07875	364	cd07875, STKc_JNK1, Catalytic domain of the Serine	8e-05
PTZ00283	496	PTZ00283, PTZ00283, serine/threonine protein kinas	8e-05
TIGR03903	1266	TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas	8e-05
cd05620	316	cd05620, STKc_nPKC_delta, Catalytic domain of the	1e-04
cd05606	278	cd05606, STKc_beta_ARK, Catalytic domain of the Pr	1e-04
cd05114	256	cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro	1e-04
cd05055	302	cd05055, PTKc_PDGFR, Catalytic domain of the Prote	1e-04
cd07876	359	cd07876, STKc_JNK2, Catalytic domain of the Serine	1e-04
cd07874	355	cd07874, STKc_JNK3, Catalytic domain of the Serine	2e-04
cd05034	261	cd05034, PTKc_Src_like, Catalytic domain of Src ki	2e-04
cd05110	303	cd05110, PTKc_HER4, Catalytic domain of the Protei	2e-04
cd07859	338	cd07859, STKc_TDY_MAPK_plant, Catalytic domain of	3e-04
cd05038	284	cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai	4e-04
cd05036	277	cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro	4e-04
cd07878	343	cd07878, STKc_p38beta_MAPK11, Catalytic domain of	4e-04
cd07877	345	cd07877, STKc_p38alpha_MAPK14, Catalytic domain of	5e-04
cd05089	297	cd05089, PTKc_Tie1, Catalytic domain of the Protei	5e-04
PTZ00024	335	PTZ00024, PTZ00024, cyclin-dependent protein kinas	6e-04
cd05148	261	cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro	6e-04
PHA03212	391	PHA03212, PHA03212, serine/threonine kinase US3; P	7e-04
cd05082	256	cd05082, PTKc_Csk, Catalytic domain of the Protein	7e-04
cd05111	279	cd05111, PTK_HER3, Pseudokinase domain of the Prot	0.001
PHA03209	357	PHA03209, PHA03209, serine/threonine kinase US3; P	0.002
cd05088	303	cd05088, PTKc_Tie2, Catalytic domain of the Protei	0.002
cd05037	259	cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom	0.002
cd05045	290	cd05045, PTKc_RET, Catalytic domain of the Protein	0.002
cd07880	343	cd07880, STKc_p38gamma_MAPK12, Catalytic domain of	0.003
cd05047	270	cd05047, PTKc_Tie, Catalytic domain of Tie Protein	0.004
cd05068	261	cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re	0.004
cd05067	260	cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro	0.004

>gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

 Score =  305 bits (782), Expect = e-106
 Identities = 127/187 (67%), Positives = 141/187 (75%), Gaps = 36/187 (19%)

Query: 21  FTSEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSN 80
           FT+EDL+DLGEIGRG FGTVNKM+H+ S T+MAVKRIRSTVDEK+Q++LLMDLDVVM+S+
Sbjct: 1   FTAEDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSS 60

Query: 81  ECPYIVQFYGALFKE------------------------------------VTVATVKAL 104
           +CPYIV+FYGALF+E                                    + VATVKAL
Sbjct: 61  DCPYIVKFYGALFREGDCWICMELMDISLDKFYKYVYEVLKSVIPEEILGKIAVATVKAL 120

Query: 105 NYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERID 164
           NYLKEELKIIHRDVKPSNILLDR G IKLCDFGISGQLVDSIAKTRDAGCRPYMAPERID
Sbjct: 121 NYLKEELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERID 180

Query: 165 PLRARGY 171
           P    GY
Sbjct: 181 PSARDGY 187

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288

>gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

 Score =  233 bits (597), Expect = 5e-78
 Identities = 93/184 (50%), Positives = 123/184 (66%), Gaps = 36/184 (19%)

Query: 24  EDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECP 83
           +DL+ + E+GRG +G V+KM H  + T+MAVKRIR+TV+ ++Q++LLMDLD+ M+S +CP
Sbjct: 1   DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCP 60

Query: 84  YIVQFYGALFKE-----------------------------------VTVATVKALNYLK 108
           Y V FYGALF+E                                   + V+ VKAL YL 
Sbjct: 61  YTVTFYGALFREGDVWICMEVMDTSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLH 120

Query: 109 EELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDP-LR 167
            +L +IHRDVKPSN+L++R G +KLCDFGISG LVDS+AKT DAGC+PYMAPERI+P L 
Sbjct: 121 SKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSVAKTIDAGCKPYMAPERINPELN 180

Query: 168 ARGY 171
            +GY
Sbjct: 181 QKGY 184

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283

>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

 Score =  216 bits (552), Expect = 3e-71
 Identities = 80/176 (45%), Positives = 104/176 (59%), Gaps = 35/176 (19%)

Query: 24  EDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECP 83
           +DL+ LGE+G G  G V+K++HR +  +MAVK IR  ++E  Q+Q+L +LD++ K N  P
Sbjct: 1   DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCN-SP 59

Query: 84  YIVQFYGALFKE---------------------------------VTVATVKALNYLKEE 110
           YIV FYGA +                                   + VA +K L YL E+
Sbjct: 60  YIVGFYGAFYNNGDISICMEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEK 119

Query: 111 LKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPL 166
            KIIHRDVKPSNIL++ RG IKLCDFG+SGQLV+S+AKT   G   YMAPERI   
Sbjct: 120 HKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAKT-FVGTSSYMAPERIQGN 174

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265

>gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

 Score =  213 bits (543), Expect = 1e-69
 Identities = 92/189 (48%), Positives = 117/189 (61%), Gaps = 33/189 (17%)

Query: 9   GKLKLSPDTVYDFTSEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQ 68
           G L +     Y     DL++LGEIG G  G V KM  + +  VMAVK++R T ++++ ++
Sbjct: 1   GYLTID-GQKYPADLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKR 59

Query: 69  LLMDLDVVMKSNECPYIVQFYGALFKE--------------------------------V 96
           +LMDLDVV+KS++CPYIV+ YG    +                                +
Sbjct: 60  ILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICMELMSTCLDKLLKRIQGPIPEDILGKM 119

Query: 97  TVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTRDAGCRP 156
           TVA VKAL+YLKE+  +IHRDVKPSNILLD  G +KLCDFGISG+LVDS AKTR AGC  
Sbjct: 120 TVAIVKALHYLKEKHGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKAKTRSAGCAA 179

Query: 157 YMAPERIDP 165
           YMAPERIDP
Sbjct: 180 YMAPERIDP 188

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296

>gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

 Score =  161 bits (408), Expect = 2e-49
 Identities = 75/186 (40%), Positives = 107/186 (57%), Gaps = 37/186 (19%)

Query: 24  EDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECP 83
           ++++ L E+G+G +G+V K++HR +   MA+K IR  +DE    Q++M+LD++ K+   P
Sbjct: 1   DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVS-P 59

Query: 84  YIVQFYGALFKE-----------------------------------VTVATVKALNYLK 108
           YIV FYGA F E                                   +T A VK L +LK
Sbjct: 60  YIVDFYGAFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLK 119

Query: 109 EELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPLRA 168
           EE  IIHRDVKP+N+L++  G +KLCDFG+SG LV S+AKT + GC+ YMAPERI     
Sbjct: 120 EEHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASLAKT-NIGCQSYMAPERIKSGGP 178

Query: 169 RGYPSF 174
              P++
Sbjct: 179 NQNPTY 184

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286

>gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

 Score =  147 bits (373), Expect = 6e-44
 Identities = 68/172 (39%), Positives = 99/172 (57%), Gaps = 34/172 (19%)

Query: 24  EDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECP 83
           +D + LGE+G G  G V K++HR S  +MA K I   +    + Q++ +L V+ + N  P
Sbjct: 1   DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNS-P 59

Query: 84  YIVQFYGALFK--------------------------------EVTVATVKALNYLKEEL 111
           YIV FYGA +                                 ++++A ++ L YL+E+ 
Sbjct: 60  YIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPENILGKISIAVLRGLTYLREKH 119

Query: 112 KIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERI 163
           KI+HRDVKPSNIL++ RG IKLCDFG+SGQL+DS+A +   G R YM+PER+
Sbjct: 120 KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSF-VGTRSYMSPERL 170

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308

>gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

 Score =  141 bits (357), Expect = 8e-42
 Identities = 67/176 (38%), Positives = 94/176 (53%), Gaps = 34/176 (19%)

Query: 20  DFTSEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKS 79
           D  +EDL+ + ++G G  G+V+K+ H  + TVMA K +        ++Q+L +L + M  
Sbjct: 1   DLRNEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQI-MHE 59

Query: 80  NECPYIVQFYGALFKE--------------------------------VTVATVKALNYL 107
              PYIV FYGA   E                                + VA V+ L YL
Sbjct: 60  CRSPYIVSFYGAFLNENNICMCMEFMDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYL 119

Query: 108 KEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERI 163
               +I+HRD+KPSNIL++ RG IKLCDFG+SG+L++SIA T   G   YM+PERI
Sbjct: 120 YNVHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSIADTF-VGTSTYMSPERI 174

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284

>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

 Score =  140 bits (354), Expect = 2e-41
 Identities = 58/183 (31%), Positives = 95/183 (51%), Gaps = 35/183 (19%)

Query: 24  EDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECP 83
            DL+ +  +G+G  G V K+ H+ +  + A+K+I    DE+ ++QLL +L  + +S E P
Sbjct: 1   SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTL-RSCESP 59

Query: 84  YIVQFYGALFKEVTVATV--------------------------------KALNYLKEEL 111
           Y+V+ YGA +KE  ++ V                                K L+YL  + 
Sbjct: 60  YVVKCYGAFYKEGEISIVLEYMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTKR 119

Query: 112 KIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTRDA-GCRPYMAPERIDPLRARG 170
            IIHRD+KPSN+L++ +G +K+ DFGIS  L +++ +     G   YM+PERI    +  
Sbjct: 120 HIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTFVGTVTYMSPERIQG-ESYS 178

Query: 171 YPS 173
           Y +
Sbjct: 179 YAA 181

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264

>gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

 Score =  130 bits (328), Expect = 1e-37
 Identities = 70/168 (41%), Positives = 95/168 (56%), Gaps = 31/168 (18%)

Query: 24  EDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECP 83
           +D+Q    +G G  GTV K  H  +  ++AVK I   +  + Q+Q++ +L+++ K +  P
Sbjct: 1   QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDS-P 59

Query: 84  YIVQFYGALFKE----------------------------VTVATVKALNYLKEELKIIH 115
           YI+ FYGA F E                            + VA VK L YL   LKI+H
Sbjct: 60  YIIGFYGAFFVENRISICTEFMDGGSLDVYRKIPEHVLGRIAVAVVKGLTYL-WSLKILH 118

Query: 116 RDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERI 163
           RDVKPSN+L++ RG +KLCDFG+S QLV+SIAKT   G   YMAPERI
Sbjct: 119 RDVKPSNMLVNTRGQVKLCDFGVSTQLVNSIAKTY-VGTNAYMAPERI 165

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score =  126 bits (318), Expect = 4e-36
 Identities = 51/177 (28%), Positives = 79/177 (44%), Gaps = 37/177 (20%)

Query: 27  QDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIV 86
           + L ++G G FG V     + +  ++A+K I+    +KD+ ++L ++ + +K  + P IV
Sbjct: 2   EILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKI-LKKLKHPNIV 60

Query: 87  QFYGA------------------LF--------------KEVTVATVKALNYLKEELKII 114
           + Y                    LF              +      + AL YL     I+
Sbjct: 61  RLYDVFEDEDKLYLVMEYCEGGDLFDLLKKRGRLSEDEARFYLRQILSALEYL-HSKGIV 119

Query: 115 HRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPLRARGY 171
           HRD+KP NILLD  G +KL DFG++ QL      T   G   YMAPE +     +GY
Sbjct: 120 HRDLKPENILLDEDGHVKLADFGLARQLDPGEKLTTFVGTPEYMAPEVL---LGKGY 173

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

 Score =  124 bits (314), Expect = 2e-35
 Identities = 66/178 (37%), Positives = 98/178 (55%), Gaps = 41/178 (23%)

Query: 24  EDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECP 83
           E + +L  +G G  G+V K   +++  + A+K I +  +   Q+Q+L +L++  KS + P
Sbjct: 1   EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEI-NKSCKSP 59

Query: 84  YIVQFYGA-----------------------LFKEV-------------TVA--TVKALN 105
           YIV++YGA                       ++K+V              +A   +K L+
Sbjct: 60  YIVKYYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLS 119

Query: 106 YLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERI 163
           YL    KIIHRD+KPSNILL R+G +KLCDFG+SG+LV+S+A T   G   YMAPERI
Sbjct: 120 YLHSR-KIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSLAGTF-TGTSFYMAPERI 175

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score =  123 bits (312), Expect = 3e-35
 Identities = 53/172 (30%), Positives = 83/172 (48%), Gaps = 36/172 (20%)

Query: 25  DLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPY 84
             + L +IG+GGFG V K  H+ +   +A+K I+    ++ + +++ ++  ++K  + P 
Sbjct: 1   LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIK-LESKEKKEKIINEIQ-ILKKCKHPN 58

Query: 85  IVQFYGA----------------------------LFKEVTVATV-----KALNYLKEEL 111
           IV++YG+                               E  +A V     K L YL    
Sbjct: 59  IVKYYGSYLKKDELWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSN- 117

Query: 112 KIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERI 163
            IIHRD+K +NILL   G +KL DFG+S QL D+ A+    G   +MAPE I
Sbjct: 118 GIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARNTMVGTPYWMAPEVI 169

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

 Score =  125 bits (315), Expect = 4e-35
 Identities = 67/176 (38%), Positives = 98/176 (55%), Gaps = 34/176 (19%)

Query: 20  DFTSEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKS 79
           +   +D + + E+G G  G V K+ H+ S  +MA K I   +    + Q++ +L V+ + 
Sbjct: 1   ELKDDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHEC 60

Query: 80  NECPYIVQFYGALFKE--------------------------------VTVATVKALNYL 107
           N  PYIV FYGA + +                                V++A +K L YL
Sbjct: 61  NS-PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYL 119

Query: 108 KEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERI 163
           +E+ KI+HRDVKPSNIL++ RG IKLCDFG+SGQL+DS+A +   G R YM+PER+
Sbjct: 120 REKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSF-VGTRSYMSPERL 174

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333

>gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

 Score =  123 bits (309), Expect = 3e-34
 Identities = 65/176 (36%), Positives = 98/176 (55%), Gaps = 34/176 (19%)

Query: 20  DFTSEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKS 79
           +   +D + + E+G G  G V K+ H+ S  +MA K I   +    + Q++ +L V+ + 
Sbjct: 1   ELKDDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHEC 60

Query: 80  NECPYIVQFYGALFKE--------------------------------VTVATVKALNYL 107
           N  PYIV FYGA + +                                V++A ++ L YL
Sbjct: 61  NS-PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYL 119

Query: 108 KEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERI 163
           +E+ +I+HRDVKPSNIL++ RG IKLCDFG+SGQL+DS+A +   G R YM+PER+
Sbjct: 120 REKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSF-VGTRSYMSPERL 174

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score =  111 bits (281), Expect = 1e-30
 Identities = 51/182 (28%), Positives = 82/182 (45%), Gaps = 38/182 (20%)

Query: 26  LQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIR-STVDEKDQRQLLMDLDVVMKSNECPY 84
            + L ++G G FGTV K  H+ +  ++AVK ++  +   K  +    ++ + ++    P 
Sbjct: 1   YELLRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRI-LRRLSHPN 59

Query: 85  IVQFYGA------------------LF--------------KEVTVATVKALNYLKEELK 112
           IV+   A                  LF              K++ +  ++ L YL     
Sbjct: 60  IVRLIDAFEDKDHLYLVMEYCEGGDLFDYLSRGGPLSEDEAKKIALQILRGLEYLHSN-G 118

Query: 113 IIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTRD-AGCRPYMAPERIDPLRARGY 171
           IIHRD+KP NILLD  G +K+ DFG++ +L+ S +      G   YMAPE +  L   GY
Sbjct: 119 IIHRDLKPENILLDENGVVKIADFGLAKKLLKSSSSLTTFVGTPWYMAPEVL--LGGNGY 176

Query: 172 PS 173
             
Sbjct: 177 GP 178

Length = 260

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score =  108 bits (272), Expect = 2e-29
 Identities = 56/175 (32%), Positives = 85/175 (48%), Gaps = 39/175 (22%)

Query: 23  SEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNEC 82
            E    L ++G G +G+V K IH+ +  V+A+K +    D ++   ++ ++ + +K  + 
Sbjct: 2   EEVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEEDLQE---IIKEISI-LKQCDS 57

Query: 83  PYIVQFYGALFKE---------------------------------VTVATVKALNYLKE 109
           PYIV++YG+ FK                                  +   T+K L YL  
Sbjct: 58  PYIVKYYGSYFKNTDLWIVMEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYL-H 116

Query: 110 ELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTRDAGCRPY-MAPERI 163
             K IHRD+K  NILL+  G  KL DFG+SGQL D++AK       P+ MAPE I
Sbjct: 117 SNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNTVIGTPFWMAPEVI 171

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score = 98.1 bits (245), Expect = 8e-26
 Identities = 49/177 (27%), Positives = 71/177 (40%), Gaps = 37/177 (20%)

Query: 32  IGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQFYGA 91
           +G GGFGTV     + +   +A+K I+         +LL ++++ +K    P IV+ YG 
Sbjct: 1   LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEI-LKKLNHPNIVKLYGV 59

Query: 92  L----------------------------FKEVTVA-----TVKALNYLKEELKIIHRDV 118
                                          E  +       ++ L YL     IIHRD+
Sbjct: 60  FEDENHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSN-GIIHRDL 118

Query: 119 KPSNILLDRR-GAIKLCDFGISGQLVDSIAKTRD-AGCRPYMAPERIDPLRARGYPS 173
           KP NILLD   G +KL DFG+S  L    +  +   G   YMAPE +         S
Sbjct: 119 KPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVGTPAYMAPEVLLGKGYYSEKS 175

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

 Score = 99.3 bits (248), Expect = 8e-26
 Identities = 54/182 (29%), Positives = 81/182 (44%), Gaps = 37/182 (20%)

Query: 24  EDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECP 83
           ED + +  IG G +G V K    ++  ++A+K I+  ++  D  +++     ++K    P
Sbjct: 3   EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIK--LEPGDDFEIIQQEISMLKECRHP 60

Query: 84  YIVQFYGALFKE---------------------------------VTVATVKALNYLKEE 110
            IV ++G+  +                                  V   T+K L YL  E
Sbjct: 61  NIVAYFGSYLRRDKLWIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYL-HE 119

Query: 111 LKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTRDAGCRPY-MAPERIDPLRAR 169
              IHRD+K +NILL   G +KL DFG+S QL  +IAK +     PY MAPE     R  
Sbjct: 120 TGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAKRKSFIGTPYWMAPEVAAVERKG 179

Query: 170 GY 171
           GY
Sbjct: 180 GY 181

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score = 95.7 bits (239), Expect = 2e-24
 Identities = 46/171 (26%), Positives = 74/171 (43%), Gaps = 40/171 (23%)

Query: 32  IGRGGFGTVNKMIHRSSDTVMAVKRIR-STVDEKDQRQLLMDLDVVMKSNECPYIVQFYG 90
           +GRG FG+V   + + +  +MAVK +  S   E++   L  ++ + + S + P IV++YG
Sbjct: 8   LGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRI-LSSLQHPNIVRYYG 66

Query: 91  A-----------------------------LFKEVTVAT-----VKALNYLKEELKIIHR 116
           +                                E  +       ++ L YL     I+HR
Sbjct: 67  SERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHSN-GIVHR 125

Query: 117 DVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTRDAGCR---PYMAPERID 164
           D+K +NIL+D  G +KL DFG + +L D          R    +MAPE I 
Sbjct: 126 DIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIR 176

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score = 95.4 bits (238), Expect = 3e-24
 Identities = 57/178 (32%), Positives = 78/178 (43%), Gaps = 46/178 (25%)

Query: 24  EDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKD----QR--QLLMDLDVVM 77
           E    L  IG+G FG V K I + ++ V+A+K I     E +    Q+  Q L       
Sbjct: 1   ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCR--- 57

Query: 78  KSNECPYIVQFYGAL--------------------------FKEVTVATV-----KALNY 106
                PYI ++YG+                             E  +A +       L Y
Sbjct: 58  ----SPYITKYYGSFLKGSKLWIIMEYCGGGSCLDLLKPGKLDETYIAFILREVLLGLEY 113

Query: 107 LKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTRDAGCRPY-MAPERI 163
           L EE K IHRD+K +NILL   G +KL DFG+SGQL  +++K       P+ MAPE I
Sbjct: 114 LHEEGK-IHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNTFVGTPFWMAPEVI 170

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score = 93.0 bits (232), Expect = 1e-23
 Identities = 47/165 (28%), Positives = 73/165 (44%), Gaps = 37/165 (22%)

Query: 32  IGRGGFGTVNKMIHRSSDTVMAVKRIR--STVDEKDQRQLLMDLDVVMKSNECPYIVQFY 89
           +G+G FG V  +  + +  + A+K ++    +  K+    L + ++ +     P+IV+ +
Sbjct: 1   LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNI-LSRINHPFIVKLH 59

Query: 90  ------------------GALFK---------EVTVA-----TVKALNYLKEELKIIHRD 117
                             G LF          E          V AL YL   L II+RD
Sbjct: 60  YAFQTEEKLYLVLEYAPGGELFSHLSKEGRFSEERARFYAAEIVLALEYL-HSLGIIYRD 118

Query: 118 VKPSNILLDRRGAIKLCDFGISGQLVDSIAKTRD-AGCRPYMAPE 161
           +KP NILLD  G IKL DFG++ +L    ++T    G   Y+APE
Sbjct: 119 LKPENILLDADGHIKLTDFGLAKELSSEGSRTNTFCGTPEYLAPE 163

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

 Score = 89.6 bits (223), Expect = 3e-22
 Identities = 52/172 (30%), Positives = 81/172 (47%), Gaps = 41/172 (23%)

Query: 29  LGE-IGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLM---DLDVVMKSNECPY 84
           LG+ IGRG FG V K ++  +   +A+K+I     +++  + +M   DL   +K+ + P 
Sbjct: 4   LGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDL---LKNLKHPN 60

Query: 85  IVQFYGA---------------------------LFKEVTVA-----TVKALNYLKEELK 112
           IV++ G+                            F E  VA      ++ L YL E+  
Sbjct: 61  IVKYIGSIETSDSLYIILEYAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQ-G 119

Query: 113 IIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTRDAGCRPY-MAPERI 163
           +IHRD+K +NIL  + G +KL DFG++ +L D           PY MAPE I
Sbjct: 120 VIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDASVVGTPYWMAPEVI 171

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254

>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

 Score = 88.1 bits (219), Expect = 1e-21
 Identities = 49/173 (28%), Positives = 76/173 (43%), Gaps = 37/173 (21%)

Query: 32  IGRGGFGTVNKMIHRSSDTVMAVKRI-RSTVDEKDQRQLLMDLDVVMKSNECPYIVQFY- 89
           IG+G FG V  +  R +  + A+K + +    EK   + +++   +++    P++V  + 
Sbjct: 8   IGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWY 67

Query: 90  -----------------GAL---------FKEVTV-----ATVKALNYLKEELKIIHRDV 118
                            G L         F E  V       V AL YL  +  IIHRD+
Sbjct: 68  SFQDEENMYLVVDLLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSK-GIIHRDI 126

Query: 119 KPSNILLDRRGAIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPLRARGY 171
           KP NILLD +G + + DF I+ ++      T  +G   YMAPE    L  +GY
Sbjct: 127 KPDNILLDEQGHVHITDFNIATKVTPDTLTTSTSGTPGYMAPEV---LCRQGY 176

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258

>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

 Score = 86.8 bits (216), Expect = 3e-21
 Identities = 51/170 (30%), Positives = 74/170 (43%), Gaps = 42/170 (24%)

Query: 31  EIGRGGFGTVNKMIHRSSDTVMAVKRIR-STVDEKDQRQLLMDLDVVMKSNECPYIVQFY 89
           +IG+G FG V  +  +S   +  +K I  S + EK++   L ++ + +K    P I+++Y
Sbjct: 7   QIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKI-LKKLNHPNIIKYY 65

Query: 90  -------------------------------GALFKE-----VTVATVKALNYLKEELKI 113
                                          G  F E       V    AL YL    KI
Sbjct: 66  ESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSR-KI 124

Query: 114 IHRDVKPSNILLDRRGAIKLCDFGISGQLVDS--IAKTRDAGCRPYMAPE 161
           +HRD+KP NI L   G +KL DFGIS  L  +  +AKT   G   Y++PE
Sbjct: 125 LHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKTV-VGTPYYLSPE 173

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258

>gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

 Score = 82.7 bits (205), Expect = 2e-19
 Identities = 52/180 (28%), Positives = 81/180 (45%), Gaps = 47/180 (26%)

Query: 28  DLGE-IGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIV 86
           +L E IG G +G V K  H+ +  ++A+K +    DE+++  +  + +++ K +  P I 
Sbjct: 9   ELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEE--IKEEYNILRKYSNHPNIA 66

Query: 87  QFYGALFKEV------------------TVA------------------------TVKAL 104
            FYGA  K+                   +V                         T++ L
Sbjct: 67  TFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGL 126

Query: 105 NYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTRDAGCRPY-MAPERI 163
            YL E  K+IHRD+K  NILL +   +KL DFG+S QL  ++ +       PY MAPE I
Sbjct: 127 AYLHEN-KVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRRNTFIGTPYWMAPEVI 185

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275

>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

 Score = 81.1 bits (201), Expect = 9e-19
 Identities = 56/194 (28%), Positives = 86/194 (44%), Gaps = 55/194 (28%)

Query: 15  PDTVYDFTSED-----LQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQL 69
              + D  SE       ++L +IG G  G V K   R++   +A+K++R     K  ++L
Sbjct: 5   KAALKDIVSEGDPRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLR---KQNKEL 61

Query: 70  LMDLDVVMKSNECPYIVQFY------------------GAL----------FKEVTVATV 101
           +++  ++MK  + P IV +Y                  G+L            E  +A V
Sbjct: 62  IINEILIMKDCKHPNIVDYYDSYLVGDELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYV 121

Query: 102 -----KALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTRDAGCR- 155
                + L YL     +IHRD+K  NILL + G++KL DFG + QL      T++   R 
Sbjct: 122 CREVLQGLEYL-HSQNVIHRDIKSDNILLSKDGSVKLADFGFAAQL------TKEKSKRN 174

Query: 156 -----PY-MAPERI 163
                PY MAPE I
Sbjct: 175 SVVGTPYWMAPEVI 188

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286

>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

 Score = 80.5 bits (199), Expect = 1e-18
 Identities = 52/175 (29%), Positives = 78/175 (44%), Gaps = 40/175 (22%)

Query: 27  QDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIR-STVDEKDQRQLLMDLDVVMKSNECPYI 85
           Q   +IG G FG V   ++  +  +MAVK IR    D K  +++  ++ V+      P +
Sbjct: 3   QRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKH-PNL 61

Query: 86  VQFYGA--------LFKEV------------------------TVATVKALNYLKEELKI 113
           V++YG         +F E                         T+  ++ L YL     I
Sbjct: 62  VKYYGVEVHREKVYIFMEYCSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSH-GI 120

Query: 114 IHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTRD-----AGCRPYMAPERI 163
           +HRD+KP+NI LD  G IKL DFG + +L ++     +     AG   YMAPE I
Sbjct: 121 VHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVI 175

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264

>gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

 Score = 80.6 bits (199), Expect = 1e-18
 Identities = 53/172 (30%), Positives = 82/172 (47%), Gaps = 35/172 (20%)

Query: 24  EDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECP 83
             L +  +IG G  G V     +S+   +AVK++   + ++ +R+LL +  V+M+  + P
Sbjct: 19  SYLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKM--DLRKQQRRELLFNEVVIMRDYQHP 76

Query: 84  YIVQFY------------------GALFKEVT--------VATV-----KALNYLKEELK 112
            IV+ Y                  GAL   VT        +ATV     KAL++L  +  
Sbjct: 77  NIVEMYSSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIATVCLAVLKALSFLHAQ-G 135

Query: 113 IIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTRDAGCRPY-MAPERI 163
           +IHRD+K  +ILL   G +KL DFG   Q+   + + +     PY MAPE I
Sbjct: 136 VIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPEVI 187

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285

>gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

 Score = 77.8 bits (191), Expect = 1e-17
 Identities = 55/167 (32%), Positives = 82/167 (49%), Gaps = 34/167 (20%)

Query: 29  LGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQF 88
           L  IG+G FG V K I   +  V+A+K I     E +   +  ++ V+ + +  PYI ++
Sbjct: 9   LERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDS-PYITRY 67

Query: 89  YGALFK--------------------------EVTVATV-----KALNYLKEELKIIHRD 117
           YG+  K                          E  +AT+     K L+YL  E KI HRD
Sbjct: 68  YGSYLKGTKLWIIMEYLGGGSALDLLKPGPLEETYIATILREILKGLDYLHSERKI-HRD 126

Query: 118 VKPSNILLDRRGAIKLCDFGISGQLVDS-IAKTRDAGCRPYMAPERI 163
           +K +N+LL  +G +KL DFG++GQL D+ I +    G   +MAPE I
Sbjct: 127 IKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVI 173

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277

>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

 Score = 77.9 bits (192), Expect = 1e-17
 Identities = 53/169 (31%), Positives = 77/169 (45%), Gaps = 43/169 (25%)

Query: 30  GEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNEC--PYIVQ 87
           GE+G G FG V K  H+ +    A K I+    E++    ++++D++   +EC  P IV 
Sbjct: 11  GELGDGAFGKVYKAQHKETGLFAAAKIIQ-IESEEELEDFMVEIDIL---SECKHPNIVG 66

Query: 88  FYGALFKE---------------------------------VTVATVKALNYLKEELKII 114
            Y A F E                                 V    ++ALN+L    K+I
Sbjct: 67  LYEAYFYENKLWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSH-KVI 125

Query: 115 HRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTRDA--GCRPYMAPE 161
           HRD+K  NILL   G +KL DFG+S +   ++ K RD   G   +MAPE
Sbjct: 126 HRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQK-RDTFIGTPYWMAPE 173

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280

>gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

 Score = 77.8 bits (191), Expect = 1e-17
 Identities = 55/172 (31%), Positives = 83/172 (48%), Gaps = 34/172 (19%)

Query: 24  EDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECP 83
           E    L +IG+G FG V K I   +  V+A+K I     E +   +  ++ V+ + +  P
Sbjct: 4   ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDS-P 62

Query: 84  YIVQFYGALFK--------------------------EVTVATV-----KALNYLKEELK 112
           Y+ ++YG+  K                          E  +AT+     K L+YL  E K
Sbjct: 63  YVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIATILREILKGLDYLHSEKK 122

Query: 113 IIHRDVKPSNILLDRRGAIKLCDFGISGQLVDS-IAKTRDAGCRPYMAPERI 163
           I HRD+K +N+LL   G +KL DFG++GQL D+ I +    G   +MAPE I
Sbjct: 123 I-HRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVI 173

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277

>gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

 Score = 77.4 bits (190), Expect = 2e-17
 Identities = 55/172 (31%), Positives = 83/172 (48%), Gaps = 34/172 (19%)

Query: 24  EDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECP 83
           E    L  IG+G FG V K I   +  V+A+K I     E +   +  ++ V+ + +  P
Sbjct: 4   ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDS-P 62

Query: 84  YIVQFYGAL--------------------------FKEVTVAT-----VKALNYLKEELK 112
           Y+ ++YG+                           F E  +AT     +K L+YL  E K
Sbjct: 63  YVTKYYGSYLKGTKLWIIMEYLGGGSALDLLRAGPFDEFQIATMLKEILKGLDYLHSEKK 122

Query: 113 IIHRDVKPSNILLDRRGAIKLCDFGISGQLVDS-IAKTRDAGCRPYMAPERI 163
           I HRD+K +N+LL  +G +KL DFG++GQL D+ I +    G   +MAPE I
Sbjct: 123 I-HRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVI 173

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277

>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

 Score = 76.1 bits (188), Expect = 5e-17
 Identities = 48/174 (27%), Positives = 73/174 (41%), Gaps = 43/174 (24%)

Query: 32  IGRGGFGTVNKMIHRSSDTVMAVKRI-RSTVDEKDQRQLLMDLDVVMKSNECPYIVQFY- 89
           I +G +G V     +S+  + A+K I ++ +  K+Q   ++    ++   + PY+V+ Y 
Sbjct: 1   ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYY 60

Query: 90  ---------------------------GALFKEV----TVATVKALNYLKEELKIIHRDV 118
                                      G+L ++V        V AL YL     IIHRD+
Sbjct: 61  SFQGKKNLYLVMEYLPGGDLASLLENVGSLDEDVARIYIAEIVLALEYLHS-NGIIHRDL 119

Query: 119 KPSNILLDRRGAIKLCDFGIS---------GQLVDSIAKTRDAGCRPYMAPERI 163
           KP NIL+D  G +KL DFG+S             D     R  G   Y+APE I
Sbjct: 120 KPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVI 173

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265

>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

 Score = 75.6 bits (186), Expect = 7e-17
 Identities = 58/177 (32%), Positives = 82/177 (46%), Gaps = 49/177 (27%)

Query: 32  IGRGGFGTVNKMIHRSSDTVMAVKRIR----STVDEKDQRQLLMDLD---VVMKSNECPY 84
           IG G FG+V   ++ SS  +MAVK++     S   +  +R +L  L     ++K  +   
Sbjct: 8   IGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHEN 67

Query: 85  IVQF----------------------------YGALFKEVTV-----ATVKALNYLKEEL 111
           IVQ+                            YGA F+E  V       +K LNYL    
Sbjct: 68  IVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGA-FEETLVRNFVRQILKGLNYLHNR- 125

Query: 112 KIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTRDAGCRP-------YMAPE 161
            IIHRD+K +NIL+D +G IK+ DFGIS +L  +   T+  G RP       +MAPE
Sbjct: 126 GIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMAPE 182

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267

>gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

 Score = 75.3 bits (186), Expect = 9e-17
 Identities = 47/166 (28%), Positives = 72/166 (43%), Gaps = 36/166 (21%)

Query: 32  IGRGGFGTVNKMIHRSSDTVMAVKRI-RSTVDEKDQRQLLMDLDVVMKSNECPYIVQFY- 89
           +G GGFG V  +  +S +   A+K + +  + E  Q++ +     +++    P+IV+ Y 
Sbjct: 1   LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYR 60

Query: 90  -----------------GALF--------------KEVTVATVKALNYLKEELKIIHRDV 118
                            G L+              +      V A  YL     II+RD+
Sbjct: 61  TFKDKKYIYMLMEYCLGGELWTILRDRGLFDEYTARFYIACVVLAFEYL-HNRGIIYRDL 119

Query: 119 KPSNILLDRRGAIKLCDFGISGQLVDSIAKTRD-AGCRPYMAPERI 163
           KP N+LLD  G +KL DFG + +L  S  KT    G   Y+APE I
Sbjct: 120 KPENLLLDSNGYVKLVDFGFAKKL-KSGQKTWTFCGTPEYVAPEII 164

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score = 74.9 bits (185), Expect = 1e-16
 Identities = 38/172 (22%), Positives = 68/172 (39%), Gaps = 44/172 (25%)

Query: 31  EIGRGGFGTVNK--MIHRSSDTVM--AVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIV 86
           ++G G FG V K  +  +     +  AVK ++    E+   + L +  + M+  + P IV
Sbjct: 6   KLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARI-MRKLDHPNIV 64

Query: 87  QFYGALF--------------------------KEVTVATV--------KALNYLKEELK 112
           +  G                             KE++++ +        + + YL E   
Sbjct: 65  KLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYL-ESKN 123

Query: 113 IIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTRDAGCR-PY--MAPE 161
            IHRD+   N L+     +K+ DFG+S + +      +  G + P   MAPE
Sbjct: 124 FIHRDLAARNCLVGENLVVKISDFGLS-RDLYDDDYYKVKGGKLPIRWMAPE 174

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

 Score = 74.8 bits (184), Expect = 1e-16
 Identities = 49/170 (28%), Positives = 75/170 (44%), Gaps = 43/170 (25%)

Query: 32  IGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKD----QR--QLLMDLDVVMKSNECPYI 85
           IGRG +G V +  H  +  V+A+K I     + D    QR   LL  L    + ++ P I
Sbjct: 9   IGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQL----RQSQPPNI 64

Query: 86  VQFYGALFKEVTV-------------------------------ATVKALNYLKEELKII 114
            ++YG+  K   +                                 + AL Y+  ++ +I
Sbjct: 65  TKYYGSYLKGPRLWIIMEYAEGGSVRTLMKAGPIAEKYISVIIREVLVALKYI-HKVGVI 123

Query: 115 HRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTRDAGCRPY-MAPERI 163
           HRD+K +NIL+   G +KLCDFG++  L  + +K       PY MAPE I
Sbjct: 124 HRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRSTFVGTPYWMAPEVI 173

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score = 74.1 bits (183), Expect = 2e-16
 Identities = 38/170 (22%), Positives = 67/170 (39%), Gaps = 41/170 (24%)

Query: 31  EIGRGGFGTVNK--MIHRSSDTVM--AVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIV 86
           ++G G FG V K  +  +     +  AVK ++    E+   + L +  + M+  + P +V
Sbjct: 6   KLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARI-MRKLDHPNVV 64

Query: 87  QFYGALFKE-------------------------VTVATV--------KALNYLKEELKI 113
           +  G   +E                         ++++ +        + + YL E    
Sbjct: 65  KLLGVCTEEEPLYIVMEYMEGGDLLSYLRKNRPKLSLSDLLSFALQIARGMEYL-ESKNF 123

Query: 114 IHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTRDAGCRPY--MAPE 161
           IHRD+   N L+     +K+ DFG+S  L D     +  G  P   MAPE
Sbjct: 124 IHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGKLPIRWMAPE 173

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score = 74.2 bits (183), Expect = 3e-16
 Identities = 37/168 (22%), Positives = 65/168 (38%), Gaps = 37/168 (22%)

Query: 29  LGEIGRGGFGTVNKMIHRSSDTVMAVKRIRS-TVDEKDQRQLLMDLDVVMKSNECPYIVQ 87
           LG IG G  G V K   R +   +A+K++    ++     Q L ++  +  + + PY+V+
Sbjct: 5   LGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQ-ACQHPYVVK 63

Query: 88  FYGALFKEVTVATV--------------------------------KALNYLKEELKIIH 115
                        V                                K + Y+     I+H
Sbjct: 64  LLDVFPHGSGFVLVMEYMPSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYM-HANGIMH 122

Query: 116 RDVKPSNILLDRRGAIKLCDFGISGQLVDSIAK--TRDAGCRPYMAPE 161
           RD+KP+N+L+   G +K+ DFG++    +   +  +     R Y APE
Sbjct: 123 RDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPE 170

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

 Score = 73.2 bits (180), Expect = 5e-16
 Identities = 45/176 (25%), Positives = 73/176 (41%), Gaps = 36/176 (20%)

Query: 32  IGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDL--DVVMKSNEC-PYIVQF 88
           +G G FG+V + ++       AVK +    D +  ++ +  L  ++ + S    P IVQ+
Sbjct: 8   LGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQY 67

Query: 89  ----------------------------YGALFKEV----TVATVKALNYLKEELKIIHR 116
                                       YG+  + V    T   +  L YL +    +HR
Sbjct: 68  LGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDR-NTVHR 126

Query: 117 DVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPLRARGYP 172
           D+K +NIL+D  G +KL DFG++ Q+V+        G   +MAPE I      G  
Sbjct: 127 DIKGANILVDTNGVVKLADFGMAKQVVEFSFAKSFKGSPYWMAPEVIAQQGGYGLA 182

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score = 73.5 bits (181), Expect = 5e-16
 Identities = 44/178 (24%), Positives = 74/178 (41%), Gaps = 36/178 (20%)

Query: 27  QDLGEIGRGGFGTVNKMIHRSSDTVMAVKRI-RSTVDEKDQRQLLMDLDVVMKSNECPYI 85
           Q LG+IG G +G V K   + +  ++A+K+I      E   +  L ++  ++K    P I
Sbjct: 2   QKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREI-KLLKELNHPNI 60

Query: 86  VQFYGALFKEVTVATVKAL----------------------NYLKEELK---------II 114
           ++       +  +  V                         +YL + L+         I+
Sbjct: 61  IKLLDVFRHKGDLYLVFEFMDTDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHGIL 120

Query: 115 HRDVKPSNILLDRRGAIKLCDFGISGQL-VDSIAKTRDAGCRPYMAPERIDPLRARGY 171
           HRD+KP N+L++  G +KL DFG++          T     R Y APE +  L  +GY
Sbjct: 121 HRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYVVTRWYRAPELL--LGDKGY 176

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

 Score = 73.5 bits (181), Expect = 9e-16
 Identities = 45/176 (25%), Positives = 74/176 (42%), Gaps = 41/176 (23%)

Query: 24  EDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIR-STVDEKDQRQLLMDLDVVMKSNEC 82
           +D + +  IGRG FG V  +  + +  V A+K +R S + +++Q   +     ++   + 
Sbjct: 1   DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADS 60

Query: 83  PYIVQFY----------------------GALFKE--VTVATVK--------ALNYLKEE 110
           P+IV+ Y                        L ++      T +        AL+ +  +
Sbjct: 61  PWIVKLYYSFQDEEHLYLVMEYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSV-HK 119

Query: 111 LKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPL 166
           L  IHRD+KP NIL+D  G IKL DFG+         K   A  R Y   +  + L
Sbjct: 120 LGFIHRDIKPDNILIDADGHIKLADFGLC-------KKMNKAKDREYYLNDSHNLL 168

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350

>gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

 Score = 71.6 bits (175), Expect = 3e-15
 Identities = 54/184 (29%), Positives = 87/184 (47%), Gaps = 46/184 (25%)

Query: 13  LSPDTVYDFTSEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMD 72
           L P+ V++        +GE+G G FG V K  ++ +  + A K I  T  E++    +++
Sbjct: 8   LDPNEVWEI-------IGELGDGAFGKVYKAKNKETGALAAAKVI-ETKSEEELEDYMVE 59

Query: 73  LDVVMKSNECPYIVQFYGALF----------------------------KEVTVATV--- 101
           ++++   N  PYIV+  GA +                             E  +  +   
Sbjct: 60  IEILATCNH-PYIVKLLGAFYWDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQ 118

Query: 102 --KALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTRDA--GCRPY 157
             +AL YL   +KIIHRD+K  N+LL   G IKL DFG+S + V ++ + RD+  G   +
Sbjct: 119 MLEALQYL-HSMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQR-RDSFIGTPYW 176

Query: 158 MAPE 161
           MAPE
Sbjct: 177 MAPE 180

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292

>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

 Score = 70.8 bits (174), Expect = 4e-15
 Identities = 49/186 (26%), Positives = 74/186 (39%), Gaps = 54/186 (29%)

Query: 31  EIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDV-----VMKSNECPYI 85
            IG G    V   I   ++  +A+KRI     + ++ Q  +D ++      M     P +
Sbjct: 8   VIGVGATAVVYAAICLPNNEKVAIKRI-----DLEKCQTSVD-ELRKEVQAMSQCNHPNV 61

Query: 86  VQFYGAL------------------------------FKEVTVATV-----KALNYLKEE 110
           V++Y +                                 E  +ATV     K L YL   
Sbjct: 62  VKYYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSN 121

Query: 111 LKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTRDA-----GCRPYMAPERIDP 165
              IHRD+K  NILL   G++K+ DFG+S  L D   +TR       G   +MAPE ++ 
Sbjct: 122 -GQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVMEQ 180

Query: 166 LRARGY 171
           +   GY
Sbjct: 181 V--HGY 184

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267

>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase

 Score = 70.6 bits (174), Expect = 4e-15
 Identities = 40/173 (23%), Positives = 68/173 (39%), Gaps = 46/173 (26%)

Query: 31  EIGRGGFGTVNK----MIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIV 86
           ++G G FG V K         ++T +AVK ++    E+++ + L +  + MK    P IV
Sbjct: 6   KLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASI-MKKLSHPNIV 64

Query: 87  QFYGALFKE-----VT------------------------------VATVKALNYLKEEL 111
           +  G   +      VT                              +A  K + YL E  
Sbjct: 65  RLLGVCTQGEPLYIVTEYMPGGDLLDFLRKHGEKLTLKDLLQMALQIA--KGMEYL-ESK 121

Query: 112 KIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTRDAGCR---PYMAPE 161
             +HRD+   N L+     +K+ DFG+S  + +     +  G +    +MAPE
Sbjct: 122 NFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKLPIKWMAPE 174

Length = 258

>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

 Score = 70.4 bits (173), Expect = 5e-15
 Identities = 51/179 (28%), Positives = 81/179 (45%), Gaps = 45/179 (25%)

Query: 29  LGEIGRGGFGTVNKMIHRSSDTVMAVKRIR-STVDEKDQRQLLMDLDV------------ 75
           L  IG+G FGTV K+  +S   ++  K I    + EK+++QL+ ++++            
Sbjct: 5   LETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRY 64

Query: 76  ----VMKSNECPYIVQFY---GAL-------------FKE-----VTVATVKALNY---- 106
               + +SN+  YIV  Y   G L              +E     +    + AL      
Sbjct: 65  YDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNR 124

Query: 107 LKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVD--SIAKTRDAGCRPYMAPERI 163
                 ++HRD+KP+NI LD    +KL DFG++  L    S AKT   G   YM+PE++
Sbjct: 125 SDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKTY-VGTPYYMSPEQL 182

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265

>gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

 Score = 71.0 bits (174), Expect = 5e-15
 Identities = 56/170 (32%), Positives = 85/170 (50%), Gaps = 39/170 (22%)

Query: 32  IGRGGFGTV---NKMIHRSSDTVMAVKRIR-STVDEKDQRQLLMDLDVVMKSNECPYIVQ 87
           +G+G FG V    K+    +  + A+K ++ +T+  +D+ +  M+ D++ + N  P+IV+
Sbjct: 4   LGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNH-PFIVK 62

Query: 88  FY------------------GALF----KEV--TVATVK--------ALNYLKEELKIIH 115
            +                  G LF    KEV  T   VK        AL++L   L II+
Sbjct: 63  LHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHL-HSLGIIY 121

Query: 116 RDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTRD-AGCRPYMAPERID 164
           RD+KP NILLD  G IKL DFG+S + +D   K     G   YMAPE ++
Sbjct: 122 RDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVN 171

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318

>gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 71.2 bits (175), Expect = 6e-15
 Identities = 44/155 (28%), Positives = 70/155 (45%), Gaps = 46/155 (29%)

Query: 24  EDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIR-STVDEKDQ-------RQLLMDLDV 75
           +D + +  IGRG FG V  +  + +  + A+K++R S + EK+Q       R +L + D 
Sbjct: 1   DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEAD- 59

Query: 76  VMKSNECPYIVQFYGA----------------------LFKEVTVATVKALNYLKE---- 109
                  P++V+ Y +                      L K+ T    +   Y+ E    
Sbjct: 60  ------NPWVVKLYYSFQDENYLYLIMEYLPGGDMMTLLMKKDTFTEEETRFYIAETILA 113

Query: 110 -----ELKIIHRDVKPSNILLDRRGAIKLCDFGIS 139
                +L  IHRD+KP N+LLD +G IKL DFG+ 
Sbjct: 114 IDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLC 148

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364

>gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

 Score = 70.9 bits (174), Expect = 8e-15
 Identities = 51/181 (28%), Positives = 86/181 (47%), Gaps = 41/181 (22%)

Query: 25  DLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRI-RSTVDEKDQ-RQLLMDLDVVMKSNEC 82
           D Q L ++G+GG+G V     + +  ++A+KR+ +S + + ++ R +L + D++  +   
Sbjct: 2   DFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKS- 60

Query: 83  PYIVQFY-----------------GALFKEVTVAT---------------VKALNYLKEE 110
            ++V+                   G  F+ +                    +A++ L  E
Sbjct: 61  EWLVKLLYAFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDAL-HE 119

Query: 111 LKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPLRARG 170
           L  IHRD+KP N L+D  G IKL DFG+S  +V + A +   G   YMAPE    LR +G
Sbjct: 120 LGYIHRDLKPENFLIDASGHIKLTDFGLSKGIV-TYANSV-VGSPDYMAPEV---LRGKG 174

Query: 171 Y 171
           Y
Sbjct: 175 Y 175

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333

>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases

 Score = 69.9 bits (172), Expect = 9e-15
 Identities = 37/178 (20%), Positives = 64/178 (35%), Gaps = 49/178 (27%)

Query: 31  EIGRGGFGTVNK-MIHRSSDTVM--AVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQ 87
           ++G G FG V K  +          AVK ++    E++++  L +  V MK    P +V+
Sbjct: 2   KLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARV-MKKLGHPNVVR 60

Query: 88  FYGA---------------------------------LFKEVTVATV--------KALNY 106
             G                                      +++  +        K + Y
Sbjct: 61  LLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEY 120

Query: 107 LKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTRDAGCR---PYMAPE 161
           L    K +HRD+   N L+     +K+ DFG+S  + D     +  G +    +MAPE
Sbjct: 121 L-ASKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWMAPE 177

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262

>gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

 Score = 69.7 bits (170), Expect = 1e-14
 Identities = 53/168 (31%), Positives = 81/168 (48%), Gaps = 39/168 (23%)

Query: 29  LGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQF 88
           +GE+G G FG V K  ++ +  V+A  ++  T  E++    ++++D+ + S + P IV+ 
Sbjct: 10  IGELGDGAFGKVYKAQNKET-GVLAAAKVIDTKSEEELEDYMVEIDI-LASCDHPNIVKL 67

Query: 89  YGALFKE---------------------------------VTVATVKALNYLKEELKIIH 115
             A + E                                 V   T++ALNYL E  KIIH
Sbjct: 68  LDAFYYENNLWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHEN-KIIH 126

Query: 116 RDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTRDA--GCRPYMAPE 161
           RD+K  NIL    G IKL DFG+S +   +I + RD+  G   +MAPE
Sbjct: 127 RDLKAGNILFTLDGDIKLADFGVSAKNTRTIQR-RDSFIGTPYWMAPE 173

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282

>gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional

 Score = 70.2 bits (172), Expect = 1e-14
 Identities = 46/174 (26%), Positives = 80/174 (45%), Gaps = 39/174 (22%)

Query: 24  EDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECP 83
            +L+ +  IG G  GTV K+IHR +  + A+K I    ++  +RQ+  ++++ ++    P
Sbjct: 74  SELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEI-LRDVNHP 132

Query: 84  YIVQFYG----------------------------ALFKEVTVATVKALNYLKEELKIIH 115
            +V+ +                                 +V    +  + YL     I+H
Sbjct: 133 NVVKCHDMFDHNGEIQVLLEFMDGGSLEGTHIADEQFLADVARQILSGIAYLHRR-HIVH 191

Query: 116 RDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTRD-----AGCRPYMAPERID 164
           RD+KPSN+L++    +K+ DFG+S  L    A+T D      G   YM+PERI+
Sbjct: 192 RDIKPSNLLINSAKNVKIADFGVSRIL----AQTMDPCNSSVGTIAYMSPERIN 241

Length = 353

>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

 Score = 68.5 bits (168), Expect = 3e-14
 Identities = 42/167 (25%), Positives = 69/167 (41%), Gaps = 35/167 (20%)

Query: 29  LGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQF 88
           LG +G G +G V K  ++++  ++A+K+ + + D++D ++  +    V++      IV  
Sbjct: 6   LGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNL 65

Query: 89  -----------------------------YG---ALFKEVTVATVKALNYLKEELKIIHR 116
                                         G      +      ++A+ Y      IIHR
Sbjct: 66  KEAFRRKGRLYLVFEYVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYC-HSHNIIHR 124

Query: 117 DVKPSNILLDRRGAIKLCDFGISGQLVDSIAK--TRDAGCRPYMAPE 161
           D+KP NIL+   G +KLCDFG +  L    A   T     R Y APE
Sbjct: 125 DIKPENILVSESGVLKLCDFGFARALRARPASPLTDYVATRWYRAPE 171

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score = 67.1 bits (165), Expect = 9e-14
 Identities = 36/146 (24%), Positives = 66/146 (45%), Gaps = 39/146 (26%)

Query: 29  LGEIGRGGFGTVNKMIHRSSDTVMAVKRIR----------STVDE-KDQRQL-------L 70
           L ++G G +G V K   + +  ++A+K+IR          + + E    ++L       L
Sbjct: 4   LEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKL 63

Query: 71  MDLDVVMKSNECPYIV---------QFYGALFKEVTVATVK--------ALNYLKEELKI 113
           +D   V+ +    Y+V         ++       ++   +K         L Y     +I
Sbjct: 64  LD---VIHTERKLYLVFEYCDMDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSH-RI 119

Query: 114 IHRDVKPSNILLDRRGAIKLCDFGIS 139
           +HRD+KP NIL++R G +KL DFG++
Sbjct: 120 LHRDLKPQNILINRDGVLKLADFGLA 145

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score = 67.5 bits (163), Expect = 1e-13
 Identities = 48/188 (25%), Positives = 72/188 (38%), Gaps = 49/188 (26%)

Query: 31  EIGRGGFGTVNKMIHRSSDTVMAVKRIRSTV--DEKDQRQLLMDLDVVMKSNECPYIVQF 88
           ++G G FG V     R    ++A+K +   +    K+  + L ++ ++   N  P IV+ 
Sbjct: 7   KLGEGSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKL 63

Query: 89  YG-----------------------------------ALFKEVTVATVKALNYLKEELKI 113
           Y                                    +    +    + AL YL     I
Sbjct: 64  YDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHS-KGI 122

Query: 114 IHRDVKPSNILLDRRG-AIKLCDFGISGQLVDSIAKTRDA-------GCRPYMAPERIDP 165
           IHRD+KP NILLDR G  +KL DFG++  L D  + +          G   YMAPE +  
Sbjct: 123 IHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLLG 182

Query: 166 LRARGYPS 173
           L      S
Sbjct: 183 LSLAYASS 190

Length = 384

>gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

 Score = 66.7 bits (163), Expect = 2e-13
 Identities = 53/175 (30%), Positives = 80/175 (45%), Gaps = 40/175 (22%)

Query: 24  EDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVK--RIRSTVDEKDQRQLLMDLDVVMKSNE 81
           +DL+ +  +G G FG V+ +  R S+   A+K   I   +  K Q Q + +   V+K   
Sbjct: 1   DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLK-QEQHVHNEKRVLKEVS 59

Query: 82  CPYIVQFY------------------GALFKEVTVA--------------TVKALNYLKE 109
            P+I++ +                  G LF  +  +               V AL YL  
Sbjct: 60  HPFIIRLFWTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYL-H 118

Query: 110 ELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTRD-AGCRPYMAPERI 163
             +I++RD+KP NILLD+ G IKL DFG + +L D   +T    G   Y+APE I
Sbjct: 119 SKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRD---RTWTLCGTPEYLAPEVI 170

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291

>gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

 Score = 66.0 bits (161), Expect = 2e-13
 Identities = 47/171 (27%), Positives = 73/171 (42%), Gaps = 42/171 (24%)

Query: 29  LGEIGRGGFGTVNKMIHRSSDTVMAVKRIR-STVDEKDQ-RQLLMDLDVVMKSNECPYIV 86
           L  I +G FG+V     RS+    A+K ++ S +  K+Q   +  +  ++M   E PY+ 
Sbjct: 1   LKPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVA 60

Query: 87  QFYGA------LF--------------------------KEVTVATVKALNYLKEELKII 114
           + Y +      L+                          K+     V  +  L +   II
Sbjct: 61  KLYYSFQSKDYLYLVMEYLNGGDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQR-GII 119

Query: 115 HRDVKPSNILLDRRGAIKLCDFGIS--GQLVDSIAKTRDAGCRPYMAPERI 163
           HRD+KP N+L+D+ G +KL DFG+S  G        T D     Y+APE I
Sbjct: 120 HRDIKPENLLIDQTGHLKLTDFGLSRNGLENKKFVGTPD-----YLAPETI 165

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260

>gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

 Score = 64.9 bits (159), Expect = 6e-13
 Identities = 50/191 (26%), Positives = 82/191 (42%), Gaps = 59/191 (30%)

Query: 24  EDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKR------IRS-----TVDEK-------- 64
           +D + +  +G G FG V  + H+ S    A+K       ++       ++EK        
Sbjct: 1   DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRH 60

Query: 65  -----------DQRQLLMDLDVVM---------KSNECP-YIVQFYGALFKEVTVATVKA 103
                      D   L + ++ V          KS   P  + +FY A   +V +A    
Sbjct: 61  PFLVNLYGSFQDDSNLYLVMEYVPGGELFSHLRKSGRFPEPVARFYAA---QVVLA---- 113

Query: 104 LNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVD---SIAKTRDAGCRPYMAP 160
           L YL   L I++RD+KP N+LLD  G IK+ DFG + ++     ++  T +     Y+AP
Sbjct: 114 LEYL-HSLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGRTYTLCGTPE-----YLAP 167

Query: 161 ERIDPLRARGY 171
           E I    ++GY
Sbjct: 168 EII---LSKGY 175

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290

>gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

 Score = 64.7 bits (157), Expect = 7e-13
 Identities = 53/184 (28%), Positives = 83/184 (45%), Gaps = 42/184 (22%)

Query: 24  EDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEK---DQRQLLMDLDVVMKSN 80
           ED + +  IG G +G V K  + ++  + A+K I+    E     Q++++M     MK  
Sbjct: 9   EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIM-----MKDC 63

Query: 81  ECPYIVQFYGALFKE--------------------------------VTVATVKALNYLK 108
           +   IV ++G+  +                                 V+  T++ L YL 
Sbjct: 64  KHSNIVAYFGSYLRRDKLWICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLH 123

Query: 109 EELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTRDAGCRPY-MAPERIDPLR 167
            + K+ HRD+K +NILL   G +KL DFG+S Q+  +IAK +     PY MAPE     R
Sbjct: 124 SKGKM-HRDIKGANILLTDNGHVKLADFGVSAQITATIAKRKSFIGTPYWMAPEVAAVER 182

Query: 168 ARGY 171
             GY
Sbjct: 183 KGGY 186

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267

>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

 Score = 64.1 bits (157), Expect = 1e-12
 Identities = 40/148 (27%), Positives = 63/148 (42%), Gaps = 35/148 (23%)

Query: 24  EDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRI--RSTVDEKDQRQLLMDLDVVMKSNE 81
           +D +    IG G F TV     + ++   A+K +  R  + EK  + + ++ +V+ + N 
Sbjct: 1   DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNG 60

Query: 82  CPYIVQFYGA------LFKEVTVAT--------------------------VKALNYLKE 109
            P I++ Y        L+  +  A                           + AL YL  
Sbjct: 61  HPGIIKLYYTFQDEENLYFVLEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYL-H 119

Query: 110 ELKIIHRDVKPSNILLDRRGAIKLCDFG 137
              IIHRD+KP NILLD+   IK+ DFG
Sbjct: 120 SKGIIHRDLKPENILLDKDMHIKITDFG 147

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280

>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

 Score = 64.0 bits (156), Expect = 1e-12
 Identities = 48/186 (25%), Positives = 79/186 (42%), Gaps = 46/186 (24%)

Query: 30  GE-IGRGGFGTVNKMIHRSSDTVMAVKRI---RSTVDEKDQRQL----LMDLDV-VMKSN 80
           GE IG+G +G V   ++ ++  +MAVK++    +     D RQ      +  ++  +K  
Sbjct: 6   GELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDL 65

Query: 81  ECPYIVQFYG--------------------------------ALFKEVTVATVKALNYLK 108
           +   IVQ+ G                                 L +  T   ++ L YL 
Sbjct: 66  DHLNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLH 125

Query: 109 EELKIIHRDVKPSNILLDRRGAIKLCDFGISGQ---LVDSIAKTRDAGCRPYMAPERIDP 165
            +  I+HRD+K  N+L+D  G  K+ DFGIS +   + D+       G   +MAPE I  
Sbjct: 126 SK-GILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAPEVIH- 183

Query: 166 LRARGY 171
             ++GY
Sbjct: 184 SYSQGY 189

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272

>gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

 Score = 63.5 bits (154), Expect = 3e-12
 Identities = 45/165 (27%), Positives = 78/165 (47%), Gaps = 36/165 (21%)

Query: 32  IGRGGFGTVNKMIHRSSDTVMAVKRI--RSTVDEKDQRQLLMDLDVVMKSNECPYIVQFY 89
           IG+G FG V    H++ +   AVK +  ++ + +K+++ ++ + +V++K+ + P++V  +
Sbjct: 3   IGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLH 62

Query: 90  ------------------GALFKEV--------------TVATVKALNYLKEELKIIHRD 117
                             G LF  +                    AL YL   L I++RD
Sbjct: 63  FSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYL-HSLNIVYRD 121

Query: 118 VKPSNILLDRRGAIKLCDFGISGQLVDSIAKTRD-AGCRPYMAPE 161
           +KP NILLD +G I L DFG+  + ++    T    G   Y+APE
Sbjct: 122 LKPENILLDSQGHIVLTDFGLCKENIEHNGTTSTFCGTPEYLAPE 166

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325

>gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

 Score = 62.4 bits (152), Expect = 5e-12
 Identities = 49/177 (27%), Positives = 79/177 (44%), Gaps = 46/177 (25%)

Query: 24  EDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDE-----------KDQRQL--- 69
           E  + L +IG G +G V K  +R +  ++A+K+   + D+           +  +QL   
Sbjct: 1   EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHP 60

Query: 70  -LMDLDVVMKSNECPYIVQFY-----------------GALFKEVTVATVKALNYLKEEL 111
            L++L  V +     ++V  Y                   L K++   T++A+N+   + 
Sbjct: 61  NLVNLIEVFRRKRKLHLVFEYCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFC-HKH 119

Query: 112 KIIHRDVKPSNILLDRRGAIKLCDFGIS-------GQLVDSIAKTRDAGCRPYMAPE 161
             IHRDVKP NIL+ ++G IKLCDFG +           D +A       R Y APE
Sbjct: 120 NCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTDYVAT------RWYRAPE 170

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286

>gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

 Score = 62.5 bits (152), Expect = 6e-12
 Identities = 56/194 (28%), Positives = 80/194 (41%), Gaps = 57/194 (29%)

Query: 23  SEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRI-------RSTV----DEK------- 64
           +ED   +  IGRG FG V  + H+SS  V A+K +       RS      +E+       
Sbjct: 42  AEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHAN 101

Query: 65  ------------DQRQLLM--------DLDVVMKSNECPY-IVQFYGALFKEVTVATVKA 103
                       D + L M        DL  +M + + P    +FY       T   V A
Sbjct: 102 SEWIVQLHYAFQDDKYLYMVMEYMPGGDLVNLMSNYDIPEKWARFY-------TAEVVLA 154

Query: 104 LNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGI------SGQLVDSIAKTRDAGCRPY 157
           L+ +   +  IHRDVKP N+LLD+ G +KL DFG       +G +    A     G   Y
Sbjct: 155 LDAI-HSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCDTA----VGTPDY 209

Query: 158 MAPERIDPLRARGY 171
           ++PE +      GY
Sbjct: 210 ISPEVLKSQGGDGY 223

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370

>gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

 Score = 62.1 bits (151), Expect = 9e-12
 Identities = 48/167 (28%), Positives = 83/167 (49%), Gaps = 36/167 (21%)

Query: 32  IGRGGFGTVNKMIHRSSDTVMAVKRI--RSTVDEKDQRQLLMDLDVVMKSNECPYIVQFY 89
           IG+G FG V    H++     AVK +  ++ + +K+Q+ ++ + +V++K+ + P++V  +
Sbjct: 3   IGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLH 62

Query: 90  ------------------GALF----KEVTVATVKALNYLKE---------ELKIIHRDV 118
                             G LF    +E +    +A  Y  E          L II+RD+
Sbjct: 63  YSFQTADKLYFVLDYVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSLNIIYRDL 122

Query: 119 KPSNILLDRRGAIKLCDFGISGQLVDSIAKTRDAGC-RP-YMAPERI 163
           KP NILLD +G + L DFG+  + ++  +KT    C  P Y+APE +
Sbjct: 123 KPENILLDSQGHVVLTDFGLCKEGIE-HSKTTSTFCGTPEYLAPEVL 168

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323

>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

 Score = 61.3 bits (149), Expect = 1e-11
 Identities = 49/187 (26%), Positives = 83/187 (44%), Gaps = 51/187 (27%)

Query: 32  IGRGGFGTVNKMIHRSSDTVMAVKRIR--STVDEKDQRQLLMDLDVVMKSNECPYIVQFY 89
           IG+G F  V K I      V+A+K+++    +D K ++  L ++D+ +K  + P ++++ 
Sbjct: 10  IGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDL-LKQLDHPNVIKYL 68

Query: 90  -------------------------------GALFKEVTVAT-----VKALNYLKEELKI 113
                                            L  E T+         AL ++  + +I
Sbjct: 69  ASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSK-RI 127

Query: 114 IHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTRDA----GCRPYMAPERIDPLRAR 169
           +HRD+KP+N+ +   G +KL D G+ G+   S  KT  A    G   YM+PERI      
Sbjct: 128 MHRDIKPANVFITATGVVKLGDLGL-GRFFSS--KTTAAHSLVGTPYYMSPERI---HEN 181

Query: 170 GYPSFKT 176
           GY +FK+
Sbjct: 182 GY-NFKS 187

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

 Score = 61.5 bits (149), Expect = 1e-11
 Identities = 48/163 (29%), Positives = 80/163 (49%), Gaps = 35/163 (21%)

Query: 31  EIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQFY- 89
           +IG+G  GTV   I  ++   +A+K++   + ++ +++L+++  +VM+ N+ P IV +  
Sbjct: 26  KIGQGASGTVYTAIDVATGQEVAIKQM--NLQQQPKKELIINEILVMRENKHPNIVNYLD 83

Query: 90  -----------------GALFKEVT--------VATV-----KALNYLKEELKIIHRDVK 119
                            G+L   VT        +A V     +AL +L    ++IHRD+K
Sbjct: 84  SYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSN-QVIHRDIK 142

Query: 120 PSNILLDRRGAIKLCDFGISGQLVDSIAKTRDAGCRPY-MAPE 161
             NILL   G++KL DFG   Q+    +K       PY MAPE
Sbjct: 143 SDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPE 185

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293

>gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

 Score = 61.5 bits (149), Expect = 1e-11
 Identities = 51/176 (28%), Positives = 84/176 (47%), Gaps = 38/176 (21%)

Query: 32  IGRGGFGTVNKMIHRSSDTVMAVKRI--RSTVDEKDQRQLLMDLDVVMKS--NECPYIV- 86
           IG+G FG V ++  + +  + A+K +  +  V +K+    + + ++++++  +E P+IV 
Sbjct: 1   IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVG 60

Query: 87  ---------QFY--------GALF----KEVTVATVKALNYLKE---------ELKIIHR 116
                      Y        G LF    KE   +  +A  Y+ E         +  I++R
Sbjct: 61  LKFSFQTDSDLYLVTDYMSGGELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYDIVYR 120

Query: 117 DVKPSNILLDRRGAIKLCDFGIS-GQLVDSIAKTRDAGCRPYMAPERIDPLRARGY 171
           D+KP NILLD  G I LCDFG+S   L D+       G   Y+APE +  L  +GY
Sbjct: 121 DLKPENILLDATGHIALCDFGLSKANLTDNKTTNTFCGTTEYLAPEVL--LDEKGY 174

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330

>gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

 Score = 61.5 bits (149), Expect = 2e-11
 Identities = 50/164 (30%), Positives = 72/164 (43%), Gaps = 35/164 (21%)

Query: 32  IGRGGFGTVNKMIHRSSDTVMAVKRIRST--VDEKDQRQLLMDLDVVMKSNECPYIV--- 86
           IG+G FG V ++  R +  + A+K IR    V   +    L +  V+ + N CP+IV   
Sbjct: 1   IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVN-CPFIVPLK 59

Query: 87  -------QFY--------GALF----KEVTVATVKALNYLKE---------ELKIIHRDV 118
                  + Y        G LF    +E      +A  Y  E         +  +I+RD+
Sbjct: 60  FSFQSPEKLYLVLAFINGGELFHHLQREGRFDLSRARFYTAELLCALENLHKFNVIYRDL 119

Query: 119 KPSNILLDRRGAIKLCDFGISG-QLVDSIAKTRDAGCRPYMAPE 161
           KP NILLD +G I LCDFG+    + D        G   Y+APE
Sbjct: 120 KPENILLDYQGHIALCDFGLCKLNMKDDDKTNTFCGTPEYLAPE 163

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312

>gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

 Score = 61.1 bits (148), Expect = 2e-11
 Identities = 46/165 (27%), Positives = 76/165 (46%), Gaps = 36/165 (21%)

Query: 32  IGRGGFGTVNKMIHRSSDTVMAVKRI--RSTVDEKDQRQLLMDLDVVMKSNECPYIVQFY 89
           IG+G FG V     +S  +  AVK +  ++ + +K+Q  ++ + +V++K+ + P++V  +
Sbjct: 3   IGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLH 62

Query: 90  ------------------GALFKEV--------------TVATVKALNYLKEELKIIHRD 117
                             G LF  +                    A+ YL   L II+RD
Sbjct: 63  YSFQTAEKLYFVLDYVNGGELFFHLQRERCFLEPRARFYAAEVASAIGYL-HSLNIIYRD 121

Query: 118 VKPSNILLDRRGAIKLCDFGISGQLVDSIAKTRD-AGCRPYMAPE 161
           +KP NILLD +G + L DFG+  + V+    T    G   Y+APE
Sbjct: 122 LKPENILLDSQGHVVLTDFGLCKEGVEPEETTSTFCGTPEYLAPE 166

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321

>gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

 Score = 60.8 bits (147), Expect = 3e-11
 Identities = 51/185 (27%), Positives = 78/185 (42%), Gaps = 39/185 (21%)

Query: 23  SEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIR--STVDEKDQRQLLMDLDVVMKSN 80
           +ED   +  IGRG FG V  + H+SS  V A+K +     +   D      + D++  +N
Sbjct: 42  AEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFAN 101

Query: 81  ECPYIVQFYGALFKE-------------------------------VTVATVKALNYLKE 109
             P++VQ + A   +                                T   V AL+ +  
Sbjct: 102 S-PWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLMSNYDVPEKWAKFYTAEVVLALDAI-H 159

Query: 110 ELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTR---DAGCRPYMAPERIDPL 166
            + +IHRDVKP N+LLD+ G +KL DFG   ++ D     R     G   Y++PE +   
Sbjct: 160 SMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKM-DETGMVRCDTAVGTPDYISPEVLKSQ 218

Query: 167 RARGY 171
              GY
Sbjct: 219 GGDGY 223

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370

>gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

 Score = 60.0 bits (145), Expect = 3e-11
 Identities = 48/175 (27%), Positives = 76/175 (43%), Gaps = 47/175 (26%)

Query: 32  IGRGGFGTVNKMIHRSSDTVMAVKRIR--STVDEKDQRQLLMDLDVVMKSNECPYIVQFY 89
           IG+G +G V K+ ++   ++ AVK +   S VDE    ++  + +++      P +V+FY
Sbjct: 30  IGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDE----EIEAEYNILQSLPNHPNVVKFY 85

Query: 90  GALFK----------------------EVTVATVKALNYLKEEL---------------- 111
           G  +K                      E+    +     L E +                
Sbjct: 86  GMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLH 145

Query: 112 --KIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDS-IAKTRDAGCRPYMAPERI 163
             +IIHRDVK +NILL   G +KL DFG+S QL  + + +    G   +MAPE I
Sbjct: 146 NNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVI 200

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291

>gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

 Score = 60.0 bits (146), Expect = 4e-11
 Identities = 40/160 (25%), Positives = 67/160 (41%), Gaps = 54/160 (33%)

Query: 27  QDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIR----------STVDEKDQRQLLMDLDVV 76
           ++L EIG G +GTV K    ++   +A+K++R          ST+ E     LL  L+  
Sbjct: 2   EELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREI---ALLKQLE-- 56

Query: 77  MKSNECPYIVQFYG-----ALFKEVTVATV-----------------------KALNYLK 108
             S E P IV+           +E+ +  V                          + ++
Sbjct: 57  --SFEHPNIVRLLDVCHGPRTDRELKLTLVFEHVDQDLATYLSKCPKPGLPPETIKDLMR 114

Query: 109 EELK---------IIHRDVKPSNILLDRRGAIKLCDFGIS 139
           + L+         I+HRD+KP NIL+   G +K+ DFG++
Sbjct: 115 QLLRGVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLA 154

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287

>gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

 Score = 59.7 bits (145), Expect = 4e-11
 Identities = 43/171 (25%), Positives = 76/171 (44%), Gaps = 34/171 (19%)

Query: 24  EDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQL-------------- 69
           E  ++LG +G G +G V K  H+ +  ++A+K+   + D+K  +++              
Sbjct: 1   EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHE 60

Query: 70  -LMDLDVVMKSNECPYIV-------------QFYGAL----FKEVTVATVKALNYLKEEL 111
            L++L  V +  +  Y+V             ++   L     ++     ++ + +     
Sbjct: 61  NLVNLIEVFRRKKRLYLVFEFVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSH- 119

Query: 112 KIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDS-IAKTRDAGCRPYMAPE 161
            IIHRD+KP NIL+ + G +KLCDFG +  L       T     R Y APE
Sbjct: 120 NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTDYVATRWYRAPE 170

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286

>gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

 Score = 59.5 bits (144), Expect = 4e-11
 Identities = 44/165 (26%), Positives = 71/165 (43%), Gaps = 36/165 (21%)

Query: 32  IGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQFY-- 89
           +GRG FG V+    ++   ++ +K+I      KD+R    +   V+K    P I+++Y  
Sbjct: 8   VGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYEN 67

Query: 90  ---------------------------GALFKEVT-----VATVKALNYLKEELKIIHRD 117
                                       +L  E T     V  + AL+++  +L I+HRD
Sbjct: 68  FLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKL-ILHRD 126

Query: 118 VKPSNILLDRRGAI-KLCDFGISGQLVDSIAKTRDAGCRPYMAPE 161
           +K  NILLD+   + K+ DFGIS  L          G   Y++PE
Sbjct: 127 LKTQNILLDKHKMVVKIGDFGISKILSSKSKAYTVVGTPCYISPE 171

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256

>gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

 Score = 60.0 bits (145), Expect = 5e-11
 Identities = 44/167 (26%), Positives = 78/167 (46%), Gaps = 36/167 (21%)

Query: 32  IGRGGFGTVNKMIHRSSDTVMAVKRIRSTV--DEKDQRQLLMDLDVVMKSNECPYIVQFY 89
           IG+G FG V     +      AVK ++  +  + K+Q+ ++ + +V++K+ + P++V  +
Sbjct: 3   IGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLH 62

Query: 90  ------------------GALF----KEVTVATVKALNYLKE---------ELKIIHRDV 118
                             G LF    +E +    +A  Y  E          + I++RD+
Sbjct: 63  YSFQTTEKLYFVLDFVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSINIVYRDL 122

Query: 119 KPSNILLDRRGAIKLCDFGISGQLVDSIAKTRDAGC--RPYMAPERI 163
           KP NILLD +G + L DFG+  + + + + T    C    Y+APE I
Sbjct: 123 KPENILLDSQGHVVLTDFGLCKEGI-AQSDTTTTFCGTPEYLAPEVI 168

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score = 59.5 bits (145), Expect = 5e-11
 Identities = 42/144 (29%), Positives = 65/144 (45%), Gaps = 37/144 (25%)

Query: 29  LGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKD--------QRQLLMDLD------ 74
           + +IG G +G V K  ++ +  ++A+K+IR   +EK+        + +LL  L       
Sbjct: 4   IAQIGEGTYGQVYKARNKKTGELVALKKIR-MENEKEGFPITAIREIKLLQKLRHPNIVR 62

Query: 75  ----VVMKSNECPYIVQFY------GAL---FKEVTVATVK--------ALNYLKEELKI 113
               V  K     Y+V  Y      G L     + T + +K         L YL     I
Sbjct: 63  LKEIVTSKGKGSIYMVFEYMDHDLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSN-GI 121

Query: 114 IHRDVKPSNILLDRRGAIKLCDFG 137
           +HRD+K SNIL++  G +KL DFG
Sbjct: 122 LHRDIKGSNILINNDGVLKLADFG 145

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

 Score = 59.7 bits (144), Expect = 6e-11
 Identities = 54/175 (30%), Positives = 79/175 (45%), Gaps = 35/175 (20%)

Query: 24  EDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECP 83
           E L    +IG G  G V     + +   +AVK++   + ++ +R+LL +  V+M+     
Sbjct: 22  EYLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKM--DLRKQQRRELLFNEVVIMRDYHHE 79

Query: 84  YIVQFY------------------GALFKEVT--------VATV-----KALNYLKEELK 112
            +V  Y                  GAL   VT        +ATV     +AL+YL  +  
Sbjct: 80  NVVDMYNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIATVCLSVLRALSYLHNQ-G 138

Query: 113 IIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTRDAGCRPY-MAPERIDPL 166
           +IHRD+K  +ILL   G IKL DFG   Q+   + K +     PY MAPE I  L
Sbjct: 139 VIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKSLVGTPYWMAPEVISRL 193

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292

>gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 59.5 bits (144), Expect = 7e-11
 Identities = 45/149 (30%), Positives = 70/149 (46%), Gaps = 34/149 (22%)

Query: 24  EDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKR-IRSTVDEKDQ-RQLLMDLDVVMKSNE 81
           ED   +  IG+G FG V  +  + +  + A+K  ++S + +KDQ   +  + DV+ +S+ 
Sbjct: 1   EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDS 60

Query: 82  CPYIVQFYGA----------------------LFKEVTVATVKALNYLKE---------E 110
            P++V  Y +                      L K  T +      Y+ E         +
Sbjct: 61  -PWVVSLYYSFQDAQYLYLIMEFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHK 119

Query: 111 LKIIHRDVKPSNILLDRRGAIKLCDFGIS 139
           L  IHRD+KP NIL+DR G IKL DFG+S
Sbjct: 120 LGFIHRDIKPDNILIDRGGHIKLSDFGLS 148

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377

>gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

 Score = 59.0 bits (143), Expect = 9e-11
 Identities = 41/150 (27%), Positives = 72/150 (48%), Gaps = 37/150 (24%)

Query: 25  DLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKD-------QRQLLMDL---- 73
           D   + +IG G +G V K  ++ +  ++A+K+IR   +E+        +  LL +L    
Sbjct: 1   DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPN 60

Query: 74  -----DVVMKSNECPYIVQFYGALFKE----------VTVATVKALNYLKEEL------- 111
                DV+M+ +    I +F     K+          +    VK+  YL + L       
Sbjct: 61  IVCLQDVLMQESRLYLIFEFLSMDLKKYLDSLPKGQYMDAELVKS--YLYQILQGILFCH 118

Query: 112 --KIIHRDVKPSNILLDRRGAIKLCDFGIS 139
             +++HRD+KP N+L+D +G IKL DFG++
Sbjct: 119 SRRVLHRDLKPQNLLIDNKGVIKLADFGLA 148

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285

>gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

 Score = 58.6 bits (142), Expect = 1e-10
 Identities = 50/166 (30%), Positives = 76/166 (45%), Gaps = 38/166 (22%)

Query: 32  IGRGGFGTVNKMIHRSSDTVMAVKRIR-STVDEKDQRQLLMDLDVV-------------- 76
           +G+G FG          D+++  K +  + + EK++R  L ++ ++              
Sbjct: 8   LGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNH 67

Query: 77  -MKSN----ECPY---------IVQFYGALFKEVTVA-----TVKALNYLKEELKIIHRD 117
            M  N    E  Y         IV+  G LF+E  V       V A++Y+ +   I+HRD
Sbjct: 68  FMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKA-GILHRD 126

Query: 118 VKPSNILLDRRGAIKLCDFGISGQLVD--SIAKTRDAGCRPYMAPE 161
           +K  NI L + G IKL DFGIS  L    S+A+T   G   YM+PE
Sbjct: 127 IKTLNIFLTKAGLIKLGDFGISKILGSEYSMAETV-VGTPYYMSPE 171

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256

>gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional

 Score = 58.7 bits (142), Expect = 1e-10
 Identities = 50/181 (27%), Positives = 76/181 (41%), Gaps = 41/181 (22%)

Query: 20  DFTSEDLQDL--GE-IGRGGFGTVNKMIHRSSDTVMAVK--RIRSTVDEKDQRQLLMDLD 74
           D +S  L D   GE +G G FG V    H+ +    A+K  + R  +  K  + +  +  
Sbjct: 11  DTSSWKLSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKS 70

Query: 75  VVMKSNECPYIVQFY------------------GALFKEVTVA--------------TVK 102
           ++M+ +  P+IV                     G LF  +  A               V 
Sbjct: 71  ILMELSH-PFIVNMMCSFQDENRVYFLLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVL 129

Query: 103 ALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTRDAGCRPYMAPER 162
           A  YL     II+RD+KP N+LLD +G +K+ DFG + ++ D        G   Y+APE 
Sbjct: 130 AFEYL-HSKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDRTFTL--CGTPEYLAPEV 186

Query: 163 I 163
           I
Sbjct: 187 I 187

Length = 329

>gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

 Score = 58.5 bits (141), Expect = 1e-10
 Identities = 51/173 (29%), Positives = 81/173 (46%), Gaps = 35/173 (20%)

Query: 26  LQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYI 85
           L +  +IG G  G V     +SS  ++AVK++   + ++ +R+LL +  V+M+  +   +
Sbjct: 22  LDNFIKIGEGSTGIVCIATVKSSGKLVAVKKM--DLRKQQRRELLFNEVVIMRDYQHENV 79

Query: 86  VQFY------------------GALFKEVT-------------VATVKALNYLKEELKII 114
           V+ Y                  GAL   VT             +A +KAL+ L  +  +I
Sbjct: 80  VEMYNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAAVCLAVLKALSVLHAQ-GVI 138

Query: 115 HRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTRDAGCRPY-MAPERIDPL 166
           HRD+K  +ILL   G +KL DFG   Q+   + + +     PY MAPE I  L
Sbjct: 139 HRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELISRL 191

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292

>gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

 Score = 58.6 bits (141), Expect = 1e-10
 Identities = 48/165 (29%), Positives = 82/165 (49%), Gaps = 35/165 (21%)

Query: 31  EIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQFY- 89
           +IG+G  GTV   I  ++   +A+K++   + ++ +++L+++  +VM+ N+ P IV +  
Sbjct: 26  KIGQGASGTVYTAIDIATGQEVAIKQM--NLQQQPKKELIINEILVMRENKNPNIVNYLD 83

Query: 90  -----------------GALFKEVT--------VATV-----KALNYLKEELKIIHRDVK 119
                            G+L   VT        +A V     +AL++L    ++IHRD+K
Sbjct: 84  SYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALDFLHSN-QVIHRDIK 142

Query: 120 PSNILLDRRGAIKLCDFGISGQLVDSIAKTRDAGCRPY-MAPERI 163
             NILL   G++KL DFG   Q+    +K       PY MAPE +
Sbjct: 143 SDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVV 187

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297

>gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

 Score = 58.1 bits (140), Expect = 2e-10
 Identities = 47/174 (27%), Positives = 79/174 (45%), Gaps = 45/174 (25%)

Query: 32  IGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQFYGA 91
           IG+G +G V K++++ + +  AVK I   + + D+ ++  + +++   ++ P +V+FYG 
Sbjct: 26  IGKGTYGKVFKVLNKKNGSKAAVK-ILDPIHDIDE-EIEAEYNILKALSDHPNVVKFYGM 83

Query: 92  LFK------------------------------------EVTVATV-----KALNYLKEE 110
            +K                                    E  +A +       L +L   
Sbjct: 84  YYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVN 143

Query: 111 LKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDS-IAKTRDAGCRPYMAPERI 163
            K IHRDVK +NILL   G +KL DFG+S QL  + + +    G   +MAPE I
Sbjct: 144 -KTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVI 196

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286

>gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

 Score = 58.2 bits (140), Expect = 2e-10
 Identities = 46/165 (27%), Positives = 81/165 (49%), Gaps = 35/165 (21%)

Query: 31  EIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQFY- 89
           +IG+G  GTV   +  ++   +A++++   + ++ +++L+++  +VM+ N+ P IV +  
Sbjct: 27  KIGQGASGTVYTAMDVATGQEVAIRQM--NLQQQPKKELIINEILVMRENKNPNIVNYLD 84

Query: 90  -----------------GALFKEVT--------VATV-----KALNYLKEELKIIHRDVK 119
                            G+L   VT        +A V     +AL +L    ++IHRD+K
Sbjct: 85  SYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSN-QVIHRDIK 143

Query: 120 PSNILLDRRGAIKLCDFGISGQLVDSIAKTRDAGCRPY-MAPERI 163
             NILL   G++KL DFG   Q+    +K       PY MAPE +
Sbjct: 144 SDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVV 188

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296

>gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

 Score = 58.3 bits (141), Expect = 2e-10
 Identities = 46/175 (26%), Positives = 74/175 (42%), Gaps = 55/175 (31%)

Query: 32  IGRGGFGTVNKMIHRSSDTVMAVKRIRSTV------------------------------ 61
           +GRG FG V  +  +++  + A+K ++ +V                              
Sbjct: 9   VGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQY 68

Query: 62  --DEKDQRQLLM------DLDVVMKSNECPY---IVQFYGALFKEVTVA--TVKALNYLK 108
              +KD   L+M      DL  ++   E  +   + QFY A   E+ +A  +V  + Y  
Sbjct: 69  AFQDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLA---ELVLAIHSVHQMGY-- 123

Query: 109 EELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLV--DSIAKTRDAGCRPYMAPE 161
                +HRD+KP N+L+DR G IKL DFG + +L     +      G   Y+APE
Sbjct: 124 -----VHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNSKLPVGTPDYIAPE 173

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330

>gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

 Score = 57.4 bits (138), Expect = 3e-10
 Identities = 48/172 (27%), Positives = 75/172 (43%), Gaps = 42/172 (24%)

Query: 32  IGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQFYGA 91
           +G G +G V K  H  +  + A+K +  T DE+++  +  +++++ K +    I  +YGA
Sbjct: 14  VGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEE--IKQEINMLKKYSHHRNIATYYGA 71

Query: 92  LFKE---------------VTVATVKAL------NYLKEEL------------------K 112
             K+                   +V  L      N LKEE                   K
Sbjct: 72  FIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHK 131

Query: 113 IIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTRDAGCRPY-MAPERI 163
           +IHRD+K  N+LL     +KL DFG+S QL  ++ +       PY MAPE I
Sbjct: 132 VIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVI 183

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272

>gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

 Score = 57.7 bits (140), Expect = 3e-10
 Identities = 45/157 (28%), Positives = 71/157 (45%), Gaps = 45/157 (28%)

Query: 24  EDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTV-DEKD------QRQL------- 69
            D + LG++G G FG V K     +  V+A+K+I   + +EKD       R++       
Sbjct: 8   RDYEILGKLGEGTFGEVYKARQIKTGRVVALKKI--LMHNEKDGFPITALREIKILKKLK 65

Query: 70  ------LMDLDVVMKSNE-----CPYIVQFY------GALFKE---VTVATVK------- 102
                 L+D+ V             Y+V  Y      G L      +T + +K       
Sbjct: 66  HPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPSVKLTESQIKCYMLQLL 125

Query: 103 -ALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGI 138
             +NYL E   I+HRD+K +NIL+D +G +K+ DFG+
Sbjct: 126 EGINYLHEN-HILHRDIKAANILIDNQGILKIADFGL 161

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311

>gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

 Score = 57.2 bits (138), Expect = 3e-10
 Identities = 45/182 (24%), Positives = 78/182 (42%), Gaps = 46/182 (25%)

Query: 32  IGRGGFGTVNKMIHRSSDTVMAVKRIR----STVDEKDQRQLLMDLDVVMKSNECPYIVQ 87
           +G G F +  +     + T+MAVK++     ++ ++++  + L     +M     P+I++
Sbjct: 8   LGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIR 67

Query: 88  FYGAL---------------------------FKE-VTVA----TVKALNYLKEELKIIH 115
             GA                            FKE V +      ++ L+YL E  +IIH
Sbjct: 68  MLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHEN-QIIH 126

Query: 116 RDVKPSNILLDRRGA-IKLCDFGISGQLVDSIAKTRD-----AGCRPYMAPERIDPLRAR 169
           RDVK +N+L+D  G  +++ DFG + +L        +      G   +MAPE    LR  
Sbjct: 127 RDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPE---VLRGE 183

Query: 170 GY 171
            Y
Sbjct: 184 QY 185

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268

>gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

 Score = 57.2 bits (139), Expect = 3e-10
 Identities = 42/176 (23%), Positives = 78/176 (44%), Gaps = 36/176 (20%)

Query: 31  EIGRGGFGTVNKMIHRSSDTVMAVKRIR---STVDE-------KDQRQL-----LMDLDV 75
           ++G G FG+V    ++ +  ++A+K+++    + +E       K  R+L     ++ L  
Sbjct: 6   QLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKE 65

Query: 76  VMKSNECPYIV---------QFY----GALFKEVTVA-----TVKALNYLKEELKIIHRD 117
           V + N+  Y V         Q      G  F E  +       ++ L ++  +    HRD
Sbjct: 66  VFRENDELYFVFEYMEGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHI-HKHGFFHRD 124

Query: 118 VKPSNILLDRRGAIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPLRARGYPS 173
           +KP N+L+     +K+ DFG++ ++      T     R Y APE +  LR+  Y S
Sbjct: 125 LKPENLLVSGPEVVKIADFGLAREIRSRPPYTDYVSTRWYRAPEIL--LRSTSYSS 178

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283

>gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

 Score = 56.9 bits (138), Expect = 4e-10
 Identities = 38/146 (26%), Positives = 63/146 (43%), Gaps = 36/146 (24%)

Query: 27  QDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIR---------ST----------------- 60
           Q + +IG G +G V K   + +  ++A+K+IR         ST                 
Sbjct: 2   QKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIV 61

Query: 61  ----VDEKDQRQLL----MDLDVVMKSNECPYIVQFYGALFKEVTVATVKALNYLKEELK 112
               V   + +  L    +DLD+    +  P        L K      ++ + Y     +
Sbjct: 62  RLLDVVHSENKLYLVFEFLDLDLKKYMDSSPLT-GLDPPLIKSYLYQLLQGIAYCHSH-R 119

Query: 113 IIHRDVKPSNILLDRRGAIKLCDFGI 138
           ++HRD+KP N+L+DR GA+KL DFG+
Sbjct: 120 VLHRDLKPQNLLIDREGALKLADFGL 145

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283

>gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

 Score = 57.4 bits (138), Expect = 4e-10
 Identities = 42/147 (28%), Positives = 70/147 (47%), Gaps = 32/147 (21%)

Query: 24  EDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIR-STVDEKDQ-RQLLMDLDVVMKSNE 81
           ED + L  IGRG FG V  +  + +  V A+K +R + + EK+Q   +  + D++++++ 
Sbjct: 1   EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADS 60

Query: 82  CPYIVQFYG---------------------ALFKEVTVATVKALNYLKE---------EL 111
              +  FY                       L K+ T+   +   Y+ E         +L
Sbjct: 61  LWVVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQL 120

Query: 112 KIIHRDVKPSNILLDRRGAIKLCDFGI 138
             IHRD+KP N+LLD +G +KL DFG+
Sbjct: 121 GFIHRDIKPDNLLLDSKGHVKLSDFGL 147

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363

>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 56.7 bits (137), Expect = 5e-10
 Identities = 47/170 (27%), Positives = 74/170 (43%), Gaps = 38/170 (22%)

Query: 32  IGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDV---VMKSNECPYIVQF 88
           +G+G FG V       +   +AVK++    D  + ++ +  L+    ++K+ +   IVQ+
Sbjct: 10  LGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQY 69

Query: 89  YGAL--------FKEVT--------VATVKALN------YLKEELK---------IIHRD 117
           YG L        F E          +    AL       Y ++ L+         I+HRD
Sbjct: 70  YGCLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSNMIVHRD 129

Query: 118 VKPSNILLDRRGAIKLCDFGISGQL---VDSIAKTRDAGCRPY-MAPERI 163
           +K +NIL D  G +KL DFG S +L     S    +     PY M+PE I
Sbjct: 130 IKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVI 179

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263

>gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

 Score = 56.4 bits (136), Expect = 6e-10
 Identities = 39/147 (26%), Positives = 70/147 (47%), Gaps = 36/147 (24%)

Query: 27  QDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIR----------------STVDEKDQRQLL 70
           Q + +IG G +G V K  ++ +  V+A+K+IR                S + E +   ++
Sbjct: 3   QKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIV 62

Query: 71  MDLDVVMKSNECPYIVQFYGALFK---------EVTVATVKALNYLKEEL---------K 112
             LDV+   N+   + +F     K          + +  +K  +YL + L         +
Sbjct: 63  KLLDVIHTENKLYLVFEFLHQDLKKFMDASPLSGIPLPLIK--SYLFQLLQGLAFCHSHR 120

Query: 113 IIHRDVKPSNILLDRRGAIKLCDFGIS 139
           ++HRD+KP N+L++  GAIKL DFG++
Sbjct: 121 VLHRDLKPQNLLINTEGAIKLADFGLA 147

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284

>gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

 Score = 56.2 bits (136), Expect = 7e-10
 Identities = 45/172 (26%), Positives = 70/172 (40%), Gaps = 40/172 (23%)

Query: 30  GEIGRGGFGTVNKMIHRSSDTV---MAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIV 86
            E+G G FG+V K ++         +AVK ++       +++ L +  V+ + +  P IV
Sbjct: 1   KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDH-PCIV 59

Query: 87  QFYG-----------------ALFK------EVTVATVKAL--------NYLKEELKIIH 115
           +  G                  L K      E+ V+ +K L         YL E    +H
Sbjct: 60  RLIGVCKGEPLMLVMELAPLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYL-ESKHFVH 118

Query: 116 RDVKPSNILLDRRGAIKLCDFGISGQLV--DSIAKTRDAGCRP--YMAPERI 163
           RD+   N+LL  R   K+ DFG+S  L       +   AG  P  + APE I
Sbjct: 119 RDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECI 170

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257

>gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

 Score = 56.2 bits (135), Expect = 8e-10
 Identities = 50/173 (28%), Positives = 77/173 (44%), Gaps = 44/173 (25%)

Query: 32  IGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQFYGA 91
           +G G +G V K  H  +  + A+K +  T DE+++ +L  +++++ K +    I  +YGA
Sbjct: 24  VGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKL--EINMLKKYSHHRNIATYYGA 81

Query: 92  LFKE--------------------VT--VATVKALNYLKEEL------------------ 111
             K+                    VT  V   K  N LKE+                   
Sbjct: 82  FIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKG-NALKEDWIAYICREILRGLAHLHAH 140

Query: 112 KIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTRDAGCRPY-MAPERI 163
           K+IHRD+K  N+LL     +KL DFG+S QL  ++ +       PY MAPE I
Sbjct: 141 KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVI 193

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282

>gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

 Score = 56.1 bits (136), Expect = 1e-09
 Identities = 39/158 (24%), Positives = 75/158 (47%), Gaps = 44/158 (27%)

Query: 16  DTVYDFTSEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQ-------R- 67
            +V ++     + L  I  G +G V +   + +  ++A+K+++  ++++ +       R 
Sbjct: 2   RSVDEY-----EKLNRIEEGTYGVVYRARDKKTGEIVALKKLK--MEKEKEGFPITSLRE 54

Query: 68  -QLLMDLD---------VVMKSN-ECPYIVQFY-----GALFKEV----TVATVKAL--- 104
             +L+ L          VV+ SN +  Y+V  Y      +L + +      + VK L   
Sbjct: 55  INILLKLQHPNIVTVKEVVVGSNLDKIYMVMEYVEHDLKSLMETMKQPFLQSEVKCLMLQ 114

Query: 105 -----NYLKEELKIIHRDVKPSNILLDRRGAIKLCDFG 137
                 +L  +  I+HRD+K SN+LL+ RG +K+CDFG
Sbjct: 115 LLSGVAHL-HDNWILHRDLKTSNLLLNNRGILKICDFG 151

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293

>gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

 Score = 56.2 bits (135), Expect = 1e-09
 Identities = 49/184 (26%), Positives = 80/184 (43%), Gaps = 37/184 (20%)

Query: 23  SEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIR--STVDEKDQRQLLMDLDVVMKSN 80
           +ED + +  IGRG FG V  + H+S+  V A+K +     +   D      + D++  +N
Sbjct: 42  AEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFAN 101

Query: 81  ECPYIVQFYGALFKE-------------------------------VTVATVKALNYLKE 109
             P++VQ + A   +                                T   V AL+ +  
Sbjct: 102 S-PWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWARFYTAEVVLALDAI-H 159

Query: 110 ELKIIHRDVKPSNILLDRRGAIKLCDFGISGQL-VDSIAKTRDA-GCRPYMAPERIDPLR 167
            +  IHRDVKP N+LLD+ G +KL DFG   ++  + + +   A G   Y++PE +    
Sbjct: 160 SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQG 219

Query: 168 ARGY 171
             GY
Sbjct: 220 GDGY 223

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371

>gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

 Score = 55.8 bits (134), Expect = 1e-09
 Identities = 51/170 (30%), Positives = 78/170 (45%), Gaps = 35/170 (20%)

Query: 26  LQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYI 85
           L++  +IG G  G V     + S   +AVK +   + ++ +R+LL +  V+M+  +   +
Sbjct: 23  LENYIKIGEGSTGIVCIAREKHSGRQVAVKMM--DLRKQQRRELLFNEVVIMRDYQHQNV 80

Query: 86  VQFY------------------GAL--------FKEVTVATV-----KALNYLKEELKII 114
           V+ Y                  GAL          E  +ATV     +AL YL  +  +I
Sbjct: 81  VEMYKSYLVGEELWVLMEFLQGGALTDIVSQTRLNEEQIATVCESVLQALCYLHSQ-GVI 139

Query: 115 HRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTRDAGCRPY-MAPERI 163
           HRD+K  +ILL   G +KL DFG   Q+   + K +     PY MAPE I
Sbjct: 140 HRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVI 189

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297

>gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

 Score = 56.0 bits (135), Expect = 1e-09
 Identities = 50/186 (26%), Positives = 76/186 (40%), Gaps = 53/186 (28%)

Query: 21  FTSED----LQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRST---VDEKDQRQLLMDL 73
           F+ +D      DL EIG G FG V       ++ V+A+K++  +    +EK Q  ++ ++
Sbjct: 8   FSKDDPEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQ-DIIKEV 66

Query: 74  DVVMKSNECPYIVQFYGALFKE--------------------------------VTVATV 101
             + +    P  +++ G   +E                                +    +
Sbjct: 67  RFLQQLRH-PNTIEYKGCYLREHTAWLVMEYCLGSASDILEVHKKPLQEVEIAAICHGAL 125

Query: 102 KALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVD---SIAKTRDAGCRPY- 157
           + L YL    + IHRD+K  NILL   G +KL DFG S  LV    S   T      PY 
Sbjct: 126 QGLAYL-HSHERIHRDIKAGNILLTEPGTVKLADFG-SASLVSPANSFVGT------PYW 177

Query: 158 MAPERI 163
           MAPE I
Sbjct: 178 MAPEVI 183

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307

>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

 Score = 55.8 bits (135), Expect = 1e-09
 Identities = 39/150 (26%), Positives = 66/150 (44%), Gaps = 45/150 (30%)

Query: 29  LGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQ------RQ-------------- 68
           L  IG G +G V +    +S  ++A+K++R   +E+D       R+              
Sbjct: 12  LNRIGEGTYGIVYRARDTTSGEIVALKKVR-MDNERDGIPISSLREITLLLNLRHPNIVE 70

Query: 69  --------------LLM-----DLDVVMKSNECPYIVQFYGALFKEVTVATVKALNYLKE 109
                         L+M     DL  ++ +   P    F  +  K + +  ++ L YL E
Sbjct: 71  LKEVVVGKHLDSIFLVMEYCEQDLASLLDNMPTP----FSESQVKCLMLQLLRGLQYLHE 126

Query: 110 ELKIIHRDVKPSNILLDRRGAIKLCDFGIS 139
              IIHRD+K SN+LL  +G +K+ DFG++
Sbjct: 127 NF-IIHRDLKVSNLLLTDKGCLKIADFGLA 155

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309

>gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

 Score = 55.5 bits (134), Expect = 1e-09
 Identities = 43/165 (26%), Positives = 68/165 (41%), Gaps = 36/165 (21%)

Query: 32  IGRGGFGTVNKMIHRSSDTVMAVKRIRSTV--DEKDQRQLLMDLDVVMKSNECPYIVQFY 89
           +G+G FG V     + +D + AVK ++  V   + D    + +  V+  + + P++ Q +
Sbjct: 3   LGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLH 62

Query: 90  ------------------GAL---------FKE-----VTVATVKALNYLKEELKIIHRD 117
                             G L         F E          V  L +L E   II+RD
Sbjct: 63  SCFQTKDRLFFVMEYVNGGDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHER-GIIYRD 121

Query: 118 VKPSNILLDRRGAIKLCDFGISGQLVDSIAKTRD-AGCRPYMAPE 161
           +K  N+LLD  G IK+ DFG+  + +     T    G   Y+APE
Sbjct: 122 LKLDNVLLDSEGHIKIADFGMCKEGILGGVTTSTFCGTPDYIAPE 166

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318

>gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

 Score = 55.6 bits (134), Expect = 2e-09
 Identities = 48/173 (27%), Positives = 76/173 (43%), Gaps = 35/173 (20%)

Query: 24  EDLQDLGEIGRGGFGTVNKMIHRSSDTVMA---------VKRIRST--VDEKD-----QR 67
           +D + L  IGRG FG V  +  +++  V A         +KR  +    +E+D      R
Sbjct: 1   DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDR 60

Query: 68  QLLMDLDVVMKSNECPYIVQFY---GALFK-----EVTVATVKALNYLKE---------E 110
           + + +L    +     Y+V  Y   G L       E  +    A  YL E         +
Sbjct: 61  RWITNLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQ 120

Query: 111 LKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVD--SIAKTRDAGCRPYMAPE 161
           L  +HRD+KP N+LLD+ G I+L DFG   +L+   ++      G   Y++PE
Sbjct: 121 LGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQSNVAVGTPDYISPE 173

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331

>gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

 Score = 55.0 bits (132), Expect = 2e-09
 Identities = 23/52 (44%), Positives = 34/52 (65%)

Query: 110 ELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTRDAGCRPYMAPE 161
            + I++RD+KP N+LLD +G  +L D G++ +L D    T+ AG   YMAPE
Sbjct: 113 SMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKTITQRAGTNGYMAPE 164

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277

>gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

 Score = 55.4 bits (133), Expect = 2e-09
 Identities = 40/147 (27%), Positives = 70/147 (47%), Gaps = 32/147 (21%)

Query: 24  EDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIR-STVDEKDQ-RQLLMDLDVVMKSNE 81
           +D + L  IGRG FG V  +  + +  + A+K +R + + EK+Q   +  + D++++++ 
Sbjct: 1   DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADG 60

Query: 82  CPYIVQFYG---------------------ALFKEVTVATVKALNYLKE---------EL 111
              +  FY                       L K+ T++      Y+ E         +L
Sbjct: 61  AWVVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQL 120

Query: 112 KIIHRDVKPSNILLDRRGAIKLCDFGI 138
             IHRD+KP N+LLD +G +KL DFG+
Sbjct: 121 GFIHRDIKPDNLLLDAKGHVKLSDFGL 147

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360

>gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

 Score = 54.7 bits (131), Expect = 2e-09
 Identities = 48/173 (27%), Positives = 80/173 (46%), Gaps = 40/173 (23%)

Query: 24  EDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECP 83
            D + +  +G G +G V K  +  +  + AVK I+  ++  D   L+     ++K  EC 
Sbjct: 9   HDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIK--LEPGDDFSLIQQEIFMVK--ECK 64

Query: 84  Y--IVQFYGALF---------------------------KEVTVA-----TVKALNYLKE 109
           +  IV ++G+                              E+ +A     T++ L YL  
Sbjct: 65  HCNIVAYFGSYLSREKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHS 124

Query: 110 ELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTRDAGCRPY-MAPE 161
           + K+ HRD+K +NILL   G +KL DFG++ ++  +IAK +     PY MAPE
Sbjct: 125 KGKM-HRDIKGANILLTDNGDVKLADFGVAAKITATIAKRKSFIGTPYWMAPE 176

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score = 54.5 bits (132), Expect = 4e-09
 Identities = 41/170 (24%), Positives = 65/170 (38%), Gaps = 45/170 (26%)

Query: 32  IGRGGFGTVNKMIHRSSDTVMAVKRIR-------------------------------ST 60
           +G G +  V K   + +  ++A+K+I+                                 
Sbjct: 8   LGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGL 67

Query: 61  VD---EKDQRQLLM-----DLDVVMKSNECPYIVQFYGALFKEVTVATVKALNYLKEELK 112
           +D    K    L+      DL+ V+K            A  K   + T++ L YL     
Sbjct: 68  LDVFGHKSNINLVFEFMETDLEKVIKDKSIVLTP----ADIKSYMLMTLRGLEYL-HSNW 122

Query: 113 IIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAK-TRDAGCRPYMAPE 161
           I+HRD+KP+N+L+   G +KL DFG++        K T     R Y APE
Sbjct: 123 ILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMTHQVVTRWYRAPE 172

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

 Score = 54.1 bits (130), Expect = 4e-09
 Identities = 44/174 (25%), Positives = 81/174 (46%), Gaps = 40/174 (22%)

Query: 25  DLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIR-STVDEKDQRQLLMDLDVVMKSNECP 83
           D + L +IG+G FG V K++ ++   V A+K+I  S ++ +++ + + +  V+ K +   
Sbjct: 1   DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDS-S 59

Query: 84  YIVQFY------------------GALFKEVT----------------VATVKALNYLKE 109
           YI+++Y                  G L K +                 +  +  L +L  
Sbjct: 60  YIIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHS 119

Query: 110 ELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDS--IAKTRDAGCRPYMAPE 161
           + KI+HRD+K  N+ LD    +K+ D G++  L D+   A T   G   Y++PE
Sbjct: 120 K-KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANTI-VGTPYYLSPE 171

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256

>gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

 Score = 54.0 bits (130), Expect = 4e-09
 Identities = 31/80 (38%), Positives = 45/80 (56%), Gaps = 10/80 (12%)

Query: 86  VQFYGALFKEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLV-D 144
           V+ Y A   E+ +A    L++L  +L II+RD+K  NILLD  G + L DFG+S + + +
Sbjct: 107 VRVYIA---EIVLA----LDHL-HQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAE 158

Query: 145 SIAKTRD-AGCRPYMAPERI 163
              +     G   YMAPE I
Sbjct: 159 EEERAYSFCGTIEYMAPEVI 178

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288

>gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

 Score = 54.3 bits (130), Expect = 4e-09
 Identities = 48/165 (29%), Positives = 79/165 (47%), Gaps = 35/165 (21%)

Query: 31  EIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQFY- 89
           +IG+G  GTV   I  ++   +A+K+I   + ++ +++L+++  +VMK  + P IV F  
Sbjct: 26  KIGQGASGTVFTAIDVATGQEVAIKQI--NLQKQPKKELIINEILVMKELKNPNIVNFLD 83

Query: 90  -----------------GAL--------FKEVTVATV-----KALNYLKEELKIIHRDVK 119
                            G+L          E  +A V     +AL +L    ++IHRD+K
Sbjct: 84  SFLVGDELFVVMEYLAGGSLTDVVTETCMDEAQIAAVCRECLQALEFLHAN-QVIHRDIK 142

Query: 120 PSNILLDRRGAIKLCDFGISGQLVDSIAKTRDAGCRPY-MAPERI 163
             N+LL   G++KL DFG   Q+    +K       PY MAPE +
Sbjct: 143 SDNVLLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVV 187

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296

>gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

 Score = 54.1 bits (131), Expect = 4e-09
 Identities = 27/71 (38%), Positives = 37/71 (52%), Gaps = 15/71 (21%)

Query: 101 VKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTRDAGCRP---- 156
           +KAL Y+     +IHRD+KPSNILL+    +KL DFG    L  S+++  +    P    
Sbjct: 117 LKALKYIHSG-NVIHRDLKPSNILLNSDCRVKLADFG----LARSLSELEENPENPVLTD 171

Query: 157 ------YMAPE 161
                 Y APE
Sbjct: 172 YVATRWYRAPE 182

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337

>gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

 Score = 53.6 bits (129), Expect = 6e-09
 Identities = 34/144 (23%), Positives = 69/144 (47%), Gaps = 35/144 (24%)

Query: 29  LGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQ------------------RQLL 70
           L +IG G +GTV K  +R +  ++A+KR+R  +D+ D+                  + ++
Sbjct: 5   LEKIGEGTYGTVFKAKNRETHEIVALKRVR--LDDDDEGVPSSALREICLLKELKHKNIV 62

Query: 71  MDLDVVMKSNECPYIVQ--------FYGALFKEVTVATVKALNY--LK-----EELKIIH 115
              DV+    +   + +        ++ +   ++    VK+  +  LK         ++H
Sbjct: 63  RLYDVLHSDKKLTLVFEYCDQDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHNVLH 122

Query: 116 RDVKPSNILLDRRGAIKLCDFGIS 139
           RD+KP N+L+++ G +KL DFG++
Sbjct: 123 RDLKPQNLLINKNGELKLADFGLA 146

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284

>gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

 Score = 53.4 bits (128), Expect = 7e-09
 Identities = 51/171 (29%), Positives = 73/171 (42%), Gaps = 40/171 (23%)

Query: 31  EIGRGGFGTVNKMIH--RSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIV-- 86
           E+G G FG V K ++  R     +A+K +++  +EK  R  +M    +M   + PYIV  
Sbjct: 2   ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNE-NEKSVRDEMMREAEIMHQLDNPYIVRM 60

Query: 87  ----------------------QFYGALFKEVTVATVKAL--------NYLKEELKIIHR 116
                                 +F      E+TV+ V  L         YL E    +HR
Sbjct: 61  IGVCEAEALMLVMEMASGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYL-EGKNFVHR 119

Query: 117 DVKPSNILLDRRGAIKLCDFGISGQLV--DSIAKTRDAGCRP--YMAPERI 163
           D+   N+LL  +   K+ DFG+S  L   DS  K R AG  P  + APE I
Sbjct: 120 DLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECI 170

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257

>gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

 Score = 53.5 bits (128), Expect = 9e-09
 Identities = 49/173 (28%), Positives = 78/173 (45%), Gaps = 35/173 (20%)

Query: 24  EDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIR--------STVDEKDQRQLLMD--- 72
           ED + L  IGRG FG V  +  +++D V A+K +          T   +++R +L++   
Sbjct: 1   EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDN 60

Query: 73  -----LDVVMKSNECPYIVQFY---GALFK-----EVTVATVKALNYLKE---------E 110
                L    +     Y+V  Y   G L       E  +    A  YL E         +
Sbjct: 61  QWITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQ 120

Query: 111 LKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVD--SIAKTRDAGCRPYMAPE 161
           L  +HRD+KP NIL+D  G I+L DFG   +L++  ++  +   G   Y++PE
Sbjct: 121 LHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPE 173

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332

>gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

 Score = 52.8 bits (127), Expect = 1e-08
 Identities = 43/191 (22%), Positives = 73/191 (38%), Gaps = 58/191 (30%)

Query: 19  YDFTSEDLQ--DLGEIGRGGFGTVNKMIHRSSDTVMAVKRIR----------STVDEKDQ 66
           + F  E  +   L +IG+G FG V K  H+ +  ++A+K++           + + E   
Sbjct: 5   FPFCDEVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKI 64

Query: 67  RQLLMDLDVV-----------MKSNECPYI-------------------VQFYGALFKEV 96
            QLL   +VV             +                         V+F  +  K+V
Sbjct: 65  LQLLKHENVVNLIEICRTKATPYNRYKGSFYLVFEFCEHDLAGLLSNKNVKFTLSEIKKV 124

Query: 97  TVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTRDAGCRP 156
               +  L Y+    KI+HRD+K +NIL+ + G +KL DFG++               R 
Sbjct: 125 MKMLLNGLYYIHRN-KILHRDMKAANILITKDGILKLADFGLA---------------RA 168

Query: 157 YMAPERIDPLR 167
           +   +   P R
Sbjct: 169 FSLSKNSKPNR 179

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310

>gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

 Score = 52.5 bits (126), Expect = 1e-08
 Identities = 42/179 (23%), Positives = 70/179 (39%), Gaps = 46/179 (25%)

Query: 29  LGEIGRGGFGTVNKM-IHRSSDTVMAVKRI-------RSTVDEKDQ--RQLLMDLDVVMK 78
           L  +G G FG V K+    +   ++A+K I            E+D+    ++ ++ ++ +
Sbjct: 5   LEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKE 64

Query: 79  SNECPYIVQFY-------------------------------GALFKE-----VTVATVK 102
               P IV++Y                                  F E     + V  V 
Sbjct: 65  QLRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVL 124

Query: 103 ALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTRDAGCRPYMAPE 161
           AL YL +E +I+HRD+ P+NI+L     + + DFG++ Q       T   G   Y  PE
Sbjct: 125 ALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPESKLTSVVGTILYSCPE 183

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269

>gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

 Score = 52.5 bits (126), Expect = 2e-08
 Identities = 43/150 (28%), Positives = 69/150 (46%), Gaps = 36/150 (24%)

Query: 24  EDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRI-------RSTVD----EKD------- 65
           ED + +  I  G +G V  + H+ +    A+K+I       R+ +     E+D       
Sbjct: 1   EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAEN 60

Query: 66  ------------QRQLLMDLDVVMKSNECPYIVQFYGALFKEVT----VATVKALNYLKE 109
                       +R L M ++ V +  +C  +++  GAL  ++       TV AL YL  
Sbjct: 61  PFVVSMFCSFETKRHLCMVMEYV-EGGDCATLLKNIGALPVDMARMYFAETVLALEYL-H 118

Query: 110 ELKIIHRDVKPSNILLDRRGAIKLCDFGIS 139
              I+HRD+KP N+L+   G IKL DFG+S
Sbjct: 119 NYGIVHRDLKPDNLLITSMGHIKLTDFGLS 148

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305

>gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

 Score = 52.3 bits (125), Expect = 2e-08
 Identities = 43/167 (25%), Positives = 73/167 (43%), Gaps = 35/167 (20%)

Query: 29  LGEIGRGGFGTVNKMIHRSSDTVMAVKRIRST-----VDEKDQRQLLM----------DL 73
           LG +G G +G V K  H+ +  ++A+K+ + +     V E   R+L M          +L
Sbjct: 6   LGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVEL 65

Query: 74  DVVMKSNECPYIVQFY--------------GALFKEV---TVATVKALNYLKEELKIIHR 116
               +     Y+V  Y              G   ++V       +KA+++  +   I+HR
Sbjct: 66  KEAFRRRGKLYLVFEYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKN-DIVHR 124

Query: 117 DVKPSNILLDRRGAIKLCDFGISGQLVD--SIAKTRDAGCRPYMAPE 161
           D+KP N+L+     +KLCDFG +  L +  +   T     R Y +PE
Sbjct: 125 DIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEYVATRWYRSPE 171

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287

>gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

 Score = 52.2 bits (125), Expect = 2e-08
 Identities = 26/66 (39%), Positives = 42/66 (63%), Gaps = 2/66 (3%)

Query: 97  TVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTRD-AGCR 155
           T   +  L +L +  +II+RD+KP N+LLD  G +++ D G++ +L D  +KT+  AG  
Sbjct: 103 TAQIISGLEHLHQR-RIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGYAGTP 161

Query: 156 PYMAPE 161
            +MAPE
Sbjct: 162 GFMAPE 167

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280

>gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

 Score = 52.5 bits (126), Expect = 2e-08
 Identities = 27/60 (45%), Positives = 36/60 (60%), Gaps = 2/60 (3%)

Query: 103 ALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTRD-AGCRPYMAPE 161
           AL +L  +  II+RD+KP NILLD +G +KL DFG+  + +     T    G   YMAPE
Sbjct: 112 ALEHL-HQQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTHTFCGTIEYMAPE 170

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323

>gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

 Score = 52.0 bits (125), Expect = 2e-08
 Identities = 46/177 (25%), Positives = 76/177 (42%), Gaps = 41/177 (23%)

Query: 26  LQDLGEIGRGGFGTVNKMIHR-SSDTV---MAVKRIRSTVDEKDQRQLLMDLDVVMKSNE 81
           L+ +  +G G FGTV K +     + V   +A+K +R     K  +++ +D   VM S +
Sbjct: 9   LEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEI-LDEAYVMASVD 67

Query: 82  CPYIVQFY-----------------GALFKEV---------------TVATVKALNYLKE 109
            P++V+                   G L   V                V   K ++YL E
Sbjct: 68  HPHVVRLLGICLSSQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYL-E 126

Query: 110 ELKIIHRDVKPSNILLDRRGAIKLCDFGISGQL-VDSIAKTRDAGCRP--YMAPERI 163
           E +++HRD+   N+L+     +K+ DFG++  L VD      + G  P  +MA E I
Sbjct: 127 EKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESI 183

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279

>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

 Score = 51.7 bits (124), Expect = 3e-08
 Identities = 26/52 (50%), Positives = 34/52 (65%), Gaps = 1/52 (1%)

Query: 110 ELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTRDAGCRPYMAPE 161
           E KI+HRD+K +NILL     +K+ D GIS  L  ++AKT+  G   YMAPE
Sbjct: 121 EQKILHRDLKSANILLVANDLVKIGDLGISKVLKKNMAKTQ-IGTPHYMAPE 171

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256

>gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

 Score = 51.3 bits (123), Expect = 4e-08
 Identities = 45/180 (25%), Positives = 72/180 (40%), Gaps = 40/180 (22%)

Query: 23  SEDLQDLGE-IGRGGFGTVNKMIHRSSDTV---MAVKRIRSTVDEKDQRQLLMDLDVVMK 78
             +   LG  IG G FG V + ++ S +     +AVK  +        R+  +    +M+
Sbjct: 4   QREDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCK-NCTSPSVREKFLQEAYIMR 62

Query: 79  SNECPYIVQF-----------------YGALFK-------EVTVATV--------KALNY 106
             + P+IV+                   G L          + +A++         AL Y
Sbjct: 63  QFDHPHIVKLIGVITENPVWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAY 122

Query: 107 LKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTRDAGCRP--YMAPERID 164
           L E  + +HRD+   N+L+     +KL DFG+S  L D        G  P  +MAPE I+
Sbjct: 123 L-ESKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKLPIKWMAPESIN 181

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270

>gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

 Score = 51.4 bits (123), Expect = 4e-08
 Identities = 27/79 (34%), Positives = 43/79 (54%), Gaps = 9/79 (11%)

Query: 87  QFYGALFKEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSI 146
           +FYGA         V AL YL     +++RD+K  N++LD+ G IK+ DFG+  + +   
Sbjct: 98  RFYGA-------EIVSALGYLHSC-DVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDG 149

Query: 147 AKTRD-AGCRPYMAPERID 164
           A  +   G   Y+APE ++
Sbjct: 150 ATMKTFCGTPEYLAPEVLE 168

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323

>gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

 Score = 51.2 bits (122), Expect = 6e-08
 Identities = 28/79 (35%), Positives = 45/79 (56%), Gaps = 8/79 (10%)

Query: 87  QFYGALFKEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSI 146
           +FYGA         V AL+YL  E  +++RD+K  N++LD+ G IK+ DFG+  + +   
Sbjct: 98  RFYGA-------EIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDG 150

Query: 147 AKTRD-AGCRPYMAPERID 164
           A  +   G   Y+APE ++
Sbjct: 151 ATMKTFCGTPEYLAPEVLE 169

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325

>gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

 Score = 50.9 bits (121), Expect = 7e-08
 Identities = 52/199 (26%), Positives = 84/199 (42%), Gaps = 46/199 (23%)

Query: 4   SIQSSGKLKLSPDTVYDFTSED----LQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRS 59
           S   +G LK  P+    F  ED      DL EIG G FG V       ++ V+A+K++  
Sbjct: 2   STSRAGSLK-DPEIAELFFKEDPEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSY 60

Query: 60  TVDEKDQR-QLLMDLDVVMKSNECPYIVQFYGALFKE----------------------- 95
           +  + +++ Q ++     ++  + P  +++ G   +E                       
Sbjct: 61  SGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEYCLGSASDLLEVHKK 120

Query: 96  ---------VTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSI 146
                    +T   ++ L YL     +IHRD+K  NILL   G +KL DFG +     SI
Sbjct: 121 PLQEVEIAAITHGALQGLAYLHSH-NMIHRDIKAGNILLTEPGQVKLADFGSA-----SI 174

Query: 147 AKTRDA--GCRPYMAPERI 163
           A   ++  G   +MAPE I
Sbjct: 175 ASPANSFVGTPYWMAPEVI 193

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317

>gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

 Score = 50.8 bits (122), Expect = 7e-08
 Identities = 45/183 (24%), Positives = 76/183 (41%), Gaps = 51/183 (27%)

Query: 23  SEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRI----RSTVDEKDQRQL--------- 69
               Q+L  IG G +G V    H+ +   +A+K+I      T  ++  R++         
Sbjct: 4   GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHE 63

Query: 70  --LMDLDVVMKSNECP----YIVQFY--GALFKEV-------------TVATVKALNYLK 108
             +  LD++   +       YIVQ      L+K +                 ++ L Y+ 
Sbjct: 64  NIIGILDIIRPPSFESFNDVYIVQELMETDLYKLIKTQHLSNDHIQYFLYQILRGLKYI- 122

Query: 109 EELKIIHRDVKPSNILLDRRGAIKLCDFGI----------SGQLVDSIAKTRDAGCRPYM 158
               ++HRD+KPSN+LL+    +K+CDFG+          +G L + +A       R Y 
Sbjct: 123 HSANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVAT------RWYR 176

Query: 159 APE 161
           APE
Sbjct: 177 APE 179

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336

>gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

 Score = 50.6 bits (121), Expect = 8e-08
 Identities = 35/164 (21%), Positives = 71/164 (43%), Gaps = 34/164 (20%)

Query: 32  IGRGGFGTVNKMIHRSSDTVMAVKRI-RSTVDEKDQRQLLMDLDVVMKSNECPYIVQFYG 90
           +G+GGFG V     +++  + A K++ +  + ++   Q+ ++   +++     +IV    
Sbjct: 1   LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAY 60

Query: 91  ALFKEVTVATV------------------------KALNYLKE---------ELKIIHRD 117
           A   +  +  V                        +A+ Y  +         + +I++RD
Sbjct: 61  AFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRD 120

Query: 118 VKPSNILLDRRGAIKLCDFGISGQLVDSIAKTRDAGCRPYMAPE 161
           +KP N+LLD  G +++ D G++ +L         AG   YMAPE
Sbjct: 121 LKPENVLLDDHGNVRISDLGLAVELKGGKKIKGRAGTPGYMAPE 164

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277

>gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

 Score = 50.2 bits (121), Expect = 9e-08
 Identities = 40/170 (23%), Positives = 72/170 (42%), Gaps = 41/170 (24%)

Query: 32  IGRGGFGTVNKMIHRSSDTVMAVKRI-RSTVDEKDQRQLLMDLDVVMKSNECPYIVQFYG 90
           IG G +G V   + + +   +A+K+I     D  D +++L ++  +++      I+    
Sbjct: 8   IGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREI-KLLRHLRHENIIGLLD 66

Query: 91  AL-------FKEVTVAT----------VKALNYLKEE------------LK------IIH 115
            L       F +V + T          +K+   L ++            LK      +IH
Sbjct: 67  ILRPPSPEDFNDVYIVTELMETDLHKVIKSPQPLTDDHIQYFLYQILRGLKYLHSANVIH 126

Query: 116 RDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTRD----AGCRPYMAPE 161
           RD+KPSNIL++    +K+CDFG++  +     +          R Y APE
Sbjct: 127 RDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEYVVTRWYRAPE 176

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330

>gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

 Score = 50.3 bits (120), Expect = 1e-07
 Identities = 44/153 (28%), Positives = 66/153 (43%), Gaps = 36/153 (23%)

Query: 24  EDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECP 83
           +DL  L E+G G FG V     R    V A+K I+     +D  + + +  V+MK +   
Sbjct: 4   KDLTFLKELGTGQFGVVKYGKWRGQYDV-AIKMIKEGSMSED--EFIEEAKVMMKLSH-E 59

Query: 84  YIVQFYGALFKEVTVATVKA-------LNYLKEELK------------------------ 112
            +VQ YG   K+  +  V         LNYL+E  K                        
Sbjct: 60  KLVQLYGVCTKQRPIYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESK 119

Query: 113 -IIHRDVKPSNILLDRRGAIKLCDFGISGQLVD 144
             IHRD+   N L+D +G +K+ DFG+S  ++D
Sbjct: 120 QFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLD 152

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256

>gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

 Score = 50.0 bits (119), Expect = 1e-07
 Identities = 46/188 (24%), Positives = 78/188 (41%), Gaps = 45/188 (23%)

Query: 15  PDTVYDFTSEDLQ----DLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQR-QL 69
           P+    F  +D +     L EIG G FG V    +  ++ V+AVK++  +  + +++ Q 
Sbjct: 8   PEIADLFYKDDPEEIFVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQD 67

Query: 70  LMDLDVVMKSNECPYIVQFYGALFKE--------------------------------VT 97
           ++     ++  + P  +++ G   KE                                +T
Sbjct: 68  IIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAIT 127

Query: 98  VATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTRDA--GCR 155
              ++ L YL     I HRD+K  NILL   G +KL DFG +     S +   ++  G  
Sbjct: 128 HGALQGLAYLHSHNMI-HRDIKAGNILLTEPGQVKLADFGSA-----SKSSPANSFVGTP 181

Query: 156 PYMAPERI 163
            +MAPE I
Sbjct: 182 YWMAPEVI 189

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313

>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

 Score = 49.8 bits (119), Expect = 1e-07
 Identities = 51/196 (26%), Positives = 84/196 (42%), Gaps = 47/196 (23%)

Query: 19  YDFTSEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQR--QLLMDLDVV 76
           Y++  ++  +   +G+G +G V      S+   +A+K I     E+D R  Q L +   +
Sbjct: 3   YEYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEI----PERDSRYVQPLHEEIAL 58

Query: 77  MKSNECPYIVQFYG---------------------ALF---------KEVTVA-----TV 101
               +   IVQ+ G                     AL           E T+       +
Sbjct: 59  HSYLKHRNIVQYLGSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQIL 118

Query: 102 KALNYLKEELKIIHRDVKPSNILLDR-RGAIKLCDFGISGQL--VDSIAKTRDAGCRPYM 158
           + L YL  + +I+HRD+K  N+L++   G +K+ DFG S +L  ++   +T   G   YM
Sbjct: 119 EGLKYL-HDNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCTETF-TGTLQYM 176

Query: 159 APERIDP-LRARGYPS 173
           APE ID   R  G P+
Sbjct: 177 APEVIDKGPRGYGAPA 192

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268

>gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

 Score = 49.8 bits (119), Expect = 1e-07
 Identities = 44/168 (26%), Positives = 70/168 (41%), Gaps = 36/168 (21%)

Query: 29  LGEIGRGGFGTVNKMIHRSSDTVMAVKRIR-STVDEKDQRQLLMDLDVVMK--------- 78
           + +IG G FG    +  +       +K I  S +  K++ +   ++ V+           
Sbjct: 5   VKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQY 64

Query: 79  -----SNECPYIVQFY---GALFKEVT----------------VATVKALNYLKEELKII 114
                 N   YIV  Y   G L+K++                 V    AL ++ +  KI+
Sbjct: 65  QESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDR-KIL 123

Query: 115 HRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTRDAGCRP-YMAPE 161
           HRD+K  NI L + G IKL DFGI+  L  ++   R     P Y++PE
Sbjct: 124 HRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELARTCIGTPYYLSPE 171

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256

>gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

 Score = 49.6 bits (118), Expect = 2e-07
 Identities = 40/174 (22%), Positives = 78/174 (44%), Gaps = 45/174 (25%)

Query: 31  EIGRGGFGTVNKMIHRSSDTVMAVKRIR--STVDEKDQRQLLMDLDVVMKSNECPYIVQF 88
           +IGRG F  V +         +A+K+++    +D K +   + ++D++ + N  P ++++
Sbjct: 9   KIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNH-PNVIKY 67

Query: 89  YGALFKEVTVATV----------KALNYLKEELKII------------------------ 114
           Y +  ++  +  V          + + + K++ ++I                        
Sbjct: 68  YASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRV 127

Query: 115 -HRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTRDA----GCRPYMAPERI 163
            HRD+KP+N+ +   G +KL D G+ G+   S  KT  A    G   YM+PERI
Sbjct: 128 MHRDIKPANVFITATGVVKLGDLGL-GRFFSS--KTTAAHSLVGTPYYMSPERI 178

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

 Score = 48.8 bits (116), Expect = 2e-07
 Identities = 46/165 (27%), Positives = 66/165 (40%), Gaps = 34/165 (20%)

Query: 32  IGRGGFGTVNKMIHRSSDTVMAVKRIR---STVDEKDQRQLLMDLDVVMKSNECP----- 83
           +G G FG    + H +SD   A+K IR   S+   +D R+  + L  +   N        
Sbjct: 8   VGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESF 67

Query: 84  ------YIVQFY--------------GALFKEVT-----VATVKALNYLKEELKIIHRDV 118
                 YIV  Y              G LF E T     V     + ++ E+ +++HRD+
Sbjct: 68  EADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEK-RVLHRDI 126

Query: 119 KPSNILLDRRGAIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERI 163
           K  NI L + G +KL DFG +  L    A        PY  P  I
Sbjct: 127 KSKNIFLTQNGKVKLGDFGSARLLTSPGAYACTYVGTPYYVPPEI 171

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255

>gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

 Score = 49.5 bits (118), Expect = 3e-07
 Identities = 32/79 (40%), Positives = 41/79 (51%), Gaps = 2/79 (2%)

Query: 103 ALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTRDAGCRPYMAPER 162
           AL+YL     IIHRD+KP N+L+   G IKL DFG+S   ++      D    P MA  +
Sbjct: 116 ALDYLHRH-GIIHRDLKPDNMLISNEGHIKLTDFGLSKVTLNRELNMMDILTTPSMAKPK 174

Query: 163 IDPLRARGYP-SFKTKLGF 180
            D  R  G   S  + LGF
Sbjct: 175 NDYSRTPGQVLSLISSLGF 193

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669

>gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

 Score = 48.6 bits (116), Expect = 4e-07
 Identities = 40/176 (22%), Positives = 69/176 (39%), Gaps = 44/176 (25%)

Query: 29  LGEIGRGGFGTV--NKMIHRSSDTVMAVKRIRSTVDEK--DQRQL--------------- 69
           + E+G+G +G V   +    S +  +A+K+I +   +K   +R L               
Sbjct: 5   IKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNI 64

Query: 70  --LMDLDVVMKSN-----------ECPYI------VQFYGALFKEVTVATVKALNYLKEE 110
             L D+D+V   N           E               A F+      +  L Y+   
Sbjct: 65  TCLYDMDIVFPGNFNELYLYEELMEADLHQIIRSGQPLTDAHFQSFIYQILCGLKYIHSA 124

Query: 111 LKIIHRDVKPSNILLDRRGAIKLCDFGIS-----GQLVDSIAKTRDAGCRPYMAPE 161
             ++HRD+KP N+L++    +K+CDFG++         ++   T     R Y APE
Sbjct: 125 -NVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYVATRWYRAPE 179

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332

>gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

 Score = 48.5 bits (115), Expect = 4e-07
 Identities = 43/173 (24%), Positives = 75/173 (43%), Gaps = 35/173 (20%)

Query: 24  EDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIR--------STVDEKDQRQLLMD--- 72
           +D + +  IGRG FG V  +  + ++ + A+K +          T   +++R +L++   
Sbjct: 1   DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDC 60

Query: 73  -----LDVVMKSNECPYIVQFY---GALFK-----EVTVATVKALNYLKE---------E 110
                L    +     Y+V  Y   G L       E  +    A  Y+ E         +
Sbjct: 61  QWITTLHYAFQDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQ 120

Query: 111 LKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVD--SIAKTRDAGCRPYMAPE 161
           L  +HRD+KP N+LLD  G I+L DFG   ++    ++  +   G   Y++PE
Sbjct: 121 LHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSVAVGTPDYISPE 173

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331

>gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

 Score = 48.5 bits (115), Expect = 4e-07
 Identities = 23/53 (43%), Positives = 34/53 (64%)

Query: 112 KIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERID 164
           +I++RD+KP NILLD RG I++ D G++ Q+ +        G   YMAPE I+
Sbjct: 122 RIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGETVRGRVGTVGYMAPEVIN 174

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285

>gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional

 Score = 48.3 bits (115), Expect = 5e-07
 Identities = 40/150 (26%), Positives = 67/150 (44%), Gaps = 35/150 (23%)

Query: 24  EDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIR----------------STVDEKDQR 67
           +  + + +IG G +G V K   R ++  +A+K+IR                S + E    
Sbjct: 2   DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHG 61

Query: 68  QLLMDLDVVMKSNECPYIVQFYGAL----FKEVTVATVKALNYLKEEL------------ 111
            ++   DVV  S +  Y+V  Y  L      + +    K    +K  L            
Sbjct: 62  NIVRLQDVV-HSEKRLYLVFEYLDLDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHS 120

Query: 112 -KIIHRDVKPSNILLDRR-GAIKLCDFGIS 139
            +++HRD+KP N+L+DRR  A+KL DFG++
Sbjct: 121 HRVLHRDLKPQNLLIDRRTNALKLADFGLA 150

Length = 294

>gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

 Score = 48.3 bits (115), Expect = 5e-07
 Identities = 28/76 (36%), Positives = 40/76 (52%), Gaps = 8/76 (10%)

Query: 86  VQFYGALFKEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDS 145
             FY A   E+T      L  L  E +I++RD+KP NILLD  G I++ D G++ ++ + 
Sbjct: 104 AVFYAA---EITCG----LEDLHRE-RIVYRDLKPENILLDDYGHIRISDLGLAVEIPEG 155

Query: 146 IAKTRDAGCRPYMAPE 161
                  G   YMAPE
Sbjct: 156 ETIRGRVGTVGYMAPE 171

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285

>gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

 Score = 48.3 bits (115), Expect = 6e-07
 Identities = 18/25 (72%), Positives = 21/25 (84%)

Query: 114 IHRDVKPSNILLDRRGAIKLCDFGI 138
           IHRD+KP NIL+DR G IKL DFG+
Sbjct: 123 IHRDIKPDNILIDRDGHIKLTDFGL 147

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376

>gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

 Score = 47.9 bits (114), Expect = 6e-07
 Identities = 37/146 (25%), Positives = 69/146 (47%), Gaps = 34/146 (23%)

Query: 27  QDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIV 86
           + L ++G G + TV K  +R++  ++A+K I    +E      + ++ + MK  +   IV
Sbjct: 3   KQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISL-MKELKHENIV 61

Query: 87  QFYGALFKE--------------------------VTVATVKALNY--LK-----EELKI 113
           + +  +  E                          +   TVK+  Y  LK      E ++
Sbjct: 62  RLHDVIHTENKLMLVFEYMDKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRV 121

Query: 114 IHRDVKPSNILLDRRGAIKLCDFGIS 139
           +HRD+KP N+L+++RG +KL DFG++
Sbjct: 122 LHRDLKPQNLLINKRGELKLADFGLA 147

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284

>gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

 Score = 48.1 bits (114), Expect = 6e-07
 Identities = 37/144 (25%), Positives = 65/144 (45%), Gaps = 36/144 (25%)

Query: 29  LGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDE-------------KD---------- 65
           L ++G G + TV K   + +D ++A+K IR   +E             KD          
Sbjct: 11  LDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLH 70

Query: 66  -----QRQL-----LMDLDVVMKSNECPYIVQFYGALFKEVTVATVKALNYLKEELKIIH 115
                ++ L      +D D+    ++C   +  +    K      ++ LNY     K++H
Sbjct: 71  DIIHTEKSLTLVFEYLDKDLKQYLDDCGNSINMHNV--KLFLFQLLRGLNYCHRR-KVLH 127

Query: 116 RDVKPSNILLDRRGAIKLCDFGIS 139
           RD+KP N+L++ RG +KL DFG++
Sbjct: 128 RDLKPQNLLINERGELKLADFGLA 151

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301

>gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2

 Score = 47.3 bits (112), Expect = 8e-07
 Identities = 47/178 (26%), Positives = 75/178 (42%), Gaps = 41/178 (23%)

Query: 25  DLQDLGEIGRGGFGTVNKMI----HRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSN 80
           +L+ +  +G G FGTV K I      +    +A+K +R     K  +++L D   VM   
Sbjct: 8   ELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEIL-DEAYVMAGV 66

Query: 81  ECPYIVQF-----------------YGALFKEV---------------TVATVKALNYLK 108
             PY+ +                  YG L   V                V   K ++YL 
Sbjct: 67  GSPYVCRLLGICLTSTVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYL- 125

Query: 109 EELKIIHRDVKPSNILLDRRGAIKLCDFGISGQL-VDSIAKTRDAGCRP--YMAPERI 163
           EE++++HRD+   N+L+     +K+ DFG++  L +D      D G  P  +MA E I
Sbjct: 126 EEVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESI 183

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279

>gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

 Score = 47.3 bits (113), Expect = 1e-06
 Identities = 37/142 (26%), Positives = 58/142 (40%), Gaps = 34/142 (23%)

Query: 29  LGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQF 88
           LG+IG G F  V K   R +    A+K ++      +Q   L ++  + + +  P I++ 
Sbjct: 4   LGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRL 63

Query: 89  YGALFKEVT--VATV----------------------KALNYLKEELK---------IIH 115
              LF   T  +A V                      +  +Y+ + LK         I H
Sbjct: 64  IEVLFDRKTGRLALVFELMDMNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNGIFH 123

Query: 116 RDVKPSNILLDRRGAIKLCDFG 137
           RD+KP NIL+     +KL DFG
Sbjct: 124 RDIKPENILIK-DDILKLADFG 144

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282

>gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

 Score = 47.3 bits (112), Expect = 1e-06
 Identities = 46/171 (26%), Positives = 71/171 (41%), Gaps = 41/171 (23%)

Query: 32  IGRGGFGTVNKMI----HRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYI-- 85
           +G G FGTV K +           +A+K +R     K  +++L D   VM S + P++  
Sbjct: 15  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEIL-DEAYVMASVDNPHVCR 73

Query: 86  ---------VQF------YGALFKEV---------------TVATVKALNYLKEELKIIH 115
                    VQ       +G L   V                V   K +NYL EE +++H
Sbjct: 74  LLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYL-EERRLVH 132

Query: 116 RDVKPSNILLDRRGAIKLCDFGISGQL-VDSIAKTRDAGCRP--YMAPERI 163
           RD+   N+L+     +K+ DFG++  L  D      + G  P  +MA E I
Sbjct: 133 RDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKWMALESI 183

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316

>gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

 Score = 46.9 bits (111), Expect = 1e-06
 Identities = 41/146 (28%), Positives = 64/146 (43%), Gaps = 34/146 (23%)

Query: 30  GEIGRGGFGTVNKMIHR--SSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQ 87
           GE+G G FGTV K +++   S+  +AVK +++  ++   +  L+    VM+  + PYIV+
Sbjct: 1   GELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVR 60

Query: 88  FYG-----------------------ALFKEVTVATVKAL--------NYLKEELKIIHR 116
             G                          K VT   +  L         YL EE   +HR
Sbjct: 61  MIGICEAESWMLVMELAELGPLNKFLQKNKHVTEKNITELVHQVSMGMKYL-EETNFVHR 119

Query: 117 DVKPSNILLDRRGAIKLCDFGISGQL 142
           D+   N+LL  +   K+ DFG+S  L
Sbjct: 120 DLAARNVLLVTQHYAKISDFGLSKAL 145

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257

>gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

 Score = 47.3 bits (113), Expect = 1e-06
 Identities = 31/95 (32%), Positives = 41/95 (43%), Gaps = 10/95 (10%)

Query: 85  IVQFYGALFKEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVD 144
           + +FY A   EV +A    L YL   L I++RD+KP NILL   G I L DF +S Q   
Sbjct: 104 VARFYAA---EVLLA----LEYL-HLLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDV 155

Query: 145 SIAKTRDAG--CRPYMAPERIDPLRARGYPSFKTK 177
                  A        +   I        PSF++ 
Sbjct: 156 EPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSN 190

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316

>gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

 Score = 47.0 bits (111), Expect = 1e-06
 Identities = 46/172 (26%), Positives = 71/172 (41%), Gaps = 43/172 (25%)

Query: 28  DLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQR--QLLMDLDVVMKSNECPYI 85
           DL EIG G FG V       +  V+A+K++  +  + +++   ++ ++  + K    P  
Sbjct: 19  DLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRH-PNT 77

Query: 86  VQFYGALFKE--------------------------------VTVATVKALNYLKEELKI 113
           +Q+ G   +E                                VT   ++ L YL     +
Sbjct: 78  IQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSH-NM 136

Query: 114 IHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTRDA--GCRPYMAPERI 163
           IHRDVK  NILL   G +KL DFG +     SI    +   G   +MAPE I
Sbjct: 137 IHRDVKAGNILLSEPGLVKLGDFGSA-----SIMAPANXFVGTPYWMAPEVI 183

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308

>gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

 Score = 47.0 bits (112), Expect = 1e-06
 Identities = 30/165 (18%), Positives = 59/165 (35%), Gaps = 47/165 (28%)

Query: 19  YDFTSEDLQDLGEIGRGGFGTV-----NKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDL 73
           ++   E +  + E+G+G FG V       ++    +T +A+K +      +++ + L + 
Sbjct: 1   WELPREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEA 60

Query: 74  DVVMKSNECPYIVQFYGALFKEVTVATVKAL-------NYLK------------------ 108
            V MK   C ++V+  G +        V  L       +YL+                  
Sbjct: 61  SV-MKEFNCHHVVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQ 119

Query: 109 ----------------EELKIIHRDVKPSNILLDRRGAIKLCDFG 137
                              K +HRD+   N ++     +K+ DFG
Sbjct: 120 KFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDLTVKIGDFG 164

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277

>gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

 Score = 47.0 bits (111), Expect = 1e-06
 Identities = 29/79 (36%), Positives = 45/79 (56%), Gaps = 9/79 (11%)

Query: 87  QFYGALFKEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQ-LVDS 145
           +FYGA         V AL+YL    KI++RD+K  N++LD+ G IK+ DFG+  + + D+
Sbjct: 98  RFYGA-------EIVSALDYLHSG-KIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDA 149

Query: 146 IAKTRDAGCRPYMAPERID 164
                  G   Y+APE ++
Sbjct: 150 ATMKTFCGTPEYLAPEVLE 168

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328

>gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional

 Score = 46.9 bits (111), Expect = 1e-06
 Identities = 24/53 (45%), Positives = 36/53 (67%), Gaps = 2/53 (3%)

Query: 109 EELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTRDAGCRPYMAPE 161
           + L I++RD+KP N+LLD+ G IK+ DFG + ++VD+   T   G   Y+APE
Sbjct: 148 QSLNIVYRDLKPENLLLDKDGFIKMTDFGFA-KVVDTRTYTL-CGTPEYIAPE 198

Length = 340

>gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

 Score = 46.2 bits (109), Expect = 2e-06
 Identities = 33/83 (39%), Positives = 45/83 (54%), Gaps = 9/83 (10%)

Query: 89  YGALFKEVTVA----TVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVD 144
           YGAL + VT       ++ ++YL   + I+HRD+K +NIL D  G +KL DFG S +L  
Sbjct: 100 YGALTESVTRKYTRQILEGMSYLHSNM-IVHRDIKGANILRDSAGNVKLGDFGASKRLQT 158

Query: 145 ---SIAKTRDAGCRPY-MAPERI 163
              S    R     PY M+PE I
Sbjct: 159 ICMSGTGIRSVTGTPYWMSPEVI 181

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266

>gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

 Score = 46.5 bits (110), Expect = 2e-06
 Identities = 27/79 (34%), Positives = 43/79 (54%), Gaps = 9/79 (11%)

Query: 87  QFYGALFKEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSI 146
           +FYGA         V AL YL     +++RD+K  N++LD+ G IK+ DFG+  + +   
Sbjct: 98  RFYGA-------EIVSALEYLHSR-DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG 149

Query: 147 AKTRD-AGCRPYMAPERID 164
           A  +   G   Y+APE ++
Sbjct: 150 ATMKTFCGTPEYLAPEVLE 168

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323

>gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

 Score = 46.5 bits (110), Expect = 2e-06
 Identities = 32/81 (39%), Positives = 44/81 (54%), Gaps = 12/81 (14%)

Query: 86  VQFYGALFKEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDS 145
           V+FY     E+    + AL +L  +L I++RD+K  NILLD  G + L DFG+S + +  
Sbjct: 107 VRFYSG---EI----ILALEHL-HKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSE 158

Query: 146 IAKTRD---AGCRPYMAPERI 163
             K R     G   YMAPE I
Sbjct: 159 -EKERTYSFCGTIEYMAPEII 178

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332

>gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

 Score = 46.0 bits (109), Expect = 3e-06
 Identities = 41/165 (24%), Positives = 67/165 (40%), Gaps = 36/165 (21%)

Query: 32  IGRGGFGTVNKMIHRSSDTVMAVKRIRSTV--DEKDQRQLLMDLDVVMKSNECPYIVQFY 89
           +G+G FG V     + S  + AVK ++  V   + D    + +  ++  +   P++ Q Y
Sbjct: 3   LGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLY 62

Query: 90  ------------------GAL---------FKE-----VTVATVKALNYLKEELKIIHRD 117
                             G L         F E            AL +L ++  II+RD
Sbjct: 63  CCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEITSALMFLHDK-GIIYRD 121

Query: 118 VKPSNILLDRRGAIKLCDFGISGQ-LVDSIAKTRDAGCRPYMAPE 161
           +K  N+LLD  G  KL DFG+  + + +    +   G   Y+APE
Sbjct: 122 LKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTSTFCGTPDYIAPE 166

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320

>gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

 Score = 46.1 bits (109), Expect = 3e-06
 Identities = 27/63 (42%), Positives = 37/63 (58%), Gaps = 3/63 (4%)

Query: 101 VKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLV-DSIAKTRD-AGCRPYM 158
           V AL +L  +L II+RD+K  NILLD  G + L DFG+S +   D + +     G   YM
Sbjct: 115 VLALEHL-HKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYSFCGTIEYM 173

Query: 159 APE 161
           AP+
Sbjct: 174 APD 176

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290

>gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

 Score = 46.2 bits (109), Expect = 3e-06
 Identities = 35/142 (24%), Positives = 68/142 (47%), Gaps = 32/142 (22%)

Query: 29  LGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEK------DQRQLLMDL--------- 73
           L ++G G + TV K   + ++ ++A+K IR   +E        +  LL +L         
Sbjct: 10  LDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLH 69

Query: 74  DVVMKSNECPYIVQFYGALFKE--------VTVATVK--------ALNYLKEELKIIHRD 117
           D++        + ++  +  K+        +++  VK         L+Y  +  KI+HRD
Sbjct: 70  DIIHTERCLTLVFEYLDSDLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKR-KILHRD 128

Query: 118 VKPSNILLDRRGAIKLCDFGIS 139
           +KP N+L++ +G +KL DFG++
Sbjct: 129 LKPQNLLINEKGELKLADFGLA 150

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288

>gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes

 Score = 45.8 bits (108), Expect = 3e-06
 Identities = 37/148 (25%), Positives = 63/148 (42%), Gaps = 33/148 (22%)

Query: 31  EIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQFYG 90
            IGRG FG V     R+ +T +AVK  R T+    + + L +  ++ + +  P IV+  G
Sbjct: 2   RIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSH-PNIVRLIG 60

Query: 91  ALFKEVTVATVKAL-------NYLKEE---LKI----------------------IHRDV 118
              ++  +  V  L        +L+ E   LK+                      IHRD+
Sbjct: 61  VCTQKQPIYIVMELVQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCIHRDL 120

Query: 119 KPSNILLDRRGAIKLCDFGISGQLVDSI 146
              N L+  +  +K+ DFG+S +  D +
Sbjct: 121 AARNCLVTEKNVLKISDFGMSREEEDGV 148

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252

>gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases

 Score = 45.5 bits (108), Expect = 3e-06
 Identities = 42/153 (27%), Positives = 63/153 (41%), Gaps = 38/153 (24%)

Query: 25  DLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRS-TVDEKDQRQLLMDLDVVMKSNECP 83
           +L  L E+G G FG V+    R    V A+K IR   + E D    + +  V+MK +  P
Sbjct: 5   ELTFLKELGSGQFGVVHLGKWRGKIDV-AIKMIREGAMSEDD---FIEEAKVMMKLSH-P 59

Query: 84  YIVQFYGALFKEVTVATVKA-------LNYLK-------------------------EEL 111
            +VQ YG   K+  +  V         LNYL+                         E  
Sbjct: 60  NLVQLYGVCTKQRPIFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESN 119

Query: 112 KIIHRDVKPSNILLDRRGAIKLCDFGISGQLVD 144
             IHRD+   N L+     +K+ DFG++  ++D
Sbjct: 120 GFIHRDLAARNCLVGEDNVVKVSDFGLARYVLD 152

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256

>gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

 Score = 45.5 bits (108), Expect = 4e-06
 Identities = 43/153 (28%), Positives = 71/153 (46%), Gaps = 43/153 (28%)

Query: 29  LGEIGRGGFGTVNKMIHRSSDTVMAVKRIR----------STVDE-KDQRQL-------L 70
           +G+IG G +G V K   + +  ++A+K++R          + + E K  RQL       L
Sbjct: 12  IGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNL 71

Query: 71  MDL-----DVV--MKSNECPYIV------QFYGAL------FKEVTVAT-----VKALNY 106
            ++     D +   K     Y+V         G L      F E  + +     ++ LNY
Sbjct: 72  KEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIKSFMKQLLEGLNY 131

Query: 107 LKEELKIIHRDVKPSNILLDRRGAIKLCDFGIS 139
             ++   +HRD+K SNILL+ +G IKL DFG++
Sbjct: 132 CHKK-NFLHRDIKCSNILLNNKGQIKLADFGLA 163

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302

>gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

 Score = 45.8 bits (108), Expect = 4e-06
 Identities = 32/93 (34%), Positives = 53/93 (56%), Gaps = 16/93 (17%)

Query: 54  VKRIRSTVDEKDQRQLLMD-------LDVVMKSNECPY-IVQFYGALFKEVTVATVKALN 105
           V R+  +  +KD    +MD       + ++++    P  + +FY A   E+T A V++++
Sbjct: 63  VVRLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMGIFPEDLARFYIA---ELTCA-VESVH 118

Query: 106 YLKEELKIIHRDVKPSNILLDRRGAIKLCDFGI 138
               ++  IHRD+KP NIL+DR G IKL DFG+
Sbjct: 119 ----KMGFIHRDIKPDNILIDRDGHIKLTDFGL 147

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382

>gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

 Score = 45.6 bits (108), Expect = 4e-06
 Identities = 27/77 (35%), Positives = 42/77 (54%), Gaps = 9/77 (11%)

Query: 88  FYGALFKEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIA 147
           FY A   E+       L +L ++  II+RD+K  N+LLD+ G IK+ DFG+  + ++   
Sbjct: 100 FYAA---EIICG----LQFLHKK-GIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEG 151

Query: 148 KTRD-AGCRPYMAPERI 163
           K     G   Y+APE +
Sbjct: 152 KASTFCGTPDYIAPEIL 168

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316

>gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

 Score = 45.4 bits (108), Expect = 4e-06
 Identities = 36/147 (24%), Positives = 66/147 (44%), Gaps = 32/147 (21%)

Query: 24  EDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEK------DQRQLLMDL---- 73
           E  + L ++G G + TV K   + +  ++A+K IR   +E        +  LL DL    
Sbjct: 5   ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHAN 64

Query: 74  -----DVV------------MKSNECPYIVQFYGAL----FKEVTVATVKALNYLKEELK 112
                D++            + ++   Y+    G L     +      ++ L Y  +  +
Sbjct: 65  IVTLHDIIHTKKTLTLVFEYLDTDLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQR-R 123

Query: 113 IIHRDVKPSNILLDRRGAIKLCDFGIS 139
           ++HRD+KP N+L+  RG +KL DFG++
Sbjct: 124 VLHRDLKPQNLLISERGELKLADFGLA 150

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291

>gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

 Score = 45.6 bits (108), Expect = 5e-06
 Identities = 21/49 (42%), Positives = 32/49 (65%), Gaps = 2/49 (4%)

Query: 113 IIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTRDAGCRPYMAPE 161
           ++HRD+KPSNIL++    +K+CDFG++ ++ D    T     R Y APE
Sbjct: 129 VVHRDLKPSNILINENCDLKICDFGLA-RIQDP-QMTGYVSTRYYRAPE 175

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328

>gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

 Score = 45.4 bits (107), Expect = 5e-06
 Identities = 44/173 (25%), Positives = 72/173 (41%), Gaps = 34/173 (19%)

Query: 25  DLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTV--DEKDQRQLLMDLDVVMKSNEC 82
           D   L  +G+G FG V     + +D + A+K ++  V   + D    +++  V+  S + 
Sbjct: 1   DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKP 60

Query: 83  PYIVQFYGAL---------------------------FKE---VTVATVKALNYLKEELK 112
           P++ Q +                              FKE   V  A   A+       K
Sbjct: 61  PFLTQLHSCFQTMDRLYFVMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSK 120

Query: 113 -IIHRDVKPSNILLDRRGAIKLCDFGISGQ-LVDSIAKTRDAGCRPYMAPERI 163
            II+RD+K  N++LD  G IK+ DFG+  + + D +      G   Y+APE I
Sbjct: 121 GIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVTTKTFCGTPDYIAPEII 173

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323

>gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

 Score = 44.9 bits (106), Expect = 5e-06
 Identities = 24/52 (46%), Positives = 32/52 (61%), Gaps = 2/52 (3%)

Query: 112 KIIHRDVKPSNILLDRRGAI-KLCDFGISGQLVDSIAKTRD-AGCRPYMAPE 161
           KI+HRD+K  NI L + G + KL DFGI+ QL DS+       G   Y++PE
Sbjct: 121 KILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYTCVGTPYYLSPE 172

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257

>gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

 Score = 45.1 bits (107), Expect = 6e-06
 Identities = 23/52 (44%), Positives = 30/52 (57%), Gaps = 8/52 (15%)

Query: 87  QFYGALFKEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGI 138
            FY A    V    V  L YL E  KI++RD+K  N+LLD  G +K+ DFG+
Sbjct: 104 VFYAA---CV----VLGLQYLHEN-KIVYRDLKLDNLLLDTEGFVKIADFGL 147

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324

>gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 45.0 bits (106), Expect = 6e-06
 Identities = 33/90 (36%), Positives = 47/90 (52%), Gaps = 21/90 (23%)

Query: 89  YGALFKEVTV----ATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFG------- 137
           YGAL + VT       ++ ++YL   + I+HRD+K +NIL D  G +KL DFG       
Sbjct: 100 YGALTENVTRRYTRQILQGVSYLHSNM-IVHRDIKGANILRDSAGNVKLGDFGASKRIQT 158

Query: 138 --ISGQLVDSIAKTRDAGCRPY-MAPERID 164
             +SG  + S+  T      PY M+PE I 
Sbjct: 159 ICMSGTGIKSVTGT------PYWMSPEVIS 182

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264

>gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

 Score = 45.0 bits (106), Expect = 6e-06
 Identities = 37/142 (26%), Positives = 65/142 (45%), Gaps = 32/142 (22%)

Query: 29  LGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEK------DQRQLLMDL--------- 73
           L ++G G + TV K   + ++ ++A+K IR   +E        +  LL DL         
Sbjct: 11  LEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLH 70

Query: 74  DVVMKSNECPYIVQFYGALFKE--------VTVATVK--------ALNYLKEELKIIHRD 117
           D+V        + ++     K+        +++  VK         L Y     K++HRD
Sbjct: 71  DIVHTDKSLTLVFEYLDKDLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRR-KVLHRD 129

Query: 118 VKPSNILLDRRGAIKLCDFGIS 139
           +KP N+L++ RG +KL DFG++
Sbjct: 130 LKPQNLLINERGELKLADFGLA 151

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309

>gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

 Score = 44.6 bits (105), Expect = 7e-06
 Identities = 30/83 (36%), Positives = 44/83 (53%), Gaps = 9/83 (10%)

Query: 89  YGALFKEVTV----ATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQL-- 142
           YGAL + VT       ++ ++YL   + I+HRD+K +NIL D  G +KL DFG S +L  
Sbjct: 100 YGALTENVTRKYTRQILEGVSYLHSNM-IVHRDIKGANILRDSVGNVKLGDFGASKRLQT 158

Query: 143 --VDSIAKTRDAGCRPYMAPERI 163
             +         G   +M+PE I
Sbjct: 159 ICLSGTGMKSVTGTPYWMSPEVI 181

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265

>gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

 Score = 44.7 bits (106), Expect = 7e-06
 Identities = 41/177 (23%), Positives = 69/177 (38%), Gaps = 46/177 (25%)

Query: 23  SEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNEC 82
           S++L+    IG+G FG V    +R     +AVK ++   D+    Q  +    VM +   
Sbjct: 5   SKELKLGATIGKGEFGDVMLGDYRGQK--VAVKCLK---DDSTAAQAFLAEASVMTTLRH 59

Query: 83  PYIVQFYGALFKEVTVATV----------------------------------KALNYLK 108
           P +VQ  G + +   +  V                                  + + YL 
Sbjct: 60  PNLVQLLGVVLQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYL- 118

Query: 109 EELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTRDAGCRP--YMAPERI 163
           EE   +HRD+   N+L+      K+ DFG    L    ++ +D+G  P  + APE +
Sbjct: 119 EEKNFVHRDLAARNVLVSEDLVAKVSDFG----LAKEASQGQDSGKLPVKWTAPEAL 171

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256

>gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

 Score = 44.7 bits (106), Expect = 7e-06
 Identities = 35/148 (23%), Positives = 54/148 (36%), Gaps = 38/148 (25%)

Query: 31  EIGRGGFGTVNKMI-HRSSDTVM--AVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQ 87
           ++G G FG V +     S   V+  AVK ++S          L +  + M S +   +++
Sbjct: 2   KLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAI-MHSLDHENLIR 60

Query: 88  FYGALF----KEVT-----------------------------VATVKALNYLKEELKII 114
            YG +       VT                             V     + YL E  + I
Sbjct: 61  LYGVVLTHPLMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYL-ESKRFI 119

Query: 115 HRDVKPSNILLDRRGAIKLCDFGISGQL 142
           HRD+   NILL     +K+ DFG+   L
Sbjct: 120 HRDLAARNILLASDDKVKIGDFGLMRAL 147

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257

>gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

 Score = 44.8 bits (106), Expect = 7e-06
 Identities = 43/174 (24%), Positives = 71/174 (40%), Gaps = 36/174 (20%)

Query: 25  DLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTV--DEKDQRQLLMDLDVVMKSNEC 82
           D   L  +G+G FG V     + +D + A+K ++  V   + D    +++  V+    + 
Sbjct: 1   DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKP 60

Query: 83  PYIVQFYGAL---------------------------FKEVTVATVKA-----LNYLKEE 110
           P++ Q +                              FKE       A     L +L  +
Sbjct: 61  PFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSK 120

Query: 111 LKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTRD-AGCRPYMAPERI 163
             II+RD+K  N++LD  G IK+ DFG+  + +     TR   G   Y+APE I
Sbjct: 121 -GIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKTTRTFCGTPDYIAPEII 173

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324

>gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

 Score = 44.5 bits (105), Expect = 9e-06
 Identities = 30/76 (39%), Positives = 43/76 (56%), Gaps = 9/76 (11%)

Query: 87  QFYGALFKEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQ-LVDS 145
           +FY A   EVT+A    L +L     +I+RD+K  NILLD  G  KL DFG+  + +++ 
Sbjct: 99  RFYAA---EVTLA----LMFLHRH-GVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNG 150

Query: 146 IAKTRDAGCRPYMAPE 161
           +  T   G   Y+APE
Sbjct: 151 VTTTTFCGTPDYIAPE 166

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321

>gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional

 Score = 44.6 bits (105), Expect = 1e-05
 Identities = 24/53 (45%), Positives = 32/53 (60%), Gaps = 3/53 (5%)

Query: 112 KIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIA---KTRDAGCRPYMAPE 161
           K++HRD+K +NI L   G IKL DFG S Q  DS++    +   G   Y+APE
Sbjct: 189 KMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYLAPE 241

Length = 478

>gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

 Score = 44.3 bits (105), Expect = 1e-05
 Identities = 22/51 (43%), Positives = 29/51 (56%)

Query: 113 IIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERI 163
           IIHRD+KPSNI++     +K+ DFG++     S   T     R Y APE I
Sbjct: 139 IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVI 189

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353

>gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional

 Score = 44.6 bits (105), Expect = 1e-05
 Identities = 45/170 (26%), Positives = 66/170 (38%), Gaps = 43/170 (25%)

Query: 32  IGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMD------------------- 72
           IG G FG V + I   +   +A+K++      K++  L+M                    
Sbjct: 74  IGNGSFGVVYEAICIDTSEKVAIKKVLQDPQYKNRELLIMKNLNHINIIFLKDYYYTECF 133

Query: 73  --------LDVVMKSNECPYIVQFYGA------------LFKEVTVATVKALNYLKEELK 112
                   L+VVM+    P  V  Y              L K  +    +AL Y+  +  
Sbjct: 134 KKNEKNIFLNVVMEF--IPQTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKF- 190

Query: 113 IIHRDVKPSNILLD-RRGAIKLCDFGISGQLVDSIAKTRDAGCRPYMAPE 161
           I HRD+KP N+L+D     +KLCDFG +  L+           R Y APE
Sbjct: 191 ICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRSVSYICSRFYRAPE 240

Length = 440

>gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional

 Score = 44.4 bits (105), Expect = 1e-05
 Identities = 21/53 (39%), Positives = 26/53 (49%), Gaps = 1/53 (1%)

Query: 101 VKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTRDAG 153
           ++AL YL     IIHRDVK  NI LD      L DFG + +L       +  G
Sbjct: 195 LEALAYLHGR-GIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTPQCYG 246

Length = 392

>gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

 Score = 43.9 bits (103), Expect = 1e-05
 Identities = 23/59 (38%), Positives = 34/59 (57%), Gaps = 1/59 (1%)

Query: 103 ALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTRDAGCRPYMAPE 161
            L  L +E +I++RD+KP NILLD  G I++ D G++  + +        G   YMAPE
Sbjct: 114 GLEDLHQE-RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPE 171

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285

>gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

 Score = 43.8 bits (103), Expect = 1e-05
 Identities = 48/188 (25%), Positives = 74/188 (39%), Gaps = 57/188 (30%)

Query: 32  IGRGGFGTVNKMIHRSSDTVMAVKRIRS----------TVDEKDQRQLLMDLDVVMKSNE 81
           +G+G FGTV  +  + +     +K ++           TV    + QLL  LD       
Sbjct: 8   LGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLD------- 60

Query: 82  CPYIVQFYGALFKEVTVATV------KALNYLKEELK----------------------- 112
            P IV+F+ +  +      +      + L+   EELK                       
Sbjct: 61  HPAIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVH 120

Query: 113 ------IIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSI-AKTRDAGCRPYMAPERIDP 165
                 I+HRD+K  NI L +   +K+ DFG+S  L+ S    T   G   YM+PE    
Sbjct: 121 YMHQRRILHRDLKAKNIFL-KNNLLKIGDFGVSRLLMGSCDLATTFTGTPYYMSPE---A 176

Query: 166 LRARGYPS 173
           L+ +GY S
Sbjct: 177 LKHQGYDS 184

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260

>gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

 Score = 43.7 bits (103), Expect = 1e-05
 Identities = 51/186 (27%), Positives = 82/186 (44%), Gaps = 49/186 (26%)

Query: 30  GEI-GRGGFGTVNKMIHRSSDTVMAVKRIR---STVD--EKDQRQLLMDLDVVMKSNECP 83
           GE+ G+G +GTV   +  +   ++AVK++    S V   EK+  +L  ++D+ +KS +  
Sbjct: 5   GEVLGKGAYGTVYCGL-TNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDL-LKSLKHV 62

Query: 84  YIVQFYGALFKEVTV----------ATVKALN------------YLKEELK--------- 112
            IVQ+ G    + T+          +    LN            Y K+ L          
Sbjct: 63  NIVQYLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNNC 122

Query: 113 IIHRDVKPSNILLDRRGAIKLCDFGISGQLV---DSIAKT---RDAGCRPY-MAPERIDP 165
           ++HRD+K +N++L   G IKL DFG + +L         +   +     PY MAPE I  
Sbjct: 123 VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVI-- 180

Query: 166 LRARGY 171
               GY
Sbjct: 181 -NESGY 185

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265

>gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

 Score = 43.9 bits (104), Expect = 1e-05
 Identities = 19/55 (34%), Positives = 28/55 (50%), Gaps = 5/55 (9%)

Query: 112 KIIHRDVKPSNILLDRRGAIKLCDFGI-----SGQLVDSIAKTRDAGCRPYMAPE 161
            +IHRD+KPSN+L++    +++ DFG+     S         T     R Y APE
Sbjct: 127 NVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVATRWYRAPE 181

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334

>gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

 Score = 43.7 bits (103), Expect = 2e-05
 Identities = 25/60 (41%), Positives = 35/60 (58%), Gaps = 2/60 (3%)

Query: 103 ALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQ-LVDSIAKTRDAGCRPYMAPE 161
           ALN+L E   II+RD+K  N+LLD  G IKL D+G+  + +      +   G   Y+APE
Sbjct: 108 ALNFLHER-GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTTSTFCGTPNYIAPE 166

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329

>gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

 Score = 44.0 bits (104), Expect = 2e-05
 Identities = 22/62 (35%), Positives = 37/62 (59%), Gaps = 3/62 (4%)

Query: 102 KALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGIS--GQLVDSIAKTRDAGCRPYMA 159
           + L YL     I+HRD+KP N+L++    +K+CDFG++   +  +S   T++   + Y A
Sbjct: 114 RGLKYL-HSAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQYYRA 172

Query: 160 PE 161
           PE
Sbjct: 173 PE 174

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372

>gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

 Score = 43.6 bits (103), Expect = 2e-05
 Identities = 36/160 (22%), Positives = 66/160 (41%), Gaps = 56/160 (35%)

Query: 29  LGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKD-QRQLLMDLDVVMKSNECPYIVQ 87
           L +IG G +G V K   +++  ++A+K+ R  +DE+      L ++ ++   +E  YIV 
Sbjct: 6   LEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIV- 64

Query: 88  FYGALFKEVTVATVKALN----------YLKEELK------------------------- 112
                 + + V  V+  N          YL  +LK                         
Sbjct: 65  ------RLLDVEHVEEKNGKPSLYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQ 118

Query: 113 ------------IIHRDVKPSNILLDR-RGAIKLCDFGIS 139
                       ++HRD+KP N+L+D+ +G +K+ D G+ 
Sbjct: 119 LLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLG 158

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295

>gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

 Score = 43.4 bits (102), Expect = 2e-05
 Identities = 41/173 (23%), Positives = 71/173 (41%), Gaps = 34/173 (19%)

Query: 25  DLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTV--DEKDQRQLLMDLDVVMKSNEC 82
           D   L  +G+G FG V     + +D + A+K ++  V   + D    +++  V+   ++ 
Sbjct: 1   DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKP 60

Query: 83  PYIVQFYGAL---------------------------FKE----VTVATVKALNYLKEEL 111
           P++ Q +                              FKE       A +    +     
Sbjct: 61  PFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRR 120

Query: 112 KIIHRDVKPSNILLDRRGAIKLCDFGISGQ-LVDSIAKTRDAGCRPYMAPERI 163
            II+RD+K  N++LD  G IK+ DFG+  + +VD +      G   Y+APE I
Sbjct: 121 GIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVTTRTFCGTPDYIAPEII 173

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323

>gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

 Score = 43.4 bits (102), Expect = 2e-05
 Identities = 37/151 (24%), Positives = 56/151 (37%), Gaps = 46/151 (30%)

Query: 31  EIGRGGFGTVNKMIHRSSDTVMAVKRIR----STVDEKDQRQLLMDLDVVMKSNECPYIV 86
           EIG G FG V          V A+K IR    S  D  ++ Q++M L         P +V
Sbjct: 11  EIGSGQFGLVWLGYWLEKRKV-AIKTIREGAMSEEDFIEEAQVMMKL-------SHPKLV 62

Query: 87  QFYGALFKEVTVATV---------------------------------KALNYLKEELKI 113
           Q YG   +   +  V                                 + + YL E   +
Sbjct: 63  QLYGVCTERSPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYL-ESSNV 121

Query: 114 IHRDVKPSNILLDRRGAIKLCDFGISGQLVD 144
           IHRD+   N L+     +K+ DFG++  ++D
Sbjct: 122 IHRDLAARNCLVGENQVVKVSDFGMTRFVLD 152

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256

>gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

 Score = 43.3 bits (102), Expect = 2e-05
 Identities = 26/61 (42%), Positives = 34/61 (55%), Gaps = 3/61 (4%)

Query: 101 VKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTRDAGCRPYMAP 160
           V AL+ L  E  I+ RD+ P+NILLD RG I+L  F    ++ DS     +A    Y AP
Sbjct: 95  VVALDALHRE-GIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSC--DGEAVENMYCAP 151

Query: 161 E 161
           E
Sbjct: 152 E 152

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237

>gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

 Score = 43.1 bits (101), Expect = 2e-05
 Identities = 40/174 (22%), Positives = 78/174 (44%), Gaps = 45/174 (25%)

Query: 31  EIGRGGFGTVNKMIHRSSDTVMAVKRIR--STVDEKDQRQLLMDLDVVMKSNECPYIVQF 88
           +IGRG F  V +         +A+K+++    +D K ++  + ++D++ + N  P ++++
Sbjct: 9   KIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNH-PNVIKY 67

Query: 89  YGALFKEVTVATV----------KALNYLKEELKII------------------------ 114
             +  ++  +  V          + + Y K++ ++I                        
Sbjct: 68  LDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRV 127

Query: 115 -HRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTRDA----GCRPYMAPERI 163
            HRD+KP+N+ +   G +KL D G+ G+   S  KT  A    G   YM+PERI
Sbjct: 128 MHRDIKPANVFITATGVVKLGDLGL-GRFFSS--KTTAAHSLVGTPYYMSPERI 178

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267

>gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

 Score = 43.5 bits (102), Expect = 2e-05
 Identities = 27/60 (45%), Positives = 35/60 (58%), Gaps = 2/60 (3%)

Query: 103 ALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQ-LVDSIAKTRDAGCRPYMAPE 161
           ALNYL E   II+RD+K  N+LLD  G IKL D+G+  + L      +   G   Y+APE
Sbjct: 108 ALNYLHER-GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPE 166

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329

>gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional

 Score = 42.9 bits (102), Expect = 2e-05
 Identities = 26/65 (40%), Positives = 35/65 (53%), Gaps = 7/65 (10%)

Query: 101 VKALNYLKEELKIIHRDVKPSNILLDR-RGAIKLCDFGISGQLVDSI-AKTRDAGCRPYM 158
           V+ALN L +   IIH D+K  N+L DR +  I LCD+G    L   I   +   G   Y 
Sbjct: 119 VEALNDLHKH-NIIHNDIKLENVLYDRAKDRIYLCDYG----LCKIIGTPSCYDGTLDYF 173

Query: 159 APERI 163
           +PE+I
Sbjct: 174 SPEKI 178

Length = 267

>gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

 Score = 43.0 bits (101), Expect = 3e-05
 Identities = 37/143 (25%), Positives = 65/143 (45%), Gaps = 32/143 (22%)

Query: 28  DLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEK------DQRQLLMDL-------- 73
           +L ++G G + TV K I R +  ++A+K I    +E        +  LL  L        
Sbjct: 9   NLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLL 68

Query: 74  -DVV------------MKSNECPYIVQFYGAL----FKEVTVATVKALNYLKEELKIIHR 116
            D++            M ++   Y++Q  G L     +      ++ L Y+  +  I+HR
Sbjct: 69  HDIIHTKETLTFVFEYMHTDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQ-HILHR 127

Query: 117 DVKPSNILLDRRGAIKLCDFGIS 139
           D+KP N+L+   G +KL DFG++
Sbjct: 128 DLKPQNLLISYLGELKLADFGLA 150

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291

>gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

 Score = 43.0 bits (101), Expect = 3e-05
 Identities = 24/72 (33%), Positives = 38/72 (52%), Gaps = 1/72 (1%)

Query: 103 ALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTRDAGCRPYMAPER 162
            L  L  E   ++RD+KP NILLD  G I++ D G++ ++ +  +     G   YMAPE 
Sbjct: 114 GLEDLHRE-NTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGESIRGRVGTVGYMAPEV 172

Query: 163 IDPLRARGYPSF 174
           ++  R    P +
Sbjct: 173 LNNQRYTLSPDY 184

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285

>gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

 Score = 43.0 bits (101), Expect = 3e-05
 Identities = 37/151 (24%), Positives = 62/151 (41%), Gaps = 40/151 (26%)

Query: 29  LGEIGRGGFGTVNKMIHRSSDTVMAVKRIR----------STVDE----KDQRQL----- 69
           + EIG G +GTV K     S   +A+K +R          STV E    K          
Sbjct: 5   VAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNI 64

Query: 70  --LMDLDVVMKSNECPYIVQFYGALFKEVTVATVKA------LNYLKEELK--------- 112
             LMD+    +++    +   +  + +++     K          +K+ ++         
Sbjct: 65  VRLMDVCATSRTDRETKVTLVFEHVDQDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFL 124

Query: 113 ----IIHRDVKPSNILLDRRGAIKLCDFGIS 139
               I+HRD+KP NIL+   G +KL DFG++
Sbjct: 125 HANCIVHRDLKPENILVTSGGQVKLADFGLA 155

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288

>gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

 Score = 42.9 bits (101), Expect = 3e-05
 Identities = 21/55 (38%), Positives = 28/55 (50%), Gaps = 3/55 (5%)

Query: 112 KIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTRDAGCR---PYMAPERI 163
           K IHRD+   NILL     +K+CDFG++  +       R    R    +MAPE I
Sbjct: 193 KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPESI 247

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337

>gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

 Score = 42.7 bits (101), Expect = 3e-05
 Identities = 25/77 (32%), Positives = 40/77 (51%), Gaps = 13/77 (16%)

Query: 104 LNYLKEELKIIHRDVKPSNILL----DRRGAIKLCDFGISGQLVDSIAKTRDAGCRP--- 156
           ++YL     ++HRD+KP+NIL+      RG +K+ D G++ +L ++  K           
Sbjct: 121 VHYLHSNW-VLHRDLKPANILVMGEGPERGVVKIGDLGLA-RLFNAPLKPLADLDPVVVT 178

Query: 157 --YMAPERIDPLRARGY 171
             Y APE +  L AR Y
Sbjct: 179 IWYRAPELL--LGARHY 193

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316

>gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

 Score = 42.6 bits (100), Expect = 4e-05
 Identities = 23/50 (46%), Positives = 31/50 (62%), Gaps = 1/50 (2%)

Query: 113 IIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTRD-AGCRPYMAPE 161
           I++RD+K  NILLD  G IK+ DFG+  + +   AKT    G   Y+APE
Sbjct: 117 IVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCTFCGTPDYIAPE 166

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316

>gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

 Score = 42.7 bits (100), Expect = 4e-05
 Identities = 45/167 (26%), Positives = 73/167 (43%), Gaps = 39/167 (23%)

Query: 32  IGRGGFGTVNKMIHRSSDTVMAVKRI-------RSTVDEKDQRQLLMDL---DVVM---- 77
           +G+G +G V+ + HR+      +K++       R     + + QLL  L   ++V     
Sbjct: 8   VGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRES 67

Query: 78  -KSNECP-YIVQFY---GALFKEVT----------------VATVKALNYLKEELKIIHR 116
            +  +   YIV  +   G L+ ++                 V    AL YL E+  I+HR
Sbjct: 68  WEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEK-HILHR 126

Query: 117 DVKPSNILLDRRGAIKLCDFGISGQLVD--SIAKTRDAGCRPYMAPE 161
           D+K  N+ L R   IK+ D GI+  L +   +A T   G   YM+PE
Sbjct: 127 DLKTQNVFLTRTNIIKVGDLGIARVLENQCDMASTL-IGTPYYMSPE 172

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257

>gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

 Score = 42.7 bits (100), Expect = 4e-05
 Identities = 29/93 (31%), Positives = 48/93 (51%), Gaps = 16/93 (17%)

Query: 54  VKRIRSTVDEKDQRQLLMD-------LDVVMKSNECP-YIVQFYGALFKEVTVATVKALN 105
           V ++  +  +KD    +MD       + ++++    P  + +FY A   E+T+A      
Sbjct: 63  VVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMEVFPEVLARFYIA---ELTLAIESV-- 117

Query: 106 YLKEELKIIHRDVKPSNILLDRRGAIKLCDFGI 138
               ++  IHRD+KP NIL+D  G IKL DFG+
Sbjct: 118 ---HKMGFIHRDIKPDNILIDLDGHIKLTDFGL 147

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381

>gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

 Score = 42.7 bits (100), Expect = 4e-05
 Identities = 21/55 (38%), Positives = 28/55 (50%), Gaps = 3/55 (5%)

Query: 112 KIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTRDAGCR---PYMAPERI 163
           K IHRD+   NILL     +K+CDFG++  +       R    R    +MAPE I
Sbjct: 194 KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKWMAPESI 248

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338

>gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

 Score = 42.4 bits (99), Expect = 4e-05
 Identities = 34/148 (22%), Positives = 67/148 (45%), Gaps = 32/148 (21%)

Query: 23  SEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIR---------STVDEKDQRQLLMDL 73
           ++  + L ++G G + TV K   + +  ++A+K IR         + + E    + L   
Sbjct: 4   ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHA 63

Query: 74  DVVM------------------KSNECPYIVQFYGAL----FKEVTVATVKALNYLKEEL 111
           ++V+                   ++ C Y+ +  G L     K      ++ L+Y+ +  
Sbjct: 64  NIVLLHDIIHTKETLTLVFEYVHTDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRY 123

Query: 112 KIIHRDVKPSNILLDRRGAIKLCDFGIS 139
            I+HRD+KP N+L+   G +KL DFG++
Sbjct: 124 -ILHRDLKPQNLLISDTGELKLADFGLA 150

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303

>gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases

 Score = 42.1 bits (99), Expect = 5e-05
 Identities = 38/147 (25%), Positives = 62/147 (42%), Gaps = 34/147 (23%)

Query: 32  IGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQFYGA 91
           IG+G FG V K + + +  V AVK  RST+    +R+ L + ++ +K  + P IV+  G 
Sbjct: 3   IGKGNFGDVYKGVLKGNTEV-AVKTCRSTLPPDLKRKFLQEAEI-LKQYDHPNIVKLIGV 60

Query: 92  LFKEVTVATV-------KALNYL---KEELKI----------------------IHRDVK 119
             ++  +  V         L +L   K  L +                      IHRD+ 
Sbjct: 61  CVQKQPIYIVMELVPGGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLA 120

Query: 120 PSNILLDRRGAIKLCDFGISGQLVDSI 146
             N L+     +K+ DFG+S +    I
Sbjct: 121 ARNCLVGENNVLKISDFGMSREEEGGI 147

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251

>gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

 Score = 42.4 bits (100), Expect = 5e-05
 Identities = 25/78 (32%), Positives = 43/78 (55%), Gaps = 20/78 (25%)

Query: 70  LMDLDV--VMKSNE------CPYIVQFYGALFKEVTVATVKALNYLKEELKIIHRDVKPS 121
           LMD D+  +++S++      C Y +  Y  L         + L Y+     ++HRD+KPS
Sbjct: 90  LMDTDLHQIIRSSQTLSDDHCQYFL--YQLL---------RGLKYIHSA-NVLHRDLKPS 137

Query: 122 NILLDRRGAIKLCDFGIS 139
           N+LL+    +K+CDFG++
Sbjct: 138 NLLLNANCDLKICDFGLA 155

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337

>gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

 Score = 42.3 bits (99), Expect = 5e-05
 Identities = 18/46 (39%), Positives = 31/46 (67%), Gaps = 1/46 (2%)

Query: 94  KEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGIS 139
           K++    ++ L++L    +++HRD+KP NIL+   G IKL DFG++
Sbjct: 113 KDMMFQLLRGLDFLHSH-RVVHRDLKPQNILVTSSGQIKLADFGLA 157

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290

>gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein

 Score = 42.3 bits (100), Expect = 5e-05
 Identities = 34/142 (23%), Positives = 56/142 (39%), Gaps = 37/142 (26%)

Query: 31  EIGRG--GFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKS----NECPY 84
            IG+       V+   H+ ++T++AVK+I      K+  +LL    +  +     N  PY
Sbjct: 5   LIGKCFEDLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPY 64

Query: 85  IVQF--------------YGAL-----------FKEVTVA-----TVKALNYLKEELKII 114
           +  F              YG+              E+ +A      + AL+Y+  +   I
Sbjct: 65  VTSFIVDSELYVVSPLMAYGSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSK-GFI 123

Query: 115 HRDVKPSNILLDRRGAIKLCDF 136
           HR VK S+ILL   G + L   
Sbjct: 124 HRSVKASHILLSGDGKVVLSGL 145

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314

>gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

 Score = 42.3 bits (100), Expect = 6e-05
 Identities = 45/172 (26%), Positives = 73/172 (42%), Gaps = 37/172 (21%)

Query: 27  QDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIR----STVDEKDQ-RQL----LMD----- 72
           Q+L  +G G +G V       +   +A+K++     S +  K   R+L     MD     
Sbjct: 18  QNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVI 77

Query: 73  --LDVVMKSNECPYIVQFY------GA------LFKEVTVATVKALNY-LKEELK----- 112
             LDV   ++        Y      GA        ++++   ++ L Y +   LK     
Sbjct: 78  GLLDVFTPASSLEDFQDVYLVTHLMGADLNNIVKCQKLSDDHIQFLVYQILRGLKYIHSA 137

Query: 113 -IIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERI 163
            IIHRD+KPSNI ++    +K+ DFG++    D +  T     R Y APE +
Sbjct: 138 GIIHRDLKPSNIAVNEDCELKILDFGLARHTDDEM--TGYVATRWYRAPEIM 187

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343

>gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

 Score = 41.9 bits (98), Expect = 6e-05
 Identities = 21/55 (38%), Positives = 28/55 (50%), Gaps = 3/55 (5%)

Query: 112 KIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTRDAGCR---PYMAPERI 163
           K IHRD+   NILL     +K+CDFG++  +       R    R    +MAPE I
Sbjct: 199 KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETI 253

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343

>gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

 Score = 41.9 bits (98), Expect = 7e-05
 Identities = 46/173 (26%), Positives = 72/173 (41%), Gaps = 52/173 (30%)

Query: 32  IGRGGFGTVNKMIHRSSDT-------VMAVKRIRSTVDEK---DQRQLLMDLDVVMKSNE 81
           IGRGGFG V     R +DT        +  KRI+    E    ++R +L     ++ + +
Sbjct: 2   IGRGGFGEVYGC--RKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLS----LVSTGD 55

Query: 82  CPYIVQFYGAL---------------------FKEVTVATVKALNYLKEELK-------- 112
           CP+IV    A                        +  V + K + +   E+         
Sbjct: 56  CPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHN 115

Query: 113 --IIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTRDA--GCRPYMAPE 161
             +++RD+KP+NILLD  G +++ D G++    D   K   A  G   YMAPE
Sbjct: 116 RFVVYRDLKPANILLDEHGHVRISDLGLA---CDFSKKKPHASVGTHGYMAPE 165

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279

>gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

 Score = 41.9 bits (98), Expect = 8e-05
 Identities = 26/60 (43%), Positives = 35/60 (58%), Gaps = 2/60 (3%)

Query: 103 ALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTRD-AGCRPYMAPE 161
           ALN+L E   II+RD+K  N+LLD  G IKL D+G+  + +     T    G   Y+APE
Sbjct: 108 ALNFLHER-GIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTTSTFCGTPNYIAPE 166

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327

>gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

 Score = 41.6 bits (98), Expect = 8e-05
 Identities = 45/206 (21%), Positives = 76/206 (36%), Gaps = 59/206 (28%)

Query: 13  LSPDTVYDFTSEDLQDLGEIGRGGFGTVNK-----MIHRSSDTVMAVKRIRSTVDEKDQR 67
           L  D  ++   + L     +G G FG V K     + + +  + +AVK ++    EKD  
Sbjct: 1   LPLDPEWELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLS 60

Query: 68  QLLMDLDVVMKSNECPYIVQFYGA------LFKEVTVA---------------------- 99
            L+ +++++    +   I+   G       L+  V  A                      
Sbjct: 61  DLVSEMEMMKMIGKHKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPD 120

Query: 100 ---------TVKAL-----------NYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGIS 139
                    T K L            +L    K IHRD+   N+L+     +K+ DFG++
Sbjct: 121 DPRPPEETLTQKDLVSFAYQVARGMEFL-ASKKCIHRDLAARNVLVTEDHVMKIADFGLA 179

Query: 140 GQL--VDSIAKTRDAGCRPY--MAPE 161
             +  +D   KT + G  P   MAPE
Sbjct: 180 RDIHHIDYYRKTTN-GRLPVKWMAPE 204

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293

>gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

 Score = 42.0 bits (98), Expect = 8e-05
 Identities = 22/51 (43%), Positives = 29/51 (56%)

Query: 113 IIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERI 163
           IIHRD+KPSNI++     +K+ DFG++     S   T     R Y APE I
Sbjct: 147 IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVI 197

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364

>gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional

 Score = 41.8 bits (98), Expect = 8e-05
 Identities = 23/53 (43%), Positives = 31/53 (58%), Gaps = 5/53 (9%)

Query: 113 IIHRDVKPSNILLDRRGAIKLCDFGIS----GQLVDSIAKTRDAGCRPYMAPE 161
           +IHRD+K +NILL   G +KL DFG S      + D + +T   G   Y+APE
Sbjct: 164 MIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTF-CGTPYYVAPE 215

Length = 496

>gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein

 Score = 42.1 bits (99), Expect = 8e-05
 Identities = 26/71 (36%), Positives = 34/71 (47%), Gaps = 16/71 (22%)

Query: 113 IIHRDVKPSNILLDRRGA---IKLCDFGISGQL-----VDSIAKTRDA---GCRPYMAPE 161
           I+HRD+KP NI++ + G     K+ DFGI   L      D    TR     G   Y APE
Sbjct: 100 IVHRDLKPQNIMVSQTGVRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPE 159

Query: 162 RIDPLRARGYP 172
           ++     RG P
Sbjct: 160 QL-----RGEP 165

This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266

>gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

 Score = 41.5 bits (97), Expect = 1e-04
 Identities = 24/51 (47%), Positives = 33/51 (64%), Gaps = 3/51 (5%)

Query: 113 IIHRDVKPSNILLDRRGAIKLCDFGISGQLV--DSIAKTRDAGCRPYMAPE 161
           II+RD+K  N++LDR G IK+ DFG+  + V  D+ A T   G   Y+APE
Sbjct: 117 IIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRASTF-CGTPDYIAPE 166

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316

>gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

 Score = 41.5 bits (97), Expect = 1e-04
 Identities = 45/173 (26%), Positives = 71/173 (41%), Gaps = 52/173 (30%)

Query: 32  IGRGGFGTVNKMIHRSSDT-------VMAVKRIRSTVDEK---DQRQLLMDLDVVMKSNE 81
           IGRGGFG V     R +DT        +  KRI+    E    ++R +L     ++ + +
Sbjct: 2   IGRGGFGEVYGC--RKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLS----LVSTGD 55

Query: 82  CPYIVQFYGAL---------------------FKEVTVATVKALNYLKEELK-------- 112
           CP+IV    A                        +  V +   + +   E+         
Sbjct: 56  CPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHN 115

Query: 113 --IIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTRDA--GCRPYMAPE 161
             +++RD+KP+NILLD  G +++ D G++    D   K   A  G   YMAPE
Sbjct: 116 RFVVYRDLKPANILLDEHGHVRISDLGLA---CDFSKKKPHASVGTHGYMAPE 165

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278

>gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

 Score = 41.0 bits (96), Expect = 1e-04
 Identities = 39/147 (26%), Positives = 62/147 (42%), Gaps = 38/147 (25%)

Query: 31  EIGRGGFGTVNKMIHRSSDTVMAVKRIRS-TVDEKDQRQLLMDLDVVMKSNECPYIVQFY 89
           E+G G FG V+    R+   V A+K I    + E+D    + +  V+MK +  P +VQ Y
Sbjct: 11  ELGSGQFGVVHLGKWRAQIKV-AIKAINEGAMSEED---FIEEAKVMMKLSH-PKLVQLY 65

Query: 90  GALFKEVTVATVKA-------LNYLK-------------------------EELKIIHRD 117
           G   ++  +  V         LNYL+                         E    IHRD
Sbjct: 66  GVCTQQKPLYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFIHRD 125

Query: 118 VKPSNILLDRRGAIKLCDFGISGQLVD 144
           +   N L+   G +K+ DFG++  ++D
Sbjct: 126 LAARNCLVSSTGVVKVSDFGMTRYVLD 152

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256

>gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

 Score = 41.3 bits (97), Expect = 1e-04
 Identities = 44/190 (23%), Positives = 74/190 (38%), Gaps = 43/190 (22%)

Query: 16  DTVYDFTSEDLQDLGEI-GRGGFG-----TVNKMIHRSSDTVMAVKRIRSTVDEKDQRQL 69
           D  ++F   +L   G+  G G FG     T   +    +   +AVK ++ T    ++  L
Sbjct: 27  DLKWEFPRNNLS-FGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREAL 85

Query: 70  LMDLDVVMKSNECPYIVQFYGALFKEVTVATVKA-------LNYLK---------EEL-- 111
           + +L ++        IV   GA      +  +         LN+L+         E+L  
Sbjct: 86  MSELKIMSHLGNHENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLS 145

Query: 112 ---------------KIIHRDVKPSNILLDRRGAIKLCDFGISGQLV-DSIAKTRDAGCR 155
                            IHRD+   N+LL     +K+CDFG++  ++ DS    +     
Sbjct: 146 FSYQVAKGMAFLASKNCIHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGNARL 205

Query: 156 P--YMAPERI 163
           P  +MAPE I
Sbjct: 206 PVKWMAPESI 215

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302

>gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

 Score = 41.2 bits (96), Expect = 1e-04
 Identities = 21/51 (41%), Positives = 29/51 (56%)

Query: 113 IIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERI 163
           IIHRD+KPSNI++     +K+ DFG++     +   T     R Y APE I
Sbjct: 144 IIHRDLKPSNIVVKSDCTLKILDFGLARTACTNFMMTPYVVTRYYRAPEVI 194

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359

>gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

 Score = 40.8 bits (95), Expect = 2e-04
 Identities = 22/51 (43%), Positives = 29/51 (56%)

Query: 113 IIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERI 163
           IIHRD+KPSNI++     +K+ DFG++     S   T     R Y APE I
Sbjct: 140 IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVI 190

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355

>gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases

 Score = 40.8 bits (96), Expect = 2e-04
 Identities = 44/173 (25%), Positives = 65/173 (37%), Gaps = 35/173 (20%)

Query: 24  EDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRS-TVDEKD-----------QRQLLM 71
           E L+   ++G G FG V       + T +AVK ++  T+  +            +   L+
Sbjct: 6   ESLKLERKLGAGQFGEVWMGTWNGT-TKVAVKTLKPGTMSPEAFLQEAQIMKKLRHDKLV 64

Query: 72  DLDVVMKSNECPYIVQFY---GALFKEVTVATVKALN----------------YLKEELK 112
            L  V    E  YIV  Y   G+L   +     K L                 YL E   
Sbjct: 65  QLYAVCSEEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYL-ESRN 123

Query: 113 IIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTRDAGCRP--YMAPERI 163
            IHRD+   NIL+      K+ DFG++  + D     R+    P  + APE  
Sbjct: 124 YIHRDLAARNILVGENLVCKIADFGLARLIEDDEYTAREGAKFPIKWTAPEAA 176

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261

>gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4

 Score = 40.8 bits (95), Expect = 2e-04
 Identities = 48/178 (26%), Positives = 76/178 (42%), Gaps = 41/178 (23%)

Query: 25  DLQDLGEIGRGGFGTVNKMIH-RSSDTV---MAVKRIRSTVDEKDQRQLLMDLDVVMKSN 80
           +L+ +  +G G FGTV K I     +TV   +A+K +  T   K   +  MD  ++M S 
Sbjct: 8   ELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEF-MDEALIMASM 66

Query: 81  ECPYIVQF-----------------YGALFKEV---------------TVATVKALNYLK 108
           + P++V+                  +G L   V                V   K + YL 
Sbjct: 67  DHPHLVRLLGVCLSPTIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYL- 125

Query: 109 EELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLV-DSIAKTRDAGCRP--YMAPERI 163
           EE +++HRD+   N+L+     +K+ DFG++  L  D      D G  P  +MA E I
Sbjct: 126 EERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECI 183

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303

>gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

 Score = 39.8 bits (93), Expect = 3e-04
 Identities = 25/70 (35%), Positives = 41/70 (58%), Gaps = 10/70 (14%)

Query: 72  DLDVVMKSNE--CPYIVQFYGALFKEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRG 129
           DL  V+K+N+   P   QF+  L++      ++AL Y+     + HRD+KP NIL +   
Sbjct: 89  DLHQVIKANDDLTPEHHQFF--LYQ-----LLRALKYIHTA-NVFHRDLKPKNILANADC 140

Query: 130 AIKLCDFGIS 139
            +K+CDFG++
Sbjct: 141 KLKICDFGLA 150

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338

>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 39.7 bits (93), Expect = 4e-04
 Identities = 29/158 (18%), Positives = 62/158 (39%), Gaps = 41/158 (25%)

Query: 21  FTSEDLQDLGEIGRGGFGTVNKMIHRSSD----TVMAVKRIRSTVDEKDQRQLLMDLDVV 76
           F    L+ + ++G G FG V    +          +AVK +  + +E+ +     ++++ 
Sbjct: 1   FEKRHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEI- 59

Query: 77  MKSNECPYIVQF--------------------YGAL---------------FKEVTVATV 101
           +++ +   IV++                     G+L                   +    
Sbjct: 60  LRTLDHENIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQIC 119

Query: 102 KALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGIS 139
           K ++YL    + IHRD+   NIL++    +K+ DFG++
Sbjct: 120 KGMDYL-GSQRYIHRDLAARNILVESEDLVKISDFGLA 156

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284

>gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

 Score = 39.3 bits (92), Expect = 4e-04
 Identities = 38/162 (23%), Positives = 61/162 (37%), Gaps = 47/162 (29%)

Query: 24  EDLQDLGEIGRGGFGTV--NKMIHRSSDTV---MAVKRIRSTVDEKDQRQLLMDLDVVMK 78
           + +  L  +G G FG V       R  D V   +AVK +  +  E+D+   LM+  ++ K
Sbjct: 6   DSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSK 65

Query: 79  SNECPYIVQFYGALFKEVTVATVKAL-------NYLK----------------------- 108
            N    IV+  G  F+ +    +  L       ++L+                       
Sbjct: 66  FNH-QNIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARD 124

Query: 109 --------EELKIIHRDVKPSNILLDRRGA---IKLCDFGIS 139
                   EE   IHRD+   N LL  +G     K+ DFG++
Sbjct: 125 VAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIADFGMA 166

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277

>gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

 Score = 39.6 bits (92), Expect = 4e-04
 Identities = 20/49 (40%), Positives = 30/49 (61%), Gaps = 2/49 (4%)

Query: 113 IIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTRDAGCRPYMAPE 161
           IIHRD+KPSN+ ++    +++ DFG++ Q  D +  T     R Y APE
Sbjct: 139 IIHRDLKPSNVAVNEDCELRILDFGLARQADDEM--TGYVATRWYRAPE 185

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343

>gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

 Score = 39.6 bits (92), Expect = 5e-04
 Identities = 22/61 (36%), Positives = 34/61 (55%), Gaps = 3/61 (4%)

Query: 101 VKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTRDAGCRPYMAP 160
           ++ L Y+     IIHRD+KPSN+ ++    +K+ DFG++    D +  T     R Y AP
Sbjct: 130 LRGLKYI-HSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM--TGYVATRWYRAP 186

Query: 161 E 161
           E
Sbjct: 187 E 187

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345

>gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1

 Score = 39.2 bits (91), Expect = 5e-04
 Identities = 41/170 (24%), Positives = 61/170 (35%), Gaps = 56/170 (32%)

Query: 20  DFTSEDLQDLGEIGRGGFGTVNKMIHRSSDTVM--AVKRIRSTVDEKDQRQLLMDLDVVM 77
           D   ED+     IG G FG V + + +     M  A+K ++    E D R    +L+V+ 
Sbjct: 3   DIKFEDV-----IGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLC 57

Query: 78  KSNECPYIVQFYGA----------------------LFKEVTVATVKA------------ 103
           K    P I+   GA                      L K   + T  A            
Sbjct: 58  KLGHHPNIINLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLT 117

Query: 104 --------------LNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGIS 139
                         + YL E+ + IHRD+   N+L+    A K+ DFG+S
Sbjct: 118 SQQLLQFASDVATGMQYLSEK-QFIHRDLAARNVLVGENLASKIADFGLS 166

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297

>gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional

 Score = 39.0 bits (91), Expect = 6e-04
 Identities = 15/48 (31%), Positives = 24/48 (50%), Gaps = 10/48 (20%)

Query: 113 IIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTRDAGCRPYMAP 160
            +HRD+ P+NI ++ +G  K+ DFG++          R  G  PY   
Sbjct: 140 FMHRDLSPANIFINSKGICKIADFGLA----------RRYGYPPYSDT 177

Length = 335

>gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

 Score = 39.0 bits (91), Expect = 6e-04
 Identities = 25/74 (33%), Positives = 36/74 (48%), Gaps = 10/74 (13%)

Query: 106 YLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTRDAGCRPY--MAPERI 163
           YL EE   IHRD+   NIL+      K+ DFG++  + + +  + D    PY   APE  
Sbjct: 119 YL-EEQNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKI-PYKWTAPE-- 174

Query: 164 DPLRARGYPSFKTK 177
               A  + +F TK
Sbjct: 175 ----AASHGTFSTK 184

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261

>gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional

 Score = 39.2 bits (91), Expect = 7e-04
 Identities = 19/46 (41%), Positives = 29/46 (63%), Gaps = 1/46 (2%)

Query: 99  ATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVD 144
           + ++A+ YL E  +IIHRD+K  NI ++  G + L DFG +   VD
Sbjct: 190 SVLRAIQYLHEN-RIIHRDIKAENIFINHPGDVCLGDFGAACFPVD 234

Length = 391

>gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

 Score = 38.8 bits (90), Expect = 7e-04
 Identities = 43/171 (25%), Positives = 69/171 (40%), Gaps = 40/171 (23%)

Query: 24  EDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIR------------STVDEKDQRQLLM 71
           ++L+ L  IG+G FG V  M+       +AVK I+            S + +     L+ 
Sbjct: 6   KELKLLQTIGKGEFGDV--MLGDYRGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQ 63

Query: 72  DLDVVMKSNECPYIVQFY-------------------GALFKEVTVATVKALNYLKEELK 112
            L V+++     YIV  Y                   G    + ++   +A+ YL E   
Sbjct: 64  LLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYL-EANN 122

Query: 113 IIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTRDAGCRP--YMAPE 161
            +HRD+   N+L+      K+ DFG    L    + T+D G  P  + APE
Sbjct: 123 FVHRDLAARNVLVSEDNVAKVSDFG----LTKEASSTQDTGKLPVKWTAPE 169

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256

>gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3

 Score = 38.4 bits (89), Expect = 0.001
 Identities = 38/157 (24%), Positives = 63/157 (40%), Gaps = 36/157 (22%)

Query: 21  FTSEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQL---LMDLDVVM 77
               +L+ L  +G G FGTV+K I       + +     T+ ++  RQ    + D  + M
Sbjct: 4   LKETELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAM 63

Query: 78  KSNECPYIVQF-----------------YGALFKEV---------------TVATVKALN 105
            S +  YIV+                   G+L   V                V   K + 
Sbjct: 64  GSLDHAYIVRLLGICPGASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMY 123

Query: 106 YLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQL 142
           YL EE +++HR++   NILL     +++ DFG++  L
Sbjct: 124 YL-EEHRMVHRNLAARNILLKSDSIVQIADFGVADLL 159

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279

>gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional

 Score = 37.9 bits (88), Expect = 0.002
 Identities = 14/39 (35%), Positives = 22/39 (56%), Gaps = 1/39 (2%)

Query: 99  ATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFG 137
             ++ L YL  + +IIHRDVK  NI ++    + + D G
Sbjct: 165 QILEGLRYLHAQ-RIIHRDVKTENIFINDVDQVCIGDLG 202

Length = 357

>gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2

 Score = 37.7 bits (87), Expect = 0.002
 Identities = 42/177 (23%), Positives = 66/177 (37%), Gaps = 54/177 (30%)

Query: 18  VYDFTSEDLQDLGEIGRGGFGTVNKMIHRSSDTVM--AVKRIRSTVDEKDQRQLLMDLDV 75
           V ++     QD+  IG G FG V K   +     M  A+KR++    + D R    +L+V
Sbjct: 3   VLEWNDIKFQDV--IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEV 60

Query: 76  VMKSNECPYIVQFYGA------LFKEVTVA------------------------------ 99
           + K    P I+   GA      L+  +  A                              
Sbjct: 61  LCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTAST 120

Query: 100 ------------TVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGIS-GQLV 143
                         + ++YL ++ + IHRD+   NIL+      K+ DFG+S GQ V
Sbjct: 121 LSSQQLLHFAADVARGMDYLSQK-QFIHRDLAARNILVGENYVAKIADFGLSRGQEV 176

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303

>gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 37.4 bits (87), Expect = 0.002
 Identities = 29/103 (28%), Positives = 44/103 (42%), Gaps = 15/103 (14%)

Query: 73  LDVVMKSNECPYIVQFYGALFKEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGA-- 130
           LDV +   +             +V      AL+YL E+ K++H +V   NIL+ R G   
Sbjct: 87  LDVFLHREKNN----VSLHWKLDVAKQLASALHYL-EDKKLVHGNVCGKNILVARYGLNE 141

Query: 131 -----IKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPLRA 168
                IKL D GI   ++    +       P++APE I   +A
Sbjct: 142 GYVPFIKLSDPGIPITVLSREERVERI---PWIAPECIRNGQA 181

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259

>gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

 Score = 37.2 bits (86), Expect = 0.002
 Identities = 17/65 (26%), Positives = 36/65 (55%), Gaps = 4/65 (6%)

Query: 102 KALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDS---IAKTRDAGCRPYM 158
           + + YL E +K++HRD+   N+L+     +K+ DFG+S  + +    + +++      +M
Sbjct: 138 RGMQYLAE-MKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWM 196

Query: 159 APERI 163
           A E +
Sbjct: 197 AIESL 201

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290

>gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

 Score = 37.2 bits (86), Expect = 0.003
 Identities = 25/63 (39%), Positives = 35/63 (55%), Gaps = 3/63 (4%)

Query: 101 VKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTRDAGCRPYMAP 160
           +K L Y+     IIHRD+KP N+ ++    +K+ DFG++ Q  DS   T     R Y AP
Sbjct: 128 LKGLKYIHAA-GIIHRDLKPGNLAVNEDCELKILDFGLARQ-TDS-EMTGYVVTRWYRAP 184

Query: 161 ERI 163
           E I
Sbjct: 185 EVI 187

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343

>gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases

 Score = 36.6 bits (84), Expect = 0.004
 Identities = 36/158 (22%), Positives = 57/158 (36%), Gaps = 51/158 (32%)

Query: 32  IGRGGFGTVNKMIHRSSDTVM--AVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQFY 89
           IG G FG V K   +     M  A+KR++    + D R    +L+V+ K    P I+   
Sbjct: 3   IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 62

Query: 90  GA------LFKEVTVA------------------------------------------TV 101
           GA      L+  +  A                                            
Sbjct: 63  GACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVA 122

Query: 102 KALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGIS 139
           + ++YL ++ + IHRD+   NIL+      K+ DFG+S
Sbjct: 123 RGMDYLSQK-QFIHRDLAARNILVGENYVAKIADFGLS 159

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270

>gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

 Score = 36.6 bits (85), Expect = 0.004
 Identities = 46/171 (26%), Positives = 74/171 (43%), Gaps = 35/171 (20%)

Query: 26  LQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRS-TVDEKD-----------QRQLLMDL 73
           +Q L ++G G FG V + +  ++ T +AVK ++  T+D KD           +   L+ L
Sbjct: 8   IQLLRKLGAGQFGEVWEGLWNNT-TPVAVKTLKPGTMDPKDFLAEAQIMKKLRHPKLIQL 66

Query: 74  DVVMKSNECPYIV---QFYGALFKEVTVATVKALN----------------YLKEELKII 114
             V    E  YIV     YG+L + +     +AL                 YL E    I
Sbjct: 67  YAVCTLEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYL-EAQNYI 125

Query: 115 HRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTRDAGCRP--YMAPERI 163
           HRD+   N+L+      K+ DFG++  + + I + R+    P  + APE  
Sbjct: 126 HRDLAARNVLVGENNICKVADFGLARVIKEDIYEAREGAKFPIKWTAPEAA 176

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261

>gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

 Score = 36.8 bits (85), Expect = 0.004
 Identities = 40/175 (22%), Positives = 75/175 (42%), Gaps = 38/175 (21%)

Query: 24  EDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECP 83
           E L+ + ++G G FG V  M + +  T +A+K ++      +    L + ++ MK  + P
Sbjct: 6   ETLKLVKKLGAGQFGEV-WMGYYNGHTKVAIKSLKQGSMSPEA--FLAEANL-MKQLQHP 61

Query: 84  YIVQFYGALFKE----VTVATVKA--LNYLK--------------------------EEL 111
            +V+ Y  + +E    +T        +++LK                          E  
Sbjct: 62  RLVRLYAVVTQEPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERK 121

Query: 112 KIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTRDAGCRP--YMAPERID 164
             IHRD++ +NIL+      K+ DFG++  + D+    R+    P  + APE I+
Sbjct: 122 NYIHRDLRAANILVSETLCCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAIN 176

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260

Conserved Domains Detected by HHsearch

Original result of HHsearch against CDD database

ID	Length	Definition	Probability
Query	187
KOG0598|consensus	357		100.0
KOG0595|consensus	429		100.0
KOG0593|consensus	396		100.0
KOG0581|consensus	364		100.0
KOG0575|consensus	592		100.0
KOG0615|consensus	475		100.0
KOG1006|consensus	361		100.0
KOG0616|consensus	355		100.0
KOG0591|consensus	375		100.0
KOG0984|consensus	282		100.0
KOG0600|consensus	560		100.0
KOG0694|consensus	694		100.0
KOG0659|consensus	318		100.0
KOG0192|consensus	362		100.0
KOG0661|consensus	538		100.0
KOG0582|consensus	516		100.0
KOG0983|consensus	391		100.0
KOG0594|consensus	323		100.0
KOG0658|consensus	364		100.0
KOG0592|consensus	604		100.0
KOG0583|consensus	370		100.0
KOG0597|consensus	808		100.0
KOG0663|consensus	419		100.0
KOG0197|consensus	468		100.0
KOG0578|consensus	550		100.0
KOG0585|consensus	576		100.0
KOG0033|consensus	355		100.0
KOG0588|consensus	786		100.0
KOG0605|consensus	550		100.0
KOG0201|consensus	467		100.0
KOG0193|consensus	678		100.0
KOG0580|consensus	281		100.0
cd07875	364	STKc_JNK1 Catalytic domain of the Serine/Threonine	100.0
cd05628	363	STKc_NDR1 Catalytic domain of the Protein Serine/T	100.0
KOG0690|consensus	516		99.98
cd07876	359	STKc_JNK2 Catalytic domain of the Serine/Threonine	99.98
PTZ00263	329	protein kinase A catalytic subunit; Provisional	99.98
KOG0198|consensus	313		99.98
cd05629	377	STKc_NDR_like_fungal Catalytic domain of Fungal Nu	99.98
cd07874	355	STKc_JNK3 Catalytic domain of the Serine/Threonine	99.98
KOG0611|consensus	668		99.98
cd05599	364	STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel	99.98
KOG0660|consensus	359		99.98
cd05598	376	STKc_LATS Catalytic domain of the Protein Serine/T	99.98
cd05626	381	STKc_LATS2 Catalytic domain of the Protein Serine/	99.98
cd05612	291	STKc_PRKX_like Catalytic domain of PRKX-like Prote	99.98
KOG0667|consensus	586		99.98
cd05621	370	STKc_ROCK2 Catalytic domain of the Protein Serine/	99.97
cd05622	371	STKc_ROCK1 Catalytic domain of the Protein Serine/	99.97
cd05625	382	STKc_LATS1 Catalytic domain of the Protein Serine/	99.97
cd05573	350	STKc_ROCK_NDR_like Catalytic domain of ROCK- and N	99.97
cd05102	338	PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi	99.97
cd05631	285	STKc_GRK4 Catalytic domain of the Protein Serine/T	99.97
cd05571	323	STKc_PKB Catalytic domain of the Protein Serine/Th	99.97
PTZ00426	340	cAMP-dependent protein kinase catalytic subunit; P	99.97
cd05600	333	STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p-	99.97
cd05627	360	STKc_NDR2 Catalytic domain of the Protein Serine/T	99.97
KOG0194|consensus	474		99.97
cd07878	343	STKc_p38beta_MAPK11 Catalytic domain of the Serine	99.97
KOG4236|consensus	888		99.97
KOG4717|consensus	864		99.97
KOG4721|consensus	904		99.97
cd07848	287	STKc_CDKL5 Catalytic domain of the Serine/Threonin	99.97
cd07859	338	STKc_TDY_MAPK_plant Catalytic domain of the Serine	99.97
cd05604	325	STKc_SGK3 Catalytic domain of the Protein Serine/T	99.97
cd05603	321	STKc_SGK2 Catalytic domain of the Protein Serine/T	99.97
cd05575	323	STKc_SGK Catalytic domain of the Protein Serine/Th	99.97
PHA03212	391	serine/threonine kinase US3; Provisional	99.97
cd05594	325	STKc_PKB_alpha Catalytic domain of the Protein Ser	99.97
cd05596	370	STKc_ROCK Catalytic domain of the Protein Serine/T	99.97
PTZ00036	440	glycogen synthase kinase; Provisional	99.97
cd07862	290	STKc_CDK6 Catalytic domain of the Serine/Threonine	99.97
KOG4279|consensus	1226		99.97
KOG0589|consensus	426		99.97
cd07863	288	STKc_CDK4 Catalytic domain of the Serine/Threonine	99.97
cd05602	325	STKc_SGK1 Catalytic domain of the Protein Serine/T	99.97
cd07869	303	STKc_PFTAIRE1 Catalytic domain of the Serine/Threo	99.97
cd05593	328	STKc_PKB_gamma Catalytic domain of the Protein Ser	99.97
PLN00034	353	mitogen-activated protein kinase kinase; Provision	99.97
KOG1035|consensus	1351		99.97
KOG0577|consensus	948		99.97
cd05616	323	STKc_cPKC_beta Catalytic domain of the Protein Ser	99.97
KOG1187|consensus	361		99.97
cd05585	312	STKc_YPK1_like Catalytic domain of Yeast Protein K	99.97
KOG1026|consensus	774		99.97
cd05624	331	STKc_MRCK_beta Catalytic domain of the Protein Ser	99.97
cd05595	323	STKc_PKB_beta Catalytic domain of the Protein Seri	99.97
cd07871	288	STKc_PCTAIRE3 Catalytic domain of the Serine/Threo	99.97
cd05601	330	STKc_CRIK Catalytic domain of the Protein Serine/T	99.97
KOG0032|consensus	382		99.97
cd05592	316	STKc_nPKC_theta_delta Catalytic domain of the Prot	99.97
cd05618	329	STKc_aPKC_iota Catalytic domain of the Protein Ser	99.97
cd05597	331	STKc_DMPK_like Catalytic domain of Myotonic Dystro	99.97
cd05591	321	STKc_nPKC_epsilon Catalytic domain of the Protein	99.97
cd07853	372	STKc_NLK Catalytic domain of the Serine/Threonine	99.97
PTZ00283	496	serine/threonine protein kinase; Provisional	99.97
cd05582	318	STKc_RSK_N N-terminal catalytic domain of the Prot	99.97
cd05588	329	STKc_aPKC Catalytic domain of the Protein Serine/T	99.97
KOG0662|consensus	292		99.97
KOG0586|consensus	596		99.97
KOG4250|consensus	732		99.97
KOG0574|consensus	502		99.97
cd05589	324	STKc_PKN Catalytic domain of the Protein Serine/Th	99.97
KOG1989|consensus	738		99.97
cd05587	324	STKc_cPKC Catalytic domain of the Protein Serine/T	99.97
cd05590	320	STKc_nPKC_eta Catalytic domain of the Protein Seri	99.97
KOG0614|consensus	732		99.97
cd05108	316	PTKc_EGFR Catalytic domain of the Protein Tyrosine	99.97
PHA03209	357	serine/threonine kinase US3; Provisional	99.97
KOG0610|consensus	459		99.97
cd06617	283	PKc_MKK3_6 Catalytic domain of the dual-specificit	99.97
cd06649	331	PKc_MEK2 Catalytic domain of the dual-specificity	99.97
cd05106	374	PTKc_CSF-1R Catalytic domain of the Protein Tyrosi	99.97
cd05584	323	STKc_p70S6K Catalytic domain of the Protein Serine	99.97
cd05586	330	STKc_Sck1_like Catalytic domain of Suppressor of l	99.97
cd05620	316	STKc_nPKC_delta Catalytic domain of the Protein Se	99.97
cd05615	323	STKc_cPKC_alpha Catalytic domain of the Protein Se	99.97
cd05623	332	STKc_MRCK_alpha Catalytic domain of the Protein Se	99.96
cd05614	332	STKc_MSK2_N N-terminal catalytic domain of the Pro	99.96
KOG0599|consensus	411		99.96
KOG0579|consensus	1187		99.96
cd05104	375	PTKc_Kit Catalytic domain of the Protein Tyrosine	99.96
PTZ00284	467	protein kinase; Provisional	99.96
cd05605	285	STKc_GRK4_like Catalytic domain of G protein-coupl	99.96
cd05054	337	PTKc_VEGFR Catalytic domain of the Protein Tyrosin	99.96
cd05617	327	STKc_aPKC_zeta Catalytic domain of the Protein Ser	99.96
cd05619	316	STKc_nPKC_theta Catalytic domain of the Protein Se	99.96
cd06616	288	PKc_MKK4 Catalytic domain of the dual-specificity	99.96
cd06650	333	PKc_MEK1 Catalytic domain of the dual-specificity	99.96
KOG0584|consensus	632		99.96
cd05096	304	PTKc_DDR1 Catalytic domain of the Protein Tyrosine	99.96
KOG0666|consensus	438		99.96
KOG1095|consensus	1025		99.96
cd05103	343	PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi	99.96
cd05570	318	STKc_PKC Catalytic domain of the Protein Serine/Th	99.96
cd05607	277	STKc_GRK7 Catalytic domain of the Protein Serine/T	99.96
KOG0986|consensus	591		99.96
PRK13184	932	pknD serine/threonine-protein kinase; Reviewed	99.96
cd07868	317	STKc_CDK8 Catalytic domain of the Serine/Threonine	99.96
cd07872	309	STKc_PCTAIRE2 Catalytic domain of the Serine/Threo	99.96
cd05105	400	PTKc_PDGFR_alpha Catalytic domain of the Protein T	99.96
PHA03211	461	serine/threonine kinase US3; Provisional	99.96
PTZ00266	1021	NIMA-related protein kinase; Provisional	99.96
KOG4645|consensus	1509		99.96
cd07850	353	STKc_JNK Catalytic domain of the Serine/Threonine	99.96
PTZ00267	478	NIMA-related protein kinase; Provisional	99.96
cd06619	279	PKc_MKK5 Catalytic domain of the dual-specificity	99.96
KOG0612|consensus	1317		99.96
cd06618	296	PKc_MKK7 Catalytic domain of the dual-specificity	99.96
PHA02882	294	putative serine/threonine kinase; Provisional	99.96
cd05630	285	STKc_GRK6 Catalytic domain of the Protein Serine/T	99.96
cd05632	285	STKc_GRK5 Catalytic domain of the Protein Serine/T	99.96
KOG2345|consensus	302		99.96
cd05608	280	STKc_GRK1 Catalytic domain of the Protein Serine/T	99.96
KOG0196|consensus	996		99.96
PHA03210	501	serine/threonine kinase US3; Provisional	99.96
KOG3653|consensus	534		99.96
cd07839	284	STKc_CDK5 Catalytic domain of the Serine/Threonine	99.96
cd05053	293	PTKc_FGFR Catalytic domain of the Protein Tyrosine	99.96
cd05064	266	PTKc_EphR_A10 Catalytic domain of the Protein Tyro	99.96
PHA03207	392	serine/threonine kinase US3; Provisional	99.96
cd05109	279	PTKc_HER2 Catalytic domain of the Protein Tyrosine	99.95
cd05091	283	PTKc_Ror2 Catalytic domain of the Protein Tyrosine	99.95
cd06645	267	STKc_MAP4K3 Catalytic domain of the Protein Serine	99.95
PF00069	260	Pkinase: Protein kinase domain Protein kinase; unc	99.95
cd05075	272	PTKc_Axl Catalytic domain of the Protein Tyrosine	99.95
cd05111	279	PTK_HER3 Pseudokinase domain of the Protein Tyrosi	99.95
cd05107	401	PTKc_PDGFR_beta Catalytic domain of the Protein Ty	99.95
cd05088	303	PTKc_Tie2 Catalytic domain of the Protein Tyrosine	99.95
cd06625	263	STKc_MEKK3_like Catalytic domain of MAP/ERK kinase	99.95
cd05089	297	PTKc_Tie1 Catalytic domain of the Protein Tyrosine	99.95
cd06646	267	STKc_MAP4K5 Catalytic domain of the Protein Serine	99.95
cd07861	285	STKc_CDK1_euk Catalytic domain of the Serine/Threo	99.95
cd05580	290	STKc_PKA Catalytic domain of the Protein Serine/Th	99.95
cd07847	286	STKc_CDKL1_4 Catalytic domain of the Serine/Threon	99.95
KOG1094|consensus	807		99.95
cd05052	263	PTKc_Abl Catalytic domain of the Protein Tyrosine	99.95
cd05062	277	PTKc_IGF-1R Catalytic domain of the Protein Tyrosi	99.95
cd05035	273	PTKc_Axl_like Catalytic Domain of Axl-like Protein	99.95
cd07849	336	STKc_ERK1_2_like Catalytic domain of Extracellular	99.95
cd07873	301	STKc_PCTAIRE1 Catalytic domain of the Serine/Threo	99.95
cd05032	277	PTKc_InsR_like Catalytic domain of Insulin Recepto	99.95
cd05072	261	PTKc_Lyn Catalytic domain of the Protein Tyrosine	99.95
KOG2052|consensus	513		99.95
cd05101	304	PTKc_FGFR2 Catalytic domain of the Protein Tyrosin	99.95
cd08228	267	STKc_Nek6 Catalytic domain of the Protein Serine/T	99.95
KOG0696|consensus	683		99.95
cd05099	314	PTKc_FGFR4 Catalytic domain of the Protein Tyrosin	99.95
cd05100	334	PTKc_FGFR3 Catalytic domain of the Protein Tyrosin	99.95
cd08529	256	STKc_FA2-like Catalytic domain of the Protein Seri	99.95
cd06613	262	STKc_MAP4K3_like Catalytic domain of Mitogen-activ	99.95
cd06652	265	STKc_MEKK2 Catalytic domain of the Protein Serine/	99.95
cd05048	283	PTKc_Ror Catalytic Domain of the Protein Tyrosine	99.95
cd06615	308	PKc_MEK Catalytic domain of the dual-specificity P	99.95
cd07877	345	STKc_p38alpha_MAPK14 Catalytic domain of the Serin	99.95
cd06622	286	PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS	99.95
cd05110	303	PTKc_HER4 Catalytic domain of the Protein Tyrosine	99.95
KOG4278|consensus	1157		99.95
cd07833	288	STKc_CDKL Catalytic domain of Cyclin-Dependent pro	99.95
cd07867	317	STKc_CDC2L6 Catalytic domain of Serine/Threonine K	99.95
PHA02988	283	hypothetical protein; Provisional	99.95
KOG0664|consensus	449		99.95
cd07846	286	STKc_CDKL2_3 Catalytic domain of the Serine/Threon	99.95
cd08219	255	STKc_Nek3 Catalytic domain of the Protein Serine/T	99.95
cd05116	257	PTKc_Syk Catalytic domain of the Protein Tyrosine	99.95
cd07831	282	STKc_MOK Catalytic domain of the Serine/Threonine	99.95
cd06644	292	STKc_STK10_LOK Catalytic domain of the Protein Ser	99.95
cd05578	258	STKc_Yank1 Catalytic domain of the Protein Serine/	99.95
cd05071	262	PTKc_Src Catalytic domain of the Protein Tyrosine	99.95
cd08223	257	STKc_Nek4 Catalytic domain of the Protein Serine/T	99.95
cd06643	282	STKc_SLK Catalytic domain of the Protein Serine/Th	99.95
cd05051	296	PTKc_DDR Catalytic domain of the Protein Tyrosine	99.95
cd05097	295	PTKc_DDR_like Catalytic domain of Discoidin Domain	99.95
cd07858	337	STKc_TEY_MAPK_plant Catalytic domain of the Serine	99.95
cd07855	334	STKc_ERK5 Catalytic domain of the Serine/Threonine	99.95
cd08227	327	PK_STRAD_alpha Pseudokinase domain of STE20-relate	99.95
cd05079	284	PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the	99.95
cd07845	309	STKc_CDK10 Catalytic domain of the Serine/Threonin	99.95
cd07870	291	STKc_PFTAIRE2 Catalytic domain of the Serine/Threo	99.95
KOG0604|consensus	400		99.95
cd08229	267	STKc_Nek7 Catalytic domain of the Protein Serine/T	99.95
cd05061	288	PTKc_InsR Catalytic domain of the Protein Tyrosine	99.95
cd06651	266	STKc_MEKK3 Catalytic domain of the Protein Serine/	99.95
cd05081	284	PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of	99.95
cd07860	284	STKc_CDK2_3 Catalytic domain of the Serine/Threoni	99.95
cd07843	293	STKc_CDC2L1 Catalytic domain of the Serine/Threoni	99.95
cd05055	302	PTKc_PDGFR Catalytic domain of the Protein Tyrosin	99.95
cd05084	252	PTKc_Fes Catalytic domain of the Protein Tyrosine	99.95
cd05057	279	PTKc_EGFR_like Catalytic domain of Epidermal Growt	99.95
cd08220	256	STKc_Nek8 Catalytic domain of the Protein Serine/T	99.95
cd07865	310	STKc_CDK9 Catalytic domain of the Serine/Threonine	99.95
cd05098	307	PTKc_FGFR1 Catalytic domain of the Protein Tyrosin	99.95
cd08217	265	STKc_Nek2 Catalytic domain of the Protein Serine/T	99.95
KOG0607|consensus	463		99.95
cd08224	267	STKc_Nek6_Nek7 Catalytic domain of the Protein Ser	99.95
cd06607	307	STKc_TAO Catalytic domain of the Protein Serine/Th	99.95
cd05090	283	PTKc_Ror1 Catalytic domain of the Protein Tyrosine	99.95
cd05574	316	STKc_phototropin_like Catalytic domain of Phototro	99.95
cd06655	296	STKc_PAK2 Catalytic domain of the Protein Serine/T	99.95
cd06653	264	STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina	99.94
cd05074	273	PTKc_Tyro3 Catalytic domain of the Protein Tyrosin	99.94
cd05067	260	PTKc_Lck_Blk Catalytic domain of the Protein Tyros	99.94
KOG0695|consensus	593		99.94
cd05043	280	PTK_Ryk Pseudokinase domain of Ryk (Receptor relat	99.94
cd07844	291	STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like	99.94
cd05148	261	PTKc_Srm_Brk Catalytic domain of the Protein Tyros	99.94
cd05068	261	PTKc_Frk_like Catalytic domain of Fyn-related kina	99.94
cd06637	272	STKc_TNIK Catalytic domain of the Protein Serine/T	99.94
cd07857	332	STKc_MPK1 Catalytic domain of the Serine/Threonine	99.94
cd08221	256	STKc_Nek9 Catalytic domain of the Protein Serine/T	99.94
cd06654	296	STKc_PAK1 Catalytic domain of the Protein Serine/T	99.94
cd07879	342	STKc_p38delta_MAPK13 Catalytic domain of the Serin	99.94
cd05093	288	PTKc_TrkB Catalytic domain of the Protein Tyrosine	99.94
cd07832	286	STKc_CCRK Catalytic domain of the Serine/Threonine	99.94
cd05033	266	PTKc_EphR Catalytic domain of Ephrin Receptor Prot	99.94
cd07866	311	STKc_BUR1 Catalytic domain of the Serine/Threonine	99.94
cd06612	256	STKc_MST1_2 Catalytic domain of the Protein Serine	99.94
cd05114	256	PTKc_Tec_Rlk Catalytic domain of the Protein Tyros	99.94
cd05049	280	PTKc_Trk Catalytic domain of the Protein Tyrosine	99.94
cd06620	284	PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr	99.94
cd06609	274	STKc_MST3_like Catalytic domain of Mammalian Ste20	99.94
PLN00009	294	cyclin-dependent kinase A; Provisional	99.94
cd07880	343	STKc_p38gamma_MAPK12 Catalytic domain of the Serin	99.94
cd06642	277	STKc_STK25-YSK1 Catalytic domain of the Protein Se	99.94
cd05095	296	PTKc_DDR2 Catalytic domain of the Protein Tyrosine	99.94
cd07852	337	STKc_MAPK15 Catalytic domain of the Serine/Threoni	99.94
cd06656	297	STKc_PAK3 Catalytic domain of the Protein Serine/T	99.94
cd06658	292	STKc_PAK5 Catalytic domain of the Protein Serine/T	99.94
cd05070	260	PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros	99.94
cd05066	267	PTKc_EphR_A Catalytic domain of the Protein Tyrosi	99.94
KOG0608|consensus	1034		99.94
cd05082	256	PTKc_Csk Catalytic domain of the Protein Tyrosine	99.94
cd06611	280	STKc_SLK_like Catalytic domain of Ste20-like kinas	99.94
cd06659	297	STKc_PAK6 Catalytic domain of the Protein Serine/T	99.94
KOG0596|consensus	677		99.94
cd07841	298	STKc_CDK7 Catalytic domain of the Serine/Threonine	99.94
cd07864	302	STKc_CDK12 Catalytic domain of the Serine/Threonin	99.94
cd05073	260	PTKc_Hck Catalytic domain of the Protein Tyrosine	99.94
cd06605	265	PKc_MAPKK Catalytic domain of the dual-specificity	99.94
cd06636	282	STKc_MAP4K4_6 Catalytic domain of the Protein Seri	99.94
cd05036	277	PTKc_ALK_LTK Catalytic domain of the Protein Tyros	99.94
cd05092	280	PTKc_TrkA Catalytic domain of the Protein Tyrosine	99.94
cd06626	264	STKc_MEKK4 Catalytic domain of the Protein Serine/	99.94
cd07837	295	STKc_CdkB_plant Catalytic domain of the Serine/Thr	99.94
cd05065	269	PTKc_EphR_B Catalytic domain of the Protein Tyrosi	99.94
cd05056	270	PTKc_FAK Catalytic domain of the Protein Tyrosine	99.94
cd07842	316	STKc_CDK8_like Catalytic domain of Cyclin-Dependen	99.94
KOG1151|consensus	775		99.94
KOG0199|consensus	1039		99.94
cd07830	283	STKc_MAK_like Catalytic domain of Male germ cell-A	99.94
cd05080	283	PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the	99.94
cd05058	262	PTKc_Met_Ron Catalytic domain of the Protein Tyros	99.94
cd05047	270	PTKc_Tie Catalytic domain of Tie Protein Tyrosine	99.94
cd07834	330	STKc_MAPK Catalytic domain of the Serine/Threonine	99.94
cd05113	256	PTKc_Btk_Bmx Catalytic domain of the Protein Tyros	99.94
cd05039	256	PTKc_Csk_like Catalytic domain of C-terminal Src k	99.94
cd05115	257	PTKc_Zap-70 Catalytic domain of the Protein Tyrosi	99.94
KOG0671|consensus	415		99.94
cd06638	286	STKc_myosinIIIA Catalytic domain of the Protein Se	99.94
cd06610	267	STKc_OSR1_SPAK Catalytic domain of the Protein Ser	99.94
cd07838	287	STKc_CDK4_6_like Catalytic domain of Cyclin-Depend	99.94
cd06628	267	STKc_MAPKKK_Byr2_like Catalytic domain of fungal B	99.94
cd06632	258	STKc_MEKK1_plant Catalytic domain of the Protein S	99.94
KOG4257|consensus	974		99.94
cd06630	268	STKc_MEKK1 Catalytic domain of the Protein Serine/	99.94
cd05609	305	STKc_MAST Catalytic domain of the Protein Serine/T	99.94
cd06647	293	STKc_PAK_I Catalytic domain of the Protein Serine/	99.94
cd05060	257	PTKc_Syk_like Catalytic domain of Spleen Tyrosine	99.94
cd05059	256	PTKc_Tec_like Catalytic domain of Tec-like Protein	99.94
cd05069	260	PTKc_Yes Catalytic domain of the Protein Tyrosine	99.94
cd05077	262	PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th	99.94
cd07856	328	STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre	99.94
cd05050	288	PTKc_Musk Catalytic domain of the Protein Tyrosine	99.94
cd05572	262	STKc_cGK_PKG Catalytic domain of the Protein Serin	99.94
cd05042	269	PTKc_Aatyk Catalytic domain of the Protein Tyrosin	99.94
KOG0669|consensus	376		99.94
cd07840	287	STKc_CDK9_like Catalytic domain of Cyclin-Dependen	99.94
cd07835	283	STKc_CDK1_like Catalytic domain of Cyclin-Dependen	99.94
cd05034	261	PTKc_Src_like Catalytic domain of Src kinase-like	99.94
cd06624	268	STKc_ASK Catalytic domain of the Protein Serine/Th	99.94
cd05063	268	PTKc_EphR_A2 Catalytic domain of the Protein Tyros	99.94
KOG0668|consensus	338		99.94
cd05037	259	PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the	99.94
cd08218	256	STKc_Nek1 Catalytic domain of the Protein Serine/T	99.94
cd07851	343	STKc_p38 Catalytic domain of the Serine/Threonine	99.94
cd07854	342	STKc_MAPK4_6 Catalytic domain of the Serine/Threon	99.93
cd05045	290	PTKc_RET Catalytic domain of the Protein Tyrosine	99.93
cd05094	291	PTKc_TrkC Catalytic domain of the Protein Tyrosine	99.93
cd06635	317	STKc_TAO1 Catalytic domain of the Protein Serine/T	99.93
cd05606	278	STKc_beta_ARK Catalytic domain of the Protein Seri	99.93
cd08528	269	STKc_Nek10 Catalytic domain of the Protein Serine/	99.93
cd05633	279	STKc_GRK3 Catalytic domain of the Protein Serine/T	99.93
cd06639	291	STKc_myosinIIIB Catalytic domain of the Protein Se	99.93
cd05087	269	PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein	99.93
cd05118	283	STKc_CMGC Catalytic domain of CMGC family Serine/T	99.93
cd05038	284	PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P	99.93
cd06917	277	STKc_NAK1_like Catalytic domain of Fungal Nak1-lik	99.93
cd07829	282	STKc_CDK_like Catalytic domain of Cyclin-Dependent	99.93
cd06629	272	STKc_MAPKKK_Bck1_like Catalytic domain of fungal B	99.93
cd06631	265	STKc_YSK4 Catalytic domain of the Protein Serine/T	99.93
KOG0587|consensus	953		99.93
cd00192	262	PTKc Catalytic domain of Protein Tyrosine Kinases.	99.93
cd05577	277	STKc_GRK Catalytic domain of the Protein Serine/Th	99.93
cd08226	328	PK_STRAD_beta Pseudokinase domain of STE20-related	99.93
cd08530	256	STKc_CNK2-like Catalytic domain of the Protein Ser	99.93
cd06621	287	PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek	99.93
cd05611	260	STKc_Rim15_like Catalytic domain of fungal Rim15-l	99.93
cd07836	284	STKc_Pho85 Catalytic domain of the Serine/Threonin	99.93
cd06640	277	STKc_MST4 Catalytic domain of the Protein Serine/T	99.93
cd05083	254	PTKc_Chk Catalytic domain of the Protein Tyrosine	99.93
cd05085	250	PTKc_Fer Catalytic domain of the Protein Tyrosine	99.93
cd06623	264	PKc_MAPKK_plant_like Catalytic domain of Plant dua	99.93
cd06641	277	STKc_MST3 Catalytic domain of the Protein Serine/T	99.93
smart00219	258	TyrKc Tyrosine kinase, catalytic domain. Phosphotr	99.93
cd05041	251	PTKc_Fes_like Catalytic domain of Fes-like Protein	99.93
PF07714	259	Pkinase_Tyr: Protein tyrosine kinase Protein kinas	99.93
cd08215	258	STKc_Nek Catalytic domain of the Protein Serine/Th	99.93
cd06634	308	STKc_TAO2 Catalytic domain of the Protein Serine/T	99.93
cd05076	274	PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th	99.93
cd08225	257	STKc_Nek5 Catalytic domain of the Protein Serine/T	99.93
cd06648	285	STKc_PAK_II Catalytic domain of the Protein Serine	99.93
KOG1152|consensus	772		99.93
cd05086	268	PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi	99.93
cd05078	258	PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain	99.93
cd05581	280	STKc_PDK1 Catalytic domain of the Protein Serine/T	99.93
KOG1025|consensus	1177		99.93
cd05112	256	PTKc_Itk Catalytic domain of the Protein Tyrosine	99.93
cd05040	257	PTKc_Ack_like Catalytic domain of the Protein Tyro	99.93
cd06627	254	STKc_Cdc7_like Catalytic domain of Cell division c	99.93
cd05046	275	PTK_CCK4 Pseudokinase domain of the Protein Tyrosi	99.93
PLN03225	566	Serine/threonine-protein kinase SNT7; Provisional	99.93
cd05579	265	STKc_MAST_like Catalytic domain of Microtubule-ass	99.93
cd05613	290	STKc_MSK1_N N-terminal catalytic domain of the Pro	99.93
cd06608	275	STKc_myosinIII_like Catalytic domain of Class III	99.92
KOG0576|consensus	829		99.92
KOG0603|consensus	612		99.92
cd06633	313	STKc_TAO3 Catalytic domain of the Protein Serine/T	99.92
PTZ00024	335	cyclin-dependent protein kinase; Provisional	99.92
cd06606	260	STKc_MAPKKK Catalytic domain of the Protein Serine	99.92
cd06657	292	STKc_PAK4 Catalytic domain of the Protein Serine/T	99.92
cd08216	314	PK_STRAD Pseudokinase domain of STE20-related kina	99.92
cd05122	253	PKc_STE Catalytic domain of STE family Protein Kin	99.92
KOG0200|consensus	609		99.92
PHA03390	267	pk1 serine/threonine-protein kinase 1; Provisional	99.92
cd06614	286	STKc_PAK Catalytic domain of the Protein Serine/Th	99.92
cd05044	269	PTKc_c-ros Catalytic domain of the Protein Tyrosin	99.92
cd05123	250	STKc_AGC Catalytic domain of AGC family Protein Se	99.91
cd08222	260	STKc_Nek11 Catalytic domain of the Protein Serine/	99.91
KOG1345|consensus	378		99.91
KOG0665|consensus	369		99.91
PRK09188	365	serine/threonine protein kinase; Provisional	99.91
cd05583	288	STKc_MSK_N N-terminal catalytic domain of the Prot	99.91
KOG0670|consensus	752		99.91
cd05576	237	STKc_RPK118_like Catalytic domain of the Protein S	99.91
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	99.9
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	99.9
PLN03224	507	probable serine/threonine protein kinase; Provisio	99.9
KOG1027|consensus	903		99.88
KOG1290|consensus	590		99.87
smart00221	225	STYKc Protein kinase; unclassified specificity. Ph	99.86
smart00220	244	S_TKc Serine/Threonine protein kinases, catalytic	99.86
KOG1167|consensus	418		99.85
KOG1024|consensus	563		99.84
cd00180	215	PKc Catalytic domain of Protein Kinases. Protein K	99.82
KOG1165|consensus	449		99.82
KOG1163|consensus	341		99.79
PRK10359	232	lipopolysaccharide core biosynthesis protein; Prov	99.78
KOG1164|consensus	322		99.77
PLN00181	793	protein SPA1-RELATED; Provisional	99.75
KOG0590|consensus	601		99.75
KOG0606|consensus	1205		99.74
cd05145	190	RIO1_like RIO kinase family; RIO1, RIO3 and simila	99.74
cd05147	190	RIO1_euk RIO kinase family; eukaryotic RIO1, catal	99.74
PF14531	288	Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_	99.69
COG0515	384	SPS1 Serine/threonine protein kinase [General func	99.68
PRK10345	210	hypothetical protein; Provisional	99.65
KOG4158|consensus	598		99.64
KOG0603|consensus	612		99.64
KOG1166|consensus	974		99.64
smart00090	237	RIO RIO-like kinase.	99.63
smart00750	176	KIND kinase non-catalytic C-lobe domain. It is an	99.61
cd05144	198	RIO2_C RIO kinase family; RIO2, C-terminal catalyt	99.59
cd05119	187	RIO RIO kinase family, catalytic domain. The RIO k	99.57
PRK12274	218	serine/threonine protein kinase; Provisional	99.56
KOG1033|consensus	516		99.56
PRK09605	535	bifunctional UGMP family protein/serine/threonine	99.49
PRK14879	211	serine/threonine protein kinase; Provisional	99.48
TIGR03724	199	arch_bud32 Kae1-associated kinase Bud32. Members o	99.46
KOG1240|consensus	1431		99.46
KOG0590|consensus	601		99.37
PRK01723	239	3-deoxy-D-manno-octulosonic-acid kinase; Reviewed	99.31
KOG0195|consensus	448		99.24
cd05120	155	APH_ChoK_like Aminoglycoside 3'-phosphotransferase	99.24
TIGR01982	437	UbiB 2-polyprenylphenol 6-hydroxylase. This model	99.14
KOG1023|consensus	484		99.12
PRK04750	537	ubiB putative ubiquinone biosynthesis protein UbiB	99.05
KOG1243|consensus	690		99.03
KOG0601|consensus	524		98.93
cd05151	170	ChoK Choline Kinase (ChoK). The ChoK subfamily is	98.88
KOG0601|consensus	524		98.75
cd05146	197	RIO3_euk RIO kinase family; eukaryotic RIO3, catal	98.66
KOG2137|consensus	700		98.59
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	98.2
KOG0606|consensus	1205		98.13
PF01163	188	RIO1: RIO1 family; InterPro: IPR018934 Protein pho	98.12
COG3642	204	Mn2+-dependent serine/threonine protein kinase [Si	98.0
COG1718	268	RIO1 Serine/threonine protein kinase involved in c	97.91
KOG3087|consensus	229		97.89
KOG1266|consensus	458		97.87
COG0661	517	AarF Predicted unusual protein kinase [General fun	97.76
KOG0576|consensus	829		97.76
PF06293	206	Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family;	97.71
cd05154	223	ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an	97.67
PRK15123	268	lipopolysaccharide core heptose(I) kinase RfaP; Pr	97.6
COG4248	637	Uncharacterized protein with protein kinase and he	97.54
KOG3741|consensus	655		97.49
COG2112	201	Predicted Ser/Thr protein kinase [Signal transduct	97.33
COG0478	304	RIO-like serine/threonine protein kinase fused to	97.31
PF13095	207	FTA2: Kinetochore Sim4 complex subunit FTA2	97.12
KOG1235|consensus	538		97.05
PF06176	229	WaaY: Lipopolysaccharide core biosynthesis protein	96.88
PF10707	199	YrbL-PhoP_reg: PhoP regulatory network protein Yrb	96.79
PRK09902	216	hypothetical protein; Provisional	96.69
PF03109	119	ABC1: ABC1 family; InterPro: IPR004147 This entry	94.39
KOG2268|consensus	465		94.16
PRK05231	319	homoserine kinase; Provisional	94.1
PF07387	308	Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099	94.09
cd05156	302	ChoK_euk Choline Kinase (ChoK) in eukaryotes. The	94.05
cd05157	235	ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes.	93.91
cd05155	235	APH_ChoK_like_1 Uncharacterized bacterial proteins	93.89
TIGR02172	226	Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou	93.75
PRK10271	188	thiK thiamine kinase; Provisional	93.67
cd05150	244	APH Aminoglycoside 3'-phosphotransferase (APH). Th	93.59
TIGR00938	307	thrB_alt homoserine kinase, Neisseria type. Homose	93.39
cd05153	296	HomoserineK_II Homoserine Kinase, type II. Homoser	93.34
TIGR02721	256	ycfN_thiK thiamine kinase. Members of this family	93.27
PF01636	239	APH: Phosphotransferase enzyme family This family	93.27
PF01633	211	Choline_kinase: Choline/ethanolamine kinase; Inter	93.15
COG0510	269	ycfN Thiamine kinase and related kinases [Coenzyme	92.67
KOG2270|consensus	520		92.57
TIGR02906	313	spore_CotS spore coat protein, CotS family. Member	92.05
smart00587	196	CHK ZnF_C4 abd HLH domain containing kinases domai	91.63
PF12260	188	PIP49_C: Protein-kinase domain of FAM69; InterPro:	91.6
PLN02236	344	choline kinase	91.53
cd05152	276	MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH	90.85
COG5072	488	ALK1 Serine/threonine kinase of the haspin family	90.71
TIGR02904	309	spore_ysxE spore coat protein YsxE. Members of thi	90.13
COG3173	321	Predicted aminoglycoside phosphotransferase [Gener	89.41
PLN02421	330	phosphotransferase, alcohol group as acceptor/kina	89.23
COG2334	331	Putative homoserine kinase type II (protein kinase	88.33
PRK06148	1013	hypothetical protein; Provisional	87.71
PHA03111	444	Ser/Thr kinase; Provisional	87.26
KOG1236|consensus	565		86.6
KOG1035|consensus	1351		86.07
PRK09550	401	mtnK methylthioribose kinase; Reviewed	83.43
PRK11768	325	serine/threonine protein kinase; Provisional	83.1
PF02958	294	EcKinase: Ecdysteroid kinase; InterPro: IPR004119	81.76

>KOG0598|consensus

Probab=100.00  E-value=2.3e-41  Score=254.07  Aligned_cols=163  Identities=30%  Similarity=0.459  Sum_probs=135.0

Q ss_pred             cCCcccccccccccccCceEEEEEEEcCCCcEEEEEEccCcc-ChHHHHHHHHHHHHHHhcCCCCchhhhhhhHHHH---
Q psy14630         20 DFTSEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTV-DEKDQRQLLMDLDVVMKSNECPYIVQFYGALFKE---   95 (187)
Q Consensus        20 ~~~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~---   95 (187)
                      ....++|+++++||+|+||+|++++.+.|++.+|+|++++.. ......+....+..++...+||+||.++-+|++.   
T Consensus        21 ~~~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kL  100 (357)
T KOG0598|consen   21 MVGPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKL  100 (357)
T ss_pred             cCChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeE
Confidence            566899999999999999999999999999999999997543 1112334445555566679999999987544322   


Q ss_pred             -----------------------------HHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEeccccccccc-c
Q psy14630         96 -----------------------------VTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVD-S  145 (187)
Q Consensus        96 -----------------------------~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg~a~~~~~-~  145 (187)
                                                   .+..++.||.|||+. +|+||||||+|||++.+|+++++|||+++.... +
T Consensus       101 ylVld~~~GGeLf~hL~~eg~F~E~~arfYlaEi~lAL~~LH~~-gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~~~~  179 (357)
T KOG0598|consen  101 YLVLDYLNGGELFYHLQREGRFSEDRARFYLAEIVLALGYLHSK-GIIYRDLKPENILLDEQGHIKLTDFGLCKEDLKDG  179 (357)
T ss_pred             EEEEeccCCccHHHHHHhcCCcchhHHHHHHHHHHHHHHHHHhC-CeeeccCCHHHeeecCCCcEEEeccccchhcccCC
Confidence                                         567789999999997 999999999999999999999999999996543 4


Q ss_pred             ccccCCCCCcCccCccccCCCccCCCCCCcceeeeEe-eeeC
Q psy14630        146 IAKTRDAGCRPYMAPERIDPLRARGYPSFKTKLGFKF-NYRI  186 (187)
Q Consensus       146 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi-~~~~  186 (187)
                      ......+||+.|||||++.   ..+|+.++|+||+|| +|.|
T Consensus       180 ~~t~tfcGT~eYmAPEil~---~~gy~~~vDWWsLGillYeM  218 (357)
T KOG0598|consen  180 DATRTFCGTPEYMAPEILL---GKGYDKAVDWWSLGILLYEM  218 (357)
T ss_pred             CccccccCCccccChHHHh---cCCCCcccchHhHHHHHHHH
Confidence            4555679999999999999   779999999999999 5543

>KOG0595|consensus

Probab=100.00  E-value=3e-41  Score=256.13  Aligned_cols=159  Identities=31%  Similarity=0.404  Sum_probs=139.1

Q ss_pred             cccccccccccccCceEEEEEEEcCCCcEEEEEEccCccChHHHHHHHHHHHHHHhcCCCCchhhhhhhH----------
Q psy14630         23 SEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQFYGAL----------   92 (187)
Q Consensus        23 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~----------   92 (187)
                      ..+|.+.+.||.|+|++||+|+++.++..||||.+......+...+.+..+..+++.++|||||++++..          
T Consensus         9 ~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVM   88 (429)
T KOG0595|consen    9 VGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVM   88 (429)
T ss_pred             cccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEE
Confidence            4689899999999999999999999999999999865444556777788888889999999999987532          


Q ss_pred             ----------------------HHHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCC------CCEEEEeccccccccc
Q psy14630         93 ----------------------FKEVTVATVKALNYLKEELKIIHRDVKPSNILLDRR------GAIKLCDFGISGQLVD  144 (187)
Q Consensus        93 ----------------------~~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~------~~~ki~dfg~a~~~~~  144 (187)
                                            .+.++.|++.|+++||++ +|+||||||+|||+...      -.+||+|||+|+.+.+
T Consensus        89 EyC~gGDLs~yi~~~~~l~e~t~r~Fm~QLA~alq~L~~~-~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~L~~  167 (429)
T KOG0595|consen   89 EYCNGGDLSDYIRRRGRLPEATARHFMQQLASALQFLHEN-NIIHRDLKPQNILLSTTARNDTSPVLKIADFGFARFLQP  167 (429)
T ss_pred             EeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC-CeeeccCCcceEEeccCCCCCCCceEEecccchhhhCCc
Confidence                                  222778999999999998 99999999999999764      3589999999999998


Q ss_pred             cccccCCCCCcCccCccccCCCccCCCCCCcceeeeEeeee
Q psy14630        145 SIAKTRDAGCRPYMAPERIDPLRARGYPSFKTKLGFKFNYR  185 (187)
Q Consensus       145 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi~~~  185 (187)
                      .......+|++.|||||++.   ...|+.|+|.||+|+++|
T Consensus       168 ~~~a~tlcGSplYMAPEV~~---~~~YdAKADLWSiG~Ily  205 (429)
T KOG0595|consen  168 GSMAETLCGSPLYMAPEVIM---SQQYDAKADLWSIGTILY  205 (429)
T ss_pred             hhHHHHhhCCccccCHHHHH---hccccchhhHHHHHHHHH
Confidence            88888889999999999998   778999999999998543

>KOG0593|consensus

Probab=100.00  E-value=1.5e-40  Score=244.44  Aligned_cols=157  Identities=25%  Similarity=0.425  Sum_probs=142.1

Q ss_pred             ccccccccccccCceEEEEEEEcCCCcEEEEEEccCccChHHHHHHHHHHHHHHhcCCCCchhhhhhhHHHH--------
Q psy14630         24 EDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQFYGALFKE--------   95 (187)
Q Consensus        24 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~--------   95 (187)
                      +.|..+.++|+|+||+|++|+++.||+.||||.+....+++...++..++..+++++.|+|+|.+.++|-+.        
T Consensus         2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE   81 (396)
T KOG0593|consen    2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFE   81 (396)
T ss_pred             cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEee
Confidence            568889999999999999999999999999999988778888899999999999999999999998776332        


Q ss_pred             ------------------------HHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEecccccccc-ccccccC
Q psy14630         96 ------------------------VTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLV-DSIAKTR  150 (187)
Q Consensus        96 ------------------------~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg~a~~~~-~~~~~~~  150 (187)
                                              +..|++.|+.|+|.+ +++||||||+||++..++.+|+||||+|+.+. ++...+.
T Consensus        82 ~~dhTvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cHk~-n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~pgd~YTD  160 (396)
T KOG0593|consen   82 YCDHTVLHELERYPNGVPSELVKKYLYQLLKAIHFCHKN-NCIHRDIKPENILITQNGVVKLCDFGFARTLSAPGDNYTD  160 (396)
T ss_pred             ecchHHHHHHHhccCCCCHHHHHHHHHHHHHHhhhhhhc-CeecccCChhheEEecCCcEEeccchhhHhhcCCcchhhh
Confidence                                    778999999999998 99999999999999999999999999999987 5666667


Q ss_pred             CCCCcCccCccccCCCccCCCCCCcceeeeEee
Q psy14630        151 DAGCRPYMAPERIDPLRARGYPSFKTKLGFKFN  183 (187)
Q Consensus       151 ~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi~  183 (187)
                      .+.|.+|+|||++.+  ...|...+|||++|.+
T Consensus       161 YVATRWYRaPELLvG--DtqYG~pVDiWAiGCv  191 (396)
T KOG0593|consen  161 YVATRWYRAPELLVG--DTQYGKPVDIWAIGCV  191 (396)
T ss_pred             hhhhhhccChhhhcc--cCcCCCcccchhhhHH
Confidence            789999999999996  4578899999999984

>KOG0581|consensus

Probab=100.00  E-value=5.7e-40  Score=246.77  Aligned_cols=159  Identities=40%  Similarity=0.740  Sum_probs=135.6

Q ss_pred             CCcccccccccccccCceEEEEEEEcCCCcEEEEEEccCccChHHHHHHHHHHHHHHhcCCCCchhhhhhhHHHH-----
Q psy14630         21 FTSEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQFYGALFKE-----   95 (187)
Q Consensus        21 ~~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~-----   95 (187)
                      +..++++.++.||+|+.|+||++.|+.|++.+|+|.+....+.....++++|.. +.+..+||+||.+|++|+..     
T Consensus        76 i~~~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~-il~~~~spyIV~~ygaF~~~~~~is  154 (364)
T KOG0581|consen   76 ISLSDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELE-ILRSCQSPYIVGFYGAFYSNGEEIS  154 (364)
T ss_pred             cCHHHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHH-HHhhCCCCCeeeEeEEEEeCCceEE
Confidence            445688889999999999999999999999999999965555555555555555 55566999999999765332     


Q ss_pred             ----------------------------HHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEecccccccccccc
Q psy14630         96 ----------------------------VTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIA  147 (187)
Q Consensus        96 ----------------------------~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg~a~~~~~~~~  147 (187)
                                                  ++.+++.||.|||+..+|+||||||+|+|++.+|.+||||||.++.+.++ .
T Consensus       155 I~mEYMDgGSLd~~~k~~g~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS-~  233 (364)
T KOG0581|consen  155 ICMEYMDGGSLDDILKRVGRIPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS-I  233 (364)
T ss_pred             eehhhcCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHeeeccCCCEEeccccccHHhhhh-h
Confidence                                        67789999999997559999999999999999999999999999998877 5


Q ss_pred             ccCCCCCcCccCccccCCCccCCCCCCcceeeeEeee
Q psy14630        148 KTRDAGCRPYMAPERIDPLRARGYPSFKTKLGFKFNY  184 (187)
Q Consensus       148 ~~~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi~~  184 (187)
                      ..+++||..|||||.+.   ...|+.++||||||+.+
T Consensus       234 a~tfvGT~~YMsPERi~---g~~Ys~~sDIWSLGLsl  267 (364)
T KOG0581|consen  234 ANTFVGTSAYMSPERIS---GESYSVKSDIWSLGLSL  267 (364)
T ss_pred             cccccccccccChhhhc---CCcCCcccceecccHHH
Confidence            56679999999999999   67899999999999954

>KOG0575|consensus

Probab=100.00  E-value=3.8e-39  Score=254.86  Aligned_cols=167  Identities=28%  Similarity=0.394  Sum_probs=145.8

Q ss_pred             CCCccccCCcccccccccccccCceEEEEEEEcCCCcEEEEEEccCc-cChHHHHHHHHHHHHHHhcCCCCchhhhhhhH
Q psy14630         14 SPDTVYDFTSEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRST-VDEKDQRQLLMDLDVVMKSNECPYIVQFYGAL   92 (187)
Q Consensus        14 ~~~~~~~~~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~   92 (187)
                      .|..+.+....+|...+.||+|+|+.||.+.+..+|+.||+|++.+. ..+..+.+.+..+..+.+.++|||||++++.|
T Consensus         8 ip~~i~D~~~~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~F   87 (592)
T KOG0575|consen    8 IPEVIEDPRSKRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFF   87 (592)
T ss_pred             CCCeeecCCcceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEe
Confidence            34455565558899999999999999999999999999999999653 34445677777788899999999999999766


Q ss_pred             HHH--------------------------------HHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEeccccc
Q psy14630         93 FKE--------------------------------VTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISG  140 (187)
Q Consensus        93 ~~~--------------------------------~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg~a~  140 (187)
                      .+.                                +..||+.|+.|||+. +|+|||||..|++++++.++||+|||+|.
T Consensus        88 EDs~nVYivLELC~~~sL~el~Krrk~ltEpEary~l~QIv~GlkYLH~~-~IiHRDLKLGNlfL~~~~~VKIgDFGLAt  166 (592)
T KOG0575|consen   88 EDSNNVYIVLELCHRGSLMELLKRRKPLTEPEARYFLRQIVEGLKYLHSL-GIIHRDLKLGNLFLNENMNVKIGDFGLAT  166 (592)
T ss_pred             ecCCceEEEEEecCCccHHHHHHhcCCCCcHHHHHHHHHHHHHHHHHHhc-CceecccchhheeecCcCcEEecccceee
Confidence            433                                778999999999998 99999999999999999999999999999


Q ss_pred             cccc-cccccCCCCCcCccCccccCCCccCCCCCCcceeeeEe-ee
Q psy14630        141 QLVD-SIAKTRDAGCRPYMAPERIDPLRARGYPSFKTKLGFKF-NY  184 (187)
Q Consensus       141 ~~~~-~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi-~~  184 (187)
                      .+.. .+.....||||.|.|||++.   ..++..-+||||+|+ +|
T Consensus       167 ~le~~~Erk~TlCGTPNYIAPEVl~---k~gHsfEvDiWSlGcvmY  209 (592)
T KOG0575|consen  167 QLEYDGERKKTLCGTPNYIAPEVLN---KSGHSFEVDIWSLGCVMY  209 (592)
T ss_pred             eecCcccccceecCCCcccChhHhc---cCCCCCchhhhhhhhHHH
Confidence            9974 46677789999999999999   789999999999999 44

>KOG0615|consensus

Probab=100.00  E-value=5.4e-39  Score=244.22  Aligned_cols=163  Identities=23%  Similarity=0.300  Sum_probs=131.8

Q ss_pred             CcccccccccccccCceEEEEEEEcCCCcEEEEEEccCccCh-----HHHHHHHHHHHHHHhcCCCCchhhhhhhHHH--
Q psy14630         22 TSEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDE-----KDQRQLLMDLDVVMKSNECPYIVQFYGALFK--   94 (187)
Q Consensus        22 ~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~-----~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~--   94 (187)
                      ..+.|.+.+.||+|+||.|.+|..+.|++.||||++.++...     ........++..+++.++|||||++++.+..  
T Consensus       170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~d  249 (475)
T KOG0615|consen  170 FNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPD  249 (475)
T ss_pred             hcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCC
Confidence            456677889999999999999999999999999999643211     1112235677888999999999998765421  


Q ss_pred             ------------------------------HHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCC---CCEEEEecccccc
Q psy14630         95 ------------------------------EVTVATVKALNYLKEELKIIHRDVKPSNILLDRR---GAIKLCDFGISGQ  141 (187)
Q Consensus        95 ------------------------------~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~---~~~ki~dfg~a~~  141 (187)
                                                    .++.|++.|+.|||++ ||+||||||+|||+..+   ..+||+|||+|+.
T Consensus       250 s~YmVlE~v~GGeLfd~vv~nk~l~ed~~K~~f~Qll~avkYLH~~-GI~HRDiKPeNILl~~~~e~~llKItDFGlAK~  328 (475)
T KOG0615|consen  250 SSYMVLEYVEGGELFDKVVANKYLREDLGKLLFKQLLTAVKYLHSQ-GIIHRDIKPENILLSNDAEDCLLKITDFGLAKV  328 (475)
T ss_pred             ceEEEEEEecCccHHHHHHhccccccchhHHHHHHHHHHHHHHHHc-CcccccCCcceEEeccCCcceEEEecccchhhc
Confidence                                          2778999999999998 99999999999999765   6799999999999


Q ss_pred             ccccccccCCCCCcCccCccccCCCccCCCCCCcceeeeEeeee
Q psy14630        142 LVDSIAKTRDAGCRPYMAPERIDPLRARGYPSFKTKLGFKFNYR  185 (187)
Q Consensus       142 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi~~~  185 (187)
                      ..........|||+.|.|||++..-.-..+..++|+||+|+++.
T Consensus       329 ~g~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLf  372 (475)
T KOG0615|consen  329 SGEGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLF  372 (475)
T ss_pred             cccceehhhhcCCccccChhheecCCeecccchheeeeccceEE
Confidence            87666667789999999999998321222446889999999654

>KOG1006|consensus

Probab=100.00  E-value=2.4e-39  Score=234.53  Aligned_cols=170  Identities=68%  Similarity=1.079  Sum_probs=152.8

Q ss_pred             CccccCCcccccccccccccCceEEEEEEEcCCCcEEEEEEccCccChHHHHHHHHHHHHHHhcCCCCchhhhhhhHHHH
Q psy14630         16 DTVYDFTSEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQFYGALFKE   95 (187)
Q Consensus        16 ~~~~~~~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~   95 (187)
                      ...++|..++++.+..||.|+||.|++..++.+++..|||.++....++++.+.+.+...+++...+||||++||+++.+
T Consensus        56 ~~~~~F~~~~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~E  135 (361)
T KOG1006|consen   56 AHLHTFTSDNLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSE  135 (361)
T ss_pred             ccccccccchHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcC
Confidence            46778999999999999999999999999999999999999988778888999999999999999999999999987665


Q ss_pred             ------------------------------------HHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEecccc
Q psy14630         96 ------------------------------------VTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGIS  139 (187)
Q Consensus        96 ------------------------------------~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg~a  139 (187)
                                                          ++...+.||.||.+...|+|||+||+|||++..|.+|+||||.+
T Consensus       136 GdcWiCMELMd~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPSNILldr~G~vKLCDFGIc  215 (361)
T KOG1006|consen  136 GDCWICMELMDISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELKIIHRDVKPSNILLDRHGDVKLCDFGIC  215 (361)
T ss_pred             CceeeeHHHHhhhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhhhhhccCChhheEEecCCCEeeecccch
Confidence                                                11224578999999889999999999999999999999999999


Q ss_pred             ccccccccccCCCCCcCccCccccCCCccCCCCCCcceeeeEe-eeeC
Q psy14630        140 GQLVDSIAKTRDAGCRPYMAPERIDPLRARGYPSFKTKLGFKF-NYRI  186 (187)
Q Consensus       140 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi-~~~~  186 (187)
                      ..+.++...+..+|..+|||||.+... ..+|+..+|+||+|| .|++
T Consensus       216 GqLv~SiAkT~daGCrpYmAPERi~p~-~~gyDiRSDvWSLGITL~Ev  262 (361)
T KOG1006|consen  216 GQLVDSIAKTVDAGCRPYMAPERIDPS-DKGYDIRSDVWSLGITLYEV  262 (361)
T ss_pred             HhHHHHHHhhhccCCccccChhccCCc-cCCcchhhhhhhhcceEeee
Confidence            999998888888999999999999865 447999999999999 6654

>KOG0616|consensus

Probab=100.00  E-value=5.4e-39  Score=235.41  Aligned_cols=160  Identities=29%  Similarity=0.507  Sum_probs=138.6

Q ss_pred             CCcccccccccccccCceEEEEEEEcCCCcEEEEEEccCcc-ChHHHHHHHHHHHHHHhcCCCCchhhhhhhHHHH----
Q psy14630         21 FTSEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTV-DEKDQRQLLMDLDVVMKSNECPYIVQFYGALFKE----   95 (187)
Q Consensus        21 ~~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~----   95 (187)
                      ...++|++++.||.|+||.|.+++++.++..+|+|++.... -+-.+.+....+..+++...||+++++++.+.+.    
T Consensus        41 ~~l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~ly  120 (355)
T KOG0616|consen   41 YSLQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLY  120 (355)
T ss_pred             cchhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEE
Confidence            67789999999999999999999999999999999986432 2233556667777888889999999998654332    


Q ss_pred             ----------------------------HHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEecccccccccccc
Q psy14630         96 ----------------------------VTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIA  147 (187)
Q Consensus        96 ----------------------------~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg~a~~~~~~~~  147 (187)
                                                  .+.+++.|++|||+. +|++|||||+|||+|..|.+||+|||.|+.+...  
T Consensus       121 mvmeyv~GGElFS~Lrk~~rF~e~~arFYAAeivlAleylH~~-~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~r--  197 (355)
T KOG0616|consen  121 MVMEYVPGGELFSYLRKSGRFSEPHARFYAAEIVLALEYLHSL-DIIYRDLKPENLLLDQNGHIKITDFGFAKRVSGR--  197 (355)
T ss_pred             EEEeccCCccHHHHHHhcCCCCchhHHHHHHHHHHHHHHHHhc-CeeeccCChHHeeeccCCcEEEEeccceEEecCc--
Confidence                                        678899999999997 9999999999999999999999999999998765  


Q ss_pred             ccCCCCCcCccCccccCCCccCCCCCCcceeeeEe-eeeC
Q psy14630        148 KTRDAGCRPYMAPERIDPLRARGYPSFKTKLGFKF-NYRI  186 (187)
Q Consensus       148 ~~~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi-~~~~  186 (187)
                      +...||||.|+|||.+.   .++|..++|+||||| +|+|
T Consensus       198 T~TlCGTPeYLAPEii~---sk~ynkavDWWalGVLIYEM  234 (355)
T KOG0616|consen  198 TWTLCGTPEYLAPEIIQ---SKGYNKAVDWWALGVLIYEM  234 (355)
T ss_pred             EEEecCCccccChHHhh---cCCCCcchhHHHHHHHHHHH
Confidence            44569999999999999   899999999999999 6654

>KOG0591|consensus

Probab=100.00  E-value=1.4e-38  Score=232.10  Aligned_cols=165  Identities=32%  Similarity=0.438  Sum_probs=137.9

Q ss_pred             ccCCcccccccccccccCceEEEEEEEcCCCcEEEEEEccCccChHHHHHHHHHHHHHHhcCCCCchhhhhhhHHHH---
Q psy14630         19 YDFTSEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQFYGALFKE---   95 (187)
Q Consensus        19 ~~~~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~---   95 (187)
                      ..-+..+|++.++||.|.||.||++.+..++..+|.|.++-...+...++....+..++++++|||||++++..+.+   
T Consensus        14 ~~~~l~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~e   93 (375)
T KOG0591|consen   14 PQKTLADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNE   93 (375)
T ss_pred             CcccHHHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccch
Confidence            44567899999999999999999999999999999999874434444455556666688999999999999732221   


Q ss_pred             -----------------------------------HHHHHHHHHHHHHh--c-CCCeeecCCCCCeEEcCCCCEEEEecc
Q psy14630         96 -----------------------------------VTVATVKALNYLKE--E-LKIIHRDVKPSNILLDRRGAIKLCDFG  137 (187)
Q Consensus        96 -----------------------------------~~~~~~~~l~~lh~--~-~~i~Hrdlk~~nili~~~~~~ki~dfg  137 (187)
                                                         ++.|++.||..+|.  . ..+.||||||.||+++..|.+|+.|||
T Consensus        94 vlnivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfG  173 (375)
T KOG0591|consen   94 VLNIVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFG  173 (375)
T ss_pred             hhHHHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccch
Confidence                                               67789999999998  3 138999999999999999999999999


Q ss_pred             cccccccc-ccccCCCCCcCccCccccCCCccCCCCCCcceeeeEe-eeeC
Q psy14630        138 ISGQLVDS-IAKTRDAGCRPYMAPERIDPLRARGYPSFKTKLGFKF-NYRI  186 (187)
Q Consensus       138 ~a~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi-~~~~  186 (187)
                      +++.+... ....+.+|||.||+||.+.   +.+|+.++||||+|. .|+|
T Consensus       174 L~r~l~s~~tfA~S~VGTPyYMSPE~i~---~~~Y~~kSDiWslGCllyEM  221 (375)
T KOG0591|consen  174 LGRFLSSKTTFAHSLVGTPYYMSPERIH---ESGYNFKSDIWSLGCLLYEM  221 (375)
T ss_pred             hHhHhcchhHHHHhhcCCCcccCHHHHh---cCCCCcchhHHHHHHHHHHH
Confidence            99998654 3445678999999999999   889999999999998 5554

>KOG0984|consensus

Probab=100.00  E-value=1.3e-37  Score=218.32  Aligned_cols=168  Identities=53%  Similarity=0.966  Sum_probs=150.8

Q ss_pred             cccCCcccccccccccccCceEEEEEEEcCCCcEEEEEEccCccChHHHHHHHHHHHHHHhcCCCCchhhhhhhHHHH--
Q psy14630         18 VYDFTSEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQFYGALFKE--   95 (187)
Q Consensus        18 ~~~~~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~--   95 (187)
                      .++++.+++.-+..||+|++|+|-+.++..+|+..|+|.++.....+.+.+.+.+....++...+|.+|++||+++++  
T Consensus        40 ~~eV~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regd  119 (282)
T KOG0984|consen   40 NFEVPADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGD  119 (282)
T ss_pred             ccccchhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhcccc
Confidence            357777888888999999999999999999999999999998888888999999999999999999999999876543  


Q ss_pred             ---------------------------------HHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEeccccccc
Q psy14630         96 ---------------------------------VTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQL  142 (187)
Q Consensus        96 ---------------------------------~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg~a~~~  142 (187)
                                                       ++..++.||.|||+++.++|||+||+||||+..|++|+||||.+..+
T Consensus       120 vwIcME~M~tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L  199 (282)
T KOG0984|consen  120 VWICMELMDTSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPSNILINYDGQVKICDFGISGYL  199 (282)
T ss_pred             EEEeHHHhhhhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcceEEEccCCcEEEcccccceee
Confidence                                             56678899999999999999999999999999999999999999999


Q ss_pred             cccccccCCCCCcCccCccccCCCccC-CCCCCcceeeeEe-eee
Q psy14630        143 VDSIAKTRDAGCRPYMAPERIDPLRAR-GYPSFKTKLGFKF-NYR  185 (187)
Q Consensus       143 ~~~~~~~~~~~t~~y~aPE~~~~~~~~-~~~~~~D~ws~gi-~~~  185 (187)
                      .++...+..+|...|||||.+....+. +|+.++|+||+|| +.+
T Consensus       200 ~dSiAkt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiE  244 (282)
T KOG0984|consen  200 VDSIAKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIE  244 (282)
T ss_pred             hhhhHHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhh
Confidence            998888777899999999999765444 8999999999999 544

>KOG0600|consensus

Probab=100.00  E-value=1.1e-37  Score=242.09  Aligned_cols=161  Identities=22%  Similarity=0.332  Sum_probs=137.0

Q ss_pred             cCCcccccccccccccCceEEEEEEEcCCCcEEEEEEccCccChHHHHHHHHHHHHHHhcCCCCchhhhhhhH-------
Q psy14630         20 DFTSEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQFYGAL-------   92 (187)
Q Consensus        20 ~~~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~-------   92 (187)
                      ....+.|+.+++||+|.||.||+|++..|+..||+|.++....+........+++.+++.++||||+++.+..       
T Consensus       113 ~r~~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~s  192 (560)
T KOG0600|consen  113 PRRADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGS  192 (560)
T ss_pred             ccchHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCce
Confidence            3456678999999999999999999999999999999976555555666777778889999999999885422       


Q ss_pred             ---------------------------HHHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEecccccccccc
Q psy14630         93 ---------------------------FKEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDS  145 (187)
Q Consensus        93 ---------------------------~~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg~a~~~~~~  145 (187)
                                                 ++.++.|++.||.|||.+ +|+|||||.+||||+++|.+||+|||+|+.+...
T Consensus       193 iYlVFeYMdhDL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH~~-gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~~  271 (560)
T KOG0600|consen  193 IYLVFEYMDHDLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCHSR-GVLHRDIKGSNILIDNNGVLKIADFGLARFYTPS  271 (560)
T ss_pred             EEEEEecccchhhhhhcCCCcccChHHHHHHHHHHHHHHHHHhhc-CeeeccccccceEEcCCCCEEeccccceeeccCC
Confidence                                       233788999999999998 9999999999999999999999999999987654


Q ss_pred             c--cccCCCCCcCccCccccCCCccCCCCCCcceeeeEee
Q psy14630        146 I--AKTRDAGCRPYMAPERIDPLRARGYPSFKTKLGFKFN  183 (187)
Q Consensus       146 ~--~~~~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi~  183 (187)
                      .  ..+..+-|.+|+|||++++  ...|..++|+||+|++
T Consensus       272 ~~~~~T~rVvTLWYRpPELLLG--~t~Yg~aVDlWS~GCI  309 (560)
T KOG0600|consen  272 GSAPYTSRVVTLWYRPPELLLG--ATSYGTAVDLWSVGCI  309 (560)
T ss_pred             CCcccccceEEeeccChHHhcC--CcccccceeehhhhHH
Confidence            3  3444567999999999997  5679999999999984

>KOG0694|consensus

Probab=100.00  E-value=4.5e-37  Score=245.92  Aligned_cols=163  Identities=25%  Similarity=0.458  Sum_probs=135.5

Q ss_pred             cCCcccccccccccccCceEEEEEEEcCCCcEEEEEEccCcc--ChHHHHHHHHHHHHHHhcCCCCchhhhhhhHHHH--
Q psy14630         20 DFTSEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTV--DEKDQRQLLMDLDVVMKSNECPYIVQFYGALFKE--   95 (187)
Q Consensus        20 ~~~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~--   95 (187)
                      .+..++|.++++||+|+||+|+++..+.+++.+|||.+++..  .+.+....+.|..+......||.+++++..|..+  
T Consensus       364 ~~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~  443 (694)
T KOG0694|consen  364 PLTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEH  443 (694)
T ss_pred             cccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCe
Confidence            456789999999999999999999999999999999997643  3333333333333322234799999999776443  


Q ss_pred             -----------------------------HHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEecccccccc-cc
Q psy14630         96 -----------------------------VTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLV-DS  145 (187)
Q Consensus        96 -----------------------------~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg~a~~~~-~~  145 (187)
                                                   ++..++.||+|||++ +|++||||.+|||+|..|++||+|||+++... ..
T Consensus       444 l~fvmey~~Ggdm~~~~~~~~F~e~rarfyaAev~l~L~fLH~~-~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m~~g  522 (694)
T KOG0694|consen  444 LFFVMEYVAGGDLMHHIHTDVFSEPRARFYAAEVVLGLQFLHEN-GIIYRDLKLDNLLLDTEGHVKIADFGLCKEGMGQG  522 (694)
T ss_pred             EEEEEEecCCCcEEEEEecccccHHHHHHHHHHHHHHHHHHHhc-CceeeecchhheEEcccCcEEecccccccccCCCC
Confidence                                         667889999999998 99999999999999999999999999999876 45


Q ss_pred             ccccCCCCCcCccCccccCCCccCCCCCCcceeeeEe-eeeC
Q psy14630        146 IAKTRDAGCRPYMAPERIDPLRARGYPSFKTKLGFKF-NYRI  186 (187)
Q Consensus       146 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi-~~~~  186 (187)
                      ..++..+|||.|||||++.   +..|+.++|+||||| +|.|
T Consensus       523 ~~TsTfCGTpey~aPEil~---e~~Yt~aVDWW~lGVLlyeM  561 (694)
T KOG0694|consen  523 DRTSTFCGTPEFLAPEVLT---EQSYTRAVDWWGLGVLLYEM  561 (694)
T ss_pred             CccccccCChhhcChhhhc---cCcccchhhHHHHHHHHHHH
Confidence            5667789999999999999   778999999999999 6654

>KOG0659|consensus

Probab=100.00  E-value=4.4e-37  Score=222.41  Aligned_cols=157  Identities=24%  Similarity=0.381  Sum_probs=129.9

Q ss_pred             ccccccccccccCceEEEEEEEcCCCcEEEEEEccCccChHHHHHHHHHHHHHHhcCCCCchhhhhhhH-----------
Q psy14630         24 EDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQFYGAL-----------   92 (187)
Q Consensus        24 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~-----------   92 (187)
                      .+|...+++|+|.||+||+|++.+|++.||||.++.............++...++.++|+||+.+.+.|           
T Consensus         2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE   81 (318)
T KOG0659|consen    2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE   81 (318)
T ss_pred             chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence            468888999999999999999999999999999975433333333444555577788999999998765           


Q ss_pred             ---------------------HHHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEeccccccccccccc-cC
Q psy14630         93 ---------------------FKEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAK-TR  150 (187)
Q Consensus        93 ---------------------~~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg~a~~~~~~~~~-~~  150 (187)
                                           .+.+..+++.|++|||+. .|+|||+||.|+||..+|.+||+|||+|+.+.+.... ..
T Consensus        82 fm~tdLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~~-~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~~~~~  160 (318)
T KOG0659|consen   82 FMPTDLEVVIKDKNIILSPADIKSYMLMTLKGLAYCHSK-WILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNRIQTH  160 (318)
T ss_pred             eccccHHHHhcccccccCHHHHHHHHHHHHHHHHHHHhh-hhhcccCCccceEEcCCCcEEeecccchhccCCCCccccc
Confidence                                 223778899999999998 9999999999999999999999999999998654322 23


Q ss_pred             CCCCcCccCccccCCCccCCCCCCcceeeeEee
Q psy14630        151 DAGCRPYMAPERIDPLRARGYPSFKTKLGFKFN  183 (187)
Q Consensus       151 ~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi~  183 (187)
                      .+-|.+|+|||++.+  ...|...+|+||.|++
T Consensus       161 ~V~TRWYRAPELLfG--sr~Yg~~VDmWavGCI  191 (318)
T KOG0659|consen  161 QVVTRWYRAPELLFG--SRQYGTGVDMWAVGCI  191 (318)
T ss_pred             ceeeeeccChHHhcc--chhcCCcchhhhHHHH
Confidence            367889999999997  5678999999999983

>KOG0192|consensus

Probab=100.00  E-value=7.8e-37  Score=237.34  Aligned_cols=166  Identities=32%  Similarity=0.446  Sum_probs=137.5

Q ss_pred             CccccCCcccccccccccccCceEEEEEEEcCCCcE-EEEEEccCccChHHHHHHHHHHHHHHhcCCCCchhhhhhhHHH
Q psy14630         16 DTVYDFTSEDLQDLGEIGRGGFGTVNKMIHRSSDTV-MAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQFYGALFK   94 (187)
Q Consensus        16 ~~~~~~~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~-vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~   94 (187)
                      ...+.+..+++...+.+|+|+||+||+|.+.  ++. ||+|++..........+.+..+..++..++|||||+++|++.+
T Consensus        33 ~~~~~i~~~~l~~~~~iG~G~~g~V~~~~~~--g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~  110 (362)
T KOG0192|consen   33 LPEEEIDPDELPIEEVLGSGSFGTVYKGKWR--GTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTS  110 (362)
T ss_pred             ccceecChHHhhhhhhcccCCceeEEEEEeC--CceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcC
Confidence            3566777888888899999999999999986  444 9999997654333336677778888888999999999875432


Q ss_pred             H-----------------------------------HHHHHHHHHHHHHhcCC-CeeecCCCCCeEEcCCC-CEEEEecc
Q psy14630         95 E-----------------------------------VTVATVKALNYLKEELK-IIHRDVKPSNILLDRRG-AIKLCDFG  137 (187)
Q Consensus        95 ~-----------------------------------~~~~~~~~l~~lh~~~~-i~Hrdlk~~nili~~~~-~~ki~dfg  137 (187)
                      .                                   ++.+++.|+.|||++ + |+|||||++|+|++.++ .+||+|||
T Consensus       111 ~~~~~~iVtEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~-~~iIHrDLK~~NiLv~~~~~~~KI~DFG  189 (362)
T KOG0192|consen  111 PPGSLCIVTEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSE-GPIIHRDLKSDNILVDLKGKTLKIADFG  189 (362)
T ss_pred             CCCceEEEEEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcC-CCeeecccChhhEEEcCCCCEEEECCCc
Confidence            1                                   677899999999998 8 99999999999999998 99999999


Q ss_pred             cccccccc-ccccCCCCCcCccCccccCCCccCCCCCCcceeeeEeeee
Q psy14630        138 ISGQLVDS-IAKTRDAGCRPYMAPERIDPLRARGYPSFKTKLGFKFNYR  185 (187)
Q Consensus       138 ~a~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi~~~  185 (187)
                      +++..... ...+...||+.|||||++.+. ...++.++|||||||.+|
T Consensus       190 lsr~~~~~~~~~~~~~GT~~wMAPEv~~~~-~~~~~~K~DvySFgIvlW  237 (362)
T KOG0192|consen  190 LSREKVISKTSMTSVAGTYRWMAPEVLRGE-KSPYTEKSDVYSFGIVLW  237 (362)
T ss_pred             cceeeccccccccCCCCCccccChhhhcCC-CCcCCccchhhhHHHHHH
Confidence            99887654 344446899999999999954 457999999999999877

>KOG0661|consensus

Probab=100.00  E-value=2.1e-37  Score=239.05  Aligned_cols=158  Identities=22%  Similarity=0.347  Sum_probs=139.7

Q ss_pred             CcccccccccccccCceEEEEEEEcCCCcEEEEEEccCccChHHHHHHHHHHHHHHhcCCCCchhhhhhhHHH-------
Q psy14630         22 TSEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQFYGALFK-------   94 (187)
Q Consensus        22 ~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~-------   94 (187)
                      ..++|.+.++||.|.||.||+|+.++++..||||.+++.....+..-.++|+..+.+...||||+++.+.+.+       
T Consensus         8 ~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~f   87 (538)
T KOG0661|consen    8 FMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYF   87 (538)
T ss_pred             HHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEee
Confidence            4578999999999999999999999999999999998766555666677888777776669999999865422       


Q ss_pred             --------------------------HHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEeccccccccccccc
Q psy14630         95 --------------------------EVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAK  148 (187)
Q Consensus        95 --------------------------~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg~a~~~~~~~~~  148 (187)
                                                .++.|+++||+++|.+ |+.|||+||+|||+.....+||+|||+||.+......
T Consensus        88 VfE~Md~NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk~-GfFHRDlKPENiLi~~~~~iKiaDFGLARev~SkpPY  166 (538)
T KOG0661|consen   88 VFEFMDCNLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHKH-GFFHRDLKPENILISGNDVIKIADFGLAREVRSKPPY  166 (538)
T ss_pred             eHHhhhhhHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhc-CcccccCChhheEecccceeEecccccccccccCCCc
Confidence                                      2778999999999998 9999999999999998899999999999999888888


Q ss_pred             cCCCCCcCccCccccCCCccCCCCCCcceeeeEe
Q psy14630        149 TRDAGCRPYMAPERIDPLRARGYPSFKTKLGFKF  182 (187)
Q Consensus       149 ~~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi  182 (187)
                      +..+.|.+|+|||++.+  +.-|+.++|+|++|.
T Consensus       167 TeYVSTRWYRAPEvLLr--s~~Ys~pvD~wA~Gc  198 (538)
T KOG0661|consen  167 TEYVSTRWYRAPEVLLR--SGYYSSPVDMWAVGC  198 (538)
T ss_pred             chhhhcccccchHHhhh--ccccCCchHHHHHHH
Confidence            88899999999999984  777999999999998

>KOG0582|consensus

Probab=100.00  E-value=1.8e-35  Score=226.98  Aligned_cols=171  Identities=29%  Similarity=0.368  Sum_probs=139.7

Q ss_pred             CceecCCCccccCCcccccccccccccCceEEEEEEEcCCCcEEEEEEccCccChHHHHHHHHHHHHHHhcCCCCchhhh
Q psy14630          9 GKLKLSPDTVYDFTSEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQF   88 (187)
Q Consensus         9 ~~~~~~~~~~~~~~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~   88 (187)
                      ..+...+-..|....++|.+..+||.|.-++||+|++..++..||||++....-+.. .+.+..+...+..++||||+.+
T Consensus        11 ~~~~~~~~~~~p~n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~-ld~l~kE~~~msl~~HPNIv~~   89 (516)
T KOG0582|consen   11 LPSASSSEKEFPLNAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNND-LDALRKEVQTMSLIDHPNIVTY   89 (516)
T ss_pred             ccccccccccCCCCccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhh-HHHHHHHHHHhhhcCCCCcceE
Confidence            334444556777888999999999999999999999999999999999865333323 4566677778899999999998


Q ss_pred             hhhHHHH----------------------------------HHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEE
Q psy14630         89 YGALFKE----------------------------------VTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLC  134 (187)
Q Consensus        89 ~~~~~~~----------------------------------~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~  134 (187)
                      +.+|.-+                                  +..++++||.|||++ |-+|||+|+.||||+.+|.+||+
T Consensus        90 ~~sFvv~~~LWvVmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~-G~IHRdvKAgnILi~~dG~VkLa  168 (516)
T KOG0582|consen   90 HCSFVVDSELWVVMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQN-GHIHRDVKAGNILIDSDGTVKLA  168 (516)
T ss_pred             EEEEEecceeEEeehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhc-CceecccccccEEEcCCCcEEEc
Confidence            7544221                                  667889999999998 99999999999999999999999


Q ss_pred             eccccccccccccc-----cCCCCCcCccCccccCCCccCCCCCCcceeeeEe
Q psy14630        135 DFGISGQLVDSIAK-----TRDAGCRPYMAPERIDPLRARGYPSFKTKLGFKF  182 (187)
Q Consensus       135 dfg~a~~~~~~~~~-----~~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi  182 (187)
                      |||....+.++...     ....||++|||||+++.. -.+|+.|+|||||||
T Consensus       169 dFgvsa~l~~~G~R~~~rf~tfvgtp~wmAPEvl~q~-~~GYdfKaDIwSfGI  220 (516)
T KOG0582|consen  169 DFGVSASLFDSGDRQVTRFNTFVGTPCWMAPEVLMQQ-LHGYDFKADIWSFGI  220 (516)
T ss_pred             CceeeeeecccCceeeEeeccccCcccccChHHhhhc-ccCccchhhhhhhhH
Confidence            99988776543211     345799999999997755 568999999999999

>KOG0983|consensus

Probab=100.00  E-value=4.5e-35  Score=213.31  Aligned_cols=171  Identities=53%  Similarity=0.857  Sum_probs=146.1

Q ss_pred             CccccCCcccccccccccccCceEEEEEEEcCCCcEEEEEEccCccChHHHHHHHHHHHHHHhcCCCCchhhhhhhHHHH
Q psy14630         16 DTVYDFTSEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQFYGALFKE   95 (187)
Q Consensus        16 ~~~~~~~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~   95 (187)
                      +..+..+.++++.+..||.|+-|+|+++..++++...|||.+.+.....+..+++.....+.+...+|+||+.||.|...
T Consensus        84 g~r~~~dindl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n  163 (391)
T KOG0983|consen   84 GQRYQADINDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITN  163 (391)
T ss_pred             CcccccChHHhhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeC
Confidence            33444566778888999999999999999999999999999988777777778888888888888899999998754221


Q ss_pred             --------------------------------HHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEecccccccc
Q psy14630         96 --------------------------------VTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLV  143 (187)
Q Consensus        96 --------------------------------~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg~a~~~~  143 (187)
                                                      +...++.||.||.+..+|+|||+||+|||+|..|++|+||||.+..+.
T Consensus       164 ~dV~IcMelMs~C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNILlDe~GniKlCDFGIsGrlv  243 (391)
T KOG0983|consen  164 TDVFICMELMSTCAEKLLKRIKGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGNIKLCDFGISGRLV  243 (391)
T ss_pred             chHHHHHHHHHHHHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHHhcceeecccCccceEEccCCCEEeecccccceee
Confidence                                            344567899999998899999999999999999999999999999998


Q ss_pred             ccccccCCCCCcCccCccccCCCccCCCCCCcceeeeEe-eeeC
Q psy14630        144 DSIAKTRDAGCRPYMAPERIDPLRARGYPSFKTKLGFKF-NYRI  186 (187)
Q Consensus       144 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi-~~~~  186 (187)
                      ++...+..+|.+.|||||.+...-...|+..+||||||| .+.+
T Consensus       244 dSkAhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveL  287 (391)
T KOG0983|consen  244 DSKAHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVEL  287 (391)
T ss_pred             cccccccccCCccccCccccCCCCCCccchhhhhhhhccchhhh
Confidence            888888889999999999998554556899999999999 5443

>KOG0594|consensus

Probab=100.00  E-value=5.2e-36  Score=224.64  Aligned_cols=157  Identities=24%  Similarity=0.382  Sum_probs=130.1

Q ss_pred             cccccccccccccCceEEEEEEEcCCCcEEEEEEccCccChHHHHHHHHHHHHHHhcCCCCc-hhhhhhhH---------
Q psy14630         23 SEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPY-IVQFYGAL---------   92 (187)
Q Consensus        23 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~-iv~~~~~~---------   92 (187)
                      ...|...++||+|+||+||+|+.+.+|+.||+|.+....++........++..+++.+.|+| |+++++.+         
T Consensus        10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~   89 (323)
T KOG0594|consen   10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGI   89 (323)
T ss_pred             HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeeccccccc
Confidence            56788889999999999999999999999999998754332223333445566778889999 88876432         


Q ss_pred             --------------------------------HHHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEeccccc
Q psy14630         93 --------------------------------FKEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISG  140 (187)
Q Consensus        93 --------------------------------~~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg~a~  140 (187)
                                                      .+.++.|++.|++|||++ +|+||||||+|++++++|.+||+|||+|+
T Consensus        90 ~~l~lvfe~~d~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~-~IlHRDLKPQNlLi~~~G~lKlaDFGlAr  168 (323)
T KOG0594|consen   90 GKLYLVFEFLDRDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSH-GILHRDLKPQNLLISSSGVLKLADFGLAR  168 (323)
T ss_pred             ceEEEEEEeecccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhC-CeecccCCcceEEECCCCcEeeeccchHH
Confidence                                            334778999999999998 99999999999999999999999999999


Q ss_pred             ccc-ccccccCCCCCcCccCccccCCCccCCCCCCcceeeeEe
Q psy14630        141 QLV-DSIAKTRDAGCRPYMAPERIDPLRARGYPSFKTKLGFKF  182 (187)
Q Consensus       141 ~~~-~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi  182 (187)
                      ... +....+....|.+|+|||++.+  ...|+..+|+||+|+
T Consensus       169 a~~ip~~~yt~evvTlWYRaPEvLlG--s~~Ys~~vDiWs~Gc  209 (323)
T KOG0594|consen  169 AFSIPMRTYTPEVVTLWYRAPEVLLG--STSYSTSVDIWSLGC  209 (323)
T ss_pred             HhcCCcccccccEEEeeccCHHHhcC--CCcCCCCcchHhHHH
Confidence            876 4444566688999999999996  445999999999998

>KOG0658|consensus

Probab=100.00  E-value=9.2e-36  Score=223.73  Aligned_cols=150  Identities=29%  Similarity=0.396  Sum_probs=123.5

Q ss_pred             cccccccccccCceEEEEEEEcCCCcEEEEEEccCccChHHHHHHHHHHHHHHhcCCCCchhhhhhhHH-----------
Q psy14630         25 DLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQFYGALF-----------   93 (187)
Q Consensus        25 ~~~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~-----------   93 (187)
                      .|...+.+|.|+||.||+|...++++.||||.+-....      ....+..+++.+.|||||++.-++.           
T Consensus        25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r------~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~ln   98 (364)
T KOG0658|consen   25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKR------YKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLN   98 (364)
T ss_pred             EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCC------cCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHH
Confidence            46677899999999999999999999999998753211      1122444566889999998742210           


Q ss_pred             -----------------------------HHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCC-CCEEEEecccccccc
Q psy14630         94 -----------------------------KEVTVATVKALNYLKEELKIIHRDVKPSNILLDRR-GAIKLCDFGISGQLV  143 (187)
Q Consensus        94 -----------------------------~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~-~~~ki~dfg~a~~~~  143 (187)
                                                   +-.+-|+..|+.|||+. +|+||||||+|+|+|.+ |.+||||||.|+.+.
T Consensus        99 lVleymP~tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~-~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L~  177 (364)
T KOG0658|consen   99 LVLEYMPETLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSH-GICHRDIKPQNLLVDPDTGVLKICDFGSAKVLV  177 (364)
T ss_pred             HHHHhchHHHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhc-CcccCCCChheEEEcCCCCeEEeccCCcceeec
Confidence                                         11567899999999996 99999999999999976 899999999999998


Q ss_pred             ccccccCCCCCcCccCccccCCCccCCCCCCcceeeeEee
Q psy14630        144 DSIAKTRDAGCRPYMAPERIDPLRARGYPSFKTKLGFKFN  183 (187)
Q Consensus       144 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi~  183 (187)
                      .+....+...|..|+|||++.+  ...|+.++|+||.|.+
T Consensus       178 ~~epniSYicSRyYRaPELifg--a~~Yt~~IDiWSaGCV  215 (364)
T KOG0658|consen  178 KGEPNISYICSRYYRAPELIFG--ATEYTTSIDIWSAGCV  215 (364)
T ss_pred             cCCCceeEEEeccccCHHHHcC--ccccCceeEEhhhhHH
Confidence            8777777788999999999997  5679999999999973

>KOG0592|consensus

Probab=100.00  E-value=1e-35  Score=232.92  Aligned_cols=160  Identities=26%  Similarity=0.365  Sum_probs=127.4

Q ss_pred             cCCcccccccccccccCceEEEEEEEcCCCcEEEEEEccCccC-hHHHHHHHHHHHHHHhc-CCCCchhhhhhhHHHH--
Q psy14630         20 DFTSEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVD-EKDQRQLLMDLDVVMKS-NECPYIVQFYGALFKE--   95 (187)
Q Consensus        20 ~~~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~~~~~~~~-~~h~~iv~~~~~~~~~--   95 (187)
                      -...+||.+++.||+|+|++|++|..+.+++.+|||++.+.-. +..-.+....+...+.. .+||.|++||-.|.++  
T Consensus        69 kk~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~s  148 (604)
T KOG0592|consen   69 KKTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEES  148 (604)
T ss_pred             cCChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccc
Confidence            3456799999999999999999999999999999999854311 11112223333333444 4999999998544332  


Q ss_pred             ------------------------------HHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEecccccccccc
Q psy14630         96 ------------------------------VTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDS  145 (187)
Q Consensus        96 ------------------------------~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg~a~~~~~~  145 (187)
                                                    .+.+|+.||+|||++ |||||||||+|||++.+++++|+|||.|+.+.+.
T Consensus       149 LYFvLe~A~nGdll~~i~K~Gsfde~caR~YAAeIldAleylH~~-GIIHRDlKPENILLd~dmhikITDFGsAK~l~~~  227 (604)
T KOG0592|consen  149 LYFVLEYAPNGDLLDLIKKYGSFDETCARFYAAEILDALEYLHSN-GIIHRDLKPENILLDKDGHIKITDFGSAKILSPS  227 (604)
T ss_pred             eEEEEEecCCCcHHHHHHHhCcchHHHHHHHHHHHHHHHHHHHhc-CceeccCChhheeEcCCCcEEEeeccccccCChh
Confidence                                          678999999999998 9999999999999999999999999999988542


Q ss_pred             ccc--------------cCCCCCcCccCccccCCCccCCCCCCcceeeeEee
Q psy14630        146 IAK--------------TRDAGCRPYMAPERIDPLRARGYPSFKTKLGFKFN  183 (187)
Q Consensus       146 ~~~--------------~~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi~  183 (187)
                      ...              .+++||-.|.+||++.   ...-+..+|+|+||++
T Consensus       228 ~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~---~~~~~~~sDiWAlGCi  276 (604)
T KOG0592|consen  228 QKSQENPVDPNQASSRRSSFVGTAEYVSPELLN---DSPAGPSSDLWALGCI  276 (604)
T ss_pred             hccccCccCcccccCcccceeeeecccCHHHhc---CCCCCcccchHHHHHH
Confidence            111              3468999999999999   6778899999999983

>KOG0583|consensus

Probab=100.00  E-value=3.3e-35  Score=229.72  Aligned_cols=160  Identities=25%  Similarity=0.401  Sum_probs=130.7

Q ss_pred             CCcccccccccccccCceEEEEEEEcCCCcEEEEEEccCcc-C-h-HHHHHHHHHHHHHHhcCC-CCchhhhhhhH----
Q psy14630         21 FTSEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTV-D-E-KDQRQLLMDLDVVMKSNE-CPYIVQFYGAL----   92 (187)
Q Consensus        21 ~~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~-~-~-~~~~~~~~~~~~~~~~~~-h~~iv~~~~~~----   92 (187)
                      .....|.+.+.||+|+||.|++|.+..++..||+|++.... . . ....+.+.++..+++.+. ||||+++++.+    
T Consensus        14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~   93 (370)
T KOG0583|consen   14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPT   93 (370)
T ss_pred             cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCC
Confidence            45678999999999999999999999999999999876431 1 1 123444555556666667 99999886432    


Q ss_pred             ----------------------------HHHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCC-CCEEEEeccccccc-
Q psy14630         93 ----------------------------FKEVTVATVKALNYLKEELKIIHRDVKPSNILLDRR-GAIKLCDFGISGQL-  142 (187)
Q Consensus        93 ----------------------------~~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~-~~~ki~dfg~a~~~-  142 (187)
                                                  ...++.|++.|++|||+. +|+||||||+|++++.+ +.+||+|||++... 
T Consensus        94 ~~~ivmEy~~gGdL~~~i~~~g~l~E~~ar~~F~Qlisav~y~H~~-gi~HRDLK~ENilld~~~~~~Kl~DFG~s~~~~  172 (370)
T KOG0583|consen   94 KIYIVMEYCSGGDLFDYIVNKGRLKEDEARKYFRQLISAVAYCHSR-GIVHRDLKPENILLDGNEGNLKLSDFGLSAISP  172 (370)
T ss_pred             eEEEEEEecCCccHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhC-CEeeCCCCHHHEEecCCCCCEEEeccccccccC
Confidence                                        122788999999999998 99999999999999999 99999999999988 


Q ss_pred             cccccccCCCCCcCccCccccCCCccCC-CC-CCcceeeeEeee
Q psy14630        143 VDSIAKTRDAGCRPYMAPERIDPLRARG-YP-SFKTKLGFKFNY  184 (187)
Q Consensus       143 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~-~~-~~~D~ws~gi~~  184 (187)
                      .........+||+.|+|||++.   ..+ |+ .++|+||+||++
T Consensus       173 ~~~~~l~t~cGsp~Y~aPEvl~---~~~~Y~g~~aDvWS~GViL  213 (370)
T KOG0583|consen  173 GEDGLLKTFCGSPAYAAPEVLS---GKGTYSGKAADVWSLGVIL  213 (370)
T ss_pred             CCCCcccCCCCCcccCCHHHhC---CCCCcCCchhhhhhhHHHH
Confidence            4555666779999999999999   444 76 899999999943

>KOG0597|consensus

Probab=100.00  E-value=4.5e-35  Score=230.67  Aligned_cols=158  Identities=30%  Similarity=0.484  Sum_probs=137.5

Q ss_pred             ccccccccccccCceEEEEEEEcCCCcEEEEEEccCccChHHHHHHHHHHHHHHhcCCCCchhhhhhhHHH---------
Q psy14630         24 EDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQFYGALFK---------   94 (187)
Q Consensus        24 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~---------   94 (187)
                      ++|.+.+.||+|+||+||||+.+.+.+.||||.+.+........+.+.++..+++.++||||+.+++++..         
T Consensus         2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte   81 (808)
T KOG0597|consen    2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE   81 (808)
T ss_pred             cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence            67899999999999999999999999999999997765555556677778888999999999999876522         


Q ss_pred             ----------------------HHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEeccccccccc-cccccCC
Q psy14630         95 ----------------------EVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVD-SIAKTRD  151 (187)
Q Consensus        95 ----------------------~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg~a~~~~~-~~~~~~~  151 (187)
                                            .+..+++.||.|||+. +|+|||+||+||+++..+.+|+||||+|+.... ....++.
T Consensus        82 ~a~g~L~~il~~d~~lpEe~v~~~a~~LVsaL~yLhs~-rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~t~vltsi  160 (808)
T KOG0597|consen   82 YAVGDLFTILEQDGKLPEEQVRAIAYDLVSALYYLHSN-RILHRDMKPQNILLEKGGTLKLCDFGLARAMSTNTSVLTSI  160 (808)
T ss_pred             hhhhhHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhc-CcccccCCcceeeecCCCceeechhhhhhhcccCceeeeec
Confidence                                  2677899999999998 999999999999999999999999999998754 3344556


Q ss_pred             CCCcCccCccccCCCccCCCCCCcceeeeEe-eee
Q psy14630        152 AGCRPYMAPERIDPLRARGYPSFKTKLGFKF-NYR  185 (187)
Q Consensus       152 ~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi-~~~  185 (187)
                      .|||.|||||+..   +.+|+..+|.||+|+ .|+
T Consensus       161 kGtPlYmAPElv~---e~pyd~~sDlWslGcilYE  192 (808)
T KOG0597|consen  161 KGTPLYMAPELVE---EQPYDHTSDLWSLGCILYE  192 (808)
T ss_pred             cCcccccCHHHHc---CCCccchhhHHHHHHHHHH
Confidence            8999999999999   778999999999999 554

>KOG0663|consensus

Probab=100.00  E-value=2.7e-35  Score=219.20  Aligned_cols=160  Identities=24%  Similarity=0.382  Sum_probs=128.8

Q ss_pred             cCCcccccccccccccCceEEEEEEEcCCCcEEEEEEccCccChHHH-HHHHHHHHHHHhcCCCCchhhhhhhH------
Q psy14630         20 DFTSEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQ-RQLLMDLDVVMKSNECPYIVQFYGAL------   92 (187)
Q Consensus        20 ~~~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~-~~~~~~~~~~~~~~~h~~iv~~~~~~------   92 (187)
                      .-+-++|..++.|++|+||.||+|++++|++.||+|.++-...+... ..-++++ .++...+|||||.+-...      
T Consensus        72 Crsv~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREI-niLl~~~H~NIV~vkEVVvG~~~d  150 (419)
T KOG0663|consen   72 CRSVEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREI-NILLKARHPNIVEVKEVVVGSNMD  150 (419)
T ss_pred             cccHHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHH-HHHHhcCCCCeeeeEEEEeccccc
Confidence            44567899999999999999999999999999999999743322222 2334444 455667899999763211      


Q ss_pred             ----------------------------HHHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEeccccccccc
Q psy14630         93 ----------------------------FKEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVD  144 (187)
Q Consensus        93 ----------------------------~~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg~a~~~~~  144 (187)
                                                  .+.++.|++.|++|||.. .|+|||||++|+|+..+|.+||+|||+||.+..
T Consensus       151 ~iy~VMe~~EhDLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~~-wilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygs  229 (419)
T KOG0663|consen  151 KIYIVMEYVEHDLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHDN-WILHRDLKTSNLLLSHKGILKIADFGLAREYGS  229 (419)
T ss_pred             eeeeeHHHHHhhHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhhc-eeEecccchhheeeccCCcEEecccchhhhhcC
Confidence                                        122778999999999998 999999999999999999999999999999865


Q ss_pred             c-ccccCCCCCcCccCccccCCCccCCCCCCcceeeeEee
Q psy14630        145 S-IAKTRDAGCRPYMAPERIDPLRARGYPSFKTKLGFKFN  183 (187)
Q Consensus       145 ~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi~  183 (187)
                      + ...+..+-|.+|+|||++.+  ...|+.++|.||+|.+
T Consensus       230 p~k~~T~lVVTLWYRaPELLLG--~~tyst~iDMWSvGCI  267 (419)
T KOG0663|consen  230 PLKPYTPLVVTLWYRAPELLLG--AKTYSTAVDMWSVGCI  267 (419)
T ss_pred             CcccCcceEEEeeecCHHHhcC--CcccCcchhhhhHHHH
Confidence            4 23344567999999999997  5679999999999973

>KOG0197|consensus

Probab=100.00  E-value=1.9e-35  Score=230.96  Aligned_cols=162  Identities=25%  Similarity=0.394  Sum_probs=134.0

Q ss_pred             CccccCCcccccccccccccCceEEEEEEEcCCCcEEEEEEccCccChHHHHHHHHHHHHHHhcCCCCchhhhhhhHHHH
Q psy14630         16 DTVYDFTSEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQFYGALFKE   95 (187)
Q Consensus        16 ~~~~~~~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~   95 (187)
                      ...|+++++.+.+.+.||+|.||.||.|.... ...||+|.++..   ....+.+.+++.+|+.++|+|||++++.+..+
T Consensus       198 ~d~wei~r~~l~l~~~LG~G~FG~V~~g~~~~-~~~vavk~ik~~---~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~  273 (468)
T KOG0197|consen  198 RDPWEIPREELKLIRELGSGQFGEVWLGKWNG-STKVAVKTIKEG---SMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQ  273 (468)
T ss_pred             cCCeeecHHHHHHHHHhcCCccceEEEEEEcC-CCcccceEEecc---ccChhHHHHHHHHHHhCcccCeEEEEEEEecC
Confidence            56788999999999999999999999999853 457899998742   22334455777889999999999998754332


Q ss_pred             ----------------------------------HHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEecccccc
Q psy14630         96 ----------------------------------VTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQ  141 (187)
Q Consensus        96 ----------------------------------~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg~a~~  141 (187)
                                                        +..||++|++||.++ ++|||||..+|||++++..+||+|||+|+.
T Consensus       274 ~piyIVtE~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~-~~IHRDLAARNiLV~~~~~vKIsDFGLAr~  352 (468)
T KOG0197|consen  274 EPIYIVTEYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESK-NYIHRDLAARNILVDEDLVVKISDFGLARL  352 (468)
T ss_pred             CceEEEEEecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhC-CccchhhhhhheeeccCceEEEcccccccc
Confidence                                              678999999999987 999999999999999999999999999996


Q ss_pred             ccccccccCCCCC--cCccCccccCCCccCCCCCCcceeeeEeeee
Q psy14630        142 LVDSIAKTRDAGC--RPYMAPERIDPLRARGYPSFKTKLGFKFNYR  185 (187)
Q Consensus       142 ~~~~~~~~~~~~t--~~y~aPE~~~~~~~~~~~~~~D~ws~gi~~~  185 (187)
                      ..+........+.  ..|+|||.+.   ...++.++|||||||.+|
T Consensus       353 ~~d~~Y~~~~~~kfPIkWtAPEa~~---~~~FS~kSDVWSFGVlL~  395 (468)
T KOG0197|consen  353 IGDDEYTASEGGKFPIKWTAPEALN---YGKFSSKSDVWSFGVLLW  395 (468)
T ss_pred             cCCCceeecCCCCCCceecCHHHHh---hCCcccccceeehhhhHH
Confidence            6555554443333  3599999999   777999999999999655

>KOG0578|consensus

Probab=100.00  E-value=1.2e-34  Score=227.71  Aligned_cols=157  Identities=27%  Similarity=0.459  Sum_probs=135.0

Q ss_pred             CcccccccccccccCceEEEEEEEcCCCcEEEEEEccCccChHHHHHHHHHHHHHHhcCCCCchhhhhhhHHHH------
Q psy14630         22 TSEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQFYGALFKE------   95 (187)
Q Consensus        22 ~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~------   95 (187)
                      +...|....+||+|+.|.||.+....+++.||||.+...  .+...+.+.++..+++..+|+|||.+++++.-.      
T Consensus       271 P~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~--~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVV  348 (550)
T KOG0578|consen  271 PRSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLR--KQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVV  348 (550)
T ss_pred             hhhhhcchhhhccccccceeeeeeccCCceEEEEEEEec--cCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEE
Confidence            445677788999999999999999999999999998643  223457788888899999999999998765322      


Q ss_pred             -------------------------HHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEeccccccccccc-ccc
Q psy14630         96 -------------------------VTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSI-AKT  149 (187)
Q Consensus        96 -------------------------~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg~a~~~~~~~-~~~  149 (187)
                                               +...++.||+|||.+ +|+|||||.+|||+..+|.+||+|||+|.++.... ...
T Consensus       349 MEym~ggsLTDvVt~~~~~E~qIA~Icre~l~aL~fLH~~-gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~KR~  427 (550)
T KOG0578|consen  349 MEYMEGGSLTDVVTKTRMTEGQIAAICREILQGLKFLHAR-GIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQSKRS  427 (550)
T ss_pred             EeecCCCchhhhhhcccccHHHHHHHHHHHHHHHHHHHhc-ceeeeccccceeEeccCCcEEEeeeeeeeccccccCccc
Confidence                                     456788999999998 99999999999999999999999999999987654 445


Q ss_pred             CCCCCcCccCccccCCCccCCCCCCcceeeeEeee
Q psy14630        150 RDAGCRPYMAPERIDPLRARGYPSFKTKLGFKFNY  184 (187)
Q Consensus       150 ~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi~~  184 (187)
                      ...||++|||||++.   ...|.+++||||+||+.
T Consensus       428 TmVGTPYWMAPEVvt---rk~YG~KVDIWSLGIMa  459 (550)
T KOG0578|consen  428 TMVGTPYWMAPEVVT---RKPYGPKVDIWSLGIMA  459 (550)
T ss_pred             cccCCCCccchhhhh---hcccCccccchhhhhHH
Confidence            568999999999999   78899999999999954

>KOG0585|consensus

Probab=100.00  E-value=7.8e-35  Score=225.04  Aligned_cols=160  Identities=24%  Similarity=0.373  Sum_probs=127.6

Q ss_pred             CcccccccccccccCceEEEEEEEcCCCcEEEEEEccCccChH--------H----HHHHHHHHHHHHhcCCCCchhhhh
Q psy14630         22 TSEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEK--------D----QRQLLMDLDVVMKSNECPYIVQFY   89 (187)
Q Consensus        22 ~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~--------~----~~~~~~~~~~~~~~~~h~~iv~~~   89 (187)
                      ..++|.+.+.||+|.||.|.+|++..+++.||||++.+.....        .    ..+...+++.+++.++|||||+|+
T Consensus        95 ~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~Li  174 (576)
T KOG0585|consen   95 QLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKLI  174 (576)
T ss_pred             ehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEEE
Confidence            4567999999999999999999999999999999996421110        1    124566677789999999999987


Q ss_pred             hhH----------------------------------HHHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEe
Q psy14630         90 GAL----------------------------------FKEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCD  135 (187)
Q Consensus        90 ~~~----------------------------------~~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~d  135 (187)
                      +.+                                  ..++...++.||+|||.+ +|+||||||+|+|++.+|.+||+|
T Consensus       175 EvLDDP~s~~~YlVley~s~G~v~w~p~d~~els~~~Ar~ylrDvv~GLEYLH~Q-giiHRDIKPsNLLl~~~g~VKIsD  253 (576)
T KOG0585|consen  175 EVLDDPESDKLYLVLEYCSKGEVKWCPPDKPELSEQQARKYLRDVVLGLEYLHYQ-GIIHRDIKPSNLLLSSDGTVKISD  253 (576)
T ss_pred             EeecCcccCceEEEEEeccCCccccCCCCcccccHHHHHHHHHHHHHHHHHHHhc-CeeccccchhheEEcCCCcEEeec
Confidence            532                                  223778899999999999 999999999999999999999999


Q ss_pred             cccccccccc------ccccCCCCCcCccCccccCCCccCCCC-CCcceeeeEe
Q psy14630        136 FGISGQLVDS------IAKTRDAGCRPYMAPERIDPLRARGYP-SFKTKLGFKF  182 (187)
Q Consensus       136 fg~a~~~~~~------~~~~~~~~t~~y~aPE~~~~~~~~~~~-~~~D~ws~gi  182 (187)
                      ||.+-....+      ......+|||.|+|||.+.+.....+. .+.||||+||
T Consensus       254 FGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGV  307 (576)
T KOG0585|consen  254 FGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGV  307 (576)
T ss_pred             cceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhh
Confidence            9998766221      122235899999999999853223344 8899999999

>KOG0033|consensus

Probab=100.00  E-value=1.4e-36  Score=218.17  Aligned_cols=163  Identities=26%  Similarity=0.369  Sum_probs=137.5

Q ss_pred             cCCcccccccccccccCceEEEEEEEcCCCcEEEEEEccCccChHHHHHHHHHHHHHHhcCCCCchhhhhhhHHH-----
Q psy14630         20 DFTSEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQFYGALFK-----   94 (187)
Q Consensus        20 ~~~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~-----   94 (187)
                      ....+.|++.+.||+|.|+.|++|.+..||+.+|+|++.........-+.+.++..+.+.++||||+++.+....     
T Consensus         7 ~~f~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~y   86 (355)
T KOG0033|consen    7 TKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHY   86 (355)
T ss_pred             cccchhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeE
Confidence            345688999999999999999999999999999999985433233344567778889999999999998754311     


Q ss_pred             ---------------------------HHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcC---CCCEEEEeccccccccc
Q psy14630         95 ---------------------------EVTVATVKALNYLKEELKIIHRDVKPSNILLDR---RGAIKLCDFGISGQLVD  144 (187)
Q Consensus        95 ---------------------------~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~---~~~~ki~dfg~a~~~~~  144 (187)
                                                 -.+.|+++++.|+|.+ +|+|||+||+|+++..   ...+|++|||+|..+.+
T Consensus        87 lvFe~m~G~dl~~eIV~R~~ySEa~aSH~~rQiLeal~yCH~n-~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~~  165 (355)
T KOG0033|consen   87 LVFDLVTGGELFEDIVAREFYSEADASHCIQQILEALAYCHSN-GIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVND  165 (355)
T ss_pred             EEEecccchHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhc-CceeccCChhheeeeeccCCCceeecccceEEEeCC
Confidence                                       1567999999999998 9999999999999954   34599999999999987


Q ss_pred             cccccCCCCCcCccCccccCCCccCCCCCCcceeeeEeeeeC
Q psy14630        145 SIAKTRDAGCRPYMAPERIDPLRARGYPSFKTKLGFKFNYRI  186 (187)
Q Consensus       145 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi~~~~  186 (187)
                      .......+|||.|||||++.   ..+|...+|+||+||++.|
T Consensus       166 g~~~~G~~GtP~fmaPEvvr---kdpy~kpvDiW~cGViLfi  204 (355)
T KOG0033|consen  166 GEAWHGFAGTPGYLSPEVLK---KDPYSKPVDIWACGVILYI  204 (355)
T ss_pred             ccccccccCCCcccCHHHhh---cCCCCCcchhhhhhHHHHH
Confidence            77777889999999999999   7889999999999996543

>KOG0588|consensus

Probab=100.00  E-value=3.9e-35  Score=234.16  Aligned_cols=157  Identities=25%  Similarity=0.334  Sum_probs=134.8

Q ss_pred             ccccccccccccCceEEEEEEEcCCCcEEEEEEccCcc-ChHHHHHHHHHHHHHHhcCCCCchhhhhhhHHHH-------
Q psy14630         24 EDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTV-DEKDQRQLLMDLDVVMKSNECPYIVQFYGALFKE-------   95 (187)
Q Consensus        24 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~-------   95 (187)
                      .-|++++.||.|+-|.|-+|++..||+.+|||++.+.. ....+..-+.++..+|+.+.|||++++|+.+...       
T Consensus        12 GpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvl   91 (786)
T KOG0588|consen   12 GPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVL   91 (786)
T ss_pred             cceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEE
Confidence            45788999999999999999999999999999996542 2223344556677789999999999998765222       


Q ss_pred             -------------------------HHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEeccccccccccccccC
Q psy14630         96 -------------------------VTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTR  150 (187)
Q Consensus        96 -------------------------~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg~a~~~~~~~~~~~  150 (187)
                                               .+.||+.|+.|+|.- +|+|||+||+|+|++.++++||+|||+|..-.+......
T Consensus        92 Eyv~gGELFdylv~kG~l~e~eaa~ff~QIi~gv~yCH~~-~icHRDLKpENlLLd~~~nIKIADFGMAsLe~~gklLeT  170 (786)
T KOG0588|consen   92 EYVPGGELFDYLVRKGPLPEREAAHFFRQILDGVSYCHAF-NICHRDLKPENLLLDVKNNIKIADFGMASLEVPGKLLET  170 (786)
T ss_pred             EecCCchhHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhhh-cceeccCCchhhhhhcccCEeeeccceeecccCCccccc
Confidence                                     678999999999997 999999999999999999999999999998777777777


Q ss_pred             CCCCcCccCccccCCCccCCCC-CCcceeeeEeee
Q psy14630        151 DAGCRPYMAPERIDPLRARGYP-SFKTKLGFKFNY  184 (187)
Q Consensus       151 ~~~t~~y~aPE~~~~~~~~~~~-~~~D~ws~gi~~  184 (187)
                      .||++.|.|||++.   +.+|+ .++||||+||++
T Consensus       171 SCGSPHYA~PEIV~---G~pYdG~~sDVWSCGVIL  202 (786)
T KOG0588|consen  171 SCGSPHYAAPEIVS---GRPYDGRPSDVWSCGVIL  202 (786)
T ss_pred             cCCCcccCCchhhc---CCCCCCCccccchhHHHH
Confidence            79999999999999   66677 999999999954

>KOG0605|consensus

Probab=100.00  E-value=8.7e-35  Score=227.35  Aligned_cols=163  Identities=27%  Similarity=0.469  Sum_probs=132.6

Q ss_pred             cCCcccccccccccccCceEEEEEEEcCCCcEEEEEEccCcc-ChHHHHHHHHHHHHHHhcCCCCchhhhhhhHHHH---
Q psy14630         20 DFTSEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTV-DEKDQRQLLMDLDVVMKSNECPYIVQFYGALFKE---   95 (187)
Q Consensus        20 ~~~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~---   95 (187)
                      .+..++|..+..||+|+||.||+|+.+.||..+|+|++++.. ....+.+.+..+..++....+|+||++|-+|.+.   
T Consensus       137 r~~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~L  216 (550)
T KOG0605|consen  137 RLSLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYL  216 (550)
T ss_pred             cCCcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCee
Confidence            346789999999999999999999999999999999997543 3334555666666677778999999998655433   


Q ss_pred             -----------------------------HHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEecccccccccc-
Q psy14630         96 -----------------------------VTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDS-  145 (187)
Q Consensus        96 -----------------------------~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg~a~~~~~~-  145 (187)
                                                   .+.+++.|++-+|+. |++||||||+|+|||..|++|++||||+..+... 
T Consensus       217 YLiMEylPGGD~mTLL~~~~~L~e~~arfYiaE~vlAI~~iH~~-gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~~~  295 (550)
T KOG0605|consen  217 YLIMEYLPGGDMMTLLMRKDTLTEDWARFYIAETVLAIESIHQL-GYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDKKH  295 (550)
T ss_pred             EEEEEecCCccHHHHHHhcCcCchHHHHHHHHHHHHHHHHHHHc-CcccccCChhheeecCCCCEeeccccccchhhhhh
Confidence                                         556778899999997 9999999999999999999999999998754210 


Q ss_pred             -----------------------cc----c--------------------cCCCCCcCccCccccCCCccCCCCCCccee
Q psy14630        146 -----------------------IA----K--------------------TRDAGCRPYMAPERIDPLRARGYPSFKTKL  178 (187)
Q Consensus       146 -----------------------~~----~--------------------~~~~~t~~y~aPE~~~~~~~~~~~~~~D~w  178 (187)
                                             ..    .                    .+.+|||-|||||++.   ..+|...+|+|
T Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll---~kgY~~~cDwW  372 (550)
T KOG0605|consen  296 RIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLL---GKGYGKECDWW  372 (550)
T ss_pred             hhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHh---cCCCCccccHH
Confidence                                   00    0                    0236999999999999   78899999999


Q ss_pred             eeEe-eeeC
Q psy14630        179 GFKF-NYRI  186 (187)
Q Consensus       179 s~gi-~~~~  186 (187)
                      |+|+ +|++
T Consensus       373 SLG~ImyEm  381 (550)
T KOG0605|consen  373 SLGCIMYEM  381 (550)
T ss_pred             HHHHHHHHH
Confidence            9998 6653

>KOG0201|consensus

Probab=100.00  E-value=2.8e-34  Score=219.95  Aligned_cols=160  Identities=33%  Similarity=0.548  Sum_probs=133.8

Q ss_pred             CcccccccccccccCceEEEEEEEcCCCcEEEEEEccCccChHHHHHHHHHHHHHHhcCCCCchhhhhhhHHHH------
Q psy14630         22 TSEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQFYGALFKE------   95 (187)
Q Consensus        22 ~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~------   95 (187)
                      ....|+..+.||+|.||.||+|.+..+++.||||++.....+.+. +-++++..++..+.++||..+|+++...      
T Consensus        11 ~~~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deI-ediqqei~~Ls~~~~~~it~yygsyl~g~~Lwii   89 (467)
T KOG0201|consen   11 PELLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEI-EDIQQEISVLSQCDSPNITEYYGSYLKGTKLWII   89 (467)
T ss_pred             cccccccchhccccccceeeeeeeccccceEEEEEechhhcchhh-HHHHHHHHHHHhcCcchHHhhhhheeecccHHHH
Confidence            345677789999999999999999999999999999765444433 3444555567778889999999876443      


Q ss_pred             --------------------------HHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEeccccccccccccc-
Q psy14630         96 --------------------------VTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAK-  148 (187)
Q Consensus        96 --------------------------~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg~a~~~~~~~~~-  148 (187)
                                                +..+++.|+.|||.+ +.+|||||+.|+++...|.+|++|||.+.++...... 
T Consensus        90 Mey~~gGsv~~lL~~~~~~~E~~i~~ilre~l~~l~ylH~~-~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~rr  168 (467)
T KOG0201|consen   90 MEYCGGGSVLDLLKSGNILDEFEIAVILREVLKGLDYLHSE-KKIHRDIKAANILLSESGDVKLADFGVAGQLTNTVKRR  168 (467)
T ss_pred             HHHhcCcchhhhhccCCCCccceeeeehHHHHHHhhhhhhc-ceecccccccceeEeccCcEEEEecceeeeeechhhcc
Confidence                                      567788999999998 9999999999999999999999999999998654333 


Q ss_pred             cCCCCCcCccCccccCCCccCCCCCCcceeeeEe-eeeC
Q psy14630        149 TRDAGCRPYMAPERIDPLRARGYPSFKTKLGFKF-NYRI  186 (187)
Q Consensus       149 ~~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi-~~~~  186 (187)
                      ..+.||+.|||||++.   ..+|+.++||||+|| .|+|
T Consensus       169 ~tfvGTPfwMAPEVI~---~~~Y~~KADIWSLGITaiEl  204 (467)
T KOG0201|consen  169 KTFVGTPFWMAPEVIK---QSGYDTKADIWSLGITAIEL  204 (467)
T ss_pred             ccccccccccchhhhc---cccccchhhhhhhhHHHHHH
Confidence            5678999999999999   678999999999999 5544

>KOG0193|consensus

Probab=100.00  E-value=8.6e-34  Score=224.54  Aligned_cols=167  Identities=25%  Similarity=0.352  Sum_probs=139.3

Q ss_pred             CccccCCcccccccccccccCceEEEEEEEcCCCcEEEEEEccCccChHHHHHHHHHHHHHHhcCCCCchhhhhhhHHHH
Q psy14630         16 DTVYDFTSEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQFYGALFKE   95 (187)
Q Consensus        16 ~~~~~~~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~   95 (187)
                      ...|+++.++..+...||+|+||+||+|.+   .-.||||.+......+++.+.++.+....+.-.|.||+-+.|++...
T Consensus       384 ~~~WeIp~~ev~l~~rIGsGsFGtV~Rg~w---hGdVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p  460 (678)
T KOG0193|consen  384 LEEWEIPPEEVLLGERIGSGSFGTVYRGRW---HGDVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNP  460 (678)
T ss_pred             ccccccCHHHhhccceeccccccceeeccc---ccceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCC
Confidence            478899999999999999999999999987   34599999976656666788888888888888999999988876332


Q ss_pred             --------------------------------HHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEecccccccc
Q psy14630         96 --------------------------------VTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLV  143 (187)
Q Consensus        96 --------------------------------~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg~a~~~~  143 (187)
                                                      ++.|+++|+.|||.. +|+|||||..||++.+++.+||.|||++..-.
T Consensus       461 ~~AIiTqwCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLHAK-~IIHrDLKSnNIFl~~~~kVkIgDFGLatvk~  539 (678)
T KOG0193|consen  461 PLAIITQWCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLHAK-NIIHRDLKSNNIFLHEDLKVKIGDFGLATVKT  539 (678)
T ss_pred             ceeeeehhccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhhhh-hhhhhhccccceEEccCCcEEEecccceeeee
Confidence                                            788999999999997 99999999999999999999999999987643


Q ss_pred             cc---ccccCCCCCcCccCccccCCCccCCCCCCcceeeeEe-eeeC
Q psy14630        144 DS---IAKTRDAGCRPYMAPERIDPLRARGYPSFKTKLGFKF-NYRI  186 (187)
Q Consensus       144 ~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi-~~~~  186 (187)
                      -.   .......|...|||||++...-..+|++++||||||+ +|+|
T Consensus       540 ~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YEL  586 (678)
T KOG0193|consen  540 RWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYEL  586 (678)
T ss_pred             eeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHH
Confidence            21   1112224677899999997555678999999999999 7764

>KOG0580|consensus

Probab=100.00  E-value=3.8e-34  Score=204.40  Aligned_cols=160  Identities=26%  Similarity=0.398  Sum_probs=136.9

Q ss_pred             cccCCcccccccccccccCceEEEEEEEcCCCcEEEEEEccC-ccChHHHHHHHHHHHHHHhcCCCCchhhhhhhHHHH-
Q psy14630         18 VYDFTSEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRS-TVDEKDQRQLLMDLDVVMKSNECPYIVQFYGALFKE-   95 (187)
Q Consensus        18 ~~~~~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~-~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~-   95 (187)
                      ..+...++|.+++.||+|-||.||+|+.++++..||+|++-+ +.........+.++..+...+.||||+++|+.|.++ 
T Consensus        16 ~~~~~l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~   95 (281)
T KOG0580|consen   16 TKTWTLDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSK   95 (281)
T ss_pred             ccccchhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccc
Confidence            345678999999999999999999999999999999999843 223333456677777788889999999999876443 


Q ss_pred             ---------------------------------HHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEeccccccc
Q psy14630         96 ---------------------------------VTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQL  142 (187)
Q Consensus        96 ---------------------------------~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg~a~~~  142 (187)
                                                       ...|++.|+.|+|.. +++|||+||+|+|++..+.+||+|||.+..-
T Consensus        96 riyLilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k-~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~  174 (281)
T KOG0580|consen   96 RIYLILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLK-RVIHRDIKPENLLLGSAGELKIADFGWSVHA  174 (281)
T ss_pred             eeEEEEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccC-CcccCCCCHHHhccCCCCCeeccCCCceeec
Confidence                                             667899999999997 9999999999999999999999999998775


Q ss_pred             cccccccCCCCCcCccCccccCCCccCCCCCCcceeeeEe
Q psy14630        143 VDSIAKTRDAGCRPYMAPERIDPLRARGYPSFKTKLGFKF  182 (187)
Q Consensus       143 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi  182 (187)
                      . .......+||.-|.+||+..   +.+++..+|+|++||
T Consensus       175 p-~~kR~tlcgt~dyl~pEmv~---~~~hd~~Vd~w~lgv  210 (281)
T KOG0580|consen  175 P-SNKRKTLCGTLDYLPPEMVE---GRGHDKFVDLWSLGV  210 (281)
T ss_pred             C-CCCceeeecccccCCHhhcC---CCCccchhhHHHHHH
Confidence            4 33445569999999999999   788999999999998

>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

Probab=100.00  E-value=4.8e-33  Score=218.54  Aligned_cols=158  Identities=24%  Similarity=0.295  Sum_probs=129.7

Q ss_pred             CcccccccccccccCceEEEEEEEcCCCcEEEEEEccCccChHHHHHHHHHHHHHHhcCCCCchhhhhhhHH--------
Q psy14630         22 TSEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQFYGALF--------   93 (187)
Q Consensus        22 ~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~--------   93 (187)
                      ..++|++.+.||+|+||.||++.+..+++.+|||.+..............++..+++.++||||+++++.+.        
T Consensus        22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~  101 (364)
T cd07875          22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF  101 (364)
T ss_pred             hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeeccccccccc
Confidence            457899999999999999999999999999999998654333333444555666778889999998765321        


Q ss_pred             ---------------------------HHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEeccccccccccc
Q psy14630         94 ---------------------------KEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSI  146 (187)
Q Consensus        94 ---------------------------~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg~a~~~~~~~  146 (187)
                                                 ..++.|++.||.|||+. +++||||||+||+++.++.+||+|||+++......
T Consensus       102 ~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~-~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~  180 (364)
T cd07875         102 QDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSA-GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF  180 (364)
T ss_pred             CeEEEEEeCCCCCHHHHHHhcCCHHHHHHHHHHHHHHHHHHhhC-CeecCCCCHHHEEECCCCcEEEEeCCCccccCCCC
Confidence                                       12567899999999997 99999999999999999999999999998765544


Q ss_pred             cccCCCCCcCccCccccCCCccCCCCCCcceeeeEee
Q psy14630        147 AKTRDAGCRPYMAPERIDPLRARGYPSFKTKLGFKFN  183 (187)
Q Consensus       147 ~~~~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi~  183 (187)
                      ......+|..|+|||++.   +..++.++|+||+|++
T Consensus       181 ~~~~~~~t~~y~aPE~~~---~~~~~~~~DiwSlG~i  214 (364)
T cd07875         181 MMTPYVVTRYYRAPEVIL---GMGYKENVDIWSVGCI  214 (364)
T ss_pred             cccCCcccCCcCCHHHHh---CCCCCchhhHHhHHHH
Confidence            444457899999999998   5678899999999993

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

Probab=100.00  E-value=2.2e-33  Score=220.49  Aligned_cols=156  Identities=29%  Similarity=0.460  Sum_probs=124.4

Q ss_pred             ccccccccccccCceEEEEEEEcCCCcEEEEEEccCcc-ChHHHHHHHHHHHHHHhcCCCCchhhhhhhH----------
Q psy14630         24 EDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTV-DEKDQRQLLMDLDVVMKSNECPYIVQFYGAL----------   92 (187)
Q Consensus        24 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~----------   92 (187)
                      ++|++.+.||+|+||.||+|.+..+++.||+|+++... ........+..+..++..++|+||+++++.+          
T Consensus         1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~   80 (363)
T cd05628           1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM   80 (363)
T ss_pred             CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence            47889999999999999999999999999999986421 1222334555566677788999999876432          


Q ss_pred             ----------------------HHHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEeccccccccccc----
Q psy14630         93 ----------------------FKEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSI----  146 (187)
Q Consensus        93 ----------------------~~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg~a~~~~~~~----  146 (187)
                                            ...++.|++.||+|||+. +++||||||+||+++.++.+||+|||+++.+....    
T Consensus        81 E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~-givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~~~~~  159 (363)
T cd05628          81 EFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQL-GFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEF  159 (363)
T ss_pred             cCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC-CeEecCCCHHHeEECCCCCEEEeeccCcccccccccccc
Confidence                                  112667899999999997 99999999999999999999999999987643210    


Q ss_pred             --------------------------------cccCCCCCcCccCccccCCCccCCCCCCcceeeeEee
Q psy14630        147 --------------------------------AKTRDAGCRPYMAPERIDPLRARGYPSFKTKLGFKFN  183 (187)
Q Consensus       147 --------------------------------~~~~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi~  183 (187)
                                                      .....+||+.|+|||++.   ...++.++|+||||++
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~---~~~~~~~~DvwSlGvi  225 (363)
T cd05628         160 YRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFM---QTGYNKLCDWWSLGVI  225 (363)
T ss_pred             cccccccccccccccccccccccchhhhccccccccccCCccccCHHHHc---CCCCCCchhhhhhHHH
Confidence                                            011346899999999998   6678999999999993

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus

>KOG0690|consensus

Probab=99.98  E-value=5.4e-33  Score=206.98  Aligned_cols=162  Identities=26%  Similarity=0.432  Sum_probs=132.1

Q ss_pred             cCCcccccccccccccCceEEEEEEEcCCCcEEEEEEccCcc--ChHHHHHHHHHHHHHHhcCCCCchhhhhhhHHHH--
Q psy14630         20 DFTSEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTV--DEKDQRQLLMDLDVVMKSNECPYIVQFYGALFKE--   95 (187)
Q Consensus        20 ~~~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~--   95 (187)
                      .+..++|..+++||+|.||+|-+|+.+.+++.+|||++++..  .+.+....+ .+.++++...||.+..+--+|...  
T Consensus       164 kvTm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTl-TE~RVL~~~~HPFLt~LKYsFQt~dr  242 (516)
T KOG0690|consen  164 KVTMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTL-TENRVLQNCRHPFLTSLKYSFQTQDR  242 (516)
T ss_pred             eeccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhh-hHHHHHHhccCcHHHHhhhhhccCce
Confidence            346778999999999999999999999999999999998653  223333333 345567778999988764332111  


Q ss_pred             ------------------------------HHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEeccccccc-cc
Q psy14630         96 ------------------------------VTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQL-VD  144 (187)
Q Consensus        96 ------------------------------~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg~a~~~-~~  144 (187)
                                                    ....|+.||.|||++ +|+.||+|.+|++++.+|++||.|||+++-- ..
T Consensus       243 lCFVMeyanGGeLf~HLsrer~FsE~RtRFYGaEIvsAL~YLHs~-~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I~~  321 (516)
T KOG0690|consen  243 LCFVMEYANGGELFFHLSRERVFSEDRTRFYGAEIVSALGYLHSR-NIVYRDLKLENLLLDKDGHIKITDFGLCKEEIKY  321 (516)
T ss_pred             EEEEEEEccCceEeeehhhhhcccchhhhhhhHHHHHHhhhhhhC-CeeeeechhhhheeccCCceEeeecccchhcccc
Confidence                                          446789999999998 9999999999999999999999999999864 34


Q ss_pred             cccccCCCCCcCccCccccCCCccCCCCCCcceeeeEe-eeeC
Q psy14630        145 SIAKTRDAGCRPYMAPERIDPLRARGYPSFKTKLGFKF-NYRI  186 (187)
Q Consensus       145 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi-~~~~  186 (187)
                      .......||||.|+|||++.   ...|..++|+||+|| +|+|
T Consensus       322 g~t~kTFCGTPEYLAPEVle---DnDYgraVDWWG~GVVMYEM  361 (516)
T KOG0690|consen  322 GDTTKTFCGTPEYLAPEVLE---DNDYGRAVDWWGVGVVMYEM  361 (516)
T ss_pred             cceeccccCChhhcCchhhc---cccccceeehhhhhHHHHHH
Confidence            45566789999999999999   777999999999999 7764

>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

Probab=99.98  E-value=1.2e-32  Score=215.90  Aligned_cols=158  Identities=23%  Similarity=0.296  Sum_probs=129.1

Q ss_pred             CcccccccccccccCceEEEEEEEcCCCcEEEEEEccCccChHHHHHHHHHHHHHHhcCCCCchhhhhhhHH--------
Q psy14630         22 TSEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQFYGALF--------   93 (187)
Q Consensus        22 ~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~--------   93 (187)
                      ..++|++.+.||+|+||.||++.+..++..||+|.+..............++..+++.++||||+++++.+.        
T Consensus        19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~   98 (359)
T cd07876          19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEF   98 (359)
T ss_pred             hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcccc
Confidence            357899999999999999999999999999999998654333333344455666778889999998765321        


Q ss_pred             ---------------------------HHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEeccccccccccc
Q psy14630         94 ---------------------------KEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSI  146 (187)
Q Consensus        94 ---------------------------~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg~a~~~~~~~  146 (187)
                                                 ..++.|++.||.|||+. +++||||||+||+++.++.+||+|||+++......
T Consensus        99 ~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~-~ivHrDlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~  177 (359)
T cd07876          99 QDVYLVMELMDANLCQVIHMELDHERMSYLLYQMLCGIKHLHSA-GIIHRDLKPSNIVVKSDCTLKILDFGLARTACTNF  177 (359)
T ss_pred             ceeEEEEeCCCcCHHHHHhccCCHHHHHHHHHHHHHHHHHHHhC-CcccCCCCHHHEEECCCCCEEEecCCCccccccCc
Confidence                                       11567899999999997 99999999999999999999999999998765444


Q ss_pred             cccCCCCCcCccCccccCCCccCCCCCCcceeeeEee
Q psy14630        147 AKTRDAGCRPYMAPERIDPLRARGYPSFKTKLGFKFN  183 (187)
Q Consensus       147 ~~~~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi~  183 (187)
                      ......+|+.|+|||.+.   ...++.++|+||+|++
T Consensus       178 ~~~~~~~t~~y~aPE~~~---~~~~~~~~DiwSlG~i  211 (359)
T cd07876         178 MMTPYVVTRYYRAPEVIL---GMGYKENVDIWSVGCI  211 (359)
T ss_pred             cCCCCcccCCCCCchhcc---CCCCCcchhhHHHHHH
Confidence            444457889999999998   5678899999999994

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>PTZ00263 protein kinase A catalytic subunit; Provisional

Probab=99.98  E-value=6.3e-33  Score=215.21  Aligned_cols=160  Identities=26%  Similarity=0.403  Sum_probs=128.6

Q ss_pred             cccCCcccccccccccccCceEEEEEEEcCCCcEEEEEEccCcc-ChHHHHHHHHHHHHHHhcCCCCchhhhhhhHH---
Q psy14630         18 VYDFTSEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTV-DEKDQRQLLMDLDVVMKSNECPYIVQFYGALF---   93 (187)
Q Consensus        18 ~~~~~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~---   93 (187)
                      ......++|++.+.||+|+||.||+|.+..+++.||+|.++... ......+.+..+..+++.++||||+++++.+.   
T Consensus        12 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~   91 (329)
T PTZ00263         12 TSSWKLSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDEN   91 (329)
T ss_pred             cCCCCchheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCC
Confidence            33445689999999999999999999999999999999986421 11122344555666777889999998874321   


Q ss_pred             -----------------------------HHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEeccccccccc
Q psy14630         94 -----------------------------KEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVD  144 (187)
Q Consensus        94 -----------------------------~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg~a~~~~~  144 (187)
                                                   ..+..|++.||+|||+. +++||||||+||+++.++.+||+|||+++....
T Consensus        92 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~-~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~  170 (329)
T PTZ00263         92 RVYFLLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHSK-DIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPD  170 (329)
T ss_pred             EEEEEEcCCCCChHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC-CeeecCCCHHHEEECCCCCEEEeeccCceEcCC
Confidence                                         11567899999999997 999999999999999999999999999987644


Q ss_pred             cccccCCCCCcCccCccccCCCccCCCCCCcceeeeEee
Q psy14630        145 SIAKTRDAGCRPYMAPERIDPLRARGYPSFKTKLGFKFN  183 (187)
Q Consensus       145 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi~  183 (187)
                      ..  ....|++.|+|||.+.   ...++.++|+||+|+.
T Consensus       171 ~~--~~~~gt~~y~aPE~~~---~~~~~~~~DiwslG~i  204 (329)
T PTZ00263        171 RT--FTLCGTPEYLAPEVIQ---SKGHGKAVDWWTMGVL  204 (329)
T ss_pred             Cc--ceecCChhhcCHHHHc---CCCCCCcceeechHHH
Confidence            32  2346899999999998   6678899999999993

>KOG0198|consensus

Probab=99.98  E-value=3.4e-32  Score=206.33  Aligned_cols=159  Identities=29%  Similarity=0.435  Sum_probs=127.1

Q ss_pred             cccccccccccccCceEEEEEEEcCCCcEEEEEEccCccChHHHHHHHHHHHHHHhcCCCCchhhhhhh--------H--
Q psy14630         23 SEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQFYGA--------L--   92 (187)
Q Consensus        23 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~--------~--   92 (187)
                      ..++...+.||+|+||.||++.+.+++...|+|.+......  ..+.+.++..++..+.|||||++++.        +  
T Consensus        16 ~~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~--~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i   93 (313)
T KOG0198|consen   16 ISNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSP--TSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNI   93 (313)
T ss_pred             cchhhhhccccCccceEEEEEEecCCCcceeeeeeecccch--hHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEe
Confidence            45688889999999999999999988999999998654211  25556777778888889999999873        0  


Q ss_pred             -------------------------HHHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcC-CCCEEEEeccccccccc--
Q psy14630         93 -------------------------FKEVTVATVKALNYLKEELKIIHRDVKPSNILLDR-RGAIKLCDFGISGQLVD--  144 (187)
Q Consensus        93 -------------------------~~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~-~~~~ki~dfg~a~~~~~--  144 (187)
                                               ....+.|+++||.|||++ +++|+||||+|||++. ++.+||+|||+++....  
T Consensus        94 ~mEy~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs~-g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~  172 (313)
T KOG0198|consen   94 FMEYAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHSK-GIVHCDIKPANILLDPSNGDVKLADFGLAKKLESKG  172 (313)
T ss_pred             eeeccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhC-CEeccCcccceEEEeCCCCeEEeccCcccccccccc
Confidence                                     122678999999999998 9999999999999999 69999999999988763  


Q ss_pred             --cccccCCCCCcCccCccccCCCccCCCCCCcceeeeEe-eeeC
Q psy14630        145 --SIAKTRDAGCRPYMAPERIDPLRARGYPSFKTKLGFKF-NYRI  186 (187)
Q Consensus       145 --~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi-~~~~  186 (187)
                        ........||+.|||||++..  .......+||||+|. +++|
T Consensus       173 ~~~~~~~~~~Gtp~~maPEvi~~--g~~~~~~sDiWSlGCtVvEM  215 (313)
T KOG0198|consen  173 TKSDSELSVQGTPNYMAPEVIRN--GEVARRESDIWSLGCTVVEM  215 (313)
T ss_pred             ccccccccccCCccccCchhhcC--CCcCCccchhhhcCCEEEec
Confidence              222334579999999999993  111225999999999 5543

>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=99.98  E-value=1.3e-32  Score=217.05  Aligned_cols=158  Identities=28%  Similarity=0.454  Sum_probs=123.9

Q ss_pred             ccccccccccccCceEEEEEEEcCCCcEEEEEEccCcc-ChHHHHHHHHHHHHHHhcCCCCchhhhhhhHH---------
Q psy14630         24 EDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTV-DEKDQRQLLMDLDVVMKSNECPYIVQFYGALF---------   93 (187)
Q Consensus        24 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~---------   93 (187)
                      ++|++.+.||+|+||.||++.+..+++.||+|.+.... ......+.+..+..+++.++||||+++++.+.         
T Consensus         1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~   80 (377)
T cd05629           1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM   80 (377)
T ss_pred             CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence            47889999999999999999999999999999985421 12223344555666778889999998864321         


Q ss_pred             -----------------------HHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEeccccccccccc----
Q psy14630         94 -----------------------KEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSI----  146 (187)
Q Consensus        94 -----------------------~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg~a~~~~~~~----  146 (187)
                                             ..++.|++.||+|||+. +++||||||+||+++.++.++++|||+++.+....    
T Consensus        81 E~~~gg~L~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~-givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~  159 (377)
T cd05629          81 EFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKL-GFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAY  159 (377)
T ss_pred             eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC-CeeccCCCHHHEEECCCCCEEEeeccccccccccccccc
Confidence                                   12567899999999997 99999999999999999999999999986432100    


Q ss_pred             --------------------------------------------cccCCCCCcCccCccccCCCccCCCCCCcceeeeEe
Q psy14630        147 --------------------------------------------AKTRDAGCRPYMAPERIDPLRARGYPSFKTKLGFKF  182 (187)
Q Consensus       147 --------------------------------------------~~~~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi  182 (187)
                                                                  .....+||+.|+|||++.   ...++.++|+||+|+
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwSlGv  236 (377)
T cd05629         160 YQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFL---QQGYGQECDWWSLGA  236 (377)
T ss_pred             ccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHc---cCCCCCceeeEecch
Confidence                                                        001236899999999998   667899999999999


Q ss_pred             -eee
Q psy14630        183 -NYR  185 (187)
Q Consensus       183 -~~~  185 (187)
                       +|+
T Consensus       237 il~e  240 (377)
T cd05629         237 IMFE  240 (377)
T ss_pred             hhhh
Confidence             443

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of

>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

Probab=99.98  E-value=8.4e-33  Score=216.46  Aligned_cols=158  Identities=25%  Similarity=0.304  Sum_probs=129.8

Q ss_pred             CcccccccccccccCceEEEEEEEcCCCcEEEEEEccCccChHHHHHHHHHHHHHHhcCCCCchhhhhhhHH--------
Q psy14630         22 TSEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQFYGALF--------   93 (187)
Q Consensus        22 ~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~--------   93 (187)
                      ..++|++.+.||+|+||.||++.+..+++.+|+|.+..............++..+++.++||||+++++.+.        
T Consensus        15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~   94 (355)
T cd07874          15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEF   94 (355)
T ss_pred             hhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeecccccccc
Confidence            457899999999999999999999999999999998654333333444555666778889999998865321        


Q ss_pred             ---------------------------HHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEeccccccccccc
Q psy14630         94 ---------------------------KEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSI  146 (187)
Q Consensus        94 ---------------------------~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg~a~~~~~~~  146 (187)
                                                 ..++.|++.||.|||+. +++||||||+||+++.++.+||+|||+++......
T Consensus        95 ~~~~lv~e~~~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~-givHrDikp~Nill~~~~~~kl~Dfg~~~~~~~~~  173 (355)
T cd07874          95 QDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSA-GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF  173 (355)
T ss_pred             ceeEEEhhhhcccHHHHHhhcCCHHHHHHHHHHHHHHHHHHHhC-CcccCCCChHHEEECCCCCEEEeeCcccccCCCcc
Confidence                                       11567899999999998 99999999999999999999999999998765544


Q ss_pred             cccCCCCCcCccCccccCCCccCCCCCCcceeeeEee
Q psy14630        147 AKTRDAGCRPYMAPERIDPLRARGYPSFKTKLGFKFN  183 (187)
Q Consensus       147 ~~~~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi~  183 (187)
                      ......+|+.|+|||.+.   ...++.++|+||+|++
T Consensus       174 ~~~~~~~t~~y~aPE~~~---~~~~~~~~DiwslG~i  207 (355)
T cd07874         174 MMTPYVVTRYYRAPEVIL---GMGYKENVDIWSVGCI  207 (355)
T ss_pred             ccCCccccCCccCHHHHc---CCCCCchhhHHHHHHH
Confidence            444557899999999998   5678899999999983

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok

>KOG0611|consensus

Probab=99.98  E-value=3.6e-33  Score=213.08  Aligned_cols=157  Identities=25%  Similarity=0.371  Sum_probs=135.6

Q ss_pred             cccccccccccccCceEEEEEEEcCCCcEEEEEEccCccChH-HHHHHHHHHHHHHhcCCCCchhhhhhhHHHH------
Q psy14630         23 SEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEK-DQRQLLMDLDVVMKSNECPYIVQFYGALFKE------   95 (187)
Q Consensus        23 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~------   95 (187)
                      ..+|.+.+.||+|.||+|.+|+....|+.||||.+++...+. ...-.+.+++.+|..++||||++.|..|..+      
T Consensus        52 kHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIviv  131 (668)
T KOG0611|consen   52 KHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIV  131 (668)
T ss_pred             hhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEE
Confidence            467999999999999999999998999999999997543222 2233456677789999999999998766322      


Q ss_pred             --------------------------HHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEecccccccccccccc
Q psy14630         96 --------------------------VTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKT  149 (187)
Q Consensus        96 --------------------------~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg~a~~~~~~~~~~  149 (187)
                                                ++.||+.|+.|+|.+ +++|||||.+|||+|.++++||+|||++-.+.+.....
T Consensus       132 MEYaS~GeLYDYiSer~~LsErEaRhfFRQIvSAVhYCHkn-rVvHRDLKLENILLD~N~NiKIADFGLSNly~~~kfLq  210 (668)
T KOG0611|consen  132 MEYASGGELYDYISERGSLSEREARHFFRQIVSAVHYCHKN-RVVHRDLKLENILLDQNNNIKIADFGLSNLYADKKFLQ  210 (668)
T ss_pred             EEecCCccHHHHHHHhccccHHHHHHHHHHHHHHHHHHhhc-cceecccchhheeecCCCCeeeeccchhhhhccccHHH
Confidence                                      788999999999998 99999999999999999999999999999888887788


Q ss_pred             CCCCCcCccCccccCCCccCCCC-CCcceeeeEee
Q psy14630        150 RDAGCRPYMAPERIDPLRARGYP-SFKTKLGFKFN  183 (187)
Q Consensus       150 ~~~~t~~y~aPE~~~~~~~~~~~-~~~D~ws~gi~  183 (187)
                      .+||++.|.+||.+.   ..+|. +.+|.||+||.
T Consensus       211 TFCGSPLYASPEIvN---G~PY~GPEVDsWsLGvL  242 (668)
T KOG0611|consen  211 TFCGSPLYASPEIVN---GTPYKGPEVDSWSLGVL  242 (668)
T ss_pred             HhcCCcccCCccccC---CCCCCCCccchhhHHHH
Confidence            889999999999999   55565 88999999993

>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=99.98  E-value=9.6e-33  Score=216.73  Aligned_cols=155  Identities=29%  Similarity=0.492  Sum_probs=124.3

Q ss_pred             ccccccccccccCceEEEEEEEcCCCcEEEEEEccCcc-ChHHHHHHHHHHHHHHhcCCCCchhhhhhhH----------
Q psy14630         24 EDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTV-DEKDQRQLLMDLDVVMKSNECPYIVQFYGAL----------   92 (187)
Q Consensus        24 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~----------   92 (187)
                      ++|++.+.||+|+||.||+|.+..+++.||||+++... ........+..+..++..++||||+++++.+          
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~   80 (364)
T cd05599           1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM   80 (364)
T ss_pred             CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence            47899999999999999999999999999999986421 1223344556666778888999999886432          


Q ss_pred             ----------------------HHHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEeccccccccccc----
Q psy14630         93 ----------------------FKEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSI----  146 (187)
Q Consensus        93 ----------------------~~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg~a~~~~~~~----  146 (187)
                                            ...++.|++.||+|||+. +++||||||+||+++.++.++|+|||+++.+....    
T Consensus        81 E~~~~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~-~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~  159 (364)
T cd05599          81 EYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKL-GYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEF  159 (364)
T ss_pred             CCCCCcHHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC-CeEeccCCHHHeEECCCCCEEEeecccceeccccccccc
Confidence                                  112667899999999997 99999999999999999999999999987643211    


Q ss_pred             -----------------------------------cccCCCCCcCccCccccCCCccCCCCCCcceeeeEe
Q psy14630        147 -----------------------------------AKTRDAGCRPYMAPERIDPLRARGYPSFKTKLGFKF  182 (187)
Q Consensus       147 -----------------------------------~~~~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi  182 (187)
                                                         ......||+.|+|||++.   ...++.++|+||+|+
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwSlG~  227 (364)
T cd05599         160 YRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFL---QTGYNKECDWWSLGV  227 (364)
T ss_pred             cccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHc---CCCCCCeeeeecchh
Confidence                                               001235899999999988   667899999999999

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica

>KOG0660|consensus

Probab=99.98  E-value=3.3e-33  Score=209.66  Aligned_cols=157  Identities=22%  Similarity=0.338  Sum_probs=128.1

Q ss_pred             ccccccccccccCceEEEEEEEcCCCcEEEEEEccCccChHHHHHHHHHHHHHHhcCCCCchhhhhhhHHH---------
Q psy14630         24 EDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQFYGALFK---------   94 (187)
Q Consensus        24 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~---------   94 (187)
                      ..|...+.||+|+||.|+.+.+..+++.||||.+.+...+....+.-.++..+++.++|+||+.+.+.+..         
T Consensus        22 ~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~Dv  101 (359)
T KOG0660|consen   22 RYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFNDV  101 (359)
T ss_pred             ceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeeccccccccccee
Confidence            34445789999999999999999999999999986544455555555556667778889999987643311         


Q ss_pred             ---------------------------HHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEeccccccccc---
Q psy14630         95 ---------------------------EVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVD---  144 (187)
Q Consensus        95 ---------------------------~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg~a~~~~~---  144 (187)
                                                 -+.-|++.||+|+|+. +++||||||.|++++.+..+||+|||+|+...+   
T Consensus       102 YiV~elMetDL~~iik~~~~L~d~H~q~f~YQiLrgLKyiHSA-nViHRDLKPsNll~n~~c~lKI~DFGLAR~~~~~~~  180 (359)
T KOG0660|consen  102 YLVFELMETDLHQIIKSQQDLTDDHAQYFLYQILRGLKYIHSA-NVIHRDLKPSNLLLNADCDLKICDFGLARYLDKFFE  180 (359)
T ss_pred             EEehhHHhhHHHHHHHcCccccHHHHHHHHHHHHHhcchhhcc-cccccccchhheeeccCCCEEeccccceeeccccCc
Confidence                                       1567899999999998 999999999999999999999999999999854   


Q ss_pred             cccccCCCCCcCccCccccCCCccCCCCCCcceeeeEee
Q psy14630        145 SIAKTRDAGCRPYMAPERIDPLRARGYPSFKTKLGFKFN  183 (187)
Q Consensus       145 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi~  183 (187)
                      ....+..+.|.+|+|||++..  ...|+.++|+||+|.+
T Consensus       181 ~~~mTeYVaTRWYRAPElll~--~~~Yt~aiDiWSvGCI  217 (359)
T KOG0660|consen  181 DGFMTEYVATRWYRAPELLLN--SSEYTKAIDIWSVGCI  217 (359)
T ss_pred             ccchhcceeeeeecCHHHHhc--cccccchhhhhhhhHH
Confidence            233345578999999999974  5679999999999984

>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

Probab=99.98  E-value=2.2e-32  Score=215.64  Aligned_cols=159  Identities=25%  Similarity=0.388  Sum_probs=124.3

Q ss_pred             ccccccccccccCceEEEEEEEcCCCcEEEEEEccCcc-ChHHHHHHHHHHHHHHhcCCCCchhhhhhhH----------
Q psy14630         24 EDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTV-DEKDQRQLLMDLDVVMKSNECPYIVQFYGAL----------   92 (187)
Q Consensus        24 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~----------   92 (187)
                      ++|++.+.||+|+||.||+|.+..+++.||+|++.... ......+.+.++..+++.+.|+||+++++.+          
T Consensus         1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~   80 (376)
T cd05598           1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM   80 (376)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEE
Confidence            46899999999999999999999999999999985321 1122334455666778889999999876432          


Q ss_pred             ----------------------HHHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEecccccccccc-----
Q psy14630         93 ----------------------FKEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDS-----  145 (187)
Q Consensus        93 ----------------------~~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg~a~~~~~~-----  145 (187)
                                            ...++.|++.||+|||+. +|+||||||+||+++.++.++|+|||+|..+...     
T Consensus        81 E~~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~-~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~~~~  159 (376)
T cd05598          81 DYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKM-GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKY  159 (376)
T ss_pred             eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC-CeEeCCCCHHHEEECCCCCEEEEeCCCCccccccccccc
Confidence                                  112567899999999997 9999999999999999999999999997533100     


Q ss_pred             ---------------------------------------ccccCCCCCcCccCccccCCCccCCCCCCcceeeeEe-eee
Q psy14630        146 ---------------------------------------IAKTRDAGCRPYMAPERIDPLRARGYPSFKTKLGFKF-NYR  185 (187)
Q Consensus       146 ---------------------------------------~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi-~~~  185 (187)
                                                             .......||+.|+|||++.   ...++.++|+||+|+ +|.
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwSlGvilye  236 (376)
T cd05598         160 YQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLL---RTGYTQLCDWWSVGVILYE  236 (376)
T ss_pred             cccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHc---CCCCCcceeeeeccceeee
Confidence                                                   0011236899999999998   667889999999999 444


Q ss_pred             C
Q psy14630        186 I  186 (187)
Q Consensus       186 ~  186 (187)
                      |
T Consensus       237 l  237 (376)
T cd05598         237 M  237 (376)
T ss_pred             h
Confidence            3

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.

>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

Probab=99.98  E-value=1.2e-32  Score=217.52  Aligned_cols=155  Identities=23%  Similarity=0.358  Sum_probs=123.0

Q ss_pred             cccccccccccCceEEEEEEEcCCCcEEEEEEccCcc-ChHHHHHHHHHHHHHHhcCCCCchhhhhhhHH----------
Q psy14630         25 DLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTV-DEKDQRQLLMDLDVVMKSNECPYIVQFYGALF----------   93 (187)
Q Consensus        25 ~~~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~----------   93 (187)
                      .|...+.||+|+||.||+|.+..+++.||+|++.... ......+.+..+..+++.++|+||+++++.+.          
T Consensus         2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E   81 (381)
T cd05626           2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD   81 (381)
T ss_pred             CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence            5788999999999999999999999999999986432 22233445566666778889999998864321          


Q ss_pred             ----------------------HHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEeccccccccccc-----
Q psy14630         94 ----------------------KEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSI-----  146 (187)
Q Consensus        94 ----------------------~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg~a~~~~~~~-----  146 (187)
                                            ..++.|++.||.|||+. +|+||||||+||+++.++.+||+|||+++.+....     
T Consensus        82 ~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~~LH~~-givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~~~~~  160 (381)
T cd05626          82 YIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKM-GFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYY  160 (381)
T ss_pred             cCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC-CeeecCCcHHHEEECCCCCEEEeeCcCCcccccccccccc
Confidence                                  11567899999999997 99999999999999999999999999976431100     


Q ss_pred             -------------------------------------------cccCCCCCcCccCccccCCCccCCCCCCcceeeeEee
Q psy14630        147 -------------------------------------------AKTRDAGCRPYMAPERIDPLRARGYPSFKTKLGFKFN  183 (187)
Q Consensus       147 -------------------------------------------~~~~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi~  183 (187)
                                                                 ......||+.|+|||.+.   ...++.++|+||+|++
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~---~~~~~~~~DiwSlG~i  237 (381)
T cd05626         161 QKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLL---RKGYTQLCDWWSVGVI  237 (381)
T ss_pred             cccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHc---CCCCCCccceeehhhH
Confidence                                                       011246899999999998   5678999999999983

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po

>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

Probab=99.98  E-value=1.1e-32  Score=210.37  Aligned_cols=153  Identities=31%  Similarity=0.476  Sum_probs=125.4

Q ss_pred             ccccccccccccCceEEEEEEEcCCCcEEEEEEccCcc-ChHHHHHHHHHHHHHHhcCCCCchhhhhhhHHH--------
Q psy14630         24 EDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTV-DEKDQRQLLMDLDVVMKSNECPYIVQFYGALFK--------   94 (187)
Q Consensus        24 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~--------   94 (187)
                      ++|++.+.||+|+||.||+|.+..+++.+|+|.+.... ......+.+.++..+++.+.||||+++++.+..        
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   80 (291)
T cd05612           1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM   80 (291)
T ss_pred             CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence            47889999999999999999999999999999986422 122234445666677888999999998754321        


Q ss_pred             ------------------------HHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEeccccccccccccccC
Q psy14630         95 ------------------------EVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTR  150 (187)
Q Consensus        95 ------------------------~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg~a~~~~~~~~~~~  150 (187)
                                              .+..|++.||+|||+. +++||||||+||+++.++.+||+|||+++......  ..
T Consensus        81 e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~-~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~--~~  157 (291)
T cd05612          81 EYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSK-EIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDRT--WT  157 (291)
T ss_pred             eCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC-CeeecCCCHHHeEECCCCCEEEEecCcchhccCCc--cc
Confidence                                    1567899999999997 99999999999999999999999999998765432  23


Q ss_pred             CCCCcCccCccccCCCccCCCCCCcceeeeEe
Q psy14630        151 DAGCRPYMAPERIDPLRARGYPSFKTKLGFKF  182 (187)
Q Consensus       151 ~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi  182 (187)
                      ..|++.|+|||.+.   ...++.++|+||+|+
T Consensus       158 ~~gt~~y~aPE~~~---~~~~~~~~DiwSlG~  186 (291)
T cd05612         158 LCGTPEYLAPEVIQ---SKGHNKAVDWWALGI  186 (291)
T ss_pred             ccCChhhcCHHHHc---CCCCCchhhHHHHHH
Confidence            46899999999988   667889999999998

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt

>KOG0667|consensus

Probab=99.98  E-value=2.2e-32  Score=218.22  Aligned_cols=151  Identities=28%  Similarity=0.356  Sum_probs=118.2

Q ss_pred             cccccccccccCceEEEEEEEcCCCcEEEEEEccCccChHHHHHHHHHHHHHHhcC-----CCCchhhhhhhH-------
Q psy14630         25 DLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSN-----ECPYIVQFYGAL-------   92 (187)
Q Consensus        25 ~~~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~-----~h~~iv~~~~~~-------   92 (187)
                      +|.+++.||+|+||+|.+|++.+|++.||||++++...  ...+...|+..+....     +.-|+|++++.|       
T Consensus       187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k~--f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~Hlc  264 (586)
T KOG0667|consen  187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKKR--FLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLC  264 (586)
T ss_pred             EEEEEEEecccccceeEEEEecCCCcEEEEEeeccChH--HHHHHHHHHHHHHHHhccCCCCCeeEEEeeecccccccee
Confidence            68889999999999999999999999999999986322  2222222322222222     234788877644       


Q ss_pred             --------------------------HHHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCC--CCEEEEeccccccccc
Q psy14630         93 --------------------------FKEVTVATVKALNYLKEELKIIHRDVKPSNILLDRR--GAIKLCDFGISGQLVD  144 (187)
Q Consensus        93 --------------------------~~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~--~~~ki~dfg~a~~~~~  144 (187)
                                                ...+..|++.+|.+||+. +|||.||||+|||+...  ..+||+|||.+.....
T Consensus       265 iVfELL~~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l-~IIHcDLKPENILL~~~~r~~vKVIDFGSSc~~~q  343 (586)
T KOG0667|consen  265 IVFELLSTNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHEL-GIIHCDLKPENILLKDPKRSRIKVIDFGSSCFESQ  343 (586)
T ss_pred             eeehhhhhhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC-CeeeccCChhheeeccCCcCceeEEecccccccCC
Confidence                                      223788999999999987 99999999999999754  4699999999988665


Q ss_pred             cccccCCCCCcCccCccccCCCccCCCCCCcceeeeEee
Q psy14630        145 SIAKTRDAGCRPYMAPERIDPLRARGYPSFKTKLGFKFN  183 (187)
Q Consensus       145 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi~  183 (187)
                      ...  ..+-+..|+|||+|.   ..+|+.+.|+||||.+
T Consensus       344 ~vy--tYiQSRfYRAPEVIL---GlpY~~~IDmWSLGCI  377 (586)
T KOG0667|consen  344 RVY--TYIQSRFYRAPEVIL---GLPYDTAIDMWSLGCI  377 (586)
T ss_pred             cce--eeeeccccccchhhc---cCCCCCccceeehhhh
Confidence            544  456788899999999   6789999999999983

>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

Probab=99.97  E-value=1.7e-32  Score=215.95  Aligned_cols=164  Identities=29%  Similarity=0.427  Sum_probs=129.6

Q ss_pred             ccCCcccccccccccccCceEEEEEEEcCCCcEEEEEEccCcc-ChHHHHHHHHHHHHHHhcCCCCchhhhhhhHH----
Q psy14630         19 YDFTSEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTV-DEKDQRQLLMDLDVVMKSNECPYIVQFYGALF----   93 (187)
Q Consensus        19 ~~~~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~----   93 (187)
                      .....++|++.+.||+|+||.||++.+..+++.+|+|.+.... ......+.+.++..+++.++||||+++++.+.    
T Consensus        38 ~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~  117 (370)
T cd05621          38 LQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKY  117 (370)
T ss_pred             cCCCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCE
Confidence            3456688999999999999999999999999999999985421 12223345666777888899999999874321    


Q ss_pred             ---------------------------HHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEeccccccccccc
Q psy14630         94 ---------------------------KEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSI  146 (187)
Q Consensus        94 ---------------------------~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg~a~~~~~~~  146 (187)
                                                 ..+..|++.||+|||+. +++||||||+||+++.++.+||+|||++.......
T Consensus       118 ~~lv~Ey~~gg~L~~~l~~~~~~~~~~~~~~~qil~aL~~LH~~-~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~~~~  196 (370)
T cd05621         118 LYMVMEYMPGGDLVNLMSNYDVPEKWAKFYTAEVVLALDAIHSM-GLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETG  196 (370)
T ss_pred             EEEEEcCCCCCcHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHC-CeEecCCCHHHEEECCCCCEEEEecccceecccCC
Confidence                                       12567899999999997 99999999999999999999999999998764322


Q ss_pred             --cccCCCCCcCccCccccCCCcc-CCCCCCcceeeeEee
Q psy14630        147 --AKTRDAGCRPYMAPERIDPLRA-RGYPSFKTKLGFKFN  183 (187)
Q Consensus       147 --~~~~~~~t~~y~aPE~~~~~~~-~~~~~~~D~ws~gi~  183 (187)
                        ......||+.|+|||++.+... ..++.++|+||+|+.
T Consensus       197 ~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~i  236 (370)
T cd05621         197 MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVF  236 (370)
T ss_pred             ceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHH
Confidence              2234578999999999874321 236789999999993

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found

>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

Probab=99.97  E-value=2.4e-32  Score=215.14  Aligned_cols=163  Identities=28%  Similarity=0.415  Sum_probs=129.5

Q ss_pred             ccCCcccccccccccccCceEEEEEEEcCCCcEEEEEEccCcc-ChHHHHHHHHHHHHHHhcCCCCchhhhhhhHH----
Q psy14630         19 YDFTSEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTV-DEKDQRQLLMDLDVVMKSNECPYIVQFYGALF----   93 (187)
Q Consensus        19 ~~~~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~----   93 (187)
                      ..+..++|++.+.||+|+||.||+|.+..+++.+|+|++.... ......+.+.++..+++.++||||+++++.+.    
T Consensus        38 ~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~  117 (371)
T cd05622          38 LRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRY  117 (371)
T ss_pred             cCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCE
Confidence            4566789999999999999999999999999999999985321 12223345566777888899999998864321    


Q ss_pred             ---------------------------HHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEeccccccccccc
Q psy14630         94 ---------------------------KEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSI  146 (187)
Q Consensus        94 ---------------------------~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg~a~~~~~~~  146 (187)
                                                 ..+..|++.||.|||+. +++||||||+||+++.++.+||+|||+++......
T Consensus       118 ~~lv~Ey~~gg~L~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~-~ivHrDLkp~NIll~~~~~ikL~DfG~a~~~~~~~  196 (371)
T cd05622         118 LYMVMEYMPGGDLVNLMSNYDVPEKWARFYTAEVVLALDAIHSM-GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEG  196 (371)
T ss_pred             EEEEEcCCCCCcHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHC-CEEeCCCCHHHEEECCCCCEEEEeCCceeEcCcCC
Confidence                                       11567899999999997 99999999999999999999999999998764322


Q ss_pred             --cccCCCCCcCccCccccCCCcc-CCCCCCcceeeeEe
Q psy14630        147 --AKTRDAGCRPYMAPERIDPLRA-RGYPSFKTKLGFKF  182 (187)
Q Consensus       147 --~~~~~~~t~~y~aPE~~~~~~~-~~~~~~~D~ws~gi  182 (187)
                        ......||+.|+|||++.+... ..++.++|+||+|+
T Consensus       197 ~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGv  235 (371)
T cd05622         197 MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGV  235 (371)
T ss_pred             cccccCcccCccccCHHHHhccCCCccCCCccceeehhH
Confidence              2234578999999999874321 23778999999999

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an

>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

Probab=99.97  E-value=2.2e-32  Score=216.08  Aligned_cols=155  Identities=24%  Similarity=0.355  Sum_probs=122.9

Q ss_pred             cccccccccccCceEEEEEEEcCCCcEEEEEEccCcc-ChHHHHHHHHHHHHHHhcCCCCchhhhhhhHH----------
Q psy14630         25 DLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTV-DEKDQRQLLMDLDVVMKSNECPYIVQFYGALF----------   93 (187)
Q Consensus        25 ~~~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~----------   93 (187)
                      .|...+.||+|+||.||+|.+..+++.+|+|.+.... ......+.+..+..+++.++|+||+++++.+.          
T Consensus         2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E   81 (382)
T cd05625           2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD   81 (382)
T ss_pred             CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence            5788999999999999999999999999999986421 12233445566667788889999998874321          


Q ss_pred             ----------------------HHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEecccccccccc------
Q psy14630         94 ----------------------KEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDS------  145 (187)
Q Consensus        94 ----------------------~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg~a~~~~~~------  145 (187)
                                            ..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++.+...      
T Consensus        82 ~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~al~~lH~~-~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~~~~~  160 (382)
T cd05625          82 YIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKM-GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYY  160 (382)
T ss_pred             CCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC-CeecCCCCHHHEEECCCCCEEEeECCCCcccccccccccc
Confidence                                  12567899999999997 9999999999999999999999999997643210      


Q ss_pred             ------------------------------------------ccccCCCCCcCccCccccCCCccCCCCCCcceeeeEee
Q psy14630        146 ------------------------------------------IAKTRDAGCRPYMAPERIDPLRARGYPSFKTKLGFKFN  183 (187)
Q Consensus       146 ------------------------------------------~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi~  183 (187)
                                                                .......||+.|+|||++.   ..+++.++|+||+|++
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~---~~~~~~~~DiwSlGvi  237 (382)
T cd05625         161 QSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLL---RTGYTQLCDWWSVGVI  237 (382)
T ss_pred             ccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhc---CCCCCCeeeEEechHH
Confidence                                                      0011236899999999998   6678999999999993

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an

>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

Probab=99.97  E-value=4e-32  Score=212.02  Aligned_cols=158  Identities=28%  Similarity=0.452  Sum_probs=127.3

Q ss_pred             ccccccccccccCceEEEEEEEcCCCcEEEEEEccCccC-hHHHHHHHHHHHHHHhcCCCCchhhhhhhHH---------
Q psy14630         24 EDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVD-EKDQRQLLMDLDVVMKSNECPYIVQFYGALF---------   93 (187)
Q Consensus        24 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~---------   93 (187)
                      ++|++.+.||+|+||.||+|.+..+++.||+|+++.... .......+.++..++..+.|+||+++++.+.         
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (350)
T cd05573           1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM   80 (350)
T ss_pred             CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence            478899999999999999999999999999999864321 1123345566666778889999999875431         


Q ss_pred             -----------------------HHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEeccccccccccc----
Q psy14630         94 -----------------------KEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSI----  146 (187)
Q Consensus        94 -----------------------~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg~a~~~~~~~----  146 (187)
                                             ..++.|++.||.|||+. +++||||||+||+++.++.+||+|||++.......    
T Consensus        81 e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~-giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~  159 (350)
T cd05573          81 EYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHKL-GFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREY  159 (350)
T ss_pred             cCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC-CeeccCCCHHHeEECCCCCEEeecCCCCccCcccCcccc
Confidence                                   11667899999999997 99999999999999999999999999998765432    


Q ss_pred             --------------------------cccCCCCCcCccCccccCCCccCCCCCCcceeeeEe-eee
Q psy14630        147 --------------------------AKTRDAGCRPYMAPERIDPLRARGYPSFKTKLGFKF-NYR  185 (187)
Q Consensus       147 --------------------------~~~~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi-~~~  185 (187)
                                                ......||+.|+|||.+.   ...++.++|+||+|+ +|+
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwSlG~il~e  222 (350)
T cd05573         160 YLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLR---GTPYGLECDWWSLGVILYE  222 (350)
T ss_pred             cccccccccccccccccccccccccccccccccCccccCHHHHc---CCCCCCceeeEecchhhhh
Confidence                                      222346899999999998   567899999999999 444

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the

>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

Probab=99.97  E-value=2.1e-32  Score=212.84  Aligned_cols=162  Identities=25%  Similarity=0.424  Sum_probs=123.1

Q ss_pred             cccCCcccccccccccccCceEEEEEEE-----cCCCcEEEEEEccCccChHHHHHHHHHHHHHHhcC-CCCchhhhhhh
Q psy14630         18 VYDFTSEDLQDLGEIGRGGFGTVNKMIH-----RSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSN-ECPYIVQFYGA   91 (187)
Q Consensus        18 ~~~~~~~~~~~~~~lg~G~fg~V~~~~~-----~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~-~h~~iv~~~~~   91 (187)
                      .|+++.++|++.+.||+|+||.||+|.+     ..++..||+|.++...........+.+.. ++..+ +||||+++++.
T Consensus         1 ~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~-~l~~l~~h~niv~~~~~   79 (338)
T cd05102           1 QWEFPRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELK-ILIHIGNHLNVVNLLGA   79 (338)
T ss_pred             CcccchhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHH-HHHHhccCcceeeEEeE
Confidence            3788899999999999999999999974     24456799999875333333333444444 44444 89999987753


Q ss_pred             HHH-----------------------------------------------------------------------------
Q psy14630         92 LFK-----------------------------------------------------------------------------   94 (187)
Q Consensus        92 ~~~-----------------------------------------------------------------------------   94 (187)
                      +..                                                                             
T Consensus        80 ~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (338)
T cd05102          80 CTKPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNP  159 (338)
T ss_pred             ecCCCCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCccccc
Confidence            210                                                                             


Q ss_pred             ------------------HHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEecccccccccccc---ccCCCC
Q psy14630         95 ------------------EVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIA---KTRDAG  153 (187)
Q Consensus        95 ------------------~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg~a~~~~~~~~---~~~~~~  153 (187)
                                        .++.|++.||.|||+. +++||||||+||+++.++.+||+|||+++.......   .....+
T Consensus       160 ~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~-~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~  238 (338)
T cd05102         160 PQETDDLWKSPLTMEDLICYSFQVARGMEFLASR-KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARL  238 (338)
T ss_pred             chhccccccCCCCHHHHHHHHHHHHHHHHHHHHC-CEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCC
Confidence                              1345899999999997 999999999999999999999999999987543211   122245


Q ss_pred             CcCccCccccCCCccCCCCCCcceeeeEeee
Q psy14630        154 CRPYMAPERIDPLRARGYPSFKTKLGFKFNY  184 (187)
Q Consensus       154 t~~y~aPE~~~~~~~~~~~~~~D~ws~gi~~  184 (187)
                      +..|+|||++.   ...++.++|+||||+.+
T Consensus       239 ~~~y~aPE~~~---~~~~~~~sDiwslG~il  266 (338)
T cd05102         239 PLKWMAPESIF---DKVYTTQSDVWSFGVLL  266 (338)
T ss_pred             CccccCcHHhh---cCCCCcccCHHHHHHHH
Confidence            67899999998   56789999999999843

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V

>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

Probab=99.97  E-value=2.3e-32  Score=207.99  Aligned_cols=155  Identities=25%  Similarity=0.405  Sum_probs=123.5

Q ss_pred             cccccccccccCceEEEEEEEcCCCcEEEEEEccCccC-hHHHHHHHHHHHHHHhcCCCCchhhhhhhHH----------
Q psy14630         25 DLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVD-EKDQRQLLMDLDVVMKSNECPYIVQFYGALF----------   93 (187)
Q Consensus        25 ~~~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~----------   93 (187)
                      .|+..+.||+|+||.||+|.+..+++.||+|.+..... .......+.++..++..++|+|++.+++.+.          
T Consensus         1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e   80 (285)
T cd05631           1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLT   80 (285)
T ss_pred             CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEE
Confidence            36778999999999999999999999999998864321 1222234455666777889999997753211          


Q ss_pred             ------------------------HHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEecccccccccccccc
Q psy14630         94 ------------------------KEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKT  149 (187)
Q Consensus        94 ------------------------~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg~a~~~~~~~~~~  149 (187)
                                              ..++.|++.|+.|||+. +++||||||+||+++.++.++|+|||++..........
T Consensus        81 ~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~-~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~  159 (285)
T cd05631          81 IMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRE-RIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGETVR  159 (285)
T ss_pred             ecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhC-CEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCCeec
Confidence                                    11567899999999997 99999999999999999999999999998765443334


Q ss_pred             CCCCCcCccCccccCCCccCCCCCCcceeeeEee
Q psy14630        150 RDAGCRPYMAPERIDPLRARGYPSFKTKLGFKFN  183 (187)
Q Consensus       150 ~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi~  183 (187)
                      ...|+..|+|||.+.   ...++.++|+||+|+.
T Consensus       160 ~~~g~~~y~aPE~~~---~~~~~~~~DvwslGvi  190 (285)
T cd05631         160 GRVGTVGYMAPEVIN---NEKYTFSPDWWGLGCL  190 (285)
T ss_pred             CCCCCCCccCHhhhc---CCCCCcccCchhHHHH
Confidence            457899999999998   6678999999999984

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i

>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

Probab=99.97  E-value=4.7e-32  Score=209.80  Aligned_cols=150  Identities=24%  Similarity=0.407  Sum_probs=117.9

Q ss_pred             ccccccCceEEEEEEEcCCCcEEEEEEccCccC-hHHHHHHHHHHHHHHhcCCCCchhhhhhhH----------------
Q psy14630         30 GEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVD-EKDQRQLLMDLDVVMKSNECPYIVQFYGAL----------------   92 (187)
Q Consensus        30 ~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~----------------   92 (187)
                      +.||+|+||.||+|.+..+++.||+|+++.... ..........+..+++.++||||+++++.+                
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~   80 (323)
T cd05571           1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG   80 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence            468999999999999999999999999864321 112223344555667788999999875321                


Q ss_pred             ----------------HHHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEeccccccccc-cccccCCCCCc
Q psy14630         93 ----------------FKEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVD-SIAKTRDAGCR  155 (187)
Q Consensus        93 ----------------~~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg~a~~~~~-~~~~~~~~~t~  155 (187)
                                      ...+..|++.||+|||+. +++||||||+||+++.++.+||+|||+++.... ........||+
T Consensus        81 ~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~-~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~gt~  159 (323)
T cd05571          81 ELFFHLSRERVFSEDRARFYGAEIVSALGYLHSC-DVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTP  159 (323)
T ss_pred             cHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhC-CeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCCCcccceecCc
Confidence                            111567899999999997 999999999999999999999999999876432 22233446899


Q ss_pred             CccCccccCCCccCCCCCCcceeeeEee
Q psy14630        156 PYMAPERIDPLRARGYPSFKTKLGFKFN  183 (187)
Q Consensus       156 ~y~aPE~~~~~~~~~~~~~~D~ws~gi~  183 (187)
                      .|+|||.+.   ...++.++|+||+|+.
T Consensus       160 ~y~aPE~~~---~~~~~~~~DiwSlG~i  184 (323)
T cd05571         160 EYLAPEVLE---DNDYGRAVDWWGLGVV  184 (323)
T ss_pred             cccChhhhc---CCCCCccccCcccchh
Confidence            999999998   6678999999999993

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be

>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional

Probab=99.97  E-value=2.4e-32  Score=212.85  Aligned_cols=165  Identities=25%  Similarity=0.381  Sum_probs=130.0

Q ss_pred             cCCCccccCCcccccccccccccCceEEEEEEEcCCC-cEEEEEEccCcc-ChHHHHHHHHHHHHHHhcCCCCchhhhhh
Q psy14630         13 LSPDTVYDFTSEDLQDLGEIGRGGFGTVNKMIHRSSD-TVMAVKRIRSTV-DEKDQRQLLMDLDVVMKSNECPYIVQFYG   90 (187)
Q Consensus        13 ~~~~~~~~~~~~~~~~~~~lg~G~fg~V~~~~~~~~~-~~vaiK~~~~~~-~~~~~~~~~~~~~~~~~~~~h~~iv~~~~   90 (187)
                      ..+........++|++.+.||+|+||.||+|.+..++ ..||+|.+.... ......+.+..+..+++.++||||+++++
T Consensus        19 ~~~~~~~~~~~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~   98 (340)
T PTZ00426         19 KEPKRKNKMKYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYG   98 (340)
T ss_pred             cccccCCCCChhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEE
Confidence            3355556778899999999999999999999876554 689999875321 11223344555666788889999998865


Q ss_pred             hHH--------------------------------HHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEeccc
Q psy14630         91 ALF--------------------------------KEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGI  138 (187)
Q Consensus        91 ~~~--------------------------------~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg~  138 (187)
                      .+.                                ..++.|++.||.|||+. +++||||||+||+++.++.+||+|||+
T Consensus        99 ~~~~~~~~~lv~Ey~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~aL~~LH~~-~ivHrDLkp~NILl~~~~~ikL~DFG~  177 (340)
T PTZ00426         99 SFKDESYLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQSL-NIVYRDLKPENLLLDKDGFIKMTDFGF  177 (340)
T ss_pred             EEEeCCEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC-CeEccCCCHHHEEECCCCCEEEecCCC
Confidence            321                                12667899999999997 999999999999999999999999999


Q ss_pred             cccccccccccCCCCCcCccCccccCCCccCCCCCCcceeeeEee
Q psy14630        139 SGQLVDSIAKTRDAGCRPYMAPERIDPLRARGYPSFKTKLGFKFN  183 (187)
Q Consensus       139 a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi~  183 (187)
                      ++.....  .....||+.|+|||++.   ...++.++|+||+|++
T Consensus       178 a~~~~~~--~~~~~gt~~y~aPE~~~---~~~~~~~~DiwSlGvi  217 (340)
T PTZ00426        178 AKVVDTR--TYTLCGTPEYIAPEILL---NVGHGKAADWWTLGIF  217 (340)
T ss_pred             CeecCCC--cceecCChhhcCHHHHh---CCCCCccccccchhhH
Confidence            9876432  22346899999999998   5668899999999993

>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

Probab=99.97  E-value=4.5e-32  Score=210.66  Aligned_cols=156  Identities=28%  Similarity=0.484  Sum_probs=125.0

Q ss_pred             ccccccccccccCceEEEEEEEcCCCcEEEEEEccCccC-hHHHHHHHHHHHHHHhcCCCCchhhhhhhH----------
Q psy14630         24 EDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVD-EKDQRQLLMDLDVVMKSNECPYIVQFYGAL----------   92 (187)
Q Consensus        24 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~----------   92 (187)
                      ++|++.+.||+|+||.||+|.+..+++.||+|+++.... .......+..+..++..+.||||+++++.+          
T Consensus         1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~   80 (333)
T cd05600           1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM   80 (333)
T ss_pred             CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence            468899999999999999999999999999999864321 112233444555667778899999876422          


Q ss_pred             ----------------------HHHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEeccccccccccccccC
Q psy14630         93 ----------------------FKEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTR  150 (187)
Q Consensus        93 ----------------------~~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg~a~~~~~~~~~~~  150 (187)
                                            ...++.|++.||.|||+. +++||||||+||+++.++.+||+|||+++....  ....
T Consensus        81 e~~~g~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~-~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~--~~~~  157 (333)
T cd05600          81 EYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHEL-GYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT--YANS  157 (333)
T ss_pred             eCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC-CccccCCCHHHEEECCCCCEEEEeCcCCccccc--ccCC
Confidence                                  112567899999999997 999999999999999999999999999987654  2334


Q ss_pred             CCCCcCccCccccCCCccCCCCCCcceeeeEe-eee
Q psy14630        151 DAGCRPYMAPERIDPLRARGYPSFKTKLGFKF-NYR  185 (187)
Q Consensus       151 ~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi-~~~  185 (187)
                      ..|++.|+|||.+.   ...++.++|+||+|+ +|+
T Consensus       158 ~~gt~~y~aPE~~~---~~~~~~~~DvwslG~il~e  190 (333)
T cd05600         158 VVGSPDYMAPEVLR---GKGYDFTVDYWSLGCMLYE  190 (333)
T ss_pred             cccCccccChhHhc---CCCCCCccceecchHHHhh
Confidence            47899999999998   557899999999998 444

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.

>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

Probab=99.97  E-value=5.2e-32  Score=212.44  Aligned_cols=158  Identities=28%  Similarity=0.472  Sum_probs=124.8

Q ss_pred             ccccccccccccCceEEEEEEEcCCCcEEEEEEccCcc-ChHHHHHHHHHHHHHHhcCCCCchhhhhhhH----------
Q psy14630         24 EDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTV-DEKDQRQLLMDLDVVMKSNECPYIVQFYGAL----------   92 (187)
Q Consensus        24 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~----------   92 (187)
                      ++|+..+.||+|+||.||++.+..+++.||+|+++... ........+..+..++..++|+||+++++.+          
T Consensus         1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~   80 (360)
T cd05627           1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM   80 (360)
T ss_pred             CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence            46888999999999999999999999999999986321 1222334455566677788999999876432          


Q ss_pred             ----------------------HHHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEeccccccccccc----
Q psy14630         93 ----------------------FKEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSI----  146 (187)
Q Consensus        93 ----------------------~~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg~a~~~~~~~----  146 (187)
                                            ...++.|++.||.|||+. +++||||||+||+++.++.++|+|||+++.+....    
T Consensus        81 E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~~L~~lH~~-givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~~~~  159 (360)
T cd05627          81 EFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQL-GFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEF  159 (360)
T ss_pred             eCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC-CeEccCCCHHHEEECCCCCEEEeeccCCccccccccccc
Confidence                                  112667899999999997 99999999999999999999999999987543210    


Q ss_pred             --------------------------------cccCCCCCcCccCccccCCCccCCCCCCcceeeeEe-eee
Q psy14630        147 --------------------------------AKTRDAGCRPYMAPERIDPLRARGYPSFKTKLGFKF-NYR  185 (187)
Q Consensus       147 --------------------------------~~~~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi-~~~  185 (187)
                                                      .....+||+.|+|||++.   +.+++.++|+||+|+ +|.
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~---~~~~~~~~DiwSlGvilye  228 (360)
T cd05627         160 YRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFM---QTGYNKLCDWWSLGVIMYE  228 (360)
T ss_pred             ccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHc---CCCCCCcceeccccceeee
Confidence                                            011346899999999998   667899999999999 444

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul

>KOG0194|consensus

Probab=99.97  E-value=4.8e-32  Score=214.33  Aligned_cols=166  Identities=25%  Similarity=0.380  Sum_probs=131.4

Q ss_pred             CccccCCcccccccccccccCceEEEEEEEcCCC----cEEEEEEccC-ccChHHHHHHHHHHHHHHhcCCCCchhhhhh
Q psy14630         16 DTVYDFTSEDLQDLGEIGRGGFGTVNKMIHRSSD----TVMAVKRIRS-TVDEKDQRQLLMDLDVVMKSNECPYIVQFYG   90 (187)
Q Consensus        16 ~~~~~~~~~~~~~~~~lg~G~fg~V~~~~~~~~~----~~vaiK~~~~-~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~   90 (187)
                      ...|++.-++..+.++||+|+||.||+|.....+    ..||+|..+. ......+...+..++++++.++|||||++||
T Consensus       149 r~~Wel~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yG  228 (474)
T KOG0194|consen  149 RQKWELSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYG  228 (474)
T ss_pred             ccccEEeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEE
Confidence            4668888788888899999999999999875432    2389999875 2244556667777888899999999999997


Q ss_pred             hHHHH---------------------------------HHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEecc
Q psy14630         91 ALFKE---------------------------------VTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFG  137 (187)
Q Consensus        91 ~~~~~---------------------------------~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg  137 (187)
                      ....+                                 +..+.+.||+|||.. +++||||..+|+|+...+.+||+|||
T Consensus       229 Va~~~~Pl~ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh~k-~~IHRDIAARNcL~~~~~~vKISDFG  307 (474)
T KOG0194|consen  229 VAVLEEPLMLVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLHSK-NCIHRDIAARNCLYSKKGVVKISDFG  307 (474)
T ss_pred             EEcCCCccEEEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHHHC-CCcchhHhHHHheecCCCeEEeCccc
Confidence            43221                                 456778999999997 99999999999999999999999999


Q ss_pred             ccccccccccccCC-CCCcCccCccccCCCccCCCCCCcceeeeEeeee
Q psy14630        138 ISGQLVDSIAKTRD-AGCRPYMAPERIDPLRARGYPSFKTKLGFKFNYR  185 (187)
Q Consensus       138 ~a~~~~~~~~~~~~-~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi~~~  185 (187)
                      +++.-..-...... .-...|+|||++.   ...++.+.|||||||+.|
T Consensus       308 Ls~~~~~~~~~~~~~klPirWLAPEtl~---~~~~s~kTDV~sfGV~~~  353 (474)
T KOG0194|consen  308 LSRAGSQYVMKKFLKKLPIRWLAPETLN---TGIFSFKTDVWSFGVLLW  353 (474)
T ss_pred             cccCCcceeeccccccCcceecChhhhc---cCccccccchhheeeeEE
Confidence            98875421111111 2346799999999   668999999999999766

>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

Probab=99.97  E-value=9e-32  Score=209.69  Aligned_cols=156  Identities=22%  Similarity=0.308  Sum_probs=126.4

Q ss_pred             cccccccccccccCceEEEEEEEcCCCcEEEEEEccCccChHHHHHHHHHHHHHHhcCCCCchhhhhhhHH---------
Q psy14630         23 SEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQFYGALF---------   93 (187)
Q Consensus        23 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~---------   93 (187)
                      .++|++.+.||+|+||.||+|.+..++..||+|.+..........+.+.++..+++.++||||+++++.+.         
T Consensus        14 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   93 (343)
T cd07878          14 PERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENFN   93 (343)
T ss_pred             hhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccccC
Confidence            37899999999999999999999999999999998643222223334445666778889999999876432         


Q ss_pred             ---------------------------HHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEeccccccccccc
Q psy14630         94 ---------------------------KEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSI  146 (187)
Q Consensus        94 ---------------------------~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg~a~~~~~~~  146 (187)
                                                 ..++.|++.||.|||+. +++||||||+||+++.++.+||+|||+++..... 
T Consensus        94 ~~~~~~~~~~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~-~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~-  171 (343)
T cd07878          94 EVYLVTNLMGADLNNIVKCQKLSDEHVQFLIYQLLRGLKYIHSA-GIIHRDLKPSNVAVNEDCELRILDFGLARQADDE-  171 (343)
T ss_pred             cEEEEeecCCCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC-CeecccCChhhEEECCCCCEEEcCCccceecCCC-
Confidence                                       11667899999999997 9999999999999999999999999999876443 


Q ss_pred             cccCCCCCcCccCccccCCCccCCCCCCcceeeeEee
Q psy14630        147 AKTRDAGCRPYMAPERIDPLRARGYPSFKTKLGFKFN  183 (187)
Q Consensus       147 ~~~~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi~  183 (187)
                       .....+++.|+|||.+.+  ...++.++|+||+|++
T Consensus       172 -~~~~~~t~~y~aPE~~~~--~~~~~~~~DiwslG~i  205 (343)
T cd07878         172 -MTGYVATRWYRAPEIMLN--WMHYNQTVDIWSVGCI  205 (343)
T ss_pred             -cCCccccccccCchHhcC--CccCCchhhhHhHHHH
Confidence             233468899999999873  2457899999999983

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is

>KOG4236|consensus

Probab=99.97  E-value=6.1e-32  Score=211.93  Aligned_cols=151  Identities=29%  Similarity=0.420  Sum_probs=131.5

Q ss_pred             ccccccCceEEEEEEEcCCCcEEEEEEccCccChHHHHHHHHHHHHHHhcCCCCchhhhhhh------------------
Q psy14630         30 GEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQFYGA------------------   91 (187)
Q Consensus        30 ~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~------------------   91 (187)
                      ++||.|-||+||-|+++++|+.||||++.+.+....+.+.++.+..++..++||.||.+-..                  
T Consensus       570 evLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~GDM  649 (888)
T KOG4236|consen  570 EVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHGDM  649 (888)
T ss_pred             hhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcchH
Confidence            78999999999999999999999999998766665667888888888999999999976321                  


Q ss_pred             ---------------HHHHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCC---CCEEEEeccccccccccccccCCCC
Q psy14630         92 ---------------LFKEVTVATVKALNYLKEELKIIHRDVKPSNILLDRR---GAIKLCDFGISGQLVDSIAKTRDAG  153 (187)
Q Consensus        92 ---------------~~~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~---~~~ki~dfg~a~~~~~~~~~~~~~~  153 (187)
                                     ..+-+..||+.||.|||.. +|+|.||||+|+|+...   -.+|+||||.|+++.......+.+|
T Consensus       650 LEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~k-nIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEksFRrsVVG  728 (888)
T KOG4236|consen  650 LEMILSSEKGRLPERITKFLVTQILVALRYLHFK-NIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKSFRRSVVG  728 (888)
T ss_pred             HHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhc-ceeeccCCchheeeccCCCCCceeeccccceeecchhhhhhhhcC
Confidence                           1222667999999999997 99999999999999643   3599999999999988877778899


Q ss_pred             CcCccCccccCCCccCCCCCCcceeeeEe-ee
Q psy14630        154 CRPYMAPERIDPLRARGYPSFKTKLGFKF-NY  184 (187)
Q Consensus       154 t~~y~aPE~~~~~~~~~~~~~~D~ws~gi-~~  184 (187)
                      |+.|+|||++.   +++|...-|.||+|| +|
T Consensus       729 TPAYLaPEVLr---nkGyNrSLDMWSVGVIiY  757 (888)
T KOG4236|consen  729 TPAYLAPEVLR---NKGYNRSLDMWSVGVIIY  757 (888)
T ss_pred             CccccCHHHHh---hccccccccceeeeEEEE
Confidence            99999999999   899999999999999 44

>KOG4717|consensus

Probab=99.97  E-value=1.7e-32  Score=214.56  Aligned_cols=157  Identities=27%  Similarity=0.364  Sum_probs=136.5

Q ss_pred             ccccccccccccCceEEEEEEEcCCCcEEEEEEccCccChHHHHHHHHHHHHHHhcCCCCchhhhhhhH-----------
Q psy14630         24 EDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQFYGAL-----------   92 (187)
Q Consensus        24 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~-----------   92 (187)
                      .=|.+.+.||+|.|.+|.+|++--||..||||++.+...+......+..+...|+..+|||||++|+..           
T Consensus        18 GLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLE   97 (864)
T KOG4717|consen   18 GLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILE   97 (864)
T ss_pred             eeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEE
Confidence            347778999999999999999999999999999987665555566677778899999999999998532           


Q ss_pred             ----------------------HHHHHHHHHHHHHHHHhcCCCeeecCCCCCeEE-cCCCCEEEEecccccccccccccc
Q psy14630         93 ----------------------FKEVTVATVKALNYLKEELKIIHRDVKPSNILL-DRRGAIKLCDFGISGQLVDSIAKT  149 (187)
Q Consensus        93 ----------------------~~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili-~~~~~~ki~dfg~a~~~~~~~~~~  149 (187)
                                            .++.+.||+.|+.|+|+- .++||||||+|+.+ ...|-+|+.|||++-.+.++....
T Consensus        98 LGD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHqL-HVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG~kL~  176 (864)
T KOG4717|consen   98 LGDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQL-HVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPGKKLT  176 (864)
T ss_pred             ecCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhhh-hhhcccCCcceeEEeeecCceEeeeccccccCCCcchhh
Confidence                                  334788999999999996 99999999999976 567899999999999999988888


Q ss_pred             CCCCCcCccCccccCCCccCCCC-CCcceeeeEeee
Q psy14630        150 RDAGCRPYMAPERIDPLRARGYP-SFKTKLGFKFNY  184 (187)
Q Consensus       150 ~~~~t~~y~aPE~~~~~~~~~~~-~~~D~ws~gi~~  184 (187)
                      ..||+..|-|||.+.   ...|+ +++||||+||++
T Consensus       177 TsCGSLAYSAPEILL---GDsYDAPAVDiWSLGVIL  209 (864)
T KOG4717|consen  177 TSCGSLAYSAPEILL---GDSYDAPAVDIWSLGVIL  209 (864)
T ss_pred             cccchhhccCchhhh---cCccCCcchhhhHHHHHH
Confidence            889999999999999   56677 899999999943

>KOG4721|consensus

Probab=99.97  E-value=5.5e-33  Score=219.24  Aligned_cols=160  Identities=28%  Similarity=0.378  Sum_probs=135.4

Q ss_pred             eecCCCccccCCcccccccccccccCceEEEEEEEcCCCcEEEEEEccCccChHHHHHHHHHHHHHHhcCCCCchhhhhh
Q psy14630         11 LKLSPDTVYDFTSEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQFYG   90 (187)
Q Consensus        11 ~~~~~~~~~~~~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~   90 (187)
                      ....-...|+++++....++=||.|+.|-||+|+..  ++.||||.++..         ..-.+..++.+.|+||+.|.|
T Consensus       111 ~k~qq~e~WeiPFe~IsELeWlGSGaQGAVF~Grl~--netVAVKKV~el---------kETdIKHLRkLkH~NII~FkG  179 (904)
T KOG4721|consen  111 HKQQQEELWEIPFEEISELEWLGSGAQGAVFLGRLH--NETVAVKKVREL---------KETDIKHLRKLKHPNIITFKG  179 (904)
T ss_pred             hhhhhhhhccCCHHHhhhhhhhccCcccceeeeecc--CceehhHHHhhh---------hhhhHHHHHhccCcceeeEee
Confidence            334456789999999999999999999999999874  678999976421         111234567789999999887


Q ss_pred             hHHHH--------------------------------HHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEeccc
Q psy14630         91 ALFKE--------------------------------VTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGI  138 (187)
Q Consensus        91 ~~~~~--------------------------------~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg~  138 (187)
                      .|.+.                                +..+|+.|+.|||.. .|+|||||..||||..+..+||+|||.
T Consensus       180 VCtqsPcyCIiMEfCa~GqL~~VLka~~~itp~llv~Wsk~IA~GM~YLH~h-KIIHRDLKSPNiLIs~~d~VKIsDFGT  258 (904)
T KOG4721|consen  180 VCTQSPCYCIIMEFCAQGQLYEVLKAGRPITPSLLVDWSKGIAGGMNYLHLH-KIIHRDLKSPNILISYDDVVKISDFGT  258 (904)
T ss_pred             eecCCceeEEeeeccccccHHHHHhccCccCHHHHHHHHHHhhhhhHHHHHh-hHhhhccCCCceEeeccceEEeccccc
Confidence            65332                                667899999999998 899999999999999999999999999


Q ss_pred             cccccccccccCCCCCcCccCccccCCCccCCCCCCcceeeeEeeee
Q psy14630        139 SGQLVDSIAKTRDAGCRPYMAPERIDPLRARGYPSFKTKLGFKFNYR  185 (187)
Q Consensus       139 a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi~~~  185 (187)
                      ++-+.+....-+++||..|||||+|.   +.+-+.|+|||||||++|
T Consensus       259 S~e~~~~STkMSFaGTVaWMAPEvIr---nePcsEKVDIwSfGVVLW  302 (904)
T KOG4721|consen  259 SKELSDKSTKMSFAGTVAWMAPEVIR---NEPCSEKVDIWSFGVVLW  302 (904)
T ss_pred             hHhhhhhhhhhhhhhhHhhhCHHHhh---cCCcccccceehhHHHHH
Confidence            99887766666789999999999999   888999999999999988

>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

Probab=99.97  E-value=6.9e-32  Score=205.22  Aligned_cols=156  Identities=23%  Similarity=0.441  Sum_probs=126.4

Q ss_pred             ccccccccccccCceEEEEEEEcCCCcEEEEEEccCccChHHHHHHHHHHHHHHhcCCCCchhhhhhhHH----------
Q psy14630         24 EDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQFYGALF----------   93 (187)
Q Consensus        24 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~----------   93 (187)
                      ++|++.+.||+|+||.||+|.+..+++.+|+|.++.........+.+..+..+++.++||||+++++.+.          
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   80 (287)
T cd07848           1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE   80 (287)
T ss_pred             CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence            4688999999999999999999999999999998654333333444555666778889999999875431          


Q ss_pred             ----------------------HHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEeccccccccccc--ccc
Q psy14630         94 ----------------------KEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSI--AKT  149 (187)
Q Consensus        94 ----------------------~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg~a~~~~~~~--~~~  149 (187)
                                            ..+..|++.||.|||+. +++||||||+||+++.++.+||+|||+++......  ...
T Consensus        81 ~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~-~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~  159 (287)
T cd07848          81 YVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKN-DIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYT  159 (287)
T ss_pred             cCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC-CeecCCCCHHHEEEcCCCcEEEeeccCccccccccccccc
Confidence                                  12667899999999997 99999999999999999999999999998764322  122


Q ss_pred             CCCCCcCccCccccCCCccCCCCCCcceeeeEee
Q psy14630        150 RDAGCRPYMAPERIDPLRARGYPSFKTKLGFKFN  183 (187)
Q Consensus       150 ~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi~  183 (187)
                      ...+++.|+|||.+.   +..++.++|+||+|+.
T Consensus       160 ~~~~~~~y~aPE~~~---~~~~~~~~DiwslGvi  190 (287)
T cd07848         160 EYVATRWYRSPELLL---GAPYGKAVDMWSVGCI  190 (287)
T ss_pred             ccccccccCCcHHHc---CCCCCCchhHHhHHHH
Confidence            346889999999998   5568899999999983

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes

>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

Probab=99.97  E-value=3.8e-32  Score=211.02  Aligned_cols=157  Identities=22%  Similarity=0.354  Sum_probs=122.8

Q ss_pred             cccccccccccCceEEEEEEEcCCCcEEEEEEccCccChHHHHHHHHHHHHHHhcCCCCchhhhhhhH------------
Q psy14630         25 DLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQFYGAL------------   92 (187)
Q Consensus        25 ~~~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~------------   92 (187)
                      +|++.+.||+|+||.||+|.+..+++.||+|.+............+..+..+++.++||||+++++.+            
T Consensus         1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~   80 (338)
T cd07859           1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY   80 (338)
T ss_pred             CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence            47889999999999999999999999999999864322222233345556677788999999876422            


Q ss_pred             ------------------------HHHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEeccccccccccc--
Q psy14630         93 ------------------------FKEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSI--  146 (187)
Q Consensus        93 ------------------------~~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg~a~~~~~~~--  146 (187)
                                              ...++.|++.||.|||+. +++||||||+||+++.++.+||+|||+++......  
T Consensus        81 lv~e~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~-~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~  159 (338)
T cd07859          81 VVFELMESDLHQVIKANDDLTPEHHQFFLYQLLRALKYIHTA-NVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPT  159 (338)
T ss_pred             EEEecCCCCHHHHHHhcccCCHHHHHHHHHHHHHHHHHHHHC-CeecCCCCHHHeEECCCCcEEEccCccccccccccCc
Confidence                                    111667899999999998 99999999999999999999999999998653221  


Q ss_pred             --cccCCCCCcCccCccccCCCccCCCCCCcceeeeEee
Q psy14630        147 --AKTRDAGCRPYMAPERIDPLRARGYPSFKTKLGFKFN  183 (187)
Q Consensus       147 --~~~~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi~  183 (187)
                        ......+++.|+|||++.+. ...++.++|+||+|++
T Consensus       160 ~~~~~~~~~t~~y~aPE~~~~~-~~~~~~~~DvwSlGvv  197 (338)
T cd07859         160 AIFWTDYVATRWYRAPELCGSF-FSKYTPAIDIWSIGCI  197 (338)
T ss_pred             cccccCCCCCCCcCCHHHHhcc-ccccCchhHHHHHHHH
Confidence              11234689999999998632 2467899999999993

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos

>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

Probab=99.97  E-value=1.4e-31  Score=207.27  Aligned_cols=150  Identities=29%  Similarity=0.461  Sum_probs=118.9

Q ss_pred             ccccccCceEEEEEEEcCCCcEEEEEEccCcc--ChHHHHHHHHHHHHHHhcCCCCchhhhhhhH---------------
Q psy14630         30 GEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTV--DEKDQRQLLMDLDVVMKSNECPYIVQFYGAL---------------   92 (187)
Q Consensus        30 ~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~---------------   92 (187)
                      +.||+|+||+||+|.+..+++.+|+|++....  ......+.+.++..+++.++||||+++++.+               
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~   80 (325)
T cd05604           1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG   80 (325)
T ss_pred             CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence            46899999999999999999999999986432  1222334455555567778999999886432               


Q ss_pred             -----------------HHHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEeccccccccc-cccccCCCCC
Q psy14630         93 -----------------FKEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVD-SIAKTRDAGC  154 (187)
Q Consensus        93 -----------------~~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg~a~~~~~-~~~~~~~~~t  154 (187)
                                       ...++.|++.||.|||+. +++||||||+||+++.++.+||+|||+++.... ........|+
T Consensus        81 ~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~-givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt  159 (325)
T cd05604          81 GELFFHLQRERSFPEPRARFYAAEIASALGYLHSI-NIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTTTTFCGT  159 (325)
T ss_pred             CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC-CeeecCCCHHHeEECCCCCEEEeecCCcccCCCCCCCcccccCC
Confidence                             112667899999999997 999999999999999999999999999876432 2223344689


Q ss_pred             cCccCccccCCCccCCCCCCcceeeeEee
Q psy14630        155 RPYMAPERIDPLRARGYPSFKTKLGFKFN  183 (187)
Q Consensus       155 ~~y~aPE~~~~~~~~~~~~~~D~ws~gi~  183 (187)
                      +.|+|||.+.   ...++.++|+||+|+.
T Consensus       160 ~~y~aPE~~~---~~~~~~~~DvwslG~i  185 (325)
T cd05604         160 PEYLAPEVIR---KQPYDNTVDWWCLGAV  185 (325)
T ss_pred             hhhCCHHHHc---CCCCCCcCccccccce
Confidence            9999999998   5678899999999994

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,

>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

Probab=99.97  E-value=1.3e-31  Score=207.08  Aligned_cols=152  Identities=28%  Similarity=0.464  Sum_probs=119.4

Q ss_pred             ccccccCceEEEEEEEcCCCcEEEEEEccCcc--ChHHHHHHHHHHHHHHhcCCCCchhhhhhhH---------------
Q psy14630         30 GEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTV--DEKDQRQLLMDLDVVMKSNECPYIVQFYGAL---------------   92 (187)
Q Consensus        30 ~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~---------------   92 (187)
                      +.||+|+||.||+|.+..+++.+|+|++....  ........+.++..+++.++||||+++++.+               
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~   80 (321)
T cd05603           1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG   80 (321)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            46899999999999999999999999986422  1122334455555567788999999886432               


Q ss_pred             -----------------HHHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEeccccccccc-cccccCCCCC
Q psy14630         93 -----------------FKEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVD-SIAKTRDAGC  154 (187)
Q Consensus        93 -----------------~~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg~a~~~~~-~~~~~~~~~t  154 (187)
                                       ...+..|++.||.|||+. +++||||||+||+++.++.+||+|||+++.... ........|+
T Consensus        81 ~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~-~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt  159 (321)
T cd05603          81 GELFFHLQRERCFLEPRARFYAAEVASAIGYLHSL-NIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETTSTFCGT  159 (321)
T ss_pred             CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC-CeEeccCCHHHeEECCCCCEEEccCCCCccCCCCCCccccccCC
Confidence                             111567899999999997 999999999999999999999999999876432 2223344689


Q ss_pred             cCccCccccCCCccCCCCCCcceeeeEe-eee
Q psy14630        155 RPYMAPERIDPLRARGYPSFKTKLGFKF-NYR  185 (187)
Q Consensus       155 ~~y~aPE~~~~~~~~~~~~~~D~ws~gi-~~~  185 (187)
                      +.|+|||.+.   ...++.++|+||+|+ .|+
T Consensus       160 ~~y~aPE~~~---~~~~~~~~DiwslG~il~e  188 (321)
T cd05603         160 PEYLAPEVLR---KEPYDRTVDWWCLGAVLYE  188 (321)
T ss_pred             cccCCHHHhc---CCCCCCcCcccccchhhhh
Confidence            9999999988   567889999999999 443

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.

>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

Probab=99.97  E-value=1.3e-31  Score=207.32  Aligned_cols=152  Identities=29%  Similarity=0.486  Sum_probs=119.2

Q ss_pred             ccccccCceEEEEEEEcCCCcEEEEEEccCcc--ChHHHHHHHHHHHHHHhcCCCCchhhhhhhH---------------
Q psy14630         30 GEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTV--DEKDQRQLLMDLDVVMKSNECPYIVQFYGAL---------------   92 (187)
Q Consensus        30 ~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~---------------   92 (187)
                      +.||+|+||.||+|.+..+++.||+|++....  ......+.+.++..+++.++||||+++++.+               
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~   80 (323)
T cd05575           1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG   80 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence            46899999999999999999999999986421  1122334445555566778999999876422               


Q ss_pred             -----------------HHHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEeccccccccc-cccccCCCCC
Q psy14630         93 -----------------FKEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVD-SIAKTRDAGC  154 (187)
Q Consensus        93 -----------------~~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg~a~~~~~-~~~~~~~~~t  154 (187)
                                       ...+..|++.||.|||+. +++||||||+||+++.++.+||+|||+++.... ........||
T Consensus        81 g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~-givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt  159 (323)
T cd05575          81 GELFFHLQRERSFPEPRARFYAAEIASALGYLHSL-NIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTTSTFCGT  159 (323)
T ss_pred             CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC-CeEeCCCCHHHeEECCCCcEEEeccCCCcccccCCCccccccCC
Confidence                             112567899999999997 999999999999999999999999999876432 2223344689


Q ss_pred             cCccCccccCCCccCCCCCCcceeeeEe-eee
Q psy14630        155 RPYMAPERIDPLRARGYPSFKTKLGFKF-NYR  185 (187)
Q Consensus       155 ~~y~aPE~~~~~~~~~~~~~~D~ws~gi-~~~  185 (187)
                      +.|+|||.+.   ...++.++|+||+|+ +|+
T Consensus       160 ~~y~aPE~~~---~~~~~~~~DvwslG~il~e  188 (323)
T cd05575         160 PEYLAPEVLR---KQPYDRTVDWWCLGAVLYE  188 (323)
T ss_pred             hhhcChhhhc---CCCCCccccccccchhhhh
Confidence            9999999988   567889999999999 443

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr

>PHA03212 serine/threonine kinase US3; Provisional

Probab=99.97  E-value=5.6e-32  Score=214.27  Aligned_cols=151  Identities=23%  Similarity=0.282  Sum_probs=123.1

Q ss_pred             CCcccccccccccccCceEEEEEEEcCCCcEEEEEEccCccChHHHHHHHHHHHHHHhcCCCCchhhhhhhH--------
Q psy14630         21 FTSEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQFYGAL--------   92 (187)
Q Consensus        21 ~~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~--------   92 (187)
                      +...+|++.+.||+|+||.||+|.+..+++.||+|....        ....++..+++.++||||+++++.+        
T Consensus        89 ~~~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~--------~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~l  160 (391)
T PHA03212         89 IEKAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR--------GGTATEAHILRAINHPSIIQLKGTFTYNKFTCL  160 (391)
T ss_pred             cccCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhh--------hhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEE
Confidence            345689999999999999999999999999999996431        1234456677888999999987532        


Q ss_pred             -----------------------HHHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEecccccccccc--cc
Q psy14630         93 -----------------------FKEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDS--IA  147 (187)
Q Consensus        93 -----------------------~~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg~a~~~~~~--~~  147 (187)
                                             ...++.|++.||.|||+. +|+||||||+||+++..+.+||+|||+++.....  ..
T Consensus       161 v~e~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~ylH~~-~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~~~  239 (391)
T PHA03212        161 ILPRYKTDLYCYLAAKRNIAICDILAIERSVLRAIQYLHEN-RIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANK  239 (391)
T ss_pred             EEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC-CcccCCCChHhEEEcCCCCEEEEeCCcccccccccccc
Confidence                                   112667899999999997 9999999999999999999999999999764322  12


Q ss_pred             ccCCCCCcCccCccccCCCccCCCCCCcceeeeEee
Q psy14630        148 KTRDAGCRPYMAPERIDPLRARGYPSFKTKLGFKFN  183 (187)
Q Consensus       148 ~~~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi~  183 (187)
                      .....||+.|+|||++.   ...++.++|+||+|++
T Consensus       240 ~~~~~gt~~y~aPE~~~---~~~~~~~~DiwSlGvi  272 (391)
T PHA03212        240 YYGWAGTIATNAPELLA---RDPYGPAVDIWSAGIV  272 (391)
T ss_pred             cccccCccCCCChhhhc---CCCCCcHHHHHHHHHH
Confidence            22347899999999998   5678999999999983

>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

Probab=99.97  E-value=3.4e-31  Score=205.13  Aligned_cols=151  Identities=25%  Similarity=0.423  Sum_probs=117.3

Q ss_pred             ccccccCceEEEEEEEcCCCcEEEEEEccCccC-hHHHHHHHHHHHHHHhcCCCCchhhhhhhH----------------
Q psy14630         30 GEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVD-EKDQRQLLMDLDVVMKSNECPYIVQFYGAL----------------   92 (187)
Q Consensus        30 ~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~----------------   92 (187)
                      +.||+|+||.||++.+..+++.||+|+++.... ..........+..+++.+.||||+++++.+                
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~   80 (325)
T cd05594           1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG   80 (325)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence            468999999999999999999999999864321 112223334455567778999999875322                


Q ss_pred             ----------------HHHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEeccccccccc-cccccCCCCCc
Q psy14630         93 ----------------FKEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVD-SIAKTRDAGCR  155 (187)
Q Consensus        93 ----------------~~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg~a~~~~~-~~~~~~~~~t~  155 (187)
                                      ...+..|++.||.|||+..+++||||||+||+++.++.+||+|||+++.... ........||+
T Consensus        81 ~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt~  160 (325)
T cd05594          81 ELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTP  160 (325)
T ss_pred             cHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEECCCCCEEEecCCCCeecCCCCcccccccCCc
Confidence                            1125678999999999734999999999999999999999999999876432 22223346899


Q ss_pred             CccCccccCCCccCCCCCCcceeeeEee
Q psy14630        156 PYMAPERIDPLRARGYPSFKTKLGFKFN  183 (187)
Q Consensus       156 ~y~aPE~~~~~~~~~~~~~~D~ws~gi~  183 (187)
                      .|+|||.+.   ...++.++|+||+|++
T Consensus       161 ~y~aPE~~~---~~~~~~~~DiwslG~i  185 (325)
T cd05594         161 EYLAPEVLE---DNDYGRAVDWWGLGVV  185 (325)
T ss_pred             ccCCHHHHc---cCCCCCccccccccce
Confidence            999999998   5678899999999993

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien

>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

Probab=99.97  E-value=1e-31  Score=211.58  Aligned_cols=164  Identities=28%  Similarity=0.387  Sum_probs=128.9

Q ss_pred             ccCCcccccccccccccCceEEEEEEEcCCCcEEEEEEccCcc-ChHHHHHHHHHHHHHHhcCCCCchhhhhhhH-----
Q psy14630         19 YDFTSEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTV-DEKDQRQLLMDLDVVMKSNECPYIVQFYGAL-----   92 (187)
Q Consensus        19 ~~~~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~-----   92 (187)
                      .....++|++.+.||+|+||.||++.+..+++.+|+|.+.... ......+.+.++..+++.++||||+++++.+     
T Consensus        38 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~  117 (370)
T cd05596          38 LRMKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKY  117 (370)
T ss_pred             CCCCHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCE
Confidence            3456789999999999999999999999999999999986421 1222334455666778889999999876432     


Q ss_pred             --------------------------HHHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEeccccccccccc
Q psy14630         93 --------------------------FKEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSI  146 (187)
Q Consensus        93 --------------------------~~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg~a~~~~~~~  146 (187)
                                                ...++.|++.||.|||+. +++||||||+||+++.++.+||+|||++.......
T Consensus       118 ~~lv~Ey~~gg~L~~~l~~~~l~~~~~~~~~~qi~~aL~~LH~~-~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~~~  196 (370)
T cd05596         118 LYMVMEYMPGGDLVNLMSNYDIPEKWARFYTAEVVLALDAIHSM-GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANG  196 (370)
T ss_pred             EEEEEcCCCCCcHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHC-CeeccCCCHHHEEEcCCCCEEEEeccceeeccCCC
Confidence                                      112567899999999997 99999999999999999999999999998764322


Q ss_pred             --cccCCCCCcCccCccccCCCc-cCCCCCCcceeeeEee
Q psy14630        147 --AKTRDAGCRPYMAPERIDPLR-ARGYPSFKTKLGFKFN  183 (187)
Q Consensus       147 --~~~~~~~t~~y~aPE~~~~~~-~~~~~~~~D~ws~gi~  183 (187)
                        ......||+.|+|||++.+.. ...++.++|+||+|+.
T Consensus       197 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvi  236 (370)
T cd05596         197 MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVF  236 (370)
T ss_pred             cccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHH
Confidence              223446899999999987432 2247789999999993

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in

>PTZ00036 glycogen synthase kinase; Provisional

Probab=99.97  E-value=6.3e-32  Score=216.97  Aligned_cols=154  Identities=25%  Similarity=0.341  Sum_probs=121.9

Q ss_pred             CCcccccccccccccCceEEEEEEEcCCCcEEEEEEccCccChHHHHHHHHHHHHHHhcCCCCchhhhhhhH--------
Q psy14630         21 FTSEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQFYGAL--------   92 (187)
Q Consensus        21 ~~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~--------   92 (187)
                      ....+|++.+.||+|+||.||+|.+..+++.||||.+.....      ...++..+++.+.||||+++++.+        
T Consensus        63 ~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~------~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~  136 (440)
T PTZ00036         63 SPNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDPQ------YKNRELLIMKNLNHINIIFLKDYYYTECFKKN  136 (440)
T ss_pred             CcCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCcc------hHHHHHHHHHhcCCCCCcceeeeEeecccccC
Confidence            455689999999999999999999999999999998753211      122355567788999999763311        


Q ss_pred             -----------------------------------HHHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCC-CEEEEec
Q psy14630         93 -----------------------------------FKEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRG-AIKLCDF  136 (187)
Q Consensus        93 -----------------------------------~~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~-~~ki~df  136 (187)
                                                         ...++.|++.||.|||+. +|+||||||+||+++.++ .+||+||
T Consensus       137 ~~~~~l~lvmE~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~-~IiHrDLKp~NILl~~~~~~vkL~DF  215 (440)
T PTZ00036        137 EKNIFLNVVMEFIPQTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSK-FICHRDLKPQNLLIDPNTHTLKLCDF  215 (440)
T ss_pred             CCceEEEEEEecCCccHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHC-CEecCCcCHHHEEEcCCCCceeeecc
Confidence                                               011456899999999997 999999999999998665 6999999


Q ss_pred             cccccccccccccCCCCCcCccCccccCCCccCCCCCCcceeeeEee
Q psy14630        137 GISGQLVDSIAKTRDAGCRPYMAPERIDPLRARGYPSFKTKLGFKFN  183 (187)
Q Consensus       137 g~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi~  183 (187)
                      |+++.+..........+|+.|+|||++.+  ...++.++|+||+|++
T Consensus       216 Gla~~~~~~~~~~~~~~t~~y~aPE~~~~--~~~~~~~~DiwSlGvi  260 (440)
T PTZ00036        216 GSAKNLLAGQRSVSYICSRFYRAPELMLG--ATNYTTHIDLWSLGCI  260 (440)
T ss_pred             ccchhccCCCCcccCCCCcCccCHHHhcC--CCCCCcHHHHHHHHHH
Confidence            99988765444445578999999999873  3458899999999984

>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

Probab=99.97  E-value=6e-32  Score=205.84  Aligned_cols=156  Identities=26%  Similarity=0.440  Sum_probs=119.0

Q ss_pred             ccccccccccccCceEEEEEEEcC-CCcEEEEEEccCccChHH-HHHHHHHHHHH--HhcCCCCchhhhhhhHH------
Q psy14630         24 EDLQDLGEIGRGGFGTVNKMIHRS-SDTVMAVKRIRSTVDEKD-QRQLLMDLDVV--MKSNECPYIVQFYGALF------   93 (187)
Q Consensus        24 ~~~~~~~~lg~G~fg~V~~~~~~~-~~~~vaiK~~~~~~~~~~-~~~~~~~~~~~--~~~~~h~~iv~~~~~~~------   93 (187)
                      ++|++.+.||+|+||.||+|.+.. +++.||+|.++....... ......+...+  +....||||+++++.+.      
T Consensus         1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~   80 (290)
T cd07862           1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR   80 (290)
T ss_pred             CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence            468899999999999999999854 568899998864322211 12222232222  23357999998765321      


Q ss_pred             --------------------------------HHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEecccccc
Q psy14630         94 --------------------------------KEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQ  141 (187)
Q Consensus        94 --------------------------------~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg~a~~  141 (187)
                                                      ..++.|++.||.|||+. +++||||||+||+++.++.+||+|||+++.
T Consensus        81 ~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~-~iiH~dlkp~Nil~~~~~~~kl~Dfg~~~~  159 (290)
T cd07862          81 ETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSH-RVVHRDLKPQNILVTSSGQIKLADFGLARI  159 (290)
T ss_pred             CCcEEEEEccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHC-CeeeCCCCHHHEEEcCCCCEEEccccceEe
Confidence                                            12667899999999997 999999999999999999999999999987


Q ss_pred             ccccccccCCCCCcCccCccccCCCccCCCCCCcceeeeEee
Q psy14630        142 LVDSIAKTRDAGCRPYMAPERIDPLRARGYPSFKTKLGFKFN  183 (187)
Q Consensus       142 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi~  183 (187)
                      ...........+++.|+|||.+.   ...++.++|+||+|+.
T Consensus       160 ~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~DiwslG~i  198 (290)
T cd07862         160 YSFQMALTSVVVTLWYRAPEVLL---QSSYATPVDLWSVGCI  198 (290)
T ss_pred             ccCCcccccccccccccChHHHh---CCCCCCccchHHHHHH
Confidence            65443344456899999999997   5668899999999984

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla

>KOG4279|consensus

Probab=99.97  E-value=9.3e-32  Score=216.48  Aligned_cols=153  Identities=29%  Similarity=0.463  Sum_probs=129.1

Q ss_pred             ccccccCceEEEEEEEcCCCcEEEEEEccCccChHHHHHHHHHHHHHHhcCCCCchhhhhhhHHHH--------------
Q psy14630         30 GEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQFYGALFKE--------------   95 (187)
Q Consensus        30 ~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~--------------   95 (187)
                      -+||+|.||+||-|++..|+.+.|||.+..  .+....+-+.|++.+.+.+.|.|||++.|++-..              
T Consensus       581 vVLGKGTYG~VYA~RD~~tqvrIaIKEIpe--kdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGS  658 (1226)
T KOG4279|consen  581 VVLGKGTYGTVYAARDMDTQVRIAIKEIPE--KDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGS  658 (1226)
T ss_pred             EEeecCceeEEEeeccccceeEEEeeeccc--ccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCc
Confidence            479999999999999999999999999864  2334556788888899999999999998764211              


Q ss_pred             ---------------------HHHHHHHHHHHHHhcCCCeeecCCCCCeEEc-CCCCEEEEeccccccccc-cccccCCC
Q psy14630         96 ---------------------VTVATVKALNYLKEELKIIHRDVKPSNILLD-RRGAIKLCDFGISGQLVD-SIAKTRDA  152 (187)
Q Consensus        96 ---------------------~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~-~~~~~ki~dfg~a~~~~~-~~~~~~~~  152 (187)
                                           ...||++||.|||++ .|+|||||-+|++++ ..|.+||+|||.++.+.. ...+..+.
T Consensus       659 LSsLLrskWGPlKDNEstm~fYtkQILeGLkYLHen-~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAginP~TETFT  737 (1226)
T KOG4279|consen  659 LSSLLRSKWGPLKDNESTMNFYTKQILEGLKYLHEN-KIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINPCTETFT  737 (1226)
T ss_pred             HHHHHHhccCCCccchhHHHHHHHHHHHHhhhhhhc-ceeeccccCCcEEEeeccceEEecccccchhhccCCccccccc
Confidence                                 567999999999998 999999999999996 589999999999988753 33455678


Q ss_pred             CCcCccCccccCCCccCCCCCCcceeeeEe-eeeC
Q psy14630        153 GCRPYMAPERIDPLRARGYPSFKTKLGFKF-NYRI  186 (187)
Q Consensus       153 ~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi-~~~~  186 (187)
                      ||..|||||+|... -.+|..++||||||. +.+|
T Consensus       738 GTLQYMAPEvIDqG-~RGYG~aADIWS~GCT~vEM  771 (1226)
T KOG4279|consen  738 GTLQYMAPEVIDQG-PRGYGKAADIWSFGCTMVEM  771 (1226)
T ss_pred             cchhhhChHhhccC-CcCCCchhhhhhccceeEee
Confidence            99999999999865 567999999999998 5443

>KOG0589|consensus

Probab=99.97  E-value=4.4e-32  Score=211.19  Aligned_cols=160  Identities=26%  Similarity=0.411  Sum_probs=136.1

Q ss_pred             cccccccccccccCceEEEEEEEcCCCcEEEEEEccCccChHHHHHHHHHHHHHHhcCCCCchhhhhhhHHHH-------
Q psy14630         23 SEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQFYGALFKE-------   95 (187)
Q Consensus        23 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~-------   95 (187)
                      .++|..++.+|+|+||.+++++++.....+++|.+.........++....+..+++.+.|||||.+.+.|..+       
T Consensus         3 m~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Iv   82 (426)
T KOG0589|consen    3 MDNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIV   82 (426)
T ss_pred             cchhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEE
Confidence            5789999999999999999999998999999999865443333344445555566679999999998765332       


Q ss_pred             ----------------------------HHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEeccccccccccc-
Q psy14630         96 ----------------------------VTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSI-  146 (187)
Q Consensus        96 ----------------------------~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg~a~~~~~~~-  146 (187)
                                                  ++.|++.|++|||+. +|+|||||+.||++..++.+++.|||+|+.+.+.. 
T Consensus        83 m~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~-~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~~~  161 (426)
T KOG0589|consen   83 MEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHEN-RVLHRDLKCANIFLTKDKKVKLGDFGLAKILNPEDS  161 (426)
T ss_pred             EeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhh-hhhcccchhhhhhccccCceeecchhhhhhcCCchh
Confidence                                        778999999999976 99999999999999999999999999999988765 


Q ss_pred             cccCCCCCcCccCccccCCCccCCCCCCcceeeeEe-eeeC
Q psy14630        147 AKTRDAGCRPYMAPERIDPLRARGYPSFKTKLGFKF-NYRI  186 (187)
Q Consensus       147 ~~~~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi-~~~~  186 (187)
                      ...+..||+.||+||.+.   +.+|..++|+||+|. +|.+
T Consensus       162 ~a~tvvGTp~YmcPEil~---d~pYn~KSDiWsLGC~~yEm  199 (426)
T KOG0589|consen  162 LASTVVGTPYYMCPEILS---DIPYNEKSDIWSLGCCLYEM  199 (426)
T ss_pred             hhheecCCCcccCHHHhC---CCCCCccCcchhhcchHHHH
Confidence            666778999999999999   788999999999998 6654

>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

Probab=99.97  E-value=8.5e-32  Score=204.73  Aligned_cols=155  Identities=26%  Similarity=0.401  Sum_probs=119.5

Q ss_pred             cccccccccccCceEEEEEEEcCCCcEEEEEEccCccChHH-HHHHHHHHHH--HHhcCCCCchhhhhhhHH--------
Q psy14630         25 DLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKD-QRQLLMDLDV--VMKSNECPYIVQFYGALF--------   93 (187)
Q Consensus        25 ~~~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~-~~~~~~~~~~--~~~~~~h~~iv~~~~~~~--------   93 (187)
                      +|++.+.||+|+||.||+|.+..+++.||+|.++....... ......+...  .+....||||+++++.+.        
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~   80 (288)
T cd07863           1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET   80 (288)
T ss_pred             CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence            47888999999999999999999999999999864321111 1112222222  223357999998764321        


Q ss_pred             ------------------------------HHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEecccccccc
Q psy14630         94 ------------------------------KEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLV  143 (187)
Q Consensus        94 ------------------------------~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg~a~~~~  143 (187)
                                                    ..++.|++.|+.|||+. +++||||||+||+++.++.+||+|||+++...
T Consensus        81 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~-~ivH~dikp~Nili~~~~~~kl~dfg~~~~~~  159 (288)
T cd07863          81 KVTLVFEHVDQDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHAN-CIVHRDLKPENILVTSGGQVKLADFGLARIYS  159 (288)
T ss_pred             eEEEEEcccccCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC-CeecCCCCHHHEEECCCCCEEECccCcccccc
Confidence                                          11567899999999997 99999999999999999999999999998765


Q ss_pred             ccccccCCCCCcCccCccccCCCccCCCCCCcceeeeEee
Q psy14630        144 DSIAKTRDAGCRPYMAPERIDPLRARGYPSFKTKLGFKFN  183 (187)
Q Consensus       144 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi~  183 (187)
                      .........++..|+|||++.   ...++.++|+||+|+.
T Consensus       160 ~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~DiwslG~~  196 (288)
T cd07863         160 CQMALTPVVVTLWYRAPEVLL---QSTYATPVDMWSVGCI  196 (288)
T ss_pred             CcccCCCccccccccCchHhh---CCCCCCcchhhhHHHH
Confidence            444444456788999999998   5668999999999983

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou

>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

Probab=99.97  E-value=1.7e-31  Score=206.80  Aligned_cols=150  Identities=27%  Similarity=0.471  Sum_probs=118.2

Q ss_pred             ccccccCceEEEEEEEcCCCcEEEEEEccCcc--ChHHHHHHHHHHHHHHhcCCCCchhhhhhhH---------------
Q psy14630         30 GEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTV--DEKDQRQLLMDLDVVMKSNECPYIVQFYGAL---------------   92 (187)
Q Consensus        30 ~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~---------------   92 (187)
                      +.||+|+||.||+|.+..+++.+|+|++....  ........+.++..+++.+.||||+++++.+               
T Consensus         1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~   80 (325)
T cd05602           1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING   80 (325)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence            46899999999999999999999999986422  1122234445555566778999999876432               


Q ss_pred             -----------------HHHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEeccccccccc-cccccCCCCC
Q psy14630         93 -----------------FKEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVD-SIAKTRDAGC  154 (187)
Q Consensus        93 -----------------~~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg~a~~~~~-~~~~~~~~~t  154 (187)
                                       ...+..|++.||.|||+. +++||||||+||+++.++.++|+|||+++.... ........||
T Consensus        81 ~~L~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~-giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~~~~~~~~gt  159 (325)
T cd05602          81 GELFYHLQRERCFLEPRARFYAAEIASALGYLHSL-NIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTSTFCGT  159 (325)
T ss_pred             CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC-CeEecCCCHHHeEECCCCCEEEccCCCCcccccCCCCcccccCC
Confidence                             111567899999999997 999999999999999999999999999876432 2223345689


Q ss_pred             cCccCccccCCCccCCCCCCcceeeeEee
Q psy14630        155 RPYMAPERIDPLRARGYPSFKTKLGFKFN  183 (187)
Q Consensus       155 ~~y~aPE~~~~~~~~~~~~~~D~ws~gi~  183 (187)
                      +.|+|||.+.   ...++.++|+||+|+.
T Consensus       160 ~~y~aPE~~~---~~~~~~~~DiwslG~i  185 (325)
T cd05602         160 PEYLAPEVLH---KQPYDRTVDWWCLGAV  185 (325)
T ss_pred             ccccCHHHHc---CCCCCCccccccccHH
Confidence            9999999998   5678899999999993

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt

>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

Probab=99.97  E-value=5.7e-32  Score=207.46  Aligned_cols=157  Identities=22%  Similarity=0.360  Sum_probs=123.5

Q ss_pred             cccccccccccccCceEEEEEEEcCCCcEEEEEEccCccChHHHHHHHHHHHHHHhcCCCCchhhhhhhH----------
Q psy14630         23 SEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQFYGAL----------   92 (187)
Q Consensus        23 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~----------   92 (187)
                      .++|++.+.||+|+||.||+|.+..+++.+|+|.++....... .....++..+++.++||||+++++.+          
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~-~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~   82 (303)
T cd07869           4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGT-PFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVF   82 (303)
T ss_pred             cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEecccccccc-chhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEE
Confidence            4789999999999999999999998999999999864332221 22334455567788999999876432          


Q ss_pred             ----------------------HHHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEecccccccccc-cccc
Q psy14630         93 ----------------------FKEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDS-IAKT  149 (187)
Q Consensus        93 ----------------------~~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg~a~~~~~~-~~~~  149 (187)
                                            ...++.|++.||+|||+. +++||||||+||+++.++.+||+|||+++..... ....
T Consensus        83 e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~-~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~  161 (303)
T cd07869          83 EYVHTDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQR-YILHRDLKPQNLLISDTGELKLADFGLARAKSVPSHTYS  161 (303)
T ss_pred             ECCCcCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHC-CeecCCCCHHHEEECCCCCEEECCCCcceeccCCCccCC
Confidence                                  112667899999999997 9999999999999999999999999998764322 2223


Q ss_pred             CCCCCcCccCccccCCCccCCCCCCcceeeeEee
Q psy14630        150 RDAGCRPYMAPERIDPLRARGYPSFKTKLGFKFN  183 (187)
Q Consensus       150 ~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi~  183 (187)
                      ...+++.|+|||.+.+  ...++.++|+||+|+.
T Consensus       162 ~~~~~~~y~aPE~~~~--~~~~~~~~DiwslG~i  193 (303)
T cd07869         162 NEVVTLWYRPPDVLLG--STEYSTCLDMWGVGCI  193 (303)
T ss_pred             CCcccCCCCChHHHcC--CCCCCcHHHHHHHHHH
Confidence            3467889999999873  3457889999999983

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an

>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

Probab=99.97  E-value=2.5e-31  Score=206.20  Aligned_cols=150  Identities=27%  Similarity=0.430  Sum_probs=118.2

Q ss_pred             ccccccCceEEEEEEEcCCCcEEEEEEccCcc-ChHHHHHHHHHHHHHHhcCCCCchhhhhhhH----------------
Q psy14630         30 GEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTV-DEKDQRQLLMDLDVVMKSNECPYIVQFYGAL----------------   92 (187)
Q Consensus        30 ~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~----------------   92 (187)
                      +.||+|+||.||++.+..+++.||+|++.... ........+..+..+++.+.||||+++++.+                
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g   80 (328)
T cd05593           1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG   80 (328)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence            36899999999999999999999999986432 1122233444555677888999999875322                


Q ss_pred             ----------------HHHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEeccccccccc-cccccCCCCCc
Q psy14630         93 ----------------FKEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVD-SIAKTRDAGCR  155 (187)
Q Consensus        93 ----------------~~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg~a~~~~~-~~~~~~~~~t~  155 (187)
                                      ...+..|++.||.|||+. +++||||||+||+++.++.+||+|||+++.... ........||+
T Consensus        81 ~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~-~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~  159 (328)
T cd05593          81 ELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSG-KIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKTFCGTP  159 (328)
T ss_pred             CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC-CeEecccCHHHeEECCCCcEEEecCcCCccCCCcccccccccCCc
Confidence                            112667899999999997 999999999999999999999999999876432 22223346899


Q ss_pred             CccCccccCCCccCCCCCCcceeeeEee
Q psy14630        156 PYMAPERIDPLRARGYPSFKTKLGFKFN  183 (187)
Q Consensus       156 ~y~aPE~~~~~~~~~~~~~~D~ws~gi~  183 (187)
                      .|+|||.+.   ...++.++|+||+|++
T Consensus       160 ~y~aPE~~~---~~~~~~~~DiwslGvi  184 (328)
T cd05593         160 EYLAPEVLE---DNDYGRAVDWWGLGVV  184 (328)
T ss_pred             CccChhhhc---CCCCCccCCccccchH
Confidence            999999998   5678899999999994

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate

>PLN00034 mitogen-activated protein kinase kinase; Provisional

Probab=99.97  E-value=3e-31  Score=207.62  Aligned_cols=161  Identities=26%  Similarity=0.436  Sum_probs=126.8

Q ss_pred             CCcccccccccccccCceEEEEEEEcCCCcEEEEEEccCccChHHHHHHHHHHHHHHhcCCCCchhhhhhhH--------
Q psy14630         21 FTSEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQFYGAL--------   92 (187)
Q Consensus        21 ~~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~--------   92 (187)
                      ...++|+..+.||+|+||.||+|.+..+++.||+|++..... ....+.+.++..+++.++|+||+++++.+        
T Consensus        71 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l  149 (353)
T PLN00034         71 KSLSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHE-DTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQV  149 (353)
T ss_pred             CCHHHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCc-HHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEE
Confidence            346788999999999999999999999999999999864332 23344556666678888999999887532        


Q ss_pred             --------------------HHHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEeccccccccccc-cccCC
Q psy14630         93 --------------------FKEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSI-AKTRD  151 (187)
Q Consensus        93 --------------------~~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg~a~~~~~~~-~~~~~  151 (187)
                                          ...++.|++.||.|||+. +++||||||+||+++.++.+||+|||+++...... .....
T Consensus       150 v~e~~~~~~L~~~~~~~~~~~~~i~~qi~~aL~~LH~~-~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~~~  228 (353)
T PLN00034        150 LLEFMDGGSLEGTHIADEQFLADVARQILSGIAYLHRR-HIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNSS  228 (353)
T ss_pred             EEecCCCCcccccccCCHHHHHHHHHHHHHHHHHHHHC-CEeecCCCHHHEEEcCCCCEEEcccccceeccccccccccc
Confidence                                123778999999999997 99999999999999999999999999998765332 22344


Q ss_pred             CCCcCccCccccCCCcc--CCCCCCcceeeeEee
Q psy14630        152 AGCRPYMAPERIDPLRA--RGYPSFKTKLGFKFN  183 (187)
Q Consensus       152 ~~t~~y~aPE~~~~~~~--~~~~~~~D~ws~gi~  183 (187)
                      .||..|+|||.+.....  .....++||||||++
T Consensus       229 ~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvi  262 (353)
T PLN00034        229 VGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVS  262 (353)
T ss_pred             ccCccccCccccccccccCcCCCcchhHHHHHHH
Confidence            78999999999853211  123468999999994

>KOG1035|consensus

Probab=99.97  E-value=7.5e-32  Score=226.73  Aligned_cols=160  Identities=27%  Similarity=0.479  Sum_probs=130.7

Q ss_pred             cccccccccccccCceEEEEEEEcCCCcEEEEEEccCccChHHHHHHHHHHHHHHhcCCCCchhhhhhhHHHH-------
Q psy14630         23 SEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQFYGALFKE-------   95 (187)
Q Consensus        23 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~-------   95 (187)
                      ..+|..++.||+|+||.||+++++-.|+.||||.+.... .......+.++..++..++|||||++|.++...       
T Consensus       478 ~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~-s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~  556 (1351)
T KOG1035|consen  478 LNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKA-SDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVL  556 (1351)
T ss_pred             hhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCch-HHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccccc
Confidence            457888899999999999999999999999999997655 333444445555567778999999999655322       


Q ss_pred             --------------------------------------------------------------------------------
Q psy14630         96 --------------------------------------------------------------------------------   95 (187)
Q Consensus        96 --------------------------------------------------------------------------------   95 (187)
                                                                                                      
T Consensus       557 ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~  636 (1351)
T KOG1035|consen  557 EIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDS  636 (1351)
T ss_pred             cccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCccccccccccccccccccc
Confidence                                                                                            


Q ss_pred             -----------------------------------------------------------------HHHHHHHHHHHHHhc
Q psy14630         96 -----------------------------------------------------------------VTVATVKALNYLKEE  110 (187)
Q Consensus        96 -----------------------------------------------------------------~~~~~~~~l~~lh~~  110 (187)
                                                                                       ++.+|++|+.|+|++
T Consensus       637 e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaYIH~~  716 (1351)
T KOG1035|consen  637 EGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAYIHDQ  716 (1351)
T ss_pred             CCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHHHHhC
Confidence                                                                             677899999999998


Q ss_pred             CCCeeecCCCCCeEEcCCCCEEEEecccccccc-------------------ccccccCCCCCcCccCccccCCCccCCC
Q psy14630        111 LKIIHRDVKPSNILLDRRGAIKLCDFGISGQLV-------------------DSIAKTRDAGCRPYMAPERIDPLRARGY  171 (187)
Q Consensus       111 ~~i~Hrdlk~~nili~~~~~~ki~dfg~a~~~~-------------------~~~~~~~~~~t~~y~aPE~~~~~~~~~~  171 (187)
                       |++||||||.||+++.++.+||.|||+|....                   +....+..+||..|+|||++.+.....|
T Consensus       717 -giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~~Y  795 (1351)
T KOG1035|consen  717 -GIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSNKY  795 (1351)
T ss_pred             -ceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccccccc
Confidence             99999999999999999999999999998721                   0113345679999999999986544469


Q ss_pred             CCCcceeeeEeee
Q psy14630        172 PSFKTKLGFKFNY  184 (187)
Q Consensus       172 ~~~~D~ws~gi~~  184 (187)
                      +.|+|+||+||++
T Consensus       796 n~KiDmYSLGIVl  808 (1351)
T KOG1035|consen  796 NSKIDMYSLGIVL  808 (1351)
T ss_pred             cchhhhHHHHHHH
Confidence            9999999999943

>KOG0577|consensus

Probab=99.97  E-value=2.5e-31  Score=210.68  Aligned_cols=155  Identities=27%  Similarity=0.470  Sum_probs=127.4

Q ss_pred             ccccccccccccCceEEEEEEEcCCCcEEEEEEccCcc--ChHHHHHHHHHHHHHHhcCCCCchhhhhhhHHHH------
Q psy14630         24 EDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTV--DEKDQRQLLMDLDVVMKSNECPYIVQFYGALFKE------   95 (187)
Q Consensus        24 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~------   95 (187)
                      .-|..++.||.|+||-||-+++..+.+.||||.+.-..  ......+++.++. .+..+.|||.+.+-+.+..+      
T Consensus        26 klf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVr-FL~~l~HPntieYkgCyLre~TaWLV  104 (948)
T KOG0577|consen   26 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVR-FLRQLRHPNTIEYKGCYLREHTAWLV  104 (948)
T ss_pred             HHHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHH-HHHhccCCCcccccceeeccchHHHH
Confidence            34778899999999999999999999999999885332  2222345555554 56778999999886544322      


Q ss_pred             --------------------------HHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEecccccccccccccc
Q psy14630         96 --------------------------VTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKT  149 (187)
Q Consensus        96 --------------------------~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg~a~~~~~~~~~~  149 (187)
                                                +..+.+.||+|||+. +.+|||||.-|||+...|.+|+.|||.|....+   ..
T Consensus       105 MEYClGSAsDlleVhkKplqEvEIAAi~~gaL~gLaYLHS~-~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~P---An  180 (948)
T KOG0577|consen  105 MEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSH-NRIHRDIKAGNILLSEPGLVKLADFGSASIMAP---AN  180 (948)
T ss_pred             HHHHhccHHHHHHHHhccchHHHHHHHHHHHHHHHHHHHHh-hHHhhhccccceEecCCCeeeeccccchhhcCc---hh
Confidence                                      556778999999997 999999999999999999999999999987654   33


Q ss_pred             CCCCCcCccCccccCCCccCCCCCCcceeeeEee
Q psy14630        150 RDAGCRPYMAPERIDPLRARGYPSFKTKLGFKFN  183 (187)
Q Consensus       150 ~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi~  183 (187)
                      +++|||+|||||+|..+-...|+-++||||+||.
T Consensus       181 sFvGTPywMAPEVILAMDEGqYdgkvDvWSLGIT  214 (948)
T KOG0577|consen  181 SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGIT  214 (948)
T ss_pred             cccCCccccchhHheeccccccCCccceeeccch
Confidence            5689999999999988877889999999999993

>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

Probab=99.97  E-value=1.6e-31  Score=206.74  Aligned_cols=155  Identities=26%  Similarity=0.395  Sum_probs=119.5

Q ss_pred             cccccccccccCceEEEEEEEcCCCcEEEEEEccCccC--hHHHHHHHHHHHHHHhcCCCCchhhhhhhH----------
Q psy14630         25 DLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVD--EKDQRQLLMDLDVVMKSNECPYIVQFYGAL----------   92 (187)
Q Consensus        25 ~~~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~----------   92 (187)
                      +|++.+.||+|+||.||+|.+..+++.||+|.++....  .........+...+....+|++|+.+++.+          
T Consensus         1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (323)
T cd05616           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM   80 (323)
T ss_pred             CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence            57889999999999999999999999999999864321  112223333444444445688887665321          


Q ss_pred             ----------------------HHHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEeccccccccc-ccccc
Q psy14630         93 ----------------------FKEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVD-SIAKT  149 (187)
Q Consensus        93 ----------------------~~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg~a~~~~~-~~~~~  149 (187)
                                            ...++.|++.||.|||+. +++||||||+||+++.++.+||+|||+++.... .....
T Consensus        81 E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~-~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~~~~~~  159 (323)
T cd05616          81 EYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSK-GIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVTTK  159 (323)
T ss_pred             cCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC-CEEecCCCHHHeEECCCCcEEEccCCCceecCCCCCccc
Confidence                                  112667899999999997 999999999999999999999999999876432 22333


Q ss_pred             CCCCCcCccCccccCCCccCCCCCCcceeeeEee
Q psy14630        150 RDAGCRPYMAPERIDPLRARGYPSFKTKLGFKFN  183 (187)
Q Consensus       150 ~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi~  183 (187)
                      ...||+.|+|||++.   ...++.++|+||+|+.
T Consensus       160 ~~~gt~~y~aPE~~~---~~~~~~~~DiwSlGvi  190 (323)
T cd05616         160 TFCGTPDYIAPEIIA---YQPYGKSVDWWAFGVL  190 (323)
T ss_pred             cCCCChhhcCHHHhc---CCCCCCccchhchhHH
Confidence            457899999999998   6678999999999993

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and

>KOG1187|consensus

Probab=99.97  E-value=2e-31  Score=207.96  Aligned_cols=155  Identities=30%  Similarity=0.482  Sum_probs=121.9

Q ss_pred             ccccccccccccCceEEEEEEEcCCCcEEEEEEccCccChHHHHHHHHHHHHHHhcCCCCchhhhhhhHHH---------
Q psy14630         24 EDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQFYGALFK---------   94 (187)
Q Consensus        24 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~---------   94 (187)
                      ++|.-...||+|+||.||+|.... ++.||||.+....... ..+ +..+..++..++|||+|+++|+|..         
T Consensus        75 ~~Fs~~~~ig~Ggfg~VYkG~l~~-~~~vAVK~~~~~~~~~-~~e-F~~Ei~~ls~l~H~Nlv~LlGyC~e~~~~~~LVY  151 (361)
T KOG1187|consen   75 NNFSESNLIGEGGFGTVYKGVLSD-GTVVAVKRLSSNSGQG-ERE-FLNEVEILSRLRHPNLVKLLGYCLEGGEHRLLVY  151 (361)
T ss_pred             hCCchhcceecCCCeEEEEEEECC-CCEEEEEEecCCCCcc-hhH-HHHHHHHHhcCCCcCcccEEEEEecCCceEEEEE
Confidence            456666899999999999998854 4889999876433321 233 5666666777889999999875531         


Q ss_pred             --------------------------HHHHHHHHHHHHHHhcC--CCeeecCCCCCeEEcCCCCEEEEeccccccccc-c
Q psy14630         95 --------------------------EVTVATVKALNYLKEEL--KIIHRDVKPSNILLDRRGAIKLCDFGISGQLVD-S  145 (187)
Q Consensus        95 --------------------------~~~~~~~~~l~~lh~~~--~i~Hrdlk~~nili~~~~~~ki~dfg~a~~~~~-~  145 (187)
                                                +++.+++.||+|||+.+  .|+|||||++|||+|.++.+||+|||+|+.... .
T Consensus       152 Eym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsDFGLa~~~~~~~  231 (361)
T KOG1187|consen  152 EYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSDFGLAKLGPEGD  231 (361)
T ss_pred             EccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccCccCcccCCccc
Confidence                                      27788999999999975  499999999999999999999999999966543 2


Q ss_pred             ccccCC-CCCcCccCccccCCCccCCCCCCcceeeeEeee
Q psy14630        146 IAKTRD-AGCRPYMAPERIDPLRARGYPSFKTKLGFKFNY  184 (187)
Q Consensus       146 ~~~~~~-~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi~~  184 (187)
                      ...... .||..|+|||.+.   ....+.++|||||||++
T Consensus       232 ~~~~~~~~gt~gY~~PEy~~---~g~lt~KsDVySFGVvl  268 (361)
T KOG1187|consen  232 TSVSTTVMGTFGYLAPEYAS---TGKLTEKSDVYSFGVVL  268 (361)
T ss_pred             cceeeecCCCCccCChhhhc---cCCcCcccccccchHHH
Confidence            222222 7899999999998   55688999999999954

>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

Probab=99.97  E-value=2.5e-31  Score=204.83  Aligned_cols=148  Identities=30%  Similarity=0.470  Sum_probs=116.9

Q ss_pred             ccccCceEEEEEEEcCCCcEEEEEEccCcc-ChHHHHHHHHHHHHHHhcCCCCchhhhhhhHH-----------------
Q psy14630         32 IGRGGFGTVNKMIHRSSDTVMAVKRIRSTV-DEKDQRQLLMDLDVVMKSNECPYIVQFYGALF-----------------   93 (187)
Q Consensus        32 lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~-----------------   93 (187)
                      ||+|+||.||+|.+..+++.||+|.++... ........+..+..+++.++||||+++++.+.                 
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L   80 (312)
T cd05585           1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL   80 (312)
T ss_pred             CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence            699999999999999999999999986421 11222334445555677789999998764321                 


Q ss_pred             ---------------HHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEecccccccccc-ccccCCCCCcCc
Q psy14630         94 ---------------KEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDS-IAKTRDAGCRPY  157 (187)
Q Consensus        94 ---------------~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg~a~~~~~~-~~~~~~~~t~~y  157 (187)
                                     ..++.|++.||.|||+. +++||||||+||+++.++.++|+|||+++..... .......||+.|
T Consensus        81 ~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~-~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y  159 (312)
T cd05585          81 FHHLQREGRFDLSRARFYTAELLCALENLHKF-NVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNTFCGTPEY  159 (312)
T ss_pred             HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC-CeEeCCCCHHHeEECCCCcEEEEECcccccCccCCCccccccCCccc
Confidence                           11567899999999997 9999999999999999999999999998864322 223345689999


Q ss_pred             cCccccCCCccCCCCCCcceeeeEee
Q psy14630        158 MAPERIDPLRARGYPSFKTKLGFKFN  183 (187)
Q Consensus       158 ~aPE~~~~~~~~~~~~~~D~ws~gi~  183 (187)
                      +|||.+.   ...++.++|+||+|++
T Consensus       160 ~aPE~~~---~~~~~~~~DvwslGvi  182 (312)
T cd05585         160 LAPELLL---GHGYTKAVDWWTLGVL  182 (312)
T ss_pred             CCHHHHc---CCCCCCccceechhHH
Confidence            9999998   5678999999999993

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl

>KOG1026|consensus

Probab=99.97  E-value=2.3e-32  Score=223.46  Aligned_cols=164  Identities=21%  Similarity=0.321  Sum_probs=135.8

Q ss_pred             ccccCCcccccccccccccCceEEEEEEEc-----CCCcEEEEEEccCccChHHHHHHHHHHHHHHhcCCCCchhhhhhh
Q psy14630         17 TVYDFTSEDLQDLGEIGRGGFGTVNKMIHR-----SSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQFYGA   91 (187)
Q Consensus        17 ~~~~~~~~~~~~~~~lg~G~fg~V~~~~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~   91 (187)
                      .+-++++.+..+.+.||+|+||+||+|...     +..+.||||.++...+.+ ...-++++..++..++|||||+++|.
T Consensus       479 ~~~~i~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~-~~~dF~REaeLla~l~H~nIVrLlGV  557 (774)
T KOG1026|consen  479 KVLEIPRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQ-ARQDFRREAELLAELQHPNIVRLLGV  557 (774)
T ss_pred             ceeEechhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHH-HHHHHHHHHHHHHhccCCCeEEEEEE
Confidence            444778888899999999999999998743     345779999998643333 45567777888999999999999875


Q ss_pred             HHHH----------------------------------------------HHHHHHHHHHHHHhcCCCeeecCCCCCeEE
Q psy14630         92 LFKE----------------------------------------------VTVATVKALNYLKEELKIIHRDVKPSNILL  125 (187)
Q Consensus        92 ~~~~----------------------------------------------~~~~~~~~l~~lh~~~~i~Hrdlk~~nili  125 (187)
                      +..+                                              ++.||+.|+.||.++ .++||||..+|+|+
T Consensus       558 C~~~~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~-~FVHRDLATRNCLV  636 (774)
T KOG1026|consen  558 CREGDPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSH-HFVHRDLATRNCLV  636 (774)
T ss_pred             EccCCeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC-cccccchhhhhcee
Confidence            4222                                              778999999999987 99999999999999


Q ss_pred             cCCCCEEEEeccccccccccccccCC---CCCcCccCccccCCCccCCCCCCcceeeeEeeee
Q psy14630        126 DRRGAIKLCDFGISGQLVDSIAKTRD---AGCRPYMAPERIDPLRARGYPSFKTKLGFKFNYR  185 (187)
Q Consensus       126 ~~~~~~ki~dfg~a~~~~~~~~~~~~---~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi~~~  185 (187)
                      .+...+||+|||+++..-.+......   .-..+||+||.|.   ...++.++|||||||++|
T Consensus       637 ge~l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIl---y~kFTteSDVWs~GVvLW  696 (774)
T KOG1026|consen  637 GENLVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESIL---YGKFTTESDVWSFGVVLW  696 (774)
T ss_pred             ccceEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhh---cCcccchhhhhhhhhhhh
Confidence            99999999999999987665444432   2246799999999   778999999999999988

>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

Probab=99.97  E-value=4.3e-31  Score=205.12  Aligned_cols=160  Identities=23%  Similarity=0.389  Sum_probs=123.9

Q ss_pred             ccccccccccccCceEEEEEEEcCCCcEEEEEEccCcc-ChHHHHHHHHHHHHHHhcCCCCchhhhhhhH----------
Q psy14630         24 EDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTV-DEKDQRQLLMDLDVVMKSNECPYIVQFYGAL----------   92 (187)
Q Consensus        24 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~----------   92 (187)
                      ++|++.+.||+|+||.||++.+..+++.||+|.+.... ........+.++..++....|+||+.+++.+          
T Consensus         1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~   80 (331)
T cd05624           1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM   80 (331)
T ss_pred             CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence            47899999999999999999999999999999986421 1222334456666777788999998765321          


Q ss_pred             -----------------------HHHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEecccccccccccc--
Q psy14630         93 -----------------------FKEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIA--  147 (187)
Q Consensus        93 -----------------------~~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg~a~~~~~~~~--  147 (187)
                                             ...++.|++.||.|||+. +++||||||+||+++.++.+||+|||+++.......  
T Consensus        81 Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~~-~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~  159 (331)
T cd05624          81 DYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQL-HYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQ  159 (331)
T ss_pred             eCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC-CeeeccCchHHEEEcCCCCEEEEeccceeeccCCCcee
Confidence                                   111567899999999997 999999999999999999999999999987643322  


Q ss_pred             ccCCCCCcCccCccccCCCcc--CCCCCCcceeeeEeee
Q psy14630        148 KTRDAGCRPYMAPERIDPLRA--RGYPSFKTKLGFKFNY  184 (187)
Q Consensus       148 ~~~~~~t~~y~aPE~~~~~~~--~~~~~~~D~ws~gi~~  184 (187)
                      .....|++.|+|||.+.+...  ..++.++|+||+|+++
T Consensus       160 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil  198 (331)
T cd05624         160 SSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCM  198 (331)
T ss_pred             eccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhh
Confidence            123468999999999873211  3467899999999943

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.

>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

Probab=99.97  E-value=2.4e-31  Score=205.84  Aligned_cols=150  Identities=25%  Similarity=0.422  Sum_probs=118.3

Q ss_pred             ccccccCceEEEEEEEcCCCcEEEEEEccCccC-hHHHHHHHHHHHHHHhcCCCCchhhhhhhHH---------------
Q psy14630         30 GEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVD-EKDQRQLLMDLDVVMKSNECPYIVQFYGALF---------------   93 (187)
Q Consensus        30 ~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~---------------   93 (187)
                      +.||+|+||.||++.+..++..||+|.++.... .......+.++..+++.+.||||+++++.+.               
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~   80 (323)
T cd05595           1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG   80 (323)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence            468999999999999999999999999864321 1122233445556777889999998764321               


Q ss_pred             -----------------HHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEeccccccccc-cccccCCCCCc
Q psy14630         94 -----------------KEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVD-SIAKTRDAGCR  155 (187)
Q Consensus        94 -----------------~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg~a~~~~~-~~~~~~~~~t~  155 (187)
                                       ..+..|++.||.|||+. +++||||||+||+++.++.+||+|||+++.... ........|++
T Consensus        81 ~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~-~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt~  159 (323)
T cd05595          81 ELFFHLSRERVFTEERARFYGAEIVSALEYLHSR-DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTP  159 (323)
T ss_pred             cHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC-CeEecCCCHHHEEEcCCCCEEecccHHhccccCCCCccccccCCc
Confidence                             12667899999999997 999999999999999999999999999876432 22223346899


Q ss_pred             CccCccccCCCccCCCCCCcceeeeEee
Q psy14630        156 PYMAPERIDPLRARGYPSFKTKLGFKFN  183 (187)
Q Consensus       156 ~y~aPE~~~~~~~~~~~~~~D~ws~gi~  183 (187)
                      .|+|||.+.   ...++.++|+||+|+.
T Consensus       160 ~y~aPE~~~---~~~~~~~~DiwSlGvi  184 (323)
T cd05595         160 EYLAPEVLE---DNDYGRAVDWWGLGVV  184 (323)
T ss_pred             CcCCccccc---CCCCCchhchhhhHHH
Confidence            999999998   5678899999999993

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in

>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

Probab=99.97  E-value=1e-31  Score=204.71  Aligned_cols=158  Identities=23%  Similarity=0.356  Sum_probs=124.1

Q ss_pred             CcccccccccccccCceEEEEEEEcCCCcEEEEEEccCccChHHHHHHHHHHHHHHhcCCCCchhhhhhhHH--------
Q psy14630         22 TSEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQFYGALF--------   93 (187)
Q Consensus        22 ~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~--------   93 (187)
                      ..++|++.+.||+|+||.||+|.+..+++.||+|.++...... ......++..+++.++||||+++++.+.        
T Consensus         3 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv   81 (288)
T cd07871           3 KLETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEG-APCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLV   81 (288)
T ss_pred             ccccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCC-cchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEE
Confidence            3567999999999999999999999999999999986432221 1223344556777889999998864321        


Q ss_pred             ------------------------HHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEecccccccccc-ccc
Q psy14630         94 ------------------------KEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDS-IAK  148 (187)
Q Consensus        94 ------------------------~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg~a~~~~~~-~~~  148 (187)
                                              ..+..|++.||+|||+. +++||||||+||+++.++.+||+|||+++..... ...
T Consensus        82 ~e~~~~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~-~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~~~~  160 (288)
T cd07871          82 FEYLDSDLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKR-KILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTY  160 (288)
T ss_pred             EeCCCcCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC-CcccCCCCHHHEEECCCCCEEECcCcceeeccCCCccc
Confidence                                    11567899999999997 9999999999999999999999999998765322 122


Q ss_pred             cCCCCCcCccCccccCCCccCCCCCCcceeeeEee
Q psy14630        149 TRDAGCRPYMAPERIDPLRARGYPSFKTKLGFKFN  183 (187)
Q Consensus       149 ~~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi~  183 (187)
                      ....+++.|+|||.+.+  ...++.++|+||+|++
T Consensus       161 ~~~~~~~~y~aPE~~~~--~~~~~~~~DiwslG~~  193 (288)
T cd07871         161 SNEVVTLWYRPPDVLLG--STEYSTPIDMWGVGCI  193 (288)
T ss_pred             cCceecccccChHHhcC--CcccCcHHHHHHHHHH
Confidence            33467889999999873  3457899999999983

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament

>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

Probab=99.97  E-value=7.4e-31  Score=203.55  Aligned_cols=161  Identities=25%  Similarity=0.423  Sum_probs=126.3

Q ss_pred             ccccccccccccCceEEEEEEEcCCCcEEEEEEccCccC-hHHHHHHHHHHHHHHhcCCCCchhhhhhhH----------
Q psy14630         24 EDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVD-EKDQRQLLMDLDVVMKSNECPYIVQFYGAL----------   92 (187)
Q Consensus        24 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~----------   92 (187)
                      ++|.+.+.||+|+||.||++.+..+++.+|+|.++.... .....+.+.++..+++..+|+||+++++.+          
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (330)
T cd05601           1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM   80 (330)
T ss_pred             CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence            468899999999999999999999999999999864321 223445566677778888999999875321          


Q ss_pred             -----------------------HHHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEecccccccccccc--
Q psy14630         93 -----------------------FKEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIA--  147 (187)
Q Consensus        93 -----------------------~~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg~a~~~~~~~~--  147 (187)
                                             ...+..|++.||.|||+. +++||||||+||+++.++.+||+|||++..+.....  
T Consensus        81 e~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~~-~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~  159 (330)
T cd05601          81 EYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQM-GYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVN  159 (330)
T ss_pred             CCCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC-CeEcccCchHheEECCCCCEEeccCCCCeECCCCCcee
Confidence                                   111567899999999997 999999999999999999999999999987653322  


Q ss_pred             ccCCCCCcCccCccccCCCc---cCCCCCCcceeeeEe-eee
Q psy14630        148 KTRDAGCRPYMAPERIDPLR---ARGYPSFKTKLGFKF-NYR  185 (187)
Q Consensus       148 ~~~~~~t~~y~aPE~~~~~~---~~~~~~~~D~ws~gi-~~~  185 (187)
                      .....+|+.|+|||++....   ...++.++|+||+|+ +|.
T Consensus       160 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~e  201 (330)
T cd05601         160 SKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYE  201 (330)
T ss_pred             eecccCCccccCHHHhccccccccCCCCCcceeecccceeee
Confidence            22336899999999986321   234678999999999 443

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor

>KOG0032|consensus

Probab=99.97  E-value=2.7e-31  Score=207.95  Aligned_cols=159  Identities=28%  Similarity=0.382  Sum_probs=130.6

Q ss_pred             cCCcccccccccccccCceEEEEEEEcCCCcEEEEEEccCccC-hHHHHHHHHHHHHHHhcCC-CCchhhhhhhHH----
Q psy14630         20 DFTSEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVD-EKDQRQLLMDLDVVMKSNE-CPYIVQFYGALF----   93 (187)
Q Consensus        20 ~~~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~~~~~~~~~~-h~~iv~~~~~~~----   93 (187)
                      ......|.+.+.||+|.||.||+|.++.|++.+|+|.+.+... .....+....+..+++.+. ||||+.+++++.    
T Consensus        31 ~~~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~  110 (382)
T KOG0032|consen   31 EDIKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDS  110 (382)
T ss_pred             ccccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCe
Confidence            3445679999999999999999999999999999999965432 2223345566666777776 999998875321    


Q ss_pred             ---------------------------HHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCC----CCEEEEeccccccc
Q psy14630         94 ---------------------------KEVTVATVKALNYLKEELKIIHRDVKPSNILLDRR----GAIKLCDFGISGQL  142 (187)
Q Consensus        94 ---------------------------~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~----~~~ki~dfg~a~~~  142 (187)
                                                 ..+..|++.++.|||+. +++|||+||+|+++...    +.+|++|||++...
T Consensus       111 ~~lvmEL~~GGeLfd~i~~~~~sE~da~~~~~~il~av~~lH~~-gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~~  189 (382)
T KOG0032|consen  111 VYLVMELCEGGELFDRIVKKHYSERDAAGIIRQILEAVKYLHSL-GVVHRDLKPENLLLASKDEGSGRIKLIDFGLAKFI  189 (382)
T ss_pred             EEEEEEecCCchHHHHHHHccCCHHHHHHHHHHHHHHHHHHHhC-CceeccCCHHHeeeccccCCCCcEEEeeCCCceEc
Confidence                                       11567899999999997 99999999999999643    47999999999998


Q ss_pred             cccccccCCCCCcCccCccccCCCccCCCCCCcceeeeEe
Q psy14630        143 VDSIAKTRDAGCRPYMAPERIDPLRARGYPSFKTKLGFKF  182 (187)
Q Consensus       143 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi  182 (187)
                      .........+||+.|+|||++.   ..+|...+|+||+|+
T Consensus       190 ~~~~~~~~~~Gtp~y~APEvl~---~~~y~~~~DiWS~Gv  226 (382)
T KOG0032|consen  190 KPGERLHTIVGTPEYVAPEVLG---GRPYGDEVDVWSIGV  226 (382)
T ss_pred             cCCceEeeecCCccccCchhhc---CCCCCcccchhHHHH
Confidence            8765666679999999999998   678999999999999

>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

Probab=99.97  E-value=3e-31  Score=204.75  Aligned_cols=150  Identities=24%  Similarity=0.449  Sum_probs=116.9

Q ss_pred             ccccccCceEEEEEEEcCCCcEEEEEEccCcc--ChHHHHHHHHHHHHHHhcCCCCchhhhhhhH---------------
Q psy14630         30 GEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTV--DEKDQRQLLMDLDVVMKSNECPYIVQFYGAL---------------   92 (187)
Q Consensus        30 ~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~---------------   92 (187)
                      +.||+|+||.||+|.+..+++.||+|.++...  ..........+...+....+||||+++++.+               
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g   80 (316)
T cd05592           1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG   80 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            46899999999999999999999999986432  1122233344444444556899999887432               


Q ss_pred             -----------------HHHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEecccccccccc-ccccCCCCC
Q psy14630         93 -----------------FKEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDS-IAKTRDAGC  154 (187)
Q Consensus        93 -----------------~~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg~a~~~~~~-~~~~~~~~t  154 (187)
                                       ...+..|++.||.|||+. +++||||||+||+++.++.+||+|||+++..... .......||
T Consensus        81 g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~-~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~~gt  159 (316)
T cd05592          81 GDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKK-GIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKASTFCGT  159 (316)
T ss_pred             CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC-CEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCCCccccccCC
Confidence                             111567899999999997 9999999999999999999999999999865332 223344689


Q ss_pred             cCccCccccCCCccCCCCCCcceeeeEee
Q psy14630        155 RPYMAPERIDPLRARGYPSFKTKLGFKFN  183 (187)
Q Consensus       155 ~~y~aPE~~~~~~~~~~~~~~D~ws~gi~  183 (187)
                      +.|+|||.+.   ...++.++|+||+|++
T Consensus       160 ~~y~aPE~~~---~~~~~~~~DvwslG~i  185 (316)
T cd05592         160 PDYIAPEILK---GQKYNESVDWWSFGVL  185 (316)
T ss_pred             ccccCHHHHc---CCCCCCcccchhHHHH
Confidence            9999999998   5668899999999984

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp

>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

Probab=99.97  E-value=6.2e-31  Score=204.07  Aligned_cols=150  Identities=25%  Similarity=0.410  Sum_probs=116.5

Q ss_pred             ccccccCceEEEEEEEcCCCcEEEEEEccCcc-ChHHHHHHHH-HHHHHHhcCCCCchhhhhhhHH--------------
Q psy14630         30 GEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTV-DEKDQRQLLM-DLDVVMKSNECPYIVQFYGALF--------------   93 (187)
Q Consensus        30 ~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~-~~~~~~~~~~h~~iv~~~~~~~--------------   93 (187)
                      +.||+|+||.||+|.+..+++.+|+|+++... ........+. +...+.+..+||||+++++.+.              
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~   80 (329)
T cd05618           1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG   80 (329)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence            46899999999999999999999999986532 1222223333 3333444568999998875321              


Q ss_pred             ------------------HHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEeccccccccc-cccccCCCCC
Q psy14630         94 ------------------KEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVD-SIAKTRDAGC  154 (187)
Q Consensus        94 ------------------~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg~a~~~~~-~~~~~~~~~t  154 (187)
                                        ..+..+++.|+.|||+. +++||||||+||+++.++.+||+|||+++.... ........||
T Consensus        81 ~~L~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~-~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt  159 (329)
T cd05618          81 GDLMFHMQRQRKLPEEHARFYSAEISLALNYLHER-GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGT  159 (329)
T ss_pred             CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC-CeeeCCCCHHHEEECCCCCEEEeeCCccccccCCCCccccccCC
Confidence                              12667899999999997 999999999999999999999999999876432 2223345789


Q ss_pred             cCccCccccCCCccCCCCCCcceeeeEee
Q psy14630        155 RPYMAPERIDPLRARGYPSFKTKLGFKFN  183 (187)
Q Consensus       155 ~~y~aPE~~~~~~~~~~~~~~D~ws~gi~  183 (187)
                      +.|+|||++.   ...++.++|+||+|++
T Consensus       160 ~~y~aPE~~~---~~~~~~~~DiwslG~i  185 (329)
T cd05618         160 PNYIAPEILR---GEDYGFSVDWWALGVL  185 (329)
T ss_pred             ccccCHHHHc---CCCCCCccceecccHH
Confidence            9999999998   5678899999999983

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o

>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

Probab=99.97  E-value=3.7e-31  Score=205.48  Aligned_cols=159  Identities=24%  Similarity=0.369  Sum_probs=123.7

Q ss_pred             ccccccccccccCceEEEEEEEcCCCcEEEEEEccCcc-ChHHHHHHHHHHHHHHhcCCCCchhhhhhhH----------
Q psy14630         24 EDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTV-DEKDQRQLLMDLDVVMKSNECPYIVQFYGAL----------   92 (187)
Q Consensus        24 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~----------   92 (187)
                      ++|++.+.||+|+||.||++.+..+++.||+|++.... ......+.+.++..++..++|+||+.+++.+          
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (331)
T cd05597           1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM   80 (331)
T ss_pred             CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence            47899999999999999999999999999999986321 1222334456666677788999999875321          


Q ss_pred             -----------------------HHHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEeccccccccccccc-
Q psy14630         93 -----------------------FKEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAK-  148 (187)
Q Consensus        93 -----------------------~~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg~a~~~~~~~~~-  148 (187)
                                             ...+..|++.||+|||+. +++||||||+||+++.++.+||+|||++......... 
T Consensus        81 e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~-~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~  159 (331)
T cd05597          81 DYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQL-GYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQ  159 (331)
T ss_pred             ecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC-CeEECCCCHHHEEECCCCCEEEEECCceeecCCCCCcc
Confidence                                   112567899999999997 9999999999999999999999999998776443221 


Q ss_pred             -cCCCCCcCccCccccCCCc--cCCCCCCcceeeeEee
Q psy14630        149 -TRDAGCRPYMAPERIDPLR--ARGYPSFKTKLGFKFN  183 (187)
Q Consensus       149 -~~~~~t~~y~aPE~~~~~~--~~~~~~~~D~ws~gi~  183 (187)
                       ....||+.|+|||++....  ...++.++|+||+|++
T Consensus       160 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~  197 (331)
T cd05597         160 SNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVC  197 (331)
T ss_pred             ccceeccccccCHHHHhhccccccCCCCcceeehhhhH
Confidence             2235899999999986321  1346789999999994

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,

>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

Probab=99.97  E-value=6.2e-31  Score=203.35  Aligned_cols=150  Identities=25%  Similarity=0.380  Sum_probs=115.8

Q ss_pred             ccccccCceEEEEEEEcCCCcEEEEEEccCccC--hHHHHHHHHHHHHHHhcCCCCchhhhhhhHH--------------
Q psy14630         30 GEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVD--EKDQRQLLMDLDVVMKSNECPYIVQFYGALF--------------   93 (187)
Q Consensus        30 ~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~--------------   93 (187)
                      +.||+|+||.||+|.+..+++.||+|+++....  .........+...+....+||||+++++.+.              
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~   80 (321)
T cd05591           1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG   80 (321)
T ss_pred             CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence            468999999999999999999999999864321  1122233334443444568999998865321              


Q ss_pred             ------------------HHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEeccccccccc-cccccCCCCC
Q psy14630         94 ------------------KEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVD-SIAKTRDAGC  154 (187)
Q Consensus        94 ------------------~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg~a~~~~~-~~~~~~~~~t  154 (187)
                                        ..+..|++.||.|||+. +++||||||+||+++.++.+||+|||+++.... ........|+
T Consensus        81 ~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~-~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt  159 (321)
T cd05591          81 GDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRH-GVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTTTTFCGT  159 (321)
T ss_pred             CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC-CeeccCCCHHHeEECCCCCEEEeecccceecccCCccccccccC
Confidence                              11567899999999997 999999999999999999999999999876432 2223344689


Q ss_pred             cCccCccccCCCccCCCCCCcceeeeEee
Q psy14630        155 RPYMAPERIDPLRARGYPSFKTKLGFKFN  183 (187)
Q Consensus       155 ~~y~aPE~~~~~~~~~~~~~~D~ws~gi~  183 (187)
                      +.|+|||++.   ...++.++|+||+|+.
T Consensus       160 ~~y~aPE~~~---~~~~~~~~DvwslG~i  185 (321)
T cd05591         160 PDYIAPEILQ---ELEYGPSVDWWALGVL  185 (321)
T ss_pred             ccccCHHHHc---CCCCCCccceechhHH
Confidence            9999999988   5678899999999993

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to

>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

Probab=99.97  E-value=8.4e-31  Score=206.41  Aligned_cols=156  Identities=22%  Similarity=0.322  Sum_probs=123.2

Q ss_pred             cccccccccccCceEEEEEEEcCCCcEEEEEEccCccChHHHHHHHHHHHHHHhcCCCCchhhhhhhHH-----------
Q psy14630         25 DLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQFYGALF-----------   93 (187)
Q Consensus        25 ~~~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~-----------   93 (187)
                      +|+..+.||+|+||.||++.+..+++.||+|.+..........+.+.++..+++.++|+||+++++.+.           
T Consensus         1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~   80 (372)
T cd07853           1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY   80 (372)
T ss_pred             CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence            477889999999999999999999999999998643333333344555666777889999998875321           


Q ss_pred             -------------------------HHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEeccccccccccc--
Q psy14630         94 -------------------------KEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSI--  146 (187)
Q Consensus        94 -------------------------~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg~a~~~~~~~--  146 (187)
                                               ..++.|++.||.|||+. +++||||||+||+++.++.+||+|||+++......  
T Consensus        81 lv~e~~~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~-~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~~~~~  159 (372)
T cd07853          81 VVTELMQSDLHKIIVSPQPLSSDHVKVFLYQILRGLKYLHSA-GILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESK  159 (372)
T ss_pred             EEeeccccCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC-CeeCCCCChHHEEECCCCCEEeccccceeecccCccc
Confidence                                     11567899999999997 99999999999999999999999999998654322  


Q ss_pred             cccCCCCCcCccCccccCCCccCCCCCCcceeeeEee
Q psy14630        147 AKTRDAGCRPYMAPERIDPLRARGYPSFKTKLGFKFN  183 (187)
Q Consensus       147 ~~~~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi~  183 (187)
                      ......+++.|+|||.+.+  ...++.++|+||+|++
T Consensus       160 ~~~~~~~~~~y~aPE~~~~--~~~~~~~~DiwslG~i  194 (372)
T cd07853         160 HMTQEVVTQYYRAPEILMG--SRHYTSAVDIWSVGCI  194 (372)
T ss_pred             cCCCCCcCCCcCCHHHHcC--CCCCCcHHHHHhHHHH
Confidence            1223357889999999873  2347889999999983

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription

>PTZ00283 serine/threonine protein kinase; Provisional

Probab=99.97  E-value=6e-31  Score=213.91  Aligned_cols=160  Identities=21%  Similarity=0.216  Sum_probs=125.7

Q ss_pred             cCCcccccccccccccCceEEEEEEEcCCCcEEEEEEccCccChHHHHHHHHHHHHHHhcCCCCchhhhhhhH-------
Q psy14630         20 DFTSEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQFYGAL-------   92 (187)
Q Consensus        20 ~~~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~-------   92 (187)
                      ....++|++.+.||+|+||.||+|.+..+++.||+|.+............+..+...+..+.|+|++++++.+       
T Consensus        28 ~~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~  107 (496)
T PTZ00283         28 KEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRN  107 (496)
T ss_pred             cccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccC
Confidence            3456799999999999999999999999999999999865433333333444555566677888888643211       


Q ss_pred             -------------------------------------HHHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEe
Q psy14630         93 -------------------------------------FKEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCD  135 (187)
Q Consensus        93 -------------------------------------~~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~d  135 (187)
                                                           ...++.|++.||.|||+. +++||||||+||+++.++.+||+|
T Consensus       108 ~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~-~IiHrDLKP~NILl~~~~~vkL~D  186 (496)
T PTZ00283        108 PENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSK-HMIHRDIKSANILLCSNGLVKLGD  186 (496)
T ss_pred             cccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhC-CEecCCCCHHHEEEeCCCCEEEEe
Confidence                                                 011567899999999998 999999999999999999999999


Q ss_pred             cccccccccc---ccccCCCCCcCccCccccCCCccCCCCCCcceeeeEee
Q psy14630        136 FGISGQLVDS---IAKTRDAGCRPYMAPERIDPLRARGYPSFKTKLGFKFN  183 (187)
Q Consensus       136 fg~a~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi~  183 (187)
                      ||+++.+...   .......||+.|+|||.+.   ...++.++|+||||++
T Consensus       187 FGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~---~~~~s~k~DVwSlGvi  234 (496)
T PTZ00283        187 FGFSKMYAATVSDDVGRTFCGTPYYVAPEIWR---RKPYSKKADMFSLGVL  234 (496)
T ss_pred             cccCeeccccccccccccccCCcceeCHHHhC---CCCCCcHHHHHHHHHH
Confidence            9999876432   1223457899999999998   6678999999999993

>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

Probab=99.97  E-value=1.2e-30  Score=201.50  Aligned_cols=152  Identities=30%  Similarity=0.394  Sum_probs=118.2

Q ss_pred             ccccccCceEEEEEEE---cCCCcEEEEEEccCccChHHHHHHHHHHHHHHhcCCCCchhhhhhhHH-------------
Q psy14630         30 GEIGRGGFGTVNKMIH---RSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQFYGALF-------------   93 (187)
Q Consensus        30 ~~lg~G~fg~V~~~~~---~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~-------------   93 (187)
                      +.||+|+||.||++++   ..+++.+|+|+++..............+..+++.++||||+++++.+.             
T Consensus         2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~   81 (318)
T cd05582           2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR   81 (318)
T ss_pred             ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence            5799999999999876   367899999998643222222233344555777889999998864321             


Q ss_pred             -------------------HHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEecccccccccc-ccccCCCC
Q psy14630         94 -------------------KEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDS-IAKTRDAG  153 (187)
Q Consensus        94 -------------------~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg~a~~~~~~-~~~~~~~~  153 (187)
                                         ..++.|++.||.|||+. +++||||||+||+++.++.++|+|||+++..... .......|
T Consensus        82 ~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~-~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~g  160 (318)
T cd05582          82 GGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSL-GIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCG  160 (318)
T ss_pred             CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC-CEecCCCCHHHeEECCCCcEEEeeccCCcccCCCCCceecccC
Confidence                               12667899999999997 9999999999999999999999999998875443 22334568


Q ss_pred             CcCccCccccCCCccCCCCCCcceeeeEe-eee
Q psy14630        154 CRPYMAPERIDPLRARGYPSFKTKLGFKF-NYR  185 (187)
Q Consensus       154 t~~y~aPE~~~~~~~~~~~~~~D~ws~gi-~~~  185 (187)
                      ++.|+|||.+.   ...++.++|+||||+ +|.
T Consensus       161 ~~~y~aPE~~~---~~~~~~~~DiwslG~il~e  190 (318)
T cd05582         161 TVEYMAPEVVN---RRGHTQSADWWSFGVLMFE  190 (318)
T ss_pred             ChhhcCHHHHc---CCCCCCccceeccceEeee
Confidence            99999999998   566889999999999 444

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate

>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

Probab=99.97  E-value=4.6e-31  Score=204.80  Aligned_cols=149  Identities=25%  Similarity=0.405  Sum_probs=115.8

Q ss_pred             ccccccCceEEEEEEEcCCCcEEEEEEccCcc-ChHHHHHHHHHHHHHHhc-CCCCchhhhhhhHH--------------
Q psy14630         30 GEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTV-DEKDQRQLLMDLDVVMKS-NECPYIVQFYGALF--------------   93 (187)
Q Consensus        30 ~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~~~~~~~~-~~h~~iv~~~~~~~--------------   93 (187)
                      +.||+|+||.||+|.+..+++.||+|+++... ......+.+..+..++.. .+||||+++++.+.              
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~   80 (329)
T cd05588           1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG   80 (329)
T ss_pred             CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence            46899999999999999999999999987432 112222334444444444 47999998764321              


Q ss_pred             ------------------HHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEecccccccc-ccccccCCCCC
Q psy14630         94 ------------------KEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLV-DSIAKTRDAGC  154 (187)
Q Consensus        94 ------------------~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg~a~~~~-~~~~~~~~~~t  154 (187)
                                        ..++.|++.|+.|||+. +++||||||+||+++.++.+||+|||+++... .........||
T Consensus        81 g~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~-~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt  159 (329)
T cd05588          81 GDLMFHMQRQRKLPEEHARFYSAEISLALNFLHER-GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTTSTFCGT  159 (329)
T ss_pred             CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC-CeEecCCCHHHeEECCCCCEEECcCccccccccCCCccccccCC
Confidence                              11567899999999997 99999999999999999999999999987532 22333345789


Q ss_pred             cCccCccccCCCccCCCCCCcceeeeEe
Q psy14630        155 RPYMAPERIDPLRARGYPSFKTKLGFKF  182 (187)
Q Consensus       155 ~~y~aPE~~~~~~~~~~~~~~D~ws~gi  182 (187)
                      +.|+|||++.   ...++.++|+||+|+
T Consensus       160 ~~y~aPE~~~---~~~~~~~~DiwslG~  184 (329)
T cd05588         160 PNYIAPEILR---GEDYGFSVDWWALGV  184 (329)
T ss_pred             ccccCHHHHc---CCCCCCccceechHH
Confidence            9999999998   567889999999998

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl

>KOG0662|consensus

Probab=99.97  E-value=2.2e-31  Score=183.91  Aligned_cols=157  Identities=23%  Similarity=0.401  Sum_probs=131.4

Q ss_pred             ccccccccccccCceEEEEEEEcCCCcEEEEEEccCccChHHHHHHHHHHHHHHhcCCCCchhhhhhhHH----------
Q psy14630         24 EDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQFYGALF----------   93 (187)
Q Consensus        24 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~----------   93 (187)
                      ..|.-.++||+|.||+||+++++++++.||+|.++...++.....-..+++-+++.+.|.|||++++.+.          
T Consensus         2 ~~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe   81 (292)
T KOG0662|consen    2 QKYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE   81 (292)
T ss_pred             cchHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHH
Confidence            3577789999999999999999999999999998765444444445556667888899999999986431          


Q ss_pred             ----------------------HHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEeccccccccccc-cccC
Q psy14630         94 ----------------------KEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSI-AKTR  150 (187)
Q Consensus        94 ----------------------~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg~a~~~~~~~-~~~~  150 (187)
                                            .+.+.|++.|+.|+|+. ++.|||+||+|++|+.+|.+|+.|||+++.+.-+. ..+.
T Consensus        82 ~cdqdlkkyfdslng~~d~~~~rsfmlqllrgl~fchsh-nvlhrdlkpqnllin~ngelkladfglarafgipvrcysa  160 (292)
T KOG0662|consen   82 FCDQDLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHSH-NVLHRDLKPQNLLINRNGELKLADFGLARAFGIPVRCYSA  160 (292)
T ss_pred             HhhHHHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhhh-hhhhccCCcceEEeccCCcEEecccchhhhcCCceEeeec
Confidence                                  22678999999999998 99999999999999999999999999999876544 3445


Q ss_pred             CCCCcCccCccccCCCccCCCCCCcceeeeEee
Q psy14630        151 DAGCRPYMAPERIDPLRARGYPSFKTKLGFKFN  183 (187)
Q Consensus       151 ~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi~  183 (187)
                      ..-|.+|++|.++.+  .+-|+...|.||.|.+
T Consensus       161 evvtlwyrppdvlfg--akly~tsidmwsagci  191 (292)
T KOG0662|consen  161 EVVTLWYRPPDVLFG--AKLYSTSIDMWSAGCI  191 (292)
T ss_pred             eeeeeeccCcceeee--eehhccchHhhhcchH
Confidence            577999999999986  5679999999999984

>KOG0586|consensus

Probab=99.97  E-value=8.3e-31  Score=207.89  Aligned_cols=159  Identities=29%  Similarity=0.361  Sum_probs=136.2

Q ss_pred             CCcccccccccccccCceEEEEEEEcCCCcEEEEEEccCccChHHHHHHHHHHHHHHhcCCCCchhhhhhhHH-------
Q psy14630         21 FTSEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQFYGALF-------   93 (187)
Q Consensus        21 ~~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~-------   93 (187)
                      .....|.+...||+|.|+.|.++++.-|+..||||++++...+....+.+.++..+++.+.|||||++|....       
T Consensus        53 ~~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lyl  132 (596)
T KOG0586|consen   53 NSVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYL  132 (596)
T ss_pred             ccccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEE
Confidence            3445688899999999999999999999999999999876554444444677777899999999999885321       


Q ss_pred             -------------------------HHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEeccccccccccccc
Q psy14630         94 -------------------------KEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAK  148 (187)
Q Consensus        94 -------------------------~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg~a~~~~~~~~~  148 (187)
                                               ...+.|++.+++|||.+ .|+|||||++|++++.+.++||+|||++..+......
T Consensus       133 V~eya~~ge~~~yl~~~gr~~e~~ar~~F~q~vsaveYcH~k-~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~~~~l  211 (596)
T KOG0586|consen  133 VMEYASGGELFDYLVKHGRMKEKEARAKFRQIVSAVEYCHSK-NIVHRDLKAENILLDENMNIKIADFGFSTFFDYGLML  211 (596)
T ss_pred             EEEeccCchhHHHHHhcccchhhhhhhhhHHHHHHHHHHhhc-ceeccccchhhcccccccceeeeccccceeecccccc
Confidence                                     12678899999999998 9999999999999999999999999999999877777


Q ss_pred             cCCCCCcCccCccccCCCccCCCC-CCcceeeeEee
Q psy14630        149 TRDAGCRPYMAPERIDPLRARGYP-SFKTKLGFKFN  183 (187)
Q Consensus       149 ~~~~~t~~y~aPE~~~~~~~~~~~-~~~D~ws~gi~  183 (187)
                      ...+|++.|.|||++.+   ..|+ +.+|+|++|++
T Consensus       212 qt~cgsppyAaPEl~~g---~~y~gpe~D~Wslgvv  244 (596)
T KOG0586|consen  212 QTFCGSPPYAAPELFNG---KKYDGPEVDIWSLGVV  244 (596)
T ss_pred             cccCCCCCccChHhhcC---cccCCcceehhhhhhh
Confidence            78899999999999994   4455 99999999993

>KOG4250|consensus

Probab=99.97  E-value=2.6e-31  Score=213.67  Aligned_cols=154  Identities=28%  Similarity=0.444  Sum_probs=125.8

Q ss_pred             cccccccccCceEEEEEEEcCCCcEEEEEEccCccChHHHHHHHHHHHHHHhcCCCCchhhhhhhH--------------
Q psy14630         27 QDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQFYGAL--------------   92 (187)
Q Consensus        27 ~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~--------------   92 (187)
                      ...+.||+|+||.||+|+++++|+.||||.++..........+.. +..+++.++|+|||++++.-              
T Consensus        16 ~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~-EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vl   94 (732)
T KOG4250|consen   16 EMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCR-EIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVL   94 (732)
T ss_pred             eehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHH-HHHHHHHcCchhhhhhcccCCccccCcccccceE
Confidence            345789999999999999999999999999986554444444444 44567778899999998531              


Q ss_pred             ---------------------------HHHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEc--CCCC--EEEEecccccc
Q psy14630         93 ---------------------------FKEVTVATVKALNYLKEELKIIHRDVKPSNILLD--RRGA--IKLCDFGISGQ  141 (187)
Q Consensus        93 ---------------------------~~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~--~~~~--~ki~dfg~a~~  141 (187)
                                                 +-.+...+..|+.|||++ +|+||||||.||++.  .+|.  -||+|||.|+.
T Consensus        95 vmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn-~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~Are  173 (732)
T KOG4250|consen   95 VMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLREN-GIVHRDLKPGNIVLQIGEDGQSIYKLTDFGAARE  173 (732)
T ss_pred             EEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHc-CceeccCCCCcEEEeecCCCceEEeeeccccccc
Confidence                                       011556678899999997 999999999999984  3343  68999999999


Q ss_pred             ccccccccCCCCCcCccCccccCCCccCCCCCCcceeeeEe-ee
Q psy14630        142 LVDSIAKTRDAGCRPYMAPERIDPLRARGYPSFKTKLGFKF-NY  184 (187)
Q Consensus       142 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi-~~  184 (187)
                      +.+.....+..||..|.+||+..+  ...|+..+|.||||+ .|
T Consensus       174 l~d~s~~~S~vGT~~YLhPel~E~--q~~y~~tVDLWS~GvtlY  215 (732)
T KOG4250|consen  174 LDDNSLFTSLVGTEEYLHPELYER--QKKYTATVDLWSFGVTLY  215 (732)
T ss_pred             CCCCCeeeeecCchhhcChHHHhh--ccCcCceeehhhhhhHHH
Confidence            998888888999999999999883  467899999999999 54

>KOG0574|consensus

Probab=99.97  E-value=1.8e-32  Score=202.45  Aligned_cols=152  Identities=38%  Similarity=0.704  Sum_probs=129.4

Q ss_pred             cccccccccccccCceEEEEEEEcCCCcEEEEEEccCccChHHHHHHHHHHHHHHhcCCCCchhhhhhhHHHH-------
Q psy14630         23 SEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQFYGALFKE-------   95 (187)
Q Consensus        23 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~-------   95 (187)
                      .+-|.+..+||+|+||.||++.++++|+.+|||.+..   +.+..+++.++ .++.++..+++|++|+++++.       
T Consensus        32 EEVFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV---~sDLQEIIKEI-SIMQQC~S~yVVKYYGSYFK~sDLWIVM  107 (502)
T KOG0574|consen   32 EEVFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPV---DTDLQEIIKEI-SIMQQCKSKYVVKYYGSYFKHSDLWIVM  107 (502)
T ss_pred             HHHHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCc---cchHHHHHHHH-HHHHHcCCchhhhhhhhhccCCceEeeh
Confidence            3457889999999999999999999999999998863   23344555544 467888999999999876543       


Q ss_pred             --------------------------HHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEeccccccccccccc-
Q psy14630         96 --------------------------VTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAK-  148 (187)
Q Consensus        96 --------------------------~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg~a~~~~~~~~~-  148 (187)
                                                +....++||+|||.. .-+|||||.-|||++.+|..|++|||.|.++.+...+ 
T Consensus       108 EYCGAGSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~~-~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTMAKR  186 (502)
T KOG0574|consen  108 EYCGAGSISDIMRARRKPLSEQEISAVLRDTLKGLQYLHDL-KKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTMAKR  186 (502)
T ss_pred             hhcCCCcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHHH-HHHHhhcccccEEEcccchhhhhhccccchhhhhHHhh
Confidence                                      445677899999996 8899999999999999999999999999998776444 


Q ss_pred             cCCCCCcCccCccccCCCccCCCCCCcceeeeEe
Q psy14630        149 TRDAGCRPYMAPERIDPLRARGYPSFKTKLGFKF  182 (187)
Q Consensus       149 ~~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi  182 (187)
                      ....||+.|||||++.   +.+|+.++||||+||
T Consensus       187 NTVIGTPFWMAPEVI~---EIGY~~~ADIWSLGI  217 (502)
T KOG0574|consen  187 NTVIGTPFWMAPEVIE---EIGYDTKADIWSLGI  217 (502)
T ss_pred             CccccCcccccHHHHH---HhccchhhhHhhhcc
Confidence            3457999999999999   889999999999999

>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

Probab=99.97  E-value=6.3e-31  Score=203.54  Aligned_cols=154  Identities=26%  Similarity=0.419  Sum_probs=119.0

Q ss_pred             ccccccccccCceEEEEEEEcCCCcEEEEEEccCcc-ChHHHHHHHHHHHH---HHhcCCCCchhhhhhhHH--------
Q psy14630         26 LQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTV-DEKDQRQLLMDLDV---VMKSNECPYIVQFYGALF--------   93 (187)
Q Consensus        26 ~~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~~~~---~~~~~~h~~iv~~~~~~~--------   93 (187)
                      |++.+.||+|+||.||+|.+..+++.||+|.++... ......+.+..+..   .+..+.||||+++++.+.        
T Consensus         1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv   80 (324)
T cd05589           1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV   80 (324)
T ss_pred             CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence            567899999999999999999999999999986431 11112222333322   234568999999875321        


Q ss_pred             -----------------------HHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEeccccccccc-ccccc
Q psy14630         94 -----------------------KEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVD-SIAKT  149 (187)
Q Consensus        94 -----------------------~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg~a~~~~~-~~~~~  149 (187)
                                             ..++.|++.|++|||+. +++||||||+||+++.++.+||+|||+++.... .....
T Consensus        81 ~E~~~~~~L~~~~~~~~l~~~~~~~~~~qi~~al~~lH~~-~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~  159 (324)
T cd05589          81 MEYAAGGDLMMHIHTDVFSEPRAVFYAACVVLGLQYLHEN-KIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDRTS  159 (324)
T ss_pred             EcCCCCCcHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhC-CeEecCCCHHHeEECCCCcEEeCcccCCccCCCCCCccc
Confidence                                   12667899999999997 999999999999999999999999999876432 22233


Q ss_pred             CCCCCcCccCccccCCCccCCCCCCcceeeeEee
Q psy14630        150 RDAGCRPYMAPERIDPLRARGYPSFKTKLGFKFN  183 (187)
Q Consensus       150 ~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi~  183 (187)
                      ...|++.|+|||.+.   +..++.++|+||||+.
T Consensus       160 ~~~g~~~y~aPE~~~---~~~~~~~~DiwslG~i  190 (324)
T cd05589         160 TFCGTPEFLAPEVLT---ETSYTRAVDWWGLGVL  190 (324)
T ss_pred             ccccCccccCHhHhc---CCCCCcccchhhHHHH
Confidence            456899999999998   5678899999999983

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved

>KOG1989|consensus

Probab=99.97  E-value=5.9e-31  Score=215.72  Aligned_cols=173  Identities=21%  Similarity=0.249  Sum_probs=136.3

Q ss_pred             ceecCCCccccCCcccccccccccccCceEEEEEEEcCCCcEEEEEEccCccChHHHHHHHHHHHHHHhcC-CCCchhhh
Q psy14630         10 KLKLSPDTVYDFTSEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSN-ECPYIVQF   88 (187)
Q Consensus        10 ~~~~~~~~~~~~~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~-~h~~iv~~   88 (187)
                      ......+..+++...++++.+.|.+|||+.||+|.+...+..+|+|.+-..  +....+.+.+|..+|+.+ .|+|||.+
T Consensus        23 ~~~~~~G~~~~Vg~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~--de~~L~~v~~EI~~MK~L~gh~nIV~y  100 (738)
T KOG1989|consen   23 SENYFVGQTFTVGSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVN--DEEALNAVKREIDIMKLLSGHKNIVSY  100 (738)
T ss_pred             cccCCCceEEEECCEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecC--CHHHHHHHHHHHHHHHHhcCCCceeeE
Confidence            334445677788889999999999999999999999888799999987543  333445555566666665 49999999


Q ss_pred             hhhH-----------------------------------------HHHHHHHHHHHHHHHHhcCC--CeeecCCCCCeEE
Q psy14630         89 YGAL-----------------------------------------FKEVTVATVKALNYLKEELK--IIHRDVKPSNILL  125 (187)
Q Consensus        89 ~~~~-----------------------------------------~~~~~~~~~~~l~~lh~~~~--i~Hrdlk~~nili  125 (187)
                      +++.                                         +-+|+.++++|+++||.. .  |+|||||.+|+|+
T Consensus       101 idss~~~~~~~~~~~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~-~pPiIHRDLKiENvLl  179 (738)
T KOG1989|consen  101 IDSSAINRSSNNGVWEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYL-KPPIIHRDLKIENVLL  179 (738)
T ss_pred             eccccccccCCCceeEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcC-CCccchhhhhhhheEE
Confidence            8731                                         001777899999999987 5  9999999999999


Q ss_pred             cCCCCEEEEecccccccccccccc----------CCCCCcCccCccccCCCccCCCCCCcceeeeEe-eee
Q psy14630        126 DRRGAIKLCDFGISGQLVDSIAKT----------RDAGCRPYMAPERIDPLRARGYPSFKTKLGFKF-NYR  185 (187)
Q Consensus       126 ~~~~~~ki~dfg~a~~~~~~~~~~----------~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi-~~~  185 (187)
                      ..+|..||||||.|..........          ....|+.|+|||+|+-.++.+.+.|+|||++|+ .|.
T Consensus       180 s~~g~~KLCDFGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYk  250 (738)
T KOG1989|consen  180 SADGNYKLCDFGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYK  250 (738)
T ss_pred             cCCCCEEeCcccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHH
Confidence            999999999999887643222110          114688999999999888889999999999999 553

>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

Probab=99.97  E-value=5.8e-31  Score=203.77  Aligned_cols=154  Identities=25%  Similarity=0.391  Sum_probs=116.0

Q ss_pred             cccccccccccCceEEEEEEEcCCCcEEEEEEccCcc--ChHHHHHHHHHHHHHHhcCCC-CchhhhhhhH---------
Q psy14630         25 DLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTV--DEKDQRQLLMDLDVVMKSNEC-PYIVQFYGAL---------   92 (187)
Q Consensus        25 ~~~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~~~~~~~~~~~h-~~iv~~~~~~---------   92 (187)
                      +|++.+.||+|+||.||+|.+..+++.||+|+++...  ..........+ ..++..+.| ++|+.+++.+         
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e-~~~l~~~~~~~~i~~~~~~~~~~~~~~lv   79 (324)
T cd05587           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVE-KRVLALPGKPPFLTQLHSCFQTMDRLYFV   79 (324)
T ss_pred             CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHH-HHHHHhcCCCCceeeeEEEEEcCCEEEEE
Confidence            5788999999999999999999999999999986432  11222233333 334444444 5566554321         


Q ss_pred             -----------------------HHHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEeccccccccc-cccc
Q psy14630         93 -----------------------FKEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVD-SIAK  148 (187)
Q Consensus        93 -----------------------~~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg~a~~~~~-~~~~  148 (187)
                                             ...+..|++.||.|||+. +++||||||+||+++.++.++|+|||+++.... ....
T Consensus        80 ~E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~-~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~  158 (324)
T cd05587          80 MEYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSK-GIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKTT  158 (324)
T ss_pred             EcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC-CeEecCCCHHHeEEcCCCCEEEeecCcceecCCCCCce
Confidence                                   011567899999999997 999999999999999999999999999875422 2222


Q ss_pred             cCCCCCcCccCccccCCCccCCCCCCcceeeeEee
Q psy14630        149 TRDAGCRPYMAPERIDPLRARGYPSFKTKLGFKFN  183 (187)
Q Consensus       149 ~~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi~  183 (187)
                      ....||+.|+|||++.   ...++.++|+||+|++
T Consensus       159 ~~~~gt~~y~aPE~~~---~~~~~~~~DiwslGvi  190 (324)
T cd05587         159 RTFCGTPDYIAPEIIA---YQPYGKSVDWWAFGVL  190 (324)
T ss_pred             eeecCCccccChhhhc---CCCCCcccchhhhHHH
Confidence            3346899999999998   5668899999999994

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory

>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

Probab=99.97  E-value=7.7e-31  Score=202.82  Aligned_cols=150  Identities=25%  Similarity=0.399  Sum_probs=116.5

Q ss_pred             ccccccCceEEEEEEEcCCCcEEEEEEccCcc--ChHHHHHHHHHHHHHHhcCCCCchhhhhhhHH--------------
Q psy14630         30 GEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTV--DEKDQRQLLMDLDVVMKSNECPYIVQFYGALF--------------   93 (187)
Q Consensus        30 ~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~--------------   93 (187)
                      +.||+|+||.||+|.+..+++.||+|.++...  ..........++..+....+||||+++++.+.              
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~   80 (320)
T cd05590           1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG   80 (320)
T ss_pred             CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence            46899999999999999999999999986422  11222333444444445568999998764321              


Q ss_pred             ------------------HHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEeccccccccc-cccccCCCCC
Q psy14630         94 ------------------KEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVD-SIAKTRDAGC  154 (187)
Q Consensus        94 ------------------~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg~a~~~~~-~~~~~~~~~t  154 (187)
                                        ..+..|++.||.|||+. +++||||||+||+++.++.++|+|||+++.... ........||
T Consensus        81 g~L~~~i~~~~~l~~~~~~~~~~ql~~~L~~lH~~-~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt  159 (320)
T cd05590          81 GDLMFHIQKSRRFDEARARFYAAEITSALMFLHDK-GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTSTFCGT  159 (320)
T ss_pred             chHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC-CeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCCCcccccccC
Confidence                              11567899999999997 999999999999999999999999999876432 2223344689


Q ss_pred             cCccCccccCCCccCCCCCCcceeeeEee
Q psy14630        155 RPYMAPERIDPLRARGYPSFKTKLGFKFN  183 (187)
Q Consensus       155 ~~y~aPE~~~~~~~~~~~~~~D~ws~gi~  183 (187)
                      +.|+|||.+.   ...++.++|+||+|++
T Consensus       160 ~~y~aPE~~~---~~~~~~~~DiwslG~i  185 (320)
T cd05590         160 PDYIAPEILQ---EMLYGPSVDWWAMGVL  185 (320)
T ss_pred             ccccCHHHHc---CCCCCCccchhhhHHH
Confidence            9999999998   5678899999999983

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal

>KOG0614|consensus

Probab=99.97  E-value=7.6e-32  Score=210.25  Aligned_cols=163  Identities=27%  Similarity=0.458  Sum_probs=135.7

Q ss_pred             cCCcccccccccccccCceEEEEEEEcCCCcEEEEEEccCcc-ChHHHHHHHHHHHHHHhcCCCCchhhhhhhHHHH---
Q psy14630         20 DFTSEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTV-DEKDQRQLLMDLDVVMKSNECPYIVQFYGALFKE---   95 (187)
Q Consensus        20 ~~~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~---   95 (187)
                      +....++.+...||-|+||.|=++........+|+|++++.. -+..+.+....+..++..+..|.||++|..+-++   
T Consensus       416 ~v~l~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyv  495 (732)
T KOG0614|consen  416 QVKLSDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYV  495 (732)
T ss_pred             ccchhhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhh
Confidence            456678888999999999999998876555568999987542 2223445555566667777899999998655332   


Q ss_pred             -----------------------------HHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEeccccccccccc
Q psy14630         96 -----------------------------VTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSI  146 (187)
Q Consensus        96 -----------------------------~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg~a~~~~~~~  146 (187)
                                                   +...+++|++|||+. +|+.|||||+|++++.+|.+|+.|||+|+++..+.
T Consensus       496 YmLmEaClGGElWTiLrdRg~Fdd~tarF~~acv~EAfeYLH~k-~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g~  574 (732)
T KOG0614|consen  496 YMLMEACLGGELWTILRDRGSFDDYTARFYVACVLEAFEYLHRK-GIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSGR  574 (732)
T ss_pred             hhhHHhhcCchhhhhhhhcCCcccchhhhhHHHHHHHHHHHHhc-CceeccCChhheeeccCCceEEeehhhHHHhccCC
Confidence                                         445678999999997 99999999999999999999999999999998888


Q ss_pred             cccCCCCCcCccCccccCCCccCCCCCCcceeeeEe-eeeC
Q psy14630        147 AKTRDAGCRPYMAPERIDPLRARGYPSFKTKLGFKF-NYRI  186 (187)
Q Consensus       147 ~~~~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi-~~~~  186 (187)
                      .+-.++|||.|.|||.+.   +++++.++|.||+|| +|++
T Consensus       575 KTwTFcGTpEYVAPEIIL---nKGHD~avDyWaLGIli~EL  612 (732)
T KOG0614|consen  575 KTWTFCGTPEYVAPEIIL---NKGHDRAVDYWALGILIYEL  612 (732)
T ss_pred             ceeeecCCcccccchhhh---ccCcchhhHHHHHHHHHHHH
Confidence            888889999999999999   999999999999999 6653

>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

Probab=99.97  E-value=8.2e-31  Score=202.17  Aligned_cols=159  Identities=25%  Similarity=0.401  Sum_probs=123.9

Q ss_pred             CCcccccccccccccCceEEEEEEEcCCCc----EEEEEEccCccChHHHHHHHHHHHHHHhcCCCCchhhhhhhHH---
Q psy14630         21 FTSEDLQDLGEIGRGGFGTVNKMIHRSSDT----VMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQFYGALF---   93 (187)
Q Consensus        21 ~~~~~~~~~~~lg~G~fg~V~~~~~~~~~~----~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~---   93 (187)
                      +...+|+..+.||+|+||.||+|.+..++.    .||+|.++...... ..+.+.++..+++.+.||||+++++.+.   
T Consensus         4 ~~~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~g~~~~~~   82 (316)
T cd05108           4 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPK-ANKEILDEAYVMASVDNPHVCRLLGICLTST   82 (316)
T ss_pred             cchhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHH-HHHHHHHHHHHHHhCCCCCCCeEEEEEcCCC
Confidence            456789999999999999999998765555    38999986433322 3344555666788889999999875321   


Q ss_pred             -----------------------------HHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEeccccccccc
Q psy14630         94 -----------------------------KEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVD  144 (187)
Q Consensus        94 -----------------------------~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg~a~~~~~  144 (187)
                                                   ..+..|++.||+|||+. +++||||||+||+++.++.+||+|||+++....
T Consensus        83 ~~~v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~-~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~~  161 (316)
T cd05108          83 VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEER-RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA  161 (316)
T ss_pred             ceeeeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHhc-CeeccccchhheEecCCCcEEEccccccccccC
Confidence                                         12567899999999998 999999999999999999999999999987653


Q ss_pred             cccc---cCCCCCcCccCccccCCCccCCCCCCcceeeeEeee
Q psy14630        145 SIAK---TRDAGCRPYMAPERIDPLRARGYPSFKTKLGFKFNY  184 (187)
Q Consensus       145 ~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi~~  184 (187)
                      ....   .....+..|+|||.+.   ...++.++|+||||+.+
T Consensus       162 ~~~~~~~~~~~~~~~y~apE~~~---~~~~~~~~Di~slGv~l  201 (316)
T cd05108         162 DEKEYHAEGGKVPIKWMALESIL---HRIYTHQSDVWSYGVTV  201 (316)
T ss_pred             CCcceeccCCccceeecChHHhc---cCCCCchhhhHHHHHHH
Confidence            3221   1123356799999998   66789999999999843

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor

>PHA03209 serine/threonine kinase US3; Provisional

Probab=99.97  E-value=8.9e-31  Score=205.29  Aligned_cols=149  Identities=20%  Similarity=0.224  Sum_probs=121.8

Q ss_pred             cccccccccccccCceEEEEEEEcCCCcEEEEEEccCccChHHHHHHHHHHHHHHhcCCCCchhhhhhhHH---------
Q psy14630         23 SEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQFYGALF---------   93 (187)
Q Consensus        23 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~---------   93 (187)
                      ..+|++.+.||+|+||.||+|.+..++..||+|.......        ..+..+++.++|+||+++++.+.         
T Consensus        65 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~~~--------~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  136 (357)
T PHA03209         65 SLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKGTT--------LIEAMLLQNVNHPSVIRMKDTLVSGAITCMVL  136 (357)
T ss_pred             hcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcccc--------HHHHHHHHhCCCCCCcChhheEEeCCeeEEEE
Confidence            4569999999999999999999999999999997543211        12444677789999999876431         


Q ss_pred             -----------------------HHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEeccccccccccccccC
Q psy14630         94 -----------------------KEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTR  150 (187)
Q Consensus        94 -----------------------~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg~a~~~~~~~~~~~  150 (187)
                                             ..++.|++.||.|||+. +++||||||+||+++..+.++|+|||+++..........
T Consensus       137 e~~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~-~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~  215 (357)
T PHA03209        137 PHYSSDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQ-RIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPAFLG  215 (357)
T ss_pred             EccCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC-CeecCCCCHHHEEECCCCCEEEecCccccccccCccccc
Confidence                                   12667899999999997 999999999999999999999999999976543333344


Q ss_pred             CCCCcCccCccccCCCccCCCCCCcceeeeEee
Q psy14630        151 DAGCRPYMAPERIDPLRARGYPSFKTKLGFKFN  183 (187)
Q Consensus       151 ~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi~  183 (187)
                      ..||+.|+|||++.   ...++.++|+||+|++
T Consensus       216 ~~gt~~y~aPE~~~---~~~~~~~~DiwSlGvv  245 (357)
T PHA03209        216 LAGTVETNAPEVLA---RDKYNSKADIWSAGIV  245 (357)
T ss_pred             ccccccccCCeecC---CCCCCchhhHHHHHHH
Confidence            56899999999998   5668999999999984

>KOG0610|consensus

Probab=99.97  E-value=1.3e-30  Score=198.75  Aligned_cols=164  Identities=24%  Similarity=0.354  Sum_probs=130.4

Q ss_pred             ccCCcccccccccccccCceEEEEEEEcCCCcEEEEEEccCccCh-HHHHHHHHHHHHHHhcCCCCchhhhhhhHHHH--
Q psy14630         19 YDFTSEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDE-KDQRQLLMDLDVVMKSNECPYIVQFYGALFKE--   95 (187)
Q Consensus        19 ~~~~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~--   95 (187)
                      ..+..++|++++.||+|.-|.||+|....++..+|+|++.+.... .......+.+..++..++||.+..+|+.+..+  
T Consensus        72 ~~l~l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~  151 (459)
T KOG0610|consen   72 GSLGLRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKY  151 (459)
T ss_pred             CccCHHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccce
Confidence            356677899999999999999999999999999999999654321 22233445566678889999999999754322  


Q ss_pred             --------------------------------HHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEecccccccc
Q psy14630         96 --------------------------------VTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLV  143 (187)
Q Consensus        96 --------------------------------~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg~a~~~~  143 (187)
                                                      .+..++.||+|||-. |||.|||||+|||+.++|++.++||.++....
T Consensus       152 ~cl~meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHml-GivYRDLKPENILvredGHIMLsDFDLS~~~~  230 (459)
T KOG0610|consen  152 SCLVMEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHML-GIVYRDLKPENILVREDGHIMLSDFDLSLRCP  230 (459)
T ss_pred             eEEEEecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhh-ceeeccCCcceeEEecCCcEEeeeccccccCC
Confidence                                            566788999999986 99999999999999999999999999865421


Q ss_pred             -------c--------------------------ccc------------------------ccCCCCCcCccCccccCCC
Q psy14630        144 -------D--------------------------SIA------------------------KTRDAGCRPYMAPERIDPL  166 (187)
Q Consensus       144 -------~--------------------------~~~------------------------~~~~~~t~~y~aPE~~~~~  166 (187)
                             .                          ...                        ..+.+||-.|.|||+|.  
T Consensus       231 ~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~--  308 (459)
T KOG0610|consen  231 VSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIR--  308 (459)
T ss_pred             CCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeee--
Confidence                   0                          000                        01236889999999999  


Q ss_pred             ccCCCCCCcceeeeEe-eeeC
Q psy14630        167 RARGYPSFKTKLGFKF-NYRI  186 (187)
Q Consensus       167 ~~~~~~~~~D~ws~gi-~~~~  186 (187)
                       +.+++.++|||+||| .|+|
T Consensus       309 -G~GHgsAVDWWtfGIflYEm  328 (459)
T KOG0610|consen  309 -GEGHGSAVDWWTFGIFLYEM  328 (459)
T ss_pred             -cCCCCchhhHHHHHHHHHHH
Confidence             789999999999999 6654

>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

Probab=99.97  E-value=2e-30  Score=196.66  Aligned_cols=160  Identities=56%  Similarity=1.004  Sum_probs=127.5

Q ss_pred             ccccccccccccCceEEEEEEEcCCCcEEEEEEccCccChHHHHHHHHHHHHHHhcCCCCchhhhhhhH-----------
Q psy14630         24 EDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQFYGAL-----------   92 (187)
Q Consensus        24 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~-----------   92 (187)
                      ++|++.+.||+|+||.||++.+..++..||+|.++.........+.+.+.....+..+|||++++++.+           
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e   80 (283)
T cd06617           1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME   80 (283)
T ss_pred             CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence            478899999999999999999999999999999876544444455666666667788999999865421           


Q ss_pred             ------------------------HHHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEeccccccccccccc
Q psy14630         93 ------------------------FKEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAK  148 (187)
Q Consensus        93 ------------------------~~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg~a~~~~~~~~~  148 (187)
                                              ...++.|++.|++|||+..+++||||||+||+++.++.+||+|||+++........
T Consensus        81 ~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~  160 (283)
T cd06617          81 VMDTSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSVAK  160 (283)
T ss_pred             hhcccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeeccccccccccccc
Confidence                                    11256789999999998658999999999999999999999999999876544333


Q ss_pred             cCCCCCcCccCccccCCCcc-CCCCCCcceeeeEee
Q psy14630        149 TRDAGCRPYMAPERIDPLRA-RGYPSFKTKLGFKFN  183 (187)
Q Consensus       149 ~~~~~t~~y~aPE~~~~~~~-~~~~~~~D~ws~gi~  183 (187)
                      ....++..|+|||.+.+... .+++.++|+||+|++
T Consensus       161 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~  196 (283)
T cd06617         161 TIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGIT  196 (283)
T ss_pred             ccccCCccccChhhcCCcccccccCccccchhhHHH
Confidence            33467888999999864322 457889999999984

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs

>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

Probab=99.97  E-value=1.4e-30  Score=202.17  Aligned_cols=158  Identities=40%  Similarity=0.722  Sum_probs=128.5

Q ss_pred             CCcccccccccccccCceEEEEEEEcCCCcEEEEEEccCccChHHHHHHHHHHHHHHhcCCCCchhhhhhhH--------
Q psy14630         21 FTSEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQFYGAL--------   92 (187)
Q Consensus        21 ~~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~--------   92 (187)
                      +..++|++.+.||+|+||.||++.+..++..+|+|.+...... ...+.+.++..+++.++||||+++++.+        
T Consensus         2 l~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l   80 (331)
T cd06649           2 LKDDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKP-AIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISI   80 (331)
T ss_pred             CCcccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCH-HHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence            4568999999999999999999999999999999998754332 2344455566677888999999887532        


Q ss_pred             ------------------------HHHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEeccccccccccccc
Q psy14630         93 ------------------------FKEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAK  148 (187)
Q Consensus        93 ------------------------~~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg~a~~~~~~~~~  148 (187)
                                              ...+..+++.|+.|||+..+++||||||+||+++.++.++|+|||+++...... .
T Consensus        81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~  159 (331)
T cd06649          81 CMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM-A  159 (331)
T ss_pred             EeecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEEEcCCCcEEEccCcccccccccc-c
Confidence                                    112567899999999986469999999999999999999999999998764432 2


Q ss_pred             cCCCCCcCccCccccCCCccCCCCCCcceeeeEee
Q psy14630        149 TRDAGCRPYMAPERIDPLRARGYPSFKTKLGFKFN  183 (187)
Q Consensus       149 ~~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi~  183 (187)
                      ....+++.|+|||.+.   ...++.++|+||+|++
T Consensus       160 ~~~~g~~~y~aPE~~~---~~~~~~~~DiwslG~i  191 (331)
T cd06649         160 NSFVGTRSYMSPERLQ---GTHYSVQSDIWSMGLS  191 (331)
T ss_pred             ccCCCCcCcCCHhHhc---CCCCCchHhHHHHHHH
Confidence            3346899999999998   5568899999999983

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst

>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

Probab=99.97  E-value=2.1e-30  Score=204.36  Aligned_cols=169  Identities=23%  Similarity=0.360  Sum_probs=128.0

Q ss_pred             ceecCCCccccCCcccccccccccccCceEEEEEEEcC-----CCcEEEEEEccCccChHHHHHHHHHHHHHHhcC-CCC
Q psy14630         10 KLKLSPDTVYDFTSEDLQDLGEIGRGGFGTVNKMIHRS-----SDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSN-ECP   83 (187)
Q Consensus        10 ~~~~~~~~~~~~~~~~~~~~~~lg~G~fg~V~~~~~~~-----~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~-~h~   83 (187)
                      ....+-...|.++.++|++.+.||+|+||.||+|.+..     ++..||+|.++....... .+.+..+..+++.+ .|+
T Consensus        24 ~~~~~~~~~~~~~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~-~~~~~~E~~il~~l~~h~  102 (374)
T cd05106          24 PTQLPYNEKWEFPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDE-REALMSELKILSHLGQHK  102 (374)
T ss_pred             CccccccccccccHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHH-HHHHHHHHHHHHhhccCC
Confidence            33455567888999999999999999999999998543     335799999875433333 33344444455555 899


Q ss_pred             chhhhhhhHH----------------------------------------------------------------------
Q psy14630         84 YIVQFYGALF----------------------------------------------------------------------   93 (187)
Q Consensus        84 ~iv~~~~~~~----------------------------------------------------------------------   93 (187)
                      ||+++++.+.                                                                      
T Consensus       103 nIv~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  182 (374)
T cd05106         103 NIVNLLGACTHGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYV  182 (374)
T ss_pred             ceeeEeeEecCCCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhccccccccccccccccccc
Confidence            9998765311                                                                      


Q ss_pred             --------------------------------HHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEecccccc
Q psy14630         94 --------------------------------KEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQ  141 (187)
Q Consensus        94 --------------------------------~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg~a~~  141 (187)
                                                      ..+..|++.||.|||+. +++||||||+||+++.++.++|+|||+++.
T Consensus       183 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~-giiHrDLkp~Nil~~~~~~~kL~DfGla~~  261 (374)
T cd05106         183 EMRPVSSSSSQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASK-NCIHRDVAARNVLLTDGRVAKICDFGLARD  261 (374)
T ss_pred             ccCCccccccccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHC-CEEeccCchheEEEeCCCeEEEeeceeeee
Confidence                                            12457899999999997 999999999999999999999999999987


Q ss_pred             ccccccc---cCCCCCcCccCccccCCCccCCCCCCcceeeeEee
Q psy14630        142 LVDSIAK---TRDAGCRPYMAPERIDPLRARGYPSFKTKLGFKFN  183 (187)
Q Consensus       142 ~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi~  183 (187)
                      .......   ....++..|+|||.+.   ...++.++|+||||+.
T Consensus       262 ~~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~DvwSlGvi  303 (374)
T cd05106         262 IMNDSNYVVKGNARLPVKWMAPESIF---DCVYTVQSDVWSYGIL  303 (374)
T ss_pred             ccCCcceeeccCCCCccceeCHHHhc---CCCCCccccHHHHHHH
Confidence            6432211   1123456799999987   5678999999999984

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti

>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

Probab=99.97  E-value=2.1e-30  Score=200.60  Aligned_cols=150  Identities=25%  Similarity=0.369  Sum_probs=116.0

Q ss_pred             ccccccCceEEEEEEEc---CCCcEEEEEEccCccC--hHHHHHHHHHHHHHHhcCCCCchhhhhhhHH-----------
Q psy14630         30 GEIGRGGFGTVNKMIHR---SSDTVMAVKRIRSTVD--EKDQRQLLMDLDVVMKSNECPYIVQFYGALF-----------   93 (187)
Q Consensus        30 ~~lg~G~fg~V~~~~~~---~~~~~vaiK~~~~~~~--~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~-----------   93 (187)
                      +.||+|+||.||+++..   .+++.||+|.++....  ..........+..+++.++||||+++++.+.           
T Consensus         2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~   81 (323)
T cd05584           2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY   81 (323)
T ss_pred             ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence            67999999999999863   5788999999864211  1112233445566788899999998764321           


Q ss_pred             ---------------------HHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEeccccccccc-cccccCC
Q psy14630         94 ---------------------KEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVD-SIAKTRD  151 (187)
Q Consensus        94 ---------------------~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg~a~~~~~-~~~~~~~  151 (187)
                                           ..++.|++.||.|||+. +++||||||+||+++.++.+||+|||+++.... .......
T Consensus        82 ~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~-~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~  160 (323)
T cd05584          82 LSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQQ-GIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTHTF  160 (323)
T ss_pred             CCCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC-CeecCCCCHHHeEECCCCCEEEeeCcCCeecccCCCccccc
Confidence                                 11556899999999997 999999999999999999999999999875432 2222334


Q ss_pred             CCCcCccCccccCCCccCCCCCCcceeeeEee
Q psy14630        152 AGCRPYMAPERIDPLRARGYPSFKTKLGFKFN  183 (187)
Q Consensus       152 ~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi~  183 (187)
                      .|++.|+|||.+.   ...++.++|+||+|+.
T Consensus       161 ~gt~~y~aPE~~~---~~~~~~~~DiwslG~i  189 (323)
T cd05584         161 CGTIEYMAPEILM---RSGHGKAVDWWSLGAL  189 (323)
T ss_pred             CCCccccChhhcc---CCCCCCcceecccHHH
Confidence            6899999999998   5568899999999983

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in

>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

Probab=99.97  E-value=3.4e-30  Score=199.86  Aligned_cols=151  Identities=28%  Similarity=0.482  Sum_probs=112.7

Q ss_pred             ccccCceEEEEEEEcCCCcEEEEEEccCcc--ChHHHHHHHHHHHHHHhcC--CCCchhhhhhhH---------------
Q psy14630         32 IGRGGFGTVNKMIHRSSDTVMAVKRIRSTV--DEKDQRQLLMDLDVVMKSN--ECPYIVQFYGAL---------------   92 (187)
Q Consensus        32 lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~~~~~~~~~~--~h~~iv~~~~~~---------------   92 (187)
                      ||+|+||.||+|.+..+++.||+|++....  ........+.+...+....  .||||+.+++.+               
T Consensus         1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~   80 (330)
T cd05586           1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG   80 (330)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence            699999999999999999999999985321  1112222333333333333  799998765321               


Q ss_pred             -----------------HHHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEeccccccccc-cccccCCCCC
Q psy14630         93 -----------------FKEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVD-SIAKTRDAGC  154 (187)
Q Consensus        93 -----------------~~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg~a~~~~~-~~~~~~~~~t  154 (187)
                                       ...++.|++.|++|||+. +++||||||+||+++.++.++|+|||+++.... ........||
T Consensus        81 g~L~~~l~~~~~~~~~~~~~~~~qil~al~~LH~~-~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt  159 (330)
T cd05586          81 GELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKY-DIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTNTFCGT  159 (330)
T ss_pred             ChHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC-CeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCCCccCccCC
Confidence                             112667899999999997 999999999999999999999999999876432 2223345689


Q ss_pred             cCccCccccCCCccCCCCCCcceeeeEe-eee
Q psy14630        155 RPYMAPERIDPLRARGYPSFKTKLGFKF-NYR  185 (187)
Q Consensus       155 ~~y~aPE~~~~~~~~~~~~~~D~ws~gi-~~~  185 (187)
                      +.|+|||.+.+  ...++.++|+||+|+ +|.
T Consensus       160 ~~y~aPE~~~~--~~~~~~~~DvwslGvil~e  189 (330)
T cd05586         160 TEYLAPEVLLD--EKGYTKHVDFWSLGVLVFE  189 (330)
T ss_pred             ccccCHHHHcC--CCCCCCccceeccccEEEE
Confidence            99999999873  335789999999999 443

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of

>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

Probab=99.97  E-value=8.4e-31  Score=202.28  Aligned_cols=150  Identities=27%  Similarity=0.405  Sum_probs=116.0

Q ss_pred             ccccccCceEEEEEEEcCCCcEEEEEEccCccC--hHHHHHHHHHHHHHHhcCCCCchhhhhhhHH--------------
Q psy14630         30 GEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVD--EKDQRQLLMDLDVVMKSNECPYIVQFYGALF--------------   93 (187)
Q Consensus        30 ~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~--------------   93 (187)
                      +.||+|+||.||+|.+..+++.||+|.++....  .........+...+....+||||+++++.+.              
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~   80 (316)
T cd05620           1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG   80 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence            468999999999999999999999999864321  1122233444444445568999998764321              


Q ss_pred             ------------------HHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEeccccccccc-cccccCCCCC
Q psy14630         94 ------------------KEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVD-SIAKTRDAGC  154 (187)
Q Consensus        94 ------------------~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg~a~~~~~-~~~~~~~~~t  154 (187)
                                        ..++.|++.||+|||+. +++||||||+||+++.++.++|+|||+++.... ........||
T Consensus        81 g~L~~~i~~~~~~~~~~~~~~~~qi~~~l~~lH~~-~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt  159 (316)
T cd05620          81 GDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSK-GIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRASTFCGT  159 (316)
T ss_pred             CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC-CeEecCCCHHHeEECCCCCEEeCccCCCeecccCCCceeccCCC
Confidence                              11567899999999997 999999999999999999999999999875322 2223345689


Q ss_pred             cCccCccccCCCccCCCCCCcceeeeEee
Q psy14630        155 RPYMAPERIDPLRARGYPSFKTKLGFKFN  183 (187)
Q Consensus       155 ~~y~aPE~~~~~~~~~~~~~~D~ws~gi~  183 (187)
                      +.|+|||.+.   ...++.++|+||+|+.
T Consensus       160 ~~y~aPE~~~---~~~~~~~~DiwslGvi  185 (316)
T cd05620         160 PDYIAPEILQ---GLKYTFSVDWWSFGVL  185 (316)
T ss_pred             cCccCHHHHc---CCCCCcccchhhhHHH
Confidence            9999999998   5678899999999983

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I

>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

Probab=99.97  E-value=1.2e-30  Score=201.95  Aligned_cols=155  Identities=25%  Similarity=0.394  Sum_probs=117.1

Q ss_pred             cccccccccccCceEEEEEEEcCCCcEEEEEEccCccC--hHHHHHHHHHHHHHHhcCCCCchhhhhhhH----------
Q psy14630         25 DLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVD--EKDQRQLLMDLDVVMKSNECPYIVQFYGAL----------   92 (187)
Q Consensus        25 ~~~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~----------   92 (187)
                      +|...+.||+|+||.||+|.+..+++.||+|++.....  .........+...+....+|++|+.+++.+          
T Consensus         1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (323)
T cd05615           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM   80 (323)
T ss_pred             CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence            46778999999999999999999999999999864321  111222333333333344567777665321          


Q ss_pred             ----------------------HHHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEecccccccccc-cccc
Q psy14630         93 ----------------------FKEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDS-IAKT  149 (187)
Q Consensus        93 ----------------------~~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg~a~~~~~~-~~~~  149 (187)
                                            ...++.|++.|+.|||+. +++||||||+||+++.++.++|+|||+++..... ....
T Consensus        81 Ey~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~-~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~~~~~  159 (323)
T cd05615          81 EYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRR-GIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVTTR  159 (323)
T ss_pred             cCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC-CeeccCCCHHHeEECCCCCEEEeccccccccCCCCcccc
Confidence                                  111667899999999997 9999999999999999999999999998864322 2233


Q ss_pred             CCCCCcCccCccccCCCccCCCCCCcceeeeEee
Q psy14630        150 RDAGCRPYMAPERIDPLRARGYPSFKTKLGFKFN  183 (187)
Q Consensus       150 ~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi~  183 (187)
                      ...||+.|+|||++.   ...++.++|+||+|++
T Consensus       160 ~~~gt~~y~aPE~~~---~~~~~~~~DiwslGvi  190 (323)
T cd05615         160 TFCGTPDYIAPEIIA---YQPYGKSVDWWAYGVL  190 (323)
T ss_pred             CccCCccccCHHHHc---CCCCCCccchhhhHHH
Confidence            446899999999998   5668899999999984

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a

>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

Probab=99.96  E-value=1.7e-30  Score=201.75  Aligned_cols=159  Identities=25%  Similarity=0.386  Sum_probs=122.6

Q ss_pred             ccccccccccccCceEEEEEEEcCCCcEEEEEEccCcc-ChHHHHHHHHHHHHHHhcCCCCchhhhhhhH----------
Q psy14630         24 EDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTV-DEKDQRQLLMDLDVVMKSNECPYIVQFYGAL----------   92 (187)
Q Consensus        24 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~----------   92 (187)
                      ++|++.+.||+|+||.||++.+..+++.+|+|.+.... ........+.++..++...+|+||+.+++.+          
T Consensus         1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (332)
T cd05623           1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM   80 (332)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence            47889999999999999999999999999999985321 1222334455666677778999988765321          


Q ss_pred             -----------------------HHHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEeccccccccccc--c
Q psy14630         93 -----------------------FKEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSI--A  147 (187)
Q Consensus        93 -----------------------~~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg~a~~~~~~~--~  147 (187)
                                             ...+..|++.|+.|||+. +++||||||+||+++.++.+||+|||++..+....  .
T Consensus        81 ey~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~~-~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~~~~  159 (332)
T cd05623          81 DYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQL-HYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQ  159 (332)
T ss_pred             eccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC-CeEecCCCHHHEEECCCCCEEEeecchheecccCCcce
Confidence                                   112567899999999997 99999999999999999999999999987654322  1


Q ss_pred             ccCCCCCcCccCccccCCCc--cCCCCCCcceeeeEee
Q psy14630        148 KTRDAGCRPYMAPERIDPLR--ARGYPSFKTKLGFKFN  183 (187)
Q Consensus       148 ~~~~~~t~~y~aPE~~~~~~--~~~~~~~~D~ws~gi~  183 (187)
                      .....||+.|+|||++....  ...++.++|+||||++
T Consensus       160 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvi  197 (332)
T cd05623         160 SSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVC  197 (332)
T ss_pred             ecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHH
Confidence            22346899999999986321  2347889999999993

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw

>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

Probab=99.96  E-value=3.1e-30  Score=200.23  Aligned_cols=156  Identities=24%  Similarity=0.327  Sum_probs=116.8

Q ss_pred             cccccccccccCceEEEEEEEc---CCCcEEEEEEccCcc--ChHHHHHHHHHHHHHHhcC-CCCchhhhhhhH------
Q psy14630         25 DLQDLGEIGRGGFGTVNKMIHR---SSDTVMAVKRIRSTV--DEKDQRQLLMDLDVVMKSN-ECPYIVQFYGAL------   92 (187)
Q Consensus        25 ~~~~~~~lg~G~fg~V~~~~~~---~~~~~vaiK~~~~~~--~~~~~~~~~~~~~~~~~~~-~h~~iv~~~~~~------   92 (187)
                      +|++.+.||+|+||.||++++.   .+++.+|+|+++...  ......+....+..++..+ +|+||+.+++.+      
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~   80 (332)
T cd05614           1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL   80 (332)
T ss_pred             CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence            4788999999999999998763   578899999986421  1111223333344444444 689999875322      


Q ss_pred             --------------------------HHHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEeccccccccccc
Q psy14630         93 --------------------------FKEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSI  146 (187)
Q Consensus        93 --------------------------~~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg~a~~~~~~~  146 (187)
                                                ...+..|++.||.|||+. +++||||||+||+++.++.+||+|||+++......
T Consensus        81 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~-~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~~~~  159 (332)
T cd05614          81 HLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEHLHKL-GIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEE  159 (332)
T ss_pred             EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC-CcEecCCCHHHeEECCCCCEEEeeCcCCccccccC
Confidence                                      112566899999999997 99999999999999999999999999998754322


Q ss_pred             --cccCCCCCcCccCccccCCCccCCCCCCcceeeeEee
Q psy14630        147 --AKTRDAGCRPYMAPERIDPLRARGYPSFKTKLGFKFN  183 (187)
Q Consensus       147 --~~~~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi~  183 (187)
                        ......||+.|+|||.+.+  ...++.++|+||+|++
T Consensus       160 ~~~~~~~~gt~~y~aPE~~~~--~~~~~~~~DiwslG~i  196 (332)
T cd05614         160 KERTYSFCGTIEYMAPEIIRG--KGGHGKAVDWWSLGIL  196 (332)
T ss_pred             CCccccccCCccccCHHHhcC--CCCCCCccccccchhh
Confidence              2223468999999999873  2347789999999993

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>KOG0599|consensus

Probab=99.96  E-value=3.2e-31  Score=193.39  Aligned_cols=160  Identities=26%  Similarity=0.404  Sum_probs=130.7

Q ss_pred             CcccccccccccccCceEEEEEEEcCCCcEEEEEEccCcc------ChHH-HHHHHHHHHHHHhcCCCCchhhhhhhH--
Q psy14630         22 TSEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTV------DEKD-QRQLLMDLDVVMKSNECPYIVQFYGAL--   92 (187)
Q Consensus        22 ~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~------~~~~-~~~~~~~~~~~~~~~~h~~iv~~~~~~--   92 (187)
                      ..+.|.-.+.||.|..+.|-+|.++.++..+|+|++....      .... ......+..++.+...||+|+++.+.+  
T Consensus        15 fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes   94 (411)
T KOG0599|consen   15 FYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYES   94 (411)
T ss_pred             HHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccC
Confidence            3456777789999999999999999999999999985321      1122 233445555566668999999876532  


Q ss_pred             ------------------------------HHHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEeccccccc
Q psy14630         93 ------------------------------FKEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQL  142 (187)
Q Consensus        93 ------------------------------~~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg~a~~~  142 (187)
                                                    ...++.|+.+|+.|||.. +|+||||||+|||++++.+++|+|||.+.++
T Consensus        95 ~sF~FlVFdl~prGELFDyLts~VtlSEK~tR~iMrqlfegVeylHa~-~IVHRDLKpENILlddn~~i~isDFGFa~~l  173 (411)
T KOG0599|consen   95 DAFVFLVFDLMPRGELFDYLTSKVTLSEKETRRIMRQLFEGVEYLHAR-NIVHRDLKPENILLDDNMNIKISDFGFACQL  173 (411)
T ss_pred             cchhhhhhhhcccchHHHHhhhheeecHHHHHHHHHHHHHHHHHHHHh-hhhhcccChhheeeccccceEEeccceeecc
Confidence                                          112788999999999998 9999999999999999999999999999999


Q ss_pred             cccccccCCCCCcCccCccccCCC---ccCCCCCCcceeeeEe
Q psy14630        143 VDSIAKTRDAGCRPYMAPERIDPL---RARGYPSFKTKLGFKF  182 (187)
Q Consensus       143 ~~~~~~~~~~~t~~y~aPE~~~~~---~~~~~~~~~D~ws~gi  182 (187)
                      .++......||||.|+|||.+...   -+.+|+..+|.|++||
T Consensus       174 ~~GekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GV  216 (411)
T KOG0599|consen  174 EPGEKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGV  216 (411)
T ss_pred             CCchhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHH
Confidence            998888888999999999998422   2557889999999999

>KOG0579|consensus

Probab=99.96  E-value=2.4e-31  Score=212.40  Aligned_cols=159  Identities=29%  Similarity=0.495  Sum_probs=127.6

Q ss_pred             CcccccccccccccCceEEEEEEEcCCCcEEEEEEccCccChHHHHHHHHHHHHHHhcCCCCchhhhhhhHHHH------
Q psy14630         22 TSEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQFYGALFKE------   95 (187)
Q Consensus        22 ~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~------   95 (187)
                      +.+.+.++..||.|+||.||+|..+.++...|.|++.-. ......+.+-++ .++..+.||+||.++++++-+      
T Consensus        30 P~d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetk-seEELEDylVEI-eILa~CdHP~ivkLl~ayy~enkLwil  107 (1187)
T KOG0579|consen   30 PRDHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETK-SEEELEDYLVEI-EILAECDHPVIVKLLSAYYFENKLWIL  107 (1187)
T ss_pred             HHHHHHHHhhhcCccchhhhhhhcccchhhhhhhhhccc-chhHHhhhhhhh-hhhhcCCChHHHHHHHHHhccCceEEE
Confidence            344567889999999999999999999999999987532 233344444444 466678899999999776433      


Q ss_pred             ---------------------------HHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEeccccccccc-ccc
Q psy14630         96 ---------------------------VTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVD-SIA  147 (187)
Q Consensus        96 ---------------------------~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg~a~~~~~-~~~  147 (187)
                                                 +..|+++||.|||++ +|+|||||.-|||+..+|.++++|||.+..... ...
T Consensus       108 iEFC~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LHs~-~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t~qk  186 (1187)
T KOG0579|consen  108 IEFCGGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLHSQ-NIIHRDLKAGNILLTLDGDIRLADFGVSAKNKSTRQK  186 (1187)
T ss_pred             EeecCCchHhHHHHHhccccchHHHHHHHHHHHHHHHHHhhc-chhhhhccccceEEEecCcEeeecccccccchhHHhh
Confidence                                       445788999999998 999999999999999999999999998877543 344


Q ss_pred             ccCCCCCcCccCccccCCC--ccCCCCCCcceeeeEee
Q psy14630        148 KTRDAGCRPYMAPERIDPL--RARGYPSFKTKLGFKFN  183 (187)
Q Consensus       148 ~~~~~~t~~y~aPE~~~~~--~~~~~~~~~D~ws~gi~  183 (187)
                      ..++.|||+|||||+.+.-  ...+|+.++|||||||.
T Consensus       187 RDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGIT  224 (1187)
T KOG0579|consen  187 RDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGIT  224 (1187)
T ss_pred             hccccCCcccccchheeeccccCCCchhhhhHHhhhhH
Confidence            4567999999999997533  34579999999999994

>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit

Probab=99.96  E-value=5.5e-30  Score=202.01  Aligned_cols=169  Identities=24%  Similarity=0.338  Sum_probs=128.0

Q ss_pred             ceecCCCccccCCcccccccccccccCceEEEEEEE-----cCCCcEEEEEEccCccChHHHHHHHHHHHHHHhcC-CCC
Q psy14630         10 KLKLSPDTVYDFTSEDLQDLGEIGRGGFGTVNKMIH-----RSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSN-ECP   83 (187)
Q Consensus        10 ~~~~~~~~~~~~~~~~~~~~~~lg~G~fg~V~~~~~-----~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~-~h~   83 (187)
                      +...+....+.++.++|++.+.||+|+||.||+|..     ..++..||+|+++....... .+.+.++..++..+ +||
T Consensus        21 ~~~~~~~~~~~~~~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~-~~~~~~Ei~il~~l~~Hp   99 (375)
T cd05104          21 PTQLPYDHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTE-REALMSELKVLSYLGNHI   99 (375)
T ss_pred             CCCCCCccccccchHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHH-HHHHHHHHHHHHHhcCCc
Confidence            344555677888899999999999999999999963     35667899999875433332 23344444555555 899


Q ss_pred             chhhhhhhHH----------------------------------------------------------------------
Q psy14630         84 YIVQFYGALF----------------------------------------------------------------------   93 (187)
Q Consensus        84 ~iv~~~~~~~----------------------------------------------------------------------   93 (187)
                      ||+++++.+.                                                                      
T Consensus       100 nIv~l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~  179 (375)
T cd05104         100 NIVNLLGACTVGGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVV  179 (375)
T ss_pred             ceeeeeeeeccCCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCccccc
Confidence            9998864321                                                                      


Q ss_pred             -------------------------------------HHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEec
Q psy14630         94 -------------------------------------KEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDF  136 (187)
Q Consensus        94 -------------------------------------~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~df  136 (187)
                                                           ..+..|++.|+.|||+. +++||||||+||+++.++.+||+||
T Consensus       180 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~-~ivH~Dlkp~Nill~~~~~~kl~Df  258 (375)
T cd05104         180 PTKADKRRSVRSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASK-NCIHRDLAARNILLTHGRITKICDF  258 (375)
T ss_pred             ccccccccccccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC-CeeccCCchhhEEEECCCcEEEecC
Confidence                                                 12456899999999997 9999999999999999999999999


Q ss_pred             cccccccccccc---cCCCCCcCccCccccCCCccCCCCCCcceeeeEee
Q psy14630        137 GISGQLVDSIAK---TRDAGCRPYMAPERIDPLRARGYPSFKTKLGFKFN  183 (187)
Q Consensus       137 g~a~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi~  183 (187)
                      |+++........   ....++..|+|||.+.   ...++.++|+||||+.
T Consensus       259 G~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~sDi~slG~~  305 (375)
T cd05104         259 GLARDIRNDSNYVVKGNARLPVKWMAPESIF---NCVYTFESDVWSYGIL  305 (375)
T ss_pred             ccceeccCcccccccCCCCCCcceeChhHhc---CCCCCCCCCHHHHHHH
Confidence            999876432211   1123456799999998   5678899999999994

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce

>PTZ00284 protein kinase; Provisional

Probab=99.96  E-value=1.5e-30  Score=210.48  Aligned_cols=158  Identities=22%  Similarity=0.350  Sum_probs=112.1

Q ss_pred             CCcccccccccccccCceEEEEEEEcCCCcEEEEEEccCccChHHHHH---HHHHHHHHHhcCCCCchhhhhhh------
Q psy14630         21 FTSEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQ---LLMDLDVVMKSNECPYIVQFYGA------   91 (187)
Q Consensus        21 ~~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~---~~~~~~~~~~~~~h~~iv~~~~~------   91 (187)
                      ...++|++.+.||+|+||.||+|.+..+++.||||+++..........   .+.+........+|++++.+++.      
T Consensus       126 ~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~~~  205 (467)
T PTZ00284        126 VSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPKYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNETG  205 (467)
T ss_pred             cCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecchhhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcCCc
Confidence            345789999999999999999999999999999999864211111101   11111111112233344433211      


Q ss_pred             ----------------H----------HHHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCC----------------
Q psy14630         92 ----------------L----------FKEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRG----------------  129 (187)
Q Consensus        92 ----------------~----------~~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~----------------  129 (187)
                                      +          ...++.|++.||.|||..++|+||||||+||+++..+                
T Consensus       206 ~~~iv~~~~g~~l~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl~~~~~~~~~~~~~~~~~~~~  285 (467)
T PTZ00284        206 HMCIVMPKYGPCLLDWIMKHGPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRALPPDPC  285 (467)
T ss_pred             eEEEEEeccCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEecCCcccccccccccCCCCc
Confidence                            1          1236779999999999744999999999999998655                


Q ss_pred             CEEEEeccccccccccccccCCCCCcCccCccccCCCccCCCCCCcceeeeEee
Q psy14630        130 AIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPLRARGYPSFKTKLGFKFN  183 (187)
Q Consensus       130 ~~ki~dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi~  183 (187)
                      .+||+|||.+.....  ......||+.|+|||++.   ...++.++||||||++
T Consensus       286 ~vkl~DfG~~~~~~~--~~~~~~gt~~Y~APE~~~---~~~~~~~~DiwSlGvi  334 (467)
T PTZ00284        286 RVRICDLGGCCDERH--SRTAIVSTRHYRSPEVVL---GLGWMYSTDMWSMGCI  334 (467)
T ss_pred             eEEECCCCccccCcc--ccccccCCccccCcHHhh---cCCCCcHHHHHHHHHH
Confidence            499999998765322  233457899999999998   6678999999999993

>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

Probab=99.96  E-value=3.4e-30  Score=196.09  Aligned_cols=155  Identities=23%  Similarity=0.384  Sum_probs=123.0

Q ss_pred             cccccccccccCceEEEEEEEcCCCcEEEEEEccCccCh-HHHHHHHHHHHHHHhcCCCCchhhhhhhHH----------
Q psy14630         25 DLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDE-KDQRQLLMDLDVVMKSNECPYIVQFYGALF----------   93 (187)
Q Consensus        25 ~~~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~----------   93 (187)
                      .|++.+.||+|+||.||++.+..+++.||+|.+...... ......+..+..+++.++||||+++++.+.          
T Consensus         1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   80 (285)
T cd05605           1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT   80 (285)
T ss_pred             CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence            377889999999999999999889999999998643221 122233444556777889999998764321          


Q ss_pred             ------------------------HHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEecccccccccccccc
Q psy14630         94 ------------------------KEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKT  149 (187)
Q Consensus        94 ------------------------~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg~a~~~~~~~~~~  149 (187)
                                              ..++.|++.|+.|||+. +++||||||+||+++.++.++|+|||++..........
T Consensus        81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~-~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~  159 (285)
T cd05605          81 LMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRE-RIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGETIR  159 (285)
T ss_pred             ccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHC-CcEecCCCHHHEEECCCCCEEEeeCCCceecCCCCccc
Confidence                                    11567899999999997 99999999999999999999999999988765443333


Q ss_pred             CCCCCcCccCccccCCCccCCCCCCcceeeeEee
Q psy14630        150 RDAGCRPYMAPERIDPLRARGYPSFKTKLGFKFN  183 (187)
Q Consensus       150 ~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi~  183 (187)
                      ...|++.|+|||.+.   ...++.++|+||+|++
T Consensus       160 ~~~~~~~y~aPE~~~---~~~~~~~~Diws~G~~  190 (285)
T cd05605         160 GRVGTVGYMAPEVVK---NERYTFSPDWWGLGCL  190 (285)
T ss_pred             cccCCCCccCcHHhc---CCCCCccccchhHHHH
Confidence            457889999999998   5668899999999983

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,

>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

Probab=99.96  E-value=4.8e-30  Score=199.70  Aligned_cols=162  Identities=25%  Similarity=0.424  Sum_probs=123.5

Q ss_pred             ccCCcccccccccccccCceEEEEEEEc-----CCCcEEEEEEccCccChHHHHHHHHHHHHHHhcCCCCchhhhhhhHH
Q psy14630         19 YDFTSEDLQDLGEIGRGGFGTVNKMIHR-----SSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQFYGALF   93 (187)
Q Consensus        19 ~~~~~~~~~~~~~lg~G~fg~V~~~~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~   93 (187)
                      |.++.++|++.+.||+|+||.||+|...     .+++.||+|.++.............+...+.+..+|+||+++++.+.
T Consensus         2 ~~~~~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~   81 (337)
T cd05054           2 WEFPRDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACT   81 (337)
T ss_pred             cccCHHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEe
Confidence            7788899999999999999999999643     34578999998654333333344444444444448999998865321


Q ss_pred             --------------------------------------------------------------------------------
Q psy14630         94 --------------------------------------------------------------------------------   93 (187)
Q Consensus        94 --------------------------------------------------------------------------------   93 (187)
                                                                                                      
T Consensus        82 ~~~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  161 (337)
T cd05054          82 KPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEE  161 (337)
T ss_pred             cCCCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchh
Confidence                                                                                            


Q ss_pred             --------------HHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEecccccccccccc---ccCCCCCcC
Q psy14630         94 --------------KEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIA---KTRDAGCRP  156 (187)
Q Consensus        94 --------------~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg~a~~~~~~~~---~~~~~~t~~  156 (187)
                                    ..+..|++.|++|||+. +++||||||+||+++.++.++|+|||+++.+.....   .....++..
T Consensus       162 ~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~-~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~  240 (337)
T cd05054         162 GDELYKEPLTLEDLISYSFQVARGMEFLASR-KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLK  240 (337)
T ss_pred             hhHHhhcCCCHHHHHHHHHHHHHHHHHHHhC-CeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCcc
Confidence                          01446899999999997 999999999999999999999999999987643211   122245667


Q ss_pred             ccCccccCCCccCCCCCCcceeeeEeee
Q psy14630        157 YMAPERIDPLRARGYPSFKTKLGFKFNY  184 (187)
Q Consensus       157 y~aPE~~~~~~~~~~~~~~D~ws~gi~~  184 (187)
                      |+|||.+.   ...++.++|+||+|+++
T Consensus       241 y~aPE~~~---~~~~~~~~Di~SlGv~l  265 (337)
T cd05054         241 WMAPESIF---DKVYTTQSDVWSFGVLL  265 (337)
T ss_pred             ccCcHHhc---CCCCCccccHHHHHHHH
Confidence            99999998   67799999999999843

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto

>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

Probab=99.96  E-value=2.2e-30  Score=200.83  Aligned_cols=150  Identities=25%  Similarity=0.377  Sum_probs=115.8

Q ss_pred             ccccccCceEEEEEEEcCCCcEEEEEEccCccC-hHHHHHHHHHHHHH-HhcCCCCchhhhhhhH---------------
Q psy14630         30 GEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVD-EKDQRQLLMDLDVV-MKSNECPYIVQFYGAL---------------   92 (187)
Q Consensus        30 ~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~~~~~-~~~~~h~~iv~~~~~~---------------   92 (187)
                      +.||+|+||.||+|.+..+++.+|+|+++.... .....+.+..+..+ .+..+||||+.+++.+               
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (327)
T cd05617           1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG   80 (327)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence            469999999999999999999999999864321 11222333344444 4445799999876422               


Q ss_pred             -----------------HHHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEecccccccc-ccccccCCCCC
Q psy14630         93 -----------------FKEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLV-DSIAKTRDAGC  154 (187)
Q Consensus        93 -----------------~~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg~a~~~~-~~~~~~~~~~t  154 (187)
                                       ...++.|++.|++|||+. +++||||||+||+++.++.+||+|||+++... .........||
T Consensus        81 ~~L~~~~~~~~~l~~~~~~~~~~qi~~al~~lH~~-~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt  159 (327)
T cd05617          81 GDLMFHMQRQRKLPEEHARFYAAEICIALNFLHER-GIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTTSTFCGT  159 (327)
T ss_pred             CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC-CeeccCCCHHHEEEeCCCCEEEeccccceeccCCCCceecccCC
Confidence                             112667899999999997 99999999999999999999999999987632 22233345789


Q ss_pred             cCccCccccCCCccCCCCCCcceeeeEee
Q psy14630        155 RPYMAPERIDPLRARGYPSFKTKLGFKFN  183 (187)
Q Consensus       155 ~~y~aPE~~~~~~~~~~~~~~D~ws~gi~  183 (187)
                      +.|+|||++.   ...++.++|+||+|++
T Consensus       160 ~~y~aPE~~~---~~~~~~~~DiwslGvi  185 (327)
T cd05617         160 PNYIAPEILR---GEEYGFSVDWWALGVL  185 (327)
T ss_pred             cccCCHHHHC---CCCCCchheeehhHHH
Confidence            9999999998   6678899999999993

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways

>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

Probab=99.96  E-value=1.7e-30  Score=200.65  Aligned_cols=150  Identities=25%  Similarity=0.408  Sum_probs=116.3

Q ss_pred             ccccccCceEEEEEEEcCCCcEEEEEEccCccC--hHHHHHHHHHHHHHHhcCCCCchhhhhhhHH--------------
Q psy14630         30 GEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVD--EKDQRQLLMDLDVVMKSNECPYIVQFYGALF--------------   93 (187)
Q Consensus        30 ~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~--------------   93 (187)
                      +.||+|+||.||+|.+..+++.||+|.++....  .........+...+.....||||+++++.+.              
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~   80 (316)
T cd05619           1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG   80 (316)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence            468999999999999999999999999864321  1222333444444444568999998764321              


Q ss_pred             ------------------HHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEeccccccccc-cccccCCCCC
Q psy14630         94 ------------------KEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVD-SIAKTRDAGC  154 (187)
Q Consensus        94 ------------------~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg~a~~~~~-~~~~~~~~~t  154 (187)
                                        ..++.|++.|+.|||+. +++||||||+||+++.++.+||+|||+++.... ........||
T Consensus        81 g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~LH~~-~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt  159 (316)
T cd05619          81 GDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSK-GIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCTFCGT  159 (316)
T ss_pred             CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhC-CeEeCCCCHHHEEECCCCCEEEccCCcceECCCCCCceeeecCC
Confidence                              12667899999999997 999999999999999999999999999876432 1222334689


Q ss_pred             cCccCccccCCCccCCCCCCcceeeeEee
Q psy14630        155 RPYMAPERIDPLRARGYPSFKTKLGFKFN  183 (187)
Q Consensus       155 ~~y~aPE~~~~~~~~~~~~~~D~ws~gi~  183 (187)
                      +.|+|||++.   ...++.++|+||+|+.
T Consensus       160 ~~y~aPE~~~---~~~~~~~~DvwslG~i  185 (316)
T cd05619         160 PDYIAPEILL---GQKYNTSVDWWSFGVL  185 (316)
T ss_pred             ccccCHHHHc---CCCCCchhhhhhHHHH
Confidence            9999999998   5678999999999994

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in

>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

Probab=99.96  E-value=2.8e-30  Score=196.47  Aligned_cols=162  Identities=77%  Similarity=1.211  Sum_probs=125.9

Q ss_pred             CcccccccccccccCceEEEEEEEcCCCcEEEEEEccCccChHHHHHHHHHHHHHHhcCCCCchhhhhhhHH--------
Q psy14630         22 TSEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQFYGALF--------   93 (187)
Q Consensus        22 ~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~--------   93 (187)
                      +.++|...+.||+|+||.||++.+..+++.+|+|.+..............+...+.+...|+||+++++.+.        
T Consensus         2 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~   81 (288)
T cd06616           2 TAEDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWIC   81 (288)
T ss_pred             cHHHhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEE
Confidence            456788889999999999999999999999999998654333334444555555555556999998764321        


Q ss_pred             ----------------------------HHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEecccccccccc
Q psy14630         94 ----------------------------KEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDS  145 (187)
Q Consensus        94 ----------------------------~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg~a~~~~~~  145 (187)
                                                  ..+..+++.|++|||+..+++||||||+||+++.++.++|+|||+++.....
T Consensus        82 ~e~~~~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~  161 (288)
T cd06616          82 MELMDISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDS  161 (288)
T ss_pred             EecccCCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHHHEEEccCCcEEEeecchhHHhccC
Confidence                                        1255678899999998558999999999999999999999999999876554


Q ss_pred             ccccCCCCCcCccCccccCCCccCCCCCCcceeeeEee
Q psy14630        146 IAKTRDAGCRPYMAPERIDPLRARGYPSFKTKLGFKFN  183 (187)
Q Consensus       146 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi~  183 (187)
                      .......++..|+|||.+.+.....++.++|+||+|++
T Consensus       162 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~i  199 (288)
T cd06616         162 IAKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGIT  199 (288)
T ss_pred             CccccccCccCccCHHHhccccccCCcchhhhhHHHHH
Confidence            44444467889999999874222368899999999984

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates

>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

Probab=99.96  E-value=3.6e-30  Score=200.09  Aligned_cols=158  Identities=41%  Similarity=0.732  Sum_probs=127.0

Q ss_pred             CCcccccccccccccCceEEEEEEEcCCCcEEEEEEccCccChHHHHHHHHHHHHHHhcCCCCchhhhhhhHH-------
Q psy14630         21 FTSEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQFYGALF-------   93 (187)
Q Consensus        21 ~~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~-------   93 (187)
                      +..++|++.+.||+|+||.||++.+..++..+|+|.+...... ...+.+..+..+++.++|+||+++++.+.       
T Consensus         2 l~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l   80 (333)
T cd06650           2 LKDDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKP-AIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISI   80 (333)
T ss_pred             cchhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCH-HHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEE
Confidence            4568999999999999999999999999999999988654332 23344555666777889999999875321       


Q ss_pred             -------------------------HHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEeccccccccccccc
Q psy14630         94 -------------------------KEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAK  148 (187)
Q Consensus        94 -------------------------~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg~a~~~~~~~~~  148 (187)
                                               ..+..+++.++.|||+..+++||||||+||+++.++.+||+|||++....... .
T Consensus        81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~-~  159 (333)
T cd06650          81 CMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM-A  159 (333)
T ss_pred             EEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhEEEcCCCCEEEeeCCcchhhhhhc-c
Confidence                                     12567899999999985479999999999999999999999999987654332 2


Q ss_pred             cCCCCCcCccCccccCCCccCCCCCCcceeeeEee
Q psy14630        149 TRDAGCRPYMAPERIDPLRARGYPSFKTKLGFKFN  183 (187)
Q Consensus       149 ~~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi~  183 (187)
                      ....++..|+|||.+.   ...++.++|+||+|++
T Consensus       160 ~~~~~~~~y~aPE~~~---~~~~~~~~DvwslG~i  191 (333)
T cd06650         160 NSFVGTRSYMSPERLQ---GTHYSVQSDIWSMGLS  191 (333)
T ss_pred             ccCCCCccccCHHHhc---CCCCCcHHHHHHHHHH
Confidence            2346889999999998   5568899999999983

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst

>KOG0584|consensus

Probab=99.96  E-value=1.5e-31  Score=212.60  Aligned_cols=160  Identities=26%  Similarity=0.407  Sum_probs=132.7

Q ss_pred             Ccccc-cccccccccCceEEEEEEEcCCCcEEEEEEccCc--cChHHHHHHHHHHHHHHhcCCCCchhhhhhhHHH----
Q psy14630         22 TSEDL-QDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRST--VDEKDQRQLLMDLDVVMKSNECPYIVQFYGALFK----   94 (187)
Q Consensus        22 ~~~~~-~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~----   94 (187)
                      +..+| ++..+||+|+|-+||+|.+..+|..||.-.++..  .......+.+.++..+++.++|+||+++|+++.+    
T Consensus        37 p~gRy~k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~  116 (632)
T KOG0584|consen   37 PTGRYLKFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNK  116 (632)
T ss_pred             CCCceeehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCc
Confidence            44455 4568899999999999999999999987665422  2333455788888899999999999999976533    


Q ss_pred             ------------------------------HHHHHHHHHHHHHHhcC-CCeeecCCCCCeEEc-CCCCEEEEeccccccc
Q psy14630         95 ------------------------------EVTVATVKALNYLKEEL-KIIHRDVKPSNILLD-RRGAIKLCDFGISGQL  142 (187)
Q Consensus        95 ------------------------------~~~~~~~~~l~~lh~~~-~i~Hrdlk~~nili~-~~~~~ki~dfg~a~~~  142 (187)
                                                    .+..||++||.|||++. .|+|||||.+||+|+ ..|.+||.|+|+|+..
T Consensus       117 ~in~iTEL~TSGtLr~Y~kk~~~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~  196 (632)
T KOG0584|consen  117 TINFITELFTSGTLREYRKKHRRVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLL  196 (632)
T ss_pred             eeeeeeecccCCcHHHHHHHhccCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcCCcCceeecchhHHHHh
Confidence                                          27889999999999873 599999999999995 6789999999999998


Q ss_pred             cccccccCCCCCcCccCccccCCCccCCCCCCcceeeeEe-eeeC
Q psy14630        143 VDSIAKTRDAGCRPYMAPERIDPLRARGYPSFKTKLGFKF-NYRI  186 (187)
Q Consensus       143 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi-~~~~  186 (187)
                      ..+.... ..|||.|||||+..    ..|+..+||||||+ +++|
T Consensus       197 r~s~aks-vIGTPEFMAPEmYE----E~YnE~VDVYaFGMCmLEM  236 (632)
T KOG0584|consen  197 RKSHAKS-VIGTPEFMAPEMYE----ENYNELVDVYAFGMCMLEM  236 (632)
T ss_pred             hccccce-eccCccccChHHHh----hhcchhhhhhhhhHHHHHH
Confidence            7765555 68999999999976    45999999999998 6654

>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

Probab=99.96  E-value=4e-30  Score=197.27  Aligned_cols=158  Identities=23%  Similarity=0.324  Sum_probs=121.8

Q ss_pred             CCcccccccccccccCceEEEEEEEcC----------------CCcEEEEEEccCccChHHHHHHHHHHHHHHhcCCCCc
Q psy14630         21 FTSEDLQDLGEIGRGGFGTVNKMIHRS----------------SDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPY   84 (187)
Q Consensus        21 ~~~~~~~~~~~lg~G~fg~V~~~~~~~----------------~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~   84 (187)
                      ++.++|++.+.||+|+||.||+|.+..                ++..||+|.+....... ....+.++..++..+.|||
T Consensus         2 ~~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~E~~~l~~l~h~n   80 (304)
T cd05096           2 FPRGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKN-ARNDFLKEVKILSRLKDPN   80 (304)
T ss_pred             CchhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHH-HHHHHHHHHHHHhhcCCCC
Confidence            567899999999999999999997532                33479999987543332 3334445555677789999


Q ss_pred             hhhhhhhH---------------------------------------------------HHHHHHHHHHHHHHHHhcCCC
Q psy14630         85 IVQFYGAL---------------------------------------------------FKEVTVATVKALNYLKEELKI  113 (187)
Q Consensus        85 iv~~~~~~---------------------------------------------------~~~~~~~~~~~l~~lh~~~~i  113 (187)
                      |+++++.+                                                   ...++.|++.|+.|||+. ++
T Consensus        81 iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~-~i  159 (304)
T cd05096          81 IIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSL-NF  159 (304)
T ss_pred             eeEEEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHC-Cc
Confidence            99876421                                                   013667899999999997 99


Q ss_pred             eeecCCCCCeEEcCCCCEEEEecccccccccccc---ccCCCCCcCccCccccCCCccCCCCCCcceeeeEee
Q psy14630        114 IHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIA---KTRDAGCRPYMAPERIDPLRARGYPSFKTKLGFKFN  183 (187)
Q Consensus       114 ~Hrdlk~~nili~~~~~~ki~dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi~  183 (187)
                      +||||||+||+++.++.+||+|||+++.......   .....++..|+|||.+.   ...++.++|+||||+.
T Consensus       160 vH~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~Dv~slG~~  229 (304)
T cd05096         160 VHRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECIL---MGKFTTASDVWAFGVT  229 (304)
T ss_pred             cccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHh---cCCCCchhhhHHHHHH
Confidence            9999999999999999999999999987643321   12224567899999987   5668899999999983

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k

>KOG0666|consensus

Probab=99.96  E-value=3e-31  Score=196.39  Aligned_cols=158  Identities=21%  Similarity=0.370  Sum_probs=123.7

Q ss_pred             cccccccccccccCceEEEEEEEcCCC----cEEEEEEccCccChHHHHHHHHHHHHHHhcCCCCchhhhhhhHHH----
Q psy14630         23 SEDLQDLGEIGRGGFGTVNKMIHRSSD----TVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQFYGALFK----   94 (187)
Q Consensus        23 ~~~~~~~~~lg~G~fg~V~~~~~~~~~----~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~----   94 (187)
                      ...|.....||+|.||.||+|....++    ..+|||.++.+.+......-..++..+.+.++|||++.+...+..    
T Consensus        23 l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~  102 (438)
T KOG0666|consen   23 LFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKK  102 (438)
T ss_pred             HHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCce
Confidence            457888999999999999999654433    268999887553332222334445567888999999988765433    


Q ss_pred             ---------------------------------HHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCC----CCEEEEecc
Q psy14630         95 ---------------------------------EVTVATVKALNYLKEELKIIHRDVKPSNILLDRR----GAIKLCDFG  137 (187)
Q Consensus        95 ---------------------------------~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~----~~~ki~dfg  137 (187)
                                                       ++.-|++.|+.|||++ =|+||||||.||++..+    |.+||.|||
T Consensus       103 v~l~fdYAEhDL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~N-WvlHRDLKPaNIlvmgdgperG~VKIaDlG  181 (438)
T KOG0666|consen  103 VWLLFDYAEHDLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSN-WVLHRDLKPANILVMGDGPERGRVKIADLG  181 (438)
T ss_pred             EEEEehhhhhhHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhh-heeeccCCcceEEEeccCCccCeeEeeccc
Confidence                                             2667899999999998 89999999999999655    899999999


Q ss_pred             cccccccccc----ccCCCCCcCccCccccCCCccCCCCCCcceeeeEee
Q psy14630        138 ISGQLVDSIA----KTRDAGCRPYMAPERIDPLRARGYPSFKTKLGFKFN  183 (187)
Q Consensus       138 ~a~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi~  183 (187)
                      +++.+.+...    ....+-|.+|+|||++.+  ...|+.++|+|++|++
T Consensus       182 laR~~~~plkpl~s~d~VVVTiWYRAPELLLG--a~hYT~AiDvWAiGCI  229 (438)
T KOG0666|consen  182 LARLFNNPLKPLASLDPVVVTIWYRAPELLLG--ARHYTKAIDVWAIGCI  229 (438)
T ss_pred             HHHHhhccccccccCCceEEEEEecChHHhcc--cccccchhhhHHHHHH
Confidence            9999865422    223456889999999997  5569999999999984

>KOG1095|consensus

Probab=99.96  E-value=1.6e-30  Score=219.15  Aligned_cols=160  Identities=23%  Similarity=0.391  Sum_probs=127.9

Q ss_pred             CCcccccccccccccCceEEEEEEEcCCC-----cEEEEEEccCccChHHHHHHHHHHHHHHhcCCCCchhhhhhhHHHH
Q psy14630         21 FTSEDLQDLGEIGRGGFGTVNKMIHRSSD-----TVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQFYGALFKE   95 (187)
Q Consensus        21 ~~~~~~~~~~~lg~G~fg~V~~~~~~~~~-----~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~   95 (187)
                      ++.....+...||+|+||.||.|......     ..||+|.+++..+..+ ...+.++..+|+..+|||||++.|.+++.
T Consensus       689 v~~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~-~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~  767 (1025)
T KOG1095|consen  689 VPRKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQE-VSDFLKEALLMSKFDHPNIVSLIGVCLDS  767 (1025)
T ss_pred             CChhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHH-HHHHHHHHHHHhcCCCcceeeEEEeecCC
Confidence            56777788899999999999999865433     3499999876545444 44555666688899999999998754332


Q ss_pred             ---------------------------------------HHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEec
Q psy14630         96 ---------------------------------------VTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDF  136 (187)
Q Consensus        96 ---------------------------------------~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~df  136 (187)
                                                             +..+++.|+.||++. +++||||..+|+|++.+..+||.||
T Consensus       768 ~~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~-~fvHRDLAaRNCLL~~~r~VKIaDF  846 (1025)
T KOG1095|consen  768 GPPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESK-HFVHRDLAARNCLLDERRVVKIADF  846 (1025)
T ss_pred             CCcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhC-CCcCcchhhhheeecccCcEEEccc
Confidence                                                   667899999999997 9999999999999999999999999


Q ss_pred             cccccccccccccCC---CCCcCccCccccCCCccCCCCCCcceeeeEeeee
Q psy14630        137 GISGQLVDSIAKTRD---AGCRPYMAPERIDPLRARGYPSFKTKLGFKFNYR  185 (187)
Q Consensus       137 g~a~~~~~~~~~~~~---~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi~~~  185 (187)
                      |+|+.+.+.......   .-...|||||.+.   ...++.++|||||||.+|
T Consensus       847 GlArDiy~~~yyr~~~~a~lPvkWm~PEsl~---d~iFtskSDvWsFGVllW  895 (1025)
T KOG1095|consen  847 GLARDIYDKDYYRKHGEAMLPVKWMPPESLK---DGIFTSKSDVWSFGVLLW  895 (1025)
T ss_pred             chhHhhhhchheeccCccccceecCCHHHHh---hcccccccchhhhHHHHH
Confidence            999965443332221   1234699999999   677999999999999877

>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

Probab=99.96  E-value=1.6e-29  Score=197.25  Aligned_cols=162  Identities=27%  Similarity=0.436  Sum_probs=124.3

Q ss_pred             ccCCcccccccccccccCceEEEEEEE-----cCCCcEEEEEEccCccChHHHHHHHHHHHHHHhcCCCCchhhhhhhHH
Q psy14630         19 YDFTSEDLQDLGEIGRGGFGTVNKMIH-----RSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQFYGALF   93 (187)
Q Consensus        19 ~~~~~~~~~~~~~lg~G~fg~V~~~~~-----~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~   93 (187)
                      |+++.++|++.+.||+|+||.||+|.+     ..+++.||+|.++.............+...+.+..+||||+++++.+.
T Consensus         2 ~~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~   81 (343)
T cd05103           2 WEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACT   81 (343)
T ss_pred             cccchhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceee
Confidence            788999999999999999999999974     356788999998754333334445555554444447899998875321


Q ss_pred             H-------------------------------------------------------------------------------
Q psy14630         94 K-------------------------------------------------------------------------------   94 (187)
Q Consensus        94 ~-------------------------------------------------------------------------------   94 (187)
                      .                                                                               
T Consensus        82 ~~~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  161 (343)
T cd05103          82 KPGGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDV  161 (343)
T ss_pred             cCCCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccc
Confidence            0                                                                               


Q ss_pred             ---------------------HHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEecccccccccccc---ccC
Q psy14630         95 ---------------------EVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIA---KTR  150 (187)
Q Consensus        95 ---------------------~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg~a~~~~~~~~---~~~  150 (187)
                                           .+..|++.|++|||+. +++||||||+||+++.++.++++|||+++.......   ...
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~-~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~  240 (343)
T cd05103         162 EEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASR-KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGD  240 (343)
T ss_pred             hhhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhC-CeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCC
Confidence                                 1345899999999997 999999999999999999999999999887533211   112


Q ss_pred             CCCCcCccCccccCCCccCCCCCCcceeeeEeee
Q psy14630        151 DAGCRPYMAPERIDPLRARGYPSFKTKLGFKFNY  184 (187)
Q Consensus       151 ~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi~~  184 (187)
                      ..++..|+|||.+.   ...++.++|+||||+.+
T Consensus       241 ~~~~~~y~aPE~~~---~~~~~~~~Di~slG~~l  271 (343)
T cd05103         241 ARLPLKWMAPETIF---DRVYTIQSDVWSFGVLL  271 (343)
T ss_pred             CCCCcceECcHHhc---CCCCCchhhHHHHHHHH
Confidence            23456799999987   56688999999999843

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp

>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

Probab=99.96  E-value=4.4e-30  Score=198.42  Aligned_cols=150  Identities=26%  Similarity=0.416  Sum_probs=114.7

Q ss_pred             ccccccCceEEEEEEEcCCCcEEEEEEccCccC--hHHHHHHHHHHHHHHhcCCCCchhhhhhhHH--------------
Q psy14630         30 GEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVD--EKDQRQLLMDLDVVMKSNECPYIVQFYGALF--------------   93 (187)
Q Consensus        30 ~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~--------------   93 (187)
                      +.||+|+||.||+|.+..+++.||+|.++....  .........+...+....+||||+++++.+.              
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~   80 (318)
T cd05570           1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG   80 (318)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            468999999999999999999999999864321  1122223333333333447999999875321              


Q ss_pred             ------------------HHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEeccccccccc-cccccCCCCC
Q psy14630         94 ------------------KEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVD-SIAKTRDAGC  154 (187)
Q Consensus        94 ------------------~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg~a~~~~~-~~~~~~~~~t  154 (187)
                                        ..+..|++.||.|||+. +++||||||+||+++.++.++|+|||+++.... ........|+
T Consensus        81 ~~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~-~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~g~  159 (318)
T cd05570          81 GDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHER-GIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTTSTFCGT  159 (318)
T ss_pred             CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhC-CeEccCCCHHHeEECCCCcEEecccCCCeecCcCCCcccceecC
Confidence                              11567899999999997 999999999999999999999999999875322 2222334689


Q ss_pred             cCccCccccCCCccCCCCCCcceeeeEee
Q psy14630        155 RPYMAPERIDPLRARGYPSFKTKLGFKFN  183 (187)
Q Consensus       155 ~~y~aPE~~~~~~~~~~~~~~D~ws~gi~  183 (187)
                      +.|+|||.+.   ...++.++|+||+|++
T Consensus       160 ~~y~aPE~~~---~~~~~~~~DiwslGvi  185 (318)
T cd05570         160 PDYIAPEILS---YQPYGPAVDWWALGVL  185 (318)
T ss_pred             ccccCHHHhc---CCCCCcchhhhhHHHH
Confidence            9999999998   5678899999999983

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re

>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

Probab=99.96  E-value=7.3e-30  Score=193.52  Aligned_cols=148  Identities=26%  Similarity=0.422  Sum_probs=116.5

Q ss_pred             ccccCceEEEEEEEcCCCcEEEEEEccCccCh-HHHHHHHHHHHHHHhcCCCCchhhhhhhHH-----------------
Q psy14630         32 IGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDE-KDQRQLLMDLDVVMKSNECPYIVQFYGALF-----------------   93 (187)
Q Consensus        32 lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~-----------------   93 (187)
                      ||+|+||.||++.+..+++.+|+|.+...... .........+..+++.++||||+++++.+.                 
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L   80 (277)
T cd05607           1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL   80 (277)
T ss_pred             CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence            69999999999999999999999998642211 112223333555677789999998753210                 


Q ss_pred             -----------------HHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEeccccccccccccccCCCCCcC
Q psy14630         94 -----------------KEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTRDAGCRP  156 (187)
Q Consensus        94 -----------------~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg~a~~~~~~~~~~~~~~t~~  156 (187)
                                       ..+..|++.|++|||+. +++||||||+||+++.++.++|+|||++.............++..
T Consensus        81 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~-~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~  159 (277)
T cd05607          81 KYHIYNVGERGLEMERVIHYSAQITCGILHLHSM-DIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKTITQRAGTNG  159 (277)
T ss_pred             HHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHC-CEEEccCChHhEEEcCCCCEEEeeceeeeecCCCceeeccCCCCC
Confidence                             11556899999999997 999999999999999999999999999987655433344568899


Q ss_pred             ccCccccCCCccCCCCCCcceeeeEee
Q psy14630        157 YMAPERIDPLRARGYPSFKTKLGFKFN  183 (187)
Q Consensus       157 y~aPE~~~~~~~~~~~~~~D~ws~gi~  183 (187)
                      |+|||.+.   ...++.++|+||+|+.
T Consensus       160 y~aPE~~~---~~~~~~~~DvwslGv~  183 (277)
T cd05607         160 YMAPEILK---EEPYSYPVDWFAMGCS  183 (277)
T ss_pred             ccCHHHHc---cCCCCCchhHHHHHHH
Confidence            99999998   5568999999999983

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr

>KOG0986|consensus

Probab=99.96  E-value=7.4e-31  Score=202.26  Aligned_cols=164  Identities=23%  Similarity=0.401  Sum_probs=133.1

Q ss_pred             ccCCcccccccccccccCceEEEEEEEcCCCcEEEEEEccCccChHH-HHHHHHHHHHHHhcCCCCchhhhhhhHH----
Q psy14630         19 YDFTSEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKD-QRQLLMDLDVVMKSNECPYIVQFYGALF----   93 (187)
Q Consensus        19 ~~~~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~-~~~~~~~~~~~~~~~~h~~iv~~~~~~~----   93 (187)
                      +.+..+.|+..++||+|+||.|+-|..+.||..+|.|.+.+.+.++. -......+..++...+.+.||.+--++.    
T Consensus       180 qpvt~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~  259 (591)
T KOG0986|consen  180 QPVTKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDA  259 (591)
T ss_pred             hhccccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCc
Confidence            44667788999999999999999999999999999998854333322 2334445555666778888887632111    


Q ss_pred             ------------------------------HHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEecccccccc
Q psy14630         94 ------------------------------KEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLV  143 (187)
Q Consensus        94 ------------------------------~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg~a~~~~  143 (187)
                                                    .-.+.+|+.||+.||+. +|+.||+||+|||+|+.|+++|+|+|+|..+.
T Consensus       260 LClVLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~-~iVYRDLKPeNILLDd~GhvRISDLGLAvei~  338 (591)
T KOG0986|consen  260 LCLVLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRR-RIVYRDLKPENILLDDHGHVRISDLGLAVEIP  338 (591)
T ss_pred             eEEEEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhc-ceeeccCChhheeeccCCCeEeeccceEEecC
Confidence                                          11667899999999998 99999999999999999999999999999988


Q ss_pred             ccccccCCCCCcCccCccccCCCccCCCCCCcceeeeEe-eeeC
Q psy14630        144 DSIAKTRDAGCRPYMAPERIDPLRARGYPSFKTKLGFKF-NYRI  186 (187)
Q Consensus       144 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi-~~~~  186 (187)
                      ........+||..|||||++.   +..|+..+|+||+|+ .|.|
T Consensus       339 ~g~~~~~rvGT~GYMAPEvl~---ne~Y~~s~Dwf~lGCllYem  379 (591)
T KOG0986|consen  339 EGKPIRGRVGTVGYMAPEVLQ---NEVYDFSPDWFSLGCLLYEM  379 (591)
T ss_pred             CCCccccccCcccccCHHHHc---CCcccCCccHHHHHhHHHHH
Confidence            776666669999999999999   777999999999999 5543

>PRK13184 pknD serine/threonine-protein kinase; Reviewed

Probab=99.96  E-value=9.4e-30  Score=214.99  Aligned_cols=156  Identities=22%  Similarity=0.312  Sum_probs=124.3

Q ss_pred             ccccccccccccCceEEEEEEEcCCCcEEEEEEccCcc-ChHHHHHHHHHHHHHHhcCCCCchhhhhhhH----------
Q psy14630         24 EDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTV-DEKDQRQLLMDLDVVMKSNECPYIVQFYGAL----------   92 (187)
Q Consensus        24 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~----------   92 (187)
                      ++|++.+.||+|+||.||+|.+..+++.||+|.+.... ......+.+.++..+++.++||||+++++.+          
T Consensus         2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM   81 (932)
T PRK13184          2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM   81 (932)
T ss_pred             CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence            57899999999999999999999999999999986432 2233344555666678888999999876421          


Q ss_pred             -----------H----------------------HHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEecccc
Q psy14630         93 -----------F----------------------KEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGIS  139 (187)
Q Consensus        93 -----------~----------------------~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg~a  139 (187)
                                 .                      ..++.|++.||+|||+. +++||||||+||+++.++.++|+|||++
T Consensus        82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~-GIIHRDLKPeNILLd~dg~vKLiDFGLA  160 (932)
T PRK13184         82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSK-GVLHRDLKPDNILLGLFGEVVILDWGAA  160 (932)
T ss_pred             EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHC-CccccCCchheEEEcCCCCEEEEecCcc
Confidence                       0                      11456889999999998 9999999999999999999999999999


Q ss_pred             ccccccc-------------------cccCCCCCcCccCccccCCCccCCCCCCcceeeeEee
Q psy14630        140 GQLVDSI-------------------AKTRDAGCRPYMAPERIDPLRARGYPSFKTKLGFKFN  183 (187)
Q Consensus       140 ~~~~~~~-------------------~~~~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi~  183 (187)
                      +......                   ......||+.|+|||.+.   +..++.++|+||+|++
T Consensus       161 k~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~---g~~~S~kSDIWSLGVI  220 (932)
T PRK13184        161 IFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLL---GVPASESTDIYALGVI  220 (932)
T ss_pred             eecccccccccccccccccccccccccCCCCCCCCCCCCHHHhc---CCCCCcHhHHHHHHHH
Confidence            8762100                   011235899999999988   5678899999999994

>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

Probab=99.96  E-value=1.1e-29  Score=195.79  Aligned_cols=148  Identities=24%  Similarity=0.345  Sum_probs=113.5

Q ss_pred             cccccccCceEEEEEEEc--CCCcEEEEEEccCccChHHHHHHHHHHHHHHhcCCCCchhhhhhhH--------------
Q psy14630         29 LGEIGRGGFGTVNKMIHR--SSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQFYGAL--------------   92 (187)
Q Consensus        29 ~~~lg~G~fg~V~~~~~~--~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~--------------   92 (187)
                      ..+||+|+||.||+|.+.  .+++.+|+|.+......    ....++..+++.+.||||+++++.+              
T Consensus         6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~~----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~   81 (317)
T cd07868           6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGIS----MSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDY   81 (317)
T ss_pred             ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCCc----HHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEec
Confidence            468999999999999865  46788999998643221    1233455567788999999875432              


Q ss_pred             ----------------------------HHHHHHHHHHHHHHHHhcCCCeeecCCCCCeEE----cCCCCEEEEeccccc
Q psy14630         93 ----------------------------FKEVTVATVKALNYLKEELKIIHRDVKPSNILL----DRRGAIKLCDFGISG  140 (187)
Q Consensus        93 ----------------------------~~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili----~~~~~~ki~dfg~a~  140 (187)
                                                  ...++.|++.||.|||+. +++||||||+||++    +..+.+||+|||+++
T Consensus        82 ~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~-~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a~  160 (317)
T cd07868          82 AEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN-WVLHRDLKPANILVMGEGPERGRVKIADMGFAR  160 (317)
T ss_pred             cCCCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhC-CEEcCCCCHHHEEEecCCCCcCcEEEeecCcee
Confidence                                        122677999999999998 99999999999999    456789999999998


Q ss_pred             cccccc----cccCCCCCcCccCccccCCCccCCCCCCcceeeeEee
Q psy14630        141 QLVDSI----AKTRDAGCRPYMAPERIDPLRARGYPSFKTKLGFKFN  183 (187)
Q Consensus       141 ~~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi~  183 (187)
                      ......    ......+|+.|+|||.+.+  ...++.++|+||+|++
T Consensus       161 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~--~~~~~~~~DiwslG~i  205 (317)
T cd07868         161 LFNSPLKPLADLDPVVVTFWYRAPELLLG--ARHYTKAIDIWAIGCI  205 (317)
T ss_pred             ccCCCCccccccCCccccccccCCHHHcC--CCCcCchhhHHHHHHH
Confidence            764321    1233467899999999873  2457899999999984

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p

>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

Probab=99.96  E-value=4e-30  Score=197.75  Aligned_cols=157  Identities=24%  Similarity=0.352  Sum_probs=122.7

Q ss_pred             cccccccccccccCceEEEEEEEcCCCcEEEEEEccCccChHHHHHHHHHHHHHHhcCCCCchhhhhhhHH---------
Q psy14630         23 SEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQFYGALF---------   93 (187)
Q Consensus        23 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~---------   93 (187)
                      .++|.+.+.||+|+||.||+|.+..++..+|+|.++....... .....++..+++.++||||+++++.+.         
T Consensus         5 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~-~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~   83 (309)
T cd07872           5 METYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGA-PCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVF   83 (309)
T ss_pred             CCceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCc-chhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEE
Confidence            4679999999999999999999999999999999864322221 222334555677789999998875321         


Q ss_pred             -----------------------HHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEecccccccccc-cccc
Q psy14630         94 -----------------------KEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDS-IAKT  149 (187)
Q Consensus        94 -----------------------~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg~a~~~~~~-~~~~  149 (187)
                                             ..++.|++.||.|||+. +++||||||+||+++.++.+||+|||+++..... ....
T Consensus        84 e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~-~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~  162 (309)
T cd07872          84 EYLDKDLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRR-KVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKTYS  162 (309)
T ss_pred             eCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC-CeecCCCCHHHEEECCCCCEEECccccceecCCCccccc
Confidence                                   11556899999999997 9999999999999999999999999998765322 2222


Q ss_pred             CCCCCcCccCccccCCCccCCCCCCcceeeeEee
Q psy14630        150 RDAGCRPYMAPERIDPLRARGYPSFKTKLGFKFN  183 (187)
Q Consensus       150 ~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi~  183 (187)
                      ...+++.|+|||.+.+  ...++.++|+||+|+.
T Consensus       163 ~~~~~~~y~aPE~~~~--~~~~~~~~DiwslG~i  194 (309)
T cd07872         163 NEVVTLWYRPPDVLLG--SSEYSTQIDMWGVGCI  194 (309)
T ss_pred             cccccccccCCHHHhC--CCCCCcHHHHHHHHHH
Confidence            3457889999999863  3457899999999983

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play

>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

Probab=99.96  E-value=1.7e-29  Score=200.47  Aligned_cols=171  Identities=25%  Similarity=0.376  Sum_probs=129.3

Q ss_pred             CceecCCCccccCCcccccccccccccCceEEEEEEEcCC-----CcEEEEEEccCccChHHHHHHHHHHHHHHhcC-CC
Q psy14630          9 GKLKLSPDTVYDFTSEDLQDLGEIGRGGFGTVNKMIHRSS-----DTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSN-EC   82 (187)
Q Consensus         9 ~~~~~~~~~~~~~~~~~~~~~~~lg~G~fg~V~~~~~~~~-----~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~-~h   82 (187)
                      .....+....|.++.++|.+.+.||+|+||.||+|.+...     +..||+|.++....... .+.+..+..++..+ .|
T Consensus        22 ~~~~~~~~~~~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~-~~~~~~Ei~~l~~l~~H  100 (400)
T cd05105          22 DPMQLPYDSRWEFPRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSE-KQALMSELKIMTHLGPH  100 (400)
T ss_pred             ccccCCCCCceeccccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHH-HHHHHHHHHHHHhcCCC
Confidence            4455666788899999999999999999999999986432     34699999865433332 33344444455555 59


Q ss_pred             CchhhhhhhHHH--------------------------------------------------------------------
Q psy14630         83 PYIVQFYGALFK--------------------------------------------------------------------   94 (187)
Q Consensus        83 ~~iv~~~~~~~~--------------------------------------------------------------------   94 (187)
                      |||+++++.+..                                                                    
T Consensus       101 pnIv~l~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  180 (400)
T cd05105         101 LNIVNLLGACTKSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDM  180 (400)
T ss_pred             CCeeeEEEEEccCCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhccccccccc
Confidence            999988743210                                                                    


Q ss_pred             ------------------------------------------------------------HHHHHHHHHHHHHHhcCCCe
Q psy14630         95 ------------------------------------------------------------EVTVATVKALNYLKEELKII  114 (187)
Q Consensus        95 ------------------------------------------------------------~~~~~~~~~l~~lh~~~~i~  114 (187)
                                                                                  .+..|++.|++|||+. +++
T Consensus       181 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~-~iv  259 (400)
T cd05105         181 KQADTTQYVPMLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASK-NCV  259 (400)
T ss_pred             ccccccccchhhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhC-Cee
Confidence                                                                        1445789999999997 999


Q ss_pred             eecCCCCCeEEcCCCCEEEEecccccccccccc---ccCCCCCcCccCccccCCCccCCCCCCcceeeeEeee
Q psy14630        115 HRDVKPSNILLDRRGAIKLCDFGISGQLVDSIA---KTRDAGCRPYMAPERIDPLRARGYPSFKTKLGFKFNY  184 (187)
Q Consensus       115 Hrdlk~~nili~~~~~~ki~dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi~~  184 (187)
                      ||||||+||+++.++.+|++|||+++.......   .....+++.|+|||.+.   ...++.++|+||||+.+
T Consensus       260 H~dikp~Nill~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~DiwSlGvil  329 (400)
T cd05105         260 HRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIF---DNLYTTLSDVWSYGILL  329 (400)
T ss_pred             CCCCChHhEEEeCCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhc---CCCCCchhhHHHHHHHH
Confidence            999999999999999999999999987543221   12234567899999988   56688999999999843

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-

>PHA03211 serine/threonine kinase US3; Provisional

Probab=99.96  E-value=3.6e-30  Score=207.11  Aligned_cols=149  Identities=21%  Similarity=0.211  Sum_probs=120.7

Q ss_pred             ccccccccccccCceEEEEEEEcCCCcEEEEEEccCccChHHHHHHHHHHHHHHhcCCCCchhhhhhhH-----------
Q psy14630         24 EDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQFYGAL-----------   92 (187)
Q Consensus        24 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~-----------   92 (187)
                      ..|.+.+.||+|+||.||+|.+..+++.||+|.....        ....+..+++.++|+||+++++.+           
T Consensus       169 ~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~~--------~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e  240 (461)
T PHA03211        169 LGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWYA--------SSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLP  240 (461)
T ss_pred             CCeEEEEEEccCCCeEEEEEEECCCCCEEEEeccccc--------CHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEE
Confidence            4688999999999999999999999999999964311        123355677788999999887531           


Q ss_pred             ---------------------HHHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEecccccccccccc---c
Q psy14630         93 ---------------------FKEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIA---K  148 (187)
Q Consensus        93 ---------------------~~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg~a~~~~~~~~---~  148 (187)
                                           ...++.|++.||.|||+. +|+||||||+||+++.++.++|+|||+++.......   .
T Consensus       241 ~~~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~-gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~~~  319 (461)
T PHA03211        241 KYRSDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGE-GIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFH  319 (461)
T ss_pred             ccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC-CEEECcCCHHHEEECCCCCEEEcccCCceecccccccccc
Confidence                                 112678899999999997 999999999999999999999999999987643211   1


Q ss_pred             cCCCCCcCccCccccCCCccCCCCCCcceeeeEeee
Q psy14630        149 TRDAGCRPYMAPERIDPLRARGYPSFKTKLGFKFNY  184 (187)
Q Consensus       149 ~~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi~~  184 (187)
                      ....||..|+|||++.   ...++.++|+||||+++
T Consensus       320 ~~~~GT~~Y~APE~~~---~~~~~~~sDvwSlGviL  352 (461)
T PHA03211        320 YGIAGTVDTNAPEVLA---GDPYTPSVDIWSAGLVI  352 (461)
T ss_pred             cccCCCcCCcCHHHHc---CCCCCchHHHHHHHHHH
Confidence            2346899999999998   56789999999999943

>PTZ00266 NIMA-related protein kinase; Provisional

Probab=99.96  E-value=1.1e-29  Score=215.64  Aligned_cols=165  Identities=22%  Similarity=0.314  Sum_probs=128.4

Q ss_pred             ccCCcccccccccccccCceEEEEEEEcCCCcEEEEEEccCccChHHHHHHHHHHHHHHhcCCCCchhhhhhhHH-----
Q psy14630         19 YDFTSEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQFYGALF-----   93 (187)
Q Consensus        19 ~~~~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~-----   93 (187)
                      .+...++|.+.+.||+|+||.||+|.+..++..+|+|.+............+..+..++..+.||||+++++.+.     
T Consensus         8 ge~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~   87 (1021)
T PTZ00266          8 GESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQ   87 (1021)
T ss_pred             CccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCC
Confidence            345668999999999999999999999999999999998654333334445556666788899999998875321     


Q ss_pred             ---------------------------------HHHHHHHHHHHHHHHhc------CCCeeecCCCCCeEEcC-------
Q psy14630         94 ---------------------------------KEVTVATVKALNYLKEE------LKIIHRDVKPSNILLDR-------  127 (187)
Q Consensus        94 ---------------------------------~~~~~~~~~~l~~lh~~------~~i~Hrdlk~~nili~~-------  127 (187)
                                                       ..++.|++.||.|||+.      .+|+||||||+|||++.       
T Consensus        88 ~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~  167 (1021)
T PTZ00266         88 KLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGK  167 (1021)
T ss_pred             EEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcccccc
Confidence                                             11567899999999984      14999999999999954       


Q ss_pred             ----------CCCEEEEeccccccccccccccCCCCCcCccCccccCCCccCCCCCCcceeeeEeee
Q psy14630        128 ----------RGAIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPLRARGYPSFKTKLGFKFNY  184 (187)
Q Consensus       128 ----------~~~~ki~dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi~~  184 (187)
                                ...+||+|||++..+..........+|+.|+|||++.+. ...++.++||||||+++
T Consensus       168 i~~~~~n~ng~~iVKLsDFGlAr~l~~~s~~~s~vGTp~YmAPEvL~ge-~~~~s~KSDVWSLG~IL  233 (1021)
T PTZ00266        168 ITAQANNLNGRPIAKIGDFGLSKNIGIESMAHSCVGTPYYWSPELLLHE-TKSYDDKSDMWALGCII  233 (1021)
T ss_pred             ccccccccCCCCceEEccCCccccccccccccccCCCccccCHHHHhcc-CCCCCchhHHHHHHHHH
Confidence                      234899999999876544334445789999999998632 23478999999999943

>KOG4645|consensus

Probab=99.96  E-value=7.7e-30  Score=215.82  Aligned_cols=160  Identities=29%  Similarity=0.451  Sum_probs=132.4

Q ss_pred             ccccccccccCceEEEEEEEcCCCcEEEEEEccCccChHHHHHHHHHHHHHHhcCCCCchhhhhhhHH------------
Q psy14630         26 LQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQFYGALF------------   93 (187)
Q Consensus        26 ~~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~------------   93 (187)
                      ++....||.|.||.||-|.+..+|...|+|.++-+......-....++..++..++|||+|++|+.-.            
T Consensus      1237 Wqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFMEyC 1316 (1509)
T KOG4645|consen 1237 WQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFMEYC 1316 (1509)
T ss_pred             eccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHHHHHh
Confidence            44567899999999999999999999999998765544334445566667778899999999986321            


Q ss_pred             --------------------HHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEeccccccccccc-----cc
Q psy14630         94 --------------------KEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSI-----AK  148 (187)
Q Consensus        94 --------------------~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg~a~~~~~~~-----~~  148 (187)
                                          +-+..|++.|++|||+. ||||||+||.||+++..|.+|..|||.|..+.+..     ..
T Consensus      1317 ~~GsLa~ll~~gri~dE~vt~vyt~qll~gla~LH~~-gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~~~~~~el 1395 (1509)
T KOG4645|consen 1317 EGGSLASLLEHGRIEDEMVTRVYTKQLLEGLAYLHEH-GIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNAQTMPGEL 1395 (1509)
T ss_pred             ccCcHHHHHHhcchhhhhHHHHHHHHHHHHHHHHHhc-CceecCCCccceeeecCCcEEeecccceeEecCchhcCCHHH
Confidence                                11567899999999998 99999999999999999999999999999986542     11


Q ss_pred             cCCCCCcCccCccccCCCccCCCCCCcceeeeEe-eeeC
Q psy14630        149 TRDAGCRPYMAPERIDPLRARGYPSFKTKLGFKF-NYRI  186 (187)
Q Consensus       149 ~~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi-~~~~  186 (187)
                      ....||+.|||||+|.+...+|+-.++||||+|+ +++|
T Consensus      1396 ~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM 1434 (1509)
T KOG4645|consen 1396 QSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEM 1434 (1509)
T ss_pred             HhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEe
Confidence            2347999999999999887788999999999998 5554

>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

Probab=99.96  E-value=1.6e-29  Score=197.76  Aligned_cols=158  Identities=24%  Similarity=0.289  Sum_probs=126.8

Q ss_pred             CcccccccccccccCceEEEEEEEcCCCcEEEEEEccCccChHHHHHHHHHHHHHHhcCCCCchhhhhhhHH--------
Q psy14630         22 TSEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQFYGALF--------   93 (187)
Q Consensus        22 ~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~--------   93 (187)
                      ..++|+..+.||+|+||.||+|.+..+++.||+|.+............+..+..+++.++|+||+++++.+.        
T Consensus        14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   93 (353)
T cd07850          14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEF   93 (353)
T ss_pred             hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcccc
Confidence            357899999999999999999999999999999998643222233333445556777889999998764321        


Q ss_pred             ---------------------------HHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEeccccccccccc
Q psy14630         94 ---------------------------KEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSI  146 (187)
Q Consensus        94 ---------------------------~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg~a~~~~~~~  146 (187)
                                                 ..++.|++.||.|||.. +++||||||+||+++.++.++++|||+++......
T Consensus        94 ~~~~lv~e~~~~~l~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~-gi~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~  172 (353)
T cd07850          94 QDVYLVMELMDANLCQVIQMDLDHERMSYLLYQMLCGIKHLHSA-GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF  172 (353)
T ss_pred             CcEEEEEeccCCCHHHHHhhcCCHHHHHHHHHHHHHHHHHHHhC-CeeeCCCCHHHEEECCCCCEEEccCccceeCCCCC
Confidence                                       11567899999999997 99999999999999999999999999998765443


Q ss_pred             cccCCCCCcCccCccccCCCccCCCCCCcceeeeEee
Q psy14630        147 AKTRDAGCRPYMAPERIDPLRARGYPSFKTKLGFKFN  183 (187)
Q Consensus       147 ~~~~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi~  183 (187)
                      ......++..|+|||.+.   ...++.++|+||+|++
T Consensus       173 ~~~~~~~~~~y~aPE~~~---~~~~~~~~DvwslG~~  206 (353)
T cd07850         173 MMTPYVVTRYYRAPEVIL---GMGYKENVDIWSVGCI  206 (353)
T ss_pred             CCCCCcccccccCHHHHh---CCCCCCchhhHhHHHH
Confidence            333446788899999998   5678899999999983

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK

>PTZ00267 NIMA-related protein kinase; Provisional

Probab=99.96  E-value=9.2e-30  Score=206.40  Aligned_cols=155  Identities=23%  Similarity=0.243  Sum_probs=124.1

Q ss_pred             cccccccccccccCceEEEEEEEcCC-CcEEEEEEccCccChHHHHHHHHHHHHHHhcCCCCchhhhhhhHH--------
Q psy14630         23 SEDLQDLGEIGRGGFGTVNKMIHRSS-DTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQFYGALF--------   93 (187)
Q Consensus        23 ~~~~~~~~~lg~G~fg~V~~~~~~~~-~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~--------   93 (187)
                      ...|.+.+.||+|+||.||+|....+ ++.||+|.+...  .......+..+..+++.++||||+++++.+.        
T Consensus        66 ~~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~--~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv  143 (478)
T PTZ00267         66 EHMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLN--DERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLI  143 (478)
T ss_pred             ceeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccC--CHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEE
Confidence            34588999999999999999998777 788999976432  2233445566677788899999998864320        


Q ss_pred             ----------------------------HHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEecccccccccc
Q psy14630         94 ----------------------------KEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDS  145 (187)
Q Consensus        94 ----------------------------~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg~a~~~~~~  145 (187)
                                                  ..++.|++.||.|||+. +++||||||+||+++.++.+||+|||+++.+...
T Consensus       144 ~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~-~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~  222 (478)
T PTZ00267        144 MEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSR-KMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDS  222 (478)
T ss_pred             EECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC-CEEECCcCHHhEEECCCCcEEEEeCcCceecCCc
Confidence                                        11556899999999997 9999999999999999999999999999876543


Q ss_pred             cc---ccCCCCCcCccCccccCCCccCCCCCCcceeeeEee
Q psy14630        146 IA---KTRDAGCRPYMAPERIDPLRARGYPSFKTKLGFKFN  183 (187)
Q Consensus       146 ~~---~~~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi~  183 (187)
                      ..   ....+||+.|+|||.+.   ...++.++|+||+|++
T Consensus       223 ~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~slG~~  260 (478)
T PTZ00267        223 VSLDVASSFCGTPYYLAPELWE---RKRYSKKADMWSLGVI  260 (478)
T ss_pred             cccccccccCCCccccCHhHhC---CCCCCcHHhHHHHHHH
Confidence            22   23446899999999998   5678899999999983

>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

Probab=99.96  E-value=1.8e-29  Score=191.43  Aligned_cols=154  Identities=40%  Similarity=0.653  Sum_probs=124.9

Q ss_pred             ccccccccccccCceEEEEEEEcCCCcEEEEEEccCccChHHHHHHHHHHHHHHhcCCCCchhhhhhhH-----------
Q psy14630         24 EDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQFYGAL-----------   92 (187)
Q Consensus        24 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~-----------   92 (187)
                      ++|++.+.||+|+||.||+|.+..+++.+|+|.+...... ...+.+..+..+++.+.||||+++++.+           
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   79 (279)
T cd06619           1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITV-ELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTE   79 (279)
T ss_pred             CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCCh-HHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEe
Confidence            4688889999999999999999999999999998643222 2333455555567778999999887532           


Q ss_pred             -----------------HHHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEeccccccccccccccCCCCCc
Q psy14630         93 -----------------FKEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTRDAGCR  155 (187)
Q Consensus        93 -----------------~~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg~a~~~~~~~~~~~~~~t~  155 (187)
                                       ...++.|++.|++|||+. +++|+||||+|++++.++.++++|||++....... .....++.
T Consensus        80 ~~~~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~-~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~~-~~~~~~~~  157 (279)
T cd06619          80 FMDGGSLDVYRKIPEHVLGRIAVAVVKGLTYLWSL-KILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSI-AKTYVGTN  157 (279)
T ss_pred             cCCCCChHHhhcCCHHHHHHHHHHHHHHHHHHHHC-CEeeCCCCHHHEEECCCCCEEEeeCCcceeccccc-ccCCCCCh
Confidence                             123678899999999997 99999999999999999999999999998764432 23346888


Q ss_pred             CccCccccCCCccCCCCCCcceeeeEee
Q psy14630        156 PYMAPERIDPLRARGYPSFKTKLGFKFN  183 (187)
Q Consensus       156 ~y~aPE~~~~~~~~~~~~~~D~ws~gi~  183 (187)
                      .|+|||.+.   ...++.++|+||+|+.
T Consensus       158 ~y~aPE~~~---~~~~~~~~DvwslG~~  182 (279)
T cd06619         158 AYMAPERIS---GEQYGIHSDVWSLGIS  182 (279)
T ss_pred             hhcCceeec---CCCCCCcchHHHHHHH
Confidence            999999998   5668899999999983

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p

>KOG0612|consensus

Probab=99.96  E-value=2.6e-30  Score=216.32  Aligned_cols=166  Identities=29%  Similarity=0.431  Sum_probs=133.0

Q ss_pred             cCCcccccccccccccCceEEEEEEEcCCCcEEEEEEccCcc-ChHHHHHHHHHHHHHHhcCCCCchhhhhhhHHHH---
Q psy14630         20 DFTSEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTV-DEKDQRQLLMDLDVVMKSNECPYIVQFYGALFKE---   95 (187)
Q Consensus        20 ~~~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~---   95 (187)
                      .+..+||.++++||+|+||.|.+++++.|++.||+|++.+-. .+.....++.++..++...+.+=|++++-+|.+.   
T Consensus        71 rl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~~L  150 (1317)
T KOG0612|consen   71 RLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDERYL  150 (1317)
T ss_pred             hCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCccce
Confidence            567899999999999999999999999999999999986421 2223346677777777666666677766444332   


Q ss_pred             -----------------------------HHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEeccccccccc--
Q psy14630         96 -----------------------------VTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVD--  144 (187)
Q Consensus        96 -----------------------------~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg~a~~~~~--  144 (187)
                                                   ++..++.||.-+|+. |.|||||||+|+|++..|++|++|||.|..+..  
T Consensus       151 YlVMdY~pGGDlltLlSk~~~~pE~~ArFY~aEiVlAldslH~m-gyVHRDiKPDNvLld~~GHikLADFGsClkm~~dG  229 (1317)
T KOG0612|consen  151 YLVMDYMPGGDLLTLLSKFDRLPEDWARFYTAEIVLALDSLHSM-GYVHRDIKPDNVLLDKSGHIKLADFGSCLKMDADG  229 (1317)
T ss_pred             EEEEecccCchHHHHHhhcCCChHHHHHHHHHHHHHHHHHHHhc-cceeccCCcceeEecccCcEeeccchhHHhcCCCC
Confidence                                         556788899999996 999999999999999999999999999988763  


Q ss_pred             cccccCCCCCcCccCccccCCCcc--CCCCCCcceeeeEe-eeeC
Q psy14630        145 SIAKTRDAGCRPYMAPERIDPLRA--RGYPSFKTKLGFKF-NYRI  186 (187)
Q Consensus       145 ~~~~~~~~~t~~y~aPE~~~~~~~--~~~~~~~D~ws~gi-~~~~  186 (187)
                      ...+...+|||-|.+||++..+..  ..|...||+||+|| +|+|
T Consensus       230 ~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEM  274 (1317)
T KOG0612|consen  230 TVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEM  274 (1317)
T ss_pred             cEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHH
Confidence            244455689999999999853322  34889999999999 7764

>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

Probab=99.96  E-value=3.7e-29  Score=191.24  Aligned_cols=169  Identities=54%  Similarity=0.869  Sum_probs=132.5

Q ss_pred             CCccccCCcccccccccccccCceEEEEEEEcCCCcEEEEEEccCccChHHHHHHHHHHHHHHhcCCCCchhhhhhhHH-
Q psy14630         15 PDTVYDFTSEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQFYGALF-   93 (187)
Q Consensus        15 ~~~~~~~~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~-   93 (187)
                      .+..+.+..++|++.+.||+|+||.||+|.+..+++.+|+|.++.........+.+.+...+.+...|+||+++++.+. 
T Consensus         6 ~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~   85 (296)
T cd06618           6 DGQKYPADLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFIT   85 (296)
T ss_pred             cceeccCCcchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeec
Confidence            4566778889999999999999999999999888999999998754333333445555555556667999999886421 


Q ss_pred             -------------------------------HHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEeccccccc
Q psy14630         94 -------------------------------KEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQL  142 (187)
Q Consensus        94 -------------------------------~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg~a~~~  142 (187)
                                                     ..+..+++.++.|||+..+++||||+|+||+++.++.++|+|||++..+
T Consensus        86 ~~~~~~v~e~~~~~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~  165 (296)
T cd06618          86 DSDVFICMELMSTCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILLDASGNVKLCDFGISGRL  165 (296)
T ss_pred             CCeEEEEeeccCcCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHHEEEcCCCCEEECccccchhc
Confidence                                           1266789999999997448999999999999999999999999998876


Q ss_pred             cccccccCCCCCcCccCccccCCCc-cCCCCCCcceeeeEee
Q psy14630        143 VDSIAKTRDAGCRPYMAPERIDPLR-ARGYPSFKTKLGFKFN  183 (187)
Q Consensus       143 ~~~~~~~~~~~t~~y~aPE~~~~~~-~~~~~~~~D~ws~gi~  183 (187)
                      ..........++..|+|||.+.+.. +..++.++|+||||++
T Consensus       166 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~i  207 (296)
T cd06618         166 VDSKAKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGIS  207 (296)
T ss_pred             cCCCcccCCCCCccccCHhhcCCCCCccccccchhHHHHHHH
Confidence            5433333345678899999987432 2347889999999984

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it

>PHA02882 putative serine/threonine kinase; Provisional

Probab=99.96  E-value=1.5e-29  Score=193.36  Aligned_cols=161  Identities=20%  Similarity=0.265  Sum_probs=117.1

Q ss_pred             ccCCcccccccccccccCceEEEEEEEcCC---CcEEEEEEccCccChHHHHH---------HHHHHHHHHhcCCCCchh
Q psy14630         19 YDFTSEDLQDLGEIGRGGFGTVNKMIHRSS---DTVMAVKRIRSTVDEKDQRQ---------LLMDLDVVMKSNECPYIV   86 (187)
Q Consensus        19 ~~~~~~~~~~~~~lg~G~fg~V~~~~~~~~---~~~vaiK~~~~~~~~~~~~~---------~~~~~~~~~~~~~h~~iv   86 (187)
                      .++...+|++.+.||+|+||.||+|.+..+   +..+|+|.............         .............|+|++
T Consensus         7 ~~i~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~   86 (294)
T PHA02882          7 IDITGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIP   86 (294)
T ss_pred             eccCCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCC
Confidence            356668999999999999999999998776   66778886432211110000         001111223456788887


Q ss_pred             hhhhh------------------------H-----------HHHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCE
Q psy14630         87 QFYGA------------------------L-----------FKEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAI  131 (187)
Q Consensus        87 ~~~~~------------------------~-----------~~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~  131 (187)
                      ++++.                        .           ...++.|++.|++|||+. +++||||||+||+++.++.+
T Consensus        87 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~-~iiHrDiKp~Nill~~~~~~  165 (294)
T PHA02882         87 KYYGCGSFKRCRMYYRFILLEKLVENTKEIFKRIKCKNKKLIKNIMKDMLTTLEYIHEH-GISHGDIKPENIMVDGNNRG  165 (294)
T ss_pred             cEEEeeeEecCCceEEEEEEehhccCHHHHHHhhccCCHHHHHHHHHHHHHHHHHHHhC-CeecCCCCHHHEEEcCCCcE
Confidence            75431                        0           112677899999999997 99999999999999999999


Q ss_pred             EEEeccccccccccc--------cccCCCCCcCccCccccCCCccCCCCCCcceeeeEee
Q psy14630        132 KLCDFGISGQLVDSI--------AKTRDAGCRPYMAPERIDPLRARGYPSFKTKLGFKFN  183 (187)
Q Consensus       132 ki~dfg~a~~~~~~~--------~~~~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi~  183 (187)
                      +|+|||+++.+....        ......||+.|+|||.+.   ...++.++|+||+|+.
T Consensus       166 ~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~---~~~~~~~~DiwSlG~~  222 (294)
T PHA02882        166 YIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHN---GACVTRRGDLESLGYC  222 (294)
T ss_pred             EEEEcCCceeeccCCcccccccccccccCCCccccCHHHhC---CCCCCcHHHHHHHHHH
Confidence            999999998763211        112236899999999988   6678999999999994

>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

Probab=99.96  E-value=2e-29  Score=191.90  Aligned_cols=154  Identities=23%  Similarity=0.386  Sum_probs=121.2

Q ss_pred             ccccccccccCceEEEEEEEcCCCcEEEEEEccCccCh-HHHHHHHHHHHHHHhcCCCCchhhhhhhH------------
Q psy14630         26 LQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDE-KDQRQLLMDLDVVMKSNECPYIVQFYGAL------------   92 (187)
Q Consensus        26 ~~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~~~~~~~~~~h~~iv~~~~~~------------   92 (187)
                      |+..+.||+|+||.||++.+..+++.+|+|.+...... .........+..+++.++|+|++.+++.+            
T Consensus         2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~   81 (285)
T cd05630           2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL   81 (285)
T ss_pred             ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEe
Confidence            66778999999999999999999999999988643221 22223344455567788999998765321            


Q ss_pred             ----------------------HHHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEeccccccccccccccC
Q psy14630         93 ----------------------FKEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTR  150 (187)
Q Consensus        93 ----------------------~~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg~a~~~~~~~~~~~  150 (187)
                                            ...++.|++.|+.|||+. +++||||||+||+++.++.++++|||++...........
T Consensus        82 ~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~-~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~  160 (285)
T cd05630          82 MNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQE-RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKG  160 (285)
T ss_pred             cCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhC-CEEeCCCCHHHEEECCCCCEEEeeccceeecCCCccccC
Confidence                                  011567899999999997 999999999999999999999999999876544333334


Q ss_pred             CCCCcCccCccccCCCccCCCCCCcceeeeEee
Q psy14630        151 DAGCRPYMAPERIDPLRARGYPSFKTKLGFKFN  183 (187)
Q Consensus       151 ~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi~  183 (187)
                      ..|+..|+|||.+.   ...++.++|+||+|++
T Consensus       161 ~~g~~~y~aPE~~~---~~~~~~~~DiwslG~~  190 (285)
T cd05630         161 RVGTVGYMAPEVVK---NERYTFSPDWWALGCL  190 (285)
T ss_pred             CCCCccccChHHHc---CCCCCCccccHHHHHH
Confidence            46899999999998   5668899999999984

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as

>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

Probab=99.96  E-value=2.1e-29  Score=191.74  Aligned_cols=154  Identities=23%  Similarity=0.399  Sum_probs=121.2

Q ss_pred             ccccccccccCceEEEEEEEcCCCcEEEEEEccCccCh-HHHHHHHHHHHHHHhcCCCCchhhhhhhH------------
Q psy14630         26 LQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDE-KDQRQLLMDLDVVMKSNECPYIVQFYGAL------------   92 (187)
Q Consensus        26 ~~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~~~~~~~~~~h~~iv~~~~~~------------   92 (187)
                      |+..+.||+|+||.||++.+..+++.+|+|.+...... ......+..+..+++.++|+|++.+++.+            
T Consensus         2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~   81 (285)
T cd05632           2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTI   81 (285)
T ss_pred             ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEe
Confidence            66778899999999999999999999999998643221 22233344455677778999998765321            


Q ss_pred             ----------------------HHHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEeccccccccccccccC
Q psy14630         93 ----------------------FKEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTR  150 (187)
Q Consensus        93 ----------------------~~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg~a~~~~~~~~~~~  150 (187)
                                            ...++.|++.|+.|||+. +++||||||+|++++.++.++|+|||++...........
T Consensus        82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~-~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~  160 (285)
T cd05632          82 MNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRE-NTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGESIRG  160 (285)
T ss_pred             ccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC-CeeecCCCHHHEEECCCCCEEEecCCcceecCCCCcccC
Confidence                                  112567899999999997 999999999999999999999999999876543333334


Q ss_pred             CCCCcCccCccccCCCccCCCCCCcceeeeEee
Q psy14630        151 DAGCRPYMAPERIDPLRARGYPSFKTKLGFKFN  183 (187)
Q Consensus       151 ~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi~  183 (187)
                      ..|+..|+|||.+.   ...++.++|+||+|+.
T Consensus       161 ~~g~~~~~aPE~~~---~~~~~~~~Di~slG~~  190 (285)
T cd05632         161 RVGTVGYMAPEVLN---NQRYTLSPDYWGLGCL  190 (285)
T ss_pred             CCCCcCccChHHhc---CCCCCcccchHHHHHH
Confidence            46889999999998   5668899999999983

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with

>KOG2345|consensus

Probab=99.96  E-value=4.2e-29  Score=179.60  Aligned_cols=166  Identities=21%  Similarity=0.278  Sum_probs=133.1

Q ss_pred             CccccCCcccccccccccccCceEEEEEEEcCCCcEEEEEEccCccChHHHHHHHHHHHHHHhcCCCCchhhhhhhHHHH
Q psy14630         16 DTVYDFTSEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQFYGALFKE   95 (187)
Q Consensus        16 ~~~~~~~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~   95 (187)
                      .....+..++|++.+.||+|+|+-|++++...++..+|+|.+.-.  ..+..+..++++...+..+|||++++++....+
T Consensus        13 ~~tv~In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~--~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~   90 (302)
T KOG2345|consen   13 RGTVIINNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCH--SQEDIEEALREIDNHRKFNSPNVLRLVDHQLRE   90 (302)
T ss_pred             CCcEEEcCceEEEeeeecCCCceeeeeecccCcccchhhheeecc--chHHHHHHHHHHHHHHhhCCcchHHHHHHHHHh
Confidence            445567789999999999999999999999999999999987532  234455566666778888999999988643322


Q ss_pred             -----------------------------------------HHHHHHHHHHHHHhcCC--CeeecCCCCCeEEcCCCCEE
Q psy14630         96 -----------------------------------------VTVATVKALNYLKEELK--IIHRDVKPSNILLDRRGAIK  132 (187)
Q Consensus        96 -----------------------------------------~~~~~~~~l~~lh~~~~--i~Hrdlk~~nili~~~~~~k  132 (187)
                                                               ++.++..||++||+. .  .+||||||.||++...+.++
T Consensus        91 ~~D~~~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~-~~~yAH~DiKP~NILls~~~~~v  169 (302)
T KOG2345|consen   91 EKDGKHEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEK-EPPYAHRDIKPANILLSDSGLPV  169 (302)
T ss_pred             hccCceeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhcc-CCcccccCCCcceeEecCCCceE
Confidence                                                     667888999999997 6  89999999999999999999


Q ss_pred             EEeccccccccccc----------cccCCCCCcCccCccccCCCccCCCCCCcceeeeEe-ee
Q psy14630        133 LCDFGISGQLVDSI----------AKTRDAGCRPYMAPERIDPLRARGYPSFKTKLGFKF-NY  184 (187)
Q Consensus       133 i~dfg~a~~~~~~~----------~~~~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi-~~  184 (187)
                      +.|||.+....-..          .+...-.|..|+|||++....+...+.++||||+|+ .|
T Consensus       170 l~D~GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLY  232 (302)
T KOG2345|consen  170 LMDLGSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLY  232 (302)
T ss_pred             EEeccCccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHH
Confidence            99999988753211          111224688999999998666677889999999998 44

>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

Probab=99.96  E-value=1.4e-29  Score=192.27  Aligned_cols=148  Identities=26%  Similarity=0.419  Sum_probs=115.4

Q ss_pred             ccccCceEEEEEEEcCCCcEEEEEEccCccChH-HHHHHHHHHHHHHhcCCCCchhhhhhhH------------------
Q psy14630         32 IGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEK-DQRQLLMDLDVVMKSNECPYIVQFYGAL------------------   92 (187)
Q Consensus        32 lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~~~~~~~~~~h~~iv~~~~~~------------------   92 (187)
                      ||+|+||+||++.+..+++.+|+|.+....... ...+.+..+..+++.++|+||+.+.+.+                  
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L   80 (280)
T cd05608           1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL   80 (280)
T ss_pred             CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence            699999999999999999999999986432111 1122334455577788999999765321                  


Q ss_pred             ------------------HHHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEecccccccccccc-ccCCCC
Q psy14630         93 ------------------FKEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIA-KTRDAG  153 (187)
Q Consensus        93 ------------------~~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg~a~~~~~~~~-~~~~~~  153 (187)
                                        ...++.|++.|+.|||+. +++||||||+||+++.++.++|+|||++..+..... .....|
T Consensus        81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~-~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~g  159 (280)
T cd05608          81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQR-RIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGYAG  159 (280)
T ss_pred             HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHC-CcccCCCCHHHEEECCCCCEEEeeCccceecCCCCccccccCC
Confidence                              011567899999999997 999999999999999999999999999987644322 223468


Q ss_pred             CcCccCccccCCCccCCCCCCcceeeeEee
Q psy14630        154 CRPYMAPERIDPLRARGYPSFKTKLGFKFN  183 (187)
Q Consensus       154 t~~y~aPE~~~~~~~~~~~~~~D~ws~gi~  183 (187)
                      ++.|+|||.+.   ...++.++|+||||++
T Consensus       160 ~~~y~aPE~~~---~~~~~~~~DvwslG~i  186 (280)
T cd05608         160 TPGFMAPELLQ---GEEYDFSVDYFALGVT  186 (280)
T ss_pred             CcCccCHHHhc---CCCCCccccHHHHHHH
Confidence            89999999998   5678899999999983

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g

>KOG0196|consensus

Probab=99.96  E-value=1.1e-29  Score=206.28  Aligned_cols=161  Identities=25%  Similarity=0.369  Sum_probs=128.3

Q ss_pred             cCCcccccccccccccCceEEEEEEEcCCC---cEEEEEEccCccChHHHHHHHHHHHHHHhcCCCCchhhhhhhHHH--
Q psy14630         20 DFTSEDLQDLGEIGRGGFGTVNKMIHRSSD---TVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQFYGALFK--   94 (187)
Q Consensus        20 ~~~~~~~~~~~~lg~G~fg~V~~~~~~~~~---~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~--   94 (187)
                      +++.....+.++||.|.||.|++|..+..+   ..||||.++..-.++ ++..+..++.+|.+.+||||++|-|...+  
T Consensus       625 EId~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~Gytek-qrrdFL~EAsIMGQFdHPNIIrLEGVVTks~  703 (996)
T KOG0196|consen  625 EIDPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEK-QRRDFLSEASIMGQFDHPNIIRLEGVVTKSK  703 (996)
T ss_pred             hcChhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHH-HHhhhhhhhhhcccCCCCcEEEEEEEEecCc
Confidence            455666778899999999999999876555   469999998654444 44455556668999999999998653321  


Q ss_pred             -------------------H------------HHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEecccccccc
Q psy14630         95 -------------------E------------VTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLV  143 (187)
Q Consensus        95 -------------------~------------~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg~a~~~~  143 (187)
                                         .            +...|+.|++||.+. +.+||||..+|||++.+-.+|++|||++|.+.
T Consensus       704 PvMIiTEyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsdm-~YVHRDLAARNILVNsnLvCKVsDFGLSRvle  782 (996)
T KOG0196|consen  704 PVMIITEYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSDM-NYVHRDLAARNILVNSNLVCKVSDFGLSRVLE  782 (996)
T ss_pred             eeEEEhhhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhhc-CchhhhhhhhheeeccceEEEeccccceeecc
Confidence                               1            566788999999875 99999999999999999999999999999886


Q ss_pred             ccc--cccCCCC--CcCccCccccCCCccCCCCCCcceeeeEeeee
Q psy14630        144 DSI--AKTRDAG--CRPYMAPERIDPLRARGYPSFKTKLGFKFNYR  185 (187)
Q Consensus       144 ~~~--~~~~~~~--t~~y~aPE~~~~~~~~~~~~~~D~ws~gi~~~  185 (187)
                      +..  ..+...|  ..+|+|||.|.   ...++.++|+|||||+.|
T Consensus       783 dd~~~~ytt~GGKIPiRWTAPEAIa---~RKFTsASDVWSyGIVmW  825 (996)
T KOG0196|consen  783 DDPEAAYTTLGGKIPIRWTAPEAIA---YRKFTSASDVWSYGIVMW  825 (996)
T ss_pred             cCCCccccccCCccceeecChhHhh---hcccCchhhccccceEEE
Confidence            543  1222233  35699999999   788999999999999888

>PHA03210 serine/threonine kinase US3; Provisional

Probab=99.96  E-value=7.5e-30  Score=207.86  Aligned_cols=157  Identities=20%  Similarity=0.271  Sum_probs=116.5

Q ss_pred             cccccccccccccCceEEEEEEEcCCC-cEEEEEEcc---------------CccChHHHHHHHHHHHHHHhcCCCCchh
Q psy14630         23 SEDLQDLGEIGRGGFGTVNKMIHRSSD-TVMAVKRIR---------------STVDEKDQRQLLMDLDVVMKSNECPYIV   86 (187)
Q Consensus        23 ~~~~~~~~~lg~G~fg~V~~~~~~~~~-~~vaiK~~~---------------~~~~~~~~~~~~~~~~~~~~~~~h~~iv   86 (187)
                      .++|++.+.||+|+||.||+|..+... ...+.|.+.               ...........+..+..+++.++||||+
T Consensus       147 ~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnIv  226 (501)
T PHA03210        147 LAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENIL  226 (501)
T ss_pred             hhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCcC
Confidence            467999999999999999998764322 222222110               0011112334455666778888999999


Q ss_pred             hhhhhH------------------------------------HHHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCC
Q psy14630         87 QFYGAL------------------------------------FKEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGA  130 (187)
Q Consensus        87 ~~~~~~------------------------------------~~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~  130 (187)
                      ++++.+                                    ...++.|++.||.|||+. +|+||||||+||+++.++.
T Consensus       227 ~l~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~-gIiHrDLKP~NILl~~~~~  305 (501)
T PHA03210        227 KIEEILRSEANTYMITQKYDFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDK-KLIHRDIKLENIFLNCDGK  305 (501)
T ss_pred             cEeEEEEECCeeEEEEeccccCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhC-CeecCCCCHHHEEECCCCC
Confidence            876421                                    112677899999999997 9999999999999999999


Q ss_pred             EEEEecccccccccccc--ccCCCCCcCccCccccCCCccCCCCCCcceeeeEee
Q psy14630        131 IKLCDFGISGQLVDSIA--KTRDAGCRPYMAPERIDPLRARGYPSFKTKLGFKFN  183 (187)
Q Consensus       131 ~ki~dfg~a~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi~  183 (187)
                      +||+|||+++.+.....  .....||..|+|||.+.   ...++.++|+||||++
T Consensus       306 vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwSlGvi  357 (501)
T PHA03210        306 IVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILA---GDGYCEITDIWSCGLI  357 (501)
T ss_pred             EEEEeCCCceecCcccccccccccCCcCCCCchhhc---CCCCCcHHHHHHHHHH
Confidence            99999999987654322  22346899999999998   5678999999999984

>KOG3653|consensus

Probab=99.96  E-value=1.1e-29  Score=196.41  Aligned_cols=159  Identities=27%  Similarity=0.343  Sum_probs=122.1

Q ss_pred             cCCcccccccccccccCceEEEEEEEcCCCcEEEEEEccCccChHHHHHHHHHHHHHHh--cCCCCchhhhhhhH-----
Q psy14630         20 DFTSEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMK--SNECPYIVQFYGAL-----   92 (187)
Q Consensus        20 ~~~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~--~~~h~~iv~~~~~~-----   92 (187)
                      ........+.+.+|+|+||.||+|...  ++.||||++..+     ..+....+..+..  .+.|+||++++++-     
T Consensus       206 l~~l~pl~l~eli~~Grfg~V~KaqL~--~~~VAVKifp~~-----~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~  278 (534)
T KOG3653|consen  206 LLELDPLQLLELIGRGRFGCVWKAQLD--NRLVAVKIFPEQ-----EKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTA  278 (534)
T ss_pred             cccCCchhhHHHhhcCccceeehhhcc--CceeEEEecCHH-----HHHHHHhHHHHHhccCccchhHHHhhchhccCCc
Confidence            344667788899999999999999874  589999998632     1222222333333  46899999998532     


Q ss_pred             ------------------------------HHHHHHHHHHHHHHHHhcC--------CCeeecCCCCCeEEcCCCCEEEE
Q psy14630         93 ------------------------------FKEVTVATVKALNYLKEEL--------KIIHRDVKPSNILLDRRGAIKLC  134 (187)
Q Consensus        93 ------------------------------~~~~~~~~~~~l~~lh~~~--------~i~Hrdlk~~nili~~~~~~ki~  134 (187)
                                                    ...++..++.||+|||+..        .|+|||||.+|+|+.+++.+.|+
T Consensus       279 ~~~eywLVt~fh~kGsL~dyL~~ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIa  358 (534)
T KOG3653|consen  279 DRMEYWLVTEFHPKGSLCDYLKANTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIA  358 (534)
T ss_pred             cccceeEEeeeccCCcHHHHHHhccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEee
Confidence                                          1126678899999999853        59999999999999999999999


Q ss_pred             eccccccccccc---cccCCCCCcCccCccccCCCccCC-CC--CCcceeeeEeeee
Q psy14630        135 DFGISGQLVDSI---AKTRDAGCRPYMAPERIDPLRARG-YP--SFKTKLGFKFNYR  185 (187)
Q Consensus       135 dfg~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~-~~--~~~D~ws~gi~~~  185 (187)
                      |||+|.++.+..   .....+||.+|||||++.+..+.. .+  .+.|+||+|+++|
T Consensus       359 DFGLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLW  415 (534)
T KOG3653|consen  359 DFGLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLW  415 (534)
T ss_pred             ccceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHH
Confidence            999999987542   223468999999999998765554 22  4599999999988

>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

Probab=99.96  E-value=2.1e-29  Score=191.26  Aligned_cols=156  Identities=24%  Similarity=0.412  Sum_probs=122.2

Q ss_pred             cccccccccccCceEEEEEEEcCCCcEEEEEEccCccChHHHHHHHHHHHHHHhcCCCCchhhhhhhHHH----------
Q psy14630         25 DLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQFYGALFK----------   94 (187)
Q Consensus        25 ~~~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~----------   94 (187)
                      +|++.+.||+|+||.||+|.+..+++.+|+|.++...........+..+..+++.++|||++++++.+..          
T Consensus         1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   80 (284)
T cd07839           1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY   80 (284)
T ss_pred             CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence            4778899999999999999999999999999986432222222334445556777899999988765421          


Q ss_pred             ----------------------HHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEeccccccccccc-cccCC
Q psy14630         95 ----------------------EVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSI-AKTRD  151 (187)
Q Consensus        95 ----------------------~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg~a~~~~~~~-~~~~~  151 (187)
                                            .++.|++.|+.|||+. +++||||||+||+++.++.++|+|||+++...... .....
T Consensus        81 ~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~-~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~  159 (284)
T cd07839          81 CDQDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSH-NVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCYSAE  159 (284)
T ss_pred             CCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC-CEecCCCCHHHEEEcCCCcEEECccchhhccCCCCCCcCCC
Confidence                                  2667899999999997 99999999999999999999999999988654322 22233


Q ss_pred             CCCcCccCccccCCCccCCCCCCcceeeeEee
Q psy14630        152 AGCRPYMAPERIDPLRARGYPSFKTKLGFKFN  183 (187)
Q Consensus       152 ~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi~  183 (187)
                      .++..|+|||.+.+  ...++.++|+||+|+.
T Consensus       160 ~~~~~y~aPE~~~~--~~~~~~~~DiwslG~i  189 (284)
T cd07839         160 VVTLWYRPPDVLFG--AKLYSTSIDMWSAGCI  189 (284)
T ss_pred             ccccCCcChHHHhC--CcccCcHHHHHHHHHH
Confidence            56788999999873  3447889999999984

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also

>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

Probab=99.96  E-value=1.5e-28  Score=187.42  Aligned_cols=166  Identities=23%  Similarity=0.346  Sum_probs=126.0

Q ss_pred             CCCccccCCcccccccccccccCceEEEEEEEcCC-----CcEEEEEEccCccChHHHHHHHHHHHHHHhcC-CCCchhh
Q psy14630         14 SPDTVYDFTSEDLQDLGEIGRGGFGTVNKMIHRSS-----DTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSN-ECPYIVQ   87 (187)
Q Consensus        14 ~~~~~~~~~~~~~~~~~~lg~G~fg~V~~~~~~~~-----~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~-~h~~iv~   87 (187)
                      +....+.+..++|++.+.||+|+||.||++.....     ...+|+|.+..........+ +..+..+++.+ .|+||++
T Consensus         2 ~~~~~~~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~-~~~E~~~l~~l~~h~~i~~   80 (293)
T cd05053           2 PLDPEWELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSD-LVSEMEMMKMIGKHKNIIN   80 (293)
T ss_pred             CCCcccccCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHH-HHHHHHHHHhhcCCCCeee
Confidence            44667888999999999999999999999987543     36799999875433333333 33344455555 7999998


Q ss_pred             hhhhH---------------------H---------------------------HHHHHHHHHHHHHHHhcCCCeeecCC
Q psy14630         88 FYGAL---------------------F---------------------------KEVTVATVKALNYLKEELKIIHRDVK  119 (187)
Q Consensus        88 ~~~~~---------------------~---------------------------~~~~~~~~~~l~~lh~~~~i~Hrdlk  119 (187)
                      +++.+                     .                           ..+..|++.|+.|||+. +++|||||
T Consensus        81 ~~~~~~~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~-~ivH~dlk  159 (293)
T cd05053          81 LLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASK-KCIHRDLA  159 (293)
T ss_pred             EEEEEcCCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHC-Cccccccc
Confidence            76421                     1                           12567899999999997 99999999


Q ss_pred             CCCeEEcCCCCEEEEecccccccccccc---ccCCCCCcCccCccccCCCccCCCCCCcceeeeEeee
Q psy14630        120 PSNILLDRRGAIKLCDFGISGQLVDSIA---KTRDAGCRPYMAPERIDPLRARGYPSFKTKLGFKFNY  184 (187)
Q Consensus       120 ~~nili~~~~~~ki~dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi~~  184 (187)
                      |+||+++.++.++++|||+++.......   .....++..|+|||.+.   ...++.++|+||||+++
T Consensus       160 p~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~Di~slG~il  224 (293)
T cd05053         160 ARNVLVTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALF---DRVYTHQSDVWSFGVLL  224 (293)
T ss_pred             eeeEEEcCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhc---cCCcCcccceeehhhHH
Confidence            9999999999999999999987654221   11123456799999987   66788999999999943

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,

>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

Probab=99.96  E-value=4.1e-29  Score=188.28  Aligned_cols=158  Identities=16%  Similarity=0.254  Sum_probs=121.4

Q ss_pred             CCcccccccccccccCceEEEEEEEc---CCCcEEEEEEccCccChHHHHHHHHHHHHHHhcCCCCchhhhhhhHH----
Q psy14630         21 FTSEDLQDLGEIGRGGFGTVNKMIHR---SSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQFYGALF----   93 (187)
Q Consensus        21 ~~~~~~~~~~~lg~G~fg~V~~~~~~---~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~----   93 (187)
                      +..++|++.+.||+|+||.||+|+..   ..+..||+|.++....... ...+.++...++.+.||||+++++.+.    
T Consensus         2 i~~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~-~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~   80 (266)
T cd05064           2 LDNKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQ-RRGFLAEALTLGQFDHSNIVRLEGVITRGNT   80 (266)
T ss_pred             CchHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHH-HHHHHHHHHHHhcCCCCCcCeEEEEEecCCC
Confidence            46688999999999999999999764   4567899999875433333 334445555667789999998765321    


Q ss_pred             -----------------------------HHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEeccccccccc
Q psy14630         94 -----------------------------KEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVD  144 (187)
Q Consensus        94 -----------------------------~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg~a~~~~~  144 (187)
                                                   ..++.+++.|++|||+. +++||||||+||+++.++.++++|||.+.....
T Consensus        81 ~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~~-~iiH~dikp~nili~~~~~~~l~dfg~~~~~~~  159 (266)
T cd05064          81 MMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEM-GYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKS  159 (266)
T ss_pred             cEEEEEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHC-CEeeccccHhhEEEcCCCcEEECCCcccccccc
Confidence                                         12667899999999997 999999999999999999999999998765432


Q ss_pred             ccccc--CCCCCcCccCccccCCCccCCCCCCcceeeeEee
Q psy14630        145 SIAKT--RDAGCRPYMAPERIDPLRARGYPSFKTKLGFKFN  183 (187)
Q Consensus       145 ~~~~~--~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi~  183 (187)
                      .....  ...++..|+|||.+.   ...++.++|+||||+.
T Consensus       160 ~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~Di~slG~~  197 (266)
T cd05064         160 EAIYTTMSGKSPVLWAAPEAIQ---YHHFSSASDVWSFGIV  197 (266)
T ss_pred             cchhcccCCCCceeecCHHHHh---hCCccchhHHHHHHHH
Confidence            21111  123456799999987   5678899999999983

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor

>PHA03207 serine/threonine kinase US3; Provisional

Probab=99.96  E-value=3e-29  Score=198.94  Aligned_cols=150  Identities=22%  Similarity=0.194  Sum_probs=119.0

Q ss_pred             CcccccccccccccCceEEEEEEEc--CCCcEEEEEEccCccChHHHHHHHHHHHHHHhcCCCCchhhhhhhH-------
Q psy14630         22 TSEDLQDLGEIGRGGFGTVNKMIHR--SSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQFYGAL-------   92 (187)
Q Consensus        22 ~~~~~~~~~~lg~G~fg~V~~~~~~--~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~-------   92 (187)
                      ...+|.+.+.||+|+||.||+|...  .++..||+|.+....       ....+..+++.++||||+++++.+       
T Consensus        90 ~~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~~-------~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~  162 (392)
T PHA03207         90 VRMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGGK-------TPGREIDILKTISHRAIINLIHAYRWKSTVC  162 (392)
T ss_pred             ccCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEeccccc-------cHHHHHHHHHhcCCCCccceeeeEeeCCEEE
Confidence            3457999999999999999999753  456789999875321       122345567778999999886422       


Q ss_pred             ------------------------HHHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEecccccccccccc-
Q psy14630         93 ------------------------FKEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIA-  147 (187)
Q Consensus        93 ------------------------~~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg~a~~~~~~~~-  147 (187)
                                              ...+..|++.||.|||+. +++||||||+||+++..+.++|+|||++........ 
T Consensus       163 lv~e~~~~~l~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~-givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~~~~  241 (392)
T PHA03207        163 MVMPKYKCDLFTYVDRSGPLPLEQAITIQRRLLEALAYLHGR-GIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDT  241 (392)
T ss_pred             EEehhcCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC-CccccCCCHHHEEEcCCCCEEEccCccccccCccccc
Confidence                                    112667899999999997 999999999999999999999999999987654321 


Q ss_pred             --ccCCCCCcCccCccccCCCccCCCCCCcceeeeEe
Q psy14630        148 --KTRDAGCRPYMAPERIDPLRARGYPSFKTKLGFKF  182 (187)
Q Consensus       148 --~~~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi  182 (187)
                        .....||+.|+|||++.   ...++.++|+||+|+
T Consensus       242 ~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslGv  275 (392)
T PHA03207        242 PQCYGWSGTLETNSPELLA---LDPYCAKTDIWSAGL  275 (392)
T ss_pred             ccccccccccCccCHhHhc---CCCCCchhhHHHHHH
Confidence              22346899999999998   567889999999998

>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2

Probab=99.95  E-value=5.9e-29  Score=188.47  Aligned_cols=157  Identities=25%  Similarity=0.411  Sum_probs=120.6

Q ss_pred             CCcccccccccccccCceEEEEEEEcCCCc----EEEEEEccCccChHHHHHHHHHHHHHHhcCCCCchhhhhhhH----
Q psy14630         21 FTSEDLQDLGEIGRGGFGTVNKMIHRSSDT----VMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQFYGAL----   92 (187)
Q Consensus        21 ~~~~~~~~~~~lg~G~fg~V~~~~~~~~~~----~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~----   92 (187)
                      +..++|++.+.||+|+||.||+|.+..++.    .||+|.++...... ..+.+..+..+++..+|+||+.+++.+    
T Consensus         4 l~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~-~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~   82 (279)
T cd05109           4 LKETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPK-ANKEILDEAYVMAGVGSPYVCRLLGICLTST   82 (279)
T ss_pred             cchhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHH-HHHHHHHHHHHHHhcCCCCCceEEEEEcCCC
Confidence            456789999999999999999998766665    48999886543332 233444555567778999998764321    


Q ss_pred             ----------------------------HHHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEeccccccccc
Q psy14630         93 ----------------------------FKEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVD  144 (187)
Q Consensus        93 ----------------------------~~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg~a~~~~~  144 (187)
                                                  ...+..|++.|++|||+. +++||||||+||+++.++.+||+|||+++....
T Consensus        83 ~~l~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~~-~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~~  161 (279)
T cd05109          83 VQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEV-RLVHRDLAARNVLVKSPNHVKITDFGLARLLDI  161 (279)
T ss_pred             cEEEEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC-CeeccccccceEEEcCCCcEEECCCCceeeccc
Confidence                                        112567999999999998 999999999999999999999999999987643


Q ss_pred             cccc---cCCCCCcCccCccccCCCccCCCCCCcceeeeEe
Q psy14630        145 SIAK---TRDAGCRPYMAPERIDPLRARGYPSFKTKLGFKF  182 (187)
Q Consensus       145 ~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi  182 (187)
                      ....   ....++..|+|||.+.   ...++.++|+||||+
T Consensus       162 ~~~~~~~~~~~~~~~y~~PE~~~---~~~~~~~~Di~slG~  199 (279)
T cd05109         162 DETEYHADGGKVPIKWMALESIL---HRRFTHQSDVWSYGV  199 (279)
T ss_pred             ccceeecCCCccchhhCCHHHhc---cCCCCchhHHHHHHH
Confidence            2211   1123456799999998   566889999999998

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve

>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

Probab=99.95  E-value=4.7e-29  Score=189.31  Aligned_cols=158  Identities=16%  Similarity=0.274  Sum_probs=122.5

Q ss_pred             CCcccccccccccccCceEEEEEEEcC-----CCcEEEEEEccCccChHHHHHHHHHHHHHHhcCCCCchhhhhhhH---
Q psy14630         21 FTSEDLQDLGEIGRGGFGTVNKMIHRS-----SDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQFYGAL---   92 (187)
Q Consensus        21 ~~~~~~~~~~~lg~G~fg~V~~~~~~~-----~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~---   92 (187)
                      +...+|++.+.||+|+||.||+|....     .++.||+|.++..... ...+.+.++..++..++||||+++++.+   
T Consensus         2 i~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~   80 (283)
T cd05091           2 INLSTVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEG-PLREEFKHEAMMRSRLQHPNIVCLLGVVTKE   80 (283)
T ss_pred             CCHHHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCH-HHHHHHHHHHHHHhcCCCCCcCeEEEEEcCC
Confidence            345789999999999999999998653     3578999998754332 2344556666677888999999775421   


Q ss_pred             ---------------------------------------------HHHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcC
Q psy14630         93 ---------------------------------------------FKEVTVATVKALNYLKEELKIIHRDVKPSNILLDR  127 (187)
Q Consensus        93 ---------------------------------------------~~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~  127 (187)
                                                                   ...++.|++.|+.|+|+. +++||||||+||+++.
T Consensus        81 ~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~-gi~H~dlkp~Nil~~~  159 (283)
T cd05091          81 QPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSH-HVVHKDLATRNVLVFD  159 (283)
T ss_pred             CceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHc-CccccccchhheEecC
Confidence                                                         012556899999999997 9999999999999999


Q ss_pred             CCCEEEEecccccccccccc---ccCCCCCcCccCccccCCCccCCCCCCcceeeeEee
Q psy14630        128 RGAIKLCDFGISGQLVDSIA---KTRDAGCRPYMAPERIDPLRARGYPSFKTKLGFKFN  183 (187)
Q Consensus       128 ~~~~ki~dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi~  183 (187)
                      ++.+|++|||+++.......   .....+++.|+|||.+.   ...++.++|+||+|+.
T Consensus       160 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~Dv~slG~~  215 (283)
T cd05091         160 KLNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIM---YGKFSIDSDIWSYGVV  215 (283)
T ss_pred             CCceEecccccccccccchheeeccCccCCccccCHHHHh---cCCCCcchhHHHHHHH
Confidence            99999999999887643221   12224567899999987   5568899999999983

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

Probab=99.95  E-value=4.9e-29  Score=187.65  Aligned_cols=160  Identities=29%  Similarity=0.460  Sum_probs=125.5

Q ss_pred             CCcccccccccccccCceEEEEEEEcCCCcEEEEEEccCccChHHHHHHHHHHHHHHhcCCCCchhhhhhhH--------
Q psy14630         21 FTSEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQFYGAL--------   92 (187)
Q Consensus        21 ~~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~--------   92 (187)
                      ...++|++.+.||+|+||.||+|.+..+++.+|+|.++....  .....+.++..+++.++||||+++++.+        
T Consensus         6 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~l   83 (267)
T cd06645           6 NPQEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPG--EDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWI   83 (267)
T ss_pred             CcHHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCch--hHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEE
Confidence            355789999999999999999999999999999999864322  2223345555677788999999876432        


Q ss_pred             ------------------------HHHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEeccccccccccc-c
Q psy14630         93 ------------------------FKEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSI-A  147 (187)
Q Consensus        93 ------------------------~~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg~a~~~~~~~-~  147 (187)
                                              ...+..+++.++.|||+. +++|+||||+||+++.++.++|+|||++....... .
T Consensus        84 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~-~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~~  162 (267)
T cd06645          84 CMEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHSK-GKMHRDIKGANILLTDNGHVKLADFGVSAQITATIAK  162 (267)
T ss_pred             EEeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC-CeecCCCCHHHEEECCCCCEEECcceeeeEccCcccc
Confidence                                    112567899999999997 99999999999999999999999999987654322 2


Q ss_pred             ccCCCCCcCccCccccCCCccCCCCCCcceeeeEee
Q psy14630        148 KTRDAGCRPYMAPERIDPLRARGYPSFKTKLGFKFN  183 (187)
Q Consensus       148 ~~~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi~  183 (187)
                      .....|+..|+|||.+.......++.++|+||+|+.
T Consensus       163 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~i  198 (267)
T cd06645         163 RKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGIT  198 (267)
T ss_pred             cccccCcccccChhhhccccCCCCCchhhhHHHHHH
Confidence            233468899999999753224457889999999983

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity

Probab=99.95  E-value=1.9e-29  Score=188.76  Aligned_cols=156  Identities=31%  Similarity=0.477  Sum_probs=123.1

Q ss_pred             ccccccccccCceEEEEEEEcCCCcEEEEEEccCccChHHHHHHHHHHHHHHhcCCCCchhhhhhhH-------------
Q psy14630         26 LQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQFYGAL-------------   92 (187)
Q Consensus        26 ~~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~-------------   92 (187)
                      |++.+.||+|+||.||++.+..+++.+|+|.+...............+...++.+.||||+++++.+             
T Consensus         1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~   80 (260)
T PF00069_consen    1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC   80 (260)
T ss_dssp             EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred             CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence            6788999999999999999999999999999976544333333333355566667999999876422             


Q ss_pred             -------------------HHHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEeccccccc-cccccccCCC
Q psy14630         93 -------------------FKEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQL-VDSIAKTRDA  152 (187)
Q Consensus        93 -------------------~~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg~a~~~-~~~~~~~~~~  152 (187)
                                         ...++.|++.||.+||+. +++|+||||+||+++.++.++++|||.+... ..........
T Consensus        81 ~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~Lh~~-~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~  159 (260)
T PF00069_consen   81 PGGSLQDYLQKNKPLSEEEILKIAYQILEALAYLHSK-GIVHRDIKPENILLDENGEVKLIDFGSSVKLSENNENFNPFV  159 (260)
T ss_dssp             TTEBHHHHHHHHSSBBHHHHHHHHHHHHHHHHHHHHT-TEEESSBSGGGEEESTTSEEEESSGTTTEESTSTTSEBSSSS
T ss_pred             ccccccccccccccccccccccccccccccccccccc-cccccccccccccccccccccccccccccccccccccccccc
Confidence                               122678899999999997 9999999999999999999999999998764 2223334457


Q ss_pred             CCcCccCccccCCCccCCCCCCcceeeeEeee
Q psy14630        153 GCRPYMAPERIDPLRARGYPSFKTKLGFKFNY  184 (187)
Q Consensus       153 ~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi~~  184 (187)
                      ++..|+|||.+..  ....+.++|+||+|+++
T Consensus       160 ~~~~y~aPE~~~~--~~~~~~~~Di~slG~il  189 (260)
T PF00069_consen  160 GTPEYMAPEVLQQ--GKKYTRKSDIWSLGIIL  189 (260)
T ss_dssp             SSGGGSCHHHHTT--TSSBSTHHHHHHHHHHH
T ss_pred             ccccccccccccc--ccccccccccccccccc
Confidence            8889999999761  45678999999999943

Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....

>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl

Probab=99.95  E-value=9.6e-29  Score=186.43  Aligned_cols=154  Identities=21%  Similarity=0.336  Sum_probs=118.2

Q ss_pred             ccccccccccCceEEEEEEEcCCCc--EEEEEEccCccChHHHHHHHHHHHHHHhcCCCCchhhhhhhH-----------
Q psy14630         26 LQDLGEIGRGGFGTVNKMIHRSSDT--VMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQFYGAL-----------   92 (187)
Q Consensus        26 ~~~~~~lg~G~fg~V~~~~~~~~~~--~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~-----------   92 (187)
                      +.+.+.||+|+||.||+|....++.  .+|+|.++.........+.+..+...++.++|+||+++++.+           
T Consensus         1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   80 (272)
T cd05075           1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS   80 (272)
T ss_pred             CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence            3467899999999999999876665  689998875433333344455555667778999999875421           


Q ss_pred             ---------------------------------HHHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEecccc
Q psy14630         93 ---------------------------------FKEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGIS  139 (187)
Q Consensus        93 ---------------------------------~~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg~a  139 (187)
                                                       ...+..|++.|++|||+. +++||||||+||+++.++.++|+|||++
T Consensus        81 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~-~i~H~dlkp~Nil~~~~~~~kl~Dfg~~  159 (272)
T cd05075          81 PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSK-SFIHRDLAARNCMLNENMNVCVADFGLS  159 (272)
T ss_pred             cEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHC-CeeccccchhheEEcCCCCEEECCCCcc
Confidence                                             011556889999999997 9999999999999999999999999999


Q ss_pred             cccccccc---ccCCCCCcCccCccccCCCccCCCCCCcceeeeEee
Q psy14630        140 GQLVDSIA---KTRDAGCRPYMAPERIDPLRARGYPSFKTKLGFKFN  183 (187)
Q Consensus       140 ~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi~  183 (187)
                      +.......   .....+++.|+|||...   ...++.++|+||||+.
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~---~~~~~~~~Di~slG~i  203 (272)
T cd05075         160 KKIYNGDYYRQGRIAKMPVKWIAIESLA---DRVYTTKSDVWSFGVT  203 (272)
T ss_pred             cccCcccceecCCcccCCcccCCHHHcc---CCCcChHHHHHHHHHH
Confidence            87654321   11224566799999988   6678899999999983

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor

>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3

Probab=99.95  E-value=1e-28  Score=187.42  Aligned_cols=158  Identities=26%  Similarity=0.386  Sum_probs=119.4

Q ss_pred             CCcccccccccccccCceEEEEEEEcCCCc----EEEEEEccCccChHHHHHHHHHHHHHHhcCCCCchhhhhhhH----
Q psy14630         21 FTSEDLQDLGEIGRGGFGTVNKMIHRSSDT----VMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQFYGAL----   92 (187)
Q Consensus        21 ~~~~~~~~~~~lg~G~fg~V~~~~~~~~~~----~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~----   92 (187)
                      +..++|++.+.||+|+||.||+|....+++    .+++|.+........ ...+..+...+..+.||||+++++.+    
T Consensus         4 ~~~~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~-~~~~~~~~~~l~~l~h~~iv~~~~~~~~~~   82 (279)
T cd05111           4 LKETELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQT-FQEITDHMLAMGSLDHAYIVRLLGICPGAS   82 (279)
T ss_pred             CCHhhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHH-HHHHHHHHHHHhcCCCCCcceEEEEECCCc
Confidence            456789999999999999999999877666    467777643222222 22333344455678999999877432    


Q ss_pred             ----------------------------HHHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEeccccccccc
Q psy14630         93 ----------------------------FKEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVD  144 (187)
Q Consensus        93 ----------------------------~~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg~a~~~~~  144 (187)
                                                  ...+..|++.|+.|||+. +++||||||+||+++.++.+|++|||+++...+
T Consensus        83 ~~~i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~-~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~~  161 (279)
T cd05111          83 LQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEH-RMVHRNLAARNILLKSDSIVQIADFGVADLLYP  161 (279)
T ss_pred             cEEEEEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHC-CEeccccCcceEEEcCCCcEEEcCCccceeccC
Confidence                                        112667899999999997 999999999999999999999999999987543


Q ss_pred             cc---cccCCCCCcCccCccccCCCccCCCCCCcceeeeEee
Q psy14630        145 SI---AKTRDAGCRPYMAPERIDPLRARGYPSFKTKLGFKFN  183 (187)
Q Consensus       145 ~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi~  183 (187)
                      ..   ......++..|+|||.+.   ...++.++|+||||+.
T Consensus       162 ~~~~~~~~~~~~~~~y~~pE~~~---~~~~~~~~Dv~slG~i  200 (279)
T cd05111         162 DDKKYFYSEHKTPIKWMALESIL---FGRYTHQSDVWSYGVT  200 (279)
T ss_pred             CCcccccCCCCCcccccCHHHhc---cCCcCchhhHHHHHHH
Confidence            21   112234567899999998   5668899999999983

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r

>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

Probab=99.95  E-value=1.1e-28  Score=195.93  Aligned_cols=170  Identities=24%  Similarity=0.390  Sum_probs=128.1

Q ss_pred             ceecCCCccccCCcccccccccccccCceEEEEEEEc-----CCCcEEEEEEccCccChHHHHHHHHHHHHHHhcCC-CC
Q psy14630         10 KLKLSPDTVYDFTSEDLQDLGEIGRGGFGTVNKMIHR-----SSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNE-CP   83 (187)
Q Consensus        10 ~~~~~~~~~~~~~~~~~~~~~~lg~G~fg~V~~~~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~-h~   83 (187)
                      +...+....|+++.++|.+.+.||+|+||.||+|.+.     .++..||+|.++.......... +..+..++..+. ||
T Consensus        23 ~~~~~~~~~~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~-~~~E~~~l~~l~~H~  101 (401)
T cd05107          23 PMQLPYDSAWEMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQA-LMSELKIMSHLGPHL  101 (401)
T ss_pred             CCCCCCCCcceecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHH-HHHHHHHHHhcCCCC
Confidence            3445556778999999999999999999999999853     3556899999975433332233 344444555555 99


Q ss_pred             chhhhhhhHHH---------------------------------------------------------------------
Q psy14630         84 YIVQFYGALFK---------------------------------------------------------------------   94 (187)
Q Consensus        84 ~iv~~~~~~~~---------------------------------------------------------------------   94 (187)
                      ||+++++.+..                                                                     
T Consensus       102 niv~~~~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  181 (401)
T cd05107         102 NIVNLLGACTKGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDM  181 (401)
T ss_pred             CeEEEEEEEccCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCcccccc
Confidence            99987643211                                                                     


Q ss_pred             -------------------------------------------------------------HHHHHHHHHHHHHHhcCCC
Q psy14630         95 -------------------------------------------------------------EVTVATVKALNYLKEELKI  113 (187)
Q Consensus        95 -------------------------------------------------------------~~~~~~~~~l~~lh~~~~i  113 (187)
                                                                                   .+..|++.|+.|||+. ++
T Consensus       182 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~-~i  260 (401)
T cd05107         182 SKDESADYVPMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASK-NC  260 (401)
T ss_pred             CCccccCccchhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcC-Cc
Confidence                                                                         1335889999999997 99


Q ss_pred             eeecCCCCCeEEcCCCCEEEEeccccccccccc---cccCCCCCcCccCccccCCCccCCCCCCcceeeeEeee
Q psy14630        114 IHRDVKPSNILLDRRGAIKLCDFGISGQLVDSI---AKTRDAGCRPYMAPERIDPLRARGYPSFKTKLGFKFNY  184 (187)
Q Consensus       114 ~Hrdlk~~nili~~~~~~ki~dfg~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi~~  184 (187)
                      +||||||+||+++..+.++++|||+++......   ......++..|+|||.+.   ...++.++|+||||+.+
T Consensus       261 vHrdlkp~NiLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~DvwslGvil  331 (401)
T cd05107         261 VHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIF---NNLYTTLSDVWSFGILL  331 (401)
T ss_pred             CcccCCcceEEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhc---CCCCCcHhHHHHHHHHH
Confidence            999999999999999999999999998653221   112234677899999998   56688999999999943

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D

>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2

Probab=99.95  E-value=1.7e-28  Score=188.37  Aligned_cols=159  Identities=25%  Similarity=0.388  Sum_probs=116.6

Q ss_pred             CCcccccccccccccCceEEEEEEEcCCCcE--EEEEEccCccChHHHHHHHHHHHHHHhcCCCCchhhhhhhH------
Q psy14630         21 FTSEDLQDLGEIGRGGFGTVNKMIHRSSDTV--MAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQFYGAL------   92 (187)
Q Consensus        21 ~~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~--vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~------   92 (187)
                      +..++|++.+.||+|+||.||+|.+..++..  +|+|.++.............+...+.+..+|+||+++++.+      
T Consensus         4 ~~~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~   83 (303)
T cd05088           4 LEWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYL   83 (303)
T ss_pred             cchhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCc
Confidence            4567899999999999999999998776654  57777654333322233333444334444899999875321      


Q ss_pred             ------------------------------------------HHHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCC
Q psy14630         93 ------------------------------------------FKEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGA  130 (187)
Q Consensus        93 ------------------------------------------~~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~  130 (187)
                                                                ...++.|++.|++|||+. +++||||||+|++++.++.
T Consensus        84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~-gi~H~dlkp~Nili~~~~~  162 (303)
T cd05088          84 YLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK-QFIHRDLAARNILVGENYV  162 (303)
T ss_pred             eEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhC-CccccccchheEEecCCCc
Confidence                                                      012556899999999997 9999999999999999999


Q ss_pred             EEEEeccccccccccccccCCCCCcCccCccccCCCccCCCCCCcceeeeEee
Q psy14630        131 IKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPLRARGYPSFKTKLGFKFN  183 (187)
Q Consensus       131 ~ki~dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi~  183 (187)
                      ++|+|||+++.............+..|+|||.+.   ...++.++|+||||++
T Consensus       163 ~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~Di~slG~i  212 (303)
T cd05088         163 AKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLN---YSVYTTNSDVWSYGVL  212 (303)
T ss_pred             EEeCccccCcccchhhhcccCCCcccccCHHHHh---ccCCcccccchhhhhH
Confidence            9999999987543222222223456799999987   5568899999999983

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A

>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=99.95  E-value=1.6e-28  Score=184.23  Aligned_cols=157  Identities=29%  Similarity=0.411  Sum_probs=123.7

Q ss_pred             ccccccccccccCceEEEEEEEcCCCcEEEEEEccCccCh---HHHHHHHHHHHHHHhcCCCCchhhhhhhHH-------
Q psy14630         24 EDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDE---KDQRQLLMDLDVVMKSNECPYIVQFYGALF-------   93 (187)
Q Consensus        24 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~-------   93 (187)
                      ++|.+.+.||+|++|.||+|.+..+++.+|+|.+......   ....+.+.++..+++.++||||+++++.+.       
T Consensus         2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~   81 (263)
T cd06625           2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI   81 (263)
T ss_pred             CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence            5688999999999999999999999999999988643221   112334555666778889999998875321       


Q ss_pred             -------------------------HHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEeccccccccccccc
Q psy14630         94 -------------------------KEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAK  148 (187)
Q Consensus        94 -------------------------~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg~a~~~~~~~~~  148 (187)
                                               ..++.+++.|+.|||+. +++|+||+|+||+++.++.++|+|||+++........
T Consensus        82 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~-~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~~~~~  160 (263)
T cd06625          82 FMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSN-MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSS  160 (263)
T ss_pred             EEEECCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhC-CeecCCCCHHHEEEcCCCCEEEeecccceeccccccc
Confidence                                     12567899999999997 9999999999999999999999999998765432111


Q ss_pred             ----cCCCCCcCccCccccCCCccCCCCCCcceeeeEeee
Q psy14630        149 ----TRDAGCRPYMAPERIDPLRARGYPSFKTKLGFKFNY  184 (187)
Q Consensus       149 ----~~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi~~  184 (187)
                          ....++..|+|||.+.   ...++.++|+||+|++.
T Consensus       161 ~~~~~~~~~~~~y~aPE~~~---~~~~~~~~Di~slG~il  197 (263)
T cd06625         161 GTGMKSVTGTPYWMSPEVIS---GEGYGRKADVWSVGCTV  197 (263)
T ss_pred             cccccCCCcCccccCcceec---cCCCCchhhhHHHHHHH
Confidence                2235678899999998   55688999999999843

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t

>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1

Probab=99.95  E-value=1.8e-28  Score=187.53  Aligned_cols=156  Identities=27%  Similarity=0.400  Sum_probs=115.3

Q ss_pred             ccccccccccccCceEEEEEEEcCCCc--EEEEEEccCccChHHHHHHHHHHHHHHhcCCCCchhhhhhhH---------
Q psy14630         24 EDLQDLGEIGRGGFGTVNKMIHRSSDT--VMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQFYGAL---------   92 (187)
Q Consensus        24 ~~~~~~~~lg~G~fg~V~~~~~~~~~~--~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~---------   92 (187)
                      ++|++.+.||+|+||.||+|....++.  .+++|.++.............+...+.+..+||||+++++.+         
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv   81 (297)
T cd05089           2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIA   81 (297)
T ss_pred             ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEE
Confidence            688999999999999999998876654  468888764333333333344444444444799999875321         


Q ss_pred             ---------------------------------------HHHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEE
Q psy14630         93 ---------------------------------------FKEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKL  133 (187)
Q Consensus        93 ---------------------------------------~~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki  133 (187)
                                                             ...++.|++.|++|||+. +++||||||+|++++.++.+||
T Consensus        82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~-~ivH~dlkp~Nill~~~~~~kl  160 (297)
T cd05089          82 IEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEK-QFIHRDLAARNVLVGENLASKI  160 (297)
T ss_pred             EEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHC-CcccCcCCcceEEECCCCeEEE
Confidence                                                   012556889999999997 9999999999999999999999


Q ss_pred             EeccccccccccccccCCCCCcCccCccccCCCccCCCCCCcceeeeEee
Q psy14630        134 CDFGISGQLVDSIAKTRDAGCRPYMAPERIDPLRARGYPSFKTKLGFKFN  183 (187)
Q Consensus       134 ~dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi~  183 (187)
                      +|||++..............+..|+|||.+.   ...++.++|+||||+.
T Consensus       161 ~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~DvwSlG~i  207 (297)
T cd05089         161 ADFGLSRGEEVYVKKTMGRLPVRWMAIESLN---YSVYTTKSDVWSFGVL  207 (297)
T ss_pred             CCcCCCccccceeccCCCCcCccccCchhhc---cCCCCchhhHHHHHHH
Confidence            9999987543222222223345699999987   5668899999999983

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.

>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

Probab=99.95  E-value=9.5e-29  Score=186.08  Aligned_cols=159  Identities=26%  Similarity=0.426  Sum_probs=124.5

Q ss_pred             CCcccccccccccccCceEEEEEEEcCCCcEEEEEEccCccChHHHHHHHHHHHHHHhcCCCCchhhhhhhHH-------
Q psy14630         21 FTSEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQFYGALF-------   93 (187)
Q Consensus        21 ~~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~-------   93 (187)
                      ....+|++.+.||+|+||.||+|.+..+++.+|+|.+......  ....+..+..+++.+.||||+++++.+.       
T Consensus         6 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~--~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~i   83 (267)
T cd06646           6 NPQHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGD--DFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWI   83 (267)
T ss_pred             CchhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccc--hHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEE
Confidence            3567899999999999999999999889999999998643221  2234445556777889999998764221       


Q ss_pred             -------------------------HHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEeccccccccccc-c
Q psy14630         94 -------------------------KEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSI-A  147 (187)
Q Consensus        94 -------------------------~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg~a~~~~~~~-~  147 (187)
                                               ..+..|++.+++|||+. +++|||++|+|++++.++.++++|||+++...... .
T Consensus        84 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~-~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~~  162 (267)
T cd06646          84 CMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSK-GKMHRDIKGANILLTDNGDVKLADFGVAAKITATIAK  162 (267)
T ss_pred             EEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC-CccccCCCHHHEEECCCCCEEECcCccceeecccccc
Confidence                                     11567899999999997 99999999999999999999999999998764322 2


Q ss_pred             ccCCCCCcCccCccccCCCccCCCCCCcceeeeEe
Q psy14630        148 KTRDAGCRPYMAPERIDPLRARGYPSFKTKLGFKF  182 (187)
Q Consensus       148 ~~~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi  182 (187)
                      .....+++.|+|||.+.......++.++|+||+|+
T Consensus       163 ~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~  197 (267)
T cd06646         163 RKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGI  197 (267)
T ss_pred             cCccccCccccCHhHcccccCCCCcchhhHHHHHH
Confidence            23346788999999985333445778999999998

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

Probab=99.95  E-value=5.5e-29  Score=188.91  Aligned_cols=156  Identities=24%  Similarity=0.401  Sum_probs=121.4

Q ss_pred             cccccccccccCceEEEEEEEcCCCcEEEEEEccCccChHHHHHHHHHHHHHHhcCCCCchhhhhhhHHH----------
Q psy14630         25 DLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQFYGALFK----------   94 (187)
Q Consensus        25 ~~~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~----------   94 (187)
                      +|++.+.||+|+||.||+|.+..+++.||+|.++...........+..+..+++.+.|||++++++.+..          
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (285)
T cd07861           1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF   80 (285)
T ss_pred             CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence            5788899999999999999999899999999986432222223344455667777889999988753211          


Q ss_pred             ------------------------HHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEeccccccccccc-ccc
Q psy14630         95 ------------------------EVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSI-AKT  149 (187)
Q Consensus        95 ------------------------~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg~a~~~~~~~-~~~  149 (187)
                                              .++.|++.||+|||+. +++|+||+|+||+++.++.++|+|||++....... ...
T Consensus        81 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~-~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~  159 (285)
T cd07861          81 LSMDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSR-RVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRVYT  159 (285)
T ss_pred             CCCCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhC-CeeecCCCHHHEEEcCCCcEEECcccceeecCCCccccc
Confidence                                    1567899999999997 99999999999999999999999999987653221 122


Q ss_pred             CCCCCcCccCccccCCCccCCCCCCcceeeeEee
Q psy14630        150 RDAGCRPYMAPERIDPLRARGYPSFKTKLGFKFN  183 (187)
Q Consensus       150 ~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi~  183 (187)
                      ...+++.|+|||.+.+  ...++.++|+||+|+.
T Consensus       160 ~~~~~~~y~aPE~~~~--~~~~~~~~Dv~slG~i  191 (285)
T cd07861         160 HEVVTLWYRAPEVLLG--SPRYSTPVDIWSIGTI  191 (285)
T ss_pred             CCcccccccChHHhcC--CCCcCcHHHHHHHHHH
Confidence            2356788999999863  3346789999999984

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2

>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

Probab=99.95  E-value=1.3e-28  Score=187.75  Aligned_cols=153  Identities=29%  Similarity=0.490  Sum_probs=124.0

Q ss_pred             ccccccccccccCceEEEEEEEcCCCcEEEEEEccCcc-ChHHHHHHHHHHHHHHhcCCCCchhhhhhhHH---------
Q psy14630         24 EDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTV-DEKDQRQLLMDLDVVMKSNECPYIVQFYGALF---------   93 (187)
Q Consensus        24 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~---------   93 (187)
                      ++|++.+.||+|+||.||++.+..+++.+|+|.++... ......+.+..+..+++.++||||+++++.+.         
T Consensus         1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   80 (290)
T cd05580           1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM   80 (290)
T ss_pred             CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence            46889999999999999999999899999999986422 12223344555666778889999998865321         


Q ss_pred             -----------------------HHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEeccccccccccccccC
Q psy14630         94 -----------------------KEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTR  150 (187)
Q Consensus        94 -----------------------~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg~a~~~~~~~~~~~  150 (187)
                                             ..+..|++.+|.|||+. +++|+||+|+||+++.++.++|+|||+++.....  ...
T Consensus        81 e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~l~~lH~~-~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~--~~~  157 (290)
T cd05580          81 EYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLHSL-DIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR--TYT  157 (290)
T ss_pred             ecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC-CEecCCCCHHHEEECCCCCEEEeeCCCccccCCC--CCC
Confidence                                   11567899999999997 9999999999999999999999999999876544  233


Q ss_pred             CCCCcCccCccccCCCccCCCCCCcceeeeEe
Q psy14630        151 DAGCRPYMAPERIDPLRARGYPSFKTKLGFKF  182 (187)
Q Consensus       151 ~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi  182 (187)
                      ..+++.|+|||.+.   +..++.++|+||+|+
T Consensus       158 ~~~~~~y~aPE~~~---~~~~~~~~Di~slG~  186 (290)
T cd05580         158 LCGTPEYLAPEIIL---SKGYGKAVDWWALGI  186 (290)
T ss_pred             CCCCccccChhhhc---CCCCCccccHHHHHH
Confidence            46888999999988   556889999999998

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi

>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

Probab=99.95  E-value=9.9e-29  Score=187.52  Aligned_cols=157  Identities=29%  Similarity=0.462  Sum_probs=124.0

Q ss_pred             ccccccccccccCceEEEEEEEcCCCcEEEEEEccCccChHHHHHHHHHHHHHHhcCCCCchhhhhhhH-----------
Q psy14630         24 EDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQFYGAL-----------   92 (187)
Q Consensus        24 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~-----------   92 (187)
                      ++|++...||+|+||.||+|.+..+++.+|+|.+..........+.+.++..+++.+.|+|++++++.+           
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e   80 (286)
T cd07847           1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE   80 (286)
T ss_pred             CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence            468889999999999999999988999999998864322222334455566677788999999876532           


Q ss_pred             ---------------------HHHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEeccccccccccc-cccC
Q psy14630         93 ---------------------FKEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSI-AKTR  150 (187)
Q Consensus        93 ---------------------~~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg~a~~~~~~~-~~~~  150 (187)
                                           ...++.|++.++.|||+. +++|+||+|+||+++.++.++|+|||++....... ....
T Consensus        81 ~~~~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~-~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~  159 (286)
T cd07847          81 YCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKH-NCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTD  159 (286)
T ss_pred             ccCccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHC-CceecCCChhhEEEcCCCcEEECccccceecCCCcccccC
Confidence                                 112677899999999997 99999999999999999999999999998765432 2223


Q ss_pred             CCCCcCccCccccCCCccCCCCCCcceeeeEee
Q psy14630        151 DAGCRPYMAPERIDPLRARGYPSFKTKLGFKFN  183 (187)
Q Consensus       151 ~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi~  183 (187)
                      ..++..|+|||.+.+  ...++.++|+||+|+.
T Consensus       160 ~~~~~~~~aPE~~~~--~~~~~~~~Di~slG~i  190 (286)
T cd07847         160 YVATRWYRAPELLVG--DTQYGPPVDVWAIGCV  190 (286)
T ss_pred             cccccccCCHHHHhC--CCCcCchhhhHHHHHH
Confidence            457788999999863  2447789999999983

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio

>KOG1094|consensus

Probab=99.95  E-value=1.1e-28  Score=195.27  Aligned_cols=163  Identities=23%  Similarity=0.319  Sum_probs=131.9

Q ss_pred             ccccCCcccccccccccccCceEEEEEEEcCCCcEEEEEEccCccChHHHHHHHHHHHHHHhcCCCCchhhhhhhHHHH-
Q psy14630         17 TVYDFTSEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQFYGALFKE-   95 (187)
Q Consensus        17 ~~~~~~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~-   95 (187)
                      ...+++++.+.+.++||+|-||.|.+|.-. ....||+|.++....+.. +..+..++.++..+.||||++++++|..+ 
T Consensus       531 al~EfPRs~L~~~ekiGeGqFGEVhLCeve-g~lkVAVK~Lr~~a~~~~-r~~F~kEIkiLsqLkhPNIveLvGVC~~De  608 (807)
T KOG1094|consen  531 ALVEFPRSRLRFKEKIGEGQFGEVHLCEVE-GPLKVAVKILRPDATKNA-RNDFLKEIKILSRLKHPNIVELLGVCVQDD  608 (807)
T ss_pred             chhhcchhheehhhhhcCcccceeEEEEec-CceEEEEeecCcccchhH-HHHHHHHHHHHhccCCCCeeEEEeeeecCC
Confidence            344788899999999999999999999874 468999999986544333 34445555566677999999999875332 


Q ss_pred             ---------------------------------HHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEeccccccc
Q psy14630         96 ---------------------------------VTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQL  142 (187)
Q Consensus        96 ---------------------------------~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg~a~~~  142 (187)
                                                       +..||+.|++||.+. +++|||+.++|+|++..+++||+|||.++.+
T Consensus       609 PicmI~EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~-nfVHrd~a~rNcLv~~e~~iKiadfgmsR~l  687 (807)
T KOG1094|consen  609 PLCMITEYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESL-NFVHRDLATRNCLVDGEFTIKIADFGMSRNL  687 (807)
T ss_pred             chHHHHHHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhh-chhhccccccceeecCcccEEecCccccccc
Confidence                                             667899999999886 9999999999999999999999999999977


Q ss_pred             cccccccCC---CCCcCccCccccCCCccCCCCCCcceeeeEeeee
Q psy14630        143 VDSIAKTRD---AGCRPYMAPERIDPLRARGYPSFKTKLGFKFNYR  185 (187)
Q Consensus       143 ~~~~~~~~~---~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi~~~  185 (187)
                      -........   .-..+|||+|.|.   ...++.++|+|+||+.+|
T Consensus       688 ysg~yy~vqgr~vlpiRwmawEsil---lgkFttaSDvWafgvTlw  730 (807)
T KOG1094|consen  688 YSGDYYRVQGRAVLPIRWMAWESIL---LGKFTTASDVWAFGVTLW  730 (807)
T ss_pred             ccCCceeeecceeeeeeehhHHHHH---hccccchhhhhhhHHHHH
Confidence            655443322   3457899999999   777999999999999655

>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

Probab=99.95  E-value=1.7e-28  Score=184.55  Aligned_cols=157  Identities=21%  Similarity=0.359  Sum_probs=123.8

Q ss_pred             ccCCcccccccccccccCceEEEEEEEcCCCcEEEEEEccCccChHHHHHHHHHHHHHHhcCCCCchhhhhhhHH-----
Q psy14630         19 YDFTSEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQFYGALF-----   93 (187)
Q Consensus        19 ~~~~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~-----   93 (187)
                      |++...+|++.+.||+|+||.||+|.+..+++.+|+|.+...  .... ..+..+...++.+.|+|++++++.+.     
T Consensus         1 ~~~~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~--~~~~-~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   77 (263)
T cd05052           1 WEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED--TMEV-EEFLKEAAVMKEIKHPNLVQLLGVCTREPPF   77 (263)
T ss_pred             CCCchHHeEEeeecCCcccceEEEEEEecCCceEEEEEecCC--chHH-HHHHHHHHHHHhCCCCChhheEEEEcCCCCc
Confidence            567788999999999999999999999889999999998642  2222 23444555667789999998764321     


Q ss_pred             -----------------------------HHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEeccccccccc
Q psy14630         94 -----------------------------KEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVD  144 (187)
Q Consensus        94 -----------------------------~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg~a~~~~~  144 (187)
                                                   ..+..|++.+++|||+. +++||||||+||+++.++.++++|||++.....
T Consensus        78 ~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~-~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~  156 (263)
T cd05052          78 YIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKK-NFIHRDLAARNCLVGENHLVKVADFGLSRLMTG  156 (263)
T ss_pred             EEEEEeCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CEeecccCcceEEEcCCCcEEeCCCcccccccc
Confidence                                         11567899999999997 999999999999999999999999999987654


Q ss_pred             ccccc--CCCCCcCccCccccCCCccCCCCCCcceeeeEe
Q psy14630        145 SIAKT--RDAGCRPYMAPERIDPLRARGYPSFKTKLGFKF  182 (187)
Q Consensus       145 ~~~~~--~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi  182 (187)
                      .....  ....+..|+|||.+.   ...++.++|+||||+
T Consensus       157 ~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~Dv~slG~  193 (263)
T cd05052         157 DTYTAHAGAKFPIKWTAPESLA---YNKFSIKSDVWAFGV  193 (263)
T ss_pred             ceeeccCCCCCccccCCHHHhc---cCCCCchhHHHHHHH
Confidence            32221  112355799999987   566889999999998

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays

>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

Probab=99.95  E-value=1.1e-28  Score=186.83  Aligned_cols=160  Identities=21%  Similarity=0.423  Sum_probs=121.9

Q ss_pred             ccCCcccccccccccccCceEEEEEEEc-----CCCcEEEEEEccCccChHHHHHHHHHHHHHHhcCCCCchhhhhhhH-
Q psy14630         19 YDFTSEDLQDLGEIGRGGFGTVNKMIHR-----SSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQFYGAL-   92 (187)
Q Consensus        19 ~~~~~~~~~~~~~lg~G~fg~V~~~~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~-   92 (187)
                      |++..++|++.+.||+|+||.||+|.+.     .++..+|+|.+........ ...+.++..+++.++||||+++++.+ 
T Consensus         1 ~~~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~-~~~~~~e~~~l~~l~~~~iv~~~~~~~   79 (277)
T cd05062           1 WEVAREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRE-RIEFLNEASVMKEFNCHHVVRLLGVVS   79 (277)
T ss_pred             CcccHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHH-HHHHHHHHHHHHhCCCCCeeeEEEEEc
Confidence            5677889999999999999999998764     2456799998864333222 23344555677788999999876421 


Q ss_pred             --------------------H---------------------HHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCE
Q psy14630         93 --------------------F---------------------KEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAI  131 (187)
Q Consensus        93 --------------------~---------------------~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~  131 (187)
                                          .                     ..+..+++.|+.|||+. +++|+||||+||+++.++.+
T Consensus        80 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~-~~vH~dlkp~Nil~~~~~~~  158 (277)
T cd05062          80 QGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNAN-KFVHRDLAARNCMVAEDFTV  158 (277)
T ss_pred             CCCCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHC-CcccCCcchheEEEcCCCCE
Confidence                                0                     11456789999999997 99999999999999999999


Q ss_pred             EEEeccccccccccccc---cCCCCCcCccCccccCCCccCCCCCCcceeeeEee
Q psy14630        132 KLCDFGISGQLVDSIAK---TRDAGCRPYMAPERIDPLRARGYPSFKTKLGFKFN  183 (187)
Q Consensus       132 ki~dfg~a~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi~  183 (187)
                      +++|||+++........   ....++..|+|||.+.   ...++.++|+||||+.
T Consensus       159 ~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~Di~slG~~  210 (277)
T cd05062         159 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLK---DGVFTTYSDVWSFGVV  210 (277)
T ss_pred             EECCCCCccccCCcceeecCCCCccCHhhcChhHhh---cCCcCchhHHHHHHHH
Confidence            99999998765432211   1223467799999988   5668899999999983

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh

>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases

Probab=99.95  E-value=3e-28  Score=183.64  Aligned_cols=154  Identities=22%  Similarity=0.317  Sum_probs=118.0

Q ss_pred             ccccccccccCceEEEEEEEcC---CCcEEEEEEccCccChHHHHHHHHHHHHHHhcCCCCchhhhhhhHH---------
Q psy14630         26 LQDLGEIGRGGFGTVNKMIHRS---SDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQFYGALF---------   93 (187)
Q Consensus        26 ~~~~~~lg~G~fg~V~~~~~~~---~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~---------   93 (187)
                      |++.+.||+|+||.||+|....   ++..+|+|.++.........+.+..+...++.++||||+++++.+.         
T Consensus         1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   80 (273)
T cd05035           1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP   80 (273)
T ss_pred             CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence            5678899999999999998754   3478999998754333333344555556777789999998764210         


Q ss_pred             -----------------------------------HHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEeccc
Q psy14630         94 -----------------------------------KEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGI  138 (187)
Q Consensus        94 -----------------------------------~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg~  138 (187)
                                                         ..+..|++.||.|||+. +++|||+||+||+++.++.+|++|||+
T Consensus        81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~-~i~H~dlkp~Nil~~~~~~~kl~dfg~  159 (273)
T cd05035          81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNR-NFIHRDLAARNCMLREDMTVCVADFGL  159 (273)
T ss_pred             ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhC-CeeccccchheEEECCCCeEEECCccc
Confidence                                               11567899999999997 999999999999999999999999999


Q ss_pred             cccccccccc---cCCCCCcCccCccccCCCccCCCCCCcceeeeEee
Q psy14630        139 SGQLVDSIAK---TRDAGCRPYMAPERIDPLRARGYPSFKTKLGFKFN  183 (187)
Q Consensus       139 a~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi~  183 (187)
                      ++........   .....+..|+|||.+.   ...++.++|+||||++
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~---~~~~~~~~Dv~SlG~i  204 (273)
T cd05035         160 SKKIYSGDYYRQGRIAKMPVKWIAIESLA---DRVYTSKSDVWAFGVT  204 (273)
T ss_pred             eeeccccccccccccccCCccccCHhhcc---cCCCCcccchHHHHHH
Confidence            9876433211   1123456799999987   6678899999999983

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu

>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

Probab=99.95  E-value=1.8e-28  Score=190.63  Aligned_cols=157  Identities=24%  Similarity=0.389  Sum_probs=122.8

Q ss_pred             cccccccccccccCceEEEEEEEcCCCcEEEEEEccCccChHHHHHHHHHHHHHHhcCCCCchhhhhhhH----------
Q psy14630         23 SEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQFYGAL----------   92 (187)
Q Consensus        23 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~----------   92 (187)
                      .++|++.+.||+|+||.||+|.+..+++.||+|.+....... .......+..+++.++|+||+++++.+          
T Consensus         4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~   82 (336)
T cd07849           4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQT-FCQRTLREIKILRRFKHENIIGILDIIRPPSFESFND   82 (336)
T ss_pred             ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccch-hHHHHHHHHHHHHhCCCCCcCchhheeecccccccce
Confidence            368999999999999999999999999999999986432222 223334455577778899999887531          


Q ss_pred             -------------------------HHHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEecccccccccccc
Q psy14630         93 -------------------------FKEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIA  147 (187)
Q Consensus        93 -------------------------~~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg~a~~~~~~~~  147 (187)
                                               ...++.|++.||.|||+. +++||||||+||+++..+.++|+|||++........
T Consensus        83 ~~lv~e~~~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~-~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~  161 (336)
T cd07849          83 VYIVQELMETDLYKLIKTQHLSNDHIQYFLYQILRGLKYIHSA-NVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHD  161 (336)
T ss_pred             EEEEehhcccCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC-CeeccCCCHHHEEECCCCCEEECcccceeecccccc
Confidence                                     111567899999999998 999999999999999999999999999887543211


Q ss_pred             ----ccCCCCCcCccCccccCCCccCCCCCCcceeeeEee
Q psy14630        148 ----KTRDAGCRPYMAPERIDPLRARGYPSFKTKLGFKFN  183 (187)
Q Consensus       148 ----~~~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi~  183 (187)
                          .....++..|+|||.+.+  ...++.++|+||+|++
T Consensus       162 ~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~~DvwslGvi  199 (336)
T cd07849         162 HTGFLTEYVATRWYRAPEIMLN--SKGYTKAIDIWSVGCI  199 (336)
T ss_pred             ccCCcCCcCcCCCccChHHhhC--CCCCCcHHHHHHHHHH
Confidence                122357888999998762  3457899999999984

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase

>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

Probab=99.95  E-value=8e-29  Score=189.78  Aligned_cols=158  Identities=25%  Similarity=0.372  Sum_probs=123.2

Q ss_pred             CcccccccccccccCceEEEEEEEcCCCcEEEEEEccCccChHHHHHHHHHHHHHHhcCCCCchhhhhhhHH--------
Q psy14630         22 TSEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQFYGALF--------   93 (187)
Q Consensus        22 ~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~--------   93 (187)
                      ..++|.+.+.||+|+||.||+|.+..+++.||+|.++....... .....++..+++.++||||+++++.+.        
T Consensus         4 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~-~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv   82 (301)
T cd07873           4 KLETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGA-PCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLV   82 (301)
T ss_pred             cccceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCc-hhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEE
Confidence            35789999999999999999999999999999999864322221 223344555677789999998875421        


Q ss_pred             ------------------------HHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEeccccccccccc-cc
Q psy14630         94 ------------------------KEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSI-AK  148 (187)
Q Consensus        94 ------------------------~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg~a~~~~~~~-~~  148 (187)
                                              ..+..|++.|+.|||+. +++|+||||+||+++.++.++++|||++....... ..
T Consensus        83 ~e~~~~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~~-~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~  161 (301)
T cd07873          83 FEYLDKDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRR-KVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTY  161 (301)
T ss_pred             EeccccCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC-CeeCCCCCHHHEEECCCCcEEECcCcchhccCCCCCcc
Confidence                                    11567899999999997 99999999999999999999999999987653221 22


Q ss_pred             cCCCCCcCccCccccCCCccCCCCCCcceeeeEee
Q psy14630        149 TRDAGCRPYMAPERIDPLRARGYPSFKTKLGFKFN  183 (187)
Q Consensus       149 ~~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi~  183 (187)
                      ....+++.|+|||.+.+  ...++.++|+||+|+.
T Consensus       162 ~~~~~~~~y~~PE~~~~--~~~~~~~~Dv~slG~~  194 (301)
T cd07873         162 SNEVVTLWYRPPDILLG--STDYSTQIDMWGVGCI  194 (301)
T ss_pred             cccceeecccCcHHHhC--CCCCccHHHHHHHHHH
Confidence            23356888999999873  3457789999999983

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl

>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

Probab=99.95  E-value=2.1e-28  Score=185.04  Aligned_cols=160  Identities=21%  Similarity=0.436  Sum_probs=124.1

Q ss_pred             ccCCcccccccccccccCceEEEEEEEcC-----CCcEEEEEEccCccChHHHHHHHHHHHHHHhcCCCCchhhhhhhH-
Q psy14630         19 YDFTSEDLQDLGEIGRGGFGTVNKMIHRS-----SDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQFYGAL-   92 (187)
Q Consensus        19 ~~~~~~~~~~~~~lg~G~fg~V~~~~~~~-----~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~-   92 (187)
                      |++..++|++.+.||+|+||.||+|....     ++..+|+|.+........ ...+.++..+++.+.|+||+++++.+ 
T Consensus         1 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~-~~~~~~e~~~l~~~~~~~i~~~~~~~~   79 (277)
T cd05032           1 WELPREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRE-RIEFLNEASVMKEFNCHHVVRLLGVVS   79 (277)
T ss_pred             CccchHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHH-HHHHHHHHHHHHhCCCCceeEEEEEEc
Confidence            56788999999999999999999998754     347899999865433222 23344555567778999999876421 


Q ss_pred             -----------------------------------------HHHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCE
Q psy14630         93 -----------------------------------------FKEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAI  131 (187)
Q Consensus        93 -----------------------------------------~~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~  131 (187)
                                                               ...++.|++.|+.|||+. +++||||||+||+++.++.+
T Consensus        80 ~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~-~i~H~di~p~nill~~~~~~  158 (277)
T cd05032          80 TGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAK-KFVHRDLAARNCMVAEDLTV  158 (277)
T ss_pred             CCCCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhC-CccccccChheEEEcCCCCE
Confidence                                                     011456899999999997 99999999999999999999


Q ss_pred             EEEecccccccccccc---ccCCCCCcCccCccccCCCccCCCCCCcceeeeEee
Q psy14630        132 KLCDFGISGQLVDSIA---KTRDAGCRPYMAPERIDPLRARGYPSFKTKLGFKFN  183 (187)
Q Consensus       132 ki~dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi~  183 (187)
                      +++|||+++.......   .....++..|+|||.+.   ...++.++|+||||++
T Consensus       159 kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~Di~slG~i  210 (277)
T cd05032         159 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLK---DGVFTTKSDVWSFGVV  210 (277)
T ss_pred             EECCcccchhhccCcccccCCCCCccccccCHHHHh---cCCCCcccchHHHHHH
Confidence            9999999887643321   12234567899999987   5668899999999983

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological

>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn

Probab=99.95  E-value=1.5e-28  Score=184.44  Aligned_cols=157  Identities=20%  Similarity=0.345  Sum_probs=123.1

Q ss_pred             ccCCcccccccccccccCceEEEEEEEcCCCcEEEEEEccCccChHHHHHHHHHHHHHHhcCCCCchhhhhhhHH-----
Q psy14630         19 YDFTSEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQFYGALF-----   93 (187)
Q Consensus        19 ~~~~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~-----   93 (187)
                      |++..++|++.++||+|+||.||+|... .+..+|+|.+....   ...+.+.++..+++.++|+||+++++.+.     
T Consensus         1 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~-~~~~v~iK~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   76 (261)
T cd05072           1 WEIPRESIKLVKKLGAGQFGEVWMGYYN-NSTKVAVKTLKPGT---MSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPI   76 (261)
T ss_pred             CcCchHHeEEeeecCCcCCceEEEEEec-CCceEEEEEccCCc---hhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCc
Confidence            5778899999999999999999999874 55679999876421   12344556666778889999998764210     


Q ss_pred             -----------------------------HHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEeccccccccc
Q psy14630         94 -----------------------------KEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVD  144 (187)
Q Consensus        94 -----------------------------~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg~a~~~~~  144 (187)
                                                   ..+..+++.+++|||+. +++|+||||+||+++.++.++++|||+++....
T Consensus        77 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~-~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~  155 (261)
T cd05072          77 YIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERK-NYIHRDLRAANVLVSESLMCKIADFGLARVIED  155 (261)
T ss_pred             EEEEecCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC-CeeccccchhhEEecCCCcEEECCCccceecCC
Confidence                                         11556899999999997 999999999999999999999999999987654


Q ss_pred             cccc--cCCCCCcCccCccccCCCccCCCCCCcceeeeEee
Q psy14630        145 SIAK--TRDAGCRPYMAPERIDPLRARGYPSFKTKLGFKFN  183 (187)
Q Consensus       145 ~~~~--~~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi~  183 (187)
                      ....  ....++..|+|||.+.   ...++.++|+||+|++
T Consensus       156 ~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~Di~slG~~  193 (261)
T cd05072         156 NEYTAREGAKFPIKWTAPEAIN---FGSFTIKSDVWSFGIL  193 (261)
T ss_pred             CceeccCCCccceecCCHHHhc---cCCCChhhhhhhhHHH
Confidence            3211  1223456799999987   5567889999999983

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa

>KOG2052|consensus

Probab=99.95  E-value=3.4e-29  Score=192.48  Aligned_cols=160  Identities=25%  Similarity=0.351  Sum_probs=120.8

Q ss_pred             cCCcccccccccccccCceEEEEEEEcCCCcEEEEEEccCccChHHHHHHHHHHHHHHh-cCCCCchhhhhhhHHHH---
Q psy14630         20 DFTSEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMK-SNECPYIVQFYGALFKE---   95 (187)
Q Consensus        20 ~~~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~-~~~h~~iv~~~~~~~~~---   95 (187)
                      ..-..+..+.+.||+|.||.||+|.+.  |+.||||++...    +...+++|...+.. .++|+||+.++++-..+   
T Consensus       207 RTiarqI~L~e~IGkGRyGEVwrG~wr--Ge~VAVKiF~sr----dE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs  280 (513)
T KOG2052|consen  207 RTIARQIVLQEIIGKGRFGEVWRGRWR--GEDVAVKIFSSR----DERSWFRETEIYQTVMLRHENILGFIAADNKDNGS  280 (513)
T ss_pred             HhhhheeEEEEEecCccccceeecccc--CCceEEEEeccc----chhhhhhHHHHHHHHHhccchhhhhhhccccCCCc
Confidence            444577888899999999999999886  788999998532    23456666554443 47999999887542111   


Q ss_pred             --------------------------------HHHHHHHHHHHHHhcC-------CCeeecCCCCCeEEcCCCCEEEEec
Q psy14630         96 --------------------------------VTVATVKALNYLKEEL-------KIIHRDVKPSNILLDRRGAIKLCDF  136 (187)
Q Consensus        96 --------------------------------~~~~~~~~l~~lh~~~-------~i~Hrdlk~~nili~~~~~~ki~df  136 (187)
                                                      ++..++.||++||...       .|.|||||..|||+..++.+-|+|+
T Consensus       281 ~TQLwLvTdYHe~GSL~DyL~r~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADL  360 (513)
T KOG2052|consen  281 WTQLWLVTDYHEHGSLYDYLNRNTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADL  360 (513)
T ss_pred             eEEEEEeeecccCCcHHHHHhhccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeec
Confidence                                            5667889999999642       4999999999999999999999999


Q ss_pred             ccccccccc-----ccccCCCCCcCccCccccCCCccCC-CC--CCcceeeeEeeee
Q psy14630        137 GISGQLVDS-----IAKTRDAGCRPYMAPERIDPLRARG-YP--SFKTKLGFKFNYR  185 (187)
Q Consensus       137 g~a~~~~~~-----~~~~~~~~t~~y~aPE~~~~~~~~~-~~--~~~D~ws~gi~~~  185 (187)
                      |+|......     ......+||.+|||||+++...+.. ++  .-+||||||++||
T Consensus       361 GLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlW  417 (513)
T KOG2052|consen  361 GLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLW  417 (513)
T ss_pred             eeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHH
Confidence            999875432     1222347999999999997322211 22  4499999999988

>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

Probab=99.95  E-value=2.4e-28  Score=187.44  Aligned_cols=165  Identities=25%  Similarity=0.363  Sum_probs=123.7

Q ss_pred             CCCccccCCcccccccccccccCceEEEEEEEc-------CCCcEEEEEEccCccChHHHHHHHHHHHHHHhcC-CCCch
Q psy14630         14 SPDTVYDFTSEDLQDLGEIGRGGFGTVNKMIHR-------SSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSN-ECPYI   85 (187)
Q Consensus        14 ~~~~~~~~~~~~~~~~~~lg~G~fg~V~~~~~~-------~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~-~h~~i   85 (187)
                      +....|++..++|.+.+.||+|+||.||+|.+.       ..+..+|+|.++......... .+..+..+++.+ .||||
T Consensus         5 ~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~-~~~~E~~~l~~l~~h~~i   83 (304)
T cd05101           5 PEDPRWEFSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLS-DLVSEMEMMKMIGKHKNI   83 (304)
T ss_pred             ccCCcccccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHH-HHHHHHHHHHhhccCCCc
Confidence            344567889999999999999999999999742       234579999886433333333 344444455555 89999


Q ss_pred             hhhhhhH---------------------H---------------------------HHHHHHHHHHHHHHHhcCCCeeec
Q psy14630         86 VQFYGAL---------------------F---------------------------KEVTVATVKALNYLKEELKIIHRD  117 (187)
Q Consensus        86 v~~~~~~---------------------~---------------------------~~~~~~~~~~l~~lh~~~~i~Hrd  117 (187)
                      +++++.+                     .                           ..+..|++.|+.|||+. +++|||
T Consensus        84 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~-givH~d  162 (304)
T cd05101          84 INLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQ-KCIHRD  162 (304)
T ss_pred             hheeEEEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHC-Ceeecc
Confidence            9876421                     0                           11356899999999997 999999


Q ss_pred             CCCCCeEEcCCCCEEEEecccccccccccc---ccCCCCCcCccCccccCCCccCCCCCCcceeeeEee
Q psy14630        118 VKPSNILLDRRGAIKLCDFGISGQLVDSIA---KTRDAGCRPYMAPERIDPLRARGYPSFKTKLGFKFN  183 (187)
Q Consensus       118 lk~~nili~~~~~~ki~dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi~  183 (187)
                      |||+||+++.++.++|+|||+++.......   .....++..|+|||.+.   ...++.++|+||||+.
T Consensus       163 lkp~Nili~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~Di~slG~~  228 (304)
T cd05101         163 LAARNVLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALF---DRVYTHQSDVWSFGVL  228 (304)
T ss_pred             cccceEEEcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhc---cCCCCchhhHHHHHHH
Confidence            999999999999999999999987643211   11223456799999987   5668899999999983

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

Probab=99.95  E-value=1.6e-28  Score=184.82  Aligned_cols=157  Identities=22%  Similarity=0.368  Sum_probs=124.4

Q ss_pred             ccccccccccccCceEEEEEEEcCCCcEEEEEEccCcc-ChHHHHHHHHHHHHHHhcCCCCchhhhhhhHH---------
Q psy14630         24 EDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTV-DEKDQRQLLMDLDVVMKSNECPYIVQFYGALF---------   93 (187)
Q Consensus        24 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~---------   93 (187)
                      ++|++.+.||+|+||.||+|.+..+++.||+|.++... .+......+..+..+++.++|||++++++.+.         
T Consensus         2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   81 (267)
T cd08228           2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL   81 (267)
T ss_pred             cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence            57899999999999999999999999999999875422 22333344555666778889999998764321         


Q ss_pred             ---------------------------HHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEeccccccccccc
Q psy14630         94 ---------------------------KEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSI  146 (187)
Q Consensus        94 ---------------------------~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg~a~~~~~~~  146 (187)
                                                 ..+..+++.|+.|||+. +++|+||+|+||+++.++.++++|||++.......
T Consensus        82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~-~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~~~  160 (267)
T cd08228          82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSR-RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKT  160 (267)
T ss_pred             EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhC-CeeCCCCCHHHEEEcCCCCEEECccccceeccchh
Confidence                                       12556889999999997 99999999999999999999999999988764322


Q ss_pred             c-ccCCCCCcCccCccccCCCccCCCCCCcceeeeEeee
Q psy14630        147 A-KTRDAGCRPYMAPERIDPLRARGYPSFKTKLGFKFNY  184 (187)
Q Consensus       147 ~-~~~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi~~  184 (187)
                      . .....+++.|+|||.+.   ...++.++|+||+|+..
T Consensus       161 ~~~~~~~~~~~~~aPE~~~---~~~~~~~~Di~slG~~l  196 (267)
T cd08228         161 TAAHSLVGTPYYMSPERIH---ENGYNFKSDIWSLGCLL  196 (267)
T ss_pred             HHHhcCCCCccccChhhhc---cCCCCchhhHHHHHHHH
Confidence            1 22346788899999988   55688999999999843

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase

>KOG0696|consensus

Probab=99.95  E-value=4.1e-29  Score=191.38  Aligned_cols=162  Identities=27%  Similarity=0.412  Sum_probs=125.5

Q ss_pred             cCCcccccccccccccCceEEEEEEEcCCCcEEEEEEccCccC-hHHHHHHHHHHHHHHhc-CCCCchhhhhhhHHHH--
Q psy14630         20 DFTSEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVD-EKDQRQLLMDLDVVMKS-NECPYIVQFYGALFKE--   95 (187)
Q Consensus        20 ~~~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~~~~~~~~-~~h~~iv~~~~~~~~~--   95 (187)
                      .+...+|.++.+||+|+||+|.++..+.+.+.+|||++++... ..+..+.-..+..++.. ..-|.+++++..+..-  
T Consensus       345 ~i~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDR  424 (683)
T KOG0696|consen  345 RIKATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDR  424 (683)
T ss_pred             ceeecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhh
Confidence            4567789999999999999999999999999999999976431 11122222223333333 3446666665433211  


Q ss_pred             ------------------------------HHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEeccccccc-cc
Q psy14630         96 ------------------------------VTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQL-VD  144 (187)
Q Consensus        96 ------------------------------~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg~a~~~-~~  144 (187)
                                                    .+..++.||-|||++ +|+.||||.+|++++..|++||.|||+++-- .+
T Consensus       425 LyFVMEyvnGGDLMyhiQQ~GkFKEp~AvFYAaEiaigLFFLh~k-gIiYRDLKLDNvmLd~eGHiKi~DFGmcKEni~~  503 (683)
T KOG0696|consen  425 LYFVMEYVNGGDLMYHIQQVGKFKEPVAVFYAAEIAIGLFFLHSK-GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIFD  503 (683)
T ss_pred             eeeEEEEecCchhhhHHHHhcccCCchhhhhhHHHHHHhhhhhcC-CeeeeeccccceEeccCCceEeeecccccccccC
Confidence                                          456788899999998 9999999999999999999999999999864 34


Q ss_pred             cccccCCCCCcCccCccccCCCccCCCCCCcceeeeEe-eee
Q psy14630        145 SIAKTRDAGCRPYMAPERIDPLRARGYPSFKTKLGFKF-NYR  185 (187)
Q Consensus       145 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi-~~~  185 (187)
                      ...+...+|||.|+|||.+.   ..+|..++|+||+|| .|+
T Consensus       504 ~~TTkTFCGTPdYiAPEIi~---YqPYgksvDWWa~GVLLyE  542 (683)
T KOG0696|consen  504 GVTTKTFCGTPDYIAPEIIA---YQPYGKSVDWWAFGVLLYE  542 (683)
T ss_pred             CcceeeecCCCcccccceEE---ecccccchhHHHHHHHHHH
Confidence            56667789999999999999   677999999999999 444

>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

Probab=99.95  E-value=3.2e-28  Score=187.62  Aligned_cols=164  Identities=23%  Similarity=0.376  Sum_probs=123.2

Q ss_pred             CCccccCCcccccccccccccCceEEEEEEEc-------CCCcEEEEEEccCccChHHHHHHHHHHHHHHhcC-CCCchh
Q psy14630         15 PDTVYDFTSEDLQDLGEIGRGGFGTVNKMIHR-------SSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSN-ECPYIV   86 (187)
Q Consensus        15 ~~~~~~~~~~~~~~~~~lg~G~fg~V~~~~~~-------~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~-~h~~iv   86 (187)
                      -...|+++.++|.+.+.||+|+||.||++.+.       .....+|+|.++.........+...+. .+++.+ +||||+
T Consensus         3 ~~~~~~~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~-~~l~~l~~h~~iv   81 (314)
T cd05099           3 LDPKWEFPRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEM-ELMKLIGKHKNII   81 (314)
T ss_pred             CcccccccHHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHH-HHHHhccCCCCee
Confidence            34567888999999999999999999999753       234578999987543333333444444 445555 699999


Q ss_pred             hhhhhHH------------------------------------------------HHHHHHHHHHHHHHHhcCCCeeecC
Q psy14630         87 QFYGALF------------------------------------------------KEVTVATVKALNYLKEELKIIHRDV  118 (187)
Q Consensus        87 ~~~~~~~------------------------------------------------~~~~~~~~~~l~~lh~~~~i~Hrdl  118 (187)
                      ++++.+.                                                ..+..|++.|+.|||+. +++||||
T Consensus        82 ~~~~~~~~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~-gi~H~dl  160 (314)
T cd05099          82 NLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESR-RCIHRDL  160 (314)
T ss_pred             eEEEEEccCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHC-Ceeeccc
Confidence            8864211                                                01356899999999997 9999999


Q ss_pred             CCCCeEEcCCCCEEEEecccccccccccc---ccCCCCCcCccCccccCCCccCCCCCCcceeeeEee
Q psy14630        119 KPSNILLDRRGAIKLCDFGISGQLVDSIA---KTRDAGCRPYMAPERIDPLRARGYPSFKTKLGFKFN  183 (187)
Q Consensus       119 k~~nili~~~~~~ki~dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi~  183 (187)
                      ||+|++++.++.+|++|||+++.......   .....++..|+|||.+.   ...++.++|+||+|+.
T Consensus       161 kp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~DiwslG~~  225 (314)
T cd05099         161 AARNVLVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALF---DRVYTHQSDVWSFGIL  225 (314)
T ss_pred             cceeEEEcCCCcEEEccccccccccccccccccccCCCCccccCHHHHc---cCCcCccchhhHHHHH
Confidence            99999999999999999999987643211   11122345799999987   5678899999999983

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

Probab=99.95  E-value=2.8e-28  Score=189.44  Aligned_cols=165  Identities=24%  Similarity=0.374  Sum_probs=123.6

Q ss_pred             CCCccccCCcccccccccccccCceEEEEEEEcC-------CCcEEEEEEccCccChHHHHHHHHHHHHHHhcC-CCCch
Q psy14630         14 SPDTVYDFTSEDLQDLGEIGRGGFGTVNKMIHRS-------SDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSN-ECPYI   85 (187)
Q Consensus        14 ~~~~~~~~~~~~~~~~~~lg~G~fg~V~~~~~~~-------~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~-~h~~i   85 (187)
                      +.+..|++...+|++.+.||+|+||.||+|.+..       .+..+|+|.++.........+...+. .+++.+ .||||
T Consensus         2 ~~~~~~~~~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~-~~l~~l~~h~~i   80 (334)
T cd05100           2 PADPKWELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEM-EMMKMIGKHKNI   80 (334)
T ss_pred             CCCcccccCHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHH-HHHHhhcCCCCe
Confidence            4457788888999999999999999999997642       22468999887543333333444444 455555 89999


Q ss_pred             hhhhhhH---------------------HH---------------------------HHHHHHHHHHHHHHhcCCCeeec
Q psy14630         86 VQFYGAL---------------------FK---------------------------EVTVATVKALNYLKEELKIIHRD  117 (187)
Q Consensus        86 v~~~~~~---------------------~~---------------------------~~~~~~~~~l~~lh~~~~i~Hrd  117 (187)
                      +++++.+                     ..                           .+..|++.|++|||+. +++|||
T Consensus        81 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~-givH~d  159 (334)
T cd05100          81 INLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQ-KCIHRD  159 (334)
T ss_pred             eeeeEEEccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC-Ceeccc
Confidence            9876421                     00                           1456899999999997 999999


Q ss_pred             CCCCCeEEcCCCCEEEEeccccccccccccc---cCCCCCcCccCccccCCCccCCCCCCcceeeeEee
Q psy14630        118 VKPSNILLDRRGAIKLCDFGISGQLVDSIAK---TRDAGCRPYMAPERIDPLRARGYPSFKTKLGFKFN  183 (187)
Q Consensus       118 lk~~nili~~~~~~ki~dfg~a~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi~  183 (187)
                      |||+||+++.++.+||+|||+++........   ....++..|+|||.+.   ...++.++|+||||++
T Consensus       160 lkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~Di~slG~i  225 (334)
T cd05100         160 LAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALF---DRVYTHQSDVWSFGVL  225 (334)
T ss_pred             cccceEEEcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhc---cCCcCchhhhHHHHHH
Confidence            9999999999999999999999876432211   1122345799999998   6678899999999984

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

Probab=99.95  E-value=4.2e-28  Score=181.21  Aligned_cols=155  Identities=26%  Similarity=0.479  Sum_probs=123.3

Q ss_pred             cccccccccccCceEEEEEEEcCCCcEEEEEEccCccChHHHHHHHHHHHHHHhcCCCCchhhhhhhHHH----------
Q psy14630         25 DLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQFYGALFK----------   94 (187)
Q Consensus        25 ~~~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~----------   94 (187)
                      +|.+.+.||+|+||.||+|.+..+++.+++|.+............+..+..+++.++|||++++++.+..          
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08529           1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY   80 (256)
T ss_pred             CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence            4778899999999999999999999999999986433223333344445556777899999988753211          


Q ss_pred             ------------------------HHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEecccccccccccc-cc
Q psy14630         95 ------------------------EVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIA-KT  149 (187)
Q Consensus        95 ------------------------~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg~a~~~~~~~~-~~  149 (187)
                                              .+..+++.++.|||+. +++|+||+|+||+++.++.++++|||+++....... ..
T Consensus        81 ~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~-~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~~~~  159 (256)
T cd08529          81 AENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSK-KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFAN  159 (256)
T ss_pred             CCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC-CcccCCCCcceEEEeCCCCEEEcccccceeccCccchhh
Confidence                                    2566899999999997 999999999999999999999999999887654322 22


Q ss_pred             CCCCCcCccCccccCCCccCCCCCCcceeeeEee
Q psy14630        150 RDAGCRPYMAPERIDPLRARGYPSFKTKLGFKFN  183 (187)
Q Consensus       150 ~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi~  183 (187)
                      ...+++.|+|||.+.   +..++.++|+||||+.
T Consensus       160 ~~~~~~~y~aPE~~~---~~~~~~~~Di~slG~i  190 (256)
T cd08529         160 TIVGTPYYLSPELCE---DKPYNEKSDVWALGVV  190 (256)
T ss_pred             ccccCccccCHHHhc---CCCCCCccchHHHHHH
Confidence            346788899999998   6668899999999984

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc

>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

Probab=99.95  E-value=3.1e-28  Score=182.52  Aligned_cols=159  Identities=31%  Similarity=0.484  Sum_probs=126.5

Q ss_pred             CcccccccccccccCceEEEEEEEcCCCcEEEEEEccCccChHHHHHHHHHHHHHHhcCCCCchhhhhhhH---------
Q psy14630         22 TSEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQFYGAL---------   92 (187)
Q Consensus        22 ~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~---------   92 (187)
                      +.++|++.+.||+|+||.||+|.+..+++.+++|.+......  ..+.+..+..+++.++|||++++++.+         
T Consensus         1 ~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~--~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~   78 (262)
T cd06613           1 PQEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGD--DFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIV   78 (262)
T ss_pred             CccceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchh--hHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEE
Confidence            457899999999999999999999888999999998643222  334555666677888999999886532         


Q ss_pred             ------------------------HHHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEeccccccccccc-c
Q psy14630         93 ------------------------FKEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSI-A  147 (187)
Q Consensus        93 ------------------------~~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg~a~~~~~~~-~  147 (187)
                                              ...+..|++.++.|||+. +++|+||+|+||+++.++.++++|||++....... .
T Consensus        79 ~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~-~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~  157 (262)
T cd06613          79 MEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHET-GKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAK  157 (262)
T ss_pred             EeCCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhC-CceecCCChhhEEECCCCCEEECccccchhhhhhhhc
Confidence                                    112667899999999997 99999999999999999999999999988765432 2


Q ss_pred             ccCCCCCcCccCccccCCCccCCCCCCcceeeeEee
Q psy14630        148 KTRDAGCRPYMAPERIDPLRARGYPSFKTKLGFKFN  183 (187)
Q Consensus       148 ~~~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi~  183 (187)
                      .....++..|+|||.+.+.....++.++|+||||+.
T Consensus       158 ~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~  193 (262)
T cd06613         158 RKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGIT  193 (262)
T ss_pred             cccccCCccccCchhhcccccCCcCchhhhHHHHHH
Confidence            233467888999999873322368899999999984

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ

>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

Probab=99.95  E-value=3.1e-28  Score=183.19  Aligned_cols=156  Identities=28%  Similarity=0.386  Sum_probs=123.0

Q ss_pred             ccccccccccccCceEEEEEEEcCCCcEEEEEEccCcc---ChHHHHHHHHHHHHHHhcCCCCchhhhhhhHH-------
Q psy14630         24 EDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTV---DEKDQRQLLMDLDVVMKSNECPYIVQFYGALF-------   93 (187)
Q Consensus        24 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~-------   93 (187)
                      ++|++.+.||+|+||.||++.+..++..||+|.+....   ......+.+..+..+++.+.||||+++++.+.       
T Consensus         2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (265)
T cd06652           2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL   81 (265)
T ss_pred             CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence            57889999999999999999999999999999875321   11223445555666778889999998664321       


Q ss_pred             ---------------------------HHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEeccccccccccc
Q psy14630         94 ---------------------------KEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSI  146 (187)
Q Consensus        94 ---------------------------~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg~a~~~~~~~  146 (187)
                                                 ..+..+++.++.|||+. +++|+||+|+||+++.++.++|+|||+++......
T Consensus        82 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~-~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~~~~  160 (265)
T cd06652          82 SIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHSN-MIVHRDIKGANILRDSVGNVKLGDFGASKRLQTIC  160 (265)
T ss_pred             EEEEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhC-CEecCCCCHHHEEecCCCCEEECcCcccccccccc
Confidence                                       11567889999999998 99999999999999999999999999988654211


Q ss_pred             ----cccCCCCCcCccCccccCCCccCCCCCCcceeeeEee
Q psy14630        147 ----AKTRDAGCRPYMAPERIDPLRARGYPSFKTKLGFKFN  183 (187)
Q Consensus       147 ----~~~~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi~  183 (187)
                          ......++..|+|||.+.   +..++.++|+||||+.
T Consensus       161 ~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~Dv~slG~i  198 (265)
T cd06652         161 LSGTGMKSVTGTPYWMSPEVIS---GEGYGRKADIWSVGCT  198 (265)
T ss_pred             ccccccccCCCCccccChhhhc---CCCCCcchhHHHHHHH
Confidence                112235788899999988   5568899999999983

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re

>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

Probab=99.95  E-value=2.2e-28  Score=185.49  Aligned_cols=158  Identities=22%  Similarity=0.357  Sum_probs=122.6

Q ss_pred             CCcccccccccccccCceEEEEEEEcCCC-----cEEEEEEccCccChHHHHHHHHHHHHHHhcCCCCchhhhhhhH---
Q psy14630         21 FTSEDLQDLGEIGRGGFGTVNKMIHRSSD-----TVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQFYGAL---   92 (187)
Q Consensus        21 ~~~~~~~~~~~lg~G~fg~V~~~~~~~~~-----~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~---   92 (187)
                      +..++|++.+.||+|+||.||+|.....+     ..+|+|.++..... .....+.++...+..++||||+++++.+   
T Consensus         2 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~-~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~   80 (283)
T cd05048           2 IPLSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEP-KVQQEFRQEAELMSDLQHPNIVCLLGVCTKE   80 (283)
T ss_pred             CChHHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCH-HHHHHHHHHHHHHHhcCCcccceEEEEEcCC
Confidence            46689999999999999999999876544     67999988644332 2334455566667778999999876421   


Q ss_pred             ------------------H---------------------------HHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcC
Q psy14630         93 ------------------F---------------------------KEVTVATVKALNYLKEELKIIHRDVKPSNILLDR  127 (187)
Q Consensus        93 ------------------~---------------------------~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~  127 (187)
                                        .                           ..+..|++.|+.|||+. +++|+||||+||+++.
T Consensus        81 ~~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~-~i~H~dlkp~Nil~~~  159 (283)
T cd05048          81 QPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSH-HFVHRDLAARNCLVGE  159 (283)
T ss_pred             CceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC-CeeccccccceEEEcC
Confidence                              0                           12667899999999998 9999999999999999


Q ss_pred             CCCEEEEeccccccccccc---cccCCCCCcCccCccccCCCccCCCCCCcceeeeEee
Q psy14630        128 RGAIKLCDFGISGQLVDSI---AKTRDAGCRPYMAPERIDPLRARGYPSFKTKLGFKFN  183 (187)
Q Consensus       128 ~~~~ki~dfg~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi~  183 (187)
                      ++.++|+|||+++......   ......+++.|+|||.+.   ...++.++|+||||++
T Consensus       160 ~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~sDv~slG~i  215 (283)
T cd05048         160 GLTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAIL---YGKFTTESDIWSFGVV  215 (283)
T ss_pred             CCcEEECCCcceeeccccccccccCCCcccccccCHHHhc---cCcCchhhhHHHHHHH
Confidence            9999999999987653321   112234577899999987   5668899999999983

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer

>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

Probab=99.95  E-value=3.3e-28  Score=187.13  Aligned_cols=155  Identities=43%  Similarity=0.767  Sum_probs=123.5

Q ss_pred             ccccccccccccCceEEEEEEEcCCCcEEEEEEccCccChHHHHHHHHHHHHHHhcCCCCchhhhhhhH-----------
Q psy14630         24 EDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQFYGAL-----------   92 (187)
Q Consensus        24 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~-----------   92 (187)
                      ++|++.+.||+|+||.||++.+..++..+|+|.+....... ....+..+..+++.++||||+++++.+           
T Consensus         1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~-~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   79 (308)
T cd06615           1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPA-IRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICME   79 (308)
T ss_pred             CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHH-HHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEee
Confidence            46889999999999999999999999999999886533332 333344555567778999999886432           


Q ss_pred             ---------------------HHHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEeccccccccccccccCC
Q psy14630         93 ---------------------FKEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTRD  151 (187)
Q Consensus        93 ---------------------~~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg~a~~~~~~~~~~~~  151 (187)
                                           ...+..|++.|+.|||+..+++|+||||+||+++.++.++++|||++....... ....
T Consensus        80 y~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~-~~~~  158 (308)
T cd06615          80 HMDGGSLDQVLKKAGRIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM-ANSF  158 (308)
T ss_pred             ccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEEecCCcEEEccCCCcccccccc-cccC
Confidence                                 112667899999999985489999999999999999999999999987664432 2334


Q ss_pred             CCCcCccCccccCCCccCCCCCCcceeeeEee
Q psy14630        152 AGCRPYMAPERIDPLRARGYPSFKTKLGFKFN  183 (187)
Q Consensus       152 ~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi~  183 (187)
                      .++..|+|||.+.   ...++.++|+||||++
T Consensus       159 ~~~~~~~aPE~~~---~~~~~~~~DiwslG~~  187 (308)
T cd06615         159 VGTRSYMSPERLQ---GTHYTVQSDIWSLGLS  187 (308)
T ss_pred             CCCcCccChhHhc---CCCCCccchHHHHHHH
Confidence            6788999999987   4557889999999984

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down

>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

Probab=99.95  E-value=3.5e-28  Score=189.80  Aligned_cols=157  Identities=22%  Similarity=0.319  Sum_probs=124.0

Q ss_pred             CcccccccccccccCceEEEEEEEcCCCcEEEEEEccCccChHHHHHHHHHHHHHHhcCCCCchhhhhhhHH--------
Q psy14630         22 TSEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQFYGALF--------   93 (187)
Q Consensus        22 ~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~--------   93 (187)
                      ..++|.+.+.||+|+||.||++.+..+++.||+|.+..........+.+.++..+++.++||||+++++.+.        
T Consensus        15 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~~~~   94 (345)
T cd07877          15 VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF   94 (345)
T ss_pred             ccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeeccccccc
Confidence            347899999999999999999999889999999998643222223344445666777889999998764321        


Q ss_pred             ----------------------------HHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEecccccccccc
Q psy14630         94 ----------------------------KEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDS  145 (187)
Q Consensus        94 ----------------------------~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg~a~~~~~~  145 (187)
                                                  ..+..|++.|++|||+. +++||||||+||+++.++.++|+|||+++.....
T Consensus        95 ~~~~lv~~~~~~~L~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~-~ivH~dlkp~NIll~~~~~~kl~dfg~~~~~~~~  173 (345)
T cd07877          95 NDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA-DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE  173 (345)
T ss_pred             ccEEEEehhcccCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC-CeeecCCChHHEEEcCCCCEEEeccccccccccc
Confidence                                        11567899999999997 9999999999999999999999999998765332


Q ss_pred             ccccCCCCCcCccCccccCCCccCCCCCCcceeeeEee
Q psy14630        146 IAKTRDAGCRPYMAPERIDPLRARGYPSFKTKLGFKFN  183 (187)
Q Consensus       146 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi~  183 (187)
                        .....++..|+|||.+.+  ...++.++|+||+|+.
T Consensus       174 --~~~~~~~~~y~aPE~~~~--~~~~~~~~DvwslG~i  207 (345)
T cd07877         174 --MTGYVATRWYRAPEIMLN--WMHYNQTVDIWSVGCI  207 (345)
T ss_pred             --ccccccCCCccCHHHHhC--ccCCCchhhHHHHHHH
Confidence              223467888999999863  2457889999999983

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14

>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

Probab=99.95  E-value=7.6e-28  Score=182.94  Aligned_cols=158  Identities=42%  Similarity=0.776  Sum_probs=122.2

Q ss_pred             ccccccccccccCceEEEEEEEcCCCcEEEEEEccCccChHHHHHHHHHHHHHHhcCCCCchhhhhhhHH----------
Q psy14630         24 EDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQFYGALF----------   93 (187)
Q Consensus        24 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~----------   93 (187)
                      ++|++.+.||+|+||.||++.+..++..+|+|.++........ ..+..+..+++.+.|+||+++++.+.          
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~-~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e   79 (286)
T cd06622           1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKF-NQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCME   79 (286)
T ss_pred             ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHH-HHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEe
Confidence            4788999999999999999999889999999988654333323 33444555667789999999876421          


Q ss_pred             -------------------------HHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEeccccccccccccc
Q psy14630         94 -------------------------KEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAK  148 (187)
Q Consensus        94 -------------------------~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg~a~~~~~~~~~  148 (187)
                                               ..+..+++.++.|||+.++++|+||+|+||+++.++.++++|||++..+.... .
T Consensus        80 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~-~  158 (286)
T cd06622          80 YMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASL-A  158 (286)
T ss_pred             ecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEECCCCCEEEeecCCcccccCCc-c
Confidence                                     11556888999999975599999999999999999999999999988764332 2


Q ss_pred             cCCCCCcCccCccccCCCc---cCCCCCCcceeeeEee
Q psy14630        149 TRDAGCRPYMAPERIDPLR---ARGYPSFKTKLGFKFN  183 (187)
Q Consensus       149 ~~~~~t~~y~aPE~~~~~~---~~~~~~~~D~ws~gi~  183 (187)
                      ....+++.|+|||.+.+..   ...++.++|+||+|+.
T Consensus       159 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~i  196 (286)
T cd06622         159 KTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLS  196 (286)
T ss_pred             ccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHH
Confidence            2335788899999986321   1235789999999984

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4

Probab=99.95  E-value=2.4e-28  Score=187.44  Aligned_cols=157  Identities=25%  Similarity=0.403  Sum_probs=121.6

Q ss_pred             CCcccccccccccccCceEEEEEEEcCCCc----EEEEEEccCccChHHHHHHHHHHHHHHhcCCCCchhhhhhhHH---
Q psy14630         21 FTSEDLQDLGEIGRGGFGTVNKMIHRSSDT----VMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQFYGALF---   93 (187)
Q Consensus        21 ~~~~~~~~~~~lg~G~fg~V~~~~~~~~~~----~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~---   93 (187)
                      +..++|+..+.||+|+||.||+|.+..++.    .+|+|.+........ ...+..+..+++.+.||||+++++.+.   
T Consensus         4 ~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~-~~~~~~e~~~~~~l~h~niv~~~~~~~~~~   82 (303)
T cd05110           4 LKETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKA-NVEFMDEALIMASMDHPHLVRLLGVCLSPT   82 (303)
T ss_pred             cchhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHH-HHHHHHHHHHHHhCCCCCcccEEEEEcCCC
Confidence            456789999999999999999999876665    478898764333222 223445556777889999998775321   


Q ss_pred             -----------------------------HHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEeccccccccc
Q psy14630         94 -----------------------------KEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVD  144 (187)
Q Consensus        94 -----------------------------~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg~a~~~~~  144 (187)
                                                   ..+..|++.|+.|||+. +++|+||||+||+++.++.+|++|||+++....
T Consensus        83 ~~~v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~-~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~~  161 (303)
T cd05110          83 IQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEER-RLVHRDLAARNVLVKSPNHVKITDFGLARLLEG  161 (303)
T ss_pred             ceeeehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhhc-CeeccccccceeeecCCCceEEccccccccccC
Confidence                                         12557899999999998 999999999999999999999999999987643


Q ss_pred             ccc---ccCCCCCcCccCccccCCCccCCCCCCcceeeeEe
Q psy14630        145 SIA---KTRDAGCRPYMAPERIDPLRARGYPSFKTKLGFKF  182 (187)
Q Consensus       145 ~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi  182 (187)
                      ...   .....++..|+|||.+.   ...++.++|+||||+
T Consensus       162 ~~~~~~~~~~~~~~~y~~PE~~~---~~~~~~~~DiwslG~  199 (303)
T cd05110         162 DEKEYNADGGKMPIKWMALECIH---YRKFTHQSDVWSYGV  199 (303)
T ss_pred             cccccccCCCccccccCCHHHhc---cCCCChHHHHHHHHH
Confidence            221   11223466899999987   566889999999998

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin

>KOG4278|consensus

Probab=99.95  E-value=8.7e-29  Score=197.58  Aligned_cols=162  Identities=22%  Similarity=0.384  Sum_probs=134.9

Q ss_pred             CccccCCcccccccccccccCceEEEEEEEcCCCcEEEEEEccCccChHHHHHHHHHHHHHHhcCCCCchhhhhhhHHHH
Q psy14630         16 DTVYDFTSEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQFYGALFKE   95 (187)
Q Consensus        16 ~~~~~~~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~   95 (187)
                      -..|++++.+.....+||-|-||.||.|.+++-...||||.++.   +....+.+..+..+|+.++|||+|++++.|..+
T Consensus       259 ~DkWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKE---DtMeveEFLkEAAvMKeikHpNLVqLLGVCT~E  335 (1157)
T KOG4278|consen  259 ADKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKE---DTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHE  335 (1157)
T ss_pred             cchhhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhh---cchhHHHHHHHHHHHHhhcCccHHHHhhhhccC
Confidence            37889999999999999999999999999988888999999874   222334455555689999999999999876443


Q ss_pred             ----------------------------------HHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEecccccc
Q psy14630         96 ----------------------------------VTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQ  141 (187)
Q Consensus        96 ----------------------------------~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg~a~~  141 (187)
                                                        ++.||..|+.||-.. +++||||..+|+|+.++..+|+.|||+++.
T Consensus       336 pPFYIiTEfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkk-nFIHRDLAARNCLVgEnhiVKvADFGLsRl  414 (1157)
T KOG4278|consen  336 PPFYIITEFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKK-NFIHRDLAARNCLVGENHIVKVADFGLSRL  414 (1157)
T ss_pred             CCeEEEEecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHh-hhhhhhhhhhhccccccceEEeeccchhhh
Confidence                                              567889999999776 999999999999999999999999999998


Q ss_pred             ccccccccCCCC---CcCccCccccCCCccCCCCCCcceeeeEeeee
Q psy14630        142 LVDSIAKTRDAG---CRPYMAPERIDPLRARGYPSFKTKLGFKFNYR  185 (187)
Q Consensus       142 ~~~~~~~~~~~~---t~~y~aPE~~~~~~~~~~~~~~D~ws~gi~~~  185 (187)
                      +...... ..+|   ...|.|||.+.   ...++.++|||+|||.+|
T Consensus       415 MtgDTYT-AHAGAKFPIKWTAPEsLA---yNtFSiKSDVWAFGVLLW  457 (1157)
T KOG4278|consen  415 MTGDTYT-AHAGAKFPIKWTAPESLA---YNTFSIKSDVWAFGVLLW  457 (1157)
T ss_pred             hcCCcee-cccCccCcccccCccccc---ccccccchhhHHHHHHHH
Confidence            7654333 2233   23599999998   677999999999999888

>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

Probab=99.95  E-value=2e-28  Score=186.03  Aligned_cols=156  Identities=27%  Similarity=0.443  Sum_probs=126.3

Q ss_pred             ccccccccccccCceEEEEEEEcCCCcEEEEEEccCccChHHHHHHHHHHHHHHhcCCCCchhhhhhhHH----------
Q psy14630         24 EDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQFYGALF----------   93 (187)
Q Consensus        24 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~----------   93 (187)
                      ++|++.+.||+|+||.||+|.+..+++.||+|.++.........+.+..+..+++.+.|+||+++++.+.          
T Consensus         1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e   80 (288)
T cd07833           1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFE   80 (288)
T ss_pred             CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEe
Confidence            3688999999999999999999989999999988654333334455566666777888999998875431          


Q ss_pred             ----------------------HHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEeccccccccccc--ccc
Q psy14630         94 ----------------------KEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSI--AKT  149 (187)
Q Consensus        94 ----------------------~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg~a~~~~~~~--~~~  149 (187)
                                            ..++.+++.++.|||+. +++|+|++|+||+++.++.++|+|||++.......  ...
T Consensus        81 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~-~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~~~~~  159 (288)
T cd07833          81 YVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSH-NIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLT  159 (288)
T ss_pred             cCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC-CeecCCCCHHHeEECCCCCEEEEeeecccccCCCcccccc
Confidence                                  12667899999999998 99999999999999999999999999988765433  223


Q ss_pred             CCCCCcCccCccccCCCccC-CCCCCcceeeeEee
Q psy14630        150 RDAGCRPYMAPERIDPLRAR-GYPSFKTKLGFKFN  183 (187)
Q Consensus       150 ~~~~t~~y~aPE~~~~~~~~-~~~~~~D~ws~gi~  183 (187)
                      ...++..|+|||.+.   .. .++.++|+||+|+.
T Consensus       160 ~~~~~~~~~~PE~~~---~~~~~~~~~Dv~slG~~  191 (288)
T cd07833         160 DYVATRWYRAPELLV---GDTNYGKPVDVWAIGCI  191 (288)
T ss_pred             CcccccCCcCCchhc---CCCCcCchhhHHHHHHH
Confidence            346788899999998   44 67899999999984

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning

>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

Probab=99.95  E-value=7.6e-29  Score=190.97  Aligned_cols=148  Identities=23%  Similarity=0.343  Sum_probs=112.3

Q ss_pred             cccccccCceEEEEEEEcC--CCcEEEEEEccCccChHHHHHHHHHHHHHHhcCCCCchhhhhhhH--------------
Q psy14630         29 LGEIGRGGFGTVNKMIHRS--SDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQFYGAL--------------   92 (187)
Q Consensus        29 ~~~lg~G~fg~V~~~~~~~--~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~--------------   92 (187)
                      ..+||+|+||.||+|....  ++..+|+|.+......    ..+.++..+++.+.||||+++++.+              
T Consensus         6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~~----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~   81 (317)
T cd07867           6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGIS----MSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDY   81 (317)
T ss_pred             ceEeccCCCeeEEEEEecCCCccceEEEEEecCCCCc----HHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEee
Confidence            3679999999999998653  5678999988643221    1234455667788999999875422              


Q ss_pred             ----------------------------HHHHHHHHHHHHHHHHhcCCCeeecCCCCCeEE----cCCCCEEEEeccccc
Q psy14630         93 ----------------------------FKEVTVATVKALNYLKEELKIIHRDVKPSNILL----DRRGAIKLCDFGISG  140 (187)
Q Consensus        93 ----------------------------~~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili----~~~~~~ki~dfg~a~  140 (187)
                                                  ...++.|++.||.|||+. +++||||||+||++    +..+.+||+|||+++
T Consensus        82 ~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~-~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~  160 (317)
T cd07867          82 AEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHAN-WVLHRDLKPANILVMGEGPERGRVKIADMGFAR  160 (317)
T ss_pred             eCCcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhC-CEEcCCCCHHHEEEccCCCCCCcEEEeecccee
Confidence                                        112567899999999997 99999999999999    456789999999998


Q ss_pred             ccccccc----ccCCCCCcCccCccccCCCccCCCCCCcceeeeEee
Q psy14630        141 QLVDSIA----KTRDAGCRPYMAPERIDPLRARGYPSFKTKLGFKFN  183 (187)
Q Consensus       141 ~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi~  183 (187)
                      .......    .....+|+.|+|||.+.+  ...++.++|+||+|+.
T Consensus       161 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~--~~~~~~~~DiwSlG~i  205 (317)
T cd07867         161 LFNSPLKPLADLDPVVVTFWYRAPELLLG--ARHYTKAIDIWAIGCI  205 (317)
T ss_pred             ccCCCcccccccCcceecccccCcHHhcC--CCccCcHHHHHhHHHH
Confidence            7643221    223467889999999873  2447889999999984

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as

>PHA02988 hypothetical protein; Provisional

Probab=99.95  E-value=2.7e-28  Score=185.63  Aligned_cols=162  Identities=11%  Similarity=0.159  Sum_probs=125.2

Q ss_pred             cccCCccccccc--ccccccCceEEEEEEEcCCCcEEEEEEccCcc-ChHHHHHHHHHHHHHHhcCCCCchhhhhhhHHH
Q psy14630         18 VYDFTSEDLQDL--GEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTV-DEKDQRQLLMDLDVVMKSNECPYIVQFYGALFK   94 (187)
Q Consensus        18 ~~~~~~~~~~~~--~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~   94 (187)
                      ...++.++++..  ..+|+|+++.||+|..  +++.||+|.++... ......+.+.++..+++.+.||||+++++.+..
T Consensus        12 ~~~i~~~~i~~~~~~~i~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~   89 (283)
T PHA02988         12 IKCIESDDIDKYTSVLIKENDQNSIYKGIF--NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIID   89 (283)
T ss_pred             ceecCHHHcCCCCCeEEeeCCceEEEEEEE--CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEe
Confidence            334455666555  6799999999999987  57899999986532 222334556677778888999999998864322


Q ss_pred             ------------------------------------HHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEeccc
Q psy14630         95 ------------------------------------EVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGI  138 (187)
Q Consensus        95 ------------------------------------~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg~  138 (187)
                                                          .++.+++.|+.|||+..+++||||||+|++++.++.+|++|||+
T Consensus        90 ~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nill~~~~~~kl~dfg~  169 (283)
T PHA02988         90 IVDDLPRLSLILEYCTRGYLREVLDKEKDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVTENYKLKIICHGL  169 (283)
T ss_pred             cccCCCceEEEEEeCCCCcHHHHHhhCCCCChhHHHHHHHHHHHHHHHHHhcCCCCCCcCChhhEEECCCCcEEEcccch
Confidence                                                15668899999999855889999999999999999999999999


Q ss_pred             cccccccccccCCCCCcCccCccccCCCccCCCCCCcceeeeEeee
Q psy14630        139 SGQLVDSIAKTRDAGCRPYMAPERIDPLRARGYPSFKTKLGFKFNY  184 (187)
Q Consensus       139 a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi~~  184 (187)
                      ++......  ....++..|+|||.+.+. ...++.++|+||||+..
T Consensus       170 ~~~~~~~~--~~~~~~~~y~aPE~~~~~-~~~~~~k~Di~SlGvil  212 (283)
T PHA02988        170 EKILSSPP--FKNVNFMVYFSYKMLNDI-FSEYTIKDDIYSLGVVL  212 (283)
T ss_pred             Hhhhcccc--ccccCcccccCHHHhhhc-cccccchhhhhHHHHHH
Confidence            88754332  234678899999998732 25688999999999943

>KOG0664|consensus

Probab=99.95  E-value=5.7e-29  Score=181.90  Aligned_cols=154  Identities=24%  Similarity=0.379  Sum_probs=121.0

Q ss_pred             cccccccccCceEEEEEEEcCCCcEEEEEEccCccChHHHHHHHHHHHHHHhcCCCCchhhhhhhH-------HHH----
Q psy14630         27 QDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQFYGAL-------FKE----   95 (187)
Q Consensus        27 ~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~-------~~~----   95 (187)
                      +-.+-||.|+||.||.+.+..+++.||.|.+..-...-...+...++..++....|.|++...+.+       +++    
T Consensus        56 ~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~  135 (449)
T KOG0664|consen   56 QPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVL  135 (449)
T ss_pred             CCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHH
Confidence            345789999999999999999999999998764333333344455555566677899988776532       222    


Q ss_pred             -------------------------HHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEecccccccccccccc-
Q psy14630         96 -------------------------VTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKT-  149 (187)
Q Consensus        96 -------------------------~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg~a~~~~~~~~~~-  149 (187)
                                               +.-||+.||+|||+. +|.||||||-|++++.+..+||||||+|+......... 
T Consensus       136 TELmQSDLHKIIVSPQ~Ls~DHvKVFlYQILRGLKYLHsA-~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d~~~hM  214 (449)
T KOG0664|consen  136 TELMQSDLHKIIVSPQALTPDHVKVFVYQILRGLKYLHTA-NILHRDIKPGNLLVNSNCILKICDFGLARTWDQRDRLNM  214 (449)
T ss_pred             HHHHHhhhhheeccCCCCCcchhhhhHHHHHhhhHHHhhc-chhhccCCCccEEeccCceEEecccccccccchhhhhhh
Confidence                                     456899999999998 99999999999999999999999999999875443322 


Q ss_pred             -CCCCCcCccCccccCCCccCCCCCCcceeeeEee
Q psy14630        150 -RDAGCRPYMAPERIDPLRARGYPSFKTKLGFKFN  183 (187)
Q Consensus       150 -~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi~  183 (187)
                       ...-|-+|+|||.+++  ...|+.++||||+|.+
T Consensus       215 TqEVVTQYYRAPEiLMG--aRhYs~AvDiWSVGCI  247 (449)
T KOG0664|consen  215 THEVVTQYYRAPELLMG--ARRYTGAVDIWSVGCI  247 (449)
T ss_pred             HHHHHHHHhccHHHhhc--chhhcCccceehhhHH
Confidence             2245778999999997  5669999999999973

>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

Probab=99.95  E-value=4.7e-28  Score=183.91  Aligned_cols=157  Identities=26%  Similarity=0.443  Sum_probs=124.3

Q ss_pred             ccccccccccccCceEEEEEEEcCCCcEEEEEEccCccChHHHHHHHHHHHHHHhcCCCCchhhhhhhHHH---------
Q psy14630         24 EDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQFYGALFK---------   94 (187)
Q Consensus        24 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~---------   94 (187)
                      ++|++.+.||+|+||.||+|.+..+++.+|+|.+..........+.+.++..+++.+.||||+++++.+..         
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   80 (286)
T cd07846           1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE   80 (286)
T ss_pred             CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence            46888999999999999999998889999999876433333334445556667777899999998765421         


Q ss_pred             -----------------------HHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEeccccccccccc-cccC
Q psy14630         95 -----------------------EVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSI-AKTR  150 (187)
Q Consensus        95 -----------------------~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg~a~~~~~~~-~~~~  150 (187)
                                             .+..+++.++.|||+. +++|+|++|+|++++.++.++++|||++....... ....
T Consensus        81 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~-~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~~~~  159 (286)
T cd07846          81 FVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSH-NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTD  159 (286)
T ss_pred             cCCccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC-CccccCCCHHHEEECCCCcEEEEeeeeeeeccCCccccCc
Confidence                                   1567899999999998 99999999999999999999999999988764432 2223


Q ss_pred             CCCCcCccCccccCCCccCCCCCCcceeeeEee
Q psy14630        151 DAGCRPYMAPERIDPLRARGYPSFKTKLGFKFN  183 (187)
Q Consensus       151 ~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi~  183 (187)
                      ..++..|+|||.+.+  ...++.++|+||||+.
T Consensus       160 ~~~~~~y~aPE~~~~--~~~~~~~~Dv~slG~~  190 (286)
T cd07846         160 YVATRWYRAPELLVG--DTKYGRAVDIWAVGCL  190 (286)
T ss_pred             ccceeeccCcHHhcc--ccccCchHhHHHHHHH
Confidence            457788999999873  2346788999999983

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI

>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

Probab=99.95  E-value=8.9e-28  Score=179.66  Aligned_cols=154  Identities=25%  Similarity=0.340  Sum_probs=121.8

Q ss_pred             cccccccccccCceEEEEEEEcCCCcEEEEEEccCccChHHHHHHHHHHHHHHhcCCCCchhhhhhhH------------
Q psy14630         25 DLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQFYGAL------------   92 (187)
Q Consensus        25 ~~~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~------------   92 (187)
                      +|++.+.||+|+||.||++.+..+++.+|+|.++...... ..+....+..+++.++|+|++++++.+            
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   79 (255)
T cd08219           1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSS-AVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEY   79 (255)
T ss_pred             CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchH-HHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEee
Confidence            5788899999999999999999999999999986433322 233344455567778999998865321            


Q ss_pred             ----------------------HHHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEeccccccccccc-ccc
Q psy14630         93 ----------------------FKEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSI-AKT  149 (187)
Q Consensus        93 ----------------------~~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg~a~~~~~~~-~~~  149 (187)
                                            ...+..+++.|+.|||+. +++|+||||+||+++.++.++++|||++....... ...
T Consensus        80 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~-~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~  158 (255)
T cd08219          80 CDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEK-RVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYAC  158 (255)
T ss_pred             CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhC-CcccCCCCcceEEECCCCcEEEcccCcceeecccccccc
Confidence                                  011567899999999997 99999999999999999999999999988764322 223


Q ss_pred             CCCCCcCccCccccCCCccCCCCCCcceeeeEee
Q psy14630        150 RDAGCRPYMAPERIDPLRARGYPSFKTKLGFKFN  183 (187)
Q Consensus       150 ~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi~  183 (187)
                      ...+++.|+|||++.   ...++.++|+||||+.
T Consensus       159 ~~~~~~~~~aPE~~~---~~~~~~~~Dv~slG~i  189 (255)
T cd08219         159 TYVGTPYYVPPEIWE---NMPYNNKSDIWSLGCI  189 (255)
T ss_pred             cccCCccccCHHHHc---cCCcCchhhhhhhchh
Confidence            346788899999987   5568899999999993

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati

>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

Probab=99.95  E-value=3.8e-28  Score=182.03  Aligned_cols=148  Identities=29%  Similarity=0.452  Sum_probs=115.7

Q ss_pred             cccccCceEEEEEEE--cCCCcEEEEEEccCccChHHHHHHHHHHHHHHhcCCCCchhhhhhhH----------------
Q psy14630         31 EIGRGGFGTVNKMIH--RSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQFYGAL----------------   92 (187)
Q Consensus        31 ~lg~G~fg~V~~~~~--~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~----------------   92 (187)
                      .||+|+||.||+|..  ..++..+|+|+++.........+.+..+..+++.+.||||+++++.+                
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~lv~e~~~~~~   81 (257)
T cd05116           2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICEAESWMLVMELAELGP   81 (257)
T ss_pred             cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCcEEEEecCCCCc
Confidence            689999999999964  45678899999875444444455566666677888999999876432                


Q ss_pred             ---------------HHHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEecccccccccccc----ccCCCC
Q psy14630         93 ---------------FKEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIA----KTRDAG  153 (187)
Q Consensus        93 ---------------~~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg~a~~~~~~~~----~~~~~~  153 (187)
                                     ...+..|++.+++|||+. +++||||||+|++++.++.++++|||+++.......    .....+
T Consensus        82 L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~-~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~  160 (257)
T cd05116          82 LNKFLQKNKHVTEKNITELVHQVSMGMKYLEET-NFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKW  160 (257)
T ss_pred             HHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC-CEeecccchhhEEEcCCCeEEECCCccccccCCCCCeeeecCCCCC
Confidence                           112667899999999997 999999999999999999999999999987643321    112234


Q ss_pred             CcCccCccccCCCccCCCCCCcceeeeEe
Q psy14630        154 CRPYMAPERIDPLRARGYPSFKTKLGFKF  182 (187)
Q Consensus       154 t~~y~aPE~~~~~~~~~~~~~~D~ws~gi  182 (187)
                      +..|+|||.+.   ...++.++|+||||+
T Consensus       161 ~~~y~aPE~~~---~~~~~~~~Di~slG~  186 (257)
T cd05116         161 PVKWYAPECMN---YYKFSSKSDVWSFGV  186 (257)
T ss_pred             CccccCHhHhc---cCCcCchhHHHHHHH
Confidence            56899999987   556888999999998

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio

>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

Probab=99.95  E-value=4.8e-28  Score=183.43  Aligned_cols=154  Identities=27%  Similarity=0.379  Sum_probs=120.0

Q ss_pred             ccccccccccCceEEEEEEEcCCCcEEEEEEccCccChHHHHHHHHHHHHHHhcCCCCchhhhhhhHH------------
Q psy14630         26 LQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQFYGALF------------   93 (187)
Q Consensus        26 ~~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~------------   93 (187)
                      |++.+.||+|+||.||+|.+..+++.+|+|.++...........+.+...+.+...|+|++++++.+.            
T Consensus         1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e   80 (282)
T cd07831           1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE   80 (282)
T ss_pred             CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence            56788999999999999999999999999998654333333344445554444556999998775321            


Q ss_pred             ----------------------HHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEeccccccccccccccCC
Q psy14630         94 ----------------------KEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTRD  151 (187)
Q Consensus        94 ----------------------~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg~a~~~~~~~~~~~~  151 (187)
                                            ..+..|++.||.|||+. +++||||+|+||+++. +.+||+|||+++...........
T Consensus        81 ~~~~~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~-~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~~~~~~  158 (282)
T cd07831          81 LMDMNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRN-GIFHRDIKPENILIKD-DILKLADFGSCRGIYSKPPYTEY  158 (282)
T ss_pred             cCCccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC-CceecccCHHHEEEcC-CCeEEEecccccccccCCCcCCC
Confidence                                  11667899999999997 9999999999999999 99999999999887554443445


Q ss_pred             CCCcCccCccccCCCccCCCCCCcceeeeEee
Q psy14630        152 AGCRPYMAPERIDPLRARGYPSFKTKLGFKFN  183 (187)
Q Consensus       152 ~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi~  183 (187)
                      .++..|+|||.+..  +..++.++|+||+|+.
T Consensus       159 ~~~~~y~aPE~~~~--~~~~~~~~Di~slGv~  188 (282)
T cd07831         159 ISTRWYRAPECLLT--DGYYGPKMDIWAVGCV  188 (282)
T ss_pred             CCCcccCChhHhhc--CCCCCcchhHHHHHHH
Confidence            67889999998652  3446789999999984

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.

>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

Probab=99.95  E-value=6.7e-28  Score=183.88  Aligned_cols=159  Identities=30%  Similarity=0.470  Sum_probs=123.1

Q ss_pred             CcccccccccccccCceEEEEEEEcCCCcEEEEEEccCccChHHHHHHHHHHHHHHhcCCCCchhhhhhhHH--------
Q psy14630         22 TSEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQFYGALF--------   93 (187)
Q Consensus        22 ~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~--------   93 (187)
                      +.+.|++.+.||+|+||.||+|.+..+++.+++|.+...  .....+.+..+...++.+.|+|++++++.+.        
T Consensus        10 ~~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   87 (292)
T cd06644          10 PNEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETK--SEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIM   87 (292)
T ss_pred             cchhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccC--CHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEE
Confidence            457799999999999999999999999999999998643  2223334444555677789999998765321        


Q ss_pred             -------------------------HHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEecccccccccc-cc
Q psy14630         94 -------------------------KEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDS-IA  147 (187)
Q Consensus        94 -------------------------~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg~a~~~~~~-~~  147 (187)
                                               ..+..|++.++.|||+. +++|||++|+||+++.++.++|+|||++...... ..
T Consensus        88 ~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~-~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~~  166 (292)
T cd06644          88 IEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSM-KIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQR  166 (292)
T ss_pred             EecCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcC-CeeecCCCcceEEEcCCCCEEEccCccceeccccccc
Confidence                                     12667899999999997 9999999999999999999999999988764332 12


Q ss_pred             ccCCCCCcCccCccccCCCc--cCCCCCCcceeeeEee
Q psy14630        148 KTRDAGCRPYMAPERIDPLR--ARGYPSFKTKLGFKFN  183 (187)
Q Consensus       148 ~~~~~~t~~y~aPE~~~~~~--~~~~~~~~D~ws~gi~  183 (187)
                      .....+++.|+|||.+.+..  ...++.++|+||||+.
T Consensus       167 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~i  204 (292)
T cd06644         167 RDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGIT  204 (292)
T ss_pred             cceecCCccccCceeeccccccCCCCCchhhhHhHHHH
Confidence            22345788999999985321  3346789999999984

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.

>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

Probab=99.95  E-value=8.9e-28  Score=179.94  Aligned_cols=154  Identities=29%  Similarity=0.489  Sum_probs=124.7

Q ss_pred             cccccccccccCceEEEEEEEcCCCcEEEEEEccCcc-ChHHHHHHHHHHHHHHhcCCCCchhhhhhhHH----------
Q psy14630         25 DLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTV-DEKDQRQLLMDLDVVMKSNECPYIVQFYGALF----------   93 (187)
Q Consensus        25 ~~~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~----------   93 (187)
                      +|++.+.||.|+||.||+|.+..+++.+|+|.+.... ......+.+.++...++.++||||+.+++.+.          
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   80 (258)
T cd05578           1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD   80 (258)
T ss_pred             CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence            4788899999999999999998899999999986432 12123345555566777889999999875431          


Q ss_pred             ----------------------HHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEeccccccccccccccCC
Q psy14630         94 ----------------------KEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTRD  151 (187)
Q Consensus        94 ----------------------~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg~a~~~~~~~~~~~~  151 (187)
                                            ..+..+++.++.|||+. +++|+||+|+||+++.++.++++|||++............
T Consensus        81 ~~~~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~-~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~  159 (258)
T cd05578          81 LLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSK-GIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTLTTST  159 (258)
T ss_pred             CCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHhC-CeeccCCCHHHeEEcCCCCEEEeecccccccCCCcccccc
Confidence                                  11567899999999997 9999999999999999999999999998877654334445


Q ss_pred             CCCcCccCccccCCCccCCCCCCcceeeeEe
Q psy14630        152 AGCRPYMAPERIDPLRARGYPSFKTKLGFKF  182 (187)
Q Consensus       152 ~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi  182 (187)
                      .++..|+|||.+.   ...++.++|+||+|+
T Consensus       160 ~~~~~y~~PE~~~---~~~~~~~~Di~slG~  187 (258)
T cd05578         160 SGTPGYMAPEVLC---RQGYSVAVDWWSLGV  187 (258)
T ss_pred             CCChhhcCHHHHc---ccCCCCcccchhhHH
Confidence            6788899999988   555889999999998

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.

>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src

Probab=99.95  E-value=2.3e-28  Score=183.85  Aligned_cols=156  Identities=21%  Similarity=0.319  Sum_probs=120.7

Q ss_pred             ccCCcccccccccccccCceEEEEEEEcCCCcEEEEEEccCccChHHHHHHHHHHHHHHhcCCCCchhhhhhhH------
Q psy14630         19 YDFTSEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQFYGAL------   92 (187)
Q Consensus        19 ~~~~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~------   92 (187)
                      |.++.++|++.+.||+|+||.||+|.+..+ ..||+|.++.....   .+.+..+..+++.++||||+++++.+      
T Consensus         1 ~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~-~~valK~~~~~~~~---~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~   76 (262)
T cd05071           1 WEIPRESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMS---PEAFLQEAQVMKKLRHEKLVQLYAVVSEEPIY   76 (262)
T ss_pred             CCCChHHeeEeeecCCCCCCcEEEEEecCC-ceEEEEecccCccC---HHHHHHHHHHHHhCCCCCcceEEEEECCCCcE
Confidence            456778999999999999999999988655 46999998743221   22344455567778999999865321      


Q ss_pred             ---------------------------HHHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEecccccccccc
Q psy14630         93 ---------------------------FKEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDS  145 (187)
Q Consensus        93 ---------------------------~~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg~a~~~~~~  145 (187)
                                                 ...+..+++.+|+|||+. +++|+||+|+||+++.++.++|+|||.++.....
T Consensus        77 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~-~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~  155 (262)
T cd05071          77 IVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERM-NYVHRDLRAANILVGENLVCKVADFGLARLIEDN  155 (262)
T ss_pred             EEEEcCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHC-CccccccCcccEEEcCCCcEEeccCCceeecccc
Confidence                                       112567889999999997 9999999999999999999999999999776433


Q ss_pred             ccc--cCCCCCcCccCccccCCCccCCCCCCcceeeeEe
Q psy14630        146 IAK--TRDAGCRPYMAPERIDPLRARGYPSFKTKLGFKF  182 (187)
Q Consensus       146 ~~~--~~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi  182 (187)
                      ...  ....++..|+|||...   ...++.++|+||+|+
T Consensus       156 ~~~~~~~~~~~~~y~~PE~~~---~~~~~~~~DvwslG~  191 (262)
T cd05071         156 EYTARQGAKFPIKWTAPEAAL---YGRFTIKSDVWSFGI  191 (262)
T ss_pred             ccccccCCcccceecCHhHhc---cCCCCchhhHHHHHH
Confidence            221  1223566799999987   566889999999998

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo

>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

Probab=99.95  E-value=8.1e-28  Score=179.89  Aligned_cols=155  Identities=25%  Similarity=0.375  Sum_probs=122.4

Q ss_pred             cccccccccccCceEEEEEEEcCCCcEEEEEEccCccChHHHHHHHHHHHHHHhcCCCCchhhhhhhHH-----------
Q psy14630         25 DLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQFYGALF-----------   93 (187)
Q Consensus        25 ~~~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~-----------   93 (187)
                      +|++.+.||+|++|.||++.+..+++.+|+|.+..........+.+..+..+.+.++|+|++++++.+.           
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e   80 (257)
T cd08223           1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG   80 (257)
T ss_pred             CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence            488899999999999999999888999999998643333333344555566777889999997653211           


Q ss_pred             ------------------------HHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEeccccccccccc-cc
Q psy14630         94 ------------------------KEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSI-AK  148 (187)
Q Consensus        94 ------------------------~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg~a~~~~~~~-~~  148 (187)
                                              ..+..+++.++.+||+. +++|+||+|+||+++.++.++|+|||++....... ..
T Consensus        81 ~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~-~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~  159 (257)
T cd08223          81 FCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEK-HILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMA  159 (257)
T ss_pred             ccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC-CeeccCCCchhEEEecCCcEEEecccceEEecccCCcc
Confidence                                    12567889999999997 99999999999999999999999999988764322 22


Q ss_pred             cCCCCCcCccCccccCCCccCCCCCCcceeeeEee
Q psy14630        149 TRDAGCRPYMAPERIDPLRARGYPSFKTKLGFKFN  183 (187)
Q Consensus       149 ~~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi~  183 (187)
                      ....+++.|+|||.+.   ...++.++|+||+|+.
T Consensus       160 ~~~~~~~~y~aPE~~~---~~~~~~~~Dv~slG~i  191 (257)
T cd08223         160 STLIGTPYYMSPELFS---NKPYNYKSDVWALGCC  191 (257)
T ss_pred             ccccCCcCccChhHhc---CCCCCchhhhHHHHHH
Confidence            2335788999999988   5668889999999983

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.

>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

Probab=99.95  E-value=9.3e-28  Score=182.17  Aligned_cols=158  Identities=34%  Similarity=0.487  Sum_probs=121.4

Q ss_pred             cccccccccccccCceEEEEEEEcCCCcEEEEEEccCccChHHHHHHHHHHHHHHhcCCCCchhhhhhhHH---------
Q psy14630         23 SEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQFYGALF---------   93 (187)
Q Consensus        23 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~---------   93 (187)
                      .+-|++.+.||+|+||.||++.+..++..+++|.+.... . ...+.+..+..+++.+.|||++++++.+.         
T Consensus         4 ~~~~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~-~-~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~   81 (282)
T cd06643           4 EEFWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKS-E-EELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILI   81 (282)
T ss_pred             HHHHHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCC-H-HHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEE
Confidence            345788899999999999999999999999999885432 2 22333444555677789999998764221         


Q ss_pred             ------------------------HHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEeccccccccccc-cc
Q psy14630         94 ------------------------KEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSI-AK  148 (187)
Q Consensus        94 ------------------------~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg~a~~~~~~~-~~  148 (187)
                                              ..+..|++.+|.|||+. +++||||||+||+++.++.++++|||++....... ..
T Consensus        82 e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~-~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~~~  160 (282)
T cd06643          82 EFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHEN-KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRR  160 (282)
T ss_pred             EecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC-CeeecCCCcccEEEccCCCEEEcccccccccccccccc
Confidence                                    11567899999999997 99999999999999999999999999987654321 22


Q ss_pred             cCCCCCcCccCccccCCC--ccCCCCCCcceeeeEee
Q psy14630        149 TRDAGCRPYMAPERIDPL--RARGYPSFKTKLGFKFN  183 (187)
Q Consensus       149 ~~~~~t~~y~aPE~~~~~--~~~~~~~~~D~ws~gi~  183 (187)
                      ....+++.|+|||.+...  ....++.++|+||+|+.
T Consensus       161 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi  197 (282)
T cd06643         161 DSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGIT  197 (282)
T ss_pred             ccccccccccCHhhccccCCCCCCCCccchhhhHHHH
Confidence            334678899999998522  13447789999999984

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.

>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

Probab=99.95  E-value=6.7e-28  Score=183.98  Aligned_cols=157  Identities=22%  Similarity=0.348  Sum_probs=120.7

Q ss_pred             CCcccccccccccccCceEEEEEEEcCCC----------------cEEEEEEccCccChHHHHHHHHHHHHHHhcCCCCc
Q psy14630         21 FTSEDLQDLGEIGRGGFGTVNKMIHRSSD----------------TVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPY   84 (187)
Q Consensus        21 ~~~~~~~~~~~lg~G~fg~V~~~~~~~~~----------------~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~   84 (187)
                      +...+|++.+.||+|+||.||+|.+..++                ..+|+|.+...... ...+.+..+..++..+.|||
T Consensus         2 ~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~-~~~~~~~~e~~~l~~l~~~~   80 (296)
T cd05051           2 FPRQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASD-NAREDFLKEVKILSRLSDPN   80 (296)
T ss_pred             CchhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCH-HHHHHHHHHHHHHHhcCCCC
Confidence            45688999999999999999998875533                45799988654333 23344555556677789999


Q ss_pred             hhhhhhhH-------------------------------------------HHHHHHHHHHHHHHHHhcCCCeeecCCCC
Q psy14630         85 IVQFYGAL-------------------------------------------FKEVTVATVKALNYLKEELKIIHRDVKPS  121 (187)
Q Consensus        85 iv~~~~~~-------------------------------------------~~~~~~~~~~~l~~lh~~~~i~Hrdlk~~  121 (187)
                      |+++++.+                                           ...+..+++.|+.|||+. +++|+||||+
T Consensus        81 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~-~i~H~dlkp~  159 (296)
T cd05051          81 IARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESL-NFVHRDLATR  159 (296)
T ss_pred             EeEEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHc-Cccccccchh
Confidence            98865321                                           012557899999999997 9999999999


Q ss_pred             CeEEcCCCCEEEEeccccccccccc---cccCCCCCcCccCccccCCCccCCCCCCcceeeeEe
Q psy14630        122 NILLDRRGAIKLCDFGISGQLVDSI---AKTRDAGCRPYMAPERIDPLRARGYPSFKTKLGFKF  182 (187)
Q Consensus       122 nili~~~~~~ki~dfg~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi  182 (187)
                      ||+++.++.++++|||+++......   ......++..|+|||.+.   ...++.++|+||||+
T Consensus       160 Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~Dv~slG~  220 (296)
T cd05051         160 NCLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVL---LGKFTTKSDVWAFGV  220 (296)
T ss_pred             ceeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhh---cCCCCccchhhhhHH
Confidence            9999999999999999988654322   112234567899999987   556889999999998

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke

>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

Probab=99.95  E-value=3.9e-28  Score=185.50  Aligned_cols=158  Identities=24%  Similarity=0.350  Sum_probs=121.3

Q ss_pred             CCcccccccccccccCceEEEEEEEcCCC--------------cEEEEEEccCccChHHHHHHHHHHHHHHhcCCCCchh
Q psy14630         21 FTSEDLQDLGEIGRGGFGTVNKMIHRSSD--------------TVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIV   86 (187)
Q Consensus        21 ~~~~~~~~~~~lg~G~fg~V~~~~~~~~~--------------~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv   86 (187)
                      ++.++|++.+.||+|+||.||+|.+..++              ..||+|.++..... ...+.+.++..+++.+.|+|++
T Consensus         2 ~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~ei~~l~~l~h~~i~   80 (295)
T cd05097           2 FPRQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTK-TARNDFLKEIKIMSRLKNPNII   80 (295)
T ss_pred             CchHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCH-HHHHHHHHHHHHHHhCCCCCcC
Confidence            56789999999999999999999875432              35899998754333 2334455566677888999999


Q ss_pred             hhhhhH---------------------H-----------------------HHHHHHHHHHHHHHHhcCCCeeecCCCCC
Q psy14630         87 QFYGAL---------------------F-----------------------KEVTVATVKALNYLKEELKIIHRDVKPSN  122 (187)
Q Consensus        87 ~~~~~~---------------------~-----------------------~~~~~~~~~~l~~lh~~~~i~Hrdlk~~n  122 (187)
                      ++++.+                     .                       ..+..+++.|+.|||+. +++|+||||+|
T Consensus        81 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~-~i~H~dlkp~N  159 (295)
T cd05097          81 RLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASL-NFVHRDLATRN  159 (295)
T ss_pred             eEEEEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhc-CeeccccChhh
Confidence            876421                     0                       11567889999999997 99999999999


Q ss_pred             eEEcCCCCEEEEecccccccccccc---ccCCCCCcCccCccccCCCccCCCCCCcceeeeEee
Q psy14630        123 ILLDRRGAIKLCDFGISGQLVDSIA---KTRDAGCRPYMAPERIDPLRARGYPSFKTKLGFKFN  183 (187)
Q Consensus       123 ili~~~~~~ki~dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi~  183 (187)
                      ++++.++.+|++|||++........   .....++..|+|||.+.   ...++.++|+||||+.
T Consensus       160 ill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~DvwSlG~~  220 (295)
T cd05097         160 CLVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESIL---LGKFTTASDVWAFGVT  220 (295)
T ss_pred             EEEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhc---cCCcCchhhHHHHHHH
Confidence            9999999999999999987543221   11223466899999987   5568899999999983

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including

>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

Probab=99.95  E-value=7.7e-28  Score=187.25  Aligned_cols=158  Identities=21%  Similarity=0.366  Sum_probs=123.0

Q ss_pred             ccccccccccccCceEEEEEEEcCCCcEEEEEEccCccChHHHHHHHHHHHHHHhcCCCCchhhhhhhHH----------
Q psy14630         24 EDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQFYGALF----------   93 (187)
Q Consensus        24 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~----------   93 (187)
                      .+|.+.+.||+|+||.||++.+..+++.||+|.+...............+..+++.++|+||+++++.+.          
T Consensus         5 ~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~   84 (337)
T cd07858           5 TKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFNDV   84 (337)
T ss_pred             cceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCcE
Confidence            5789999999999999999999999999999988643222222223334555677789999998875321          


Q ss_pred             --------------------------HHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEecccccccccc-c
Q psy14630         94 --------------------------KEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDS-I  146 (187)
Q Consensus        94 --------------------------~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg~a~~~~~~-~  146 (187)
                                                ..+..|++.|+.|||+. +++||||||+||+++.++.+||+|||++...... .
T Consensus        85 ~lv~e~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~-~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~  163 (337)
T cd07858          85 YIVYELMDTDLHQIIRSSQTLSDDHCQYFLYQLLRGLKYIHSA-NVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGD  163 (337)
T ss_pred             EEEEeCCCCCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC-CEecCCCCHHHEEEcCCCCEEECcCccccccCCCcc
Confidence                                      11567899999999997 9999999999999999999999999999876443 2


Q ss_pred             cccCCCCCcCccCccccCCCccCCCCCCcceeeeEeee
Q psy14630        147 AKTRDAGCRPYMAPERIDPLRARGYPSFKTKLGFKFNY  184 (187)
Q Consensus       147 ~~~~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi~~  184 (187)
                      ......++..|+|||.+..  ...++.++|+||+|+.+
T Consensus       164 ~~~~~~~~~~y~aPE~~~~--~~~~~~~~DiwslG~il  199 (337)
T cd07858         164 FMTEYVVTRWYRAPELLLN--CSEYTTAIDVWSVGCIF  199 (337)
T ss_pred             cccccccccCccChHHHhc--CCCCCCcccHHHHHHHH
Confidence            2223457888999999873  23478999999999843

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati

>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

Probab=99.95  E-value=8.1e-28  Score=186.88  Aligned_cols=157  Identities=23%  Similarity=0.358  Sum_probs=123.7

Q ss_pred             ccccccccccccCceEEEEEEEcCCCcEEEEEEccCccChHHHHHHHHHHHHHHhcCCCCchhhhhhhHH----------
Q psy14630         24 EDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQFYGALF----------   93 (187)
Q Consensus        24 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~----------   93 (187)
                      ++|++.+.||+|+||.||+|.+..+++.||+|.+............+..+..+++.+.||||+++++.+.          
T Consensus         5 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   84 (334)
T cd07855           5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDVY   84 (334)
T ss_pred             hceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceEE
Confidence            6888999999999999999999999999999998653322223334444556777889999998775431          


Q ss_pred             -------------------------HHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEeccccccccccccc
Q psy14630         94 -------------------------KEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAK  148 (187)
Q Consensus        94 -------------------------~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg~a~~~~~~~~~  148 (187)
                                               ..++.|++.||.|||+. +++||||||+||+++.++.+||+|||++.........
T Consensus        85 lv~e~~~~~l~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~-~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~  163 (334)
T cd07855          85 VVMDLMESDLHHIIHSDQPLTEEHIRYFLYQLLRGLKYIHSA-NVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTE  163 (334)
T ss_pred             EEEehhhhhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC-CeecCCCCHHHEEEcCCCcEEecccccceeecccCcC
Confidence                                     11567899999999997 9999999999999999999999999998776432211


Q ss_pred             -----cCCCCCcCccCccccCCCccCCCCCCcceeeeEee
Q psy14630        149 -----TRDAGCRPYMAPERIDPLRARGYPSFKTKLGFKFN  183 (187)
Q Consensus       149 -----~~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi~  183 (187)
                           ....++..|+|||.+..  ...++.++|+||+|+.
T Consensus       164 ~~~~~~~~~~~~~y~~PE~~~~--~~~~~~~~Di~slG~~  201 (334)
T cd07855         164 HKYFMTEYVATRWYRAPELLLS--LPEYTTAIDMWSVGCI  201 (334)
T ss_pred             CCcccccccccccccChHHhcC--CcccccccchHHHHHH
Confidence                 23367888999999863  2347899999999984

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the

>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha

Probab=99.95  E-value=3.5e-28  Score=188.37  Aligned_cols=154  Identities=23%  Similarity=0.314  Sum_probs=118.9

Q ss_pred             cccccccc--CceEEEEEEEcCCCcEEEEEEccCccChHHHHHHHHHHHHHHhcCCCCchhhhhhhH-------------
Q psy14630         28 DLGEIGRG--GFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQFYGAL-------------   92 (187)
Q Consensus        28 ~~~~lg~G--~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~-------------   92 (187)
                      +.++||+|  +|++||++.+..+++.||+|.++.........+.+.++..+++.++||||+++++.+             
T Consensus         2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~   81 (327)
T cd08227           2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM   81 (327)
T ss_pred             hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence            46789999  788999999999999999999875443444556677777788889999999876422             


Q ss_pred             ---------------------HHHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEeccccccccccc-----
Q psy14630         93 ---------------------FKEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSI-----  146 (187)
Q Consensus        93 ---------------------~~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg~a~~~~~~~-----  146 (187)
                                           ...+..|++.||+|||+. +++||||||+||+++.++.+++.||+.+.......     
T Consensus        82 ~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~-~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~~~  160 (327)
T cd08227          82 AYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHM-GYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRLRV  160 (327)
T ss_pred             CCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC-CEecCCCChhhEEEecCCcEEEcccchhhccccccccccc
Confidence                                 112567899999999997 99999999999999999999999998655432111     


Q ss_pred             ---cccCCCCCcCccCccccCCCccCCCCCCcceeeeEee
Q psy14630        147 ---AKTRDAGCRPYMAPERIDPLRARGYPSFKTKLGFKFN  183 (187)
Q Consensus       147 ---~~~~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi~  183 (187)
                         ......++..|+|||.+.+. ..+++.++|+||+|++
T Consensus       161 ~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~~DiwslG~i  199 (327)
T cd08227         161 VHDFPKYSVKVLPWLSPEVLQQN-LQGYDAKSDIYSVGIT  199 (327)
T ss_pred             cccccccccceecccChHHhhcc-cCCCCchhhHHHHHHH
Confidence               01122456779999998731 2358899999999984

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype

>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=99.95  E-value=1.5e-27  Score=181.24  Aligned_cols=156  Identities=20%  Similarity=0.299  Sum_probs=121.0

Q ss_pred             CcccccccccccccCceEEEEEEE----cCCCcEEEEEEccCccChHHHHHHHHHHHHHHhcCCCCchhhhhhhHH----
Q psy14630         22 TSEDLQDLGEIGRGGFGTVNKMIH----RSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQFYGALF----   93 (187)
Q Consensus        22 ~~~~~~~~~~lg~G~fg~V~~~~~----~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~----   93 (187)
                      +..-|++.+.||+|+||.||+|..    ..++..+|+|.++...... ..+.+..+..+++.+.|||++++++.+.    
T Consensus         2 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   80 (284)
T cd05079           2 EKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGN-HIADLKKEIEILRNLYHENIVKYKGICTEDGG   80 (284)
T ss_pred             chhhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHH-HHHHHHHHHHHHHhCCCCCeeeeeeEEecCCC
Confidence            345678899999999999999974    4567889999986543222 3344556666778889999987654210    


Q ss_pred             -------------------------------HHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEeccccccc
Q psy14630         94 -------------------------------KEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQL  142 (187)
Q Consensus        94 -------------------------------~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg~a~~~  142 (187)
                                                     ..+..+++.+++|||+. +++||||||+||+++.++.++++|||+++.+
T Consensus        81 ~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~~-gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~~  159 (284)
T cd05079          81 NGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSR-QYVHRDLAARNVLVESEHQVKIGDFGLTKAI  159 (284)
T ss_pred             CceEEEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC-CeeecccchheEEEcCCCCEEECCCcccccc
Confidence                                           12567899999999998 9999999999999999999999999999876


Q ss_pred             ccccc----ccCCCCCcCccCccccCCCccCCCCCCcceeeeEe
Q psy14630        143 VDSIA----KTRDAGCRPYMAPERIDPLRARGYPSFKTKLGFKF  182 (187)
Q Consensus       143 ~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi  182 (187)
                      .....    .....++..|+|||.+.   +..++.++|+||+|+
T Consensus       160 ~~~~~~~~~~~~~~~~~~y~apE~~~---~~~~~~~~Di~slG~  200 (284)
T cd05079         160 ETDKEYYTVKDDLDSPVFWYAPECLI---QSKFYIASDVWSFGV  200 (284)
T ss_pred             ccCccceeecCCCCCCccccCHHHhc---cCCCCccccchhhhh
Confidence            43221    12234566799999987   566889999999998

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a

>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

Probab=99.95  E-value=2.4e-28  Score=187.77  Aligned_cols=159  Identities=25%  Similarity=0.367  Sum_probs=122.3

Q ss_pred             CcccccccccccccCceEEEEEEEcCCCcEEEEEEccCccChHHHHHHHHHHHHHHhcCCCCchhhhhhhHH--------
Q psy14630         22 TSEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQFYGALF--------   93 (187)
Q Consensus        22 ~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~--------   93 (187)
                      +.++|++.+.||+|+||.||+|.+..+++.||+|.++..............+..+++.++|+|++++++.+.        
T Consensus         5 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~   84 (309)
T cd07845           5 SVTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIF   84 (309)
T ss_pred             cccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEE
Confidence            567899999999999999999999999999999998643222211122233455677789999997754221        


Q ss_pred             --------------------------HHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEeccccccccccc-
Q psy14630         94 --------------------------KEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSI-  146 (187)
Q Consensus        94 --------------------------~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg~a~~~~~~~-  146 (187)
                                                ..+..|++.|+.|||+. +++||||+|+||+++.++.++|+|||++....... 
T Consensus        85 lv~e~~~~~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~~-~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~~~~  163 (309)
T cd07845          85 LVMEYCEQDLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHEN-FIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAK  163 (309)
T ss_pred             EEEecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhC-CeecCCCCHHHEEECCCCCEEECccceeeecCCccC
Confidence                                      12667899999999997 99999999999999999999999999998765432 


Q ss_pred             cccCCCCCcCccCccccCCCccCCCCCCcceeeeEee
Q psy14630        147 AKTRDAGCRPYMAPERIDPLRARGYPSFKTKLGFKFN  183 (187)
Q Consensus       147 ~~~~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi~  183 (187)
                      ......++..|+|||.+.+  ...++.++|+||+|+.
T Consensus       164 ~~~~~~~~~~y~aPE~~~~--~~~~~~~~DvwslG~i  198 (309)
T cd07845         164 PMTPKVVTLWYRAPELLLG--CTTYTTAIDMWAVGCI  198 (309)
T ss_pred             CCCcccccccccChhhhcC--CCCcCchHHHHHHHHH
Confidence            1222245678999999873  3457899999999984

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing

>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

Probab=99.95  E-value=4.1e-28  Score=184.92  Aligned_cols=158  Identities=23%  Similarity=0.352  Sum_probs=120.9

Q ss_pred             cccccccccccccCceEEEEEEEcCCCcEEEEEEccCccChHHHHHHHHHHHHHHhcCCCCchhhhhhhH----------
Q psy14630         23 SEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQFYGAL----------   92 (187)
Q Consensus        23 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~----------   92 (187)
                      .++|++.+.||+|+||.||+|.+..++..+|+|.++....... .....++..+++.+.|+||+++++.+          
T Consensus         4 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~-~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~   82 (291)
T cd07870           4 ATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGV-PFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVF   82 (291)
T ss_pred             cceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCC-cHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEE
Confidence            3689999999999999999999988999999999864322221 11223444566778999998776421          


Q ss_pred             ----------------------HHHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEecccccccccc-cccc
Q psy14630         93 ----------------------FKEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDS-IAKT  149 (187)
Q Consensus        93 ----------------------~~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg~a~~~~~~-~~~~  149 (187)
                                            ...+..|++.||.|||+. +++|+||||+||+++.++.++|+|||+++..... ....
T Consensus        83 e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~-~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~  161 (291)
T cd07870          83 EYMHTDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQ-HILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYS  161 (291)
T ss_pred             ecccCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhC-CcccCCCChHHEEEcCCCcEEEeccccccccCCCCCCCC
Confidence                                  112567899999999997 9999999999999999999999999998764322 1222


Q ss_pred             CCCCCcCccCccccCCCccCCCCCCcceeeeEeee
Q psy14630        150 RDAGCRPYMAPERIDPLRARGYPSFKTKLGFKFNY  184 (187)
Q Consensus       150 ~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi~~  184 (187)
                      ...+++.|+|||.+.+  ...++.++|+||+|+.+
T Consensus       162 ~~~~~~~y~aPE~~~~--~~~~~~~~Dv~slG~~l  194 (291)
T cd07870         162 SEVVTLWYRPPDVLLG--ATDYSSALDIWGAGCIF  194 (291)
T ss_pred             CccccccccCCceeec--CCCCCcHHHHHHHHHHH
Confidence            3356888999999873  23477899999999843

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess

>KOG0604|consensus

Probab=99.95  E-value=1.5e-28  Score=181.22  Aligned_cols=152  Identities=23%  Similarity=0.322  Sum_probs=122.1

Q ss_pred             cccccc-ccccccCceEEEEEEEcCCCcEEEEEEccCccChHHHHHHHHHHHHHHhcCCCCchhhhhhhHHH--------
Q psy14630         24 EDLQDL-GEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQFYGALFK--------   94 (187)
Q Consensus        24 ~~~~~~-~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~--------   94 (187)
                      ++|++. ++||-|-.|.|..|.++.|++.+|+|++...      .+.-.|....+....|||||+..+.+..        
T Consensus        61 edY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds------~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkcL  134 (400)
T KOG0604|consen   61 EDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS------PKARREVELHWMASGHPHIVSIIDVYENSYQGRKCL  134 (400)
T ss_pred             hhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC------HHHHhHhhhhhhhcCCCceEEeehhhhhhccCceee
Confidence            566654 6899999999999999999999999998632      1222334445566789999987754311        


Q ss_pred             ------------------------------HHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcC---CCCEEEEecccccc
Q psy14630         95 ------------------------------EVTVATVKALNYLKEELKIIHRDVKPSNILLDR---RGAIKLCDFGISGQ  141 (187)
Q Consensus        95 ------------------------------~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~---~~~~ki~dfg~a~~  141 (187)
                                                    +++.||..|+.|||+. +|.||||||+|+|...   +..+|++|||+|+.
T Consensus       135 LiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~-nIAHRDlKpENLLyt~t~~na~lKLtDfGFAK~  213 (400)
T KOG0604|consen  135 LIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSM-NIAHRDLKPENLLYTTTSPNAPLKLTDFGFAKE  213 (400)
T ss_pred             EeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhc-chhhccCChhheeeecCCCCcceEecccccccc
Confidence                                          2778899999999997 9999999999999964   55799999999998


Q ss_pred             ccccccccCCCCCcCccCccccCCCccCCCCCCcceeeeEe-eee
Q psy14630        142 LVDSIAKTRDAGCRPYMAPERIDPLRARGYPSFKTKLGFKF-NYR  185 (187)
Q Consensus       142 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi-~~~  185 (187)
                      -.........+-|++|.|||++-   ...|+..+|+||+|| +|-
T Consensus       214 t~~~~~L~TPc~TPyYvaPevlg---~eKydkscdmwSlgVimYI  255 (400)
T KOG0604|consen  214 TQEPGDLMTPCFTPYYVAPEVLG---PEKYDKSCDMWSLGVIMYI  255 (400)
T ss_pred             cCCCccccCCcccccccCHHHhC---chhcCCCCCccchhHHHHH
Confidence            77655556667899999999987   556999999999999 553

>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

Probab=99.95  E-value=7.2e-28  Score=181.20  Aligned_cols=156  Identities=22%  Similarity=0.395  Sum_probs=123.2

Q ss_pred             ccccccccccccCceEEEEEEEcCCCcEEEEEEccCcc-ChHHHHHHHHHHHHHHhcCCCCchhhhhhhHHH--------
Q psy14630         24 EDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTV-DEKDQRQLLMDLDVVMKSNECPYIVQFYGALFK--------   94 (187)
Q Consensus        24 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~--------   94 (187)
                      ++|++.+.||+|+||.||++.+..++..+|+|.+.... .+......+.++..+++.+.|+||+++++.+..        
T Consensus         2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~   81 (267)
T cd08229           2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL   81 (267)
T ss_pred             chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence            57889999999999999999998899999999875422 122223344555667777899999987753211        


Q ss_pred             ----------------------------HHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEeccccccccccc
Q psy14630         95 ----------------------------EVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSI  146 (187)
Q Consensus        95 ----------------------------~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg~a~~~~~~~  146 (187)
                                                  .+..+++.++.|||+. +++|+||+|+||+++.++.++++|||++.......
T Consensus        82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~-~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~  160 (267)
T cd08229          82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSR-RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKT  160 (267)
T ss_pred             EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHC-CeecCCCCHHHEEEcCCCCEEECcchhhhccccCC
Confidence                                        1456899999999997 99999999999999999999999999987764322


Q ss_pred             c-ccCCCCCcCccCccccCCCccCCCCCCcceeeeEee
Q psy14630        147 A-KTRDAGCRPYMAPERIDPLRARGYPSFKTKLGFKFN  183 (187)
Q Consensus       147 ~-~~~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi~  183 (187)
                      . .....++..|+|||.+.   ...++.++|+||||+.
T Consensus       161 ~~~~~~~~~~~~~ape~~~---~~~~~~~~Dv~slG~i  195 (267)
T cd08229         161 TAAHSLVGTPYYMSPERIH---ENGYNFKSDIWSLGCL  195 (267)
T ss_pred             cccccccCCcCccCHHHhc---CCCccchhhHHHHHHH
Confidence            1 22346788999999987   5668899999999984

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.

>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

Probab=99.95  E-value=6.4e-28  Score=183.74  Aligned_cols=160  Identities=22%  Similarity=0.414  Sum_probs=121.8

Q ss_pred             ccCCcccccccccccccCceEEEEEEEc-----CCCcEEEEEEccCccChHHHHHHHHHHHHHHhcCCCCchhhhhhhH-
Q psy14630         19 YDFTSEDLQDLGEIGRGGFGTVNKMIHR-----SSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQFYGAL-   92 (187)
Q Consensus        19 ~~~~~~~~~~~~~lg~G~fg~V~~~~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~-   92 (187)
                      |+...++|++.+.||+|+||.||+|...     ..+..||+|.+.......... .+.++...++.++||||+++++.+ 
T Consensus         1 ~~~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~-~~~~e~~~l~~l~~~~i~~~~~~~~   79 (288)
T cd05061           1 WEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERI-EFLNEASVMKGFTCHHVVRLLGVVS   79 (288)
T ss_pred             CcccHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHH-HHHHHHHHHHhCCCCCeeeEEEEEc
Confidence            6677899999999999999999999754     234579999876443322222 344455577788999999876421 


Q ss_pred             --------------------H---------------------HHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCE
Q psy14630         93 --------------------F---------------------KEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAI  131 (187)
Q Consensus        93 --------------------~---------------------~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~  131 (187)
                                          .                     ..+..|++.|+.|||+. +++||||||+||+++.++.+
T Consensus        80 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~-~i~H~dikp~nili~~~~~~  158 (288)
T cd05061          80 KGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAK-KFVHRDLAARNCMVAHDFTV  158 (288)
T ss_pred             CCCCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCcCCCCChheEEEcCCCcE
Confidence                                0                     12556889999999997 99999999999999999999


Q ss_pred             EEEeccccccccccccc---cCCCCCcCccCccccCCCccCCCCCCcceeeeEee
Q psy14630        132 KLCDFGISGQLVDSIAK---TRDAGCRPYMAPERIDPLRARGYPSFKTKLGFKFN  183 (187)
Q Consensus       132 ki~dfg~a~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi~  183 (187)
                      +++|||+++........   ....++..|+|||.+.   ...++.++|+||||++
T Consensus       159 ~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~---~~~~~~~~DvwslG~~  210 (288)
T cd05061         159 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLK---DGVFTTSSDMWSFGVV  210 (288)
T ss_pred             EECcCCccccccccccccccCCCcccccccCHHHhc---cCCCChHhHHHHHHHH
Confidence            99999998865432111   1123456799999987   5568899999999983

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta

>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

Probab=99.95  E-value=9.3e-28  Score=180.76  Aligned_cols=155  Identities=27%  Similarity=0.397  Sum_probs=122.5

Q ss_pred             ccccccccccccCceEEEEEEEcCCCcEEEEEEccCcc---ChHHHHHHHHHHHHHHhcCCCCchhhhhhhHH-------
Q psy14630         24 EDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTV---DEKDQRQLLMDLDVVMKSNECPYIVQFYGALF-------   93 (187)
Q Consensus        24 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~-------   93 (187)
                      .+|+..+.||+|+||.||++.+..++..+|+|.+....   ......+.+.++..+++.++||||+++++.+.       
T Consensus         2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (266)
T cd06651           2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL   81 (266)
T ss_pred             CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence            46888999999999999999999999999999875432   11223345566666788889999998764321       


Q ss_pred             ---------------------------HHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEeccccccccccc
Q psy14630         94 ---------------------------KEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSI  146 (187)
Q Consensus        94 ---------------------------~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg~a~~~~~~~  146 (187)
                                                 ..+..|++.+++|||+. +++|+||+|+||+++.++.++|+|||+++......
T Consensus        82 ~l~~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~LH~~-~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~~~~  160 (266)
T cd06651          82 TIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSN-MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTIC  160 (266)
T ss_pred             EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhC-CeeeCCCCHHHEEECCCCCEEEccCCCcccccccc
Confidence                                       11567899999999987 99999999999999999999999999988654311


Q ss_pred             ----cccCCCCCcCccCccccCCCccCCCCCCcceeeeEe
Q psy14630        147 ----AKTRDAGCRPYMAPERIDPLRARGYPSFKTKLGFKF  182 (187)
Q Consensus       147 ----~~~~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi  182 (187)
                          ......++..|+|||.+.   ...++.++|+||+|+
T Consensus       161 ~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~Dv~slG~  197 (266)
T cd06651         161 MSGTGIRSVTGTPYWMSPEVIS---GEGYGRKADVWSLGC  197 (266)
T ss_pred             ccCCccccCCccccccCHHHhC---CCCCCchhhhHHHHH
Confidence                112235788899999998   566889999999998

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development

>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=99.95  E-value=7.2e-28  Score=182.88  Aligned_cols=156  Identities=21%  Similarity=0.363  Sum_probs=119.5

Q ss_pred             CcccccccccccccCceEEEEEEE----cCCCcEEEEEEccCccChHHHHHHHHHHHHHHhcCCCCchhhhhhhHH----
Q psy14630         22 TSEDLQDLGEIGRGGFGTVNKMIH----RSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQFYGALF----   93 (187)
Q Consensus        22 ~~~~~~~~~~lg~G~fg~V~~~~~----~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~----   93 (187)
                      ...+|++.+.||+|+||.||+|..    ..++..||+|.+...  .....+.+..+..++..+.||||+++++.+.    
T Consensus         2 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~   79 (284)
T cd05081           2 EERHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHS--TAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGR   79 (284)
T ss_pred             ccccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccC--CHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCC
Confidence            346889999999999999999873    457889999998643  2223344555666777889999998754210    


Q ss_pred             -------------------------------HHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEeccccccc
Q psy14630         94 -------------------------------KEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQL  142 (187)
Q Consensus        94 -------------------------------~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg~a~~~  142 (187)
                                                     ..++.+++.||+|||+. +++||||||+||+++.++.++|+|||+++..
T Consensus        80 ~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~~-~i~H~dlkp~nili~~~~~~~l~dfg~~~~~  158 (284)
T cd05081          80 RNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSK-RYVHRDLATRNILVESENRVKIGDFGLTKVL  158 (284)
T ss_pred             CceEEEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHC-CceeccCCHhhEEECCCCeEEECCCcccccc
Confidence                                           11567899999999998 9999999999999999999999999999876


Q ss_pred             cccccc----cCCCCCcCccCccccCCCccCCCCCCcceeeeEee
Q psy14630        143 VDSIAK----TRDAGCRPYMAPERIDPLRARGYPSFKTKLGFKFN  183 (187)
Q Consensus       143 ~~~~~~----~~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi~  183 (187)
                      ......    ....++..|+|||.+.   ...++.++|+||+|+.
T Consensus       159 ~~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~Di~slG~~  200 (284)
T cd05081         159 PQDKEYYKVREPGESPIFWYAPESLT---ESKFSVASDVWSFGVV  200 (284)
T ss_pred             cCCCcceeecCCCCCceEeeCHHHhc---cCCcChHHHHHHHHHH
Confidence            432211    1112344699999987   5568899999999983

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th

>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

Probab=99.95  E-value=7.3e-28  Score=182.77  Aligned_cols=155  Identities=25%  Similarity=0.423  Sum_probs=121.8

Q ss_pred             cccccccccccCceEEEEEEEcCCCcEEEEEEccCccChHHHHHHHHHHHHHHhcCCCCchhhhhhhHHH----------
Q psy14630         25 DLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQFYGALFK----------   94 (187)
Q Consensus        25 ~~~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~----------   94 (187)
                      +|+..+.||.|+||.||+|.+..+++.+|+|.++...........+..+..+++.++||||+++++.+..          
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (284)
T cd07860           1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF   80 (284)
T ss_pred             CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence            4788899999999999999999899999999886433332233445556667788899999998765311          


Q ss_pred             -----------------------HHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEeccccccccccc-cccC
Q psy14630         95 -----------------------EVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSI-AKTR  150 (187)
Q Consensus        95 -----------------------~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg~a~~~~~~~-~~~~  150 (187)
                                             .+..+++.|++|||+. +++|+||+|+||+++.++.++++|||++....... ....
T Consensus        81 ~~~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~-~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~~~~~  159 (284)
T cd07860          81 LHQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSH-RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTH  159 (284)
T ss_pred             cccCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHC-CeecCCCCHHHEEECCCCCEEEeeccchhhcccCcccccc
Confidence                                   2566899999999997 99999999999999999999999999987654321 1222


Q ss_pred             CCCCcCccCccccCCCccCCCCCCcceeeeEe
Q psy14630        151 DAGCRPYMAPERIDPLRARGYPSFKTKLGFKF  182 (187)
Q Consensus       151 ~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi  182 (187)
                      ..++..|+|||.+.+  ...++.++|+||+|+
T Consensus       160 ~~~~~~y~aPE~~~~--~~~~~~~~Dv~slG~  189 (284)
T cd07860         160 EVVTLWYRAPEILLG--CKYYSTAVDIWSLGC  189 (284)
T ss_pred             ccccccccCCeEEec--CCCCCcHHHHHHHHH
Confidence            346788999998873  234578899999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex

>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

Probab=99.95  E-value=3.8e-28  Score=185.26  Aligned_cols=158  Identities=22%  Similarity=0.358  Sum_probs=122.1

Q ss_pred             cccccccccccccCceEEEEEEEcCCCcEEEEEEccCccChHHHHHHHHHHHHHHhcCCCCchhhhhhhHH---------
Q psy14630         23 SEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQFYGALF---------   93 (187)
Q Consensus        23 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~---------   93 (187)
                      .++|++.+.||+|+||.||+|.+..+++.+|+|.++.............++..+++.+.||||+++++.+.         
T Consensus         4 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~l   83 (293)
T cd07843           4 VDEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYM   83 (293)
T ss_pred             hhhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEE
Confidence            36899999999999999999999889999999998643322222223334445666778999998754221         


Q ss_pred             -------------------------HHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEecccccccccc-cc
Q psy14630         94 -------------------------KEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDS-IA  147 (187)
Q Consensus        94 -------------------------~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg~a~~~~~~-~~  147 (187)
                                               ..+..|++.||+|||+. +++|+||+|+||+++.++.++++|||+++..... ..
T Consensus        84 v~e~~~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~-~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~  162 (293)
T cd07843          84 VMEYVEHDLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDN-WILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKP  162 (293)
T ss_pred             EehhcCcCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC-CeeeccCCHHHEEECCCCcEEEeecCceeeccCCccc
Confidence                                     11667899999999997 9999999999999999999999999998876543 22


Q ss_pred             ccCCCCCcCccCccccCCCccCCCCCCcceeeeEee
Q psy14630        148 KTRDAGCRPYMAPERIDPLRARGYPSFKTKLGFKFN  183 (187)
Q Consensus       148 ~~~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi~  183 (187)
                      .....+++.|+|||.+.+  ...++.++|+||+|+.
T Consensus       163 ~~~~~~~~~~~aPE~~~~--~~~~~~~~Di~slG~~  196 (293)
T cd07843         163 YTQLVVTLWYRAPELLLG--AKEYSTAIDMWSVGCI  196 (293)
T ss_pred             cccccccccccCchhhcC--CccccchhhHHHHHHH
Confidence            233456788999999873  2336789999999984

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the

>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

Probab=99.95  E-value=9e-28  Score=184.26  Aligned_cols=165  Identities=25%  Similarity=0.370  Sum_probs=124.8

Q ss_pred             CCCccccCCcccccccccccccCceEEEEEEE-----cCCCcEEEEEEccCccChHHHHHHHHHHHHHHhcC-CCCchhh
Q psy14630         14 SPDTVYDFTSEDLQDLGEIGRGGFGTVNKMIH-----RSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSN-ECPYIVQ   87 (187)
Q Consensus        14 ~~~~~~~~~~~~~~~~~~lg~G~fg~V~~~~~-----~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~-~h~~iv~   87 (187)
                      +....+.+..++|.+.+.||+|+||.||++.+     ..++..+|+|.++...... ..+.+..+..+++.+ +|+||++
T Consensus        25 ~~~~~~~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~E~~~l~~l~~h~~iv~  103 (302)
T cd05055          25 PYDLKWEFPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSS-EREALMSELKIMSHLGNHENIVN  103 (302)
T ss_pred             cccccccccHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChH-HHHHHHHHHHHHHhccCCCCcce
Confidence            44456778889999999999999999999975     2345679999886543322 233444444556666 7999998


Q ss_pred             hhhhHH----------------------------------HHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEE
Q psy14630         88 FYGALF----------------------------------KEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKL  133 (187)
Q Consensus        88 ~~~~~~----------------------------------~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki  133 (187)
                      +++.+.                                  ..+..+++.|++|||+. +++|+||||+||+++.++.+++
T Consensus       104 ~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~-~ivH~dlkp~Nil~~~~~~~~l  182 (302)
T cd05055         104 LLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASK-NCIHRDLAARNVLLTHGKIVKI  182 (302)
T ss_pred             EEEEEecCCceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHC-CeehhhhccceEEEcCCCeEEE
Confidence            764210                                  11557899999999997 9999999999999999999999


Q ss_pred             Eecccccccccccc---ccCCCCCcCccCccccCCCccCCCCCCcceeeeEee
Q psy14630        134 CDFGISGQLVDSIA---KTRDAGCRPYMAPERIDPLRARGYPSFKTKLGFKFN  183 (187)
Q Consensus       134 ~dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi~  183 (187)
                      +|||+++.......   .....++..|+|||.+.   ...++.++|+||+|+.
T Consensus       183 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~DiwslGvi  232 (302)
T cd05055         183 CDFGLARDIMNDSNYVVKGNARLPVKWMAPESIF---NCVYTFESDVWSYGIL  232 (302)
T ss_pred             CCCcccccccCCCceeecCCCCcccccCCHhhhc---cCCCCcHhHHHHHHHH
Confidence            99999987643221   11223567799999988   5668899999999984

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept

>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes

Probab=99.95  E-value=7.8e-28  Score=179.67  Aligned_cols=148  Identities=27%  Similarity=0.423  Sum_probs=114.7

Q ss_pred             ccccccCceEEEEEEEcCCCcEEEEEEccCccChHHHHHHHHHHHHHHhcCCCCchhhhhhhHH----------------
Q psy14630         30 GEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQFYGALF----------------   93 (187)
Q Consensus        30 ~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~----------------   93 (187)
                      +.||+|+||.||+|.+..+++.+|+|.+...... .....+.++..+++.+.||||+++++.+.                
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~   79 (252)
T cd05084           1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPP-DLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGD   79 (252)
T ss_pred             CccCcccCccEEEEEEecCCceEEEEecCccCCH-HHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCc
Confidence            4689999999999999889999999987644332 23344555556777889999998764321                


Q ss_pred             -----------------HHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEecccccccccccccc---CCCC
Q psy14630         94 -----------------KEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKT---RDAG  153 (187)
Q Consensus        94 -----------------~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg~a~~~~~~~~~~---~~~~  153 (187)
                                       ..+..|++.||.|||+. +++|+||+|+||+++.++.++++|||+++...+.....   ....
T Consensus        80 L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~-~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~  158 (252)
T cd05084          80 FLTFLRTEGPRLKVKELIQMVENAAAGMEYLESK-HCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQI  158 (252)
T ss_pred             HHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhC-CccccccchheEEEcCCCcEEECccccCcccccccccccCCCCCC
Confidence                             11667899999999997 99999999999999999999999999987654321111   1122


Q ss_pred             CcCccCccccCCCccCCCCCCcceeeeEe
Q psy14630        154 CRPYMAPERIDPLRARGYPSFKTKLGFKF  182 (187)
Q Consensus       154 t~~y~aPE~~~~~~~~~~~~~~D~ws~gi  182 (187)
                      +..|+|||.+.   ...++.++|+||+|+
T Consensus       159 ~~~y~aPE~~~---~~~~~~~~Dv~slG~  184 (252)
T cd05084         159 PVKWTAPEALN---YGRYSSESDVWSFGI  184 (252)
T ss_pred             ceeecCchhhc---CCCCChHHHHHHHHH
Confidence            35699999988   556889999999998

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular

>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

Probab=99.95  E-value=1.1e-27  Score=181.62  Aligned_cols=158  Identities=25%  Similarity=0.393  Sum_probs=121.7

Q ss_pred             CCcccccccccccccCceEEEEEEEcCCCc----EEEEEEccCccChHHHHHHHHHHHHHHhcCCCCchhhhhhhHH---
Q psy14630         21 FTSEDLQDLGEIGRGGFGTVNKMIHRSSDT----VMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQFYGALF---   93 (187)
Q Consensus        21 ~~~~~~~~~~~lg~G~fg~V~~~~~~~~~~----~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~---   93 (187)
                      +...+|++.+.||+|+||.||+|.+..++.    .+|+|........ .....+.++...++.+.|||++++++.+.   
T Consensus         4 ~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   82 (279)
T cd05057           4 LKETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSP-KANKEILDEAYVMASVDHPHVVRLLGICLSSQ   82 (279)
T ss_pred             cCHHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCH-HHHHHHHHHHHHHHhCCCCCcceEEEEEecCc
Confidence            466889999999999999999998765554    5899987654332 23344455555677789999998764321   


Q ss_pred             -----------------------------HHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEeccccccccc
Q psy14630         94 -----------------------------KEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVD  144 (187)
Q Consensus        94 -----------------------------~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg~a~~~~~  144 (187)
                                                   ..++.|++.|++|||+. +++||||+|+||+++.++.++++|||+++....
T Consensus        83 ~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~-~i~H~di~p~nil~~~~~~~kL~dfg~~~~~~~  161 (279)
T cd05057          83 VQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEK-RLVHRDLAARNVLVKTPQHVKITDFGLAKLLDV  161 (279)
T ss_pred             eEEEEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC-CEEecccCcceEEEcCCCeEEECCCcccccccC
Confidence                                         12567899999999997 999999999999999999999999999987653


Q ss_pred             ccccc---CCCCCcCccCccccCCCccCCCCCCcceeeeEee
Q psy14630        145 SIAKT---RDAGCRPYMAPERIDPLRARGYPSFKTKLGFKFN  183 (187)
Q Consensus       145 ~~~~~---~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi~  183 (187)
                      .....   ...++..|+|||.+.   ...++.++|+||||+.
T Consensus       162 ~~~~~~~~~~~~~~~y~~PE~~~---~~~~~~~~Di~slG~~  200 (279)
T cd05057         162 DEKEYHAEGGKVPIKWMALESIL---HRIYTHKSDVWSYGVT  200 (279)
T ss_pred             cccceecCCCcccccccCHHHhh---cCCcCchhhHHHHHHH
Confidence            32211   112356799999987   5678899999999983

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea

>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

Probab=99.95  E-value=1.2e-27  Score=178.71  Aligned_cols=156  Identities=26%  Similarity=0.415  Sum_probs=123.4

Q ss_pred             cccccccccccCceEEEEEEEcCCCcEEEEEEccCccChHHHHHHHHHHHHHHhcCCCCchhhhhhhHH-----------
Q psy14630         25 DLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQFYGALF-----------   93 (187)
Q Consensus        25 ~~~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~-----------   93 (187)
                      +|+..+.||+|+||.||++.+..+++.+|+|.+..........+.+..+..+++.++|||++++++.+.           
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08220           1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY   80 (256)
T ss_pred             CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence            478889999999999999999999999999998654323333455566666778889999998764221           


Q ss_pred             -----------------------HHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCC-CEEEEecccccccccccccc
Q psy14630         94 -----------------------KEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRG-AIKLCDFGISGQLVDSIAKT  149 (187)
Q Consensus        94 -----------------------~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~-~~ki~dfg~a~~~~~~~~~~  149 (187)
                                             ..+..+++.++.|||++ +++|+|++|+||+++.++ .++++|||.+..........
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~-~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~~~  159 (256)
T cd08220          81 APGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTK-LILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAY  159 (256)
T ss_pred             CCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhC-CeecCCCCHHHEEEcCCCCEEEEccCCCceecCCCcccc
Confidence                                   11556889999999997 999999999999998654 58999999998775543333


Q ss_pred             CCCCCcCccCccccCCCccCCCCCCcceeeeEeee
Q psy14630        150 RDAGCRPYMAPERIDPLRARGYPSFKTKLGFKFNY  184 (187)
Q Consensus       150 ~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi~~  184 (187)
                      ...++..|+|||.+.   ...++.++|+||+|+..
T Consensus       160 ~~~~~~~y~aPE~~~---~~~~~~~~Dv~slG~~l  191 (256)
T cd08220         160 TVVGTPCYISPELCE---GKPYNQKSDIWALGCVL  191 (256)
T ss_pred             ccccCCcccCchhcc---CCCCCcccchHHHHHHH
Confidence            446788999999988   55678999999999843

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with

>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

Probab=99.95  E-value=4.9e-28  Score=185.67  Aligned_cols=158  Identities=25%  Similarity=0.369  Sum_probs=121.0

Q ss_pred             CcccccccccccccCceEEEEEEEcCCCcEEEEEEccCccChHHHHHHHHHHHHHHhcCCCCchhhhhhhH---------
Q psy14630         22 TSEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQFYGAL---------   92 (187)
Q Consensus        22 ~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~---------   92 (187)
                      ..++|++.+.||+|+||.||+|.+..+++.||+|.+...............+..+++.+.||||+++++.+         
T Consensus        10 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~   89 (310)
T cd07865          10 EVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNR   89 (310)
T ss_pred             hhhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccC
Confidence            34679999999999999999999999999999998854322222222233445567778999999876421         


Q ss_pred             -------------------------------HHHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEecccccc
Q psy14630         93 -------------------------------FKEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQ  141 (187)
Q Consensus        93 -------------------------------~~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg~a~~  141 (187)
                                                     ...+..|++.|++|||+. +++|+||+|+||+++.++.++|+|||++..
T Consensus        90 ~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~-~i~H~dl~p~nil~~~~~~~kl~dfg~~~~  168 (310)
T cd07865          90 YKGSFYLVFEFCEHDLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHRN-KILHRDMKAANILITKDGILKLADFGLARA  168 (310)
T ss_pred             CCceEEEEEcCCCcCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHC-CeeccCCCHHHEEECCCCcEEECcCCCccc
Confidence                                           112567899999999997 999999999999999999999999999987


Q ss_pred             ccccccc-----cCCCCCcCccCccccCCCccCCCCCCcceeeeEe
Q psy14630        142 LVDSIAK-----TRDAGCRPYMAPERIDPLRARGYPSFKTKLGFKF  182 (187)
Q Consensus       142 ~~~~~~~-----~~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi  182 (187)
                      .......     ....++..|+|||.+.+  ...++.++|+||||+
T Consensus       169 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~~Di~slG~  212 (310)
T cd07865         169 FSLSKNSKPNRYTNRVVTLWYRPPELLLG--ERDYGPPIDMWGAGC  212 (310)
T ss_pred             ccCCcccCCCCccCcccCccccCcHHhcC--CcccCchhhhHHHHH
Confidence            6432211     12346778999999873  234678999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl

>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

Probab=99.95  E-value=5.7e-28  Score=185.60  Aligned_cols=168  Identities=24%  Similarity=0.358  Sum_probs=123.6

Q ss_pred             CCCccccCCcccccccccccccCceEEEEEEEcC-------CCcEEEEEEccCccChHHHHHHHHHHHHHHhcCCCCchh
Q psy14630         14 SPDTVYDFTSEDLQDLGEIGRGGFGTVNKMIHRS-------SDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIV   86 (187)
Q Consensus        14 ~~~~~~~~~~~~~~~~~~lg~G~fg~V~~~~~~~-------~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv   86 (187)
                      +..+.|++..++|.+.+.||+|+||.||++.+..       +...+|+|.++.........+...+...+.+...||||+
T Consensus         8 ~~~~~~~~~~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~   87 (307)
T cd05098           8 PEDPRWEVPRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNII   87 (307)
T ss_pred             CCCCcceeehHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEe
Confidence            3455778888999999999999999999997642       235699999875433333334444444333334799998


Q ss_pred             hhhhhH---------------------H---------------------------HHHHHHHHHHHHHHHhcCCCeeecC
Q psy14630         87 QFYGAL---------------------F---------------------------KEVTVATVKALNYLKEELKIIHRDV  118 (187)
Q Consensus        87 ~~~~~~---------------------~---------------------------~~~~~~~~~~l~~lh~~~~i~Hrdl  118 (187)
                      ++++.+                     .                           ..++.|++.||+|||+. +++||||
T Consensus        88 ~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~-gi~H~dl  166 (307)
T cd05098          88 NLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASK-KCIHRDL  166 (307)
T ss_pred             eEEEEEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC-Ccccccc
Confidence            876421                     0                           12467889999999997 9999999


Q ss_pred             CCCCeEEcCCCCEEEEeccccccccccccc---cCCCCCcCccCccccCCCccCCCCCCcceeeeEe-eee
Q psy14630        119 KPSNILLDRRGAIKLCDFGISGQLVDSIAK---TRDAGCRPYMAPERIDPLRARGYPSFKTKLGFKF-NYR  185 (187)
Q Consensus       119 k~~nili~~~~~~ki~dfg~a~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi-~~~  185 (187)
                      ||+||+++.++.++++|||+++........   ....++..|+|||.+.   ...++.++|+||+|+ +|+
T Consensus       167 kp~Nill~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~DvwslG~~l~e  234 (307)
T cd05098         167 AARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALF---DRIYTHQSDVWSFGVLLWE  234 (307)
T ss_pred             cHHheEEcCCCcEEECCCcccccccccchhhccccCCCccceeChHHhc---cCCCCcHHHHHHHHHHHHH
Confidence            999999999999999999998765432111   1112346799999987   556889999999998 443

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

Probab=99.95  E-value=1.1e-27  Score=179.55  Aligned_cols=155  Identities=27%  Similarity=0.446  Sum_probs=124.8

Q ss_pred             cccccccccccCceEEEEEEEcCCCcEEEEEEccCccChHHHHHHHHHHHHHHhcCCCCchhhhhhhHH-----------
Q psy14630         25 DLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQFYGALF-----------   93 (187)
Q Consensus        25 ~~~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~-----------   93 (187)
                      +|++.+.||.|+||.||++.+..+++.+|+|.+..........+.+..+..+++.+.|+|++++++.+.           
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~   80 (265)
T cd08217           1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM   80 (265)
T ss_pred             CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence            578889999999999999999999999999998654333344455556666788889999998754211           


Q ss_pred             ---------------------------HHHHHHHHHHHHHHH-----hcCCCeeecCCCCCeEEcCCCCEEEEecccccc
Q psy14630         94 ---------------------------KEVTVATVKALNYLK-----EELKIIHRDVKPSNILLDRRGAIKLCDFGISGQ  141 (187)
Q Consensus        94 ---------------------------~~~~~~~~~~l~~lh-----~~~~i~Hrdlk~~nili~~~~~~ki~dfg~a~~  141 (187)
                                                 ..+..+++.++.|||     .. +++|+||+|+||+++.++.++++|||++..
T Consensus        81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~-~i~h~dl~p~nili~~~~~~kl~d~g~~~~  159 (265)
T cd08217          81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGN-TVLHRDLKPANIFLDANNNVKLGDFGLAKI  159 (265)
T ss_pred             hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccC-cceecCCCHHHEEEecCCCEEEeccccccc
Confidence                                       115678999999999     76 899999999999999999999999999988


Q ss_pred             cccccc-ccCCCCCcCccCccccCCCccCCCCCCcceeeeEee
Q psy14630        142 LVDSIA-KTRDAGCRPYMAPERIDPLRARGYPSFKTKLGFKFN  183 (187)
Q Consensus       142 ~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi~  183 (187)
                      ...... .....+++.|+|||.+.   ...++.++|+||||+.
T Consensus       160 ~~~~~~~~~~~~~~~~~~~pE~~~---~~~~~~~~Dv~slG~i  199 (265)
T cd08217         160 LGHDSSFAKTYVGTPYYMSPEQLN---HMSYDEKSDIWSLGCL  199 (265)
T ss_pred             ccCCcccccccccCCCccChhhhc---CCCCCchhHHHHHHHH
Confidence            754332 33346788999999998   5568899999999984

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi

>KOG0607|consensus

Probab=99.95  E-value=5e-28  Score=179.99  Aligned_cols=157  Identities=22%  Similarity=0.348  Sum_probs=121.8

Q ss_pred             cccc-ccccccCceEEEEEEEcCCCcEEEEEEccCccChHHHHHHHHHHHHHHhcCCCCchhhhhhhHHHH---------
Q psy14630         26 LQDL-GEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQFYGALFKE---------   95 (187)
Q Consensus        26 ~~~~-~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~---------   95 (187)
                      |++. +.||+|+|+.|--|....++.++|||++.++.. ....+.+++.........|+||++++++|.++         
T Consensus        79 YkLt~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~g-HsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEK  157 (463)
T KOG0607|consen   79 YKLTSELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPG-HSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEK  157 (463)
T ss_pred             HHhHHHHhcCccceeeeeeeeeccchhhhhhhhhcCCc-hHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEec
Confidence            4443 689999999999999999999999999987633 33456677777776777899999999876443         


Q ss_pred             -----------------------HHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCC---CEEEEeccccccccccccc-
Q psy14630         96 -----------------------VTVATVKALNYLKEELKIIHRDVKPSNILLDRRG---AIKLCDFGISGQLVDSIAK-  148 (187)
Q Consensus        96 -----------------------~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~---~~ki~dfg~a~~~~~~~~~-  148 (187)
                                             +...++.||.|||.. ||.|||+||+|||.....   .+|||||.+.......... 
T Consensus       158 m~GGplLshI~~~~~F~E~EAs~vvkdia~aLdFlH~k-gIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~s  236 (463)
T KOG0607|consen  158 MRGGPLLSHIQKRKHFNEREASRVVKDIASALDFLHTK-GIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDCS  236 (463)
T ss_pred             ccCchHHHHHHHhhhccHHHHHHHHHHHHHHHHHHhhc-CcccccCCccceeecCCCCcCceeeeccccccccccCCCCC
Confidence                                   566788999999997 999999999999996543   4899999988775422111 


Q ss_pred             -------cCCCCCcCccCccccCCCc--cCCCCCCcceeeeEeee
Q psy14630        149 -------TRDAGCRPYMAPERIDPLR--ARGYPSFKTKLGFKFNY  184 (187)
Q Consensus       149 -------~~~~~t~~y~aPE~~~~~~--~~~~~~~~D~ws~gi~~  184 (187)
                             .+.+|+..|||||+..-..  ..-|+..+|.||+||++
T Consensus       237 pastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIl  281 (463)
T KOG0607|consen  237 PASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVIL  281 (463)
T ss_pred             CCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHH
Confidence                   1236777899999974321  23488999999999944

>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

Probab=99.95  E-value=1.1e-27  Score=180.08  Aligned_cols=157  Identities=25%  Similarity=0.401  Sum_probs=124.1

Q ss_pred             ccccccccccccCceEEEEEEEcCCCcEEEEEEccCcc-ChHHHHHHHHHHHHHHhcCCCCchhhhhhhHH---------
Q psy14630         24 EDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTV-DEKDQRQLLMDLDVVMKSNECPYIVQFYGALF---------   93 (187)
Q Consensus        24 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~---------   93 (187)
                      ++|++.+.||+|+||.||+|.+..+++.+|+|.++... ......+.+.++..+++.+.|+|++++++.+.         
T Consensus         2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~   81 (267)
T cd08224           2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL   81 (267)
T ss_pred             CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence            57899999999999999999998899999999886422 22233444555666777889999988764321         


Q ss_pred             ---------------------------HHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEeccccccccccc
Q psy14630         94 ---------------------------KEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSI  146 (187)
Q Consensus        94 ---------------------------~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg~a~~~~~~~  146 (187)
                                                 ..+..+++.++.|||+. +++|+||+|+||+++.++.++++|||++.......
T Consensus        82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~-~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~  160 (267)
T cd08224          82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSK-RIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKT  160 (267)
T ss_pred             ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhC-CEecCCcChhhEEECCCCcEEEeccceeeeccCCC
Confidence                                       11466889999999997 99999999999999999999999999987654322


Q ss_pred             -cccCCCCCcCccCccccCCCccCCCCCCcceeeeEeee
Q psy14630        147 -AKTRDAGCRPYMAPERIDPLRARGYPSFKTKLGFKFNY  184 (187)
Q Consensus       147 -~~~~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi~~  184 (187)
                       ......++..|+|||.+.   ...++.++|+||||+..
T Consensus       161 ~~~~~~~~~~~y~apE~~~---~~~~~~~~Di~slG~il  196 (267)
T cd08224         161 TAAHSLVGTPYYMSPERIH---ENGYNFKSDIWSLGCLL  196 (267)
T ss_pred             cccceecCCccccCHHHhc---cCCCCchhcHHHHHHHH
Confidence             122345788899999987   56788999999999843

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a

>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

Probab=99.95  E-value=3e-27  Score=181.64  Aligned_cols=160  Identities=25%  Similarity=0.407  Sum_probs=123.8

Q ss_pred             CCcccccccccccccCceEEEEEEEcCCCcEEEEEEccCcc-ChHHHHHHHHHHHHHHhcCCCCchhhhhhhHH------
Q psy14630         21 FTSEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTV-DEKDQRQLLMDLDVVMKSNECPYIVQFYGALF------   93 (187)
Q Consensus        21 ~~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~------   93 (187)
                      .+...|+..+.||+|+||.||+|....+++.||+|.+.... ......+.+..+..+++.++|||++++.+.+.      
T Consensus        12 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~   91 (307)
T cd06607          12 DPEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAW   91 (307)
T ss_pred             CcchhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEE
Confidence            34467999999999999999999998889999999875322 22222333445555777789999998764321      


Q ss_pred             --------------------------HHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEecccccccccccc
Q psy14630         94 --------------------------KEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIA  147 (187)
Q Consensus        94 --------------------------~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg~a~~~~~~~~  147 (187)
                                                ..++.|++.++.|||+. +++|+||+|+||+++.++.++|+|||++......  
T Consensus        92 lv~e~~~g~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~~-~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~--  168 (307)
T cd06607          92 LVMEYCLGSASDILEVHKKPLQEVEIAAICHGALQGLAYLHSH-ERIHRDIKAGNILLTEPGTVKLADFGSASLVSPA--  168 (307)
T ss_pred             EEHHhhCCCHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHHC-CceecCCCcccEEECCCCCEEEeecCcceecCCC--
Confidence                                      11567899999999997 9999999999999999999999999998765432  


Q ss_pred             ccCCCCCcCccCccccCCCccCCCCCCcceeeeEeee
Q psy14630        148 KTRDAGCRPYMAPERIDPLRARGYPSFKTKLGFKFNY  184 (187)
Q Consensus       148 ~~~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi~~  184 (187)
                       ....+++.|+|||.+.......++.++|+||||+..
T Consensus       169 -~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il  204 (307)
T cd06607         169 -NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITC  204 (307)
T ss_pred             -CCccCCccccCceeeeccCCCCCCcccchHHHHHHH
Confidence             223577889999998533245588999999999843

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily

>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

Probab=99.95  E-value=8.2e-28  Score=182.57  Aligned_cols=158  Identities=19%  Similarity=0.318  Sum_probs=121.3

Q ss_pred             CCcccccccccccccCceEEEEEEE----cCCCcEEEEEEccCccChHHHHHHHHHHHHHHhcCCCCchhhhhhhH----
Q psy14630         21 FTSEDLQDLGEIGRGGFGTVNKMIH----RSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQFYGAL----   92 (187)
Q Consensus        21 ~~~~~~~~~~~lg~G~fg~V~~~~~----~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~----   92 (187)
                      ++.++|++.+.||+|+||.||+|..    ..++..+|+|.+....... ....+..+..+++.++||||+++++.+    
T Consensus         2 ~~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~   80 (283)
T cd05090           2 LPLSAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQ-QWGEFQQEASLMAELHHPNIVCLLGVVTQEQ   80 (283)
T ss_pred             CChhhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHH-HHHHHHHHHHHHhhCCCCCeeeEEEEEecCC
Confidence            4568899999999999999999984    3456789999987543332 233445556677888999999775321    


Q ss_pred             -----------------H----------------------------HHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcC
Q psy14630         93 -----------------F----------------------------KEVTVATVKALNYLKEELKIIHRDVKPSNILLDR  127 (187)
Q Consensus        93 -----------------~----------------------------~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~  127 (187)
                                       .                            ..+..+++.|++|||+. +++||||||+|++++.
T Consensus        81 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~-~i~H~dlkp~nili~~  159 (283)
T cd05090          81 PVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSH-FFVHKDLAARNILIGE  159 (283)
T ss_pred             ceEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhc-CeehhccccceEEEcC
Confidence                             0                            11556899999999998 9999999999999999


Q ss_pred             CCCEEEEeccccccccccc---cccCCCCCcCccCccccCCCccCCCCCCcceeeeEee
Q psy14630        128 RGAIKLCDFGISGQLVDSI---AKTRDAGCRPYMAPERIDPLRARGYPSFKTKLGFKFN  183 (187)
Q Consensus       128 ~~~~ki~dfg~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi~  183 (187)
                      ++.+|++|||+++......   ......++..|+|||.+.   ...++.++|+||||+.
T Consensus       160 ~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~Dv~slG~i  215 (283)
T cd05090         160 QLHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIM---YGKFSSDSDIWSFGVV  215 (283)
T ss_pred             CCcEEeccccccccccCCcceecccCCCccceecChHHhc---cCCCCchhhhHHHHHH
Confidence            9999999999998764321   112223456799999987   4568899999999983

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

Probab=99.95  E-value=1.2e-27  Score=184.43  Aligned_cols=155  Identities=23%  Similarity=0.367  Sum_probs=122.3

Q ss_pred             ccccccccccccCceEEEEEEEcCCCcEEEEEEccCccCh-HHHHHHHHHHHHHHhcCCCCchhhhhhhHH---------
Q psy14630         24 EDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDE-KDQRQLLMDLDVVMKSNECPYIVQFYGALF---------   93 (187)
Q Consensus        24 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~---------   93 (187)
                      ++|+..+.||+|+||.||+|.+..+++.+|+|.+...... ....+.+.++...++.+.|+||+++++.+.         
T Consensus         1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   80 (316)
T cd05574           1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM   80 (316)
T ss_pred             CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence            4688899999999999999999888999999998653322 223344556666777889999998864321         


Q ss_pred             -------------------------HHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEecccccccccccc-
Q psy14630         94 -------------------------KEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIA-  147 (187)
Q Consensus        94 -------------------------~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg~a~~~~~~~~-  147 (187)
                                               ..+..|++.+|+|||.. +++|+||||+||+++.++.+++.|||++........ 
T Consensus        81 e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~-~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~  159 (316)
T cd05574          81 DYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLL-GIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPP  159 (316)
T ss_pred             EecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHC-CeeccCCChHHeEEcCCCCEEEeecchhhcccccccc
Confidence                                     11557899999999997 999999999999999999999999999876532110 


Q ss_pred             -----------------------------ccCCCCCcCccCccccCCCccCCCCCCcceeeeEe
Q psy14630        148 -----------------------------KTRDAGCRPYMAPERIDPLRARGYPSFKTKLGFKF  182 (187)
Q Consensus       148 -----------------------------~~~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi  182 (187)
                                                   .....|+..|+|||.+.   ...++.++|+||||+
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~---~~~~~~~~Di~slG~  220 (316)
T cd05574         160 VSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVIS---GDGHGSAVDWWTLGI  220 (316)
T ss_pred             cccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHc---CCCCCchHHHHHHHH
Confidence                                         01225678899999998   566889999999998

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin

>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

Probab=99.95  E-value=9.6e-28  Score=183.61  Aligned_cols=156  Identities=28%  Similarity=0.478  Sum_probs=124.9

Q ss_pred             CcccccccccccccCceEEEEEEEcCCCcEEEEEEccCccChHHHHHHHHHHHHHHhcCCCCchhhhhhhHHH-------
Q psy14630         22 TSEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQFYGALFK-------   94 (187)
Q Consensus        22 ~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~-------   94 (187)
                      ...+|++.+.||.|+||.||++.+..+++.|++|.+......  ..+.+.++...++.++|||++++++.+..       
T Consensus        17 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~--~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv   94 (296)
T cd06655          17 PKKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQP--KKELIINEILVMKELKNPNIVNFLDSFLVGDELFVV   94 (296)
T ss_pred             CcceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCc--hHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEE
Confidence            446799999999999999999999999999999988643222  23344555667778899999988754311       


Q ss_pred             ------------------------HHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEecccccccccccc-cc
Q psy14630         95 ------------------------EVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIA-KT  149 (187)
Q Consensus        95 ------------------------~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg~a~~~~~~~~-~~  149 (187)
                                              .+..+++.++.|||+. +++|+||+|+||+++.++.++|+|||++........ ..
T Consensus        95 ~e~~~~~~L~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~-~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~~  173 (296)
T cd06655          95 MEYLAGGSLTDVVTETCMDEAQIAAVCRECLQALEFLHAN-QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRS  173 (296)
T ss_pred             EEecCCCcHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHC-CcccCCCCHHHEEECCCCCEEEccCccchhcccccccCC
Confidence                                    1556889999999997 999999999999999999999999999887643322 22


Q ss_pred             CCCCCcCccCccccCCCccCCCCCCcceeeeEee
Q psy14630        150 RDAGCRPYMAPERIDPLRARGYPSFKTKLGFKFN  183 (187)
Q Consensus       150 ~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi~  183 (187)
                      ...++..|+|||.+.   ...++.++|+||||+.
T Consensus       174 ~~~~~~~y~aPE~~~---~~~~~~~~Dv~slGvi  204 (296)
T cd06655         174 TMVGTPYWMAPEVVT---RKAYGPKVDIWSLGIM  204 (296)
T ss_pred             CcCCCccccCcchhc---CCCCCchhhHHHHHHH
Confidence            346788999999988   5668899999999984

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=99.94  E-value=1.1e-27  Score=180.17  Aligned_cols=156  Identities=28%  Similarity=0.392  Sum_probs=123.0

Q ss_pred             ccccccccccccCceEEEEEEEcCCCcEEEEEEccCcc---ChHHHHHHHHHHHHHHhcCCCCchhhhhhhHH-------
Q psy14630         24 EDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTV---DEKDQRQLLMDLDVVMKSNECPYIVQFYGALF-------   93 (187)
Q Consensus        24 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~-------   93 (187)
                      .+|++.+.||+|+||.||+|.+..++..+|+|.+....   ........+..+..+++.++|+||+++++.+.       
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (264)
T cd06653           2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL   81 (264)
T ss_pred             CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence            57899999999999999999999999999999874321   11223345556666788889999998764321       


Q ss_pred             ---------------------------HHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEecccccccccc-
Q psy14630         94 ---------------------------KEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDS-  145 (187)
Q Consensus        94 ---------------------------~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg~a~~~~~~-  145 (187)
                                                 ..+..+++.++.|||+. +++|+||+|+||+++.++.++++|||+++..... 
T Consensus        82 ~~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~al~~LH~~-~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~  160 (264)
T cd06653          82 SIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLHSN-MIVHRDIKGANILRDSAGNVKLGDFGASKRIQTIC  160 (264)
T ss_pred             EEEEEeCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhC-CEecCCCCHHHEEEcCCCCEEECcccccccccccc
Confidence                                       11557899999999998 9999999999999999999999999999876431 


Q ss_pred             ---ccccCCCCCcCccCccccCCCccCCCCCCcceeeeEee
Q psy14630        146 ---IAKTRDAGCRPYMAPERIDPLRARGYPSFKTKLGFKFN  183 (187)
Q Consensus       146 ---~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi~  183 (187)
                         .......++..|+|||.+.   ...++.++|+||||+.
T Consensus       161 ~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~Di~slG~i  198 (264)
T cd06653         161 MSGTGIKSVTGTPYWMSPEVIS---GEGYGRKADVWSVACT  198 (264)
T ss_pred             ccCccccccCCcccccCHhhhc---CCCCCccccHHHHHHH
Confidence               1112335788899999998   5567899999999983

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho

>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3

Probab=99.94  E-value=1.1e-27  Score=180.69  Aligned_cols=154  Identities=19%  Similarity=0.325  Sum_probs=118.2

Q ss_pred             ccccccccccCceEEEEEEEc---CCCcEEEEEEccCccChHHHHHHHHHHHHHHhcCCCCchhhhhhhH----------
Q psy14630         26 LQDLGEIGRGGFGTVNKMIHR---SSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQFYGAL----------   92 (187)
Q Consensus        26 ~~~~~~lg~G~fg~V~~~~~~---~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~----------   92 (187)
                      |++.+.||+|+||.||+|...   .+++.+|+|.+..........+.+..+..+++.++|||++++++.+          
T Consensus         1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   80 (273)
T cd05074           1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP   80 (273)
T ss_pred             CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence            567789999999999999854   4578899999875443333344445555677888999998876521          


Q ss_pred             ----------------------------------HHHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEeccc
Q psy14630         93 ----------------------------------FKEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGI  138 (187)
Q Consensus        93 ----------------------------------~~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg~  138 (187)
                                                        ...+..|++.|++|||+. +++||||||+||+++.++.++++|||+
T Consensus        81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~-~i~H~dikp~nili~~~~~~kl~dfg~  159 (273)
T cd05074          81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSK-NFIHRDLAARNCMLNENMTVCVADFGL  159 (273)
T ss_pred             ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CEeecccchhhEEEcCCCCEEECcccc
Confidence                                              012557888999999997 999999999999999999999999999


Q ss_pred             ccccccccc---ccCCCCCcCccCccccCCCccCCCCCCcceeeeEee
Q psy14630        139 SGQLVDSIA---KTRDAGCRPYMAPERIDPLRARGYPSFKTKLGFKFN  183 (187)
Q Consensus       139 a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi~  183 (187)
                      ++.......   .....+++.|++||.+.   ...++.++|+||||+.
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~---~~~~~~~sDi~slG~i  204 (273)
T cd05074         160 SKKIYSGDYYRQGCASKLPVKWLALESLA---DNVYTTHSDVWAFGVT  204 (273)
T ss_pred             cccccCCcceecCCCccCchhhcCHhHHh---cCccchhhhhHHHHHH
Confidence            987643221   11223456799999987   6678899999999984

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac

>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

Probab=99.94  E-value=5.4e-28  Score=181.41  Aligned_cols=156  Identities=21%  Similarity=0.355  Sum_probs=121.6

Q ss_pred             ccCCcccccccccccccCceEEEEEEEcCCCcEEEEEEccCccChHHHHHHHHHHHHHHhcCCCCchhhhhhhHH-----
Q psy14630         19 YDFTSEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQFYGALF-----   93 (187)
Q Consensus        19 ~~~~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~-----   93 (187)
                      |++..++|++.+.||+|+||.||+|... +++.+|+|.+......   .+.+.++..+++.++|+|++++++.+.     
T Consensus         1 ~~~~~~~~~~~~~ig~G~~g~v~~~~~~-~~~~~a~K~~~~~~~~---~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~   76 (260)
T cd05067           1 WEVPRETLKLVKKLGAGQFGEVWMGYYN-GHTKVAIKSLKQGSMS---PEAFLAEANLMKQLQHPRLVRLYAVVTQEPIY   76 (260)
T ss_pred             CccchHHceeeeeeccCccceEEeeecC-CCceEEEEEecCCCCc---HHHHHHHHHHHHhcCCcCeeeEEEEEccCCcE
Confidence            5677899999999999999999999864 5678999988643322   223444556777889999988764321     


Q ss_pred             ----------------------------HHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEecccccccccc
Q psy14630         94 ----------------------------KEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDS  145 (187)
Q Consensus        94 ----------------------------~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg~a~~~~~~  145 (187)
                                                  ..+..+++.+++|||+. +++|+||+|+|++++.++.++++|||++......
T Consensus        77 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~-~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~  155 (260)
T cd05067          77 IITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERK-NYIHRDLRAANILVSETLCCKIADFGLARLIEDN  155 (260)
T ss_pred             EEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcC-CeecccccHHhEEEcCCCCEEEccCcceeecCCC
Confidence                                        11566899999999987 9999999999999999999999999998776532


Q ss_pred             ccc--cCCCCCcCccCccccCCCccCCCCCCcceeeeEe
Q psy14630        146 IAK--TRDAGCRPYMAPERIDPLRARGYPSFKTKLGFKF  182 (187)
Q Consensus       146 ~~~--~~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi  182 (187)
                      ...  ....++..|+|||.+.   ...++.++|+||||+
T Consensus       156 ~~~~~~~~~~~~~y~~pe~~~---~~~~~~~~Di~slG~  191 (260)
T cd05067         156 EYTAREGAKFPIKWTAPEAIN---YGTFTIKSDVWSFGI  191 (260)
T ss_pred             CcccccCCcccccccCHHHhc---cCCcCcccchHHHHH
Confidence            211  1223456799999987   556788999999998

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr

>KOG0695|consensus

Probab=99.94  E-value=1.8e-28  Score=183.83  Aligned_cols=162  Identities=25%  Similarity=0.381  Sum_probs=134.0

Q ss_pred             ccccCCcccccccccccccCceEEEEEEEcCCCcEEEEEEccCcc-ChHHHHHHHHHHHHH-HhcCCCCchhhhhhhHHH
Q psy14630         17 TVYDFTSEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTV-DEKDQRQLLMDLDVV-MKSNECPYIVQFYGALFK   94 (187)
Q Consensus        17 ~~~~~~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~~~~~-~~~~~h~~iv~~~~~~~~   94 (187)
                      ..|.+..++|+++.+||+|+|++|.++.+++|.+.+|+|++++.. .+.+..++.+.+..+ ....+||.+|-+...|..
T Consensus       243 ~~~~l~l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqt  322 (593)
T KOG0695|consen  243 ISQGLGLQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQT  322 (593)
T ss_pred             cccccccccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcc
Confidence            456678899999999999999999999999999999999997653 333444555544433 334678999987765433


Q ss_pred             H--------------------------------HHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEeccccccc
Q psy14630         95 E--------------------------------VTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQL  142 (187)
Q Consensus        95 ~--------------------------------~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg~a~~~  142 (187)
                      +                                ....+..||.|||++ ||+.||||.+|++++..|++|+.|+|.++--
T Consensus       323 esrlffvieyv~ggdlmfhmqrqrklpeeharfys~ei~lal~flh~r-giiyrdlkldnvlldaeghikltdygmcke~  401 (593)
T KOG0695|consen  323 ESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEICLALNFLHER-GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEG  401 (593)
T ss_pred             cceEEEEEEEecCcceeeehhhhhcCcHHHhhhhhHHHHHHHHHHhhc-CeeeeeccccceEEccCCceeecccchhhcC
Confidence            2                                445678899999998 9999999999999999999999999999864


Q ss_pred             -cccccccCCCCCcCccCccccCCCccCCCCCCcceeeeEe
Q psy14630        143 -VDSIAKTRDAGCRPYMAPERIDPLRARGYPSFKTKLGFKF  182 (187)
Q Consensus       143 -~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi  182 (187)
                       .+...++.++|||.|.|||.+.   ...|...+|+|++||
T Consensus       402 l~~gd~tstfcgtpnyiapeilr---geeygfsvdwwalgv  439 (593)
T KOG0695|consen  402 LGPGDTTSTFCGTPNYIAPEILR---GEEYGFSVDWWALGV  439 (593)
T ss_pred             CCCCcccccccCCCcccchhhhc---ccccCceehHHHHHH
Confidence             5566777889999999999998   677999999999999

>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

Probab=99.94  E-value=1.1e-27  Score=181.44  Aligned_cols=159  Identities=18%  Similarity=0.249  Sum_probs=123.4

Q ss_pred             cCCcccccccccccccCceEEEEEEEcC----CCcEEEEEEccCccChHHHHHHHHHHHHHHhcCCCCchhhhhhhHH--
Q psy14630         20 DFTSEDLQDLGEIGRGGFGTVNKMIHRS----SDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQFYGALF--   93 (187)
Q Consensus        20 ~~~~~~~~~~~~lg~G~fg~V~~~~~~~----~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~--   93 (187)
                      .+..++|++.+.||+|+||.||+|.+..    ++..|++|.+...... ...+.+.++...++.+.|+|++++++.+.  
T Consensus         2 ~~~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~   80 (280)
T cd05043           2 AISRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASE-IQVTLLLQESCLLYGLSHQNILPILHVCIED   80 (280)
T ss_pred             ccchhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCH-HHHHHHHHHHHHHHhCCCCCCCeEEEEEecC
Confidence            3567899999999999999999999865    3578999988654333 33444555566777889999998754211  


Q ss_pred             ---------------------------------------HHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEE
Q psy14630         94 ---------------------------------------KEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLC  134 (187)
Q Consensus        94 ---------------------------------------~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~  134 (187)
                                                             ..+..+++.|+.|||+. +++||||||+|++++.++.+|++
T Consensus        81 ~~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~-~i~H~di~p~nil~~~~~~~kl~  159 (280)
T cd05043          81 GEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKR-GVIHKDIAARNCVIDEELQVKIT  159 (280)
T ss_pred             CCCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHC-CEeecccCHhhEEEcCCCcEEEC
Confidence                                                   01556889999999997 99999999999999999999999


Q ss_pred             eccccccccccccc---cCCCCCcCccCccccCCCccCCCCCCcceeeeEee
Q psy14630        135 DFGISGQLVDSIAK---TRDAGCRPYMAPERIDPLRARGYPSFKTKLGFKFN  183 (187)
Q Consensus       135 dfg~a~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi~  183 (187)
                      |||+++.+......   ....++..|+|||.+.   ...++.++|+||+|+.
T Consensus       160 d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~---~~~~~~~~Di~slG~~  208 (280)
T cd05043         160 DNALSRDLFPMDYHCLGDNENRPVKWMALESLV---NKEYSSASDVWSFGVL  208 (280)
T ss_pred             CCCCcccccCCceEEeCCCCCcchhccCHHHHh---cCCCCchhhHHHhHHH
Confidence            99999876432211   1224566799999988   6678899999999984

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It

>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

Probab=99.94  E-value=5.1e-28  Score=184.29  Aligned_cols=158  Identities=22%  Similarity=0.373  Sum_probs=121.6

Q ss_pred             cccccccccccccCceEEEEEEEcCCCcEEEEEEccCccChHHHHHHHHHHHHHHhcCCCCchhhhhhhHH---------
Q psy14630         23 SEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQFYGALF---------   93 (187)
Q Consensus        23 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~---------   93 (187)
                      .++|++.+.||+|+||.||+|.+..+++.||+|.+........ .....++..+++.++|+||+++++.+.         
T Consensus         4 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~-~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   82 (291)
T cd07844           4 LETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGA-PFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVF   82 (291)
T ss_pred             ccceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCC-chhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEE
Confidence            4789999999999999999999988999999999864322211 122334566777889999998764321         


Q ss_pred             -----------------------HHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEecccccccccc-cccc
Q psy14630         94 -----------------------KEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDS-IAKT  149 (187)
Q Consensus        94 -----------------------~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg~a~~~~~~-~~~~  149 (187)
                                             ..+..|++.||.|||+. +++||||+|+||+++.++.++++|||+++..... ....
T Consensus        83 e~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~-~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~  161 (291)
T cd07844          83 EYLDTDLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQR-RVLHRDLKPQNLLISERGELKLADFGLARAKSVPSKTYS  161 (291)
T ss_pred             ecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhC-CeecccCCHHHEEEcCCCCEEECccccccccCCCCcccc
Confidence                                   12556899999999997 9999999999999999999999999998764322 1112


Q ss_pred             CCCCCcCccCccccCCCccCCCCCCcceeeeEeee
Q psy14630        150 RDAGCRPYMAPERIDPLRARGYPSFKTKLGFKFNY  184 (187)
Q Consensus       150 ~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi~~  184 (187)
                      ...++..|+|||.+.+  ...++.++|+||+|+.+
T Consensus       162 ~~~~~~~~~aPE~~~~--~~~~~~~~Dv~slG~il  194 (291)
T cd07844         162 NEVVTLWYRPPDVLLG--STEYSTSLDMWGVGCIF  194 (291)
T ss_pred             ccccccccCCcHHhhc--CcccCcHHHHHHHHHHH
Confidence            2346788999999873  24578899999999843

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the

>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

Probab=99.94  E-value=7.2e-28  Score=180.63  Aligned_cols=157  Identities=18%  Similarity=0.304  Sum_probs=123.6

Q ss_pred             ccCCcccccccccccccCceEEEEEEEcCCCcEEEEEEccCccChHHHHHHHHHHHHHHhcCCCCchhhhhhhH------
Q psy14630         19 YDFTSEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQFYGAL------   92 (187)
Q Consensus        19 ~~~~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~------   92 (187)
                      |+.+..+|++.+.||.|+||.||+|.+.. +..+|+|.+....  ......+..+..+++.++|+||+++++.+      
T Consensus         1 ~~~~~~~y~~~~~ig~g~~~~vy~~~~~~-~~~~~~k~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   77 (261)
T cd05148           1 WERPREEFTLERKLGSGYFGEVWEGLWKN-RVRVAIKILKSDD--LLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPV   77 (261)
T ss_pred             CcCcHHHHHHhhhhccCCCccEEEeEecC-CCcEEEEeccccc--hhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCe
Confidence            45677899999999999999999999976 8889999986432  21233445555677788999999876431      


Q ss_pred             ----------------------------HHHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEeccccccccc
Q psy14630         93 ----------------------------FKEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVD  144 (187)
Q Consensus        93 ----------------------------~~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg~a~~~~~  144 (187)
                                                  ...+..+++.|+.|||+. +++|+||+|+|++++.++.++++|||.+.....
T Consensus        78 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~-~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~  156 (261)
T cd05148          78 YIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQ-NSIHRDLAARNILVGEDLVCKVADFGLARLIKE  156 (261)
T ss_pred             EEEEeecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHC-CeeccccCcceEEEcCCceEEEccccchhhcCC
Confidence                                        112667899999999997 999999999999999999999999999987643


Q ss_pred             cccc-cCCCCCcCccCccccCCCccCCCCCCcceeeeEe
Q psy14630        145 SIAK-TRDAGCRPYMAPERIDPLRARGYPSFKTKLGFKF  182 (187)
Q Consensus       145 ~~~~-~~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi  182 (187)
                      .... ....++..|+|||.+.   ...++.++|+||||+
T Consensus       157 ~~~~~~~~~~~~~~~~PE~~~---~~~~~~~~DiwslG~  192 (261)
T cd05148         157 DVYLSSDKKIPYKWTAPEAAS---HGTFSTKSDVWSFGI  192 (261)
T ss_pred             ccccccCCCCceEecCHHHHc---cCCCCchhhHHHHHH
Confidence            3221 1223456799999987   567889999999998

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom

>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

Probab=99.94  E-value=1.2e-27  Score=179.68  Aligned_cols=157  Identities=22%  Similarity=0.377  Sum_probs=120.9

Q ss_pred             ccCCcccccccccccccCceEEEEEEEcCCCcEEEEEEccCccChHHHHHHHHHHHHHHhcCCCCchhhhhhhH------
Q psy14630         19 YDFTSEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQFYGAL------   92 (187)
Q Consensus        19 ~~~~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~------   92 (187)
                      |++..++|++.+.||+|+||.||+|.+. +++.||+|.++.....   .+.+.++..+++.++|+|++++++.+      
T Consensus         1 ~~~~~~~~~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   76 (261)
T cd05068           1 WEIDRTSIQLLRKLGAGQFGEVWEGLWN-NTTPVAVKTLKPGTMD---PKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPI   76 (261)
T ss_pred             CccchhheeeEEEecccCCccEEEEEec-CCeEEEEEeeCCCccc---HHHHHHHHHHHHHCCCCCccceeEEEecCCCe
Confidence            4677889999999999999999999874 4567999998643221   22344455567778999999876422      


Q ss_pred             ----------------------------HHHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEeccccccccc
Q psy14630         93 ----------------------------FKEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVD  144 (187)
Q Consensus        93 ----------------------------~~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg~a~~~~~  144 (187)
                                                  ...+..+++.|+.|||+. +++|+||||+||+++.++.++++|||+++....
T Consensus        77 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~-~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~  155 (261)
T cd05068          77 YIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQ-NYIHRDLAARNVLVGENNICKVADFGLARVIKE  155 (261)
T ss_pred             eeeeecccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhC-CeeeccCCcceEEEcCCCCEEECCcceEEEccC
Confidence                                        112567889999999997 999999999999999999999999999987653


Q ss_pred             cccccC--CCCCcCccCccccCCCccCCCCCCcceeeeEee
Q psy14630        145 SIAKTR--DAGCRPYMAPERIDPLRARGYPSFKTKLGFKFN  183 (187)
Q Consensus       145 ~~~~~~--~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi~  183 (187)
                      ......  ...+..|+|||.+.   ...++.++|+||||+.
T Consensus       156 ~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~Di~slG~~  193 (261)
T cd05068         156 DIYEAREGAKFPIKWTAPEAAL---YNRFSIKSDVWSFGIL  193 (261)
T ss_pred             CcccccCCCcCceeccCccccc---cCCCCchhhHHHHHHH
Confidence            322111  11234699999987   5668899999999984

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a

>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

Probab=99.94  E-value=8.1e-28  Score=181.39  Aligned_cols=159  Identities=26%  Similarity=0.421  Sum_probs=120.8

Q ss_pred             CcccccccccccccCceEEEEEEEcCCCcEEEEEEccCccChHHHHHHHHHHHHHHhcCCCCchhhhhhhHH--------
Q psy14630         22 TSEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQFYGALF--------   93 (187)
Q Consensus        22 ~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~--------   93 (187)
                      +.+.|++.+.||+|+||.||+|....+++.+|+|.+......  ......++..+.+..+|+|++++++.+.        
T Consensus         4 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~--~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~   81 (272)
T cd06637           4 PAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDE--EEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMD   81 (272)
T ss_pred             hhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCCcc--HHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCC
Confidence            346788899999999999999999999999999998643222  2233344444444447999998764321        


Q ss_pred             --------------------------------HHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEecccccc
Q psy14630         94 --------------------------------KEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQ  141 (187)
Q Consensus        94 --------------------------------~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg~a~~  141 (187)
                                                      ..+..|++.|++|||+. +++|+|++|+||+++.++.++|+|||++..
T Consensus        82 ~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~-~ivh~dl~~~nili~~~~~~~l~Dfg~~~~  160 (272)
T cd06637          82 DQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQH-KVIHRDIKGQNVLLTENAEVKLVDFGVSAQ  160 (272)
T ss_pred             cEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC-CCccCCCCHHHEEECCCCCEEEccCCCcee
Confidence                                            11567899999999998 999999999999999999999999999886


Q ss_pred             ccccc-cccCCCCCcCccCccccCCCc--cCCCCCCcceeeeEee
Q psy14630        142 LVDSI-AKTRDAGCRPYMAPERIDPLR--ARGYPSFKTKLGFKFN  183 (187)
Q Consensus       142 ~~~~~-~~~~~~~t~~y~aPE~~~~~~--~~~~~~~~D~ws~gi~  183 (187)
                      ..... ......|+..|+|||++....  ...++.++|+||+|++
T Consensus       161 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~  205 (272)
T cd06637         161 LDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGIT  205 (272)
T ss_pred             cccccccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHH
Confidence            54322 223346888999999986321  3357889999999984

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ

>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

Probab=99.94  E-value=1e-27  Score=186.19  Aligned_cols=156  Identities=22%  Similarity=0.402  Sum_probs=118.3

Q ss_pred             cccccccccccCceEEEEEEEcCC--CcEEEEEEccCccChHHHH-HHHHHHHHHHhcCCCCchhhhhhhH---------
Q psy14630         25 DLQDLGEIGRGGFGTVNKMIHRSS--DTVMAVKRIRSTVDEKDQR-QLLMDLDVVMKSNECPYIVQFYGAL---------   92 (187)
Q Consensus        25 ~~~~~~~lg~G~fg~V~~~~~~~~--~~~vaiK~~~~~~~~~~~~-~~~~~~~~~~~~~~h~~iv~~~~~~---------   92 (187)
                      +|++.+.||+|+||.||++.+..+  +..+|+|.+.......... ....+...+.+..+||||+++++..         
T Consensus         1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~   80 (332)
T cd07857           1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE   80 (332)
T ss_pred             CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence            477889999999999999999877  8899999986433222222 3333444344444799999886421         


Q ss_pred             --------------------------HHHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEeccccccccccc
Q psy14630         93 --------------------------FKEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSI  146 (187)
Q Consensus        93 --------------------------~~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg~a~~~~~~~  146 (187)
                                                ...+..|++.||.|||+. +++||||||+||+++.++.++|+|||+++......
T Consensus        81 ~~~~~e~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~-givH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~  159 (332)
T cd07857          81 LYLYEELMEADLHQIIRSGQPLTDAHFQSFIYQILCGLKYIHSA-NVLHRDLKPGNLLVNADCELKICDFGLARGFSENP  159 (332)
T ss_pred             EEEEEecccCCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC-CcccCCCCHHHeEEcCCCCEEeCcCCCceeccccc
Confidence                                      011667899999999997 99999999999999999999999999998764321


Q ss_pred             c-----ccCCCCCcCccCccccCCCccCCCCCCcceeeeEee
Q psy14630        147 A-----KTRDAGCRPYMAPERIDPLRARGYPSFKTKLGFKFN  183 (187)
Q Consensus       147 ~-----~~~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi~  183 (187)
                      .     .....++..|+|||.+.+  ...++.++|+||+|+.
T Consensus       160 ~~~~~~~~~~~g~~~y~aPE~~~~--~~~~~~~~Di~slGv~  199 (332)
T cd07857         160 GENAGFMTEYVATRWYRAPEIMLS--FQSYTKAIDVWSVGCI  199 (332)
T ss_pred             ccccccccCcccCccccCcHHHhC--CCCCCcHHHHHHHHHH
Confidence            1     122367889999998762  3457899999999984

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co

>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

Probab=99.94  E-value=1.5e-27  Score=178.47  Aligned_cols=155  Identities=25%  Similarity=0.380  Sum_probs=123.5

Q ss_pred             cccccccccccCceEEEEEEEcCCCcEEEEEEccCccChHHHHHHHHHHHHHHhcCCCCchhhhhhhHH-----------
Q psy14630         25 DLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQFYGALF-----------   93 (187)
Q Consensus        25 ~~~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~-----------   93 (187)
                      +|+..+.||.|+||.||.+....+++.+++|.+............+..+..+++.++|+||+++++.+.           
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~   80 (256)
T cd08221           1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY   80 (256)
T ss_pred             CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence            488899999999999999999999999999987643323333444555666778889999998864321           


Q ss_pred             -----------------------HHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEeccccccccccc-ccc
Q psy14630         94 -----------------------KEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSI-AKT  149 (187)
Q Consensus        94 -----------------------~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg~a~~~~~~~-~~~  149 (187)
                                             ..+..+++.++.|||+. +++|+||+|+||+++.++.+||+|||++....... ...
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~-~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~~~~  159 (256)
T cd08221          81 ANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKA-GILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAE  159 (256)
T ss_pred             cCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhC-CccccCCChHhEEEeCCCCEEECcCcceEEccccccccc
Confidence                                   11556889999999987 99999999999999999999999999988764432 223


Q ss_pred             CCCCCcCccCccccCCCccCCCCCCcceeeeEee
Q psy14630        150 RDAGCRPYMAPERIDPLRARGYPSFKTKLGFKFN  183 (187)
Q Consensus       150 ~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi~  183 (187)
                      ...+++.|+|||.+.   +..++.++|+||+|+.
T Consensus       160 ~~~~~~~y~ape~~~---~~~~~~~~Dv~slG~i  190 (256)
T cd08221         160 TVVGTPYYMSPELCQ---GVKYNFKSDIWALGCV  190 (256)
T ss_pred             ccCCCccccCHhhcC---CCCCCCcchhHHHHHH
Confidence            346788999999988   5557889999999983

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa

>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

Probab=99.94  E-value=6.3e-28  Score=184.59  Aligned_cols=156  Identities=26%  Similarity=0.489  Sum_probs=124.1

Q ss_pred             CcccccccccccccCceEEEEEEEcCCCcEEEEEEccCccChHHHHHHHHHHHHHHhcCCCCchhhhhhhHH--------
Q psy14630         22 TSEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQFYGALF--------   93 (187)
Q Consensus        22 ~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~--------   93 (187)
                      ...+|++.+.||+|+||.||++.+..+++.+|+|.+......  ..+.+.++..+++...|+|++++++.+.        
T Consensus        18 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~--~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv   95 (296)
T cd06654          18 PKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP--KKELIINEILVMRENKNPNIVNYLDSYLVGDELWVV   95 (296)
T ss_pred             cccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcc--hHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEe
Confidence            456899999999999999999999899999999988643222  2344555556777889999998764321        


Q ss_pred             -----------------------HHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEecccccccccccc-cc
Q psy14630         94 -----------------------KEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIA-KT  149 (187)
Q Consensus        94 -----------------------~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg~a~~~~~~~~-~~  149 (187)
                                             ..++.|++.|+.|||+. +++|+||||+||+++.++.++|+|||++........ ..
T Consensus        96 ~e~~~~~~L~~~~~~~~~~~~~~~~i~~ql~~aL~~LH~~-gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~  174 (296)
T cd06654          96 MEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSN-QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRS  174 (296)
T ss_pred             ecccCCCCHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHC-CcccCCCCHHHEEEcCCCCEEECccccchhccccccccC
Confidence                                   12566899999999997 999999999999999999999999999886543221 22


Q ss_pred             CCCCCcCccCccccCCCccCCCCCCcceeeeEee
Q psy14630        150 RDAGCRPYMAPERIDPLRARGYPSFKTKLGFKFN  183 (187)
Q Consensus       150 ~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi~  183 (187)
                      ...+++.|+|||.+.   ...++.++|+||||++
T Consensus       175 ~~~~~~~y~aPE~~~---~~~~~~~~Dv~s~Gvi  205 (296)
T cd06654         175 TMVGTPYWMAPEVVT---RKAYGPKVDIWSLGIM  205 (296)
T ss_pred             cccCCccccCHHHHc---CCCCCccchHHHHHHH
Confidence            346788999999988   5567899999999983

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

Probab=99.94  E-value=1.3e-27  Score=186.33  Aligned_cols=160  Identities=21%  Similarity=0.321  Sum_probs=123.9

Q ss_pred             cccCCcccccccccccccCceEEEEEEEcCCCcEEEEEEccCccChHHHHHHHHHHHHHHhcCCCCchhhhhhhHH----
Q psy14630         18 VYDFTSEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQFYGALF----   93 (187)
Q Consensus        18 ~~~~~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~----   93 (187)
                      .|++. ++|.....||+|+||.||+|.+..+++.+|+|.++...........+..+..+++.+.||||+++++.+.    
T Consensus        10 ~~~~~-~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~   88 (342)
T cd07879          10 VWELP-ERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVS   88 (342)
T ss_pred             hhccc-cceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheeccccc
Confidence            44543 6899999999999999999999889999999998643222222233445555677789999998875421    


Q ss_pred             -------------------------------HHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEeccccccc
Q psy14630         94 -------------------------------KEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQL  142 (187)
Q Consensus        94 -------------------------------~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg~a~~~  142 (187)
                                                     ..++.|++.|++|||+. +++||||||+||+++.++.++++|||+++..
T Consensus        89 ~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~-~i~H~dlkp~NIll~~~~~~kL~dfg~~~~~  167 (342)
T cd07879          89 GDEFQDFYLVMPYMQTDLQKIMGHPLSEDKVQYLVYQMLCGLKYIHSA-GIIHRDLKPGNLAVNEDCELKILDFGLARHA  167 (342)
T ss_pred             CCCCceEEEEecccccCHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC-CcccCCCCHHHEEECCCCCEEEeeCCCCcCC
Confidence                                           11567899999999997 9999999999999999999999999998765


Q ss_pred             cccccccCCCCCcCccCccccCCCccCCCCCCcceeeeEee
Q psy14630        143 VDSIAKTRDAGCRPYMAPERIDPLRARGYPSFKTKLGFKFN  183 (187)
Q Consensus       143 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi~  183 (187)
                      ...  .....++..|+|||.+.+  ...++.++|+||+|++
T Consensus       168 ~~~--~~~~~~~~~y~aPE~~~~--~~~~~~~~Dv~slGvi  204 (342)
T cd07879         168 DAE--MTGYVVTRWYRAPEVILN--WMHYNQTVDIWSVGCI  204 (342)
T ss_pred             CCC--CCCceeeecccChhhhcC--ccccCchHHHHHHHHH
Confidence            322  223356788999999873  2347889999999984

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13

>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

Probab=99.94  E-value=1.4e-27  Score=181.81  Aligned_cols=157  Identities=20%  Similarity=0.315  Sum_probs=120.4

Q ss_pred             CCcccccccccccccCceEEEEEEE-----cCCCcEEEEEEccCccChHHHHHHHHHHHHHHhcCCCCchhhhhhhHH--
Q psy14630         21 FTSEDLQDLGEIGRGGFGTVNKMIH-----RSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQFYGALF--   93 (187)
Q Consensus        21 ~~~~~~~~~~~lg~G~fg~V~~~~~-----~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~--   93 (187)
                      +..++|.+.+.||+|+||.||++.+     ..++..+|+|.+....  ....+.+..+..+++.+.|||++++++.+.  
T Consensus         2 ~~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~   79 (288)
T cd05093           2 IKRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDAS--DNARKDFHREAELLTNLQHEHIVKFYGVCVEG   79 (288)
T ss_pred             CchHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcC--HHHHHHHHHHHHHHHhCCCCCcceEEEEEecC
Confidence            3568899999999999999999975     2345678999886432  223344555666777789999998764210  


Q ss_pred             -------------------------------------------HHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCC
Q psy14630         94 -------------------------------------------KEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGA  130 (187)
Q Consensus        94 -------------------------------------------~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~  130 (187)
                                                                 ..+..|++.+++|||+. +++||||||+||+++.++.
T Consensus        80 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~-~i~H~dlkp~Nili~~~~~  158 (288)
T cd05093          80 DPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQ-HFVHRDLATRNCLVGENLL  158 (288)
T ss_pred             CccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CeeecccCcceEEEccCCc
Confidence                                                       11567899999999997 9999999999999999999


Q ss_pred             EEEEecccccccccccc---ccCCCCCcCccCccccCCCccCCCCCCcceeeeEee
Q psy14630        131 IKLCDFGISGQLVDSIA---KTRDAGCRPYMAPERIDPLRARGYPSFKTKLGFKFN  183 (187)
Q Consensus       131 ~ki~dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi~  183 (187)
                      ++++|||+++.......   .....++..|+|||.+.   ...++.++|+||||+.
T Consensus       159 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~sDiwslG~i  211 (288)
T cd05093         159 VKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIM---YRKFTTESDVWSLGVV  211 (288)
T ss_pred             EEeccCCccccccCCceeecCCCCCccccccCHHHhc---cCCCCchhhHHHHHHH
Confidence            99999999986543211   11223467899999988   5678899999999983

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly

>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

Probab=99.94  E-value=1e-27  Score=181.91  Aligned_cols=155  Identities=25%  Similarity=0.398  Sum_probs=122.3

Q ss_pred             cccccccccccCceEEEEEEEcCCCcEEEEEEccCccChHHHHHHHHHHHHHHhcCCCCchhhhhhhHH-----------
Q psy14630         25 DLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQFYGALF-----------   93 (187)
Q Consensus        25 ~~~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~-----------   93 (187)
                      +|++.+.||+|+||.||+|.+..++..+|+|.+..........+.+..+..+.+.+.|||++++++.+.           
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~   80 (286)
T cd07832           1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY   80 (286)
T ss_pred             CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence            578899999999999999999889999999998654322233344555556677788999998765321           


Q ss_pred             ---------------------HHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEeccccccccccc--cccC
Q psy14630         94 ---------------------KEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSI--AKTR  150 (187)
Q Consensus        94 ---------------------~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg~a~~~~~~~--~~~~  150 (187)
                                           ..++.|++.+++|||+. +++|+||+|+||+++.++.++++|||++.......  ....
T Consensus        81 ~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~-~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~~~~~  159 (286)
T cd07832          81 MPSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHAN-GIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSH  159 (286)
T ss_pred             cCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC-CeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCCCcccc
Confidence                                 12567899999999997 99999999999999999999999999988765432  1223


Q ss_pred             CCCCcCccCccccCCCccCCCCCCcceeeeEe
Q psy14630        151 DAGCRPYMAPERIDPLRARGYPSFKTKLGFKF  182 (187)
Q Consensus       151 ~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi  182 (187)
                      ..++..|+|||.+.+  ...++.++|+||+|+
T Consensus       160 ~~~~~~y~aPE~~~~--~~~~~~~~Di~slG~  189 (286)
T cd07832         160 QVATRWYRAPELLYG--ARKYDPGVDLWAVGC  189 (286)
T ss_pred             ccCcccccCceeeec--cccCCchhHHHHHHH
Confidence            467889999999863  334689999999998

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea

>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

Probab=99.94  E-value=2.1e-27  Score=178.78  Aligned_cols=157  Identities=25%  Similarity=0.354  Sum_probs=120.1

Q ss_pred             CcccccccccccccCceEEEEEEEcCC---CcEEEEEEccCccChHHHHHHHHHHHHHHhcCCCCchhhhhhhH------
Q psy14630         22 TSEDLQDLGEIGRGGFGTVNKMIHRSS---DTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQFYGAL------   92 (187)
Q Consensus        22 ~~~~~~~~~~lg~G~fg~V~~~~~~~~---~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~------   92 (187)
                      ..++|++.+.||+|+||.||+|....+   ...||+|.++....... ...+..+...++.++||||+++++.+      
T Consensus         2 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   80 (266)
T cd05033           2 DPSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQ-RLDFLTEASIMGQFDHPNIIRLEGVVTKSRPV   80 (266)
T ss_pred             ChHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHH-HHHHHHHHHHHHhCCCCCcceEeEEEecCCce
Confidence            467899999999999999999987543   46799999865433332 33344455567778999999876432      


Q ss_pred             ---------------------------HHHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEecccccccccc
Q psy14630         93 ---------------------------FKEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDS  145 (187)
Q Consensus        93 ---------------------------~~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg~a~~~~~~  145 (187)
                                                 ...+..+++.|+.|||+. +++|+|++|+||+++.++.++++|||+++.....
T Consensus        81 ~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~-~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~  159 (266)
T cd05033          81 MIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEM-NYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDS  159 (266)
T ss_pred             EEEEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC-CcccCCCCcceEEEcCCCCEEECccchhhccccc
Confidence                                       112567899999999997 9999999999999999999999999999887421


Q ss_pred             cc---ccCCCCCcCccCccccCCCccCCCCCCcceeeeEee
Q psy14630        146 IA---KTRDAGCRPYMAPERIDPLRARGYPSFKTKLGFKFN  183 (187)
Q Consensus       146 ~~---~~~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi~  183 (187)
                      ..   .....++..|+|||.+.   ...++.++|+||||+.
T Consensus       160 ~~~~~~~~~~~~~~y~~Pe~~~---~~~~~~~~Dv~slG~~  197 (266)
T cd05033         160 EATYTTKGGKIPIRWTAPEAIA---YRKFTSASDVWSFGIV  197 (266)
T ss_pred             ccceeccCCCCCccccChhhhc---cCCCccccchHHHHHH
Confidence            11   11123456799999988   5668899999999983

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment

>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

Probab=99.94  E-value=9.8e-28  Score=184.08  Aligned_cols=159  Identities=27%  Similarity=0.416  Sum_probs=122.0

Q ss_pred             cccccccccccccCceEEEEEEEcCCCcEEEEEEccCccChHHHHHHHHHHHHHHhcCCCCchhhhhhhHH---------
Q psy14630         23 SEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQFYGALF---------   93 (187)
Q Consensus        23 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~---------   93 (187)
                      .++|++.+.||+|+||.||+|.+..+++.+|+|.+..............++..+++.++||||+++++.+.         
T Consensus         7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   86 (311)
T cd07866           7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK   86 (311)
T ss_pred             cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence            58999999999999999999999999999999988533222111122334455677789999999875421         


Q ss_pred             -------------------------------HHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEeccccccc
Q psy14630         94 -------------------------------KEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQL  142 (187)
Q Consensus        94 -------------------------------~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg~a~~~  142 (187)
                                                     ..+..|++++|+|||+. +++|+||||+||+++.++.++++|||+++..
T Consensus        87 ~~~~~lv~~~~~~~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH~~-~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~  165 (311)
T cd07866          87 RGSVYMVTPYMDHDLSGLLENPSVKLTESQIKCYMLQLLEGINYLHEN-HILHRDIKAANILIDNQGILKIADFGLARPY  165 (311)
T ss_pred             CceEEEEEecCCcCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhC-CeecCCCCHHHEEECCCCCEEECcCccchhc
Confidence                                           11667899999999997 9999999999999999999999999999875


Q ss_pred             cccccc------------cCCCCCcCccCccccCCCccCCCCCCcceeeeEeee
Q psy14630        143 VDSIAK------------TRDAGCRPYMAPERIDPLRARGYPSFKTKLGFKFNY  184 (187)
Q Consensus       143 ~~~~~~------------~~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi~~  184 (187)
                      ......            ....+++.|+|||.+.+  ...++.++|+||||+++
T Consensus       166 ~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~~Dv~slG~il  217 (311)
T cd07866         166 DGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLG--ERRYTTAVDIWGIGCVF  217 (311)
T ss_pred             cCCCcccccCCcccccccccceeccCcCChHHhhC--CCccCchhHhHHHHHHH
Confidence            432111            11245778999999863  34578899999999843

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic

>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

Probab=99.94  E-value=1.4e-27  Score=178.33  Aligned_cols=153  Identities=37%  Similarity=0.644  Sum_probs=124.0

Q ss_pred             cccccccccccccCceEEEEEEEcCCCcEEEEEEccCccChHHHHHHHHHHHHHHhcCCCCchhhhhhhHH---------
Q psy14630         23 SEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQFYGALF---------   93 (187)
Q Consensus        23 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~---------   93 (187)
                      .++|++.+.||+|+||.||+|....+++.+++|.+...   .. .+.+.++...++.++|+|++++++.+.         
T Consensus         2 ~~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~---~~-~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~   77 (256)
T cd06612           2 EEVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVE---ED-LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVM   77 (256)
T ss_pred             cccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecH---HH-HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEE
Confidence            57899999999999999999999888899999998642   11 344555666677789999998775321         


Q ss_pred             ------------------------HHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEeccccccccccc-cc
Q psy14630         94 ------------------------KEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSI-AK  148 (187)
Q Consensus        94 ------------------------~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg~a~~~~~~~-~~  148 (187)
                                              ..+..+++.++.|||+. +++|+|++|+||+++.++.++++|||++....... ..
T Consensus        78 e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~~-~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~~~  156 (256)
T cd06612          78 EYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSN-KKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKR  156 (256)
T ss_pred             ecCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHC-CcccCCCCcceEEECCCCcEEEcccccchhcccCcccc
Confidence                                    12667899999999997 99999999999999999999999999998765433 22


Q ss_pred             cCCCCCcCccCccccCCCccCCCCCCcceeeeEee
Q psy14630        149 TRDAGCRPYMAPERIDPLRARGYPSFKTKLGFKFN  183 (187)
Q Consensus       149 ~~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi~  183 (187)
                      ....++..|+|||.+.   +..++.++|+||||+.
T Consensus       157 ~~~~~~~~y~~PE~~~---~~~~~~~~Di~s~G~i  188 (256)
T cd06612         157 NTVIGTPFWMAPEVIQ---EIGYNNKADIWSLGIT  188 (256)
T ss_pred             ccccCCccccCHHHHh---cCCCCchhhHHHHHHH
Confidence            2335788899999987   5578899999999983

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a

>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

Probab=99.94  E-value=1.1e-27  Score=179.43  Aligned_cols=154  Identities=24%  Similarity=0.376  Sum_probs=118.3

Q ss_pred             CcccccccccccccCceEEEEEEEcCCCcEEEEEEccCccChHHHHHHHHHHHHHHhcCCCCchhhhhhhHH--------
Q psy14630         22 TSEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQFYGALF--------   93 (187)
Q Consensus        22 ~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~--------   93 (187)
                      +.++|++.+.||+|+||.||++... .+..+|+|.+......   .+.+..+..+++.++||||+++++.+.        
T Consensus         2 ~~~~~~~~~~lg~G~~~~vy~~~~~-~~~~~a~K~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv   77 (256)
T cd05114           2 NPSELTFMKELGSGQFGVVHLGKWR-AQIKVAIKAINEGAMS---EEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIV   77 (256)
T ss_pred             CHHHcEEeeEecCCcCceEEEEEec-cCceEEEEecccCCcc---HHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEE
Confidence            4578999999999999999999875 4567899987643221   223444555777889999998764321        


Q ss_pred             -------------------------HHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEeccccccccccccc
Q psy14630         94 -------------------------KEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAK  148 (187)
Q Consensus        94 -------------------------~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg~a~~~~~~~~~  148 (187)
                                               ..+..+++.|+.|||+. +++||||+|+|++++.++.++++|||.++........
T Consensus        78 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~-~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~  156 (256)
T cd05114          78 TEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERN-SFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYT  156 (256)
T ss_pred             EEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHC-CccccccCcceEEEcCCCeEEECCCCCccccCCCcee
Confidence                                     12566889999999997 9999999999999999999999999998876432222


Q ss_pred             c--CCCCCcCccCccccCCCccCCCCCCcceeeeEee
Q psy14630        149 T--RDAGCRPYMAPERIDPLRARGYPSFKTKLGFKFN  183 (187)
Q Consensus       149 ~--~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi~  183 (187)
                      .  ...++..|+|||.+.   ...++.++|+||||+.
T Consensus       157 ~~~~~~~~~~y~aPE~~~---~~~~~~~~Di~s~G~~  190 (256)
T cd05114         157 SSSGAKFPVKWSPPEVFN---FSKYSSKSDVWSFGVL  190 (256)
T ss_pred             ccCCCCCchhhCChhhcc---cCccchhhhhHHHHHH
Confidence            1  223456799999988   5568899999999983

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h

>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

Probab=99.94  E-value=1.6e-27  Score=180.53  Aligned_cols=158  Identities=22%  Similarity=0.328  Sum_probs=121.9

Q ss_pred             CCcccccccccccccCceEEEEEEEc-----CCCcEEEEEEccCccChHHHHHHHHHHHHHHhcCCCCchhhhhhhHH--
Q psy14630         21 FTSEDLQDLGEIGRGGFGTVNKMIHR-----SSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQFYGALF--   93 (187)
Q Consensus        21 ~~~~~~~~~~~lg~G~fg~V~~~~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~--   93 (187)
                      +..++|.+.+.||+|+||.||+|.+.     .++..+|+|.++...... ..+.+.++..+++.+.|+||+++++.+.  
T Consensus         2 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~   80 (280)
T cd05049           2 VQRDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASND-ARKDFEREAELLTNFQHENIVKFYGVCTEG   80 (280)
T ss_pred             CChHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHH-HHHHHHHHHHHHHhcCCCCchheeeEEecC
Confidence            34678999999999999999999864     345789999987543332 3344555556777789999998764311  


Q ss_pred             --------------------------------------------HHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCC
Q psy14630         94 --------------------------------------------KEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRG  129 (187)
Q Consensus        94 --------------------------------------------~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~  129 (187)
                                                                  ..+..+++.++.|||+. +++||||||+||+++.++
T Consensus        81 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~-~i~h~dlkp~nili~~~~  159 (280)
T cd05049          81 DPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQ-HFVHRDLATRNCLVGYDL  159 (280)
T ss_pred             CCeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhC-CeeccccccceEEEcCCC
Confidence                                                        12467899999999997 999999999999999999


Q ss_pred             CEEEEeccccccccccc---cccCCCCCcCccCccccCCCccCCCCCCcceeeeEee
Q psy14630        130 AIKLCDFGISGQLVDSI---AKTRDAGCRPYMAPERIDPLRARGYPSFKTKLGFKFN  183 (187)
Q Consensus       130 ~~ki~dfg~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi~  183 (187)
                      .++++|||+++......   ......+++.|+|||.+.   ...++.++|+||+|+.
T Consensus       160 ~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~Di~slG~i  213 (280)
T cd05049         160 VVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIM---YRKFTTESDVWSFGVV  213 (280)
T ss_pred             eEEECCcccceecccCcceecCCCCcccceecChhhhc---cCCcchhhhHHHHHHH
Confidence            99999999987653221   112234567899999998   5678899999999983

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt

>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

Probab=99.94  E-value=1.1e-27  Score=182.10  Aligned_cols=158  Identities=39%  Similarity=0.691  Sum_probs=125.1

Q ss_pred             CCcccccccccccccCceEEEEEEEcCCCcEEEEEEccCccChHHHHHHHHHHHHHHhcCCCCchhhhhhhH--------
Q psy14630         21 FTSEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQFYGAL--------   92 (187)
Q Consensus        21 ~~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~--------   92 (187)
                      +..++|++.+.||+|+||.||++.+..+++.+|+|++...... ...+.+..+..+++.++||||+++++.+        
T Consensus         2 l~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l   80 (284)
T cd06620           2 LRNEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKS-SVRKQILRELQIMHECRSPYIVSFYGAFLNENNICM   80 (284)
T ss_pred             ccHHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcc-hHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEE
Confidence            4567899999999999999999999989999999987643222 2334445555567778999999876432        


Q ss_pred             ------------------------HHHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEeccccccccccccc
Q psy14630         93 ------------------------FKEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAK  148 (187)
Q Consensus        93 ------------------------~~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg~a~~~~~~~~~  148 (187)
                                              ...+..+++.++.|||+..+++|+||+|+|++++.++.++|+|||++....... .
T Consensus        81 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~~-~  159 (284)
T cd06620          81 CMEFMDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSI-A  159 (284)
T ss_pred             EEecCCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEEECCCCcEEEccCCcccchhhhc-c
Confidence                                    122567888999999975589999999999999999999999999987653322 2


Q ss_pred             cCCCCCcCccCccccCCCccCCCCCCcceeeeEee
Q psy14630        149 TRDAGCRPYMAPERIDPLRARGYPSFKTKLGFKFN  183 (187)
Q Consensus       149 ~~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi~  183 (187)
                      ....++..|+|||.+.   ...++.++|+||||+.
T Consensus       160 ~~~~~~~~~~aPE~~~---~~~~~~~~Di~slG~~  191 (284)
T cd06620         160 DTFVGTSTYMSPERIQ---GGKYTVKSDVWSLGIS  191 (284)
T ss_pred             CccccCcccCCHHHHc---cCCCCccchHHHHHHH
Confidence            2346889999999987   5578899999999983

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

Probab=99.94  E-value=1.3e-27  Score=180.66  Aligned_cols=154  Identities=34%  Similarity=0.541  Sum_probs=123.6

Q ss_pred             ccccccccccccCceEEEEEEEcCCCcEEEEEEccCccChHHHHHHHHHHHHHHhcCCCCchhhhhhhHH----------
Q psy14630         24 EDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQFYGALF----------   93 (187)
Q Consensus        24 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~----------   93 (187)
                      ++|++.+.||.|+||.||+|.+..+++.+|+|.+....... ....+..+..+++.++|+|++++++.+.          
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e   79 (274)
T cd06609           1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAED-EIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIME   79 (274)
T ss_pred             ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccch-HHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEE
Confidence            46888999999999999999999999999999986432222 2233445556677788999998765321          


Q ss_pred             ---------------------HHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEecccccccccc-ccccCC
Q psy14630         94 ---------------------KEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDS-IAKTRD  151 (187)
Q Consensus        94 ---------------------~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg~a~~~~~~-~~~~~~  151 (187)
                                           ..+..|++.++.|||+. +++|+|++|+|++++.++.++++|||+++..... ......
T Consensus        80 ~~~~~~L~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~-~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~~~~  158 (274)
T cd06609          80 YCGGGSCLDLLKPGKLDETYIAFILREVLLGLEYLHEE-GKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNTF  158 (274)
T ss_pred             eeCCCcHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHhC-CcccCCCCHHHEEECCCCCEEEcccccceeecccccccccc
Confidence                                 12667899999999997 9999999999999999999999999999887543 222334


Q ss_pred             CCCcCccCccccCCCccCCCCCCcceeeeEe
Q psy14630        152 AGCRPYMAPERIDPLRARGYPSFKTKLGFKF  182 (187)
Q Consensus       152 ~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi  182 (187)
                      .+++.|+|||.+.   ...++.++|+||||+
T Consensus       159 ~~~~~y~~PE~~~---~~~~~~~sDv~slG~  186 (274)
T cd06609         159 VGTPFWMAPEVIK---QSGYDEKADIWSLGI  186 (274)
T ss_pred             cCCccccChhhhc---cCCCCchhhHHHHHH
Confidence            6788899999998   555889999999998

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)

>PLN00009 cyclin-dependent kinase A; Provisional

Probab=99.94  E-value=1e-27  Score=183.02  Aligned_cols=157  Identities=24%  Similarity=0.402  Sum_probs=120.8

Q ss_pred             ccccccccccccCceEEEEEEEcCCCcEEEEEEccCccChHHHHHHHHHHHHHHhcCCCCchhhhhhhHH----------
Q psy14630         24 EDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQFYGALF----------   93 (187)
Q Consensus        24 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~----------   93 (187)
                      ++|++.+.||+|++|.||+|.+..+++.+|+|.+..........+.+..+..+++.+.|||++++++.+.          
T Consensus         2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   81 (294)
T PLN00009          2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE   81 (294)
T ss_pred             CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence            5789999999999999999999889999999988643222223334455566777889999998875421          


Q ss_pred             -----------------------HHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcC-CCCEEEEeccccccccccc-cc
Q psy14630         94 -----------------------KEVTVATVKALNYLKEELKIIHRDVKPSNILLDR-RGAIKLCDFGISGQLVDSI-AK  148 (187)
Q Consensus        94 -----------------------~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~-~~~~ki~dfg~a~~~~~~~-~~  148 (187)
                                             ..++.|++.||+|||+. +++|+||+|+||+++. .+.+|++|||++....... ..
T Consensus        82 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~-~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~~~~  160 (294)
T PLN00009         82 YLDLDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSH-RVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTF  160 (294)
T ss_pred             cccccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhC-CeeCCCCCcceEEEECCCCEEEEcccccccccCCCcccc
Confidence                                   12556899999999997 9999999999999985 4579999999997653221 12


Q ss_pred             cCCCCCcCccCccccCCCccCCCCCCcceeeeEee
Q psy14630        149 TRDAGCRPYMAPERIDPLRARGYPSFKTKLGFKFN  183 (187)
Q Consensus       149 ~~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi~  183 (187)
                      ....+++.|+|||.+.+  ...++.++|+||+|+.
T Consensus       161 ~~~~~~~~y~~PE~~~~--~~~~~~~~Dv~slG~i  193 (294)
T PLN00009        161 THEVVTLWYRAPEILLG--SRHYSTPVDIWSVGCI  193 (294)
T ss_pred             ccCceeecccCHHHHhC--CCCCCcHHHHHHHHHH
Confidence            22356788999999863  3457889999999983

>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

Probab=99.94  E-value=1.9e-27  Score=185.55  Aligned_cols=161  Identities=22%  Similarity=0.342  Sum_probs=126.3

Q ss_pred             ccccCCcccccccccccccCceEEEEEEEcCCCcEEEEEEccCccChHHHHHHHHHHHHHHhcCCCCchhhhhhhHH---
Q psy14630         17 TVYDFTSEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQFYGALF---   93 (187)
Q Consensus        17 ~~~~~~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~---   93 (187)
                      ..|++ .++|++.+.||+|+||.||++.+..++..||+|.+..........+.+..+..+++.+.||||+++++.+.   
T Consensus         9 ~~~~~-~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~   87 (343)
T cd07880           9 TIWEV-PDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDL   87 (343)
T ss_pred             hhhcc-ccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCc
Confidence            34443 47799999999999999999999999999999998643333333344556666788889999998754221   


Q ss_pred             ---------------------------------HHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEeccccc
Q psy14630         94 ---------------------------------KEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISG  140 (187)
Q Consensus        94 ---------------------------------~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg~a~  140 (187)
                                                       ..++.|++.|+.|||+. +++||||||+||+++.++.++++|||++.
T Consensus        88 ~~~~~~~~~lv~e~~~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~-gi~H~dlkp~Nill~~~~~~kl~dfg~~~  166 (343)
T cd07880          88 SLDRFHDFYLVMPFMGTDLGKLMKHEKLSEDRIQFLVYQMLKGLKYIHAA-GIIHRDLKPGNLAVNEDCELKILDFGLAR  166 (343)
T ss_pred             cccccceEEEEEecCCCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC-CeecCCCCHHHEEEcCCCCEEEeeccccc
Confidence                                             12667899999999997 99999999999999999999999999988


Q ss_pred             cccccccccCCCCCcCccCccccCCCccCCCCCCcceeeeEee
Q psy14630        141 QLVDSIAKTRDAGCRPYMAPERIDPLRARGYPSFKTKLGFKFN  183 (187)
Q Consensus       141 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi~  183 (187)
                      .....  .....+++.|+|||.+.+  ...++.++|+||+|+.
T Consensus       167 ~~~~~--~~~~~~~~~y~aPE~~~~--~~~~~~~~Di~slG~l  205 (343)
T cd07880         167 QTDSE--MTGYVVTRWYRAPEVILN--WMHYTQTVDIWSVGCI  205 (343)
T ss_pred             ccccC--ccccccCCcccCHHHHhC--CCCCCcHHHHHHHHHH
Confidence            65432  223356888999999873  2347789999999984

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12

>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

Probab=99.94  E-value=2.4e-27  Score=179.53  Aligned_cols=156  Identities=33%  Similarity=0.563  Sum_probs=124.5

Q ss_pred             cccccccccccccCceEEEEEEEcCCCcEEEEEEccCccChHHHHHHHHHHHHHHhcCCCCchhhhhhhHHH--------
Q psy14630         23 SEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQFYGALFK--------   94 (187)
Q Consensus        23 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~--------   94 (187)
                      .+.|+..+.||+|+||.||+|.+..+++.||+|.++...... ..+.+..+..+++.+.||||+++++.+..        
T Consensus         3 ~~~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   81 (277)
T cd06642           3 EELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAED-EIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIM   81 (277)
T ss_pred             HHHHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchH-HHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEE
Confidence            356788899999999999999998889999999886433332 33445555567777899999998864321        


Q ss_pred             -----------------------HHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEecccccccccccc-ccC
Q psy14630         95 -----------------------EVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIA-KTR  150 (187)
Q Consensus        95 -----------------------~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg~a~~~~~~~~-~~~  150 (187)
                                             .++.+++.++.|||+. +++|+||+|+||+++.++.++++|||++..+..... ...
T Consensus        82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~-~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~~~  160 (277)
T cd06642          82 EYLGGGSALDLLKPGPLEETYIATILREILKGLDYLHSE-RKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNT  160 (277)
T ss_pred             EccCCCcHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcC-CeeccCCChheEEEeCCCCEEEccccccccccCcchhhhc
Confidence                                   1567899999999997 999999999999999999999999999987654321 222


Q ss_pred             CCCCcCccCccccCCCccCCCCCCcceeeeEee
Q psy14630        151 DAGCRPYMAPERIDPLRARGYPSFKTKLGFKFN  183 (187)
Q Consensus       151 ~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi~  183 (187)
                      ..++..|+|||.+.   ...++.++|+||||+.
T Consensus       161 ~~~~~~y~aPE~~~---~~~~~~~~Dv~slG~i  190 (277)
T cd06642         161 FVGTPFWMAPEVIK---QSAYDFKADIWSLGIT  190 (277)
T ss_pred             ccCcccccCHHHhC---cCCCchhhhHHHHHHH
Confidence            35788899999988   5568899999999984

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25

>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

Probab=99.94  E-value=1.8e-27  Score=181.96  Aligned_cols=159  Identities=21%  Similarity=0.325  Sum_probs=119.7

Q ss_pred             cCCcccccccccccccCceEEEEEEEcC----------------CCcEEEEEEccCccChHHHHHHHHHHHHHHhcCCCC
Q psy14630         20 DFTSEDLQDLGEIGRGGFGTVNKMIHRS----------------SDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECP   83 (187)
Q Consensus        20 ~~~~~~~~~~~~lg~G~fg~V~~~~~~~----------------~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~h~   83 (187)
                      +++.++|++.+.||+|+||.||++.+..                +...+|+|.+....... ....+..+..+++.++|+
T Consensus         1 ~~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~-~~~~~~~E~~~l~~l~~~   79 (296)
T cd05095           1 EFPRKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKN-ARNDFLKEIKIMSRLKDP   79 (296)
T ss_pred             CCChhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHH-HHHHHHHHHHHHHhCCCC
Confidence            3567889999999999999999985432                34568999986543322 233444555567778999


Q ss_pred             chhhhhhhH-------------------------------------------HHHHHHHHHHHHHHHHhcCCCeeecCCC
Q psy14630         84 YIVQFYGAL-------------------------------------------FKEVTVATVKALNYLKEELKIIHRDVKP  120 (187)
Q Consensus        84 ~iv~~~~~~-------------------------------------------~~~~~~~~~~~l~~lh~~~~i~Hrdlk~  120 (187)
                      ||+++++.+                                           ...++.+++.|++|||+. +++|+||||
T Consensus        80 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~-~i~H~dlkp  158 (296)
T cd05095          80 NIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSL-NFVHRDLAT  158 (296)
T ss_pred             CcceEEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHC-CeecccCCh
Confidence            998775321                                           122567889999999997 999999999


Q ss_pred             CCeEEcCCCCEEEEecccccccccccc---ccCCCCCcCccCccccCCCccCCCCCCcceeeeEee
Q psy14630        121 SNILLDRRGAIKLCDFGISGQLVDSIA---KTRDAGCRPYMAPERIDPLRARGYPSFKTKLGFKFN  183 (187)
Q Consensus       121 ~nili~~~~~~ki~dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi~  183 (187)
                      +||+++.++.++++|||+++.+.....   .....++..|+|||...   ...++.++|+||||+.
T Consensus       159 ~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~---~~~~~~~~DiwSlG~~  221 (296)
T cd05095         159 RNCLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESIL---LGKFTTASDVWAFGVT  221 (296)
T ss_pred             heEEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHh---cCCccchhhhhHHHHH
Confidence            999999999999999999887543221   11223456799999877   4568899999999983

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit

>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

Probab=99.94  E-value=1.9e-27  Score=184.96  Aligned_cols=158  Identities=28%  Similarity=0.408  Sum_probs=122.9

Q ss_pred             cccccccccccccCceEEEEEEEcCCCcEEEEEEccCccChHHHHHHHHHHHHHHhcC-CCCchhhhhhhHH--------
Q psy14630         23 SEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSN-ECPYIVQFYGALF--------   93 (187)
Q Consensus        23 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~-~h~~iv~~~~~~~--------   93 (187)
                      .++|++.+.||+|+||.||+|.+..+++.+|+|.+............+..+..++..+ +||||+++++.+.        
T Consensus         6 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~~   85 (337)
T cd07852           6 LRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDIY   85 (337)
T ss_pred             hhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceEE
Confidence            4789999999999999999999988899999998754322222223334455566677 9999998876421        


Q ss_pred             ------------------------HHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEeccccccccccc---
Q psy14630         94 ------------------------KEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSI---  146 (187)
Q Consensus        94 ------------------------~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg~a~~~~~~~---  146 (187)
                                              ..++.|++.||.|||+. +++||||+|+||+++.++.++++|||+++......   
T Consensus        86 lv~e~~~~~L~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~-~i~H~dl~p~nill~~~~~~kl~d~g~~~~~~~~~~~~  164 (337)
T cd07852          86 LVFEYMETDLHAVIRANILEDVHKRYIMYQLLKALKYIHSG-NVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENP  164 (337)
T ss_pred             EEecccccCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC-CeecCCCCHHHEEEcCCCcEEEeeccchhccccccccc
Confidence                                    11567899999999997 99999999999999999999999999998764322   


Q ss_pred             ---cccCCCCCcCccCccccCCCccCCCCCCcceeeeEee
Q psy14630        147 ---AKTRDAGCRPYMAPERIDPLRARGYPSFKTKLGFKFN  183 (187)
Q Consensus       147 ---~~~~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi~  183 (187)
                         ......++..|+|||.+.+  ...++.++|+||||++
T Consensus       165 ~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~sDi~slG~~  202 (337)
T cd07852         165 ENPVLTDYVATRWYRAPEILLG--STRYTKGVDMWSVGCI  202 (337)
T ss_pred             cCcchhcccccccccCceeeec--cccccccchHHHHHHH
Confidence               1123357888999999863  3457789999999984

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul

>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

Probab=99.94  E-value=1.2e-27  Score=183.16  Aligned_cols=156  Identities=27%  Similarity=0.495  Sum_probs=124.3

Q ss_pred             CcccccccccccccCceEEEEEEEcCCCcEEEEEEccCccChHHHHHHHHHHHHHHhcCCCCchhhhhhhHH--------
Q psy14630         22 TSEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQFYGALF--------   93 (187)
Q Consensus        22 ~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~--------   93 (187)
                      ...+|++.+.||+|+||.||++.+..+++.||+|.+......  ..+.+..+..+++.++|+|++++++.+.        
T Consensus        17 ~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv   94 (297)
T cd06656          17 PKKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQP--KKELIINEILVMRENKNPNIVNYLDSYLVGDELWVV   94 (297)
T ss_pred             hhhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccc--hHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEe
Confidence            347899999999999999999999889999999998643222  2334455556777889999998865321        


Q ss_pred             -----------------------HHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEecccccccccccc-cc
Q psy14630         94 -----------------------KEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIA-KT  149 (187)
Q Consensus        94 -----------------------~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg~a~~~~~~~~-~~  149 (187)
                                             ..+..+++.++.|||+. +++||||||+||+++.++.++++|||++........ ..
T Consensus        95 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~-~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~  173 (297)
T cd06656          95 MEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALDFLHSN-QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRS  173 (297)
T ss_pred             ecccCCCCHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHC-CcccCCCCHHHEEECCCCCEEECcCccceEccCCccCcC
Confidence                                   12556889999999997 999999999999999999999999999877543322 22


Q ss_pred             CCCCCcCccCccccCCCccCCCCCCcceeeeEee
Q psy14630        150 RDAGCRPYMAPERIDPLRARGYPSFKTKLGFKFN  183 (187)
Q Consensus       150 ~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi~  183 (187)
                      ...+++.|+|||.+.   ...++.++|+||+|+.
T Consensus       174 ~~~~~~~y~aPE~~~---~~~~~~~~Di~slGvi  204 (297)
T cd06656         174 TMVGTPYWMAPEVVT---RKAYGPKVDIWSLGIM  204 (297)
T ss_pred             cccCCccccCHHHHc---CCCCCcHHHHHHHHHH
Confidence            346788899999988   5667899999999983

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

Probab=99.94  E-value=2e-27  Score=181.56  Aligned_cols=153  Identities=29%  Similarity=0.499  Sum_probs=121.2

Q ss_pred             ccccccccccccCceEEEEEEEcCCCcEEEEEEccCccChHHHHHHHHHHHHHHhcCCCCchhhhhhhHH----------
Q psy14630         24 EDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQFYGALF----------   93 (187)
Q Consensus        24 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~----------   93 (187)
                      +.|.....||+|+||.||++.+..++..||||.+...  .....+.+.++...++.++|+|++++++.+.          
T Consensus        22 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e   99 (292)
T cd06658          22 EYLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLR--KQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVME   99 (292)
T ss_pred             HHHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecc--hHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEe
Confidence            5566678899999999999999889999999987532  2223344555556777789999999875421          


Q ss_pred             ---------------------HHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEeccccccccccc-cccCC
Q psy14630         94 ---------------------KEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSI-AKTRD  151 (187)
Q Consensus        94 ---------------------~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg~a~~~~~~~-~~~~~  151 (187)
                                           ..+..+++.++.|||+. +++||||||+|++++.++.++|+|||++....... .....
T Consensus       100 ~~~~~~L~~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~-~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~~~~~~  178 (292)
T cd06658         100 FLEGGALTDIVTHTRMNEEQIATVCLSVLRALSYLHNQ-GVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKSL  178 (292)
T ss_pred             CCCCCcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC-CEeecCCCHHHEEEcCCCCEEEccCcchhhcccccccCcee
Confidence                                 12567899999999997 99999999999999999999999999987653322 12233


Q ss_pred             CCCcCccCccccCCCccCCCCCCcceeeeEe
Q psy14630        152 AGCRPYMAPERIDPLRARGYPSFKTKLGFKF  182 (187)
Q Consensus       152 ~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi  182 (187)
                      .++..|+|||.+.   ...++.++|+||+|+
T Consensus       179 ~~~~~y~aPE~~~---~~~~~~~~Dv~slGv  206 (292)
T cd06658         179 VGTPYWMAPEVIS---RLPYGTEVDIWSLGI  206 (292)
T ss_pred             ecCccccCHHHHc---cCCCCchhhHHHHHH
Confidence            5788999999987   566889999999998

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express

>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

Probab=99.94  E-value=9.2e-28  Score=180.14  Aligned_cols=157  Identities=22%  Similarity=0.337  Sum_probs=121.2

Q ss_pred             ccCCcccccccccccccCceEEEEEEEcCCCcEEEEEEccCccChHHHHHHHHHHHHHHhcCCCCchhhhhhhH------
Q psy14630         19 YDFTSEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQFYGAL------   92 (187)
Q Consensus        19 ~~~~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~------   92 (187)
                      |++..++|++.+.||+|+||.||+|... .+..+|+|.+......   .+.+.++..+++.++|+|++++++.+      
T Consensus         1 ~~~~~~~~~~~~~ig~g~~~~v~~~~~~-~~~~~~~k~~~~~~~~---~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~   76 (260)
T cd05070           1 WEIPRESLQLIKKLGNGQFGEVWMGTWN-GNTKVAVKTLKPGTMS---PESFLEEAQIMKKLRHDKLVQLYAVVSEEPIY   76 (260)
T ss_pred             CCCchHHhhhhheeccccCceEEEEEec-CCceeEEEEecCCCCC---HHHHHHHHHHHHhcCCCceEEEEeEECCCCcE
Confidence            5677889999999999999999999875 5567999998643222   22344555677778999998776321      


Q ss_pred             ---------------------------HHHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEecccccccccc
Q psy14630         93 ---------------------------FKEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDS  145 (187)
Q Consensus        93 ---------------------------~~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg~a~~~~~~  145 (187)
                                                 ...+..+++.++.|||+. +++||||+|+|++++.++.++++|||++......
T Consensus        77 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~-~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~  155 (260)
T cd05070          77 IVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERM-NYIHRDLRSANILVGDGLVCKIADFGLARLIEDN  155 (260)
T ss_pred             EEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHC-CcccCCCccceEEEeCCceEEeCCceeeeeccCc
Confidence                                       112567899999999997 9999999999999999999999999999876443


Q ss_pred             cccc--CCCCCcCccCccccCCCccCCCCCCcceeeeEee
Q psy14630        146 IAKT--RDAGCRPYMAPERIDPLRARGYPSFKTKLGFKFN  183 (187)
Q Consensus       146 ~~~~--~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi~  183 (187)
                      ....  ...++..|+|||.+.   ...++.++|+||||+.
T Consensus       156 ~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~Di~slG~~  192 (260)
T cd05070         156 EYTARQGAKFPIKWTAPEAAL---YGRFTIKSDVWSFGIL  192 (260)
T ss_pred             ccccccCCCCCccccChHHHh---cCCCcchhhhHHHHHH
Confidence            2211  123456799999987   5568899999999983

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r

>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

Probab=99.94  E-value=2.1e-27  Score=178.87  Aligned_cols=156  Identities=24%  Similarity=0.335  Sum_probs=119.9

Q ss_pred             CcccccccccccccCceEEEEEEEcCCC---cEEEEEEccCccChHHHHHHHHHHHHHHhcCCCCchhhhhhhHH-----
Q psy14630         22 TSEDLQDLGEIGRGGFGTVNKMIHRSSD---TVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQFYGALF-----   93 (187)
Q Consensus        22 ~~~~~~~~~~lg~G~fg~V~~~~~~~~~---~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~-----   93 (187)
                      ..++|++.+.||+|+||.||+|.+..++   ..+|+|.++...... ..+.+..+..+++.++||||+++++.+.     
T Consensus         2 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   80 (267)
T cd05066           2 DASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEK-QRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPV   80 (267)
T ss_pred             CHHHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHH-HHHHHHHHHHHHHhCCCCCcceEEEEEecCCcc
Confidence            4578999999999999999999875443   369999986543333 3344455556677789999998864321     


Q ss_pred             ----------------------------HHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEecccccccccc
Q psy14630         94 ----------------------------KEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDS  145 (187)
Q Consensus        94 ----------------------------~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg~a~~~~~~  145 (187)
                                                  ..+..+++.++.|||+. +++||||||+|++++.++.++++|||+++.....
T Consensus        81 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~-~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~~  159 (267)
T cd05066          81 MIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDM-GYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDD  159 (267)
T ss_pred             EEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC-CEeehhhchhcEEECCCCeEEeCCCCcccccccc
Confidence                                        11557889999999997 9999999999999999999999999999876543


Q ss_pred             ccc----cCCCCCcCccCccccCCCccCCCCCCcceeeeEe
Q psy14630        146 IAK----TRDAGCRPYMAPERIDPLRARGYPSFKTKLGFKF  182 (187)
Q Consensus       146 ~~~----~~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi  182 (187)
                      ...    ....++..|+|||.+.   ...++.++|+||||+
T Consensus       160 ~~~~~~~~~~~~~~~y~~pe~~~---~~~~~~~~Dv~slG~  197 (267)
T cd05066         160 PEAAYTTRGGKIPIRWTAPEAIA---YRKFTSASDVWSYGI  197 (267)
T ss_pred             cceeeecCCCccceeecCHhHhc---cCccCchhhhHHHHH
Confidence            211    1112345799999998   566889999999998

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul

>KOG0608|consensus

Probab=99.94  E-value=3.2e-28  Score=194.45  Aligned_cols=159  Identities=25%  Similarity=0.399  Sum_probs=125.0

Q ss_pred             CCcccccccccccccCceEEEEEEEcCCCcEEEEEEccCc-cChHHHHHHHHHHHHHHhcCCCCchhhhhhhHHHH----
Q psy14630         21 FTSEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRST-VDEKDQRQLLMDLDVVMKSNECPYIVQFYGALFKE----   95 (187)
Q Consensus        21 ~~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~----   95 (187)
                      ++..-|..++.||-|+||+|.++....|...+|+|.+++. +....+......+..++...+++-||+||-+|.++    
T Consensus       626 MdKSmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLY  705 (1034)
T KOG0608|consen  626 MDKSMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLY  705 (1034)
T ss_pred             ccccceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceE
Confidence            4555677789999999999999998899999999998532 23333444555566667777888899887544332    


Q ss_pred             ----------------------------HHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEecccccccccc--
Q psy14630         96 ----------------------------VTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDS--  145 (187)
Q Consensus        96 ----------------------------~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg~a~~~~~~--  145 (187)
                                                  .+..+..|+++.|.. |+|||||||+|||||.+|++|+.|||||..+...  
T Consensus       706 FVMdYIPGGDmMSLLIrmgIFeE~LARFYIAEltcAiesVHkm-GFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTHd  784 (1034)
T KOG0608|consen  706 FVMDYIPGGDMMSLLIRMGIFEEDLARFYIAELTCAIESVHKM-GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHD  784 (1034)
T ss_pred             EEEeccCCccHHHHHHHhccCHHHHHHHHHHHHHHHHHHHHhc-cceecccCccceEEccCCceeeeeccccccceeccc
Confidence                                        345667789999986 9999999999999999999999999999875310  


Q ss_pred             -----------------------------------------ccccCCCCCcCccCccccCCCccCCCCCCcceeeeEee
Q psy14630        146 -----------------------------------------IAKTRDAGCRPYMAPERIDPLRARGYPSFKTKLGFKFN  183 (187)
Q Consensus       146 -----------------------------------------~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi~  183 (187)
                                                               ......+||+.|+|||++.   ..+|+.-||+||.||+
T Consensus       785 skYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~---r~g~~q~cdwws~gvi  860 (1034)
T KOG0608|consen  785 SKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLA---RTGYTQLCDWWSVGVI  860 (1034)
T ss_pred             cccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhc---ccCccccchhhHhhHH
Confidence                                                     0001346999999999999   7889999999999994

>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

Probab=99.94  E-value=1.2e-27  Score=179.22  Aligned_cols=152  Identities=23%  Similarity=0.403  Sum_probs=119.7

Q ss_pred             ccCCcccccccccccccCceEEEEEEEcCCCcEEEEEEccCccChHHHHHHHHHHHHHHhcCCCCchhhhhhhHH-----
Q psy14630         19 YDFTSEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQFYGALF-----   93 (187)
Q Consensus        19 ~~~~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~-----   93 (187)
                      |.+...+|++.+.||+|+||.||++...  +..+|+|.++...    ..+.+..+..+++.+.|+|++++++.+.     
T Consensus         1 ~~~~~~~~~~~~~lg~g~~~~v~~~~~~--~~~~~~k~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   74 (256)
T cd05082           1 WALNMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGG   74 (256)
T ss_pred             CCccHHhCeeeeeecccCCCeEEEEEEc--CCcEEEEEeCCCc----hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCc
Confidence            4567789999999999999999999764  6789999876422    2233455566777889999998764211     


Q ss_pred             ------------------------------HHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEecccccccc
Q psy14630         94 ------------------------------KEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLV  143 (187)
Q Consensus        94 ------------------------------~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg~a~~~~  143 (187)
                                                    ..+..+++.+++|||+. +++||||||+||+++.++.+|++|||+++...
T Consensus        75 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~-~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~  153 (256)
T cd05082          75 LYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEAN-NFVHRDLAARNVLVSEDNVAKVSDFGLTKEAS  153 (256)
T ss_pred             eEEEEECCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC-CEeccccchheEEEcCCCcEEecCCccceecc
Confidence                                          12566889999999997 99999999999999999999999999988654


Q ss_pred             ccccccCCCCCcCccCccccCCCccCCCCCCcceeeeEe
Q psy14630        144 DSIAKTRDAGCRPYMAPERIDPLRARGYPSFKTKLGFKF  182 (187)
Q Consensus       144 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi  182 (187)
                      ...  .....+..|+|||.+.   ...++.++|+||+|+
T Consensus       154 ~~~--~~~~~~~~y~aPE~~~---~~~~~~~~Dv~slG~  187 (256)
T cd05082         154 STQ--DTGKLPVKWTAPEALR---EKKFSTKSDVWSFGI  187 (256)
T ss_pred             ccC--CCCccceeecCHHHHc---cCCCCchhhhHHHHH
Confidence            322  2223456799999987   566889999999998

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re

>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

Probab=99.94  E-value=1.6e-27  Score=180.59  Aligned_cols=160  Identities=29%  Similarity=0.446  Sum_probs=123.7

Q ss_pred             CcccccccccccccCceEEEEEEEcCCCcEEEEEEccCccChHHHHHHHHHHHHHHhcCCCCchhhhhhhHH--------
Q psy14630         22 TSEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQFYGALF--------   93 (187)
Q Consensus        22 ~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~--------   93 (187)
                      +.++|++.+.||.|+||.||++.+..++..+|+|.+...  .....+.+..+..+++.++|+|++++++.+.        
T Consensus         3 ~~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   80 (280)
T cd06611           3 PNDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIE--SEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWIL   80 (280)
T ss_pred             chhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeC--CHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEE
Confidence            457899999999999999999999888999999998642  2223334444555677788999998865321        


Q ss_pred             -------------------------HHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEecccccccccc-cc
Q psy14630         94 -------------------------KEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDS-IA  147 (187)
Q Consensus        94 -------------------------~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg~a~~~~~~-~~  147 (187)
                                               ..++.|++.++.|||+. +++|+|++|+|++++.++.++|+|||++...... ..
T Consensus        81 ~e~~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~-~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~  159 (280)
T cd06611          81 IEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSH-KVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQK  159 (280)
T ss_pred             eeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC-CcccCCCChhhEEECCCCCEEEccCccchhhcccccc
Confidence                                     12667899999999998 9999999999999999999999999988765432 22


Q ss_pred             ccCCCCCcCccCccccCCC--ccCCCCCCcceeeeEeee
Q psy14630        148 KTRDAGCRPYMAPERIDPL--RARGYPSFKTKLGFKFNY  184 (187)
Q Consensus       148 ~~~~~~t~~y~aPE~~~~~--~~~~~~~~~D~ws~gi~~  184 (187)
                      .....+++.|+|||.+...  ....++.++|+||+|+++
T Consensus       160 ~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il  198 (280)
T cd06611         160 RDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITL  198 (280)
T ss_pred             cceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHH
Confidence            2234578899999997522  134477899999999843

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti

>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

Probab=99.94  E-value=1.8e-27  Score=182.22  Aligned_cols=155  Identities=28%  Similarity=0.444  Sum_probs=122.1

Q ss_pred             cccccccccccccCceEEEEEEEcCCCcEEEEEEccCccChHHHHHHHHHHHHHHhcCCCCchhhhhhhHH---------
Q psy14630         23 SEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQFYGALF---------   93 (187)
Q Consensus        23 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~---------   93 (187)
                      +..|.....||+|+||.||++.+..+++.||+|.+.....  ...+.+.++...+..+.|||++++++.+.         
T Consensus        20 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~--~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~   97 (297)
T cd06659          20 RSLLENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQ--QRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLM   97 (297)
T ss_pred             hhhHHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEeccc--chHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEE
Confidence            3556667789999999999999988999999999854222  12334455556677789999999876431         


Q ss_pred             ----------------------HHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEeccccccccccc-cccC
Q psy14630         94 ----------------------KEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSI-AKTR  150 (187)
Q Consensus        94 ----------------------~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg~a~~~~~~~-~~~~  150 (187)
                                            ..+..|++.|+.|||+. +++|+||+|+||+++.++.++|+|||++....... ....
T Consensus        98 e~~~~~~L~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~-~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~~~~~  176 (297)
T cd06659          98 EFLQGGALTDIVSQTRLNEEQIATVCESVLQALCYLHSQ-GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKS  176 (297)
T ss_pred             ecCCCCCHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHhC-CeecCCCCHHHeEEccCCcEEEeechhHhhcccccccccc
Confidence                                  12667899999999997 99999999999999999999999999987654322 2223


Q ss_pred             CCCCcCccCccccCCCccCCCCCCcceeeeEee
Q psy14630        151 DAGCRPYMAPERIDPLRARGYPSFKTKLGFKFN  183 (187)
Q Consensus       151 ~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi~  183 (187)
                      ..++..|+|||.+.   ...++.++|+||||+.
T Consensus       177 ~~~~~~y~aPE~~~---~~~~~~~~Dv~slG~i  206 (297)
T cd06659         177 LVGTPYWMAPEVIS---RTPYGTEVDIWSLGIM  206 (297)
T ss_pred             eecCccccCHHHHc---cCCCCchhhHHHHHHH
Confidence            46788999999998   5568899999999983

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i

>KOG0596|consensus

Probab=99.94  E-value=1.7e-27  Score=187.40  Aligned_cols=163  Identities=24%  Similarity=0.398  Sum_probs=128.1

Q ss_pred             ccccCCcccccccccccccCceEEEEEEEcCCCcEEEEEEcc-CccChHHHHHHHHHHHHHHhcCCCCchhhhhh-----
Q psy14630         17 TVYDFTSEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIR-STVDEKDQRQLLMDLDVVMKSNECPYIVQFYG-----   90 (187)
Q Consensus        17 ~~~~~~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~-~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~-----   90 (187)
                      ..+.+....|+++++||+||.+.||++..... +.+|+|.+. ...+.+.......|+..+.+.-+|-+|+++++     
T Consensus       354 ~~i~Vkg~~Yeilk~iG~GGSSkV~kV~~s~~-~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d  432 (677)
T KOG0596|consen  354 EIIKVKGREYEILKQIGSGGSSKVFKVLNSDK-QIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTD  432 (677)
T ss_pred             eeEEECcchhhHHHhhcCCCcceeeeeecCCC-cchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccC
Confidence            34456777899999999999999999987544 455666553 34455555666667776777778999999874     


Q ss_pred             ---------------------------hHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEecccccccc
Q psy14630         91 ---------------------------ALFKEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLV  143 (187)
Q Consensus        91 ---------------------------~~~~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg~a~~~~  143 (187)
                                                 ++...+..|++.++.++|+. ||||.||||.|+++. +|.+||+|||.|..+.
T Consensus       433 ~~lYmvmE~Gd~DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH~~-gIVHSDLKPANFLlV-kG~LKLIDFGIA~aI~  510 (677)
T KOG0596|consen  433 GYLYMVMECGDIDLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIHQH-GIVHSDLKPANFLLV-KGRLKLIDFGIANAIQ  510 (677)
T ss_pred             ceEEEEeecccccHHHHHHhccCCCchHHHHHHHHHHHHHHHHHHHh-ceeecCCCcccEEEE-eeeEEeeeechhcccC
Confidence                                       34445778999999999998 999999999999997 5899999999999876


Q ss_pred             c---cccccCCCCCcCccCccccCCCccC--------CCCCCcceeeeEe
Q psy14630        144 D---SIAKTRDAGCRPYMAPERIDPLRAR--------GYPSFKTKLGFKF  182 (187)
Q Consensus       144 ~---~~~~~~~~~t~~y~aPE~~~~~~~~--------~~~~~~D~ws~gi  182 (187)
                      .   +.....++||+.||+||.+..+-..        -..+++||||+|+
T Consensus       511 ~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGC  560 (677)
T KOG0596|consen  511 PDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGC  560 (677)
T ss_pred             ccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhh
Confidence            4   3445577999999999999755222        1558899999998

>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

Probab=99.94  E-value=2.6e-27  Score=180.93  Aligned_cols=156  Identities=24%  Similarity=0.355  Sum_probs=121.7

Q ss_pred             cccccccccccCceEEEEEEEcCCCcEEEEEEccCccCh---HHHHHHHHHHHHHHhcCCCCchhhhhhhHH--------
Q psy14630         25 DLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDE---KDQRQLLMDLDVVMKSNECPYIVQFYGALF--------   93 (187)
Q Consensus        25 ~~~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~--------   93 (187)
                      +|++.+.||+|+||.||+|.+..+++.||+|.++.....   ......+..+..+++.++|+||+++++.+.        
T Consensus         1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv   80 (298)
T cd07841           1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV   80 (298)
T ss_pred             CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence            477888999999999999999888999999998654322   223333444555677788999998875321        


Q ss_pred             ------------------------HHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEeccccccccccc-cc
Q psy14630         94 ------------------------KEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSI-AK  148 (187)
Q Consensus        94 ------------------------~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg~a~~~~~~~-~~  148 (187)
                                              ..+..|++.||.|||+. +++|+||+|+||+++.++.++|+|||+++...... ..
T Consensus        81 ~e~~~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~~-~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~~~  159 (298)
T cd07841          81 FEFMETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSN-WILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKM  159 (298)
T ss_pred             EcccCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhC-CeeecCCChhhEEEcCCCCEEEccceeeeeccCCCccc
Confidence                                    12667899999999997 99999999999999999999999999998765432 22


Q ss_pred             cCCCCCcCccCccccCCCccCCCCCCcceeeeEee
Q psy14630        149 TRDAGCRPYMAPERIDPLRARGYPSFKTKLGFKFN  183 (187)
Q Consensus       149 ~~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi~  183 (187)
                      ....+++.|+|||.+.+  ...++.++|+||||+.
T Consensus       160 ~~~~~~~~y~aPE~~~~--~~~~~~~~Dv~slG~i  192 (298)
T cd07841         160 THQVVTRWYRAPELLFG--ARHYGVGVDMWSVGCI  192 (298)
T ss_pred             cccccceeeeCHHHHhC--CCCCCcHHHHHHHHHH
Confidence            22346778999999863  3457889999999983

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is

>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

Probab=99.94  E-value=1.9e-27  Score=181.97  Aligned_cols=161  Identities=23%  Similarity=0.330  Sum_probs=123.4

Q ss_pred             CCcccccccccccccCceEEEEEEEcCCCcEEEEEEccCccChHHHHHHHHHHHHHHhcCCCCchhhhhhhHH-------
Q psy14630         21 FTSEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQFYGALF-------   93 (187)
Q Consensus        21 ~~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~-------   93 (187)
                      ...++|++.+.||+|+||.||+|.+..+++.||+|.++...........+..+..+++.++|||++++++.+.       
T Consensus         4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~   83 (302)
T cd07864           4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALD   83 (302)
T ss_pred             hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhh
Confidence            3457899999999999999999999989999999998643222222233444555677789999998754321       


Q ss_pred             -----------------------------------HHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEeccc
Q psy14630         94 -----------------------------------KEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGI  138 (187)
Q Consensus        94 -----------------------------------~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg~  138 (187)
                                                         ..+..|++.||.|||+. +++|+||+|+||+++.++.+||+|||+
T Consensus        84 ~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~-~i~H~dl~p~nili~~~~~~kl~dfg~  162 (302)
T cd07864          84 FKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKK-NFLHRDIKCSNILLNNKGQIKLADFGL  162 (302)
T ss_pred             ccccCCcEEEEEcccCccHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC-CeecCCCCHHHEEECCCCcEEeCcccc
Confidence                                               11567899999999998 999999999999999999999999999


Q ss_pred             ccccccccc--ccCCCCCcCccCccccCCCccCCCCCCcceeeeEeee
Q psy14630        139 SGQLVDSIA--KTRDAGCRPYMAPERIDPLRARGYPSFKTKLGFKFNY  184 (187)
Q Consensus       139 a~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi~~  184 (187)
                      +........  .....++..|+|||.+.+  ...++.++|+||+|+.+
T Consensus       163 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~--~~~~~~~~Di~slG~~~  208 (302)
T cd07864         163 ARLYNSEESRPYTNKVITLWYRPPELLLG--EERYGPAIDVWSCGCIL  208 (302)
T ss_pred             cccccCCcccccccceeccCccChHHhcC--CCCCCchhHHHHHHHHH
Confidence            987653321  122245778999998863  33467899999999843

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely

>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

Probab=99.94  E-value=3.6e-27  Score=177.03  Aligned_cols=156  Identities=21%  Similarity=0.321  Sum_probs=120.9

Q ss_pred             ccCCcccccccccccccCceEEEEEEEcCCCcEEEEEEccCccChHHHHHHHHHHHHHHhcCCCCchhhhhhhHH-----
Q psy14630         19 YDFTSEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQFYGALF-----   93 (187)
Q Consensus        19 ~~~~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~-----   93 (187)
                      |++..++|++.+.||+|+||.||++... .+..+|+|.+...   ....+.+.++..+++.++|+|++++++.+.     
T Consensus         1 ~~~~~~~~~~~~~lg~g~~~~vy~~~~~-~~~~~~iK~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   76 (260)
T cd05073           1 WEIPRESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPG---SMSVEAFLAEANVMKTLQHDKLVKLHAVVTKEPIY   76 (260)
T ss_pred             CcccccceeEEeEecCccceEEEEEEec-CCccEEEEecCCC---hhHHHHHHHHHHHHHhcCCCCcceEEEEEcCCCeE
Confidence            5678899999999999999999999864 4556899987642   222334455566777889999998754210     


Q ss_pred             ----------------------------HHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEecccccccccc
Q psy14630         94 ----------------------------KEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDS  145 (187)
Q Consensus        94 ----------------------------~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg~a~~~~~~  145 (187)
                                                  ..+..+++.++.|||+. +++|+||+|+|++++..+.++++|||++......
T Consensus        77 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~-~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~  155 (260)
T cd05073          77 IITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQR-NYIHRDLRAANILVSASLVCKIADFGLARVIEDN  155 (260)
T ss_pred             EEEEeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhC-CccccccCcceEEEcCCCcEEECCCcceeeccCC
Confidence                                        11557899999999997 9999999999999999999999999998776432


Q ss_pred             ccc--cCCCCCcCccCccccCCCccCCCCCCcceeeeEe
Q psy14630        146 IAK--TRDAGCRPYMAPERIDPLRARGYPSFKTKLGFKF  182 (187)
Q Consensus       146 ~~~--~~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi  182 (187)
                      ...  ....++..|+|||.+.   ...++.++|+||||+
T Consensus       156 ~~~~~~~~~~~~~y~~PE~~~---~~~~~~~~Di~slG~  191 (260)
T cd05073         156 EYTAREGAKFPIKWTAPEAIN---FGSFTIKSDVWSFGI  191 (260)
T ss_pred             CcccccCCcccccccCHhHhc---cCCcCccccchHHHH
Confidence            211  1123456799999987   556888999999998

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa

>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

Probab=99.94  E-value=1.9e-27  Score=178.61  Aligned_cols=154  Identities=48%  Similarity=0.821  Sum_probs=122.8

Q ss_pred             ccccccccccccCceEEEEEEEcCCCcEEEEEEccCccChHHHHHHHHHHHHHHhcCCCCchhhhhhhHH----------
Q psy14630         24 EDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQFYGALF----------   93 (187)
Q Consensus        24 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~----------   93 (187)
                      ++|+..+.||+|+||.||++.+..+++.+|+|.+........ .+.+..+...++.+.||||+++++.+.          
T Consensus         1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~-~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e   79 (265)
T cd06605           1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAI-QKQILRELDILHKCNSPYIVGFYGAFYNNGDISICME   79 (265)
T ss_pred             CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHH-HHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEE
Confidence            468888999999999999999999999999999875433333 333444455566678999998864321          


Q ss_pred             -----------------------HHHHHHHHHHHHHHHh-cCCCeeecCCCCCeEEcCCCCEEEEecccccccccccccc
Q psy14630         94 -----------------------KEVTVATVKALNYLKE-ELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKT  149 (187)
Q Consensus        94 -----------------------~~~~~~~~~~l~~lh~-~~~i~Hrdlk~~nili~~~~~~ki~dfg~a~~~~~~~~~~  149 (187)
                                             ..+..+++.++.|||+ . +++|+||+|+||+++.++.++++|||.+..........
T Consensus        80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~-~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~~  158 (265)
T cd06605          80 YMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKH-KIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAKT  158 (265)
T ss_pred             ecCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcCCC-CeecCCCCHHHEEECCCCCEEEeecccchhhHHHHhhc
Confidence                                   1266788999999999 6 99999999999999999999999999987764432222


Q ss_pred             CCCCCcCccCccccCCCccCCCCCCcceeeeEee
Q psy14630        150 RDAGCRPYMAPERIDPLRARGYPSFKTKLGFKFN  183 (187)
Q Consensus       150 ~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi~  183 (187)
                       ..++..|+|||.+.   ...++.++|+||+|++
T Consensus       159 -~~~~~~y~~PE~~~---~~~~~~~~Dv~slG~~  188 (265)
T cd06605         159 -FVGTSSYMAPERIQ---GNDYSVKSDIWSLGLS  188 (265)
T ss_pred             -ccCChhccCHHHHc---CCCCCchhhHHHHHHH
Confidence             56788899999988   5578899999999983

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity

>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

Probab=99.94  E-value=5.4e-27  Score=177.92  Aligned_cols=159  Identities=26%  Similarity=0.422  Sum_probs=121.1

Q ss_pred             CcccccccccccccCceEEEEEEEcCCCcEEEEEEccCccChHHHHHHHHHHHHHHhcCCCCchhhhhhhHHH-------
Q psy14630         22 TSEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQFYGALFK-------   94 (187)
Q Consensus        22 ~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~-------   94 (187)
                      +.+.|++.+.||+|+||.||+|.+..+++.+|+|.+...  .....+...+...+.+..+|+|++++++.+..       
T Consensus        14 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~--~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~   91 (282)
T cd06636          14 PAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVT--EDEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGHD   91 (282)
T ss_pred             hhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecC--hHHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccCCC
Confidence            557899999999999999999999999999999987542  22223333344444444579999987654321       


Q ss_pred             ---------------------------------HHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEecccccc
Q psy14630         95 ---------------------------------EVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQ  141 (187)
Q Consensus        95 ---------------------------------~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg~a~~  141 (187)
                                                       .+..|++.++.|||+. +++|+|++|+||+++.++.++|+|||++..
T Consensus        92 ~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~-~ivH~dl~~~nili~~~~~~~l~dfg~~~~  170 (282)
T cd06636          92 DQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAH-KVIHRDIKGQNVLLTENAEVKLVDFGVSAQ  170 (282)
T ss_pred             CEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHC-CcccCCCCHHHEEECCCCCEEEeeCcchhh
Confidence                                             1456899999999998 999999999999999999999999999876


Q ss_pred             cccc-ccccCCCCCcCccCccccCCCc--cCCCCCCcceeeeEee
Q psy14630        142 LVDS-IAKTRDAGCRPYMAPERIDPLR--ARGYPSFKTKLGFKFN  183 (187)
Q Consensus       142 ~~~~-~~~~~~~~t~~y~aPE~~~~~~--~~~~~~~~D~ws~gi~  183 (187)
                      .... .......+++.|+|||.+....  ...++.++|+||+|+.
T Consensus       171 ~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~  215 (282)
T cd06636         171 LDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGIT  215 (282)
T ss_pred             hhccccCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHH
Confidence            5432 1223346788999999976221  2357789999999984

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea

>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

Probab=99.94  E-value=2.2e-27  Score=179.78  Aligned_cols=158  Identities=25%  Similarity=0.376  Sum_probs=120.1

Q ss_pred             CCcccccccccccccCceEEEEEEEcC-----CCcEEEEEEccCccChHHHHHHHHHHHHHHhcCCCCchhhhhhhHH--
Q psy14630         21 FTSEDLQDLGEIGRGGFGTVNKMIHRS-----SDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQFYGALF--   93 (187)
Q Consensus        21 ~~~~~~~~~~~lg~G~fg~V~~~~~~~-----~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~--   93 (187)
                      +..++|++.+.||+|+||.||+|.+..     ++..||+|.+........... +..+..+++.++|+||+++++.+.  
T Consensus         3 ~~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~-~~~e~~~l~~l~~~~i~~~~~~~~~~   81 (277)
T cd05036           3 VPRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESD-FLMEALIMSKFNHQNIVRLIGVSFER   81 (277)
T ss_pred             CCHHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHH-HHHHHHHHHhCCCCCEeeEEEEEccC
Confidence            456789999999999999999999876     778899998865433333333 444555677789999998764211  


Q ss_pred             -------------------------------------HHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCC---CEEE
Q psy14630         94 -------------------------------------KEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRG---AIKL  133 (187)
Q Consensus        94 -------------------------------------~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~---~~ki  133 (187)
                                                           ..++.+++.+++|||+. +++|+||||+||+++..+   .+|+
T Consensus        82 ~~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~-~ivH~dlkp~nil~~~~~~~~~~kl  160 (277)
T cd05036          82 LPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEEN-HFIHRDIAARNCLLTCKGPGRVAKI  160 (277)
T ss_pred             CCcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHC-CEeecccchheEEEeccCCCcceEe
Confidence                                                 01567899999999997 999999999999998654   5999


Q ss_pred             Eeccccccccccccc---cCCCCCcCccCccccCCCccCCCCCCcceeeeEee
Q psy14630        134 CDFGISGQLVDSIAK---TRDAGCRPYMAPERIDPLRARGYPSFKTKLGFKFN  183 (187)
Q Consensus       134 ~dfg~a~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi~  183 (187)
                      +|||+++........   .....+..|+|||.+.   ...++.++|+||||++
T Consensus       161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~DiwslG~i  210 (277)
T cd05036         161 ADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFL---DGIFTSKTDVWSFGVL  210 (277)
T ss_pred             ccCccccccCCccceecCCCCCccHhhCCHHHHh---cCCcCchhHHHHHHHH
Confidence            999999876432211   1122345799999998   5668999999999983

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well

>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

Probab=99.94  E-value=2.2e-27  Score=180.09  Aligned_cols=156  Identities=23%  Similarity=0.325  Sum_probs=119.4

Q ss_pred             CCcccccccccccccCceEEEEEEE-----cCCCcEEEEEEccCccChHHHHHHHHHHHHHHhcCCCCchhhhhhhHH--
Q psy14630         21 FTSEDLQDLGEIGRGGFGTVNKMIH-----RSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQFYGALF--   93 (187)
Q Consensus        21 ~~~~~~~~~~~lg~G~fg~V~~~~~-----~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~--   93 (187)
                      +...++++.++||+|+||.||++..     ..++..+|+|.++...  ......+..+..+++.++|+||+++++.+.  
T Consensus         2 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~   79 (280)
T cd05092           2 IKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEAS--ESARQDFQREAELLTVLQHQHIVRFYGVCTEG   79 (280)
T ss_pred             CChHhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCC--HHHHHHHHHHHHHHhcCCCCCCceEEEEEecC
Confidence            3567889999999999999999964     2356688999876432  223344555666777889999998764210  


Q ss_pred             ---------------------------------------------HHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCC
Q psy14630         94 ---------------------------------------------KEVTVATVKALNYLKEELKIIHRDVKPSNILLDRR  128 (187)
Q Consensus        94 ---------------------------------------------~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~  128 (187)
                                                                   ..+..|++.|++|||+. +++||||||+||+++.+
T Consensus        80 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~-~i~H~dlkp~nil~~~~  158 (280)
T cd05092          80 RPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASL-HFVHRDLATRNCLVGQG  158 (280)
T ss_pred             CceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHC-CeecccccHhhEEEcCC
Confidence                                                         12456899999999997 99999999999999999


Q ss_pred             CCEEEEecccccccccccc---ccCCCCCcCccCccccCCCccCCCCCCcceeeeEe
Q psy14630        129 GAIKLCDFGISGQLVDSIA---KTRDAGCRPYMAPERIDPLRARGYPSFKTKLGFKF  182 (187)
Q Consensus       129 ~~~ki~dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi  182 (187)
                      +.++|+|||++........   .....+++.|+|||.+.   ...++.++|+||||+
T Consensus       159 ~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~Di~slG~  212 (280)
T cd05092         159 LVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESIL---YRKFTTESDIWSFGV  212 (280)
T ss_pred             CCEEECCCCceeEcCCCceeecCCCccccccccCHHHhc---cCCcCchhhHHHHHH
Confidence            9999999999876543211   11223467899999988   566889999999998

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory

>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

Probab=99.94  E-value=6.3e-27  Score=175.60  Aligned_cols=158  Identities=32%  Similarity=0.484  Sum_probs=125.1

Q ss_pred             cccccccccccCceEEEEEEEcCCCcEEEEEEccCccChHHHHHHHHHHHHHHhcCCCCchhhhhhhH------------
Q psy14630         25 DLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQFYGAL------------   92 (187)
Q Consensus        25 ~~~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~------------   92 (187)
                      +|++.+.||+|+||.||++.+..+++.+++|.++.........+.+..+...++.++|+||+++++..            
T Consensus         1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (264)
T cd06626           1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY   80 (264)
T ss_pred             CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence            47888999999999999999988899999999875544333455566666678888999999887532            


Q ss_pred             --------------------HHHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEecccccccccccccc---
Q psy14630         93 --------------------FKEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKT---  149 (187)
Q Consensus        93 --------------------~~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg~a~~~~~~~~~~---  149 (187)
                                          ...++.+++.|+.|||+. +++|+||+|+||+++..+.++|+|||++..........   
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~-~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~~~~~  159 (264)
T cd06626          81 CSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSH-GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEE  159 (264)
T ss_pred             CCCCcHHHHHhhcCCCChHHHHHHHHHHHHHHHHHHHC-CcccCCCCHHHEEECCCCCEEEcccccccccCCCCCccccc
Confidence                                112667899999999997 99999999999999999999999999988765332211   


Q ss_pred             --CCCCCcCccCccccCCCccCCCCCCcceeeeEee
Q psy14630        150 --RDAGCRPYMAPERIDPLRARGYPSFKTKLGFKFN  183 (187)
Q Consensus       150 --~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi~  183 (187)
                        ...++..|+|||.+.+.....++.++|+||||+.
T Consensus       160 ~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~i  195 (264)
T cd06626         160 VQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCV  195 (264)
T ss_pred             ccCCcCCcCccChhhccCCCCCCCCcccchHHHHHH
Confidence              2356788999999984322347899999999983

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4

>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

Probab=99.94  E-value=2.1e-27  Score=181.19  Aligned_cols=156  Identities=24%  Similarity=0.401  Sum_probs=116.8

Q ss_pred             ccccccccccccCceEEEEEEEcCCCcEEEEEEccCccChHHH-HHHHHHHHHHHhcC-CCCchhhhhhhH---------
Q psy14630         24 EDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQ-RQLLMDLDVVMKSN-ECPYIVQFYGAL---------   92 (187)
Q Consensus        24 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~-~~~~~~~~~~~~~~-~h~~iv~~~~~~---------   92 (187)
                      ++|++.+.||+|+||.||+|.+..+++.||+|.++........ .....+.. +++.+ +||||+++++.+         
T Consensus         1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~-~l~~l~~~~~i~~~~~~~~~~~~~~~~   79 (295)
T cd07837           1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREIS-LLQMLSESIYIVRLLDVEHVEEKNGKP   79 (295)
T ss_pred             CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHH-HHHHccCCCCccceeeeEeecCCCCCc
Confidence            4688899999999999999999999999999987643222211 23333333 44444 679998776421         


Q ss_pred             --------------------------------HHHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcC-CCCEEEEecccc
Q psy14630         93 --------------------------------FKEVTVATVKALNYLKEELKIIHRDVKPSNILLDR-RGAIKLCDFGIS  139 (187)
Q Consensus        93 --------------------------------~~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~-~~~~ki~dfg~a  139 (187)
                                                      ...+..|++.||.|||+. +++||||+|+||+++. ++.++++|||++
T Consensus        80 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~-~i~H~dl~~~nil~~~~~~~~kl~dfg~~  158 (295)
T cd07837          80 SLYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKH-GVMHRDLKPQNLLVDKQKGLLKIADLGLG  158 (295)
T ss_pred             eEEEEeeccCcCHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHC-CeeecCCChHHEEEecCCCeEEEeecccc
Confidence                                            011567899999999997 9999999999999998 889999999998


Q ss_pred             cccccc-ccccCCCCCcCccCccccCCCccCCCCCCcceeeeEee
Q psy14630        140 GQLVDS-IAKTRDAGCRPYMAPERIDPLRARGYPSFKTKLGFKFN  183 (187)
Q Consensus       140 ~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi~  183 (187)
                      +..... .......+++.|+|||.+.+  ...++.++|+||||+.
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~aPE~~~~--~~~~~~~~Di~slG~~  201 (295)
T cd07837         159 RAFSIPVKSYTHEIVTLWYRAPEVLLG--STHYSTPVDIWSVGCI  201 (295)
T ss_pred             eecCCCccccCCcccccCCCChHHhhC--CCCCCchHHHHHHHHH
Confidence            865432 11222356788999999863  3457899999999983

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm

>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

Probab=99.94  E-value=3.8e-27  Score=177.63  Aligned_cols=157  Identities=25%  Similarity=0.342  Sum_probs=119.8

Q ss_pred             CcccccccccccccCceEEEEEEEcCCCc---EEEEEEccCccChHHHHHHHHHHHHHHhcCCCCchhhhhhhHH-----
Q psy14630         22 TSEDLQDLGEIGRGGFGTVNKMIHRSSDT---VMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQFYGALF-----   93 (187)
Q Consensus        22 ~~~~~~~~~~lg~G~fg~V~~~~~~~~~~---~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~-----   93 (187)
                      ...+|++.+.||+|+||.||+|....++.   .||+|.++...... ....+..+..+++.+.||||+++++.+.     
T Consensus         2 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~   80 (269)
T cd05065           2 DVSCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEK-QRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPV   80 (269)
T ss_pred             ChHHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHH-HHHHHHHHHHHHHhCCCcCcceEEEEECCCCce
Confidence            35678899999999999999999866554   59999986543332 3344555666777889999998764321     


Q ss_pred             ----------------------------HHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEecccccccccc
Q psy14630         94 ----------------------------KEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDS  145 (187)
Q Consensus        94 ----------------------------~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg~a~~~~~~  145 (187)
                                                  ..+..|++.|+.|||+. +++|+||||+|++++.++.++++|||++......
T Consensus        81 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~~-g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~  159 (269)
T cd05065          81 MIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEM-NYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDD  159 (269)
T ss_pred             EEEEecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHC-CEeecccChheEEEcCCCcEEECCCccccccccC
Confidence                                        11557889999999997 9999999999999999999999999998765432


Q ss_pred             cccc----CCC--CCcCccCccccCCCccCCCCCCcceeeeEee
Q psy14630        146 IAKT----RDA--GCRPYMAPERIDPLRARGYPSFKTKLGFKFN  183 (187)
Q Consensus       146 ~~~~----~~~--~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi~  183 (187)
                      ....    ...  .+..|+|||.+.   ...++.++|+||+|+.
T Consensus       160 ~~~~~~~~~~~~~~~~~y~~PE~~~---~~~~~~~~DvwslG~~  200 (269)
T cd05065         160 TSDPTYTSSLGGKIPIRWTAPEAIA---YRKFTSASDVWSYGIV  200 (269)
T ss_pred             ccccccccccCCCcceeecCHhHhc---cCcccchhhhhhhHHH
Confidence            2111    111  134699999988   5678899999999983

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr

>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

Probab=99.94  E-value=4.7e-27  Score=177.22  Aligned_cols=159  Identities=27%  Similarity=0.398  Sum_probs=122.3

Q ss_pred             cCCcccccccccccccCceEEEEEEEcCC---CcEEEEEEccCccChHHHHHHHHHHHHHHhcCCCCchhhhhhhHH---
Q psy14630         20 DFTSEDLQDLGEIGRGGFGTVNKMIHRSS---DTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQFYGALF---   93 (187)
Q Consensus        20 ~~~~~~~~~~~~lg~G~fg~V~~~~~~~~---~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~---   93 (187)
                      +...++|.+.+.||+|+||.||+|.+...   ...+|+|........ ...+.+.++..+++.+.||||+++++.+.   
T Consensus         2 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~-~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~   80 (270)
T cd05056           2 EIQREDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSP-SVREKFLQEAYIMRQFDHPHIVKLIGVITENP   80 (270)
T ss_pred             eechhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCH-HHHHHHHHHHHHHHhCCCCchhceeEEEcCCC
Confidence            45677899999999999999999987543   456899988654332 33445555666778889999999875321   


Q ss_pred             -----------------------------HHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEeccccccccc
Q psy14630         94 -----------------------------KEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVD  144 (187)
Q Consensus        94 -----------------------------~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg~a~~~~~  144 (187)
                                                   ..++.+++.|+.|||+. +++|+||||+||+++..+.++++|||+++....
T Consensus        81 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~-~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~  159 (270)
T cd05056          81 VWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESK-RFVHRDIAARNVLVSSPDCVKLGDFGLSRYLED  159 (270)
T ss_pred             cEEEEEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhC-CeeccccChheEEEecCCCeEEccCceeeeccc
Confidence                                         11557899999999997 999999999999999999999999999887644


Q ss_pred             cccc--cCCCCCcCccCccccCCCccCCCCCCcceeeeEee
Q psy14630        145 SIAK--TRDAGCRPYMAPERIDPLRARGYPSFKTKLGFKFN  183 (187)
Q Consensus       145 ~~~~--~~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi~  183 (187)
                      ....  ....++..|+|||.+.   ...++.++|+||+|+.
T Consensus       160 ~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~Di~slG~i  197 (270)
T cd05056         160 ESYYKASKGKLPIKWMAPESIN---FRRFTSASDVWMFGVC  197 (270)
T ss_pred             ccceecCCCCccccccChhhhc---cCCCCchhhhHHHHHH
Confidence            3211  1223346799999987   5678899999999983

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions

>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

Probab=99.94  E-value=1.1e-27  Score=184.23  Aligned_cols=156  Identities=22%  Similarity=0.321  Sum_probs=119.4

Q ss_pred             cccccccccccCceEEEEEEEcC--CCcEEEEEEccCcc-ChHHHHHHHHHHHHHHhcCCCCchhhhhhhHH--------
Q psy14630         25 DLQDLGEIGRGGFGTVNKMIHRS--SDTVMAVKRIRSTV-DEKDQRQLLMDLDVVMKSNECPYIVQFYGALF--------   93 (187)
Q Consensus        25 ~~~~~~~lg~G~fg~V~~~~~~~--~~~~vaiK~~~~~~-~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~--------   93 (187)
                      .|++.+.||+|+||.||+|.+..  +++.+|+|.+.... ......+....+..+++.++||||+++++.+.        
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~   80 (316)
T cd07842           1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY   80 (316)
T ss_pred             CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence            47788999999999999999987  78999999987532 11112233344455677789999998764221        


Q ss_pred             ------------------------------HHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcC----CCCEEEEecccc
Q psy14630         94 ------------------------------KEVTVATVKALNYLKEELKIIHRDVKPSNILLDR----RGAIKLCDFGIS  139 (187)
Q Consensus        94 ------------------------------~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~----~~~~ki~dfg~a  139 (187)
                                                    ..++.|++.|+.|||+. +++||||||+||+++.    ++.+|++|||++
T Consensus        81 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~-~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg~~  159 (316)
T cd07842          81 LLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSN-WVLHRDLKPANILVMGEGPERGVVKIGDLGLA  159 (316)
T ss_pred             EEEeCCCcCHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhC-CEeeCCCCHHHEEEcCCCCccceEEECCCccc
Confidence                                          12567899999999997 9999999999999998    899999999998


Q ss_pred             cccccccc----ccCCCCCcCccCccccCCCccCCCCCCcceeeeEee
Q psy14630        140 GQLVDSIA----KTRDAGCRPYMAPERIDPLRARGYPSFKTKLGFKFN  183 (187)
Q Consensus       140 ~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi~  183 (187)
                      ........    .....+++.|+|||.+.+  ...++.++|+||||+.
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~~Dv~slG~~  205 (316)
T cd07842         160 RLFNAPLKPLADLDPVVVTIWYRAPELLLG--ARHYTKAIDIWAIGCI  205 (316)
T ss_pred             cccCCCcccccccCCccccccccCHHHHhC--CCCCCcHHHHHHHHHH
Confidence            87643221    122356888999999873  3457889999999983

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the

>KOG1151|consensus

Probab=99.94  E-value=1.1e-27  Score=185.05  Aligned_cols=161  Identities=28%  Similarity=0.362  Sum_probs=125.8

Q ss_pred             cccccccccccccCceEEEEEEEcCCCcEEEEEEccCc-----cChHHHHHHHHHHHHHHhcCCCCchhhhhhhHH----
Q psy14630         23 SEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRST-----VDEKDQRQLLMDLDVVMKSNECPYIVQFYGALF----   93 (187)
Q Consensus        23 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~-----~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~----   93 (187)
                      .++|.++..||+|+|+.||++.+...++.||+|+-...     ..+..-.+...++..+.+.++||.||++|+.|.    
T Consensus       462 n~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtd  541 (775)
T KOG1151|consen  462 NDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTD  541 (775)
T ss_pred             HHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeeccc
Confidence            46788899999999999999999999999999985422     111222344566778899999999999986541    


Q ss_pred             -----------------------------HHHHHHHHHHHHHHHhcC-CCeeecCCCCCeEEc---CCCCEEEEeccccc
Q psy14630         94 -----------------------------KEVTVATVKALNYLKEEL-KIIHRDVKPSNILLD---RRGAIKLCDFGISG  140 (187)
Q Consensus        94 -----------------------------~~~~~~~~~~l~~lh~~~-~i~Hrdlk~~nili~---~~~~~ki~dfg~a~  140 (187)
                                                   ..++.|++.||.||.+.. .|+|-||||.|||+.   ..|.+||.|||+++
T Consensus       542 sFCTVLEYceGNDLDFYLKQhklmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacGeIKITDFGLSK  621 (775)
T KOG1151|consen  542 SFCTVLEYCEGNDLDFYLKQHKLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGEIKITDFGLSK  621 (775)
T ss_pred             cceeeeeecCCCchhHHHHhhhhhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCcccceeEeeecchhh
Confidence                                         127889999999998752 599999999999994   47889999999999


Q ss_pred             cccccc--------cccCCCCCcCccCccccCCCccC-CCCCCcceeeeEee
Q psy14630        141 QLVDSI--------AKTRDAGCRPYMAPERIDPLRAR-GYPSFKTKLGFKFN  183 (187)
Q Consensus       141 ~~~~~~--------~~~~~~~t~~y~aPE~~~~~~~~-~~~~~~D~ws~gi~  183 (187)
                      ++.+..        .++..+||.+|++||.+.-.... ..+.++||||+||+
T Consensus       622 IMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVI  673 (775)
T KOG1151|consen  622 IMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVI  673 (775)
T ss_pred             hccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehh
Confidence            986432        22345799999999998643222 25689999999993

>KOG0199|consensus

Probab=99.94  E-value=1.3e-27  Score=192.58  Aligned_cols=161  Identities=22%  Similarity=0.381  Sum_probs=127.3

Q ss_pred             cCCcccccccccccccCceEEEEEEEcC-CC--cEEEEEEccCccChHHHHHHHHHHHHHHhcCCCCchhhhhhhHHH--
Q psy14630         20 DFTSEDLQDLGEIGRGGFGTVNKMIHRS-SD--TVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQFYGALFK--   94 (187)
Q Consensus        20 ~~~~~~~~~~~~lg~G~fg~V~~~~~~~-~~--~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~--   94 (187)
                      .++.++.++.++||+|+||.|++|.+.. +|  ..||||+++.........+++.|. .+|..++|+|++++||...+  
T Consensus       106 lIpee~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEa-s~M~~L~H~hliRLyGvVl~qp  184 (1039)
T KOG0199|consen  106 LIPEEQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREA-SHMLKLQHPHLIRLYGVVLDQP  184 (1039)
T ss_pred             eccHHHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHH-HHHHhccCcceeEEeeeeccch
Confidence            4677888899999999999999986532 33  458999998655554444555554 45667899999999975432  


Q ss_pred             -------------------------------HHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEecccccccc
Q psy14630         95 -------------------------------EVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLV  143 (187)
Q Consensus        95 -------------------------------~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg~a~~~~  143 (187)
                                                     .+..|++.|+.||-.+ ++|||||..+|+++.....+||+|||+.+.+.
T Consensus       185 ~mMV~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLesk-rlvHRDLAARNlllasprtVKI~DFGLmRaLg  263 (1039)
T KOG0199|consen  185 AMMVFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESK-RLVHRDLAARNLLLASPRTVKICDFGLMRALG  263 (1039)
T ss_pred             hhHHhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhh-hhhhhhhhhhhheecccceeeeecccceeccC
Confidence                                           2677999999999887 99999999999999999999999999999875


Q ss_pred             ccccccCC----CCCcCccCccccCCCccCCCCCCcceeeeEeeee
Q psy14630        144 DSIAKTRD----AGCRPYMAPERIDPLRARGYPSFKTKLGFKFNYR  185 (187)
Q Consensus       144 ~~~~~~~~----~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi~~~  185 (187)
                      .....-..    .-...|.|||.+.   +..++.++|+|+|||.+|
T Consensus       264 ~ned~Yvm~p~rkvPfAWCaPEsLr---h~kFShaSDvWmyGVTiW  306 (1039)
T KOG0199|consen  264 ENEDMYVMAPQRKVPFAWCAPESLR---HRKFSHASDVWMYGVTIW  306 (1039)
T ss_pred             CCCcceEecCCCcCcccccCHhHhc---cccccccchhhhhhhhHH
Confidence            43222111    1234599999999   888999999999999887

>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

Probab=99.94  E-value=1.7e-26  Score=175.08  Aligned_cols=155  Identities=20%  Similarity=0.355  Sum_probs=120.4

Q ss_pred             ccccccccccCceEEEEEEEcCCCcEEEEEEccCccChHHHHHHHHHHHHHHhcCC-CCchhhhhhhHHH----------
Q psy14630         26 LQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNE-CPYIVQFYGALFK----------   94 (187)
Q Consensus        26 ~~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~-h~~iv~~~~~~~~----------   94 (187)
                      |++.+.||+|+||.||+|....+++.++||.+..............+.. .++.+. |+|++++++.+..          
T Consensus         1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~-~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~   79 (283)
T cd07830           1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVK-SLRKLNEHPNIVKLKEVFRENDELYFVFEY   79 (283)
T ss_pred             CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHH-HHHhccCCCCchhHHHHhhcCCcEEEEEec
Confidence            5678899999999999999988899999998764332222222333333 444556 9999998865422          


Q ss_pred             -----------------------HHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEeccccccccccccccCC
Q psy14630         95 -----------------------EVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTRD  151 (187)
Q Consensus        95 -----------------------~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg~a~~~~~~~~~~~~  151 (187)
                                             .+..|++.++.|||+. +++|+||+|+||+++.++.++++|||++............
T Consensus        80 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~-~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~  158 (283)
T cd07830          80 MEGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKH-GFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPPYTDY  158 (283)
T ss_pred             CCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHC-CcccCCCChhhEEEcCCCCEEEeecccceeccCCCCcCCC
Confidence                                   1556899999999997 9999999999999999999999999999876554443445


Q ss_pred             CCCcCccCccccCCCccCCCCCCcceeeeEeee
Q psy14630        152 AGCRPYMAPERIDPLRARGYPSFKTKLGFKFNY  184 (187)
Q Consensus       152 ~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi~~  184 (187)
                      .++..|+|||.+..  ...++.++|+||||+.+
T Consensus       159 ~~~~~~~aPE~~~~--~~~~~~~~Di~s~G~~l  189 (283)
T cd07830         159 VSTRWYRAPEILLR--STSYSSPVDIWALGCIM  189 (283)
T ss_pred             CCcccccCceeeec--CcCcCCccchhhHHHHH
Confidence            67888999999863  34578999999999854

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili

>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=99.94  E-value=3.4e-27  Score=179.16  Aligned_cols=153  Identities=20%  Similarity=0.324  Sum_probs=116.8

Q ss_pred             ccccccccccCceEEEEEE----EcCCCcEEEEEEccCccChHHHHHHHHHHHHHHhcCCCCchhhhhhhHH--------
Q psy14630         26 LQDLGEIGRGGFGTVNKMI----HRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQFYGALF--------   93 (187)
Q Consensus        26 ~~~~~~lg~G~fg~V~~~~----~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~--------   93 (187)
                      |+..+.||+|+||+||++.    ...++..+|+|.++...... ..+.+.++..+++.++||||+++++.+.        
T Consensus         6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~   84 (283)
T cd05080           6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQ-NTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQ   84 (283)
T ss_pred             ceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChH-HHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEE
Confidence            3888999999999998765    33567789999986543222 2334445556777889999998765321        


Q ss_pred             -------------------------HHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEecccccccccccc-
Q psy14630         94 -------------------------KEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIA-  147 (187)
Q Consensus        94 -------------------------~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg~a~~~~~~~~-  147 (187)
                                               ..+..+++.|+.|||+. +++||||||+||+++.++.++++|||+++....... 
T Consensus        85 lv~e~~~~~~l~~~~~~~~l~~~~~~~i~~~l~~~l~~lH~~-~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~  163 (283)
T cd05080          85 LIMEYVPLGSLRDYLPKHKLNLAQLLLFAQQICEGMAYLHSQ-HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEY  163 (283)
T ss_pred             EEecCCCCCCHHHHHHHcCCCHHHHHHHHHHHHHHHHHHHHC-CeeccccChheEEEcCCCcEEEeecccccccCCcchh
Confidence                                     11567899999999997 999999999999999999999999999987643221 


Q ss_pred             ---ccCCCCCcCccCccccCCCccCCCCCCcceeeeEee
Q psy14630        148 ---KTRDAGCRPYMAPERIDPLRARGYPSFKTKLGFKFN  183 (187)
Q Consensus       148 ---~~~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi~  183 (187)
                         .....++..|+|||.+.   ...++.++|+||||+.
T Consensus       164 ~~~~~~~~~~~~~~~PE~~~---~~~~~~~~Di~slG~~  199 (283)
T cd05080         164 YRVREDGDSPVFWYAVECLK---ENKFSYASDVWSFGVT  199 (283)
T ss_pred             hccCCCCCCCceeeCHhHhc---ccCCCcccccHHHHHH
Confidence               11223456799999987   5568899999999983

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign

>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

Probab=99.94  E-value=3.6e-27  Score=176.96  Aligned_cols=149  Identities=23%  Similarity=0.375  Sum_probs=112.3

Q ss_pred             ccccccCceEEEEEEEcC---CCcEEEEEEccCccChHHHHHHHHHHHHHHhcCCCCchhhhhhhHHH------------
Q psy14630         30 GEIGRGGFGTVNKMIHRS---SDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQFYGALFK------------   94 (187)
Q Consensus        30 ~~lg~G~fg~V~~~~~~~---~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~------------   94 (187)
                      +.||+|+||.||+|....   ....+|+|.+....... ..+.+..+..+++.++|||++++++.+..            
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~   79 (262)
T cd05058           1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLE-EVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYM   79 (262)
T ss_pred             CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHH-HHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecC
Confidence            468999999999998643   34679999875432222 23344455557778899999987653210            


Q ss_pred             ----------------------HHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEeccccccccccc-----c
Q psy14630         95 ----------------------EVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSI-----A  147 (187)
Q Consensus        95 ----------------------~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg~a~~~~~~~-----~  147 (187)
                                            .+..+++.|+.|||+. +++||||||+||+++.++.+|++|||+++......     .
T Consensus        80 ~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~-~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~  158 (262)
T cd05058          80 KHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASK-KFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHN  158 (262)
T ss_pred             CCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC-CccccccCcceEEEcCCCcEEECCccccccccCCcceeecc
Confidence                                  1456899999999997 99999999999999999999999999998654321     1


Q ss_pred             ccCCCCCcCccCccccCCCccCCCCCCcceeeeEee
Q psy14630        148 KTRDAGCRPYMAPERIDPLRARGYPSFKTKLGFKFN  183 (187)
Q Consensus       148 ~~~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi~  183 (187)
                      .....++..|+|||...   ...++.++|+||||+.
T Consensus       159 ~~~~~~~~~y~aPE~~~---~~~~~~~~Di~slG~~  191 (262)
T cd05058         159 HTGAKLPVKWMALESLQ---TQKFTTKSDVWSFGVL  191 (262)
T ss_pred             cccCcCCccccChhHhc---cCccchHHHHHHHHHH
Confidence            11224566899999987   5668899999999983

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca

>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases

Probab=99.94  E-value=4.8e-27  Score=177.29  Aligned_cols=150  Identities=26%  Similarity=0.404  Sum_probs=109.4

Q ss_pred             ccccccCceEEEEEEEcCCCc--EEEEEEccCccChHHHHHHHHHHHHHHhcCCCCchhhhhhhH---------------
Q psy14630         30 GEIGRGGFGTVNKMIHRSSDT--VMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQFYGAL---------------   92 (187)
Q Consensus        30 ~~lg~G~fg~V~~~~~~~~~~--~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~---------------   92 (187)
                      +.||+|+||.||+|...+++.  .+++|.++.............+...+.+..+||||+++++.+               
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~   80 (270)
T cd05047           1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH   80 (270)
T ss_pred             CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence            468999999999999877765  468888764333333333444444444444899999875321               


Q ss_pred             ---------------------------------HHHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEecccc
Q psy14630         93 ---------------------------------FKEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGIS  139 (187)
Q Consensus        93 ---------------------------------~~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg~a  139 (187)
                                                       ...+..+++.|++|||+. +++||||||+|++++.++.+|++|||++
T Consensus        81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~-~i~H~dikp~nili~~~~~~kl~dfgl~  159 (270)
T cd05047          81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK-QFIHRDLAARNILVGENYVAKIADFGLS  159 (270)
T ss_pred             CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHC-CEeecccccceEEEcCCCeEEECCCCCc
Confidence                                             012556788999999997 9999999999999999999999999998


Q ss_pred             ccccccccccCCCCCcCccCccccCCCccCCCCCCcceeeeEee
Q psy14630        140 GQLVDSIAKTRDAGCRPYMAPERIDPLRARGYPSFKTKLGFKFN  183 (187)
Q Consensus       140 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi~  183 (187)
                      ..............+..|+|||.+.   ...++.++|+||||++
T Consensus       160 ~~~~~~~~~~~~~~~~~y~apE~~~---~~~~~~~~Di~slG~i  200 (270)
T cd05047         160 RGQEVYVKKTMGRLPVRWMAIESLN---YSVYTTNSDVWSYGVL  200 (270)
T ss_pred             cccchhhhccCCCCccccCChHHHc---cCCCCchhhHHHHHHH
Confidence            6533221122223356799999987   5668899999999983

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l

>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

Probab=99.94  E-value=5.9e-27  Score=181.55  Aligned_cols=155  Identities=24%  Similarity=0.366  Sum_probs=124.8

Q ss_pred             cccccccccccCceEEEEEEEcCCCcEEEEEEccCccChHHHHHHHHHHHHHHhcCCCCchhhhhhhHHH----------
Q psy14630         25 DLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQFYGALFK----------   94 (187)
Q Consensus        25 ~~~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~----------   94 (187)
                      +|++.+.||+|+||.||+|.+..+++.+|+|.+..........+.+..+...++.++|+||+++++.+..          
T Consensus         1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~   80 (330)
T cd07834           1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY   80 (330)
T ss_pred             CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence            4788899999999999999998889999999986543323334455556667778889999988764311          


Q ss_pred             --------------------------HHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEeccccccccccc--
Q psy14630         95 --------------------------EVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSI--  146 (187)
Q Consensus        95 --------------------------~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg~a~~~~~~~--  146 (187)
                                                .++.+++.|++|||+. +++|+||||+||+++.++.++++|||++.......  
T Consensus        81 lv~e~~~~~l~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~-gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~~~~~~  159 (330)
T cd07834          81 IVTELMETDLHKVIKSPQPLTDDHIQYFLYQILRGLKYLHSA-NVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDE  159 (330)
T ss_pred             EEecchhhhHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhC-CeecCCCCHHHEEEcCCCCEEEcccCceEeecccccc
Confidence                                      1567889999999997 99999999999999999999999999998865442  


Q ss_pred             --cccCCCCCcCccCccccCCCccC-CCCCCcceeeeEee
Q psy14630        147 --AKTRDAGCRPYMAPERIDPLRAR-GYPSFKTKLGFKFN  183 (187)
Q Consensus       147 --~~~~~~~t~~y~aPE~~~~~~~~-~~~~~~D~ws~gi~  183 (187)
                        ......++..|+|||.+.   .. .++.++|+||+|+.
T Consensus       160 ~~~~~~~~~~~~y~aPE~~~---~~~~~~~~sDi~slG~i  196 (330)
T cd07834         160 KGFLTEYVVTRWYRAPELLL---SSSRYTKAIDIWSVGCI  196 (330)
T ss_pred             cccccccccccCcCCceeee---cccCCCcchhHHHHHHH
Confidence              223345788899999998   34 68899999999983

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and

>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

Probab=99.94  E-value=2.1e-27  Score=178.00  Aligned_cols=154  Identities=26%  Similarity=0.369  Sum_probs=118.9

Q ss_pred             CcccccccccccccCceEEEEEEEcCCCcEEEEEEccCccChHHHHHHHHHHHHHHhcCCCCchhhhhhhHH--------
Q psy14630         22 TSEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQFYGALF--------   93 (187)
Q Consensus        22 ~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~--------   93 (187)
                      ..++|++.+.||+|+||.||++.... +..+|+|.+......   .+.+.++..+++.++||||+++++.+.        
T Consensus         2 ~~~~~~~~~~lg~G~~~~vy~~~~~~-~~~~aik~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   77 (256)
T cd05113           2 DPKDLTFLKELGTGQFGVVKYGKWRG-QYDVAIKMIKEGSMS---EDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIV   77 (256)
T ss_pred             ChHHeEEeeEecCcccceEEEEEecC-CCcEEEEEcCCCccc---HHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEE
Confidence            46789999999999999999997743 456999988643221   233445556777889999998875321        


Q ss_pred             -------------------------HHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEeccccccccccccc
Q psy14630         94 -------------------------KEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAK  148 (187)
Q Consensus        94 -------------------------~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg~a~~~~~~~~~  148 (187)
                                               ..++.+++.|+.|||+. +++|+||||+||+++.++.+|++|||+++........
T Consensus        78 ~e~~~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~~-~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~  156 (256)
T cd05113          78 TEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESK-QFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYT  156 (256)
T ss_pred             EEcCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC-CeeccccCcceEEEcCCCCEEECCCccceecCCCcee
Confidence                                     12667899999999997 9999999999999999999999999998866443221


Q ss_pred             c--CCCCCcCccCccccCCCccCCCCCCcceeeeEee
Q psy14630        149 T--RDAGCRPYMAPERIDPLRARGYPSFKTKLGFKFN  183 (187)
Q Consensus       149 ~--~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi~  183 (187)
                      .  ...++..|+|||.+.   ...++.++|+||||+.
T Consensus       157 ~~~~~~~~~~y~~pe~~~---~~~~~~~~Di~slG~~  190 (256)
T cd05113         157 SSVGSKFPVRWSPPEVLL---YSKFSSKSDVWAFGVL  190 (256)
T ss_pred             ecCCCccChhhCCHHHHh---cCcccchhHHHHHHHH
Confidence            1  123456799999997   5568899999999983

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds

>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

Probab=99.94  E-value=3.7e-27  Score=176.37  Aligned_cols=154  Identities=23%  Similarity=0.380  Sum_probs=121.7

Q ss_pred             ccCCcccccccccccccCceEEEEEEEcCCCcEEEEEEccCccChHHHHHHHHHHHHHHhcCCCCchhhhhhhHH-----
Q psy14630         19 YDFTSEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQFYGALF-----   93 (187)
Q Consensus        19 ~~~~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~-----   93 (187)
                      |.+..++|++.+.||.|+||.||+|...  ++.+|+|.++....   ..+.+..+..+++.++|+|++++++.+.     
T Consensus         1 ~~~~~~~~~~~~~ig~g~~g~v~~~~~~--~~~v~iK~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   75 (256)
T cd05039           1 WAINSKELKLGATIGKGEFGDVMLGDYR--GQKVAVKCLKDDST---AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPL   75 (256)
T ss_pred             CccChhhccceeeeecCCCceEEEEEec--CcEEEEEEeccchh---HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCe
Confidence            3456789999999999999999999874  78899999875322   2334455556777789999998764321     


Q ss_pred             -----------------------------HHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEeccccccccc
Q psy14630         94 -----------------------------KEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVD  144 (187)
Q Consensus        94 -----------------------------~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg~a~~~~~  144 (187)
                                                   ..+..|++.++.|||+. +++|+||||+||+++.++.++|+|||.++....
T Consensus        76 ~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~-~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~  154 (256)
T cd05039          76 YIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEK-NFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQ  154 (256)
T ss_pred             EEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC-CccchhcccceEEEeCCCCEEEccccccccccc
Confidence                                         12667899999999997 999999999999999999999999999987643


Q ss_pred             cccccCCCCCcCccCccccCCCccCCCCCCcceeeeEee
Q psy14630        145 SIAKTRDAGCRPYMAPERIDPLRARGYPSFKTKLGFKFN  183 (187)
Q Consensus       145 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi~  183 (187)
                      ...  ....+..|+|||.+.   ...++.++|+||+|+.
T Consensus       155 ~~~--~~~~~~~~~ape~~~---~~~~~~~~Di~slG~i  188 (256)
T cd05039         155 GQD--SGKLPVKWTAPEALR---EKKFSTKSDVWSFGIL  188 (256)
T ss_pred             ccc--cCCCcccccCchhhc---CCcCCcHHHHHHHHHH
Confidence            222  223456799999987   5567889999999984

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk

>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

Probab=99.94  E-value=4.7e-27  Score=176.30  Aligned_cols=148  Identities=26%  Similarity=0.430  Sum_probs=112.7

Q ss_pred             cccccCceEEEEEEEc--CCCcEEEEEEccCccChHHHHHHHHHHHHHHhcCCCCchhhhhhhHH---------------
Q psy14630         31 EIGRGGFGTVNKMIHR--SSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQFYGALF---------------   93 (187)
Q Consensus        31 ~lg~G~fg~V~~~~~~--~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~---------------   93 (187)
                      .||+|+||.||+|.+.  .++..||+|.+..... ....+.+.++..+++.++||||+++++.+.               
T Consensus         2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~-~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~lv~e~~~~~~   80 (257)
T cd05115           2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENE-KSVRDEMMREAEIMHQLDNPYIVRMIGVCEAEALMLVMEMASGGP   80 (257)
T ss_pred             ccCCCCcccEEEEEEecCCCceeEEEEEcccccC-hHHHHHHHHHHHHHHhcCCCCeEEEEEEEcCCCeEEEEEeCCCCC
Confidence            4899999999999764  4456799999865433 233445556666778889999998764321               


Q ss_pred             -----------------HHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEecccccccccccc----ccCCC
Q psy14630         94 -----------------KEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIA----KTRDA  152 (187)
Q Consensus        94 -----------------~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg~a~~~~~~~~----~~~~~  152 (187)
                                       ..+..+++.++.|||+. +++||||||+||+++.++.+|++|||+++.......    .....
T Consensus        81 L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~-~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~  159 (257)
T cd05115          81 LNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGK-NFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGK  159 (257)
T ss_pred             HHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhc-CeeecccchheEEEcCCCcEEeccCCccccccCCccceeccCCCC
Confidence                             12567899999999997 999999999999999999999999999886543211    11112


Q ss_pred             CCcCccCccccCCCccCCCCCCcceeeeEee
Q psy14630        153 GCRPYMAPERIDPLRARGYPSFKTKLGFKFN  183 (187)
Q Consensus       153 ~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi~  183 (187)
                      ++..|+|||.+.   ...++.++|+||||+.
T Consensus       160 ~~~~y~aPE~~~---~~~~~~~~Di~slG~~  187 (257)
T cd05115         160 WPLKWYAPECIN---FRKFSSRSDVWSYGIT  187 (257)
T ss_pred             CCcccCCHHHHc---cCCCCchhhHHHHHHH
Confidence            356799999987   5568889999999983

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho

>KOG0671|consensus

Probab=99.94  E-value=9.8e-27  Score=176.03  Aligned_cols=157  Identities=27%  Similarity=0.411  Sum_probs=115.3

Q ss_pred             cCCcccccccccccccCceEEEEEEEcCCCcEEEEEEccCccChHHHHHHHHHHHHHHhcCCC-Cc----hhhh------
Q psy14630         20 DFTSEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNEC-PY----IVQF------   88 (187)
Q Consensus        20 ~~~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~h-~~----iv~~------   88 (187)
                      +...++|.+.+.+|+|.||.|-.|++.+++..||+|+++.-  ++.....+.|+..+.+...+ |+    ++.+      
T Consensus        85 D~l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V--~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdy  162 (415)
T KOG0671|consen   85 DILTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNV--DKYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDY  162 (415)
T ss_pred             cccccceehhhhhcCCcccceEEEeecCCCceehHHHHHHH--HHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhc
Confidence            55678899999999999999999999999999999998742  22222333344333332111 11    2222      


Q ss_pred             ----------hh-----------------hHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcC--------------
Q psy14630         89 ----------YG-----------------ALFKEVTVATVKALNYLKEELKIIHRDVKPSNILLDR--------------  127 (187)
Q Consensus        89 ----------~~-----------------~~~~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~--------------  127 (187)
                                +|                 ..+..+..|++++++|||+. +++|.||||+||++..              
T Consensus       163 rghiCivfellG~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~-kl~HTDLKPENILfvss~~~~~~~~k~~~~  241 (415)
T KOG0671|consen  163 RGHICIVFELLGLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDL-KLTHTDLKPENILFVSSEYFKTYNPKKKVC  241 (415)
T ss_pred             cCceEEEEeccChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhc-ceeecCCChheEEEeccceEEEeccCCccc
Confidence                      12                 11333778999999999997 9999999999999842              


Q ss_pred             ------CCCEEEEeccccccccccccccCCCCCcCccCccccCCCccCCCCCCcceeeeEeee
Q psy14630        128 ------RGAIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPLRARGYPSFKTKLGFKFNY  184 (187)
Q Consensus       128 ------~~~~ki~dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi~~  184 (187)
                            ...++++|||.|..-...  ....+.|..|+|||+++   +.+|+..+|+||+|.++
T Consensus       242 ~~r~~ks~~I~vIDFGsAtf~~e~--hs~iVsTRHYRAPEViL---gLGwS~pCDvWSiGCIL  299 (415)
T KOG0671|consen  242 FIRPLKSTAIKVIDFGSATFDHEH--HSTIVSTRHYRAPEVIL---GLGWSQPCDVWSIGCIL  299 (415)
T ss_pred             eeccCCCcceEEEecCCcceeccC--cceeeeccccCCchhee---ccCcCCccCceeeeeEE
Confidence                  224799999999874433  34456789999999999   88999999999999743

>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

Probab=99.94  E-value=6.1e-27  Score=177.88  Aligned_cols=160  Identities=29%  Similarity=0.432  Sum_probs=120.3

Q ss_pred             CCcccccccccccccCceEEEEEEEcCCCcEEEEEEccCccChHHHHHHHHHHHHHHhcC-CCCchhhhhhhHH------
Q psy14630         21 FTSEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSN-ECPYIVQFYGALF------   93 (187)
Q Consensus        21 ~~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~-~h~~iv~~~~~~~------   93 (187)
                      ...++|++.+.||+|+||.||++.+..+++.+|+|.+......  . ..+..+..+++.+ +||||+++++.+.      
T Consensus        15 ~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~--~-~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~   91 (286)
T cd06638          15 DPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDI--D-EEIEAEYNILKALSDHPNVVKFYGMYYKKDVKN   91 (286)
T ss_pred             CcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccccch--H-HHHHHHHHHHHHHhcCCCeeeeeeeeeecccCC
Confidence            3567899999999999999999999999999999987542211  1 2222333344444 7999998764321      


Q ss_pred             -----------------------------------HHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEeccc
Q psy14630         94 -----------------------------------KEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGI  138 (187)
Q Consensus        94 -----------------------------------~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg~  138 (187)
                                                         ..+..+++.|+.|||+. +++|||+||+||+++.++.++++|||+
T Consensus        92 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~-~i~H~dlkp~nili~~~~~~kl~dfg~  170 (286)
T cd06638          92 GDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVN-KTIHRDVKGNNILLTTEGGVKLVDFGV  170 (286)
T ss_pred             CCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhC-CccccCCCHHhEEECCCCCEEEccCCc
Confidence                                               01556788999999997 999999999999999999999999999


Q ss_pred             cccccccc-cccCCCCCcCccCccccCCC--ccCCCCCCcceeeeEeee
Q psy14630        139 SGQLVDSI-AKTRDAGCRPYMAPERIDPL--RARGYPSFKTKLGFKFNY  184 (187)
Q Consensus       139 a~~~~~~~-~~~~~~~t~~y~aPE~~~~~--~~~~~~~~~D~ws~gi~~  184 (187)
                      ++...... ......+++.|+|||.+...  ....++.++|+||+|+.+
T Consensus       171 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~  219 (286)
T cd06638         171 SAQLTSTRLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITA  219 (286)
T ss_pred             eeecccCCCccccccCCCcccChhhhchhhhccccccchhhhhhHHHHH
Confidence            88764322 22334688899999997521  123478899999999843

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear

>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

Probab=99.94  E-value=4.4e-27  Score=176.62  Aligned_cols=156  Identities=29%  Similarity=0.445  Sum_probs=123.1

Q ss_pred             ccccccccccccCceEEEEEEEcCCCcEEEEEEccCccChHHHHHHHHHHHHHHhcCCCCchhhhhhhH-----------
Q psy14630         24 EDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQFYGAL-----------   92 (187)
Q Consensus        24 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~-----------   92 (187)
                      ++|++.+.||.|+||.||+|....++..+|+|.+....... ..+.+.++...++.+.|+|++++++.+           
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e   79 (267)
T cd06610           1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQT-SVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMP   79 (267)
T ss_pred             CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcch-HHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEe
Confidence            47889999999999999999988889999999986433222 334455555667778999999876321           


Q ss_pred             ------------------------HHHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEeccccccccccccc
Q psy14630         93 ------------------------FKEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAK  148 (187)
Q Consensus        93 ------------------------~~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg~a~~~~~~~~~  148 (187)
                                              ...+..|++.|+.|||+. +++|+||+|+||++++++.++++|||++..+......
T Consensus        80 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~-~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~~  158 (267)
T cd06610          80 YLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSN-GQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDR  158 (267)
T ss_pred             ccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhC-CeecCCCCHHhEEEcCCCCEEEcccchHHHhccCccc
Confidence                                    112567899999999997 9999999999999999999999999998876543222


Q ss_pred             -----cCCCCCcCccCccccCCCccCCCCCCcceeeeEee
Q psy14630        149 -----TRDAGCRPYMAPERIDPLRARGYPSFKTKLGFKFN  183 (187)
Q Consensus       149 -----~~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi~  183 (187)
                           ....++..|+|||.+..  ...++.++|+||||+.
T Consensus       159 ~~~~~~~~~~~~~y~~Pe~~~~--~~~~~~~~Dv~slG~i  196 (267)
T cd06610         159 TRKVRKTFVGTPCWMAPEVMEQ--VHGYDFKADIWSFGIT  196 (267)
T ss_pred             cccccccccCChhhcChHHHcc--ccCcCcccchHhHhHH
Confidence                 23357888999999883  2268899999999983

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1

>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

Probab=99.94  E-value=5.3e-27  Score=178.01  Aligned_cols=153  Identities=27%  Similarity=0.430  Sum_probs=116.7

Q ss_pred             ccccccccccCceEEEEEEEcCCCcEEEEEEccCccChHHHHHHHHHHHHHH---hcCCCCchhhhhhhHH---------
Q psy14630         26 LQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVM---KSNECPYIVQFYGALF---------   93 (187)
Q Consensus        26 ~~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~---~~~~h~~iv~~~~~~~---------   93 (187)
                      |++.+.||+|+||.||+|.+..+++.+|+|.++..............+..++   ....|+|++++++.+.         
T Consensus         1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~   80 (287)
T cd07838           1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK   80 (287)
T ss_pred             CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence            5678899999999999999988899999999864333222222222222222   3346999887753211         


Q ss_pred             -----------------------------HHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEeccccccccc
Q psy14630         94 -----------------------------KEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVD  144 (187)
Q Consensus        94 -----------------------------~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg~a~~~~~  144 (187)
                                                   ..+..+++.|+.|||+. +++|+|++|+|++++.++.++++|||++.....
T Consensus        81 ~~l~~e~~~~~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~-~i~h~~l~~~nili~~~~~~~l~dfg~~~~~~~  159 (287)
T cd07838          81 LTLVFEHVDQDLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSH-RIVHRDLKPQNILVTSDGQVKIADFGLARIYSF  159 (287)
T ss_pred             eEEEehhcccCHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHC-CeeeccCChhhEEEccCCCEEEeccCcceeccC
Confidence                                         11667899999999997 999999999999999999999999999988654


Q ss_pred             cccccCCCCCcCccCccccCCCccCCCCCCcceeeeEe
Q psy14630        145 SIAKTRDAGCRPYMAPERIDPLRARGYPSFKTKLGFKF  182 (187)
Q Consensus       145 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi  182 (187)
                      ........++..|+|||.+.   ...++.++|+||||+
T Consensus       160 ~~~~~~~~~~~~~~~PE~~~---~~~~~~~~Di~s~G~  194 (287)
T cd07838         160 EMALTSVVVTLWYRAPEVLL---QSSYATPVDMWSVGC  194 (287)
T ss_pred             CcccccccccccccChHHhc---cCCCCCcchhhhHHH
Confidence            43333445788899999998   556889999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both

>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

Probab=99.94  E-value=4.7e-27  Score=176.77  Aligned_cols=155  Identities=31%  Similarity=0.439  Sum_probs=121.2

Q ss_pred             cccccccccccCceEEEEEEEcCCCcEEEEEEccCccCh-------HHHHHHHHHHHHHHhcCCCCchhhhhhhH-----
Q psy14630         25 DLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDE-------KDQRQLLMDLDVVMKSNECPYIVQFYGAL-----   92 (187)
Q Consensus        25 ~~~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~-------~~~~~~~~~~~~~~~~~~h~~iv~~~~~~-----   92 (187)
                      +|.+...||+|+||.||+|.+..+++.+|+|.+......       ....+.+.++..+++.++||||+++++.+     
T Consensus         1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   80 (267)
T cd06628           1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH   80 (267)
T ss_pred             CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence            366788999999999999999888999999987542211       11224455666678888999999886432     


Q ss_pred             ---------------------------HHHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEecccccccccc
Q psy14630         93 ---------------------------FKEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDS  145 (187)
Q Consensus        93 ---------------------------~~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg~a~~~~~~  145 (187)
                                                 ...++.+++.+++|||+. +++|+||+|+||+++.++.++|+|||.++.....
T Consensus        81 ~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lH~~-~ivH~di~p~nil~~~~~~~~l~dfg~~~~~~~~  159 (267)
T cd06628          81 LNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHNR-GIIHRDIKGANILVDNKGGIKISDFGISKKLEAN  159 (267)
T ss_pred             cEEEEEecCCCCHHHHHHhccCccHHHHHHHHHHHHHHHHHHHhc-CcccccCCHHHEEEcCCCCEEecccCCCcccccc
Confidence                                       112667899999999997 9999999999999999999999999998876522


Q ss_pred             cc-------ccCCCCCcCccCccccCCCccCCCCCCcceeeeEee
Q psy14630        146 IA-------KTRDAGCRPYMAPERIDPLRARGYPSFKTKLGFKFN  183 (187)
Q Consensus       146 ~~-------~~~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi~  183 (187)
                      ..       .....++..|+|||.+.   ...++.++|+||+|++
T Consensus       160 ~~~~~~~~~~~~~~~~~~y~~pe~~~---~~~~~~~~Dv~slG~i  201 (267)
T cd06628         160 SLSTKTNGARPSLQGSVFWMAPEVVK---QTSYTRKADIWSLGCL  201 (267)
T ss_pred             cccCCccccccccCCCcCccChhHhc---cCCCCchhhhHHHHHH
Confidence            11       11234678899999988   5667889999999983

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate

>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

Probab=99.94  E-value=5e-27  Score=175.49  Aligned_cols=154  Identities=27%  Similarity=0.411  Sum_probs=122.3

Q ss_pred             cccccccccccCceEEEEEEEcCCCcEEEEEEccCcc---ChHHHHHHHHHHHHHHhcCCCCchhhhhhhHHH-------
Q psy14630         25 DLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTV---DEKDQRQLLMDLDVVMKSNECPYIVQFYGALFK-------   94 (187)
Q Consensus        25 ~~~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~-------   94 (187)
                      +|+..+.||+|+||.||+|....++..|++|.+....   ..+...+.+..+..+++.++|+|++++++.+..       
T Consensus         1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv   80 (258)
T cd06632           1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF   80 (258)
T ss_pred             CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence            4677889999999999999998889999999875322   112233445556667778899999988753211       


Q ss_pred             -------------------------HHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEecccccccccccccc
Q psy14630         95 -------------------------EVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKT  149 (187)
Q Consensus        95 -------------------------~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg~a~~~~~~~~~~  149 (187)
                                               .+..+++.++.|||+. +++|+||+|+||+++.++.+||+|||++..........
T Consensus        81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~-~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~~~~~  159 (258)
T cd06632          81 LELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDR-NTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFSFAK  159 (258)
T ss_pred             EEecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC-CcccCCCCHHHEEECCCCCEEEccCccceecccccccc
Confidence                                     1566899999999997 99999999999999999999999999988765444334


Q ss_pred             CCCCCcCccCccccCCCccCC-CCCCcceeeeEe
Q psy14630        150 RDAGCRPYMAPERIDPLRARG-YPSFKTKLGFKF  182 (187)
Q Consensus       150 ~~~~t~~y~aPE~~~~~~~~~-~~~~~D~ws~gi  182 (187)
                      ...++..|+|||.+.   ... ++.++|+||||+
T Consensus       160 ~~~~~~~y~~pe~~~---~~~~~~~~~D~~slG~  190 (258)
T cd06632         160 SFKGSPYWMAPEVIA---QQGGYGLAADIWSLGC  190 (258)
T ss_pred             ccCCCcceeCHHHhc---CCCCCCchhhhHHHHH
Confidence            456788999999987   344 789999999998

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops

>KOG4257|consensus

Probab=99.94  E-value=1.8e-27  Score=189.86  Aligned_cols=165  Identities=26%  Similarity=0.411  Sum_probs=131.1

Q ss_pred             CccccCCcccccccccccccCceEEEEEEEcC----CCcEEEEEEccCccChHHHHHHHHHHHHHHhcCCCCchhhhhhh
Q psy14630         16 DTVYDFTSEDLQDLGEIGRGGFGTVNKMIHRS----SDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQFYGA   91 (187)
Q Consensus        16 ~~~~~~~~~~~~~~~~lg~G~fg~V~~~~~~~----~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~   91 (187)
                      ...+++.++.....+.||.|-||.||+|.+-.    ..--||||.++..-.. +..+.+..+..+|+..+||||++++|.
T Consensus       381 ~rnyel~Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~-d~tekflqEa~iMrnfdHphIikLIGv  459 (974)
T KOG4257|consen  381 VRNYELRRELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTP-DDTEKFLQEASIMRNFDHPHIIKLIGV  459 (974)
T ss_pred             CCcceeehhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCCh-hhHHHHHHHHHHHHhCCCcchhheeee
Confidence            44556666677777899999999999997532    2235899998764333 335666667778999999999999875


Q ss_pred             HHHH--------------------------------HHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEecccc
Q psy14630         92 LFKE--------------------------------VTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGIS  139 (187)
Q Consensus        92 ~~~~--------------------------------~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg~a  139 (187)
                      +...                                ...|+..+|.|||+. +++||||..+|||+.....+|+.|||++
T Consensus       460 ~~e~P~WivmEL~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLeSk-rfVHRDIAaRNiLVsSp~CVKLaDFGLS  538 (974)
T KOG4257|consen  460 CVEQPMWIVMELAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLESK-RFVHRDIAARNILVSSPQCVKLADFGLS  538 (974)
T ss_pred             eeccceeEEEecccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHHhh-chhhhhhhhhheeecCcceeeecccchh
Confidence            4222                                446888999999997 9999999999999999999999999999


Q ss_pred             ccccccccccCCCCC--cCccCccccCCCccCCCCCCcceeeeEeeee
Q psy14630        140 GQLVDSIAKTRDAGC--RPYMAPERIDPLRARGYPSFKTKLGFKFNYR  185 (187)
Q Consensus       140 ~~~~~~~~~~~~~~t--~~y~aPE~~~~~~~~~~~~~~D~ws~gi~~~  185 (187)
                      +.+.+.....+..|.  ..|||||.+.   .+.++.++|||=|||-.|
T Consensus       539 R~~ed~~yYkaS~~kLPIKWmaPESIN---fRrFTtASDVWMFgVCmW  583 (974)
T KOG4257|consen  539 RYLEDDAYYKASRGKLPIKWMAPESIN---FRRFTTASDVWMFGVCMW  583 (974)
T ss_pred             hhccccchhhccccccceeecCccccc---hhcccchhhHHHHHHHHH
Confidence            999876555544444  3599999999   788999999999999433

>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

Probab=99.94  E-value=7.3e-27  Score=175.73  Aligned_cols=155  Identities=26%  Similarity=0.400  Sum_probs=121.9

Q ss_pred             cccccccccccCceEEEEEEEcCCCcEEEEEEccCccCh----HHHHHHHHHHHHHHhcCCCCchhhhhhhHH-------
Q psy14630         25 DLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDE----KDQRQLLMDLDVVMKSNECPYIVQFYGALF-------   93 (187)
Q Consensus        25 ~~~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~----~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~-------   93 (187)
                      +|+..+.||+|+||.||++.+..+++.+|+|.++.....    ....+.+..+...++.++|+|++++++.+.       
T Consensus         1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~   80 (268)
T cd06630           1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL   80 (268)
T ss_pred             CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence            477889999999999999999999999999998643211    122345556666777889999999876431       


Q ss_pred             -------------------------HHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCC-CEEEEecccccccccccc
Q psy14630         94 -------------------------KEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRG-AIKLCDFGISGQLVDSIA  147 (187)
Q Consensus        94 -------------------------~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~-~~ki~dfg~a~~~~~~~~  147 (187)
                                               ..++.|++.|+.|||+. +++|+||+|+||+++.++ .++++|||.+........
T Consensus        81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ql~~al~~LH~~-~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~~~~  159 (268)
T cd06630          81 FVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHEN-QIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGT  159 (268)
T ss_pred             EEeccCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhC-CeecCCCCHHHEEEcCCCCEEEEcccccccccccccc
Confidence                                     12567899999999997 999999999999998776 599999999887653211


Q ss_pred             -----ccCCCCCcCccCccccCCCccCCCCCCcceeeeEee
Q psy14630        148 -----KTRDAGCRPYMAPERIDPLRARGYPSFKTKLGFKFN  183 (187)
Q Consensus       148 -----~~~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi~  183 (187)
                           .....++..|+|||.+.   ...++.++|+||+|+.
T Consensus       160 ~~~~~~~~~~~~~~~~~PE~~~---~~~~~~~~Dv~slG~~  197 (268)
T cd06630         160 GAGEFQGQLLGTIAFMAPEVLR---GEQYGRSCDVWSVGCV  197 (268)
T ss_pred             cCCccccccccccceeCHhHhc---cCCCCcccchHHHHHH
Confidence                 12235788899999987   5668899999999983

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their

>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

Probab=99.94  E-value=6.7e-27  Score=179.52  Aligned_cols=156  Identities=29%  Similarity=0.448  Sum_probs=121.1

Q ss_pred             ccccccccccccCceEEEEEEEcCCCcEEEEEEccCccC-hHHHHHHHHHHHHHHhcCCCCchhhhhhhH----------
Q psy14630         24 EDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVD-EKDQRQLLMDLDVVMKSNECPYIVQFYGAL----------   92 (187)
Q Consensus        24 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~----------   92 (187)
                      ++|++.+.||+|+||.||++.+..+++.|++|.+..... .....+.+.++..+++..+||||+++++.+          
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (305)
T cd05609           1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM   80 (305)
T ss_pred             CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence            468889999999999999999999999999998864321 122334455666677888999999887432          


Q ss_pred             ----------------------HHHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEeccccccccccc----
Q psy14630         93 ----------------------FKEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSI----  146 (187)
Q Consensus        93 ----------------------~~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg~a~~~~~~~----  146 (187)
                                            ...++.+++.|+.|||+. +++||||+|+||+++..+.++++|||+++......    
T Consensus        81 e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~-~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~~~~  159 (305)
T cd05609          81 EYVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLHNY-GIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNL  159 (305)
T ss_pred             ecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC-CccccCCchHHEEECCCCCEEEeeCCCccccCcCccccc
Confidence                                  112566888999999997 99999999999999999999999999887421100    


Q ss_pred             ------------cccCCCCCcCccCccccCCCccCCCCCCcceeeeEee
Q psy14630        147 ------------AKTRDAGCRPYMAPERIDPLRARGYPSFKTKLGFKFN  183 (187)
Q Consensus       147 ------------~~~~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi~  183 (187)
                                  ......++..|+|||.+.   ...++.++|+||||+.
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~Di~slG~v  205 (305)
T cd05609         160 YEGHIEKDTREFLDKQVCGTPEYIAPEVIL---RQGYGKPVDWWAMGII  205 (305)
T ss_pred             cccccccchhhccccCCccCccccCchhcc---CCCCCchhhHHHHHHH
Confidence                        011234677899999987   5668899999999983

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a

>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

Probab=99.94  E-value=6.9e-27  Score=178.62  Aligned_cols=157  Identities=27%  Similarity=0.486  Sum_probs=123.8

Q ss_pred             CcccccccccccccCceEEEEEEEcCCCcEEEEEEccCccChHHHHHHHHHHHHHHhcCCCCchhhhhhhHH--------
Q psy14630         22 TSEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQFYGALF--------   93 (187)
Q Consensus        22 ~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~--------   93 (187)
                      ...+|.+.+.||+|+||.||++.+..++..+|+|.+......  ..+.+..+..+++.++|||++++++.+.        
T Consensus        17 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~--~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv   94 (293)
T cd06647          17 PKKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQP--KKELIINEILVMRENKHPNIVNYLDSYLVGDELWVV   94 (293)
T ss_pred             chhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccch--HHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEE
Confidence            457899999999999999999998888999999987532222  2233444555677789999998875431        


Q ss_pred             -----------------------HHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEecccccccccccc-cc
Q psy14630         94 -----------------------KEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIA-KT  149 (187)
Q Consensus        94 -----------------------~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg~a~~~~~~~~-~~  149 (187)
                                             ..+..+++.++.|||+. +++|+|++|+|++++.++.++|+|||++........ ..
T Consensus        95 ~e~~~~~~L~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~-gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~~~~  173 (293)
T cd06647          95 MEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSN-QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRS  173 (293)
T ss_pred             EecCCCCcHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHhC-CEeeccCCHHHEEEcCCCCEEEccCcceecccccccccc
Confidence                                   12567889999999997 999999999999999999999999998876644322 22


Q ss_pred             CCCCCcCccCccccCCCccCCCCCCcceeeeEeee
Q psy14630        150 RDAGCRPYMAPERIDPLRARGYPSFKTKLGFKFNY  184 (187)
Q Consensus       150 ~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi~~  184 (187)
                      ...+++.|+|||.+.   ...++.++|+||||+..
T Consensus       174 ~~~~~~~y~~PE~~~---~~~~~~~~Dv~slG~ll  205 (293)
T cd06647         174 TMVGTPYWMAPEVVT---RKAYGPKVDIWSLGIMA  205 (293)
T ss_pred             cccCChhhcCchhhc---cCCCCchhhHHHHHHHH
Confidence            335788899999987   55678999999999843

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi

>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

Probab=99.94  E-value=7.8e-27  Score=174.81  Aligned_cols=149  Identities=26%  Similarity=0.377  Sum_probs=113.8

Q ss_pred             ccccccCceEEEEEEEcCCC---cEEEEEEccCccChHHHHHHHHHHHHHHhcCCCCchhhhhhhH--------------
Q psy14630         30 GEIGRGGFGTVNKMIHRSSD---TVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQFYGAL--------------   92 (187)
Q Consensus        30 ~~lg~G~fg~V~~~~~~~~~---~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~--------------   92 (187)
                      +.||+|+||.||+|.+..++   ..+|+|.+...... ...+.+..+..+++.+.|+|++++++.+              
T Consensus         1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~v~e~~~~   79 (257)
T cd05060           1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIA-AGKKEFLREASVMAQLDHPCIVRLIGVCKGEPLMLVMELAPL   79 (257)
T ss_pred             CccCccCceeEEEeEeeccCCCcceEEEEecccccch-HHHHHHHHHHHHHHhcCCCCeeeEEEEEcCCceEEEEEeCCC
Confidence            47999999999999865544   78999998754333 2333444455567778999999886432              


Q ss_pred             -----------------HHHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEecccccccccccccc----CC
Q psy14630         93 -----------------FKEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKT----RD  151 (187)
Q Consensus        93 -----------------~~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg~a~~~~~~~~~~----~~  151 (187)
                                       ...+..|++.++.|||.. +++|+||||+|++++.++.++++|||+++.........    ..
T Consensus        80 ~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lh~~-~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~~~~~~  158 (257)
T cd05060          80 GPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESK-HFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAG  158 (257)
T ss_pred             CcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhc-CeeccCcccceEEEcCCCcEEeccccccceeecCCcccccccCc
Confidence                             112667899999999997 99999999999999999999999999998764332211    11


Q ss_pred             CCCcCccCccccCCCccCCCCCCcceeeeEee
Q psy14630        152 AGCRPYMAPERIDPLRARGYPSFKTKLGFKFN  183 (187)
Q Consensus       152 ~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi~  183 (187)
                      .++..|+|||.+.   ...++.++|+||||+.
T Consensus       159 ~~~~~y~aPE~~~---~~~~~~~~Di~slG~~  187 (257)
T cd05060         159 RWPLKWYAPECIN---YGKFSSKSDVWSYGVT  187 (257)
T ss_pred             cccccccCHHHhc---CCCCCccchHHHHHHH
Confidence            2245799999987   5668899999999983

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi

>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases

Probab=99.94  E-value=2.8e-27  Score=177.20  Aligned_cols=154  Identities=25%  Similarity=0.399  Sum_probs=116.9

Q ss_pred             CcccccccccccccCceEEEEEEEcCCCcEEEEEEccCccChHHHHHHHHHHHHHHhcCCCCchhhhhhhH---------
Q psy14630         22 TSEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQFYGAL---------   92 (187)
Q Consensus        22 ~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~---------   92 (187)
                      ...+|++.+.||+|+||.||++.+. ++..+|+|.+......  ..+ +..+..+++.++||||+++++.+         
T Consensus         2 ~~~~~~~~~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~~~~--~~~-~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv   77 (256)
T cd05059           2 DPSELTFLKELGSGQFGVVHLGKWR-GKIDVAIKMIREGAMS--EDD-FIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIV   77 (256)
T ss_pred             ChHHcchhhhhccCCCceEEEeEec-CCccEEEEEeccCCCC--HHH-HHHHHHHHHhCCCCCEEEEEEEEcCCCceEEE
Confidence            4567899999999999999999875 4667899987643221  122 33345566778999999876321         


Q ss_pred             ------------------------HHHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEeccccccccccccc
Q psy14630         93 ------------------------FKEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAK  148 (187)
Q Consensus        93 ------------------------~~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg~a~~~~~~~~~  148 (187)
                                              ...+..|++.++.|||+. +++|||+||+||+++.++.+|++|||+++...+....
T Consensus        78 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~-~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~  156 (256)
T cd05059          78 TEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESN-GFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYT  156 (256)
T ss_pred             EecCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHC-CcccccccHhhEEECCCCcEEECCcccceeccccccc
Confidence                                    112567899999999997 9999999999999999999999999998876433221


Q ss_pred             cC--CCCCcCccCccccCCCccCCCCCCcceeeeEee
Q psy14630        149 TR--DAGCRPYMAPERIDPLRARGYPSFKTKLGFKFN  183 (187)
Q Consensus       149 ~~--~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi~  183 (187)
                      ..  ..++..|+|||.+.   ...++.++|+||||+.
T Consensus       157 ~~~~~~~~~~y~~Pe~~~---~~~~~~~~Di~slG~i  190 (256)
T cd05059         157 SSQGTKFPVKWAPPEVFD---YSRFSSKSDVWSFGVL  190 (256)
T ss_pred             ccCCCCCCccccCHHHhc---cCCCCchhhHHHHHHH
Confidence            11  12345799999988   5668899999999983

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows

>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes

Probab=99.94  E-value=3e-27  Score=177.44  Aligned_cols=156  Identities=20%  Similarity=0.313  Sum_probs=119.6

Q ss_pred             ccCCcccccccccccccCceEEEEEEEcCCCcEEEEEEccCccChHHHHHHHHHHHHHHhcCCCCchhhhhhhH------
Q psy14630         19 YDFTSEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQFYGAL------   92 (187)
Q Consensus        19 ~~~~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~------   92 (187)
                      |++..++|++.+.||+|+||.||+|.+..+ ..+|+|.+.....   ..+.+..+..+++.+.|+|++++++.+      
T Consensus         1 ~~~~~~~~~~~~~ig~g~~~~v~~~~~~~~-~~~~lK~~~~~~~---~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~   76 (260)
T cd05069           1 WEIPRESLRLDVKLGQGCFGEVWMGTWNGT-TKVAIKTLKPGTM---MPEAFLQEAQIMKKLRHDKLVPLYAVVSEEPIY   76 (260)
T ss_pred             CcCChHHeeeeeeecCcCCCeEEEEEEcCC-ceEEEEEcccCCc---cHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCcE
Confidence            456778899999999999999999987554 4689998764322   223344455677778999998765321      


Q ss_pred             ---------------------------HHHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEecccccccccc
Q psy14630         93 ---------------------------FKEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDS  145 (187)
Q Consensus        93 ---------------------------~~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg~a~~~~~~  145 (187)
                                                 ...+..+++.|+.|||+. +++|+||+|+|++++.++.++|+|||++......
T Consensus        77 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~-~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~  155 (260)
T cd05069          77 IVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERM-NYIHRDLRAANILVGDNLVCKIADFGLARLIEDN  155 (260)
T ss_pred             EEEEcCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CEeecccCcceEEEcCCCeEEECCCccceEccCC
Confidence                                       112567899999999997 9999999999999999999999999999776432


Q ss_pred             ccc--cCCCCCcCccCccccCCCccCCCCCCcceeeeEe
Q psy14630        146 IAK--TRDAGCRPYMAPERIDPLRARGYPSFKTKLGFKF  182 (187)
Q Consensus       146 ~~~--~~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi  182 (187)
                      ...  ....++..|+|||.+.   ....+.++|+||+|+
T Consensus       156 ~~~~~~~~~~~~~y~~Pe~~~---~~~~~~~~Di~slG~  191 (260)
T cd05069         156 EYTARQGAKFPIKWTAPEAAL---YGRFTIKSDVWSFGI  191 (260)
T ss_pred             cccccCCCccchhhCCHHHhc---cCCcChHHHHHHHHH
Confidence            211  1123456799999987   556889999999998

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an

>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=99.94  E-value=6e-27  Score=176.22  Aligned_cols=146  Identities=25%  Similarity=0.386  Sum_probs=109.7

Q ss_pred             ccccccCceEEEEEEEcC------------CCcEEEEEEccCccChHHHHHHHHHHHHHHhcCCCCchhhhhhhHH----
Q psy14630         30 GEIGRGGFGTVNKMIHRS------------SDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQFYGALF----   93 (187)
Q Consensus        30 ~~lg~G~fg~V~~~~~~~------------~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~----   93 (187)
                      +.||+|+||.||+|....            ....+++|.+...  .......+.++..++..+.||||+++++.+.    
T Consensus         1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~--~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~   78 (262)
T cd05077           1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPS--HRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVE   78 (262)
T ss_pred             CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChh--hhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCC
Confidence            468999999999997432            2335888887542  2223345566666778889999999875321    


Q ss_pred             -----------------------------HHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCC-------EEEEecc
Q psy14630         94 -----------------------------KEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGA-------IKLCDFG  137 (187)
Q Consensus        94 -----------------------------~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~-------~ki~dfg  137 (187)
                                                   ..++.|++.|++|||+. +++||||||+||+++.++.       ++++|||
T Consensus        79 ~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~-~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~g  157 (262)
T cd05077          79 NIMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDK-DLVHGNVCTKNILLAREGIDGECGPFIKLSDPG  157 (262)
T ss_pred             CEEEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhC-CeECCCCCcccEEEecCCccCCCCceeEeCCCC
Confidence                                         12667899999999997 9999999999999987654       8999999


Q ss_pred             ccccccccccccCCCCCcCccCccccCCCccCCCCCCcceeeeEee
Q psy14630        138 ISGQLVDSIAKTRDAGCRPYMAPERIDPLRARGYPSFKTKLGFKFN  183 (187)
Q Consensus       138 ~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi~  183 (187)
                      ++......   ....++..|+|||.+..  ...++.++|+||||+.
T Consensus       158 ~~~~~~~~---~~~~~~~~y~aPE~~~~--~~~~~~~~DiwslG~~  198 (262)
T cd05077         158 IPITVLSR---QECVERIPWIAPECVED--SKNLSIAADKWSFGTT  198 (262)
T ss_pred             CCccccCc---ccccccccccChhhhcC--CCCCCchhHHHHHHHH
Confidence            98765322   12356788999998762  3457889999999994

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom

>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

Probab=99.94  E-value=4.1e-27  Score=182.62  Aligned_cols=156  Identities=22%  Similarity=0.321  Sum_probs=122.6

Q ss_pred             CcccccccccccccCceEEEEEEEcCCCcEEEEEEccCccChHHHHHHHHHHHHHHhcCCCCchhhhhhhHH--------
Q psy14630         22 TSEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQFYGALF--------   93 (187)
Q Consensus        22 ~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~--------   93 (187)
                      ..++|++.+.||.|+||.||++.+..++..+|+|.+..........+.+..+..+++.+.|||++++.+.+.        
T Consensus         8 ~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~l   87 (328)
T cd07856           8 ITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIYF   87 (328)
T ss_pred             cccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEEE
Confidence            346799999999999999999999999999999987543222223334445556777889999998765331        


Q ss_pred             -----------------------HHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEeccccccccccccccC
Q psy14630         94 -----------------------KEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTR  150 (187)
Q Consensus        94 -----------------------~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg~a~~~~~~~~~~~  150 (187)
                                             ..+..|++.|+.|||+. +++||||+|+|++++.++.++++|||++......  ...
T Consensus        88 v~e~~~~~L~~~~~~~~~~~~~~~~~~~ql~~aL~~LH~~-~iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~~~--~~~  164 (328)
T cd07856          88 VTELLGTDLHRLLTSRPLEKQFIQYFLYQILRGLKYVHSA-GVVHRDLKPSNILINENCDLKICDFGLARIQDPQ--MTG  164 (328)
T ss_pred             EeehhccCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC-CcccCCCCHHHEeECCCCCEEeCccccccccCCC--cCC
Confidence                                   11567899999999997 9999999999999999999999999998764332  223


Q ss_pred             CCCCcCccCccccCCCccCCCCCCcceeeeEe
Q psy14630        151 DAGCRPYMAPERIDPLRARGYPSFKTKLGFKF  182 (187)
Q Consensus       151 ~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi  182 (187)
                      ..++..|+|||.+.+  ...++.++|+||+|+
T Consensus       165 ~~~~~~y~aPE~~~~--~~~~~~~~Dv~slG~  194 (328)
T cd07856         165 YVSTRYYRAPEIMLT--WQKYDVEVDIWSAGC  194 (328)
T ss_pred             CcccccccCceeeec--cCCcCcHHHHHHHHH
Confidence            356788999998762  245789999999998

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U

>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

Probab=99.94  E-value=4.5e-27  Score=178.93  Aligned_cols=158  Identities=23%  Similarity=0.370  Sum_probs=121.5

Q ss_pred             CCcccccccccccccCceEEEEEEEc-----CCCcEEEEEEccCccChHHHHHHHHHHHHHHhcCCCCchhhhhhhH---
Q psy14630         21 FTSEDLQDLGEIGRGGFGTVNKMIHR-----SSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQFYGAL---   92 (187)
Q Consensus        21 ~~~~~~~~~~~lg~G~fg~V~~~~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~---   92 (187)
                      .+.++|++.+.||+|+||.||++.+.     .++..+|+|.++...... ..+.+..+..+++.+.|||++++++.+   
T Consensus         2 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~   80 (288)
T cd05050           2 YPRNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASAD-MQADFQREAALMAEFDHPNIVKLLGVCAVG   80 (288)
T ss_pred             CChHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHH-HHHHHHHHHHHHHhcCCCchheEEEEEcCC
Confidence            45688999999999999999999864     367889999987543332 233445555567778999999876321   


Q ss_pred             ------------------H---------------------------------HHHHHHHHHHHHHHHhcCCCeeecCCCC
Q psy14630         93 ------------------F---------------------------------KEVTVATVKALNYLKEELKIIHRDVKPS  121 (187)
Q Consensus        93 ------------------~---------------------------------~~~~~~~~~~l~~lh~~~~i~Hrdlk~~  121 (187)
                                        .                                 ..+..+++.||.|||+. +++||||||+
T Consensus        81 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~-~i~H~dl~p~  159 (288)
T cd05050          81 KPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSER-KFVHRDLATR  159 (288)
T ss_pred             CccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC-CeecccccHh
Confidence                              0                                 13667889999999997 9999999999


Q ss_pred             CeEEcCCCCEEEEecccccccccccc---ccCCCCCcCccCccccCCCccCCCCCCcceeeeEee
Q psy14630        122 NILLDRRGAIKLCDFGISGQLVDSIA---KTRDAGCRPYMAPERIDPLRARGYPSFKTKLGFKFN  183 (187)
Q Consensus       122 nili~~~~~~ki~dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi~  183 (187)
                      |++++.++.++++|||+++.......   ......+..|+|||.+.   ...++.++|+||||+.
T Consensus       160 nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~Dv~slG~i  221 (288)
T cd05050         160 NCLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIF---YNRYTTESDVWAYGVV  221 (288)
T ss_pred             heEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHh---cCCCCchhHHHHHHHH
Confidence            99999999999999999876533211   11223456799999987   5678899999999983

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M

>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

Probab=99.94  E-value=1.2e-26  Score=174.15  Aligned_cols=148  Identities=30%  Similarity=0.486  Sum_probs=119.1

Q ss_pred             ccccCceEEEEEEEcCCCcEEEEEEccCcc-ChHHHHHHHHHHHHHHhcCCCCchhhhhhhHH-----------------
Q psy14630         32 IGRGGFGTVNKMIHRSSDTVMAVKRIRSTV-DEKDQRQLLMDLDVVMKSNECPYIVQFYGALF-----------------   93 (187)
Q Consensus        32 lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~-----------------   93 (187)
                      ||.|+||.||+|.+..+++.+|+|.+.... ......+.+..+..+++.+.||||+++++.+.                 
T Consensus         1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (262)
T cd05572           1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL   80 (262)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence            699999999999999889999999986432 22233455666666778889999998764321                 


Q ss_pred             ---------------HHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEeccccccccccccccCCCCCcCcc
Q psy14630         94 ---------------KEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTRDAGCRPYM  158 (187)
Q Consensus        94 ---------------~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg~a~~~~~~~~~~~~~~t~~y~  158 (187)
                                     ..+..+++.|+.|||+. +++|+||+|+||+++.++.++++|||++.............+++.|+
T Consensus        81 ~~~l~~~~~l~~~~~~~~~~~i~~~l~~lH~~-~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~  159 (262)
T cd05572          81 WTILRDRGLFDEYTARFYIACVVLAFEYLHNR-GIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTWTFCGTPEYV  159 (262)
T ss_pred             HHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhC-CcccCCCCHHHEEEcCCCCEEEeeCCcccccCcccccccccCCcCcc
Confidence                           11556899999999997 99999999999999999999999999998876543333446788999


Q ss_pred             CccccCCCccCCCCCCcceeeeEee
Q psy14630        159 APERIDPLRARGYPSFKTKLGFKFN  183 (187)
Q Consensus       159 aPE~~~~~~~~~~~~~~D~ws~gi~  183 (187)
                      +||.+.   ...++.++|+||+|+.
T Consensus       160 ~PE~~~---~~~~~~~~Di~slG~i  181 (262)
T cd05572         160 APEIIL---NKGYDFSVDYWSLGIL  181 (262)
T ss_pred             ChhHhc---CCCCCChhhhhhhHHH
Confidence            999987   5668899999999983

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi

>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

Probab=99.94  E-value=5.3e-27  Score=176.83  Aligned_cols=152  Identities=20%  Similarity=0.273  Sum_probs=109.7

Q ss_pred             ccccccCceEEEEEEEc--CCCcEEEEEEccCccChHHHHHHHHHHHHHHhcCCCCchhhhhhhH---------------
Q psy14630         30 GEIGRGGFGTVNKMIHR--SSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQFYGAL---------------   92 (187)
Q Consensus        30 ~~lg~G~fg~V~~~~~~--~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~---------------   92 (187)
                      +.||+|+||.||+|...  .....+++|.+........ ...+.++...++.++|+||+++++.+               
T Consensus         1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~-~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~   79 (269)
T cd05042           1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDE-QLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPL   79 (269)
T ss_pred             CcCCccCCceEEEEEEecCCCCeEEEEeecCccCChHH-HHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCC
Confidence            36899999999999643  2445788888764333222 33344455566778999999876421               


Q ss_pred             ----------------------HHHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEeccccccccccc---c
Q psy14630         93 ----------------------FKEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSI---A  147 (187)
Q Consensus        93 ----------------------~~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg~a~~~~~~~---~  147 (187)
                                            ...++.|++.|++|||+. +++||||||+|++++.++.+|++|||+++......   .
T Consensus        80 g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~-~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~  158 (269)
T cd05042          80 GDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQA-DFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYIT  158 (269)
T ss_pred             CcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhc-CEecccccHhheEecCCCcEEEeccccccccccchheec
Confidence                                  112557899999999998 99999999999999999999999999987643221   1


Q ss_pred             ccCCCCCcCccCccccCCC----ccCCCCCCcceeeeEee
Q psy14630        148 KTRDAGCRPYMAPERIDPL----RARGYPSFKTKLGFKFN  183 (187)
Q Consensus       148 ~~~~~~t~~y~aPE~~~~~----~~~~~~~~~D~ws~gi~  183 (187)
                      .....++..|+|||++...    ....++.++|+||+|+.
T Consensus       159 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~  198 (269)
T cd05042         159 KDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVT  198 (269)
T ss_pred             cCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHH
Confidence            1223456779999997521    12346789999999983

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina

>KOG0669|consensus

Probab=99.94  E-value=1.4e-28  Score=177.87  Aligned_cols=161  Identities=23%  Similarity=0.311  Sum_probs=122.8

Q ss_pred             cCCcccccccccccccCceEEEEEEEcCCCcEEEEEEccCccChHHHHHHHHHHHHHHhcCCCCchhhhhhhHH------
Q psy14630         20 DFTSEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQFYGALF------   93 (187)
Q Consensus        20 ~~~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~------   93 (187)
                      ....+.|....++|+|.||.||+|+++.+++.||+|.+--...+........++..++..+.|+|++.+.+.+-      
T Consensus        13 ~~~~~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~   92 (376)
T KOG0669|consen   13 CDEVSKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPT   92 (376)
T ss_pred             eecchHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCc
Confidence            34556788889999999999999999999999999875211111112222333445677789999998875431      


Q ss_pred             ----------------------------------HHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEecccc
Q psy14630         94 ----------------------------------KEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGIS  139 (187)
Q Consensus        94 ----------------------------------~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg~a  139 (187)
                                                        +.++.++..||.|+|+. .|+|||+|+.|++|+.+|.+||+|||++
T Consensus        93 ~r~r~t~ylVf~~cehDLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iHr~-kilHRDmKaaNvLIt~dgilklADFGla  171 (376)
T KOG0669|consen   93 NRDRATFYLVFDFCEHDLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIHRN-KILHRDMKAANVLITKDGILKLADFGLA  171 (376)
T ss_pred             ccccceeeeeHHHhhhhHHHHhcCccccccHHHHHHHHHHHHHHHHHHHHh-hHHhhcccHhhEEEcCCceEEeeccccc
Confidence                                              22567788999999998 9999999999999999999999999999


Q ss_pred             ccccccccc-----cCCCCCcCccCccccCCCccCCCCCCcceeeeEee
Q psy14630        140 GQLVDSIAK-----TRDAGCRPYMAPERIDPLRARGYPSFKTKLGFKFN  183 (187)
Q Consensus       140 ~~~~~~~~~-----~~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi~  183 (187)
                      +.+..+...     +..+-|.+|++||.+.+  ...|.++.|+|+.|.+
T Consensus       172 r~fs~~~n~~kprytnrvvTLwYrppEllLG--~r~yg~~iDiWgAgCi  218 (376)
T KOG0669|consen  172 RAFSTSKNVVKPRYTNRVVTLWYRPPELLLG--DREYGPPIDIWGAGCI  218 (376)
T ss_pred             cceecccccCCCCcccceeeeecCCHHHhhc--ccccCCcchhHhHHHH
Confidence            877533211     12245889999999997  4558899999999873

>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

Probab=99.94  E-value=6.3e-27  Score=177.49  Aligned_cols=156  Identities=24%  Similarity=0.348  Sum_probs=121.3

Q ss_pred             ccccccccccCceEEEEEEEcCCCcEEEEEEccCccChHHHHHHHHHHHHHHhcCCCCchhhhhhhHH------------
Q psy14630         26 LQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQFYGALF------------   93 (187)
Q Consensus        26 ~~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~------------   93 (187)
                      |++.+.||+|+||.||+|.+..+++.+|+|.+............+..+..+++.+.|+|++++++.+.            
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e   80 (287)
T cd07840           1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE   80 (287)
T ss_pred             CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence            56788999999999999999988999999998754322233334445555677788999998764321            


Q ss_pred             ----------------------HHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEeccccccccccc--ccc
Q psy14630         94 ----------------------KEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSI--AKT  149 (187)
Q Consensus        94 ----------------------~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg~a~~~~~~~--~~~  149 (187)
                                            ..+..+++.|++|||+. +++|+||+|+||+++.++.++++|||++.......  ...
T Consensus        81 ~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~-~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~  159 (287)
T cd07840          81 YMDHDLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSN-GILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYT  159 (287)
T ss_pred             cccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC-CceeccCcHHHeEEcCCCCEEEccccceeeccCCCccccc
Confidence                                  12567899999999997 99999999999999999999999999998765432  122


Q ss_pred             CCCCCcCccCccccCCCccCCCCCCcceeeeEeee
Q psy14630        150 RDAGCRPYMAPERIDPLRARGYPSFKTKLGFKFNY  184 (187)
Q Consensus       150 ~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi~~  184 (187)
                      ...++..|+|||.+.+  ...++.++|+||||+.+
T Consensus       160 ~~~~~~~y~~PE~~~~--~~~~~~~~Dv~slG~~l  192 (287)
T cd07840         160 NRVITLWYRPPELLLG--ATRYGPEVDMWSVGCIL  192 (287)
T ss_pred             ccccccccCCceeeEc--cccCChHHHHHHHHHHH
Confidence            2356778999998763  33578899999999844

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po

>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

Probab=99.94  E-value=8.8e-27  Score=176.76  Aligned_cols=156  Identities=25%  Similarity=0.438  Sum_probs=119.5

Q ss_pred             ccccccccccCceEEEEEEEcCCCcEEEEEEccCccChHHHHHHHHHHHHHHhcCCCCchhhhhhhHHH-----------
Q psy14630         26 LQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQFYGALFK-----------   94 (187)
Q Consensus        26 ~~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~-----------   94 (187)
                      |++.+.||.|++|.||+|.+..++..||+|.+..........+.+..+...++.++|||++++++.+..           
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~   80 (283)
T cd07835           1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL   80 (283)
T ss_pred             CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence            567889999999999999998899999999986432222222334445556777889999988754211           


Q ss_pred             ----------------------HHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEeccccccccccc-cccCC
Q psy14630         95 ----------------------EVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSI-AKTRD  151 (187)
Q Consensus        95 ----------------------~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg~a~~~~~~~-~~~~~  151 (187)
                                            .+..|++.+|+|||+. +++|+|++|+||+++.++.++++|||++....... .....
T Consensus        81 ~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~-~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~  159 (283)
T cd07835          81 DLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSH-RVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTYTHE  159 (283)
T ss_pred             CcCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHC-CeeCCCCCHHHEEEcCCCcEEEeecccccccCCCccccCcc
Confidence                                  2567899999999997 99999999999999999999999999987653221 11223


Q ss_pred             CCCcCccCccccCCCccCCCCCCcceeeeEeee
Q psy14630        152 AGCRPYMAPERIDPLRARGYPSFKTKLGFKFNY  184 (187)
Q Consensus       152 ~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi~~  184 (187)
                      .++..|+|||.+.+  ...++.++|+||+|+.+
T Consensus       160 ~~~~~~~aPE~~~~--~~~~~~~~Di~slG~~l  190 (283)
T cd07835         160 VVTLWYRAPEILLG--SRQYSTPVDIWSIGCIF  190 (283)
T ss_pred             ccccCCCCCceeec--CcccCcHHHHHHHHHHH
Confidence            46788999998863  23467899999999843

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc

>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases

Probab=99.94  E-value=4.3e-27  Score=176.42  Aligned_cols=156  Identities=22%  Similarity=0.320  Sum_probs=121.5

Q ss_pred             ccCCcccccccccccccCceEEEEEEEcCCCcEEEEEEccCccChHHHHHHHHHHHHHHhcCCCCchhhhhhhHH-----
Q psy14630         19 YDFTSEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQFYGALF-----   93 (187)
Q Consensus        19 ~~~~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~-----   93 (187)
                      |++..++|.+.+.||+|+||.||++.+. .++.+|+|.+......   .+.+.++...++.+.|+|++++++.+.     
T Consensus         1 ~~~~~~~~~i~~~ig~g~~~~v~~~~~~-~~~~~~vK~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   76 (261)
T cd05034           1 WEIPRESLKLERKLGAGQFGEVWMGTWN-GTTKVAVKTLKPGTMS---PEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPI   76 (261)
T ss_pred             CccchhheeeeeeeccCcceEEEEEEEc-CCceEEEEEecCCccC---HHHHHHHHHHHhhCCCCCEeeeeeeeecCCce
Confidence            5678899999999999999999999875 4577999988643221   223444555677789999998864321     


Q ss_pred             -----------------------------HHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEeccccccccc
Q psy14630         94 -----------------------------KEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVD  144 (187)
Q Consensus        94 -----------------------------~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg~a~~~~~  144 (187)
                                                   ..+..+++.|+.|||+. +++|+||+|+||+++.++.++++|||++.....
T Consensus        77 ~~v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~-~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~  155 (261)
T cd05034          77 YIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESR-NYIHRDLAARNILVGENLVCKIADFGLARLIED  155 (261)
T ss_pred             EEEEeccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhC-CcccCCcchheEEEcCCCCEEECccccceeccc
Confidence                                         12567889999999997 999999999999999999999999999887653


Q ss_pred             cccc--cCCCCCcCccCccccCCCccCCCCCCcceeeeEe
Q psy14630        145 SIAK--TRDAGCRPYMAPERIDPLRARGYPSFKTKLGFKF  182 (187)
Q Consensus       145 ~~~~--~~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi  182 (187)
                      ....  .....+..|+|||.+.   ....+.++|+||+|+
T Consensus       156 ~~~~~~~~~~~~~~y~~PE~~~---~~~~~~~~Di~slG~  192 (261)
T cd05034         156 DEYTAREGAKFPIKWTAPEAAN---YGRFTIKSDVWSFGI  192 (261)
T ss_pred             hhhhhhhccCCCccccCHHHhc---cCCcCchhHHHHHHH
Confidence            2211  1122456799999988   556789999999998

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t

>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

Probab=99.94  E-value=1.7e-26  Score=174.03  Aligned_cols=160  Identities=27%  Similarity=0.396  Sum_probs=120.6

Q ss_pred             CCcccccccccccccCceEEEEEEEcCCCcEEEEEEccCccChHHHHHHHHHHHHHHhcCCCCchhhhhhhHHH------
Q psy14630         21 FTSEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQFYGALFK------   94 (187)
Q Consensus        21 ~~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~------   94 (187)
                      +..+.......||+|+||.||+|.+..++..+|+|.+...  .....+.+.++..+++.++|+||+++++.+..      
T Consensus         5 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l   82 (268)
T cd06624           5 YEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPER--DSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKI   82 (268)
T ss_pred             cccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCC--CHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEE
Confidence            3445555567899999999999999889999999987643  22233445556667778899999987643211      


Q ss_pred             -----------------------------HHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcC-CCCEEEEeccccccccc
Q psy14630         95 -----------------------------EVTVATVKALNYLKEELKIIHRDVKPSNILLDR-RGAIKLCDFGISGQLVD  144 (187)
Q Consensus        95 -----------------------------~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~-~~~~ki~dfg~a~~~~~  144 (187)
                                                   .+..|++.|++|||+. +++||||||+||+++. .+.++|+|||++.....
T Consensus        83 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~-~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~  161 (268)
T cd06624          83 FMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDN-QIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAG  161 (268)
T ss_pred             EEecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHC-CEeecCCCHHHEEEcCCCCeEEEecchhheeccc
Confidence                                         1456899999999997 9999999999999976 67899999999876543


Q ss_pred             cc-cccCCCCCcCccCccccCCCccCCCCCCcceeeeEeee
Q psy14630        145 SI-AKTRDAGCRPYMAPERIDPLRARGYPSFKTKLGFKFNY  184 (187)
Q Consensus       145 ~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi~~  184 (187)
                      .. ......+++.|+|||.+.+. ...++.++|+||+|+++
T Consensus       162 ~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~~~Dv~slGvvl  201 (268)
T cd06624         162 INPCTETFTGTLQYMAPEVIDKG-PRGYGAPADIWSLGCTI  201 (268)
T ss_pred             CCCccccCCCCccccChhhhccc-cccCCchhhhHHHHHHH
Confidence            21 12233578899999998632 23477899999999843

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina

>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

Probab=99.94  E-value=7.8e-27  Score=175.74  Aligned_cols=158  Identities=25%  Similarity=0.349  Sum_probs=120.1

Q ss_pred             CCcccccccccccccCceEEEEEEEcCCCc---EEEEEEccCccChHHHHHHHHHHHHHHhcCCCCchhhhhhhHH----
Q psy14630         21 FTSEDLQDLGEIGRGGFGTVNKMIHRSSDT---VMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQFYGALF----   93 (187)
Q Consensus        21 ~~~~~~~~~~~lg~G~fg~V~~~~~~~~~~---~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~----   93 (187)
                      +..++|+..+.||+|+||.||+|....++.   .+|+|.++....... .+.+..+..+++.+.|+|++++++.+.    
T Consensus         2 i~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   80 (268)
T cd05063           2 IHPSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQ-RQDFLSEASIMGQFSHHNIIRLEGVVTKFKP   80 (268)
T ss_pred             CChHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHH-HHHHHHHHHHHhcCCCCCeeEEEEEEccCCC
Confidence            456788899999999999999999865554   689998865433332 334445556777889999988764321    


Q ss_pred             -----------------------------HHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEeccccccccc
Q psy14630         94 -----------------------------KEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVD  144 (187)
Q Consensus        94 -----------------------------~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg~a~~~~~  144 (187)
                                                   ..+..+++.|++|||+. +++|+|+||+||+++.++.++++|||++.....
T Consensus        81 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~-~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~  159 (268)
T cd05063          81 AMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDM-NYVHRDLAARNILVNSNLECKVSDFGLSRVLED  159 (268)
T ss_pred             cEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC-CeeccccchhhEEEcCCCcEEECCCccceeccc
Confidence                                         12567889999999997 999999999999999999999999999887643


Q ss_pred             ccccc----CCCCCcCccCccccCCCccCCCCCCcceeeeEee
Q psy14630        145 SIAKT----RDAGCRPYMAPERIDPLRARGYPSFKTKLGFKFN  183 (187)
Q Consensus       145 ~~~~~----~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi~  183 (187)
                      .....    ....+..|+|||.+.   ...++.++|+||||+.
T Consensus       160 ~~~~~~~~~~~~~~~~y~~PE~~~---~~~~~~~~Dv~slG~i  199 (268)
T cd05063         160 DPEGTYTTSGGKIPIRWTAPEAIA---YRKFTSASDVWSFGIV  199 (268)
T ss_pred             ccccceeccCCCcCceecCHHHhh---cCCcChHhHHHHHHHH
Confidence            22111    112345699999988   5668899999999983

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored

>KOG0668|consensus

Probab=99.94  E-value=2.7e-27  Score=169.02  Aligned_cols=156  Identities=19%  Similarity=0.344  Sum_probs=127.1

Q ss_pred             CcccccccccccccCceEEEEEEEcCCCcEEEEEEccCccChHHHHHHHHHHHHHHhcCCCCchhhhhhhHHHH------
Q psy14630         22 TSEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQFYGALFKE------   95 (187)
Q Consensus        22 ~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~------   95 (187)
                      ..++|++.+++|+|-|+.||.|.+..+++.++||+++.-.    ..++.+|+.++.....||||+.+++...+.      
T Consensus        36 ~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVk----kkKIkREikIL~nL~gg~NIi~L~DiV~Dp~Sktpa  111 (338)
T KOG0668|consen   36 NQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVK----KKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPS  111 (338)
T ss_pred             ccchHHHHHHHcCccHhhHhcccccCCCceEEEeeechHH----HHHHHHHHHHHHhccCCCCeeehhhhhcCccccCch
Confidence            5678999999999999999999999999999999987421    234445555555666799999998653221      


Q ss_pred             -------------------------HHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCC-CCEEEEecccccccccccccc
Q psy14630         96 -------------------------VTVATVKALNYLKEELKIIHRDVKPSNILLDRR-GAIKLCDFGISGQLVDSIAKT  149 (187)
Q Consensus        96 -------------------------~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~-~~~ki~dfg~a~~~~~~~~~~  149 (187)
                                               .+.++++||.|+|+. ||.|||+||.|++|+.. ..++++|+|+|-...+.....
T Consensus       112 LiFE~v~n~Dfk~ly~tl~d~dIryY~~elLkALdyCHS~-GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp~~eYn  190 (338)
T KOG0668|consen  112 LIFEYVNNTDFKQLYPTLTDYDIRYYIYELLKALDYCHSM-GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYN  190 (338)
T ss_pred             hHhhhhccccHHHHhhhhchhhHHHHHHHHHHHHhHHHhc-CcccccCCcceeeechhhceeeeeecchHhhcCCCceee
Confidence                                     556899999999997 99999999999999864 469999999999988776666


Q ss_pred             CCCCCcCccCccccCCCccCCCCCCcceeeeEeee
Q psy14630        150 RDAGCRPYMAPERIDPLRARGYPSFKTKLGFKFNY  184 (187)
Q Consensus       150 ~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi~~  184 (187)
                      ..+.+..|.-||++...  .-|+..-|+||||+++
T Consensus       191 VRVASRyfKGPELLVdy--~~YDYSLD~WS~Gcml  223 (338)
T KOG0668|consen  191 VRVASRYFKGPELLVDY--QMYDYSLDMWSLGCML  223 (338)
T ss_pred             eeeehhhcCCchheeec--hhccccHHHHHHHHHH
Confidence            56778889999999843  3488999999999853

>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=99.94  E-value=7.1e-27  Score=174.87  Aligned_cols=146  Identities=26%  Similarity=0.385  Sum_probs=111.7

Q ss_pred             ccccccCceEEEEEEEcCCC----------cEEEEEEccCccChHHHHHHHHHHHHHHhcCCCCchhhhhhhHH------
Q psy14630         30 GEIGRGGFGTVNKMIHRSSD----------TVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQFYGALF------   93 (187)
Q Consensus        30 ~~lg~G~fg~V~~~~~~~~~----------~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~------   93 (187)
                      +.||+|+||.||+|.+..++          ..+++|.......  . ...+.++..+++.+.||||+++++.+.      
T Consensus         1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~--~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~l   77 (259)
T cd05037           1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHR--D-SLAFFETASLMSQLSHKHLVKLYGVCVRDENIM   77 (259)
T ss_pred             CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchh--h-HHHHHHHHHHHHcCCCcchhheeeEEecCCcEE
Confidence            46899999999999987666          3578887653211  1 344555666778889999998876431      


Q ss_pred             --------------------------HHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCC-------CEEEEeccccc
Q psy14630         94 --------------------------KEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRG-------AIKLCDFGISG  140 (187)
Q Consensus        94 --------------------------~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~-------~~ki~dfg~a~  140 (187)
                                                ..++.|++.||+|||+. +++||||||+||+++.++       .++++|||++.
T Consensus        78 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~-~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~a~  156 (259)
T cd05037          78 VEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDK-KLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPI  156 (259)
T ss_pred             EEEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhC-CeecccCccceEEEecCccccCCceeEEeCCCCccc
Confidence                                      11557899999999997 999999999999999887       79999999988


Q ss_pred             cccccccccCCCCCcCccCccccCCCccCCCCCCcceeeeEee
Q psy14630        141 QLVDSIAKTRDAGCRPYMAPERIDPLRARGYPSFKTKLGFKFN  183 (187)
Q Consensus       141 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi~  183 (187)
                      .....   ....++..|+|||.+.+. ...++.++|+||+|+.
T Consensus       157 ~~~~~---~~~~~~~~y~aPE~~~~~-~~~~~~~~Di~slG~~  195 (259)
T cd05037         157 TVLSR---EERVERIPWIAPECIRNG-QASLTIAADKWSFGTT  195 (259)
T ss_pred             ccccc---cccccCCCccChhhhcCC-CCCcchhhHHHHHHHH
Confidence            75442   223456789999998732 1367899999999983

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki

>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

Probab=99.94  E-value=1.1e-26  Score=173.84  Aligned_cols=155  Identities=26%  Similarity=0.382  Sum_probs=121.7

Q ss_pred             cccccccccccCceEEEEEEEcCCCcEEEEEEccCccChHHHHHHHHHHHHHHhcCCCCchhhhhhhHH-----------
Q psy14630         25 DLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQFYGALF-----------   93 (187)
Q Consensus        25 ~~~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~-----------   93 (187)
                      +|++.+.||+|+||.+|++.+..+++.+|+|.+..........+.+.++...++.++||||+++++.+.           
T Consensus         1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08218           1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY   80 (256)
T ss_pred             CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence            478899999999999999999989999999988643222222334455555777889999998764321           


Q ss_pred             -----------------------HHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEecccccccccccc-cc
Q psy14630         94 -----------------------KEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIA-KT  149 (187)
Q Consensus        94 -----------------------~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg~a~~~~~~~~-~~  149 (187)
                                             ..+..|++.++.|||+. +++|+||+|+||+++.++.++++|||++........ ..
T Consensus        81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~-~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~  159 (256)
T cd08218          81 CEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDR-KILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELAR  159 (256)
T ss_pred             CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhC-CEecCCCCHHHEEEcCCCCEEEeeccceeecCcchhhhh
Confidence                                   12567899999999997 999999999999999999999999999887644221 22


Q ss_pred             CCCCCcCccCccccCCCccCCCCCCcceeeeEee
Q psy14630        150 RDAGCRPYMAPERIDPLRARGYPSFKTKLGFKFN  183 (187)
Q Consensus       150 ~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi~  183 (187)
                      ...+++.|+|||.+.   +..++.++|+||||+.
T Consensus       160 ~~~~~~~~~~pe~~~---~~~~~~~~Dv~slG~i  190 (256)
T cd08218         160 TCIGTPYYLSPEICE---NRPYNNKSDIWALGCV  190 (256)
T ss_pred             hccCCccccCHHHhC---CCCCCCccchhHHHHH
Confidence            335788899999988   5567889999999983

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti

>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

Probab=99.94  E-value=2.1e-26  Score=179.67  Aligned_cols=156  Identities=21%  Similarity=0.327  Sum_probs=123.0

Q ss_pred             cccccccccccccCceEEEEEEEcCCCcEEEEEEccCccChHHHHHHHHHHHHHHhcCCCCchhhhhhhHH---------
Q psy14630         23 SEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQFYGALF---------   93 (187)
Q Consensus        23 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~---------   93 (187)
                      .++|++...||+|+||.||+|.+..+++.||+|.+..........+.+..+..+++.+.|+|++++.+.+.         
T Consensus        14 ~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   93 (343)
T cd07851          14 PDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDFQ   93 (343)
T ss_pred             cCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccccc
Confidence            46799999999999999999999999999999988643222223333444555677789999998765331         


Q ss_pred             ---------------------------HHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEeccccccccccc
Q psy14630         94 ---------------------------KEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSI  146 (187)
Q Consensus        94 ---------------------------~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg~a~~~~~~~  146 (187)
                                                 ..++.|++.+++|||+. +++||||+|+|++++.++.++|+|||++...... 
T Consensus        94 ~~~lv~e~~~~~L~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~-gi~H~dlkp~Nill~~~~~~kL~dfg~~~~~~~~-  171 (343)
T cd07851          94 DVYLVTHLMGADLNNIVKCQKLSDDHIQFLVYQILRGLKYIHSA-GIIHRDLKPSNIAVNEDCELKILDFGLARHTDDE-  171 (343)
T ss_pred             cEEEEEecCCCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC-CeecCCCCHHHeEECCCCCEEEcccccccccccc-
Confidence                                       11567899999999997 9999999999999999999999999999876433 


Q ss_pred             cccCCCCCcCccCccccCCCccCCCCCCcceeeeEee
Q psy14630        147 AKTRDAGCRPYMAPERIDPLRARGYPSFKTKLGFKFN  183 (187)
Q Consensus       147 ~~~~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi~  183 (187)
                       .....++..|+|||.+.+  ...++.++|+||+|+.
T Consensus       172 -~~~~~~~~~y~aPE~~~~--~~~~~~~~DvwslGv~  205 (343)
T cd07851         172 -MTGYVATRWYRAPEIMLN--WMHYNQTVDIWSVGCI  205 (343)
T ss_pred             -ccCCcccccccCHHHHhC--CCCCCchHhHHHHHHH
Confidence             223357888999999863  2357789999999983

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK

>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

Probab=99.93  E-value=1.3e-26  Score=180.67  Aligned_cols=157  Identities=20%  Similarity=0.304  Sum_probs=120.9

Q ss_pred             cccccccccccccCceEEEEEEEcCCCcEEEEEEccCccChHHHHHHHHHHHHHHhcCCCCchhhhhhhHH---------
Q psy14630         23 SEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQFYGALF---------   93 (187)
Q Consensus        23 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~---------   93 (187)
                      ..+|.+.+.||.|+||.||+|.+..+++.||+|.+.....  ...+.+.++..+++.++||||+++++.+.         
T Consensus         4 ~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~--~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~   81 (342)
T cd07854           4 GSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDP--QSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTED   81 (342)
T ss_pred             CcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCC--chHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccc
Confidence            3789999999999999999999999999999998854322  22334445556677889999998874321         


Q ss_pred             -----------------------------------HHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcC-CCCEEEEecc
Q psy14630         94 -----------------------------------KEVTVATVKALNYLKEELKIIHRDVKPSNILLDR-RGAIKLCDFG  137 (187)
Q Consensus        94 -----------------------------------~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~-~~~~ki~dfg  137 (187)
                                                         ..++.|++.|+.|||+. +++||||||+||+++. ++.++++|||
T Consensus        82 ~~~~~~~~~~~lv~e~~~~~L~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~-givH~dikp~Nili~~~~~~~kl~dfg  160 (342)
T cd07854          82 VGSLTELNSVYIVQEYMETDLANVLEQGPLSEEHARLFMYQLLRGLKYIHSA-NVLHRDLKPANVFINTEDLVLKIGDFG  160 (342)
T ss_pred             cccccccceEEEEeecccccHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhC-CcccCCCCHHHEEEcCCCceEEECCcc
Confidence                                               11567899999999997 9999999999999974 5578999999


Q ss_pred             ccccccccc----cccCCCCCcCccCccccCCCccCCCCCCcceeeeEeee
Q psy14630        138 ISGQLVDSI----AKTRDAGCRPYMAPERIDPLRARGYPSFKTKLGFKFNY  184 (187)
Q Consensus       138 ~a~~~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi~~  184 (187)
                      +++......    ......++..|+|||.+.+  ...++.++|+||+|+.+
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~~DiwSlGvil  209 (342)
T cd07854         161 LARIVDPHYSHKGYLSEGLVTKWYRSPRLLLS--PNNYTKAIDMWAAGCIF  209 (342)
T ss_pred             cceecCCccccccccccccccccccCHHHHhC--ccccCchhhHHHHHHHH
Confidence            987653221    1122356788999998763  34577899999999843

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi

>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

Probab=99.93  E-value=1.5e-26  Score=176.33  Aligned_cols=154  Identities=23%  Similarity=0.362  Sum_probs=116.9

Q ss_pred             cccccccccccCceEEEEEEEcC-----CCcEEEEEEccCccChHHHHHHHHHHHHHHhcCCCCchhhhhhhH-------
Q psy14630         25 DLQDLGEIGRGGFGTVNKMIHRS-----SDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQFYGAL-------   92 (187)
Q Consensus        25 ~~~~~~~lg~G~fg~V~~~~~~~-----~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~-------   92 (187)
                      +|++.+.||+|+||.||+|....     ....+++|.+......... +.+..+..+++.+.||||+++++.+       
T Consensus         1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~-~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   79 (290)
T cd05045           1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSEL-RDLLSEFNLLKQVNHPHVIKLYGACSQDGPLL   79 (290)
T ss_pred             CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHH-HHHHHHHHHHhhCCCCCEeeEEEEEecCCCcE
Confidence            47788999999999999998643     2356899988654433333 3344455577788999999876421       


Q ss_pred             --------------H-----------------------------------HHHHHHHHHHHHHHHhcCCCeeecCCCCCe
Q psy14630         93 --------------F-----------------------------------KEVTVATVKALNYLKEELKIIHRDVKPSNI  123 (187)
Q Consensus        93 --------------~-----------------------------------~~~~~~~~~~l~~lh~~~~i~Hrdlk~~ni  123 (187)
                                    .                                   ..+..|++.++.|||+. +++||||||+||
T Consensus        80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~-~ivH~dikp~ni  158 (290)
T cd05045          80 LIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEM-KLVHRDLAARNV  158 (290)
T ss_pred             EEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHC-CeehhhhhhheE
Confidence                          0                                   13567899999999997 999999999999


Q ss_pred             EEcCCCCEEEEecccccccccccc---ccCCCCCcCccCccccCCCccCCCCCCcceeeeEee
Q psy14630        124 LLDRRGAIKLCDFGISGQLVDSIA---KTRDAGCRPYMAPERIDPLRARGYPSFKTKLGFKFN  183 (187)
Q Consensus       124 li~~~~~~ki~dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi~  183 (187)
                      +++.++.++|+|||+++.......   .....++..|+|||.+.   ...++.++|+||||+.
T Consensus       159 ll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~---~~~~~~~~Di~slG~~  218 (290)
T cd05045         159 LVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLF---DHIYTTQSDVWSFGVL  218 (290)
T ss_pred             EEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHc---cCCcchHhHHHHHHHH
Confidence            999999999999999986533211   12224566899999987   5668899999999983

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi

>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

Probab=99.93  E-value=1.2e-26  Score=176.88  Aligned_cols=156  Identities=22%  Similarity=0.326  Sum_probs=119.8

Q ss_pred             CCcccccccccccccCceEEEEEEEc-----CCCcEEEEEEccCccChHHHHHHHHHHHHHHhcCCCCchhhhhhhH---
Q psy14630         21 FTSEDLQDLGEIGRGGFGTVNKMIHR-----SSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQFYGAL---   92 (187)
Q Consensus        21 ~~~~~~~~~~~lg~G~fg~V~~~~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~---   92 (187)
                      +...+|.+.+.||+|+||.||+|.+.     .++..+++|.+....  ....+.+.++...+..+.|+||+++++.+   
T Consensus         2 ~~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~   79 (291)
T cd05094           2 IKRRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPT--LAARKDFQREAELLTNLQHEHIVKFYGVCGDG   79 (291)
T ss_pred             CchHHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCcc--HHHHHHHHHHHHHHhcCCCCCcceEEEEEccC
Confidence            45678999999999999999999753     345668999876422  22234455566677788999999865321   


Q ss_pred             ---------------------------------------------HHHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcC
Q psy14630         93 ---------------------------------------------FKEVTVATVKALNYLKEELKIIHRDVKPSNILLDR  127 (187)
Q Consensus        93 ---------------------------------------------~~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~  127 (187)
                                                                   ...+..+++.+++|||+. +++||||||+||+++.
T Consensus        80 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~-~i~H~dlkp~Nil~~~  158 (291)
T cd05094          80 DPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQ-HFVHRDLATRNCLVGA  158 (291)
T ss_pred             CceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhC-CeeecccCcceEEEcc
Confidence                                                         012567899999999997 9999999999999999


Q ss_pred             CCCEEEEecccccccccccc---ccCCCCCcCccCccccCCCccCCCCCCcceeeeEe
Q psy14630        128 RGAIKLCDFGISGQLVDSIA---KTRDAGCRPYMAPERIDPLRARGYPSFKTKLGFKF  182 (187)
Q Consensus       128 ~~~~ki~dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi  182 (187)
                      ++.++++|||++........   .....++..|+|||.+.   ...++.++|+||||+
T Consensus       159 ~~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~Di~slG~  213 (291)
T cd05094         159 NLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIM---YRKFTTESDVWSFGV  213 (291)
T ss_pred             CCcEEECCCCcccccCCCceeecCCCCCcceeecChHHhc---cCCCCchhhHHHHHH
Confidence            99999999999876543221   12234577899999988   567889999999998

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n

>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

Probab=99.93  E-value=2.8e-26  Score=177.05  Aligned_cols=158  Identities=26%  Similarity=0.429  Sum_probs=122.2

Q ss_pred             CcccccccccccccCceEEEEEEEcCCCcEEEEEEccCcc-ChHHHHHHHHHHHHHHhcCCCCchhhhhhhHH-------
Q psy14630         22 TSEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTV-DEKDQRQLLMDLDVVMKSNECPYIVQFYGALF-------   93 (187)
Q Consensus        22 ~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~-------   93 (187)
                      ..+.|...+.||+|+||.||++.+..++..+|+|.+.... ........+..+...++.++|||++++++.+.       
T Consensus        23 ~~~~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l  102 (317)
T cd06635          23 PEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWL  102 (317)
T ss_pred             chhhhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEE
Confidence            4456888899999999999999998899999999885321 22222333444555677789999998765321       


Q ss_pred             -------------------------HHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEeccccccccccccc
Q psy14630         94 -------------------------KEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAK  148 (187)
Q Consensus        94 -------------------------~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg~a~~~~~~~~~  148 (187)
                                               ..+..+++.++.|||+. +++|+||+|+||+++.++.++++|||++......   
T Consensus       103 v~e~~~g~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~-~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~~---  178 (317)
T cd06635         103 VMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSH-NMIHRDIKAGNILLTEPGQVKLADFGSASIASPA---  178 (317)
T ss_pred             EEeCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC-CcccCCCCcccEEECCCCCEEEecCCCccccCCc---
Confidence                                     11567889999999997 9999999999999999999999999988754322   


Q ss_pred             cCCCCCcCccCccccCCCccCCCCCCcceeeeEee
Q psy14630        149 TRDAGCRPYMAPERIDPLRARGYPSFKTKLGFKFN  183 (187)
Q Consensus       149 ~~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi~  183 (187)
                      ....+++.|+|||.+.......++.++|+||||++
T Consensus       179 ~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvi  213 (317)
T cd06635         179 NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGIT  213 (317)
T ss_pred             ccccCCccccChhhhhcCCCCCCCccccHHHHHHH
Confidence            22357888999999853324557899999999984

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron

>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

Probab=99.93  E-value=1.6e-26  Score=175.29  Aligned_cols=149  Identities=26%  Similarity=0.451  Sum_probs=110.7

Q ss_pred             cccccCceEEEEEEEcCCCcEEEEEEccCccCh-HHHHHHHHHH---HHHHhcCCCCchhhhhhhH--------------
Q psy14630         31 EIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDE-KDQRQLLMDL---DVVMKSNECPYIVQFYGAL--------------   92 (187)
Q Consensus        31 ~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~~---~~~~~~~~h~~iv~~~~~~--------------   92 (187)
                      .||+|+||.||++.+..+++.||+|.+...... .........+   ........||+++.+.+.+              
T Consensus         1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~   80 (278)
T cd05606           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN   80 (278)
T ss_pred             CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence            489999999999999889999999998643211 1111111112   2233446789998765321              


Q ss_pred             ------------------HHHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEeccccccccccccccCCCCC
Q psy14630         93 ------------------FKEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTRDAGC  154 (187)
Q Consensus        93 ------------------~~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg~a~~~~~~~~~~~~~~t  154 (187)
                                        ...+..|++.|+.|||+. +++|||+||+||+++.++.++|+|||++....... .....|+
T Consensus        81 g~~L~~~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~-~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~-~~~~~~~  158 (278)
T cd05606          81 GGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNR-FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK-PHASVGT  158 (278)
T ss_pred             CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC-CEEcCCCCHHHEEECCCCCEEEccCcCccccCccC-CcCcCCC
Confidence                              112667899999999997 99999999999999999999999999987654332 2234688


Q ss_pred             cCccCccccCCCccCCCCCCcceeeeEee
Q psy14630        155 RPYMAPERIDPLRARGYPSFKTKLGFKFN  183 (187)
Q Consensus       155 ~~y~aPE~~~~~~~~~~~~~~D~ws~gi~  183 (187)
                      ..|+|||.+.+  ...++.++|+||+|++
T Consensus       159 ~~y~aPE~~~~--~~~~~~~~Di~s~G~~  185 (278)
T cd05606         159 HGYMAPEVLQK--GVAYDSSADWFSLGCM  185 (278)
T ss_pred             cCCcCcHHhcC--CCCCCcccchHhHHHH
Confidence            99999999873  2347889999999984

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co

>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

Probab=99.93  E-value=1.3e-26  Score=174.70  Aligned_cols=156  Identities=26%  Similarity=0.468  Sum_probs=119.9

Q ss_pred             cccccccccccCceEEEEEEEcC-CCcEEEEEEccCcc---------ChHHHHHHHHHHHHHHhcCCCCchhhhhhhHH-
Q psy14630         25 DLQDLGEIGRGGFGTVNKMIHRS-SDTVMAVKRIRSTV---------DEKDQRQLLMDLDVVMKSNECPYIVQFYGALF-   93 (187)
Q Consensus        25 ~~~~~~~lg~G~fg~V~~~~~~~-~~~~vaiK~~~~~~---------~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~-   93 (187)
                      +|++.+.||+|+||.||++.+.. +++.+|+|.+....         ......+...+...+.+...|||++++++.+. 
T Consensus         1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~   80 (269)
T cd08528           1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE   80 (269)
T ss_pred             CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence            47888999999999999999877 67889999875321         11222334444444555678999998764321 


Q ss_pred             -----------------------------------HHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEeccc
Q psy14630         94 -----------------------------------KEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGI  138 (187)
Q Consensus        94 -----------------------------------~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg~  138 (187)
                                                         ..+..+++.++.|||...+++|+||+|+||+++.++.++++|||+
T Consensus        81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~nil~~~~~~~~l~dfg~  160 (269)
T cd08528          81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFGL  160 (269)
T ss_pred             CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHHHEEECCCCcEEEecccc
Confidence                                               114568899999999644899999999999999999999999999


Q ss_pred             cccccccccccCCCCCcCccCccccCCCccCCCCCCcceeeeEee
Q psy14630        139 SGQLVDSIAKTRDAGCRPYMAPERIDPLRARGYPSFKTKLGFKFN  183 (187)
Q Consensus       139 a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi~  183 (187)
                      +.............++..|+|||.+.   ...++.++|+||||+.
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~Pe~~~---~~~~~~~~Dv~slG~l  202 (269)
T cd08528         161 AKQKQPESKLTSVVGTILYSCPEIVK---NEPYGEKADVWAFGCI  202 (269)
T ss_pred             eeecccccccccccCcccCcChhhhc---CCCCchHHHHHHHHHH
Confidence            98765543334456788999999998   5568899999999983

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.

>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

Probab=99.93  E-value=8.6e-27  Score=176.92  Aligned_cols=149  Identities=26%  Similarity=0.463  Sum_probs=110.2

Q ss_pred             cccccCceEEEEEEEcCCCcEEEEEEccCccCh-HHHHHHHHHHH---HHHhcCCCCchhhhhhhH--------------
Q psy14630         31 EIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDE-KDQRQLLMDLD---VVMKSNECPYIVQFYGAL--------------   92 (187)
Q Consensus        31 ~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~~~---~~~~~~~h~~iv~~~~~~--------------   92 (187)
                      .||+|+||.||++.+..+++.+|+|.+...... ........++.   .+.....|||++.+++.+              
T Consensus         1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~   80 (279)
T cd05633           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN   80 (279)
T ss_pred             CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence            489999999999999999999999988543211 11111222222   233345789988654321              


Q ss_pred             ------------------HHHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEeccccccccccccccCCCCC
Q psy14630         93 ------------------FKEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTRDAGC  154 (187)
Q Consensus        93 ------------------~~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg~a~~~~~~~~~~~~~~t  154 (187)
                                        ...+..|++.|++|||+. +++||||||+||+++.++.++++|||++....... .....++
T Consensus        81 ~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~-~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~-~~~~~~~  158 (279)
T cd05633          81 GGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNR-FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK-PHASVGT  158 (279)
T ss_pred             CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC-CcCCCCCCHHHEEECCCCCEEEccCCcceeccccC-ccCcCCC
Confidence                              112667899999999997 99999999999999999999999999987654332 2234688


Q ss_pred             cCccCccccCCCccCCCCCCcceeeeEee
Q psy14630        155 RPYMAPERIDPLRARGYPSFKTKLGFKFN  183 (187)
Q Consensus       155 ~~y~aPE~~~~~~~~~~~~~~D~ws~gi~  183 (187)
                      ..|+|||.+.+  ...++.++|+||+|+.
T Consensus       159 ~~y~aPE~~~~--~~~~~~~~Di~slG~~  185 (279)
T cd05633         159 HGYMAPEVLQK--GTAYDSSADWFSLGCM  185 (279)
T ss_pred             cCccCHHHhcC--CCCCCchhhhHHHHHH
Confidence            99999999862  3457889999999983

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi

>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

Probab=99.93  E-value=2.5e-26  Score=175.05  Aligned_cols=159  Identities=28%  Similarity=0.497  Sum_probs=118.9

Q ss_pred             CcccccccccccccCceEEEEEEEcCCCcEEEEEEccCccChHHHHHHHHHHHHHHhcCCCCchhhhhhhHH--------
Q psy14630         22 TSEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQFYGALF--------   93 (187)
Q Consensus        22 ~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~--------   93 (187)
                      ..++|.+.+.||+|+||.||++....+++.+|+|.+......  ......+...+.+..+|||++++++.+.        
T Consensus        20 ~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~~~--~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~~~   97 (291)
T cd06639          20 PTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDV--DEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVGG   97 (291)
T ss_pred             CCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccccH--HHHHHHHHHHHHHhcCCCCeEEEEEEEEeccccCCC
Confidence            467899999999999999999999999999999998643211  1222233333333347999998654211        


Q ss_pred             ---------------------------------HHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEeccccc
Q psy14630         94 ---------------------------------KEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISG  140 (187)
Q Consensus        94 ---------------------------------~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg~a~  140 (187)
                                                       ..+..|++.++.|||+. +++|+||||+|++++.++.++++|||+++
T Consensus        98 ~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~-~ivH~dlkp~nili~~~~~~kl~dfg~~~  176 (291)
T cd06639          98 QLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNN-RIIHRDVKGNNILLTTEGGVKLVDFGVSA  176 (291)
T ss_pred             eeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhC-CeeccCCCHHHEEEcCCCCEEEeecccch
Confidence                                             11556889999999997 99999999999999999999999999988


Q ss_pred             cccccc-cccCCCCCcCccCccccCCCc--cCCCCCCcceeeeEee
Q psy14630        141 QLVDSI-AKTRDAGCRPYMAPERIDPLR--ARGYPSFKTKLGFKFN  183 (187)
Q Consensus       141 ~~~~~~-~~~~~~~t~~y~aPE~~~~~~--~~~~~~~~D~ws~gi~  183 (187)
                      ...... ......++..|+|||.+....  ...++.++|+||+|+.
T Consensus       177 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi  222 (291)
T cd06639         177 QLTSTRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGIT  222 (291)
T ss_pred             hcccccccccCccCCccccChhhhcCCCCcccccCCccchHHHHHH
Confidence            764322 222346788899999976321  1236789999999984

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre

>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

Probab=99.93  E-value=2.5e-26  Score=173.21  Aligned_cols=152  Identities=20%  Similarity=0.239  Sum_probs=111.7

Q ss_pred             ccccccCceEEEEEEEc--CCCcEEEEEEccCccChHHHHHHHHHHHHHHhcCCCCchhhhhhhH---------------
Q psy14630         30 GEIGRGGFGTVNKMIHR--SSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQFYGAL---------------   92 (187)
Q Consensus        30 ~~lg~G~fg~V~~~~~~--~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~---------------   92 (187)
                      +.||+|+||.||+|...  .++..+|+|.++......... .+.++..+++.++||||+++++.+               
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~-~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~   79 (269)
T cd05087           1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQM-KFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPL   79 (269)
T ss_pred             CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHH-HHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCC
Confidence            36899999999999753  455679999886543333223 344455677788999999876421               


Q ss_pred             ----------------------HHHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEeccccccccccc---c
Q psy14630         93 ----------------------FKEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSI---A  147 (187)
Q Consensus        93 ----------------------~~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg~a~~~~~~~---~  147 (187)
                                            ...+..|++.|+.|||+. +++|||+||+|++++.++.++++|||++.......   .
T Consensus        80 g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~-~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~~  158 (269)
T cd05087          80 GDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKN-NFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVT  158 (269)
T ss_pred             CcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHC-CEeccccCcceEEEcCCCcEEECCccccccccCcceeec
Confidence                                  012456889999999997 99999999999999999999999999987543221   1


Q ss_pred             ccCCCCCcCccCccccCCCcc----CCCCCCcceeeeEee
Q psy14630        148 KTRDAGCRPYMAPERIDPLRA----RGYPSFKTKLGFKFN  183 (187)
Q Consensus       148 ~~~~~~t~~y~aPE~~~~~~~----~~~~~~~D~ws~gi~  183 (187)
                      .....++..|+|||++.+...    ..++.++|+||||+.
T Consensus       159 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~  198 (269)
T cd05087         159 PDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVT  198 (269)
T ss_pred             CCCcCCcccccCHhHhccccccccccCCCccchhHHHHHH
Confidence            122356778999999863211    235789999999983

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells

>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases

Probab=99.93  E-value=2.3e-26  Score=174.21  Aligned_cols=155  Identities=25%  Similarity=0.427  Sum_probs=121.8

Q ss_pred             ccccccccccCceEEEEEEEcCCCcEEEEEEccCccChHHHHHHHHHHHHHHhcCCCCchhhhhhhHHH-----------
Q psy14630         26 LQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQFYGALFK-----------   94 (187)
Q Consensus        26 ~~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~-----------   94 (187)
                      |++.+.||+|++|.||+|.+..+++.+++|.++...........+..+...++.+.|+|++++++.+..           
T Consensus         1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~   80 (283)
T cd05118           1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM   80 (283)
T ss_pred             CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence            567789999999999999998899999999986543332233444445556777789999998764311           


Q ss_pred             ---------------------HHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEeccccccccccc-cccCCC
Q psy14630         95 ---------------------EVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSI-AKTRDA  152 (187)
Q Consensus        95 ---------------------~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg~a~~~~~~~-~~~~~~  152 (187)
                                           .+..+++.++.|||+. +++|+||+|+||+++.++.++|+|||.+....... ......
T Consensus        81 ~~~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~-~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~~~~~~~~  159 (283)
T cd05118          81 DTDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSH-GILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYV  159 (283)
T ss_pred             CCCHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHHC-CeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCcccccCcc
Confidence                                 1667899999999998 99999999999999999999999999988765433 222345


Q ss_pred             CCcCccCccccCCCccCCCCCCcceeeeEee
Q psy14630        153 GCRPYMAPERIDPLRARGYPSFKTKLGFKFN  183 (187)
Q Consensus       153 ~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi~  183 (187)
                      ++..|+|||.+.+  ...++.++|+||+|+.
T Consensus       160 ~~~~~~~PE~~~~--~~~~~~~~Di~slG~~  188 (283)
T cd05118         160 VTRWYRAPELLLG--DKGYSTPVDIWSVGCI  188 (283)
T ss_pred             CcccccCcHHHhc--CCCCCchhHHHHHHHH
Confidence            7788999999873  2268899999999983

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They

>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=99.93  E-value=4.6e-26  Score=172.62  Aligned_cols=157  Identities=22%  Similarity=0.351  Sum_probs=120.8

Q ss_pred             CcccccccccccccCceEEEEEEEc----CCCcEEEEEEccCccChHHHHHHHHHHHHHHhcCCCCchhhhhhhHH----
Q psy14630         22 TSEDLQDLGEIGRGGFGTVNKMIHR----SSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQFYGALF----   93 (187)
Q Consensus        22 ~~~~~~~~~~lg~G~fg~V~~~~~~----~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~----   93 (187)
                      ..++|++.+.||+|+||.||++...    .++..+|+|.++..... ...+.+..+...++.+.|+||+++++.+.    
T Consensus         2 ~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~-~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~   80 (284)
T cd05038           2 EKRHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEE-QHRSDFEREIEILRTLDHENIVKYKGVCEKPGG   80 (284)
T ss_pred             chhhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccch-HHHHHHHHHHHHHHhCCCCChheEEeeeecCCC
Confidence            4567888999999999999999854    35788999998754332 23444555556677789999998754321    


Q ss_pred             -------------------------------HHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEeccccccc
Q psy14630         94 -------------------------------KEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQL  142 (187)
Q Consensus        94 -------------------------------~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg~a~~~  142 (187)
                                                     ..++.+++.||+|||+. +++|+||||+||+++.++.++++|||++...
T Consensus        81 ~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~~-~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~  159 (284)
T cd05038          81 RSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQ-RYIHRDLAARNILVESEDLVKISDFGLAKVL  159 (284)
T ss_pred             CceEEEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHhC-CeecCCCCHHhEEEcCCCCEEEccccccccc
Confidence                                           11567899999999997 9999999999999999999999999999876


Q ss_pred             cccccc----cCCCCCcCccCccccCCCccCCCCCCcceeeeEee
Q psy14630        143 VDSIAK----TRDAGCRPYMAPERIDPLRARGYPSFKTKLGFKFN  183 (187)
Q Consensus       143 ~~~~~~----~~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi~  183 (187)
                      ......    ....++..|+|||.+.   ...++.++|+||||+.
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~Pe~~~---~~~~~~~~Di~slG~~  201 (284)
T cd05038         160 PEDKDYYYVKEPGESPIFWYAPECLR---TSKFSSASDVWSFGVT  201 (284)
T ss_pred             ccCCcceeccCCCCCcccccCcHHHc---cCCCCcccchHHHhhh
Confidence            532111    1123455699999987   5578899999999983

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut

>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

Probab=99.93  E-value=1.8e-26  Score=174.49  Aligned_cols=156  Identities=29%  Similarity=0.495  Sum_probs=119.0

Q ss_pred             cccccccccccCceEEEEEEEcCCCcEEEEEEccCccChHHHHHHHHHHHHHHhcC---CCCchhhhhhhHHH-------
Q psy14630         25 DLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSN---ECPYIVQFYGALFK-------   94 (187)
Q Consensus        25 ~~~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~---~h~~iv~~~~~~~~-------   94 (187)
                      .|+..+.||+|+||.||+|.+..++..+|+|.++.........+. ..+..+++.+   .|||++++++.+..       
T Consensus         2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~-~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv   80 (277)
T cd06917           2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDI-QREVALLSQLRQSQPPNITKYYGSYLKGPRLWII   80 (277)
T ss_pred             hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHH-HHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEE
Confidence            477889999999999999999899999999998654333222223 3333344444   49999987653211       


Q ss_pred             ------------------------HHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEecccccccccccc-cc
Q psy14630         95 ------------------------EVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIA-KT  149 (187)
Q Consensus        95 ------------------------~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg~a~~~~~~~~-~~  149 (187)
                                              .+..+++.++.|||+. +++|+||+|+||+++.++.++++|||++........ ..
T Consensus        81 ~e~~~~~~L~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~-~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~~  159 (277)
T cd06917          81 MEYAEGGSVRTLMKAGPIAEKYISVIIREVLVALKYIHKV-GVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRS  159 (277)
T ss_pred             EecCCCCcHHHHHHccCCCHHHHHHHHHHHHHHHHHHHhC-CcccCCcCHHHEEEcCCCCEEEccCCceeecCCCccccc
Confidence                                    1566899999999997 999999999999999999999999999887654322 23


Q ss_pred             CCCCCcCccCccccCCCccCCCCCCcceeeeEeee
Q psy14630        150 RDAGCRPYMAPERIDPLRARGYPSFKTKLGFKFNY  184 (187)
Q Consensus       150 ~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi~~  184 (187)
                      ...++..|+|||.+..  ...++.++|+||||+.+
T Consensus       160 ~~~~~~~y~aPE~~~~--~~~~~~~~Dv~slG~~l  192 (277)
T cd06917         160 TFVGTPYWMAPEVITE--GKYYDTKADIWSLGITI  192 (277)
T ss_pred             cccCCcceeCHHHhcc--CCccccchhHHHHHHHH
Confidence            3467889999999863  34467899999999843

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent

>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

Probab=99.93  E-value=4.5e-26  Score=172.49  Aligned_cols=155  Identities=25%  Similarity=0.437  Sum_probs=120.3

Q ss_pred             ccccccccccCceEEEEEEEcCCCcEEEEEEccCccChHHHHHHHHHHHHHHhcCCCCchhhhhhhHHH-----------
Q psy14630         26 LQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQFYGALFK-----------   94 (187)
Q Consensus        26 ~~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~-----------   94 (187)
                      |+..+.||+|+||.||+|....+++.+|+|.+..........+.+..+...++.+.|+|++++++.+..           
T Consensus         1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~   80 (282)
T cd07829           1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC   80 (282)
T ss_pred             CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence            566788999999999999999999999999987543222223334445556677789999998764321           


Q ss_pred             ---------------------HHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEeccccccccccc-cccCCC
Q psy14630         95 ---------------------EVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSI-AKTRDA  152 (187)
Q Consensus        95 ---------------------~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg~a~~~~~~~-~~~~~~  152 (187)
                                           .++.+++.+++|||+. +++|+||+|+||+++.++.++|+|||+++...... ......
T Consensus        81 ~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~~-~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~~~~~~  159 (282)
T cd07829          81 DMDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSH-RILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTHEV  159 (282)
T ss_pred             CcCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHC-CcccCCCChheEEEcCCCCEEEecCCcccccCCCccccCccc
Confidence                                 1567889999999998 99999999999999999999999999988764432 222334


Q ss_pred             CCcCccCccccCCCccCCCCCCcceeeeEee
Q psy14630        153 GCRPYMAPERIDPLRARGYPSFKTKLGFKFN  183 (187)
Q Consensus       153 ~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi~  183 (187)
                      ++..|+|||.+..  ...++.++|+||+|+.
T Consensus       160 ~~~~~~aPE~~~~--~~~~~~~~Dv~slG~~  188 (282)
T cd07829         160 VTLWYRAPEILLG--SKHYSTAVDIWSVGCI  188 (282)
T ss_pred             cCcCcCChHHhcC--CcCCCccccHHHHHHH
Confidence            5678999999872  2367899999999983

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the

>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

Probab=99.93  E-value=2.2e-26  Score=173.64  Aligned_cols=158  Identities=28%  Similarity=0.391  Sum_probs=119.7

Q ss_pred             cccccccccccCceEEEEEEEcCCCcEEEEEEccCccCh--------HHHHHHHHHHHHHHhcCCCCchhhhhhhH----
Q psy14630         25 DLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDE--------KDQRQLLMDLDVVMKSNECPYIVQFYGAL----   92 (187)
Q Consensus        25 ~~~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~--------~~~~~~~~~~~~~~~~~~h~~iv~~~~~~----   92 (187)
                      +|...+.||+|+||.||+|.+..+++.+|+|.++.....        ....+.+..+..+++.++|||++++++.+    
T Consensus         2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   81 (272)
T cd06629           2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE   81 (272)
T ss_pred             ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence            467788999999999999999888999999987532110        11123445556677888999999876432    


Q ss_pred             ----------------------------HHHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEeccccccccc
Q psy14630         93 ----------------------------FKEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVD  144 (187)
Q Consensus        93 ----------------------------~~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg~a~~~~~  144 (187)
                                                  ...+..+++.++.|||+. +++|+||+|+||+++.++.++++|||+++....
T Consensus        82 ~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~-~i~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~  160 (272)
T cd06629          82 YLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLHSK-GILHRDLKADNLLVDADGICKISDFGISKKSDD  160 (272)
T ss_pred             ceEEEEecCCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhC-CeeecCCChhhEEEcCCCeEEEeeccccccccc
Confidence                                        112567899999999997 999999999999999999999999999876543


Q ss_pred             cc---cccCCCCCcCccCccccCCCccCCCCCCcceeeeEeee
Q psy14630        145 SI---AKTRDAGCRPYMAPERIDPLRARGYPSFKTKLGFKFNY  184 (187)
Q Consensus       145 ~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi~~  184 (187)
                      ..   ......++..|+|||.+... ...++.++|+||+|+++
T Consensus       161 ~~~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~~~Dv~slG~~l  202 (272)
T cd06629         161 IYDNDQNMSMQGSVFWMAPEVIHSY-SQGYSAKVDIWSLGCVV  202 (272)
T ss_pred             cccccccccccCCccccCHHHhccc-cCCCCccchhHHHHHHH
Confidence            21   11223577889999998732 13478999999999843

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte

>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

Probab=99.93  E-value=1.9e-26  Score=173.36  Aligned_cols=153  Identities=26%  Similarity=0.388  Sum_probs=119.0

Q ss_pred             cccccccccccCceEEEEEEEcCCCcEEEEEEccCccC----hHHHHHHHHHHHHHHhcCCCCchhhhhhhHH-------
Q psy14630         25 DLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVD----EKDQRQLLMDLDVVMKSNECPYIVQFYGALF-------   93 (187)
Q Consensus        25 ~~~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~~----~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~-------   93 (187)
                      +|++.+.||+|+||.||+|.. .+++.+|+|.+.....    .......+.++...++.+.|+||+++++.+.       
T Consensus         1 ~~~~~~~ig~g~~~~v~~~~~-~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l   79 (265)
T cd06631           1 EWTKGEVLGKGAYGTVYCGLT-NQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISI   79 (265)
T ss_pred             CccccceEeccCCeEEEEEEE-cCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEE
Confidence            478889999999999999987 5788899998864321    1222344566666778889999998765321       


Q ss_pred             -------------------------HHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEecccccccccc---
Q psy14630         94 -------------------------KEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDS---  145 (187)
Q Consensus        94 -------------------------~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg~a~~~~~~---  145 (187)
                                               ..++.|++.+++|||+. +++|+||+|+||+++.++.++++|||++......   
T Consensus        80 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~-~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~  158 (265)
T cd06631          80 FMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNN-CVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLH  158 (265)
T ss_pred             EEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC-CcccCCcCHHhEEECCCCeEEeccchhhHhhhhcccc
Confidence                                     12567899999999997 9999999999999999999999999998765321   


Q ss_pred             ----ccccCCCCCcCccCccccCCCccCCCCCCcceeeeEe
Q psy14630        146 ----IAKTRDAGCRPYMAPERIDPLRARGYPSFKTKLGFKF  182 (187)
Q Consensus       146 ----~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi  182 (187)
                          .......++..|+|||.+.   ...++.++|+||+|+
T Consensus       159 ~~~~~~~~~~~~~~~~~~pe~~~---~~~~~~~~Dv~slG~  196 (265)
T cd06631         159 GTHSNMLKSMHGTPYWMAPEVIN---ESGYGRKSDIWSIGC  196 (265)
T ss_pred             ccccccccccCCCccccChhhhc---CCCCcchhhHHHHHH
Confidence                1112235788899999988   566889999999998

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.

>KOG0587|consensus

Probab=99.93  E-value=4.3e-26  Score=187.19  Aligned_cols=159  Identities=28%  Similarity=0.459  Sum_probs=127.1

Q ss_pred             CcccccccccccccCceEEEEEEEcCCCcEEEEEEccCccChHHHHHHHHHHHHHHhcCCCCchhhhhhhHHHH------
Q psy14630         22 TSEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQFYGALFKE------   95 (187)
Q Consensus        22 ~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~------   95 (187)
                      +.+-+.+.+++|.|.+|.||+++++.+++.+|+|+.....+.  ..++..+...++...+|||++.+|+.+...      
T Consensus        17 p~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~--deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~D   94 (953)
T KOG0587|consen   17 PADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDE--EEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNGD   94 (953)
T ss_pred             CCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCccc--cHHHHHHHHHHHhccCCCCcceEEEEEEEecCCCCC
Confidence            345677889999999999999999999999999998654333  334444455566678999999998654221      


Q ss_pred             ---------------------------------HHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEeccccccc
Q psy14630         96 ---------------------------------VTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQL  142 (187)
Q Consensus        96 ---------------------------------~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg~a~~~  142 (187)
                                                       +...++.|+..||.. .++|||+|-.|||+...+.+|++|||+++++
T Consensus        95 qLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~n-kviHRDikG~NiLLT~e~~VKLvDFGvSaQl  173 (953)
T KOG0587|consen   95 QLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNN-KVIHRDIKGQNVLLTENAEVKLVDFGVSAQL  173 (953)
T ss_pred             eEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhc-ceeeecccCceEEEeccCcEEEeeeeeeeee
Confidence                                             455677889999998 8999999999999999999999999999998


Q ss_pred             ccc-ccccCCCCCcCccCccccCCCc--cCCCCCCcceeeeEee
Q psy14630        143 VDS-IAKTRDAGCRPYMAPERIDPLR--ARGYPSFKTKLGFKFN  183 (187)
Q Consensus       143 ~~~-~~~~~~~~t~~y~aPE~~~~~~--~~~~~~~~D~ws~gi~  183 (187)
                      ... .......||+.|||||+|....  ...|+..+|+||+||.
T Consensus       174 dsT~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGIT  217 (953)
T KOG0587|consen  174 DSTVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGIT  217 (953)
T ss_pred             ecccccccCcCCCcccccceeeecccCCCCCcccccchhhccce
Confidence            653 2334458999999999997543  3347788999999993

>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases

Probab=99.93  E-value=3e-26  Score=171.33  Aligned_cols=148  Identities=28%  Similarity=0.424  Sum_probs=116.7

Q ss_pred             ccccccCceEEEEEEEcCC---CcEEEEEEccCccChHHHHHHHHHHHHHHhcCCCCchhhhhhhHH-------------
Q psy14630         30 GEIGRGGFGTVNKMIHRSS---DTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQFYGALF-------------   93 (187)
Q Consensus        30 ~~lg~G~fg~V~~~~~~~~---~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~-------------   93 (187)
                      +.||+|+||.||+|.....   +..+++|.+....... ..+.+..+......+.|+|++++++.+.             
T Consensus         1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~   79 (262)
T cd00192           1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEE-ERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYME   79 (262)
T ss_pred             CccccCCceEEEEEEEecCCCCCceEEeEeeccccchh-HHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEecc
Confidence            4689999999999998765   8889999987544333 3444555555666778999998764311             


Q ss_pred             ----------------------------HHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEecccccccccc
Q psy14630         94 ----------------------------KEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDS  145 (187)
Q Consensus        94 ----------------------------~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg~a~~~~~~  145 (187)
                                                  ..+..+++.|+.|||+. +++|+||+|+||+++.++.++++|||.+......
T Consensus        80 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~-~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~  158 (262)
T cd00192          80 GGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASK-KFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDD  158 (262)
T ss_pred             CCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcC-CcccCccCcceEEECCCCcEEEcccccccccccc
Confidence                                        12567889999999997 9999999999999999999999999999876543


Q ss_pred             c---cccCCCCCcCccCccccCCCccCCCCCCcceeeeEe
Q psy14630        146 I---AKTRDAGCRPYMAPERIDPLRARGYPSFKTKLGFKF  182 (187)
Q Consensus       146 ~---~~~~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi  182 (187)
                      .   ......++..|+|||.+.   ...++.++|+||+|+
T Consensus       159 ~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~Di~slG~  195 (262)
T cd00192         159 DYYRKKTGGKLPIRWMAPESLK---DGIFTSKSDVWSFGV  195 (262)
T ss_pred             cccccccCCCcCccccCHHHhc---cCCcchhhccHHHHH
Confidence            2   222335678899999988   457889999999998

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan

>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

Probab=99.93  E-value=1.3e-26  Score=175.62  Aligned_cols=147  Identities=24%  Similarity=0.409  Sum_probs=115.1

Q ss_pred             ccccCceEEEEEEEcCCCcEEEEEEccCccCh-HHHHHHHHHHHHHHhcCCCCchhhhhhhHH-----------------
Q psy14630         32 IGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDE-KDQRQLLMDLDVVMKSNECPYIVQFYGALF-----------------   93 (187)
Q Consensus        32 lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~-----------------   93 (187)
                      ||+|+||.||+|.+..+++.+|+|.+...... ......+..+..+++.++|||++.+++.+.                 
T Consensus         1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (277)
T cd05577           1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL   80 (277)
T ss_pred             CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence            68999999999999999999999998643211 122333445556677888999998763210                 


Q ss_pred             -----------------HHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEeccccccccccccccCCCCCcC
Q psy14630         94 -----------------KEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTRDAGCRP  156 (187)
Q Consensus        94 -----------------~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg~a~~~~~~~~~~~~~~t~~  156 (187)
                                       ..+..|++.++.|||+. +++|+||+|+||+++.++.++++|||.+.............++..
T Consensus        81 ~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~-~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~  159 (277)
T cd05577          81 KYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQR-RIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKKIKGRAGTPG  159 (277)
T ss_pred             HHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhC-CcccCCCCHHHEEECCCCCEEEccCcchhhhccCCccccccCCCC
Confidence                             11556899999999997 999999999999999999999999999887654333334467788


Q ss_pred             ccCccccCCCccCCCCCCcceeeeEe
Q psy14630        157 YMAPERIDPLRARGYPSFKTKLGFKF  182 (187)
Q Consensus       157 y~aPE~~~~~~~~~~~~~~D~ws~gi  182 (187)
                      |+|||.+.   ...++.++|+||+|+
T Consensus       160 y~~PE~~~---~~~~~~~~Di~slG~  182 (277)
T cd05577         160 YMAPEVLQ---GEVYDFSVDWFALGC  182 (277)
T ss_pred             cCCHHHhc---CCCCCchhhhHHHHH
Confidence            99999987   455889999999998

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of

>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta

Probab=99.93  E-value=1.7e-26  Score=179.00  Aligned_cols=152  Identities=22%  Similarity=0.323  Sum_probs=114.1

Q ss_pred             cccccc--CceEEEEEEEcCCCcEEEEEEccCccChHHHHHHHHHHHHHHhcCCCCchhhhhhhHH--------------
Q psy14630         30 GEIGRG--GFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQFYGALF--------------   93 (187)
Q Consensus        30 ~~lg~G--~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~--------------   93 (187)
                      ..||+|  +||+||++.+..+++.||+|+...........+.+.++..+.+.++||||+++++.+.              
T Consensus         4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~   83 (328)
T cd08226           4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY   83 (328)
T ss_pred             HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence            456666  9999999999999999999998654333344466677777778889999998754321              


Q ss_pred             --------------------HHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEeccccccccccccc-----
Q psy14630         94 --------------------KEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAK-----  148 (187)
Q Consensus        94 --------------------~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg~a~~~~~~~~~-----  148 (187)
                                          ..+..|++.||+|||+. +++||||||+||+++.++.+++.||+.+.........     
T Consensus        84 ~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~-~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~~~~  162 (328)
T cd08226          84 GSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQN-GYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKVVY  162 (328)
T ss_pred             CCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhC-CeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCccccccc
Confidence                                12567899999999997 9999999999999999999999999865433211000     


Q ss_pred             ---cCCCCCcCccCccccCCCccCCCCCCcceeeeEee
Q psy14630        149 ---TRDAGCRPYMAPERIDPLRARGYPSFKTKLGFKFN  183 (187)
Q Consensus       149 ---~~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi~  183 (187)
                         ....++..|+|||.+.+. ...++.++|+||+|++
T Consensus       163 ~~~~~~~~~~~y~aPE~~~~~-~~~~~~~~DiwslG~~  199 (328)
T cd08226         163 DFPQFSTSVLPWLSPELLRQD-LYGYNVKSDIYSVGIT  199 (328)
T ss_pred             cccccccCccCccChhhhcCC-CCCCCchhhHHHHHHH
Confidence               111245679999998732 2457899999999983

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig

>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

Probab=99.93  E-value=6e-26  Score=169.48  Aligned_cols=153  Identities=27%  Similarity=0.442  Sum_probs=121.9

Q ss_pred             cccccccccccCceEEEEEEEcCCCcEEEEEEccCccChHHHHHHHHHHHHHHhcCCCCchhhhhhhHHH----------
Q psy14630         25 DLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQFYGALFK----------   94 (187)
Q Consensus        25 ~~~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~----------   94 (187)
                      +|++.+.||+|+||.||++.+..+++.+++|.+............+..+...++.++|+||+++++.+..          
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   80 (256)
T cd08530           1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY   80 (256)
T ss_pred             CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence            4788899999999999999998899999999986533222233334445556777889999987654211          


Q ss_pred             --------------------------HHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEeccccccccccccc
Q psy14630         95 --------------------------EVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAK  148 (187)
Q Consensus        95 --------------------------~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg~a~~~~~~~~~  148 (187)
                                                .+..+++.|++|||+. +++|+||+|.||+++.++.++++|||++...... ..
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~-~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~-~~  158 (256)
T cd08530          81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQ-KILHRDLKSANILLVANDLVKIGDLGISKVLKKN-MA  158 (256)
T ss_pred             cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhC-CcccCCCCcceEEEecCCcEEEeeccchhhhccC-Cc
Confidence                                      2556789999999997 9999999999999999999999999999876554 22


Q ss_pred             cCCCCCcCccCccccCCCccCCCCCCcceeeeEe
Q psy14630        149 TRDAGCRPYMAPERIDPLRARGYPSFKTKLGFKF  182 (187)
Q Consensus       149 ~~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi  182 (187)
                      ....+++.|++||...   ...++.++|+||+|+
T Consensus       159 ~~~~~~~~~~~Pe~~~---~~~~~~~~D~~slG~  189 (256)
T cd08530         159 KTQIGTPHYMAPEVWK---GRPYSYKSDIWSLGC  189 (256)
T ss_pred             ccccCCccccCHHHHC---CCCCCchhhHHHHHH
Confidence            2345788899999987   566788999999998

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an

>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

Probab=99.93  E-value=3e-26  Score=174.48  Aligned_cols=154  Identities=38%  Similarity=0.684  Sum_probs=122.0

Q ss_pred             ccccccccccccCceEEEEEEEcCCCcEEEEEEccCccChHHHHHHHHHHHHHHhcCCCCchhhhhhhHH----------
Q psy14630         24 EDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQFYGALF----------   93 (187)
Q Consensus        24 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~----------   93 (187)
                      ++|...+.||.|++|.||+|.+..+++.+|+|.+........ ...+..+..+++.++||||+++++.+.          
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~-~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv   79 (287)
T cd06621           1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDL-QKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIA   79 (287)
T ss_pred             CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHH-HHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEE
Confidence            467888999999999999999988999999999875433322 333444555677789999998754210          


Q ss_pred             ----------------------------HHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEecccccccccc
Q psy14630         94 ----------------------------KEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDS  145 (187)
Q Consensus        94 ----------------------------~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg~a~~~~~~  145 (187)
                                                  ..++.+++.++.|||+. +++|+|++|+||+++.++.++++|||++......
T Consensus        80 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~-~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~  158 (287)
T cd06621          80 MEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSR-KIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNS  158 (287)
T ss_pred             EEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC-CcccCCCCHHHEEEecCCeEEEeecccccccccc
Confidence                                        12567889999999997 9999999999999999999999999998765433


Q ss_pred             ccccCCCCCcCccCccccCCCccCCCCCCcceeeeEee
Q psy14630        146 IAKTRDAGCRPYMAPERIDPLRARGYPSFKTKLGFKFN  183 (187)
Q Consensus       146 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi~  183 (187)
                      .. ....++..|+|||.+.   ...++.++|+||+|+.
T Consensus       159 ~~-~~~~~~~~y~~pE~~~---~~~~~~~~Dv~slG~i  192 (287)
T cd06621         159 LA-GTFTGTSFYMAPERIQ---GKPYSITSDVWSLGLT  192 (287)
T ss_pred             cc-ccccCCccccCHHHhc---CCCCCchhhHHHHHHH
Confidence            22 2335678899999987   5668899999999983

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

Probab=99.93  E-value=3e-26  Score=171.83  Aligned_cols=146  Identities=28%  Similarity=0.490  Sum_probs=113.7

Q ss_pred             ccccccCceEEEEEEEcCCCcEEEEEEccCccC--hHHHHHHHHHHHHHHhcCCCCchhhhhhhHH--------------
Q psy14630         30 GEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVD--EKDQRQLLMDLDVVMKSNECPYIVQFYGALF--------------   93 (187)
Q Consensus        30 ~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~--------------   93 (187)
                      +.||+|+||.||+|.+..+++.||+|.++....  .........+...+.....|+|++++++.+.              
T Consensus         2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   81 (260)
T cd05611           2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG   81 (260)
T ss_pred             ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence            578999999999999988999999999864321  1112233344444455668999998874321              


Q ss_pred             ------------------HHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEeccccccccccccccCCCCCc
Q psy14630         94 ------------------KEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTRDAGCR  155 (187)
Q Consensus        94 ------------------~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg~a~~~~~~~~~~~~~~t~  155 (187)
                                        ..+..|++.||.|||+. +++|+||+|+||+++.++.++++|||+++....   .....++.
T Consensus        82 ~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~-~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~---~~~~~~~~  157 (260)
T cd05611          82 GDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQR-GIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE---NKKFVGTP  157 (260)
T ss_pred             CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC-CeecCCCCHHHeEECCCCcEEEeecccceeccc---cccCCCCc
Confidence                              12667899999999997 999999999999999999999999998876433   22335788


Q ss_pred             CccCccccCCCccCCCCCCcceeeeEe
Q psy14630        156 PYMAPERIDPLRARGYPSFKTKLGFKF  182 (187)
Q Consensus       156 ~y~aPE~~~~~~~~~~~~~~D~ws~gi  182 (187)
                      .|+|||.+.   ...++.++|+||+|+
T Consensus       158 ~y~~pe~~~---~~~~~~~~Dv~slG~  181 (260)
T cd05611         158 DYLAPETIL---GVGDDKMSDWWSLGC  181 (260)
T ss_pred             CccChhhhc---CCCCcchhhhHHHHH
Confidence            899999988   445789999999998

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do

>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

Probab=99.93  E-value=1.7e-26  Score=175.22  Aligned_cols=155  Identities=25%  Similarity=0.418  Sum_probs=120.1

Q ss_pred             cccccccccccCceEEEEEEEcCCCcEEEEEEccCccChHHHHHHHHHHHHHHhcCCCCchhhhhhhHH-----------
Q psy14630         25 DLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQFYGALF-----------   93 (187)
Q Consensus        25 ~~~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~-----------   93 (187)
                      +|++.+.||.|++|.||+|.+..++..||+|.++........ +...++..+++.++|+|++++++.+.           
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~-~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   79 (284)
T cd07836           1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTP-STAIREISLMKELKHENIVRLHDVIHTENKLMLVFEY   79 (284)
T ss_pred             CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccch-HHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEec
Confidence            478899999999999999999999999999998653322222 23334455677789999998865321           


Q ss_pred             -----------------------HHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEecccccccccccc-cc
Q psy14630         94 -----------------------KEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIA-KT  149 (187)
Q Consensus        94 -----------------------~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg~a~~~~~~~~-~~  149 (187)
                                             ..+..|++.|++|||+. +++|+|++|+||+++.++.++++|||+++....... ..
T Consensus        80 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~-~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~~~~  158 (284)
T cd07836          80 MDKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHEN-RVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFS  158 (284)
T ss_pred             CCccHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHC-CeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCccccc
Confidence                                   12567899999999987 999999999999999999999999999876543221 12


Q ss_pred             CCCCCcCccCccccCCCccCCCCCCcceeeeEee
Q psy14630        150 RDAGCRPYMAPERIDPLRARGYPSFKTKLGFKFN  183 (187)
Q Consensus       150 ~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi~  183 (187)
                      ...++..|++||.+.+  ...++.++|+||+|+.
T Consensus       159 ~~~~~~~y~~PE~~~~--~~~~~~~~Dv~slG~~  190 (284)
T cd07836         159 NEVVTLWYRAPDVLLG--SRTYSTSIDIWSVGCI  190 (284)
T ss_pred             cccccccccChHHhcC--CCCCCcHHHHHHHHHH
Confidence            2356788999999863  3346789999999984

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.

>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

Probab=99.93  E-value=1.9e-26  Score=174.60  Aligned_cols=155  Identities=34%  Similarity=0.565  Sum_probs=122.3

Q ss_pred             ccccccccccccCceEEEEEEEcCCCcEEEEEEccCccChHHHHHHHHHHHHHHhcCCCCchhhhhhhHH----------
Q psy14630         24 EDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQFYGALF----------   93 (187)
Q Consensus        24 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~----------   93 (187)
                      ..|+..+.||.|+||.||+|.+..++..+|+|.+....... ....+..+..+++.+.|+|++++++.+.          
T Consensus         4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   82 (277)
T cd06640           4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAED-EIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIME   82 (277)
T ss_pred             HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHH-HHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEe
Confidence            56888899999999999999998889999999986432222 2344444555667789999998764321          


Q ss_pred             ---------------------HHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEeccccccccccc-cccCC
Q psy14630         94 ---------------------KEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSI-AKTRD  151 (187)
Q Consensus        94 ---------------------~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg~a~~~~~~~-~~~~~  151 (187)
                                           ..+..+++.+++|||+. +++|+||+|+||+++.++.++++|||++....... .....
T Consensus        83 ~~~~~~L~~~i~~~~l~~~~~~~~~~~l~~~l~~lh~~-~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~  161 (277)
T cd06640          83 YLGGGSALDLLRAGPFDEFQIATMLKEILKGLDYLHSE-KKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTF  161 (277)
T ss_pred             cCCCCcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC-CccCcCCChhhEEEcCCCCEEEcccccceeccCCccccccc
Confidence                                 12567889999999997 99999999999999999999999999997764432 22233


Q ss_pred             CCCcCccCccccCCCccCCCCCCcceeeeEee
Q psy14630        152 AGCRPYMAPERIDPLRARGYPSFKTKLGFKFN  183 (187)
Q Consensus       152 ~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi~  183 (187)
                      .++..|+|||.+.   ...++.++|+||||+.
T Consensus       162 ~~~~~y~apE~~~---~~~~~~~~Dv~slG~i  190 (277)
T cd06640         162 VGTPFWMAPEVIQ---QSAYDSKADIWSLGIT  190 (277)
T ss_pred             cCcccccCHhHhc---cCCCccHHHHHHHHHH
Confidence            5778899999987   5568899999999983

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter

>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

Probab=99.93  E-value=1.5e-26  Score=173.03  Aligned_cols=152  Identities=23%  Similarity=0.370  Sum_probs=118.0

Q ss_pred             cCCcccccccccccccCceEEEEEEEcCCCcEEEEEEccCccChHHHHHHHHHHHHHHhcCCCCchhhhhhhHH------
Q psy14630         20 DFTSEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQFYGALF------   93 (187)
Q Consensus        20 ~~~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~------   93 (187)
                      -+..++|++.+.||+|+||.||++..  +++.+|+|.++...    ..+.+..+..+++.++|||++++++.+.      
T Consensus         2 ~~~~~~~~~~~~lg~g~~g~v~~~~~--~~~~~~iK~~~~~~----~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~   75 (254)
T cd05083           2 LLNLQKLTLGEIIGEGEFGAVLQGEY--TGQKVAVKNIKCDV----TAQAFLEETAVMTKLHHKNLVRLLGVILHNGLYI   75 (254)
T ss_pred             cccHHHceeeeeeccCCCCceEeccc--CCCceEEEeecCcc----hHHHHHHHHHHHHhCCCCCcCeEEEEEcCCCcEE
Confidence            34568899999999999999999864  57789999886422    1233445555677789999998764321      


Q ss_pred             ---------------------------HHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEeccccccccccc
Q psy14630         94 ---------------------------KEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSI  146 (187)
Q Consensus        94 ---------------------------~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg~a~~~~~~~  146 (187)
                                                 ..++.|++.|+.|||+. +++|||+||+|++++.++.++++|||+++......
T Consensus        76 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~-~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~~  154 (254)
T cd05083          76 VMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESK-KLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGV  154 (254)
T ss_pred             EEECCCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhC-CeeccccCcceEEEcCCCcEEECCCccceeccccC
Confidence                                       11567899999999997 99999999999999999999999999987643321


Q ss_pred             cccCCCCCcCccCccccCCCccCCCCCCcceeeeEee
Q psy14630        147 AKTRDAGCRPYMAPERIDPLRARGYPSFKTKLGFKFN  183 (187)
Q Consensus       147 ~~~~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi~  183 (187)
                        .....+..|+|||.+.   ...++.++|+||+|+.
T Consensus       155 --~~~~~~~~y~~pe~~~---~~~~~~~~Dv~slG~~  186 (254)
T cd05083         155 --DNSKLPVKWTAPEALK---HKKFSSKSDVWSYGVL  186 (254)
T ss_pred             --CCCCCCceecCHHHhc---cCCcCchhhHHHHHHH
Confidence              1223456799999987   5668899999999983

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki

>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer

Probab=99.93  E-value=3e-26  Score=170.81  Aligned_cols=147  Identities=24%  Similarity=0.395  Sum_probs=111.9

Q ss_pred             ccccccCceEEEEEEEcCCCcEEEEEEccCccChHHHHHHHHHHHHHHhcCCCCchhhhhhhHH----------------
Q psy14630         30 GEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQFYGALF----------------   93 (187)
Q Consensus        30 ~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~----------------   93 (187)
                      +.||+|+||.||+|... ++..+|+|.+....... ....+..+..+++.++||||+++++.+.                
T Consensus         1 ~~ig~g~~g~vy~~~~~-~~~~~a~K~~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~   78 (250)
T cd05085           1 ELLGKGNFGEVFKGTLK-DKTPVAVKTCKEDLPQE-LKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGD   78 (250)
T ss_pred             CccCCCCCceEEEEEec-CCcEEEEEecCCcCCHH-HHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCc
Confidence            46899999999999864 67889999986543332 2333445555677789999998764211                


Q ss_pred             -----------------HHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEecccccccccccccc--CCCCC
Q psy14630         94 -----------------KEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKT--RDAGC  154 (187)
Q Consensus        94 -----------------~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg~a~~~~~~~~~~--~~~~t  154 (187)
                                       ..+..+++.++.|+|+. +++|+|++|+||+++.++.++++|||++..........  ...++
T Consensus        79 L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~-~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~  157 (250)
T cd05085          79 FLSFLRKKKDELKTKQLVKFALDAAAGMAYLESK-NCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIP  157 (250)
T ss_pred             HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC-CeeecccChheEEEcCCCeEEECCCccceeccccccccCCCCCCc
Confidence                             12567888999999997 99999999999999999999999999987654332211  11335


Q ss_pred             cCccCccccCCCccCCCCCCcceeeeEe
Q psy14630        155 RPYMAPERIDPLRARGYPSFKTKLGFKF  182 (187)
Q Consensus       155 ~~y~aPE~~~~~~~~~~~~~~D~ws~gi  182 (187)
                      ..|+|||.+.   ...++.++|+||||+
T Consensus       158 ~~y~aPE~~~---~~~~~~~~Di~slG~  182 (250)
T cd05085         158 IKWTAPEALN---YGRYSSESDVWSYGI  182 (250)
T ss_pred             ccccCHHHhc---cCCCCchhHHHHHHH
Confidence            6799999987   556889999999998

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c

>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

Probab=99.93  E-value=2.6e-26  Score=172.13  Aligned_cols=155  Identities=34%  Similarity=0.632  Sum_probs=123.3

Q ss_pred             ccccccccccccCceEEEEEEEcCCCcEEEEEEccCccChHHHHHHHHHHHHHHhcCCCCchhhhhhhHH----------
Q psy14630         24 EDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQFYGALF----------   93 (187)
Q Consensus        24 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~----------   93 (187)
                      ++|++.+.||+|++|.||+|.+..+++.+++|.+...... ...+.+..+......++|+|++++++.+.          
T Consensus         1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e   79 (264)
T cd06623           1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDE-EFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLE   79 (264)
T ss_pred             CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcch-HHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEE
Confidence            4688899999999999999999999999999998654332 23334445555566678999998864321          


Q ss_pred             ----------------------HHHHHHHHHHHHHHHh-cCCCeeecCCCCCeEEcCCCCEEEEecccccccccccccc-
Q psy14630         94 ----------------------KEVTVATVKALNYLKE-ELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKT-  149 (187)
Q Consensus        94 ----------------------~~~~~~~~~~l~~lh~-~~~i~Hrdlk~~nili~~~~~~ki~dfg~a~~~~~~~~~~-  149 (187)
                                            ..+..+++.++.|||+ . +++|+||+|+||+++.++.++++|||.+.......... 
T Consensus        80 ~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lh~~~-~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~~~~  158 (264)
T cd06623          80 YMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTKR-HIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCN  158 (264)
T ss_pred             ecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhccC-CCccCCCCHHHEEECCCCCEEEccCccceecccCCCccc
Confidence                                  1266789999999999 7 99999999999999999999999999988765433222 


Q ss_pred             CCCCCcCccCccccCCCccCCCCCCcceeeeEee
Q psy14630        150 RDAGCRPYMAPERIDPLRARGYPSFKTKLGFKFN  183 (187)
Q Consensus       150 ~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi~  183 (187)
                      ...++..|+|||.+.   ...++.++|+||||+.
T Consensus       159 ~~~~~~~y~~pE~~~---~~~~~~~~Dv~slG~i  189 (264)
T cd06623         159 TFVGTVTYMSPERIQ---GESYSYAADIWSLGLT  189 (264)
T ss_pred             ceeecccccCHhhhC---CCCCCchhhHHHHHHH
Confidence            335778899999987   5678899999999983

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of

>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

Probab=99.93  E-value=2.6e-26  Score=173.87  Aligned_cols=155  Identities=34%  Similarity=0.577  Sum_probs=122.0

Q ss_pred             ccccccccccccCceEEEEEEEcCCCcEEEEEEccCccChHHHHHHHHHHHHHHhcCCCCchhhhhhhHH----------
Q psy14630         24 EDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQFYGALF----------   93 (187)
Q Consensus        24 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~----------   93 (187)
                      +-|+..+.||.|+||.||+|.+..++..+|+|.+...... ...+.+.++...+..+.||||+++++.+.          
T Consensus         4 ~~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   82 (277)
T cd06641           4 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAE-DEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIME   82 (277)
T ss_pred             HhhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccch-HHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEE
Confidence            4577889999999999999999888999999987643222 23344555556777789999998764321          


Q ss_pred             ---------------------HHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEeccccccccccc-cccCC
Q psy14630         94 ---------------------KEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSI-AKTRD  151 (187)
Q Consensus        94 ---------------------~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg~a~~~~~~~-~~~~~  151 (187)
                                           ..+..+++.++.|||+. +++|+||+|+|++++.++.++++|||++..+.... .....
T Consensus        83 ~~~~~~l~~~i~~~~~~~~~~~~~~~~l~~~l~~lh~~-~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~~~~~~  161 (277)
T cd06641          83 YLGGGSALDLLEPGPLDETQIATILREILKGLDYLHSE-KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTF  161 (277)
T ss_pred             eCCCCcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHccC-CeecCCCCHHhEEECCCCCEEEeecccceecccchhhhccc
Confidence                                 12567889999999997 99999999999999999999999999987654322 22234


Q ss_pred             CCCcCccCccccCCCccCCCCCCcceeeeEee
Q psy14630        152 AGCRPYMAPERIDPLRARGYPSFKTKLGFKFN  183 (187)
Q Consensus       152 ~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi~  183 (187)
                      .++..|+|||.+.   ...++.++|+||+|+.
T Consensus       162 ~~~~~y~~PE~~~---~~~~~~~~Dv~slG~~  190 (277)
T cd06641         162 VGTPFWMAPEVIK---QSAYDSKADIWSLGIT  190 (277)
T ss_pred             cCCccccChhhhc---cCCCCchhhHHHHHHH
Confidence            5788899999987   5567889999999983

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int

>smart00219 TyrKc Tyrosine kinase, catalytic domain

Probab=99.93  E-value=3.5e-26  Score=170.78  Aligned_cols=153  Identities=25%  Similarity=0.383  Sum_probs=118.6

Q ss_pred             ccccccccccCceEEEEEEEcCCC----cEEEEEEccCccChHHHHHHHHHHHHHHhcCCCCchhhhhhhHH--------
Q psy14630         26 LQDLGEIGRGGFGTVNKMIHRSSD----TVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQFYGALF--------   93 (187)
Q Consensus        26 ~~~~~~lg~G~fg~V~~~~~~~~~----~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~--------   93 (187)
                      +++.+.||.|+||.||+|.+..++    ..+|+|.++...... ..+.+..+...++.++|+||+++++.+.        
T Consensus         1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i   79 (258)
T smart00219        1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQ-QIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIV   79 (258)
T ss_pred             CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChH-HHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEE
Confidence            356789999999999999987766    889999986543322 3344555555666779999998874321        


Q ss_pred             --------------------------HHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEecccccccccccc
Q psy14630         94 --------------------------KEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIA  147 (187)
Q Consensus        94 --------------------------~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg~a~~~~~~~~  147 (187)
                                                ..+..|++.++.|||+. +++|+||+|+||+++.++.++++|||+++.......
T Consensus        80 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~-~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~  158 (258)
T smart00219       80 MEYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESK-NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDY  158 (258)
T ss_pred             EeccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcC-CeeecccccceEEEccCCeEEEcccCCceecccccc
Confidence                                      11556889999999998 999999999999999999999999999987654322


Q ss_pred             cc--CCCCCcCccCccccCCCccCCCCCCcceeeeEee
Q psy14630        148 KT--RDAGCRPYMAPERIDPLRARGYPSFKTKLGFKFN  183 (187)
Q Consensus       148 ~~--~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi~  183 (187)
                      ..  ...++..|+|||.+.   ...++.++|+||+|++
T Consensus       159 ~~~~~~~~~~~y~~Pe~~~---~~~~~~~~Di~slG~i  193 (258)
T smart00219      159 YKKKGGKLPIRWMAPESLK---DGKFTSKSDVWSFGVL  193 (258)
T ss_pred             cccccCCCcccccChHHhc---cCCCCcchhHHHHHHH
Confidence            11  123567899999986   6678899999999983

Phosphotransferases. Tyrosine-specific kinase subfamily.

>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases

Probab=99.93  E-value=2.7e-26  Score=171.16  Aligned_cols=147  Identities=27%  Similarity=0.446  Sum_probs=112.6

Q ss_pred             ccccccCceEEEEEEEcCCCcEEEEEEccCccChHHHHHHHHHHHHHHhcCCCCchhhhhhhHH----------------
Q psy14630         30 GEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQFYGALF----------------   93 (187)
Q Consensus        30 ~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~----------------   93 (187)
                      +.||+|+||.||++.+.. ++.||+|.+...... .....+..+..+++.+.|+||+++++.+.                
T Consensus         1 ~~lg~g~~g~v~~~~~~~-~~~v~~K~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~   78 (251)
T cd05041           1 EKIGKGNFGDVYKGVLKG-NTEVAVKTCRSTLPP-DLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGS   78 (251)
T ss_pred             CccccCCCceEEEEEEeC-CCcEEEEeccccCCH-HHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCc
Confidence            468999999999999877 899999988654333 23344555666778889999997653210                


Q ss_pred             -----------------HHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEeccccccccccccc---cCCCC
Q psy14630         94 -----------------KEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAK---TRDAG  153 (187)
Q Consensus        94 -----------------~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg~a~~~~~~~~~---~~~~~  153 (187)
                                       ..+..+++.++.|||++ +++|||++|+||+++.++.++++|||++.........   .....
T Consensus        79 l~~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~~-~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~  157 (251)
T cd05041          79 LLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESK-NCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQI  157 (251)
T ss_pred             HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC-CEehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccCcc
Confidence                             12556788999999998 9999999999999999999999999998865422111   11123


Q ss_pred             CcCccCccccCCCccCCCCCCcceeeeEe
Q psy14630        154 CRPYMAPERIDPLRARGYPSFKTKLGFKF  182 (187)
Q Consensus       154 t~~y~aPE~~~~~~~~~~~~~~D~ws~gi  182 (187)
                      +..|+|||.+.   ...++.++|+||+|+
T Consensus       158 ~~~y~~PE~~~---~~~~~~~~Di~slG~  183 (251)
T cd05041         158 PIKWTAPEALN---YGRYTSESDVWSYGI  183 (251)
T ss_pred             eeccCChHhhc---cCCCCcchhHHHHHH
Confidence            45699999987   456889999999998

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k

>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity

Probab=99.93  E-value=3.4e-27  Score=177.33  Aligned_cols=152  Identities=28%  Similarity=0.502  Sum_probs=114.9

Q ss_pred             ccccccccCceEEEEEEEc----CCCcEEEEEEccCccChHHHHHHHHHHHHHHhcCCCCchhhhhhhHH----------
Q psy14630         28 DLGEIGRGGFGTVNKMIHR----SSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQFYGALF----------   93 (187)
Q Consensus        28 ~~~~lg~G~fg~V~~~~~~----~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~----------   93 (187)
                      +.+.||.|.||.||+|...    ..+..|+||.++....... .+.+.++...++.++||||+++++.+.          
T Consensus         3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~-~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e   81 (259)
T PF07714_consen    3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEE-EEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVME   81 (259)
T ss_dssp             EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHH-HHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE
T ss_pred             EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEecccccccc-ceeeeeccccccccccccccccccccccccccccccc
Confidence            5678999999999999876    4567899999965333333 444455555666679999999876432          


Q ss_pred             ------------------------HHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEecccccccccc---c
Q psy14630         94 ------------------------KEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDS---I  146 (187)
Q Consensus        94 ------------------------~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg~a~~~~~~---~  146 (187)
                                              ..++.|++.||.|||+. +++|++|+++||+++.++.+||+|||++......   .
T Consensus        82 ~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~-~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~~~  160 (259)
T PF07714_consen   82 YCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSN-NIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSKYK  160 (259)
T ss_dssp             --TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHT-TEEEST-SGGGEEEETTTEEEEESTTTGEETTTSSSEE
T ss_pred             ccccccccccccccccccccccccccccccccccccccccc-cccccccccccccccccccccccccccccccccccccc
Confidence                                    12678999999999997 9999999999999999999999999999876321   1


Q ss_pred             cccCCCCCcCccCccccCCCccCCCCCCcceeeeEeee
Q psy14630        147 AKTRDAGCRPYMAPERIDPLRARGYPSFKTKLGFKFNY  184 (187)
Q Consensus       147 ~~~~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi~~  184 (187)
                      ..........|+|||.+.   ...++.++||||||+..
T Consensus       161 ~~~~~~~~~~~~aPE~~~---~~~~~~ksDVysfG~~l  195 (259)
T PF07714_consen  161 NDSSQQLPLRYLAPEVLK---DGEYTKKSDVYSFGMLL  195 (259)
T ss_dssp             ESTTSESGGGGS-HHHHH---HSEESHHHHHHHHHHHH
T ss_pred             cccccccccccccccccc---ccccccccccccccccc
Confidence            112234567799999988   55588999999999943

Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....

>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

Probab=99.93  E-value=3.7e-26  Score=170.43  Aligned_cols=155  Identities=28%  Similarity=0.462  Sum_probs=123.9

Q ss_pred             cccccccccccCceEEEEEEEcCCCcEEEEEEccCccChHHHHHHHHHHHHHHhcCCCCchhhhhhhH------------
Q psy14630         25 DLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQFYGAL------------   92 (187)
Q Consensus        25 ~~~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~------------   92 (187)
                      +|++.+.||.|+||.||++.+..++..+++|.+............+.++....+.+.|+|++++.+.+            
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~   80 (258)
T cd08215           1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY   80 (258)
T ss_pred             CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence            47888999999999999999988999999999875444334444555666677788899999875321            


Q ss_pred             ------------------------HHHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEeccccccccccc-c
Q psy14630         93 ------------------------FKEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSI-A  147 (187)
Q Consensus        93 ------------------------~~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg~a~~~~~~~-~  147 (187)
                                              ...+..+++.|+.|||+. +++|+||+|+|++++.++.++++|||.+....... .
T Consensus        81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~-~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~  159 (258)
T cd08215          81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSR-KILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDL  159 (258)
T ss_pred             cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhC-CEecccCChHHeEEcCCCcEEECCccceeecccCcce
Confidence                                    012566899999999998 99999999999999999999999999988765432 2


Q ss_pred             ccCCCCCcCccCccccCCCccCCCCCCcceeeeEee
Q psy14630        148 KTRDAGCRPYMAPERIDPLRARGYPSFKTKLGFKFN  183 (187)
Q Consensus       148 ~~~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi~  183 (187)
                      .....+++.|+|||...   ...++.++|+||+|+.
T Consensus       160 ~~~~~~~~~y~~pe~~~---~~~~~~~~Dv~slG~~  192 (258)
T cd08215         160 AKTVVGTPYYLSPELCQ---NKPYNYKSDIWSLGCV  192 (258)
T ss_pred             ecceeeeecccChhHhc---cCCCCccccHHHHHHH
Confidence            22346788899999987   5668899999999983

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They

>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

Probab=99.93  E-value=3.9e-26  Score=175.59  Aligned_cols=158  Identities=28%  Similarity=0.433  Sum_probs=121.7

Q ss_pred             CcccccccccccccCceEEEEEEEcCCCcEEEEEEccCcc-ChHHHHHHHHHHHHHHhcCCCCchhhhhhhHH-------
Q psy14630         22 TSEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTV-DEKDQRQLLMDLDVVMKSNECPYIVQFYGALF-------   93 (187)
Q Consensus        22 ~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~-------   93 (187)
                      +...|+..+.||+|+||.||+|.+..++..+|+|.+.... ........+.++..+++.++|+|++++.+.+.       
T Consensus        13 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   92 (308)
T cd06634          13 PEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWL   92 (308)
T ss_pred             cHHHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEE
Confidence            4566888899999999999999998899999999875321 12222233444556777789999998754211       


Q ss_pred             -------------------------HHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEeccccccccccccc
Q psy14630         94 -------------------------KEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAK  148 (187)
Q Consensus        94 -------------------------~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg~a~~~~~~~~~  148 (187)
                                               ..++.+++.++.|||+. +++||||+|+||+++.++.++++|||++......   
T Consensus        93 v~e~~~~~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~-~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~---  168 (308)
T cd06634          93 VMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSH-NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA---  168 (308)
T ss_pred             EEEccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhC-CcccCCCCHHhEEECCCCcEEECCcccceeecCc---
Confidence                                     11556889999999997 9999999999999999999999999998765432   


Q ss_pred             cCCCCCcCccCccccCCCccCCCCCCcceeeeEee
Q psy14630        149 TRDAGCRPYMAPERIDPLRARGYPSFKTKLGFKFN  183 (187)
Q Consensus       149 ~~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi~  183 (187)
                      ....+++.|+|||.+.+.....++.++|+||||+.
T Consensus       169 ~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~i  203 (308)
T cd06634         169 NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGIT  203 (308)
T ss_pred             ccccCCccccCHHHHhhcccCCCCcccchHHHHHH
Confidence            22357889999999853324457889999999984

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin

>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=99.93  E-value=1.8e-26  Score=174.79  Aligned_cols=146  Identities=22%  Similarity=0.314  Sum_probs=108.1

Q ss_pred             ccccccCceEEEEEEEcC------------------------CCcEEEEEEccCccChHHHHHHHHHHHHHHhcCCCCch
Q psy14630         30 GEIGRGGFGTVNKMIHRS------------------------SDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYI   85 (187)
Q Consensus        30 ~~lg~G~fg~V~~~~~~~------------------------~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i   85 (187)
                      .+||+|+||.||+|....                        ....|++|.+...  .......+.++..+++.+.||||
T Consensus         1 ~~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~--~~~~~~~~~~~~~~~~~l~h~ni   78 (274)
T cd05076           1 AHLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPS--HRDIALAFFETASLMSQVSHIHL   78 (274)
T ss_pred             CCcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChH--HHHHHHHHHHHHHHHhcCCCCCe
Confidence            369999999999987422                        1245888887532  22233445556667888999999


Q ss_pred             hhhhhhHH---------------------------------HHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCC---
Q psy14630         86 VQFYGALF---------------------------------KEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRG---  129 (187)
Q Consensus        86 v~~~~~~~---------------------------------~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~---  129 (187)
                      +++++.+.                                 ..++.|++.|++|||+. +++||||||+||+++..+   
T Consensus        79 v~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~-~iiH~dlkp~Nill~~~~~~~  157 (274)
T cd05076          79 AFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLEDK-NLVHGNVCAKNILLARLGLAE  157 (274)
T ss_pred             eeEEEEEEeCCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcC-CccCCCCCcccEEEeccCccc
Confidence            98875321                                 11667899999999997 999999999999997543   


Q ss_pred             ----CEEEEeccccccccccccccCCCCCcCccCccccCCCccCCCCCCcceeeeEee
Q psy14630        130 ----AIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPLRARGYPSFKTKLGFKFN  183 (187)
Q Consensus       130 ----~~ki~dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi~  183 (187)
                          .++++|||++......   ....++..|+|||.+.+  ...++.++|+||||+.
T Consensus       158 ~~~~~~kl~d~g~~~~~~~~---~~~~~~~~~~aPe~~~~--~~~~~~~~Dv~slG~~  210 (274)
T cd05076         158 GTSPFIKLSDPGVSFTALSR---EERVERIPWIAPECVPG--GNSLSTAADKWSFGTT  210 (274)
T ss_pred             CccceeeecCCccccccccc---cccccCCcccCchhhcC--CCCCCcHHHHHHHHHH
Confidence                3899999987654322   12256788999999873  2457899999999983

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt

>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

Probab=99.93  E-value=3.1e-26  Score=171.23  Aligned_cols=155  Identities=26%  Similarity=0.389  Sum_probs=120.7

Q ss_pred             cccccccccccCceEEEEEEEcCCCcEEEEEEccCccChHHHHHHHHHHHHHHhcCCCCchhhhhhhHH-----------
Q psy14630         25 DLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQFYGALF-----------   93 (187)
Q Consensus        25 ~~~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~-----------   93 (187)
                      +|++.+.||+|+||.||++....++..+|+|.+..........+.+..+..+++.+.|+|++++++.+.           
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~   80 (257)
T cd08225           1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY   80 (257)
T ss_pred             CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence            477889999999999999999999999999998643222122334455666777889999999875421           


Q ss_pred             -----------------------HHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCC-EEEEeccccccccccccc-
Q psy14630         94 -----------------------KEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGA-IKLCDFGISGQLVDSIAK-  148 (187)
Q Consensus        94 -----------------------~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~-~ki~dfg~a~~~~~~~~~-  148 (187)
                                             ..+..+++.++.|||+. +++|+|++|+||+++.++. ++++|||.+......... 
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~-~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~~~  159 (257)
T cd08225          81 CDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDR-KILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELA  159 (257)
T ss_pred             CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC-CcccccCCHHHEEEcCCCCeEEecccccchhccCCcccc
Confidence                                   11556889999999997 9999999999999988764 699999998876543221 


Q ss_pred             cCCCCCcCccCccccCCCccCCCCCCcceeeeEee
Q psy14630        149 TRDAGCRPYMAPERIDPLRARGYPSFKTKLGFKFN  183 (187)
Q Consensus       149 ~~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi~  183 (187)
                      ....+++.|+|||...   ...++.++|+||||+.
T Consensus       160 ~~~~~~~~~~ape~~~---~~~~~~~~Dv~slG~i  191 (257)
T cd08225         160 YTCVGTPYYLSPEICQ---NRPYNNKTDIWSLGCV  191 (257)
T ss_pred             cccCCCccccCHHHHc---CCCCCchhhHHHHHHH
Confidence            2235788899999987   5568899999999984

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.

>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

Probab=99.93  E-value=4.1e-26  Score=173.67  Aligned_cols=154  Identities=31%  Similarity=0.510  Sum_probs=121.0

Q ss_pred             ccccccccccccCceEEEEEEEcCCCcEEEEEEccCccChHHHHHHHHHHHHHHhcCCCCchhhhhhhH-----------
Q psy14630         24 EDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQFYGAL-----------   92 (187)
Q Consensus        24 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~-----------   92 (187)
                      ..|...+.||+|++|.||++.+..+++.+++|.+...  .....+.+.++..+++.+.|||++++++.+           
T Consensus        19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~--~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e   96 (285)
T cd06648          19 SYLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLR--KQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVME   96 (285)
T ss_pred             HhhhcceEeccCCCeEEEEEEECCCCCEEEEEEEecc--chhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEe
Confidence            4566678999999999999999888999999987532  222234455556677788999999887532           


Q ss_pred             --------------------HHHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEeccccccccccc-cccCC
Q psy14630         93 --------------------FKEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSI-AKTRD  151 (187)
Q Consensus        93 --------------------~~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg~a~~~~~~~-~~~~~  151 (187)
                                          ...+..+++.+++|||+. +++||||+|+||+++.++.++++|||.+....... .....
T Consensus        97 ~~~~~~L~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~-~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~  175 (285)
T cd06648          97 FLEGGALTDIVTHTRMNEEQIATVCLAVLKALSFLHAQ-GVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRKSL  175 (285)
T ss_pred             ccCCCCHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhC-CeecCCCChhhEEEcCCCcEEEcccccchhhccCCcccccc
Confidence                                112667899999999997 99999999999999999999999999887654321 12234


Q ss_pred             CCCcCccCccccCCCccCCCCCCcceeeeEee
Q psy14630        152 AGCRPYMAPERIDPLRARGYPSFKTKLGFKFN  183 (187)
Q Consensus       152 ~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi~  183 (187)
                      .+++.|+|||.+.   ...++.++|+||||+.
T Consensus       176 ~~~~~y~aPE~~~---~~~~~~~~Dv~slGv~  204 (285)
T cd06648         176 VGTPYWMAPEVIS---RLPYGTEVDIWSLGIM  204 (285)
T ss_pred             cCCccccCHHHhc---CCCCCCcccHHHHHHH
Confidence            5788999999987   5568899999999983

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun

>KOG1152|consensus

Probab=99.93  E-value=1.5e-26  Score=182.97  Aligned_cols=155  Identities=21%  Similarity=0.335  Sum_probs=121.1

Q ss_pred             CcccccccccccccCceEEEEEEEcCCCcEEEEEEccCcc--Ch-----HHHHHHHHHHHHHHhcC---CCCchhhhhhh
Q psy14630         22 TSEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTV--DE-----KDQRQLLMDLDVVMKSN---ECPYIVQFYGA   91 (187)
Q Consensus        22 ~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~--~~-----~~~~~~~~~~~~~~~~~---~h~~iv~~~~~   91 (187)
                      ...+|..++.+|+|+||.|++|.++++...|.||.+.+.+  .+     +.....-. ++.++..+   .|+||+++.+.
T Consensus       559 k~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~-EIqIla~l~~~sH~NIlKlLdf  637 (772)
T KOG1152|consen  559 KFSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPS-EIQILATLNKHSHENILKLLDF  637 (772)
T ss_pred             ccccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccch-hHHHHHHhhhcCccchhhhhhe
Confidence            3456889999999999999999999999999999986432  11     11111222 33334433   49999999876


Q ss_pred             HHHH---------------------------------HHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEeccc
Q psy14630         92 LFKE---------------------------------VTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGI  138 (187)
Q Consensus        92 ~~~~---------------------------------~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg~  138 (187)
                      |.+.                                 ++.|++.|++.||.+ +|+|||||-+|++++.+|.+|++|||.
T Consensus       638 FEddd~yyl~te~hg~gIDLFd~IE~kp~m~E~eAk~IFkQV~agi~hlh~~-~ivhrdikdenvivd~~g~~klidfgs  716 (772)
T KOG1152|consen  638 FEDDDYYYLETEVHGEGIDLFDFIEFKPRMDEPEAKLIFKQVVAGIKHLHDQ-GIVHRDIKDENVIVDSNGFVKLIDFGS  716 (772)
T ss_pred             eecCCeeEEEecCCCCCcchhhhhhccCccchHHHHHHHHHHHhcccccccc-CceecccccccEEEecCCeEEEeeccc
Confidence            5332                                 788999999999998 999999999999999999999999998


Q ss_pred             cccccccccccCCCCCcCccCccccCCCccCCCC-CCcceeeeEe
Q psy14630        139 SGQLVDSIAKTRDAGCRPYMAPERIDPLRARGYP-SFKTKLGFKF  182 (187)
Q Consensus       139 a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~-~~~D~ws~gi  182 (187)
                      |.....+ ....+.||..|.|||++-+   ..|- ..-|||++||
T Consensus       717 aa~~ksg-pfd~f~gtv~~aapevl~g---~~y~gk~qdiwalgi  757 (772)
T KOG1152|consen  717 AAYTKSG-PFDVFVGTVDYAAPEVLGG---EKYLGKPQDIWALGI  757 (772)
T ss_pred             hhhhcCC-CcceeeeeccccchhhhCC---CccCCCcchhhhhhh
Confidence            8775544 3445689999999999984   3333 6789999999

>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

Probab=99.93  E-value=1.1e-25  Score=169.67  Aligned_cols=152  Identities=16%  Similarity=0.243  Sum_probs=108.3

Q ss_pred             ccccccCceEEEEEEEcC--CCcEEEEEEccCccChHHHHHHHHHHHHHHhcCCCCchhhhhhhHH--------------
Q psy14630         30 GEIGRGGFGTVNKMIHRS--SDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQFYGALF--------------   93 (187)
Q Consensus        30 ~~lg~G~fg~V~~~~~~~--~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~--------------   93 (187)
                      +.||+|+||.||++....  ....+++|.+........ .+.+.++..+++.++||||+++++.+.              
T Consensus         1 ~~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~-~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~   79 (268)
T cd05086           1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKE-QNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCEL   79 (268)
T ss_pred             CcCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHH-HHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCC
Confidence            368999999999986432  234566777654322222 334455555677789999998764221              


Q ss_pred             ----------------------HHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEeccccccccccc---cc
Q psy14630         94 ----------------------KEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSI---AK  148 (187)
Q Consensus        94 ----------------------~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg~a~~~~~~~---~~  148 (187)
                                            ..+..|++.||+|||+. +++||||||+||+++.++.++++|||++.......   ..
T Consensus        80 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~-~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~  158 (268)
T cd05086          80 GDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKH-NFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETE  158 (268)
T ss_pred             CcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHC-CeeccCCccceEEEcCCccEEecccccccccCcchhhhcc
Confidence                                  12456889999999997 99999999999999999999999999986532211   11


Q ss_pred             cCCCCCcCccCccccCCC----ccCCCCCCcceeeeEee
Q psy14630        149 TRDAGCRPYMAPERIDPL----RARGYPSFKTKLGFKFN  183 (187)
Q Consensus       149 ~~~~~t~~y~aPE~~~~~----~~~~~~~~~D~ws~gi~  183 (187)
                      ....++..|+|||++...    ....++.++|+||||+.
T Consensus       159 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~  197 (268)
T cd05086         159 DDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVT  197 (268)
T ss_pred             cCCcCcccccCchhcccccCccccCCCCCcchhHHHHHH
Confidence            233577889999997521    12245789999999983

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage

>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=99.93  E-value=1.4e-26  Score=173.69  Aligned_cols=146  Identities=24%  Similarity=0.331  Sum_probs=110.3

Q ss_pred             ccccccCceEEEEEEEcCCCc-------EEEEEEccCccChHHHHHHHHHHHHHHhcCCCCchhhhhhhHHH--------
Q psy14630         30 GEIGRGGFGTVNKMIHRSSDT-------VMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQFYGALFK--------   94 (187)
Q Consensus        30 ~~lg~G~fg~V~~~~~~~~~~-------~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~--------   94 (187)
                      +.||+|+||.||+|.+...+.       .+++|.....  .....+.+.++..+++.+.|||++++++.+..        
T Consensus         1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~   78 (258)
T cd05078           1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKS--HRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQ   78 (258)
T ss_pred             CCCCcccchhheeeeecccccccccccchhhHHhhcch--hHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEE
Confidence            468999999999998755443       3788876432  22334455666677888899999988754211        


Q ss_pred             -------------------------HHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCC--------EEEEecccccc
Q psy14630         95 -------------------------EVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGA--------IKLCDFGISGQ  141 (187)
Q Consensus        95 -------------------------~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~--------~ki~dfg~a~~  141 (187)
                                               .+..|++.|++|||+. +++||||||+||+++.++.        ++++|||++..
T Consensus        79 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~-~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~~  157 (258)
T cd05078          79 EYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDK-GLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISIT  157 (258)
T ss_pred             ecCCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHC-CeecCCCccceEEEecccccccCCCceEEecccccccc
Confidence                                     1567899999999997 9999999999999987654        69999998876


Q ss_pred             ccccccccCCCCCcCccCccccCCCccCCCCCCcceeeeEee
Q psy14630        142 LVDSIAKTRDAGCRPYMAPERIDPLRARGYPSFKTKLGFKFN  183 (187)
Q Consensus       142 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi~  183 (187)
                      ....   ....++..|+|||.+.+  ...++.++|+||||+.
T Consensus       158 ~~~~---~~~~~~~~y~aPE~~~~--~~~~~~~~DiwslG~~  194 (258)
T cd05078         158 VLPK---EILLERIPWVPPECIEN--PQNLSLAADKWSFGTT  194 (258)
T ss_pred             cCCc---hhccccCCccCchhccC--CCCCCchhhHHHHHHH
Confidence            5432   22357788999999873  2347889999999983

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity

>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

Probab=99.93  E-value=1.1e-25  Score=170.16  Aligned_cols=156  Identities=25%  Similarity=0.335  Sum_probs=121.6

Q ss_pred             ccccccccccccCceEEEEEEEcCCCcEEEEEEccCccC-hHHHHHHHHHHHHHHhcCC-CCchhhhhhhHHH-------
Q psy14630         24 EDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVD-EKDQRQLLMDLDVVMKSNE-CPYIVQFYGALFK-------   94 (187)
Q Consensus        24 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~~~~~~~~~~-h~~iv~~~~~~~~-------   94 (187)
                      ++|.+.+.||+|+||.||++....+++.+|+|++..... .....+.+..+..+++.+. |+||+++++.+..       
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv   80 (280)
T cd05581           1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV   80 (280)
T ss_pred             CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence            478899999999999999999988999999999864221 1122233444455556666 9999998865421       


Q ss_pred             -------------------------HHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEecccccccccccc--
Q psy14630         95 -------------------------EVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIA--  147 (187)
Q Consensus        95 -------------------------~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg~a~~~~~~~~--  147 (187)
                                               .+..|++.++.|||+. +++|+|++|+||+++.++.++++|||++........  
T Consensus        81 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~Lh~~-~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~~~~  159 (280)
T cd05581          81 LEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHSK-GIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPE  159 (280)
T ss_pred             EcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC-CeeecCCCHHHeEECCCCCEEecCCccccccCCccccc
Confidence                                     1667899999999997 999999999999999999999999999887643221  


Q ss_pred             -------------------ccCCCCCcCccCccccCCCccCCCCCCcceeeeEee
Q psy14630        148 -------------------KTRDAGCRPYMAPERIDPLRARGYPSFKTKLGFKFN  183 (187)
Q Consensus       148 -------------------~~~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi~  183 (187)
                                         .....++..|+|||...   ...++.++|+||+|+.
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~---~~~~~~~~Di~slG~~  211 (280)
T cd05581         160 SNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLN---EKPAGKSSDLWALGCI  211 (280)
T ss_pred             cCCCCCccccccccccccccccccCCccccCHHHhC---CCCCChhhhHHHHHHH
Confidence                               11234678899999987   4558889999999984

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto

>KOG1025|consensus

Probab=99.93  E-value=6.7e-26  Score=185.33  Aligned_cols=157  Identities=25%  Similarity=0.378  Sum_probs=122.7

Q ss_pred             ccccccccccccCceEEEEEEEcCCCc----EEEEEEccCccChHHHHHHHHHHHHHHhcCCCCchhhhhhhHHHH----
Q psy14630         24 EDLQDLGEIGRGGFGTVNKMIHRSSDT----VMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQFYGALFKE----   95 (187)
Q Consensus        24 ~~~~~~~~lg~G~fg~V~~~~~~~~~~----~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~----   95 (187)
                      ...+..++||+|+||+||+|.....++    +||||++......+...+. .+++..+..+.|||++++++.+..+    
T Consensus       696 telkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~-LdeAl~masldHpnl~RLLgvc~~s~~ql  774 (1177)
T KOG1025|consen  696 TELKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIEL-LDEALRMASLDHPNLLRLLGVCMLSTLQL  774 (1177)
T ss_pred             hhhhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHH-HHHHHHHhcCCCchHHHHhhhcccchHHH
Confidence            345566899999999999997643343    5799987654444444444 4455567778999999998765322    


Q ss_pred             ----------------------------HHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEecccccccccccc
Q psy14630         96 ----------------------------VTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIA  147 (187)
Q Consensus        96 ----------------------------~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg~a~~~~~~~~  147 (187)
                                                  +..||++|+.|||++ +++||||..+|+|+..-..+||.|||+++.+.....
T Consensus       775 vtq~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~q-rlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~~  853 (1177)
T KOG1025|consen  775 VTQLMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEEQ-RLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDEK  853 (1177)
T ss_pred             HHHhcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhc-chhhhhhhhhheeecCCCeEEEEecchhhccCcccc
Confidence                                        557899999999998 999999999999999999999999999999865432


Q ss_pred             cc---CCCCCcCccCccccCCCccCCCCCCcceeeeEeeee
Q psy14630        148 KT---RDAGCRPYMAPERIDPLRARGYPSFKTKLGFKFNYR  185 (187)
Q Consensus       148 ~~---~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi~~~  185 (187)
                      .-   ...-.+.|||=|.+.   ...|+.++|||||||..|
T Consensus       854 ey~~~~gK~pikwmale~i~---~~~~thqSDVWsfGVtiW  891 (1177)
T KOG1025|consen  854 EYSAPGGKVPIKWMALESIR---IRKYTHQSDVWSFGVTIW  891 (1177)
T ss_pred             cccccccccCcHHHHHHHhh---ccCCCchhhhhhhhhhHH
Confidence            22   112345699999999   778999999999999877

>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

Probab=99.93  E-value=3.3e-26  Score=171.20  Aligned_cols=153  Identities=25%  Similarity=0.361  Sum_probs=117.2

Q ss_pred             CcccccccccccccCceEEEEEEEcCCCcEEEEEEccCccChHHHHHHHHHHHHHHhcCCCCchhhhhhhHH--------
Q psy14630         22 TSEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQFYGALF--------   93 (187)
Q Consensus        22 ~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~--------   93 (187)
                      +..+|++.+.||+|+||.||++.+. .+..+|+|.++.....   ...+..+..+++.+.|||++++++.+.        
T Consensus         2 ~~~~~~~~~~ig~g~~g~v~~~~~~-~~~~~~~k~~~~~~~~---~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v   77 (256)
T cd05112           2 HPSELTLVQEIGSGQFGLVWLGYWL-EKRKVAIKTIREGAMS---EEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLV   77 (256)
T ss_pred             ChhHeEEEeeecCcccceEEEEEEe-CCCeEEEEECCCCCCC---HHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEE
Confidence            4568899999999999999999875 4668999988643222   122344555677789999998764321        


Q ss_pred             -------------------------HHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEeccccccccccccc
Q psy14630         94 -------------------------KEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAK  148 (187)
Q Consensus        94 -------------------------~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg~a~~~~~~~~~  148 (187)
                                               ..+..+++.++.|||+. +++|+|++|+|++++.++.++|+|||+++........
T Consensus        78 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~-~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~  156 (256)
T cd05112          78 FEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESS-NVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYT  156 (256)
T ss_pred             EEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHC-CccccccccceEEEcCCCeEEECCCcceeecccCccc
Confidence                                     11556788999999997 9999999999999999999999999998765432211


Q ss_pred             --cCCCCCcCccCccccCCCccCCCCCCcceeeeEe
Q psy14630        149 --TRDAGCRPYMAPERIDPLRARGYPSFKTKLGFKF  182 (187)
Q Consensus       149 --~~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi  182 (187)
                        ....++..|+|||.+.   ...++.++|+||+|+
T Consensus       157 ~~~~~~~~~~~~aPe~~~---~~~~~~~~Dv~slG~  189 (256)
T cd05112         157 SSTGTKFPVKWSSPEVFS---FSKYSSKSDVWSFGV  189 (256)
T ss_pred             ccCCCccchhhcCHhHhc---cCCcChHHHHHHHHH
Confidence              1223456799999987   566889999999998

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ

>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

Probab=99.93  E-value=6.2e-26  Score=169.77  Aligned_cols=149  Identities=23%  Similarity=0.393  Sum_probs=114.1

Q ss_pred             ccccccCceEEEEEEEcC-CC--cEEEEEEccCccChHHHHHHHHHHHHHHhcCCCCchhhhhhhHH-------------
Q psy14630         30 GEIGRGGFGTVNKMIHRS-SD--TVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQFYGALF-------------   93 (187)
Q Consensus        30 ~~lg~G~fg~V~~~~~~~-~~--~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~-------------   93 (187)
                      +.||+|++|.||+|.+.. .+  ..+|+|.+...... ...+.+..+...++.++||||+++++.+.             
T Consensus         1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~v~e~~~~   79 (257)
T cd05040           1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLS-DIMDDFLKEAAIMHSLDHENLIRLYGVVLTHPLMMVTELAPL   79 (257)
T ss_pred             CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccH-HHHHHHHHHHHHHhhcCCCCccceeEEEcCCeEEEEEEecCC
Confidence            468999999999998754 23  36899998754333 33445555666777889999998764321             


Q ss_pred             --------------------HHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEeccccccccccc----ccc
Q psy14630         94 --------------------KEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSI----AKT  149 (187)
Q Consensus        94 --------------------~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg~a~~~~~~~----~~~  149 (187)
                                          ..+..|++.||+|||+. +++|+||+|+|++++.++.+|++|||+++......    ...
T Consensus        80 ~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~-~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~  158 (257)
T cd05040          80 GSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESK-RFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEE  158 (257)
T ss_pred             CcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhC-CccccccCcccEEEecCCEEEeccccccccccccccceeccc
Confidence                                11556899999999997 99999999999999999999999999998764321    111


Q ss_pred             CCCCCcCccCccccCCCccCCCCCCcceeeeEee
Q psy14630        150 RDAGCRPYMAPERIDPLRARGYPSFKTKLGFKFN  183 (187)
Q Consensus       150 ~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi~  183 (187)
                      ...++..|+|||.+.   ...++.++|+||+|+.
T Consensus       159 ~~~~~~~y~~pE~~~---~~~~~~~~Di~slG~~  189 (257)
T cd05040         159 HLKVPFAWCAPESLR---TRTFSHASDVWMFGVT  189 (257)
T ss_pred             CCCCCceecCHHHhc---ccCcCchhhhHHHHHH
Confidence            234567899999987   5668899999999983

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and

>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

Probab=99.93  E-value=9.8e-26  Score=168.03  Aligned_cols=155  Identities=29%  Similarity=0.461  Sum_probs=123.9

Q ss_pred             cccccccccccCceEEEEEEEcCCCcEEEEEEccCccChHHHHHHHHHHHHHHhcCCCCchhhhhhhH------------
Q psy14630         25 DLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQFYGAL------------   92 (187)
Q Consensus        25 ~~~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~------------   92 (187)
                      +|++.+.||+|++|.||++.+..+++.+++|.+..........+.+.++..++..+.|+|++++++.+            
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   80 (254)
T cd06627           1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY   80 (254)
T ss_pred             CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence            47788999999999999999988899999999875443333445566666677778999999875421            


Q ss_pred             --------------------HHHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEecccccccccccc-ccCC
Q psy14630         93 --------------------FKEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIA-KTRD  151 (187)
Q Consensus        93 --------------------~~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg~a~~~~~~~~-~~~~  151 (187)
                                          ...+..+++.++.|||+. +++|+|++|+||+++.++.++|+|||++........ ....
T Consensus        81 ~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~-~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~~  159 (254)
T cd06627          81 AENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQ-GVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDASV  159 (254)
T ss_pred             CCCCcHHHHHHhccCCCHHHHHHHHHHHHHHHHHHhhC-CcccCCCCHHHEEECCCCCEEEeccccceecCCCccccccc
Confidence                                112667899999999997 999999999999999999999999999988754332 1234


Q ss_pred             CCCcCccCccccCCCccCCCCCCcceeeeEee
Q psy14630        152 AGCRPYMAPERIDPLRARGYPSFKTKLGFKFN  183 (187)
Q Consensus       152 ~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi~  183 (187)
                      .++..|+|||...   ...++.++|+|++|+.
T Consensus       160 ~~~~~y~~pe~~~---~~~~~~~~Dv~~lG~~  188 (254)
T cd06627         160 VGTPYWMAPEVIE---MSGASTASDIWSLGCT  188 (254)
T ss_pred             ccchhhcCHhhhc---CCCCCcchhHHHHHHH
Confidence            5788899999987   4457899999999983

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast

>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

Probab=99.93  E-value=5e-26  Score=171.94  Aligned_cols=158  Identities=19%  Similarity=0.307  Sum_probs=119.4

Q ss_pred             CCcccccccccccccCceEEEEEEEcC-----CCcEEEEEEccCccChHHHHHHHHHHHHHHhcCCCCchhhhhhhHH--
Q psy14630         21 FTSEDLQDLGEIGRGGFGTVNKMIHRS-----SDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQFYGALF--   93 (187)
Q Consensus        21 ~~~~~~~~~~~lg~G~fg~V~~~~~~~-----~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~--   93 (187)
                      +.+++|+....||+|+||.||+|....     +.+.+++|.+...... ...+.+..+..+++.+.|+|++++++.+.  
T Consensus         2 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~   80 (275)
T cd05046           2 FPRSNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDE-NLQSEFRRELDMFRKLSHKNVVRLLGLCREA   80 (275)
T ss_pred             CChHhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccch-HHHHHHHHHHHHHHhcCCcceeeeEEEECCC
Confidence            456889999999999999999998653     3467899987643322 23334455556677789999998764211  


Q ss_pred             ---------------------------------------HHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEE
Q psy14630         94 ---------------------------------------KEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLC  134 (187)
Q Consensus        94 ---------------------------------------~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~  134 (187)
                                                             ..+..|++.+++|||+. +++||||||+|++++.++.++++
T Consensus        81 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~-~i~H~dlkp~Nili~~~~~~~l~  159 (275)
T cd05046          81 EPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNA-RFVHRDLAARNCLVSSQREVKVS  159 (275)
T ss_pred             CcceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhc-CcccCcCccceEEEeCCCcEEEc
Confidence                                                   11456899999999997 99999999999999999999999


Q ss_pred             eccccccccccc--cccCCCCCcCccCccccCCCccCCCCCCcceeeeEee
Q psy14630        135 DFGISGQLVDSI--AKTRDAGCRPYMAPERIDPLRARGYPSFKTKLGFKFN  183 (187)
Q Consensus       135 dfg~a~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi~  183 (187)
                      |||++.......  ......++..|+|||.+.   ...++.++|+||+|+.
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~---~~~~~~~~Di~slG~~  207 (275)
T cd05046         160 LLSLSKDVYNSEYYKLRNALIPLRWLAPEAVQ---EDDFSTKSDVWSFGVL  207 (275)
T ss_pred             ccccccccCcccccccCCceeEEeecChhhhc---cCCCCchhhHHHHHHH
Confidence            999987643221  112234567799999987   4557789999999983

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s

>PLN03225 Serine/threonine-protein kinase SNT7; Provisional

Probab=99.93  E-value=2.7e-25  Score=182.92  Aligned_cols=163  Identities=19%  Similarity=0.218  Sum_probs=107.0

Q ss_pred             cCCcccccccccccccCceEEEEEEEcCC----CcEEEEEEccCccChHH-HHHHHHHH-----HHHHhcC---------
Q psy14630         20 DFTSEDLQDLGEIGRGGFGTVNKMIHRSS----DTVMAVKRIRSTVDEKD-QRQLLMDL-----DVVMKSN---------   80 (187)
Q Consensus        20 ~~~~~~~~~~~~lg~G~fg~V~~~~~~~~----~~~vaiK~~~~~~~~~~-~~~~~~~~-----~~~~~~~---------   80 (187)
                      .+..++|.+.+.||+|+||.||+|.+..+    +..||+|.+........ ..+.+...     .......         
T Consensus       128 ~~~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~e~~~~e~l~~~~~~~~~~~~~~~~~~~~~~~~  207 (566)
T PLN03225        128 SFKKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAVEIWMNERVRRACPNSCADFVYGFLEPVSSKKE  207 (566)
T ss_pred             CCccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchhHHHHHHHHHhhchhhHHHHHHhhhcccccccC
Confidence            34667899999999999999999999888    89999998754221111 01111000     0000000         


Q ss_pred             ----------CCCchhhhh---------------------------hhHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCe
Q psy14630         81 ----------ECPYIVQFY---------------------------GALFKEVTVATVKALNYLKEELKIIHRDVKPSNI  123 (187)
Q Consensus        81 ----------~h~~iv~~~---------------------------~~~~~~~~~~~~~~l~~lh~~~~i~Hrdlk~~ni  123 (187)
                                .+..+..++                           ......++.|++.||.|||+. +|+||||||+||
T Consensus       208 ~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~-gIiHRDLKP~NI  286 (566)
T PLN03225        208 DEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHST-GIVHRDVKPQNI  286 (566)
T ss_pred             CceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHC-CEEeCcCCHHHE
Confidence                      000010110                           011234678899999999998 999999999999


Q ss_pred             EEcC-CCCEEEEecccccccccc--ccccCCCCCcCccCccccCCCcc-------------------CCCCCCcceeeeE
Q psy14630        124 LLDR-RGAIKLCDFGISGQLVDS--IAKTRDAGCRPYMAPERIDPLRA-------------------RGYPSFKTKLGFK  181 (187)
Q Consensus       124 li~~-~~~~ki~dfg~a~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~-------------------~~~~~~~D~ws~g  181 (187)
                      |++. .+.+||+|||+++.+...  .......+++.|+|||.+.....                   ..++.++|+||+|
T Consensus       287 Ll~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DVwSlG  366 (566)
T PLN03225        287 IFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAG  366 (566)
T ss_pred             EEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcccHHHH
Confidence            9985 578999999999875432  12234568899999997542111                   1244567999999


Q ss_pred             ee
Q psy14630        182 FN  183 (187)
Q Consensus       182 i~  183 (187)
                      ++
T Consensus       367 vi  368 (566)
T PLN03225        367 LI  368 (566)
T ss_pred             HH
Confidence            93

>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

Probab=99.93  E-value=1.4e-25  Score=168.00  Aligned_cols=147  Identities=31%  Similarity=0.479  Sum_probs=115.7

Q ss_pred             ccccCceEEEEEEEcCCCcEEEEEEccCccC-hHHHHHHHHHHHHHHhcCCCCchhhhhhhHH-----------------
Q psy14630         32 IGRGGFGTVNKMIHRSSDTVMAVKRIRSTVD-EKDQRQLLMDLDVVMKSNECPYIVQFYGALF-----------------   93 (187)
Q Consensus        32 lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~-----------------   93 (187)
                      ||.|+||.||++.+..+++.+++|.+..... .....+.+..+..+++.+.|||++++++.+.                 
T Consensus         1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (265)
T cd05579           1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL   80 (265)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence            6899999999999988899999999864322 2233445555666777788999998875321                 


Q ss_pred             ---------------HHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEeccccccccccc---------ccc
Q psy14630         94 ---------------KEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSI---------AKT  149 (187)
Q Consensus        94 ---------------~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg~a~~~~~~~---------~~~  149 (187)
                                     ..+..|++.+|+|||+. +++|+||+|+||+++.++.++++|||++.......         ...
T Consensus        81 ~~~l~~~~~~~~~~~~~i~~qi~~~L~~lH~~-~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~  159 (265)
T cd05579          81 ASLLENVGSLDEDVARIYIAEIVLALEYLHSN-GIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDK  159 (265)
T ss_pred             HHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHc-CeecCCCCHHHeEEcCCCCEEEEecccchhcccCccccccccccccc
Confidence                           12667899999999997 99999999999999999999999999987653321         122


Q ss_pred             CCCCCcCccCccccCCCccCCCCCCcceeeeEe
Q psy14630        150 RDAGCRPYMAPERIDPLRARGYPSFKTKLGFKF  182 (187)
Q Consensus       150 ~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi  182 (187)
                      ...++..|+|||...   ....+.++|+||||+
T Consensus       160 ~~~~~~~~~~Pe~~~---~~~~~~~~Dv~slG~  189 (265)
T cd05579         160 RIVGTPDYIAPEVIL---GQGHSKTVDWWSLGC  189 (265)
T ss_pred             CcccCccccCHHHhc---CCCCCcchhhHHHHH
Confidence            335677899999988   455789999999998

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re

>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

Probab=99.93  E-value=1e-25  Score=171.57  Aligned_cols=157  Identities=24%  Similarity=0.302  Sum_probs=115.7

Q ss_pred             cccccccccccCceEEEEEEEc---CCCcEEEEEEccCccC--hHHHHHHHHHHHHHHhcC-CCCchhhhhhhHH-----
Q psy14630         25 DLQDLGEIGRGGFGTVNKMIHR---SSDTVMAVKRIRSTVD--EKDQRQLLMDLDVVMKSN-ECPYIVQFYGALF-----   93 (187)
Q Consensus        25 ~~~~~~~lg~G~fg~V~~~~~~---~~~~~vaiK~~~~~~~--~~~~~~~~~~~~~~~~~~-~h~~iv~~~~~~~-----   93 (187)
                      +|++.+.||+|+||.||++...   .++..||+|.++....  .....+....+..++..+ +|+||+.+++.+.     
T Consensus         1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~   80 (290)
T cd05613           1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL   80 (290)
T ss_pred             CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence            4778899999999999999874   4788999999864211  111223333444445555 6899998753221     


Q ss_pred             ---------------------------HHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEeccccccccccc
Q psy14630         94 ---------------------------KEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSI  146 (187)
Q Consensus        94 ---------------------------~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg~a~~~~~~~  146 (187)
                                                 ..+..|++.++.|||+. +++||||+|+||+++.++.++|+|||+++......
T Consensus        81 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~-~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~  159 (290)
T cd05613          81 HLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEHLHKL-GIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDE  159 (290)
T ss_pred             EEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhC-CeeccCCCHHHeEECCCCCEEEeeCccceeccccc
Confidence                                       11445899999999997 99999999999999999999999999988764322


Q ss_pred             --cccCCCCCcCccCccccCCCccCCCCCCcceeeeEee
Q psy14630        147 --AKTRDAGCRPYMAPERIDPLRARGYPSFKTKLGFKFN  183 (187)
Q Consensus       147 --~~~~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi~  183 (187)
                        ......++..|+|||.+.+. ...++.++|+||||+.
T Consensus       160 ~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~~Dv~slG~~  197 (290)
T cd05613         160 VERAYSFCGTIEYMAPDIVRGG-DGGHDKAVDWWSMGVL  197 (290)
T ss_pred             ccccccccCCcccCChhhccCC-CCCCCccccHHHHHHH
Confidence              11234578899999998732 2346789999999984

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

Probab=99.92  E-value=1e-25  Score=169.72  Aligned_cols=157  Identities=29%  Similarity=0.491  Sum_probs=119.1

Q ss_pred             CcccccccccccccCceEEEEEEEcCCCcEEEEEEccCccChHHHHHHHHHHHHHHhcC-CCCchhhhhhhHH-------
Q psy14630         22 TSEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSN-ECPYIVQFYGALF-------   93 (187)
Q Consensus        22 ~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~-~h~~iv~~~~~~~-------   93 (187)
                      +.++|++.+.||+|+||.||+|.+..+++.+++|.+.....  .. +.+..+..+++.+ .|+||+++++.+.       
T Consensus         4 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~-~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~   80 (275)
T cd06608           4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED--EE-EEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGN   80 (275)
T ss_pred             chhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch--hH-HHHHHHHHHHHHhcCCCChheEEEEEEecCCCCc
Confidence            45789999999999999999999988899999999864322  22 2334444444444 7999988754321       


Q ss_pred             -----------------------------------HHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEeccc
Q psy14630         94 -----------------------------------KEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGI  138 (187)
Q Consensus        94 -----------------------------------~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg~  138 (187)
                                                         ..+..|++.|+.|||+. +++|+||+|+||+++.++.++++|||+
T Consensus        81 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~-~i~H~~l~p~ni~~~~~~~~~l~d~~~  159 (275)
T cd06608          81 DDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHEN-KVIHRDIKGQNILLTKNAEVKLVDFGV  159 (275)
T ss_pred             ceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcC-CcccCCCCHHHEEEccCCeEEECCCcc
Confidence                                               01556899999999997 999999999999999999999999999


Q ss_pred             cccccccc-cccCCCCCcCccCccccCCCc--cCCCCCCcceeeeEe
Q psy14630        139 SGQLVDSI-AKTRDAGCRPYMAPERIDPLR--ARGYPSFKTKLGFKF  182 (187)
Q Consensus       139 a~~~~~~~-~~~~~~~t~~y~aPE~~~~~~--~~~~~~~~D~ws~gi  182 (187)
                      +....... ......++..|+|||.+....  ...++.++|+||+|+
T Consensus       160 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~  206 (275)
T cd06608         160 SAQLDSTLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGI  206 (275)
T ss_pred             ceecccchhhhcCccccccccCHhHhcccccccCCccccccHHHhHH
Confidence            87654322 122345788899999875321  234678899999998

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I

>KOG0576|consensus

Probab=99.92  E-value=6.8e-27  Score=187.33  Aligned_cols=159  Identities=30%  Similarity=0.480  Sum_probs=134.5

Q ss_pred             CCcccccccccccccCceEEEEEEEcCCCcEEEEEEccCccChHHHHHHHHHHHHHHhcCCCCchhhhhhhHHHH-----
Q psy14630         21 FTSEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQFYGALFKE-----   95 (187)
Q Consensus        21 ~~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~-----   95 (187)
                      =++++|..+..+|.|.||.|||+++..++...|+|+++....+  .-+.++.++.+++.+.||||+.+++.+.+.     
T Consensus        12 nP~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~d--d~~~iqqei~~~~dc~h~nivay~gsylr~dklwi   89 (829)
T KOG0576|consen   12 NPQDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGD--DFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWI   89 (829)
T ss_pred             CCccchhheeeecCCcccchhhhcccccCchhhheeeeccCCc--cccccccceeeeecCCCcChHHHHhhhhhhcCcEE
Confidence            4678999999999999999999999999999999999864332  234455666778899999999999877554     


Q ss_pred             ---------------------------HHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEeccccccccccccc
Q psy14630         96 ---------------------------VTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAK  148 (187)
Q Consensus        96 ---------------------------~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg~a~~~~~~~~~  148 (187)
                                                 +-...+.+++|||+. +-+|||+|-.||++...|.+|+.|||.+..+.....+
T Consensus        90 cMEycgggslQdiy~~TgplselqiayvcRetl~gl~ylhs~-gk~hRdiKGanilltd~gDvklaDfgvsaqitati~K  168 (829)
T KOG0576|consen   90 CMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLKYLHSQ-GKIHRDIKGANILLTDEGDVKLADFGVSAQITATIAK  168 (829)
T ss_pred             EEEecCCCcccceeeecccchhHHHHHHHhhhhccchhhhcC-CcccccccccceeecccCceeecccCchhhhhhhhhh
Confidence                                       223456799999997 9999999999999999999999999999988765333


Q ss_pred             -cCCCCCcCccCccccCCCccCCCCCCcceeeeEe
Q psy14630        149 -TRDAGCRPYMAPERIDPLRARGYPSFKTKLGFKF  182 (187)
Q Consensus       149 -~~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi  182 (187)
                       .+..||++|||||+..-.+..+|...+|+|++||
T Consensus       169 rksfiGtpywmapEvaaverkggynqlcdiwa~gi  203 (829)
T KOG0576|consen  169 RKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGI  203 (829)
T ss_pred             hhcccCCccccchhHHHHHhccccccccccccccc
Confidence             4568999999999987666888999999999997

>KOG0603|consensus

Probab=99.92  E-value=1.3e-26  Score=184.87  Aligned_cols=150  Identities=27%  Similarity=0.384  Sum_probs=121.6

Q ss_pred             CcccccccccccccCceEEEEEEEcCCCcEEEEEEccCccChHHHHHHHHHHHHHHhcCCCCchhhhhhhH---------
Q psy14630         22 TSEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQFYGAL---------   92 (187)
Q Consensus        22 ~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~---------   92 (187)
                      ..++|.+...+|.|+|+.|..|.+..+.+..++|++.+...+     .-.++.......+|||++.+.+.+         
T Consensus       320 ~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~~-----~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v  394 (612)
T KOG0603|consen  320 FTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRADD-----NQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLV  394 (612)
T ss_pred             cchhhccccccCCCCccceeeeeccccccchhheeccccccc-----cccccchhhhhcCCCcceeecceecCCceeeee
Confidence            367788888999999999999999999999999998754111     112233455667899999876432         


Q ss_pred             ----------------------HHHHHHHHHHHHHHHHhcCCCeeecCCCCCeEE-cCCCCEEEEecccccccccccccc
Q psy14630         93 ----------------------FKEVTVATVKALNYLKEELKIIHRDVKPSNILL-DRRGAIKLCDFGISGQLVDSIAKT  149 (187)
Q Consensus        93 ----------------------~~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili-~~~~~~ki~dfg~a~~~~~~~~~~  149 (187)
                                            ...++.+++.++.|||++ |++||||||+|||+ +..++++|+|||.++.....  +.
T Consensus       395 ~e~l~g~ell~ri~~~~~~~~e~~~w~~~lv~Av~~LH~~-gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~--~~  471 (612)
T KOG0603|consen  395 MELLDGGELLRRIRSKPEFCSEASQWAAELVSAVDYLHEQ-GVVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS--CD  471 (612)
T ss_pred             ehhccccHHHHHHHhcchhHHHHHHHHHHHHHHHHHHHhc-CeeecCCChhheeecCCCCcEEEEEechhhhCchh--hc
Confidence                                  122788999999999997 99999999999999 68999999999999987765  22


Q ss_pred             CCCCCcCccCccccCCCccCCCCCCcceeeeEe
Q psy14630        150 RDAGCRPYMAPERIDPLRARGYPSFKTKLGFKF  182 (187)
Q Consensus       150 ~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi  182 (187)
                      ..+=|..|.|||++.   ..+|++++||||+|+
T Consensus       472 tp~~t~~y~APEvl~---~~~yt~acD~WSLGv  501 (612)
T KOG0603|consen  472 TPALTLQYVAPEVLA---IQEYTEACDWWSLGV  501 (612)
T ss_pred             ccchhhcccChhhhc---cCCCCcchhhHHHHH
Confidence            224577899999999   678999999999999

>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

Probab=99.92  E-value=1.9e-25  Score=172.18  Aligned_cols=154  Identities=27%  Similarity=0.446  Sum_probs=118.6

Q ss_pred             ccccccccccCceEEEEEEEcCCCcEEEEEEccCcc-ChHHHHHHHHHHHHHHhcCCCCchhhhhhhHH-----------
Q psy14630         26 LQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTV-DEKDQRQLLMDLDVVMKSNECPYIVQFYGALF-----------   93 (187)
Q Consensus        26 ~~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~-----------   93 (187)
                      |.....||+|+||.||+|.+..++..+++|.+.... ........+..+..+++.++|||++++++.+.           
T Consensus        23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  102 (313)
T cd06633          23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY  102 (313)
T ss_pred             hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence            555678999999999999998899999999985422 22223333444556777789999998764321           


Q ss_pred             ---------------------HHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEeccccccccccccccCCC
Q psy14630         94 ---------------------KEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTRDA  152 (187)
Q Consensus        94 ---------------------~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg~a~~~~~~~~~~~~~  152 (187)
                                           ..+..|++.++.|||+. +++|+||+|+||+++.++.++++|||++.....   .....
T Consensus       103 ~~~~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~~-gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~~---~~~~~  178 (313)
T cd06633         103 CLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSH-NMIHRDIKAGNILLTEPGQVKLADFGSASKSSP---ANSFV  178 (313)
T ss_pred             CCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC-CeecCCCChhhEEECCCCCEEEeecCCCcccCC---CCCcc
Confidence                                 11567899999999997 999999999999999999999999998865322   22346


Q ss_pred             CCcCccCccccCCCccCCCCCCcceeeeEee
Q psy14630        153 GCRPYMAPERIDPLRARGYPSFKTKLGFKFN  183 (187)
Q Consensus       153 ~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi~  183 (187)
                      ++..|+|||.+.......++.++|+||||+.
T Consensus       179 ~~~~y~aPE~~~~~~~~~~~~~sDv~slGvi  209 (313)
T cd06633         179 GTPYWMAPEVILAMDEGQYDGKVDVWSLGIT  209 (313)
T ss_pred             ccccccChhhccccCCCCCCchhhHHHHHHH
Confidence            7888999999864324557889999999984

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co

>PTZ00024 cyclin-dependent protein kinase; Provisional

Probab=99.92  E-value=5.9e-26  Score=176.39  Aligned_cols=157  Identities=21%  Similarity=0.287  Sum_probs=117.7

Q ss_pred             cccc-ccccccccCceEEEEEEEcCCCcEEEEEEccCccChHHH------------HHHHHHHHHHHhcCCCCchhhhhh
Q psy14630         24 EDLQ-DLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQ------------RQLLMDLDVVMKSNECPYIVQFYG   90 (187)
Q Consensus        24 ~~~~-~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~------------~~~~~~~~~~~~~~~h~~iv~~~~   90 (187)
                      ++|. +.+.||.|+||.||+|.+..+++.||+|.++........            ...+.++..+++.+.|+||+++++
T Consensus         8 ~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~   87 (335)
T PTZ00024          8 ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVD   87 (335)
T ss_pred             cchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeE
Confidence            5565 457799999999999999989999999998543211100            112344555677889999998775


Q ss_pred             hHH-------------------------------HHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEecccc
Q psy14630         91 ALF-------------------------------KEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGIS  139 (187)
Q Consensus        91 ~~~-------------------------------~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg~a  139 (187)
                      .+.                               ..++.|++.|+.|||+. +++|+||+|+||+++.++.++++|||++
T Consensus        88 ~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~-~i~H~dl~~~nill~~~~~~kl~dfg~~  166 (335)
T PTZ00024         88 VYVEGDFINLVMDIMASDLKKVVDRKIRLTESQVKCILLQILNGLNVLHKW-YFMHRDLSPANIFINSKGICKIADFGLA  166 (335)
T ss_pred             EEecCCcEEEEEeccccCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC-CeecccccHHHeEECCCCCEEECCccce
Confidence            421                               12667899999999997 9999999999999999999999999998


Q ss_pred             cccccc---------------ccccCCCCCcCccCccccCCCccCCCCCCcceeeeEee
Q psy14630        140 GQLVDS---------------IAKTRDAGCRPYMAPERIDPLRARGYPSFKTKLGFKFN  183 (187)
Q Consensus       140 ~~~~~~---------------~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi~  183 (187)
                      +....+               .......++..|+|||.+.+  ...++.++|+||+|+.
T Consensus       167 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~~Dv~slG~~  223 (335)
T PTZ00024        167 RRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMG--AEKYHFAVDMWSVGCI  223 (335)
T ss_pred             eecccccccccccccccccccccccccccccCCCCChhccc--CCCCCcHHHHHHHHHH
Confidence            765411               11112245778999999873  2346889999999983

>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

Probab=99.92  E-value=1.1e-25  Score=167.73  Aligned_cols=154  Identities=30%  Similarity=0.470  Sum_probs=124.9

Q ss_pred             cccccccccccCceEEEEEEEcCCCcEEEEEEccCccChHHHHHHHHHHHHHHhcCCCCchhhhhhhHH-----------
Q psy14630         25 DLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQFYGALF-----------   93 (187)
Q Consensus        25 ~~~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~-----------   93 (187)
                      +|+..+.||+|++|.||+|.+..+++.+++|.+..........+.+.++...++.++|+||+++++.+.           
T Consensus         1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~   80 (260)
T cd06606           1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL   80 (260)
T ss_pred             CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence            467789999999999999999889999999998654333344556666666778889999998764211           


Q ss_pred             -----------------------HHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEecccccccccccc---
Q psy14630         94 -----------------------KEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIA---  147 (187)
Q Consensus        94 -----------------------~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg~a~~~~~~~~---  147 (187)
                                             ..+..+++.++.|||+. +++|+|++|+||+++.++.++|+|||.+........   
T Consensus        81 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~-~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~  159 (260)
T cd06606          81 EYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHSN-GIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEG  159 (260)
T ss_pred             EecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC-CccccCCCHHHEEEcCCCCEEEcccccEEeccccccccc
Confidence                                   12667899999999997 999999999999999999999999999888765432   


Q ss_pred             ccCCCCCcCccCccccCCCccCCCCCCcceeeeEe
Q psy14630        148 KTRDAGCRPYMAPERIDPLRARGYPSFKTKLGFKF  182 (187)
Q Consensus       148 ~~~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi  182 (187)
                      .....++..|+|||.+.   ....+.++|+||+|+
T Consensus       160 ~~~~~~~~~y~~pE~~~---~~~~~~~~Dv~slG~  191 (260)
T cd06606         160 TGSVRGTPYWMAPEVIR---GEEYGRAADIWSLGC  191 (260)
T ss_pred             ccCCCCCccccCHhhhc---CCCCCchhhHHHHHH
Confidence            33446788899999988   455889999999998

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK

>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

Probab=99.92  E-value=1e-25  Score=172.14  Aligned_cols=153  Identities=30%  Similarity=0.480  Sum_probs=119.3

Q ss_pred             cccccccccccCceEEEEEEEcCCCcEEEEEEccCccChHHHHHHHHHHHHHHhcCCCCchhhhhhhH------------
Q psy14630         25 DLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQFYGAL------------   92 (187)
Q Consensus        25 ~~~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~------------   92 (187)
                      .|.....||+|+||.||++....++..+|+|.+...  .......+..+..+++.++|+|++++++.+            
T Consensus        21 ~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   98 (292)
T cd06657          21 YLDNFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLR--KQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEF   98 (292)
T ss_pred             HhhhHHHcCCCCCeEEEEEEEcCCCeEEEEEEeccc--chhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEec
Confidence            344457899999999999999999999999987532  222334455555577788999999886432            


Q ss_pred             -------------------HHHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEeccccccccccc-cccCCC
Q psy14630         93 -------------------FKEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSI-AKTRDA  152 (187)
Q Consensus        93 -------------------~~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg~a~~~~~~~-~~~~~~  152 (187)
                                         ...+..|++.+++|||+. +++|+|++|+||+++.++.++++|||++....... ......
T Consensus        99 ~~~~~L~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~-givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~~~~~~~  177 (292)
T cd06657          99 LEGGALTDIVTHTRMNEEQIAAVCLAVLKALSVLHAQ-GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLV  177 (292)
T ss_pred             CCCCcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC-CeecCCCCHHHEEECCCCCEEEcccccceecccccccccccc
Confidence                               112667899999999997 99999999999999999999999999887654322 222346


Q ss_pred             CCcCccCccccCCCccCCCCCCcceeeeEee
Q psy14630        153 GCRPYMAPERIDPLRARGYPSFKTKLGFKFN  183 (187)
Q Consensus       153 ~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi~  183 (187)
                      +++.|+|||.+.   ...++.++|+||+|++
T Consensus       178 ~~~~y~~pE~~~---~~~~~~~~Dv~slGvi  205 (292)
T cd06657         178 GTPYWMAPELIS---RLPYGPEVDIWSLGIM  205 (292)
T ss_pred             cCccccCHHHhc---CCCCCchhhHHHHHHH
Confidence            788899999987   4557889999999983

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo

>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein

Probab=99.92  E-value=2.8e-25  Score=171.03  Aligned_cols=147  Identities=22%  Similarity=0.339  Sum_probs=108.9

Q ss_pred             CceEEEEEEEcCCCcEEEEEEccCccChHHHHHHHHHHHHHHhcCCCCchhhhhhhHHH---------------------
Q psy14630         36 GFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQFYGALFK---------------------   94 (187)
Q Consensus        36 ~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~---------------------   94 (187)
                      +++.||++.+..+++.||+|.+..........+.+..+...++.++|+||+++++.+..                     
T Consensus        12 ~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~~l~   91 (314)
T cd08216          12 DLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSCEDLLK   91 (314)
T ss_pred             CCceEEEEEecCCCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCCHHHHHH
Confidence            44556666666789999999986542233344456666667778899999998753211                     


Q ss_pred             -------------HHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEecccccccccccc--------ccCCCC
Q psy14630         95 -------------EVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIA--------KTRDAG  153 (187)
Q Consensus        95 -------------~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg~a~~~~~~~~--------~~~~~~  153 (187)
                                   .++.|++.||+|||+. +++||||||+||+++.++.++++|||.+........        .....+
T Consensus        92 ~~~~~~~~~~~~~~~~~~l~~~L~~LH~~-~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~  170 (314)
T cd08216          92 THFPEGLPELAIAFILKDVLNALDYIHSK-GFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVK  170 (314)
T ss_pred             HhcccCCCHHHHHHHHHHHHHHHHHHHHC-CeecCCCCcceEEEecCCceEEecCccceeeccccccccccccccccccc
Confidence                         1567899999999997 999999999999999999999999998876532211        122346


Q ss_pred             CcCccCccccCCCccCCCCCCcceeeeEeee
Q psy14630        154 CRPYMAPERIDPLRARGYPSFKTKLGFKFNY  184 (187)
Q Consensus       154 t~~y~aPE~~~~~~~~~~~~~~D~ws~gi~~  184 (187)
                      +..|+|||.+... ..+++.++|+||+|+..
T Consensus       171 ~~~y~aPE~~~~~-~~~~~~~~Diws~G~il  200 (314)
T cd08216         171 NLPWLSPEVLQQN-LQGYNEKSDIYSVGITA  200 (314)
T ss_pred             cccccCHHHhcCC-CCCCCcchhHHHHHHHH
Confidence            6789999998732 23578899999999843

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc

>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases

Probab=99.92  E-value=1.5e-25  Score=166.43  Aligned_cols=152  Identities=34%  Similarity=0.577  Sum_probs=121.3

Q ss_pred             cccccccccccCceEEEEEEEcCCCcEEEEEEccCccChHHHHHHHHHHHHHHhcCCCCchhhhhhhHH-----------
Q psy14630         25 DLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQFYGALF-----------   93 (187)
Q Consensus        25 ~~~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~-----------   93 (187)
                      +|+..+.||+|++|.||++.+..++..+++|.+.....  ...+.+..+...++.+.|+|++++.+.+.           
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~   78 (253)
T cd05122           1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESK--EKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEF   78 (253)
T ss_pred             CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccch--hHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEec
Confidence            47788999999999999999988899999999865332  22334445555677778999988764321           


Q ss_pred             ----------------------HHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEeccccccccccccccCC
Q psy14630         94 ----------------------KEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTRD  151 (187)
Q Consensus        94 ----------------------~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg~a~~~~~~~~~~~~  151 (187)
                                            ..+..+++.++.+||+. +++|+|++|+||+++.++.++|+|||.+............
T Consensus        79 ~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~-~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~  157 (253)
T cd05122          79 CSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSN-GIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARNTM  157 (253)
T ss_pred             CCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcC-CEecCCCCHHHEEEccCCeEEEeeccccccccccccccce
Confidence                                  11567899999999996 9999999999999999999999999998877554323344


Q ss_pred             CCCcCccCccccCCCccCCCCCCcceeeeEe
Q psy14630        152 AGCRPYMAPERIDPLRARGYPSFKTKLGFKF  182 (187)
Q Consensus       152 ~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi  182 (187)
                      .++..|+|||.+.   ....+.++|+||+|+
T Consensus       158 ~~~~~~~~PE~~~---~~~~~~~~Dv~slG~  185 (253)
T cd05122         158 VGTPYWMAPEVIN---GKPYDYKADIWSLGI  185 (253)
T ss_pred             ecCCcccCHHHHc---CCCCCccccHHHHHH
Confidence            6788899999988   455789999999998

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core

>KOG0200|consensus

Probab=99.92  E-value=2.3e-25  Score=184.83  Aligned_cols=165  Identities=24%  Similarity=0.403  Sum_probs=129.3

Q ss_pred             ccccCCcccccccccccccCceEEEEEEEc----C---CCcEEEEEEccCccChHHHHHHHHHHHHHHhcCCCCchhhhh
Q psy14630         17 TVYDFTSEDLQDLGEIGRGGFGTVNKMIHR----S---SDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQFY   89 (187)
Q Consensus        17 ~~~~~~~~~~~~~~~lg~G~fg~V~~~~~~----~---~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~   89 (187)
                      ..|+++.+++.+.+.||.|.||.|++|...    .   ....||+|..+......+......+...+.....|+||+.+.
T Consensus       289 ~~~e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~ll  368 (609)
T KOG0200|consen  289 PKWEIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLL  368 (609)
T ss_pred             CceeechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhhe
Confidence            378999999988899999999999998632    1   256799999987666654555555555555567799999987


Q ss_pred             hhHHH------------------------------------------------HHHHHHHHHHHHHHhcCCCeeecCCCC
Q psy14630         90 GALFK------------------------------------------------EVTVATVKALNYLKEELKIIHRDVKPS  121 (187)
Q Consensus        90 ~~~~~------------------------------------------------~~~~~~~~~l~~lh~~~~i~Hrdlk~~  121 (187)
                      +++.+                                                .+..|++.|++||++. .++||||..+
T Consensus       369 G~~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~-~~vHRDLAaR  447 (609)
T KOG0200|consen  369 GACTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASV-PCVHRDLAAR  447 (609)
T ss_pred             eeeccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhC-Cccchhhhhh
Confidence            64322                                                1557899999999997 8999999999


Q ss_pred             CeEEcCCCCEEEEecccccccccccccc--CCCC--CcCccCccccCCCccCCCCCCcceeeeEeeee
Q psy14630        122 NILLDRRGAIKLCDFGISGQLVDSIAKT--RDAG--CRPYMAPERIDPLRARGYPSFKTKLGFKFNYR  185 (187)
Q Consensus       122 nili~~~~~~ki~dfg~a~~~~~~~~~~--~~~~--t~~y~aPE~~~~~~~~~~~~~~D~ws~gi~~~  185 (187)
                      ||++..+..+||+|||+|+...+.....  ...+  ...|||||.+.   ...++.++|||||||.+|
T Consensus       448 NVLi~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~---~~~ft~kSDVWSfGI~L~  512 (609)
T KOG0200|consen  448 NVLITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLF---DRVFTSKSDVWSFGILLW  512 (609)
T ss_pred             hEEecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhc---cCcccccchhhHHHHHHH
Confidence            9999999999999999999765443332  1122  23499999999   677999999999999555

>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional

Probab=99.92  E-value=1.3e-25  Score=169.42  Aligned_cols=147  Identities=24%  Similarity=0.398  Sum_probs=111.9

Q ss_pred             ccccccccc--cccCceEEEEEEEcCCCcEEEEEEccCccChHHHHHHHHHHHHHHhcCCCCchhhhhhhH---------
Q psy14630         24 EDLQDLGEI--GRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQFYGAL---------   92 (187)
Q Consensus        24 ~~~~~~~~l--g~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~---------   92 (187)
                      ++|.+.+.+  |+|+||.||++.+..++..+|+|.+.......  .+.  ....+  ...|||++++++.+         
T Consensus        14 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~--~e~--~~~~~--~~~h~~iv~~~~~~~~~~~~~iv   87 (267)
T PHA03390         14 KNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA--IEP--MVHQL--MKDNPNFIKLYYSVTTLKGHVLI   87 (267)
T ss_pred             HhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch--hhH--HHHHH--hhcCCCEEEEEEEEecCCeeEEE
Confidence            456666655  99999999999999999999999976421111  011  11111  23689999876432         


Q ss_pred             -----------------------HHHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCC-CEEEEeccccccccccccc
Q psy14630         93 -----------------------FKEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRG-AIKLCDFGISGQLVDSIAK  148 (187)
Q Consensus        93 -----------------------~~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~-~~ki~dfg~a~~~~~~~~~  148 (187)
                                             ...+..|++.|+.|||+. +++||||+|+||+++.++ .++++|||+++.....   
T Consensus        88 ~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~-~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~---  163 (267)
T PHA03390         88 MDYIKDGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHKH-NIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTP---  163 (267)
T ss_pred             EEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC-CeeeCCCCHHHEEEeCCCCeEEEecCccceecCCC---
Confidence                                   112677899999999997 999999999999999988 9999999998765432   


Q ss_pred             cCCCCCcCccCccccCCCccCCCCCCcceeeeEee
Q psy14630        149 TRDAGCRPYMAPERIDPLRARGYPSFKTKLGFKFN  183 (187)
Q Consensus       149 ~~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi~  183 (187)
                      ....++..|+|||.+.   ...++.++|+||+|+.
T Consensus       164 ~~~~~~~~y~aPE~~~---~~~~~~~~DvwslG~i  195 (267)
T PHA03390        164 SCYDGTLDYFSPEKIK---GHNYDVSFDWWAVGVL  195 (267)
T ss_pred             ccCCCCCcccChhhhc---CCCCCchhhHHHHHHH
Confidence            2235788999999998   5668899999999983

>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

Probab=99.92  E-value=3.1e-25  Score=168.63  Aligned_cols=154  Identities=31%  Similarity=0.545  Sum_probs=121.6

Q ss_pred             CcccccccccccccCceEEEEEEEcCCCcEEEEEEccCccChHHHHHHHHHHHHHHhcCCCCchhhhhhhH---------
Q psy14630         22 TSEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQFYGAL---------   92 (187)
Q Consensus        22 ~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~---------   92 (187)
                      ..+.|+....||+|+||.||++.+..++..+++|.+.....   ..+.+..+...++.++|+|++++++.+         
T Consensus        17 ~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv   93 (286)
T cd06614          17 PRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ---NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVV   93 (286)
T ss_pred             ccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch---hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEE
Confidence            45678889999999999999999988899999999864322   233344455567788999999876421         


Q ss_pred             ------------------------HHHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEeccccccccccc-c
Q psy14630         93 ------------------------FKEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSI-A  147 (187)
Q Consensus        93 ------------------------~~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg~a~~~~~~~-~  147 (187)
                                              ...++.+++.++.|||+. +++|+|++|+||+++.++.++|+|||++....... .
T Consensus        94 ~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~~-gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~  172 (286)
T cd06614          94 MEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQ-NVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSK  172 (286)
T ss_pred             EeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhC-CeeeCCCChhhEEEcCCCCEEECccchhhhhccchhh
Confidence                                    111567899999999997 99999999999999999999999999887654321 1


Q ss_pred             ccCCCCCcCccCccccCCCccCCCCCCcceeeeEe
Q psy14630        148 KTRDAGCRPYMAPERIDPLRARGYPSFKTKLGFKF  182 (187)
Q Consensus       148 ~~~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi  182 (187)
                      .....++..|+|||.+.   ...++.++|+||||+
T Consensus       173 ~~~~~~~~~y~~PE~~~---~~~~~~~~Dv~slGv  204 (286)
T cd06614         173 RNSVVGTPYWMAPEVIK---RKDYGPKVDIWSLGI  204 (286)
T ss_pred             hccccCCcccCCHhHhc---CCCCCCccccHHHHH
Confidence            12334678899999987   556889999999998

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou

>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros

Probab=99.92  E-value=2e-25  Score=168.09  Aligned_cols=149  Identities=23%  Similarity=0.369  Sum_probs=111.2

Q ss_pred             ccccccCceEEEEEEEcCCC------cEEEEEEccCccChHHHHHHHHHHHHHHhcCCCCchhhhhhhHH----------
Q psy14630         30 GEIGRGGFGTVNKMIHRSSD------TVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQFYGALF----------   93 (187)
Q Consensus        30 ~~lg~G~fg~V~~~~~~~~~------~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~----------   93 (187)
                      +.||+|+||.||+|......      +.+|+|.+....... ....+.++..+++.++||||+++++.+.          
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e   79 (269)
T cd05044           1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQ-EKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIME   79 (269)
T ss_pred             CccccccceeEEeeeecccccCcccceeehhhhhhcccchh-hHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEe
Confidence            36899999999999875433      679999875432222 2334445566778889999998764321          


Q ss_pred             -----------------------------HHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCC-----CEEEEecccc
Q psy14630         94 -----------------------------KEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRG-----AIKLCDFGIS  139 (187)
Q Consensus        94 -----------------------------~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~-----~~ki~dfg~a  139 (187)
                                                   ..+..+++.++.|||+. +++|+||+|+||+++.++     .++++|||++
T Consensus        80 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~-~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~~  158 (269)
T cd05044          80 LMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQM-HFIHRDLAARNCLVSEKGYDADRVVKIGDFGLA  158 (269)
T ss_pred             ccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhC-CcccCCCChheEEEecCCCCCCcceEECCcccc
Confidence                                         01456888999999987 999999999999999877     8999999998


Q ss_pred             ccccccccc---cCCCCCcCccCccccCCCccCCCCCCcceeeeEee
Q psy14630        140 GQLVDSIAK---TRDAGCRPYMAPERIDPLRARGYPSFKTKLGFKFN  183 (187)
Q Consensus       140 ~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi~  183 (187)
                      +........   ....++..|+|||.+.   ...++.++|+||||++
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~Dv~slG~i  202 (269)
T cd05044         159 RDIYKSDYYRKEGEGLLPVRWMAPESLL---DGKFTTQSDVWSFGVL  202 (269)
T ss_pred             cccccccccccCcccCCCccccCHHHHc---cCCcccchhHHHHHHH
Confidence            865432211   1223467899999988   5568899999999983

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male

>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases

Probab=99.91  E-value=1.9e-24  Score=160.95  Aligned_cols=148  Identities=28%  Similarity=0.443  Sum_probs=117.1

Q ss_pred             ccccCceEEEEEEEcCCCcEEEEEEccCccC-hHHHHHHHHHHHHHHhcCCCCchhhhhhhHH-----------------
Q psy14630         32 IGRGGFGTVNKMIHRSSDTVMAVKRIRSTVD-EKDQRQLLMDLDVVMKSNECPYIVQFYGALF-----------------   93 (187)
Q Consensus        32 lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~-----------------   93 (187)
                      ||+|+||.||++.+..+++.+|+|.+..... .....+....+..+++.+.|+|++++++.+.                 
T Consensus         1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L   80 (250)
T cd05123           1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL   80 (250)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence            6999999999999988899999999865322 2223344455556777889999998875421                 


Q ss_pred             ---------------HHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEecccccccccc-ccccCCCCCcCc
Q psy14630         94 ---------------KEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDS-IAKTRDAGCRPY  157 (187)
Q Consensus        94 ---------------~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg~a~~~~~~-~~~~~~~~t~~y  157 (187)
                                     ..+..|++.++.|+|+. +++|+||+|+||+++.++.++++|||++...... .......++..|
T Consensus        81 ~~~l~~~~~l~~~~~~~~~~qi~~~l~~lh~~-~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~  159 (250)
T cd05123          81 FSHLSKEGRFSEERARFYAAEIVLALEYLHSL-GIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTFCGTPEY  159 (250)
T ss_pred             HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC-CceecCCCcceEEEcCCCcEEEeecCcceecccCCCcccCCcCCccc
Confidence                           11567899999999997 9999999999999999999999999998876543 233344678889


Q ss_pred             cCccccCCCccCCCCCCcceeeeEee
Q psy14630        158 MAPERIDPLRARGYPSFKTKLGFKFN  183 (187)
Q Consensus       158 ~aPE~~~~~~~~~~~~~~D~ws~gi~  183 (187)
                      +|||.+.   ....+.++|+||||+.
T Consensus       160 ~~Pe~~~---~~~~~~~~D~~slG~~  182 (250)
T cd05123         160 LAPEVLL---GKGYGKAVDWWSLGVL  182 (250)
T ss_pred             cChHHhC---CCCCCchhhHHHHHHH
Confidence            9999988   5557889999999983

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the

>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

Probab=99.91  E-value=1.2e-24  Score=163.21  Aligned_cols=155  Identities=24%  Similarity=0.388  Sum_probs=115.8

Q ss_pred             cccccccccccCceEEEEEEEcCCCcEEEEEEccCcc---ChHHHHHHHHHHHHHHhcCCCCchhhhhhhHHH-------
Q psy14630         25 DLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTV---DEKDQRQLLMDLDVVMKSNECPYIVQFYGALFK-------   94 (187)
Q Consensus        25 ~~~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~-------   94 (187)
                      +|.+.+.||+|+||.||++.+..++..+++|.++...   ...........+..+++.++||||+++++.+..       
T Consensus         1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   80 (260)
T cd08222           1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII   80 (260)
T ss_pred             CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence            4788899999999999999988777777777765321   111111222334456677899999998764321       


Q ss_pred             -----------------------------HHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEecccccccccc
Q psy14630         95 -----------------------------EVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDS  145 (187)
Q Consensus        95 -----------------------------~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg~a~~~~~~  145 (187)
                                                   .+..|++.|+.|||+. +++|+|++|+|++++. +.++++|||++......
T Consensus        81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~-~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~~~  158 (260)
T cd08222          81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQR-RILHRDLKAKNIFLKN-NLLKIGDFGVSRLLMGS  158 (260)
T ss_pred             EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHc-CccccCCChhheEeec-CCEeecccCceeecCCC
Confidence                                         1456889999999997 9999999999999975 56999999998876443


Q ss_pred             cc-ccCCCCCcCccCccccCCCccCCCCCCcceeeeEeee
Q psy14630        146 IA-KTRDAGCRPYMAPERIDPLRARGYPSFKTKLGFKFNY  184 (187)
Q Consensus       146 ~~-~~~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi~~  184 (187)
                      .. .....+++.|+|||.+.   ...++.++|+||||++.
T Consensus       159 ~~~~~~~~~~~~~~~pe~~~---~~~~~~~~Dv~slG~~~  195 (260)
T cd08222         159 CDLATTFTGTPYYMSPEALK---HQGYDSKSDIWSLGCIL  195 (260)
T ss_pred             cccccCCCCCcCccCHHHHc---cCCCCchhhHHHHHHHH
Confidence            22 22345788899999987   56678899999999843

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check

>KOG1345|consensus

Probab=99.91  E-value=1.7e-24  Score=158.07  Aligned_cols=155  Identities=23%  Similarity=0.366  Sum_probs=116.3

Q ss_pred             ccccccccccccCceEEEEEEEcCCCcEEEEEEccCccChHHHHHHHHHHHHHHhcCCCCchhhhhhhHH----------
Q psy14630         24 EDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQFYGALF----------   93 (187)
Q Consensus        24 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~----------   93 (187)
                      +.|.+.+.||+|.||.+.+|.++++++++++|.++..  ...+.+..+|-.--.....|.||+.-|+..+          
T Consensus        24 d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p--~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~q  101 (378)
T KOG1345|consen   24 DVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRP--QTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQ  101 (378)
T ss_pred             hhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcc--hhhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEee
Confidence            6788999999999999999999999999999998642  2233444444333334557889998775432          


Q ss_pred             ----------------------HHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEc--CCCCEEEEecccccccccccccc
Q psy14630         94 ----------------------KEVTVATVKALNYLKEELKIIHRDVKPSNILLD--RRGAIKLCDFGISGQLVDSIAKT  149 (187)
Q Consensus        94 ----------------------~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~--~~~~~ki~dfg~a~~~~~~~~~~  149 (187)
                                            +.++.|++.|+.|+|+. +++|||||.+||||-  +..++|+||||+.+.........
T Consensus       102 E~aP~gdL~snv~~~GigE~~~K~v~~ql~SAi~fMHsk-nlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~tV~~~  180 (378)
T KOG1345|consen  102 EFAPRGDLRSNVEAAGIGEANTKKVFAQLLSAIEFMHSK-NLVHRDLKAENILIFDADFYRVKLCDFGLTRKVGTTVKYL  180 (378)
T ss_pred             ccCccchhhhhcCcccccHHHHHHHHHHHHHHHHHhhcc-chhhcccccceEEEecCCccEEEeeecccccccCceehhh
Confidence                                  23788999999999997 999999999999994  34479999999987643322111


Q ss_pred             CCCCCcCccCccccCCCccCC--CCCCcceeeeEee
Q psy14630        150 RDAGCRPYMAPERIDPLRARG--YPSFKTKLGFKFN  183 (187)
Q Consensus       150 ~~~~t~~y~aPE~~~~~~~~~--~~~~~D~ws~gi~  183 (187)
                        -.+..|-+||.+..-++..  -++..|+|.|||+
T Consensus       181 --~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi  214 (378)
T KOG1345|consen  181 --EYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGII  214 (378)
T ss_pred             --hhhcccCCcHHHhhccccceEecccccchheeee
Confidence              2345688999986444443  4588999999994

>KOG0665|consensus

Probab=99.91  E-value=4e-25  Score=164.10  Aligned_cols=157  Identities=22%  Similarity=0.274  Sum_probs=127.2

Q ss_pred             CcccccccccccccCceEEEEEEEcCCCcEEEEEEccCccChHHHHHHHHHHHHHHhcCCCCchhhhhhhHHH-------
Q psy14630         22 TSEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQFYGALFK-------   94 (187)
Q Consensus        22 ~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~-------   94 (187)
                      ...+|.-++.+|.|.- .|..+.+.-++++||+|.+..........+...++..++..+.|+|+++++..+..       
T Consensus        15 v~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~   93 (369)
T KOG0665|consen   15 VPKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEF   93 (369)
T ss_pred             eeeeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHH
Confidence            4467777888999998 67778888889999999875444444444555666778888999999998765421       


Q ss_pred             ----------------------------HHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEeccccccccccc
Q psy14630         95 ----------------------------EVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSI  146 (187)
Q Consensus        95 ----------------------------~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg~a~~~~~~~  146 (187)
                                                  .+..|++.|+++||+. +|+||||||+||++..+..+||.|||+|+.-...-
T Consensus        94 ~e~y~v~e~m~~nl~~vi~~elDH~tis~i~yq~~~~ik~lhs~-~IihRdLkPsnivv~~~~~lKi~dfg~ar~e~~~~  172 (369)
T KOG0665|consen   94 QEVYLVMELMDANLCQVILMELDHETISYILYQMLCGIKHLHSA-GIIHRDLKPSNIVVNSDCTLKILDFGLARTEDTDF  172 (369)
T ss_pred             HhHHHHHHhhhhHHHHHHHHhcchHHHHHHHHHHHHHHHHHHhc-ceeecccCcccceecchhheeeccchhhcccCccc
Confidence                                        2667889999999998 99999999999999999999999999999865554


Q ss_pred             cccCCCCCcCccCccccCCCccCCCCCCcceeeeEee
Q psy14630        147 AKTRDAGCRPYMAPERIDPLRARGYPSFKTKLGFKFN  183 (187)
Q Consensus       147 ~~~~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi~  183 (187)
                      .-+....|..|+|||++.   +.++.+.+||||.|+.
T Consensus       173 ~mtpyVvtRyyrapevil---~~~~ke~vdiwSvGci  206 (369)
T KOG0665|consen  173 MMTPYVVTRYYRAPEVIL---GMGYKENVDIWSVGCI  206 (369)
T ss_pred             ccCchhheeeccCchhee---ccCCcccchhhhhhhH
Confidence            445567888999999999   5669999999999983

>PRK09188 serine/threonine protein kinase; Provisional

Probab=99.91  E-value=7.9e-24  Score=164.84  Aligned_cols=150  Identities=23%  Similarity=0.234  Sum_probs=113.5

Q ss_pred             CCccccCCcccccccccccccCceEEEEEEEcC-CCcEEEEEEccCcc---ChHHHHHHHHHHHHHHhcCCCCchhh-hh
Q psy14630         15 PDTVYDFTSEDLQDLGEIGRGGFGTVNKMIHRS-SDTVMAVKRIRSTV---DEKDQRQLLMDLDVVMKSNECPYIVQ-FY   89 (187)
Q Consensus        15 ~~~~~~~~~~~~~~~~~lg~G~fg~V~~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~~~~~~~~~~~~h~~iv~-~~   89 (187)
                      |........++|.+.+.||+|+||+||+|.+.. +++.+|||.+....   ......+.+..+..+++.+.|+|++. ++
T Consensus         9 ~~~~~~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~   88 (365)
T PRK09188          9 PGDQIPALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLL   88 (365)
T ss_pred             cccccccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEE
Confidence            344445566889999999999999999998875 67778999865321   12334556777778888899999884 21


Q ss_pred             hh--------------H-------HHHHHHHHHHHHHHHHhcCCCeeecC-CCCCeEEcCCCCEEEEecccccccccccc
Q psy14630         90 GA--------------L-------FKEVTVATVKALNYLKEELKIIHRDV-KPSNILLDRRGAIKLCDFGISGQLVDSIA  147 (187)
Q Consensus        90 ~~--------------~-------~~~~~~~~~~~l~~lh~~~~i~Hrdl-k~~nili~~~~~~ki~dfg~a~~~~~~~~  147 (187)
                      +.              +       ...+..+++.+|.|||+. +++|||| ||+||+++.++.++|+|||+|+.+.....
T Consensus        89 ~~~~~~LVmE~~~G~~L~~~~~~~~~~~~~~i~~aL~~lH~~-gIiHrDL~KP~NILv~~~~~ikLiDFGlA~~~~~~~~  167 (365)
T PRK09188         89 ATGKDGLVRGWTEGVPLHLARPHGDPAWFRSAHRALRDLHRA-GITHNDLAKPQNWLMGPDGEAAVIDFQLASVFRRRGA  167 (365)
T ss_pred             EcCCcEEEEEccCCCCHHHhCccchHHHHHHHHHHHHHHHHC-CCeeCCCCCcceEEEcCCCCEEEEECccceecccCcc
Confidence            10              0       124667889999999997 9999999 99999999899999999999997754321


Q ss_pred             c---------cCCCCCcCccCccccCC
Q psy14630        148 K---------TRDAGCRPYMAPERIDP  165 (187)
Q Consensus       148 ~---------~~~~~t~~y~aPE~~~~  165 (187)
                      .         ....+++.|+|||.+..
T Consensus       168 ~~~~~~~~d~~~~~~~~~~~~pe~~~~  194 (365)
T PRK09188        168 LYRIAAYEDLRHLLKHKRTYAPDALTP  194 (365)
T ss_pred             hhhhhhhhhhhhhhccCccCCcccCCh
Confidence            1         12357788999999874

>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

Probab=99.91  E-value=2.1e-24  Score=164.24  Aligned_cols=157  Identities=25%  Similarity=0.355  Sum_probs=114.6

Q ss_pred             cccccccccccCceEEEEEEEc---CCCcEEEEEEccCccC--hHHHHHHHHHHHHHHhcC-CCCchhhhhhhH------
Q psy14630         25 DLQDLGEIGRGGFGTVNKMIHR---SSDTVMAVKRIRSTVD--EKDQRQLLMDLDVVMKSN-ECPYIVQFYGAL------   92 (187)
Q Consensus        25 ~~~~~~~lg~G~fg~V~~~~~~---~~~~~vaiK~~~~~~~--~~~~~~~~~~~~~~~~~~-~h~~iv~~~~~~------   92 (187)
                      +|++.+.||+|+||.||++.+.   .++..+|+|.++....  .....+.+..+..++..+ +||||+.+++.+      
T Consensus         1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~   80 (288)
T cd05583           1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL   80 (288)
T ss_pred             CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence            4778899999999999998753   4678899999864211  111222333344444444 799999876422      


Q ss_pred             --------------------------HHHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEeccccccccccc
Q psy14630         93 --------------------------FKEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSI  146 (187)
Q Consensus        93 --------------------------~~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg~a~~~~~~~  146 (187)
                                                ...+..|++.+|.|||+. +++|+||+|+||+++.++.++++|||+++......
T Consensus        81 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~-~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~  159 (288)
T cd05583          81 HLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDHLHQL-GIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEE  159 (288)
T ss_pred             EEEEecCCCCcHHHHHhhcCCcCHHHHHHHHHHHHHHHHHHHHC-CeeccCCCHHHeEECCCCCEEEEECcccccccccc
Confidence                                      111456899999999997 99999999999999999999999999988765432


Q ss_pred             cc--cCCCCCcCccCccccCCCccCCCCCCcceeeeEee
Q psy14630        147 AK--TRDAGCRPYMAPERIDPLRARGYPSFKTKLGFKFN  183 (187)
Q Consensus       147 ~~--~~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi~  183 (187)
                      ..  ....++..|+|||.+.+. ....+.++|+||+|+.
T Consensus       160 ~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~~Dv~slG~i  197 (288)
T cd05583         160 EERAYSFCGTIEYMAPEVIRGG-SGGHDKAVDWWSLGVL  197 (288)
T ss_pred             ccccccccCCccccCHHHhcCC-CCCCcchhhhHHHHHH
Confidence            21  223578899999998732 2236789999999983

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines

>KOG0670|consensus

Probab=99.91  E-value=6.1e-24  Score=166.78  Aligned_cols=156  Identities=25%  Similarity=0.348  Sum_probs=112.5

Q ss_pred             ccccccccccccCceEEEEEEEcCCCcEEEEEEccCccChHHHHHHHHHHHHHHhcC-----CCCchhhhhhhH------
Q psy14630         24 EDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSN-----ECPYIVQFYGAL------   92 (187)
Q Consensus        24 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~-----~h~~iv~~~~~~------   92 (187)
                      .+|.+....|+|-|+.|.+|.+...++.||||++.+..  -....-+.+..++.++.     .--++++++..|      
T Consensus       432 ~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE--~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~hknHL  509 (752)
T KOG0670|consen  432 SRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNE--VMHKTGLKELEILKKLNDADPEDKFHCLRLFRHFKHKNHL  509 (752)
T ss_pred             ceeEEEeccccceeeeeeeccccCCCCeeEEEEeecch--HHhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhhccee
Confidence            45777788999999999999999899999999997532  11111222222222211     112344444322      


Q ss_pred             ----------------------------HHHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCC-CCEEEEecccccccc
Q psy14630         93 ----------------------------FKEVTVATVKALNYLKEELKIIHRDVKPSNILLDRR-GAIKLCDFGISGQLV  143 (187)
Q Consensus        93 ----------------------------~~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~-~~~ki~dfg~a~~~~  143 (187)
                                                  +..++.|+..||..|..+ +|+|.||||.|||+++. ..+||||||.|....
T Consensus       510 ClVFE~LslNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c-~vlHaDIKPDNiLVNE~k~iLKLCDfGSA~~~~  588 (752)
T KOG0670|consen  510 CLVFEPLSLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKC-GVLHADIKPDNILVNESKNILKLCDFGSASFAS  588 (752)
T ss_pred             EEEehhhhchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhc-CeeecccCccceEeccCcceeeeccCccccccc
Confidence                                        122677889999999886 99999999999999865 458999999998876


Q ss_pred             ccccccCCCCCcCccCccccCCCccCCCCCCcceeeeEe-eeeC
Q psy14630        144 DSIAKTRDAGCRPYMAPERIDPLRARGYPSFKTKLGFKF-NYRI  186 (187)
Q Consensus       144 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi-~~~~  186 (187)
                      ....+. ..-+..|+|||.|.   +.+|+...|+||+|+ .|++
T Consensus       589 eneitP-YLVSRFYRaPEIiL---G~~yd~~iD~WSvgctLYEl  628 (752)
T KOG0670|consen  589 ENEITP-YLVSRFYRAPEIIL---GLPYDYPIDTWSVGCTLYEL  628 (752)
T ss_pred             cccccH-HHHHHhccCcceee---cCcccCCccceeeceeeEEe
Confidence            554322 23456799999999   778999999999999 7764

>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

Probab=99.91  E-value=1.8e-24  Score=160.54  Aligned_cols=135  Identities=24%  Similarity=0.282  Sum_probs=104.2

Q ss_pred             cCceEEEEEEEcCCCcEEEEEEccCccChHHHHHHHHHHHHHHhcCCCCchhhhhhhHH---------------------
Q psy14630         35 GGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQFYGALF---------------------   93 (187)
Q Consensus        35 G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~---------------------   93 (187)
                      |.||.||++.+..+++.+|+|.++......       .+........|||++++++.+.                     
T Consensus         4 g~~~~v~~~~~~~~~~~~~~K~i~~~~~~~-------~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l   76 (237)
T cd05576           4 GVIDKVLLVMDTRTQQTFILKGLRKSSEYS-------RERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHI   76 (237)
T ss_pred             cccceEEEEEEccCCcEEEEEeecchhhhh-------hHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHH
Confidence            899999999999999999999986432111       1122223346899998875321                     


Q ss_pred             -----------HHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEeccccccccccccccCCCCCcCccCccc
Q psy14630         94 -----------KEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTRDAGCRPYMAPER  162 (187)
Q Consensus        94 -----------~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg~a~~~~~~~~~~~~~~t~~y~aPE~  162 (187)
                                 ..+..|++.|++|||+. +++||||||+|++++.++.++++|||.+.......  ....++..|+|||.
T Consensus        77 ~~~~~l~~~~~~~~~~ql~~~l~~lH~~-~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~~--~~~~~~~~y~aPE~  153 (237)
T cd05576          77 SKFLNIPEECVKRWAAEMVVALDALHRE-GIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSC--DGEAVENMYCAPEV  153 (237)
T ss_pred             HHhcCCCHHHHHHHHHHHHHHHHHHHhC-CeeccCCCHHHEEEcCCCCEEEecccchhcccccc--ccCCcCccccCCcc
Confidence                       12567899999999997 99999999999999999999999999877654332  22345677999999


Q ss_pred             cCCCccCCCCCCcceeeeEe
Q psy14630        163 IDPLRARGYPSFKTKLGFKF  182 (187)
Q Consensus       163 ~~~~~~~~~~~~~D~ws~gi  182 (187)
                      +.   ...++.++|+||+|+
T Consensus       154 ~~---~~~~~~~~DvwslG~  170 (237)
T cd05576         154 GG---ISEETEACDWWSLGA  170 (237)
T ss_pred             cC---CCCCCchhhHHHHHH
Confidence            87   556788999999998

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=99.90  E-value=8.9e-24  Score=177.36  Aligned_cols=158  Identities=25%  Similarity=0.351  Sum_probs=122.2

Q ss_pred             cccccccccccccCceEEEEEEEcCCCcEEEEEEccCcc-ChHHHHHHHHHHHHHHhcCCCCchhhhhhhH---------
Q psy14630         23 SEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTV-DEKDQRQLLMDLDVVMKSNECPYIVQFYGAL---------   92 (187)
Q Consensus        23 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~---------   92 (187)
                      .++|.+.+.||+|+||.||+|.+..+++.||+|+++... ........+..+..+++.+.|+||+++++.+         
T Consensus         3 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lV   82 (669)
T cd05610           3 IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLV   82 (669)
T ss_pred             cCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEE
Confidence            468999999999999999999999999999999986432 2233344555566677788999999876321         


Q ss_pred             -----------------------HHHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEeccccccccccc-cc
Q psy14630         93 -----------------------FKEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSI-AK  148 (187)
Q Consensus        93 -----------------------~~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg~a~~~~~~~-~~  148 (187)
                                             ...++.|++.||.|||.. +|+||||||+||+++.++.++|+|||+++...... ..
T Consensus        83 mEy~~g~~L~~li~~~~~l~~~~~~~i~~qil~aL~yLH~~-gIiHrDLKP~NILl~~~g~vkL~DFGls~~~~~~~~~~  161 (669)
T cd05610          83 MEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHRH-GIIHRDLKPDNMLISNEGHIKLTDFGLSKVTLNRELNM  161 (669)
T ss_pred             EeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC-CEEeCCccHHHEEEcCCCCEEEEeCCCCccccCCcccc
Confidence                                   122667899999999997 99999999999999999999999999998765432 22


Q ss_pred             cCCCCCcCccCccccCCCccCCCCCCcceeeeEee
Q psy14630        149 TRDAGCRPYMAPERIDPLRARGYPSFKTKLGFKFN  183 (187)
Q Consensus       149 ~~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi~  183 (187)
                      ....+|+.|++||....  ..+-....++|++|+.
T Consensus       162 ~~~~~t~~~~~pe~~~~--~~~~~~~s~~~s~g~~  194 (669)
T cd05610         162 MDILTTPSMAKPKNDYS--RTPGQVLSLISSLGFN  194 (669)
T ss_pred             cccccCccccCcccccc--CCCCceeeeeeecCcC
Confidence            33468899999998652  2333456778888863

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=99.90  E-value=2.5e-24  Score=187.58  Aligned_cols=147  Identities=21%  Similarity=0.295  Sum_probs=111.2

Q ss_pred             cccccccccccCceEEEEEEEcCCCcEEEEEEccCccChHHHHHHHHHHHHHHhcCCCCchhhhhhhHHH----------
Q psy14630         25 DLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQFYGALFK----------   94 (187)
Q Consensus        25 ~~~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~----------   94 (187)
                      .+...+.||+|+||.||+|.+..++..||+|.+........      ++...++.++||||+++++.+..          
T Consensus       691 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~------~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey  764 (968)
T PLN00113        691 SLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSIPS------SEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEY  764 (968)
T ss_pred             hCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccccH------HHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeC
Confidence            35556789999999999999988999999998864322111      12345667799999998864311          


Q ss_pred             -------------------HHHHHHHHHHHHHHhc--CCCeeecCCCCCeEEcCCCCEEEEeccccccccccccccCCCC
Q psy14630         95 -------------------EVTVATVKALNYLKEE--LKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTRDAG  153 (187)
Q Consensus        95 -------------------~~~~~~~~~l~~lh~~--~~i~Hrdlk~~nili~~~~~~ki~dfg~a~~~~~~~~~~~~~~  153 (187)
                                         .++.+++.|++|||..  .+++|||+||+||+++.++..++. ++........   ....+
T Consensus       765 ~~~g~L~~~l~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~~---~~~~~  840 (968)
T PLN00113        765 IEGKNLSEVLRNLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTD---TKCFI  840 (968)
T ss_pred             CCCCcHHHHHhcCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-eccccccccC---CCccc
Confidence                               2667899999999932  289999999999999988888775 6655433211   12357


Q ss_pred             CcCccCccccCCCccCCCCCCcceeeeEeee
Q psy14630        154 CRPYMAPERIDPLRARGYPSFKTKLGFKFNY  184 (187)
Q Consensus       154 t~~y~aPE~~~~~~~~~~~~~~D~ws~gi~~  184 (187)
                      ++.|+|||++.   ...++.++|||||||+.
T Consensus       841 t~~y~aPE~~~---~~~~~~~sDv~S~Gvvl  868 (968)
T PLN00113        841 SSAYVAPETRE---TKDITEKSDIYGFGLIL  868 (968)
T ss_pred             cccccCccccc---CCCCCcccchhhHHHHH
Confidence            88999999988   66789999999999943

>PLN03224 probable serine/threonine protein kinase; Provisional

Probab=99.90  E-value=3.3e-23  Score=167.56  Aligned_cols=86  Identities=26%  Similarity=0.383  Sum_probs=66.0

Q ss_pred             HHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEeccccccccccccccC--CCCCcCccCccccCCCcc-----
Q psy14630         96 VTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTR--DAGCRPYMAPERIDPLRA-----  168 (187)
Q Consensus        96 ~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg~a~~~~~~~~~~~--~~~t~~y~aPE~~~~~~~-----  168 (187)
                      +..+++.++.|||+. +++||||||+||+++.++.+||+|||+++..........  ..+++.|+|||.+.....     
T Consensus       314 i~~ql~~aL~~lH~~-~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aPE~l~~~~~~~~~~  392 (507)
T PLN03224        314 VMRQVLTGLRKLHRI-GIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPPEELVMPQSCPRAP  392 (507)
T ss_pred             HHHHHHHHHHHHHHC-CeecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeChhhhcCCCCCCccc
Confidence            566888999999997 999999999999999999999999999976543322222  234789999999863211     


Q ss_pred             --------------CCCCCCcceeeeEe
Q psy14630        169 --------------RGYPSFKTKLGFKF  182 (187)
Q Consensus       169 --------------~~~~~~~D~ws~gi  182 (187)
                                    .+.....|+||+|+
T Consensus       393 ~~~~~~~l~~~~~~yg~~~~~DvwSlGv  420 (507)
T PLN03224        393 APAMAALLSPFAWLYGRPDLFDSYTAGV  420 (507)
T ss_pred             hhhhhhhhhhhHHhcCCCCccchhhHHH
Confidence                          11234579999999

>KOG1027|consensus

Probab=99.88  E-value=4.6e-23  Score=168.85  Aligned_cols=143  Identities=25%  Similarity=0.382  Sum_probs=108.5

Q ss_pred             cccccccCceE-EEEEEEcCCCcEEEEEEccCccChHHHHHH-HHHHHHHHhcCCCCchhhhhhhHH-------------
Q psy14630         29 LGEIGRGGFGT-VNKMIHRSSDTVMAVKRIRSTVDEKDQRQL-LMDLDVVMKSNECPYIVQFYGALF-------------   93 (187)
Q Consensus        29 ~~~lg~G~fg~-V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~-~~~~~~~~~~~~h~~iv~~~~~~~-------------   93 (187)
                      -+.+|.|+-|+ ||+|...  ++.||||.+-.     +..+. .+|+..+.....||||+++|+.-.             
T Consensus       514 ~eilG~Gs~Gt~Vf~G~ye--~R~VAVKrll~-----e~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC~  586 (903)
T KOG1027|consen  514 KEILGYGSNGTVVFRGVYE--GREVAVKRLLE-----EFFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELCA  586 (903)
T ss_pred             HHHcccCCCCcEEEEEeeC--CceehHHHHhh-----HhHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHhh
Confidence            46788999885 7999985  77999998642     12222 344455556678999999985311             


Q ss_pred             ----------------------HHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcC---C--CCEEEEeccccccccccc
Q psy14630         94 ----------------------KEVTVATVKALNYLKEELKIIHRDVKPSNILLDR---R--GAIKLCDFGISGQLVDSI  146 (187)
Q Consensus        94 ----------------------~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~---~--~~~ki~dfg~a~~~~~~~  146 (187)
                                            ..+..|+++|++.||.. +|+||||||+||||..   +  ..++|+|||+++++....
T Consensus       587 ~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl-~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~~~  665 (903)
T KOG1027|consen  587 CSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSL-KIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAGGK  665 (903)
T ss_pred             hhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhc-ccccccCCCceEEEEccCCCcceeEEecccccccccCCCc
Confidence                                  11556889999999996 9999999999999975   3  358899999999986432


Q ss_pred             c----ccCCCCCcCccCccccCCCccCCCCCCcceeeeEe
Q psy14630        147 A----KTRDAGCRPYMAPERIDPLRARGYPSFKTKLGFKF  182 (187)
Q Consensus       147 ~----~~~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi  182 (187)
                      .    .....||-.|+|||++.   +.....++|++|+|.
T Consensus       666 sS~~r~s~~sGt~GW~APE~L~---~~~~~~avDiFslGC  702 (903)
T KOG1027|consen  666 SSFSRLSGGSGTSGWQAPEQLR---EDRKTQAVDIFSLGC  702 (903)
T ss_pred             chhhcccCCCCcccccCHHHHh---ccccCcccchhhcCc
Confidence            2    22346899999999998   555667999999998

>KOG1290|consensus

Probab=99.87  E-value=3e-22  Score=156.01  Aligned_cols=108  Identities=25%  Similarity=0.371  Sum_probs=78.4

Q ss_pred             ccccCCc-ccccccccccccCceEEEEEEEcCCCcEEEEEEccCccChHHHHHHHHHHHHHHhcC----CC---Cchhhh
Q psy14630         17 TVYDFTS-EDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSN----EC---PYIVQF   88 (187)
Q Consensus        17 ~~~~~~~-~~~~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~----~h---~~iv~~   88 (187)
                      .+.+.+. .+|.+.++||.|.|++||+|++.++.+.||+|+++...  ......+.|+..+....    ++   .+||+|
T Consensus        70 ~IGD~F~~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAq--hYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~L  147 (590)
T KOG1290|consen   70 RIGDVFNGGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQ--HYTEAALDEIKLLQQVREGDPNDPGKKCVVQL  147 (590)
T ss_pred             eccccccCceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhh--HHHHHHHHHHHHHHHHHhcCCCCCCCceeeee
Confidence            3445545 78999999999999999999999999999999987421  11222223332222211    12   346666


Q ss_pred             hhhH-------------------------------------HHHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEc
Q psy14630         89 YGAL-------------------------------------FKEVTVATVKALNYLKEELKIIHRDVKPSNILLD  126 (187)
Q Consensus        89 ~~~~-------------------------------------~~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~  126 (187)
                      ++.|                                     ++++..|++.||.|||+.++|+|.||||+|+|+.
T Consensus       148 lD~FkhsGpNG~HVCMVfEvLGdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ecgIIHTDlKPENvLl~  222 (590)
T KOG1290|consen  148 LDHFKHSGPNGQHVCMVFEVLGDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHRECGIIHTDLKPENVLLC  222 (590)
T ss_pred             eccceecCCCCcEEEEEehhhhhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhcCccccCCCcceeeee
Confidence            5432                                     4458889999999999999999999999999984

>smart00221 STYKc Protein kinase; unclassified specificity

Probab=99.86  E-value=8.4e-22  Score=144.07  Aligned_cols=154  Identities=29%  Similarity=0.449  Sum_probs=118.3

Q ss_pred             ccccccccccCceEEEEEEEcCCCcEEEEEEccCccChHHHHHHHHHHHHHHhcCCCCchhhhhhhH-------------
Q psy14630         26 LQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQFYGAL-------------   92 (187)
Q Consensus        26 ~~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~-------------   92 (187)
                      |++.+.||+|++|.||++.+..+++.+++|.+...... ...+.+..+...+..+.|+|++++++.+             
T Consensus         1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~   79 (225)
T smart00221        1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTE-KQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYC   79 (225)
T ss_pred             CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccch-HHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEecc
Confidence            45678899999999999999888899999998653322 1233444455556667899998876421             


Q ss_pred             --------------------HHHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEeccccccccccc--cccC
Q psy14630         93 --------------------FKEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSI--AKTR  150 (187)
Q Consensus        93 --------------------~~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg~a~~~~~~~--~~~~  150 (187)
                                          ...+..+++.++.+||.. +++|+|+++.|++++..+.++++|||.+.......  ....
T Consensus        80 ~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~-~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~~~~~  158 (225)
T smart00221       80 EGGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLHSL-GIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAALLKT  158 (225)
T ss_pred             CCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhC-CeecCCCCHHHEEEcCCCCEEEeeCceeeEecCcccccccc
Confidence                                112556788999999998 99999999999999999999999999988875432  2233


Q ss_pred             CCCCcCccCccccCCCccCCCCCCcceeeeEee
Q psy14630        151 DAGCRPYMAPERIDPLRARGYPSFKTKLGFKFN  183 (187)
Q Consensus       151 ~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi~  183 (187)
                      ..++..|++||.+.  ....++.++|+|+||+.
T Consensus       159 ~~~~~~~~~pe~~~--~~~~~~~~~Dv~~lG~~  189 (225)
T smart00221      159 VKGTPFYLAPEVLL--GGKGYGEAVDIWSLGVI  189 (225)
T ss_pred             eeccCCcCCHhHhc--CCCCCCchhhHHHHHHH
Confidence            45677899999983  15567789999999983

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.

>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain

Probab=99.86  E-value=1e-21  Score=144.79  Aligned_cols=143  Identities=32%  Similarity=0.471  Sum_probs=113.4

Q ss_pred             CceEEEEEEEcCCCcEEEEEEccCccChHHHHHHHHHHHHHHhcCCCCchhhhhhhHHH---------------------
Q psy14630         36 GFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQFYGALFK---------------------   94 (187)
Q Consensus        36 ~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~---------------------   94 (187)
                      +||.||+|....+++.+++|.+........ .+.+..+....+.++|+|++++++.+..                     
T Consensus         1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~-~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~   79 (244)
T smart00220        1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKK-RERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLK   79 (244)
T ss_pred             CceEEEEEEECCCCcEEEEEEecccccccH-HHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHH
Confidence            589999999988899999999865332221 3445555556667799999988754311                     


Q ss_pred             -----------HHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEeccccccccccccccCCCCCcCccCcccc
Q psy14630         95 -----------EVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERI  163 (187)
Q Consensus        95 -----------~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg~a~~~~~~~~~~~~~~t~~y~aPE~~  163 (187)
                                 .+..+++.++.+||+. +++|+|++|+|++++.++.++++|||.+.............++..|++||..
T Consensus        80 ~~~~~~~~~~~~~~~~l~~~l~~lh~~-~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~pE~~  158 (244)
T smart00220       80 KRGRLSEDEARFYARQILSALEYLHSN-GIIHRDLKPENILLDEDGHVKLADFGLARQLDPGGLLTTFVGTPEYMAPEVL  158 (244)
T ss_pred             hccCCCHHHHHHHHHHHHHHHHHHHHc-CeecCCcCHHHeEECCCCcEEEccccceeeeccccccccccCCcCCCCHHHH
Confidence                       2566788999999998 9999999999999999999999999999887654334445678889999998


Q ss_pred             CCCccCCCCCCcceeeeEee
Q psy14630        164 DPLRARGYPSFKTKLGFKFN  183 (187)
Q Consensus       164 ~~~~~~~~~~~~D~ws~gi~  183 (187)
                      .   ...++.++|+|++|+.
T Consensus       159 ~---~~~~~~~~Di~slG~~  175 (244)
T smart00220      159 L---GKGYGKAVDVWSLGVI  175 (244)
T ss_pred             c---cCCCCchhhHHHHHHH
Confidence            8   5667889999999984

Phosphotransferases. Serine or threonine-specific kinase subfamily.

>KOG1167|consensus

Probab=99.85  E-value=1.3e-21  Score=149.88  Aligned_cols=157  Identities=25%  Similarity=0.337  Sum_probs=113.0

Q ss_pred             CcccccccccccccCceEEEEEEEcC---CCcEEEEEEccCccChHHHHHHHHHHHHHHhcCCCCchhhhhhhH------
Q psy14630         22 TSEDLQDLGEIGRGGFGTVNKMIHRS---SDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQFYGAL------   92 (187)
Q Consensus        22 ~~~~~~~~~~lg~G~fg~V~~~~~~~---~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~------   92 (187)
                      -.+.|....+||+|.|+.||++.+..   ....||+|.+........   ...|...+.....+.||+.+.+.+      
T Consensus        34 ~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~p~r---i~~El~~L~~~gG~~ni~~~~~~~rnnd~v  110 (418)
T KOG1167|consen   34 ISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSSPSR---ILNELEMLYRLGGSDNIIKLNGCFRNNDQV  110 (418)
T ss_pred             hhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccCchH---HHHHHHHHHHhccchhhhcchhhhccCCee
Confidence            34568888999999999999998876   778899999875443322   333333333445667777665432      


Q ss_pred             -----------------------HHHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCC-CCEEEEeccccccccc----
Q psy14630         93 -----------------------FKEVTVATVKALNYLKEELKIIHRDVKPSNILLDRR-GAIKLCDFGISGQLVD----  144 (187)
Q Consensus        93 -----------------------~~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~-~~~ki~dfg~a~~~~~----  144 (187)
                                             .......++.||+++|.. ||+|||+||.|++.+.. +.-.+.|||+|.....    
T Consensus       111 ~ivlp~~~H~~f~~l~~~l~~~~i~~Yl~~ll~Al~~~h~~-GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~~~d~~~~~  189 (418)
T KOG1167|consen  111 AIVLPYFEHDRFRDLYRSLSLAEIRWYLRNLLKALAHLHKN-GIVHRDIKPSNFLYNRRTQRGVLVDFGLAQRYDGYQQT  189 (418)
T ss_pred             EEEecccCccCHHHHHhcCCHHHHHHHHHHHHHHhhhhhcc-CccccCCCccccccccccCCceEEechhHHHHHhhhhh
Confidence                                   223566788999999998 99999999999999754 5678999999983210    


Q ss_pred             ----c-------c-------------------cc-----------cCCCCCcCccCccccCCCccCCCCCCcceeeeEee
Q psy14630        145 ----S-------I-------------------AK-----------TRDAGCRPYMAPERIDPLRARGYPSFKTKLGFKFN  183 (187)
Q Consensus       145 ----~-------~-------------------~~-----------~~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi~  183 (187)
                          .       .                   ..           ...+||+.|+|||++.+++  .-+.++|+||.||+
T Consensus       190 ~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~--~QttaiDiws~GVI  267 (418)
T KOG1167|consen  190 EHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCP--RQTTAIDIWSAGVI  267 (418)
T ss_pred             hhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhcc--CcCCccceeeccce
Confidence                0       0                   00           0125899999999999653  24689999999995


Q ss_pred             e
Q psy14630        184 Y  184 (187)
Q Consensus       184 ~  184 (187)
                      .
T Consensus       268 ~  268 (418)
T KOG1167|consen  268 L  268 (418)
T ss_pred             e
Confidence            4

>KOG1024|consensus

Probab=99.84  E-value=2.6e-22  Score=153.16  Aligned_cols=160  Identities=18%  Similarity=0.257  Sum_probs=121.8

Q ss_pred             CCcccccccccccccCceEEEEEEEcC-----CCcEEEEEEccCccChHHHHHHHHHHHHHHhcCCCCchhhhhhhH---
Q psy14630         21 FTSEDLQDLGEIGRGGFGTVNKMIHRS-----SDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQFYGAL---   92 (187)
Q Consensus        21 ~~~~~~~~~~~lg~G~fg~V~~~~~~~-----~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~---   92 (187)
                      +.+.+++....+-+|.||.||.|...+     ..+.|-+|.++.... +.+...+..+..++....|||+....+..   
T Consensus       281 v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS-~iQv~~~L~es~lly~~sH~nll~V~~V~ie~  359 (563)
T KOG1024|consen  281 VQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHAS-QIQVNLLLQESMLLYGASHPNLLSVLGVSIED  359 (563)
T ss_pred             hhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhccc-HHHHHHHHHHHHHHhcCcCCCccceeEEEeec
Confidence            444556666778899999999995543     234466777765433 23455666666677778899998765321   


Q ss_pred             -------------------HH-------------------HHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEE
Q psy14630         93 -------------------FK-------------------EVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLC  134 (187)
Q Consensus        93 -------------------~~-------------------~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~  134 (187)
                                         ..                   .+..|++.|+++||+. +++|.||..+|++|++.-.+|++
T Consensus       360 ~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~-~ViHkDiAaRNCvIdd~LqVklt  438 (563)
T KOG1024|consen  360 YATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNH-GVIHKDIAARNCVIDDQLQVKLT  438 (563)
T ss_pred             cCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhc-CcccchhhhhcceehhheeEEec
Confidence                               11                   0567889999999998 99999999999999999999999


Q ss_pred             eccccccccccccccC---CCCCcCccCccccCCCccCCCCCCcceeeeEeeee
Q psy14630        135 DFGISGQLVDSIAKTR---DAGCRPYMAPERIDPLRARGYPSFKTKLGFKFNYR  185 (187)
Q Consensus       135 dfg~a~~~~~~~~~~~---~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi~~~  185 (187)
                      |-.++|.+.+.....-   .-....||+||.+.   +..|+.++|+|||||.+|
T Consensus       439 DsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~---n~~yssasDvWsfGVllW  489 (563)
T KOG1024|consen  439 DSALSRDLFPGDYHCLGDNENRPVKWMSLEALQ---NSHYSSASDVWSFGVLLW  489 (563)
T ss_pred             cchhccccCcccccccCCCCCCcccccCHHHHh---hhhhcchhhhHHHHHHHH
Confidence            9999999876544331   12455699999999   889999999999999877

>cd00180 PKc Catalytic domain of Protein Kinases

Probab=99.82  E-value=3.1e-20  Score=133.72  Aligned_cols=147  Identities=32%  Similarity=0.501  Sum_probs=113.6

Q ss_pred             ccccCceEEEEEEEcCCCcEEEEEEccCccChHHHHHHHHHHHHHHhcCCCCchhhhhhhHH------------------
Q psy14630         32 IGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQFYGALF------------------   93 (187)
Q Consensus        32 lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~------------------   93 (187)
                      ||+|.+|.||++....+++.+++|.+....... ..+.+..+...++.+.|++++++++.+.                  
T Consensus         1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~-~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~   79 (215)
T cd00180           1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSS-LLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLK   79 (215)
T ss_pred             CCcCCceEEEEEEecCCCcEEEEEEeccccchh-HHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHH
Confidence            689999999999998889999999987533221 2344555666677778888887653211                  


Q ss_pred             ---------------HHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcC-CCCEEEEeccccccccccc-cccCCCCCcC
Q psy14630         94 ---------------KEVTVATVKALNYLKEELKIIHRDVKPSNILLDR-RGAIKLCDFGISGQLVDSI-AKTRDAGCRP  156 (187)
Q Consensus        94 ---------------~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~-~~~~ki~dfg~a~~~~~~~-~~~~~~~t~~  156 (187)
                                     ..+..+++.++.+||+. +++|+|++|.||+++. .+.++++|||.+....... ......+...
T Consensus        80 ~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~-~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~  158 (215)
T cd00180          80 DLLKENEGKLSEDEILRILLQILEGLEYLHSN-GIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVGTPA  158 (215)
T ss_pred             HHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC-CeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcchhhcccCCCC
Confidence                           12567888999999998 9999999999999999 8999999999988765432 1223356778


Q ss_pred             ccCccccCCCccC-CCCCCcceeeeEee
Q psy14630        157 YMAPERIDPLRAR-GYPSFKTKLGFKFN  183 (187)
Q Consensus       157 y~aPE~~~~~~~~-~~~~~~D~ws~gi~  183 (187)
                      |++||.+.   .. ..+.+.|+|++|++
T Consensus       159 ~~~pe~~~---~~~~~~~~~D~~~lg~~  183 (215)
T cd00180         159 YMAPEVLL---GKGYYSEKSDIWSLGVI  183 (215)
T ss_pred             ccChhHhc---ccCCCCchhhhHHHHHH
Confidence            99999987   44 67899999999983

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which

>KOG1165|consensus

Probab=99.82  E-value=1.7e-19  Score=135.28  Aligned_cols=161  Identities=20%  Similarity=0.265  Sum_probs=111.2

Q ss_pred             ccCCcccccccccccccCceEEEEEEEcCCCcEEEEEEccCccChHHHHHHHHHHHHHHhcCCCCchhh-----------
Q psy14630         19 YDFTSEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQ-----------   87 (187)
Q Consensus        19 ~~~~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~-----------   87 (187)
                      ..+..-.|+++++||+|+||+.+.|.+.-+++.||||........+......+--.   .....+.|..           
T Consensus        23 ~~~VG~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS~APQLrdEYr~YK---lL~g~~GIP~vYYFGqeG~~N   99 (449)
T KOG1165|consen   23 VLMVGPHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKSEAPQLRDEYRTYK---LLGGTEGIPQVYYFGQEGKYN   99 (449)
T ss_pred             ceEecccceeccccccCcceeeecccccccCceEEEEeccccCCcchHHHHHHHHH---HHcCCCCCCceeeeccccchh
Confidence            34567789999999999999999999999999999998754333332222222111   1122233322           


Q ss_pred             -------------hhhhHHH--------HHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCC-----CCEEEEecccccc
Q psy14630         88 -------------FYGALFK--------EVTVATVKALNYLKEELKIIHRDVKPSNILLDRR-----GAIKLCDFGISGQ  141 (187)
Q Consensus        88 -------------~~~~~~~--------~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~-----~~~ki~dfg~a~~  141 (187)
                                   +|++|-.        -++.|++.-++|+|+. .+|.|||||+|+||...     ..+.++|||+|+.
T Consensus       100 iLVidLLGPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH~k-~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~  178 (449)
T KOG1165|consen  100 ILVIDLLGPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVHEK-DLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKE  178 (449)
T ss_pred             hhhhhhhCcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHHhc-ceeecccCccceeecCCCCCCCceEEEEeccchhh
Confidence                         2222211        1677888899999998 99999999999999754     3489999999999


Q ss_pred             ccccccc--------cCCCCCcCccCccccCCCccCCCCCCcceeeeE--eeeeC
Q psy14630        142 LVDSIAK--------TRDAGCRPYMAPERIDPLRARGYPSFKTKLGFK--FNYRI  186 (187)
Q Consensus       142 ~~~~~~~--------~~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~g--i~~~~  186 (187)
                      +.+..+.        .+..||.+||+=..+.+   ..-+..-|.=|+|  ++|+|
T Consensus       179 YrDp~TkqHIPYrE~KSLsGTARYMSINTHlG---rEQSRRDDLEaLGHvFmYFL  230 (449)
T KOG1165|consen  179 YRDPKTKQHIPYREHKSLSGTARYMSINTHLG---REQSRRDDLEALGHVFMYFL  230 (449)
T ss_pred             hcCccccccCccccccccccceeeeEeecccc---chhhhhhhHHHhhhhhhhhc
Confidence            8765433        35579999999888873   3334444444444  46654

>KOG1163|consensus

Probab=99.79  E-value=1.2e-18  Score=125.79  Aligned_cols=157  Identities=18%  Similarity=0.258  Sum_probs=105.0

Q ss_pred             CCcccccccccccccCceEEEEEEEcCCCcEEEEEEccCccChHHHHHHHHHHHHHHh-cCCCCchh-------------
Q psy14630         21 FTSEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMK-SNECPYIV-------------   86 (187)
Q Consensus        21 ~~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~-~~~h~~iv-------------   86 (187)
                      +....|++.++||.|+||-+|+|.+..+|..||||........+... ....+..+++ ...-|+|-             
T Consensus        12 iv~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~hpqL~-yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVM   90 (341)
T KOG1163|consen   12 IVGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAKHPQLL-YESKVYRILQGGVGIPHIRHYGTEKDYNVLVM   90 (341)
T ss_pred             eeccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCCCcchh-HHHHHHHHhccCCCCchhhhhccccccceeee
Confidence            45678999999999999999999999999999999876443322211 1111111221 12223322             


Q ss_pred             --------hhhhhHHHH--------HHHHHHHHHHHHHhcCCCeeecCCCCCeEEc---CCCCEEEEecccccccccccc
Q psy14630         87 --------QFYGALFKE--------VTVATVKALNYLKEELKIIHRDVKPSNILLD---RRGAIKLCDFGISGQLVDSIA  147 (187)
Q Consensus        87 --------~~~~~~~~~--------~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~---~~~~~ki~dfg~a~~~~~~~~  147 (187)
                              +++..|...        ++.|++.-++|+|.. +++||||||+|+|+.   ....+.++|||+|+.+.+...
T Consensus        91 dLLGPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~r-~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~d~~t  169 (341)
T KOG1163|consen   91 DLLGPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVHLR-NFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYRDIRT  169 (341)
T ss_pred             eccCccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHhh-ccccccCCccceeeccccccceEEEEeccchhhhccccc
Confidence                    222223222        567888889999998 999999999999995   356789999999999865321


Q ss_pred             --------ccCCCCCcCccCccccCCCccCCCCCCcceeeeEe
Q psy14630        148 --------KTRDAGCRPYMAPERIDPLRARGYPSFKTKLGFKF  182 (187)
Q Consensus       148 --------~~~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi  182 (187)
                              .....||.+|.+-....+   ..-+..-|.=|+|-
T Consensus       170 ~~HIpyre~r~ltGTaRYASinAh~g---~eqSRRDDmeSvgY  209 (341)
T KOG1163|consen  170 RQHIPYREDRNLTGTARYASINAHLG---IEQSRRDDMESVGY  209 (341)
T ss_pred             cccCccccCCccceeeeehhhhhhhh---hhhhhhhhhhhhcc
Confidence                    123478999988766552   22334445555554

>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional

Probab=99.78  E-value=6.1e-19  Score=129.01  Aligned_cols=148  Identities=14%  Similarity=0.147  Sum_probs=101.9

Q ss_pred             cCCcccccccccccccCceEEEEEEEcCCCcEEEEEEccCccChHH-HHHH------HHHHHHHHhcCCCCchhhhhhhH
Q psy14630         20 DFTSEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKD-QRQL------LMDLDVVMKSNECPYIVQFYGAL   92 (187)
Q Consensus        20 ~~~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~-~~~~------~~~~~~~~~~~~h~~iv~~~~~~   92 (187)
                      ++-..+|+..+.+|.|+||.||+...  ++..+|+|.+........ ..+.      +..+...+..+.|++|....+.+
T Consensus        27 ~~l~~~y~~~~~l~~~~f~~v~l~~~--~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~  104 (232)
T PRK10359         27 DFLSYNIKTIKVFRNIDDTKVSLIDT--DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFY  104 (232)
T ss_pred             HHhhCceEEEEEecCCCceEEEEEec--CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEee
Confidence            34567899999999999999999655  366799999865432221 1111      34444444555777766543221


Q ss_pred             --------------------------------HHHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEeccccc
Q psy14630         93 --------------------------------FKEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISG  140 (187)
Q Consensus        93 --------------------------------~~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg~a~  140 (187)
                                                      ......++..++..+|+. +++|+|++|.|+++++++ ++++|||...
T Consensus       105 ~~~~~~~~~~~~~~~lvmEyi~G~tL~~~~~~~~~~~~~i~~~l~~lH~~-gi~H~Dikp~Nili~~~g-i~liDfg~~~  182 (232)
T PRK10359        105 LLAERKTLRYAHTYIMLIEYIEGVELNDMPEISEDVKAKIKASIESLHQH-GMVSGDPHKGNFIVSKNG-LRIIDLSGKR  182 (232)
T ss_pred             eecccccccccCCeEEEEEEECCccHHHhhhccHHHHHHHHHHHHHHHHc-CCccCCCChHHEEEeCCC-EEEEECCCcc
Confidence                                            012355788899999998 999999999999999888 9999999876


Q ss_pred             cccccccccCCCCCcCccCccccCCCccCCCCCCcceeeeEeeee
Q psy14630        141 QLVDSIAKTRDAGCRPYMAPERIDPLRARGYPSFKTKLGFKFNYR  185 (187)
Q Consensus       141 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi~~~  185 (187)
                      ......            |-+.+.  ....++.++|+||+|+.+-
T Consensus       183 ~~~e~~------------a~d~~v--ler~y~~~~di~~lg~~~~  213 (232)
T PRK10359        183 CTAQRK------------AKDRID--LERHYGIKNEIKDLGYYLL  213 (232)
T ss_pred             cccchh------------hHHHHH--HHhHhcccccccceeEeeh
Confidence            543211            112222  1445678999999999653

>KOG1164|consensus

Probab=99.77  E-value=5.9e-19  Score=136.68  Aligned_cols=152  Identities=20%  Similarity=0.257  Sum_probs=101.1

Q ss_pred             cccccccccccCceEEEEEEEcCCC-cEEEEEEccCccChHHHHHHHHHHHHHHhcC---CCCchhhhhhhH--------
Q psy14630         25 DLQDLGEIGRGGFGTVNKMIHRSSD-TVMAVKRIRSTVDEKDQRQLLMDLDVVMKSN---ECPYIVQFYGAL--------   92 (187)
Q Consensus        25 ~~~~~~~lg~G~fg~V~~~~~~~~~-~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~---~h~~iv~~~~~~--------   92 (187)
                      +|.+.+.||+|+||.||+|.+..++ ..+|+|........... ....+...+....   ..+++..+++..        
T Consensus        19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~-~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~   97 (322)
T KOG1164|consen   19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPS-VLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNF   97 (322)
T ss_pred             ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCc-cchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeE
Confidence            8999999999999999999987664 67899987543221110 1111111111111   011222221110        


Q ss_pred             --------------------------HHHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCC-----CCEEEEecccccc
Q psy14630         93 --------------------------FKEVTVATVKALNYLKEELKIIHRDVKPSNILLDRR-----GAIKLCDFGISGQ  141 (187)
Q Consensus        93 --------------------------~~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~-----~~~ki~dfg~a~~  141 (187)
                                                .-.+..|++.+|.++|+. |++||||||.|+++...     ..+.+.|||+++.
T Consensus        98 iVM~l~G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~-G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGlar~  176 (322)
T KOG1164|consen   98 IVMSLLGPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSK-GFIHRDIKPENFVVGQSSRSEVRTLYLLDFGLARR  176 (322)
T ss_pred             EEEeccCccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhc-CcccCCcCHHHeeecCCCCcccceEEEEecCCCcc
Confidence                                      011677999999999998 99999999999999765     4589999999993


Q ss_pred             cc--ccc--------c-ccCCCCCcCccCccccCCCccCCCCCCcceeeeE
Q psy14630        142 LV--DSI--------A-KTRDAGCRPYMAPERIDPLRARGYPSFKTKLGFK  181 (187)
Q Consensus       142 ~~--~~~--------~-~~~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~g  181 (187)
                      ..  ...        . .....||.+|.++.++.   .......-|+||++
T Consensus       177 ~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~---~~e~~r~DDles~~  224 (322)
T KOG1164|consen  177 FKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHL---GIEQGRRDDLESLF  224 (322)
T ss_pred             ccccCCCCcccccCCCCccCCCCccccccHHHhC---CCccCCchhhhhHH
Confidence            32  111        1 12335999999999988   55677889999843

>PLN00181 protein SPA1-RELATED; Provisional

Probab=99.75  E-value=3.1e-19  Score=152.89  Aligned_cols=87  Identities=15%  Similarity=0.161  Sum_probs=65.8

Q ss_pred             HHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcC-------------------CCCEEEEecccccccccc----------
Q psy14630         95 EVTVATVKALNYLKEELKIIHRDVKPSNILLDR-------------------RGAIKLCDFGISGQLVDS----------  145 (187)
Q Consensus        95 ~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~-------------------~~~~ki~dfg~a~~~~~~----------  145 (187)
                      .++.|++.||.|||++ +|+||||||+|||++.                   ++.+|++|||+++.....          
T Consensus        84 ~i~~qi~~al~~lH~~-gIvHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~  162 (793)
T PLN00181         84 HVFRQIVEIVNAAHSQ-GIVVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEE  162 (793)
T ss_pred             HHHHHHHHHHHHHHhC-CeeeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhc
Confidence            4778999999999997 9999999999999954                   345666677766542110          


Q ss_pred             -------ccccCCCCCcCccCccccCCCccCCCCCCcceeeeEe-eee
Q psy14630        146 -------IAKTRDAGCRPYMAPERIDPLRARGYPSFKTKLGFKF-NYR  185 (187)
Q Consensus       146 -------~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi-~~~  185 (187)
                             .......||+.|||||++.   ...++.++||||||+ +|+
T Consensus       163 ~~~~~~~~~~~~~~gt~~Y~APE~~~---~~~~~~~sDVwSlGviL~E  207 (793)
T PLN00181        163 VKKQPFPMKQILAMEMSWYTSPEEDN---GSSSNCASDVYRLGVLLFE  207 (793)
T ss_pred             cccCCCcccccccCCCcceEChhhhc---cCCCCchhhhhhHHHHHHH
Confidence                   0001135788899999998   566899999999999 444

>KOG0590|consensus

Probab=99.75  E-value=5.6e-18  Score=139.94  Aligned_cols=154  Identities=22%  Similarity=0.334  Sum_probs=108.2

Q ss_pred             cccccccccCceEEEEEEEcCCCcEEEEEEcc----CccChHHHHHHHHHHHHHHhcCCCCchhhhhhhH----------
Q psy14630         27 QDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIR----STVDEKDQRQLLMDLDVVMKSNECPYIVQFYGAL----------   92 (187)
Q Consensus        27 ~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~----~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~----------   92 (187)
                      .....+|.|++|.|+.+........++.|..+    ...........+..+..+...+.|+|++.....+          
T Consensus       321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~m  400 (601)
T KOG0590|consen  321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSM  400 (601)
T ss_pred             CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhh
Confidence            45678999999977777665555545555433    1112222222244444455567888876543211          


Q ss_pred             ---------------------HHHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEecccccccccc-----c
Q psy14630         93 ---------------------FKEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDS-----I  146 (187)
Q Consensus        93 ---------------------~~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg~a~~~~~~-----~  146 (187)
                                           ....+.|++.|++|+|.. |+.|||+|++|+++...|.+||+|||.+.-+.-.     .
T Consensus       401 E~~~~Dlf~~~~~~~~~~~~e~~c~fKqL~~Gv~y~h~~-GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~e~~~~  479 (601)
T KOG0590|consen  401 EYCPYDLFSLVMSNGKLTPLEADCFFKQLLRGVKYLHSM-GLAHRDLKLENLLVTENGILKIIDFGAASVFRYPWEKNIH  479 (601)
T ss_pred             hcccHHHHHHHhcccccchhhhhHHHHHHHHHHHHHHhc-CceeccCccccEEEecCCceEEeecCcceeeccCcchhhh
Confidence                                 011567899999999997 9999999999999999999999999988876432     2


Q ss_pred             cccCCCCCcCccCccccCCCccCCCC-CCcceeeeEeee
Q psy14630        147 AKTRDAGCRPYMAPERIDPLRARGYP-SFKTKLGFKFNY  184 (187)
Q Consensus       147 ~~~~~~~t~~y~aPE~~~~~~~~~~~-~~~D~ws~gi~~  184 (187)
                      .....+|+..|+|||++.   ...|+ ..+|+||.||.|
T Consensus       480 ~~~g~~gS~pY~apE~~~---~~~ydpr~vDiwS~~ii~  515 (601)
T KOG0590|consen  480 ESSGIVGSDPYLAPEVLT---GKEYDPRAVDVWSCGIIY  515 (601)
T ss_pred             hhcCcccCCcCcCccccc---ccccCcchhhhhhccceE
Confidence            223457899999999999   55566 889999999965

>KOG0606|consensus

Probab=99.74  E-value=2.6e-19  Score=150.41  Aligned_cols=146  Identities=29%  Similarity=0.489  Sum_probs=110.5

Q ss_pred             cccccccccccccCceEEEEEEEcCCCcEEEEEEccCccChHHHHHHHHHHHHHHhcCCCCchhhhhhhHHHH---HHHH
Q psy14630         23 SEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQFYGALFKE---VTVA   99 (187)
Q Consensus        23 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~---~~~~   99 (187)
                      ..+|..++.+.-|+||-||.++|+.+.+++|+|+=++.       -+++.   ++....+|.+|--.....+.   ...+
T Consensus        82 e~df~~IklisngAygavylvrh~~trqrfa~kiNkq~-------lilRn---ilt~a~npfvvgDc~tllk~~g~lPvd  151 (1205)
T KOG0606|consen   82 ESDFNTIKLISNGAYGAVYLVRHKETRQRFAMKINKQN-------LILRN---ILTFAGNPFVVGDCATLLKNIGPLPVD  151 (1205)
T ss_pred             ccccceeEeeccCCCCceeeeeccccccchhhcccccc-------hhhhc---cccccCCcceechhhhhcccCCCCcch
Confidence            46788999999999999999999999999999753211       11111   33445667665222222221   3345


Q ss_pred             HHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEeccccccccccc----------------cccCCCCCcCccCcccc
Q psy14630        100 TVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSI----------------AKTRDAGCRPYMAPERI  163 (187)
Q Consensus       100 ~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg~a~~~~~~~----------------~~~~~~~t~~y~aPE~~  163 (187)
                      ++.+++|+|+. +|+|||+||+|.+|..-|++|+.|||+.+......                .....+||+.|+|||++
T Consensus       152 mvla~Eylh~y-givhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVi  230 (1205)
T KOG0606|consen  152 MVLAVEYLHSY-GIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVI  230 (1205)
T ss_pred             hhHHhHhhccC-CeecCCCCCCcceeeecccccccchhhhhhhhhhccchhhhcchHHHHHHhhhccccCCccccChhhh
Confidence            57889999998 99999999999999999999999999987642110                11234899999999999


Q ss_pred             CCCccCCCCCCcceeeeEe
Q psy14630        164 DPLRARGYPSFKTKLGFKF  182 (187)
Q Consensus       164 ~~~~~~~~~~~~D~ws~gi  182 (187)
                      .   ..+|...+|||++|+
T Consensus       231 l---rqgygkpvdwwamGi  246 (1205)
T KOG0606|consen  231 L---RQGYGKPVDWWAMGI  246 (1205)
T ss_pred             h---hhccCCCccHHHHHH
Confidence            9   678999999999999

>cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain

Probab=99.74  E-value=8.2e-18  Score=120.98  Aligned_cols=112  Identities=18%  Similarity=0.083  Sum_probs=77.9

Q ss_pred             cccccccCceEEEEEEEcCCCcEEEEEEccCccChH------------------------HHHHHHHHHHHHHhcCCCCc
Q psy14630         29 LGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEK------------------------DQRQLLMDLDVVMKSNECPY   84 (187)
Q Consensus        29 ~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~------------------------~~~~~~~~~~~~~~~~~h~~   84 (187)
                      ...||+|+||.||+|.+. +|+.||||+++......                        ........+...+..+.+++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~-~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~   80 (190)
T cd05145           2 NGCISTGKEANVYHARTG-DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAG   80 (190)
T ss_pred             CceeecCCCcEEEEEEcC-CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCC
Confidence            568999999999999986 89999999986432110                        00112223333333344444


Q ss_pred             hhh--------------hh-h---------------hHHHHHHHHHHHHHHHHHh-cCCCeeecCCCCCeEEcCCCCEEE
Q psy14630         85 IVQ--------------FY-G---------------ALFKEVTVATVKALNYLKE-ELKIIHRDVKPSNILLDRRGAIKL  133 (187)
Q Consensus        85 iv~--------------~~-~---------------~~~~~~~~~~~~~l~~lh~-~~~i~Hrdlk~~nili~~~~~~ki  133 (187)
                      +..              +. +               .....+..+++.++.++|+ . +++|||+||+||+++ ++.+++
T Consensus        81 i~~p~~~~~~~~~lVmE~~~g~~~~~~~l~~~~~~~~~~~~i~~~l~~~l~~lH~~~-givHrDlkP~NIll~-~~~~~l  158 (190)
T cd05145          81 VPVPEPILLKKNVLVMEFIGDDGSPAPRLKDVPLEEEEAEELYEQVVEQMRRLYQEA-GLVHGDLSEYNILYH-DGKPYI  158 (190)
T ss_pred             CCCceEEEecCCEEEEEEecCCCchhhhhhhccCCHHHHHHHHHHHHHHHHHHHHhC-CEecCCCChhhEEEE-CCCEEE
Confidence            311              00 0               0112266789999999999 6 999999999999998 789999


Q ss_pred             Eecccccccc
Q psy14630        134 CDFGISGQLV  143 (187)
Q Consensus       134 ~dfg~a~~~~  143 (187)
                      +|||++....
T Consensus       159 iDFG~a~~~~  168 (190)
T cd05145         159 IDVSQAVELD  168 (190)
T ss_pred             EEcccceecC
Confidence            9999998754

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro

>cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain

Probab=99.74  E-value=3.7e-18  Score=122.66  Aligned_cols=111  Identities=19%  Similarity=0.252  Sum_probs=74.2

Q ss_pred             cccccccCceEEEEEEEcCCCcEEEEEEccCccChH-H-----------------------HHHHHHHHHHHHhcCC---
Q psy14630         29 LGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEK-D-----------------------QRQLLMDLDVVMKSNE---   81 (187)
Q Consensus        29 ~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~-~-----------------------~~~~~~~~~~~~~~~~---   81 (187)
                      ...||+|+||.||+|.+. +|+.||+|+++...... .                       .......+...+..+.   
T Consensus         2 ~~~ig~G~~~~Vy~a~~~-~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~   80 (190)
T cd05147           2 NGCISTGKEANVYHATTA-NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAG   80 (190)
T ss_pred             CCccccccceEEEEEECC-CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCC
Confidence            468999999999999986 89999999986431100 0                       0111112323333332   


Q ss_pred             --CCchhhh---------hh------h----------HHHHHHHHHHHHHHHH-HhcCCCeeecCCCCCeEEcCCCCEEE
Q psy14630         82 --CPYIVQF---------YG------A----------LFKEVTVATVKALNYL-KEELKIIHRDVKPSNILLDRRGAIKL  133 (187)
Q Consensus        82 --h~~iv~~---------~~------~----------~~~~~~~~~~~~l~~l-h~~~~i~Hrdlk~~nili~~~~~~ki  133 (187)
                        +|+++..         .+      .          ....+..|++.++.++ |+. +++|||+||+||+++ .+.+++
T Consensus        81 v~~p~~~~~~~~~iVmE~i~g~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~l~H~~-giiHrDlkP~NIli~-~~~v~L  158 (190)
T cd05147          81 IPCPEPILLKSHVLVMEFIGDDGWAAPRLKDAPLSESKARELYLQVIQIMRILYQDC-RLVHADLSEYNLLYH-DGKLYI  158 (190)
T ss_pred             CCCCcEEEecCCEEEEEEeCCCCCcchhhhcCCCCHHHHHHHHHHHHHHHHHHHHhC-CcccCCCCHHHEEEE-CCcEEE
Confidence              2332210         10      0          0123567889999999 576 999999999999998 478999


Q ss_pred             Eeccccccc
Q psy14630        134 CDFGISGQL  142 (187)
Q Consensus       134 ~dfg~a~~~  142 (187)
                      +|||+|...
T Consensus       159 iDFG~a~~~  167 (190)
T cd05147         159 IDVSQSVEH  167 (190)
T ss_pred             EEccccccC
Confidence            999998754

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c

>PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A

Probab=99.69  E-value=8.3e-18  Score=126.56  Aligned_cols=160  Identities=22%  Similarity=0.274  Sum_probs=99.2

Q ss_pred             ccccccccccccCceEEEEEEEcCCCcEEEEEEccCcc-ChHHHHHHHHHHHHHHhcCCC---Cc--------hh-----
Q psy14630         24 EDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTV-DEKDQRQLLMDLDVVMKSNEC---PY--------IV-----   86 (187)
Q Consensus        24 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~~~~~~~~~~h---~~--------iv-----   86 (187)
                      ..+...+.||.|+|+.||.+.+.+|++.+|+|+..... .....-+.+.++........+   |-        ++     
T Consensus        12 r~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~   91 (288)
T PF14531_consen   12 RTLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLL   91 (288)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEE
T ss_pred             eEEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEE
Confidence            34566789999999999999999999999999873221 111122333333322211111   00        00     


Q ss_pred             hhh-----------------------------------hhHH--------------HHHHHHHHHHHHHHHhcCCCeeec
Q psy14630         87 QFY-----------------------------------GALF--------------KEVTVATVKALNYLKEELKIIHRD  117 (187)
Q Consensus        87 ~~~-----------------------------------~~~~--------------~~~~~~~~~~l~~lh~~~~i~Hrd  117 (187)
                      ++-                                   ..+.              -.++.|++..+++||.. |++|+|
T Consensus        92 ~i~~~~~~~~~~~~~~~~~v~n~~~l~P~~~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~-GlVHgd  170 (288)
T PF14531_consen   92 RIPGKPPFFERGPGQSIYWVLNRFLLMPRAQGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSY-GLVHGD  170 (288)
T ss_dssp             EETTS-SEEEECETTEEEEEESEEEEEE--SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT-TEEEST
T ss_pred             EEcCCCcceecCCCCccceeehhhhccchhhhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhc-ceEecc
Confidence            000                                   0000              01557888999999998 999999


Q ss_pred             CCCCCeEEcCCCCEEEEeccccccccccccccCCCCCcCccCccccCCC-----ccCCCCCCcceeeeEe-eeeC
Q psy14630        118 VKPSNILLDRRGAIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPL-----RARGYPSFKTKLGFKF-NYRI  186 (187)
Q Consensus       118 lk~~nili~~~~~~ki~dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~-----~~~~~~~~~D~ws~gi-~~~~  186 (187)
                      |+|+|++++.+|.+.+.||+...........  ...+..|.+||.....     .+..++.+.|.|++|+ .|||
T Consensus       171 i~~~nfll~~~G~v~Lg~F~~~~r~g~~~~~--~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~l  243 (288)
T PF14531_consen  171 IKPENFLLDQDGGVFLGDFSSLVRAGTRYRC--SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSL  243 (288)
T ss_dssp             -SGGGEEE-TTS-EEE--GGGEEETTEEEEG--GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHH
T ss_pred             cceeeEEEcCCCCEEEcChHHHeecCceeec--cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHH
Confidence            9999999999999999999877765543332  2334668899987521     1234788999999999 6654

>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

Probab=99.68  E-value=8.4e-17  Score=122.64  Aligned_cols=153  Identities=31%  Similarity=0.466  Sum_probs=112.4

Q ss_pred             ccccccccccCceEEEEEEEcCCCcEEEEEEccCccChHH-HHHHHHHHHHHHhcCCCC-chhhhhhhH-----------
Q psy14630         26 LQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKD-QRQLLMDLDVVMKSNECP-YIVQFYGAL-----------   92 (187)
Q Consensus        26 ~~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~-~~~~~~~~~~~~~~~~h~-~iv~~~~~~-----------   92 (187)
                      |.+.+.||.|+|+.||++.+.   ..+++|.+........ ....+..+......+.|+ +++++.+.+           
T Consensus         2 ~~~~~~l~~g~~~~v~~~~~~---~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~   78 (384)
T COG0515           2 YRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVME   78 (384)
T ss_pred             ceeEEeecCCCCeEEEEEEec---cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEe
Confidence            667889999999999999886   6789999865433322 233344444455555655 677654211           


Q ss_pred             ------------------------HHHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCC-CEEEEeccccccccccc-
Q psy14630         93 ------------------------FKEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRG-AIKLCDFGISGQLVDSI-  146 (187)
Q Consensus        93 ------------------------~~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~-~~ki~dfg~a~~~~~~~-  146 (187)
                                              ...+..+++.++.|+|+. +++|||+||+|++++..+ .++++|||.++...... 
T Consensus        79 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~-~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~~  157 (384)
T COG0515          79 YVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSK-GIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGS  157 (384)
T ss_pred             cCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhC-CeeccCCCHHHeeecCCCCeEEEeccCcceecCCCCc
Confidence                                    112566788899999998 999999999999999988 69999999998654432 


Q ss_pred             ------cccCCCCCcCccCccccCCCccCCCCCCcceeeeEe
Q psy14630        147 ------AKTRDAGCRPYMAPERIDPLRARGYPSFKTKLGFKF  182 (187)
Q Consensus       147 ------~~~~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi  182 (187)
                            ......++..|+|||.+.+..........|+|++|+
T Consensus       158 ~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~  199 (384)
T COG0515         158 TSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGI  199 (384)
T ss_pred             cccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHH
Confidence                  234557899999999998310046779999999995

>PRK10345 hypothetical protein; Provisional

Probab=99.65  E-value=4.1e-16  Score=113.39  Aligned_cols=110  Identities=22%  Similarity=0.304  Sum_probs=75.8

Q ss_pred             ccccccccccCceEEEEEEEcCCCcEEEEEEccCccChHHHHHHHHHHHHHHhcC-----CCCchhhhhhhHHHH-----
Q psy14630         26 LQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSN-----ECPYIVQFYGALFKE-----   95 (187)
Q Consensus        26 ~~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~-----~h~~iv~~~~~~~~~-----   95 (187)
                      +.-...||+|+|+.||.  ++.++.. +||++......  ..+...++..+++.+     .||||+++++.+...     
T Consensus         4 L~~~~~LG~G~~~~Vy~--hp~~~~k-~IKv~~~~~~~--~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~   78 (210)
T PRK10345          4 LSEQSPLGTGRHRKCYA--HPEDAQR-CIKIVYHRGDG--GDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGY   78 (210)
T ss_pred             cCCcceecCCCceEEEE--CCCCcCe-EEEEEeccccc--hHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeE
Confidence            34457899999999995  7777666 69987642211  223344455555555     689999988432110     


Q ss_pred             ------------------------------HHHHHHHHH-HHHHhcCCCeeecCCCCCeEEcCC----CCEEEEe-cccc
Q psy14630         96 ------------------------------VTVATVKAL-NYLKEELKIIHRDVKPSNILLDRR----GAIKLCD-FGIS  139 (187)
Q Consensus        96 ------------------------------~~~~~~~~l-~~lh~~~~i~Hrdlk~~nili~~~----~~~ki~d-fg~a  139 (187)
                                                    ...+++.++ +|||+. +|+||||||+||+++..    ..++|+| ||.+
T Consensus        79 v~~~I~e~~G~~~~tL~~~l~~~~~~e~~~~~~~~L~~l~~yLh~~-~IvhrDlKp~NILl~~~~~~~~~~~LiDg~G~~  157 (210)
T PRK10345         79 VYDVIADFDGKPSITLTEFAEQCRYEEDVAQLRQLLKKLKRYLLDN-RIVTMELKPQNILCQRISESEVIPVVCDNIGES  157 (210)
T ss_pred             EEEEEecCCCCcchhHHHHHHcccccHhHHHHHHHHHHHHHHHHHC-CEeecCCCHHHEEEeccCCCCCcEEEEECCCCc
Confidence                                          245666666 899998 99999999999999743    3799999 5544


Q ss_pred             cc
Q psy14630        140 GQ  141 (187)
Q Consensus       140 ~~  141 (187)
                      ..
T Consensus       158 ~~  159 (210)
T PRK10345        158 TF  159 (210)
T ss_pred             ce
Confidence            33

>KOG4158|consensus

Probab=99.64  E-value=1.1e-16  Score=123.10  Aligned_cols=90  Identities=22%  Similarity=0.291  Sum_probs=64.9

Q ss_pred             HHHHHHHHHHHHHhcCCCeeecCCCCCeEEc--CCC--CEEEEecccccccccc-------ccccCCCCCcCccCccccC
Q psy14630         96 VTVATVKALNYLKEELKIIHRDVKPSNILLD--RRG--AIKLCDFGISGQLVDS-------IAKTRDAGCRPYMAPERID  164 (187)
Q Consensus        96 ~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~--~~~--~~ki~dfg~a~~~~~~-------~~~~~~~~t~~y~aPE~~~  164 (187)
                      +..|+++|+.+||++ ++.|||+|.+||++.  +++  .+.++|||++---...       .......|.-..||||+..
T Consensus       346 ~laQlLEav~hL~~h-gvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~t  424 (598)
T KOG4158|consen  346 ILAQLLEAVTHLHKH-GVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIAT  424 (598)
T ss_pred             HHHHHHHHHHHHHHc-cchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhh
Confidence            667999999999998 999999999999993  344  4789999987543221       1111224566789999987


Q ss_pred             CCccCC--CC-CCcceeeeEe-eeeC
Q psy14630        165 PLRARG--YP-SFKTKLGFKF-NYRI  186 (187)
Q Consensus       165 ~~~~~~--~~-~~~D~ws~gi-~~~~  186 (187)
                      ..+...  .+ .++|.|+.|- .|+|
T Consensus       425 a~PGp~avvny~kAD~WA~GalaYEI  450 (598)
T KOG4158|consen  425 AVPGPNAVVNYEKADTWAAGALAYEI  450 (598)
T ss_pred             cCCCCceeeccchhhhhhhhhhHHHH
Confidence            543321  22 6899999997 6654

>KOG0603|consensus

Probab=99.64  E-value=6.1e-18  Score=135.72  Aligned_cols=143  Identities=27%  Similarity=0.346  Sum_probs=103.4

Q ss_pred             cccccCceEEEEEE---EcCCCcEEEEEEccCccChHHHH-HHHHHHHHHHhcCCCCchhhhhhhHHHH-----------
Q psy14630         31 EIGRGGFGTVNKMI---HRSSDTVMAVKRIRSTVDEKDQR-QLLMDLDVVMKSNECPYIVQFYGALFKE-----------   95 (187)
Q Consensus        31 ~lg~G~fg~V~~~~---~~~~~~~vaiK~~~~~~~~~~~~-~~~~~~~~~~~~~~h~~iv~~~~~~~~~-----------   95 (187)
                      ++|+|+||.|+++.   -...+..+|+|..++........ ....+...+....+||.++.+.-.+..+           
T Consensus         1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r   80 (612)
T KOG0603|consen    1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR   80 (612)
T ss_pred             CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence            47999999998753   33567778999886432111111 1222222233334588888765322111           


Q ss_pred             ---------------------HHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEeccccccccccccccCCCCC
Q psy14630         96 ---------------------VTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTRDAGC  154 (187)
Q Consensus        96 ---------------------~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg~a~~~~~~~~~~~~~~t  154 (187)
                                           ....++.+++.+|.. ++++||+|++||+++..|++++.|||+++...+....   +||
T Consensus        81 gg~lft~l~~~~~f~~~~~~~~~aelaLald~lh~l-~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~~---cgt  156 (612)
T KOG0603|consen   81 GGDLFTRLSKEVMFDELDVAFYLAELALALDHLHKL-GIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKIA---CGT  156 (612)
T ss_pred             cchhhhccccCCchHHHHHHHHHHHHHHHHhhcchh-HHHHhcccccceeecccCccccCCchhhhHhHhhhhc---ccc
Confidence                                 345567789999997 9999999999999999999999999999886554333   889


Q ss_pred             cCccCccccCCCccCCCCCCcceeeeEe
Q psy14630        155 RPYMAPERIDPLRARGYPSFKTKLGFKF  182 (187)
Q Consensus       155 ~~y~aPE~~~~~~~~~~~~~~D~ws~gi  182 (187)
                      ..|||||++.     ++..++|+||||+
T Consensus       157 ~eymApEI~~-----gh~~a~D~ws~gv  179 (612)
T KOG0603|consen  157 YEYRAPEIIN-----GHLSAADWWSFGV  179 (612)
T ss_pred             hhhhhhHhhh-----ccCCcccchhhhh
Confidence            9999999987     5789999999998

>KOG1166|consensus

Probab=99.64  E-value=5.7e-16  Score=131.68  Aligned_cols=168  Identities=23%  Similarity=0.306  Sum_probs=114.1

Q ss_pred             ceecCCCccccCCcccccccccccccCceEEEEEEEcCCCcEEEEEEccCcc-----ChHHHHHHHH--------HHHHH
Q psy14630         10 KLKLSPDTVYDFTSEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTV-----DEKDQRQLLM--------DLDVV   76 (187)
Q Consensus        10 ~~~~~~~~~~~~~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~~~~~~--------~~~~~   76 (187)
                      .....+........+.|.+...+|+|+||.||+|.+.. ++.||+|+-+...     .......++.        .....
T Consensus       684 ~~~l~~~~~~~~~~~~~~I~~e~G~g~y~~vy~a~~~~-~~~~alK~e~P~~~WEfYI~~q~~~RLk~~~~~~~~~~~~a  762 (974)
T KOG1166|consen  684 VPKLNPNTEFEVGGEKFCISKEIGEGSYGSVYVATHSN-GKLVALKVEKPPNPWEFYICLQVMERLKPQMLPSIMHISSA  762 (974)
T ss_pred             ccccCccceeeecceeEEEEeeeccccceEEEEeecCC-CcEEEEEeecCCCceeeeehHHHHHhhchhhhcchHHHHHH
Confidence            33445566677888899999999999999999999876 9999999875321     1111122222        00000


Q ss_pred             HhcCCCCchhh-h--hhhH--------------HHHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcC-------CCCEE
Q psy14630         77 MKSNECPYIVQ-F--YGAL--------------FKEVTVATVKALNYLKEELKIIHRDVKPSNILLDR-------RGAIK  132 (187)
Q Consensus        77 ~~~~~h~~iv~-~--~~~~--------------~~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~-------~~~~k  132 (187)
                      ....+-..++. +  +|.+              +-.+..|++.-++.||.. +|||+||||+|+|+..       ...++
T Consensus       763 ~~~~~~S~lv~ey~~~Gtlld~~N~~~~m~e~lv~~~~~qml~ive~lH~~-~IIHgDiKPDNfll~~~~~~~~~~~~l~  841 (974)
T KOG1166|consen  763 HVFQNASVLVSEYSPYGTLLDLINTNKVMDEYLVMFFSCQMLRIVEHLHAM-GIIHGDIKPDNFLLRREICADSDSKGLY  841 (974)
T ss_pred             HccCCcceeeeeccccccHHHhhccCCCCCchhhhHHHHHHHHHHHHHHhc-ceecccCCcceeEeecccCCCCcccceE
Confidence            00000011111 1  1221              122677889999999997 9999999999999943       34599


Q ss_pred             EEecccccccc---ccccccCCCCCcCccCccccCCCccCCCCCCcceeeeEe
Q psy14630        133 LCDFGISGQLV---DSIAKTRDAGCRPYMAPERIDPLRARGYPSFKTKLGFKF  182 (187)
Q Consensus       133 i~dfg~a~~~~---~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi  182 (187)
                      |+|||.+-.+.   +.......++|-.+-++|+..   +++|+.++|.||+.-
T Consensus       842 lIDfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~---grpWtYq~DyfGlAa  891 (974)
T KOG1166|consen  842 LIDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMRE---GRPWTYQIDYFGLAA  891 (974)
T ss_pred             EEecccceeeeEcCCCcEEeeeeccccchhHHHhc---CCCCchhhhhHHHHH
Confidence            99999887754   233344557788899999999   788999999999753

>smart00090 RIO RIO-like kinase

Probab=99.63  E-value=1.1e-15  Score=113.47  Aligned_cols=118  Identities=20%  Similarity=0.092  Sum_probs=80.3

Q ss_pred             cccccccccccCceEEEEEE-EcCCCcEEEEEEccCccCh--------------------H--HHHHHHHHHHHHHhcCC
Q psy14630         25 DLQDLGEIGRGGFGTVNKMI-HRSSDTVMAVKRIRSTVDE--------------------K--DQRQLLMDLDVVMKSNE   81 (187)
Q Consensus        25 ~~~~~~~lg~G~fg~V~~~~-~~~~~~~vaiK~~~~~~~~--------------------~--~~~~~~~~~~~~~~~~~   81 (187)
                      .|++.+.||+|+||.||+|. +..+++.||+|+++.....                    .  .....+..+...++.+.
T Consensus        29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~  108 (237)
T smart00090       29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY  108 (237)
T ss_pred             hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence            47788999999999999998 6678999999998642110                    0  00111222332332222


Q ss_pred             CCc--hhhhh-------------h-----h----------HHHHHHHHHHHHHHHHHhcCC-CeeecCCCCCeEEcCCCC
Q psy14630         82 CPY--IVQFY-------------G-----A----------LFKEVTVATVKALNYLKEELK-IIHRDVKPSNILLDRRGA  130 (187)
Q Consensus        82 h~~--iv~~~-------------~-----~----------~~~~~~~~~~~~l~~lh~~~~-i~Hrdlk~~nili~~~~~  130 (187)
                      +..  +...+             +     .          -...+..+++.++.+||.. + ++|+|+||+||+++ .+.
T Consensus       109 ~~~i~~p~~~~~~~~~lV~E~~~g~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~-g~iiH~Dikp~NIli~-~~~  186 (237)
T smart00090      109 EAGVPVPKPIAWRRNVLVMEFIGGDGLPAPRLKDVEPEEEEEFELYDDILEEMRKLYKE-GELVHGDLSEYNILVH-DGK  186 (237)
T ss_pred             hcCCCCCeeeEecCceEEEEEecCCcccccccccCCcchHHHHHHHHHHHHHHHHHHhc-CCEEeCCCChhhEEEE-CCC
Confidence            211  11110             0     0          0124678899999999998 8 99999999999999 789


Q ss_pred             EEEEeccccccccc
Q psy14630        131 IKLCDFGISGQLVD  144 (187)
Q Consensus       131 ~ki~dfg~a~~~~~  144 (187)
                      ++++|||.+.....
T Consensus       187 i~LiDFg~a~~~~~  200 (237)
T smart00090      187 VVIIDVSQSVELDH  200 (237)
T ss_pred             EEEEEChhhhccCC
Confidence            99999999886543

>smart00750 KIND kinase non-catalytic C-lobe domain

Probab=99.61  E-value=1.9e-16  Score=112.13  Aligned_cols=77  Identities=25%  Similarity=0.271  Sum_probs=64.8

Q ss_pred             hHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEeccccccccccccccCCCCCcCccCccccCCCccCC
Q psy14630         91 ALFKEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPLRARG  170 (187)
Q Consensus        91 ~~~~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~  170 (187)
                      .....++.|++.||.|||+. +      ||+||+++.++.+++  ||+++......    ..|++.|+|||++.   ...
T Consensus        17 ~~~~~i~~qi~~~L~~lH~~-~------kp~Nil~~~~~~~~~--fG~~~~~~~~~----~~g~~~y~aPE~~~---~~~   80 (176)
T smart00750       17 EEIWAVCLQCLRALRELHRQ-A------KSGNILLTWDGLLKL--DGSVAFKTPEQ----SRVDPYFMAPEVIQ---GQS   80 (176)
T ss_pred             HHHHHHHHHHHHHHHHHHhc-C------CcccEeEcCccceee--ccceEeecccc----CCCcccccChHHhc---CCC
Confidence            34456889999999999997 5      999999999999999  99987754322    25789999999998   667


Q ss_pred             CCCCcceeeeEee
Q psy14630        171 YPSFKTKLGFKFN  183 (187)
Q Consensus       171 ~~~~~D~ws~gi~  183 (187)
                      ++.++||||||++
T Consensus        81 ~~~~~DiwSlG~i   93 (176)
T smart00750       81 YTEKADIYSLGIT   93 (176)
T ss_pred             CcchhhHHHHHHH
Confidence            8899999999993

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features

>cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain

Probab=99.59  E-value=1.3e-14  Score=105.01  Aligned_cols=117  Identities=18%  Similarity=0.025  Sum_probs=78.9

Q ss_pred             ccccccccccCceEEEEEEEcCCCcEEEEEEccCccChH--------------------HHHHHHHHHHHHHhcCCCCc-
Q psy14630         26 LQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEK--------------------DQRQLLMDLDVVMKSNECPY-   84 (187)
Q Consensus        26 ~~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~--------------------~~~~~~~~~~~~~~~~~h~~-   84 (187)
                      |.+.+.||+|+||.||++... +++.+|||+++......                    ........+...+..+.+++ 
T Consensus        17 ~~~~~~i~~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i   95 (198)
T cd05144          17 ESLGNQIGVGKESDVYLALDP-DGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGF   95 (198)
T ss_pred             hhcCCccccCcceEEEEEEcC-CCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCC
Confidence            777899999999999999874 78999999865321000                    00011122222233233331 


Q ss_pred             -hhhhh---------------------h-hHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEecccccc
Q psy14630         85 -IVQFY---------------------G-ALFKEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQ  141 (187)
Q Consensus        85 -iv~~~---------------------~-~~~~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg~a~~  141 (187)
                       +...+                     . .-...+..+++.++.++|+. +++|+|++|.|++++.++.++++|||.+..
T Consensus        96 ~v~~~~~~~~~~lv~e~~~g~~L~~~~~~~~~~~~~~~i~~~l~~lh~~-gi~H~Dl~p~Nill~~~~~~~liDfg~~~~  174 (198)
T cd05144          96 PVPKPIDWNRHAVVMEYIDGVELYRVRVLEDPEEVLDEILEEIVKAYKH-GIIHGDLSEFNILVDDDEKIYIIDWPQMVS  174 (198)
T ss_pred             CCCceeecCCceEEEEEeCCcchhhccccccHHHHHHHHHHHHHHHHHC-CCCcCCCCcccEEEcCCCcEEEEECCcccc
Confidence             11111                     0 11223667888999999997 999999999999999999999999999976


Q ss_pred             ccc
Q psy14630        142 LVD  144 (187)
Q Consensus       142 ~~~  144 (187)
                      ...
T Consensus       175 ~~~  177 (198)
T cd05144         175 TDH  177 (198)
T ss_pred             CCC
Confidence            543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom

>cd05119 RIO RIO kinase family, catalytic domain

Probab=99.57  E-value=2.3e-14  Score=102.57  Aligned_cols=49  Identities=22%  Similarity=0.337  Sum_probs=42.7

Q ss_pred             HHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEeccccccccc
Q psy14630         95 EVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVD  144 (187)
Q Consensus        95 ~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg~a~~~~~  144 (187)
                      .+..+++.++.++|...+++|+|++|+|++++ ++.++++|||.+.....
T Consensus       118 ~~~~~~~~~l~~lh~~~~ivH~Dl~p~Nili~-~~~~~liDfg~a~~~~~  166 (187)
T cd05119         118 ELYDQILELMRKLYREAGLVHGDLSEYNILVD-DGKVYIIDVPQAVEIDH  166 (187)
T ss_pred             HHHHHHHHHHHHHhhccCcCcCCCChhhEEEE-CCcEEEEECcccccccC
Confidence            46778899999999933999999999999999 89999999999976543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct

>PRK12274 serine/threonine protein kinase; Provisional

Probab=99.56  E-value=4.2e-14  Score=101.96  Aligned_cols=113  Identities=13%  Similarity=0.129  Sum_probs=79.6

Q ss_pred             ccccccccCceEEEEEEEcCCCcEEEEEEccCccC--hHHHHHHHHHHHHHHhcC-CCCchhhhhhh-------------
Q psy14630         28 DLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVD--EKDQRQLLMDLDVVMKSN-ECPYIVQFYGA-------------   91 (187)
Q Consensus        28 ~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~~~~~~~~~~-~h~~iv~~~~~-------------   91 (187)
                      +...|++|+||+|+.+..  .+..++.+.+....-  .......+..+..+++.+ +++++..+++.             
T Consensus         6 ~~~~l~~~~f~~v~~~~~--~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~~~~~lvmeyI~G~   83 (218)
T PRK12274          6 VNEPLKSDTFGRILLVRG--GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHWDGRHLDRSYLAGA   83 (218)
T ss_pred             cceeecCCCcceEEEeec--CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEEcCEEEEEeeecCc
Confidence            457899999999997654  567777676643211  111122455566666666 34555555321             


Q ss_pred             -HH-------HHHHHHHHHHHHHHHhcCCCeeecC-CCCCeEEcCCCCEEEEecccccccc
Q psy14630         92 -LF-------KEVTVATVKALNYLKEELKIIHRDV-KPSNILLDRRGAIKLCDFGISGQLV  143 (187)
Q Consensus        92 -~~-------~~~~~~~~~~l~~lh~~~~i~Hrdl-k~~nili~~~~~~ki~dfg~a~~~~  143 (187)
                       +.       ..+..+++.++.++|+. |++|||| ||+||+++.++.++|+|||+|....
T Consensus        84 ~L~~~~~~~~~~~~~qi~~~L~~lH~~-GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~  143 (218)
T PRK12274         84 AMYQRPPRGDLAYFRAARRLLQQLHRC-GVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGN  143 (218)
T ss_pred             cHHhhhhhhhHHHHHHHHHHHHHHHHC-cCccCCCCCcceEEEcCCCCEEEEECCCceecC
Confidence             11       12556788899999998 9999999 7999999999999999999998644

>KOG1033|consensus

Probab=99.56  E-value=7.7e-17  Score=127.23  Aligned_cols=79  Identities=29%  Similarity=0.504  Sum_probs=65.0

Q ss_pred             HHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEeccccccccccc-------cccCCCCCcCccCccccCCCccCC
Q psy14630         98 VATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSI-------AKTRDAGCRPYMAPERIDPLRARG  170 (187)
Q Consensus        98 ~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg~a~~~~~~~-------~~~~~~~t~~y~aPE~~~~~~~~~  170 (187)
                      .|+..++.|   + +.+|||+||.||....+..+||.|||+........       ..+...||..||+||.+.   +..
T Consensus       366 ~q~~~~~~y---k-~~ihrdlkp~nif~~~d~q~kIgDFgl~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~---g~~  438 (516)
T KOG1033|consen  366 KQIAPAVEY---K-GLIHRDLKPSNIFFSDDDQLKIGDFGLVTSQDKDETVAPAAASHTQQVGTLLYMSPEQIR---GQQ  438 (516)
T ss_pred             Hhhccchhh---c-cchhhhccccccccccchhhhhhhhhheeecccCCcccchhhhhhhcccccccCCHHHHh---hhh
Confidence            344455555   3 78999999999999999999999999988765433       334557999999999999   778


Q ss_pred             CCCCcceeeeEee
Q psy14630        171 YPSFKTKLGFKFN  183 (187)
Q Consensus       171 ~~~~~D~ws~gi~  183 (187)
                      |..++|||++|++
T Consensus       439 y~~kvdIyaLGli  451 (516)
T KOG1033|consen  439 YSEKVDIYALGLI  451 (516)
T ss_pred             hhhhcchhhHHHH
Confidence            9999999999984

>PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated

Probab=99.49  E-value=1.1e-13  Score=114.05  Aligned_cols=113  Identities=18%  Similarity=0.160  Sum_probs=78.9

Q ss_pred             cccccccccCceEEEEEEEcCCCcEEEEEEc-cC-ccC----hHHHHHHHHHHHHHHhcCCCCchhhhh-----------
Q psy14630         27 QDLGEIGRGGFGTVNKMIHRSSDTVMAVKRI-RS-TVD----EKDQRQLLMDLDVVMKSNECPYIVQFY-----------   89 (187)
Q Consensus        27 ~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~-~~-~~~----~~~~~~~~~~~~~~~~~~~h~~iv~~~-----------   89 (187)
                      ...+.||+|+||.||++......  +++|.. .. ...    .....+.+..+..++..+.|++++...           
T Consensus       336 ~~~~~iG~G~~g~Vy~~~~~~~~--~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~l  413 (535)
T PRK09605        336 IPDHLIGKGAEADIKKGEYLGRD--AVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEEKTI  413 (535)
T ss_pred             CccceeccCCcEEEEEEeecCcc--ceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCCCEE
Confidence            45688999999999999875433  344432 11 111    111234455666677777888765421           


Q ss_pred             -----------hhH--HHHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEecccccccc
Q psy14630         90 -----------GAL--FKEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLV  143 (187)
Q Consensus        90 -----------~~~--~~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg~a~~~~  143 (187)
                                 +.+  ...+..+++.++.+||+. +++|||+||+||++ .++.++++|||+++...
T Consensus       414 v~E~~~g~~L~~~l~~~~~~~~~i~~~L~~lH~~-giiHrDlkp~NILl-~~~~~~liDFGla~~~~  478 (535)
T PRK09605        414 VMEYIGGKDLKDVLEGNPELVRKVGEIVAKLHKA-GIVHGDLTTSNFIV-RDDRLYLIDFGLGKYSD  478 (535)
T ss_pred             EEEecCCCcHHHHHHHHHHHHHHHHHHHHHHHhC-CCccCCCChHHEEE-ECCcEEEEeCcccccCC
Confidence                       011  233667899999999997 99999999999999 57889999999998754

>PRK14879 serine/threonine protein kinase; Provisional

Probab=99.48  E-value=1.8e-13  Score=99.75  Aligned_cols=109  Identities=19%  Similarity=0.131  Sum_probs=74.6

Q ss_pred             ccccccCceEEEEEEEcCCCcEEEEEEccCccC-hH-----HHHHHHHHHHHHHhcCCCCchhhhh--------------
Q psy14630         30 GEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVD-EK-----DQRQLLMDLDVVMKSNECPYIVQFY--------------   89 (187)
Q Consensus        30 ~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~~-~~-----~~~~~~~~~~~~~~~~~h~~iv~~~--------------   89 (187)
                      +.||+|++|.||+|..  .+..+++|....... ..     ........+..++..+.|+++....              
T Consensus         2 ~~l~~G~~~~vy~~~~--~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e   79 (211)
T PRK14879          2 KLIKRGAEAEIYLGDF--LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVME   79 (211)
T ss_pred             cccccCceEEEEEEee--CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEE
Confidence            5789999999999987  567789997643221 11     1122233344444444444443211              


Q ss_pred             --------hhH------HHHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEeccccccc
Q psy14630         90 --------GAL------FKEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQL  142 (187)
Q Consensus        90 --------~~~------~~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg~a~~~  142 (187)
                              +..      ...+..+++.++.++|+. +++|+|++|.||+++ .+.++++|||.++..
T Consensus        80 ~~~G~~L~~~~~~~~~~~~~i~~~i~~~l~~lH~~-~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~~  144 (211)
T PRK14879         80 YIEGEPLKDLINSNGMEELELSREIGRLVGKLHSA-GIIHGDLTTSNMILS-GGKIYLIDFGLAEFS  144 (211)
T ss_pred             EeCCcCHHHHHHhccHHHHHHHHHHHHHHHHHHhC-CcccCCCCcccEEEE-CCCEEEEECCcccCC
Confidence                    011      114566788899999997 999999999999999 788999999998764

>TIGR03724 arch_bud32 Kae1-associated kinase Bud32

Probab=99.46  E-value=8e-13  Score=95.50  Aligned_cols=109  Identities=16%  Similarity=0.169  Sum_probs=74.1

Q ss_pred             cccccCceEEEEEEEcCCCcEEEEEEccCcc--Ch----HHHHHHHHHHHHHHhcCCCCchh--hhh-------------
Q psy14630         31 EIGRGGFGTVNKMIHRSSDTVMAVKRIRSTV--DE----KDQRQLLMDLDVVMKSNECPYIV--QFY-------------   89 (187)
Q Consensus        31 ~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~--~~----~~~~~~~~~~~~~~~~~~h~~iv--~~~-------------   89 (187)
                      .||+|+||.||++..  ++..+++|......  ..    ....+.+..+..++..+.++++.  ..+             
T Consensus         1 ~ig~G~~~~vy~~~~--~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~   78 (199)
T TIGR03724         1 LIAKGAEAIIYLGDF--LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEY   78 (199)
T ss_pred             CCCCCceEEEEEeec--CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEE
Confidence            489999999999984  46788999854321  11    11122333344444444444322  111             


Q ss_pred             -------hhHHH---HHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEecccccccc
Q psy14630         90 -------GALFK---EVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLV  143 (187)
Q Consensus        90 -------~~~~~---~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg~a~~~~  143 (187)
                             +....   .+..+++.++.++|+. +++|+|++|.|++++ .+.++++|||+++...
T Consensus        79 ~~g~~l~~~~~~~~~~~~~~i~~~l~~lH~~-gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~~~  140 (199)
T TIGR03724        79 IEGKPLKDVIEEGNDELLREIGRLVGKLHKA-GIVHGDLTTSNIIVR-DDKLYLIDFGLGKYSD  140 (199)
T ss_pred             ECCccHHHHHhhcHHHHHHHHHHHHHHHHHC-CeecCCCCcceEEEE-CCcEEEEECCCCcCCC
Confidence                   11111   4678889999999997 999999999999999 7899999999987743

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine.

>KOG1240|consensus

Probab=99.46  E-value=4.9e-14  Score=119.71  Aligned_cols=154  Identities=19%  Similarity=0.196  Sum_probs=105.8

Q ss_pred             cccccccccccCceEEEEEEEcCCCcEEEEEEccCccChHH---HHHHHHHHHHHHhcCCCCchhhhhhhHHHH------
Q psy14630         25 DLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKD---QRQLLMDLDVVMKSNECPYIVQFYGALFKE------   95 (187)
Q Consensus        25 ~~~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~---~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~------   95 (187)
                      ++...+.||.+.|=+|.+|++.+ |. |+||++-+..+.-.   ..+.+.++.  ....++||++.+-......      
T Consensus        24 e~~~~~~LGstRFlKv~r~k~~e-G~-vVvKVFvk~~p~~sL~~~~qrL~~ik--~~l~~~pn~lPfqk~~~t~kAAylv   99 (1431)
T KOG1240|consen   24 ECHYVENLGSTRFLKVARAKDRE-GL-VVVKVFVKQDPTISLRPFKQRLEEIK--FALMKAPNCLPFQKVLVTDKAAYLV   99 (1431)
T ss_pred             ceeeecccCchhhhhhhhccCCC-ce-EEEEEEeccCCCCCchHHHHHHHHHH--HHhhcCCcccchHHHHHhhHHHHHH
Confidence            67778999999999999999854 43 88998744322222   233333333  4456889988764322111      


Q ss_pred             -------------------------HHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEecccccccc---c-cc
Q psy14630         96 -------------------------VTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLV---D-SI  146 (187)
Q Consensus        96 -------------------------~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg~a~~~~---~-~~  146 (187)
                                               ++.|++.|+.-+|.. +|+|+|||.+||||..-+.+.++||...+..-   + +.
T Consensus       100 RqyvkhnLyDRlSTRPFL~~iEKkWiaFQLL~al~qcH~~-gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeDNPa  178 (1431)
T KOG1240|consen  100 RQYVKHNLYDRLSTRPFLVLIEKKWIAFQLLKALSQCHKL-GVCHGDIKSENILITSWNWLYLTDFASFKPTYLPEDNPA  178 (1431)
T ss_pred             HHHHhhhhhhhhccchHHHHHHHHHHHHHHHHHHHHHHHc-CccccccccceEEEeeechhhhhcccccCCccCCCCCcc
Confidence                                     678999999999997 99999999999999999999999997665421   1 11


Q ss_pred             cccCC----CCCcCccCccccCCCc-------cCC-CCCCcceeeeEee
Q psy14630        147 AKTRD----AGCRPYMAPERIDPLR-------ARG-YPSFKTKLGFKFN  183 (187)
Q Consensus       147 ~~~~~----~~t~~y~aPE~~~~~~-------~~~-~~~~~D~ws~gi~  183 (187)
                      ...-+    ..-..|.|||.+....       ..+ -.++.||+|+|.+
T Consensus       179 df~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCV  227 (1431)
T KOG1240|consen  179 DFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCV  227 (1431)
T ss_pred             cceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHH
Confidence            11111    1234699999986311       111 4678999999973

>KOG0590|consensus

Probab=99.37  E-value=1.2e-13  Score=114.51  Aligned_cols=160  Identities=24%  Similarity=0.315  Sum_probs=113.2

Q ss_pred             CcccccccccccccCceEEEEEEE-cCCCcEEEEEEccCccChHHHHHHHHHHHHHHhcCC-CCchhhhhhhH-------
Q psy14630         22 TSEDLQDLGEIGRGGFGTVNKMIH-RSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNE-CPYIVQFYGAL-------   92 (187)
Q Consensus        22 ~~~~~~~~~~lg~G~fg~V~~~~~-~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~-h~~iv~~~~~~-------   92 (187)
                      +...|.+.+.||+|+|+.|-.... ..+...+|.|.+..........+....+..+.+... |.|++.+++..       
T Consensus        18 ~~~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~   97 (601)
T KOG0590|consen   18 PNSQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYL   97 (601)
T ss_pred             ccccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCcccc
Confidence            467788888999999999987665 334455677766432211222222233333444444 89999876421       


Q ss_pred             ---------------------------HHHHHHHHHHHHHHHH-hcCCCeeecCCCCCeEEcCCC-CEEEEecccccccc
Q psy14630         93 ---------------------------FKEVTVATVKALNYLK-EELKIIHRDVKPSNILLDRRG-AIKLCDFGISGQLV  143 (187)
Q Consensus        93 ---------------------------~~~~~~~~~~~l~~lh-~~~~i~Hrdlk~~nili~~~~-~~ki~dfg~a~~~~  143 (187)
                                                 .+....|+..++.|+| +. ++.|||+||+|.+++..+ .+++.|||+|..+.
T Consensus        98 ~~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~-~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~  176 (601)
T KOG0590|consen   98 LSLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPEN-GVTHRDIKPSNSLLDESGSALKIADFGLATAYR  176 (601)
T ss_pred             cccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCccc-ccccCCCCCccchhccCCCcccCCCchhhcccc
Confidence                                       1125678889999999 76 999999999999999999 99999999999876


Q ss_pred             c-ccc---ccCCCC-CcCccCccccCCCccCCCCCCcceeeeEeee
Q psy14630        144 D-SIA---KTRDAG-CRPYMAPERIDPLRARGYPSFKTKLGFKFNY  184 (187)
Q Consensus       144 ~-~~~---~~~~~~-t~~y~aPE~~~~~~~~~~~~~~D~ws~gi~~  184 (187)
                      . ...   ....+| ++.|+|||...+.  .-.....|+||.|+.+
T Consensus       177 ~~~g~~~~~~~~~g~s~~y~a~E~~~~~--~~~~~~~d~~S~g~~l  220 (601)
T KOG0590|consen  177 NKNGAERSLKDRCGSSPPYGAPEHLSGK--AYRGPSVDVWSLGIVL  220 (601)
T ss_pred             ccCCcceeeecccCCCCCCCCcccccch--hhcCCCcccccccccc
Confidence            5 221   123467 9999999999831  2344889999999954

>PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed

Probab=99.31  E-value=9.8e-12  Score=92.47  Aligned_cols=119  Identities=18%  Similarity=0.134  Sum_probs=76.9

Q ss_pred             Ccccccc-ccccc-ccCceEEEEEEEcCCCcEEEEEEccCcc------C-----hHHHHHHHHHHHHHHhcCCCCch--h
Q psy14630         22 TSEDLQD-LGEIG-RGGFGTVNKMIHRSSDTVMAVKRIRSTV------D-----EKDQRQLLMDLDVVMKSNECPYI--V   86 (187)
Q Consensus        22 ~~~~~~~-~~~lg-~G~fg~V~~~~~~~~~~~vaiK~~~~~~------~-----~~~~~~~~~~~~~~~~~~~h~~i--v   86 (187)
                      ..+.+.. ...|| .|+.|.||.+...  +..+++|.+....      .     ..........+..++..+.|+++  .
T Consensus        28 ~~~~~~~~~~~lg~~~g~gtv~~v~~~--~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP  105 (239)
T PRK01723         28 DPDFWQQQARVVGSAKGRGTTWFVQTP--GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVP  105 (239)
T ss_pred             CHHHHhhcCceeecCCCCccEEEEEeC--CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCc
Confidence            3344433 34687 8899999988764  6678999874210      0     01112233334444444444442  1


Q ss_pred             hhh---------------------h--hH---------HHHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEE
Q psy14630         87 QFY---------------------G--AL---------FKEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLC  134 (187)
Q Consensus        87 ~~~---------------------~--~~---------~~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~  134 (187)
                      ..+                     +  .+         ......+++.++.+||+. ||+|||+||.||+++.++.++++
T Consensus       106 ~pl~~~~~~~~~~~~~~lV~e~l~G~~~L~~~l~~~~l~~~~~~~i~~~l~~lH~~-GI~HrDlkp~NILv~~~~~v~LI  184 (239)
T PRK01723        106 RPIAARVVRHGLFYRADILIERIEGARDLVALLQEAPLSEEQWQAIGQLIARFHDA-GVYHADLNAHNILLDPDGKFWLI  184 (239)
T ss_pred             eeEeeeeeecCcceeeeEEEEecCCCCCHHHHHhcCCCCHHHHHHHHHHHHHHHHC-CCCCCCCCchhEEEcCCCCEEEE
Confidence            111                     0  01         112456788999999998 99999999999999988899999


Q ss_pred             ecccccccc
Q psy14630        135 DFGISGQLV  143 (187)
Q Consensus       135 dfg~a~~~~  143 (187)
                      |||.+....
T Consensus       185 Dfg~~~~~~  193 (239)
T PRK01723        185 DFDRGELRT  193 (239)
T ss_pred             ECCCcccCC
Confidence            999888754

>KOG0195|consensus

Probab=99.24  E-value=6.4e-13  Score=98.12  Aligned_cols=156  Identities=10%  Similarity=0.091  Sum_probs=102.4

Q ss_pred             ccccccccccccCceEEEEEEEcCCCcEEEEEEccCccChHHHHHHHHHHHHHHhcCCCCchhhhhhhHHHH--------
Q psy14630         24 EDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQFYGALFKE--------   95 (187)
Q Consensus        24 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~--------   95 (187)
                      .++.+..+|.+...|..|+|+...  ..++.|++....-.....+-+.++---++...||||+...+++.+.        
T Consensus       190 ~~lnl~tkl~e~hsgelwrgrwqg--ndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq  267 (448)
T KOG0195|consen  190 SSLNLITKLAESHSGELWRGRWQG--NDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQ  267 (448)
T ss_pred             hhhhhhhhhccCCCcccccccccC--cchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeee
Confidence            345566788899999999998853  3456687753322222233345554455667899999888765332        


Q ss_pred             --------------------------HHHHHHHHHHHHHhcCCCe-eecCCCCCeEEcCCCCEEEEeccccccccccccc
Q psy14630         96 --------------------------VTVATVKALNYLKEELKII-HRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAK  148 (187)
Q Consensus        96 --------------------------~~~~~~~~l~~lh~~~~i~-Hrdlk~~nili~~~~~~ki~dfg~a~~~~~~~~~  148 (187)
                                                +...++.|++|||+-..++ ---|+...++|+++-..+|+- +-++.   +-..
T Consensus       268 ~mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmidedltarism-ad~kf---sfqe  343 (448)
T KOG0195|consen  268 YMPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDEDLTARISM-ADTKF---SFQE  343 (448)
T ss_pred             eccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEecchhhhheec-cccee---eeec
Confidence                                      5667889999999854433 235778889998876655431 11111   0001


Q ss_pred             cCCCCCcCccCccccCCCccCCCCCCcceeeeEeeee
Q psy14630        149 TRDAGCRPYMAPERIDPLRARGYPSFKTKLGFKFNYR  185 (187)
Q Consensus       149 ~~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi~~~  185 (187)
                      ....-.|.||+||.+.+-+...-..++|.|||.|.+|
T Consensus       344 ~gr~y~pawmspealqrkped~n~raadmwsfaillw  380 (448)
T KOG0195|consen  344 VGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLW  380 (448)
T ss_pred             cccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHH
Confidence            1113467899999999665555668999999999877

>cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

Probab=99.24  E-value=3e-11  Score=82.67  Aligned_cols=109  Identities=15%  Similarity=0.109  Sum_probs=73.3

Q ss_pred             ccccccccCceEEEEEEEcCCCcEEEEEEccCccChHHHHHHHHHHHHHHhcCCC--Cchhhhhh---------------
Q psy14630         28 DLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNEC--PYIVQFYG---------------   90 (187)
Q Consensus        28 ~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~h--~~iv~~~~---------------   90 (187)
                      +.+.+|+|.++.||++...+  ..+++|.......    ...+..+...+..+.+  +++.+++.               
T Consensus         2 ~~~~i~~g~~~~v~~~~~~~--~~~~iK~~~~~~~----~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~   75 (155)
T cd05120           2 SIKLLKGGLTNRVYLLGTKD--EDYVLKINPSREK----GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWI   75 (155)
T ss_pred             cceecccccccceEEEEecC--CeEEEEecCCCCc----hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEec
Confidence            35679999999999998753  6789998865332    1112222222222222  23333221               


Q ss_pred             ----------hHHHHHHHHHHHHHHHHHhc--CCCeeecCCCCCeEEcCCCCEEEEeccccccc
Q psy14630         91 ----------ALFKEVTVATVKALNYLKEE--LKIIHRDVKPSNILLDRRGAIKLCDFGISGQL  142 (187)
Q Consensus        91 ----------~~~~~~~~~~~~~l~~lh~~--~~i~Hrdlk~~nili~~~~~~ki~dfg~a~~~  142 (187)
                                ........+++.++.++|..  .+++|+|++|.|++++..+.+++.|||.++..
T Consensus        76 ~g~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~~  139 (155)
T cd05120          76 EGETLDEVSEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGYG  139 (155)
T ss_pred             CCeecccCCHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccCC
Confidence                      11223566788899999974  26999999999999998899999999988753

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves

>TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase

Probab=99.14  E-value=6.8e-10  Score=89.39  Aligned_cols=40  Identities=38%  Similarity=0.674  Sum_probs=35.7

Q ss_pred             HHHHHhcCCCeeecCCCCCeEEcCCCCEEEEeccccccccc
Q psy14630        104 LNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVD  144 (187)
Q Consensus       104 l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg~a~~~~~  144 (187)
                      +..+|.. |++|+|++|.|+++..++.++++|||++..+.+
T Consensus       270 l~ql~~~-g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~~  309 (437)
T TIGR01982       270 LNQVLRD-GFFHADLHPGNIFVLKDGKIIALDFGIVGRLSE  309 (437)
T ss_pred             HHHHHhC-CceeCCCCcccEEECCCCcEEEEeCCCeeECCH
Confidence            5567887 999999999999999999999999999988753

This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species.

>KOG1023|consensus

Probab=99.12  E-value=6.9e-12  Score=100.53  Aligned_cols=92  Identities=26%  Similarity=0.313  Sum_probs=68.7

Q ss_pred             HHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEecccccccccc---ccccCCCCCcCccCccccCCCccCC-
Q psy14630         95 EVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDS---IAKTRDAGCRPYMAPERIDPLRARG-  170 (187)
Q Consensus        95 ~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg~a~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~-  170 (187)
                      .....+++|++|+|......|+.++..|++++..+.+|++|||+.......   ...........|.|||++....... 
T Consensus        52 s~~rdi~~Gl~ylh~s~i~~hg~l~s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~  131 (484)
T KOG1023|consen   52 SFIRDISKGLAYLHNSPIGYHGALKSSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSL  131 (484)
T ss_pred             HHHHHHHHHHHHHhcCcceeeeeeccccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccc
Confidence            366788999999998733499999999999999999999999998876431   1111112345699999997532232 


Q ss_pred             ---CCCCcceeeeEe-eeeC
Q psy14630        171 ---YPSFKTKLGFKF-NYRI  186 (187)
Q Consensus       171 ---~~~~~D~ws~gi-~~~~  186 (187)
                         .+.++|+||||| +|+|
T Consensus       132 ~~~~~~~gdiYs~~ii~~ei  151 (484)
T KOG1023|consen  132 ESALTQKGDIYSFGIIMYEI  151 (484)
T ss_pred             cccccccCCeehHHHHHHHH
Confidence               467899999999 5543

>PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed

Probab=99.05  E-value=7.5e-10  Score=90.66  Aligned_cols=35  Identities=31%  Similarity=0.543  Sum_probs=31.1

Q ss_pred             hcCCCeeecCCCCCeEEcCCC----CEEEEeccccccccc
Q psy14630        109 EELKIIHRDVKPSNILLDRRG----AIKLCDFGISGQLVD  144 (187)
Q Consensus       109 ~~~~i~Hrdlk~~nili~~~~----~~ki~dfg~a~~~~~  144 (187)
                      .. |++|+|++|.||+++.++    .++++|||+...+.+
T Consensus       278 ~~-GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~  316 (537)
T PRK04750        278 RD-GFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK  316 (537)
T ss_pred             hC-CeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence            44 999999999999999888    899999999887753

>KOG1243|consensus

Probab=99.03  E-value=7.5e-10  Score=90.58  Aligned_cols=137  Identities=15%  Similarity=0.182  Sum_probs=96.4

Q ss_pred             EEEEcCCCcEEEEEEccCccChHHHHHHHHHHHHHHhcCCCCchhhhhhhHHHH--------------------------
Q psy14630         42 KMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQFYGALFKE--------------------------   95 (187)
Q Consensus        42 ~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~--------------------------   95 (187)
                      .|..+.++.+|.+..++....  ...+...+...-++.++||||+++++.+..+                          
T Consensus        30 ~~t~k~~~~~vsVF~~~~~~~--~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~Pl~~~lk~l~~~~v~  107 (690)
T KOG1243|consen   30 DGTRKADGGPVSVFVYKRSNG--EVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVRPLETVLKELGKEEVC  107 (690)
T ss_pred             ccceeccCCceEEEEEeCCCc--hhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccccHHHHHHHhHHHHHH
Confidence            355667788899888875433  4455566667778889999999998654222                          


Q ss_pred             -HHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEecccccccccccc-ccCCCCCcCccCccccCCCccCCCCC
Q psy14630         96 -VTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIA-KTRDAGCRPYMAPERIDPLRARGYPS  173 (187)
Q Consensus        96 -~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg~a~~~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~  173 (187)
                       .+.||+.||.|||+.++++|++|....++++..|..||.+|.++........ .....---.|..|+.+.   ..  .-
T Consensus       108 ~Gl~qIl~AL~FL~~d~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~~~~~~~~~~s~~~P~~~~---~s--~~  182 (690)
T KOG1243|consen  108 LGLFQILAALSFLNDDCNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNAPAKSLYLIESFDDPEEID---PS--EW  182 (690)
T ss_pred             HHHHHHHHHHHHHhccCCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCcccccchhhhcccChhhcC---cc--cc
Confidence             5678999999999888999999999999999999999999988765432211 00001111255666655   11  13


Q ss_pred             CcceeeeEeeee
Q psy14630        174 FKTKLGFKFNYR  185 (187)
Q Consensus       174 ~~D~ws~gi~~~  185 (187)
                      ..|.|+||+..|
T Consensus       183 s~D~~~Lg~li~  194 (690)
T KOG1243|consen  183 SIDSWGLGCLIE  194 (690)
T ss_pred             chhhhhHHHHHH
Confidence            579999987543

>KOG0601|consensus

Probab=98.93  E-value=1.8e-10  Score=92.73  Aligned_cols=162  Identities=22%  Similarity=0.210  Sum_probs=114.2

Q ss_pred             ccCCcccccccccccc--cCceEEEEEEE--cCCCcEEEEEEccCccCh-HHHHHHHHHHHHHHhcCCCCchhhhhhhH-
Q psy14630         19 YDFTSEDLQDLGEIGR--GGFGTVNKMIH--RSSDTVMAVKRIRSTVDE-KDQRQLLMDLDVVMKSNECPYIVQFYGAL-   92 (187)
Q Consensus        19 ~~~~~~~~~~~~~lg~--G~fg~V~~~~~--~~~~~~vaiK~~~~~~~~-~~~~~~~~~~~~~~~~~~h~~iv~~~~~~-   92 (187)
                      .+++...+.....+|.  |.+|.||.+..  ..+...+|+|.-+..... ......+.+....++.-.|+|.++.+..+ 
T Consensus       109 ~s~~~~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e  188 (524)
T KOG0601|consen  109 DSFFDQRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWE  188 (524)
T ss_pred             cchhhhhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccc
Confidence            3455566777788999  99999999887  888889999974322111 11222233333344455678877755332 


Q ss_pred             -------------------------------HHHHHHHHHH----HHHHHHhcCCCeeecCCCCCeEEcCC-CCEEEEec
Q psy14630         93 -------------------------------FKEVTVATVK----ALNYLKEELKIIHRDVKPSNILLDRR-GAIKLCDF  136 (187)
Q Consensus        93 -------------------------------~~~~~~~~~~----~l~~lh~~~~i~Hrdlk~~nili~~~-~~~ki~df  136 (187)
                                                     .+....+...    |+..+|.+ .++|.|+||.|+++..+ ..+++.||
T Consensus       189 ~~~~lfiqtE~~~~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~-~~~~~~~kp~~i~~~~~~~s~~~~df  267 (524)
T KOG0601|consen  189 GSGILFIQTELCGESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLHSN-NIVHDDLKPANIFTTSDWTSCKLTDF  267 (524)
T ss_pred             cCCcceeeeccccchhHHhhhcccccCCchhhhhHHhhhhhcccccccccCCC-cccccccchhheecccccceeecCCc
Confidence                                           1223444555    89999998 99999999999999988 78999999


Q ss_pred             ccccccccccccc------CCCCCcCccCccccCCCccCCCCCCcceeeeEeeee
Q psy14630        137 GISGQLVDSIAKT------RDAGCRPYMAPERIDPLRARGYPSFKTKLGFKFNYR  185 (187)
Q Consensus       137 g~a~~~~~~~~~~------~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi~~~  185 (187)
                      |+...+.+.....      ..-+...|++||+..+    .+..+.|++++|.+|.
T Consensus       268 ~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~----l~~~~~di~sl~ev~l  318 (524)
T KOG0601|consen  268 GLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNG----LATFASDIFSLGEVIL  318 (524)
T ss_pred             ceeEEccCCccccceeeeecCCCCceEeChhhhcc----ccchHhhhcchhhhhH
Confidence            9998876543221      1135567999999873    3778999999998664

>cd05151 ChoK Choline Kinase (ChoK)

Probab=98.88  E-value=2.7e-08  Score=69.81  Aligned_cols=107  Identities=19%  Similarity=0.125  Sum_probs=67.9

Q ss_pred             cccccccCceEEEEEEEcCCCcEEEEEEccCccChHHHHHHHHHHHHHHhcCC----CCchhhhhh--------------
Q psy14630         29 LGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNE----CPYIVQFYG--------------   90 (187)
Q Consensus        29 ~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~----h~~iv~~~~--------------   90 (187)
                      .+.++.|.++.||++...  +..+++|..........  .. ..+...++.+.    .|-++....              
T Consensus         3 ~~~l~~G~~~~vy~~~~~--~~~~~lK~~~~~~~~~~--~~-~~E~~~l~~l~~~~~~P~~~~~~~~~~~lv~e~i~G~~   77 (170)
T cd05151           3 ISPLKGGMTNKNYRVEVA--NKKYVVRIPGNGTELLI--NR-ENEAENSKLAAEAGIGPKLYYFDPETGVLITEFIEGSE   77 (170)
T ss_pred             eeecCCcccCceEEEEEC--CeEEEEEeCCCCccccc--CH-HHHHHHHHHHHHhCCCCceEEEeCCCCeEEEEecCCCc
Confidence            356788999999998864  67899998754321100  11 11111111111    122221110              


Q ss_pred             -----hHHHHHHHHHHHHHHHHHhcCC-----CeeecCCCCCeEEcCCCCEEEEeccccccc
Q psy14630         91 -----ALFKEVTVATVKALNYLKEELK-----IIHRDVKPSNILLDRRGAIKLCDFGISGQL  142 (187)
Q Consensus        91 -----~~~~~~~~~~~~~l~~lh~~~~-----i~Hrdlk~~nili~~~~~~ki~dfg~a~~~  142 (187)
                           ........+++.++..||.. +     ++|+|++|.|++++ .+.++++||+.+..-
T Consensus        78 l~~~~~~~~~~~~~l~~~l~~LH~~-~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~~  137 (170)
T cd05151          78 LLTEDFSDPENLEKIAKLLKKLHSS-PLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGMN  137 (170)
T ss_pred             cccccccCHHHHHHHHHHHHHHhCC-CCCCceeecCCCCcCcEEEE-CCeEEEEecccccCC
Confidence                 01123566788999999986 6     49999999999998 678999999988753

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph

>KOG0601|consensus

Probab=98.75  E-value=9.8e-09  Score=82.93  Aligned_cols=156  Identities=22%  Similarity=0.166  Sum_probs=103.9

Q ss_pred             CcccccccccccccCceEEEEEEEc-CCCcEEEEEEccCccChHH-HHHHHHHHHHHHhcCCCCchhhhhhhHHH-----
Q psy14630         22 TSEDLQDLGEIGRGGFGTVNKMIHR-SSDTVMAVKRIRSTVDEKD-QRQLLMDLDVVMKSNECPYIVQFYGALFK-----   94 (187)
Q Consensus        22 ~~~~~~~~~~lg~G~fg~V~~~~~~-~~~~~vaiK~~~~~~~~~~-~~~~~~~~~~~~~~~~h~~iv~~~~~~~~-----   94 (187)
                      ...+|.....||.|.|+.|+.+... .++..+++|.+.+...... ...-+.+.........|.+++.++..+.+     
T Consensus       263 ~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~  342 (524)
T KOG0601|consen  263 KLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGY  342 (524)
T ss_pred             ecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCcccccccc
Confidence            4457778889999999999987654 6778899998765432222 12223333333334456667765432211     


Q ss_pred             ---------------------------HHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCC-CCEEEEeccccccccccc
Q psy14630         95 ---------------------------EVTVATVKALNYLKEELKIIHRDVKPSNILLDRR-GAIKLCDFGISGQLVDSI  146 (187)
Q Consensus        95 ---------------------------~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~-~~~ki~dfg~a~~~~~~~  146 (187)
                                                 .+..+++.++.++|+. .++|+|++|+||++.++ +..++.|||+...+.-..
T Consensus       343 ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s~-~~~~~d~~psni~i~~~~~~~~~~~~~~~t~~~~~~  421 (524)
T KOG0601|consen  343 IPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHSK-LFVHLDVKPSNILISNDGFFSKLGDFGCWTRLAFSS  421 (524)
T ss_pred             CchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccch-hhhcccccccceeeccchhhhhccccccccccceec
Confidence                                       1556788899999986 99999999999999886 788999999887532221


Q ss_pred             cccCCCCCcCcc-CccccCCCccCCCCCCcceeeeEe
Q psy14630        147 AKTRDAGCRPYM-APERIDPLRARGYPSFKTKLGFKF  182 (187)
Q Consensus       147 ~~~~~~~t~~y~-aPE~~~~~~~~~~~~~~D~ws~gi  182 (187)
                      .  ......++. .+|.+..  ...+-.++|+++||+
T Consensus       422 ~--~~~~~~r~~p~~~~~~e--~~~~~~~~~~~sl~~  454 (524)
T KOG0601|consen  422 G--VFHHIDRLYPIAEILLE--DYPHLSKADIFSLGL  454 (524)
T ss_pred             c--cccccccccccchhhcc--ccccccccccccccc
Confidence            1  112333444 2455442  566779999999996

>cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain

Probab=98.66  E-value=1.5e-07  Score=67.67  Aligned_cols=46  Identities=22%  Similarity=0.307  Sum_probs=38.2

Q ss_pred             HHHHHHHHHHHH-HhcCCCeeecCCCCCeEEcCCCCEEEEecccccccc
Q psy14630         96 VTVATVKALNYL-KEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLV  143 (187)
Q Consensus        96 ~~~~~~~~l~~l-h~~~~i~Hrdlk~~nili~~~~~~ki~dfg~a~~~~  143 (187)
                      +..+++.++..+ |+. +++|+||++.||++. ++.+.++|||.+....
T Consensus       129 i~~~i~~~l~~l~H~~-glVHGDLs~~NIL~~-~~~v~iIDF~qav~~~  175 (197)
T cd05146         129 AYYQVLSMMKQLYKEC-NLVHADLSEYNMLWH-DGKVWFIDVSQSVEPT  175 (197)
T ss_pred             HHHHHHHHHHHHHHhC-CeecCCCCHHHEEEE-CCcEEEEECCCceeCC
Confidence            456778888887 776 999999999999997 4789999999876543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown.

>KOG2137|consensus

Probab=98.59  E-value=5.9e-08  Score=79.99  Aligned_cols=85  Identities=18%  Similarity=0.299  Sum_probs=68.2

Q ss_pred             HHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEeccccccccccccc----------cCCCCCcCccCccccCCCcc
Q psy14630         99 ATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAK----------TRDAGCRPYMAPERIDPLRA  168 (187)
Q Consensus        99 ~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg~a~~~~~~~~~----------~~~~~t~~y~aPE~~~~~~~  168 (187)
                      +.+.|+.|+|+.-+++|+++.|+++.++..+..||+.|+.+.........          ........|.|||.+.   +
T Consensus       107 ~v~dgl~flh~sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~---~  183 (700)
T KOG2137|consen  107 NVADGLAFLHRSAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLL---G  183 (700)
T ss_pred             cccchhhhhccCcceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhc---c
Confidence            34589999999889999999999999999999999999988776542111          0112345699999999   5


Q ss_pred             CCCCCCcceeeeEe-eeeC
Q psy14630        169 RGYPSFKTKLGFKF-NYRI  186 (187)
Q Consensus       169 ~~~~~~~D~ws~gi-~~~~  186 (187)
                      ..-+.++|++|+|+ +|||
T Consensus       184 ~~~~~~sd~fSlG~li~~i  202 (700)
T KOG2137|consen  184 TTNTPASDVFSLGVLIYTI  202 (700)
T ss_pred             ccccccccceeeeeEEEEE
Confidence            66779999999999 8886

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=98.20  E-value=2.5e-07  Score=78.55  Aligned_cols=67  Identities=12%  Similarity=0.097  Sum_probs=49.3

Q ss_pred             eeecCCCC-CeEEcCCCCEEEEeccccccccccc---cccCCCCCcCccCccccCCCccCCCCCCcceeeeEee
Q psy14630        114 IHRDVKPS-NILLDRRGAIKLCDFGISGQLVDSI---AKTRDAGCRPYMAPERIDPLRARGYPSFKTKLGFKFN  183 (187)
Q Consensus       114 ~Hrdlk~~-nili~~~~~~ki~dfg~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi~  183 (187)
                      .+++..|. |+++...+..++.|||.++......   ......||+.|+|||++.   ...++.++|+||||++
T Consensus       499 ~~~~~~p~~~~~~~p~~~~~~~~~~~~~~~~~g~~~~~~~~~vGT~~Y~APE~l~---~~~~~~~~DiwSlG~i  569 (669)
T cd05610         499 PTQKPRPHGNLYQTPKQVKIGTPYRTPKSVRRGAAPVEGERILGTPDYLAPELLL---GKPHGPAVDWWALGVC  569 (669)
T ss_pred             CCCCCCCCCceeECCccccccccCCCchhhhcccccccCCceeeCccccCHHHcC---CCCCCcHHHHHHHHHH
Confidence            34555555 5666777777889999887754322   123347899999999998   5668999999999994

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>KOG0606|consensus

Probab=98.13  E-value=4.2e-07  Score=78.23  Aligned_cols=162  Identities=19%  Similarity=0.197  Sum_probs=101.9

Q ss_pred             ccCCcccccccccccccCceEEEEEEEcCCCcEEEEEEccCccC-hHHHHHHHHHHHHHHhcCCCCchhhhhhh------
Q psy14630         19 YDFTSEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVD-EKDQRQLLMDLDVVMKSNECPYIVQFYGA------   91 (187)
Q Consensus        19 ~~~~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~~~~~~~~~~h~~iv~~~~~------   91 (187)
                      +....+++.+.+-+-.|.++.++.+.-..++...++|....... .....+-......+.....+|.+++.+-.      
T Consensus       799 yrsS~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP  878 (1205)
T KOG0606|consen  799 YRSSPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSP  878 (1205)
T ss_pred             ccCCCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCC
Confidence            56677888888889999999999887666665556665432100 00000001111111111233444432211      


Q ss_pred             ------------HHH--------------HHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEecccccccc--
Q psy14630         92 ------------LFK--------------EVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLV--  143 (187)
Q Consensus        92 ------------~~~--------------~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg~a~~~~--  143 (187)
                                  +..              .....++.+.++||.. .+.|||++|.|.++...+..++.+||+.....  
T Consensus       879 ~~L~~~~~~~~~~~Skl~~~~~~saepaRs~i~~~vqs~e~L~s~-~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~~  957 (1205)
T KOG0606|consen  879 LPLVGHYLNGGDLPSKLHNSGCLSAEPARSPILERVQSLESLHSS-LRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGLI  957 (1205)
T ss_pred             cchhhHHhccCCchhhhhcCCCcccccccchhHHHHhhhhccccc-hhhcccccccchhhcccCCcccCccccccccccc
Confidence                        111              1344567788999986 68999999999999999999999998433210  


Q ss_pred             ----cc--------------------------ccccCCCCCcCccCccccCCCccCCCCCCcceeeeEeee
Q psy14630        144 ----DS--------------------------IAKTRDAGCRPYMAPERIDPLRARGYPSFKTKLGFKFNY  184 (187)
Q Consensus       144 ----~~--------------------------~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi~~  184 (187)
                          +.                          .......+|+-|.+||...   .......+|+|++|+.+
T Consensus       958 ~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~l---g~~hgs~ad~~~~g~~l 1025 (1205)
T KOG0606|consen  958 PPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILL---GRRHGSAADWWSSGVCL 1025 (1205)
T ss_pred             cCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccc---cccCCCcchhhhhhhhh
Confidence                00                          0112335889999999999   56678899999999854

>PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.12  E-value=0.00012  Score=52.54  Aligned_cols=46  Identities=24%  Similarity=0.372  Sum_probs=33.4

Q ss_pred             HHHHHHHHHHH-HHhcCCCeeecCCCCCeEEcCCCCEEEEecccccccc
Q psy14630         96 VTVATVKALNY-LKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLV  143 (187)
Q Consensus        96 ~~~~~~~~l~~-lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg~a~~~~  143 (187)
                      +..+++..+.. +|.. |++|+|+.+.||+++.. .+.++|||.+....
T Consensus       111 ~~~~il~~~~~~~~~~-givHGDLs~~NIlv~~~-~~~iIDf~qav~~~  157 (188)
T PF01163_consen  111 LLEEILEEIIKMLHKA-GIVHGDLSEYNILVDDG-KVYIIDFGQAVDSS  157 (188)
T ss_dssp             HHHHHHHHHHHHHHCT-TEEESS-STTSEEEETT-CEEE--GTTEEETT
T ss_pred             HHHHHHHHHHHHHHhc-CceecCCChhhEEeecc-eEEEEecCcceecC
Confidence            55566664544 5665 99999999999999877 99999999876643

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A.

>COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

Probab=98.00  E-value=8e-05  Score=52.83  Aligned_cols=41  Identities=29%  Similarity=0.447  Sum_probs=34.4

Q ss_pred             HHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEeccccccc
Q psy14630        100 TVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQL  142 (187)
Q Consensus       100 ~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg~a~~~  142 (187)
                      +-..+.-||.. +|+|+||.++|+++...+ +.++|||++..-
T Consensus       101 vG~~vg~lH~~-givHGDLTtsNiIl~~~~-i~~IDfGLg~~s  141 (204)
T COG3642         101 VGRLVGKLHKA-GIVHGDLTTSNIILSGGR-IYFIDFGLGEFS  141 (204)
T ss_pred             HHHHHHHHHhc-CeecCCCccceEEEeCCc-EEEEECCccccc
Confidence            33456789998 999999999999997654 999999998753

>COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning]

Probab=97.91  E-value=0.00022  Score=52.98  Aligned_cols=47  Identities=21%  Similarity=0.280  Sum_probs=36.7

Q ss_pred             HHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEecccccccc
Q psy14630         96 VTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLV  143 (187)
Q Consensus        96 ~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg~a~~~~  143 (187)
                      ...++++.+.-|-...+++|+||+.=|||+. ++.+.|+|+|-|....
T Consensus       171 ~~~~~v~~~~~l~~~a~LVHgDLSEyNiL~~-~~~p~iID~~QaV~~~  217 (268)
T COG1718         171 LYEDVVEYMRRLYKEAGLVHGDLSEYNILVH-DGEPYIIDVSQAVTID  217 (268)
T ss_pred             HHHHHHHHHHHHHHhcCcccccchhhheEEE-CCeEEEEECccccccC
Confidence            3445666666554434999999999999999 8999999999887654

>KOG3087|consensus

Probab=97.89  E-value=6.1e-05  Score=53.47  Aligned_cols=46  Identities=35%  Similarity=0.494  Sum_probs=36.7

Q ss_pred             HHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCC---CEEEEeccccccc
Q psy14630         96 VTVATVKALNYLKEELKIIHRDVKPSNILLDRRG---AIKLCDFGISGQL  142 (187)
Q Consensus        96 ~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~---~~ki~dfg~a~~~  142 (187)
                      ....+-..+.-||.. +++|+||..+||++.+++   .+.++|||++..-
T Consensus       118 ~~~~iG~~igklH~n-diiHGDLTTSNill~~~~~~~~~~lIdfgls~~s  166 (229)
T KOG3087|consen  118 LARRIGELIGKLHDN-DIIHGDLTTSNILLRSDGNQITPILIDFGLSSVS  166 (229)
T ss_pred             HHHHHHHHHHHhhhC-CeecccccccceEEecCCCcCceEEEeecchhcc
Confidence            334455678889998 999999999999997655   3689999998654

>KOG1266|consensus

Probab=97.87  E-value=1.7e-05  Score=60.89  Aligned_cols=83  Identities=20%  Similarity=0.267  Sum_probs=58.0

Q ss_pred             HHHHHHHHHHHHHhc-CCCeeecCCCCCeEEcCCCCEEEEecccccccccc------ccccCCCCCcCccCccccCCCcc
Q psy14630         96 VTVATVKALNYLKEE-LKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDS------IAKTRDAGCRPYMAPERIDPLRA  168 (187)
Q Consensus        96 ~~~~~~~~l~~lh~~-~~i~Hrdlk~~nili~~~~~~ki~dfg~a~~~~~~------~~~~~~~~t~~y~aPE~~~~~~~  168 (187)
                      +..|++.||.|||.. --++|+++..+.+++..+|-+|+.--. -.....+      ..+....+-+.|.|||.-.   .
T Consensus       181 w~tqIlsal~yLhs~~PpiihgnlTc~tifiq~ngLIkig~~a-p~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~---~  256 (458)
T KOG1266|consen  181 WCTQILSALSYLHSCDPPIIHGNLTCDTIFIQHNGLIKIGSVA-PDSTHPSVNSTREAEKSVNTSLPGFSAPESGT---T  256 (458)
T ss_pred             HHHHHHhhhhhhhccCCccccCCcchhheeecCCceEEecccC-ccccchhhhhhhHhhhhccccCCccccCCcCc---c
Confidence            667899999999986 248999999999999988888864211 1111111      1112234567799999876   4


Q ss_pred             CCCCCCcceeeeEe
Q psy14630        169 RGYPSFKTKLGFKF  182 (187)
Q Consensus       169 ~~~~~~~D~ws~gi  182 (187)
                      ..-+.++|||+||.
T Consensus       257 tn~~~a~dIy~fgm  270 (458)
T KOG1266|consen  257 TNTTGASDIYKFGM  270 (458)
T ss_pred             cccccchhhhhhhH
Confidence            44567899999995

>COG0661 AarF Predicted unusual protein kinase [General function prediction only]

Probab=97.76  E-value=0.00047  Score=56.81  Aligned_cols=33  Identities=45%  Similarity=0.719  Sum_probs=30.7

Q ss_pred             CCeeecCCCCCeEEcCCCCEEEEeccccccccc
Q psy14630        112 KIIHRDVKPSNILLDRRGAIKLCDFGISGQLVD  144 (187)
Q Consensus       112 ~i~Hrdlk~~nili~~~~~~ki~dfg~a~~~~~  144 (187)
                      |+.|.|..|-|+++..+|.+.+.|||+...+.+
T Consensus       285 gffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~  317 (517)
T COG0661         285 GFFHADPHPGNILVRSDGRIVLLDFGIVGRLDP  317 (517)
T ss_pred             CccccCCCccceEEecCCcEEEEcCcceecCCH
Confidence            899999999999999999999999999887654

>KOG0576|consensus

Probab=97.76  E-value=1e-05  Score=66.96  Aligned_cols=138  Identities=18%  Similarity=0.178  Sum_probs=93.2

Q ss_pred             ccccccccCceEEEEEEEcCCCcEEEEEEccCccChHHHHHHHHHHHHHHhcCCCCc-hhhhhhhHHHH-----------
Q psy14630         28 DLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPY-IVQFYGALFKE-----------   95 (187)
Q Consensus        28 ~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~-iv~~~~~~~~~-----------   95 (187)
                      .....+++++++++|.+...+...+ .+.+...       ....-+..++.+.+||| .+..++....+           
T Consensus       246 ~fh~fvK~altknpKkRptaeklL~-h~fvs~~-------l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i~s  317 (829)
T KOG0576|consen  246 FFHNFVKGALTKNPKKRPTAEKLLQ-HPFVSQT-------LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRICS  317 (829)
T ss_pred             HHHHHHHHHhcCCCccCCChhhhee-ceeeccc-------hhhHHHHHHHHHccCCCCcccccccCCcccccchhhhhhc
Confidence            3456788999999998765554443 5665432       11122344667789999 55554322111           


Q ss_pred             -----------------------HHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEeccccccccccccccCCC
Q psy14630         96 -----------------------VTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTRDA  152 (187)
Q Consensus        96 -----------------------~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg~a~~~~~~~~~~~~~  152 (187)
                                             ....-+++++++|+. .-+|||    |++..+ +..+..+|+....+..........
T Consensus       318 ~~rs~~~~~~~se~~~~~~~~~~~~r~et~~l~~l~~~-~~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~~~~t~~  391 (829)
T KOG0576|consen  318 TGRSSALEMTVSEIALEQYQFAYPLRKETRPLAELHSS-YKVHRD----NILGSE-EEVKLLDFAVPPQLTRTMKPRTAI  391 (829)
T ss_pred             CCccccccCChhhHhhhhhhhhhhhhhhcccccccccc-cccCcc----cccccc-cccccccccCCcccCcccccccCC
Confidence                                   111223456777765 457887    665544 678999999998887766566678


Q ss_pred             CCcCccCccccCCCccCCCCCCcceeeeEe
Q psy14630        153 GCRPYMAPERIDPLRARGYPSFKTKLGFKF  182 (187)
Q Consensus       153 ~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi  182 (187)
                      +++.++|||++.   ...++...|.|+.++
T Consensus       392 ~~~~~~~pev~~---~~~~~~~p~~~~~~~  418 (829)
T KOG0576|consen  392 GTPEPLAPEVIQ---ENTIDGCPDSGSLAV  418 (829)
T ss_pred             CCCCCCCchhhc---ccccccCCCccCCCc
Confidence            999999999998   777899999999986

>PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=97.71  E-value=7.6e-05  Score=54.35  Aligned_cols=48  Identities=29%  Similarity=0.353  Sum_probs=41.1

Q ss_pred             HHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCC---CEEEEecccccccc
Q psy14630         95 EVTVATVKALNYLKEELKIIHRDVKPSNILLDRRG---AIKLCDFGISGQLV  143 (187)
Q Consensus        95 ~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~---~~ki~dfg~a~~~~  143 (187)
                      .+..++...+.-||+. |++|+|+++.|||++...   .+.++||+.++...
T Consensus       122 ~ll~~l~~~i~~lH~~-gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~~  172 (206)
T PF06293_consen  122 ELLRALARLIAKLHDA-GIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFRP  172 (206)
T ss_pred             HHHHHHHHHHHHHHHC-cCCCCCCCcccEEEeCCCCceeEEEEcchhceeCC
Confidence            3666777888999998 999999999999999887   79999999877643

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane

>cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins

Probab=97.67  E-value=0.00022  Score=51.86  Aligned_cols=30  Identities=17%  Similarity=0.407  Sum_probs=25.9

Q ss_pred             CCeeecCCCCCeEEcC--CCCEEEEecccccc
Q psy14630        112 KIIHRDVKPSNILLDR--RGAIKLCDFGISGQ  141 (187)
Q Consensus       112 ~i~Hrdlk~~nili~~--~~~~ki~dfg~a~~  141 (187)
                      .++|+|+.+.|++++.  .+.+.++||+.+..
T Consensus       175 ~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~  206 (223)
T cd05154         175 GLVHGDYRLGNVLFHPDEPRVVAVLDWELATL  206 (223)
T ss_pred             EEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence            3799999999999998  56689999998764

This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain

>PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional

Probab=97.60  E-value=0.0001  Score=55.78  Aligned_cols=45  Identities=16%  Similarity=0.150  Sum_probs=38.2

Q ss_pred             HHHHHHHHHHHHHhcCCCeeecCCCCCeEEcC-------CCCEEEEecccccc
Q psy14630         96 VTVATVKALNYLKEELKIIHRDVKPSNILLDR-------RGAIKLCDFGISGQ  141 (187)
Q Consensus        96 ~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~-------~~~~ki~dfg~a~~  141 (187)
                      +..+++..+.-||.. |++|+|+++.||+++.       ...+.++||+.++.
T Consensus       143 ll~~la~~i~~LH~~-Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r~~~  194 (268)
T PRK15123        143 LIKRVATMVRDMHAA-GINHRDCYICHFLLHLPFPGREEDLKLSVIDLHRAQI  194 (268)
T ss_pred             HHHHHHHHHHHHHHC-cCccCCCChhhEEEeccccCCCCCceEEEEECCcccc
Confidence            455677888899998 9999999999999975       46789999998854

>COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only]

Probab=97.54  E-value=0.00048  Score=54.95  Aligned_cols=87  Identities=15%  Similarity=0.126  Sum_probs=65.5

Q ss_pred             HHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEeccccccccccccccCCCCCcCccCccccCCC--ccCCCCC
Q psy14630         96 VTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPL--RARGYPS  173 (187)
Q Consensus        96 ~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~--~~~~~~~  173 (187)
                      +...++.+.+-||+. |-+-+|++++|+|+.+.+.+.+.|-..-..-.+.......+|...|++||.-.-.  .+.+.+.
T Consensus       122 vaRnlA~aFA~lH~~-Gh~vGDVn~~~~lVsd~~~V~LVdsDsfqi~~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~  200 (637)
T COG4248         122 VARNLASAFATLHEH-GHVVGDVNQNSFLVSDDSKVVLVDSDSFQINANGTLHLCPVGVSEFTPPELQTLPSFVGFERTA  200 (637)
T ss_pred             HHHHHHHHHHHHHhc-CCcccccCccceeeecCceEEEEcccceeeccCCceEecccCccccCCHHHhccccccccCCCc
Confidence            556678888899998 9899999999999999999999886544443334344445788999999985411  1334667


Q ss_pred             CcceeeeEee
Q psy14630        174 FKTKLGFKFN  183 (187)
Q Consensus       174 ~~D~ws~gi~  183 (187)
                      ..|.|++||.
T Consensus       201 ~hD~FGLavL  210 (637)
T COG4248         201 NHDNFGLAVL  210 (637)
T ss_pred             cccchhHHHH
Confidence            8999999884

>KOG3741|consensus

Probab=97.49  E-value=0.00053  Score=55.85  Aligned_cols=105  Identities=16%  Similarity=0.140  Sum_probs=75.1

Q ss_pred             CceEEEEEEEcCCCcEEEEEEccCccChHHHHHHHHHHHHHHhcCCCCchhhhhhhHHH---------------------
Q psy14630         36 GFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQFYGALFK---------------------   94 (187)
Q Consensus        36 ~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~---------------------   94 (187)
                      --.+.|+++...+|..|+.|.+......  ............+.+.|+|+|.+-+.+..                     
T Consensus       288 ~~~Ttyk~~s~~DG~~YvLkRlhg~r~~--~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL  365 (655)
T KOG3741|consen  288 FSITTYKATSNVDGNAYVLKRLHGDRDQ--STNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTL  365 (655)
T ss_pred             ccceeEeeeeccCCceeeeeeecccccc--CcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchH
Confidence            3346799999999999999998422111  11111223445677889999988655431                     


Q ss_pred             -------------------------------HHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEecccccccc
Q psy14630         95 -------------------------------EVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLV  143 (187)
Q Consensus        95 -------------------------------~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg~a~~~~  143 (187)
                                                     .++.|+..||.++|+. |+.=+-|.+.+|+++.+-+++|+.-|..-.+.
T Consensus       366 ~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHss-GLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~  444 (655)
T KOG3741|consen  366 YDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSS-GLACKTLDLKKILVTGKMRIRISGCGIMDVLQ  444 (655)
T ss_pred             HHHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhc-CceeecccHhHeEeeCcceEEEecccceeeec
Confidence                                           1678999999999998 99889999999999877778877666554443

>COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms]

Probab=97.33  E-value=0.0028  Score=44.85  Aligned_cols=110  Identities=18%  Similarity=0.184  Sum_probs=63.5

Q ss_pred             ccccccccccCceEEEEEEEcCCCcEEEEEEccCccChHHHHHHHHHHHHHHhcCCCCchhh---hhh------------
Q psy14630         26 LQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQ---FYG------------   90 (187)
Q Consensus        26 ~~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~---~~~------------   90 (187)
                      .+..+.|++|.+|.||+|...  +..+|+|+-+....    +..+..+..++..+.-.++..   +|+            
T Consensus        24 ~~v~~~L~KG~~s~Vyl~~~~--~~~~a~Kvrr~ds~----r~~l~kEakiLeil~g~~~~p~vy~yg~~~i~me~i~G~   97 (201)
T COG2112          24 LRVEKELAKGTTSVVYLGEWR--GGEVALKVRRRDSP----RRNLEKEAKILEILAGEGVTPEVYFYGEDFIRMEYIDGR   97 (201)
T ss_pred             hhhhhhhhcccccEEEEeecc--CceEEEEEecCCcc----hhhHHHHHHHHHHhhhcCCCceEEEechhhhhhhhhcCc
Confidence            455688999999999999864  56889998653222    222333333333222222211   111            


Q ss_pred             ----hHH---HHHHHHHHHHHHHHHhcCCCeeecCCC-CCeEEcCCCCEEEEeccccccc
Q psy14630         91 ----ALF---KEVTVATVKALNYLKEELKIIHRDVKP-SNILLDRRGAIKLCDFGISGQL  142 (187)
Q Consensus        91 ----~~~---~~~~~~~~~~l~~lh~~~~i~Hrdlk~-~nili~~~~~~ki~dfg~a~~~  142 (187)
                          ...   .+-...+++. +|.-..+||-|.+++- ...++..++.+.|+||..|+..
T Consensus        98 ~L~~~~~~~~rk~l~~vlE~-a~~LD~~GI~H~El~~~~k~vlv~~~~~~iIDFd~At~k  156 (201)
T COG2112          98 PLGKLEIGGDRKHLLRVLEK-AYKLDRLGIEHGELSRPWKNVLVNDRDVYIIDFDSATFK  156 (201)
T ss_pred             chhhhhhcccHHHHHHHHHH-HHHHHHhccchhhhcCCceeEEecCCcEEEEEccchhhc
Confidence                000   1122233343 4444556999999874 5555666669999999988843

>COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms]

Probab=97.31  E-value=0.0064  Score=45.96  Aligned_cols=44  Identities=20%  Similarity=0.267  Sum_probs=33.2

Q ss_pred             HHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEecccccc
Q psy14630         97 TVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQ  141 (187)
Q Consensus        97 ~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg~a~~  141 (187)
                      ...+++-+.-.-+. |++|+|+++=||+++++|.+.++||--+..
T Consensus       208 l~~il~~~~~~~~~-GiVHGDlSefNIlV~~dg~~~vIDwPQ~v~  251 (304)
T COG0478         208 LDKILEEVRKAYRR-GIVHGDLSEFNILVTEDGDIVVIDWPQAVP  251 (304)
T ss_pred             HHHHHHHHHHHHHc-CccccCCchheEEEecCCCEEEEeCccccc
Confidence            33344433333354 999999999999999999999999976654

>PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2

Probab=97.12  E-value=0.0075  Score=43.71  Aligned_cols=35  Identities=26%  Similarity=0.346  Sum_probs=29.7

Q ss_pred             cCCcccccccccccccCc-eEEEEEEEcCCCcEEEEEE
Q psy14630         20 DFTSEDLQDLGEIGRGGF-GTVNKMIHRSSDTVMAVKR   56 (187)
Q Consensus        20 ~~~~~~~~~~~~lg~G~f-g~V~~~~~~~~~~~vaiK~   56 (187)
                      .....+++.++.||.|.- |.||++...  |+.+|+|.
T Consensus        33 ~~h~~~I~flefLg~g~~~~~V~kv~I~--g~~YALKl   68 (207)
T PF13095_consen   33 THHGDDIEFLEFLGHGSHDGYVFKVEID--GRIYALKL   68 (207)
T ss_pred             CCCCCcEeeeeecCCCCceeEEEEEEEC--CeEEEEEE
Confidence            334478899999999999 999999874  67999999

>KOG1235|consensus

Probab=97.05  E-value=0.018  Score=47.80  Aligned_cols=33  Identities=30%  Similarity=0.478  Sum_probs=28.8

Q ss_pred             CCeeecCCCCCeEEcC----CCCEEEEeccccccccc
Q psy14630        112 KIIHRDVKPSNILLDR----RGAIKLCDFGISGQLVD  144 (187)
Q Consensus       112 ~i~Hrdlk~~nili~~----~~~~ki~dfg~a~~~~~  144 (187)
                      |++|.|-.|-||++..    ++.+.+.|||+...+.+
T Consensus       321 GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~  357 (538)
T KOG1235|consen  321 GFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISH  357 (538)
T ss_pred             CCccCCCCCCcEEEecCCCCCccEEEEcccccccccH
Confidence            8999999999999984    66799999999887653

>PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY)

Probab=96.88  E-value=0.0025  Score=46.76  Aligned_cols=44  Identities=23%  Similarity=0.351  Sum_probs=36.4

Q ss_pred             HHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEecccccc
Q psy14630         96 VTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQ  141 (187)
Q Consensus        96 ~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg~a~~  141 (187)
                      +...+.+++.-+|.. |+.|+|..|.|+++.. +.++++||+..+.
T Consensus       140 ~~~ki~~~ikqlH~~-G~~HGD~hpgNFlv~~-~~i~iID~~~k~~  183 (229)
T PF06176_consen  140 LAEKIVEAIKQLHKH-GFYHGDPHPGNFLVSN-NGIRIIDTQGKRM  183 (229)
T ss_pred             HHHHHHHHHHHHHHc-CCccCCCCcCcEEEEC-CcEEEEECccccc
Confidence            335577888999997 9999999999999985 4599999986543

The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process

>PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP

Probab=96.79  E-value=0.013  Score=42.42  Aligned_cols=38  Identities=34%  Similarity=0.589  Sum_probs=27.5

Q ss_pred             HHHHHHhcCCCeeecCCCCCeEEcCCC----CEEEEe-cccccc
Q psy14630        103 ALNYLKEELKIIHRDVKPSNILLDRRG----AIKLCD-FGISGQ  141 (187)
Q Consensus       103 ~l~~lh~~~~i~Hrdlk~~nili~~~~----~~ki~d-fg~a~~  141 (187)
                      ...||-+. .|+.+|++|.||++....    .+.++| ||....
T Consensus       130 f~~~l~~~-~Iv~~dl~~~NIv~~~~~~~~~~lvlIDG~G~~~~  172 (199)
T PF10707_consen  130 FKRYLLDH-HIVIRDLNPHNIVVQRRDSGEFRLVLIDGLGEKEL  172 (199)
T ss_pred             HHHHHHHc-CCeecCCCcccEEEEecCCCceEEEEEeCCCCccc
Confidence            34677676 899999999999996432    477777 665443

PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner [].

>PRK09902 hypothetical protein; Provisional

Probab=96.69  E-value=0.0032  Score=45.91  Aligned_cols=47  Identities=15%  Similarity=0.107  Sum_probs=40.0

Q ss_pred             HHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCC--EEEEeccccccc
Q psy14630         95 EVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGA--IKLCDFGISGQL  142 (187)
Q Consensus        95 ~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~--~ki~dfg~a~~~  142 (187)
                      .+...+...+.-||.. |+.|+|+.+.||+++..+.  ++++||.-++..
T Consensus       132 ~il~~va~~ia~LH~~-Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r~~  180 (216)
T PRK09902        132 AMLKAVALAFKKMHSV-NRQHGCCYVRHIYVKTEGKAEAGFLDLEKSRRR  180 (216)
T ss_pred             HHHHHHHHHHHHHHHC-CCcCCCCCHhheeecCCCCeeEEEEEhhccchh
Confidence            3566778889999998 9999999999999986677  999999877654

>PF03109 ABC1: ABC1 family; InterPro: IPR004147 This entry includes ABC1 from yeast [] and AarF from Escherichia coli []

Probab=94.39  E-value=0.097  Score=34.59  Aligned_cols=31  Identities=16%  Similarity=0.176  Sum_probs=25.9

Q ss_pred             cccccccCceEEEEEEEcCCCcEEEEEEccCc
Q psy14630         29 LGEIGRGGFGTVNKMIHRSSDTVMAVKRIRST   60 (187)
Q Consensus        29 ~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~   60 (187)
                      ..-|+.|+.|+||+|... +|+.||||+.+..
T Consensus        16 ~~PlasASiaQVh~a~l~-~g~~VaVKV~rP~   46 (119)
T PF03109_consen   16 PEPLASASIAQVHRARLK-DGEEVAVKVQRPG   46 (119)
T ss_pred             cchhhheehhhheeeeec-ccchhhhhhcchH
Confidence            367999999999999874 4899999997653

These proteins have a nuclear or mitochondrial subcellular location in eukaryotes. The exact molecular functions of these proteins is not clear, however yeast ABC1 suppresses a cytochrome b mRNA translation defect and is essential for the electron transfer in the bc 1 complex [] and E. coli AarF is required for ubiquinone production []. It has been suggested that members of the ABC1 family are novel chaperonins []. These proteins are unrelated to the ABC transporter proteins.

>KOG2268|consensus

Probab=94.16  E-value=0.35  Score=38.09  Aligned_cols=37  Identities=24%  Similarity=0.320  Sum_probs=30.7

Q ss_pred             HHHHHhcCCCeeecCCCCCeEEcCCCCEEEEecccccc
Q psy14630        104 LNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQ  141 (187)
Q Consensus       104 l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg~a~~  141 (187)
                      +--|... |++|+|.+-=||+++.++.++++||--.-.
T Consensus       215 Iv~la~~-GlIHgDFNEFNimv~dd~~i~vIDFPQmvS  251 (465)
T KOG2268|consen  215 IVRLANH-GLIHGDFNEFNIMVKDDDKIVVIDFPQMVS  251 (465)
T ss_pred             HHHHHHc-CceecccchheeEEecCCCEEEeechHhhc
Confidence            3445565 999999999999999999999999975443

>PRK05231 homoserine kinase; Provisional

Probab=94.10  E-value=0.041  Score=42.63  Aligned_cols=30  Identities=23%  Similarity=0.366  Sum_probs=25.8

Q ss_pred             CCeeecCCCCCeEEcCCCCEEEEecccccc
Q psy14630        112 KIIHRDVKPSNILLDRRGAIKLCDFGISGQ  141 (187)
Q Consensus       112 ~i~Hrdlk~~nili~~~~~~ki~dfg~a~~  141 (187)
                      +++|+|+.+.|++++.+...-++||+.+..
T Consensus       188 ~liHgD~~~~Nil~~~~~~~~iIDf~~~~~  217 (319)
T PRK05231        188 GVIHADLFRDNVLFEGDRLSGFIDFYFACN  217 (319)
T ss_pred             ccCCCCCCCCcEEEECCceEEEEecccccC
Confidence            799999999999998665568999997754

>PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length

Probab=94.09  E-value=0.054  Score=40.09  Aligned_cols=38  Identities=34%  Similarity=0.489  Sum_probs=31.7

Q ss_pred             HHHHHHHH-hcCCCeeecCCCCCeEEcCCCCEEEEeccc
Q psy14630        101 VKALNYLK-EELKIIHRDVKPSNILLDRRGAIKLCDFGI  138 (187)
Q Consensus       101 ~~~l~~lh-~~~~i~Hrdlk~~nili~~~~~~ki~dfg~  138 (187)
                      +..|.-.| +..+.+|+|..|+||+-+..|.+|+.|=+.
T Consensus       151 i~~L~~fH~~~~~~lHGD~np~NiM~D~~G~lKlVDP~~  189 (308)
T PF07387_consen  151 IKDLMDFHSENQHCLHGDCNPDNIMCDKFGYLKLVDPVC  189 (308)
T ss_pred             HHHHHHhhccCCCeecCCCChhheeecCCCCEEecChhh
Confidence            45567788 344799999999999999999999999764

The function of this family is unknown.

>cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes

Probab=94.05  E-value=0.05  Score=41.80  Aligned_cols=31  Identities=29%  Similarity=0.357  Sum_probs=27.2

Q ss_pred             CCeeecCCCCCeEEcCC----CCEEEEeccccccc
Q psy14630        112 KIIHRDVKPSNILLDRR----GAIKLCDFGISGQL  142 (187)
Q Consensus       112 ~i~Hrdlk~~nili~~~----~~~ki~dfg~a~~~  142 (187)
                      .++|+|+.+.||+++.+    +.+.++||..|..-
T Consensus       180 ~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~~~  214 (302)
T cd05156         180 VFCHNDLQEGNILLLNPSSETKKLVLIDFEYASYN  214 (302)
T ss_pred             eEEecCCCcCeEEecCCCCCCCcEEEEeeCCCCCC
Confidence            57999999999999875    78999999988753

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer

>cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes

Probab=93.91  E-value=0.055  Score=39.85  Aligned_cols=30  Identities=23%  Similarity=0.541  Sum_probs=26.6

Q ss_pred             CCeeecCCCCCeEEcC-CCCEEEEecccccc
Q psy14630        112 KIIHRDVKPSNILLDR-RGAIKLCDFGISGQ  141 (187)
Q Consensus       112 ~i~Hrdlk~~nili~~-~~~~ki~dfg~a~~  141 (187)
                      .++|+|+.+.||+++. ++.+.++||..|..
T Consensus       171 ~l~H~Dl~~~Nil~~~~~~~~~lIDwe~a~~  201 (235)
T cd05157         171 VFCHNDLLSGNIIYNEEKNSVKFIDYEYAGY  201 (235)
T ss_pred             EEEcCCCCcCcEEEeCCCCCEEEEEcccCCc
Confidence            5899999999999997 57899999987765

ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo

>cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members

Probab=93.89  E-value=0.055  Score=40.02  Aligned_cols=31  Identities=29%  Similarity=0.439  Sum_probs=26.0

Q ss_pred             CCeeecCCCCCeEEcCCCCEEEEeccccccc
Q psy14630        112 KIIHRDVKPSNILLDRRGAIKLCDFGISGQL  142 (187)
Q Consensus       112 ~i~Hrdlk~~nili~~~~~~ki~dfg~a~~~  142 (187)
                      .++|+|+.+.|++++..+..-|+||+.+..-
T Consensus       165 ~l~HGD~~~~Nvlv~~~~i~giIDw~~a~~g  195 (235)
T cd05155         165 VWFHGDLAPGNLLVQDGRLSAVIDFGCLGVG  195 (235)
T ss_pred             eEEeCCCCCCcEEEECCCEEEEEeCcccCcC
Confidence            4899999999999987655679999987653

The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista

>TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172

Probab=93.75  E-value=0.059  Score=39.84  Aligned_cols=29  Identities=24%  Similarity=0.402  Sum_probs=25.8

Q ss_pred             CCeeecCCCCCeEEcCCCCEEEEecccccc
Q psy14630        112 KIIHRDVKPSNILLDRRGAIKLCDFGISGQ  141 (187)
Q Consensus       112 ~i~Hrdlk~~nili~~~~~~ki~dfg~a~~  141 (187)
                      .++|+|+.|.|++++..+ +.++||+.+..
T Consensus       154 ~~~HgD~~~~Nii~~~~~-~~iIDwe~a~~  182 (226)
T TIGR02172       154 TCLHGDFQIGNLITSGKG-TYWIDLGDFGY  182 (226)
T ss_pred             ceEecCCCCCcEEEcCCC-cEEEechhcCc
Confidence            468999999999999887 99999998764

This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636.

>PRK10271 thiK thiamine kinase; Provisional

Probab=93.67  E-value=0.068  Score=38.30  Aligned_cols=29  Identities=28%  Similarity=0.531  Sum_probs=25.5

Q ss_pred             CeeecCCCCCeEEcCCCCEEEEeccccccc
Q psy14630        113 IIHRDVKPSNILLDRRGAIKLCDFGISGQL  142 (187)
Q Consensus       113 i~Hrdlk~~nili~~~~~~ki~dfg~a~~~  142 (187)
                      .+|+|+.|.|+++..++ ++++||+.+..-
T Consensus        79 p~H~D~~~~N~~~~~~~-~~lIDwe~a~~g  107 (188)
T PRK10271         79 PLHMDVHAGNLVHSASG-LRLIDWEYAGDG  107 (188)
T ss_pred             eecCCCCCccEEEECCC-EEEEeCCcccCC
Confidence            58999999999998777 999999988754

>cd05150 APH Aminoglycoside 3'-phosphotransferase (APH)

Probab=93.59  E-value=0.063  Score=39.84  Aligned_cols=31  Identities=26%  Similarity=0.307  Sum_probs=27.0

Q ss_pred             CCeeecCCCCCeEEcCCCCEEEEeccccccc
Q psy14630        112 KIIHRDVKPSNILLDRRGAIKLCDFGISGQL  142 (187)
Q Consensus       112 ~i~Hrdlk~~nili~~~~~~ki~dfg~a~~~  142 (187)
                      .++|+|+.|.|++++..+...|+||+.+..-
T Consensus       164 ~l~HgD~~~~Nil~~~~~~~~iIDwe~a~~g  194 (244)
T cd05150         164 VVTHGDACLPNIIVDPGKFSGFIDLGRLGVA  194 (244)
T ss_pred             EEECCCCCCccEEEeCCcEEEEEEccccccc
Confidence            4899999999999998777889999988653

The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio

>TIGR00938 thrB_alt homoserine kinase, Neisseria type

Probab=93.39  E-value=0.066  Score=41.34  Aligned_cols=31  Identities=29%  Similarity=0.459  Sum_probs=27.1

Q ss_pred             CCCeeecCCCCCeEEcCCCCEEEEecccccc
Q psy14630        111 LKIIHRDVKPSNILLDRRGAIKLCDFGISGQ  141 (187)
Q Consensus       111 ~~i~Hrdlk~~nili~~~~~~ki~dfg~a~~  141 (187)
                      .+++|+|+.+.|++++.++.+.++||+.+..
T Consensus       187 ~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~~  217 (307)
T TIGR00938       187 RGVIHADLFPDNVLFDGDSVKGVIDFYFACT  217 (307)
T ss_pred             CccCCCCCCcCcEEEECCceEEEeecccccC
Confidence            3799999999999999887778999998754

Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase.

>cd05153 HomoserineK_II Homoserine Kinase, type II

Probab=93.34  E-value=0.063  Score=41.05  Aligned_cols=30  Identities=27%  Similarity=0.380  Sum_probs=26.6

Q ss_pred             CCeeecCCCCCeEEcCCCCEEEEecccccc
Q psy14630        112 KIIHRDVKPSNILLDRRGAIKLCDFGISGQ  141 (187)
Q Consensus       112 ~i~Hrdlk~~nili~~~~~~ki~dfg~a~~  141 (187)
                      +++|+|+.|.|++++..+.+.|+||+.+..
T Consensus       176 ~l~HgD~~~~Nil~~~~~~~~iIDfe~a~~  205 (296)
T cd05153         176 GVIHADLFRDNVLFDGDELSGVIDFYFACT  205 (296)
T ss_pred             cCCccCcCcccEEEeCCceEEEeehhhhcC
Confidence            689999999999999877788999987654

Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine.

>TIGR02721 ycfN_thiK thiamine kinase

Probab=93.27  E-value=0.072  Score=39.92  Aligned_cols=30  Identities=27%  Similarity=0.471  Sum_probs=26.0

Q ss_pred             CCeeecCCCCCeEEcCCCCEEEEeccccccc
Q psy14630        112 KIIHRDVKPSNILLDRRGAIKLCDFGISGQL  142 (187)
Q Consensus       112 ~i~Hrdlk~~nili~~~~~~ki~dfg~a~~~  142 (187)
                      .++|+|+.|.|++++.++ +.++||..+..-
T Consensus       147 ~l~H~Dl~~~Nil~~~~~-~~lIDwE~a~~g  176 (256)
T TIGR02721       147 APLHMDVHAYNLVVTPQG-LKLIDWEYASDG  176 (256)
T ss_pred             eeecCCCCcCcEEEeCCC-CEEEeccccCcC
Confidence            479999999999998876 789999987653

Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function.

>PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily

Probab=93.27  E-value=0.041  Score=40.07  Aligned_cols=30  Identities=43%  Similarity=0.730  Sum_probs=21.1

Q ss_pred             CCeeecCCCCCeEEc-CCCCEEEEecccccc
Q psy14630        112 KIIHRDVKPSNILLD-RRGAIKLCDFGISGQ  141 (187)
Q Consensus       112 ~i~Hrdlk~~nili~-~~~~~ki~dfg~a~~  141 (187)
                      .++|+|+.+.|++++ .++.+.++||+.+..
T Consensus       167 ~~~HgD~~~~Nil~~~~~~~i~iID~e~a~~  197 (239)
T PF01636_consen  167 VLIHGDLHPGNILVDPSDGRIGIIDFEDAGW  197 (239)
T ss_dssp             EEE-SS-SGGGEEEESSTTEEEE--GTT-EE
T ss_pred             EEEEeccccccceeeeccceeEEEecccceE
Confidence            589999999999999 566678999988755

; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B ....

>PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2

Probab=93.15  E-value=0.054  Score=39.39  Aligned_cols=30  Identities=40%  Similarity=0.789  Sum_probs=21.5

Q ss_pred             CCeeecCCCCCeEE-cCCCCEEEEecccccc
Q psy14630        112 KIIHRDVKPSNILL-DRRGAIKLCDFGISGQ  141 (187)
Q Consensus       112 ~i~Hrdlk~~nili-~~~~~~ki~dfg~a~~  141 (187)
                      .++|+|+.+.||++ ..++.++++||..|..
T Consensus       144 v~cHnDl~~~Nil~~~~~~~~~lIDfEya~~  174 (211)
T PF01633_consen  144 VFCHNDLNPGNILINNKDGEVKLIDFEYAGY  174 (211)
T ss_dssp             EEE-S--SGGGEEETSSSSCEEE--GTT-EE
T ss_pred             eEeeccCccccEEeccCCCeEEEecHHHHhh
Confidence            47999999999999 8889999999998765

7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B ....

>COG0510 ycfN Thiamine kinase and related kinases [Coenzyme transport and metabolism]

Probab=92.67  E-value=0.11  Score=39.41  Aligned_cols=30  Identities=33%  Similarity=0.618  Sum_probs=27.3

Q ss_pred             CCeeecCCCCCeEEcCCCCEEEEecccccc
Q psy14630        112 KIIHRDVKPSNILLDRRGAIKLCDFGISGQ  141 (187)
Q Consensus       112 ~i~Hrdlk~~nili~~~~~~ki~dfg~a~~  141 (187)
                      -++|.|+.|.|++.+.++.++++||.-|..
T Consensus       154 v~cH~Dl~~~N~l~t~~~~l~LIDWEyAg~  183 (269)
T COG0510         154 VPCHNDLNPGNLLLTDKGGLFLIDWEYAGL  183 (269)
T ss_pred             eeecCCCCccceEEcCCCcEEEEecccCCC
Confidence            489999999999999999999999987754

>KOG2270|consensus

Probab=92.57  E-value=0.84  Score=36.63  Aligned_cols=44  Identities=20%  Similarity=0.353  Sum_probs=33.0

Q ss_pred             HHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEeccccc
Q psy14630         96 VTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISG  140 (187)
Q Consensus        96 ~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg~a~  140 (187)
                      .-.+++.-+.-|-+.+++||.||.==|+|+. +|.+.|+|-+-+.
T Consensus       269 ~Y~~~v~~MR~lY~~c~LVHADLSEfN~Lyh-dG~lyiIDVSQSV  312 (520)
T KOG2270|consen  269 LYQQCVRIMRRLYQKCRLVHADLSEFNLLYH-DGKLYIIDVSQSV  312 (520)
T ss_pred             HHHHHHHHHHHHHHHhceeccchhhhhheEE-CCEEEEEEccccc
Confidence            3345565566665666999999999998875 6889999987554

>TIGR02906 spore_CotS spore coat protein, CotS family

Probab=92.05  E-value=0.14  Score=39.46  Aligned_cols=30  Identities=27%  Similarity=0.338  Sum_probs=25.6

Q ss_pred             CCCeeecCCCCCeEEcCCCCEEEEecccccc
Q psy14630        111 LKIIHRDVKPSNILLDRRGAIKLCDFGISGQ  141 (187)
Q Consensus       111 ~~i~Hrdlk~~nili~~~~~~ki~dfg~a~~  141 (187)
                      .+++|+|+.+.|++++. +.+.++||+.+..
T Consensus       187 ~~liHgD~~~~Nil~~~-~~i~lIDfd~~~~  216 (313)
T TIGR02906       187 RGFCHQDYAYHNILLKD-NEVYVIDFDYCTI  216 (313)
T ss_pred             CceEcCCCCcccEEEeC-CcEEEEECccccc
Confidence            37899999999999987 6789999996543

Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers.

>smart00587 CHK ZnF_C4 abd HLH domain containing kinases domain

Probab=91.63  E-value=0.18  Score=36.36  Aligned_cols=32  Identities=25%  Similarity=0.325  Sum_probs=26.4

Q ss_pred             CCeeecCCCCCeEEcCCC-----CEEEEecccccccc
Q psy14630        112 KIIHRDVKPSNILLDRRG-----AIKLCDFGISGQLV  143 (187)
Q Consensus       112 ~i~Hrdlk~~nili~~~~-----~~ki~dfg~a~~~~  143 (187)
                      .++|+|+.+.|+++..++     .+.++||..++.-.
T Consensus       121 vl~HgD~~~~N~~~~~~~~~~~~~~~liDfq~~~~g~  157 (196)
T smart00587      121 VLNHGDLWANNIMFKYDDEGKPEDVALIDFQLSHYGS  157 (196)
T ss_pred             EEeeCCCCccceeeccCCCCCccceEEEecccCCcCC
Confidence            589999999999997543     58999999887643

subfamily of choline kinases

>PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C)

Probab=91.60  E-value=0.35  Score=34.70  Aligned_cols=48  Identities=21%  Similarity=0.205  Sum_probs=38.4

Q ss_pred             HHHHHHHHHHHHHHhc--CCCeeecCCCCCeEEcCCCCEEEEeccccccc
Q psy14630         95 EVTVATVKALNYLKEE--LKIIHRDVKPSNILLDRRGAIKLCDFGISGQL  142 (187)
Q Consensus        95 ~~~~~~~~~l~~lh~~--~~i~Hrdlk~~nili~~~~~~ki~dfg~a~~~  142 (187)
                      +++.++++.+.++++.  ..+.-.|++++|+.+..++.+|++|...+...
T Consensus        63 ~iA~~lL~~l~~l~~~~~~~~~lcDv~~~nfgv~~~~~lk~iDld~v~~~  112 (188)
T PF12260_consen   63 KIALQLLELLEELDHGPLGFFYLCDVSPDNFGVNDDGRLKLIDLDDVFVE  112 (188)
T ss_pred             HHHHHHHHHHHHHhcCCCCcEEEeecchHHeEEeCCCcEEEEechhcchh
Confidence            4777888888888762  14667999999999999999999999865543

Proteins in this uncharacterised family are described as transmembrane proteins.

>PLN02236 choline kinase

Probab=91.53  E-value=0.16  Score=39.98  Aligned_cols=31  Identities=26%  Similarity=0.442  Sum_probs=26.6

Q ss_pred             CCeeecCCCCCeEEcC-CCCEEEEeccccccc
Q psy14630        112 KIIHRDVKPSNILLDR-RGAIKLCDFGISGQL  142 (187)
Q Consensus       112 ~i~Hrdlk~~nili~~-~~~~ki~dfg~a~~~  142 (187)
                      .++|+|+++.||++++ .+.+.++||..+..-
T Consensus       201 ~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~~  232 (344)
T PLN02236        201 GFCHNDLQYGNIMIDEETRAITIIDYEYASYN  232 (344)
T ss_pred             eEEeCCCCcCcEEEeCCCCcEEEEeehhcccc
Confidence            4799999999999976 467999999987753

>cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2')

Probab=90.85  E-value=0.21  Score=38.15  Aligned_cols=31  Identities=26%  Similarity=0.440  Sum_probs=26.0

Q ss_pred             CCeeecCCCCCeEEcCCCC-EEEEeccccccc
Q psy14630        112 KIIHRDVKPSNILLDRRGA-IKLCDFGISGQL  142 (187)
Q Consensus       112 ~i~Hrdlk~~nili~~~~~-~ki~dfg~a~~~  142 (187)
                      .++|+|+.+.|++++.++. .-|+||+.+..-
T Consensus       186 ~lvHGD~~~~Nilv~~~~~~~gviDWe~a~iG  217 (276)
T cd05152         186 VLVHGDLHPGHILIDEDARVTGLIDWTEAKVG  217 (276)
T ss_pred             eeEeCCCCCCcEEEeCCCCEEEEECcHhcccC
Confidence            4899999999999987555 569999988764

MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported

>COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning]

Probab=90.71  E-value=0.46  Score=37.95  Aligned_cols=30  Identities=37%  Similarity=0.643  Sum_probs=27.6

Q ss_pred             CCCeeecCCCCCeEEcCCCCEEEEecccccc
Q psy14630        111 LKIIHRDVKPSNILLDRRGAIKLCDFGISGQ  141 (187)
Q Consensus       111 ~~i~Hrdlk~~nili~~~~~~ki~dfg~a~~  141 (187)
                      ...-|||+...||+|+ .|.+.++||.++|.
T Consensus       341 f~fehrnlt~~niLId-~GnvtLIDfklsRl  370 (488)
T COG5072         341 FPFEHRNLTLDNILID-EGNVTLIDFKLSRL  370 (488)
T ss_pred             CCcccccccccceeee-cCceEEEEeeeeec
Confidence            3578999999999999 99999999999984

>TIGR02904 spore_ysxE spore coat protein YsxE

Probab=90.13  E-value=0.2  Score=38.80  Aligned_cols=30  Identities=17%  Similarity=0.242  Sum_probs=27.3

Q ss_pred             CCeeecCCCCCeEEcCCCCEEEEecccccc
Q psy14630        112 KIIHRDVKPSNILLDRRGAIKLCDFGISGQ  141 (187)
Q Consensus       112 ~i~Hrdlk~~nili~~~~~~ki~dfg~a~~  141 (187)
                      +++|+|+.+.|++++.++.+.++||..+..
T Consensus       197 ~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~~  226 (309)
T TIGR02904       197 VLVHGKLSLSHFLYDETRGGYFINFEKASF  226 (309)
T ss_pred             eeeCCCCcHHhEEEcCCCCEEEEEhhhccc
Confidence            699999999999999988999999987654

Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat.

>COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only]

Probab=89.41  E-value=0.37  Score=37.58  Aligned_cols=33  Identities=18%  Similarity=0.376  Sum_probs=29.1

Q ss_pred             CCeeecCCCCCeEEcCCCCEEEEeccccccccc
Q psy14630        112 KIIHRDVKPSNILLDRRGAIKLCDFGISGQLVD  144 (187)
Q Consensus       112 ~i~Hrdlk~~nili~~~~~~ki~dfg~a~~~~~  144 (187)
                      .++|+|+.+.|+++++.+.+-+.||+++..-.+
T Consensus       199 ~lvHGD~~~gNlii~~~~~~gVlDwe~~~lGDP  231 (321)
T COG3173         199 VLVHGDYRPGNLIIDPGRPTGVLDWELATLGDP  231 (321)
T ss_pred             eeeeCCcccCCEEEeCCCeeEEEeccccccCCc
Confidence            489999999999999988899999999876543

>PLN02421 phosphotransferase, alcohol group as acceptor/kinase

Probab=89.23  E-value=0.33  Score=37.99  Aligned_cols=30  Identities=23%  Similarity=0.480  Sum_probs=25.9

Q ss_pred             CeeecCCCCCeEEcC-CCCEEEEeccccccc
Q psy14630        113 IIHRDVKPSNILLDR-RGAIKLCDFGISGQL  142 (187)
Q Consensus       113 i~Hrdlk~~nili~~-~~~~ki~dfg~a~~~  142 (187)
                      ++|+|+.+.||++++ .+.++++||..|..-
T Consensus       184 ~CHnDl~~~NiL~~~~~~~l~lID~EYag~n  214 (330)
T PLN02421        184 FAHNDLLSGNLMLNEDEGKLYFIDFEYGSYS  214 (330)
T ss_pred             EEECCCCcccEEEeCCCCcEEEEcccccCCC
Confidence            689999999999975 478999999987653

>COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only]

Probab=88.33  E-value=0.47  Score=37.23  Aligned_cols=29  Identities=38%  Similarity=0.642  Sum_probs=25.6

Q ss_pred             CeeecCCCCCeEEcCCCC-EEEEecccccc
Q psy14630        113 IIHRDVKPSNILLDRRGA-IKLCDFGISGQ  141 (187)
Q Consensus       113 i~Hrdlk~~nili~~~~~-~ki~dfg~a~~  141 (187)
                      ++|.|+.+.|++++.... +.++||+-+..
T Consensus       199 iIH~D~~~~NVl~d~~~~~~g~iDFdDa~~  228 (331)
T COG2334         199 IIHGDLHPDNVLFDDDTDVSGFIDFDDAGY  228 (331)
T ss_pred             eeecCCCccceeEcCCCCeeeEEEcccccc
Confidence            899999999999998875 88999997653

>PRK06148 hypothetical protein; Provisional

Probab=87.71  E-value=0.49  Score=42.79  Aligned_cols=30  Identities=40%  Similarity=0.615  Sum_probs=25.2

Q ss_pred             CCeeecCCCCCeEEcCCC--CEE-EEecccccc
Q psy14630        112 KIIHRDVKPSNILLDRRG--AIK-LCDFGISGQ  141 (187)
Q Consensus       112 ~i~Hrdlk~~nili~~~~--~~k-i~dfg~a~~  141 (187)
                      +++|+|+++.|++++.++  .+. |+|||-+..
T Consensus       204 ~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~~  236 (1013)
T PRK06148        204 QVIHNDANDYNILVDADDGERISGLIDFGDAVH  236 (1013)
T ss_pred             ceECCCCCcccEEEcCCCCcceEEEEECccccc
Confidence            699999999999998775  555 999997654

>PHA03111 Ser/Thr kinase; Provisional

Probab=87.26  E-value=1.6  Score=34.46  Aligned_cols=17  Identities=41%  Similarity=0.632  Sum_probs=14.6

Q ss_pred             CCCeeecCCCCCeEEcC
Q psy14630        111 LKIIHRDVKPSNILLDR  127 (187)
Q Consensus       111 ~~i~Hrdlk~~nili~~  127 (187)
                      .+.+|.||||+|||+-+
T Consensus       302 ~nF~H~DLKPdNILiFd  318 (444)
T PHA03111        302 DNFLHVDLKPDNILIFD  318 (444)
T ss_pred             ceeeeccCCCCcEEEec
Confidence            37899999999999943

>KOG1236|consensus

Probab=86.60  E-value=3.1  Score=34.02  Aligned_cols=32  Identities=22%  Similarity=0.316  Sum_probs=23.6

Q ss_pred             ccccccCceEEEEEEE---------------cCCCcEEEEEEccCcc
Q psy14630         30 GEIGRGGFGTVNKMIH---------------RSSDTVMAVKRIRSTV   61 (187)
Q Consensus        30 ~~lg~G~fg~V~~~~~---------------~~~~~~vaiK~~~~~~   61 (187)
                      .-||.|+-++||+|.-               +.+.+.+|||+.+...
T Consensus       195 ~PIGsG~IAQVY~atl~~a~lekd~~~~~~~~~~tq~~AiKv~Hp~V  241 (565)
T KOG1236|consen  195 EPIGSGCIAQVYRATLKTAYLEKDSGKEYVQKLGTQSCAIKVLHPNV  241 (565)
T ss_pred             cccccchhhhhhhhhhhHHHhhcccchhhhcCCccceeeeeccCccH
Confidence            4589999999999842               2345679999987543

>KOG1035|consensus

Probab=86.07  E-value=0.89  Score=41.35  Aligned_cols=83  Identities=18%  Similarity=0.178  Sum_probs=50.6

Q ss_pred             HHHHHHHHHHHHHhcCCCeeecCCCC---CeEEcCCCCEEEE--eccccccccccccccCCCCCcCccCccccCCCccCC
Q psy14630         96 VTVATVKALNYLKEELKIIHRDVKPS---NILLDRRGAIKLC--DFGISGQLVDSIAKTRDAGCRPYMAPERIDPLRARG  170 (187)
Q Consensus        96 ~~~~~~~~l~~lh~~~~i~Hrdlk~~---nili~~~~~~ki~--dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~  170 (187)
                      ...+.++|+.|+|.. ...|.-+..+   +-..+..+...+.  ||+..+.+.+........-+..+-++|...   ...
T Consensus       291 ~~~~~~~GL~~~h~~-~l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~~~~~~~~~~~~~e~~~---~~~  366 (1351)
T KOG1035|consen  291 LHQKLLEGLAYLHSL-SLEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKSFSDLLAEIRNADEDLK---ENT  366 (1351)
T ss_pred             HHHHHhhhHHHHHHh-ccceeEEecccccccccCccceeecchhhhcccccCCCcccchhhcCccccccccccc---ccc
Confidence            345677899999987 5555555444   3334445555555  887777665444333334445567788776   444


Q ss_pred             CCCC--cceeeeEe
Q psy14630        171 YPSF--KTKLGFKF  182 (187)
Q Consensus       171 ~~~~--~D~ws~gi  182 (187)
                      .+.+  .|+|.+|.
T Consensus       367 ~~~~r~~dL~~lgl  380 (1351)
T KOG1035|consen  367 AKKSRLTDLWCLGL  380 (1351)
T ss_pred             chhhhhhHHHHHHH
Confidence            4433  58888775

>PRK09550 mtnK methylthioribose kinase; Reviewed

Probab=83.43  E-value=1.2  Score=36.02  Aligned_cols=29  Identities=17%  Similarity=0.299  Sum_probs=24.7

Q ss_pred             CCeeecCCCCCeEEcCCCCEEEEecccccc
Q psy14630        112 KIIHRDVKPSNILLDRRGAIKLCDFGISGQ  141 (187)
Q Consensus       112 ~i~Hrdlk~~nili~~~~~~ki~dfg~a~~  141 (187)
                      .++|+|+.+.||++..+ .++++|+..+..
T Consensus       224 ~l~HgDl~~gni~~~~~-~~~viD~E~a~~  252 (401)
T PRK09550        224 ALLHGDLHTGSIFVTEE-ETKVIDPEFAFY  252 (401)
T ss_pred             ceeeccCCcccEEeeCC-CcEEEecccccc
Confidence            58999999999999765 699999986653

>PRK11768 serine/threonine protein kinase; Provisional

Probab=83.10  E-value=0.93  Score=35.41  Aligned_cols=28  Identities=25%  Similarity=0.355  Sum_probs=23.9

Q ss_pred             CCeeecCCCCCeEEcCCCCEEEEecccccc
Q psy14630        112 KIIHRDVKPSNILLDRRGAIKLCDFGISGQ  141 (187)
Q Consensus       112 ~i~Hrdlk~~nili~~~~~~ki~dfg~a~~  141 (187)
                      +++|+|+.+.|++++ + .+.++||+-+..
T Consensus       197 ~liHgD~h~~NvL~~-d-~~~iIDFDd~~~  224 (325)
T PRK11768        197 LRLHGDCHPGNILWR-D-GPHFVDLDDARM  224 (325)
T ss_pred             cceecCCCchhcccc-C-CcEEEeCCCCCC
Confidence            689999999999995 3 578999997764

>PF02958 EcKinase: Ecdysteroid kinase; InterPro: IPR004119 This family includes proteins of unknown function

Probab=81.76  E-value=0.81  Score=34.95  Aligned_cols=30  Identities=30%  Similarity=0.438  Sum_probs=25.0

Q ss_pred             CeeecCCCCCeEEcCC--C---CEEEEeccccccc
Q psy14630        113 IIHRDVKPSNILLDRR--G---AIKLCDFGISGQL  142 (187)
Q Consensus       113 i~Hrdlk~~nili~~~--~---~~ki~dfg~a~~~  142 (187)
                      ++|+|+.+.|+++..+  |   .+++.||-+++.-
T Consensus       217 l~HGD~w~nNilf~~~~~g~~~~~~liDfQ~~~~g  251 (294)
T PF02958_consen  217 LCHGDFWTNNILFKYDDDGKPIDVVLIDFQLARYG  251 (294)
T ss_pred             EEcCccCHHhEeEccccccccccceeeccccccCC
Confidence            8999999999999654  3   5899999887653

All known members of this group are proteins from drosophila and Caenorhabditis elegans.

---

Homologous Structure Templates

Structure Templates Detected by BLAST

Original result of BLAST against Protein Data Bank

ID	Length	Definition	E-value
Query	187
3aln_A	327	Crystal Structure Of Human Non-Phosphorylated Mkk4		8e-73
3vn9_A	340	Rifined Crystal Structure Of Non-Phosphorylated Map		2e-46
3fme_A	290	Crystal Structure Of Human Mitogen-Activated Protei		1e-44
2dyl_A	318	Crystal Structure Of Human Mitogen-Activated Protei		2e-41
3enm_A	316	The Structure Of The Map2k Mek6 Reveals An Autoinhi		5e-41
2y4i_C	395	Ksr2-Mek1 Heterodimer Length = 395		5e-29
3eqc_A	360	X-Ray Structure Of The Human Mitogen-Activated Prot		7e-29
3sls_A	304	Crystal Structure Of Human Mek-1 Kinase In Complex		7e-29
3orn_A	307	Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In		9e-29
2p55_A	333	X-Ray Structure Of The Human Mitogen-Activated Prot		1e-28
1s9j_A	341	X-Ray Structure Of The Human Mitogen-Activated Prot		1e-28
3mbl_A	328	Crystal Structure Of The Human Mitogen-Activated Pr		1e-28
3dv3_A	322	Mek1 With Pf-04622664 Bound Length = 322		1e-28
1s9i_A	354	X-Ray Structure Of The Human Mitogen-Activated Prot		1e-28
4an2_A	301	Crystal Structures Of Human Mek1 With Carboxamide-B		5e-28
3com_A	314	Crystal Structure Of Mst1 Kinase Length = 314		2e-17
3zhp_C	294	Human Mst3 (stk24) In Complex With Mo25beta Length		5e-15
4fr4_A	384	Crystal Structure Of Human SerineTHREONINE-Protein		7e-15
3a7f_A	303	Human Mst3 Kinase Length = 303		8e-15
3ckx_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		8e-15
3ckw_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		8e-15
2xik_A	294	Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K		2e-14
3ggf_A	301	Crystal Structure Of Human SerineTHREONINE-Protein		2e-13
2j51_A	325	Crystal Structure Of Human Ste20-Like Kinase Bound		7e-13
2r5t_A	373	Crystal Structure Of Inactive Serum And Glucocortic		1e-12
2jfm_A	325	Crystal Structure Of Human Ste20-Like Kinase (Unlig		1e-12
2jfl_A	325	Crystal Structure Of Human Ste20-Like Kinase ( Diph		2e-12
2j7t_A	302	Crystal Structure Of Human Serine Threonine Kinase-		1e-11
4bc6_A	293	Crystal Structure Of Human Serine Threonine Kinase-		2e-11
2uv2_A	287	Crystal Structure Of Human Ste20-Like Kinase Bound		5e-11
3g51_A	325	Structural Diversity Of The Active Conformation Of		2e-10
2z7q_A	321	Crystal Structure Of The N-Terminal Kinase Domain O		2e-10
4el9_A	305	Structure Of N-Terminal Kinase Domain Of Rsk2 With		2e-10
3ubd_A	304	Structure Of N-Terminal Domain Of Rsk2 Kinase In Co		2e-10
2f2u_A	402	Crystal Structure Of The Rho-Kinase Kinase Domain L		4e-10
4agu_A	311	Crystal Structure Of The Human Cdkl1 Kinase Domain		7e-10
1yhv_A	297	Crystal Structure Of Pak1 Kinase Domain With Two Po		1e-09
1oit_A	299	Imidazopyridines: A Potent And Selective Class Of C		2e-09
1gz8_A	299	Human Cyclin Dependent Kinase 2 Complexed With The		2e-09
4erw_A	306	Cdk2 In Complex With Staurosporine Length = 306		2e-09
3pxf_A	306	Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N		2e-09
3ezr_A	300	Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ		2e-09
2w17_A	299	Cdk2 In Complex With The Imidazole Pyrimidine Amide		2e-09
1fin_A	298	Cyclin A-Cyclin-Dependent Kinase 2 Complex Length =		2e-09
3pj8_A	299	Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]		2e-09
1pf8_A	298	Crystal Structure Of Human Cyclin-dependent Kinase		2e-09
1vyw_A	309	Structure Of Cdk2CYCLIN A WITH PNU-292137 Length =		2e-09
1f3m_C	297	Crystal Structure Of Human SerineTHREONINE KINASE P		2e-09
1fot_A	318	Structure Of The Unliganded Camp-Dependent Protein		3e-09
2v55_A	406	Mechanism Of Multi-site Phosphorylation From A Rock		3e-09
2x7f_A	326	Crystal Structure Of The Kinase Domain Of Human Tra		3e-09
3fxz_A	297	Crystal Structure Of Pak1 Kinase Domain With Ruthen		3e-09
2iw6_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com		3e-09
2esm_A	415	Crystal Structure Of Rock 1 Bound To Fasudil Length		3e-09
3q52_A	306	Structure Of Phosphorylated Pak1 Kinase Domain Leng		3e-09
3v8s_A	410	Human Rho-Associated Protein Kinase 1 (Rock 1) In C		3e-09
2x4z_A	296	Crystal Structure Of The Human P21-Activated Kinase		3e-09
2q0n_A	301	Structure Of Human P21 Activating Kinase 4 (Pak4) I		3e-09
2bva_A	292	Crystal Structure Of The Human P21-Activated Kinase		3e-09
4eom_A	301	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		3e-09
2cdz_A	303	Crystal Structure Of The Human P21-Activated Kinase		3e-09
4eon_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		3e-09
4fie_A	423	Full-Length Human Pak4 Length = 423		4e-09
4fif_A	346	Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid		4e-09
2pml_X	348	Crystal Structure Of Pfpk7 In Complex With An Atp A		4e-09
4aaa_A	331	Crystal Structure Of The Human Cdkl2 Kinase Domain		4e-09
4eoq_A	301	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		4e-09
4eop_A	300	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		4e-09
4bcq_A	301	Structure Of Cdk2 In Complex With Cyclin A And A 2-		4e-09
4eos_A	300	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		4e-09
4eoo_A	299	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		4e-09
3daj_A	272	Crystal Structure Of Aurora A Complexed With An Inh		4e-09
4i3z_A	296	Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES		4e-09
1jst_A	298	Phosphorylated Cyclin-Dependent Kinase-2 Bound To C		4e-09
3qhr_A	298	Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic		4e-09
2bfy_A	284	Complex Of Aurora-B With Incenp And Hesperidin. Len		4e-09
3bht_A	300	Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN		4e-09
1qmz_A	299	Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com		5e-09
1h1p_A	303	Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP		5e-09
1ogu_A	302	Structure Of Human Thr160-phospho Cdk2/cyclin A Com		5e-09
4eoj_A	302	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		5e-09
1w98_A	298	The Structural Basis Of Cdk2 Activation By Cyclin E		5e-09
3p1a_A	311	Structure Of Human Membrane-Associated Tyrosine- An		5e-09
1e9h_A	297	Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex		5e-09
3s95_A	310	Crystal Structure Of The Human Limk1 Kinase Domain		5e-09
4eok_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		5e-09
2jgz_A	289	Crystal Structure Of Phospho-Cdk2 In Complex With C		5e-09
2f57_A	317	Crystal Structure Of The Human P21-activated Kinase		5e-09
3d14_A	272	Crystal Structure Of Mouse Aurora A (Asn186->gly, L		5e-09
3ppz_A	309	Crystal Structure Of Ctr1 Kinase Domain In Complex		7e-09
4eoi_A	299	Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc		7e-09
3q4z_A	306	Structure Of Unphosphorylated Pak1 Kinase Domain Le		8e-09
4gs6_A	315	Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz		8e-09
1oir_A	299	Imidazopyridines: A Potent And Selective Class Of C		8e-09
1h01_A	298	Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili		8e-09
3fhi_A	350	Crystal Structure Of A Complex Between The Catalyti		8e-09
3p86_A	309	Crystal Structure Of Ctr1 Kinase Domain Mutant D676		8e-09
2eva_A	307	Structural Basis For The Interaction Of Tak1 Kinase		8e-09
2phk_A	277	The Crystal Structure Of A Phosphorylase Kinase Pep		1e-08
1gii_A	298	Human Cyclin Dependent Kinase 2 Complexed With The		1e-08
1phk_A	298	Two Structures Of The Catalytic Domain Of Phosphory		1e-08
3qa8_A	676	Crystal Structure Of Inhibitor Of Kappa B Kinase Be		1e-08
3rzf_A	677	Crystal Structure Of Inhibitor Of Kappab Kinase Bet		1e-08
2bfx_B	284	Mechanism Of Aurora-B Activation By Incenp And Inhi		1e-08
2vrx_A	285	Structure Of Aurora B Kinase In Complex With Zm4474		1e-08
1ql6_A	298	The Catalytic Mechanism Of Phosphorylase Kinase Pro		2e-08
3ama_A	351	Protein Kinase A Sixfold Mutant Model Of Aurora B W		2e-08
2zv2_A	298	Crystal Structure Of Human CalciumCALMODULIN-Depend		2e-08
4dfy_A	371	Crystal Structure Of R194a Mutant Of Camp-Dependent		2e-08
1ua2_A	346	Crystal Structure Of Human Cdk7 Length = 346		2e-08
2iw8_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82		3e-08
1j3h_A	350	Crystal Structure Of Apoenzyme Camp-Dependent Prote		3e-08
3pvb_A	345	Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca		4e-08
1syk_A	350	Crystal Structure Of E230q Mutant Of Camp-Dependent		4e-08
1fmo_E	350	Crystal Structure Of A Polyhistidine-Tagged Recombi		4e-08
3qal_E	350	Crystal Structure Of Arg280ala Mutant Of Catalytic		4e-08
1l3r_E	350	Crystal Structure Of A Transition State Mimic Of Th		4e-08
3mn3_A	271	An Inhibited Conformation For The Protein Kinase Do		4e-08
2erz_E	351	Crystal Structure Of C-amp Dependent Kinase (pka) B		4e-08
4dfx_E	350	Crystal Structure Of Myristoylated K7c Catalytic Su		4e-08
2qcs_A	350	A Complex Structure Between The Catalytic And Regul		4e-08
1bkx_A	350	A Binary Complex Of The Catalytic Subunit Of Camp-D		4e-08
1jbp_E	350	Crystal Structure Of The Catalytic Subunit Of Camp-		4e-08
1apm_E	350	2.0 Angstrom Refined Crystal Structure Of The Catal		4e-08
2qur_A	350	Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe		4e-08
2fh9_A	274	Structure And Dimerization Of The Kinase Domain Fro		4e-08
3dae_A	283	Crystal Structure Of Phosphorylated Snf1 Kinase Dom		4e-08
3hyh_A	275	Crystal Structure Of The Protein Kinase Domain Of Y		4e-08
2gnj_A	350	Pka Three Fold Mutant Model Of Rho-Kinase With Y-27		4e-08
4dg3_E	371	Crystal Structure Of R336a Mutant Of Camp-dependent		4e-08
4aw2_A	437	Crystal Structure Of Cdc42 Binding Protein Kinase A		5e-08
3uiu_A	306	Crystal Structure Of Apo-Pkr Kinase Domain Length =		5e-08
2gu8_A	337	Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel		5e-08
2w5a_A	279	Human Nek2 Kinase Adp-Bound Length = 279		5e-08
2gnf_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		6e-08
3l9m_A	351	Crystal Structure Of Pkab3 (Pka Triple Mutant V123a		6e-08
2gng_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		6e-08
2a19_B	284	Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng		7e-08
4ae9_A	343	Structure And Function Of The Human Sperm-specific		8e-08
4ae6_A	343	Structure And Function Of The Human Sperm-specific		8e-08
3qbn_A	281	Structure Of Human Aurora A In Complex With A Diami		8e-08
3agm_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		8e-08
3nx8_A	351	Human Camp Dependent Protein Kinase In Complex With		8e-08
3o7l_B	350	Crystal Structure Of Phospholamban (1-19):pka C-Sub		9e-08
3agl_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		9e-08
3coh_A	268	Crystal Structure Of Aurora-A In Complex With A Pen		9e-08
3h4j_B	336	Crystal Structure Of Pombe Ampk Kdaid Fragment Leng		9e-08
3mvj_A	371	Human Cyclic Amp-Dependent Protein Kinase Pka Inhib		9e-08
1ctp_E	350	Structure Of The Mammalian Catalytic Subunit Of Cam		1e-07
2c30_A	321	Crystal Structure Of The Human P21-Activated Kinase		1e-07
1cmk_E	350	Crystal Structures Of The Myristylated Catalytic Su		1e-07
1cdk_A	350	Camp-Dependent Protein Kinase Catalytic Subunit (E.		1e-07
2xru_A	280	Aurora-A T288e Complexed With Pha-828300 Length = 2		1e-07
2nry_A	307	Crystal Structure Of Irak-4 Length = 307		1e-07
3unz_A	279	Aurora A In Complex With Rpm1679 Length = 279		1e-07
2dwb_A	285	Aurora-A Kinase Complexed With Amppnp Length = 285		1e-07
3e5a_A	268	Crystal Structure Of Aurora A In Complex With Vx-68		1e-07
1kob_A	387	Twitchin Kinase Fragment (Aplysia), Autoregulated P		1e-07
2pk9_A	317	Structure Of The Pho85-pho80 Cdk-cyclin Complex Of		1e-07
3o50_A	267	Crystal Structure Of Benzamide 9 Bound To Auroraa L		1e-07
1mq4_A	272	Crystal Structure Of Aurora-A Protein Kinase Length		2e-07
2x6d_A	285	Aurora-A Bound To An Inhibitor Length = 285		2e-07
2xng_A	283	Structure Of Aurora-A Bound To A Selective Imidazop		2e-07
2j50_A	280	Structure Of Aurora-2 In Complex With Pha-739358 Le		2e-07
3r21_A	271	Design, Synthesis, And Biological Evaluation Of Pyr		2e-07
1xh9_A	350	Crystal Structures Of Protein Kinase B Selective In		2e-07
2j4z_A	306	Structure Of Aurora-2 In Complex With Pha-680626 Le		2e-07
1q61_A	350	Pka Triple Mutant Model Of Pkb Length = 350		2e-07
2bmc_A	306	Aurora-2 T287d T288d Complexed With Pha-680632 Leng		2e-07
2w1d_A	275	Structure Determination Of Aurora Kinase In Complex		2e-07
2wtw_A	285	Aurora-A Inhibitor Structure (2nd Crystal Form) Len		2e-07
1szm_A	350	Dual Binding Mode Of Bisindolylmaleimide 2 To Prote		2e-07
1u59_A	287	Crystal Structure Of The Zap-70 Kinase Domain In Co		2e-07
1muo_A	297	Crystal Structure Of Aurora-2, An Oncogenic Serine-		2e-07
2nru_A	307	Crystal Structure Of Irak-4 Length = 307		2e-07
1u5q_A	348	Crystal Structure Of The Tao2 Kinase Domain: Activa		2e-07
3o96_A	446	Crystal Structure Of Human Akt1 With An Allosteric		2e-07
2uzt_A	336	Pka Structures Of Akt, Indazole-Pyridine Inhibitors		2e-07
4gv1_A	340	Pkb Alpha In Complex With Azd5363 Length = 340		2e-07
4ejn_A	446	Crystal Structure Of Autoinhibited Form Of Akt1 In		2e-07
3ocb_A	341	Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor		2e-07
3fdn_A	279	Structure-Based Drug Design Of Novel Aurora Kinase		2e-07
3cqu_A	342	Crystal Structure Of Akt-1 Complexed With Substrate		2e-07
2c6e_A	283	Aurora A Kinase Activated Mutant (T287d) In Complex		2e-07
1xh7_A	350	Crystal Structures Of Protein Kinase B Selective In		2e-07
2c6d_A	275	Aurora A Kinase Activated Mutant (T287d) In Complex		2e-07
2c1a_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		2e-07
3nrm_A	283	Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito		2e-07
3qam_E	350	Crystal Structure Of Glu208ala Mutant Of Catalytic		2e-07
2jav_A	279	Human Kinase With Pyrrole-Indolinone Ligand Length		2e-07
2jdt_A	351	Structure Of Pka-Pkb Chimera Complexed With Isoquin		2e-07
3dnd_A	350	Camp-Dependent Protein Kinase Pka Catalytic Subunit		2e-07
1q8w_A	350	The Catalytic Subunit Of Camp-Dependent Protein Kin		2e-07
1stc_E	350	Camp-Dependent Protein Kinase, Alpha-Catalytic Subu		2e-07
2f7e_E	351	Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu		2e-07
1svh_A	350	Crystal Structure Of Protein Kinase A In Complex Wi		2e-07
3h0y_A	268	Aurora A In Complex With A Bisanilinopyrimidine Len		2e-07
2jds_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		2e-07
1ydt_E	350	Structure Of Camp-Dependent Protein Kinase, Alpha-C		2e-07
3lau_A	287	Crystal Structure Of Aurora2 Kinase In Complex With		2e-07
2vo0_A	351	Structure Of Pka-Pkb Chimera Complexed With C-(4-(4		2e-07
2uvy_A	351	Structure Of Pka-pkb Chimera Complexed With Methyl-		2e-07
3kl8_A	269	Camkiintide Inhibitor Complex Length = 269		3e-07
3f69_A	311	Crystal Structure Of The Mycobacterium Tuberculosis		3e-07
2bdw_A	362	Crystal Structure Of The Auto-Inhibited Kinase Doma		3e-07
2oib_A	301	Crystal Structure Of Irak4 Kinase Domain Apo Form L		3e-07
4a4x_A	279	Nek2-Ede Bound To Cct248662 Length = 279		4e-07
1smh_A	350	Protein Kinase A Variant Complex With Completely Or		4e-07
2xne_A	272	Structure Of Aurora-A Bound To An Imidazopyrazine I		4e-07
1q24_A	350	Pka Double Mutant Model Of Pkb In Complex With Mgat		4e-07
3kk9_A	282	Camkii Substrate Complex B Length = 282		4e-07
3kk8_A	284	Camkii Substrate Complex A Length = 284		4e-07
1rdq_E	350	Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of		4e-07
1ol6_A	282	Structure Of Unphosphorylated D274n Mutant Of Auror		4e-07
3ha6_A	268	Crystal Structure Of Aurora A In Complex With Tpx2		5e-07
2gcd_A	309	Tao2 Kinase Domain-Staurosporine Structure Length =		5e-07
1ol5_A	282	Structure Of Aurora-A 122-403, Phosphorylated On Th		6e-07
2wtv_A	285	Aurora-A Inhibitor Structure Length = 285		6e-07
1o6y_A	299	Catalytic Domain Of Pknb Kinase From Mycobacterium		6e-07
2ozo_A	613	Autoinhibited Intact Human Zap-70 Length = 613		6e-07
2w1c_A	275	Structure Determination Of Aurora Kinase In Complex		6e-07
2wqe_A	262	Structure Of S155r Aurora-A Somatic Mutant Length =		6e-07
3orm_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain D76a		7e-07
3ori_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain L33d		7e-07
3f61_A	311	Crystal Structure Of M. Tuberculosis Pknb Leu33aspV		7e-07
1mru_A	311	Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob		7e-07
1h4l_A	292	Structure And Regulation Of The Cdk5-P25(Nck5a) Com		7e-07
2vwi_A	303	Structure Of The Osr1 Kinase, A Hypertension Drug T		1e-06
3dak_A	290	Crystal Structure Of Domain-Swapped Osr1 Kinase Dom		1e-06
2j0l_A	276	Crystal Structure Of A The Active Conformation Of T		1e-06
4ec8_A	373	Structure Of Full Length Cdk9 In Complex With Cycli		1e-06
3is5_A	285	Crystal Structure Of Cdpk Kinase Domain From Toxopl		1e-06
3mi9_A	351	Crystal Structure Of Hiv-1 Tat Complexed With Human		1e-06
4eqm_A	294	Structural Analysis Of Staphylococcus Aureus Serine		2e-06
1zmw_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		2e-06
4bcf_A	331	Structure Of Cdk9 In Complex With Cyclin T And A 2-		2e-06
3a62_A	327	Crystal Structure Of Phosphorylated P70s6k1 Length		2e-06
3tku_A	433	Mrck Beta In Complex With Fasudil Length = 433		2e-06
3qfv_A	415	Mrck Beta In Complex With Tpca-1 Length = 415		2e-06
3blh_A	331	Crystal Structure Of Human Cdk9CYCLINT1 Length = 33		2e-06
3a60_A	327	Crystal Structure Of Unphosphorylated P70s6k1 (Form		2e-06
2j0j_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		2e-06
2etm_A	281	Crystal Structure Of Focal Adhesion Kinase Domain C		2e-06
3pxk_A	282	Focal Adhesion Kinase Catalytic Domain In Complex W		2e-06
2y7j_A	365	Structure Of Human Phosphorylase Kinase, Gamma 2 Le		2e-06
3iec_A	319	Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K		2e-06
1mp8_A	281	Crystal Structure Of Focal Adhesion Kinase (Fak) Le		2e-06
4ebw_A	304	Structure Of Focal Adhesion Kinase Catalytic Domain		2e-06
3dxn_A	287	Crystal Structure Of The Calcium-dependent Kinase F		2e-06
2o8y_A	298	Apo Irak4 Kinase Domain Length = 298		2e-06
2jkm_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		2e-06
3bz3_A	276	Crystal Structure Analysis Of Focal Adhesion Kinase		2e-06
2r0i_A	327	Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len		2e-06
2j0m_B	276	Crystal Structure A Two-Chain Complex Between The F		2e-06
1zmu_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		2e-06
3mfr_A	351	Cask-4m Cam Kinase Domain, Native Length = 351		2e-06
3mtl_A	324	Crystal Structure Of The Pctaire1 Kinase In Complex		2e-06
1ung_A	292	Structural Mechanism For The Inhibition Of Cdk5-P25		2e-06
3say_A	430	Crystal Structure Of Human Glycogen Synthase Kinase		3e-06
2j0k_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		3e-06
3lij_A	494	Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820)		3e-06
4g31_A	299	Crystal Structure Of Gsk6414 Bound To Perk (R587-R1		3e-06
3zrk_A	371	Identification Of 2-(4-Pyridyl)thienopyridinones As		3e-06
1o9u_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		3e-06
4afj_A	367	5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec		3e-06
1gng_A	378	Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With		3e-06
2ow3_A	352	Glycogen Synthase Kinase-3 Beta In Complex With Bis		3e-06
3gb2_A	353	Gsk3beta Inhibitor Complex Length = 353		3e-06
3f88_A	349	Glycogen Synthase Kinase 3beta Inhibitor Complex Le		3e-06
3f7z_A	350	X-ray Co-crystal Structure Of Glycogen Synthase Kin		3e-06
4dit_A	382	Crystal Structure Of Gsk3beta In Complex With A Imi		3e-06
3c4w_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		3e-06
3zdi_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		3e-06
2jkk_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		3e-06
3c4x_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		3e-06
3t8o_A	543	Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu		3e-06
2wzj_A	327	Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82		3e-06
3fe3_A	328	Crystal Structure Of The Kinase Mark3PAR-1: T211a-S		3e-06
3qc9_A	543	Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4		3e-06
3hzt_A	467	Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4		4e-06
1koa_A	491	Twitchin Kinase Fragment (C.Elegans), Autoregulated		4e-06
4acc_A	465	Gsk3b In Complex With Inhibitor Length = 465		4e-06
1q5k_A	414	Crystal Structure Of Glycogen Synthase Kinase 3 In		4e-06
1i09_A	420	Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len		4e-06
1r0e_A	391	Glycogen Synthase Kinase-3 Beta In Complex With 3-I		4e-06
3cd3_A	377	Crystal Structure Of Phosphorylated Human Feline Sa		4e-06
1zmv_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		4e-06
1uv5_A	350	Glycogen Synthase Kinase 3 Beta Complexed With 6-Br		4e-06
1q3d_A	424	Gsk-3 Beta Complexed With Staurosporine Length = 42		4e-06
1pyx_A	422	Gsk-3 Beta Complexed With Amp-Pnp Length = 422		4e-06
3uto_A	573	Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-		4e-06
3lm0_A	327	Crystal Structure Of Human SerineTHREONINE KINASE 1		4e-06
3sd0_A	350	Identification Of A Glycogen Synthase Kinase-3b Inh		4e-06
2o5k_A	372	Crystal Structure Of Gsk3beta In Complex With A Ben		4e-06
1h8f_A	352	Glycogen Synthase Kinase 3 Beta. Length = 352		4e-06
1vzo_A	355	The Structure Of The N-Terminal Kinase Domain Of Ms		5e-06
3niz_A	311	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		5e-06
2qkr_A	313	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		5e-06
2vd5_A	412	Structure Of Human Myotonic Dystrophy Protein Kinas		5e-06
3sxr_A	268	Crystal Structure Of Bmx Non-Receptor Tyrosine Kina		5e-06
3oz6_A	388	Crystal Structure Of Mapk From Cryptosporidium Parv		5e-06
2wqm_A	310	Structure Of Apo Human Nek7 Length = 310		5e-06
3dfa_A	286	Crystal Structure Of Kinase Domain Of Calcium-depen		6e-06
2wei_A	287	Crystal Structure Of The Kinase Domain Of Cryptospo		6e-06
3bkb_A	377	Crystal Structure Of Human Feline Sarcoma Viral Onc		6e-06
3ujg_A	361	Crystal Structure Of Snrk2.6 In Complex With Hab1 L		6e-06
3igo_A	486	Crystal Structure Of Cryptosporidium Parvum Cdpk1,		6e-06
1y8g_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		6e-06
2h6d_A	276	Protein Kinase Domain Of The Human 5'-Amp-Activated		7e-06
3uc3_A	361	The Crystal Structure Of Snf1-Related Kinase 2.3 Le		7e-06
2qnj_A	328	Kinase And Ubiquitin-Associated Domains Of Mark3PAR		7e-06
2qr7_A	342	2.0a X-Ray Structure Of C-Terminal Kinase Domain Of		8e-06
3ma6_A	298	Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr		8e-06
3pp0_A	338	Crystal Structure Of The Kinase Domain Of Human Her		8e-06
2yza_A	276	Crystal Structure Of Kinase Domain Of Human 5'-Amp-		9e-06
2qr8_A	342	2.0a X-ray Structure Of C-terminal Kinase Domain Of		1e-05
3i79_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		1e-05
4b99_A	398	Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le		1e-05
4ic7_A	442	Crystal Structure Of The Erk5 Kinase Domain In Comp		1e-05
2vx3_A	382	Crystal Structure Of The Human Dual Specificity Tyr		1e-05
3k54_A	283	Structures Of Human Bruton's Tyrosine Kinase In Act		1e-05
1o6l_A	337	Crystal Structure Of An Activated Akt/protein Kinas		1e-05
1gzk_A	315	Molecular Mechanism For The Regulation Of Protein K		1e-05
1mrv_A	339	Crystal Structure Of An Inactive Akt2 Kinase Domain		1e-05
3i7c_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		1e-05
3ku2_A	507	Crystal Structure Of Inactivated Form Of Cdpk1 From		1e-05
1gzn_A	335	Structure Of Pkb Kinase Domain Length = 335		1e-05
3anq_A	368	Human Dyrk1aINHIBITOR COMPLEX Length = 368		1e-05
2hak_A	328	Catalytic And Ubiqutin-Associated Domains Of Mark1P		1e-05
1yhs_A	273	Crystal Structure Of Pim-1 Bound To Staurosporine L		1e-05
2jdo_A	342	Structure Of Pkb-Beta (Akt2) Complexed With Isoquin		1e-05
4g3d_A	371	Crystal Structure Of Human Nf-kappab Inducing Kinas		1e-05
3hx4_A	508	Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg		1e-05
4h1j_A	293	Crystal Structure Of Pyk2 With The Pyrazole 13a Len		1e-05
1o6k_A	336	Structure Of Activated Form Of Pkb Kinase Domain S4		1e-05
3e87_A	335	Crystal Structures Of The Kinase Domain Of Akt2 In		1e-05
4dtk_A	276	Novel And Selective Pan-Pim Kinase Inhibitor Length		1e-05
4as0_A	273	Cyclometalated Phthalimides As Protein Kinase Inhib		1e-05
3c4e_A	273	Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7		1e-05
1yxs_A	293	Crystal Structure Of Kinase Pim1 With P123m Mutatio		1e-05
3fzo_A	277	Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin		1e-05
4dn5_A	356	Crystal Structure Of Nf-kb-inducing Kinase (nik) Le		1e-05
3cc6_A	281	Crystal Structure Of Kinase Domain Of Protein Tyros		1e-05
2i0e_A	353	Structure Of Catalytic Domain Of Human Protein Kina		1e-05
3zh8_A	349	A Novel Small Molecule Apkc Inhibitor Length = 349		1e-05
1ywv_A	293	Crystal Structures Of Proto-Oncogene Kinase Pim1: A		1e-05
3jxw_A	294	Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-		1e-05
3uix_A	298	Crystal Structure Of Pim1 Kinase In Complex With Sm		2e-05
4a7c_A	308	Crystal Structure Of Pim1 Kinase With Etp46546 Leng		2e-05
4aze_A	382	Human Dyrk1a In Complex With Leucettine L41 Length		2e-05
3a8w_A	345	Crystal Structure Of Pkciota Kinase Domain Length =		2e-05
3r00_A	299	The Discovery Of Novel Benzofuran-2-Carboxylic Acid		2e-05
3nup_A	307	Cdk6 (Monomeric) In Complex With Inhibitor Length =		2e-05
1zrz_A	364	Crystal Structure Of The Catalytic Domain Of Atypic		2e-05
4alv_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		2e-05
4alu_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		2e-05
2bil_B	313	The Human Protein Kinase Pim1 In Complex With Its C		2e-05
3cy3_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		2e-05
2y94_A	476	Structure Of An Active Form Of Mammalian Ampk Lengt		2e-05
3jpv_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		2e-05
2bik_B	313	Human Pim1 Phosphorylated On Ser261 Length = 313		2e-05
3pfq_A	674	Crystal Structure And Allosteric Activation Of Prot		2e-05
3cxw_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		2e-05
4g3f_A	336	Crystal Structure Of Murine Nf-kappab Inducing Kina		2e-05
3ma3_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		2e-05
2j2i_B	312	Crystal Structure Of The Humab Pim1 In Complex With		2e-05
1xws_A	313	Crystal Structure Of The Human Pim1 Kinase Domain L		2e-05
4g3c_A	352	Crystal Structure Of Apo Murine Nf-kappab Inducing		2e-05
4apc_A	350	Crystal Structure Of Human Nima-Related Kinase 1 (N		2e-05
3ll6_A	337	Crystal Structure Of The Human Cyclin G Associated		2e-05
1jow_B	308	Crystal Structure Of A Complex Of Human Cdk6 And A		2e-05
1zys_A	273	Co-Crystal Structure Of Checkpoint Kinase Chk1 With		2e-05
3dcv_A	328	Crystal Structure Of Human Pim1 Kinase Complexed Wi		2e-05
3ocs_A	271	Crystal Structure Of Bruton's Tyrosine Kinase In Co		2e-05
1xqz_A	300	Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut		2e-05
2xj0_A	301	Protein Kinase Pim-1 In Complex With Fragment-4 Fro		2e-05
1bi8_A	326	Mechanism Of G1 Cyclin Dependent Kinase Inhibition		2e-05
2v7o_A	336	Crystal Structure Of Human Calcium-Calmodulin-Depen		2e-05
2xiy_A	301	Protein Kinase Pim-1 In Complex With Fragment-2 Fro		2e-05
2obj_A	333	Crystal Structure Of Human Pim-1 Kinase In Complex		2e-05
3f2a_A	300	Crystal Structure Of Human Pim-1 In Complex With Da		2e-05
2xix_A	301	Protein Kinase Pim-1 In Complex With Fragment-1 Fro		2e-05
3gen_A	283	The 1.6 A Crystal Structure Of Human Bruton's Tyros		2e-05
3n9x_A	432	Crystal Structure Of Map Kinase From Plasmodium Ber		2e-05
3p08_A	267	Crystal Structure Of The Human Btk Kinase Domain Le		2e-05
3a99_A	320	Structure Of Pim-1 Kinase Crystallized In The Prese		2e-05
2iwi_A	312	Crystal Structure Of The Human Pim2 In Complex With		2e-05
4g3g_A	350	Crystal Structure Of Murine Nf-kappab Inducing Kina		2e-05
3pix_A	274	Crystal Structure Of Btk Kinase Domain Complexed Wi		2e-05
4fsy_A	279	Crystal Structure Of The Chk1 Length = 279		2e-05
2ydj_A	276	Discovery Of Checkpoint Kinase Inhibitor Azd7762 By		2e-05
2clq_A	295	Structure Of Mitogen-Activated Protein Kinase Kinas		3e-05
4fsz_A	279	Crystal Structure Of The Chk1 Length = 279		3e-05
2f9g_A	353	Crystal Structure Of Fus3 Phosphorylated On Tyr182		3e-05
3vw6_A	269	Crystal Structure Of Human Apoptosis Signal-Regulat		3e-05
1zyc_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		3e-05
1zy4_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		3e-05
3nie_A	429	Crystal Structure Of Pf11_0147 Length = 429		3e-05
4hct_A	269	Crystal Structure Of Itk In Complex With Compound 5		3e-05
3oct_A	265	Crystal Structure Of Bruton's Tyrosine Kinase Mutan		3e-05
3miy_A	266	X-Ray Crystal Structure Of Itk Complexed With Sunit		3e-05
3uc4_A	362	The Crystal Structure Of Snf1-Related Kinase 2.6 Le		3e-05
3t9t_A	267	Crystal Structure Of Btk Mutant (F435t,K596r) Compl		4e-05
3eb0_A	383	Crystal Structure Of Cgd4_240 From Cryptosporidium		4e-05
2r0u_A	323	Crystal Structure Of Chek1 In Complex With Inhibito		4e-05
3iw4_A	360	Crystal Structure Of Pkc Alpha In Complex With Nvp-		4e-05
2e9v_A	268	Structure Of H-Chk1 Complexed With A859017 Length =		4e-05
4dc2_A	396	Structure Of Pkc In Complex With A Substrate Peptid		4e-05
2ghg_A	269	H-Chk1 Complexed With A431994 Length = 269		4e-05
3nay_A	311	Pdk1 In Complex With Inhibitor Mp6 Length = 311		4e-05
3nax_A	311	Pdk1 In Complex With Inhibitor Mp7 Length = 311		4e-05
2ayp_A	269	Crystal Structure Of Chk1 With An Indol Inhibitor L		4e-05
2hog_A	322	Crystal Structure Of Chek1 In Complex With Inhibito		4e-05
1k2p_A	263	Crystal Structure Of Bruton's Tyrosine Kinase Domai		4e-05
4fsm_A	279	Crystal Structure Of The Chk1 Length = 279		4e-05
4fsn_A	278	Crystal Structure Of The Chk1 Length = 278		4e-05
4a07_A	311	Human Pdk1 Kinase Domain In Complex With Allosteric		4e-05
2x8e_A	276	Discovery Of A Novel Class Of Triazolones As Checkp		4e-05
3jvr_A	271	Characterization Of The Chk1 Allosteric Inhibitor B		4e-05
4fst_A	269	Crystal Structure Of The Chk1 Length = 269		4e-05
4ft3_A	279	Crystal Structure Of The Chk1 Length = 279		4e-05
2br1_A	297	Structure-Based Design Of Novel Chk1 Inhibitors: In		4e-05
2b9f_A	353	Crystal Structure Of Non-Phosphorylated Fus3 Length		4e-05
1ia8_A	289	The 1.7 A Crystal Structure Of Human Cell Cycle Che		4e-05
1zlt_A	295	Crystal Structure Of Chk1 Complexed With A Hymenald		4e-05
3sc1_A	311	Novel Isoquinolone Pdk1 Inhibitors Discovered Throu		4e-05
2xck_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		4e-05
3ot3_A	273	X-Ray Crystal Structure Of Compound 22k Bound To Hu		4e-05
1uu3_A	310	Structure Of Human Pdk1 Kinase Domain In Complex Wi		4e-05
3qc4_A	314	Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length =		4e-05
2biy_A	310	Structure Of Pdk1-S241a Mutant Kinase Domain Length		4e-05
3rwp_A	311	Discovery Of A Novel, Potent And Selective Inhibito		4e-05
3iop_A	312	Pdk-1 In Complex With The Inhibitor Compound-8i Len		4e-05
3nun_A	292	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea		4e-05
3nus_A	286	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra		4e-05
2xch_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		4e-05
3pwy_A	311	Crystal Structure Of An Extender (Spd28345)-Modifie		4e-05
2r7b_A	312	Crystal Structure Of The Phosphoinositide-Dependent		4e-05
4fsw_A	279	Crystal Structure Of The Chk1 Length = 279		4e-05
3hrc_A	311	Crystal Structure Of A Mutant Of Human Pdk1 Kinase		4e-05
3q5i_A	504	Crystal Structure Of Pbanka_031420 Length = 504		5e-05
3h9o_A	311	Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1)		5e-05
1uu9_A	286	Structure Of Human Pdk1 Kinase Domain In Complex Wi		5e-05
1z5m_A	286	Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr		5e-05
3zut_A	362	The Structure Of Ost1 (D160a) Kinase Length = 362		5e-05
1h1w_A	289	High Resolution Crystal Structure Of The Human Pdk1		5e-05
3cek_A	313	Crystal Structure Of Human Dual Specificity Protein		5e-05
2jed_A	352	The Crystal Structure Of The Kinase Domain Of The P		5e-05
3orx_A	316	Pdk1 Mutant Bound To Allosteric Disulfide Fragment		5e-05
1zxe_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		5e-05
3dbq_A	343	Crystal Structure Of Ttk Kinase Domain Length = 343		5e-05
2zmd_A	390	Crystal Structure Of Human Mps1 Catalytic Domain T6		5e-05
3c7q_A	316	Structure Of Vegfr2 Kinase Domain In Complex With B		6e-05
4h3q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		6e-05
2b9h_A	353	Crystal Structure Of Fus3 With A Docking Motif From		6e-05
1v0o_A	288	Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho		6e-05
3uib_A	362	Map Kinase Lmampk10 From Leishmania Major In Comple		6e-05
4af3_A	292	Human Aurora B Kinase In Complex With Incenp And Vx		6e-05
2r4b_A	321	Erbb4 Kinase Domain Complexed With A Thienopyrimidi		6e-05
2acx_A	576	Crystal Structure Of G Protein Coupled Receptor Kin		6e-05
1v0b_A	288	Crystal Structure Of The T198a Mutant Of Pfpk5 Leng		6e-05
3dtc_A	271	Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp		6e-05
3zuu_A	362	The Structure Of Ost1 (D160a, S175d) Kinase In Comp		6e-05
3bbt_B	328	Crystal Structure Of The Erbb4 Kinase In Complex Wi		6e-05
3pg1_A	362	Map Kinase Lmampk10 From Leishmania Major (1.95 Ang		6e-05
2zmc_A	390	Crystal Structure Of Human Mitotic Checkpoint Kinas		6e-05
2x9e_A	317	Human Mps1 In Complex With Nms-P715 Length = 317		6e-05
3cjg_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		6e-05
3vqu_A	320	Crystal Structure Of Human Mps1 Catalytic Domain In		7e-05
3hmn_A	342	Crystal Structure Of Human Mps1 Catalytic Domain In		7e-05
3v5j_A	266	Crystal Structure Of Interleukin-2 Inducible T-Cell		7e-05
3vum_A	370	Crystal Structure Of A Cysteine-deficient Mutant M7		7e-05
3vul_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		7e-05
3nyn_A	576	Crystal Structure Of G Protein-Coupled Receptor Kin		7e-05
1sm2_A	264	Crystal Structure Of The Phosphorylated Interleukin		7e-05
3e3p_A	360	Glycogen Synthase Kinase From Leishmania Major Leng		7e-05
3v3v_A	379	Structural And Functional Analysis Of Quercetagetin		8e-05
4gsb_A	364	Monoclinic Crystal Form Of The Apo-Erk2 Length = 36		8e-05
1ob3_A	288	Structure Of P. Falciparum Pfpk5 Length = 288		8e-05
4fv7_A	360	Crystal Structure Of The Erk2 Complexed With E94 Le		8e-05
2w0j_A	323	Crystal Structure Of Chk2 In Complex With Nsc 10955		8e-05
2cn5_A	329	Crystal Structure Of Human Chk2 In Complex With Adp		8e-05
4fux_A	360	Crystal Structure Of The Erk2 Complexed With E75 Le		8e-05
3qyw_A	364	Crystal Structure Of Erk2 In Complex With An Inhibi		8e-05
2xk9_A	322	Structural Analysis Of Checkpoint Kinase 2 (Chk2) I		8e-05
3i6w_A	443	Structure And Activation Mechanism Of The Chk2 Dna-		8e-05
3vuk_A	370	Crystal Structure Of A Cysteine-deficient Mutant M5		8e-05
2ycf_A	322	Crystal Structure Of Checkpoint Kinase 2 In Complex		8e-05
2ycr_A	323	Crystal Structure Of Checkpoint Kinase 2 In Complex		9e-05
1pme_A	380	Structure Of Penta Mutant Human Erk2 Map Kinase Com		9e-05
2wnt_A	330	Crystal Structure Of The Human Ribosomal Protein S6		9e-05
2w4o_A	349	Crystal Structure Of Human Camk4 In Complex With 4-		9e-05
3vui_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		9e-05
3i6u_A	419	Structure And Activation Mechanism Of The Chk2 Dna-		9e-05
3vuh_A	370	Crystal Structure Of A Cysteine-deficient Mutant M3		1e-04
3rny_A	346	Crystal Structure Of Human Rsk1 C-Terminal Kinase D		1e-04
3tei_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		1e-04
4fv6_A	360	Crystal Structure Of The Erk2 Complexed With E57 Le		1e-04
2y9q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		1e-04
3o71_A	358	Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length		1e-04
1xjd_A	345	Crystal Structure Of Pkc-Theta Complexed With Staur		1e-04
3krw_A	688	Human Grk2 In Complex With Gbetgamma Subunits And B		1e-04
3zu7_A	365	Crystal Structure Of A Designed Selected Ankyrin Re		1e-04
2z7l_A	366	Unphosphorylated Mitogen Activated Protein Kinase E		1e-04
3c9w_A	357	Crystal Structure Of Erk-2 With Hypothemycin Covale		1e-04
2fys_B	364	Crystal Structure Of Erk2 Complex With Kim Peptide		1e-04
3hgk_A	327	Crystal Structure Of Effect Protein Avrptob Complex		1e-04
2qkw_B	321	Structural Basis For Activation Of Plant Immunity B		1e-04
2ojg_A	380	Crystal Structure Of Erk2 In Complex With N,n-dimet		1e-04
3cik_A	689	Human Grk2 In Complex With Gbetagamma Subunits Leng		1e-04
1wzy_A	368	Crystal Structure Of Human Erk2 Complexed With A Py		1e-04
1tvo_A	368	The Structure Of Erk2 In Complex With A Small Molec		1e-04
4fsu_A	279	Crystal Structure Of The Chk1 Length = 279		1e-04
1omw_A	689	Crystal Structure Of The Complex Between G Protein-		1e-04
3r63_A	358	Structure Of Erk2 (Spe) Mutant (S246e) Length = 358		1e-04
3psc_A	695	Bovine Grk2 In Complex With Gbetagamma Subunits Len		1e-04
2p2i_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		1e-04
2p2h_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		1e-04
1gol_A	364	Coordinates Of Rat Map Kinase Erk2 With An Arginine		1e-04
2oh4_A	316	Crystal Structure Of Vegfr2 With A Benzimidazole-Ur		1e-04
1ywn_A	316	Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p		1e-04
3zuv_A	364	Crystal Structure Of A Designed Selected Ankyrin Re		1e-04
2erk_A	365	Phosphorylated Map Kinase Erk2 Length = 365		1e-04
2gph_A	364	Docking Motif Interactions In The Map Kinase Erk2 L		1e-04
2zoq_A	382	Structural Dissection Of Human Mitogen-Activated Ki		1e-04
1vr2_A	316	Human Vascular Endothelial Growth Factor Receptor 2		1e-04
3d5w_A	317	Crystal Structure Of A Phosphorylated Polo-Like Kin		1e-04
3d5u_A	317	Crystal Structure Of A Wildtype Polo-Like Kinase 1		1e-04
3fi3_A	364	Crystal Structure Of Jnk3 With Indazole Inhibitor,		1e-04
3vhk_A	368	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-04
4e7w_A	394	Structure Of Gsk3 From Ustilago Maydis Length = 394		2e-04
3fv8_A	355	Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le		2e-04
3ewh_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-04
3vhe_A	359	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		2e-04
1y6a_A	366	Crystal Structure Of Vegfr2 In Complex With A 2-Ani		2e-04
3db6_A	301	Crystal Structure Of An Activated (Thr->asp) Polo-L		2e-04
3kvx_A	364	Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le		2e-04
4agc_A	353	Crystal Structure Of Vegfr2 (Juxtamembrane And Kina		2e-04
3u6j_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-04
3vid_A	356	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		2e-04
3tl8_A	349	The Avrptob-Bak1 Complex Reveals Two Structurally S		2e-04
3txo_A	353	Pkc Eta Kinase In Complex With A Naphthyridine Leng		2e-04
2xir_A	316	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-04
3fi2_A	353	Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib		2e-04
3vnt_A	318	Crystal Structure Of The Kinase Domain Of Human Veg		2e-04
3d5v_A	317	Crystal Structure Of An Activated (Thr->asp) Polo-L		2e-04
2r9s_A	356	C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu		2e-04
3hng_A	360	Crystal Structure Of Vegfr1 In Complex With N-(4-ch		2e-04
3udb_A	317	Crystal Structure Of Snrk2.6 Length = 317		2e-04
1py5_A	326	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		2e-04
3ika_A	331	Crystal Structure Of Egfr 696-1022 T790m Mutant Cov		2e-04
3tzm_A	309	Tgf-Beta Receptor Type 1 In Complex With Sb431542 L		2e-04
1b6c_B	342	Crystal Structure Of The Cytoplasmic Domain Of The		2e-04
3h9f_A	313	Crystal Structure Of Human Dual Specificity Protein		2e-04
2gs7_A	330	Crystal Structure Of The Inactive Egfr Kinase Domai		2e-04
3qgw_A	286	Crystal Structure Of Itk Kinase Bound To An Inhibit		2e-04
2jiu_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		2e-04
2j5f_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		2e-04
1rw8_A	301	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		2e-04
1m14_A	333	Tyrosine Kinase Domain From Epidermal Growth Factor		2e-04
2ya9_A	361	Crystal Structure Of The Autoinhibited Form Of Mous		2e-04
4i23_A	329	Crystal Structure Of The Wild-type Egfr Kinase Doma		2e-04
1vjy_A	303	Crystal Structure Of A Naphthyridine Inhibitor Of H		2e-04
4hjo_A	337	Crystal Structure Of The Inactive Egfr Tyrosine Kin		2e-04
3bel_A	315	X-Ray Structure Of Egfr In Complex With Oxime Inhib		2e-04
1xkk_A	352	Egfr Kinase Domain Complexed With A Quinazoline Inh		2e-04
4g5p_A	330	Crystal Structure Of Egfr Kinase T790m In Complex W		2e-04
2wot_A	306	Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)		2e-04
3vug_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		2e-04
2gs2_A	330	Crystal Structure Of The Active Egfr Kinase Domain		2e-04
4i24_A	329	Structure Of T790m Egfr Kinase Domain Co-crystalliz		2e-04
2jit_A	327	Crystal Structure Of Egfr Kinase Domain T790m Mutat		2e-04
1zws_A	288	Crystal Structure Of The Catalytic Domain Of Human		2e-04
4g5j_A	330	Crystal Structure Of Egfr Kinase In Complex With Bi		2e-04
3oxi_A	362	Design And Synthesis Of Disubstituted Thiophene And		2e-04
3g33_A	308	Crystal Structure Of Cdk4CYCLIN D3 Length = 308		2e-04
2a2a_A	321	High-resolution Crystallographic Analysis Of The Au		2e-04
2a27_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		2e-04
3vjo_A	334	Crystal Structure Of The Wild-Type Egfr Kinase Doma		2e-04
3npc_A	364	Crystal Structure Of Jnk2 Complexed With Birb796 Le		2e-04
1jnk_A	423	The C-Jun N-Terminal Kinase (Jnk3s) Complexed With		2e-04
2o0u_A	364	Crystal Structure Of Human Jnk3 Complexed With N-{3		2e-04
2fso_X	367	Mitogen Activated Protein Kinase P38alpha (D176a) A		2e-04
1z9x_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		2e-04
1pmn_A	364	Crystal Structure Of Jnk3 In Complex With An Imidaz		3e-04
3ptg_A	363	Design And Synthesis Of A Novel, Orally Efficacious		3e-04
2ok1_A	365	Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3		3e-04
2b1p_A	355	Inhibitor Complex Of Jnk3 Length = 355		3e-04
3vud_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		3e-04
4h36_A	356	Crystal Structure Of Jnk3 In Complex With Atf2 Pept		3e-04
2j5e_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		3e-04
2exc_X	356	Inhibitor Complex Of Jnk3 Length = 356		3e-04
4e6d_A	298	Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W		3e-04
2fsl_X	367	Mitogen Activated Protein Kinase P38alpha (D176a+f3		3e-04
2fst_X	367	Mitogen Activated Protein Kinase P38alpha (d176a+f3		3e-04
1ukh_A	369	Structural Basis For The Selective Inhibition Of Jn		3e-04
3pze_A	358	Jnk1 In Complex With Inhibitor Length = 358		3e-04
3lzb_A	327	Egfr Kinase Domain Complexed With An Imidazo[2,1-B]		3e-04
3tac_A	361	Crystal Structure Of The Liprin-AlphaCASK COMPLEX L		3e-04
3ttj_A	464	Crystal Structure Of Jnk3 Complexed With Cc-359, A		3e-04
1wmk_A	321	Human Death-Associated Kinase Drp-1, Mutant S308d D		3e-04
2jiv_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		3e-04
2xrw_A	371	Linear Binding Motifs For Jnk And For Calcineurin A		3e-04
3elj_A	369	Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine		3e-04
3c0g_A	351	Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len		3e-04
1ove_A	366	The Structure Of P38 Alpha In Complex With A Dihydr		3e-04
2y8o_A	362	Crystal Structure Of Human P38alpha Complexed With		3e-04
3e7o_A	360	Crystal Structure Of Jnk2 Length = 360		4e-04
2g01_A	370	Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit		4e-04
3o17_A	370	Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3		4e-04
2wel_A	327	Crystal Structure Of Su6656-Bound CalciumCALMODULIN		4e-04
2baq_A	365	P38alpha Bound To Ro3201195 Length = 365		4e-04
2ghl_A	348	Mutant Mus Musculus P38 Kinase Domain In Complex Wi		4e-04
3nnx_A	354	Crystal Structure Of Phosphorylated P38 Alpha In Co		4e-04
3d83_A	360	Crystal Structure Of P38 Kinase In Complex With A B		4e-04
1ywr_A	360	Crystal Structure Analysis Of Inactive P38 Kinase D		4e-04
3ugc_A	295	Structural Basis Of Jak2 Inhibition By The Type Ii		4e-04
2wqb_A	324	Structure Of The Tie2 Kinase Domain In Complex With		4e-04
4fl3_A	635	Structural And Biophysical Characterization Of The		4e-04
2zv7_A	279	Lyn Tyrosine Kinase Domain, Apo Form Length = 279		4e-04
3dk6_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		4e-04
2dq7_X	283	Crystal Structure Of Fyn Kinase Domain Complexed Wi		5e-04
1yw2_A	360	Mutated Mus Musculus P38 Kinase (Mp38) Length = 360		5e-04
4fl2_A	636	Structural And Biophysical Characterization Of The		5e-04
3gc9_A	370	The Structure Of P38beta C119s, C162s In Complex Wi		5e-04
2vn9_A	301	Crystal Structure Of Human Calcium Calmodulin Depen		5e-04
3e62_A	293	Fragment Based Discovery Of Jak-2 Inhibitors Length		5e-04
3ka0_A	320	Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4		5e-04
2w1i_A	326	Structure Determination Of Aurora Kinase In Complex		5e-04
2bal_A	365	P38alpha Map Kinase Bound To Pyrazoloamine Length =		5e-04
2b7a_A	293	The Structural Basis Of Janus Kinase 2 Inhibition B		5e-04
3e92_A	371	Crystal Structure Of P38 Kinase In Complex With A B		5e-04
4hge_A	300	Jak2 Kinase (Jh1 Domain) In Complex With Compound 8		5e-04
4aqc_A	301	Triazolopyridine-Based Inhibitor Of Janus Kinase 2		5e-04
3io7_A	313	2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel		5e-04
3jy9_A	311	Janus Kinase 2 Inhibitors Length = 311		5e-04
4e4m_A	302	Jak2 Kinase (Jh1 Domain) In Complex With Compound 3		5e-04
2xa4_A	298	Inhibitors Of Jak2 Kinase Domain Length = 298		5e-04
3q32_A	301	Structure Of Janus Kinase 2 With A Pyrrolotriazine		5e-04
3lpb_A	295	Crystal Structure Of Jak2 Complexed With A Potent 2		5e-04
3rvg_A	303	Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido		5e-04
3gok_A	334	Binding Site Mapping Of Protein Ligands Length = 33		5e-04
3gc8_A	370	The Structure Of P38beta C162s In Complex With A Di		5e-04
4i20_A	329	Crystal Structure Of Monomeric (v948r) Primary Onco		5e-04
2jbo_A	326	Protein Kinase Mk2 In Complex With An Inhibitor (Cr		5e-04
4i1z_A	329	Crystal Structure Of The Monomeric (v948r) Form Of		5e-04
3tjc_A	298	Co-Crystal Structure Of Jak2 With Thienopyridine 8		5e-04
2itt_A	327	Crystal Structure Of Egfr Kinase Domain L858r Mutat		5e-04
4i21_A	329	Crystal Structure Of L858r + T790m Egfr Kinase Doma		6e-04
3fpm_A	325	Crystal Structure Of A Squarate Inhibitor Bound To		6e-04
3kxz_A	287	The Complex Crystal Structure Of Lck With A Probe M		6e-04
2eb3_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (L8		6e-04
3r2y_A	319	Mk2 Kinase Bound To Compound 1 Length = 319		6e-04
2pzy_A	324	Structure Of Mk2 Complexed With Compound 76 Length		6e-04
3r2b_A	318	Mk2 Kinase Bound To Compound 5b Length = 318		6e-04
3p4k_A	370	The Third Conformation Of P38a Map Kinase Observed		6e-04
2p3g_X	327	Crystal Structure Of A Pyrrolopyridine Inhibitor Bo		6e-04
3w2o_A	331	Egfr Kinase Domain T790m/l858r Mutant With Tak-285		6e-04
3emg_A	291	Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami		6e-04
2vz6_A	313	Structure Of Human Calcium Calmodulin Dependent Pro		6e-04
2rfd_A	324	Crystal Structure Of The Complex Between The Egfr K		6e-04
2gtm_A	348	Mutated Mouse P38 Map Kinase Domain In Complex With		6e-04
2puu_A	348	Crystal Structure Of P38 Complex With 1-(5-Tert-But		6e-04
3tub_A	293	Crystal Structure Of Syk Kinase Domain With 1-(5-(6		6e-04
3vf8_A	299	Crystal Structure Of Spleen Tyrosine Kinase Syk Cat		6e-04
3k3i_A	350	P38alpha Bound To Novel Dgf-Out Compound Pf-0021595		6e-04
2zm1_A	285	Crystal Structure Of Imidazo Pyrazin 1 Bound To The		6e-04
3srv_B	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		6e-04
2w99_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		6e-04
3oht_A	389	Crystal Structure Of Salmo Salar P38alpha Length =		6e-04
2onl_C	406	Crystal Structure Of The P38a-Mapkap Kinase 2 Heter		6e-04
1zzl_A	351	Crystal Structure Of P38 With Triazolopyridine Leng		7e-04
3kmm_A	288	Structure Of Human Lck Kinase With A Small Molecule		7e-04
1kwp_A	400	Crystal Structure Of Mapkap2 Length = 400		7e-04
3hec_A	348	P38 In Complex With Imatinib Length = 348		7e-04
3gcp_A	360	Human P38 Map Kinase In Complex With Sb203580 Lengt		7e-04
3d7z_A	360	Crystal Structure Of P38 Kinase In Complex With A B		7e-04
2w9f_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		7e-04
3s3i_A	349	P38 Kinase Crystal Structure In Complex With Small		7e-04
2w96_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		7e-04
1fvr_A	327	Tie2 Kinase Domain Length = 327		7e-04
1oz1_A	372	P38 Mitogen-Activated Kinase In Complex With 4-Azai		7e-04
1ian_A	366	Human P38 Map Kinase Inhibitor Complex Length = 366		7e-04
3fi4_A	372	P38 Kinase Crystal Structure In Complex With Ro4499		7e-04
3gcu_A	360	Human P38 Map Kinase In Complex With Rl48 Length =		7e-04
2gfs_A	372	P38 Kinase Crystal Structure In Complex With Ro3201		7e-04
1m7q_A	366	Crystal Structure Of P38 Map Kinase In Complex With		7e-04
2oo8_X	317	Synthesis, Structural Analysis, And Sar Studies Of		7e-04
2baj_A	365	P38alpha Bound To Pyrazolourea Length = 365		7e-04
3uim_A	326	Structural Basis For The Impact Of Phosphorylation		7e-04
3oef_X	360	Crystal Structure Of Y323f Inactive Mutant Of P38al		7e-04
3od6_X	360	Crystal Structure Of P38alpha Y323t Active Mutant L		7e-04
3nnu_A	354	Crystal Structure Of P38 Alpha In Complex With Dp13		7e-04
3hrb_A	359	P38 Kinase Crystal Structure In Complex With Small		7e-04
3cok_A	278	Crystal Structure Of Plk4 Kinase Length = 278		7e-04
3mpt_A	371	Crystal Structure Of P38 Kinase In Complex With A P		7e-04
1bmk_A	379	The Complex Structure Of The Map Kinase P38SB218655		7e-04
4fk3_A	292	B-Raf Kinase V600e Oncogenic Mutant In Complex With		7e-04
3tg1_A	380	Crystal Structure Of P38alpha In Complex With A Map		7e-04
3hko_A	345	Crystal Structure Of A Cdpk Kinase Domain From Cryp		7e-04
1lew_A	360	Crystal Structure Of Map Kinase P38 Complexed To Th		7e-04
3odz_X	360	Crystal Structure Of P38alpha Y323r Active Mutant L		7e-04
3omv_A	307	Crystal Structure Of C-Raf (Raf-1) Length = 307		7e-04
1di9_A	360	The Structure Of P38 Mitogen-Activated Protein Kina		7e-04
4e5a_X	360	The W197a Mutant Of P38a Map Kinase Length = 360		7e-04
3zsg_A	362	X-Ray Structure Of P38alpha Bound To Tak-715 Length		7e-04
3ody_X	360	Crystal Structure Of P38alpha Y323q Active Mutant L		7e-04
3dt1_A	383	P38 Complexed With A Quinazoline Inhibitor Length =		7e-04
2npq_A	367	A Novel Lipid Binding Site In The P38 Alpha Map Kin		7e-04
2oza_B	366	Structure Of P38alpha Complex Length = 366		7e-04
1qpe_A	279	Structural Analysis Of The Lymphocyte-Specific Kina		7e-04
3kq7_A	380	Structure Of Human P38alpha With N-[4-Methyl-3-(6-{		7e-04
3k3j_A	362	P38alpha Bound To Novel Dfg-Out Compound Pf-0041612		7e-04
3hvc_A	362	Crystal Structure Of Human P38alpha Map Kinase Leng		7e-04
1bl6_A	379	The Complex Structure Of The Map Kinase P38SB216995		7e-04
1nxk_A	400	Crystal Structure Of Staurosporine Bound To Map Kap		7e-04
2oza_A	356	Structure Of P38alpha Complex Length = 356		7e-04
4f4p_A	273	Syk In Complex With Ligand Lasw836 Length = 273		7e-04
3srv_A	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		7e-04
4dfl_A	274	Crystal Structure Of Spleen Tyrosine Kinase Complex		8e-04
2lgc_A	359	Joint Nmr And X-Ray Refinement Reveals The Structur		8e-04
3og7_A	289	B-Raf Kinase V600e Oncogenic Mutant In Complex With		8e-04
3lck_A	271	The Kinase Domain Of Human Lymphocyte Kinase (Lck),		8e-04
2ofu_A	273	X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam		8e-04
2qg5_A	294	Cryptosporidium Parvum Calcium Dependent Protein Ki		8e-04
3c4c_A	280	B-Raf Kinase In Complex With Plx4720 Length = 280		8e-04
2pl0_A	289	Lck Bound To Imatinib Length = 289		8e-04
1xba_A	291	Crystal Structure Of Apo Syk Tyrosine Kinase Domain		8e-04
2ac5_A	316	Structure Of Human Mnk2 Kinase Domain Mutant D228g		8e-04
3bym_A	272	X-Ray Co-Crystal Structure Aminobenzimidazole Triaz		8e-04
3bhh_A	295	Crystal Structure Of Human Calcium/calmodulin-depen		8e-04
3fpq_A	290	Crystal Structure Of The Kinase Domain Of Wnk1 Leng		9e-04
3f3z_A	277	Crystal Structure Of Cryptosporidium Parvum Calcium		9e-04

>pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327

Iteration: 1
 Score =  269 bits (687), Expect = 8e-73,   Method: Compositional matrix adjust.
 Identities = 135/205 (65%), Positives = 157/205 (76%), Gaps = 37/205 (18%)
Query: 4   SIQSSGKLKLSPDTVYDFTSEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDE 63
           SI+SSGKLK+SP+  +DFT+EDL+DLGEIGRG +G+VNKM+H+ S  +MAVKRIRSTVDE
Sbjct: 2   SIESSGKLKISPEQHWDFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDE 61
Query: 64  KDQRQLLMDLDVVMKSNECPYIVQFYGALFKE---------------------------- 95
           K+Q+QLLMDLDVVM+S++CPYIVQFYGALF+E                            
Sbjct: 62  KEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICMELMSTSFDKFYKYVYSVLDDV 121
Query: 96  --------VTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIA 147
                   +T+ATVKALN+LKE LKIIHRD+KPSNILLDR G IKLCDFGISGQLVDSIA
Sbjct: 122 IPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIA 181
Query: 148 KTRDAGCRPYMAPERIDPLRAR-GY 171
           KTRDAGCRPYMAPERIDP  +R GY
Sbjct: 182 KTRDAGCRPYMAPERIDPSASRQGY 206

>pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340

Iteration: 1
 Score =  181 bits (460), Expect = 2e-46,   Method: Compositional matrix adjust.
 Identities = 88/189 (46%), Positives = 123/189 (65%), Gaps = 36/189 (19%)
Query: 19  YDFTSEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMK 78
           ++  ++DL+ + E+GRG +G V KM H  S  +MAVKRIR+TV+ ++Q++LLMDLD+ M+
Sbjct: 46  FEVKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMR 105
Query: 79  SNECPYIVQFYGALFKE-----------------------------------VTVATVKA 103
           + +CP+ V FYGALF+E                                   + V+ VKA
Sbjct: 106 TVDCPFTVTFYGALFREGDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKA 165
Query: 104 LNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERI 163
           L +L  +L +IHRDVKPSN+L++  G +K+CDFGISG LVDS+AKT DAGC+PYMAPERI
Sbjct: 166 LEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDSVAKTIDAGCKPYMAPERI 225
Query: 164 DP-LRARGY 171
           +P L  +GY
Sbjct: 226 NPELNQKGY 234

>pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290

Iteration: 1
 Score =  175 bits (444), Expect = 1e-44,   Method: Compositional matrix adjust.
 Identities = 86/185 (46%), Positives = 119/185 (64%), Gaps = 36/185 (19%)
Query: 23  SEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNEC 82
           ++DL+ + E+GRG +G V KM H  S  +MAVKRIR+TV+ ++Q++LLMDLD+ M++ +C
Sbjct: 6   ADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDC 65
Query: 83  PYIVQFYGALFKE-----------------------------------VTVATVKALNYL 107
           P+ V FYGALF+E                                   + V+ VKAL +L
Sbjct: 66  PFTVTFYGALFREGDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHL 125
Query: 108 KEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDP-L 166
             +L +IHRDVKPSN+L++  G +K+CDFGISG LVD +AK  DAGC+PYMAPERI+P L
Sbjct: 126 HSKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAKDIDAGCKPYMAPERINPEL 185
Query: 167 RARGY 171
             +GY
Sbjct: 186 NQKGY 190

>pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318

Iteration: 1
 Score =  164 bits (416), Expect = 2e-41,   Method: Compositional matrix adjust.
 Identities = 88/179 (49%), Positives = 113/179 (63%), Gaps = 32/179 (17%)
Query: 19  YDFTSEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMK 78
           Y     DL++LGE+G G  G V KM  R +  V+AVK++R + ++++ +++LMDLDVV+K
Sbjct: 20  YQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLK 79
Query: 79  SNECPYIVQFYGA--------------------------------LFKEVTVATVKALNY 106
           S++CPYIVQ +G                                 +  ++TVA VKAL Y
Sbjct: 80  SHDCPYIVQCFGTFITNTDVFIAMELMGTCAEKLKKRMQGPIPERILGKMTVAIVKALYY 139
Query: 107 LKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDP 165
           LKE+  +IHRDVKPSNILLD RG IKLCDFGISG+LVD  AK R AGC  YMAPERIDP
Sbjct: 140 LKEKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKAKDRSAGCAAYMAPERIDP 198

>pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316

Iteration: 1
 Score =  163 bits (412), Expect = 5e-41,   Method: Compositional matrix adjust.
 Identities = 81/189 (42%), Positives = 115/189 (60%), Gaps = 36/189 (19%)
Query: 19  YDFTSEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMK 78
           ++  ++DL+ + E+GRG +G V K  H  S  + AVKRIR+TV+ ++Q++LL DLD+  +
Sbjct: 29  FEVKADDLEPIXELGRGAYGVVEKXRHVPSGQIXAVKRIRATVNSQEQKRLLXDLDISXR 88
Query: 79  SNECPYIVQFYGALFKE-----------------------------------VTVATVKA 103
           + +CP+ V FYGALF+E                                   + V+ VKA
Sbjct: 89  TVDCPFTVTFYGALFREGDVWICXELXDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKA 148
Query: 104 LNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERI 163
           L +L  +L +IHRDVKPSN+L++  G +K CDFGISG LVD +AK  DAGC+PY APERI
Sbjct: 149 LEHLHSKLSVIHRDVKPSNVLINALGQVKXCDFGISGYLVDDVAKDIDAGCKPYXAPERI 208
Query: 164 DP-LRARGY 171
           +P L  +GY
Sbjct: 209 NPELNQKGY 217

>pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395

Iteration: 1
 Score =  123 bits (309), Expect = 5e-29,   Method: Compositional matrix adjust.
 Identities = 69/178 (38%), Positives = 99/178 (55%), Gaps = 34/178 (19%)
Query: 18  VYDFTSEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVM 77
           V +   +D + + E+G G  G V K+ H+ S  VMA K I   +    + Q++ +L V+ 
Sbjct: 62  VGELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLH 121
Query: 78  KSNECPYIVQFYGALFKE--------------------------------VTVATVKALN 105
           + N  PYIV FYGA + +                                V++A +K L 
Sbjct: 122 ECN-SPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLT 180
Query: 106 YLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERI 163
           YL+E+ KI+HRDVKPSNIL++ RG IKLCDFG+SGQL+DS+A +   G R YM+PER+
Sbjct: 181 YLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSF-VGTRSYMSPERL 237

>pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360

Iteration: 1
 Score =  123 bits (308), Expect = 7e-29,   Method: Compositional matrix adjust.
 Identities = 69/178 (38%), Positives = 99/178 (55%), Gaps = 34/178 (19%)
Query: 18  VYDFTSEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVM 77
           V +   +D + + E+G G  G V K+ H+ S  VMA K I   +    + Q++ +L V+ 
Sbjct: 27  VGELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLH 86
Query: 78  KSNECPYIVQFYGALFKE--------------------------------VTVATVKALN 105
           + N  PYIV FYGA + +                                V++A +K L 
Sbjct: 87  ECN-SPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLT 145
Query: 106 YLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERI 163
           YL+E+ KI+HRDVKPSNIL++ RG IKLCDFG+SGQL+DS+A +   G R YM+PER+
Sbjct: 146 YLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSF-VGTRSYMSPERL 202

>pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304

Iteration: 1
 Score =  123 bits (308), Expect = 7e-29,   Method: Compositional matrix adjust.
 Identities = 69/178 (38%), Positives = 99/178 (55%), Gaps = 34/178 (19%)
Query: 18  VYDFTSEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVM 77
           V +   +D + + E+G G  G V K+ H+ S  VMA K I   +    + Q++ +L V+ 
Sbjct: 19  VGELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLH 78
Query: 78  KSNECPYIVQFYGALFKE--------------------------------VTVATVKALN 105
           + N  PYIV FYGA + +                                V++A +K L 
Sbjct: 79  ECNS-PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLT 137
Query: 106 YLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERI 163
           YL+E+ KI+HRDVKPSNIL++ RG IKLCDFG+SGQL+DS+A +   G R YM+PER+
Sbjct: 138 YLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSF-VGTRSYMSPERL 194

>pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307

Iteration: 1
 Score =  122 bits (307), Expect = 9e-29,   Method: Compositional matrix adjust.
 Identities = 68/176 (38%), Positives = 98/176 (55%), Gaps = 34/176 (19%)
Query: 20  DFTSEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKS 79
           +   +D + + E+G G  G V K+ H+ S  VMA K I   +    + Q++ +L V+ + 
Sbjct: 2   ELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHEC 61
Query: 80  NECPYIVQFYGALFKE--------------------------------VTVATVKALNYL 107
           N  PYIV FYGA + +                                V++A +K L YL
Sbjct: 62  NS-PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYL 120
Query: 108 KEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERI 163
           +E+ KI+HRDVKPSNIL++ RG IKLCDFG+SGQL+DS+A +   G R YM+PER+
Sbjct: 121 REKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSF-VGTRSYMSPERL 175

>pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333

Iteration: 1
 Score =  122 bits (307), Expect = 1e-28,   Method: Compositional matrix adjust.
 Identities = 68/176 (38%), Positives = 98/176 (55%), Gaps = 34/176 (19%)
Query: 20  DFTSEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKS 79
           +   +D + + E+G G  G V K+ H+ S  VMA K I   +    + Q++ +L V+ + 
Sbjct: 2   ELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHEC 61
Query: 80  NECPYIVQFYGALFKE--------------------------------VTVATVKALNYL 107
           N  PYIV FYGA + +                                V++A +K L YL
Sbjct: 62  NS-PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYL 120
Query: 108 KEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERI 163
           +E+ KI+HRDVKPSNIL++ RG IKLCDFG+SGQL+DS+A +   G R YM+PER+
Sbjct: 121 REKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSF-VGTRSYMSPERL 175

>pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341

Iteration: 1
 Score =  122 bits (306), Expect = 1e-28,   Method: Compositional matrix adjust.
 Identities = 68/176 (38%), Positives = 98/176 (55%), Gaps = 34/176 (19%)
Query: 20  DFTSEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKS 79
           +   +D + + E+G G  G V K+ H+ S  VMA K I   +    + Q++ +L V+ + 
Sbjct: 2   ELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHEC 61
Query: 80  NECPYIVQFYGALFKE--------------------------------VTVATVKALNYL 107
           N  PYIV FYGA + +                                V++A +K L YL
Sbjct: 62  NS-PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYL 120
Query: 108 KEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERI 163
           +E+ KI+HRDVKPSNIL++ RG IKLCDFG+SGQL+DS+A +   G R YM+PER+
Sbjct: 121 REKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSF-VGTRSYMSPERL 175

>pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328

Iteration: 1
 Score =  122 bits (306), Expect = 1e-28,   Method: Compositional matrix adjust.
 Identities = 68/176 (38%), Positives = 98/176 (55%), Gaps = 34/176 (19%)
Query: 20  DFTSEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKS 79
           +   +D + + E+G G  G V K+ H+ S  VMA K I   +    + Q++ +L V+ + 
Sbjct: 2   ELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHEC 61
Query: 80  NECPYIVQFYGALFKE--------------------------------VTVATVKALNYL 107
           N  PYIV FYGA + +                                V++A +K L YL
Sbjct: 62  NS-PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYL 120
Query: 108 KEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERI 163
           +E+ KI+HRDVKPSNIL++ RG IKLCDFG+SGQL+DS+A +   G R YM+PER+
Sbjct: 121 REKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSF-VGTRSYMSPERL 175

>pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322

Iteration: 1
 Score =  122 bits (306), Expect = 1e-28,   Method: Compositional matrix adjust.
 Identities = 68/176 (38%), Positives = 98/176 (55%), Gaps = 34/176 (19%)
Query: 20  DFTSEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKS 79
           +   +D + + E+G G  G V K+ H+ S  VMA K I   +    + Q++ +L V+ + 
Sbjct: 2   ELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHEC 61
Query: 80  NECPYIVQFYGALFKE--------------------------------VTVATVKALNYL 107
           N  PYIV FYGA + +                                V++A +K L YL
Sbjct: 62  NS-PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYL 120
Query: 108 KEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERI 163
           +E+ KI+HRDVKPSNIL++ RG IKLCDFG+SGQL+DS+A +   G R YM+PER+
Sbjct: 121 REKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSF-VGTRSYMSPERL 175

>pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354

Iteration: 1
 Score =  122 bits (306), Expect = 1e-28,   Method: Compositional matrix adjust.
 Identities = 68/178 (38%), Positives = 99/178 (55%), Gaps = 34/178 (19%)
Query: 18  VYDFTSEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVM 77
           V +   +D + + E+G G  G V K+ HR S  +MA K I   +    + Q++ +L V+ 
Sbjct: 10  VGELKDDDFERISELGAGNGGVVTKVQHRPSGLIMARKLIHLEIKPAIRNQIIRELQVLH 69
Query: 78  KSNECPYIVQFYGALFKE--------------------------------VTVATVKALN 105
           + N  PYIV FYGA + +                                V++A ++ L 
Sbjct: 70  ECN-SPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLA 128
Query: 106 YLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERI 163
           YL+E+ +I+HRDVKPSNIL++ RG IKLCDFG+SGQL+DS+A +   G R YMAPER+
Sbjct: 129 YLREKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSF-VGTRSYMAPERL 185

>pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301

Iteration: 1
 Score =  120 bits (300), Expect = 5e-28,   Method: Compositional matrix adjust.
 Identities = 67/176 (38%), Positives = 96/176 (54%), Gaps = 34/176 (19%)
Query: 20  DFTSEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKS 79
           +   +D + + E+G G  G V K+ H+ S  VMA K I   +    + Q++ +L V+ + 
Sbjct: 5   ELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHEC 64
Query: 80  NECPYIVQFYGALFKE--------------------------------VTVATVKALNYL 107
           N  PYIV FYGA + +                                V++A +K L YL
Sbjct: 65  NS-PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYL 123
Query: 108 KEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERI 163
           +E+ KI+HRDVKPSNIL++ RG IKLCDFG+SGQL+D +A     G R YM+PER+
Sbjct: 124 REKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDEMA-NEFVGTRSYMSPERL 178

>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314

Iteration: 1
 Score = 85.5 bits (210), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 55/186 (29%), Positives = 93/186 (50%), Gaps = 39/186 (20%)
Query: 12  KLSPDTVYDFTSEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLM 71
           KL  D++     E    L ++G G +G+V K IH+ +  ++A+K++     E D ++++ 
Sbjct: 17  KLDEDSLTKQPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPV---ESDLQEIIK 73
Query: 72  DLDVVMKSNECPYIVQFYGALFKEVTV--------------------------------- 98
           ++ + M+  + P++V++YG+ FK   +                                 
Sbjct: 74  EISI-MQQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQ 132
Query: 99  ATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTRDAGCRP-Y 157
           +T+K L YL   ++ IHRD+K  NILL+  G  KL DFG++GQL D +AK       P +
Sbjct: 133 STLKGLEYL-HFMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDXMAKRNXVIGTPFW 191
Query: 158 MAPERI 163
           MAPE I
Sbjct: 192 MAPEVI 197

>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294

Iteration: 1
 Score = 77.0 bits (188), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 61/199 (30%), Positives = 93/199 (46%), Gaps = 39/199 (19%)
Query: 1   MCQSIQSSGKLKLSPDTVYDFTSEDLQDL----GEIGRGGFGTVNKMIHRSSDTVMAVKR 56
           M      S  + L  + +Y F S D ++L     +IG+G FG V K I   +  V+A+K 
Sbjct: 1   MHHHHHHSSGVDLGTENLY-FQSMDPEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKI 59
Query: 57  IRSTVDEKDQRQLLMDLDVVMKSNECPYIVQFYGALFK---------------------- 94
           I     E +   +  ++  V+   + PY+ ++YG+  K                      
Sbjct: 60  IDLEEAEDEIEDIQQEI-TVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEP 118
Query: 95  ----EVTVATV-----KALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDS 145
               E  +AT+     K L+YL  E KI HRD+K +N+LL   G +KL DFG++GQL D+
Sbjct: 119 GPLDETQIATILREILKGLDYLHSEKKI-HRDIKAANVLLSEHGEVKLADFGVAGQLTDT 177
Query: 146 -IAKTRDAGCRPYMAPERI 163
            I +    G   +MAPE I
Sbjct: 178 QIKRNTFVGTPFWMAPEVI 196

>pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384

Iteration: 1
 Score = 76.6 bits (187), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 56/190 (29%), Positives = 85/190 (44%), Gaps = 36/190 (18%)
Query: 16  DTVYDFTSEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRI--RSTVDEKDQRQLLMDL 73
           D   D   +  + L  IG+G FG V  +    +  + A+K +  +  V+  + R +  +L
Sbjct: 7   DENEDVNFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKEL 66
Query: 74  DVVMKSNECPYIVQFYGAL---------------------------FKEVTV-----ATV 101
            + M+  E P++V  + +                            FKE TV       V
Sbjct: 67  QI-MQGLEHPFLVNLWYSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELV 125
Query: 102 KALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTRDAGCRPYMAPE 161
            AL+YL+ + +IIHRD+KP NILLD  G + + DF I+  L      T  AG +PYMAPE
Sbjct: 126 MALDYLQNQ-RIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQITTMAGTKPYMAPE 184
Query: 162 RIDPLRARGY 171
                +  GY
Sbjct: 185 MFSSRKGAGY 194

>pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303

Iteration: 1
 Score = 76.6 bits (187), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 54/167 (32%), Positives = 81/167 (48%), Gaps = 34/167 (20%)
Query: 29  LGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQF 88
           L +IG+G FG V K I   +  V+A+K I     E +   +  ++  V+   + PY+ ++
Sbjct: 27  LEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEI-TVLSQCDSPYVTKY 85
Query: 89  YGALFK--------------------------EVTVATV-----KALNYLKEELKIIHRD 117
           YG+  K                          E  +AT+     K L+YL  E KI HRD
Sbjct: 86  YGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIATILREILKGLDYLHSEKKI-HRD 144
Query: 118 VKPSNILLDRRGAIKLCDFGISGQLVDS-IAKTRDAGCRPYMAPERI 163
           +K +N+LL   G +KL DFG++GQL D+ I +    G   +MAPE I
Sbjct: 145 IKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNXFVGTPFWMAPEVI 191

>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304

Iteration: 1
 Score = 76.6 bits (187), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 54/167 (32%), Positives = 82/167 (49%), Gaps = 34/167 (20%)
Query: 29  LGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQF 88
           L +IG+G FG V K I   +  V+A+K I     E +   +  ++ V+ + +  PY+ ++
Sbjct: 12  LEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCD-SPYVTKY 70
Query: 89  YGALFK--------------------------EVTVATV-----KALNYLKEELKIIHRD 117
           YG+  K                          E  +AT+     K L+YL  E KI HRD
Sbjct: 71  YGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIATILREILKGLDYLHSEKKI-HRD 129
Query: 118 VKPSNILLDRRGAIKLCDFGISGQLVDS-IAKTRDAGCRPYMAPERI 163
           +K +N+LL   G +KL DFG++GQL D+ I +    G   +MAPE I
Sbjct: 130 IKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNXFVGTPFWMAPEVI 176

>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304

Iteration: 1
 Score = 76.6 bits (187), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 54/167 (32%), Positives = 81/167 (48%), Gaps = 34/167 (20%)
Query: 29  LGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQF 88
           L +IG+G FG V K I   +  V+A+K I     E +   +  ++  V+   + PY+ ++
Sbjct: 12  LEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEI-TVLSQCDSPYVTKY 70
Query: 89  YGALFK--------------------------EVTVATV-----KALNYLKEELKIIHRD 117
           YG+  K                          E  +AT+     K L+YL  E KI HRD
Sbjct: 71  YGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIATILREILKGLDYLHSEKKI-HRD 129
Query: 118 VKPSNILLDRRGAIKLCDFGISGQLVDS-IAKTRDAGCRPYMAPERI 163
           +K +N+LL   G +KL DFG++GQL D+ I +    G   +MAPE I
Sbjct: 130 IKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVI 176

>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294

Iteration: 1
 Score = 75.1 bits (183), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 55/172 (31%), Positives = 82/172 (47%), Gaps = 34/172 (19%)
Query: 24  EDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECP 83
           E    L  IG+G FG V K I   +  V+A+K I     E +   +  ++  V+   + P
Sbjct: 19  ELFTKLDRIGKGSFGEVYKGIDNHTKEVVAIKIIDLEEAEDEIEDIQQEI-TVLSQCDSP 77
Query: 84  YIVQFYGALFK--------------------------EVTVATV-----KALNYLKEELK 112
           YI +++G+  K                          E  +AT+     K L+YL  E K
Sbjct: 78  YITRYFGSYLKSTKLWIIMEYLGGGSALDLLKPGPLEETYIATILREILKGLDYLHSERK 137
Query: 113 IIHRDVKPSNILLDRRGAIKLCDFGISGQLVDS-IAKTRDAGCRPYMAPERI 163
           I HRD+K +N+LL  +G +KL DFG++GQL D+ I +    G   +MAPE I
Sbjct: 138 I-HRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNXFVGTPFWMAPEVI 188

>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301

Iteration: 1
 Score = 72.0 bits (175), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 53/167 (31%), Positives = 81/167 (48%), Gaps = 34/167 (20%)
Query: 29  LGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQF 88
           L  IG+G FG V K I   +  V+A+K I     E +   +  ++ V+ + +   Y+ ++
Sbjct: 28  LERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSS-YVTKY 86
Query: 89  YGAL--------------------------FKEVTVAT-----VKALNYLKEELKIIHRD 117
           YG+                           F E  +AT     +K L+YL  E KI HRD
Sbjct: 87  YGSYLKGSKLWIIMEYLGGGSALDLLRAGPFDEFQIATMLKEILKGLDYLHSEKKI-HRD 145
Query: 118 VKPSNILLDRRGAIKLCDFGISGQLVDS-IAKTRDAGCRPYMAPERI 163
           +K +N+LL  +G +KL DFG++GQL D+ I +    G   +MAPE I
Sbjct: 146 IKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVI 192

>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 70.1 bits (170), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 55/180 (30%), Positives = 86/180 (47%), Gaps = 40/180 (22%)
Query: 20  DFTSEDLQDL-GEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMK 78
           D   ED  ++ GE+G G FG V K  ++ + +V+A  ++  T  E++    ++++D+ + 
Sbjct: 32  DLNPEDFWEIIGELGDGAFGKVYKAQNKET-SVLAAAKVIDTKSEEELEDYMVEIDI-LA 89
Query: 79  SNECPYIVQFYGALFKE---------------------------------VTVATVKALN 105
           S + P IV+   A + E                                 V   T+ ALN
Sbjct: 90  SCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALN 149
Query: 106 YLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTRDA--GCRPYMAPERI 163
           YL +  KIIHRD+K  NIL    G IKL DFG+S +   +I + RD+  G   +MAPE +
Sbjct: 150 YLHDN-KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQR-RDSFIGTPYWMAPEVV 207

>pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373

Iteration: 1
 Score = 69.7 bits (169), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 50/189 (26%), Positives = 87/189 (46%), Gaps = 36/189 (19%)
Query: 8   SGKLKLSPDTVYDFTSEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRI--RSTVDEKD 65
           S ++ L P +       D   L  IG+G FG V    H++ +   AVK +  ++ + +K+
Sbjct: 22  SQQINLGPSSNPHAKPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKE 81
Query: 66  QRQLLMDLDVVMKSNECPYIVQFY------------------GALFKEV----------- 96
           ++ ++ + +V++K+ + P++V  +                  G LF  +           
Sbjct: 82  EKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRA 141
Query: 97  ---TVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTRD-A 152
                    AL YL   L I++RD+KP NILLD +G I L DFG+  + ++  + T    
Sbjct: 142 RFYAAEIASALGYL-HSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNSTTSTFC 200
Query: 153 GCRPYMAPE 161
           G   Y+APE
Sbjct: 201 GTPEYLAPE 209

>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325

Iteration: 1
 Score = 69.3 bits (168), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 55/180 (30%), Positives = 85/180 (47%), Gaps = 40/180 (22%)
Query: 20  DFTSEDLQDL-GEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMK 78
           D   ED  ++ GE+G G FG V K  ++ + +V+A  ++  T  E++    ++++D+ + 
Sbjct: 32  DLNPEDFWEIIGELGDGAFGKVYKAQNKET-SVLAAAKVIDTKSEEELEDYMVEIDI-LA 89
Query: 79  SNECPYIVQFYGALFKE---------------------------------VTVATVKALN 105
           S + P IV+   A + E                                 V   T+ ALN
Sbjct: 90  SCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALN 149
Query: 106 YLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTRDA--GCRPYMAPERI 163
           YL +  KIIHRD+K  NIL    G IKL DFG+S +    I + RD+  G   +MAPE +
Sbjct: 150 YLHDN-KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRXIQR-RDSFIGTPYWMAPEVV 207

>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 68.6 bits (166), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 55/180 (30%), Positives = 84/180 (46%), Gaps = 40/180 (22%)
Query: 20  DFTSEDLQDL-GEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMK 78
           D   ED  ++ GE+G G FG V K  ++ + +V+A  ++  T  E++    ++++D+ + 
Sbjct: 32  DLNPEDFWEIIGELGDGAFGKVYKAQNKET-SVLAAAKVIDTKSEEELEDYMVEIDI-LA 89
Query: 79  SNECPYIVQFYGALFKE---------------------------------VTVATVKALN 105
           S + P IV+   A + E                                 V   T+ ALN
Sbjct: 90  SCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALN 149
Query: 106 YLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTRDA--GCRPYMAPERI 163
           YL +  KIIHRD+K  NIL    G IKL DFG+S +    I + RD   G   +MAPE +
Sbjct: 150 YLHDN-KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRXIQR-RDXFIGTPYWMAPEVV 207

>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 50/186 (26%), Positives = 89/186 (47%), Gaps = 46/186 (24%)
Query: 13  LSPDTVYDFTSEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMD 72
           L P+ V++        +GE+G G FG V K  ++ +  + A K I  T  E++    +++
Sbjct: 15  LDPNEVWEI-------VGELGDGAFGKVYKAKNKETGALAAAKVIE-TKSEEELEDYIVE 66
Query: 73  LDVVMKSNECPYIVQFYGALFKE---------------------------------VTVA 99
           ++++   +  PYIV+  GA + +                                 V   
Sbjct: 67  IEILATCDH-PYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQ 125
Query: 100 TVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTRDA--GCRPY 157
            ++ALN+L  + +IIHRD+K  N+L+   G I+L DFG+S + + ++ K RD+  G   +
Sbjct: 126 MLEALNFLHSK-RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQK-RDSFIGTPYW 183
Query: 158 MAPERI 163
           MAPE +
Sbjct: 184 MAPEVV 189

>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293

Iteration: 1
 Score = 65.5 bits (158), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 50/186 (26%), Positives = 89/186 (47%), Gaps = 46/186 (24%)
Query: 13  LSPDTVYDFTSEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMD 72
           L P+ V++        +GE+G G FG V K  ++ +  + A K I  T  E++    +++
Sbjct: 7   LDPNEVWEI-------VGELGDGAFGKVYKAKNKETGALAAAKVIE-TKSEEELEDYIVE 58
Query: 73  LDVVMKSNECPYIVQFYGALFKE---------------------------------VTVA 99
           ++++   +  PYIV+  GA + +                                 V   
Sbjct: 59  IEILATCDH-PYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQ 117
Query: 100 TVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTRDA--GCRPY 157
            ++ALN+L  + +IIHRD+K  N+L+   G I+L DFG+S + + ++ K RD+  G   +
Sbjct: 118 MLEALNFLHSK-RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQK-RDSFIGTPYW 175
Query: 158 MAPERI 163
           MAPE +
Sbjct: 176 MAPEVV 181

>pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325

Iteration: 1
 Score = 62.4 bits (150), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 53/169 (31%), Positives = 81/169 (47%), Gaps = 37/169 (21%)
Query: 32  IGRGGFGTV---NKMIHRSSDTVMAVKRIR-STVDEKDQRQLLMDLDVVMKSNECPYIVQ 87
           +G+G FG V    K+    +  + A+K ++ +T+  +D+ +  M+ D++++ N  P+IV+
Sbjct: 32  LGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNH-PFIVK 90
Query: 88  FY------------------GALF----KEVTVATVKALNYLKE---------ELKIIHR 116
            +                  G LF    KEV         YL E          L II+R
Sbjct: 91  LHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYR 150
Query: 117 DVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTRD-AGCRPYMAPERID 164
           D+KP NILLD  G IKL DFG+S + +D   K     G   YMAPE ++
Sbjct: 151 DLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVN 199

>pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321

Iteration: 1
 Score = 62.4 bits (150), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 53/169 (31%), Positives = 79/169 (46%), Gaps = 37/169 (21%)
Query: 32  IGRGGFGTV---NKMIHRSSDTVMAVKRIR-STVDEKDQRQLLMDLDVVMKSNECPYIVQ 87
           +G+G FG V    K+    S  + A+K ++ +T+  +D+ +  M+ D++   N  P++V+
Sbjct: 36  LGQGSFGKVFLVRKVTRPDSGHLYAMKVLKKATLKVRDRVRTKMERDILADVNH-PFVVK 94
Query: 88  FY------------------GALF----KEVTVATVKALNYLKE---------ELKIIHR 116
            +                  G LF    KEV         YL E          L II+R
Sbjct: 95  LHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALGLDHLHSLGIIYR 154
Query: 117 DVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTRD-AGCRPYMAPERID 164
           D+KP NILLD  G IKL DFG+S + +D   K     G   YMAPE ++
Sbjct: 155 DLKPENILLDEEGHIKLTDFGLSKEAIDHEKKAYSFCGTVEYMAPEVVN 203

>pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305

Iteration: 1
 Score = 62.4 bits (150), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 53/169 (31%), Positives = 81/169 (47%), Gaps = 37/169 (21%)
Query: 32  IGRGGFGTV---NKMIHRSSDTVMAVKRIR-STVDEKDQRQLLMDLDVVMKSNECPYIVQ 87
           +G+G FG V    K+    +  + A+K ++ +T+  +D+ +  M+ D++++ N  P+IV+
Sbjct: 33  LGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNH-PFIVK 91
Query: 88  FY------------------GALF----KEVTVATVKALNYLKE---------ELKIIHR 116
            +                  G LF    KEV         YL E          L II+R
Sbjct: 92  LHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYR 151
Query: 117 DVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTRD-AGCRPYMAPERID 164
           D+KP NILLD  G IKL DFG+S + +D   K     G   YMAPE ++
Sbjct: 152 DLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVN 200

>pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304

Iteration: 1
 Score = 62.0 bits (149), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 53/169 (31%), Positives = 81/169 (47%), Gaps = 37/169 (21%)
Query: 32  IGRGGFGTV---NKMIHRSSDTVMAVKRIR-STVDEKDQRQLLMDLDVVMKSNECPYIVQ 87
           +G+G FG V    K+    +  + A+K ++ +T+  +D+ +  M+ D++++ N  P+IV+
Sbjct: 32  LGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNH-PFIVK 90
Query: 88  FY------------------GALF----KEVTVATVKALNYLKE---------ELKIIHR 116
            +                  G LF    KEV         YL E          L II+R
Sbjct: 91  LHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYR 150
Query: 117 DVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTRD-AGCRPYMAPERID 164
           D+KP NILLD  G IKL DFG+S + +D   K     G   YMAPE ++
Sbjct: 151 DLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVN 199

>pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402

Iteration: 1
 Score = 60.8 bits (146), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 49/184 (26%), Positives = 79/184 (42%), Gaps = 37/184 (20%)
Query: 23  SEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIR--STVDEKDQRQLLMDLDVVMKSN 80
           +ED   +  IGRG FG V  + H++S  V A+K +     +   D      + D++  +N
Sbjct: 74  AEDYDVVKVIGRGAFGEVQLVRHKASQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFAN 133
Query: 81  ECPYIVQFYGAL-------------------------------FKEVTVATVKALNYLKE 109
             P++VQ + A                                 K  T   V AL+ +  
Sbjct: 134 -SPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLMSNYDVPEKWAKFYTAEVVLALDAI-H 191
Query: 110 ELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDS--IAKTRDAGCRPYMAPERIDPLR 167
            + +IHRDVKP N+LLD+ G +KL DFG   ++ ++  +      G   Y++PE +    
Sbjct: 192 SMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVHCDTAVGTPDYISPEVLKSQG 251
Query: 168 ARGY 171
             GY
Sbjct: 252 GDGY 255

>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311

Iteration: 1
 Score = 60.1 bits (144), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 44/171 (25%), Positives = 75/171 (43%), Gaps = 34/171 (19%)
Query: 24  EDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECP 83
           E  + +G+IG G +G V K  +R +  ++A+K+   + D+   +++ +    ++K  + P
Sbjct: 3   EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHP 62
Query: 84  YIVQFYGA--------------------------------LFKEVTVATVKALNYLKEEL 111
            +V                                     L K +T  T++A+N+  +  
Sbjct: 63  NLVNLLEVFRRKRRLHLVFEYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKH- 121
Query: 112 KIIHRDVKPSNILLDRRGAIKLCDFGISGQLV-DSIAKTRDAGCRPYMAPE 161
             IHRDVKP NIL+ +   IKLCDFG +  L   S     +   R Y +PE
Sbjct: 122 NCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVATRWYRSPE 172

>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297

Iteration: 1
 Score = 59.3 bits (142), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 46/164 (28%), Positives = 81/164 (49%), Gaps = 35/164 (21%)
Query: 32  IGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQFY-- 89
           IG+G  GTV   +  ++   +A++++   + ++ +++L+++  +VM+ N+ P IV +   
Sbjct: 28  IGQGASGTVYTAMDVATGQEVAIRQM--NLQQQPKKELIINEILVMRENKNPNIVNYLDS 85
Query: 90  ----------------GALFKEVT--------VATV-----KALNYLKEELKIIHRDVKP 120
                           G+L   VT        +A V     +AL +L    ++IHRD+K 
Sbjct: 86  YLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSN-QVIHRDIKS 144
Query: 121 SNILLDRRGAIKLCDFGISGQLVDSIAKTRDAGCRPY-MAPERI 163
            NILL   G++KL DFG   Q+    +K  +    PY MAPE +
Sbjct: 145 DNILLGMDGSVKLTDFGFCAQITPEQSKRSEMVGTPYWMAPEVV 188

>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299

Iteration: 1
 Score = 58.9 bits (141), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 44/172 (25%), Positives = 76/172 (44%), Gaps = 35/172 (20%)
Query: 24  EDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIR----------------STVDEKDQR 67
           E+ Q + +IG G +G V K  ++ +  V+A+K+IR                S + E +  
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 68  QLLMDLDVVMKSNECPYIVQFYG-----------------ALFKEVTVATVKALNYLKEE 110
            ++  LDV+   N+   + +F                    L K      ++ L++    
Sbjct: 63  NIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLSFCHSH 122
Query: 111 LKIIHRDVKPSNILLDRRGAIKLCDFGISGQL-VDSIAKTRDAGCRPYMAPE 161
            +++HRD+KP N+L++  GAIKL DFG++    V     T +     Y APE
Sbjct: 123 -RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPE 173

>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299

Iteration: 1
 Score = 58.9 bits (141), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 46/171 (26%), Positives = 77/171 (45%), Gaps = 33/171 (19%)
Query: 24  EDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIR----------------STVDEKDQR 67
           E+ Q + +IG G +G V K  ++ +  V+A+K+IR                S + E +  
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 68  QLLMDLDVVMKSNECPYIVQFYGA---LFKEVTVATVKALNYLKEEL------------- 111
            ++  LDV+   N+   + +F       F + +  T   L  +K  L             
Sbjct: 63  NIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 122
Query: 112 KIIHRDVKPSNILLDRRGAIKLCDFGISGQL-VDSIAKTRDAGCRPYMAPE 161
           +++HRD+KP N+L++  GAIKL DFG++    V     T +     Y APE
Sbjct: 123 RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPE 173

>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306

Iteration: 1
 Score = 58.9 bits (141), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 46/171 (26%), Positives = 77/171 (45%), Gaps = 33/171 (19%)
Query: 24  EDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIR----------------STVDEKDQR 67
           E+ Q + +IG G +G V K  ++ +  V+A+K+IR                S + E +  
Sbjct: 10  ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 69
Query: 68  QLLMDLDVVMKSNECPYIVQFYGA---LFKEVTVATVKALNYLKEEL------------- 111
            ++  LDV+   N+   + +F       F + +  T   L  +K  L             
Sbjct: 70  NIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 129
Query: 112 KIIHRDVKPSNILLDRRGAIKLCDFGISGQL-VDSIAKTRDAGCRPYMAPE 161
           +++HRD+KP N+L++  GAIKL DFG++    V     T +     Y APE
Sbjct: 130 RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPE 180

>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 46/171 (26%), Positives = 77/171 (45%), Gaps = 33/171 (19%)
Query: 24  EDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIR----------------STVDEKDQR 67
           E+ Q + +IG G +G V K  ++ +  V+A+K+IR                S + E +  
Sbjct: 10  ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 69
Query: 68  QLLMDLDVVMKSNECPYIVQFYGA---LFKEVTVATVKALNYLKEEL------------- 111
            ++  LDV+   N+   + +F       F + +  T   L  +K  L             
Sbjct: 70  NIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 129
Query: 112 KIIHRDVKPSNILLDRRGAIKLCDFGISGQL-VDSIAKTRDAGCRPYMAPE 161
           +++HRD+KP N+L++  GAIKL DFG++    V     T +     Y APE
Sbjct: 130 RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPE 180

>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 46/171 (26%), Positives = 77/171 (45%), Gaps = 33/171 (19%)
Query: 24  EDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIR----------------STVDEKDQR 67
           E+ Q + +IG G +G V K  ++ +  V+A+K+IR                S + E +  
Sbjct: 4   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 63
Query: 68  QLLMDLDVVMKSNECPYIVQFYGA---LFKEVTVATVKALNYLKEEL------------- 111
            ++  LDV+   N+   + +F       F + +  T   L  +K  L             
Sbjct: 64  NIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 123
Query: 112 KIIHRDVKPSNILLDRRGAIKLCDFGISGQL-VDSIAKTRDAGCRPYMAPE 161
           +++HRD+KP N+L++  GAIKL DFG++    V     T +     Y APE
Sbjct: 124 RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPE 174

>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 46/171 (26%), Positives = 77/171 (45%), Gaps = 33/171 (19%)
Query: 24  EDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIR----------------STVDEKDQR 67
           E+ Q + +IG G +G V K  ++ +  V+A+K+IR                S + E +  
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 68  QLLMDLDVVMKSNECPYIVQFYGA---LFKEVTVATVKALNYLKEEL------------- 111
            ++  LDV+   N+   + +F       F + +  T   L  +K  L             
Sbjct: 63  NIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 122
Query: 112 KIIHRDVKPSNILLDRRGAIKLCDFGISGQL-VDSIAKTRDAGCRPYMAPE 161
           +++HRD+KP N+L++  GAIKL DFG++    V     T +     Y APE
Sbjct: 123 RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPE 173

>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 46/171 (26%), Positives = 77/171 (45%), Gaps = 33/171 (19%)
Query: 24  EDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIR----------------STVDEKDQR 67
           E+ Q + +IG G +G V K  ++ +  V+A+K+IR                S + E +  
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 68  QLLMDLDVVMKSNECPYIVQFYGA---LFKEVTVATVKALNYLKEEL------------- 111
            ++  LDV+   N+   + +F       F + +  T   L  +K  L             
Sbjct: 62  NIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 121
Query: 112 KIIHRDVKPSNILLDRRGAIKLCDFGISGQL-VDSIAKTRDAGCRPYMAPE 161
           +++HRD+KP N+L++  GAIKL DFG++    V     T +     Y APE
Sbjct: 122 RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPE 172

>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 46/171 (26%), Positives = 77/171 (45%), Gaps = 33/171 (19%)
Query: 24  EDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIR----------------STVDEKDQR 67
           E+ Q + +IG G +G V K  ++ +  V+A+K+IR                S + E +  
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 68  QLLMDLDVVMKSNECPYIVQFYGA---LFKEVTVATVKALNYLKEEL------------- 111
            ++  LDV+   N+   + +F       F + +  T   L  +K  L             
Sbjct: 63  NIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 122
Query: 112 KIIHRDVKPSNILLDRRGAIKLCDFGISGQL-VDSIAKTRDAGCRPYMAPE 161
           +++HRD+KP N+L++  GAIKL DFG++    V     T +     Y APE
Sbjct: 123 RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPE 173

>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 46/171 (26%), Positives = 77/171 (45%), Gaps = 33/171 (19%)
Query: 24  EDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIR----------------STVDEKDQR 67
           E+ Q + +IG G +G V K  ++ +  V+A+K+IR                S + E +  
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 68  QLLMDLDVVMKSNECPYIVQFYGA---LFKEVTVATVKALNYLKEEL------------- 111
            ++  LDV+   N+   + +F       F + +  T   L  +K  L             
Sbjct: 62  NIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 121
Query: 112 KIIHRDVKPSNILLDRRGAIKLCDFGISGQL-VDSIAKTRDAGCRPYMAPE 161
           +++HRD+KP N+L++  GAIKL DFG++    V     T +     Y APE
Sbjct: 122 RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPE 172

>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 46/171 (26%), Positives = 77/171 (45%), Gaps = 33/171 (19%)
Query: 24  EDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIR----------------STVDEKDQR 67
           E+ Q + +IG G +G V K  ++ +  V+A+K+IR                S + E +  
Sbjct: 7   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 66
Query: 68  QLLMDLDVVMKSNECPYIVQFYGA---LFKEVTVATVKALNYLKEEL------------- 111
            ++  LDV+   N+   + +F       F + +  T   L  +K  L             
Sbjct: 67  NIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 126
Query: 112 KIIHRDVKPSNILLDRRGAIKLCDFGISGQL-VDSIAKTRDAGCRPYMAPE 161
           +++HRD+KP N+L++  GAIKL DFG++    V     T +     Y APE
Sbjct: 127 RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPE 177

>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 46/165 (27%), Positives = 81/165 (49%), Gaps = 35/165 (21%)
Query: 31  EIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQFY- 89
           +IG+G  GTV   +  ++   +A++++   + ++ +++L+++  +VM+ N+ P IV +  
Sbjct: 27  KIGQGASGTVYTAMDVATGQEVAIRQM--NLQQQPKKELIINEILVMRENKNPNIVNYLD 84
Query: 90  -----------------GALFKEVT--------VATV-----KALNYLKEELKIIHRDVK 119
                            G+L   VT        +A V     +AL +L    ++IHRD+K
Sbjct: 85  SYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSN-QVIHRDIK 143
Query: 120 PSNILLDRRGAIKLCDFGISGQLVDSIAKTRDAGCRPY-MAPERI 163
             NILL   G++KL DFG   Q+    +K       PY MAPE +
Sbjct: 144 SDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVV 188

>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318

Iteration: 1
 Score = 58.2 bits (139), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 53/183 (28%), Positives = 82/183 (44%), Gaps = 50/183 (27%)
Query: 21  FTSEDLQDLGEIGRGGFGTVNKMIHRSS-----------DTVMAVKRIRSTVDEK----- 64
           ++ +D Q L  +G G FG V+ +  R +           + V+ +K++  T DE+     
Sbjct: 3   YSLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSI 62
Query: 65  --------------DQRQLLMDLDVV---------MKSNECPY-IVQFYGALFKEVTVAT 100
                         D +Q+ M +D +          KS   P  + +FY A   EV +A 
Sbjct: 63  VTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAA---EVCLA- 118
Query: 101 VKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTRDAGCRPYMAP 160
              L YL  +  II+RD+KP NILLD+ G IK+ DFG +  + D        G   Y+AP
Sbjct: 119 ---LEYLHSK-DIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYXL--CGTPDYIAP 172
Query: 161 ERI 163
           E +
Sbjct: 173 EVV 175

>pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406

Iteration: 1
 Score = 58.2 bits (139), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 49/184 (26%), Positives = 80/184 (43%), Gaps = 37/184 (20%)
Query: 23  SEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIR--STVDEKDQRQLLMDLDVVMKSN 80
           +ED + +  IGRG FG V  + H+S+  V A+K +     +   D      + D++  +N
Sbjct: 73  AEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFAN 132
Query: 81  ECPYIVQFYGALFKE-------------------------------VTVATVKALNYLKE 109
             P++VQ + A   +                                T   V AL+ +  
Sbjct: 133 -SPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWARFYTAEVVLALDAI-H 190
Query: 110 ELKIIHRDVKPSNILLDRRGAIKLCDFGISGQL-VDSIAKTRDA-GCRPYMAPERIDPLR 167
            +  IHRDVKP N+LLD+ G +KL DFG   ++  + + +   A G   Y++PE +    
Sbjct: 191 SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQG 250
Query: 168 ARGY 171
             GY
Sbjct: 251 GDGY 254

>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326

Iteration: 1
 Score = 58.2 bits (139), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 48/172 (27%), Positives = 75/172 (43%), Gaps = 42/172 (24%)
Query: 32  IGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQFYGA 91
           +G G +G V K  H  +  + A+K +  T DE+++  +  +++++ K +    I  +YGA
Sbjct: 32  VGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEE--IKQEINMLKKYSHHRNIATYYGA 89
Query: 92  LFKE---------------VTVATVKAL------NYLKEEL------------------K 112
             K+                   +V  L      N LKEE                   K
Sbjct: 90  FIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHK 149
Query: 113 IIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTRDAGCRPY-MAPERI 163
           +IHRD+K  N+LL     +KL DFG+S QL  ++ +       PY MAPE I
Sbjct: 150 VIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVI 201

>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297

Iteration: 1
 Score = 58.2 bits (139), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 46/164 (28%), Positives = 80/164 (48%), Gaps = 35/164 (21%)
Query: 32  IGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQFY-- 89
           IG+G  GTV   +  ++   +A++++   + ++ +++L+++  +VM+ N+ P IV +   
Sbjct: 28  IGQGASGTVYTAMDVATGQEVAIRQM--NLQQQPKKELIINEILVMRENKNPNIVNYLDS 85
Query: 90  ----------------GALFKEVT--------VATV-----KALNYLKEELKIIHRDVKP 120
                           G+L   VT        +A V     +AL +L    ++IHRD+K 
Sbjct: 86  YLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSN-QVIHRDIKS 144
Query: 121 SNILLDRRGAIKLCDFGISGQLVDSIAKTRDAGCRPY-MAPERI 163
            NILL   G++KL DFG   Q+    +K       PY MAPE +
Sbjct: 145 DNILLGMDGSVKLTDFGFCAQITPEQSKRSXMVGTPYWMAPEVV 188

>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 58.2 bits (139), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 40/148 (27%), Positives = 70/148 (47%), Gaps = 32/148 (21%)
Query: 24  EDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIR----------------STVDEKDQR 67
           E+ Q + +IG G +G V K  ++ +  V+A+K+IR                S + E +  
Sbjct: 6   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 65
Query: 68  QLLMDLDVVMKSNECPYIVQFYGA---LFKEVTVATVKALNYLKEEL------------- 111
            ++  LDV+   N+   + +F       F + +  T   L  +K  L             
Sbjct: 66  NIVKLLDVIHTENKLYLVFEFLHQDLKTFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 125
Query: 112 KIIHRDVKPSNILLDRRGAIKLCDFGIS 139
           +++HRD+KP N+L++  GAIKL DFG++
Sbjct: 126 RVLHRDLKPQNLLINTEGAIKLADFGLA 153

>pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415

Iteration: 1
 Score = 58.2 bits (139), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 49/184 (26%), Positives = 80/184 (43%), Gaps = 37/184 (20%)
Query: 23  SEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIR--STVDEKDQRQLLMDLDVVMKSN 80
           +ED + +  IGRG FG V  + H+S+  V A+K +     +   D      + D++  +N
Sbjct: 73  AEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFAN 132
Query: 81  ECPYIVQFYGALFKE-------------------------------VTVATVKALNYLKE 109
             P++VQ + A   +                                T   V AL+ +  
Sbjct: 133 -SPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWARFYTAEVVLALDAI-H 190
Query: 110 ELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLV-DSIAKTRDA-GCRPYMAPERIDPLR 167
            +  IHRDVKP N+LLD+ G +KL DFG   ++  + + +   A G   Y++PE +    
Sbjct: 191 SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQG 250
Query: 168 ARGY 171
             GY
Sbjct: 251 GDGY 254

>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 58.2 bits (139), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 46/164 (28%), Positives = 80/164 (48%), Gaps = 35/164 (21%)
Query: 32  IGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQFY-- 89
           IG+G  GTV   +  ++   +A++++   + ++ +++L+++  +VM+ N+ P IV +   
Sbjct: 29  IGQGASGTVYTAMDVATGQEVAIRQM--NLQQQPKKELIINEILVMRENKNPNIVNYLDS 86
Query: 90  ----------------GALFKEVT--------VATV-----KALNYLKEELKIIHRDVKP 120
                           G+L   VT        +A V     +AL +L    ++IHRD+K 
Sbjct: 87  YLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSN-QVIHRDIKS 145
Query: 121 SNILLDRRGAIKLCDFGISGQLVDSIAKTRDAGCRPY-MAPERI 163
            NILL   G++KL DFG   Q+    +K       PY MAPE +
Sbjct: 146 DNILLGMDGSVKLTDFGFCAQITPEQSKRSXMVGTPYWMAPEVV 189

>pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410

Iteration: 1
 Score = 58.2 bits (139), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 49/184 (26%), Positives = 80/184 (43%), Gaps = 37/184 (20%)
Query: 23  SEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIR--STVDEKDQRQLLMDLDVVMKSN 80
           +ED + +  IGRG FG V  + H+S+  V A+K +     +   D      + D++  +N
Sbjct: 68  AEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFAN 127
Query: 81  ECPYIVQFYGALFKE-------------------------------VTVATVKALNYLKE 109
             P++VQ + A   +                                T   V AL+ +  
Sbjct: 128 -SPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWARFYTAEVVLALDAI-H 185
Query: 110 ELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLV-DSIAKTRDA-GCRPYMAPERIDPLR 167
            +  IHRDVKP N+LLD+ G +KL DFG   ++  + + +   A G   Y++PE +    
Sbjct: 186 SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQG 245
Query: 168 ARGY 171
             GY
Sbjct: 246 GDGY 249

>pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296

Iteration: 1
 Score = 58.2 bits (139), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 51/173 (29%), Positives = 81/173 (46%), Gaps = 35/173 (20%)
Query: 26  LQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYI 85
           L +  +IG G  G V     RSS  ++AVK++   + ++ +R+LL +  V+M+  +   +
Sbjct: 26  LDNFIKIGEGSTGIVCIATVRSSGKLVAVKKM--DLRKQQRRELLFNEVVIMRDYQHENV 83
Query: 86  VQFY------------------GALFKEVT-------------VATVKALNYLKEELKII 114
           V+ Y                  GAL   VT             +A ++AL+ L  +  +I
Sbjct: 84  VEMYNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAAVCLAVLQALSVLHAQ-GVI 142
Query: 115 HRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTRDAGCRPY-MAPERIDPL 166
           HRD+K  +ILL   G +KL DFG   Q+   + + +     PY MAPE I  L
Sbjct: 143 HRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELISRL 195

>pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301

Iteration: 1
 Score = 58.2 bits (139), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 51/173 (29%), Positives = 81/173 (46%), Gaps = 35/173 (20%)
Query: 26  LQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYI 85
           L +  +IG G  G V     RSS  ++AVK++   + ++ +R+LL +  V+M+  +   +
Sbjct: 31  LDNFIKIGEGSTGIVCIATVRSSGKLVAVKKM--DLRKQQRRELLFNEVVIMRDYQHENV 88
Query: 86  VQFY------------------GALFKEVT-------------VATVKALNYLKEELKII 114
           V+ Y                  GAL   VT             +A ++AL+ L  +  +I
Sbjct: 89  VEMYNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAAVCLAVLQALSVLHAQ-GVI 147
Query: 115 HRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTRDAGCRPY-MAPERIDPL 166
           HRD+K  +ILL   G +KL DFG   Q+   + + +     PY MAPE I  L
Sbjct: 148 HRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELISRL 200

>pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292

Iteration: 1
 Score = 58.2 bits (139), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 51/173 (29%), Positives = 81/173 (46%), Gaps = 35/173 (20%)
Query: 26  LQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYI 85
           L +  +IG G  G V     RSS  ++AVK++   + ++ +R+LL +  V+M+  +   +
Sbjct: 22  LDNFIKIGEGSTGIVCIATVRSSGKLVAVKKM--DLRKQQRRELLFNEVVIMRDYQHENV 79
Query: 86  VQFY------------------GALFKEVT-------------VATVKALNYLKEELKII 114
           V+ Y                  GAL   VT             +A ++AL+ L  +  +I
Sbjct: 80  VEMYNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAAVCLAVLQALSVLHAQ-GVI 138
Query: 115 HRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTRDAGCRPY-MAPERIDPL 166
           HRD+K  +ILL   G +KL DFG   Q+   + + +     PY MAPE I  L
Sbjct: 139 HRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELISRL 191

>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 58.2 bits (139), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 40/148 (27%), Positives = 70/148 (47%), Gaps = 32/148 (21%)
Query: 24  EDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIR----------------STVDEKDQR 67
           E+ Q + +IG G +G V K  ++ +  V+A+K+IR                S + E +  
Sbjct: 6   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 65
Query: 68  QLLMDLDVVMKSNECPYIVQFYGA---LFKEVTVATVKALNYLKEEL------------- 111
            ++  LDV+   N+   + +F       F + +  T   L  +K  L             
Sbjct: 66  NIVKLLDVIHTENKLYLVFEFLSMDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 125
Query: 112 KIIHRDVKPSNILLDRRGAIKLCDFGIS 139
           +++HRD+KP N+L++  GAIKL DFG++
Sbjct: 126 RVLHRDLKPENLLINTEGAIKLADFGLA 153

>pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303

Iteration: 1
 Score = 57.8 bits (138), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 51/173 (29%), Positives = 81/173 (46%), Gaps = 35/173 (20%)
Query: 26  LQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYI 85
           L +  +IG G  G V     RSS  ++AVK++   + ++ +R+LL +  V+M+  +   +
Sbjct: 33  LDNFIKIGEGSTGIVCIATVRSSGKLVAVKKM--DLRKQQRRELLFNEVVIMRDYQHENV 90
Query: 86  VQFY------------------GALFKEVT-------------VATVKALNYLKEELKII 114
           V+ Y                  GAL   VT             +A ++AL+ L  +  +I
Sbjct: 91  VEMYNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAAVCLAVLQALSVLHAQ-GVI 149
Query: 115 HRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTRDAGCRPY-MAPERIDPL 166
           HRD+K  +ILL   G +KL DFG   Q+   + + +     PY MAPE I  L
Sbjct: 150 HRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELISRL 202

>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 57.8 bits (138), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 40/148 (27%), Positives = 70/148 (47%), Gaps = 32/148 (21%)
Query: 24  EDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIR----------------STVDEKDQR 67
           E+ Q + +IG G +G V K  ++ +  V+A+K+IR                S + E +  
Sbjct: 4   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 63
Query: 68  QLLMDLDVVMKSNECPYIVQFYGA---LFKEVTVATVKALNYLKEEL------------- 111
            ++  LDV+   N+   + +F       F + +  T   L  +K  L             
Sbjct: 64  NIVKLLDVIHTENKLYLVFEFLSMDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 123
Query: 112 KIIHRDVKPSNILLDRRGAIKLCDFGIS 139
           +++HRD+KP N+L++  GAIKL DFG++
Sbjct: 124 RVLHRDLKPENLLINTEGAIKLADFGLA 151

>pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423

Iteration: 1
 Score = 57.8 bits (138), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 50/170 (29%), Positives = 80/170 (47%), Gaps = 35/170 (20%)
Query: 26  LQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYI 85
           L +  +IG G  G V     RSS  ++AVK++   + ++ +R+LL +  V+M+  +   +
Sbjct: 153 LDNFIKIGEGSTGIVCIATVRSSGKLVAVKKM--DLRKQQRRELLFNEVVIMRDYQHENV 210
Query: 86  VQFY------------------GALFKEVT-------------VATVKALNYLKEELKII 114
           V+ Y                  GAL   VT             +A ++AL+ L  +  +I
Sbjct: 211 VEMYNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAAVCLAVLQALSVLHAQ-GVI 269
Query: 115 HRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTRDAGCRPY-MAPERI 163
           HRD+K  +ILL   G +KL DFG   Q+   + + +     PY MAPE I
Sbjct: 270 HRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELI 319

>pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346

Iteration: 1
 Score = 57.8 bits (138), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 50/170 (29%), Positives = 80/170 (47%), Gaps = 35/170 (20%)
Query: 26  LQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYI 85
           L +  +IG G  G V     RSS  ++AVK++   + ++ +R+LL +  V+M+  +   +
Sbjct: 76  LDNFIKIGEGSTGIVCIATVRSSGKLVAVKKM--DLRKQQRRELLFNEVVIMRDYQHENV 133
Query: 86  VQFY------------------GALFKEVT-------------VATVKALNYLKEELKII 114
           V+ Y                  GAL   VT             +A ++AL+ L  +  +I
Sbjct: 134 VEMYNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAAVCLAVLQALSVLHAQ-GVI 192
Query: 115 HRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTRDAGCRPY-MAPERI 163
           HRD+K  +ILL   G +KL DFG   Q+   + + +     PY MAPE I
Sbjct: 193 HRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELI 242

>pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348

Iteration: 1
 Score = 57.8 bits (138), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 34/97 (35%), Positives = 52/97 (53%), Gaps = 7/97 (7%)
Query: 71  MDLDVVMKSNECPYIVQFYGALFKEVTV------ATVKALNYLKEELKIIHRDVKPSNIL 124
           M+ D ++K +E  +++      F  + V      + + + +Y+  E  I HRDVKPSNIL
Sbjct: 125 MENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNIL 184
Query: 125 LDRRGAIKLCDFGISGQLVDSIAKTRDAGCRPYMAPE 161
           +D+ G +KL DFG S  +VD   K    G   +M PE
Sbjct: 185 MDKNGRVKLSDFGESEYMVDKKIKG-SRGTYEFMPPE 220

>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331

Iteration: 1
 Score = 57.4 bits (137), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 49/187 (26%), Positives = 82/187 (43%), Gaps = 33/187 (17%)
Query: 7   SSGKLKLSPDTVYDFTSEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQ 66
           SSG + L  + +Y  + E  ++LG +G G +G V K  ++ +  ++A+K+   + D+K  
Sbjct: 9   SSG-VDLGTENLYFQSMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMV 67
Query: 67  RQLLMD----------------LDVVMKSNECPYIVQFY-------------GALFKEVT 97
           +++ M                 L+V  K      + +F              G  ++ V 
Sbjct: 68  KKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVFEFVDHTILDDLELFPNGLDYQVVQ 127
Query: 98  VATVKALNYLK--EELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTRD-AGC 154
               + +N +       IIHRD+KP NIL+ + G +KLCDFG +  L        D    
Sbjct: 128 KYLFQIINGIGFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEVAT 187
Query: 155 RPYMAPE 161
           R Y APE
Sbjct: 188 RWYRAPE 194

>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 57.4 bits (137), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 40/148 (27%), Positives = 70/148 (47%), Gaps = 32/148 (21%)
Query: 24  EDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIR----------------STVDEKDQR 67
           E+ Q + +IG G +G V K  ++ +  V+A+K+IR                S + E +  
Sbjct: 6   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 65
Query: 68  QLLMDLDVVMKSNECPYIVQFYGA---LFKEVTVATVKALNYLKEEL------------- 111
            ++  LDV+   N+   + +F       F + +  T   L  +K  L             
Sbjct: 66  NIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 125
Query: 112 KIIHRDVKPSNILLDRRGAIKLCDFGIS 139
           +++HRD+KP N+L++  GAIKL DFG++
Sbjct: 126 RVLHRDLKPQNLLINTEGAIKLADFGLA 153

>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 57.4 bits (137), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 40/148 (27%), Positives = 70/148 (47%), Gaps = 32/148 (21%)
Query: 24  EDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIR----------------STVDEKDQR 67
           E+ Q + +IG G +G V K  ++ +  V+A+K+IR                S + E +  
Sbjct: 5   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 64
Query: 68  QLLMDLDVVMKSNECPYIVQFYGA---LFKEVTVATVKALNYLKEEL------------- 111
            ++  LDV+   N+   + +F       F + +  T   L  +K  L             
Sbjct: 65  NIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 124
Query: 112 KIIHRDVKPSNILLDRRGAIKLCDFGIS 139
           +++HRD+KP N+L++  GAIKL DFG++
Sbjct: 125 RVLHRDLKPENLLINTEGAIKLADFGLA 152

>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301

Iteration: 1
 Score = 57.4 bits (137), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 40/148 (27%), Positives = 70/148 (47%), Gaps = 32/148 (21%)
Query: 24  EDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIR----------------STVDEKDQR 67
           E+ Q + +IG G +G V K  ++ +  V+A+K+IR                S + E +  
Sbjct: 5   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 64
Query: 68  QLLMDLDVVMKSNECPYIVQFYGA---LFKEVTVATVKALNYLKEEL------------- 111
            ++  LDV+   N+   + +F       F + +  T   L  +K  L             
Sbjct: 65  NIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 124
Query: 112 KIIHRDVKPSNILLDRRGAIKLCDFGIS 139
           +++HRD+KP N+L++  GAIKL DFG++
Sbjct: 125 RVLHRDLKPQNLLINTEGAIKLADFGLA 152

>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 57.4 bits (137), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 40/148 (27%), Positives = 70/148 (47%), Gaps = 32/148 (21%)
Query: 24  EDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIR----------------STVDEKDQR 67
           E+ Q + +IG G +G V K  ++ +  V+A+K+IR                S + E +  
Sbjct: 5   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 64
Query: 68  QLLMDLDVVMKSNECPYIVQFYGA---LFKEVTVATVKALNYLKEEL------------- 111
            ++  LDV+   N+   + +F       F + +  T   L  +K  L             
Sbjct: 65  NIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 124
Query: 112 KIIHRDVKPSNILLDRRGAIKLCDFGIS 139
           +++HRD+KP N+L++  GAIKL DFG++
Sbjct: 125 RVLHRDLKPQNLLINTEGAIKLADFGLA 152

>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299

Iteration: 1
 Score = 57.4 bits (137), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 40/148 (27%), Positives = 70/148 (47%), Gaps = 32/148 (21%)
Query: 24  EDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIR----------------STVDEKDQR 67
           E+ Q + +IG G +G V K  ++ +  V+A+K+IR                S + E +  
Sbjct: 4   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 63
Query: 68  QLLMDLDVVMKSNECPYIVQFYGA---LFKEVTVATVKALNYLKEEL------------- 111
            ++  LDV+   N+   + +F       F + +  T   L  +K  L             
Sbjct: 64  NIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 123
Query: 112 KIIHRDVKPSNILLDRRGAIKLCDFGIS 139
           +++HRD+KP N+L++  GAIKL DFG++
Sbjct: 124 RVLHRDLKPENLLINTEGAIKLADFGLA 151

>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272

Iteration: 1
 Score = 57.4 bits (137), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 53/180 (29%), Positives = 81/180 (45%), Gaps = 41/180 (22%)
Query: 21  FTSEDLQDLGE-IGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKS 79
           +T ED  D+G  +G+G FG V     R S  ++A+K +  T  EK   +  +  +V ++S
Sbjct: 9   WTLEDF-DIGRPLGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQS 67
Query: 80  N-ECPYIVQFYGAL---------------------------FKEVTVAT-----VKALNY 106
           +   P I++ YG                             F E   AT       AL+Y
Sbjct: 68  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSRFDEQRTATYITELANALSY 127
Query: 107 LKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTRDAGCRP--YMAPERID 164
              + ++IHRD+KP N+LL   G +K+ DFG S   V + +  RD  C    Y+ PE I+
Sbjct: 128 CHSK-RVIHRDIKPENLLLGSNGELKIADFGWS---VHAPSSRRDTLCGTLDYLPPEMIE 183

>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296

Iteration: 1
 Score = 57.4 bits (137), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 40/148 (27%), Positives = 70/148 (47%), Gaps = 32/148 (21%)
Query: 24  EDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIR----------------STVDEKDQR 67
           E+ Q + +IG G +G V K  ++ +  V+A+K+IR                S + E +  
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 68  QLLMDLDVVMKSNECPYIVQFYGA---LFKEVTVATVKALNYLKEEL------------- 111
            ++  LDV+   N+   + +F       F + +  T   L  +K  L             
Sbjct: 62  NIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 121
Query: 112 KIIHRDVKPSNILLDRRGAIKLCDFGIS 139
           +++HRD+KP N+L++  GAIKL DFG++
Sbjct: 122 RVLHRDLKPQNLLINTEGAIKLADFGLA 149

>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298

Iteration: 1
 Score = 57.4 bits (137), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 40/148 (27%), Positives = 70/148 (47%), Gaps = 32/148 (21%)
Query: 24  EDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIR----------------STVDEKDQR 67
           E+ Q + +IG G +G V K  ++ +  V+A+K+IR                S + E +  
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 68  QLLMDLDVVMKSNECPYIVQFYGA---LFKEVTVATVKALNYLKEEL------------- 111
            ++  LDV+   N+   + +F       F + +  T   L  +K  L             
Sbjct: 62  NIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 121
Query: 112 KIIHRDVKPSNILLDRRGAIKLCDFGIS 139
           +++HRD+KP N+L++  GAIKL DFG++
Sbjct: 122 RVLHRDLKPQNLLINTEGAIKLADFGLA 149

>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298

Iteration: 1
 Score = 57.4 bits (137), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 40/148 (27%), Positives = 70/148 (47%), Gaps = 32/148 (21%)
Query: 24  EDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIR----------------STVDEKDQR 67
           E+ Q + +IG G +G V K  ++ +  V+A+K+IR                S + E +  
Sbjct: 4   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 63
Query: 68  QLLMDLDVVMKSNECPYIVQFYGA---LFKEVTVATVKALNYLKEEL------------- 111
            ++  LDV+   N+   + +F       F + +  T   L  +K  L             
Sbjct: 64  NIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 123
Query: 112 KIIHRDVKPSNILLDRRGAIKLCDFGIS 139
           +++HRD+KP N+L++  GAIKL DFG++
Sbjct: 124 RVLHRDLKPQNLLINTEGAIKLADFGLA 151

>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284

Iteration: 1
 Score = 57.4 bits (137), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 48/177 (27%), Positives = 82/177 (46%), Gaps = 35/177 (19%)
Query: 21  FTSEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSN 80
           FT +D   +  +G+G FG V     + +  +MA+K +  +  EK+  +  +  ++ ++S+
Sbjct: 11  FTIDDFDIVRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSH 70
Query: 81  -ECPYIVQFY------------------GALFKEVT---------VAT-----VKALNYL 107
              P I++ Y                  G L+KE+           AT       AL+Y 
Sbjct: 71  LRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYC 130
Query: 108 KEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERID 164
            E  K+IHRD+KP N+L+  +G +K+ DFG S     S+ +    G   Y+ PE I+
Sbjct: 131 HER-KVIHRDIKPENLLMGYKGELKIADFGWSVH-APSLRRRXMCGTLDYLPPEMIE 185

>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300

Iteration: 1
 Score = 57.4 bits (137), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 40/148 (27%), Positives = 70/148 (47%), Gaps = 32/148 (21%)
Query: 24  EDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIR----------------STVDEKDQR 67
           E+ Q + +IG G +G V K  ++ +  V+A+K+IR                S + E +  
Sbjct: 4   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 63
Query: 68  QLLMDLDVVMKSNECPYIVQFYGA---LFKEVTVATVKALNYLKEEL------------- 111
            ++  LDV+   N+   + +F       F + +  T   L  +K  L             
Sbjct: 64  NIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 123
Query: 112 KIIHRDVKPSNILLDRRGAIKLCDFGIS 139
           +++HRD+KP N+L++  GAIKL DFG++
Sbjct: 124 RVLHRDLKPQNLLINTEGAIKLADFGLA 151

>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299

Iteration: 1
 Score = 57.4 bits (137), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 40/148 (27%), Positives = 70/148 (47%), Gaps = 32/148 (21%)
Query: 24  EDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIR----------------STVDEKDQR 67
           E+ Q + +IG G +G V K  ++ +  V+A+K+IR                S + E +  
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 68  QLLMDLDVVMKSNECPYIVQFYGA---LFKEVTVATVKALNYLKEEL------------- 111
            ++  LDV+   N+   + +F       F + +  T   L  +K  L             
Sbjct: 63  NIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 122
Query: 112 KIIHRDVKPSNILLDRRGAIKLCDFGIS 139
           +++HRD+KP N+L++  GAIKL DFG++
Sbjct: 123 RVLHRDLKPQNLLINTEGAIKLADFGLA 150

>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303

Iteration: 1
 Score = 57.4 bits (137), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 40/148 (27%), Positives = 70/148 (47%), Gaps = 32/148 (21%)
Query: 24  EDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIR----------------STVDEKDQR 67
           E+ Q + +IG G +G V K  ++ +  V+A+K+IR                S + E +  
Sbjct: 7   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 66
Query: 68  QLLMDLDVVMKSNECPYIVQFYGA---LFKEVTVATVKALNYLKEEL------------- 111
            ++  LDV+   N+   + +F       F + +  T   L  +K  L             
Sbjct: 67  NIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 126
Query: 112 KIIHRDVKPSNILLDRRGAIKLCDFGIS 139
           +++HRD+KP N+L++  GAIKL DFG++
Sbjct: 127 RVLHRDLKPQNLLINTEGAIKLADFGLA 154

>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 57.4 bits (137), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 40/148 (27%), Positives = 70/148 (47%), Gaps = 32/148 (21%)
Query: 24  EDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIR----------------STVDEKDQR 67
           E+ Q + +IG G +G V K  ++ +  V+A+K+IR                S + E +  
Sbjct: 6   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 65
Query: 68  QLLMDLDVVMKSNECPYIVQFYGA---LFKEVTVATVKALNYLKEEL------------- 111
            ++  LDV+   N+   + +F       F + +  T   L  +K  L             
Sbjct: 66  NIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 125
Query: 112 KIIHRDVKPSNILLDRRGAIKLCDFGIS 139
           +++HRD+KP N+L++  GAIKL DFG++
Sbjct: 126 RVLHRDLKPQNLLINTEGAIKLADFGLA 153

>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302

Iteration: 1
 Score = 57.4 bits (137), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 40/148 (27%), Positives = 70/148 (47%), Gaps = 32/148 (21%)
Query: 24  EDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIR----------------STVDEKDQR 67
           E+ Q + +IG G +G V K  ++ +  V+A+K+IR                S + E +  
Sbjct: 6   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 65
Query: 68  QLLMDLDVVMKSNECPYIVQFYGAL---FKEVTVATVKALNYLKEEL------------- 111
            ++  LDV+   N+   + +F       F + +  T   L  +K  L             
Sbjct: 66  NIVKLLDVIHTENKLYLVFEFLSMDLKDFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 125
Query: 112 KIIHRDVKPSNILLDRRGAIKLCDFGIS 139
           +++HRD+KP N+L++  GAIKL DFG++
Sbjct: 126 RVLHRDLKPQNLLINTEGAIKLADFGLA 153

>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298

Iteration: 1
 Score = 57.4 bits (137), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 40/148 (27%), Positives = 70/148 (47%), Gaps = 32/148 (21%)
Query: 24  EDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIR----------------STVDEKDQR 67
           E+ Q + +IG G +G V K  ++ +  V+A+K+IR                S + E +  
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 68  QLLMDLDVVMKSNECPYIVQFYGA---LFKEVTVATVKALNYLKEEL------------- 111
            ++  LDV+   N+   + +F       F + +  T   L  +K  L             
Sbjct: 63  NIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 122
Query: 112 KIIHRDVKPSNILLDRRGAIKLCDFGIS 139
           +++HRD+KP N+L++  GAIKL DFG++
Sbjct: 123 RVLHRDLKPQNLLINTEGAIKLADFGLA 150

>pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311

Iteration: 1
 Score = 57.4 bits (137), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 54/192 (28%), Positives = 79/192 (41%), Gaps = 37/192 (19%)
Query: 3   QSIQSSGKLKLSPDTVYDFTSEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTV- 61
           +++QS G     P     F  +  Q L  +G G +G V K+  +    + AVKR  S   
Sbjct: 39  ETLQSPG---YDPSRPESFFQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFR 95
Query: 62  DEKDQRQLLMDLDVVMKSNECPYIVQF---------------------------YGALFK 94
             KD+ + L ++    K  + P  V+                            +GA   
Sbjct: 96  GPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQTELCGPSLQQHCEAWGASLP 155
Query: 95  EVTVA-----TVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKT 149
           E  V      T+ AL +L  +  ++H DVKP+NI L  RG  KL DFG+  +L  + A  
Sbjct: 156 EAQVWGYLRDTLLALAHLHSQ-GLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGE 214
Query: 150 RDAGCRPYMAPE 161
              G   YMAPE
Sbjct: 215 VQEGDPRYMAPE 226

>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297

Iteration: 1
 Score = 57.4 bits (137), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 40/148 (27%), Positives = 70/148 (47%), Gaps = 32/148 (21%)
Query: 24  EDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIR----------------STVDEKDQR 67
           E+ Q + +IG G +G V K  ++ +  V+A+K+IR                S + E +  
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 68  QLLMDLDVVMKSNECPYIVQFYGA---LFKEVTVATVKALNYLKEEL------------- 111
            ++  LDV+   N+   + +F       F + +  T   L  +K  L             
Sbjct: 63  NIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 122
Query: 112 KIIHRDVKPSNILLDRRGAIKLCDFGIS 139
           +++HRD+KP N+L++  GAIKL DFG++
Sbjct: 123 RVLHRDLKPQNLLINTEGAIKLADFGLA 150

>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310

Iteration: 1
 Score = 57.4 bits (137), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 51/192 (26%), Positives = 79/192 (41%), Gaps = 48/192 (25%)
Query: 21  FTSEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSN 80
           F   DL     +G+G FG   K+ HR +  VM +K +    DE+ QR  L ++  VM+  
Sbjct: 7   FRPSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKEL-IRFDEETQRTFLKEVK-VMRCL 64
Query: 81  ECPYIVQFYGALFKEVTVATVKALNYLKEELK---------------------------- 112
           E P +++F G L+K+      K LN++ E +K                            
Sbjct: 65  EHPNVLKFIGVLYKD------KRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIA 118
Query: 113 ----------IIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTRDAGCRPYMAPER 162
                     IIHRD+   N L+     + + DFG++  +VD   KT+  G R    P+R
Sbjct: 119 SGMAYLHSMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDE--KTQPEGLRSLKKPDR 176
Query: 163 IDPLRARGYPSF 174
                  G P +
Sbjct: 177 KKRYTVVGNPYW 188

>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300

Iteration: 1
 Score = 57.4 bits (137), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 40/148 (27%), Positives = 70/148 (47%), Gaps = 32/148 (21%)
Query: 24  EDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIR----------------STVDEKDQR 67
           E+ Q + +IG G +G V K  ++ +  V+A+K+IR                S + E +  
Sbjct: 5   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 64
Query: 68  QLLMDLDVVMKSNECPYIVQFYGAL---FKEVTVATVKALNYLKEEL------------- 111
            ++  LDV+   N+   + +F       F + +  T   L  +K  L             
Sbjct: 65  NIVKLLDVIHTENKLYLVFEFLSMDLKDFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 124
Query: 112 KIIHRDVKPSNILLDRRGAIKLCDFGIS 139
           +++HRD+KP N+L++  GAIKL DFG++
Sbjct: 125 RVLHRDLKPQNLLINTEGAIKLADFGLA 152

>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289

Iteration: 1
 Score = 57.4 bits (137), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 40/148 (27%), Positives = 70/148 (47%), Gaps = 32/148 (21%)
Query: 24  EDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIR----------------STVDEKDQR 67
           E+ Q + +IG G +G V K  ++ +  V+A+K+IR                S + E +  
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 68  QLLMDLDVVMKSNECPYIVQFYGA---LFKEVTVATVKALNYLKEEL------------- 111
            ++  LDV+   N+   + +F       F + +  T   L  +K  L             
Sbjct: 63  NIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 122
Query: 112 KIIHRDVKPSNILLDRRGAIKLCDFGIS 139
           +++HRD+KP N+L++  GAIKL DFG++
Sbjct: 123 RVLHRDLKPQNLLINTEGAIKLADFGLA 150

>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317

Iteration: 1
 Score = 57.4 bits (137), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 54/175 (30%), Positives = 80/175 (45%), Gaps = 35/175 (20%)
Query: 24  EDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECP 83
           E L +  +IG G  G V     + +   +AVK++   + ++ +R+LL +  V+M+     
Sbjct: 45  EYLANFIKIGEGSTGIVCIATEKHTGKQVAVKKM--DLRKQQRRELLFNEVVIMRDYHHD 102
Query: 84  YIVQFY------------------GALFKEVT--------VATV-----KALNYLKEELK 112
            +V  Y                  GAL   VT        +ATV     +AL+YL  +  
Sbjct: 103 NVVDMYSSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIATVCLSVLRALSYLHNQ-G 161
Query: 113 IIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTRDAGCRPY-MAPERIDPL 166
           +IHRD+K  +ILL   G IKL DFG   Q+   + K +     PY MAPE I  L
Sbjct: 162 VIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKXLVGTPYWMAPEVISRL 216

>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272

Iteration: 1
 Score = 57.0 bits (136), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 52/178 (29%), Positives = 79/178 (44%), Gaps = 37/178 (20%)
Query: 21  FTSEDLQDLGE-IGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKS 79
           +T ED  D+G  +G+G FG V     R S  ++A+K +  T  EK   +  +  +V ++S
Sbjct: 9   WTLEDF-DIGRPLGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQS 67
Query: 80  N-ECPYIVQFYGAL---------------------------FKEVTVAT-----VKALNY 106
           +   P I++ YG                             F E   AT       AL+Y
Sbjct: 68  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSRFDEQRTATYITELANALSY 127
Query: 107 LKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERID 164
              + ++IHRD+KP N+LL   G +K+ DFG S     S  +T   G   Y+ PE I+
Sbjct: 128 CHSK-RVIHRDIKPENLLLGSNGELKIADFGWSVH-APSSRRTTLCGTLDYLPPEMIE 183

>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 57.0 bits (136), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 48/179 (26%), Positives = 74/179 (41%), Gaps = 39/179 (21%)
Query: 20  DFTSEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKS 79
           D    DL    +IG G FGTV++     SD  +AVK +       ++    +    +MK 
Sbjct: 33  DIPWCDLNIKEKIGAGSFGTVHRAEWHGSD--VAVKILMEQDFHAERVNEFLREVAIMKR 90
Query: 80  NECPYIVQFYGALFKEVTVATV-----------------------------------KAL 104
              P IV F GA+ +   ++ V                                   K +
Sbjct: 91  LRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGM 150
Query: 105 NYLKE-ELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTRDAGCRP-YMAPE 161
           NYL      I+HRD+K  N+L+D++  +K+CDFG+S         ++ A   P +MAPE
Sbjct: 151 NYLHNRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKASXFLXSKXAAGTPEWMAPE 209

>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299

Iteration: 1
 Score = 56.6 bits (135), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 40/148 (27%), Positives = 70/148 (47%), Gaps = 32/148 (21%)
Query: 24  EDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIR----------------STVDEKDQR 67
           E+ Q + +IG G +G V K  ++ +  V+A+K+IR                S + E +  
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 68  QLLMDLDVVMKSNECPYIVQFYGAL---FKEVTVATVKALNYLKEEL------------- 111
            ++  LDV+   N+   + +F       F + +  T   L  +K  L             
Sbjct: 63  NIVKLLDVIHTENKLYLVFEFLHQDLKDFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 122
Query: 112 KIIHRDVKPSNILLDRRGAIKLCDFGIS 139
           +++HRD+KP N+L++  GAIKL DFG++
Sbjct: 123 RVLHRDLKPENLLINTEGAIKLADFGLA 150

>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 56.6 bits (135), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 45/164 (27%), Positives = 80/164 (48%), Gaps = 35/164 (21%)
Query: 32  IGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQFY-- 89
           IG+G  GTV   +  ++   +A++++   + ++ +++L+++  +VM+ N+ P IV +   
Sbjct: 29  IGQGASGTVYTAMDVATGQEVAIRQM--NLQQQPKKELIINEILVMRENKNPNIVNYLDS 86
Query: 90  ----------------GALFKEVT--------VATV-----KALNYLKEELKIIHRDVKP 120
                           G+L   VT        +A V     +AL +L    ++IHR++K 
Sbjct: 87  YLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSN-QVIHRNIKS 145
Query: 121 SNILLDRRGAIKLCDFGISGQLVDSIAKTRDAGCRPY-MAPERI 163
            NILL   G++KL DFG   Q+    +K       PY MAPE +
Sbjct: 146 DNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVV 189

>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315

Iteration: 1
 Score = 56.6 bits (135), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 46/166 (27%), Positives = 74/166 (44%), Gaps = 44/166 (26%)
Query: 32  IGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQFYGA 91
           +GRG FG V K   R+ D  +A+K+I S   E +++  +++L  + + N  P IV+ YGA
Sbjct: 17  VGRGAFGVVCKAKWRAKD--VAIKQIES---ESERKAFIVELRQLSRVNH-PNIVKLYGA 70
Query: 92  LFKEVTVA---------------------------------TVKALNYLK--EELKIIHR 116
               V +                                    + + YL   +   +IHR
Sbjct: 71  CLNPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHR 130
Query: 117 DVKPSNILLDRRGAI-KLCDFGISGQLVDSIAKTRDAGCRPYMAPE 161
           D+KP N+LL   G + K+CDFG +  +   +  T + G   +MAPE
Sbjct: 131 DLKPPNLLLVAGGTVLKICDFGTACDIQTHM--TNNKGSAAWMAPE 174

>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299

Iteration: 1
 Score = 56.6 bits (135), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 45/171 (26%), Positives = 76/171 (44%), Gaps = 33/171 (19%)
Query: 24  EDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIR----------------STVDEKDQR 67
           E+ Q + +IG G +G V K  ++ +  V+A+ +IR                S + E +  
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 68  QLLMDLDVVMKSNECPYIVQFYGA---LFKEVTVATVKALNYLKEEL------------- 111
            ++  LDV+   N+   + +F       F + +  T   L  +K  L             
Sbjct: 63  NIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 122
Query: 112 KIIHRDVKPSNILLDRRGAIKLCDFGISGQL-VDSIAKTRDAGCRPYMAPE 161
           +++HRD+KP N+L++  GAIKL DFG++    V     T +     Y APE
Sbjct: 123 RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPE 173

>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 56.6 bits (135), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 45/171 (26%), Positives = 76/171 (44%), Gaps = 33/171 (19%)
Query: 24  EDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIR----------------STVDEKDQR 67
           E+ Q + +IG G +G V K  ++ +  V+A+ +IR                S + E +  
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 68  QLLMDLDVVMKSNECPYIVQFYGA---LFKEVTVATVKALNYLKEEL------------- 111
            ++  LDV+   N+   + +F       F + +  T   L  +K  L             
Sbjct: 62  NIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 121
Query: 112 KIIHRDVKPSNILLDRRGAIKLCDFGISGQL-VDSIAKTRDAGCRPYMAPE 161
           +++HRD+KP N+L++  GAIKL DFG++    V     T +     Y APE
Sbjct: 122 RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPE 172

>pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350

Iteration: 1
 Score = 56.6 bits (135), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 49/173 (28%), Positives = 77/173 (44%), Gaps = 39/173 (22%)
Query: 32  IGRGGFGTVNKMIHRSSDT-----------VMAVKRIRSTVDEKDQRQ-----LLMDLDV 75
           +G G FG V  + H+ S             V+ +K+I  T++EK   Q      L+ L+ 
Sbjct: 49  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 76  VMKSNECPYIVQFY---GALFKEV--------------TVATVKALNYLKEELKIIHRDV 118
             K N   Y+V  Y   G +F  +                  V    YL   L +I+RD+
Sbjct: 109 SFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYL-HSLDLIYRDL 167
Query: 119 KPSNILLDRRGAIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPLRARGY 171
           KP N+L+D++G I++ DFG + ++         AG   Y+APE I    ++GY
Sbjct: 168 KPENLLIDQQGYIQVTDFGFAKRVKGRTWXL--AGTPEYLAPEII---LSKGY 215

>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 56.6 bits (135), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 47/179 (26%), Positives = 75/179 (41%), Gaps = 39/179 (21%)
Query: 20  DFTSEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKS 79
           D    DL    +IG G FGTV++     SD  +AVK +       ++    +    +MK 
Sbjct: 33  DIPWCDLNIKEKIGAGSFGTVHRAEWHGSD--VAVKILMEQDFHAERVNEFLREVAIMKR 90
Query: 80  NECPYIVQFYGALFKEVTVATV-----------------------------------KAL 104
              P IV F GA+ +   ++ V                                   K +
Sbjct: 91  LRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGM 150
Query: 105 NYLKE-ELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTRDAGCRP-YMAPE 161
           NYL      I+HR++K  N+L+D++  +K+CDFG+S     +   ++ A   P +MAPE
Sbjct: 151 NYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKSAAGTPEWMAPE 209

>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307

Iteration: 1
 Score = 56.6 bits (135), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 46/166 (27%), Positives = 74/166 (44%), Gaps = 44/166 (26%)
Query: 32  IGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQFYGA 91
           +GRG FG V K   R+ D  +A+K+I S   E +++  +++L  + + N  P IV+ YGA
Sbjct: 16  VGRGAFGVVCKAKWRAKD--VAIKQIES---ESERKAFIVELRQLSRVNH-PNIVKLYGA 69
Query: 92  LFKEVTVA---------------------------------TVKALNYLK--EELKIIHR 116
               V +                                    + + YL   +   +IHR
Sbjct: 70  CLNPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHR 129
Query: 117 DVKPSNILLDRRGAI-KLCDFGISGQLVDSIAKTRDAGCRPYMAPE 161
           D+KP N+LL   G + K+CDFG +  +   +  T + G   +MAPE
Sbjct: 130 DLKPPNLLLVAGGTVLKICDFGTACDIQTHM--TNNKGSAAWMAPE 173

>pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277

Iteration: 1
 Score = 56.2 bits (134), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 59/183 (32%), Positives = 87/183 (47%), Gaps = 41/183 (22%)
Query: 32  IGRGGFGTVNKMIHRSSDTVMAVKRIRST----VDEKDQRQL----LMDLDVVMKSNECP 83
           +GRG    V + IH+ +    AVK I  T       ++ ++L    L ++D++ K +  P
Sbjct: 12  LGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHP 71
Query: 84  YIVQ----------FY--------GALF----KEVTVA---TVKALNYLKE------ELK 112
            I+Q          F+        G LF    ++VT++   T K +  L E      +L 
Sbjct: 72  NIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLN 131
Query: 113 IIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTRDA-GCRPYMAPERIDPLRARGY 171
           I+HRD+KP NILLD    IKL DFG S QL D   K R+  G   Y+APE I+      +
Sbjct: 132 IVHRDLKPENILLDDDMNIKLTDFGFSCQL-DPGEKLREVCGTPSYLAPEIIECSMNDNH 190
Query: 172 PSF 174
           P +
Sbjct: 191 PGY 193

>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 56.2 bits (134), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 45/171 (26%), Positives = 76/171 (44%), Gaps = 33/171 (19%)
Query: 24  EDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIR----------------STVDEKDQR 67
           E+ Q + +IG G +G V K  ++ +  V+A+K+IR                S + E +  
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 68  QLLMDLDVVMKSNECPYIVQFYGA---LFKEVTVATVKALNYLKEEL------------- 111
            ++  LDV+   N+   + +        F + +  T   L  +K  L             
Sbjct: 62  NIVKLLDVIHTENKLYLVFEHVHQDLKTFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 121
Query: 112 KIIHRDVKPSNILLDRRGAIKLCDFGISGQL-VDSIAKTRDAGCRPYMAPE 161
           +++HRD+KP N+L++  GAIKL DFG++    V     T +     Y APE
Sbjct: 122 RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPE 172

>pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298

Iteration: 1
 Score = 56.2 bits (134), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 59/183 (32%), Positives = 87/183 (47%), Gaps = 41/183 (22%)
Query: 32  IGRGGFGTVNKMIHRSSDTVMAVKRIRST----VDEKDQRQL----LMDLDVVMKSNECP 83
           +GRG    V + IH+ +    AVK I  T       ++ ++L    L ++D++ K +  P
Sbjct: 25  LGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHP 84
Query: 84  YIVQ----------FY--------GALF----KEVTVA---TVKALNYLKE------ELK 112
            I+Q          F+        G LF    ++VT++   T K +  L E      +L 
Sbjct: 85  NIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLN 144
Query: 113 IIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTRDA-GCRPYMAPERIDPLRARGY 171
           I+HRD+KP NILLD    IKL DFG S QL D   K R+  G   Y+APE I+      +
Sbjct: 145 IVHRDLKPENILLDDDMNIKLTDFGFSCQL-DPGEKLREVCGTPSYLAPEIIECSMNDNH 203
Query: 172 PSF 174
           P +
Sbjct: 204 PGY 206

>pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676

Iteration: 1
 Score = 56.2 bits (134), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 48/176 (27%), Positives = 77/176 (43%), Gaps = 44/176 (25%)
Query: 32  IGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSN--------ECP 83
           +G GGFG V + IH+ +   +A+K+ R  +  K++ +  +++ ++ K N        E P
Sbjct: 22  LGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVP 81
Query: 84  --------------------------YIVQFYGAL-FKEVTVATV-----KALNYLKEEL 111
                                     Y+ QF      KE  + T+      AL YL E  
Sbjct: 82  DGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHEN- 140
Query: 112 KIIHRDVKPSNILLD---RRGAIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERID 164
           +IIHRD+KP NI+L    +R   K+ D G + +L      T   G   Y+APE ++
Sbjct: 141 RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEFVGTLQYLAPELLE 196

>pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677

Iteration: 1
 Score = 56.2 bits (134), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 48/176 (27%), Positives = 77/176 (43%), Gaps = 44/176 (25%)
Query: 32  IGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSN--------ECP 83
           +G GGFG V + IH+ +   +A+K+ R  +  K++ +  +++ ++ K N        E P
Sbjct: 23  LGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVP 82
Query: 84  --------------------------YIVQFYGAL-FKEVTVATV-----KALNYLKEEL 111
                                     Y+ QF      KE  + T+      AL YL E  
Sbjct: 83  DGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHEN- 141
Query: 112 KIIHRDVKPSNILLD---RRGAIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERID 164
           +IIHRD+KP NI+L    +R   K+ D G + +L      T   G   Y+APE ++
Sbjct: 142 RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEFVGTLQYLAPELLE 197

>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 50/178 (28%), Positives = 84/178 (47%), Gaps = 37/178 (20%)
Query: 21  FTSEDLQDLGE-IGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKS 79
           FT +D  D+G  +G+G FG V     + +  +MA+K +  +  EK+  +  +  ++ ++S
Sbjct: 12  FTIDDF-DIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQS 70
Query: 80  N-ECPYIVQFY------------------GALFKEVT---------VAT-----VKALNY 106
           +   P I++ Y                  G L+KE+           AT       AL+Y
Sbjct: 71  HLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHY 130
Query: 107 LKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERID 164
             E  K+IHRD+KP N+L+  +G +K+ DFG S     S+ +    G   Y+ PE I+
Sbjct: 131 CHER-KVIHRDIKPENLLMGYKGELKIADFGWSVH-APSLRRRXMCGTLDYLPPEMIE 186

>pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298

Iteration: 1
 Score = 55.5 bits (132), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 59/183 (32%), Positives = 86/183 (46%), Gaps = 41/183 (22%)
Query: 32  IGRGGFGTVNKMIHRSSDTVMAVKRIRST----VDEKDQRQL----LMDLDVVMKSNECP 83
           +GRG    V + IH+ +    AVK I  T       ++ ++L    L ++D++ K +  P
Sbjct: 25  LGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHP 84
Query: 84  YIVQ----------FY--------GALF----KEVTVA---TVKALNYLKE------ELK 112
            I+Q          F+        G LF    ++VT++   T K +  L E      +L 
Sbjct: 85  NIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLN 144
Query: 113 IIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTRDA-GCRPYMAPERIDPLRARGY 171
           I+HRD+KP NILLD    IKL DFG S QL D   K R   G   Y+APE I+      +
Sbjct: 145 IVHRDLKPENILLDDDMNIKLTDFGFSCQL-DPGEKLRSVCGTPSYLAPEIIECSMNDNH 203
Query: 172 PSF 174
           P +
Sbjct: 204 PGY 206

>pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351

Iteration: 1
 Score = 55.5 bits (132), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 46/165 (27%), Positives = 73/165 (44%), Gaps = 36/165 (21%)
Query: 32  IGRGGFGTVNKMIHRSSDT-----------VMAVKRIRSTVDEKDQRQ-----LLMDLDV 75
           +G G FG V  + H+ +             V+ +K+I  T++EK  +Q      L+ L+ 
Sbjct: 50  LGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRIQQAVNFPFLVKLEF 109
Query: 76  VMKSNECPYIVQFY---GALFKEV--------------TVATVKALNYLKEELKIIHRDV 118
             K N   Y+V  Y   G +F  +                  V    YL   L +I+RD+
Sbjct: 110 SFKDNSNLYMVLEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYL-HSLDLIYRDL 168
Query: 119 KPSNILLDRRGAIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERI 163
           KP N+L+D++G IK+ DFG + ++          G   Y+APE I
Sbjct: 169 KPENLLIDQQGYIKVADFGFAKRVKGRTWXL--CGTPEYLAPEII 211

>pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 29/68 (42%), Positives = 41/68 (60%), Gaps = 2/68 (2%)
Query: 101 VKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIA-KTRDAGCRPYMA 159
           +K + YL  + KIIHRD+KPSN+L+   G IK+ DFG+S +   S A  +   G   +MA
Sbjct: 147 IKGIEYLHYQ-KIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDALLSNTVGTPAFMA 205
Query: 160 PERIDPLR 167
           PE +   R
Sbjct: 206 PESLSETR 213

>pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 48/173 (27%), Positives = 77/173 (44%), Gaps = 39/173 (22%)
Query: 32  IGRGGFGTVNKMIHRSSDT-----------VMAVKRIRSTVDEKDQRQ-----LLMDLDV 75
           +G G FG V  + H+ S             V+ +K+I  T++EK   Q      L+ L+ 
Sbjct: 70  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 129
Query: 76  VMKSNECPYIVQFY---GALFKEV--------------TVATVKALNYLKEELKIIHRDV 118
             K N   Y+V  Y   G +F  +                  V    YL   L +I+RD+
Sbjct: 130 SFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYL-HSLDLIYRDL 188
Query: 119 KPSNILLDRRGAIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPLRARGY 171
           KP N+L+D++G I++ DFG + ++  +       G   Y+APE I    ++GY
Sbjct: 189 KPENLLIDQQGYIQVTDFGFAKRVKGATWTL--CGTPEYLAPEII---LSKGY 236

>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 48/184 (26%), Positives = 77/184 (41%), Gaps = 45/184 (24%)
Query: 27  QDLGEIGRGGFGTVNKMIHRSSDTVMAVKRI----RSTVDEKDQRQLL------------ 70
           + L  +G G F TV K   ++++ ++A+K+I    RS   +   R  L            
Sbjct: 13  EKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHP 72
Query: 71  -----------------------MDLDVVMKSNECPYIVQFYGALFKEVTVATVKALNYL 107
                                   DL+V++K N     +    +  K   + T++ L YL
Sbjct: 73  NIIGLLDAFGHKSNISLVFDFMETDLEVIIKDNS----LVLTPSHIKAYMLMTLQGLEYL 128
Query: 108 KEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQL-VDSIAKTRDAGCRPYMAPERIDPL 166
            +   I+HRD+KP+N+LLD  G +KL DFG++      + A       R Y APE +   
Sbjct: 129 HQHW-ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYXHQVVTRWYRAPELLFGA 187
Query: 167 RARG 170
           R  G
Sbjct: 188 RMYG 191

>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302

Iteration: 1
 Score = 54.7 bits (130), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 41/150 (27%), Positives = 71/150 (47%), Gaps = 36/150 (24%)
Query: 24  EDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIR----------------STVDEKDQR 67
           E+ Q + +IG G +G V K  ++ +  V+A+K+IR                S + E +  
Sbjct: 6   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 65
Query: 68  QLLMDLDVVMKSNECPYIV---------QFYGA---------LFKEVTVATVKALNYLKE 109
            ++  LDV+   N+  Y+V         +F  A         L K      ++ L +   
Sbjct: 66  NIVKLLDVIHTENKL-YLVFEHVDQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 124
Query: 110 ELKIIHRDVKPSNILLDRRGAIKLCDFGIS 139
             +++HRD+KP N+L++  GAIKL DFG++
Sbjct: 125 H-RVLHRDLKPQNLLINTEGAIKLADFGLA 153

>pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350

Iteration: 1
 Score = 54.7 bits (130), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 48/173 (27%), Positives = 76/173 (43%), Gaps = 39/173 (22%)
Query: 32  IGRGGFGTVNKMIHRSSDT-----------VMAVKRIRSTVDEKDQRQ-----LLMDLDV 75
           +G G FG V  + H+ S             V+ +K+I  T++EK   Q      L+ L+ 
Sbjct: 49  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 76  VMKSNECPYIVQFY---GALFKEV--------------TVATVKALNYLKEELKIIHRDV 118
             K N   Y+V  Y   G +F  +                  V    YL   L +I+RD+
Sbjct: 109 SFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYL-HSLDLIYRDL 167
Query: 119 KPSNILLDRRGAIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPLRARGY 171
           KP N+L+D++G I++ DFG + ++          G   Y+APE I    ++GY
Sbjct: 168 KPENLLIDQQGYIQVTDFGFAKRVKGRTWXL--XGTPEYLAPEII---LSKGY 215

>pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345

Iteration: 1
 Score = 54.3 bits (129), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 48/173 (27%), Positives = 76/173 (43%), Gaps = 39/173 (22%)
Query: 32  IGRGGFGTVNKMIHRSSDT-----------VMAVKRIRSTVDEKDQRQ-----LLMDLDV 75
           +G G FG V  + H+ S             V+ +K+I  T++EK   Q      L+ L+ 
Sbjct: 44  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 103
Query: 76  VMKSNECPYIVQFY---GALFKEV--------------TVATVKALNYLKEELKIIHRDV 118
             K N   Y+V  Y   G +F  +                  V    YL   L +I+RD+
Sbjct: 104 SFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYL-HSLDLIYRDL 162
Query: 119 KPSNILLDRRGAIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPLRARGY 171
           KP N+L+D++G I++ DFG + ++          G   Y+APE I    ++GY
Sbjct: 163 KPENLLIDQQGYIQVTDFGFAKRVKGRTWXL--CGTPEYLAPEII---LSKGY 210

>pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350

Iteration: 1
 Score = 54.3 bits (129), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 48/173 (27%), Positives = 76/173 (43%), Gaps = 39/173 (22%)
Query: 32  IGRGGFGTVNKMIHRSSDT-----------VMAVKRIRSTVDEKDQRQ-----LLMDLDV 75
           +G G FG V  + H+ S             V+ +K+I  T++EK   Q      L+ L+ 
Sbjct: 49  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 76  VMKSNECPYIVQFY---GALFKEV--------------TVATVKALNYLKEELKIIHRDV 118
             K N   Y+V  Y   G +F  +                  V    YL   L +I+RD+
Sbjct: 109 SFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYL-HSLDLIYRDL 167
Query: 119 KPSNILLDRRGAIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPLRARGY 171
           KP N+L+D++G I++ DFG + ++          G   Y+APE I    ++GY
Sbjct: 168 KPENLLIDQQGYIQVTDFGFAKRVKGRTWXL--CGTPEYLAPEII---LSKGY 215

>pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350

Iteration: 1
 Score = 54.3 bits (129), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 48/173 (27%), Positives = 76/173 (43%), Gaps = 39/173 (22%)
Query: 32  IGRGGFGTVNKMIHRSSDT-----------VMAVKRIRSTVDEKDQRQ-----LLMDLDV 75
           +G G FG V  + H+ S             V+ +K+I  T++EK   Q      L+ L+ 
Sbjct: 49  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 76  VMKSNECPYIVQFY---GALFKEV--------------TVATVKALNYLKEELKIIHRDV 118
             K N   Y+V  Y   G +F  +                  V    YL   L +I+RD+
Sbjct: 109 SFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYL-HSLDLIYRDL 167
Query: 119 KPSNILLDRRGAIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPLRARGY 171
           KP N+L+D++G I++ DFG + ++          G   Y+APE I    ++GY
Sbjct: 168 KPENLLIDQQGYIQVTDFGFAKRVKGRTWXL--CGTPEYLAPEII---LSKGY 215

>pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 54.3 bits (129), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 48/173 (27%), Positives = 76/173 (43%), Gaps = 39/173 (22%)
Query: 32  IGRGGFGTVNKMIHRSSDT-----------VMAVKRIRSTVDEKDQRQ-----LLMDLDV 75
           +G G FG V  + H+ S             V+ +K+I  T++EK   Q      L+ L+ 
Sbjct: 49  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 76  VMKSNECPYIVQFY---GALFKEV--------------TVATVKALNYLKEELKIIHRDV 118
             K N   Y+V  Y   G +F  +                  V    YL   L +I+RD+
Sbjct: 109 SFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYL-HSLDLIYRDL 167
Query: 119 KPSNILLDRRGAIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPLRARGY 171
           KP N+L+D++G I++ DFG + ++          G   Y+APE I    ++GY
Sbjct: 168 KPENLLIDQQGYIQVTDFGFAKRVKGRTWXL--CGTPEYLAPEII---LSKGY 215

>pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 54.3 bits (129), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 48/173 (27%), Positives = 76/173 (43%), Gaps = 39/173 (22%)
Query: 32  IGRGGFGTVNKMIHRSSDT-----------VMAVKRIRSTVDEKDQRQ-----LLMDLDV 75
           +G G FG V  + H+ S             V+ +K+I  T++EK   Q      L+ L+ 
Sbjct: 49  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 76  VMKSNECPYIVQFY---GALFKEV--------------TVATVKALNYLKEELKIIHRDV 118
             K N   Y+V  Y   G +F  +                  V    YL   L +I+RD+
Sbjct: 109 SFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYL-HSLDLIYRDL 167
Query: 119 KPSNILLDRRGAIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPLRARGY 171
           KP N+L+D++G I++ DFG + ++          G   Y+APE I    ++GY
Sbjct: 168 KPENLLIDQQGYIQVTDFGFAKRVKGRTWXL--CGTPEYLAPEII---LSKGY 215

>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271

Iteration: 1
 Score = 54.3 bits (129), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 43/171 (25%), Positives = 68/171 (39%), Gaps = 33/171 (19%)
Query: 25  DLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQ---------------- 68
           + Q +  +G G FG V    H ++   +A+K I   V  K   Q                
Sbjct: 5   NYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHP 64
Query: 69  -LLMDLDVVMKSNECPYIVQFYGALFKEVTVA---------------TVKALNYLKEELK 112
            ++   DV+   +E   ++++ G    +  V                 + A+ Y     K
Sbjct: 65  HIIKLYDVIKSKDEIIMVIEYAGNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRH-K 123
Query: 113 IIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERI 163
           I+HRD+KP N+LLD    +K+ DFG+S  + D        G   Y APE I
Sbjct: 124 IVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVI 174

>pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351

Iteration: 1
 Score = 54.3 bits (129), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 48/173 (27%), Positives = 76/173 (43%), Gaps = 39/173 (22%)
Query: 32  IGRGGFGTVNKMIHRSSDT-----------VMAVKRIRSTVDEKDQRQ-----LLMDLDV 75
           +G G FG V  + H+ S             V+ +K+I  T++EK   Q      L+ L+ 
Sbjct: 50  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 109
Query: 76  VMKSNECPYIVQFY---GALFKEV--------------TVATVKALNYLKEELKIIHRDV 118
             K N   Y+V  Y   G +F  +                  V    YL   L +I+RD+
Sbjct: 110 SFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYL-HSLDLIYRDL 168
Query: 119 KPSNILLDRRGAIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPLRARGY 171
           KP N+L+D++G I++ DFG + ++          G   Y+APE I    ++GY
Sbjct: 169 KPENLLIDQQGYIQVTDFGFAKRVKGRTWXL--CGTPEYLAPEII---LSKGY 216

>pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350

Iteration: 1
 Score = 54.3 bits (129), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 48/173 (27%), Positives = 76/173 (43%), Gaps = 39/173 (22%)
Query: 32  IGRGGFGTVNKMIHRSSDT-----------VMAVKRIRSTVDEKDQRQ-----LLMDLDV 75
           +G G FG V  + H+ S             V+ +K+I  T++EK   Q      L+ L+ 
Sbjct: 49  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 76  VMKSNECPYIVQFY---GALFKEV--------------TVATVKALNYLKEELKIIHRDV 118
             K N   Y+V  Y   G +F  +                  V    YL   L +I+RD+
Sbjct: 109 SFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYL-HSLDLIYRDL 167
Query: 119 KPSNILLDRRGAIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPLRARGY 171
           KP N+L+D++G I++ DFG + ++          G   Y+APE I    ++GY
Sbjct: 168 KPENLLIDQQGYIQVTDFGFAKRVKGRTWXL--CGTPEYLAPEII---LSKGY 215

>pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350

Iteration: 1
 Score = 54.3 bits (129), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 48/173 (27%), Positives = 76/173 (43%), Gaps = 39/173 (22%)
Query: 32  IGRGGFGTVNKMIHRSSDT-----------VMAVKRIRSTVDEKDQRQ-----LLMDLDV 75
           +G G FG V  + H+ S             V+ +K+I  T++EK   Q      L+ L+ 
Sbjct: 49  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 76  VMKSNECPYIVQFY---GALFKEV--------------TVATVKALNYLKEELKIIHRDV 118
             K N   Y+V  Y   G +F  +                  V    YL   L +I+RD+
Sbjct: 109 SFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYL-HSLDLIYRDL 167
Query: 119 KPSNILLDRRGAIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPLRARGY 171
           KP N+L+D++G I++ DFG + ++          G   Y+APE I    ++GY
Sbjct: 168 KPENLLIDQQGYIQVTDFGFAKRVKGRTWXL--CGTPEYLAPEII---LSKGY 215

>pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350

Iteration: 1
 Score = 54.3 bits (129), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 48/173 (27%), Positives = 76/173 (43%), Gaps = 39/173 (22%)
Query: 32  IGRGGFGTVNKMIHRSSDT-----------VMAVKRIRSTVDEKDQRQ-----LLMDLDV 75
           +G G FG V  + H+ S             V+ +K+I  T++EK   Q      L+ L+ 
Sbjct: 49  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 76  VMKSNECPYIVQFY---GALFKEV--------------TVATVKALNYLKEELKIIHRDV 118
             K N   Y+V  Y   G +F  +                  V    YL   L +I+RD+
Sbjct: 109 SFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYL-HSLDLIYRDL 167
Query: 119 KPSNILLDRRGAIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPLRARGY 171
           KP N+L+D++G I++ DFG + ++          G   Y+APE I    ++GY
Sbjct: 168 KPENLLIDQQGYIQVTDFGFAKRVKGRTWXL--CGTPEYLAPEII---LSKGY 215

>pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350

Iteration: 1
 Score = 54.3 bits (129), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 48/173 (27%), Positives = 76/173 (43%), Gaps = 39/173 (22%)
Query: 32  IGRGGFGTVNKMIHRSSDT-----------VMAVKRIRSTVDEKDQRQ-----LLMDLDV 75
           +G G FG V  + H+ S             V+ +K+I  T++EK   Q      L+ L+ 
Sbjct: 49  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 76  VMKSNECPYIVQFY---GALFKEV--------------TVATVKALNYLKEELKIIHRDV 118
             K N   Y+V  Y   G +F  +                  V    YL   L +I+RD+
Sbjct: 109 SFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYL-HSLDLIYRDL 167
Query: 119 KPSNILLDRRGAIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPLRARGY 171
           KP N+L+D++G I++ DFG + ++          G   Y+APE I    ++GY
Sbjct: 168 KPENLLIDQQGYIQVTDFGFAKRVKGRTWXL--CGTPEYLAPEII---LSKGY 215

>pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350

Iteration: 1
 Score = 54.3 bits (129), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 48/173 (27%), Positives = 76/173 (43%), Gaps = 39/173 (22%)
Query: 32  IGRGGFGTVNKMIHRSSDT-----------VMAVKRIRSTVDEKDQRQ-----LLMDLDV 75
           +G G FG V  + H+ S             V+ +K+I  T++EK   Q      L+ L+ 
Sbjct: 49  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 76  VMKSNECPYIVQFY---GALFKEV--------------TVATVKALNYLKEELKIIHRDV 118
             K N   Y+V  Y   G +F  +                  V    YL   L +I+RD+
Sbjct: 109 SFKDNSNLYMVMEYVAGGEMFSHLRRIGRFAEPHARFYAAQIVLTFEYL-HSLDLIYRDL 167
Query: 119 KPSNILLDRRGAIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPLRARGY 171
           KP N+L+D++G I++ DFG + ++          G   Y+APE I    ++GY
Sbjct: 168 KPENLLIDQQGYIQVTDFGFAKRVKGRTWXL--CGTPEYLAPEII---LSKGY 215

>pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 54.3 bits (129), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 48/173 (27%), Positives = 76/173 (43%), Gaps = 39/173 (22%)
Query: 32  IGRGGFGTVNKMIHRSSDT-----------VMAVKRIRSTVDEKDQRQ-----LLMDLDV 75
           +G G FG V  + H+ S             V+ +K+I  T++EK   Q      L+ L+ 
Sbjct: 49  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 76  VMKSNECPYIVQFY---GALFKEV--------------TVATVKALNYLKEELKIIHRDV 118
             K N   Y+V  Y   G +F  +                  V    YL   L +I+RD+
Sbjct: 109 SFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYL-HSLDLIYRDL 167
Query: 119 KPSNILLDRRGAIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPLRARGY 171
           KP N+L+D++G I++ DFG + ++          G   Y+APE I    ++GY
Sbjct: 168 KPENLLIDQQGYIQVTDFGFAKRVKGRTWXL--CGTPEYLAPEII---LSKGY 215

>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274

Iteration: 1
 Score = 54.3 bits (129), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 43/171 (25%), Positives = 68/171 (39%), Gaps = 33/171 (19%)
Query: 25  DLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQ---------------- 68
           + Q +  +G G FG V    H ++   +A+K I   V  K   Q                
Sbjct: 9   NYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHP 68
Query: 69  -LLMDLDVVMKSNECPYIVQFYGALFKEVTVA---------------TVKALNYLKEELK 112
            ++   DV+   +E   ++++ G    +  V                 + A+ Y     K
Sbjct: 69  HIIKLYDVIKSKDEIIMVIEYAGNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRH-K 127
Query: 113 IIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERI 163
           I+HRD+KP N+LLD    +K+ DFG+S  + D        G   Y APE I
Sbjct: 128 IVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVI 178

>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283

Iteration: 1
 Score = 54.3 bits (129), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 43/171 (25%), Positives = 68/171 (39%), Gaps = 33/171 (19%)
Query: 25  DLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQ---------------- 68
           + Q +  +G G FG V    H ++   +A+K I   V  K   Q                
Sbjct: 15  NYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHP 74
Query: 69  -LLMDLDVVMKSNECPYIVQFYGALFKEVTVA---------------TVKALNYLKEELK 112
            ++   DV+   +E   ++++ G    +  V                 + A+ Y     K
Sbjct: 75  HIIKLYDVIKSKDEIIMVIEYAGNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRH-K 133
Query: 113 IIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERI 163
           I+HRD+KP N+LLD    +K+ DFG+S  + D        G   Y APE I
Sbjct: 134 IVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVI 184

>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275

Iteration: 1
 Score = 54.3 bits (129), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 43/171 (25%), Positives = 68/171 (39%), Gaps = 33/171 (19%)
Query: 25  DLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQ---------------- 68
           + Q +  +G G FG V    H ++   +A+K I   V  K   Q                
Sbjct: 14  NYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHP 73
Query: 69  -LLMDLDVVMKSNECPYIVQFYGALFKEVTVA---------------TVKALNYLKEELK 112
            ++   DV+   +E   ++++ G    +  V                 + A+ Y     K
Sbjct: 74  HIIKLYDVIKSKDEIIMVIEYAGNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRH-K 132
Query: 113 IIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERI 163
           I+HRD+KP N+LLD    +K+ DFG+S  + D        G   Y APE I
Sbjct: 133 IVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVI 183

>pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350

Iteration: 1
 Score = 54.3 bits (129), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 49/173 (28%), Positives = 75/173 (43%), Gaps = 39/173 (22%)
Query: 32  IGRGGFGTVNKMIHRSSDT-----------VMAVKRIRSTVDEKDQRQ-----LLMDLDV 75
           IG G FG V  + H  +             V+ +K+I  T++EK   Q      L+ L+ 
Sbjct: 49  IGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 76  VMKSNECPYIVQFY---GALFKEV--------------TVATVKALNYLKEELKIIHRDV 118
             K N   Y+V  Y   G +F  +                  V    YL   L +I+RD+
Sbjct: 109 SFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYL-HSLDLIYRDL 167
Query: 119 KPSNILLDRRGAIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPLRARGY 171
           KP N+L+D++G IK+ DFG + ++          G   Y+APE I    ++GY
Sbjct: 168 KPENLLIDQQGYIKVADFGFAKRVKGRTWXL--CGTPEYLAPEII---LSKGY 215

>pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371

Iteration: 1
 Score = 54.3 bits (129), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 48/173 (27%), Positives = 76/173 (43%), Gaps = 39/173 (22%)
Query: 32  IGRGGFGTVNKMIHRSSDT-----------VMAVKRIRSTVDEKDQRQ-----LLMDLDV 75
           +G G FG V  + H+ S             V+ +K+I  T++EK   Q      L+ L+ 
Sbjct: 70  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 129
Query: 76  VMKSNECPYIVQFY---GALFKEV--------------TVATVKALNYLKEELKIIHRDV 118
             K N   Y+V  Y   G +F  +                  V    YL   L +I+RD+
Sbjct: 130 SFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYL-HSLDLIYRDL 188
Query: 119 KPSNILLDRRGAIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPLRARGY 171
           KP N+L+D++G I++ DFG + ++          G   Y+APE I    ++GY
Sbjct: 189 KPENLLIDQQGYIQVTDFGFAKRVKGRTWXL--CGTPEYLAPEII---LSKGY 236

>pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437

Iteration: 1
 Score = 53.9 bits (128), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 49/173 (28%), Positives = 79/173 (45%), Gaps = 35/173 (20%)
Query: 24  EDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIR--------STVDEKDQRQLLMD--- 72
           ED + L  IGRG FG V  +  +++D V A+K +          T   +++R +L++   
Sbjct: 74  EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDS 133
Query: 73  -----LDVVMKSNECPYIVQFY---GALFK-----EVTVATVKALNYLKE---------E 110
                L    + +   Y+V  Y   G L       E  +    A  YL E         +
Sbjct: 134 KWITTLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQ 193
Query: 111 LKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVD--SIAKTRDAGCRPYMAPE 161
           L  +HRD+KP NIL+D  G I+L DFG   +L++  ++  +   G   Y++PE
Sbjct: 194 LHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPE 246

>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306

Iteration: 1
 Score = 53.9 bits (128), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 29/72 (40%), Positives = 45/72 (62%), Gaps = 5/72 (6%)
Query: 92  LFKEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTRD 151
           LF+++T    K ++Y+  + K+IHRD+KPSNI L     +K+ DFG+   L +   +TR 
Sbjct: 141 LFEQIT----KGVDYIHSK-KLIHRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTRS 195
Query: 152 AGCRPYMAPERI 163
            G   YM+PE+I
Sbjct: 196 KGTLRYMSPEQI 207

>pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337

Iteration: 1
 Score = 53.9 bits (128), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 48/173 (27%), Positives = 75/173 (43%), Gaps = 39/173 (22%)
Query: 32  IGRGGFGTVNKMIHRSSDT-----------VMAVKRIRSTVDEKDQRQ-----LLMDLDV 75
           +G G FG V  + H+ S             V+ +K+I  T++EK   Q      L+ L+ 
Sbjct: 36  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 95
Query: 76  VMKSNECPYIVQFY---GALFKEV--------------TVATVKALNYLKEELKIIHRDV 118
             K N   Y+V  Y   G +F  +                  V    YL   L +I+RD+
Sbjct: 96  SFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYL-HSLDLIYRDL 154
Query: 119 KPSNILLDRRGAIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPLRARGY 171
           KP N+L+D +G I++ DFG + ++          G   Y+APE I    ++GY
Sbjct: 155 KPENLLIDEQGYIQVTDFGFAKRVKGRTWXL--CGTPEYLAPEII---LSKGY 202

>pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279

Iteration: 1
 Score = 53.9 bits (128), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 46/186 (24%), Positives = 78/186 (41%), Gaps = 45/186 (24%)
Query: 23  SEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNEC 82
           +ED + L  IG G +G   K+  +S   ++  K +      + ++Q+L+    +++  + 
Sbjct: 5   AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKH 64
Query: 83  PYIVQFY-------------------GALFKEVTVATVKALNYLKEEL------------ 111
           P IV++Y                   G     V     K   YL EE             
Sbjct: 65  PNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLAL 124
Query: 112 -----------KIIHRDVKPSNILLDRRGAIKLCDFGISGQLVD--SIAKTRDAGCRPYM 158
                       ++HRD+KP+N+ LD +  +KL DFG++  L    S AKT   G   YM
Sbjct: 125 KECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTF-VGTPYYM 183
Query: 159 APERID 164
           +PE+++
Sbjct: 184 SPEQMN 189

>pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350

Iteration: 1
 Score = 53.9 bits (128), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 49/173 (28%), Positives = 75/173 (43%), Gaps = 39/173 (22%)
Query: 32  IGRGGFGTVNKMIHRSSDT-----------VMAVKRIRSTVDEKDQRQ-----LLMDLDV 75
           IG G FG V  + H  +             V+ +K+I  T++EK   Q      L+ L+ 
Sbjct: 49  IGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 76  VMKSNECPYIVQFY---GALFKEV--------------TVATVKALNYLKEELKIIHRDV 118
             K N   Y+V  Y   G +F  +                  V    YL   L +I+RD+
Sbjct: 109 SFKDNSNLYMVMEYMPGGDMFSHLRRIGRFSEPHARFYAAQIVLTFEYL-HSLDLIYRDL 167
Query: 119 KPSNILLDRRGAIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPLRARGY 171
           KP N+L+D++G IK+ DFG + ++          G   Y+APE I    ++GY
Sbjct: 168 KPENLLIDQQGYIKVADFGFAKRVKGRTWXL--CGTPEYLAPEII---LSKGY 215

>pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351

Iteration: 1
 Score = 53.5 bits (127), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 47/173 (27%), Positives = 76/173 (43%), Gaps = 39/173 (22%)
Query: 32  IGRGGFGTVNKMIHRSSDT-----------VMAVKRIRSTVDEKDQRQ-----LLMDLDV 75
           +G G FG V  + H+ +             V+ +K+I  T++EK   Q      L+ L+ 
Sbjct: 50  LGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 109
Query: 76  VMKSNECPYIVQFY---GALFKEV--------------TVATVKALNYLKEELKIIHRDV 118
             K N   Y+V  Y   G +F  +                  V    YL   L +I+RD+
Sbjct: 110 SFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYL-HSLDLIYRDL 168
Query: 119 KPSNILLDRRGAIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPLRARGY 171
           KP N+++D++G IK+ DFG + ++          G   Y+APE I    ++GY
Sbjct: 169 KPENLMIDQQGYIKVTDFGFAKRVKGRTWXL--CGTPEYLAPEII---LSKGY 216

>pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350

Iteration: 1
 Score = 53.5 bits (127), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 49/173 (28%), Positives = 75/173 (43%), Gaps = 39/173 (22%)
Query: 32  IGRGGFGTVNKMIHRSSDT-----------VMAVKRIRSTVDEKDQRQ-----LLMDLDV 75
           IG G FG V  + H  +             V+ +K+I  T++EK   Q      L+ L+ 
Sbjct: 49  IGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 76  VMKSNECPYIVQFY---GALFKEV--------------TVATVKALNYLKEELKIIHRDV 118
             K N   Y+V  Y   G +F  +                  V    YL   L +I+RD+
Sbjct: 109 SFKDNSNLYMVMEYMPGGDMFSHLRRIGRFSEPHARFYAAQIVLTFEYL-HSLDLIYRDL 167
Query: 119 KPSNILLDRRGAIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPLRARGY 171
           KP N+L+D++G IK+ DFG + ++          G   Y+APE I    ++GY
Sbjct: 168 KPENLLIDQQGYIKVADFGFAKRVKGRTWXL--CGTPEYLAPEII---LSKGY 215

>pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284

Iteration: 1
 Score = 53.5 bits (127), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 51/188 (27%), Positives = 81/188 (43%), Gaps = 55/188 (29%)
Query: 25  DLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQL--LMDLDVV--MKSN 80
           D +++  IG GGFG V K  HR       +KR++   +EK +R++  L  LD V  +  N
Sbjct: 12  DFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYN-NEKAEREVKALAKLDHVNIVHYN 70
Query: 81  EC------------------------------------PYIVQFYGA---------LFKE 95
            C                                     +I +  G          LF++
Sbjct: 71  GCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQ 130
Query: 96  VTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTRDAGCR 155
           +T    K ++Y+  + K+I+RD+KPSNI L     +K+ DFG+   L +   + R  G  
Sbjct: 131 IT----KGVDYIHSK-KLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRXRSKGTL 185
Query: 156 PYMAPERI 163
            YM+PE+I
Sbjct: 186 RYMSPEQI 193

>pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343

Iteration: 1
 Score = 53.5 bits (127), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 47/173 (27%), Positives = 76/173 (43%), Gaps = 39/173 (22%)
Query: 32  IGRGGFGTVNKMIHRSSDT-----------VMAVKRIRSTVDEKDQRQ-----LLMDLDV 75
           +G G FG V  + H+ +             V+ +K+I  T++EK   Q      L+ L+ 
Sbjct: 42  LGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 101
Query: 76  VMKSNECPYIVQFY---GALFKEV--------------TVATVKALNYLKEELKIIHRDV 118
             K N   Y+V  Y   G +F  +                  V    YL   L +I+RD+
Sbjct: 102 SFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYL-HSLDLIYRDL 160
Query: 119 KPSNILLDRRGAIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPLRARGY 171
           KP N+L+D++G I++ DFG + ++          G   Y+APE I    ++GY
Sbjct: 161 KPENLLIDQQGYIQVTDFGFAKRVKGRTWXL--CGTPEYLAPEII---LSKGY 208

>pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343

Iteration: 1
 Score = 53.1 bits (126), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 47/173 (27%), Positives = 76/173 (43%), Gaps = 39/173 (22%)
Query: 32  IGRGGFGTVNKMIHRSSDT-----------VMAVKRIRSTVDEKDQRQ-----LLMDLDV 75
           +G G FG V  + H+ +             V+ +K+I  T++EK   Q      L+ L+ 
Sbjct: 42  LGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 101
Query: 76  VMKSNECPYIVQFY---GALFKEV--------------TVATVKALNYLKEELKIIHRDV 118
             K N   Y+V  Y   G +F  +                  V    YL   L +I+RD+
Sbjct: 102 SFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYL-HSLDLIYRDL 160
Query: 119 KPSNILLDRRGAIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPLRARGY 171
           KP N+L+D++G I++ DFG + ++          G   Y+APE I    ++GY
Sbjct: 161 KPENLLIDQQGYIQVTDFGFAKRVKGRTWXL--CGTPEYLAPEII---LSKGY 208

>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281

Iteration: 1
 Score = 53.1 bits (126), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 47/178 (26%), Positives = 76/178 (42%), Gaps = 35/178 (19%)
Query: 20  DFTSEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKS 79
            +  ED +    +G+G FG V     + S  ++A+K +     EK   +  +  +V ++S
Sbjct: 5   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 64
Query: 80  N-ECPYIVQFYGAL---------------------------FKEVTVAT-----VKALNY 106
           +   P I++ YG                             F E   AT       AL+Y
Sbjct: 65  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSY 124
Query: 107 LKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERID 164
              + ++IHRD+KP N+LL   G +K+ DFG S     S  +T  +G   Y+ PE I+
Sbjct: 125 CHSK-RVIHRDIKPENLLLGSAGELKIADFGWSCH-APSSRRTTLSGTLDYLPPEMIE 180

>pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351

Iteration: 1
 Score = 53.1 bits (126), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 47/173 (27%), Positives = 76/173 (43%), Gaps = 39/173 (22%)
Query: 32  IGRGGFGTVNKMIHRSSDT-----------VMAVKRIRSTVDEKDQRQ-----LLMDLDV 75
           +G G FG V  + H+ +             V+ +K+I  T++EK   Q      L+ L+ 
Sbjct: 50  LGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 109
Query: 76  VMKSNECPYIVQFY---GALFKEV--------------TVATVKALNYLKEELKIIHRDV 118
             K N   Y+V  Y   G +F  +                  V    YL   L +I+RD+
Sbjct: 110 SFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYL-HSLDLIYRDL 168
Query: 119 KPSNILLDRRGAIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPLRARGY 171
           KP N+L+D++G I++ DFG + ++          G   Y+APE I    ++GY
Sbjct: 169 KPENLLIDQQGYIQVTDFGFAKRVKGRTWXL--CGTPEYLAPEII---LSKGY 216

>pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351

Iteration: 1
 Score = 53.1 bits (126), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 47/173 (27%), Positives = 76/173 (43%), Gaps = 39/173 (22%)
Query: 32  IGRGGFGTVNKMIHRSSDT-----------VMAVKRIRSTVDEKDQRQ-----LLMDLDV 75
           +G G FG V  + H+ +             V+ +K+I  T++EK   Q      L+ L+ 
Sbjct: 50  LGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 109
Query: 76  VMKSNECPYIVQFY---GALFKEV--------------TVATVKALNYLKEELKIIHRDV 118
             K N   Y+V  Y   G +F  +                  V    YL   L +I+RD+
Sbjct: 110 SFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYL-HSLDLIYRDL 168
Query: 119 KPSNILLDRRGAIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPLRARGY 171
           KP N+L+D++G I++ DFG + ++          G   Y+APE I    ++GY
Sbjct: 169 KPENLLIDQQGYIQVTDFGFAKRVKGRTWXL--CGTPEYLAPEII---LSKGY 216

>pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350

Iteration: 1
 Score = 53.1 bits (126), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 45/165 (27%), Positives = 72/165 (43%), Gaps = 36/165 (21%)
Query: 32  IGRGGFGTVNKMIHRSSDT-----------VMAVKRIRSTVDEKDQRQ-----LLMDLDV 75
           +G G FG V  + H+ S             V+ +K+I  T++EK   Q      L+ L+ 
Sbjct: 49  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 76  VMKSNECPYIVQFY---GALFKEV--------------TVATVKALNYLKEELKIIHRDV 118
             K N   Y+V  Y   G +F  +                  V    YL   L +I+RD+
Sbjct: 109 SFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYL-HSLDLIYRDL 167
Query: 119 KPSNILLDRRGAIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERI 163
           KP N+++D++G I++ DFG + ++          G   Y+APE I
Sbjct: 168 KPENLIIDQQGYIQVTDFGFAKRVKGRTWXL--CGTPEYLAPEII 210

>pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351

Iteration: 1
 Score = 53.1 bits (126), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 47/173 (27%), Positives = 76/173 (43%), Gaps = 39/173 (22%)
Query: 32  IGRGGFGTVNKMIHRSSDT-----------VMAVKRIRSTVDEKDQRQ-----LLMDLDV 75
           +G G FG V  + H+ +             V+ +K+I  T++EK   Q      L+ L+ 
Sbjct: 50  LGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 109
Query: 76  VMKSNECPYIVQFY---GALFKEV--------------TVATVKALNYLKEELKIIHRDV 118
             K N   Y+V  Y   G +F  +                  V    YL   L +I+RD+
Sbjct: 110 SFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYL-HSLDLIYRDL 168
Query: 119 KPSNILLDRRGAIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPLRARGY 171
           KP N+L+D++G I++ DFG + ++          G   Y+APE I    ++GY
Sbjct: 169 KPENLLIDQQGYIQVTDFGFAKRVKGRTWXL--CGTPEYLAPEII---LSKGY 216

>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268

Iteration: 1
 Score = 53.1 bits (126), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 49/179 (27%), Positives = 78/179 (43%), Gaps = 39/179 (21%)
Query: 21  FTSEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSN 80
           +  ED +    +G+G FG V     ++S  ++A+K +     EK   +  +  +V ++S+
Sbjct: 5   WALEDFEIGRPLGKGKFGNVYLAREKNSKFILALKVLFKAQLEKAGVEHQLRREVEIQSH 64
Query: 81  -ECPYIVQFYGAL---------------------------FKEVTVAT-----VKALNYL 107
              P I++ YG                             F E   AT       AL+Y 
Sbjct: 65  LRHPNILRLYGYFHDSTRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYC 124
Query: 108 KEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTRDAGCRP--YMAPERID 164
             + K+IHRD+KP N+LL   G +K+ DFG S   V + +  R A C    Y+ PE I+
Sbjct: 125 HSK-KVIHRDIKPENLLLGSAGELKIADFGWS---VHAPSSRRAALCGTLDYLPPEMIE 179

>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336

Iteration: 1
 Score = 53.1 bits (126), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 40/164 (24%), Positives = 69/164 (42%), Gaps = 31/164 (18%)
Query: 32  IGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDV-VMKSNECPYIVQFYG 90
           +G G FG V    H  +   +A+K I   + +K    + ++ ++  +K    P+I++ Y 
Sbjct: 17  LGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYD 76
Query: 91  ALFKEVTVATV------KALNYLKEE------------------------LKIIHRDVKP 120
            +     +  V      +  +Y+ E+                         KI+HRD+KP
Sbjct: 77  VITTPTDIVMVIEYAGGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKP 136
Query: 121 SNILLDRRGAIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERID 164
            N+LLD    +K+ DFG+S  + D        G   Y APE I+
Sbjct: 137 ENLLLDDNLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVIN 180

>pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371

Iteration: 1
 Score = 53.1 bits (126), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 45/165 (27%), Positives = 72/165 (43%), Gaps = 36/165 (21%)
Query: 32  IGRGGFGTVNKMIHRSSDT-----------VMAVKRIRSTVDEKDQRQ-----LLMDLDV 75
           +G G FG V  + H+ +             V+ +K+I  T++EK   Q      L+ L+ 
Sbjct: 70  LGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 129
Query: 76  VMKSNECPYIVQFY---GALFKEV--------------TVATVKALNYLKEELKIIHRDV 118
             K N   Y+V  Y   G +F  +                  V    YL   L +I+RD+
Sbjct: 130 SFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYL-HSLDLIYRDL 188
Query: 119 KPSNILLDRRGAIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERI 163
           KP N+L+D++G I++ DFG + ++          G   Y+APE I
Sbjct: 189 KPENLLIDQQGYIQVTDFGFAKRVKGRTWXL--CGTPEYLAPEII 231

>pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350

Iteration: 1
 Score = 53.1 bits (126), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 47/173 (27%), Positives = 76/173 (43%), Gaps = 39/173 (22%)
Query: 32  IGRGGFGTVNKMIHRSSDT-----------VMAVKRIRSTVDEKDQRQ-----LLMDLDV 75
           +G G FG V  + H+ +             V+ +K+I  T++EK   Q      L+ L+ 
Sbjct: 49  LGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEY 108
Query: 76  VMKSNECPYIVQFY---GALFKEV--------------TVATVKALNYLKEELKIIHRDV 118
             K N   Y+V  Y   G +F  +                  V    YL   L +I+RD+
Sbjct: 109 SFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYL-HSLDLIYRDL 167
Query: 119 KPSNILLDRRGAIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPLRARGY 171
           KP N+L+D++G I++ DFG + ++          G   Y+APE I    ++GY
Sbjct: 168 KPENLLIDQQGYIQVTDFGFAKRVKGRTWXL--CGTPEYLAPEII---LSKGY 215

>pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321

Iteration: 1
 Score = 52.8 bits (125), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 50/165 (30%), Positives = 75/165 (45%), Gaps = 35/165 (21%)
Query: 31  EIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQFY- 89
           +IG G  G V     + S   +AVK +   + ++ +R+LL +  V+M+  +   +V+ Y 
Sbjct: 52  KIGEGSTGIVCLAREKHSGRQVAVKMM--DLRKQQRRELLFNEVVIMRDYQHFNVVEMYK 109
Query: 90  -----------------GAL--------FKEVTVATV-----KALNYLKEELKIIHRDVK 119
                            GAL          E  +ATV     +AL YL  +  +IHRD+K
Sbjct: 110 SYLVGEELWVLMEFLQGGALTDIVSQVRLNEEQIATVCEAVLQALAYLHAQ-GVIHRDIK 168
Query: 120 PSNILLDRRGAIKLCDFGISGQLVDSIAKTRDAGCRPY-MAPERI 163
             +ILL   G +KL DFG   Q+   + K +     PY MAPE I
Sbjct: 169 SDSILLTLDGRVKLSDFGFCAQISKDVPKRKXLVGTPYWMAPEVI 213

>pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350

Iteration: 1
 Score = 52.8 bits (125), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 47/173 (27%), Positives = 76/173 (43%), Gaps = 39/173 (22%)
Query: 32  IGRGGFGTVNKMIHRSSDT-----------VMAVKRIRSTVDEKDQRQ-----LLMDLDV 75
           +G G FG V  + H+ +             V+ +K+I  T++EK   Q      L+ L+ 
Sbjct: 49  LGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEY 108
Query: 76  VMKSNECPYIVQFY---GALFKEV--------------TVATVKALNYLKEELKIIHRDV 118
             K N   Y+V  Y   G +F  +                  V    YL   L +I+RD+
Sbjct: 109 SFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYL-HSLDLIYRDL 167
Query: 119 KPSNILLDRRGAIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPLRARGY 171
           KP N+L+D++G I++ DFG + ++          G   Y+APE I    ++GY
Sbjct: 168 KPENLLIDQQGYIQVTDFGFAKRVKGRTWXL--CGTPEYLAPEII---LSKGY 215

>pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350

Iteration: 1
 Score = 52.8 bits (125), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 47/173 (27%), Positives = 76/173 (43%), Gaps = 39/173 (22%)
Query: 32  IGRGGFGTVNKMIHRSSDT-----------VMAVKRIRSTVDEKDQRQ-----LLMDLDV 75
           +G G FG V  + H+ +             V+ +K+I  T++EK   Q      L+ L+ 
Sbjct: 49  LGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEY 108
Query: 76  VMKSNECPYIVQFY---GALFKEV--------------TVATVKALNYLKEELKIIHRDV 118
             K N   Y+V  Y   G +F  +                  V    YL   L +I+RD+
Sbjct: 109 SFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYL-HSLDLIYRDL 167
Query: 119 KPSNILLDRRGAIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPLRARGY 171
           KP N+L+D++G I++ DFG + ++          G   Y+APE I    ++GY
Sbjct: 168 KPENLLIDQQGYIQVTDFGFAKRVKGRTWXL--CGTPEYLAPEII---LSKGY 215

>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280

Iteration: 1
 Score = 52.8 bits (125), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 47/178 (26%), Positives = 75/178 (42%), Gaps = 35/178 (19%)
Query: 20  DFTSEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKS 79
            +  ED +    +G+G FG V     + S  ++A+K +     EK   +  +  +V ++S
Sbjct: 4   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 63
Query: 80  N-ECPYIVQFYGAL---------------------------FKEVTVAT-----VKALNY 106
           +   P I++ YG                             F E   AT       AL+Y
Sbjct: 64  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSY 123
Query: 107 LKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERID 164
              + ++IHRD+KP N+LL   G +K+ DFG S     S  +T   G   Y+ PE I+
Sbjct: 124 CHSK-RVIHRDIKPENLLLGSAGELKIADFGWSVH-APSSRRTELCGTLDYLPPEMIE 179

>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score = 52.8 bits (125), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 45/174 (25%), Positives = 74/174 (42%), Gaps = 43/174 (24%)
Query: 30  GEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVD---EKDQRQLLMDLDVVMKSNE----- 81
            ++G GGFG V K     ++T +AVK++ + VD   E+ ++Q   ++ V+ K        
Sbjct: 37  NKMGEGGFGVVYK--GYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVE 94
Query: 82  ------------CPYIVQFYGALFK-----------------EVTVATVKALNYLKEELK 112
                         Y+    G+L                   ++       +N+L E   
Sbjct: 95  LLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHH 154
Query: 113 IIHRDVKPSNILLDRRGAIKLCDFGI---SGQLVDSIAKTRDAGCRPYMAPERI 163
           I HRD+K +NILLD     K+ DFG+   S +   ++  +R  G   YMAPE +
Sbjct: 155 I-HRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMXSRIVGTTAYMAPEAL 207

>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279

Iteration: 1
 Score = 52.8 bits (125), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 48/179 (26%), Positives = 77/179 (43%), Gaps = 39/179 (21%)
Query: 21  FTSEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSN 80
           +  ED +    +G+G FG V     + S  ++A+K +     EK   +  +  +V ++S+
Sbjct: 6   WALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSH 65
Query: 81  -ECPYIVQFYGAL---------------------------FKEVTVAT-----VKALNYL 107
              P I++ YG                             F E   AT       AL+Y 
Sbjct: 66  LRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYC 125
Query: 108 KEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTRDAGCRP--YMAPERID 164
             + ++IHRD+KP N+LL   G +K+ DFG S   V + +  RD  C    Y+ PE I+
Sbjct: 126 HSK-RVIHRDIKPENLLLGSAGELKIADFGWS---VHAPSSRRDTLCGTLDYLPPEMIE 180

>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285

Iteration: 1
 Score = 52.8 bits (125), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 47/177 (26%), Positives = 75/177 (42%), Gaps = 35/177 (19%)
Query: 21  FTSEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSN 80
           +  ED +    +G+G FG V     + S  ++A+K +     EK   +  +  +V ++S+
Sbjct: 10  WALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSH 69
Query: 81  -ECPYIVQFYGAL---------------------------FKEVTVAT-----VKALNYL 107
              P I++ YG                             F E   AT       AL+Y 
Sbjct: 70  LRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYC 129
Query: 108 KEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERID 164
             + ++IHRD+KP N+LL   G +K+ DFG S     S  +T   G   Y+ PE I+
Sbjct: 130 HSK-RVIHRDIKPENLLLGSAGELKIADFGWSVH-APSSRRTTLCGTLDYLPPEXIE 184

>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268

Iteration: 1
 Score = 52.8 bits (125), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 47/178 (26%), Positives = 75/178 (42%), Gaps = 35/178 (19%)
Query: 20  DFTSEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKS 79
            +  ED +    +G+G FG V     + S  ++A+K +     EK   +  +  +V ++S
Sbjct: 4   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 63
Query: 80  N-ECPYIVQFYGAL---------------------------FKEVTVAT-----VKALNY 106
           +   P I++ YG                             F E   AT       AL+Y
Sbjct: 64  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSY 123
Query: 107 LKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERID 164
              + ++IHRD+KP N+LL   G +K+ DFG S     S  +T   G   Y+ PE I+
Sbjct: 124 CHSK-RVIHRDIKPENLLLGSAGELKIADFGWSVH-APSSRRTXLCGTLDYLPPEMIE 179

>pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 47/181 (25%), Positives = 84/181 (46%), Gaps = 38/181 (20%)
Query: 17  TVYDFTSEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIR--------------STVD 62
           +VYD+   D+  L E+G G FG V++ + +++  V   K I               S ++
Sbjct: 48  SVYDYY--DI--LEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMN 103
Query: 63  EKDQRQLLMDLDVVMKSNECPYIVQFY--GALFKEVT-----VATVKALNYLKE------ 109
           +    +L+   D      E   I++F   G LF  +      ++  + +NY+++      
Sbjct: 104 QLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLK 163
Query: 110 ---ELKIIHRDVKPSNILLDRRGA--IKLCDFGISGQL-VDSIAKTRDAGCRPYMAPERI 163
              E  I+H D+KP NI+ + + A  +K+ DFG++ +L  D I K   A    + APE +
Sbjct: 164 HMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAE-FAAPEIV 222
Query: 164 D 164
           D
Sbjct: 223 D 223

>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 38/153 (24%), Positives = 70/153 (45%), Gaps = 35/153 (22%)
Query: 22  TSEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIR---------------STVDEKDQ 66
           +S   + L ++G G + TV K +++++   +A+K ++               S + E   
Sbjct: 3   SSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKH 62
Query: 67  RQLLMDLDVVMKSNECPYIVQFYGALFKEV----TVATVK---ALNYLK----------- 108
             ++   DV+   N+   + +F     K+     TV        LN +K           
Sbjct: 63  ENIVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLA 122
Query: 109 --EELKIIHRDVKPSNILLDRRGAIKLCDFGIS 139
              E KI+HRD+KP N+L+++RG +KL DFG++
Sbjct: 123 FCHENKILHRDLKPQNLLINKRGQLKLGDFGLA 155

>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 47/178 (26%), Positives = 75/178 (42%), Gaps = 35/178 (19%)
Query: 20  DFTSEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKS 79
            +  ED +    +G+G FG V     + S  ++A+K +     EK   +  +  +V ++S
Sbjct: 3   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 62
Query: 80  N-ECPYIVQFYGAL---------------------------FKEVTVAT-----VKALNY 106
           +   P I++ YG                             F E   AT       AL+Y
Sbjct: 63  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSY 122
Query: 107 LKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERID 164
              + ++IHRD+KP N+LL   G +K+ DFG S     S  +T   G   Y+ PE I+
Sbjct: 123 CHSK-RVIHRDIKPENLLLGSAGELKIADFGWSVH-APSSRRTTLCGTLDYLPPEMIE 178

>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272

Iteration: 1
 Score = 52.4 bits (124), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 47/178 (26%), Positives = 75/178 (42%), Gaps = 35/178 (19%)
Query: 20  DFTSEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKS 79
            +  ED +    +G+G FG V     + S  ++A+K +     EK   +  +  +V ++S
Sbjct: 8   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 67
Query: 80  N-ECPYIVQFYGAL---------------------------FKEVTVAT-----VKALNY 106
           +   P I++ YG                             F E   AT       AL+Y
Sbjct: 68  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSY 127
Query: 107 LKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERID 164
              + ++IHRD+KP N+LL   G +K+ DFG S     S  +T   G   Y+ PE I+
Sbjct: 128 CHSK-RVIHRDIKPENLLLGSAGELKIADFGWSVH-APSSRRTTLCGTLDYLPPEMIE 183

>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285

Iteration: 1
 Score = 52.4 bits (124), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 47/178 (26%), Positives = 75/178 (42%), Gaps = 35/178 (19%)
Query: 20  DFTSEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKS 79
            +  ED +    +G+G FG V     + S  ++A+K +     EK   +  +  +V ++S
Sbjct: 9   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 68
Query: 80  N-ECPYIVQFYGAL---------------------------FKEVTVAT-----VKALNY 106
           +   P I++ YG                             F E   AT       AL+Y
Sbjct: 69  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSY 128
Query: 107 LKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERID 164
              + ++IHRD+KP N+LL   G +K+ DFG S     S  +T   G   Y+ PE I+
Sbjct: 129 CHSK-RVIHRDIKPENLLLGSAGELKIADFGWSVH-APSSRRTTLCGTLDYLPPEMIE 184

>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283

Iteration: 1
 Score = 52.4 bits (124), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 47/178 (26%), Positives = 75/178 (42%), Gaps = 35/178 (19%)
Query: 20  DFTSEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKS 79
            +  ED +    +G+G FG V     + S  ++A+K +     EK   +  +  +V ++S
Sbjct: 7   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 66
Query: 80  N-ECPYIVQFYGAL---------------------------FKEVTVAT-----VKALNY 106
           +   P I++ YG                             F E   AT       AL+Y
Sbjct: 67  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSY 126
Query: 107 LKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERID 164
              + ++IHRD+KP N+LL   G +K+ DFG S     S  +T   G   Y+ PE I+
Sbjct: 127 CHSK-RVIHRDIKPENLLLGSAGELKIADFGWSVH-APSSRRTTLCGTLDYLPPEMIE 182

>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280

Iteration: 1
 Score = 52.4 bits (124), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 47/178 (26%), Positives = 75/178 (42%), Gaps = 35/178 (19%)
Query: 20  DFTSEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKS 79
            +  ED +    +G+G FG V     + S  ++A+K +     EK   +  +  +V ++S
Sbjct: 4   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 63
Query: 80  N-ECPYIVQFYGAL---------------------------FKEVTVAT-----VKALNY 106
           +   P I++ YG                             F E   AT       AL+Y
Sbjct: 64  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSY 123
Query: 107 LKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERID 164
              + ++IHRD+KP N+LL   G +K+ DFG S     S  +T   G   Y+ PE I+
Sbjct: 124 CHSK-RVIHRDIKPENLLLGSAGELKIADFGWSVH-APSSRRTTLCGTLDYLPPEMIE 179

>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271

Iteration: 1
 Score = 52.4 bits (124), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 48/179 (26%), Positives = 77/179 (43%), Gaps = 39/179 (21%)
Query: 21  FTSEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSN 80
           +  ED +    +G+G FG V     + S  ++A+K +     EK   +  +  +V ++S+
Sbjct: 8   WALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSH 67
Query: 81  -ECPYIVQFYGAL---------------------------FKEVTVAT-----VKALNYL 107
              P I++ YG                             F E   AT       AL+Y 
Sbjct: 68  LRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYC 127
Query: 108 KEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTRD--AGCRPYMAPERID 164
             + ++IHRD+KP N+LL   G +K+ DFG S   V + +  RD   G   Y+ PE I+
Sbjct: 128 HSK-RVIHRDIKPENLLLGSAGELKIADFGWS---VHAPSSRRDDLCGTLDYLPPEMIE 182

>pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 52.4 bits (124), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 47/173 (27%), Positives = 75/173 (43%), Gaps = 39/173 (22%)
Query: 32  IGRGGFGTVNKMIHRSSDT-----------VMAVKRIRSTVDEKDQRQ-----LLMDLDV 75
           +G G FG V  + H  +             V+ +K I  T++EK   Q      L+ L+ 
Sbjct: 49  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKEIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 76  VMKSNECPYIVQFY---GALFKEV--------------TVATVKALNYLKEELKIIHRDV 118
             K N   Y+V  Y   G +F  +                  V    YL   L +I+RD+
Sbjct: 109 SFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYL-HSLDLIYRDL 167
Query: 119 KPSNILLDRRGAIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPLRARGY 171
           KP N+++D++G IK+ DFG++ ++          G   Y+APE I    ++GY
Sbjct: 168 KPENLMIDQQGYIKVTDFGLAKRVKGRTWXL--CGTPEYLAPEII---LSKGY 215

>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306

Iteration: 1
 Score = 52.4 bits (124), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 47/177 (26%), Positives = 75/177 (42%), Gaps = 35/177 (19%)
Query: 21  FTSEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSN 80
           +  ED +    +G+G FG V     + S  ++A+K +     EK   +  +  +V ++S+
Sbjct: 31  WALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSH 90
Query: 81  -ECPYIVQFYGAL---------------------------FKEVTVAT-----VKALNYL 107
              P I++ YG                             F E   AT       AL+Y 
Sbjct: 91  LRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYC 150
Query: 108 KEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERID 164
             + ++IHRD+KP N+LL   G +K+ DFG S     S  +T   G   Y+ PE I+
Sbjct: 151 HSK-RVIHRDIKPENLLLGSAGELKIADFGWSVH-APSSRRTTLCGTLDYLPPEMIE 205

>pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350

Iteration: 1
 Score = 52.4 bits (124), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 47/173 (27%), Positives = 75/173 (43%), Gaps = 39/173 (22%)
Query: 32  IGRGGFGTVNKMIHRSSDT-----------VMAVKRIRSTVDEKDQRQ-----LLMDLDV 75
           +G G FG V  + H  +             V+ +K+I  T++EK   Q      L+ L+ 
Sbjct: 49  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 76  VMKSNECPYIVQFY---GALFKEV--------------TVATVKALNYLKEELKIIHRDV 118
             K N   Y+V  Y   G +F  +                  V    YL   L +I+RD+
Sbjct: 109 SFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYL-HSLDLIYRDL 167
Query: 119 KPSNILLDRRGAIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPLRARGY 171
           KP N+++D++G IK+ DFG + ++          G   Y+APE I    ++GY
Sbjct: 168 KPENLMIDQQGYIKVTDFGFAKRVKGRTWXL--CGTPEYLAPEII---LSKGY 215

>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306

Iteration: 1
 Score = 52.4 bits (124), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 48/179 (26%), Positives = 77/179 (43%), Gaps = 39/179 (21%)
Query: 21  FTSEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSN 80
           +  ED +    +G+G FG V     + S  ++A+K +     EK   +  +  +V ++S+
Sbjct: 31  WALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSH 90
Query: 81  -ECPYIVQFYGAL---------------------------FKEVTVAT-----VKALNYL 107
              P I++ YG                             F E   AT       AL+Y 
Sbjct: 91  LRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYC 150
Query: 108 KEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTRD--AGCRPYMAPERID 164
             + ++IHRD+KP N+LL   G +K+ DFG S   V + +  RD   G   Y+ PE I+
Sbjct: 151 HSK-RVIHRDIKPENLLLGSAGELKIADFGWS---VHAPSSRRDDLCGTLDYLPPEMIE 205

>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 52.4 bits (124), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 47/178 (26%), Positives = 75/178 (42%), Gaps = 35/178 (19%)
Query: 20  DFTSEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKS 79
            +  ED +    +G+G FG V     + S  ++A+K +     EK   +  +  +V ++S
Sbjct: 7   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 66
Query: 80  N-ECPYIVQFYGAL---------------------------FKEVTVAT-----VKALNY 106
           +   P I++ YG                             F E   AT       AL+Y
Sbjct: 67  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSY 126
Query: 107 LKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERID 164
              + ++IHRD+KP N+LL   G +K+ DFG S     S  +T   G   Y+ PE I+
Sbjct: 127 CHSK-RVIHRDIKPENLLLGSAGELKIADFGWSVH-APSSRRTTLCGTLDYLPPEMIE 182

>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285

Iteration: 1
 Score = 52.0 bits (123), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 47/178 (26%), Positives = 75/178 (42%), Gaps = 35/178 (19%)
Query: 20  DFTSEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKS 79
            +  ED +    +G+G FG V     + S  ++A+K +     EK   +  +  +V ++S
Sbjct: 9   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 68
Query: 80  N-ECPYIVQFYGAL---------------------------FKEVTVAT-----VKALNY 106
           +   P I++ YG                             F E   AT       AL+Y
Sbjct: 69  HLRHPNILRLYGYFHDATRVYLILEYAPRGEVYKELQKLSKFDEQRTATYITELANALSY 128
Query: 107 LKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERID 164
              + ++IHRD+KP N+LL   G +K+ DFG S     S  +T   G   Y+ PE I+
Sbjct: 129 CHSK-RVIHRDIKPENLLLGSAGELKIADFGWSVH-APSSRRTTLCGTLDYLPPEMIE 184

>pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350

Iteration: 1
 Score = 52.0 bits (123), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 47/173 (27%), Positives = 75/173 (43%), Gaps = 39/173 (22%)
Query: 32  IGRGGFGTVNKMIHRSSDT-----------VMAVKRIRSTVDEKDQRQ-----LLMDLDV 75
           +G G FG V  + H  +             V+ +K+I  T++EK   Q      L+ L+ 
Sbjct: 49  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 76  VMKSNECPYIVQFY---GALFKEV--------------TVATVKALNYLKEELKIIHRDV 118
             K N   Y+V  Y   G +F  +                  V    YL   L +I+RD+
Sbjct: 109 SFKDNSNLYMVMEYAPGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYL-HSLDLIYRDL 167
Query: 119 KPSNILLDRRGAIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPLRARGY 171
           KP N+++D++G IK+ DFG + ++          G   Y+APE I    ++GY
Sbjct: 168 KPENLMIDQQGYIKVTDFGFAKRVKGRTWXL--CGTPEYLAPEII---LSKGY 215

>pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287

Iteration: 1
 Score = 52.0 bits (123), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 49/172 (28%), Positives = 77/172 (44%), Gaps = 40/172 (23%)
Query: 31  EIGRGGFGTVNKMIHR--SSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQF 88
           E+G G FG+V + ++R       +A+K ++   ++ D  +++ +  + M   + PYIV+ 
Sbjct: 17  ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQI-MHQLDNPYIVRL 75
Query: 89  YG-----ALF-------------------KEVTVATVKAL--------NYLKEELKIIHR 116
            G     AL                    +E+ V+ V  L         YL EE   +HR
Sbjct: 76  IGVCQAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYL-EEKNFVHR 134
Query: 117 DVKPSNILLDRRGAIKLCDFGISGQLV--DSIAKTRDAGCRP--YMAPERID 164
           D+   N+LL  R   K+ DFG+S  L   DS    R AG  P  + APE I+
Sbjct: 135 DLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECIN 186

>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297

Iteration: 1
 Score = 52.0 bits (123), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 47/177 (26%), Positives = 75/177 (42%), Gaps = 35/177 (19%)
Query: 21  FTSEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSN 80
           +  ED +    +G+G FG V     + S  ++A+K +     EK   +  +  +V ++S+
Sbjct: 22  WALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSH 81
Query: 81  -ECPYIVQFYGAL---------------------------FKEVTVAT-----VKALNYL 107
              P I++ YG                             F E   AT       AL+Y 
Sbjct: 82  LRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYC 141
Query: 108 KEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERID 164
             + ++IHRD+KP N+LL   G +K+ DFG S     S  +T   G   Y+ PE I+
Sbjct: 142 HSK-RVIHRDIKPENLLLGSAGELKIADFGWSVH-APSSRRTTLCGTLDYLPPEMIE 196

>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score = 52.0 bits (123), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 45/174 (25%), Positives = 73/174 (41%), Gaps = 43/174 (24%)
Query: 30  GEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVD---EKDQRQLLMDLDVVMKSNE----- 81
            ++G GGFG V K     ++T +AVK++ + VD   E+ ++Q   ++ V+ K        
Sbjct: 37  NKMGEGGFGVVYK--GYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVE 94
Query: 82  ------------CPYIVQFYGALFK-----------------EVTVATVKALNYLKEELK 112
                         Y+    G+L                   ++       +N+L E   
Sbjct: 95  LLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHH 154
Query: 113 IIHRDVKPSNILLDRRGAIKLCDFGI---SGQLVDSIAKTRDAGCRPYMAPERI 163
           I HRD+K +NILLD     K+ DFG+   S +   ++   R  G   YMAPE +
Sbjct: 155 I-HRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMXXRIVGTTAYMAPEAL 207

>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348

Iteration: 1
 Score = 52.0 bits (123), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 51/193 (26%), Positives = 78/193 (40%), Gaps = 42/193 (21%)
Query: 8   SGKLKLSPDTVYDFTSED----LQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDE 63
           +G LK  PD    F  +D      DL EIG G FG V       +  V+A+K++  +  +
Sbjct: 35  AGSLK-DPDVAELFFKDDPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQ 93
Query: 64  KDQRQLLMDLDV-VMKSNECPYIVQFYGALFKE--------------------------- 95
            +++   +  +V  ++    P  +Q+ G   +E                           
Sbjct: 94  SNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQE 153
Query: 96  -----VTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTR 150
                VT   ++ L YL     +IHRDVK  NILL   G +KL DFG +  +  +     
Sbjct: 154 VEIAAVTHGALQGLAYLHSH-NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA---NX 209
Query: 151 DAGCRPYMAPERI 163
             G   +MAPE I
Sbjct: 210 FVGTPYWMAPEVI 222

>pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446

Iteration: 1
 Score = 52.0 bits (123), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 28/80 (35%), Positives = 45/80 (56%), Gaps = 8/80 (10%)
Query: 86  VQFYGALFKEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDS 145
            +FYGA         V AL+YL  E  +++RD+K  N++LD+ G IK+ DFG+  + +  
Sbjct: 253 ARFYGA-------EIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKD 305
Query: 146 IAKTRD-AGCRPYMAPERID 164
            A  +   G   Y+APE ++
Sbjct: 306 GATMKTFCGTPEYLAPEVLE 325

>pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336

Iteration: 1
 Score = 52.0 bits (123), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 47/173 (27%), Positives = 75/173 (43%), Gaps = 39/173 (22%)
Query: 32  IGRGGFGTVNKMIHRSSDT-----------VMAVKRIRSTVDEKDQRQ-----LLMDLDV 75
           +G G FG V  + H  +             V+ +K+I  T++EK   Q      L+ L+ 
Sbjct: 35  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 94
Query: 76  VMKSNECPYIVQFY---GALFKEV--------------TVATVKALNYLKEELKIIHRDV 118
             K N   Y+V  Y   G +F  +                  V    YL   L +I+RD+
Sbjct: 95  SFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYL-HSLDLIYRDL 153
Query: 119 KPSNILLDRRGAIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPLRARGY 171
           KP N+L+D++G I++ DFG + ++          G   Y+APE I    ++GY
Sbjct: 154 KPENLLIDQQGYIQVTDFGFAKRVKGRTWTL--CGTPEYLAPEII---LSKGY 201

>pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340

Iteration: 1
 Score = 52.0 bits (123), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 28/80 (35%), Positives = 45/80 (56%), Gaps = 8/80 (10%)
Query: 86  VQFYGALFKEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDS 145
            +FYGA         V AL+YL  E  +++RD+K  N++LD+ G IK+ DFG+  + +  
Sbjct: 110 ARFYGA-------EIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKD 162
Query: 146 IAKTRD-AGCRPYMAPERID 164
            A  +   G   Y+APE ++
Sbjct: 163 GATMKXFCGTPEYLAPEVLE 182

>pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446

Iteration: 1
 Score = 52.0 bits (123), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 28/80 (35%), Positives = 45/80 (56%), Gaps = 8/80 (10%)
Query: 86  VQFYGALFKEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDS 145
            +FYGA         V AL+YL  E  +++RD+K  N++LD+ G IK+ DFG+  + +  
Sbjct: 250 ARFYGA-------EIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKD 302
Query: 146 IAKTRD-AGCRPYMAPERID 164
            A  +   G   Y+APE ++
Sbjct: 303 GATMKTFCGTPEYLAPEVLE 322

>pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341

Iteration: 1
 Score = 52.0 bits (123), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 28/80 (35%), Positives = 45/80 (56%), Gaps = 8/80 (10%)
Query: 86  VQFYGALFKEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDS 145
            +FYGA         V AL+YL  E  +++RD+K  N++LD+ G IK+ DFG+  + +  
Sbjct: 111 ARFYGA-------EIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKD 163
Query: 146 IAKTRD-AGCRPYMAPERID 164
            A  +   G   Y+APE ++
Sbjct: 164 GATMKXFCGTPEYLAPEVLE 183

>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279

Iteration: 1
 Score = 52.0 bits (123), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 47/177 (26%), Positives = 75/177 (42%), Gaps = 35/177 (19%)
Query: 21  FTSEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSN 80
           +  ED +    +G+G FG V     + S  ++A+K +     EK   +  +  +V ++S+
Sbjct: 6   WALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSH 65
Query: 81  -ECPYIVQFYGAL---------------------------FKEVTVAT-----VKALNYL 107
              P I++ YG                             F E   AT       AL+Y 
Sbjct: 66  LRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYC 125
Query: 108 KEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERID 164
             + ++IHRD+KP N+LL   G +K+ DFG S     S  +T   G   Y+ PE I+
Sbjct: 126 HSK-RVIHRDIKPENLLLGSAGELKIADFGWSVH-APSSRRTDLCGTLDYLPPEMIE 180

>pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342

Iteration: 1
 Score = 52.0 bits (123), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 28/80 (35%), Positives = 45/80 (56%), Gaps = 8/80 (10%)
Query: 86  VQFYGALFKEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDS 145
            +FYGA         V AL+YL  E  +++RD+K  N++LD+ G IK+ DFG+  + +  
Sbjct: 112 ARFYGA-------EIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKD 164
Query: 146 IAKTRD-AGCRPYMAPERID 164
            A  +   G   Y+APE ++
Sbjct: 165 GATMKXFCGTPEYLAPEVLE 184

>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283

Iteration: 1
 Score = 52.0 bits (123), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 47/177 (26%), Positives = 75/177 (42%), Gaps = 35/177 (19%)
Query: 21  FTSEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSN 80
           +  ED +    +G+G FG V     + S  ++A+K +     EK   +  +  +V ++S+
Sbjct: 10  WALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSH 69
Query: 81  -ECPYIVQFYGAL---------------------------FKEVTVAT-----VKALNYL 107
              P I++ YG                             F E   AT       AL+Y 
Sbjct: 70  LRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYC 129
Query: 108 KEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERID 164
             + ++IHRD+KP N+LL   G +K+ DFG S     S  +T   G   Y+ PE I+
Sbjct: 130 HSK-RVIHRDIKPENLLLGSAGELKIADFGWSVH-APSSRRTDLCGTLDYLPPEMIE 184

>pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 52.0 bits (123), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 47/173 (27%), Positives = 75/173 (43%), Gaps = 39/173 (22%)
Query: 32  IGRGGFGTVNKMIHRSSDT-----------VMAVKRIRSTVDEKDQRQ-----LLMDLDV 75
           +G G FG V  + H  +             V+ +K+I  T++EK   Q      L+ L+ 
Sbjct: 49  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 76  VMKSNECPYIVQFY---GALFKEV--------------TVATVKALNYLKEELKIIHRDV 118
             K N   Y+V  Y   G +F  +                  V    YL   L +I+RD+
Sbjct: 109 SFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYL-HSLDLIYRDL 167
Query: 119 KPSNILLDRRGAIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPLRARGY 171
           KP N+L+D++G I++ DFG + ++          G   Y+APE I    ++GY
Sbjct: 168 KPENLLIDQQGYIQVTDFGFAKRVKGRTWXL--CGTPEYLAPEII---LSKGY 215

>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275

Iteration: 1
 Score = 52.0 bits (123), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 47/177 (26%), Positives = 75/177 (42%), Gaps = 35/177 (19%)
Query: 21  FTSEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSN 80
           +  ED +    +G+G FG V     + S  ++A+K +     EK   +  +  +V ++S+
Sbjct: 5   WALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSH 64
Query: 81  -ECPYIVQFYGAL---------------------------FKEVTVAT-----VKALNYL 107
              P I++ YG                             F E   AT       AL+Y 
Sbjct: 65  LRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYC 124
Query: 108 KEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERID 164
             + ++IHRD+KP N+LL   G +K+ DFG S     S  +T   G   Y+ PE I+
Sbjct: 125 HSK-RVIHRDIKPENLLLGSAGELKIADFGWSVH-APSSRRTDLCGTLDYLPPEMIE 179

>pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351

Iteration: 1
 Score = 52.0 bits (123), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 47/173 (27%), Positives = 75/173 (43%), Gaps = 39/173 (22%)
Query: 32  IGRGGFGTVNKMIHRSSDT-----------VMAVKRIRSTVDEKDQRQ-----LLMDLDV 75
           +G G FG V  + H  +             V+ +K+I  T++EK   Q      L+ L+ 
Sbjct: 50  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 109
Query: 76  VMKSNECPYIVQFY---GALFKEV--------------TVATVKALNYLKEELKIIHRDV 118
             K N   Y+V  Y   G +F  +                  V    YL   L +I+RD+
Sbjct: 110 SFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYL-HSLDLIYRDL 168
Query: 119 KPSNILLDRRGAIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPLRARGY 171
           KP N+L+D++G I++ DFG + ++          G   Y+APE I    ++GY
Sbjct: 169 KPENLLIDQQGYIQVTDFGFAKRVKGRTWXL--CGTPEYLAPEII---LSKGY 216

>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283

Iteration: 1
 Score = 52.0 bits (123), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 48/180 (26%), Positives = 77/180 (42%), Gaps = 39/180 (21%)
Query: 20  DFTSEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKS 79
            +  ED +    +G+G FG V     + S  ++A+K +     EK   +  +  +V ++S
Sbjct: 7   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 66
Query: 80  N-ECPYIVQFYGAL---------------------------FKEVTVAT-----VKALNY 106
           +   P I++ YG                             F E   AT       AL+Y
Sbjct: 67  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSY 126
Query: 107 LKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTRDAGCRP--YMAPERID 164
              + ++IHRD+KP N+LL   G +K+ DFG S   V + +  R A C    Y+ PE I+
Sbjct: 127 CHSK-RVIHRDIKPENLLLGSAGELKIADFGWS---VHAPSSRRAALCGTLDYLPPEMIE 182

>pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 52.0 bits (123), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 47/173 (27%), Positives = 75/173 (43%), Gaps = 39/173 (22%)
Query: 32  IGRGGFGTVNKMIHRSSDT-----------VMAVKRIRSTVDEKDQRQ-----LLMDLDV 75
           +G G FG V  + H+ S             V+ +K+I  T++EK   Q      L+ L+ 
Sbjct: 49  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 76  VMKSNECPYIVQFY---GALFKEV--------------TVATVKALNYLKEELKIIHRDV 118
             K N   Y+V  Y   G +F  +                  V    YL   L +I+RD+
Sbjct: 109 SFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYL-HSLDLIYRDL 167
Query: 119 KPSNILLDRRGAIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPLRARGY 171
           KP N+L+D++G I++ DFG + ++          G   Y+AP  I    ++GY
Sbjct: 168 KPENLLIDQQGYIQVTDFGFAKRVKGRTWXL--CGTPEYLAPAII---LSKGY 215

>pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279

Iteration: 1
 Score = 52.0 bits (123), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 45/186 (24%), Positives = 77/186 (41%), Gaps = 45/186 (24%)
Query: 23  SEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNEC 82
           +ED + L  IG G +G   K+  +S   ++  K +      + ++Q+L+    +++  + 
Sbjct: 5   AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKH 64
Query: 83  PYIVQFY-------------------GALFKEVTVATVKALNYLKEEL------------ 111
           P IV++Y                   G     V     K   YL EE             
Sbjct: 65  PNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLAL 124
Query: 112 -----------KIIHRDVKPSNILLDRRGAIKLCDFGISGQLVD--SIAKTRDAGCRPYM 158
                       ++HRD+KP+N+ LD +  +KL DFG++  L    S AK    G   YM
Sbjct: 125 KECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAF-VGTPYYM 183
Query: 159 APERID 164
           +PE+++
Sbjct: 184 SPEQMN 189

>pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351

Iteration: 1
 Score = 52.0 bits (123), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 47/173 (27%), Positives = 74/173 (42%), Gaps = 39/173 (22%)
Query: 32  IGRGGFGTVNKMIHRSSDT-----------VMAVKRIRSTVDEKDQRQ-----LLMDLDV 75
           +G G FG V  + H  +             V+ +K+I  T++EK   Q      L  L+ 
Sbjct: 50  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLTKLEF 109
Query: 76  VMKSNECPYIVQFY---GALFKEV--------------TVATVKALNYLKEELKIIHRDV 118
             K N   Y+V  Y   G +F  +                  V    YL   L +I+RD+
Sbjct: 110 SFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYL-HSLDLIYRDL 168
Query: 119 KPSNILLDRRGAIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPLRARGY 171
           KP N+++D++G IK+ DFG + ++          G   Y+APE I    ++GY
Sbjct: 169 KPENLMIDQQGYIKVTDFGFAKRVKGRTWXL--CGTPEYLAPEII---LSKGY 216

>pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350

Iteration: 1
 Score = 52.0 bits (123), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 47/173 (27%), Positives = 75/173 (43%), Gaps = 39/173 (22%)
Query: 32  IGRGGFGTVNKMIHRSSDT-----------VMAVKRIRSTVDEKDQRQ-----LLMDLDV 75
           +G G FG V  + H  +             V+ +K+I  T++EK   Q      L+ L+ 
Sbjct: 49  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 76  VMKSNECPYIVQFY---GALFKEV--------------TVATVKALNYLKEELKIIHRDV 118
             K N   Y+V  Y   G +F  +                  V    YL   L +I+RD+
Sbjct: 109 SFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYL-HSLDLIYRDL 167
Query: 119 KPSNILLDRRGAIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPLRARGY 171
           KP N+L+D++G I++ DFG + ++          G   Y+APE I    ++GY
Sbjct: 168 KPENLLIDQQGYIQVTDFGFAKRVKGRTWXL--CGTPEYLAPEII---LSKGY 215

>pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350

Iteration: 1
 Score = 52.0 bits (123), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 47/173 (27%), Positives = 75/173 (43%), Gaps = 39/173 (22%)
Query: 32  IGRGGFGTVNKMIHRSSDT-----------VMAVKRIRSTVDEKDQRQ-----LLMDLDV 75
           +G G FG V  + H  +             V+ +K+I  T++EK   Q      L+ L+ 
Sbjct: 49  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 76  VMKSNECPYIVQFY---GALFKEV--------------TVATVKALNYLKEELKIIHRDV 118
             K N   Y+V  Y   G +F  +                  V    YL   L +I+RD+
Sbjct: 109 SFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYL-HSLDLIYRDL 167
Query: 119 KPSNILLDRRGAIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPLRARGY 171
           KP N+L+D++G I++ DFG + ++          G   Y+APE I    ++GY
Sbjct: 168 KPENLLIDQQGYIQVTDFGFAKRVKGRTWXL--CGTPEYLAPEII---LSKGY 215

>pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350

Iteration: 1
 Score = 52.0 bits (123), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 47/173 (27%), Positives = 75/173 (43%), Gaps = 39/173 (22%)
Query: 32  IGRGGFGTVNKMIHRSSDT-----------VMAVKRIRSTVDEKDQRQ-----LLMDLDV 75
           +G G FG V  + H  +             V+ +K+I  T++EK   Q      L+ L+ 
Sbjct: 49  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 76  VMKSNECPYIVQFY---GALFKEV--------------TVATVKALNYLKEELKIIHRDV 118
             K N   Y+V  Y   G +F  +                  V    YL   L +I+RD+
Sbjct: 109 SFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYL-HSLDLIYRDL 167
Query: 119 KPSNILLDRRGAIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPLRARGY 171
           KP N+L+D++G I++ DFG + ++          G   Y+APE I    ++GY
Sbjct: 168 KPENLLIDQQGYIQVTDFGFAKRVKGRTWXL--CGTPEYLAPEII---LSKGY 215

>pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351

Iteration: 1
 Score = 52.0 bits (123), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 47/173 (27%), Positives = 75/173 (43%), Gaps = 39/173 (22%)
Query: 32  IGRGGFGTVNKMIHRSSDT-----------VMAVKRIRSTVDEKDQRQ-----LLMDLDV 75
           +G G FG V  + H  +             V+ +K+I  T++EK   Q      L+ L+ 
Sbjct: 50  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 109
Query: 76  VMKSNECPYIVQFY---GALFKEV--------------TVATVKALNYLKEELKIIHRDV 118
             K N   Y+V  Y   G +F  +                  V    YL   L +I+RD+
Sbjct: 110 SFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYL-HSLDLIYRDL 168
Query: 119 KPSNILLDRRGAIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPLRARGY 171
           KP N+L+D++G I++ DFG + ++          G   Y+APE I    ++GY
Sbjct: 169 KPENLLIDQQGYIQVTDFGFAKRVKGRTWTL--CGTPEYLAPEII---LSKGY 216

>pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 47/173 (27%), Positives = 75/173 (43%), Gaps = 39/173 (22%)
Query: 32  IGRGGFGTVNKMIHRSSDT-----------VMAVKRIRSTVDEKDQRQ-----LLMDLDV 75
           +G G FG V  + H  +             V+ +K+I  T++EK   Q      L+ L+ 
Sbjct: 49  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 76  VMKSNECPYIVQFY---GALFKEV--------------TVATVKALNYLKEELKIIHRDV 118
             K N   Y+V  Y   G +F  +                  V    YL   L +I+RD+
Sbjct: 109 SFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYL-HSLDLIYRDL 167
Query: 119 KPSNILLDRRGAIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPLRARGY 171
           KP N+L+D++G I++ DFG + ++          G   Y+APE I    ++GY
Sbjct: 168 KPENLLIDQQGYIQVTDFGFAKRVKGRTWXL--CGTPEYLAPEII---LSKGY 215

>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 48/180 (26%), Positives = 77/180 (42%), Gaps = 39/180 (21%)
Query: 20  DFTSEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKS 79
            +  ED +    +G+G FG V     + S  ++A+K +     EK   +  +  +V ++S
Sbjct: 4   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 63
Query: 80  N-ECPYIVQFYGAL---------------------------FKEVTVAT-----VKALNY 106
           +   P I++ YG                             F E   AT       AL+Y
Sbjct: 64  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSY 123
Query: 107 LKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTRDAGCRP--YMAPERID 164
              + ++IHRD+KP N+LL   G +K+ DFG S   V + +  R A C    Y+ PE I+
Sbjct: 124 CHSK-RVIHRDIKPENLLLGSAGELKIADFGWS---VHAPSSRRAALCGTLDYLPPEMIE 179

>pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 47/173 (27%), Positives = 75/173 (43%), Gaps = 39/173 (22%)
Query: 32  IGRGGFGTVNKMIHRSSDT-----------VMAVKRIRSTVDEKDQRQ-----LLMDLDV 75
           +G G FG V  + H  +             V+ +K+I  T++EK   Q      L+ L+ 
Sbjct: 50  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 109
Query: 76  VMKSNECPYIVQFY---GALFKEV--------------TVATVKALNYLKEELKIIHRDV 118
             K N   Y+V  Y   G +F  +                  V    YL   L +I+RD+
Sbjct: 110 SFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYL-HSLDLIYRDL 168
Query: 119 KPSNILLDRRGAIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPLRARGY 171
           KP N+L+D++G I++ DFG + ++          G   Y+APE I    ++GY
Sbjct: 169 KPENLLIDQQGYIQVTDFGFAKRVKGRTWXL--CGTPEYLAPEII---LSKGY 216

>pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 47/173 (27%), Positives = 75/173 (43%), Gaps = 39/173 (22%)
Query: 32  IGRGGFGTVNKMIHRSSDT-----------VMAVKRIRSTVDEKDQRQ-----LLMDLDV 75
           +G G FG V  + H  +             V+ +K+I  T++EK   Q      L+ L+ 
Sbjct: 49  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 76  VMKSNECPYIVQFY---GALFKEV--------------TVATVKALNYLKEELKIIHRDV 118
             K N   Y+V  Y   G +F  +                  V    YL   L +I+RD+
Sbjct: 109 SFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYL-HSLDLIYRDL 167
Query: 119 KPSNILLDRRGAIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPLRARGY 171
           KP N+L+D++G I++ DFG + ++          G   Y+APE I    ++GY
Sbjct: 168 KPENLLIDQQGYIQVTDFGFAKRVKGRTWXL--CGTPEYLAPEII---LSKGY 215

>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 47/177 (26%), Positives = 75/177 (42%), Gaps = 35/177 (19%)
Query: 21  FTSEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSN 80
           +  ED +    +G+G FG V     + S  ++A+K +     EK   +  +  +V ++S+
Sbjct: 5   WALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSH 64
Query: 81  -ECPYIVQFYGAL---------------------------FKEVTVAT-----VKALNYL 107
              P I++ YG                             F E   AT       AL+Y 
Sbjct: 65  LRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYC 124
Query: 108 KEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERID 164
             + ++IHRD+KP N+LL   G +K+ DFG S     S  +T   G   Y+ PE I+
Sbjct: 125 HSK-RVIHRDIKPENLLLGSAGELKIADFGWSVH-APSSRRTDLCGTLDYLPPEMIE 179

>pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 47/173 (27%), Positives = 74/173 (42%), Gaps = 39/173 (22%)
Query: 32  IGRGGFGTVNKMIHRSSDT-----------VMAVKRIRSTVDEKDQRQ-----LLMDLDV 75
           +G G FG V  + H  +             V+ +K+I  T++EK   Q      L  L+ 
Sbjct: 50  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLTKLEF 109
Query: 76  VMKSNECPYIVQFY---GALFKEV--------------TVATVKALNYLKEELKIIHRDV 118
             K N   Y+V  Y   G +F  +                  V    YL   L +I+RD+
Sbjct: 110 SFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYL-HSLDLIYRDL 168
Query: 119 KPSNILLDRRGAIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPLRARGY 171
           KP N+++D++G IK+ DFG + ++          G   Y+APE I    ++GY
Sbjct: 169 KPENLMIDQQGYIKVTDFGFAKRVKGRTWXL--CGTPEYLAPEII---LSKGY 216

>pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 47/173 (27%), Positives = 74/173 (42%), Gaps = 39/173 (22%)
Query: 32  IGRGGFGTVNKMIHRSSDT-----------VMAVKRIRSTVDEKDQRQ-----LLMDLDV 75
           +G G FG V  + H  +             V+ +K+I  T++EK   Q      L  L+ 
Sbjct: 50  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLTKLEF 109
Query: 76  VMKSNECPYIVQFY---GALFKEV--------------TVATVKALNYLKEELKIIHRDV 118
             K N   Y+V  Y   G +F  +                  V    YL   L +I+RD+
Sbjct: 110 SFKDNSNLYMVMEYAPGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYL-HSLDLIYRDL 168
Query: 119 KPSNILLDRRGAIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPLRARGY 171
           KP N+++D++G IK+ DFG + ++          G   Y+APE I    ++GY
Sbjct: 169 KPENLMIDQQGYIKVTDFGFAKRVKGRTWXL--CGTPEYLAPEII---LSKGY 216

>pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269

Iteration: 1
 Score = 51.2 bits (121), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 42/166 (25%), Positives = 79/166 (47%), Gaps = 36/166 (21%)
Query: 31  EIGRGGFGTVNKMIHRSSDTVMAVKRIRST-VDEKDQRQLLMDLDVVMKSNECPYIVQFY 89
           E+G+G F  V + +H+++    A K I +  +  +D ++L  +  +  K    P IV+ +
Sbjct: 13  ELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH-PNIVRLH 71
Query: 90  ------------------GALFKEVTV----ATVKALNYLKEELK---------IIHRDV 118
                             G LF+++      +   A + +++ L+         I+HR++
Sbjct: 72  DSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNL 131
Query: 119 KPSNILLDRRG---AIKLCDFGISGQLVDSIAKTRDAGCRPYMAPE 161
           KP N+LL  +    A+KL DFG++ ++ DS A    AG   Y++PE
Sbjct: 132 KPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPE 177

>pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311

Iteration: 1
 Score = 51.2 bits (121), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 33/81 (40%), Positives = 47/81 (58%), Gaps = 7/81 (8%)
Query: 95  EVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVD---SIAKTRD 151
           EV     +ALN+  +   IIHRDVKP+NIL+    A+K+ DFGI+  + D   S+ +T  
Sbjct: 120 EVIADACQALNFSHQN-GIIHRDVKPANILISATNAVKVVDFGIARAIADSGNSVXQTAA 178
Query: 152 A-GCRPYMAPE--RIDPLRAR 169
             G   Y++PE  R D + AR
Sbjct: 179 VIGTAQYLSPEQARGDSVDAR 199

>pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362

Iteration: 1
 Score = 51.2 bits (121), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 42/166 (25%), Positives = 79/166 (47%), Gaps = 36/166 (21%)
Query: 31  EIGRGGFGTVNKMIHRSSDTVMAVKRIRST-VDEKDQRQLLMDLDVVMKSNECPYIVQFY 89
           E+G+G F  V + +H+++    A K I +  +  +D ++L  +  +  K    P IV+ +
Sbjct: 36  ELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH-PNIVRLH 94
Query: 90  ------------------GALFKEVTV----ATVKALNYLKEELK---------IIHRDV 118
                             G LF+++      +   A + +++ L+         I+HR++
Sbjct: 95  DSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNL 154
Query: 119 KPSNILLDRRG---AIKLCDFGISGQLVDSIAKTRDAGCRPYMAPE 161
           KP N+LL  +    A+KL DFG++ ++ DS A    AG   Y++PE
Sbjct: 155 KPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPE 200

>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301

Iteration: 1
 Score = 51.2 bits (121), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 45/173 (26%), Positives = 72/173 (41%), Gaps = 43/173 (24%)
Query: 31  EIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVD---EKDQRQLLMDLDVVMKSNE------ 81
           ++G GGFG V K     ++T +AVK++ + VD   E+ ++Q   ++ V+ K         
Sbjct: 32  KMGEGGFGVVYK--GYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVEL 89
Query: 82  -----------CPYIVQFYGALFKEVTV-----------------ATVKALNYLKEELKI 113
                        Y+    G+L   ++                       +N+L E   I
Sbjct: 90  LGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHI 149
Query: 114 IHRDVKPSNILLDRRGAIKLCDFGI---SGQLVDSIAKTRDAGCRPYMAPERI 163
            HRD+K +NILLD     K+ DFG+   S +    +   R  G   YMAPE +
Sbjct: 150 -HRDIKSANILLDEAFTAKISDFGLARASEKFAQXVMXXRIVGTTAYMAPEAL 201

>pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279

Iteration: 1
 Score = 50.8 bits (120), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 43/185 (23%), Positives = 75/185 (40%), Gaps = 43/185 (23%)
Query: 23  SEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNEC 82
           +ED + L  IG G +G   K+  +S   ++  K +      + ++Q+L+    +++  + 
Sbjct: 5   AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKH 64
Query: 83  PYIVQFY-------------------GALFKEVTVATVKALNYLKEEL------------ 111
           P IV++Y                   G     V     K   YL EE             
Sbjct: 65  PNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLAL 124
Query: 112 -----------KIIHRDVKPSNILLDRRGAIKLCDFGISGQL-VDSIAKTRDAGCRPYMA 159
                       ++HRD+KP+N+ LD +  +KL DFG++  L  D        G   YM+
Sbjct: 125 KECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDEDFAKEFVGTPYYMS 184
Query: 160 PERID 164
           PE+++
Sbjct: 185 PEQMN 189

>pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350

Iteration: 1
 Score = 50.8 bits (120), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 46/173 (26%), Positives = 75/173 (43%), Gaps = 39/173 (22%)
Query: 32  IGRGGFGTVNKMIHRSSDT-----------VMAVKRIRSTVDEKDQRQ-----LLMDLDV 75
           +G G FG V  + H  +             V+ +K I  T++EK   Q      L+ L+ 
Sbjct: 49  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKEIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 76  VMKSNECPYIVQFY---GALFKEV--------------TVATVKALNYLKEELKIIHRDV 118
             K N   Y+V  Y   G +F  +                  V    YL   L +I+RD+
Sbjct: 109 SFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYL-HSLDLIYRDL 167
Query: 119 KPSNILLDRRGAIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPLRARGY 171
           KP N+++D++G I++ DFG++ ++          G   Y+APE I    ++GY
Sbjct: 168 KPENLMIDQQGYIQVTDFGLAKRVKGRTWXL--CGTPEYLAPEII---LSKGY 215

>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272

Iteration: 1
 Score = 50.8 bits (120), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 46/178 (25%), Positives = 75/178 (42%), Gaps = 35/178 (19%)
Query: 20  DFTSEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKS 79
            +  ED +    +G+G FG V     + S  ++A+K +     EK   +  +  +V ++S
Sbjct: 7   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 66
Query: 80  N-ECPYIVQFYGAL---------------------------FKEVTVAT-----VKALNY 106
           +   P I++ YG                             F E   AT       AL+Y
Sbjct: 67  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSY 126
Query: 107 LKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERID 164
              + ++IHRD+KP N+LL   G +K+ +FG S     S  +T   G   Y+ PE I+
Sbjct: 127 CHSK-RVIHRDIKPENLLLGSAGELKIANFGWSVH-APSSRRTTLCGTLDYLPPEMIE 182

>pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350

Iteration: 1
 Score = 50.8 bits (120), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 46/173 (26%), Positives = 75/173 (43%), Gaps = 39/173 (22%)
Query: 32  IGRGGFGTVNKMIHRSSDT-----------VMAVKRIRSTVDEKDQRQ-----LLMDLDV 75
           +G G FG V  + H  +             V+ +K+I  T++EK   Q      L+ L+ 
Sbjct: 49  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 76  VMKSNECPYIVQFY---GALFKEV--------------TVATVKALNYLKEELKIIHRDV 118
             K N   Y+V  Y   G +F  +                  V    YL   L +I+RD+
Sbjct: 109 SFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYL-HSLDLIYRDL 167
Query: 119 KPSNILLDRRGAIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPLRARGY 171
           KP N+++D++G I++ DFG + ++          G   Y+APE I    ++GY
Sbjct: 168 KPENLMIDQQGYIQVTDFGFAKRVKGRTWXL--CGTPEYLAPEII---LSKGY 215

>pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282

Iteration: 1
 Score = 50.8 bits (120), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 42/166 (25%), Positives = 79/166 (47%), Gaps = 36/166 (21%)
Query: 31  EIGRGGFGTVNKMIHRSSDTVMAVKRIRST-VDEKDQRQLLMDLDVVMKSNECPYIVQFY 89
           E+G+G F  V + +H+++    A K I +  +  +D ++L  +  +  K    P IV+ +
Sbjct: 12  ELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH-PNIVRLH 70
Query: 90  ------------------GALFKEVTV----ATVKALNYLKEELK---------IIHRDV 118
                             G LF+++      +   A + +++ L+         I+HR++
Sbjct: 71  DSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNL 130
Query: 119 KPSNILLDRRG---AIKLCDFGISGQLVDSIAKTRDAGCRPYMAPE 161
           KP N+LL  +    A+KL DFG++ ++ DS A    AG   Y++PE
Sbjct: 131 KPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPE 176

>pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284

Iteration: 1
 Score = 50.8 bits (120), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 42/166 (25%), Positives = 79/166 (47%), Gaps = 36/166 (21%)
Query: 31  EIGRGGFGTVNKMIHRSSDTVMAVKRIRST-VDEKDQRQLLMDLDVVMKSNECPYIVQFY 89
           E+G+G F  V + +H+++    A K I +  +  +D ++L  +  +  K    P IV+ +
Sbjct: 13  ELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH-PNIVRLH 71
Query: 90  ------------------GALFKEVTV----ATVKALNYLKEELK---------IIHRDV 118
                             G LF+++      +   A + +++ L+         I+HR++
Sbjct: 72  DSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNL 131
Query: 119 KPSNILLDRRG---AIKLCDFGISGQLVDSIAKTRDAGCRPYMAPE 161
           KP N+LL  +    A+KL DFG++ ++ DS A    AG   Y++PE
Sbjct: 132 KPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPE 177

>pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 50.8 bits (120), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 40/141 (28%), Positives = 63/141 (44%), Gaps = 34/141 (24%)
Query: 32  IGRGGFGTVNKMIHRSSDT-----------VMAVKRIRSTVDEKDQRQ-----LLMDLDV 75
           +G G FG V  + H+ S             V+ +K+I  T++EK   Q      L+ L+ 
Sbjct: 49  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 76  VMKSNECPYIVQFY---GALFKEV--------------TVATVKALNYLKEELKIIHRDV 118
             K N   Y+V  Y   G +F  +                  V    YL   L +I+RD+
Sbjct: 109 SFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYL-HSLDLIYRDL 167
Query: 119 KPSNILLDRRGAIKLCDFGIS 139
           KP N+L+D++G I++ DFG +
Sbjct: 168 KPENLLIDQQGYIQVTDFGFA 188

>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282

Iteration: 1
 Score = 50.8 bits (120), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 46/178 (25%), Positives = 75/178 (42%), Gaps = 35/178 (19%)
Query: 20  DFTSEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKS 79
            +  ED +    +G+G FG V     + S  ++A+K +     EK   +  +  +V ++S
Sbjct: 6   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 65
Query: 80  N-ECPYIVQFYGAL---------------------------FKEVTVAT-----VKALNY 106
           +   P I++ YG                             F E   AT       AL+Y
Sbjct: 66  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSY 125
Query: 107 LKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERID 164
              + ++IHRD+KP N+LL   G +K+ +FG S     S  +T   G   Y+ PE I+
Sbjct: 126 CHSK-RVIHRDIKPENLLLGSAGELKIANFGWSVH-APSSRRTTLCGTLDYLPPEMIE 181

>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268

Iteration: 1
 Score = 50.4 bits (119), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 46/178 (25%), Positives = 74/178 (41%), Gaps = 35/178 (19%)
Query: 20  DFTSEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKS 79
            +  ED +    +G+G FG V     + S  ++A+K +     EK   +  +  +V ++S
Sbjct: 4   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 63
Query: 80  N-ECPYIVQFYGAL---------------------------FKEVTVAT-----VKALNY 106
           +   P I++ YG                             F E   AT       AL+Y
Sbjct: 64  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSY 123
Query: 107 LKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERID 164
              + ++IHRD+KP N+LL   G +K+ DFG S     S  +    G   Y+ PE I+
Sbjct: 124 CHSK-RVIHRDIKPENLLLGSAGELKIADFGWSVH-APSSRRXXLCGTLDYLPPEMIE 179

>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309

Iteration: 1
 Score = 50.4 bits (119), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 48/186 (25%), Positives = 74/186 (39%), Gaps = 41/186 (22%)
Query: 15  PDTVYDFTSED----LQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLL 70
           PD    F  +D      DL EIG G FG V       +  V+A+K++  +  + +++   
Sbjct: 2   PDVAELFFKDDPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQD 61
Query: 71  MDLDV-VMKSNECPYIVQFYGALFKE--------------------------------VT 97
           +  +V  ++    P  +Q+ G   +E                                VT
Sbjct: 62  IIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVT 121
Query: 98  VATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTRDAGCRPY 157
              ++ L YL     +IHRDVK  NILL   G +KL DFG +  +  +       G   +
Sbjct: 122 HGALQGLAYLHSH-NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA---NXFVGTPYW 177
Query: 158 MAPERI 163
           MAPE I
Sbjct: 178 MAPEVI 183

>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282

Iteration: 1
 Score = 50.4 bits (119), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 46/178 (25%), Positives = 74/178 (41%), Gaps = 35/178 (19%)
Query: 20  DFTSEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKS 79
            +  ED +    +G+G FG V     + S  ++A+K +     EK   +  +  +V ++S
Sbjct: 6   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 65
Query: 80  N-ECPYIVQFYGAL---------------------------FKEVTVAT-----VKALNY 106
           +   P I++ YG                             F E   AT       AL+Y
Sbjct: 66  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSY 125
Query: 107 LKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERID 164
              + ++IHRD+KP N+LL   G +K+ DFG S     S  +    G   Y+ PE I+
Sbjct: 126 CHSK-RVIHRDIKPENLLLGSAGELKIADFGWSVH-APSSRRXXLCGTLDYLPPEMIE 181

>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285

Iteration: 1
 Score = 50.4 bits (119), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 46/178 (25%), Positives = 74/178 (41%), Gaps = 35/178 (19%)
Query: 20  DFTSEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKS 79
            +  ED +    +G+G FG V     + S  ++A+K +     EK   +  +  +V ++S
Sbjct: 9   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 68
Query: 80  N-ECPYIVQFYGAL---------------------------FKEVTVAT-----VKALNY 106
           +   P I++ YG                             F E   AT       AL+Y
Sbjct: 69  HLRHPNILRLYGYFHDATRVYLILEYAPRGEVYKELQKLSKFDEQRTATYITELANALSY 128
Query: 107 LKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERID 164
              + ++IHRD+KP N+LL   G +K+ DFG S     S  +    G   Y+ PE I+
Sbjct: 129 CHSK-RVIHRDIKPENLLLGSAGELKIADFGWSVH-APSSRRXXLXGTLDYLPPEMIE 184

>pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299

Iteration: 1
 Score = 50.4 bits (119), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 32/81 (39%), Positives = 47/81 (58%), Gaps = 7/81 (8%)
Query: 95  EVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVD---SIAKTRD 151
           EV     +ALN+  +   IIHRDVKP+NI++    A+K+ DFGI+  + D   S+ +T  
Sbjct: 137 EVIADACQALNFSHQN-GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAA 195
Query: 152 A-GCRPYMAPE--RIDPLRAR 169
             G   Y++PE  R D + AR
Sbjct: 196 VIGTAQYLSPEQARGDSVDAR 216

>pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613

Iteration: 1
 Score = 50.4 bits (119), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 48/172 (27%), Positives = 77/172 (44%), Gaps = 40/172 (23%)
Query: 31  EIGRGGFGTVNKMIHR--SSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQF 88
           E+G G FG+V + ++R       +A+K ++   ++ D  +++ +  + M   + PYIV+ 
Sbjct: 343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQI-MHQLDNPYIVRL 401
Query: 89  YG-----ALF-------------------KEVTVATVKAL--------NYLKEELKIIHR 116
            G     AL                    +E+ V+ V  L         YL EE   +HR
Sbjct: 402 IGVCQAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYL-EEKNFVHR 460
Query: 117 DVKPSNILLDRRGAIKLCDFGISGQLV--DSIAKTRDAGCRP--YMAPERID 164
           ++   N+LL  R   K+ DFG+S  L   DS    R AG  P  + APE I+
Sbjct: 461 NLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECIN 512

>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 50.4 bits (119), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 46/178 (25%), Positives = 74/178 (41%), Gaps = 35/178 (19%)
Query: 20  DFTSEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKS 79
            +  ED +    +G+G FG V     + S  ++A+K +     EK   +  +  +V ++S
Sbjct: 7   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 66
Query: 80  N-ECPYIVQFYGAL---------------------------FKEVTVAT-----VKALNY 106
           +   P I++ YG                             F E   AT       AL+Y
Sbjct: 67  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSY 126
Query: 107 LKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERID 164
              + ++IHRD+KP N+LL   G +K+ DFG S     S  +    G   Y+ PE I+
Sbjct: 127 CHSK-RVIHRDIKPENLLLGSAGELKIADFGWSVH-APSSRRXXLCGTLDYLPPEMIE 182

>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262

Iteration: 1
 Score = 50.4 bits (119), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 46/178 (25%), Positives = 74/178 (41%), Gaps = 35/178 (19%)
Query: 20  DFTSEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKS 79
            +  ED +    +G+G FG V     +    ++A+K +     EK   +  +  +V ++S
Sbjct: 1   QWALEDFEIGRPLGKGKFGNVYLAREKQRKFILALKVLFKAQLEKAGVEHQLRREVEIQS 60
Query: 80  N-ECPYIVQFYGAL---------------------------FKEVTVAT-----VKALNY 106
           +   P I++ YG                             F E   AT       AL+Y
Sbjct: 61  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSY 120
Query: 107 LKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERID 164
              + ++IHRD+KP N+LL   G +K+ DFG S     S  +T   G   Y+ PE I+
Sbjct: 121 CHSK-RVIHRDIKPENLLLGSAGELKIADFGWSVH-APSSRRTTLCGTLDYLPPEMIE 176

>pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311

Iteration: 1
 Score = 50.1 bits (118), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 32/81 (39%), Positives = 47/81 (58%), Gaps = 7/81 (8%)
Query: 95  EVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVD---SIAKTRD 151
           EV     +ALN+  +   IIHRDVKP+NI++    A+K+ DFGI+  + D   S+ +T  
Sbjct: 120 EVIADACQALNFSHQN-GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAA 178
Query: 152 A-GCRPYMAPE--RIDPLRAR 169
             G   Y++PE  R D + AR
Sbjct: 179 VIGTAQYLSPEQARGDSVDAR 199

>pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311

Iteration: 1
 Score = 50.1 bits (118), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 32/81 (39%), Positives = 47/81 (58%), Gaps = 7/81 (8%)
Query: 95  EVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVD---SIAKTRD 151
           EV     +ALN+  +   IIHRDVKP+NI++    A+K+ DFGI+  + D   S+ +T  
Sbjct: 120 EVIADACQALNFSHQN-GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAA 178
Query: 152 A-GCRPYMAPE--RIDPLRAR 169
             G   Y++PE  R D + AR
Sbjct: 179 VIGTAQYLSPEQARGDSVDAR 199

>pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311

Iteration: 1
 Score = 50.1 bits (118), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 32/81 (39%), Positives = 47/81 (58%), Gaps = 7/81 (8%)
Query: 95  EVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVD---SIAKTRD 151
           EV     +ALN+  +   IIHRDVKP+NI++    A+K+ DFGI+  + D   S+ +T  
Sbjct: 120 EVIADACQALNFSHQN-GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAA 178
Query: 152 A-GCRPYMAPE--RIDPLRAR 169
             G   Y++PE  R D + AR
Sbjct: 179 VIGTAQYLSPEQARGDSVDAR 199

>pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311

Iteration: 1
 Score = 50.1 bits (118), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 32/81 (39%), Positives = 47/81 (58%), Gaps = 7/81 (8%)
Query: 95  EVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVD---SIAKTRD 151
           EV     +ALN+  +   IIHRDVKP+NI++    A+K+ DFGI+  + D   S+ +T  
Sbjct: 120 EVIADACQALNFSHQN-GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAA 178
Query: 152 A-GCRPYMAPE--RIDPLRAR 169
             G   Y++PE  R D + AR
Sbjct: 179 VIGTAQYLSPEQARGDSVDAR 199

>pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292

Iteration: 1
 Score = 50.1 bits (118), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 35/145 (24%), Positives = 63/145 (43%), Gaps = 33/145 (22%)
Query: 27  QDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVD----------------EKDQRQLL 70
           + L +IG G +GTV K  +R +  ++A+KR+R   D                E   + ++
Sbjct: 5   EKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIV 64
Query: 71  MDLDVVMKSNECPYIVQFYG----------------ALFKEVTVATVKALNYLKEELKII 114
              DV+    +   + +F                   + K      +K L +      ++
Sbjct: 65  RLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSR-NVL 123
Query: 115 HRDVKPSNILLDRRGAIKLCDFGIS 139
           HRD+KP N+L++R G +KL DFG++
Sbjct: 124 HRDLKPQNLLINRNGELKLADFGLA 148

>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303

Iteration: 1
 Score = 49.7 bits (117), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 33/92 (35%), Positives = 49/92 (53%), Gaps = 14/92 (15%)
Query: 91  ALFKEVTVATV-----KALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDS 145
            +  E T+AT+     + L YL +  +I HRDVK  NILL   G++++ DFG+S  L   
Sbjct: 116 GVLDESTIATILREVLEGLEYLHKNGQI-HRDVKAGNILLGEDGSVQIADFGVSAFLATG 174
Query: 146 IAKTRD------AGCRPYMAPERIDPLRARGY 171
              TR+       G   +MAPE ++  + RGY
Sbjct: 175 GDITRNKVRKTFVGTPCWMAPEVME--QVRGY 204

>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290

Iteration: 1
 Score = 49.7 bits (117), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 33/92 (35%), Positives = 49/92 (53%), Gaps = 14/92 (15%)
Query: 91  ALFKEVTVATV-----KALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDS 145
            +  E T+AT+     + L YL +  +I HRDVK  NILL   G++++ DFG+S  L   
Sbjct: 111 GVLDESTIATILREVLEGLEYLHKNGQI-HRDVKAGNILLGEDGSVQIADFGVSAFLATG 169
Query: 146 IAKTRD------AGCRPYMAPERIDPLRARGY 171
              TR+       G   +MAPE ++  + RGY
Sbjct: 170 GDITRNKVRKTFVGTPCWMAPEVME--QVRGY 199

>pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276

Iteration: 1
 Score = 49.3 bits (116), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 44/183 (24%), Positives = 79/183 (43%), Gaps = 39/183 (21%)
Query: 19  YDFTSEDLQDLGEIGRGGFGTVNKMIHRSSDT---VMAVKRIRSTVDEKDQRQLLMDLDV 75
           Y+   E ++    IG G FG V++ I+ S +     +A+K  ++   +  + + L +  +
Sbjct: 5   YEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQE-AL 63
Query: 76  VMKSNECPYIVQFYGALFKE--------VTVATVK------------------------A 103
            M+  + P+IV+  G + +          T+  ++                        A
Sbjct: 64  TMRQFDHPHIVKLIGVITENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTA 123
Query: 104 LNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTRDAGCRP--YMAPE 161
           L YL E  + +HRD+   N+L+     +KL DFG+S  + DS       G  P  +MAPE
Sbjct: 124 LAYL-ESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTXXKASKGKLPIKWMAPE 182
Query: 162 RID 164
            I+
Sbjct: 183 SIN 185

>pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373

Iteration: 1
 Score = 49.3 bits (116), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 41/153 (26%), Positives = 67/153 (43%), Gaps = 41/153 (26%)
Query: 27  QDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIR----------STVDEKDQRQLLMDLDVV 76
           + L +IG+G FG V K  HR +   +A+K++           + + E    QLL   +VV
Sbjct: 21  EKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVV 80
Query: 77  -----MKSNECPY-------------------------IVQFYGALFKEVTVATVKALNY 106
                 ++   PY                         +V+F  +  K V    +  L Y
Sbjct: 81  NLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYY 140
Query: 107 LKEELKIIHRDVKPSNILLDRRGAIKLCDFGIS 139
           +    KI+HRD+K +N+L+ R G +KL DFG++
Sbjct: 141 IHRN-KILHRDMKAANVLITRDGVLKLADFGLA 172

>pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285

Iteration: 1
 Score = 49.3 bits (116), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 45/168 (26%), Positives = 71/168 (42%), Gaps = 39/168 (23%)
Query: 32  IGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQFY-- 89
           +G G FG V+ +  RSS     +K I     +    Q+  +++V +KS + P I++ +  
Sbjct: 30  LGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEV-LKSLDHPNIIKIFEV 88
Query: 90  ----------------GALFKEVTVATV--KALN--YLKEELK-------------IIHR 116
                           G L + +  A    KAL+  Y+ E +K             ++H+
Sbjct: 89  FEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHK 148
Query: 117 DVKPSNILLDR---RGAIKLCDFGISGQLVDSIAKTRDAGCRPYMAPE 161
           D+KP NIL         IK+ DFG++         T  AG   YMAPE
Sbjct: 149 DLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTNAAGTALYMAPE 196

>pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 41/153 (26%), Positives = 67/153 (43%), Gaps = 41/153 (26%)
Query: 27  QDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIR----------STVDEKDQRQLLMDLDVV 76
           + L +IG+G FG V K  HR +   +A+K++           + + E    QLL   +VV
Sbjct: 20  EKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVV 79
Query: 77  -----MKSNECPY-------------------------IVQFYGALFKEVTVATVKALNY 106
                 ++   PY                         +V+F  +  K V    +  L Y
Sbjct: 80  NLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYY 139
Query: 107 LKEELKIIHRDVKPSNILLDRRGAIKLCDFGIS 139
           +    KI+HRD+K +N+L+ R G +KL DFG++
Sbjct: 140 IHRN-KILHRDMKAANVLITRDGVLKLADFGLA 171

>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294

Iteration: 1
 Score = 48.9 bits (115), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 36/110 (32%), Positives = 61/110 (55%), Gaps = 13/110 (11%)
Query: 61  VDEKDQRQLLMDLDVVMKSNECPYIVQF---YGALFKEVTVA-TVKALNYLKE--ELKII 114
           VDE+D    L     VM+  E P + ++   +G L  +  +  T + L+ +K   +++I+
Sbjct: 79  VDEEDDCYYL-----VMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHDMRIV 133
Query: 115 HRDVKPSNILLDRRGAIKLCDFGISGQLVD-SIAKTRDA-GCRPYMAPER 162
           HRD+KP NIL+D    +K+ DFGI+  L + S+ +T    G   Y +PE+
Sbjct: 134 HRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQ 183

>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327

Iteration: 1
 Score = 48.9 bits (115), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 47/167 (28%), Positives = 64/167 (38%), Gaps = 37/167 (22%)
Query: 29  LGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQF 88
           L  IG+G F  V    H  +   +AVK I  T       Q L     +MK    P IV+ 
Sbjct: 19  LKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKL 78
Query: 89  YGALFKEVTV--------------------------------ATVKALNYLKEELKIIHR 116
           +  +  E T+                                  V A+ Y  ++  I+HR
Sbjct: 79  FEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYCHQKF-IVHR 137
Query: 117 DVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTRDAGC--RPYMAPE 161
           D+K  N+LLD    IK+ DFG S +   +     DA C   PY APE
Sbjct: 138 DLKAENLLLDADMNIKIADFGFSNEF--TFGNKLDAFCGAPPYAAPE 182

>pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331

Iteration: 1
 Score = 48.9 bits (115), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 41/153 (26%), Positives = 67/153 (43%), Gaps = 41/153 (26%)
Query: 27  QDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIR----------STVDEKDQRQLLMDLDVV 76
           + L +IG+G FG V K  HR +   +A+K++           + + E    QLL   +VV
Sbjct: 21  EKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVV 80
Query: 77  -----MKSNECPY-------------------------IVQFYGALFKEVTVATVKALNY 106
                 ++   PY                         +V+F  +  K V    +  L Y
Sbjct: 81  NLIEICRTKASPYNRCKASIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYY 140
Query: 107 LKEELKIIHRDVKPSNILLDRRGAIKLCDFGIS 139
           +    KI+HRD+K +N+L+ R G +KL DFG++
Sbjct: 141 IHRN-KILHRDMKAANVLITRDGVLKLADFGLA 172

>pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327

Iteration: 1
 Score = 48.9 bits (115), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 45/167 (26%), Positives = 75/167 (44%), Gaps = 37/167 (22%)
Query: 32  IGRGGFG---TVNKMIHRSSDTVMAVKRIRS---------TVDEKDQRQLL--------M 71
           +G+GG+G    V K+   ++  + A+K ++          T   K +R +L        +
Sbjct: 25  LGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIV 84
Query: 72  DLDVVMKSNECPYIVQFY---GALFKEVTVATV----KALNYLKE---------ELKIIH 115
           DL    ++    Y++  Y   G LF ++    +     A  YL E         +  II+
Sbjct: 85  DLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLHQKGIIY 144
Query: 116 RDVKPSNILLDRRGAIKLCDFGISGQLV-DSIAKTRDAGCRPYMAPE 161
           RD+KP NI+L+ +G +KL DFG+  + + D        G   YMAPE
Sbjct: 145 RDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHXFCGTIEYMAPE 191

>pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433

Iteration: 1
 Score = 48.9 bits (115), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 41/173 (23%), Positives = 76/173 (43%), Gaps = 35/173 (20%)
Query: 24  EDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRI-RSTVDEKDQRQLLMDLDVVMKSNEC 82
           ED + +  IGRG FG V  +  ++++ + A+K + +  + ++ +     +   V+ + +C
Sbjct: 90  EDFEIIKVIGRGAFGEVAVVKMKNTERIYAMKILNKWEMLKRAETACFREERDVLVNGDC 149
Query: 83  PYIVQFYGALFKEVTVATVK-----------------------ALNYLKE---------E 110
            +I   + A   E  +  V                        A  Y+ E         +
Sbjct: 150 QWITALHYAFQDENHLYLVMDYYVGGDLLTLLSKFEDKLPEDMARFYIGEMVLAIDSIHQ 209
Query: 111 LKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVD--SIAKTRDAGCRPYMAPE 161
           L  +HRD+KP N+LLD  G I+L DFG   ++ D  ++  +   G   Y++PE
Sbjct: 210 LHYVHRDIKPDNVLLDVNGHIRLADFGSCLKMNDDGTVQSSVAVGTPDYISPE 262

>pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415

Iteration: 1
 Score = 48.9 bits (115), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 41/173 (23%), Positives = 76/173 (43%), Gaps = 35/173 (20%)
Query: 24  EDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRI-RSTVDEKDQRQLLMDLDVVMKSNEC 82
           ED + +  IGRG FG V  +  ++++ + A+K + +  + ++ +     +   V+ + +C
Sbjct: 74  EDFEIIKVIGRGAFGEVAVVKMKNTERIYAMKILNKWEMLKRAETACFREERDVLVNGDC 133
Query: 83  PYIVQFYGALFKEVTVATVK-----------------------ALNYLKE---------E 110
            +I   + A   E  +  V                        A  Y+ E         +
Sbjct: 134 QWITALHYAFQDENHLYLVMDYYVGGDLLTLLSKFEDKLPEDMARFYIGEMVLAIDSIHQ 193
Query: 111 LKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVD--SIAKTRDAGCRPYMAPE 161
           L  +HRD+KP N+LLD  G I+L DFG   ++ D  ++  +   G   Y++PE
Sbjct: 194 LHYVHRDIKPDNVLLDVNGHIRLADFGSCLKMNDDGTVQSSVAVGTPDYISPE 246

>pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331

Iteration: 1
 Score = 48.9 bits (115), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 41/153 (26%), Positives = 67/153 (43%), Gaps = 41/153 (26%)
Query: 27  QDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIR----------STVDEKDQRQLLMDLDVV 76
           + L +IG+G FG V K  HR +   +A+K++           + + E    QLL   +VV
Sbjct: 21  EKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVV 80
Query: 77  -----MKSNECPY-------------------------IVQFYGALFKEVTVATVKALNY 106
                 ++   PY                         +V+F  +  K V    +  L Y
Sbjct: 81  NLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYY 140
Query: 107 LKEELKIIHRDVKPSNILLDRRGAIKLCDFGIS 139
           +    KI+HRD+K +N+L+ R G +KL DFG++
Sbjct: 141 IHRN-KILHRDMKAANVLITRDGVLKLADFGLA 172

>pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327

Iteration: 1
 Score = 48.9 bits (115), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 45/167 (26%), Positives = 75/167 (44%), Gaps = 37/167 (22%)
Query: 32  IGRGGFG---TVNKMIHRSSDTVMAVKRIRS---------TVDEKDQRQLL--------M 71
           +G+GG+G    V K+   ++  + A+K ++          T   K +R +L        +
Sbjct: 25  LGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIV 84
Query: 72  DLDVVMKSNECPYIVQFY---GALFKEVTVATV----KALNYLKE---------ELKIIH 115
           DL    ++    Y++  Y   G LF ++    +     A  YL E         +  II+
Sbjct: 85  DLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLHQKGIIY 144
Query: 116 RDVKPSNILLDRRGAIKLCDFGISGQLV-DSIAKTRDAGCRPYMAPE 161
           RD+KP NI+L+ +G +KL DFG+  + + D        G   YMAPE
Sbjct: 145 RDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHTFCGTIEYMAPE 191

>pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656

Iteration: 1
 Score = 48.9 bits (115), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 42/170 (24%), Positives = 74/170 (43%), Gaps = 39/170 (22%)
Query: 32  IGRGGFGTVNKMIHRSSDT---VMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQF 88
           IG G FG V++ I+ S +     +A+K  ++   +  + + L +  + M+  + P+IV+ 
Sbjct: 398 IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEA-LTMRQFDHPHIVKL 456
Query: 89  YGALFKE--------VTVATVK------------------------ALNYLKEELKIIHR 116
            G + +          T+  ++                        AL YL E  + +HR
Sbjct: 457 IGVITENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYL-ESKRFVHR 515
Query: 117 DVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTRDAGCRP--YMAPERID 164
           D+   N+L+     +KL DFG+S  + DS       G  P  +MAPE I+
Sbjct: 516 DIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESIN 565

>pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281

Iteration: 1
 Score = 48.9 bits (115), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 42/170 (24%), Positives = 74/170 (43%), Gaps = 39/170 (22%)
Query: 32  IGRGGFGTVNKMIHRSSDT---VMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQF 88
           IG G FG V++ I+ S +     +A+K  ++   +  + + L +  + M+  + P+IV+ 
Sbjct: 20  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQE-ALTMRQFDHPHIVKL 78
Query: 89  YGALFKE--------VTVATVK------------------------ALNYLKEELKIIHR 116
            G + +          T+  ++                        AL YL E  + +HR
Sbjct: 79  IGVITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYL-ESKRFVHR 137
Query: 117 DVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTRDAGCRP--YMAPERID 164
           D+   N+L+     +KL DFG+S  + DS       G  P  +MAPE I+
Sbjct: 138 DIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESIN 187

>pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282

Iteration: 1
 Score = 48.5 bits (114), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 42/170 (24%), Positives = 74/170 (43%), Gaps = 39/170 (22%)
Query: 32  IGRGGFGTVNKMIHRSSDT---VMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQF 88
           IG G FG V++ I+ S +     +A+K  ++   +  + + L +  + M+  + P+IV+ 
Sbjct: 21  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQE-ALTMRQFDHPHIVKL 79
Query: 89  YGALFKE--------VTVATVK------------------------ALNYLKEELKIIHR 116
            G + +          T+  ++                        AL YL E  + +HR
Sbjct: 80  IGVITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYL-ESKRFVHR 138
Query: 117 DVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTRDAGCRP--YMAPERID 164
           D+   N+L+     +KL DFG+S  + DS       G  P  +MAPE I+
Sbjct: 139 DIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESIN 188

>pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365

Iteration: 1
 Score = 48.5 bits (114), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 43/169 (25%), Positives = 67/169 (39%), Gaps = 40/169 (23%)
Query: 32  IGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQL-------LMDLDVVMKSNECPY 84
           IGRG    V + +HR++    AVK +  T +     QL         +  ++ +    P+
Sbjct: 102 IGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPH 161
Query: 85  IVQFY------------------GALF--------------KEVTVATVKALNYLKEELK 112
           I+                     G LF              + +  + ++A+++L     
Sbjct: 162 IITLIDSYESSSFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHAN-N 220
Query: 113 IIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTRDAGCRPYMAPE 161
           I+HRD+KP NILLD    I+L DFG S  L          G   Y+APE
Sbjct: 221 IVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEKLRELCGTPGYLAPE 269

>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319

Iteration: 1
 Score = 48.5 bits (114), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 46/164 (28%), Positives = 62/164 (37%), Gaps = 31/164 (18%)
Query: 29  LGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQF 88
           L  IG+G F  V    H  +   +AVK I  T       Q L     +MK    P IV+ 
Sbjct: 12  LKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKL 71
Query: 89  YGALFKEVTVATVK-------------ALNYLKEELK------------------IIHRD 117
           +  +  E T+  V              A  ++KE+                    I+HRD
Sbjct: 72  FEVIETEKTLYLVMEYASGGEVFDYLVAHGWMKEKEARAKFRQIVSAVQYCHQKFIVHRD 131
Query: 118 VKPSNILLDRRGAIKLCDFGISGQLVDSIAKTRDAGCRPYMAPE 161
           +K  N+LLD    IK+ DFG S +           G  PY APE
Sbjct: 132 LKAENLLLDADMNIKIADFGFSNEFTFGNKLDTFCGSPPYAAPE 175

>pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281

Iteration: 1
 Score = 48.5 bits (114), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 44/183 (24%), Positives = 79/183 (43%), Gaps = 39/183 (21%)
Query: 19  YDFTSEDLQDLGEIGRGGFGTVNKMIHRSSDT---VMAVKRIRSTVDEKDQRQLLMDLDV 75
           Y+   E ++    IG G FG V++ I+ S +     +A+K  ++   +  + + L +  +
Sbjct: 10  YEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQE-AL 68
Query: 76  VMKSNECPYIVQFYGALFKE--------VTVATVK------------------------A 103
            M+  + P+IV+  G + +          T+  ++                        A
Sbjct: 69  TMRQFDHPHIVKLIGVITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTA 128
Query: 104 LNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTRDAGCRP--YMAPE 161
           L YL E  + +HRD+   N+L+     +KL DFG+S  + DS       G  P  +MAPE
Sbjct: 129 LAYL-ESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPE 187
Query: 162 RID 164
            I+
Sbjct: 188 SIN 190

>pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304

Iteration: 1
 Score = 48.5 bits (114), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 42/170 (24%), Positives = 74/170 (43%), Gaps = 39/170 (22%)
Query: 32  IGRGGFGTVNKMIHRSSDT---VMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQF 88
           IG G FG V++ I+ S +     +A+K  ++   +  + + L +  + M+  + P+IV+ 
Sbjct: 46  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQE-ALTMRQFDHPHIVKL 104
Query: 89  YGALFKE--------VTVATVK------------------------ALNYLKEELKIIHR 116
            G + +          T+  ++                        AL YL E  + +HR
Sbjct: 105 IGVITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYL-ESKRFVHR 163
Query: 117 DVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTRDAGCRP--YMAPERID 164
           D+   N+L+     +KL DFG+S  + DS       G  P  +MAPE I+
Sbjct: 164 DIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESIN 213

>pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287

Iteration: 1
 Score = 48.5 bits (114), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 47/174 (27%), Positives = 74/174 (42%), Gaps = 35/174 (20%)
Query: 23  SEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIR-STVDEKDQRQLLMDLDVVMKSNE 81
           S+  Q + ++G G +G V     + +    A+K I+ S+V        L+D   V+K  +
Sbjct: 20  SDRYQRVKKLGSGAYGEVLLCKDKLTGAERAIKIIKKSSVTTTSNSGALLDEVAVLKQLD 79
Query: 82  CPYIVQFY------------------GALFKEVTV----ATVKALNYLKEEL-------- 111
            P I++ Y                  G LF E+ +    + V A   +K+ L        
Sbjct: 80  HPNIMKLYEFFEDKRNYYLVMEVYRGGELFDEIILRQKFSEVDAAVIMKQVLSGTTYLHK 139
Query: 112 -KIIHRDVKPSNILLD---RRGAIKLCDFGISGQLVDSIAKTRDAGCRPYMAPE 161
             I+HRD+KP N+LL+   R   IK+ DFG+S             G   Y+APE
Sbjct: 140 HNIVHRDLKPENLLLESKSRDALIKIVDFGLSAHFEVGGKMKERLGTAYYIAPE 193

>pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298

Iteration: 1
 Score = 48.5 bits (114), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 44/171 (25%), Positives = 69/171 (40%), Gaps = 43/171 (25%)
Query: 33  GRGGFGTVNKMIHRSSDTVMAVKRIRSTVD---EKDQRQLLMDLDVVMKSNE-------- 81
           G GGFG V K     ++T +AVK++ + VD   E+ ++Q   ++ V  K           
Sbjct: 31  GEGGFGVVYKGY--VNNTTVAVKKLAAMVDITTEELKQQFDQEIKVXAKCQHENLVELLG 88
Query: 82  ---------CPYIVQFYGALFK-----------------EVTVATVKALNYLKEELKIIH 115
                      Y+    G+L                   ++       +N+L E   I H
Sbjct: 89  FSSDGDDLCLVYVYXPNGSLLDRLSCLDGTPPLSWHXRCKIAQGAANGINFLHENHHI-H 147
Query: 116 RDVKPSNILLDRRGAIKLCDFGI---SGQLVDSIAKTRDAGCRPYMAPERI 163
           RD+K +NILLD     K+ DFG+   S +    +  +R  G   Y APE +
Sbjct: 148 RDIKSANILLDEAFTAKISDFGLARASEKFAQXVXXSRIVGTTAYXAPEAL 198

>pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 48.5 bits (114), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 44/183 (24%), Positives = 79/183 (43%), Gaps = 39/183 (21%)
Query: 19  YDFTSEDLQDLGEIGRGGFGTVNKMIHRSSDT---VMAVKRIRSTVDEKDQRQLLMDLDV 75
           Y+   E ++    IG G FG V++ I+ S +     +A+K  ++   +  + + L +  +
Sbjct: 5   YEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQE-AL 63
Query: 76  VMKSNECPYIVQFYGALFKE--------VTVATVK------------------------A 103
            M+  + P+IV+  G + +          T+  ++                        A
Sbjct: 64  TMRQFDHPHIVKLIGVITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTA 123
Query: 104 LNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTRDAGCRP--YMAPE 161
           L YL E  + +HRD+   N+L+     +KL DFG+S  + DS       G  P  +MAPE
Sbjct: 124 LAYL-ESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPE 182
Query: 162 RID 164
            I+
Sbjct: 183 SIN 185

>pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 48.5 bits (114), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 42/170 (24%), Positives = 74/170 (43%), Gaps = 39/170 (22%)
Query: 32  IGRGGFGTVNKMIHRSSDT---VMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQF 88
           IG G FG V++ I+ S +     +A+K  ++   +  + + L +  + M+  + P+IV+ 
Sbjct: 15  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQE-ALTMRQFDHPHIVKL 73
Query: 89  YGALFKE--------VTVATVK------------------------ALNYLKEELKIIHR 116
            G + +          T+  ++                        AL YL E  + +HR
Sbjct: 74  IGVITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYL-ESKRFVHR 132
Query: 117 DVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTRDAGCRP--YMAPERID 164
           D+   N+L+     +KL DFG+S  + DS       G  P  +MAPE I+
Sbjct: 133 DIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESIN 182

>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327

Iteration: 1
 Score = 48.5 bits (114), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 45/165 (27%), Positives = 61/165 (36%), Gaps = 33/165 (20%)
Query: 29  LGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQF 88
           L  IG+G F  V    H  +   +AVK I  T       Q L     +MK    P IV+ 
Sbjct: 19  LKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKL 78
Query: 89  YGALFKEVTV--------------------------------ATVKALNYLKEELKIIHR 116
           +  +  E T+                                  V A+ Y  ++  I+HR
Sbjct: 79  FEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYCHQKF-IVHR 137
Query: 117 DVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTRDAGCRPYMAPE 161
           D+K  N+LLD    IK+ DFG S +           G  PY APE
Sbjct: 138 DLKAENLLLDADMNIKIADFGFSNEFTFGNKLDTFCGSPPYAAPE 182

>pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276

Iteration: 1
 Score = 48.5 bits (114), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 44/183 (24%), Positives = 79/183 (43%), Gaps = 39/183 (21%)
Query: 19  YDFTSEDLQDLGEIGRGGFGTVNKMIHRSSDT---VMAVKRIRSTVDEKDQRQLLMDLDV 75
           Y+   E ++    IG G FG V++ I+ S +     +A+K  ++   +  + + L +  +
Sbjct: 5   YEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQE-AL 63
Query: 76  VMKSNECPYIVQFYGALFKE--------VTVATVK------------------------A 103
            M+  + P+IV+  G + +          T+  ++                        A
Sbjct: 64  TMRQFDHPHIVKLIGVITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTA 123
Query: 104 LNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTRDAGCRP--YMAPE 161
           L YL E  + +HRD+   N+L+     +KL DFG+S  + DS       G  P  +MAPE
Sbjct: 124 LAYL-ESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPE 182
Query: 162 RID 164
            I+
Sbjct: 183 SIN 185

>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327

Iteration: 1
 Score = 48.5 bits (114), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 45/165 (27%), Positives = 61/165 (36%), Gaps = 33/165 (20%)
Query: 29  LGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQF 88
           L  IG+G F  V    H  +   +AVK I  T       Q L     +MK    P IV+ 
Sbjct: 19  LKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKL 78
Query: 89  YGALFKEVTV--------------------------------ATVKALNYLKEELKIIHR 116
           +  +  E T+                                  V A+ Y  ++  I+HR
Sbjct: 79  FEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYCHQKF-IVHR 137
Query: 117 DVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTRDAGCRPYMAPE 161
           D+K  N+LLD    IK+ DFG S +           G  PY APE
Sbjct: 138 DLKAENLLLDADMNIKIADFGFSNEFTFGNKLDTFCGSPPYAAPE 182

>pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351

Iteration: 1
 Score = 48.5 bits (114), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 55/189 (29%), Positives = 83/189 (43%), Gaps = 47/189 (24%)
Query: 20  DFTSEDLQDLGE-IGRGGFGTVNKMIHRSSDTVMAVKRIR----------STVDEKDQRQ 68
           D   ED+ +L E IG+G F  V + I+R +    AVK +           ST D K +  
Sbjct: 19  DVLFEDVYELCEVIGKGAFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREAS 78
Query: 69  ----------------------LLMDLDVVMKSNECPYIVQFY--GALFKEVTVA----- 99
                                 L M  + +  ++ C  IV+    G ++ E   +     
Sbjct: 79  ICHMLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQ 138
Query: 100 TVKALNYLKEELKIIHRDVKPSNILL---DRRGAIKLCDFGISGQLVDS--IAKTRDAGC 154
            ++AL Y  +   IIHRDVKP N+LL   +    +KL DFG++ QL +S  +A  R  G 
Sbjct: 139 ILEALRYCHDN-NIIHRDVKPENVLLASKENSAPVKLGDFGVAIQLGESGLVAGGR-VGT 196
Query: 155 RPYMAPERI 163
             +MAPE +
Sbjct: 197 PHFMAPEVV 205

>pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324

Iteration: 1
 Score = 48.5 bits (114), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 36/144 (25%), Positives = 64/144 (44%), Gaps = 36/144 (25%)
Query: 29  LGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDE-------------KDQRQL------ 69
           L ++G G + TV K   + +D ++A+K IR   +E             KD +        
Sbjct: 7   LDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLH 66
Query: 70  --------------LMDLDVVMKSNECPYIVQFYGALFKEVTVATVKALNYLKEELKIIH 115
                          +D D+    ++C  I+  +    K      ++ L Y   + K++H
Sbjct: 67  DIIHTEKSLTLVFEYLDKDLKQYLDDCGNIINMHNV--KLFLFQLLRGLAYCHRQ-KVLH 123
Query: 116 RDVKPSNILLDRRGAIKLCDFGIS 139
           RD+KP N+L++ RG +KL DFG++
Sbjct: 124 RDLKPQNLLINERGELKLADFGLA 147

>pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292

Iteration: 1
 Score = 48.5 bits (114), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 34/145 (23%), Positives = 63/145 (43%), Gaps = 33/145 (22%)
Query: 27  QDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVD----------------EKDQRQLL 70
           + L +IG G +GTV K  +R +  ++A+KR+R   D                E   + ++
Sbjct: 5   EKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIV 64
Query: 71  MDLDVVMKSNECPYIVQFYG----------------ALFKEVTVATVKALNYLKEELKII 114
              DV+    +   + +F                   + K      +K L +      ++
Sbjct: 65  RLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSR-NVL 123
Query: 115 HRDVKPSNILLDRRGAIKLCDFGIS 139
           HRD+KP N+L++R G +KL +FG++
Sbjct: 124 HRDLKPQNLLINRNGELKLANFGLA 148

>pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430

Iteration: 1
 Score = 48.1 bits (113), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 28/63 (44%), Positives = 35/63 (55%), Gaps = 2/63 (3%)
Query: 102 KALNYLKEELKIIHRDVKPSNILLDRRGAI-KLCDFGISGQLVDSIAKTRDAGCRPYMAP 160
           ++L Y+     I HRD+KP N+LLD   A+ KLCDFG + QLV           R Y AP
Sbjct: 167 RSLAYI-HSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYRAP 225
Query: 161 ERI 163
           E I
Sbjct: 226 ELI 228

>pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656

Iteration: 1
 Score = 48.1 bits (113), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 42/170 (24%), Positives = 74/170 (43%), Gaps = 39/170 (22%)
Query: 32  IGRGGFGTVNKMIHRSSDT---VMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQF 88
           IG G FG V++ I+ S +     +A+K  ++   +  + + L +  + M+  + P+IV+ 
Sbjct: 398 IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEA-LTMRQFDHPHIVKL 456
Query: 89  YGALFKE--------VTVATVK------------------------ALNYLKEELKIIHR 116
            G + +          T+  ++                        AL YL E  + +HR
Sbjct: 457 IGVITENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYL-ESKRFVHR 515
Query: 117 DVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTRDAGCRP--YMAPERID 164
           D+   N+L+     +KL DFG+S  + DS       G  P  +MAPE I+
Sbjct: 516 DIAARNVLVSATDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESIN 565

>pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494

Iteration: 1
 Score = 48.1 bits (113), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 46/174 (26%), Positives = 71/174 (40%), Gaps = 36/174 (20%)
Query: 23  SEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNEC 82
           SE  Q + ++G G +G V     + +    A+K IR T         L++   V+K  + 
Sbjct: 36  SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDH 95
Query: 83  PYIVQFY------------------GAL---------FKEVTVATV-----KALNYLKEE 110
           P I++ Y                  G L         F EV  A +       + YL + 
Sbjct: 96  PNIMKLYDFFEDKRNYYLVMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKH 155
Query: 111 LKIIHRDVKPSNILLDRR---GAIKLCDFGISGQLVDSIAKTRDAGCRPYMAPE 161
             I+HRD+KP N+LL+ +     IK+ DFG+S    +        G   Y+APE
Sbjct: 156 -NIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMKERLGTAYYIAPE 208

>pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299

Iteration: 1
 Score = 48.1 bits (113), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 48/198 (24%), Positives = 83/198 (41%), Gaps = 60/198 (30%)
Query: 25  DLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPY 84
           D + +  +GRGGFG V +  ++  D   A+KRIR    E  + +++ ++  + K  E P 
Sbjct: 6   DFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKL-EHPG 64
Query: 85  IVQFYGALFKEVTVATVKALN---YL--------KEELK--------------------- 112
           IV+++ A  ++ T   ++  +   YL        KE LK                     
Sbjct: 65  IVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIF 124
Query: 113 --------------IIHRDVKPSNILLDRRGAIKLCDFGISGQL------------VDSI 146
                         ++HRD+KPSNI       +K+ DFG+   +            + + 
Sbjct: 125 LQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAY 184
Query: 147 AK-TRDAGCRPYMAPERI 163
           A+ T   G + YM+PE+I
Sbjct: 185 ARHTGQVGTKLYMSPEQI 202

>pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371

Iteration: 1
 Score = 48.1 bits (113), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 28/63 (44%), Positives = 35/63 (55%), Gaps = 2/63 (3%)
Query: 102 KALNYLKEELKIIHRDVKPSNILLDRRGAI-KLCDFGISGQLVDSIAKTRDAGCRPYMAP 160
           ++L Y+     I HRD+KP N+LLD   A+ KLCDFG + QLV           R Y AP
Sbjct: 145 RSLAYI-HSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYRAP 203
Query: 161 ERI 163
           E I
Sbjct: 204 ELI 206

>pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350

Iteration: 1
 Score = 48.1 bits (113), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 28/63 (44%), Positives = 35/63 (55%), Gaps = 2/63 (3%)
Query: 102 KALNYLKEELKIIHRDVKPSNILLDRRGAI-KLCDFGISGQLVDSIAKTRDAGCRPYMAP 160
           ++L Y+     I HRD+KP N+LLD   A+ KLCDFG + QLV           R Y AP
Sbjct: 133 RSLAYI-HSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYRAP 191
Query: 161 ERI 163
           E I
Sbjct: 192 ELI 194

>pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367

Iteration: 1
 Score = 48.1 bits (113), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 28/63 (44%), Positives = 35/63 (55%), Gaps = 2/63 (3%)
Query: 102 KALNYLKEELKIIHRDVKPSNILLDRRGAI-KLCDFGISGQLVDSIAKTRDAGCRPYMAP 160
           ++L Y+     I HRD+KP N+LLD   A+ KLCDFG + QLV           R Y AP
Sbjct: 141 RSLAYI-HSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYRAP 199
Query: 161 ERI 163
           E I
Sbjct: 200 ELI 202

>pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378

Iteration: 1
 Score = 48.1 bits (113), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 28/63 (44%), Positives = 35/63 (55%), Gaps = 2/63 (3%)
Query: 102 KALNYLKEELKIIHRDVKPSNILLDRRGAI-KLCDFGISGQLVDSIAKTRDAGCRPYMAP 160
           ++L Y+     I HRD+KP N+LLD   A+ KLCDFG + QLV           R Y AP
Sbjct: 152 RSLAYI-HSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYRAP 210
Query: 161 ERI 163
           E I
Sbjct: 211 ELI 213

>pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352

Iteration: 1
 Score = 48.1 bits (113), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 28/63 (44%), Positives = 35/63 (55%), Gaps = 2/63 (3%)
Query: 102 KALNYLKEELKIIHRDVKPSNILLDRRGAI-KLCDFGISGQLVDSIAKTRDAGCRPYMAP 160
           ++L Y+     I HRD+KP N+LLD   A+ KLCDFG + QLV           R Y AP
Sbjct: 133 RSLAYI-HSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYRAP 191
Query: 161 ERI 163
           E I
Sbjct: 192 ELI 194

>pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353

Iteration: 1
 Score = 48.1 bits (113), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 28/63 (44%), Positives = 35/63 (55%), Gaps = 2/63 (3%)
Query: 102 KALNYLKEELKIIHRDVKPSNILLDRRGAI-KLCDFGISGQLVDSIAKTRDAGCRPYMAP 160
           ++L Y+     I HRD+KP N+LLD   A+ KLCDFG + QLV           R Y AP
Sbjct: 137 RSLAYI-HSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYRAP 195
Query: 161 ERI 163
           E I
Sbjct: 196 ELI 198

>pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349

Iteration: 1
 Score = 48.1 bits (113), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 28/63 (44%), Positives = 35/63 (55%), Gaps = 2/63 (3%)
Query: 102 KALNYLKEELKIIHRDVKPSNILLDRRGAI-KLCDFGISGQLVDSIAKTRDAGCRPYMAP 160
           ++L Y+     I HRD+KP N+LLD   A+ KLCDFG + QLV           R Y AP
Sbjct: 133 RSLAYI-HSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYRAP 191
Query: 161 ERI 163
           E I
Sbjct: 192 ELI 194

>pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350

Iteration: 1
 Score = 48.1 bits (113), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 28/63 (44%), Positives = 35/63 (55%), Gaps = 2/63 (3%)
Query: 102 KALNYLKEELKIIHRDVKPSNILLDRRGAI-KLCDFGISGQLVDSIAKTRDAGCRPYMAP 160
           ++L Y+     I HRD+KP N+LLD   A+ KLCDFG + QLV           R Y AP
Sbjct: 134 RSLAYI-HSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYRAP 192
Query: 161 ERI 163
           E I
Sbjct: 193 ELI 195

>pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382

Iteration: 1
 Score = 48.1 bits (113), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 28/63 (44%), Positives = 35/63 (55%), Gaps = 2/63 (3%)
Query: 102 KALNYLKEELKIIHRDVKPSNILLDRRGAI-KLCDFGISGQLVDSIAKTRDAGCRPYMAP 160
           ++L Y+     I HRD+KP N+LLD   A+ KLCDFG + QLV           R Y AP
Sbjct: 145 RSLAYI-HSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYRAP 203
Query: 161 ERI 163
           E I
Sbjct: 204 ELI 206

>pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543

Iteration: 1
 Score = 48.1 bits (113), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 26/66 (39%), Positives = 39/66 (59%), Gaps = 2/66 (3%)
Query: 97  TVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTRD-AGCR 155
           T   V  L +L +   II+RD+KP N+LLD  G +++ D G++ +L     KT+  AG  
Sbjct: 295 TAQIVSGLEHLHQR-NIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTP 353
Query: 156 PYMAPE 161
            +MAPE
Sbjct: 354 GFMAPE 359

>pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350

Iteration: 1
 Score = 48.1 bits (113), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 28/63 (44%), Positives = 35/63 (55%), Gaps = 2/63 (3%)
Query: 102 KALNYLKEELKIIHRDVKPSNILLDRRGAI-KLCDFGISGQLVDSIAKTRDAGCRPYMAP 160
           ++L Y+     I HRD+KP N+LLD   A+ KLCDFG + QLV           R Y AP
Sbjct: 133 RSLAYI-HSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYRAP 191
Query: 161 ERI 163
           E I
Sbjct: 192 ELI 194

>pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 48.1 bits (113), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 44/183 (24%), Positives = 79/183 (43%), Gaps = 39/183 (21%)
Query: 19  YDFTSEDLQDLGEIGRGGFGTVNKMIHRSSDT---VMAVKRIRSTVDEKDQRQLLMDLDV 75
           Y+   E ++    IG G FG V++ I+ S +     +A+K  ++   +  + + L +  +
Sbjct: 5   YEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQE-AL 63
Query: 76  VMKSNECPYIVQFYGALFKE--------VTVATVK------------------------A 103
            M+  + P+IV+  G + +          T+  ++                        A
Sbjct: 64  TMRQFDHPHIVKLIGVITENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTA 123
Query: 104 LNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTRDAGCRP--YMAPE 161
           L YL E  + +HRD+   N+L+     +KL DFG+S  + DS       G  P  +MAPE
Sbjct: 124 LAYL-ESKRFVHRDIAARNVLVSATDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPE 182
Query: 162 RID 164
            I+
Sbjct: 183 SIN 185

>pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543

Iteration: 1
 Score = 48.1 bits (113), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 26/66 (39%), Positives = 39/66 (59%), Gaps = 2/66 (3%)
Query: 97  TVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTRD-AGCR 155
           T   V  L +L +   II+RD+KP N+LLD  G +++ D G++ +L     KT+  AG  
Sbjct: 295 TAQIVSGLEHLHQR-NIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTP 353
Query: 156 PYMAPE 161
            +MAPE
Sbjct: 354 GFMAPE 359

>pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543

Iteration: 1
 Score = 48.1 bits (113), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 26/66 (39%), Positives = 39/66 (59%), Gaps = 2/66 (3%)
Query: 97  TVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTRD-AGCR 155
           T   V  L +L +   II+RD+KP N+LLD  G +++ D G++ +L     KT+  AG  
Sbjct: 295 TAQIVSGLEHLHQR-NIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTP 353
Query: 156 PYMAPE 161
            +MAPE
Sbjct: 354 GFMAPE 359

>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327

Iteration: 1
 Score = 47.8 bits (112), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 44/165 (26%), Positives = 61/165 (36%), Gaps = 33/165 (20%)
Query: 29  LGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQF 88
           L  IG+G F  V    H  +   +AV+ I  T       Q L     +MK    P IV+ 
Sbjct: 19  LKTIGKGNFAKVKLARHILTGKEVAVRIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKL 78
Query: 89  YGALFKEVTV--------------------------------ATVKALNYLKEELKIIHR 116
           +  +  E T+                                  V A+ Y  ++  I+HR
Sbjct: 79  FEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYCHQKF-IVHR 137
Query: 117 DVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTRDAGCRPYMAPE 161
           D+K  N+LLD    IK+ DFG S +           G  PY APE
Sbjct: 138 DLKAENLLLDADMNIKIADFGFSNEFTFGNKLDEFCGSPPYAAPE 182

>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328

Iteration: 1
 Score = 47.8 bits (112), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 46/167 (27%), Positives = 66/167 (39%), Gaps = 37/167 (22%)
Query: 29  LGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQF 88
           L  IG+G F  V    H  +   +A+K I  T       Q L     +MK    P IV+ 
Sbjct: 20  LKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKL 79
Query: 89  YGALFKEVTV--------------------------------ATVKALNYLKEELKIIHR 116
           +  +  E T+                                  V A+ Y  ++ +I+HR
Sbjct: 80  FEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQK-RIVHR 138
Query: 117 DVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTRDAGCR--PYMAPE 161
           D+K  N+LLD    IK+ DFG S +   ++    DA C   PY APE
Sbjct: 139 DLKAENLLLDADMNIKIADFGFSNEF--TVGGKLDAFCGAPPYAAPE 183

>pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543

Iteration: 1
 Score = 47.8 bits (112), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 26/66 (39%), Positives = 39/66 (59%), Gaps = 2/66 (3%)
Query: 97  TVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTRD-AGCR 155
           T   V  L +L +   II+RD+KP N+LLD  G +++ D G++ +L     KT+  AG  
Sbjct: 295 TAQIVSGLEHLHQR-NIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTP 353
Query: 156 PYMAPE 161
            +MAPE
Sbjct: 354 GFMAPE 359

>pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467

Iteration: 1
 Score = 47.8 bits (112), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 47/174 (27%), Positives = 74/174 (42%), Gaps = 35/174 (20%)
Query: 23  SEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIR-STVDEKDQRQLLMDLDVVMKSNE 81
           S+  Q + ++G G +G V     + +    A+K I+ S+V        L+D   V+K  +
Sbjct: 3   SDRYQRVKKLGSGAYGEVLLCKDKLTGAERAIKIIKKSSVTTTSNSGALLDEVAVLKQLD 62
Query: 82  CPYIVQFY------------------GALFKEVTV----ATVKALNYLKEEL-------- 111
            P I++ Y                  G LF E+ +    + V A   +K+ L        
Sbjct: 63  HPNIMKLYEFFEDKRNYYLVMEVYRGGELFDEIILRQKFSEVDAAVIMKQVLSGTTYLHK 122
Query: 112 -KIIHRDVKPSNILLD---RRGAIKLCDFGISGQLVDSIAKTRDAGCRPYMAPE 161
             I+HRD+KP N+LL+   R   IK+ DFG+S             G   Y+APE
Sbjct: 123 HNIVHRDLKPENLLLESKSRDALIKIVDFGLSAHFEVGGKMKERLGTAYYIAPE 176

>pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491

Iteration: 1
 Score = 47.8 bits (112), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 43/164 (26%), Positives = 72/164 (43%), Gaps = 34/164 (20%)
Query: 31  EIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQL--------------LMDL-DV 75
           E+G G FG V+++  R++    A K +  T  E D+  +              L++L D 
Sbjct: 58  ELGTGAFGVVHRVTERATGNNFAAKFVM-TPHESDKETVRKEIQTMSVLRHPTLVNLHDA 116
Query: 76  VMKSNECPYIVQFY--GALFKEVT-----VATVKALNYLKE---------ELKIIHRDVK 119
               NE   I +F   G LF++V      ++  +A+ Y+++         E   +H D+K
Sbjct: 117 FEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLK 176
Query: 120 PSNILL--DRRGAIKLCDFGISGQLVDSIAKTRDAGCRPYMAPE 161
           P NI+    R   +KL DFG++  L    +     G   + APE
Sbjct: 177 PENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPE 220

>pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465

Iteration: 1
 Score = 47.8 bits (112), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 28/63 (44%), Positives = 35/63 (55%), Gaps = 2/63 (3%)
Query: 102 KALNYLKEELKIIHRDVKPSNILLDRRGAI-KLCDFGISGQLVDSIAKTRDAGCRPYMAP 160
           ++L Y+     I HRD+KP N+LLD   A+ KLCDFG + QLV           R Y AP
Sbjct: 212 RSLAYI-HSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAP 270
Query: 161 ERI 163
           E I
Sbjct: 271 ELI 273

>pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414

Iteration: 1
 Score = 47.8 bits (112), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 28/63 (44%), Positives = 35/63 (55%), Gaps = 2/63 (3%)
Query: 102 KALNYLKEELKIIHRDVKPSNILLDRRGAI-KLCDFGISGQLVDSIAKTRDAGCRPYMAP 160
           ++L Y+     I HRD+KP N+LLD   A+ KLCDFG + QLV           R Y AP
Sbjct: 161 RSLAYI-HSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAP 219
Query: 161 ERI 163
           E I
Sbjct: 220 ELI 222

>pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420

Iteration: 1
 Score = 47.4 bits (111), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 28/63 (44%), Positives = 35/63 (55%), Gaps = 2/63 (3%)
Query: 102 KALNYLKEELKIIHRDVKPSNILLDRRGAI-KLCDFGISGQLVDSIAKTRDAGCRPYMAP 160
           ++L Y+     I HRD+KP N+LLD   A+ KLCDFG + QLV           R Y AP
Sbjct: 167 RSLAYI-HSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAP 225
Query: 161 ERI 163
           E I
Sbjct: 226 ELI 228

>pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391

Iteration: 1
 Score = 47.4 bits (111), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 28/63 (44%), Positives = 35/63 (55%), Gaps = 2/63 (3%)
Query: 102 KALNYLKEELKIIHRDVKPSNILLDRRGAI-KLCDFGISGQLVDSIAKTRDAGCRPYMAP 160
           ++L Y+     I HRD+KP N+LLD   A+ KLCDFG + QLV           R Y AP
Sbjct: 138 RSLAYI-HSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAP 196
Query: 161 ERI 163
           E I
Sbjct: 197 ELI 199

>pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377

Iteration: 1
 Score = 47.4 bits (111), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 46/186 (24%), Positives = 77/186 (41%), Gaps = 38/186 (20%)
Query: 15  PDTVYDFTSEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLD 74
           P   +    EDL    +IGRG FG V     R+ +T++AVK  R T+    + + L +  
Sbjct: 105 PKDKWVLNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEAR 164
Query: 75  VVMKSNECPYIVQFYGALFKEVTVATVKA-------LNYLKEE---LKI----------- 113
            ++K    P IV+  G   ++  +  V         L +L+ E   L++           
Sbjct: 165 -ILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAA 223
Query: 114 -----------IHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTRDAGCRP----YM 158
                      IHRD+   N L+  +  +K+ DFG+S +  D +      G R     + 
Sbjct: 224 AGMEYLESKCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVXAA-SGGLRQVPVKWT 282
Query: 159 APERID 164
           APE ++
Sbjct: 283 APEALN 288

>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327

Iteration: 1
 Score = 47.4 bits (111), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 44/165 (26%), Positives = 61/165 (36%), Gaps = 33/165 (20%)
Query: 29  LGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQF 88
           L  IG+G F  V    H  +   +AV+ I  T       Q L     +MK    P IV+ 
Sbjct: 19  LKTIGKGNFAKVKLARHILTGKEVAVRIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKL 78
Query: 89  YGALFKEVTV--------------------------------ATVKALNYLKEELKIIHR 116
           +  +  E T+                                  V A+ Y  ++  I+HR
Sbjct: 79  FEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYCHQKF-IVHR 137
Query: 117 DVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTRDAGCRPYMAPE 161
           D+K  N+LLD    IK+ DFG S +           G  PY APE
Sbjct: 138 DLKAENLLLDADMNIKIADFGFSNEFTFGNKLDTFCGSPPYAAPE 182

>pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350

Iteration: 1
 Score = 47.4 bits (111), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 28/63 (44%), Positives = 35/63 (55%), Gaps = 2/63 (3%)
Query: 102 KALNYLKEELKIIHRDVKPSNILLDRRGAI-KLCDFGISGQLVDSIAKTRDAGCRPYMAP 160
           ++L Y+     I HRD+KP N+LLD   A+ KLCDFG + QLV           R Y AP
Sbjct: 133 RSLAYI-HSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAP 191
Query: 161 ERI 163
           E I
Sbjct: 192 ELI 194

>pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424

Iteration: 1
 Score = 47.4 bits (111), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 28/63 (44%), Positives = 35/63 (55%), Gaps = 2/63 (3%)
Query: 102 KALNYLKEELKIIHRDVKPSNILLDRRGAI-KLCDFGISGQLVDSIAKTRDAGCRPYMAP 160
           ++L Y+     I HRD+KP N+LLD   A+ KLCDFG + QLV           R Y AP
Sbjct: 171 RSLAYI-HSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAP 229
Query: 161 ERI 163
           E I
Sbjct: 230 ELI 232

>pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422

Iteration: 1
 Score = 47.4 bits (111), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 28/63 (44%), Positives = 35/63 (55%), Gaps = 2/63 (3%)
Query: 102 KALNYLKEELKIIHRDVKPSNILLDRRGAI-KLCDFGISGQLVDSIAKTRDAGCRPYMAP 160
           ++L Y+     I HRD+KP N+LLD   A+ KLCDFG + QLV           R Y AP
Sbjct: 169 RSLAYI-HSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAP 227
Query: 161 ERI 163
           E I
Sbjct: 228 ELI 230

>pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573

Iteration: 1
 Score = 47.4 bits (111), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 43/164 (26%), Positives = 72/164 (43%), Gaps = 34/164 (20%)
Query: 31  EIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQL--------------LMDL-DV 75
           E+G G FG V+++  R++    A K +  T  E D+  +              L++L D 
Sbjct: 164 ELGTGAFGVVHRVTERATGNNFAAKFVM-TPHESDKETVRKEIQTMSVLRHPTLVNLHDA 222
Query: 76  VMKSNECPYIVQFY--GALFKEVT-----VATVKALNYLKE---------ELKIIHRDVK 119
               NE   I +F   G LF++V      ++  +A+ Y+++         E   +H D+K
Sbjct: 223 FEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLK 282
Query: 120 PSNILL--DRRGAIKLCDFGISGQLVDSIAKTRDAGCRPYMAPE 161
           P NI+    R   +KL DFG++  L    +     G   + APE
Sbjct: 283 PENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPE 326

>pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327

Iteration: 1
 Score = 47.4 bits (111), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 43/176 (24%), Positives = 75/176 (42%), Gaps = 41/176 (23%)
Query: 31  EIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQR-QLLMDLDVVMKSNECPYIVQFY 89
           E+GRG F  V + I +S+    A K ++     +D R ++L ++ V+  +  CP ++  +
Sbjct: 36  ELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLH 95
Query: 90  ------------------GALFK----------------EVTVATVKALNYLKEELKIIH 115
                             G +F                  +    ++ + YL +   I+H
Sbjct: 96  EVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQN-NIVH 154
Query: 116 RDVKPSNILLDR---RGAIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERI--DPL 166
            D+KP NILL      G IK+ DFG+S ++  +       G   Y+APE +  DP+
Sbjct: 155 LDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELREIMGTPEYLAPEILNYDPI 210

>pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350

Iteration: 1
 Score = 47.4 bits (111), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 28/63 (44%), Positives = 35/63 (55%), Gaps = 2/63 (3%)
Query: 102 KALNYLKEELKIIHRDVKPSNILLDRRGAI-KLCDFGISGQLVDSIAKTRDAGCRPYMAP 160
           ++L Y+     I HRD+KP N+LLD   A+ KLCDFG + QLV           R Y AP
Sbjct: 133 RSLAYI-HSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAP 191
Query: 161 ERI 163
           E I
Sbjct: 192 ELI 194

>pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372

Iteration: 1
 Score = 47.4 bits (111), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 28/63 (44%), Positives = 35/63 (55%), Gaps = 2/63 (3%)
Query: 102 KALNYLKEELKIIHRDVKPSNILLDRRGAI-KLCDFGISGQLVDSIAKTRDAGCRPYMAP 160
           ++L Y+     I HRD+KP N+LLD   A+ KLCDFG + QLV           R Y AP
Sbjct: 146 RSLAYI-HSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAP 204
Query: 161 ERI 163
           E I
Sbjct: 205 ELI 207

>pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352

Iteration: 1
 Score = 47.4 bits (111), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 28/63 (44%), Positives = 35/63 (55%), Gaps = 2/63 (3%)
Query: 102 KALNYLKEELKIIHRDVKPSNILLDRRGAI-KLCDFGISGQLVDSIAKTRDAGCRPYMAP 160
           ++L Y+     I HRD+KP N+LLD   A+ KLCDFG + QLV           R Y AP
Sbjct: 133 RSLAYI-HSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAP 191
Query: 161 ERI 163
           E I
Sbjct: 192 ELI 194

>pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355

Iteration: 1
 Score = 47.4 bits (111), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 29/63 (46%), Positives = 38/63 (60%), Gaps = 3/63 (4%)
Query: 101 VKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLV-DSIAKTRD-AGCRPYM 158
           V AL +L  +L II+RD+K  NILLD  G + L DFG+S + V D   +  D  G   YM
Sbjct: 169 VLALEHL-HKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYM 227
Query: 159 APE 161
           AP+
Sbjct: 228 APD 230

>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311

Iteration: 1
 Score = 47.4 bits (111), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 40/147 (27%), Positives = 64/147 (43%), Gaps = 32/147 (21%)
Query: 24  EDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIR----------------STVDEKDQR 67
           E  Q L ++G G +G V K    S   ++A+KRIR                S + E    
Sbjct: 21  EKYQKLEKVGEGTYGVVYKA-KDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHP 79
Query: 68  QLLMDLDVVMKSNECPYIVQFYGALFKEVTVATVKALN------YLKEELK--------- 112
            ++  +DV+        + +F     K+V       L       YL + L+         
Sbjct: 80  NIVSLIDVIHSERCLTLVFEFMEKDLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHR 139
Query: 113 IIHRDVKPSNILLDRRGAIKLCDFGIS 139
           I+HRD+KP N+L++  GA+KL DFG++
Sbjct: 140 ILHRDLKPQNLLINSDGALKLADFGLA 166

>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313

Iteration: 1
 Score = 47.4 bits (111), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 40/147 (27%), Positives = 64/147 (43%), Gaps = 32/147 (21%)
Query: 24  EDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIR----------------STVDEKDQR 67
           E  Q L ++G G +G V K    S   ++A+KRIR                S + E    
Sbjct: 21  EKYQKLEKVGEGTYGVVYKA-KDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHP 79
Query: 68  QLLMDLDVVMKSNECPYIVQFYGALFKEVTVATVKALN------YLKEELK--------- 112
            ++  +DV+        + +F     K+V       L       YL + L+         
Sbjct: 80  NIVSLIDVIHSERCLTLVFEFMEKDLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHR 139
Query: 113 IIHRDVKPSNILLDRRGAIKLCDFGIS 139
           I+HRD+KP N+L++  GA+KL DFG++
Sbjct: 140 ILHRDLKPQNLLINSDGALKLADFGLA 166

>pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412

Iteration: 1
 Score = 47.4 bits (111), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 49/173 (28%), Positives = 73/173 (42%), Gaps = 35/173 (20%)
Query: 24  EDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVK-----------RIRSTVDEKD-----QR 67
           +D + L  IGRG F  V  +  + +  V A+K            +    +E+D      R
Sbjct: 61  DDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDR 120
Query: 68  QLLMDLDVVMKSNECPYIVQFY---GALFKEVT-----VATVKALNYLKE---------E 110
           + +  L    +     Y+V  Y   G L   ++     +    A  YL E          
Sbjct: 121 RWITQLHFAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHR 180
Query: 111 LKIIHRDVKPSNILLDRRGAIKLCDFGISGQL-VDSIAKTRDA-GCRPYMAPE 161
           L  +HRD+KP NILLDR G I+L DFG   +L  D   ++  A G   Y++PE
Sbjct: 181 LGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVAVGTPDYLSPE 233

>pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268

Iteration: 1
 Score = 47.4 bits (111), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 42/153 (27%), Positives = 66/153 (43%), Gaps = 36/153 (23%)
Query: 24  EDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECP 83
           E++  L E+G G FG V K+        +AVK I+     +D+     +   +MK +  P
Sbjct: 8   EEITLLKELGSGQFGVV-KLGKWKGQYDVAVKMIKEGSMSEDE--FFQEAQTMMKLSH-P 63
Query: 84  YIVQFYGALFKEVTVATVKA-------LNYLK-------------------------EEL 111
            +V+FYG   KE  +  V         LNYL+                         E  
Sbjct: 64  KLVKFYGVCSKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESH 123
Query: 112 KIIHRDVKPSNILLDRRGAIKLCDFGISGQLVD 144
           + IHRD+   N L+DR   +K+ DFG++  ++D
Sbjct: 124 QFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLD 156

>pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388

Iteration: 1
 Score = 47.4 bits (111), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 40/153 (26%), Positives = 68/153 (44%), Gaps = 46/153 (30%)
Query: 31  EIGRGGFGTVNKMIHRSSDTVMAVKRI-----RSTVDEKDQRQLLM-------------- 71
           ++G+G +G V K I R +  V+AVK+I      ST  ++  R++++              
Sbjct: 16  KLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLL 75
Query: 72  --------------------DLDVVMKSNECPYIVQFYGALFKEVTVATVKALNYLKEEL 111
                               DL  V+++N    + + Y      V    +K + YL    
Sbjct: 76  NVLRADNDRDVYLVFDYMETDLHAVIRANILEPVHKQY------VVYQLIKVIKYLHSG- 128
Query: 112 KIIHRDVKPSNILLDRRGAIKLCDFGISGQLVD 144
            ++HRD+KPSNILL+    +K+ DFG+S   V+
Sbjct: 129 GLLHRDMKPSNILLNAECHVKVADFGLSRSFVN 161

>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310

Iteration: 1
 Score = 47.4 bits (111), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 47/205 (22%), Positives = 91/205 (44%), Gaps = 46/205 (22%)
Query: 13  LSPDTVYDFTSEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIR--STVDEKDQRQLL 70
           L PD  Y+ T  + +   +IGRG F  V +         +A+K+++    +D K +   +
Sbjct: 22  LRPDMGYN-TLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCI 80
Query: 71  MDLDVVMKSNECPYIVQFYGALFKEVTVATV----------KALNYLKEELKII------ 114
            ++D++ + N  P ++++Y +  ++  +  V          + + + K++ ++I      
Sbjct: 81  KEIDLLKQLNH-PNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVW 139
Query: 115 -------------------HRDVKPSNILLDRRGAIKLCDFGISGQLVDS--IAKTRDAG 153
                              HRD+KP+N+ +   G +KL D G+ G+   S   A     G
Sbjct: 140 KYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGL-GRFFSSKTTAAHSLVG 198
Query: 154 CRPYMAPERIDPLRARGYPSFKTKL 178
              YM+PERI      GY +FK+ +
Sbjct: 199 TPYYMSPERI---HENGY-NFKSDI 219

>pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286

Iteration: 1
 Score = 47.0 bits (110), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 43/166 (25%), Positives = 71/166 (42%), Gaps = 38/166 (22%)
Query: 32  IGRGGFGTVNKMIHRSSDTVMAVKRI-RSTVDEKDQRQLLMDLDVVMKSNECPYIVQFY- 89
           +G+G FG V K   R +    AVK I +++   KD   +L +++++ K +  P I++ + 
Sbjct: 30  LGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDH-PNIMKLFE 88
Query: 90  -----------------GALFKEVTV--------------ATVKALNYLKEELKIIHRDV 118
                            G LF E+                     + Y+ +   I+HRD+
Sbjct: 89  ILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKH-NIVHRDL 147
Query: 119 KPSNILLDRRGA---IKLCDFGISGQLVDSIAKTRDAGCRPYMAPE 161
           KP NILL+ +     IK+ DFG+S     +       G   Y+APE
Sbjct: 148 KPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPE 193

>pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287

Iteration: 1
 Score = 47.0 bits (110), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 43/166 (25%), Positives = 71/166 (42%), Gaps = 38/166 (22%)
Query: 32  IGRGGFGTVNKMIHRSSDTVMAVKRI-RSTVDEKDQRQLLMDLDVVMKSNECPYIVQFY- 89
           +G+G FG V K   R +    AVK I +++   KD   +L +++++ K +  P I++ + 
Sbjct: 30  LGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDH-PNIMKLFE 88
Query: 90  -----------------GALFKEVTV--------------ATVKALNYLKEELKIIHRDV 118
                            G LF E+                     + Y+ +   I+HRD+
Sbjct: 89  ILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKH-NIVHRDL 147
Query: 119 KPSNILLDRRGA---IKLCDFGISGQLVDSIAKTRDAGCRPYMAPE 161
           KP NILL+ +     IK+ DFG+S     +       G   Y+APE
Sbjct: 148 KPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPE 193

>pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377

Iteration: 1
 Score = 47.0 bits (110), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 46/186 (24%), Positives = 77/186 (41%), Gaps = 38/186 (20%)
Query: 15  PDTVYDFTSEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLD 74
           P   +    EDL    +IGRG FG V     R+ +T++AVK  R T+    + + L +  
Sbjct: 105 PKDKWVLNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEAR 164
Query: 75  VVMKSNECPYIVQFYGALFKEVTVATVKA-------LNYLKEE---LKI----------- 113
            ++K    P IV+  G   ++  +  V         L +L+ E   L++           
Sbjct: 165 -ILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAA 223
Query: 114 -----------IHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTRDAGCRP----YM 158
                      IHRD+   N L+  +  +K+ DFG+S +  D +      G R     + 
Sbjct: 224 AGMEYLESKCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAA-SGGLRQVPVKWT 282
Query: 159 APERID 164
           APE ++
Sbjct: 283 APEALN 288

>pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361

Iteration: 1
 Score = 47.0 bits (110), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 41/162 (25%), Positives = 70/162 (43%), Gaps = 32/162 (19%)
Query: 31  EIGRGGFGTVNKMIHRSSDTVMAVKRIR--STVDEKDQRQLLMDL-----------DVVM 77
           +IG G FG    M  + S+ ++AVK I     +DE  +R+++              +V++
Sbjct: 25  DIGSGNFGVARLMRDKQSNELVAVKYIERGEKIDENVKREIINHRSLRHPNIVRFKEVIL 84
Query: 78  KSNECPYIVQFY--GALFKEVTVA--------------TVKALNYLKEELKIIHRDVKPS 121
                  ++++   G LF+ +  A               +  ++Y    +++ HRD+K  
Sbjct: 85  TPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYC-HAMQVCHRDLKLE 143
Query: 122 NILLDRRGA--IKLCDFGISGQLVDSIAKTRDAGCRPYMAPE 161
           N LLD   A  +K+CDFG S   V         G   Y+APE
Sbjct: 144 NTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPE 185

>pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486

Iteration: 1
 Score = 47.0 bits (110), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 44/165 (26%), Positives = 72/165 (43%), Gaps = 36/165 (21%)
Query: 32  IGRGGFGTVNKMIHRSSDTVMAVKRI-RSTVDEKDQRQLLMDLDV--------------V 76
           +G+G FG V K   R +    AVK I +++   KD   +L ++++              +
Sbjct: 30  LGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEI 89
Query: 77  MKSNECPYIV-QFY--GALFKEVTV--------------ATVKALNYLKEELKIIHRDVK 119
           ++ +   YIV + Y  G LF E+                     + Y+ +   I+HRD+K
Sbjct: 90  LEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKH-NIVHRDLK 148
Query: 120 PSNILLDRRGA---IKLCDFGISGQLVDSIAKTRDAGCRPYMAPE 161
           P NILL+ +     IK+ DFG+S     +       G   Y+APE
Sbjct: 149 PENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPE 193

>pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327

Iteration: 1
 Score = 47.0 bits (110), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 46/167 (27%), Positives = 63/167 (37%), Gaps = 37/167 (22%)
Query: 29  LGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQF 88
           L  IG+G F  V    H  +   +AVK I  T       Q L     + K    P IV+ 
Sbjct: 19  LKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIXKVLNHPNIVKL 78
Query: 89  YGALFKEVTV--------------------------------ATVKALNYLKEELKIIHR 116
           +  +  E T+                                  V A+ Y  ++  I+HR
Sbjct: 79  FEVIETEKTLYLVXEYASGGEVFDYLVAHGRXKEKEARAKFRQIVSAVQYCHQKF-IVHR 137
Query: 117 DVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTRDAGC--RPYMAPE 161
           D+K  N+LLD    IK+ DFG S +   +     DA C   PY APE
Sbjct: 138 DLKAENLLLDADXNIKIADFGFSNEF--TFGNKLDAFCGAPPYAAPE 182

>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276

Iteration: 1
 Score = 47.0 bits (110), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 25/72 (34%), Positives = 39/72 (54%), Gaps = 5/72 (6%)
Query: 92  LFKEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTRD 151
           LF+++    + A++Y    + ++HRD+KP N+LLD     K+ DFG+S  + D       
Sbjct: 116 LFQQI----LSAVDYCHRHM-VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTS 170
Query: 152 AGCRPYMAPERI 163
            G   Y APE I
Sbjct: 171 CGSPNYAAPEVI 182

>pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361

Iteration: 1
 Score = 47.0 bits (110), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 45/174 (25%), Positives = 74/174 (42%), Gaps = 39/174 (22%)
Query: 19  YDFTSEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIR--STVDEKDQRQLLMDL--- 73
           YDF       + +IG G FG    M  + +  ++AVK I   + +DE  QR+++      
Sbjct: 22  YDF-------VKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQREIINHRSLR 74
Query: 74  --------DVVMKSNECPYIVQFY--GALFKEVTVA--------------TVKALNYLKE 109
                   +V++       I+++   G L++ +  A               +  ++Y   
Sbjct: 75  HPNIVRFKEVILTPTHLAIIMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYC-H 133
Query: 110 ELKIIHRDVKPSNILLDRRGA--IKLCDFGISGQLVDSIAKTRDAGCRPYMAPE 161
            ++I HRD+K  N LLD   A  +K+CDFG S   V         G   Y+APE
Sbjct: 134 SMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPE 187

>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328

Iteration: 1
 Score = 46.6 bits (109), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 44/165 (26%), Positives = 62/165 (37%), Gaps = 33/165 (20%)
Query: 29  LGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQF 88
           L  IG+G F  V    H  +   +A+K I  T       Q L     +MK    P IV+ 
Sbjct: 17  LKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKL 76
Query: 89  YGALFKEVTV--------------------------------ATVKALNYLKEELKIIHR 116
           +  +  E T+                                  V A+ Y  ++ +I+HR
Sbjct: 77  FEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQK-RIVHR 135
Query: 117 DVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTRDAGCRPYMAPE 161
           D+K  N+LLD    IK+ DFG S +           G  PY APE
Sbjct: 136 DLKAENLLLDADMNIKIADFGFSNEFTVGGKLDTFCGSPPYAAPE 180

>pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342

Iteration: 1
 Score = 46.6 bits (109), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 37/148 (25%), Positives = 66/148 (44%), Gaps = 42/148 (28%)
Query: 31  EIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQFYG 90
           +IG G +    + IH++++   AVK I     +K +R    +++++++  + P I+    
Sbjct: 29  DIGVGSYSVCKRCIHKATNXEFAVKII-----DKSKRDPTEEIEILLRYGQHPNIITLKD 83
Query: 91  A---------------------------LFKEVTVATV-----KALNYLKEELKIIHRDV 118
                                        F E   + V     K + YL  +  ++HRD+
Sbjct: 84  VYDDGKYVYVVTELXKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQ-GVVHRDL 142
Query: 119 KPSNIL-LDRRG---AIKLCDFGISGQL 142
           KPSNIL +D  G   +I++CDFG + QL
Sbjct: 143 KPSNILYVDESGNPESIRICDFGFAKQL 170

>pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298

Iteration: 1
 Score = 46.6 bits (109), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 44/165 (26%), Positives = 72/165 (43%), Gaps = 35/165 (21%)
Query: 32  IGRGGFGTVNKMIHRSSDTVMAVKRI-RSTVDEKDQRQLLMDLDVVMKSNECPYIVQFY- 89
           +G+G FG V     + +    AVK I +  V +K  ++ L+    ++K  + P I++ Y 
Sbjct: 40  LGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYE 99
Query: 90  -----------------GALFKEVT----VATVKALNYLKEEL---------KIIHRDVK 119
                            G LF E+      + V A   +++ L         KI+HRD+K
Sbjct: 100 FFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNKIVHRDLK 159
Query: 120 PSNILLDRR---GAIKLCDFGISGQLVDSIAKTRDAGCRPYMAPE 161
           P N+LL+ +     I++ DFG+S     S       G   Y+APE
Sbjct: 160 PENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPE 204

>pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338

Iteration: 1
 Score = 46.6 bits (109), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 45/178 (25%), Positives = 75/178 (42%), Gaps = 41/178 (23%)
Query: 25  DLQDLGEIGRGGFGTVNKMIH----RSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSN 80
           +L+ +  +G G FGTV K I      +    +A+K +R     K  +++L D   VM   
Sbjct: 18  ELRKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEIL-DEAYVMAGV 76
Query: 81  ECPYIVQF-----------------YGALFKEV---------------TVATVKALNYLK 108
             PY+ +                  YG L   V                +   K ++YL 
Sbjct: 77  GSPYVSRLLGICLTSTVQLVTQLMPYGCLLDHVRENRGRLGSQDLLNWCMQIAKGMSYL- 135
Query: 109 EELKIIHRDVKPSNILLDRRGAIKLCDFGISGQL-VDSIAKTRDAGCRP--YMAPERI 163
           E+++++HRD+   N+L+     +K+ DFG++  L +D      D G  P  +MA E I
Sbjct: 136 EDVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESI 193

>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276

Iteration: 1
 Score = 46.6 bits (109), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 25/72 (34%), Positives = 39/72 (54%), Gaps = 5/72 (6%)
Query: 92  LFKEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTRD 151
           LF+++    + A++Y    + ++HRD+KP N+LLD     K+ DFG+S  + D       
Sbjct: 116 LFQQI----LSAVDYCHRHM-VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRDS 170
Query: 152 AGCRPYMAPERI 163
            G   Y APE I
Sbjct: 171 CGSPNYAAPEVI 182

>pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342

Iteration: 1
 Score = 46.2 bits (108), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 37/148 (25%), Positives = 66/148 (44%), Gaps = 42/148 (28%)
Query: 31  EIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQFYG 90
           +IG G +    + IH++++   AVK I     +K +R    +++++++  + P I+    
Sbjct: 29  DIGVGSYSVCKRCIHKATNMEFAVKII-----DKSKRDPTEEIEILLRYGQHPNIITLKD 83
Query: 91  A---------------------------LFKEVTVATV-----KALNYLKEELKIIHRDV 118
                                        F E   + V     K + YL  +  ++HRD+
Sbjct: 84  VYDDGKYVYVVTELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQ-GVVHRDL 142
Query: 119 KPSNIL-LDRRG---AIKLCDFGISGQL 142
           KPSNIL +D  G   +I++CDFG + QL
Sbjct: 143 KPSNILYVDESGNPESIRICDFGFAKQL 170

>pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484

Iteration: 1
 Score = 46.2 bits (108), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 44/165 (26%), Positives = 72/165 (43%), Gaps = 35/165 (21%)
Query: 32  IGRGGFGTVNKMIHRSSDTVMAVKRI-RSTVDEKDQRQLLMDLDVVMKSNECPYIVQFY- 89
           +G+G FG V     + +    AVK I +  V +K  ++ L+    ++K  + P I++ Y 
Sbjct: 34  LGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYE 93
Query: 90  -----------------GALFKEVT----VATVKALNYLKEEL---------KIIHRDVK 119
                            G LF E+      + V A   +++ L         KI+HRD+K
Sbjct: 94  FFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNKIVHRDLK 153
Query: 120 PSNILLDRR---GAIKLCDFGISGQLVDSIAKTRDAGCRPYMAPE 161
           P N+LL+ +     I++ DFG+S     S       G   Y+APE
Sbjct: 154 PENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPE 198

>pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398

Iteration: 1
 Score = 46.2 bits (108), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 39/125 (31%), Positives = 62/125 (49%), Gaps = 9/125 (7%)
Query: 45  HRSSDTVMAVKRI-RSTVDEKDQRQLLMDLDVVMKSNECPYIVQFYGALFKEVTVATVKA 103
           H   D ++A+K I R TV   + + + + LD+ M+S+    I        + V     + 
Sbjct: 109 HFKHDNIIAIKDILRPTVPYGEFKSVYVVLDL-MESDLHQIIHSSQPLTLEHVRYFLYQL 167
Query: 104 LNYLK--EELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAK-----TRDAGCRP 156
           L  LK     ++IHRD+KPSN+L++    +K+ DFG++  L  S A+     T     R 
Sbjct: 168 LRGLKYMHSAQVIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEYVATRW 227
Query: 157 YMAPE 161
           Y APE
Sbjct: 228 YRAPE 232

>pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442

Iteration: 1
 Score = 46.2 bits (108), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 39/125 (31%), Positives = 62/125 (49%), Gaps = 9/125 (7%)
Query: 45  HRSSDTVMAVKRI-RSTVDEKDQRQLLMDLDVVMKSNECPYIVQFYGALFKEVTVATVKA 103
           H   D ++A+K I R TV   + + + + LD+ M+S+    I        + V     + 
Sbjct: 110 HFKHDNIIAIKDILRPTVPYGEFKSVYVVLDL-MESDLHQIIHSSQPLTLEHVRYFLYQL 168
Query: 104 LNYLK--EELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAK-----TRDAGCRP 156
           L  LK     ++IHRD+KPSN+L++    +K+ DFG++  L  S A+     T     R 
Sbjct: 169 LRGLKYMHSAQVIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEYVATRW 228
Query: 157 YMAPE 161
           Y APE
Sbjct: 229 YRAPE 233

>pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382

Iteration: 1
 Score = 46.2 bits (108), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 52/169 (30%), Positives = 74/169 (43%), Gaps = 41/169 (24%)
Query: 32  IGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECP---YIVQF 88
           IG+G FG V K   R     +A+K I++     +Q Q+ + L  +M  ++     YIV  
Sbjct: 62  IGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTEMKYYIVHL 121
Query: 89  ---------------------YGAL----FKEVTVATVK--------ALNYLKE-ELKII 114
                                Y  L    F+ V++   +        AL +L   EL II
Sbjct: 122 KRHFMFRNHLCLVFEMLSYNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSII 181
Query: 115 HRDVKPSNILL--DRRGAIKLCDFGISGQLVDSIAKTRDAGCRPYMAPE 161
           H D+KP NILL   +R AIK+ DFG S QL   I +   +  R Y +PE
Sbjct: 182 HCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQXIQS--RFYRSPE 228

>pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283

Iteration: 1
 Score = 46.2 bits (108), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 47/191 (24%), Positives = 77/191 (40%), Gaps = 40/191 (20%)
Query: 19  YDFTSEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMK 78
           ++   +DL  L E+G G FG V     R    V A+K I+     +D+    ++   VM 
Sbjct: 19  WEIDPKDLTFLKELGTGQFGVVKYGKWRGQYDV-AIKMIKEGSMSEDE---FIEEAKVMM 74
Query: 79  SNECPYIVQFYGALFKEVTVATVKA-------LNYLK----------------------- 108
           +     +VQ YG   K+  +  +         LNYL+                       
Sbjct: 75  NLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAME 134
Query: 109 --EELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPL 166
             E  + +HRD+   N L++ +G +K+ DFG+S  ++D   +T   G +    P R  P 
Sbjct: 135 YLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDD-EETSSVGSK---FPVRWSPP 190
Query: 167 RARGYPSFKTK 177
               Y  F +K
Sbjct: 191 EVLMYSKFSSK 201

>pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337

Iteration: 1
 Score = 46.2 bits (108), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 27/80 (33%), Positives = 43/80 (53%), Gaps = 9/80 (11%)
Query: 86  VQFYGALFKEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDS 145
            +FYGA         V AL YL     +++RD+K  N++LD+ G IK+ DFG+  + +  
Sbjct: 107 ARFYGA-------EIVSALEYLHSR-DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD 158
Query: 146 IAKTRD-AGCRPYMAPERID 164
            A  +   G   Y+APE ++
Sbjct: 159 GATMKXFCGTPEYLAPEVLE 178

>pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315

Iteration: 1
 Score = 46.2 bits (108), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 27/80 (33%), Positives = 43/80 (53%), Gaps = 9/80 (11%)
Query: 86  VQFYGALFKEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDS 145
            +FYGA         V AL YL     +++RD+K  N++LD+ G IK+ DFG+  + +  
Sbjct: 107 ARFYGA-------EIVSALEYLHSR-DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD 158
Query: 146 IAKTRD-AGCRPYMAPERID 164
            A  +   G   Y+APE ++
Sbjct: 159 GATMKTFCGTPEYLAPEVLE 178

>pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339

Iteration: 1
 Score = 46.2 bits (108), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 27/80 (33%), Positives = 43/80 (53%), Gaps = 9/80 (11%)
Query: 86  VQFYGALFKEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDS 145
            +FYGA         V AL YL     +++RD+K  N++LD+ G IK+ DFG+  + +  
Sbjct: 110 ARFYGA-------EIVSALEYLHSR-DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD 161
Query: 146 IAKTRD-AGCRPYMAPERID 164
            A  +   G   Y+APE ++
Sbjct: 162 GATMKTFCGTPEYLAPEVLE 181

>pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484

Iteration: 1
 Score = 46.2 bits (108), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 44/165 (26%), Positives = 71/165 (43%), Gaps = 35/165 (21%)
Query: 32  IGRGGFGTVNKMIHRSSDTVMAVKRI-RSTVDEKDQRQLLMDLDVVMKSNECPYIVQFY- 89
           +G+G FG V     + +    AVK I +  V +K  ++ L+    ++K  + P I + Y 
Sbjct: 34  LGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIXKLYE 93
Query: 90  -----------------GALFKEVT----VATVKALNYLKEEL---------KIIHRDVK 119
                            G LF E+      + V A   +++ L         KI+HRD+K
Sbjct: 94  FFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYXHKNKIVHRDLK 153
Query: 120 PSNILLDRR---GAIKLCDFGISGQLVDSIAKTRDAGCRPYMAPE 161
           P N+LL+ +     I++ DFG+S     S       G   Y+APE
Sbjct: 154 PENLLLESKSKDANIRIIDFGLSTHFEASKKXKDKIGTAYYIAPE 198

>pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507

Iteration: 1
 Score = 46.2 bits (108), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 44/165 (26%), Positives = 72/165 (43%), Gaps = 35/165 (21%)
Query: 32  IGRGGFGTVNKMIHRSSDTVMAVKRI-RSTVDEKDQRQLLMDLDVVMKSNECPYIVQFY- 89
           +G+G FG V     + +    AVK I +  V +K  ++ L+    ++K  + P I++ Y 
Sbjct: 57  LGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYE 116
Query: 90  -----------------GALFKEVT----VATVKALNYLKEEL---------KIIHRDVK 119
                            G LF E+      + V A   +++ L         KI+HRD+K
Sbjct: 117 FFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNKIVHRDLK 176
Query: 120 PSNILLDRR---GAIKLCDFGISGQLVDSIAKTRDAGCRPYMAPE 161
           P N+LL+ +     I++ DFG+S     S       G   Y+APE
Sbjct: 177 PENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPE 221

>pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335

Iteration: 1
 Score = 46.2 bits (108), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 27/80 (33%), Positives = 43/80 (53%), Gaps = 9/80 (11%)
Query: 86  VQFYGALFKEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDS 145
            +FYGA         V AL YL     +++RD+K  N++LD+ G IK+ DFG+  + +  
Sbjct: 107 ARFYGA-------EIVSALEYLHSR-DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD 158
Query: 146 IAKTRD-AGCRPYMAPERID 164
            A  +   G   Y+APE ++
Sbjct: 159 GATMKTFCGTPEYLAPEVLE 178

>pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368

Iteration: 1
 Score = 46.2 bits (108), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 52/169 (30%), Positives = 74/169 (43%), Gaps = 41/169 (24%)
Query: 32  IGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECP---YIVQF 88
           IG+G FG V K   R     +A+K I++     +Q Q+ + L  +M  ++     YIV  
Sbjct: 43  IGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTEMKYYIVHL 102
Query: 89  ---------------------YGAL----FKEVTVATVK--------ALNYLKE-ELKII 114
                                Y  L    F+ V++   +        AL +L   EL II
Sbjct: 103 KRHFMFRNHLCLVFEMLSYNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSII 162
Query: 115 HRDVKPSNILL--DRRGAIKLCDFGISGQLVDSIAKTRDAGCRPYMAPE 161
           H D+KP NILL   +R AIK+ DFG S QL   I +   +  R Y +PE
Sbjct: 163 HCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQXIQS--RFYRSPE 209

>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328

Iteration: 1
 Score = 46.2 bits (108), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 44/162 (27%), Positives = 60/162 (37%), Gaps = 33/162 (20%)
Query: 32  IGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQFYGA 91
           IG+G F  V    H  +   +AVK I  T       Q L     +MK    P IV+ +  
Sbjct: 23  IGKGNFAKVKLARHVLTGREVAVKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEV 82
Query: 92  LFKEVTV--------------------------------ATVKALNYLKEELKIIHRDVK 119
           +  E T+                                  V A+ Y  ++  I+HRD+K
Sbjct: 83  IETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYCHQKY-IVHRDLK 141
Query: 120 PSNILLDRRGAIKLCDFGISGQLVDSIAKTRDAGCRPYMAPE 161
             N+LLD    IK+ DFG S +           G  PY APE
Sbjct: 142 AENLLLDGDMNIKIADFGFSNEFTVGNKLDTFCGSPPYAAPE 183

>pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273

Iteration: 1
 Score = 46.2 bits (108), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 29/68 (42%), Positives = 36/68 (52%), Gaps = 2/68 (2%)
Query: 113 IIHRDVKPSNILLD-RRGAIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPLRARGY 171
           ++HRD+K  NIL+D  RG +KL DFG SG L+     T   G R Y  PE I   R  G 
Sbjct: 131 VLHRDIKDENILIDLNRGELKLIDFG-SGALLKDTVYTDFDGTRVYSPPEWIRYHRYHGR 189
Query: 172 PSFKTKLG 179
            +    LG
Sbjct: 190 SAAVWSLG 197

>pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342

Iteration: 1
 Score = 46.2 bits (108), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 27/80 (33%), Positives = 43/80 (53%), Gaps = 9/80 (11%)
Query: 86  VQFYGALFKEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDS 145
            +FYGA         V AL YL     +++RD+K  N++LD+ G IK+ DFG+  + +  
Sbjct: 112 ARFYGA-------EIVSALEYLHSR-DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD 163
Query: 146 IAKTRD-AGCRPYMAPERID 164
            A  +   G   Y+APE ++
Sbjct: 164 GATMKXFCGTPEYLAPEVLE 183

>pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371

Iteration: 1
 Score = 46.2 bits (108), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 50/170 (29%), Positives = 72/170 (42%), Gaps = 45/170 (26%)
Query: 32  IGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQFYGA 91
           +GRG FG V++M  + +    AVK++R  V   ++      L         P IV  YGA
Sbjct: 101 LGRGSFGEVHRMEDKQTGFQCAVKKVRLEVFRAEELMACAGLTS-------PRIVPLYGA 153
Query: 92  --------LFKEV--------------TVATVKALNYLKEEL---------KIIHRDVKP 120
                   +F E+               +   +AL YL + L         +I+H DVK 
Sbjct: 154 VREGPWVNIFMELLEGGSLGQLVKEQGCLPEDRALYYLGQALEGLEYLHSRRILHGDVKA 213
Query: 121 SNILLDRRGA-IKLCDFGISGQL-VDSIAK---TRD--AGCRPYMAPERI 163
            N+LL   G+   LCDFG +  L  D + K   T D   G   +MAPE +
Sbjct: 214 DNVLLSSDGSHAALCDFGHAVCLQPDGLGKSLLTGDYIPGTETHMAPEVV 263

>pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508

Iteration: 1
 Score = 46.2 bits (108), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 44/165 (26%), Positives = 72/165 (43%), Gaps = 35/165 (21%)
Query: 32  IGRGGFGTVNKMIHRSSDTVMAVKRI-RSTVDEKDQRQLLMDLDVVMKSNECPYIVQFY- 89
           +G+G FG V     + +    AVK I +  V +K  ++ L+    ++K  + P I++ Y 
Sbjct: 58  LGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYE 117
Query: 90  -----------------GALFKEVT----VATVKALNYLKEEL---------KIIHRDVK 119
                            G LF E+      + V A   +++ L         KI+HRD+K
Sbjct: 118 FFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNKIVHRDLK 177
Query: 120 PSNILLDRR---GAIKLCDFGISGQLVDSIAKTRDAGCRPYMAPE 161
           P N+LL+ +     I++ DFG+S     S       G   Y+APE
Sbjct: 178 PENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPE 222

>pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293

Iteration: 1
 Score = 45.8 bits (107), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 48/185 (25%), Positives = 77/185 (41%), Gaps = 43/185 (23%)
Query: 19  YDFTSEDLQDLGEIGRGGFGTVNKMI---HRSSDTVMAVKRIR--STVDEKDQRQLLMDL 73
           Y    ED+     +G G FG V + +   H+     +AVK  +   T+D K++    M  
Sbjct: 19  YGIAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEK---FMSE 75
Query: 74  DVVMKSNECPYIVQFYGALFKEVT--------------------------------VATV 101
            V+MK+ + P+IV+  G + +E T                                +   
Sbjct: 76  AVIMKNLDHPHIVKLIGIIEEEPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQIC 135
Query: 102 KALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTRDAGCRP--YMA 159
           KA+ YL E +  +HRD+   NIL+     +KL DFG+S  + D           P  +M+
Sbjct: 136 KAMAYL-ESINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMS 194
Query: 160 PERID 164
           PE I+
Sbjct: 195 PESIN 199

>pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336

Iteration: 1
 Score = 45.8 bits (107), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 27/80 (33%), Positives = 43/80 (53%), Gaps = 9/80 (11%)
Query: 86  VQFYGALFKEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDS 145
            +FYGA         V AL YL     +++RD+K  N++LD+ G IK+ DFG+  + +  
Sbjct: 107 ARFYGA-------EIVSALEYLHSR-DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD 158
Query: 146 IAKTRD-AGCRPYMAPERID 164
            A  +   G   Y+APE ++
Sbjct: 159 GATMKXFCGTPEYLAPEVLE 178

>pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335

Iteration: 1
 Score = 45.8 bits (107), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 27/80 (33%), Positives = 43/80 (53%), Gaps = 9/80 (11%)
Query: 86  VQFYGALFKEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDS 145
            +FYGA         V AL YL     +++RD+K  N++LD+ G IK+ DFG+  + +  
Sbjct: 107 ARFYGA-------EIVSALEYLHSR-DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD 158
Query: 146 IAKTRD-AGCRPYMAPERID 164
            A  +   G   Y+APE ++
Sbjct: 159 GATMKXFCGTPEYLAPEVLE 178

>pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276

Iteration: 1
 Score = 45.8 bits (107), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 29/68 (42%), Positives = 36/68 (52%), Gaps = 2/68 (2%)
Query: 113 IIHRDVKPSNILLD-RRGAIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPLRARGY 171
           ++HRD+K  NIL+D  RG +KL DFG SG L+     T   G R Y  PE I   R  G 
Sbjct: 134 VLHRDIKDENILIDLNRGELKLIDFG-SGALLKDTVYTDFDGTRVYSPPEWIRYHRYHGR 192
Query: 172 PSFKTKLG 179
            +    LG
Sbjct: 193 SAAVWSLG 200

>pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273

Iteration: 1
 Score = 45.8 bits (107), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 29/68 (42%), Positives = 36/68 (52%), Gaps = 2/68 (2%)
Query: 113 IIHRDVKPSNILLD-RRGAIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPLRARGY 171
           ++HRD+K  NIL+D  RG +KL DFG SG L+     T   G R Y  PE I   R  G 
Sbjct: 131 VLHRDIKDENILIDLNRGELKLIDFG-SGALLKDTVYTDFDGTRVYSPPEWIRYHRYHGR 189
Query: 172 PSFKTKLG 179
            +    LG
Sbjct: 190 SAAVWSLG 197

>pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273

Iteration: 1
 Score = 45.8 bits (107), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 29/68 (42%), Positives = 36/68 (52%), Gaps = 2/68 (2%)
Query: 113 IIHRDVKPSNILLD-RRGAIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPLRARGY 171
           ++HRD+K  NIL+D  RG +KL DFG SG L+     T   G R Y  PE I   R  G 
Sbjct: 131 VLHRDIKDENILIDLNRGELKLIDFG-SGALLKDTVYTDFDGTRVYSPPEWIRYHRYHGR 189
Query: 172 PSFKTKLG 179
            +    LG
Sbjct: 190 SAAVWSLG 197

>pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293

Iteration: 1
 Score = 45.8 bits (107), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 29/68 (42%), Positives = 36/68 (52%), Gaps = 2/68 (2%)
Query: 113 IIHRDVKPSNILLD-RRGAIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPLRARGY 171
           ++HRD+K  NIL+D  RG +KL DFG SG L+     T   G R Y  PE I   R  G 
Sbjct: 135 VLHRDIKDENILIDLNRGELKLIDFG-SGALLKDTVYTDFDGTRVYSPPEWIRYHRYHGR 193
Query: 172 PSFKTKLG 179
            +    LG
Sbjct: 194 SAAVWSLG 201

>pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277

Iteration: 1
 Score = 45.8 bits (107), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 48/185 (25%), Positives = 77/185 (41%), Gaps = 43/185 (23%)
Query: 19  YDFTSEDLQDLGEIGRGGFGTVNKMI---HRSSDTVMAVKRIR--STVDEKDQRQLLMDL 73
           Y    ED+     +G G FG V + +   H+     +AVK  +   T+D K++    M  
Sbjct: 3   YGIAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEK---FMSE 59
Query: 74  DVVMKSNECPYIVQFYGALFKEVT--------------------------------VATV 101
            V+MK+ + P+IV+  G + +E T                                +   
Sbjct: 60  AVIMKNLDHPHIVKLIGIIEEEPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQIC 119
Query: 102 KALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTRDAGCRP--YMA 159
           KA+ YL E +  +HRD+   NIL+     +KL DFG+S  + D           P  +M+
Sbjct: 120 KAMAYL-ESINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMS 178
Query: 160 PERID 164
           PE I+
Sbjct: 179 PESIN 183

>pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356

Iteration: 1
 Score = 45.8 bits (107), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 50/170 (29%), Positives = 72/170 (42%), Gaps = 45/170 (26%)
Query: 32  IGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQFYGA 91
           +GRG FG V++M  + +    AVK++R  V   ++      L         P IV  YGA
Sbjct: 82  LGRGSFGEVHRMEDKQTGFQCAVKKVRLEVFRAEELMACAGLTS-------PRIVPLYGA 134
Query: 92  --------LFKEV--------------TVATVKALNYLKEEL---------KIIHRDVKP 120
                   +F E+               +   +AL YL + L         +I+H DVK 
Sbjct: 135 VREGPWVNIFMELLEGGSLGQLVKEQGCLPEDRALYYLGQALEGLEYLHSRRILHGDVKA 194
Query: 121 SNILLDRRGA-IKLCDFGISGQL-VDSIAK---TRD--AGCRPYMAPERI 163
            N+LL   G+   LCDFG +  L  D + K   T D   G   +MAPE +
Sbjct: 195 DNVLLSSDGSHAALCDFGHAVCLQPDGLGKDLLTGDYIPGTETHMAPEVV 244

>pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281

Iteration: 1
 Score = 45.8 bits (107), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 48/185 (25%), Positives = 77/185 (41%), Gaps = 43/185 (23%)
Query: 19  YDFTSEDLQDLGEIGRGGFGTVNKMI---HRSSDTVMAVKRIR--STVDEKDQRQLLMDL 73
           Y    ED+     +G G FG V + +   H+     +AVK  +   T+D K++    M  
Sbjct: 7   YGIAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEK---FMSE 63
Query: 74  DVVMKSNECPYIVQFYGALFKEVT--------------------------------VATV 101
            V+MK+ + P+IV+  G + +E T                                +   
Sbjct: 64  AVIMKNLDHPHIVKLIGIIEEEPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQIC 123
Query: 102 KALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTRDAGCRP--YMA 159
           KA+ YL E +  +HRD+   NIL+     +KL DFG+S  + D           P  +M+
Sbjct: 124 KAMAYL-ESINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMS 182
Query: 160 PERID 164
           PE I+
Sbjct: 183 PESIN 187

>pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353

Iteration: 1
 Score = 45.8 bits (107), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 41/173 (23%), Positives = 70/173 (40%), Gaps = 34/173 (19%)
Query: 25  DLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTV--DEKDQRQLLMDLDVVMKSNEC 82
           D   L  +G+G FG V     + +D + AVK ++  V   + D    +++  V+    + 
Sbjct: 21  DFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKP 80
Query: 83  PYIVQFYGAL---------------------------FKE----VTVATVKALNYLKEEL 111
           P++ Q +                              FKE       A +    +  +  
Sbjct: 81  PFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSK 140
Query: 112 KIIHRDVKPSNILLDRRGAIKLCDFGISGQ-LVDSIAKTRDAGCRPYMAPERI 163
            II+RD+K  N++LD  G IK+ DFG+  + + D +      G   Y+APE I
Sbjct: 141 GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKXFCGTPDYIAPEII 193

>pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349

Iteration: 1
 Score = 45.8 bits (107), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 44/173 (25%), Positives = 73/173 (42%), Gaps = 36/173 (20%)
Query: 24  EDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTV--DEKDQRQLLMDLDVVMKSNE 81
           +D   L  IGRG +  V  +  + +D + A+K ++  +  D++D   +  +  V  +++ 
Sbjct: 5   QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASN 64
Query: 82  CPYIVQFYGALFKEVTVATV--------------------------------KALNYLKE 109
            P++V  +     E  +  V                                 ALNYL E
Sbjct: 65  HPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHE 124
Query: 110 ELKIIHRDVKPSNILLDRRGAIKLCDFGISGQ-LVDSIAKTRDAGCRPYMAPE 161
              II+RD+K  N+LLD  G IKL D+G+  + L      +   G   Y+APE
Sbjct: 125 R-GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSXFCGTPNYIAPE 176

>pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293

Iteration: 1
 Score = 45.8 bits (107), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 29/68 (42%), Positives = 36/68 (52%), Gaps = 2/68 (2%)
Query: 113 IIHRDVKPSNILLD-RRGAIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPLRARGY 171
           ++HRD+K  NIL+D  RG +KL DFG SG L+     T   G R Y  PE I   R  G 
Sbjct: 135 VLHRDIKDENILIDLNRGELKLIDFG-SGALLKDTVYTDFDGTRVYSPPEWIRYHRYHGR 193
Query: 172 PSFKTKLG 179
            +    LG
Sbjct: 194 SAAVWSLG 201

>pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294

Iteration: 1
 Score = 45.8 bits (107), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 29/68 (42%), Positives = 36/68 (52%), Gaps = 2/68 (2%)
Query: 113 IIHRDVKPSNILLD-RRGAIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPLRARGY 171
           ++HRD+K  NIL+D  RG +KL DFG SG L+     T   G R Y  PE I   R  G 
Sbjct: 136 VLHRDIKDENILIDLNRGELKLIDFG-SGALLKDTVYTDFDGTRVYSPPEWIRYHRYHGR 194
Query: 172 PSFKTKLG 179
            +    LG
Sbjct: 195 SAAVWSLG 202

>pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298

Iteration: 1
 Score = 45.8 bits (107), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 29/68 (42%), Positives = 36/68 (52%), Gaps = 2/68 (2%)
Query: 113 IIHRDVKPSNILLD-RRGAIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPLRARGY 171
           ++HRD+K  NIL+D  RG +KL DFG SG L+     T   G R Y  PE I   R  G 
Sbjct: 136 VLHRDIKDENILIDLNRGELKLIDFG-SGALLKDTVYTDFDGTRVYSPPEWIRYHRYHGR 194
Query: 172 PSFKTKLG 179
            +    LG
Sbjct: 195 SAAVWSLG 202

>pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308

Iteration: 1
 Score = 45.8 bits (107), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 29/68 (42%), Positives = 36/68 (52%), Gaps = 2/68 (2%)
Query: 113 IIHRDVKPSNILLD-RRGAIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPLRARGY 171
           ++HRD+K  NIL+D  RG +KL DFG SG L+     T   G R Y  PE I   R  G 
Sbjct: 158 VLHRDIKDENILIDLNRGELKLIDFG-SGALLKDTVYTDFDGTRVYSPPEWIRYHRYHGR 216
Query: 172 PSFKTKLG 179
            +    LG
Sbjct: 217 SAAVWSLG 224

>pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41 Length = 382

Iteration: 1
 Score = 45.8 bits (107), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 52/169 (30%), Positives = 74/169 (43%), Gaps = 41/169 (24%)
Query: 32  IGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECP---YIVQF 88
           IG+G FG V K   R     +A+K I++     +Q Q+ + L  +M  ++     YIV  
Sbjct: 62  IGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTEMKYYIVHL 121
Query: 89  ---------------------YGAL----FKEVTVATVK--------ALNYLKE-ELKII 114
                                Y  L    F+ V++   +        AL +L   EL II
Sbjct: 122 KRHFMFRNHLCLVFEMLSYNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSII 181
Query: 115 HRDVKPSNILL--DRRGAIKLCDFGISGQLVDSIAKTRDAGCRPYMAPE 161
           H D+KP NILL   +R AIK+ DFG S QL   I +   +  R Y +PE
Sbjct: 182 HCDLKPENILLCNPKRXAIKIVDFGSSCQLGQRIYQXIQS--RFYRSPE 228

>pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345

Iteration: 1
 Score = 45.8 bits (107), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 44/173 (25%), Positives = 73/173 (42%), Gaps = 36/173 (20%)
Query: 24  EDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTV--DEKDQRQLLMDLDVVMKSNE 81
           +D   L  IGRG +  V  +  + +D + A+K ++  +  D++D   +  +  V  +++ 
Sbjct: 9   QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASN 68
Query: 82  CPYIVQFYGALFKEVTVATV--------------------------------KALNYLKE 109
            P++V  +     E  +  V                                 ALNYL E
Sbjct: 69  HPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHE 128
Query: 110 ELKIIHRDVKPSNILLDRRGAIKLCDFGISGQ-LVDSIAKTRDAGCRPYMAPE 161
              II+RD+K  N+LLD  G IKL D+G+  + L      +   G   Y+APE
Sbjct: 129 R-GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSXFCGTPNYIAPE 180

>pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299

Iteration: 1
 Score = 45.8 bits (107), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 29/68 (42%), Positives = 36/68 (52%), Gaps = 2/68 (2%)
Query: 113 IIHRDVKPSNILLD-RRGAIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPLRARGY 171
           ++HRD+K  NIL+D  RG +KL DFG SG L+     T   G R Y  PE I   R  G 
Sbjct: 136 VLHRDIKDENILIDLNRGELKLIDFG-SGALLKDTVYTDFDGTRVYSPPEWIRYHRYHGR 194
Query: 172 PSFKTKLG 179
            +    LG
Sbjct: 195 SAAVWSLG 202

>pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307

Iteration: 1
 Score = 45.4 bits (106), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 24/68 (35%), Positives = 38/68 (55%), Gaps = 1/68 (1%)
Query: 94  KEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTRDAG 153
           K++    ++ L++L    +++HRD+KP NIL+   G IKL DFG++      +A T    
Sbjct: 123 KDMMFQLLRGLDFLHSH-RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVV 181
Query: 154 CRPYMAPE 161
              Y APE
Sbjct: 182 TLWYRAPE 189

>pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364

Iteration: 1
 Score = 45.4 bits (106), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 44/173 (25%), Positives = 73/173 (42%), Gaps = 36/173 (20%)
Query: 24  EDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTV--DEKDQRQLLMDLDVVMKSNE 81
           +D   L  IGRG +  V  +  + +D + A+K ++  +  D++D   +  +  V  +++ 
Sbjct: 20  QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASN 79
Query: 82  CPYIVQFYGALFKEVTVATV--------------------------------KALNYLKE 109
            P++V  +     E  +  V                                 ALNYL E
Sbjct: 80  HPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHE 139
Query: 110 ELKIIHRDVKPSNILLDRRGAIKLCDFGISGQ-LVDSIAKTRDAGCRPYMAPE 161
              II+RD+K  N+LLD  G IKL D+G+  + L      +   G   Y+APE
Sbjct: 140 R-GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSXFCGTPNYIAPE 191

>pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score = 45.4 bits (106), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 29/68 (42%), Positives = 36/68 (52%), Gaps = 2/68 (2%)
Query: 113 IIHRDVKPSNILLD-RRGAIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPLRARGY 171
           ++HRD+K  NIL+D  RG +KL DFG SG L+     T   G R Y  PE I   R  G 
Sbjct: 178 VLHRDIKDENILIDLNRGELKLIDFG-SGALLKDTVYTDFDGTRVYSPPEWIRYHRYHGR 236
Query: 172 PSFKTKLG 179
            +    LG
Sbjct: 237 SAAVWSLG 244

>pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score = 45.4 bits (106), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 29/68 (42%), Positives = 36/68 (52%), Gaps = 2/68 (2%)
Query: 113 IIHRDVKPSNILLD-RRGAIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPLRARGY 171
           ++HRD+K  NIL+D  RG +KL DFG SG L+     T   G R Y  PE I   R  G 
Sbjct: 178 VLHRDIKDENILIDLNRGELKLIDFG-SGALLKDTVYTDFDGTRVYSPPEWIRYHRYHGR 236
Query: 172 PSFKTKLG 179
            +    LG
Sbjct: 237 SAAVWSLG 244

>pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313

Iteration: 1
 Score = 45.4 bits (106), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 29/68 (42%), Positives = 36/68 (52%), Gaps = 2/68 (2%)
Query: 113 IIHRDVKPSNILLD-RRGAIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPLRARGY 171
           ++HRD+K  NIL+D  RG +KL DFG SG L+     T   G R Y  PE I   R  G 
Sbjct: 163 VLHRDIKDENILIDLNRGELKLIDFG-SGALLKDTVYTDFDGTRVYSPPEWIRYHRYHGR 221
Query: 172 PSFKTKLG 179
            +    LG
Sbjct: 222 SAAVWSLG 229

>pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314

Iteration: 1
 Score = 45.4 bits (106), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 29/68 (42%), Positives = 36/68 (52%), Gaps = 2/68 (2%)
Query: 113 IIHRDVKPSNILLD-RRGAIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPLRARGY 171
           ++HRD+K  NIL+D  RG +KL DFG SG L+     T   G R Y  PE I   R  G 
Sbjct: 164 VLHRDIKDENILIDLNRGELKLIDFG-SGALLKDTVYTDFDGTRVYSPPEWIRYHRYHGR 222
Query: 172 PSFKTKLG 179
            +    LG
Sbjct: 223 SAAVWSLG 230

>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476

Iteration: 1
 Score = 45.4 bits (106), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 44/173 (25%), Positives = 66/173 (38%), Gaps = 50/173 (28%)
Query: 32  IGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVV---------MKSNEC 82
           +G G FG V    H  +   +AVK +         RQ +  LDVV         +K    
Sbjct: 24  LGVGTFGKVKVGKHELTGHKVAVKIL--------NRQKIRSLDVVGKIRREIQNLKLFRH 75
Query: 83  PYIVQFY------------------GALF--------------KEVTVATVKALNYLKEE 110
           P+I++ Y                  G LF              + +    +  ++Y    
Sbjct: 76  PHIIKLYQVISTPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHRH 135
Query: 111 LKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERI 163
           + ++HRD+KP N+LLD     K+ DFG+S  + D        G   Y APE I
Sbjct: 136 M-VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRXSCGSPNYAAPEVI 187

>pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313

Iteration: 1
 Score = 45.4 bits (106), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 29/68 (42%), Positives = 36/68 (52%), Gaps = 2/68 (2%)
Query: 113 IIHRDVKPSNILLD-RRGAIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPLRARGY 171
           ++HRD+K  NIL+D  RG +KL DFG SG L+     T   G R Y  PE I   R  G 
Sbjct: 164 VLHRDIKDENILIDLNRGELKLIDFG-SGALLKDTVYTDFDGTRVYSPPEWIRYHRYHGR 222
Query: 172 PSFKTKLG 179
            +    LG
Sbjct: 223 SAAVWSLG 230

>pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313

Iteration: 1
 Score = 45.4 bits (106), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 29/68 (42%), Positives = 36/68 (52%), Gaps = 2/68 (2%)
Query: 113 IIHRDVKPSNILLD-RRGAIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPLRARGY 171
           ++HRD+K  NIL+D  RG +KL DFG SG L+     T   G R Y  PE I   R  G 
Sbjct: 163 VLHRDIKDENILIDLNRGELKLIDFG-SGALLKDTVYTDFDGTRVYSPPEWIRYHRYHGR 221
Query: 172 PSFKTKLG 179
            +    LG
Sbjct: 222 SAAVWSLG 229

>pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674

Iteration: 1
 Score = 45.4 bits (106), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 41/173 (23%), Positives = 70/173 (40%), Gaps = 34/173 (19%)
Query: 25  DLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTV--DEKDQRQLLMDLDVVMKSNEC 82
           D   L  +G+G FG V     + +D + AVK ++  V   + D    +++  V+    + 
Sbjct: 342 DFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKP 401
Query: 83  PYIVQFYGAL---------------------------FKE----VTVATVKALNYLKEEL 111
           P++ Q +                              FKE       A +    +  +  
Sbjct: 402 PFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSK 461
Query: 112 KIIHRDVKPSNILLDRRGAIKLCDFGISGQ-LVDSIAKTRDAGCRPYMAPERI 163
            II+RD+K  N++LD  G IK+ DFG+  + + D +      G   Y+APE I
Sbjct: 462 GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKXFCGTPDYIAPEII 514

>pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314

Iteration: 1
 Score = 45.4 bits (106), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 29/68 (42%), Positives = 36/68 (52%), Gaps = 2/68 (2%)
Query: 113 IIHRDVKPSNILLD-RRGAIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPLRARGY 171
           ++HRD+K  NIL+D  RG +KL DFG SG L+     T   G R Y  PE I   R  G 
Sbjct: 164 VLHRDIKDENILIDLNRGELKLIDFG-SGALLKDTVYTDFDGTRVYSPPEWIRYHRYHGR 222
Query: 172 PSFKTKLG 179
            +    LG
Sbjct: 223 SAAVWSLG 230

>pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336

Iteration: 1
 Score = 45.4 bits (106), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 50/170 (29%), Positives = 72/170 (42%), Gaps = 45/170 (26%)
Query: 32  IGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQFYGA 91
           +GRG FG V++M  + +    AVK++R  V   ++        V       P IV  YGA
Sbjct: 66  VGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFRVEEL-------VACAGLSSPRIVPLYGA 118
Query: 92  --------LFKEV--------------TVATVKALNYLKEEL---------KIIHRDVKP 120
                   +F E+               +   +AL YL + L         +I+H DVK 
Sbjct: 119 VREGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDVKA 178
Query: 121 SNILLDRRGA-IKLCDFGISGQL-VDSIAK---TRD--AGCRPYMAPERI 163
            N+LL   G+   LCDFG +  L  D + K   T D   G   +MAPE +
Sbjct: 179 DNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVV 228

>pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313

Iteration: 1
 Score = 45.4 bits (106), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 29/68 (42%), Positives = 36/68 (52%), Gaps = 2/68 (2%)
Query: 113 IIHRDVKPSNILLD-RRGAIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPLRARGY 171
           ++HRD+K  NIL+D  RG +KL DFG SG L+     T   G R Y  PE I   R  G 
Sbjct: 164 VLHRDIKDENILIDLNRGELKLIDFG-SGALLKDTVYTDFDGTRVYSPPEWIRYHRYHGR 222
Query: 172 PSFKTKLG 179
            +    LG
Sbjct: 223 SAAVWSLG 230

>pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312

Iteration: 1
 Score = 45.4 bits (106), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 29/68 (42%), Positives = 36/68 (52%), Gaps = 2/68 (2%)
Query: 113 IIHRDVKPSNILLD-RRGAIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPLRARGY 171
           ++HRD+K  NIL+D  RG +KL DFG SG L+     T   G R Y  PE I   R  G 
Sbjct: 163 VLHRDIKDENILIDLNRGELKLIDFG-SGALLKDTVYTDFDGTRVYSPPEWIRYHRYHGR 221
Query: 172 PSFKTKLG 179
            +    LG
Sbjct: 222 SAAVWSLG 229

>pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313

Iteration: 1
 Score = 45.4 bits (106), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 29/68 (42%), Positives = 36/68 (52%), Gaps = 2/68 (2%)
Query: 113 IIHRDVKPSNILLD-RRGAIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPLRARGY 171
           ++HRD+K  NIL+D  RG +KL DFG SG L+     T   G R Y  PE I   R  G 
Sbjct: 163 VLHRDIKDENILIDLNRGELKLIDFG-SGALLKDTVYTDFDGTRVYSPPEWIRYHRYHGR 221
Query: 172 PSFKTKLG 179
            +    LG
Sbjct: 222 SAAVWSLG 229

>pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352

Iteration: 1
 Score = 45.4 bits (106), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 50/170 (29%), Positives = 72/170 (42%), Gaps = 45/170 (26%)
Query: 32  IGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQFYGA 91
           +GRG FG V++M  + +    AVK++R  V   ++        V       P IV  YGA
Sbjct: 82  VGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFRVEEL-------VACAGLSSPRIVPLYGA 134
Query: 92  --------LFKEV--------------TVATVKALNYLKEEL---------KIIHRDVKP 120
                   +F E+               +   +AL YL + L         +I+H DVK 
Sbjct: 135 VREGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDVKA 194
Query: 121 SNILLDRRGA-IKLCDFGISGQL-VDSIAK---TRD--AGCRPYMAPERI 163
            N+LL   G+   LCDFG +  L  D + K   T D   G   +MAPE +
Sbjct: 195 DNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVV 244

>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350

Iteration: 1
 Score = 45.4 bits (106), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 50/192 (26%), Positives = 85/192 (44%), Gaps = 41/192 (21%)
Query: 7   SSGKLKLSPDTVYDFTSEDLQDLGEIGRGGFGTVNKMIHRSSD-------TVMAVKRIRS 59
           SSG + L  + +Y  + E    L +IG G FG    ++ +S++         + + R+ S
Sbjct: 8   SSG-VDLGTENLYFQSMEKYVRLQKIGEGSFGKA--ILVKSTEDGRQYVIKEINISRMSS 64
Query: 60  TVDEKDQRQLLMDLDV----------VMKSNECPYIVQFY---GALFKEVT--------- 97
              E+ +R++ +  ++            + N   YIV  Y   G LFK +          
Sbjct: 65  KEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQE 124
Query: 98  -------VATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTR 150
                  V    AL ++ +  KI+HRD+K  NI L + G ++L DFGI+  L  ++   R
Sbjct: 125 DQILDWFVQICLALKHVHDR-KILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELAR 183
Query: 151 DAGCRP-YMAPE 161
                P Y++PE
Sbjct: 184 ACIGTPYYLSPE 195

>pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337

Iteration: 1
 Score = 45.4 bits (106), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 45/169 (26%), Positives = 71/169 (42%), Gaps = 53/169 (31%)
Query: 20  DFTSEDLQDLGEI--------GRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLM 71
           DF  + + +LGE+          GGF  V +     S    A+KR+ S  +EK+ R ++ 
Sbjct: 17  DFVGQTV-ELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKN-RAIIQ 74
Query: 72  DLDVVMKSNECPYIVQFYGA----------------LFKE-------------------- 95
           ++  + K +  P IVQF  A                L  E                    
Sbjct: 75  EVCFMKKLSGHPNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLS 134
Query: 96  ------VTVATVKALNYL-KEELKIIHRDVKPSNILLDRRGAIKLCDFG 137
                 +   T +A+ ++ +++  IIHRD+K  N+LL  +G IKLCDFG
Sbjct: 135 CDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFG 183

>pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308

Iteration: 1
 Score = 45.4 bits (106), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 24/68 (35%), Positives = 38/68 (55%), Gaps = 1/68 (1%)
Query: 94  KEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTRDAG 153
           K++    ++ L++L    +++HRD+KP NIL+   G IKL DFG++      +A T    
Sbjct: 123 KDMMFQLLRGLDFLHSH-RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVV 181
Query: 154 CRPYMAPE 161
              Y APE
Sbjct: 182 TLWYRAPE 189

>pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273

Iteration: 1
 Score = 45.4 bits (106), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 44/176 (25%), Positives = 79/176 (44%), Gaps = 43/176 (24%)
Query: 24  EDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRI--RSTVD--EKDQRQLLMDLDVVMKS 79
           ED   +  +G G +G V   ++R ++  +AVK +  +  VD  E  ++++ ++    M +
Sbjct: 7   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICIN---AMLN 63
Query: 80  NECPYIVQFYGA--------LFKE--------------VTVATVKALNYLKEELK----- 112
           +E   +V+FYG         LF E              + +    A  +  + +      
Sbjct: 64  HE--NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYL 121
Query: 113 ----IIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAK---TRDAGCRPYMAPE 161
               I HRD+KP N+LLD R  +K+ DFG++     +  +    +  G  PY+APE
Sbjct: 122 HGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPE 177

>pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328

Iteration: 1
 Score = 45.4 bits (106), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 29/68 (42%), Positives = 36/68 (52%), Gaps = 2/68 (2%)
Query: 113 IIHRDVKPSNILLD-RRGAIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPLRARGY 171
           ++HRD+K  NIL+D  RG +KL DFG SG L+     T   G R Y  PE I   R  G 
Sbjct: 178 VLHRDIKDENILIDLNRGELKLIDFG-SGALLKDTVYTDFDGTRVYSPPEWIRYHRYHGR 236
Query: 172 PSFKTKLG 179
            +    LG
Sbjct: 237 SAAVWSLG 244

>pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271

Iteration: 1
 Score = 45.4 bits (106), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 47/191 (24%), Positives = 76/191 (39%), Gaps = 40/191 (20%)
Query: 19  YDFTSEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMK 78
           ++   +DL  L E+G G FG V     R    V A+K I+     +D+    ++   VM 
Sbjct: 4   WEIDPKDLTFLKELGTGQFGVVKYGKWRGQYDV-AIKMIKEGSMSEDE---FIEEAKVMM 59
Query: 79  SNECPYIVQFYGALFKEVTVATVKA-------LNYLK----------------------- 108
           +     +VQ YG   K+  +  +         LNYL+                       
Sbjct: 60  NLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAME 119
Query: 109 --EELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPL 166
             E  + +HRD+   N L++ +G +K+ DFG+S  ++D    T   G +    P R  P 
Sbjct: 120 YLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDD-EYTSSVGSK---FPVRWSPP 175
Query: 167 RARGYPSFKTK 177
               Y  F +K
Sbjct: 176 EVLMYSKFSSK 186

>pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300

Iteration: 1
 Score = 45.4 bits (106), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 29/68 (42%), Positives = 36/68 (52%), Gaps = 2/68 (2%)
Query: 113 IIHRDVKPSNILLD-RRGAIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPLRARGY 171
           ++HRD+K  NIL+D  RG +KL DFG SG L+     T   G R Y  PE I   R  G 
Sbjct: 150 VLHRDIKDENILIDLNRGELKLIDFG-SGALLKDTVYTDFDGTRVYSPPEWIRYHRYHGR 208
Query: 172 PSFKTKLG 179
            +    LG
Sbjct: 209 SAAVWSLG 216

>pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 45.4 bits (106), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 29/68 (42%), Positives = 36/68 (52%), Gaps = 2/68 (2%)
Query: 113 IIHRDVKPSNILLD-RRGAIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPLRARGY 171
           ++HRD+K  NIL+D  RG +KL DFG SG L+     T   G R Y  PE I   R  G 
Sbjct: 151 VLHRDIKDENILIDLNRGELKLIDFG-SGALLKDTVYTDFDGTRVYSPPEWIRYHRYHGR 209
Query: 172 PSFKTKLG 179
            +    LG
Sbjct: 210 SAAVWSLG 217

>pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326

Iteration: 1
 Score = 45.4 bits (106), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 24/68 (35%), Positives = 38/68 (55%), Gaps = 1/68 (1%)
Query: 94  KEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTRDAG 153
           K++    ++ L++L    +++HRD+KP NIL+   G IKL DFG++      +A T    
Sbjct: 123 KDMMFQLLRGLDFLHSH-RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVV 181
Query: 154 CRPYMAPE 161
              Y APE
Sbjct: 182 TLWYRAPE 189

>pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336

Iteration: 1
 Score = 45.4 bits (106), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 43/181 (23%), Positives = 79/181 (43%), Gaps = 39/181 (21%)
Query: 23  SEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNEC 82
           ++D Q   E+G+G F  V + + ++     A K I +        Q L     + +  + 
Sbjct: 30  TDDYQLFEELGKGAFSVVRRCVKKTPTQEYAAKIINTKKLSARDHQKLEREARICRLLKH 89
Query: 83  PYIVQFY------------------GALFKEVTV--------------ATVKALNYLKEE 110
           P IV+ +                  G LF+++                  ++++N++ + 
Sbjct: 90  PNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIHQILESVNHIHQH 149
Query: 111 LKIIHRDVKPSNILLDRR---GAIKLCDFGISGQLV-DSIAKTRDAGCRPYMAPE--RID 164
             I+HRD+KP N+LL  +    A+KL DFG++ ++  +  A    AG   Y++PE  R D
Sbjct: 150 -DIVHRDLKPENLLLASKCKGAAVKLADFGLAIEVQGEQQAWFGFAGTPGYLSPEVLRKD 208
Query: 165 P 165
           P
Sbjct: 209 P 209

>pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 45.4 bits (106), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 29/68 (42%), Positives = 36/68 (52%), Gaps = 2/68 (2%)
Query: 113 IIHRDVKPSNILLD-RRGAIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPLRARGY 171
           ++HRD+K  NIL+D  RG +KL DFG SG L+     T   G R Y  PE I   R  G 
Sbjct: 151 VLHRDIKDENILIDLNRGELKLIDFG-SGALLKDTVYTDFDGTRVYSPPEWIRYHRYHGR 209
Query: 172 PSFKTKLG 179
            +    LG
Sbjct: 210 SAAVWSLG 217

>pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333

Iteration: 1
 Score = 45.4 bits (106), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 29/68 (42%), Positives = 36/68 (52%), Gaps = 2/68 (2%)
Query: 113 IIHRDVKPSNILLD-RRGAIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPLRARGY 171
           ++HRD+K  NIL+D  RG +KL DFG SG L+     T   G R Y  PE I   R  G 
Sbjct: 183 VLHRDIKDENILIDLNRGELKLIDFG-SGALLKDTVYTDFDGTRVYSPPEWIRYHRYHGR 241
Query: 172 PSFKTKLG 179
            +    LG
Sbjct: 242 SAAVWSLG 249

>pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300

Iteration: 1
 Score = 45.1 bits (105), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 29/68 (42%), Positives = 36/68 (52%), Gaps = 2/68 (2%)
Query: 113 IIHRDVKPSNILLD-RRGAIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPLRARGY 171
           ++HRD+K  NIL+D  RG +KL DFG SG L+     T   G R Y  PE I   R  G 
Sbjct: 150 VLHRDIKDENILIDLNRGELKLIDFG-SGALLKDTVYTDFDGTRVYSPPEWIRYHRYHGR 208
Query: 172 PSFKTKLG 179
            +    LG
Sbjct: 209 SAAVWSLG 216

>pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 45.1 bits (105), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 29/68 (42%), Positives = 36/68 (52%), Gaps = 2/68 (2%)
Query: 113 IIHRDVKPSNILLD-RRGAIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPLRARGY 171
           ++HRD+K  NIL+D  RG +KL DFG SG L+     T   G R Y  PE I   R  G 
Sbjct: 151 VLHRDIKDENILIDLNRGELKLIDFG-SGALLKDTVYTDFDGTRVYSPPEWIRYHRYHGR 209
Query: 172 PSFKTKLG 179
            +    LG
Sbjct: 210 SAAVWSLG 217

>pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283

Iteration: 1
 Score = 45.1 bits (105), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 47/191 (24%), Positives = 76/191 (39%), Gaps = 40/191 (20%)
Query: 19  YDFTSEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMK 78
           ++   +DL  L E+G G FG V     R    V A+K I+     +D+    ++   VM 
Sbjct: 19  WEIDPKDLTFLKELGTGQFGVVKYGKWRGQYDV-AIKMIKEGSMSEDE---FIEEAKVMM 74
Query: 79  SNECPYIVQFYGALFKEVTVATVKA-------LNYLK----------------------- 108
           +     +VQ YG   K+  +  +         LNYL+                       
Sbjct: 75  NLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAME 134
Query: 109 --EELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPL 166
             E  + +HRD+   N L++ +G +K+ DFG+S  ++D    T   G +    P R  P 
Sbjct: 135 YLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDD-EYTSSVGSK---FPVRWSPP 190
Query: 167 RARGYPSFKTK 177
               Y  F +K
Sbjct: 191 EVLMYSKFSSK 201

>pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432

Iteration: 1
 Score = 45.1 bits (105), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 38/146 (26%), Positives = 72/146 (49%), Gaps = 41/146 (28%)
Query: 32  IGRGGFGTVNKMIHRSSDTVMAVKRI-RSTVDEKDQRQLLMDLDVV--MKSNECPYIVQF 88
           IGRG +G V     ++++  +A+K++ R   D  D +++L ++ ++  +KS+   YI++ 
Sbjct: 34  IGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSD---YIIRL 90
Query: 89  YGAL-------FKEVTVATVKALNYLKEELK----------------------------I 113
           Y  +       F E+ +    A + LK+  K                            I
Sbjct: 91  YDLIIPDDLLKFDELYIVLEIADSDLKKLFKTPIFLTEEHIKTILYNLLLGENFIHESGI 150
Query: 114 IHRDVKPSNILLDRRGAIKLCDFGIS 139
           IHRD+KP+N LL++  ++K+CDFG++
Sbjct: 151 IHRDLKPANCLLNQDCSVKVCDFGLA 176

>pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267

Iteration: 1
 Score = 45.1 bits (105), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 47/191 (24%), Positives = 76/191 (39%), Gaps = 40/191 (20%)
Query: 19  YDFTSEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMK 78
           ++   +DL  L E+G G FG V     R    V A+K I+     +D+    ++   VM 
Sbjct: 3   WEIDPKDLTFLKELGTGQFGVVKYGKWRGQYDV-AIKMIKEGSMSEDE---FIEEAKVMM 58
Query: 79  SNECPYIVQFYGALFKEVTVATVKA-------LNYLK----------------------- 108
           +     +VQ YG   K+  +  +         LNYL+                       
Sbjct: 59  NLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAME 118
Query: 109 --EELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPL 166
             E  + +HRD+   N L++ +G +K+ DFG+S  ++D    T   G +    P R  P 
Sbjct: 119 YLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDD-EYTSSVGSK---FPVRWSPP 174
Query: 167 RARGYPSFKTK 177
               Y  F +K
Sbjct: 175 EVLMYSKFSSK 185

>pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320

Iteration: 1
 Score = 45.1 bits (105), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 29/68 (42%), Positives = 36/68 (52%), Gaps = 2/68 (2%)
Query: 113 IIHRDVKPSNILLD-RRGAIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPLRARGY 171
           ++HRD+K  NIL+D  RG +KL DFG SG L+     T   G R Y  PE I   R  G 
Sbjct: 170 VLHRDIKDENILIDLNRGELKLIDFG-SGALLKDTVYTDFDGTRVYSPPEWIRYHRYHGR 228
Query: 172 PSFKTKLG 179
            +    LG
Sbjct: 229 SAAVWSLG 236

>pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312

Iteration: 1
 Score = 45.1 bits (105), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 29/68 (42%), Positives = 36/68 (52%), Gaps = 2/68 (2%)
Query: 113 IIHRDVKPSNILLD-RRGAIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPLRARGY 171
           ++HRD+K  NIL+D RRG  KL DFG SG L+     T   G R Y  PE I   +    
Sbjct: 160 VVHRDIKDENILIDLRRGCAKLIDFG-SGALLHDEPYTDFDGTRVYSPPEWISRHQYHAL 218
Query: 172 PSFKTKLG 179
           P+    LG
Sbjct: 219 PATVWSLG 226

>pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350

Iteration: 1
 Score = 45.1 bits (105), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 50/170 (29%), Positives = 72/170 (42%), Gaps = 45/170 (26%)
Query: 32  IGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQFYGA 91
           +GRG FG V++M  + +    AVK++R  V   ++        V       P IV  YGA
Sbjct: 80  LGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFRVEEL-------VACAGLSSPRIVPLYGA 132
Query: 92  --------LFKEV--------------TVATVKALNYLKEEL---------KIIHRDVKP 120
                   +F E+               +   +AL YL + L         +I+H DVK 
Sbjct: 133 VREGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDVKA 192
Query: 121 SNILLDRRGA-IKLCDFGISGQL-VDSIAK---TRD--AGCRPYMAPERI 163
            N+LL   G+   LCDFG +  L  D + K   T D   G   +MAPE +
Sbjct: 193 DNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVV 242

>pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274

Iteration: 1
 Score = 45.1 bits (105), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 47/191 (24%), Positives = 76/191 (39%), Gaps = 40/191 (20%)
Query: 19  YDFTSEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMK 78
           ++   +DL  L E+G G FG V     R    V A+K I+     +D+    ++   VM 
Sbjct: 10  WEIDPKDLTFLKELGTGQFGVVKYGKWRGQYDV-AIKMIKEGSMSEDE---FIEEAKVMM 65
Query: 79  SNECPYIVQFYGALFKEVTVATVKA-------LNYLK----------------------- 108
           +     +VQ YG   K+  +  +         LNYL+                       
Sbjct: 66  NLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAME 125
Query: 109 --EELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPL 166
             E  + +HRD+   N L++ +G +K+ DFG+S  ++D    T   G +    P R  P 
Sbjct: 126 YLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDD-EYTSSVGSK---FPVRWSPP 181
Query: 167 RARGYPSFKTK 177
               Y  F +K
Sbjct: 182 EVLMYSKFSSK 192

>pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 45.1 bits (105), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 41/174 (23%), Positives = 75/174 (43%), Gaps = 39/174 (22%)
Query: 24  EDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRI--RSTVDEKDQRQLLMDLDVVMKSNE 81
           ED   +  +G G +G V   ++R ++  +AVK +  +  VD  +  +  + ++ ++    
Sbjct: 6   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHEN 65
Query: 82  CPYIVQFYGA--------LFKE--------------VTVATVKALNYLKEELK------- 112
              +V+FYG         LF E              + +    A  +  + +        
Sbjct: 66  ---VVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 122
Query: 113 --IIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAK---TRDAGCRPYMAPE 161
             I HRD+KP N+LLD R  +K+ DFG++     +  +    +  G  PY+APE
Sbjct: 123 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPE 176

>pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276

Iteration: 1
 Score = 45.1 bits (105), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 41/174 (23%), Positives = 75/174 (43%), Gaps = 39/174 (22%)
Query: 24  EDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRI--RSTVDEKDQRQLLMDLDVVMKSNE 81
           ED   +  +G G +G V   ++R ++  +AVK +  +  VD  +  +  + ++ ++    
Sbjct: 7   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHEN 66
Query: 82  CPYIVQFYGA--------LFKE--------------VTVATVKALNYLKEELK------- 112
              +V+FYG         LF E              + +    A  +  + +        
Sbjct: 67  ---VVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 123
Query: 113 --IIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAK---TRDAGCRPYMAPE 161
             I HRD+KP N+LLD R  +K+ DFG++     +  +    +  G  PY+APE
Sbjct: 124 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPE 177

>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295

Iteration: 1
 Score = 45.1 bits (105), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 53/192 (27%), Positives = 81/192 (42%), Gaps = 45/192 (23%)
Query: 19  YDFTSEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQR--QLLMDLDVV 76
           YD+  ++  D   +G+G +G V      S+   +A+K I     E+D R  Q L +   +
Sbjct: 17  YDYEYDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEI----PERDSRYSQPLHEEIAL 72
Query: 77  MKSNECPYIVQFYGA--------LFKE---------------------------VTVATV 101
            K  +   IVQ+ G+        +F E                            T   +
Sbjct: 73  HKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQIL 132
Query: 102 KALNYLKEELKIIHRDVKPSNILLDR-RGAIKLCDFGISGQLVDSIAKTRD-AGCRPYMA 159
           + L YL +  +I+HRD+K  N+L++   G +K+ DFG S +L      T    G   YMA
Sbjct: 133 EGLKYLHDN-QIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMA 191
Query: 160 PERIDPLRARGY 171
           PE ID    RGY
Sbjct: 192 PEIIDK-GPRGY 202

>pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 45.1 bits (105), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 41/174 (23%), Positives = 75/174 (43%), Gaps = 39/174 (22%)
Query: 24  EDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRI--RSTVDEKDQRQLLMDLDVVMKSNE 81
           ED   +  +G G +G V   ++R ++  +AVK +  +  VD  +  +  + ++ ++    
Sbjct: 6   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHEN 65
Query: 82  CPYIVQFYGA--------LFKE--------------VTVATVKALNYLKEELK------- 112
              +V+FYG         LF E              + +    A  +  + +        
Sbjct: 66  ---VVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 122
Query: 113 --IIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAK---TRDAGCRPYMAPE 161
             I HRD+KP N+LLD R  +K+ DFG++     +  +    +  G  PY+APE
Sbjct: 123 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPE 176

>pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353

Iteration: 1
 Score = 45.1 bits (105), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 45/189 (23%), Positives = 81/189 (42%), Gaps = 47/189 (24%)
Query: 18  VYDFTSEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRI----------RSTVDEKDQR 67
           VY+ +S D Q    +G G +G V    H+ +  ++A+K+I          R+  + K  +
Sbjct: 6   VYNISS-DFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILK 64
Query: 68  QLLMDLDVVMKSNECP---------YIVQ--FYGALFKEVTVA-------------TVKA 103
               +  + + + + P         YI+Q      L + ++               T++A
Sbjct: 65  HFKHENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQYFIYQTLRA 124
Query: 104 LNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAK-----------TRDA 152
           +  L     +IHRD+KPSN+L++    +K+CDFG++  + +S A            T   
Sbjct: 125 VKVLHGS-NVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMTEXV 183
Query: 153 GCRPYMAPE 161
             R Y APE
Sbjct: 184 ATRWYRAPE 192

>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269

Iteration: 1
 Score = 44.7 bits (104), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 53/192 (27%), Positives = 81/192 (42%), Gaps = 45/192 (23%)
Query: 19  YDFTSEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQR--QLLMDLDVV 76
           YD+  ++  D   +G+G +G V      S+   +A+K I     E+D R  Q L +   +
Sbjct: 3   YDYEYDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEI----PERDSRYSQPLHEEIAL 58
Query: 77  MKSNECPYIVQFYGA--------LFKE---------------------------VTVATV 101
            K  +   IVQ+ G+        +F E                            T   +
Sbjct: 59  HKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQIL 118
Query: 102 KALNYLKEELKIIHRDVKPSNILLDR-RGAIKLCDFGISGQLVDSIAKTRD-AGCRPYMA 159
           + L YL +  +I+HRD+K  N+L++   G +K+ DFG S +L      T    G   YMA
Sbjct: 119 EGLKYLHDN-QIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMA 177
Query: 160 PERIDPLRARGY 171
           PE ID    RGY
Sbjct: 178 PEIIDK-GPRGY 188

>pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303

Iteration: 1
 Score = 44.7 bits (104), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 37/174 (21%), Positives = 73/174 (41%), Gaps = 58/174 (33%)
Query: 23  SEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNEC 82
           + D +++  +G+G FG V K  +       A+K+IR T   +++   ++   +++ S   
Sbjct: 5   ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT---EEKLSTILSEVMLLASLNH 61
Query: 83  PYIVQFYGA--------------------------------------------------L 92
            Y+V++Y A                                                  L
Sbjct: 62  QYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENRTLYDLIHSENLNQQRDEYWRL 121
Query: 93  FKEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSI 146
           F+++    ++AL+Y+  +  IIHRD+KP NI +D    +K+ DFG++  +  S+
Sbjct: 122 FRQI----LEALSYIHSQ-GIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSL 170

>pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303

Iteration: 1
 Score = 44.7 bits (104), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 37/174 (21%), Positives = 73/174 (41%), Gaps = 58/174 (33%)
Query: 23  SEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNEC 82
           + D +++  +G+G FG V K  +       A+K+IR T   +++   ++   +++ S   
Sbjct: 5   ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT---EEKLSTILSEVMLLASLNH 61
Query: 83  PYIVQFYGA--------------------------------------------------L 92
            Y+V++Y A                                                  L
Sbjct: 62  QYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRL 121
Query: 93  FKEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSI 146
           F+++    ++AL+Y+  +  IIHRD+KP NI +D    +K+ DFG++  +  S+
Sbjct: 122 FRQI----LEALSYIHSQ-GIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSL 170

>pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429

Iteration: 1
 Score = 44.7 bits (104), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 37/146 (25%), Positives = 70/146 (47%), Gaps = 41/146 (28%)
Query: 32  IGRGGFGTVNKMIHRSSDTVMAVKRI-RSTVDEKDQRQLLMDLDVV--MKSNECPYIVQF 88
           IGRG +G V     ++++  +A+K++ R   D  D +++L ++ ++  +KS+   YI++ 
Sbjct: 36  IGRGSYGYVYLAYDKNANKNVAIKKVNRMFEDLIDCKRILREITILNRLKSD---YIIRL 92
Query: 89  YGALFKE----------------------------VTVATVKALNY-------LKEELKI 113
           +  +  E                            +T   VK + Y          E  I
Sbjct: 93  HDLIIPEDLLKFDELYIVLEIADSDLKKLFKTPIFLTEQHVKTILYNLLLGEKFIHESGI 152
Query: 114 IHRDVKPSNILLDRRGAIKLCDFGIS 139
           IHRD+KP+N LL++  ++K+CDFG++
Sbjct: 153 IHRDLKPANCLLNQDCSVKICDFGLA 178

>pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269

Iteration: 1
 Score = 44.7 bits (104), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 45/171 (26%), Positives = 72/171 (42%), Gaps = 48/171 (28%)
Query: 8   SGKLKLSPDTVYDFTSEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRS-TVDEKDQ 66
           SGK  + P         +L  + EIG G FG V+     + D V A+K IR   + E+D 
Sbjct: 2   SGKWVIDPS--------ELTFVQEIGSGQFGLVHLGYWLNKDKV-AIKTIREGAMSEED- 51
Query: 67  RQLLMDLDVVMKSNECPYIVQFYGALFKEVTVATV------------------------- 101
              + + +V+MK +  P +VQ YG   ++  +  V                         
Sbjct: 52  --FIEEAEVMMKLSH-PKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETL 108
Query: 102 --------KALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVD 144
                   + + YL EE  +IHRD+   N L+     IK+ DFG++  ++D
Sbjct: 109 LGMCLDVCEGMAYL-EEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLD 158

>pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265

Iteration: 1
 Score = 44.7 bits (104), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 47/191 (24%), Positives = 76/191 (39%), Gaps = 40/191 (20%)
Query: 19  YDFTSEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMK 78
           ++   +DL  L E+G G FG V     R    V A+K I+     +D+    ++   VM 
Sbjct: 4   WEIDPKDLTFLKELGTGQFGVVKYGKWRGQYDV-AIKMIKEGSMSEDE---FIEEAKVMM 59
Query: 79  SNECPYIVQFYGALFKEVTVATVKA-------LNYLK----------------------- 108
           +     +VQ YG   K+  +  +         LNYL+                       
Sbjct: 60  NLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAME 119
Query: 109 --EELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPL 166
             E  + +HRD+   N L++ +G +K+ DFG+S  ++D    T   G +    P R  P 
Sbjct: 120 YLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDD-EYTSSRGSK---FPVRWSPP 175
Query: 167 RARGYPSFKTK 177
               Y  F +K
Sbjct: 176 EVLMYSKFSSK 186

>pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266

Iteration: 1
 Score = 44.7 bits (104), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 41/154 (26%), Positives = 67/154 (43%), Gaps = 40/154 (25%)
Query: 25  DLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRS-TVDEKDQRQLLMDLDVVMKSNECP 83
           +L  + EIG G FG V+     + D V A+K IR   + E+D    + + +V+MK +  P
Sbjct: 8   ELTFVQEIGSGQFGLVHLGYWLNKDKV-AIKTIREGAMSEED---FIEEAEVMMKLSH-P 62
Query: 84  YIVQFYGALFKEVTVATV---------------------------------KALNYLKEE 110
            +VQ YG   ++  +  V                                 + + YL EE
Sbjct: 63  KLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYL-EE 121
Query: 111 LKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVD 144
             +IHRD+   N L+     IK+ DFG++  ++D
Sbjct: 122 ASVIHRDLAARNCLVGENQVIKVSDFGMTRFVLD 155

>pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362

Iteration: 1
 Score = 44.7 bits (104), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 40/162 (24%), Positives = 69/162 (42%), Gaps = 32/162 (19%)
Query: 31  EIGRGGFGTVNKMIHRSSDTVMAVKRI-----------RSTVDEKDQRQ--LLMDLDVVM 77
           +IG G FG    M  + S+ ++AVK I           R  ++ +  R   ++   +V++
Sbjct: 26  DIGSGNFGVARLMRDKQSNELVAVKYIERGEKIAANVKREIINHRSLRHPNIVRFKEVIL 85
Query: 78  KSNECPYIVQFY--GALFKEVTVA--------------TVKALNYLKEELKIIHRDVKPS 121
                  ++++   G LF+ +  A               +  ++Y    +++ HRD+K  
Sbjct: 86  TPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYC-HAMQVCHRDLKLE 144
Query: 122 NILLDRRGA--IKLCDFGISGQLVDSIAKTRDAGCRPYMAPE 161
           N LLD   A  +K+CDFG S   V         G   Y+APE
Sbjct: 145 NTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPE 186

>pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267

Iteration: 1
 Score = 44.7 bits (104), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 41/153 (26%), Positives = 67/153 (43%), Gaps = 38/153 (24%)
Query: 25  DLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRS-TVDEKDQRQLLMDLDVVMKSNECP 83
           +L  + EIG G FG V+     + D V A+K IR   + E+D    + + +V+MK +  P
Sbjct: 9   ELTFVQEIGSGQFGLVHLGYWLNKDKV-AIKTIREGAMSEED---FIEEAEVMMKLSH-P 63
Query: 84  YIVQFYGALFKEVTVATVKAL-------NYLK-------------------------EEL 111
            +VQ YG   ++  +  V          +YL+                         EE 
Sbjct: 64  KLVQLYGVCLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEA 123
Query: 112 KIIHRDVKPSNILLDRRGAIKLCDFGISGQLVD 144
            +IHRD+   N L+     IK+ DFG++  ++D
Sbjct: 124 CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLD 156

>pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383

Iteration: 1
 Score = 44.7 bits (104), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 22/54 (40%), Positives = 31/54 (57%), Gaps = 1/54 (1%)
Query: 109 EELKIIHRDVKPSNILLDRR-GAIKLCDFGISGQLVDSIAKTRDAGCRPYMAPE 161
             L I HRD+KP N+L++ +   +KLCDFG + +L+ S         R Y APE
Sbjct: 158 HSLGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPSVAXICSRFYRAPE 211

>pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323

Iteration: 1
 Score = 44.7 bits (104), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 41/174 (23%), Positives = 75/174 (43%), Gaps = 39/174 (22%)
Query: 24  EDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRI--RSTVDEKDQRQLLMDLDVVMKSNE 81
           ED   +  +G G +G V   ++R ++  +AVK +  +  VD  +  +  + ++ ++    
Sbjct: 7   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 66
Query: 82  CPYIVQFYGA--------LFKE--------------VTVATVKALNYLKEELK------- 112
              +V+FYG         LF E              + +    A  +  + +        
Sbjct: 67  ---VVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 123
Query: 113 --IIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAK---TRDAGCRPYMAPE 161
             I HRD+KP N+LLD R  +K+ DFG++     +  +    +  G  PY+APE
Sbjct: 124 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPE 177

>pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360

Iteration: 1
 Score = 44.3 bits (103), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 39/173 (22%), Positives = 72/173 (41%), Gaps = 34/173 (19%)
Query: 25  DLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTV--DEKDQRQLLMDLDVVMKSNEC 82
           D   L  +G+G FG V     + ++ + A+K ++  V   + D    +++  V+   ++ 
Sbjct: 20  DFNFLMVLGKGSFGKVMLADRKGTEELYAIKILKKDVVIQDDDVECTMVEKRVLALLDKP 79
Query: 83  PYIVQFYGAL---------------------------FKE----VTVATVKALNYLKEEL 111
           P++ Q +                              FKE       A +    +   + 
Sbjct: 80  PFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISIGLFFLHKR 139
Query: 112 KIIHRDVKPSNILLDRRGAIKLCDFGISGQ-LVDSIAKTRDAGCRPYMAPERI 163
            II+RD+K  N++LD  G IK+ DFG+  + ++D +      G   Y+APE I
Sbjct: 140 GIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMMDGVTTREFCGTPDYIAPEII 192

>pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268

Iteration: 1
 Score = 44.3 bits (103), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 44/176 (25%), Positives = 79/176 (44%), Gaps = 43/176 (24%)
Query: 24  EDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRI--RSTVD--EKDQRQLLMDLDVVMKS 79
           ED   +  +G G +G V   ++R ++  +AVK +  +  VD  E  ++++ ++    M +
Sbjct: 6   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICIN---KMLN 62
Query: 80  NECPYIVQFYGA--------LFKE--------------VTVATVKALNYLKEELK----- 112
           +E   +V+FYG         LF E              + +    A  +  + +      
Sbjct: 63  HE--NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYL 120
Query: 113 ----IIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAK---TRDAGCRPYMAPE 161
               I HRD+KP N+LLD R  +K+ DFG++     +  +    +  G  PY+APE
Sbjct: 121 HGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPE 176

>pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396

Iteration: 1
 Score = 44.3 bits (103), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 43/173 (24%), Positives = 73/173 (42%), Gaps = 36/173 (20%)
Query: 24  EDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTV--DEKDQRQLLMDLDVVMKSNE 81
           +D   L  IGRG +  V  +  + +D + A++ ++  +  D++D   +  +  V  +++ 
Sbjct: 52  QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASN 111
Query: 82  CPYIVQFYGALFKEVTVATV--------------------------------KALNYLKE 109
            P++V  +     E  +  V                                 ALNYL E
Sbjct: 112 HPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHE 171
Query: 110 ELKIIHRDVKPSNILLDRRGAIKLCDFGISGQ-LVDSIAKTRDAGCRPYMAPE 161
              II+RD+K  N+LLD  G IKL D+G+  + L      +   G   Y+APE
Sbjct: 172 R-GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPE 223

>pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269

Iteration: 1
 Score = 44.3 bits (103), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 44/176 (25%), Positives = 79/176 (44%), Gaps = 43/176 (24%)
Query: 24  EDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRI--RSTVD--EKDQRQLLMDLDVVMKS 79
           ED   +  +G G +G V   ++R ++  +AVK +  +  VD  E  ++++ ++    M +
Sbjct: 6   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICIN---KMLN 62
Query: 80  NECPYIVQFYGA--------LFKE--------------VTVATVKALNYLKEELK----- 112
           +E   +V+FYG         LF E              + +    A  +  + +      
Sbjct: 63  HE--NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYL 120
Query: 113 ----IIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAK---TRDAGCRPYMAPE 161
               I HRD+KP N+LLD R  +K+ DFG++     +  +    +  G  PY+APE
Sbjct: 121 HGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPE 176

>pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311

Iteration: 1
 Score = 44.3 bits (103), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 27/68 (39%), Positives = 36/68 (52%), Gaps = 4/68 (5%)
Query: 97  TVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTRD---AG 153
           T   V AL YL  +  IIHRD+KP NILL+    I++ DFG +  L     + R     G
Sbjct: 135 TAEIVSALEYLHGK-GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVG 193
Query: 154 CRPYMAPE 161
              Y++PE
Sbjct: 194 TAQYVSPE 201

>pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311

Iteration: 1
 Score = 44.3 bits (103), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 27/68 (39%), Positives = 36/68 (52%), Gaps = 4/68 (5%)
Query: 97  TVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTRD---AG 153
           T   V AL YL  +  IIHRD+KP NILL+    I++ DFG +  L     + R     G
Sbjct: 135 TAEIVSALEYLHGK-GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVG 193
Query: 154 CRPYMAPE 161
              Y++PE
Sbjct: 194 TAQYVSPE 201

>pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269

Iteration: 1
 Score = 44.3 bits (103), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 44/176 (25%), Positives = 79/176 (44%), Gaps = 43/176 (24%)
Query: 24  EDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRI--RSTVD--EKDQRQLLMDLDVVMKS 79
           ED   +  +G G +G V   ++R ++  +AVK +  +  VD  E  ++++ ++    M +
Sbjct: 7   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICIN---KMLN 63
Query: 80  NECPYIVQFYGA--------LFKE--------------VTVATVKALNYLKEELK----- 112
           +E   +V+FYG         LF E              + +    A  +  + +      
Sbjct: 64  HE--NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYL 121
Query: 113 ----IIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAK---TRDAGCRPYMAPE 161
               I HRD+KP N+LLD R  +K+ DFG++     +  +    +  G  PY+APE
Sbjct: 122 HGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPE 177

>pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322

Iteration: 1
 Score = 44.3 bits (103), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 44/176 (25%), Positives = 79/176 (44%), Gaps = 43/176 (24%)
Query: 24  EDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRI--RSTVD--EKDQRQLLMDLDVVMKS 79
           ED   +  +G G +G V   ++R ++  +AVK +  +  VD  E  ++++ ++    M +
Sbjct: 6   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICIN---KMLN 62
Query: 80  NECPYIVQFYGA--------LFKE--------------VTVATVKALNYLKEELK----- 112
           +E   +V+FYG         LF E              + +    A  +  + +      
Sbjct: 63  HE--NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYL 120
Query: 113 ----IIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAK---TRDAGCRPYMAPE 161
               I HRD+KP N+LLD R  +K+ DFG++     +  +    +  G  PY+APE
Sbjct: 121 HGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPE 176

>pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263

Iteration: 1
 Score = 44.3 bits (103), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 47/185 (25%), Positives = 73/185 (39%), Gaps = 40/185 (21%)
Query: 25  DLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPY 84
           DL  L E+G G FG V     R    V A+K I+     +D+    ++   VM +     
Sbjct: 5   DLTFLKELGTGQFGVVKYGKWRGQYDV-AIKMIKEGSMSEDE---FIEEAKVMMNLSHEK 60
Query: 85  IVQFYGALFKEVTVATVKA-------LNYLK-------------------------EELK 112
           +VQ YG   K+  +  +         LNYL+                         E  +
Sbjct: 61  LVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQ 120
Query: 113 IIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPLRARGYP 172
            +HRD+   N L++ +G +K+ DFG+S  ++D    T   G +    P R  P     Y 
Sbjct: 121 FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDD-EYTSSVGSK---FPVRWSPPEVLMYS 176
Query: 173 SFKTK 177
            F +K
Sbjct: 177 KFSSK 181

>pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 44.3 bits (103), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 44/176 (25%), Positives = 79/176 (44%), Gaps = 43/176 (24%)
Query: 24  EDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRI--RSTVD--EKDQRQLLMDLDVVMKS 79
           ED   +  +G G +G V   ++R ++  +AVK +  +  VD  E  ++++ ++    M +
Sbjct: 6   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICIN---KMLN 62
Query: 80  NECPYIVQFYGA--------LFKE--------------VTVATVKALNYLKEELK----- 112
           +E   +V+FYG         LF E              + +    A  +  + +      
Sbjct: 63  HE--NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYL 120
Query: 113 ----IIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAK---TRDAGCRPYMAPE 161
               I HRD+KP N+LLD R  +K+ DFG++     +  +    +  G  PY+APE
Sbjct: 121 HGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPE 176

>pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278

Iteration: 1
 Score = 44.3 bits (103), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 44/176 (25%), Positives = 79/176 (44%), Gaps = 43/176 (24%)
Query: 24  EDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRI--RSTVD--EKDQRQLLMDLDVVMKS 79
           ED   +  +G G +G V   ++R ++  +AVK +  +  VD  E  ++++ ++    M +
Sbjct: 5   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICIN---KMLN 61
Query: 80  NECPYIVQFYGA--------LFKE--------------VTVATVKALNYLKEELK----- 112
           +E   +V+FYG         LF E              + +    A  +  + +      
Sbjct: 62  HE--NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYL 119
Query: 113 ----IIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAK---TRDAGCRPYMAPE 161
               I HRD+KP N+LLD R  +K+ DFG++     +  +    +  G  PY+APE
Sbjct: 120 HGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPE 175

>pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311

Iteration: 1
 Score = 44.3 bits (103), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 27/68 (39%), Positives = 36/68 (52%), Gaps = 4/68 (5%)
Query: 97  TVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTRD---AG 153
           T   V AL YL  +  IIHRD+KP NILL+    I++ DFG +  L     + R     G
Sbjct: 138 TAEIVSALEYLHGK-GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVG 196
Query: 154 CRPYMAPE 161
              Y++PE
Sbjct: 197 TAQYVSPE 204

>pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276

Iteration: 1
 Score = 44.3 bits (103), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 44/176 (25%), Positives = 79/176 (44%), Gaps = 43/176 (24%)
Query: 24  EDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRI--RSTVD--EKDQRQLLMDLDVVMKS 79
           ED   +  +G G +G V   ++R ++  +AVK +  +  VD  E  ++++ ++    M +
Sbjct: 7   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICIN---KMLN 63
Query: 80  NECPYIVQFYGA--------LFKE--------------VTVATVKALNYLKEELK----- 112
           +E   +V+FYG         LF E              + +    A  +  + +      
Sbjct: 64  HE--NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYL 121
Query: 113 ----IIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAK---TRDAGCRPYMAPE 161
               I HRD+KP N+LLD R  +K+ DFG++     +  +    +  G  PY+APE
Sbjct: 122 HGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPE 177

>pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271

Iteration: 1
 Score = 44.3 bits (103), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 44/176 (25%), Positives = 79/176 (44%), Gaps = 43/176 (24%)
Query: 24  EDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRI--RSTVD--EKDQRQLLMDLDVVMKS 79
           ED   +  +G G +G V   ++R ++  +AVK +  +  VD  E  ++++ ++    M +
Sbjct: 6   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICIN---KMLN 62
Query: 80  NECPYIVQFYGA--------LFKE--------------VTVATVKALNYLKEELK----- 112
           +E   +V+FYG         LF E              + +    A  +  + +      
Sbjct: 63  HE--NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYL 120
Query: 113 ----IIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAK---TRDAGCRPYMAPE 161
               I HRD+KP N+LLD R  +K+ DFG++     +  +    +  G  PY+APE
Sbjct: 121 HGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPE 176

>pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269

Iteration: 1
 Score = 44.3 bits (103), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 44/176 (25%), Positives = 79/176 (44%), Gaps = 43/176 (24%)
Query: 24  EDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRI--RSTVD--EKDQRQLLMDLDVVMKS 79
           ED   +  +G G +G V   ++R ++  +AVK +  +  VD  E  ++++ ++    M +
Sbjct: 6   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICIN---KMLN 62
Query: 80  NECPYIVQFYGA--------LFKE--------------VTVATVKALNYLKEELK----- 112
           +E   +V+FYG         LF E              + +    A  +  + +      
Sbjct: 63  HEN--VVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYL 120
Query: 113 ----IIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAK---TRDAGCRPYMAPE 161
               I HRD+KP N+LLD R  +K+ DFG++     +  +    +  G  PY+APE
Sbjct: 121 HGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPE 176

>pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 44.3 bits (103), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 44/176 (25%), Positives = 79/176 (44%), Gaps = 43/176 (24%)
Query: 24  EDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRI--RSTVD--EKDQRQLLMDLDVVMKS 79
           ED   +  +G G +G V   ++R ++  +AVK +  +  VD  E  ++++ ++    M +
Sbjct: 6   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICIN---KMLN 62
Query: 80  NECPYIVQFYGA--------LFKE--------------VTVATVKALNYLKEELK----- 112
           +E   +V+FYG         LF E              + +    A  +  + +      
Sbjct: 63  HEN--VVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYL 120
Query: 113 ----IIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAK---TRDAGCRPYMAPE 161
               I HRD+KP N+LLD R  +K+ DFG++     +  +    +  G  PY+APE
Sbjct: 121 HGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPE 176

>pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297

Iteration: 1
 Score = 44.3 bits (103), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 41/174 (23%), Positives = 75/174 (43%), Gaps = 39/174 (22%)
Query: 24  EDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRI--RSTVDEKDQRQLLMDLDVVMKSNE 81
           ED   +  +G G +G V   ++R ++  +AVK +  +  VD  +  +  + ++ ++    
Sbjct: 7   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 66
Query: 82  CPYIVQFYGA--------LFKE--------------VTVATVKALNYLKEELK------- 112
              +V+FYG         LF E              + +    A  +  + +        
Sbjct: 67  ---VVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 123
Query: 113 --IIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAK---TRDAGCRPYMAPE 161
             I HRD+KP N+LLD R  +K+ DFG++     +  +    +  G  PY+APE
Sbjct: 124 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPE 177

>pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353

Iteration: 1
 Score = 44.3 bits (103), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 45/189 (23%), Positives = 81/189 (42%), Gaps = 47/189 (24%)
Query: 18  VYDFTSEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRI----------RSTVDEKDQR 67
           VY+ +S D Q    +G G +G V    H+ +  ++A+K+I          R+  + K  +
Sbjct: 6   VYNISS-DFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILK 64
Query: 68  QLLMDLDVVMKSNECP---------YIVQ--FYGALFKEVTVA-------------TVKA 103
               +  + + + + P         YI+Q      L + ++               T++A
Sbjct: 65  HFKHENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQYFIYQTLRA 124
Query: 104 LNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAK-----------TRDA 152
           +  L     +IHRD+KPSN+L++    +K+CDFG++  + +S A            T   
Sbjct: 125 VKVLHGS-NVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMTEYV 183
Query: 153 GCRPYMAPE 161
             R Y APE
Sbjct: 184 ATRWYRAPE 192

>pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289

Iteration: 1
 Score = 44.3 bits (103), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 41/174 (23%), Positives = 75/174 (43%), Gaps = 39/174 (22%)
Query: 24  EDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRI--RSTVDEKDQRQLLMDLDVVMKSNE 81
           ED   +  +G G +G V   ++R ++  +AVK +  +  VD  +  +  + ++ ++    
Sbjct: 7   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 66
Query: 82  CPYIVQFYGA--------LFKE--------------VTVATVKALNYLKEELK------- 112
              +V+FYG         LF E              + +    A  +  + +        
Sbjct: 67  ---VVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 123
Query: 113 --IIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAK---TRDAGCRPYMAPE 161
             I HRD+KP N+LLD R  +K+ DFG++     +  +    +  G  PY+APE
Sbjct: 124 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPE 177

>pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295

Iteration: 1
 Score = 44.3 bits (103), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 41/174 (23%), Positives = 75/174 (43%), Gaps = 39/174 (22%)
Query: 24  EDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRI--RSTVDEKDQRQLLMDLDVVMKSNE 81
           ED   +  +G G +G V   ++R ++  +AVK +  +  VD  +  +  + ++ ++    
Sbjct: 7   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 66
Query: 82  CPYIVQFYGA--------LFKE--------------VTVATVKALNYLKEELK------- 112
              +V+FYG         LF E              + +    A  +  + +        
Sbjct: 67  ---VVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 123
Query: 113 --IIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAK---TRDAGCRPYMAPE 161
             I HRD+KP N+LLD R  +K+ DFG++     +  +    +  G  PY+APE
Sbjct: 124 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPE 177

>pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311

Iteration: 1
 Score = 44.3 bits (103), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 27/68 (39%), Positives = 36/68 (52%), Gaps = 4/68 (5%)
Query: 97  TVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTRD---AG 153
           T   V AL YL  +  IIHRD+KP NILL+    I++ DFG +  L     + R     G
Sbjct: 138 TAEIVSALEYLHGK-GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVG 196
Query: 154 CRPYMAPE 161
              Y++PE
Sbjct: 197 TAQYVSPE 204

>pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 44.3 bits (103), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 27/68 (39%), Positives = 36/68 (52%), Gaps = 4/68 (5%)
Query: 97  TVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTRD---AG 153
           T   V AL YL  +  IIHRD+KP NILL+    I++ DFG +  L     + R     G
Sbjct: 136 TAEIVSALEYLHGK-GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVG 194
Query: 154 CRPYMAPE 161
              Y++PE
Sbjct: 195 TAQYVSPE 202

>pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273

Iteration: 1
 Score = 44.3 bits (103), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 44/176 (25%), Positives = 79/176 (44%), Gaps = 43/176 (24%)
Query: 24  EDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRI--RSTVD--EKDQRQLLMDLDVVMKS 79
           ED   +  +G G +G V   ++R ++  +AVK +  +  VD  E  ++++ ++    M +
Sbjct: 6   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICIN---KMLN 62
Query: 80  NECPYIVQFYGA--------LFKE--------------VTVATVKALNYLKEELK----- 112
           +E   +V+FYG         LF E              + +    A  +  + +      
Sbjct: 63  HE--NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYL 120
Query: 113 ----IIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAK---TRDAGCRPYMAPE 161
               I HRD+KP N+LLD R  +K+ DFG++     +  +    +  G  PY+APE
Sbjct: 121 HGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPE 176

>pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310

Iteration: 1
 Score = 44.3 bits (103), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 27/68 (39%), Positives = 36/68 (52%), Gaps = 4/68 (5%)
Query: 97  TVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTRD---AG 153
           T   V AL YL  +  IIHRD+KP NILL+    I++ DFG +  L     + R     G
Sbjct: 136 TAEIVSALEYLHGK-GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVG 194
Query: 154 CRPYMAPE 161
              Y++PE
Sbjct: 195 TAQYVSPE 202

>pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314

Iteration: 1
 Score = 44.3 bits (103), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 27/68 (39%), Positives = 36/68 (52%), Gaps = 4/68 (5%)
Query: 97  TVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTRD---AG 153
           T   V AL YL  +  IIHRD+KP NILL+    I++ DFG +  L     + R     G
Sbjct: 141 TAEIVSALEYLHGK-GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVG 199
Query: 154 CRPYMAPE 161
              Y++PE
Sbjct: 200 TAQYVSPE 207

>pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310

Iteration: 1
 Score = 44.3 bits (103), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 27/68 (39%), Positives = 36/68 (52%), Gaps = 4/68 (5%)
Query: 97  TVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTRD---AG 153
           T   V AL YL  +  IIHRD+KP NILL+    I++ DFG +  L     + R     G
Sbjct: 136 TAEIVSALEYLHGK-GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANAFVG 194
Query: 154 CRPYMAPE 161
              Y++PE
Sbjct: 195 TAQYVSPE 202

>pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311

Iteration: 1
 Score = 44.3 bits (103), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 27/68 (39%), Positives = 36/68 (52%), Gaps = 4/68 (5%)
Query: 97  TVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTRD---AG 153
           T   V AL YL  +  IIHRD+KP NILL+    I++ DFG +  L     + R     G
Sbjct: 138 TAEIVSALEYLHGK-GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVG 196
Query: 154 CRPYMAPE 161
              Y++PE
Sbjct: 197 TAQYVSPE 204

>pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312

Iteration: 1
 Score = 44.3 bits (103), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 27/68 (39%), Positives = 36/68 (52%), Gaps = 4/68 (5%)
Query: 97  TVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTRD---AG 153
           T   V AL YL  +  IIHRD+KP NILL+    I++ DFG +  L     + R     G
Sbjct: 139 TAEIVSALEYLHGK-GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVG 197
Query: 154 CRPYMAPE 161
              Y++PE
Sbjct: 198 TAQYVSPE 205

>pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292

Iteration: 1
 Score = 44.3 bits (103), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 27/68 (39%), Positives = 36/68 (52%), Gaps = 4/68 (5%)
Query: 97  TVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTRD---AG 153
           T   V AL YL  +  IIHRD+KP NILL+    I++ DFG +  L     + R     G
Sbjct: 120 TAEIVSALEYLHGK-GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVG 178
Query: 154 CRPYMAPE 161
              Y++PE
Sbjct: 179 TAQYVSPE 186

>pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286

Iteration: 1
 Score = 44.3 bits (103), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 27/68 (39%), Positives = 36/68 (52%), Gaps = 4/68 (5%)
Query: 97  TVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTRD---AG 153
           T   V AL YL  +  IIHRD+KP NILL+    I++ DFG +  L     + R     G
Sbjct: 114 TAEIVSALEYLHGK-GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVG 172
Query: 154 CRPYMAPE 161
              Y++PE
Sbjct: 173 TAQYVSPE 180

>pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 44.3 bits (103), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 27/68 (39%), Positives = 36/68 (52%), Gaps = 4/68 (5%)
Query: 97  TVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTRD---AG 153
           T   V AL YL  +  IIHRD+KP NILL+    I++ DFG +  L     + R     G
Sbjct: 136 TAEIVSALEYLHGK-GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVG 194
Query: 154 CRPYMAPE 161
              Y++PE
Sbjct: 195 TAQYVSPE 202

>pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311

Iteration: 1
 Score = 44.3 bits (103), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 27/68 (39%), Positives = 36/68 (52%), Gaps = 4/68 (5%)
Query: 97  TVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTRD---AG 153
           T   V AL YL  +  IIHRD+KP NILL+    I++ DFG +  L     + R     G
Sbjct: 138 TAEIVSALEYLHGK-GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVG 196
Query: 154 CRPYMAPE 161
              Y++PE
Sbjct: 197 TAQYVSPE 204

>pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312

Iteration: 1
 Score = 44.3 bits (103), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 27/68 (39%), Positives = 36/68 (52%), Gaps = 4/68 (5%)
Query: 97  TVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTRD---AG 153
           T   V AL YL  +  IIHRD+KP NILL+    I++ DFG +  L     + R     G
Sbjct: 139 TAEIVSALEYLHGK-GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVG 197
Query: 154 CRPYMAPE 161
              Y++PE
Sbjct: 198 TAQYVSPE 205

>pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 44.3 bits (103), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 44/176 (25%), Positives = 79/176 (44%), Gaps = 43/176 (24%)
Query: 24  EDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRI--RSTVD--EKDQRQLLMDLDVVMKS 79
           ED   +  +G G +G V   ++R ++  +AVK +  +  VD  E  ++++ ++    M +
Sbjct: 6   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICIN---KMLN 62
Query: 80  NECPYIVQFYGA--------LFKE--------------VTVATVKALNYLKEELK----- 112
           +E   +V+FYG         LF E              + +    A  +  + +      
Sbjct: 63  HEN--VVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYL 120
Query: 113 ----IIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAK---TRDAGCRPYMAPE 161
               I HRD+KP N+LLD R  +K+ DFG++     +  +    +  G  PY+APE
Sbjct: 121 HGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPE 176

>pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311

Iteration: 1
 Score = 44.3 bits (103), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 27/68 (39%), Positives = 36/68 (52%), Gaps = 4/68 (5%)
Query: 97  TVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTRD---AG 153
           T   V AL YL  +  IIHRD+KP NILL+    I++ DFG +  L     + R     G
Sbjct: 138 TAEIVSALEYLHGK-GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVG 196
Query: 154 CRPYMAPE 161
              Y++PE
Sbjct: 197 TAQYVSPE 204

>pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504

Iteration: 1
 Score = 44.3 bits (103), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 41/150 (27%), Positives = 67/150 (44%), Gaps = 23/150 (15%)
Query: 31  EIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQFY- 89
           +  +G +   NK I +  + +     +  ++D  +  +L    DV         + +FY 
Sbjct: 73  QFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLF---DVFEDKKYFYLVTEFYE 129
Query: 90  -GALFKEVT----VATVKALNYLKEEL---------KIIHRDVKPSNILLDRRGA---IK 132
            G LF+++          A N +K+ L          I+HRD+KP NILL+ + +   IK
Sbjct: 130 GGELFEQIINRHKFDECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIK 189
Query: 133 LCDFGISGQLVDSIAKTRD-AGCRPYMAPE 161
           + DFG+S        K RD  G   Y+APE
Sbjct: 190 IVDFGLSS-FFSKDYKLRDRLGTAYYIAPE 218

>pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311

Iteration: 1
 Score = 44.3 bits (103), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 27/68 (39%), Positives = 36/68 (52%), Gaps = 4/68 (5%)
Query: 97  TVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTRD---AG 153
           T   V AL YL  +  IIHRD+KP NILL+    I++ DFG +  L     + R     G
Sbjct: 138 TAEIVSALEYLHGK-GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVG 196
Query: 154 CRPYMAPE 161
              Y++PE
Sbjct: 197 TAQYVSPE 204

>pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286

Iteration: 1
 Score = 43.9 bits (102), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 27/68 (39%), Positives = 36/68 (52%), Gaps = 4/68 (5%)
Query: 97  TVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTRD---AG 153
           T   V AL YL  +  IIHRD+KP NILL+    I++ DFG +  L     + R     G
Sbjct: 115 TAEIVSALEYLHGK-GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVG 173
Query: 154 CRPYMAPE 161
              Y++PE
Sbjct: 174 TAQYVSPE 181

>pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286

Iteration: 1
 Score = 43.9 bits (102), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 27/68 (39%), Positives = 36/68 (52%), Gaps = 4/68 (5%)
Query: 97  TVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTRD---AG 153
           T   V AL YL  +  IIHRD+KP NILL+    I++ DFG +  L     + R     G
Sbjct: 113 TAEIVSALEYLHGK-GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVG 171
Query: 154 CRPYMAPE 161
              Y++PE
Sbjct: 172 TAQYVSPE 179

>pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362

Iteration: 1
 Score = 43.9 bits (102), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 40/162 (24%), Positives = 69/162 (42%), Gaps = 32/162 (19%)
Query: 31  EIGRGGFGTVNKMIHRSSDTVMAVKRIR--STVDEKDQRQLLMDL-----------DVVM 77
           +IG G FG    M  + S+ ++AVK I     +DE  +R+++              +V++
Sbjct: 26  DIGSGNFGVARLMRDKQSNELVAVKYIERGEKIDENVKREIINHRSLRHPNIVRFKEVIL 85
Query: 78  KSNECPYIVQFY--GALFKEVTVA--------------TVKALNYLKEELKIIHRDVKPS 121
                  ++++   G LF+ +  A               +  ++Y    +++ HRD+K  
Sbjct: 86  TPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYC-HAMQVCHRDLKLE 144
Query: 122 NILLDRRGA--IKLCDFGISGQLVDSIAKTRDAGCRPYMAPE 161
           N LLD   A  +K+C FG S   V         G   Y+APE
Sbjct: 145 NTLLDGSPAPRLKICAFGYSKSSVLHSQPKSTVGTPAYIAPE 186

>pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289

Iteration: 1
 Score = 43.9 bits (102), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 27/68 (39%), Positives = 36/68 (52%), Gaps = 4/68 (5%)
Query: 97  TVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTRD---AG 153
           T   V AL YL  +  IIHRD+KP NILL+    I++ DFG +  L     + R     G
Sbjct: 116 TAEIVSALEYLHGK-GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVG 174
Query: 154 CRPYMAPE 161
              Y++PE
Sbjct: 175 TAQYVSPE 182

>pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313

Iteration: 1
 Score = 43.9 bits (102), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 23/54 (42%), Positives = 31/54 (57%), Gaps = 4/54 (7%)
Query: 113 IIHRDVKPSNILLDRRGAIKLCDFGISGQL---VDSIAKTRDAGCRPYMAPERI 163
           I+H D+KP+N L+   G +KL DFGI+ Q+     S+ K    G   YM PE I
Sbjct: 148 IVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAI 200

>pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352

Iteration: 1
 Score = 43.9 bits (102), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 23/50 (46%), Positives = 33/50 (66%), Gaps = 1/50 (2%)
Query: 113 IIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTRD-AGCRPYMAPE 161
           I++RD+K  NILLD+ G IK+ DFG+  + +   AKT +  G   Y+APE
Sbjct: 140 IVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNEFCGTPDYIAPE 189

>pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316

Iteration: 1
 Score = 43.9 bits (102), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 27/68 (39%), Positives = 36/68 (52%), Gaps = 4/68 (5%)
Query: 97  TVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTRD---AG 153
           T   V AL YL  +  IIHRD+KP NILL+    I++ DFG +  L     + R     G
Sbjct: 143 TAEIVSALEYLHGK-GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVG 201
Query: 154 CRPYMAPE 161
              Y++PE
Sbjct: 202 TAQYVSPE 209

>pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303

Iteration: 1
 Score = 43.9 bits (102), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 38/174 (21%), Positives = 73/174 (41%), Gaps = 58/174 (33%)
Query: 23  SEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNEC 82
           + D +++  +G+G FG V K  +       A+K+IR T  E+    +L ++ ++   N  
Sbjct: 5   ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT--EEKLSTILSEVXLLASLNH- 61
Query: 83  PYIVQFYGA--------------------------------------------------L 92
            Y+V++Y A                                                  L
Sbjct: 62  QYVVRYYAAWLERRNFVKPXTAVKKKSTLFIQXEYCENRTLYDLIHSENLNQQRDEYWRL 121
Query: 93  FKEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSI 146
           F+++    ++AL+Y+  +  IIHR++KP NI +D    +K+ DFG++  +  S+
Sbjct: 122 FRQI----LEALSYIHSQ-GIIHRNLKPXNIFIDESRNVKIGDFGLAKNVHRSL 170

>pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343

Iteration: 1
 Score = 43.9 bits (102), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 23/54 (42%), Positives = 31/54 (57%), Gaps = 4/54 (7%)
Query: 113 IIHRDVKPSNILLDRRGAIKLCDFGISGQL---VDSIAKTRDAGCRPYMAPERI 163
           I+H D+KP+N L+   G +KL DFGI+ Q+     S+ K    G   YM PE I
Sbjct: 129 IVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAI 181

>pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390

Iteration: 1
 Score = 43.9 bits (102), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 23/54 (42%), Positives = 31/54 (57%), Gaps = 4/54 (7%)
Query: 113 IIHRDVKPSNILLDRRGAIKLCDFGISGQL---VDSIAKTRDAGCRPYMAPERI 163
           I+H D+KP+N L+   G +KL DFGI+ Q+     S+ K    G   YM PE I
Sbjct: 176 IVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAI 228

>pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316

Iteration: 1
 Score = 43.9 bits (102), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 42/200 (21%), Positives = 74/200 (37%), Gaps = 56/200 (28%)
Query: 19  YDFTSEDLQDLGEIGRGGFGTVNK-----MIHRSSDTVMAVKRIRSTVDEKDQRQLLMDL 73
           ++F  + L+    +GRG FG V +     +   ++   +AVK ++      + R L+ +L
Sbjct: 24  WEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSEL 83
Query: 74  DVVMKSNECPYIVQFYGA--------------------------------------LFKE 95
            +++       +V   GA                                      L+K+
Sbjct: 84  KILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKPEDLYKD 143
Query: 96  V---------TVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSI 146
                     +    K + +L    K IHRD+   NILL  +  +K+CDFG++  +    
Sbjct: 144 FLTLEHLIXYSFQVAKGMEFLASR-KXIHRDLAARNILLSEKNVVKICDFGLARDIXKDP 202
Query: 147 AKTRDAGCR---PYMAPERI 163
              R    R    +MAPE I
Sbjct: 203 DXVRKGDARLPLKWMAPETI 222

>pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 43.9 bits (102), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 27/81 (33%), Positives = 44/81 (54%), Gaps = 19/81 (23%)
Query: 101 VKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGI----------SGQLVDSIAKTR 150
           ++ L Y+     ++HRD+KPSN+LL+    +K+CDFG+          +G L + +A   
Sbjct: 136 LRGLKYIHSA-NVLHRDLKPSNLLLNTTSDLKICDFGLARVADPDHDHTGFLTEYVA--- 191
Query: 151 DAGCRPYMAPERIDPLRARGY 171
               R Y APE +  L ++GY
Sbjct: 192 ---TRWYRAPEIM--LNSKGY 207

>pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353

Iteration: 1
 Score = 43.9 bits (102), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 44/189 (23%), Positives = 81/189 (42%), Gaps = 47/189 (24%)
Query: 18  VYDFTSEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRI----------RSTVDEKDQR 67
           VY+ +S D Q    +G G +G V    H+ +  ++A+K+I          R+  + K  +
Sbjct: 6   VYNISS-DFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILK 64
Query: 68  QLLMDLDVVMKSNECP---------YIVQ--FYGALFKEVTVA-------------TVKA 103
               +  + + + + P         YI+Q      L + ++               T++A
Sbjct: 65  HFKHENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQYFIYQTLRA 124
Query: 104 LNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTRD-----------A 152
           +  L     +IHRD+KPSN+L++    +K+CDFG++  + +S A   +            
Sbjct: 125 VKVLHGS-NVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFV 183
Query: 153 GCRPYMAPE 161
             R Y APE
Sbjct: 184 ATRWYRAPE 192

>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288

Iteration: 1
 Score = 43.9 bits (102), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 40/170 (23%), Positives = 73/170 (42%), Gaps = 33/170 (19%)
Query: 24  EDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIR----------------STVDEKDQR 67
           E    L +IG G +G V K  +   +T  A+K+IR                S + E    
Sbjct: 2   EKYHGLEKIGEGTYGVVYKAQNNYGET-FALKKIRLEKEDEGIPSTTIREISILKELKHS 60
Query: 68  QLLMDLDVVMKSNECPYIVQFYGALFKEVT------VATVKALNYLKEEL---------K 112
            ++   DV+        + +      K++       + +V A ++L + L         +
Sbjct: 61  NIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRR 120
Query: 113 IIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAK-TRDAGCRPYMAPE 161
           ++HRD+KP N+L++R G +K+ DFG++      + K T +     Y AP+
Sbjct: 121 VLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEVVTLWYRAPD 170

>pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362

Iteration: 1
 Score = 43.9 bits (102), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 20/58 (34%), Positives = 30/58 (51%)
Query: 106 YLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERI 163
           ++  E  ++HRD+ P NILL     I +CDF ++ +      KT     R Y APE +
Sbjct: 148 HVLHEAGVVHRDLHPGNILLADNNDITICDFNLAREDTADANKTHYVTHRWYRAPELV 205

>pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292

Iteration: 1
 Score = 43.9 bits (102), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 49/185 (26%), Positives = 85/185 (45%), Gaps = 36/185 (19%)
Query: 14  SPDTVY-DFTSEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKD--QRQLL 70
           +PD +   FT +D +    +G+G FG V     + S  ++A+K +  +  EK+  + QL 
Sbjct: 12  TPDILTRHFTIDDFEIGRPLGKGKFGNVYLAREKKSHFIVALKVLFKSQIEKEGVEHQLR 71
Query: 71  MDLDVVMKSNECPYIVQFY------------------GALFKEVTVA-------TVKALN 105
            ++++    +  P I++ Y                  G L+KE+  +       T   + 
Sbjct: 72  REIEIQAHLHH-PNILRLYNYFYDRRRIYLILEYAPRGELYKELQKSCTFDEQRTATIME 130
Query: 106 YLKEEL------KIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTRDAGCRPYMA 159
            L + L      K+IHRD+KP N+LL  +G +K+ DFG S     S+ +    G   Y+ 
Sbjct: 131 ELADALMYCHGKKVIHRDIKPENLLLGLKGELKIADFGWSVH-APSLRRKTMCGTLDYLP 189
Query: 160 PERID 164
           PE I+
Sbjct: 190 PEMIE 194

>pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321

Iteration: 1
 Score = 43.9 bits (102), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 47/178 (26%), Positives = 74/178 (41%), Gaps = 41/178 (23%)
Query: 25  DLQDLGEIGRGGFGTVNKMIH-RSSDTV---MAVKRIRSTVDEKDQRQLLMDLDVVMKSN 80
           +L+ +  +G G FGTV K I     +TV   +A+K +  T   K   +  MD  ++M S 
Sbjct: 39  ELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEF-MDEALIMASM 97
Query: 81  ECPYIVQFYGA--------------------------------LFKEVTVATVKALNYLK 108
           + P++V+  G                                 L     V   K + YL 
Sbjct: 98  DHPHLVRLLGVCLSPTIQLVTQLMPHGCLLEYVHEHKDNIGSQLLLNWCVQIAKGMMYL- 156
Query: 109 EELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLV-DSIAKTRDAGCRP--YMAPERI 163
           EE +++HRD+   N+L+     +K+ DFG++  L  D      D G  P  +MA E I
Sbjct: 157 EERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECI 214

>pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576

Iteration: 1
 Score = 43.9 bits (102), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 22/63 (34%), Positives = 34/63 (53%)
Query: 112 KIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPLRARGY 171
           +I++RD+KP NILLD  G I++ D G++  + +        G   YMAPE +   R    
Sbjct: 306 RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVKNERYTFS 365
Query: 172 PSF 174
           P +
Sbjct: 366 PDW 368

>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288

Iteration: 1
 Score = 43.5 bits (101), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 40/170 (23%), Positives = 73/170 (42%), Gaps = 33/170 (19%)
Query: 24  EDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIR----------------STVDEKDQR 67
           E    L +IG G +G V K  +   +T  A+K+IR                S + E    
Sbjct: 2   EKYHGLEKIGEGTYGVVYKAQNNYGET-FALKKIRLEKEDEGIPSTTIREISILKELKHS 60
Query: 68  QLLMDLDVVMKSNECPYIVQFYGALFKEVT------VATVKALNYLKEEL---------K 112
            ++   DV+        + +      K++       + +V A ++L + L         +
Sbjct: 61  NIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRR 120
Query: 113 IIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAK-TRDAGCRPYMAPE 161
           ++HRD+KP N+L++R G +K+ DFG++      + K T +     Y AP+
Sbjct: 121 VLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEVVTLWYRAPD 170

>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271

Iteration: 1
 Score = 43.5 bits (101), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 52/191 (27%), Positives = 77/191 (40%), Gaps = 56/191 (29%)
Query: 20  DFTSEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMD------L 73
           DF    L+++  IG GGFG V +      +  +AVK  R   DE D  Q + +      L
Sbjct: 5   DFAELTLEEI--IGIGGFGKVYRAFWIGDE--VAVKAARHDPDE-DISQTIENVRQEAKL 59
Query: 74  DVVMKSNECPYIVQFYGALFKE-------------------------------VTVATVK 102
             ++K    P I+   G   KE                                 V   +
Sbjct: 60  FAMLKH---PNIIALRGVCLKEPNLCLVMEFARGGPLNRVLSGKRIPPDILVNWAVQIAR 116
Query: 103 ALNYLKEE--LKIIHRDVKPSNILLDRR--------GAIKLCDFGISGQLVDSIAKTRDA 152
            +NYL +E  + IIHRD+K SNIL+ ++          +K+ DFG++ +      K   A
Sbjct: 117 GMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREW-HRTTKMSAA 175
Query: 153 GCRPYMAPERI 163
           G   +MAPE I
Sbjct: 176 GAYAWMAPEVI 186

>pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362

Iteration: 1
 Score = 43.5 bits (101), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 40/162 (24%), Positives = 69/162 (42%), Gaps = 32/162 (19%)
Query: 31  EIGRGGFGTVNKMIHRSSDTVMAVKRIR--STVDEKDQRQLLMDL-----------DVVM 77
           +IG G FG    M  + S+ ++AVK I     +DE  +R+++              +V++
Sbjct: 26  DIGSGNFGVARLMRDKQSNELVAVKYIERGEKIDENVKREIINHRSLRHPNIVRFKEVIL 85
Query: 78  KSNECPYIVQFY--GALFKEVTVA--------------TVKALNYLKEELKIIHRDVKPS 121
                  ++++   G LF+ +  A               +  ++Y    +++ HRD+K  
Sbjct: 86  TPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYC-HAMQVCHRDLKLE 144
Query: 122 NILLDRRGA--IKLCDFGISGQLVDSIAKTRDAGCRPYMAPE 161
           N LLD   A  +K+C FG S   V         G   Y+APE
Sbjct: 145 NTLLDGSPAPRLKICAFGYSKSSVLHSQPKDTVGTPAYIAPE 186

>pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328

Iteration: 1
 Score = 43.5 bits (101), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 47/178 (26%), Positives = 74/178 (41%), Gaps = 41/178 (23%)
Query: 25  DLQDLGEIGRGGFGTVNKMIH-RSSDTV---MAVKRIRSTVDEKDQRQLLMDLDVVMKSN 80
           +L+ +  +G G FGTV K I     +TV   +A+K +  T   K   +  MD  ++M S 
Sbjct: 16  ELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEF-MDEALIMASM 74
Query: 81  ECPYIVQFYGA--------------------------------LFKEVTVATVKALNYLK 108
           + P++V+  G                                 L     V   K + YL 
Sbjct: 75  DHPHLVRLLGVCLSPTIQLVTQLMPHGCLLEYVHEHKDNIGSQLLLNWCVQIAKGMMYL- 133
Query: 109 EELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLV-DSIAKTRDAGCRP--YMAPERI 163
           EE +++HRD+   N+L+     +K+ DFG++  L  D      D G  P  +MA E I
Sbjct: 134 EERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECI 191

>pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362

Iteration: 1
 Score = 43.5 bits (101), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 20/58 (34%), Positives = 30/58 (51%)
Query: 106 YLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERI 163
           ++  E  ++HRD+ P NILL     I +CDF ++ +      KT     R Y APE +
Sbjct: 148 HVLHEAGVVHRDLHPGNILLADNNDITICDFNLAREDTADANKTHYVTHRWYRAPELV 205

>pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390

Iteration: 1
 Score = 43.5 bits (101), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 23/54 (42%), Positives = 31/54 (57%), Gaps = 4/54 (7%)
Query: 113 IIHRDVKPSNILLDRRGAIKLCDFGISGQL---VDSIAKTRDAGCRPYMAPERI 163
           I+H D+KP+N L+   G +KL DFGI+ Q+     S+ K    G   YM PE I
Sbjct: 176 IVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAI 228

>pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317

Iteration: 1
 Score = 43.5 bits (101), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 23/54 (42%), Positives = 31/54 (57%), Gaps = 4/54 (7%)
Query: 113 IIHRDVKPSNILLDRRGAIKLCDFGISGQL---VDSIAKTRDAGCRPYMAPERI 163
           I+H D+KP+N L+   G +KL DFGI+ Q+     S+ K    G   YM PE I
Sbjct: 132 IVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAI 184

>pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 43.5 bits (101), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 42/198 (21%), Positives = 73/198 (36%), Gaps = 54/198 (27%)
Query: 19  YDFTSEDLQDLGEIGRGGFGTVNK-----MIHRSSDTVMAVKRIRSTVDEKDQRQLLMDL 73
           ++F  + L     +GRG FG V +     +   ++   +AVK ++      + R L+ +L
Sbjct: 22  WEFPRDRLNLGKPLGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSEL 81
Query: 74  DVVMKSNECPYIVQFYGA------------------------------------LFKEV- 96
            +++       +V   GA                                    L+K+  
Sbjct: 82  KILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKDLYKDFL 141
Query: 97  --------TVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAK 148
                   +    K + +L    K IHRD+   NILL  +  +K+CDFG++  +      
Sbjct: 142 TLEHLICYSFQVAKGMEFLASR-KXIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDY 200
Query: 149 TRDAGCR---PYMAPERI 163
            R    R    +MAPE I
Sbjct: 201 VRKGDARLPLKWMAPETI 218

>pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320

Iteration: 1
 Score = 43.5 bits (101), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 23/54 (42%), Positives = 31/54 (57%), Gaps = 4/54 (7%)
Query: 113 IIHRDVKPSNILLDRRGAIKLCDFGISGQL---VDSIAKTRDAGCRPYMAPERI 163
           I+H D+KP+N L+   G +KL DFGI+ Q+     S+ K    G   YM PE I
Sbjct: 128 IVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAI 180

>pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342

Iteration: 1
 Score = 43.5 bits (101), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 23/54 (42%), Positives = 31/54 (57%), Gaps = 4/54 (7%)
Query: 113 IIHRDVKPSNILLDRRGAIKLCDFGISGQL---VDSIAKTRDAGCRPYMAPERI 163
           I+H D+KP+N L+   G +KL DFGI+ Q+     S+ K    G   YM PE I
Sbjct: 176 IVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAI 228

>pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266

Iteration: 1
 Score = 43.5 bits (101), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 41/154 (26%), Positives = 67/154 (43%), Gaps = 40/154 (25%)
Query: 25  DLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRS-TVDEKDQRQLLMDLDVVMKSNECP 83
           +L  + EIG G FG V+     + D V A+K IR   + E+D    + + +V+MK +  P
Sbjct: 8   ELTFVQEIGSGQFGLVHLGYWLNKDKV-AIKTIREGAMSEED---FIEEAEVMMKLSH-P 62
Query: 84  YIVQFYGALFKEVTVATV---------------------------------KALNYLKEE 110
            +VQ YG   ++  +  V                                 + + YL EE
Sbjct: 63  KLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYL-EE 121
Query: 111 LKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVD 144
             +IHRD+   N L+     IK+ DFG++  ++D
Sbjct: 122 ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLD 155

>pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 43.5 bits (101), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 22/51 (43%), Positives = 29/51 (56%)
Query: 113 IIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERI 163
           IIHRD+KPSNI++     +K+ DFG++     S   T     R Y APE I
Sbjct: 147 IIHRDLKPSNIVVKSDATLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVI 197

>pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 43.5 bits (101), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 22/51 (43%), Positives = 29/51 (56%)
Query: 113 IIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERI 163
           IIHRD+KPSNI++     +K+ DFG++     S   T     R Y APE I
Sbjct: 147 IIHRDLKPSNIVVKSDATLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVI 197

>pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576

Iteration: 1
 Score = 43.5 bits (101), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 22/63 (34%), Positives = 34/63 (53%)
Query: 112 KIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPLRARGY 171
           +I++RD+KP NILLD  G I++ D G++  + +        G   YMAPE +   R    
Sbjct: 306 RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVKNERYTFS 365
Query: 172 PSF 174
           P +
Sbjct: 366 PDW 368

>pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264

Iteration: 1
 Score = 43.5 bits (101), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 41/154 (26%), Positives = 67/154 (43%), Gaps = 40/154 (25%)
Query: 25  DLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRS-TVDEKDQRQLLMDLDVVMKSNECP 83
           +L  + EIG G FG V+     + D V A+K IR   + E+D    + + +V+MK +  P
Sbjct: 6   ELTFVQEIGSGQFGLVHLGYWLNKDKV-AIKTIREGAMSEED---FIEEAEVMMKLSH-P 60
Query: 84  YIVQFYGALFKEVTVATV---------------------------------KALNYLKEE 110
            +VQ YG   ++  +  V                                 + + YL EE
Sbjct: 61  KLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYL-EE 119
Query: 111 LKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVD 144
             +IHRD+   N L+     IK+ DFG++  ++D
Sbjct: 120 ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLD 153

>pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360

Iteration: 1
 Score = 43.5 bits (101), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 22/54 (40%), Positives = 31/54 (57%), Gaps = 1/54 (1%)
Query: 111 LKIIHRDVKPSNILLDRR-GAIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERI 163
           + + HRD+KP N+L++   G +KLCDFG + +L  S         R Y APE I
Sbjct: 150 VNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPNVAYICSRYYRAPELI 203

>pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379

Iteration: 1
 Score = 43.5 bits (101), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 22/51 (43%), Positives = 30/51 (58%)
Query: 113 IIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERI 163
           IIHRD+KPSNI++     +K+ DFG++     S   T +   R Y APE I
Sbjct: 147 IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPEVVTRYYRAPEVI 197

>pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364

Iteration: 1
 Score = 43.5 bits (101), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 27/81 (33%), Positives = 44/81 (54%), Gaps = 19/81 (23%)
Query: 101 VKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGI----------SGQLVDSIAKTR 150
           ++ L Y+     ++HRD+KPSN+LL+    +K+CDFG+          +G L + +A   
Sbjct: 138 LRGLKYIHSA-NVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVA--- 193
Query: 151 DAGCRPYMAPERIDPLRARGY 171
               R Y APE +  L ++GY
Sbjct: 194 ---TRWYRAPEIM--LNSKGY 209

>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288

Iteration: 1
 Score = 43.1 bits (100), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 40/170 (23%), Positives = 73/170 (42%), Gaps = 33/170 (19%)
Query: 24  EDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIR----------------STVDEKDQR 67
           E    L +IG G +G V K  +   +T  A+K+IR                S + E    
Sbjct: 2   EKYHGLEKIGEGTYGVVYKAQNNYGET-FALKKIRLEKEDEGIPSTTIREISILKELKHS 60
Query: 68  QLLMDLDVVMKSNECPYIVQFYGALFKEVT------VATVKALNYLKEEL---------K 112
            ++   DV+        + +      K++       + +V A ++L + L         +
Sbjct: 61  NIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRR 120
Query: 113 IIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAK-TRDAGCRPYMAPE 161
           ++HRD+KP N+L++R G +K+ DFG++      + K T +     Y AP+
Sbjct: 121 VLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPD 170

>pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360

Iteration: 1
 Score = 43.1 bits (100), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 27/81 (33%), Positives = 44/81 (54%), Gaps = 19/81 (23%)
Query: 101 VKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGI----------SGQLVDSIAKTR 150
           ++ L Y+     ++HRD+KPSN+LL+    +K+CDFG+          +G L + +A   
Sbjct: 134 LRGLKYIHSA-NVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVA--- 189
Query: 151 DAGCRPYMAPERIDPLRARGY 171
               R Y APE +  L ++GY
Sbjct: 190 ---TRWYRAPEIM--LNSKGY 205

>pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323

Iteration: 1
 Score = 43.1 bits (100), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 28/72 (38%), Positives = 38/72 (52%), Gaps = 4/72 (5%)
Query: 103 ALNYLKEELKIIHRDVKPSNILLDRRGA---IKLCDFGISGQLVDSIAKTRDAGCRPYMA 159
           A+ YL E   IIHRD+KP N+LL  +     IK+ DFG S  L ++       G   Y+A
Sbjct: 126 AVQYLHEN-GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLA 184
Query: 160 PERIDPLRARGY 171
           PE +  +   GY
Sbjct: 185 PEVLVSVGTAGY 196

>pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329

Iteration: 1
 Score = 43.1 bits (100), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 28/72 (38%), Positives = 38/72 (52%), Gaps = 4/72 (5%)
Query: 103 ALNYLKEELKIIHRDVKPSNILLDRRGA---IKLCDFGISGQLVDSIAKTRDAGCRPYMA 159
           A+ YL E   IIHRD+KP N+LL  +     IK+ DFG S  L ++       G   Y+A
Sbjct: 132 AVQYLHEN-GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLA 190
Query: 160 PERIDPLRARGY 171
           PE +  +   GY
Sbjct: 191 PEVLVSVGTAGY 202

>pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360

Iteration: 1
 Score = 43.1 bits (100), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 27/81 (33%), Positives = 44/81 (54%), Gaps = 19/81 (23%)
Query: 101 VKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGI----------SGQLVDSIAKTR 150
           ++ L Y+     ++HRD+KPSN+LL+    +K+CDFG+          +G L + +A   
Sbjct: 134 LRGLKYIHSA-NVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVA--- 189
Query: 151 DAGCRPYMAPERIDPLRARGY 171
               R Y APE +  L ++GY
Sbjct: 190 ---TRWYRAPEIM--LNSKGY 205

>pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364

Iteration: 1
 Score = 43.1 bits (100), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 27/81 (33%), Positives = 44/81 (54%), Gaps = 19/81 (23%)
Query: 101 VKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGI----------SGQLVDSIAKTR 150
           ++ L Y+     ++HRD+KPSN+LL+    +K+CDFG+          +G L + +A   
Sbjct: 138 LRGLKYIHSA-NVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVA--- 193
Query: 151 DAGCRPYMAPERIDPLRARGY 171
               R Y APE +  L ++GY
Sbjct: 194 ---TRWYRAPEIM--LNSKGY 209

>pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322

Iteration: 1
 Score = 43.1 bits (100), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 28/72 (38%), Positives = 38/72 (52%), Gaps = 4/72 (5%)
Query: 103 ALNYLKEELKIIHRDVKPSNILLDRRGA---IKLCDFGISGQLVDSIAKTRDAGCRPYMA 159
           A+ YL E   IIHRD+KP N+LL  +     IK+ DFG S  L ++       G   Y+A
Sbjct: 125 AVQYLHEN-GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLA 183
Query: 160 PERIDPLRARGY 171
           PE +  +   GY
Sbjct: 184 PEVLVSVGTAGY 195

>pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443

Iteration: 1
 Score = 43.1 bits (100), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 28/72 (38%), Positives = 38/72 (52%), Gaps = 4/72 (5%)
Query: 103 ALNYLKEELKIIHRDVKPSNILLDRRGA---IKLCDFGISGQLVDSIAKTRDAGCRPYMA 159
           A+ YL E   IIHRD+KP N+LL  +     IK+ DFG S  L ++       G   Y+A
Sbjct: 265 AVQYLHEN-GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLA 323
Query: 160 PERIDPLRARGY 171
           PE +  +   GY
Sbjct: 324 PEVLVSVGTAGY 335

>pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 43.1 bits (100), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 22/51 (43%), Positives = 29/51 (56%)
Query: 113 IIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERI 163
           IIHRD+KPSNI++     +K+ DFG++     S   T     R Y APE I
Sbjct: 147 IIHRDLKPSNIVVKSDATLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVI 197

>pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322

Iteration: 1
 Score = 43.1 bits (100), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 28/72 (38%), Positives = 38/72 (52%), Gaps = 4/72 (5%)
Query: 103 ALNYLKEELKIIHRDVKPSNILLDRRGA---IKLCDFGISGQLVDSIAKTRDAGCRPYMA 159
           A+ YL E   IIHRD+KP N+LL  +     IK+ DFG S  L ++       G   Y+A
Sbjct: 126 AVQYLHEN-GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLA 184
Query: 160 PERIDPLRARGY 171
           PE +  +   GY
Sbjct: 185 PEVLVSVGTAGY 196

>pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323

Iteration: 1
 Score = 43.1 bits (100), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 28/72 (38%), Positives = 38/72 (52%), Gaps = 4/72 (5%)
Query: 103 ALNYLKEELKIIHRDVKPSNILLDRRGA---IKLCDFGISGQLVDSIAKTRDAGCRPYMA 159
           A+ YL E   IIHRD+KP N+LL  +     IK+ DFG S  L ++       G   Y+A
Sbjct: 126 AVQYLHEN-GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLA 184
Query: 160 PERIDPLRARGY 171
           PE +  +   GY
Sbjct: 185 PEVLVSVGTAGY 196

>pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380

Iteration: 1
 Score = 43.1 bits (100), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 27/81 (33%), Positives = 44/81 (54%), Gaps = 19/81 (23%)
Query: 101 VKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGI----------SGQLVDSIAKTR 150
           ++ L Y+     ++HRD+KPSN+LL+    +K+CDFG+          +G L + +A   
Sbjct: 154 LRGLKYIHSA-NVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVA--- 209
Query: 151 DAGCRPYMAPERIDPLRARGY 171
               R Y APE +  L ++GY
Sbjct: 210 ---TRWYRAPEIM--LNSKGY 225

>pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330

Iteration: 1
 Score = 43.1 bits (100), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 34/147 (23%), Positives = 66/147 (44%), Gaps = 42/147 (28%)
Query: 32  IGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIV----- 86
           IG G +    + +H++++   AVK I     +K +R    +++++++  + P I+     
Sbjct: 35  IGVGSYSECKRCVHKATNMEYAVKVI-----DKSKRDPSEEIEILLRYGQHPNIITLKDV 89
Query: 87  --------------------------QFYGALFKEVTVATV-KALNYLKEELKIIHRDVK 119
                                     +F+        + T+ K + YL  +  ++HRD+K
Sbjct: 90  YDDGKHVYLVTELMRGGELLDKILRQKFFSEREASFVLHTIGKTVEYLHSQ-GVVHRDLK 148
Query: 120 PSNIL-LDRRG---AIKLCDFGISGQL 142
           PSNIL +D  G    +++CDFG + QL
Sbjct: 149 PSNILYVDESGNPECLRICDFGFAKQL 175

>pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349

Iteration: 1
 Score = 43.1 bits (100), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 48/191 (25%), Positives = 78/191 (40%), Gaps = 37/191 (19%)
Query: 7   SSGKLKLSPDTVYDFTSED-LQDL----GEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTV 61
           + G   L PD   D ++ D L D      E+GRG    V +   + +    A+K ++ TV
Sbjct: 31  APGTASLVPDYWIDGSNRDALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV 90
Query: 62  DEKDQRQ---LLMDL---------DVVMKSNECPYIVQFY--GALFKEVTV--------- 98
           D+K  R    +L+ L         ++     E   +++    G LF  +           
Sbjct: 91  DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLELVTGGELFDRIVEKGYYSERDA 150
Query: 99  -----ATVKALNYLKEELKIIHRDVKPSNILLDR---RGAIKLCDFGISGQLVDSIAKTR 150
                  ++A+ YL E   I+HRD+KP N+L         +K+ DFG+S  +   +    
Sbjct: 151 ADAVKQILEAVAYLHEN-GIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKT 209
Query: 151 DAGCRPYMAPE 161
             G   Y APE
Sbjct: 210 VCGTPGYCAPE 220

>pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 43.1 bits (100), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 22/51 (43%), Positives = 29/51 (56%)
Query: 113 IIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERI 163
           IIHRD+KPSNI++     +K+ DFG++     S   T     R Y APE I
Sbjct: 147 IIHRDLKPSNIVVKSDATLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVI 197

>pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419

Iteration: 1
 Score = 43.1 bits (100), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 28/72 (38%), Positives = 38/72 (52%), Gaps = 4/72 (5%)
Query: 103 ALNYLKEELKIIHRDVKPSNILLDRRGA---IKLCDFGISGQLVDSIAKTRDAGCRPYMA 159
           A+ YL E   IIHRD+KP N+LL  +     IK+ DFG S  L ++       G   Y+A
Sbjct: 251 AVQYLHEN-GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLA 309
Query: 160 PERIDPLRARGY 171
           PE +  +   GY
Sbjct: 310 PEVLVSVGTAGY 321

>pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 43.1 bits (100), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 22/51 (43%), Positives = 29/51 (56%)
Query: 113 IIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERI 163
           IIHRD+KPSNI++     +K+ DFG++     S   T     R Y APE I
Sbjct: 147 IIHRDLKPSNIVVKSDATLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVI 197

>pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346

Iteration: 1
 Score = 43.1 bits (100), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 34/147 (23%), Positives = 66/147 (44%), Gaps = 42/147 (28%)
Query: 32  IGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIV----- 86
           IG G +    + +H++++   AVK I     +K +R    +++++++  + P I+     
Sbjct: 35  IGVGSYSECKRCVHKATNMEYAVKVI-----DKSKRDPSEEIEILLRYGQHPNIITLKDV 89
Query: 87  --------------------------QFYGALFKEVTVATV-KALNYLKEELKIIHRDVK 119
                                     +F+        + T+ K + YL  +  ++HRD+K
Sbjct: 90  YDDGKHVYLVTELMRGGELLDKILRQKFFSEREASFVLHTIGKTVEYLHSQ-GVVHRDLK 148
Query: 120 PSNIL-LDRRG---AIKLCDFGISGQL 142
           PSNIL +D  G    +++CDFG + QL
Sbjct: 149 PSNILYVDESGNPECLRICDFGFAKQL 175

>pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 42.7 bits (99), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 27/81 (33%), Positives = 44/81 (54%), Gaps = 19/81 (23%)
Query: 101 VKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGI----------SGQLVDSIAKTR 150
           ++ L Y+     ++HRD+KPSN+LL+    +K+CDFG+          +G L + +A   
Sbjct: 136 LRGLKYIHSA-NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVA--- 191
Query: 151 DAGCRPYMAPERIDPLRARGY 171
               R Y APE +  L ++GY
Sbjct: 192 ---TRWYRAPEIM--LNSKGY 207

>pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360

Iteration: 1
 Score = 42.7 bits (99), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 27/81 (33%), Positives = 44/81 (54%), Gaps = 19/81 (23%)
Query: 101 VKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGI----------SGQLVDSIAKTR 150
           ++ L Y+     ++HRD+KPSN+LL+    +K+CDFG+          +G L + +A   
Sbjct: 134 LRGLKYIHSA-NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVA--- 189
Query: 151 DAGCRPYMAPERIDPLRARGY 171
               R Y APE +  L ++GY
Sbjct: 190 ---TRWYRAPEIM--LNSKGY 205

>pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 42.7 bits (99), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 27/81 (33%), Positives = 44/81 (54%), Gaps = 19/81 (23%)
Query: 101 VKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGI----------SGQLVDSIAKTR 150
           ++ L Y+     ++HRD+KPSN+LL+    +K+CDFG+          +G L + +A   
Sbjct: 136 LRGLKYIHSA-NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVA--- 191
Query: 151 DAGCRPYMAPERIDPLRARGY 171
               R Y APE +  L ++GY
Sbjct: 192 ---TRWYRAPEIM--LNSKGY 207

>pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358

Iteration: 1
 Score = 42.7 bits (99), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 27/81 (33%), Positives = 44/81 (54%), Gaps = 19/81 (23%)
Query: 101 VKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGI----------SGQLVDSIAKTR 150
           ++ L Y+     ++HRD+KPSN+LL+    +K+CDFG+          +G L + +A   
Sbjct: 132 LRGLKYIHSA-NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVA--- 187
Query: 151 DAGCRPYMAPERIDPLRARGY 171
               R Y APE +  L ++GY
Sbjct: 188 ---TRWYRAPEIM--LNSKGY 203

>pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345

Iteration: 1
 Score = 42.7 bits (99), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 23/50 (46%), Positives = 32/50 (64%), Gaps = 1/50 (2%)
Query: 113 IIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTRD-AGCRPYMAPE 161
           I++RD+K  NILLD+ G IK+ DFG+  + +   AKT    G   Y+APE
Sbjct: 139 IVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNXFCGTPDYIAPE 188

>pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688

Iteration: 1
 Score = 42.7 bits (99), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 37/166 (22%), Positives = 65/166 (39%), Gaps = 38/166 (22%)
Query: 32  IGRGGFGTVNKMIHRSSDTVMAVKRI-RSTVDEKDQRQLLMDLDVVMK---SNECPYIV- 86
           IGRGGFG V       +  + A+K + +  +  K    L ++  +++    + +CP+IV 
Sbjct: 196 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 255
Query: 87  -------------------------------QFYGALFKEVTVATVKALNYLKEELKIIH 115
                                           F  A  +      +  L ++     +++
Sbjct: 256 MSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRF-VVY 314
Query: 116 RDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTRDAGCRPYMAPE 161
           RD+KP+NILLD  G +++ D G++             G   YMAPE
Sbjct: 315 RDLKPANILLDEHGHVRISDLGLACDFSKKKPHA-SVGTHGYMAPE 359

>pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 42.7 bits (99), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 27/81 (33%), Positives = 44/81 (54%), Gaps = 19/81 (23%)
Query: 101 VKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGI----------SGQLVDSIAKTR 150
           ++ L Y+     ++HRD+KPSN+LL+    +K+CDFG+          +G L + +A   
Sbjct: 139 LRGLKYIHSA-NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVA--- 194
Query: 151 DAGCRPYMAPERIDPLRARGY 171
               R Y APE +  L ++GY
Sbjct: 195 ---TRWYRAPEIM--LNSKGY 210

>pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366

Iteration: 1
 Score = 42.7 bits (99), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 27/81 (33%), Positives = 44/81 (54%), Gaps = 19/81 (23%)
Query: 101 VKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGI----------SGQLVDSIAKTR 150
           ++ L Y+     ++HRD+KPSN+LL+    +K+CDFG+          +G L + +A   
Sbjct: 140 LRGLKYIHSA-NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVA--- 195
Query: 151 DAGCRPYMAPERIDPLRARGY 171
               R Y APE +  L ++GY
Sbjct: 196 ---TRWYRAPEIM--LNSKGY 211

>pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357

Iteration: 1
 Score = 42.7 bits (99), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 27/81 (33%), Positives = 44/81 (54%), Gaps = 19/81 (23%)
Query: 101 VKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGI----------SGQLVDSIAKTR 150
           ++ L Y+     ++HRD+KPSN+LL+    +K+CDFG+          +G L + +A   
Sbjct: 131 LRGLKYIHSA-NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVA--- 186
Query: 151 DAGCRPYMAPERIDPLRARGY 171
               R Y APE +  L ++GY
Sbjct: 187 ---TRWYRAPEIM--LNSKGY 202

>pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364

Iteration: 1
 Score = 42.7 bits (99), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 27/81 (33%), Positives = 44/81 (54%), Gaps = 19/81 (23%)
Query: 101 VKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGI----------SGQLVDSIAKTR 150
           ++ L Y+     ++HRD+KPSN+LL+    +K+CDFG+          +G L + +A   
Sbjct: 138 LRGLKYIHSA-NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVA--- 193
Query: 151 DAGCRPYMAPERIDPLRARGY 171
               R Y APE +  L ++GY
Sbjct: 194 ---TRWYRAPEIM--LNSKGY 209

>pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327

Iteration: 1
 Score = 42.7 bits (99), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 22/45 (48%), Positives = 27/45 (60%), Gaps = 1/45 (2%)
Query: 95  EVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGIS 139
           E+ +   + L+YL     IIHRDVK  NILLD     K+ DFGIS
Sbjct: 143 EICIGAARGLHYLHTR-AIIHRDVKSINILLDENFVPKITDFGIS 186

>pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321

Iteration: 1
 Score = 42.7 bits (99), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 22/45 (48%), Positives = 27/45 (60%), Gaps = 1/45 (2%)
Query: 95  EVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGIS 139
           E+ +   + L+YL     IIHRDVK  NILLD     K+ DFGIS
Sbjct: 143 EICIGAARGLHYLHTR-AIIHRDVKSINILLDENFVPKITDFGIS 186

>pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380

Iteration: 1
 Score = 42.7 bits (99), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 27/81 (33%), Positives = 44/81 (54%), Gaps = 19/81 (23%)
Query: 101 VKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGI----------SGQLVDSIAKTR 150
           ++ L Y+     ++HRD+KPSN+LL+    +K+CDFG+          +G L + +A   
Sbjct: 154 LRGLKYIHSA-NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVA--- 209
Query: 151 DAGCRPYMAPERIDPLRARGY 171
               R Y APE +  L ++GY
Sbjct: 210 ---TRWYRAPEIM--LNSKGY 225

>pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689

Iteration: 1
 Score = 42.7 bits (99), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 37/166 (22%), Positives = 65/166 (39%), Gaps = 38/166 (22%)
Query: 32  IGRGGFGTVNKMIHRSSDTVMAVKRI-RSTVDEKDQRQLLMDLDVVMK---SNECPYIV- 86
           IGRGGFG V       +  + A+K + +  +  K    L ++  +++    + +CP+IV 
Sbjct: 197 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 256
Query: 87  -------------------------------QFYGALFKEVTVATVKALNYLKEELKIIH 115
                                           F  A  +      +  L ++     +++
Sbjct: 257 MSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRF-VVY 315
Query: 116 RDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTRDAGCRPYMAPE 161
           RD+KP+NILLD  G +++ D G++             G   YMAPE
Sbjct: 316 RDLKPANILLDEHGHVRISDLGLACDFSKKKPHA-SVGTHGYMAPE 360

>pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368

Iteration: 1
 Score = 42.7 bits (99), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 27/81 (33%), Positives = 44/81 (54%), Gaps = 19/81 (23%)
Query: 101 VKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGI----------SGQLVDSIAKTR 150
           ++ L Y+     ++HRD+KPSN+LL+    +K+CDFG+          +G L + +A   
Sbjct: 142 LRGLKYIHSA-NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVA--- 197
Query: 151 DAGCRPYMAPERIDPLRARGY 171
               R Y APE +  L ++GY
Sbjct: 198 ---TRWYRAPEIM--LNSKGY 213

>pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368

Iteration: 1
 Score = 42.7 bits (99), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 27/81 (33%), Positives = 44/81 (54%), Gaps = 19/81 (23%)
Query: 101 VKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGI----------SGQLVDSIAKTR 150
           ++ L Y+     ++HRD+KPSN+LL+    +K+CDFG+          +G L + +A   
Sbjct: 134 LRGLKYIHSA-NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVA--- 189
Query: 151 DAGCRPYMAPERIDPLRARGY 171
               R Y APE +  L ++GY
Sbjct: 190 ---TRWYRAPEIM--LNSKGY 205

>pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 42.7 bits (99), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 21/52 (40%), Positives = 31/52 (59%), Gaps = 3/52 (5%)
Query: 113 IIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAK---TRDAGCRPYMAPE 161
           I HRD+KP N+LLD R  +K+ DFG++     +  +    +  G  PY+APE
Sbjct: 125 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPE 176

>pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689

Iteration: 1
 Score = 42.7 bits (99), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 37/166 (22%), Positives = 65/166 (39%), Gaps = 38/166 (22%)
Query: 32  IGRGGFGTVNKMIHRSSDTVMAVKRI-RSTVDEKDQRQLLMDLDVVMK---SNECPYIV- 86
           IGRGGFG V       +  + A+K + +  +  K    L ++  +++    + +CP+IV 
Sbjct: 197 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 256
Query: 87  -------------------------------QFYGALFKEVTVATVKALNYLKEELKIIH 115
                                           F  A  +      +  L ++     +++
Sbjct: 257 MSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRF-VVY 315
Query: 116 RDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTRDAGCRPYMAPE 161
           RD+KP+NILLD  G +++ D G++             G   YMAPE
Sbjct: 316 RDLKPANILLDEHGHVRISDLGLACDFSKKKPHA-SVGTHGYMAPE 360

>pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358

Iteration: 1
 Score = 42.7 bits (99), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 27/81 (33%), Positives = 44/81 (54%), Gaps = 19/81 (23%)
Query: 101 VKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGI----------SGQLVDSIAKTR 150
           ++ L Y+     ++HRD+KPSN+LL+    +K+CDFG+          +G L + +A   
Sbjct: 132 LRGLKYIHSA-NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVA--- 187
Query: 151 DAGCRPYMAPERIDPLRARGY 171
               R Y APE +  L ++GY
Sbjct: 188 ---TRWYRAPEIM--LNSKGY 203

>pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695

Iteration: 1
 Score = 42.7 bits (99), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 37/166 (22%), Positives = 65/166 (39%), Gaps = 38/166 (22%)
Query: 32  IGRGGFGTVNKMIHRSSDTVMAVKRI-RSTVDEKDQRQLLMDLDVVMK---SNECPYIV- 86
           IGRGGFG V       +  + A+K + +  +  K    L ++  +++    + +CP+IV 
Sbjct: 197 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 256
Query: 87  -------------------------------QFYGALFKEVTVATVKALNYLKEELKIIH 115
                                           F  A  +      +  L ++     +++
Sbjct: 257 MSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRF-VVY 315
Query: 116 RDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTRDAGCRPYMAPE 161
           RD+KP+NILLD  G +++ D G++             G   YMAPE
Sbjct: 316 RDLKPANILLDEHGHVRISDLGLACDFSKKKPHA-SVGTHGYMAPE 360

>pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314

Iteration: 1
 Score = 42.7 bits (99), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 23/70 (32%), Positives = 34/70 (48%), Gaps = 4/70 (5%)
Query: 97  TVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTRDAGCR- 155
           +    K + +L    K IHRD+   NILL  +  +K+CDFG++  +       R    R 
Sbjct: 145 SFQVAKGMEFLASR-KCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDARL 203
Query: 156 --PYMAPERI 163
              +MAPE I
Sbjct: 204 PLKWMAPETI 213

>pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314

Iteration: 1
 Score = 42.7 bits (99), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 23/70 (32%), Positives = 34/70 (48%), Gaps = 4/70 (5%)
Query: 97  TVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTRDAGCR- 155
           +    K + +L    K IHRD+   NILL  +  +K+CDFG++  +       R    R 
Sbjct: 145 SFQVAKGMEFLASR-KCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDARL 203
Query: 156 --PYMAPERI 163
              +MAPE I
Sbjct: 204 PLKWMAPETI 213

>pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364

Iteration: 1
 Score = 42.7 bits (99), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 27/81 (33%), Positives = 44/81 (54%), Gaps = 19/81 (23%)
Query: 101 VKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGI----------SGQLVDSIAKTR 150
           ++ L Y+     ++HRD+KPSN+LL+    +K+CDFG+          +G L + +A   
Sbjct: 138 LRGLKYIHSA-NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVA--- 193
Query: 151 DAGCRPYMAPERIDPLRARGY 171
               R Y APE +  L ++GY
Sbjct: 194 ---TRWYRAPEIM--LNSKGY 209

>pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316

Iteration: 1
 Score = 42.7 bits (99), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 23/70 (32%), Positives = 34/70 (48%), Gaps = 4/70 (5%)
Query: 97  TVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTRDAGCR- 155
           +    K + +L    K IHRD+   NILL  +  +K+CDFG++  +       R    R 
Sbjct: 154 SFQVAKGMEFLASR-KCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDARL 212
Query: 156 --PYMAPERI 163
              +MAPE I
Sbjct: 213 PLKWMAPETI 222

>pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316

Iteration: 1
 Score = 42.7 bits (99), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 23/70 (32%), Positives = 34/70 (48%), Gaps = 4/70 (5%)
Query: 97  TVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTRDAGCR- 155
           +    K + +L    K IHRD+   NILL  +  +K+CDFG++  +       R    R 
Sbjct: 154 SFQVAKGMEFLASR-KCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDARL 212
Query: 156 --PYMAPERI 163
              +MAPE I
Sbjct: 213 PLKWMAPETI 222

>pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 42.7 bits (99), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 27/81 (33%), Positives = 44/81 (54%), Gaps = 19/81 (23%)
Query: 101 VKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGI----------SGQLVDSIAKTR 150
           ++ L Y+     ++HRD+KPSN+LL+    +K+CDFG+          +G L + +A   
Sbjct: 138 LRGLKYIHSA-NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXEXVA--- 193
Query: 151 DAGCRPYMAPERIDPLRARGY 171
               R Y APE +  L ++GY
Sbjct: 194 ---TRWYRAPEIM--LNSKGY 209

>pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 42.7 bits (99), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 27/81 (33%), Positives = 44/81 (54%), Gaps = 19/81 (23%)
Query: 101 VKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGI----------SGQLVDSIAKTR 150
           ++ L Y+     ++HRD+KPSN+LL+    +K+CDFG+          +G L + +A   
Sbjct: 139 LRGLKYIHSA-NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXEXVA--- 194
Query: 151 DAGCRPYMAPERIDPLRARGY 171
               R Y APE +  L ++GY
Sbjct: 195 ---TRWYRAPEIM--LNSKGY 210

>pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 42.7 bits (99), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 27/81 (33%), Positives = 44/81 (54%), Gaps = 19/81 (23%)
Query: 101 VKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGI----------SGQLVDSIAKTR 150
           ++ L Y+     ++HRD+KPSN+LL+    +K+CDFG+          +G L + +A   
Sbjct: 138 LRGLKYIHSA-NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVAT-- 194
Query: 151 DAGCRPYMAPERIDPLRARGY 171
               R Y APE +  L ++GY
Sbjct: 195 ----RWYRAPEIM--LNSKGY 209

>pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382

Iteration: 1
 Score = 42.7 bits (99), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 25/76 (32%), Positives = 43/76 (56%), Gaps = 9/76 (11%)
Query: 101 VKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAK-----TRDAGCR 155
           ++ L Y+     ++HRD+KPSN+L++    +K+CDFG++ ++ D         T     R
Sbjct: 154 LRGLKYIHSA-NVLHRDLKPSNLLINTTCDLKICDFGLA-RIADPEHDHTGFLTEXVATR 211
Query: 156 PYMAPERIDPLRARGY 171
            Y APE +  L ++GY
Sbjct: 212 WYRAPEIM--LNSKGY 225

>pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316

Iteration: 1
 Score = 42.7 bits (99), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 23/70 (32%), Positives = 34/70 (48%), Gaps = 4/70 (5%)
Query: 97  TVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTRDAGCR- 155
           +    K + +L    K IHRD+   NILL  +  +K+CDFG++  +       R    R 
Sbjct: 154 SFQVAKGMEFLASR-KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDXVRKGDARL 212
Query: 156 --PYMAPERI 163
              +MAPE I
Sbjct: 213 PLKWMAPETI 222

>pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317

Iteration: 1
 Score = 42.7 bits (99), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 46/189 (24%), Positives = 80/189 (42%), Gaps = 36/189 (19%)
Query: 8   SGKLKLSPDTVYDFTSEDLQDLGE-IGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQ 66
           S  LK  PD + D  +      G  +G+GGF    ++    +  V A K +  ++  K  
Sbjct: 25  SAPLKEIPDVLVDPRTMKRYMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPH 84
Query: 67  RQLLMDLDV-VMKSNECPYIVQFYGAL------------------------FKEVTVA-- 99
           ++  M  ++ + KS + P++V F+G                           K VT    
Sbjct: 85  QKEKMSTEIAIHKSLDNPHVVGFHGFFEDDDFVYVVLEICRRRSLLELHKRRKAVTEPEA 144
Query: 100 ------TVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQL-VDSIAKTRDA 152
                 T++ + YL    ++IHRD+K  N+ L+    +K+ DFG++ ++  D   K    
Sbjct: 145 RYFMRQTIQGVQYLHNN-RVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKXLC 203
Query: 153 GCRPYMAPE 161
           G   Y+APE
Sbjct: 204 GTPNYIAPE 212

>pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317

Iteration: 1
 Score = 42.7 bits (99), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 46/189 (24%), Positives = 80/189 (42%), Gaps = 36/189 (19%)
Query: 8   SGKLKLSPDTVYDFTSEDLQDLGE-IGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQ 66
           S  LK  PD + D  +      G  +G+GGF    ++    +  V A K +  ++  K  
Sbjct: 25  SAPLKEIPDVLVDPRTMKRYMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPH 84
Query: 67  RQLLMDLDV-VMKSNECPYIVQFYGAL------------------------FKEVTVA-- 99
           ++  M  ++ + KS + P++V F+G                           K VT    
Sbjct: 85  QKEKMSTEIAIHKSLDNPHVVGFHGFFEDDDFVYVVLEICRRRSLLELHKRRKAVTEPEA 144
Query: 100 ------TVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQL-VDSIAKTRDA 152
                 T++ + YL    ++IHRD+K  N+ L+    +K+ DFG++ ++  D   K    
Sbjct: 145 RYFMRQTIQGVQYLHNN-RVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKTLC 203
Query: 153 GCRPYMAPE 161
           G   Y+APE
Sbjct: 204 GTPNYIAPE 212

>pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364

Iteration: 1
 Score = 42.4 bits (98), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 22/51 (43%), Positives = 29/51 (56%)
Query: 113 IIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERI 163
           IIHRD+KPSNI++     +K+ DFG++     S   T     R Y APE I
Sbjct: 147 IIHRDLKPSNIVVKSDXTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVI 197

>pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368

Iteration: 1
 Score = 42.4 bits (98), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 23/70 (32%), Positives = 34/70 (48%), Gaps = 4/70 (5%)
Query: 97  TVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTRDAGCR- 155
           +    K + +L    K IHRD+   NILL  +  +K+CDFG++  +       R    R 
Sbjct: 206 SFQVAKGMEFLASR-KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARL 264
Query: 156 --PYMAPERI 163
              +MAPE I
Sbjct: 265 PLKWMAPETI 274

>pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394

Iteration: 1
 Score = 42.4 bits (98), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 27/73 (36%), Positives = 37/73 (50%), Gaps = 2/73 (2%)
Query: 92  LFKEVTVATVKALNYLKEELKIIHRDVKPSNILLD-RRGAIKLCDFGISGQLVDSIAKTR 150
           L K      +++L Y+   + I HRD+KP N+LLD   G +KL DFG +  L+       
Sbjct: 142 LIKLYMYQLLRSLAYI-HSIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVS 200
Query: 151 DAGCRPYMAPERI 163
               R Y APE I
Sbjct: 201 XICSRYYRAPELI 213

>pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355

Iteration: 1
 Score = 42.4 bits (98), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 22/51 (43%), Positives = 29/51 (56%)
Query: 113 IIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERI 163
           IIHRD+KPSNI++     +K+ DFG++     S   T     R Y APE I
Sbjct: 147 IIHRDLKPSNIVVKSDXTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVI 197

>pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314

Iteration: 1
 Score = 42.4 bits (98), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 23/70 (32%), Positives = 34/70 (48%), Gaps = 4/70 (5%)
Query: 97  TVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTRDAGCR- 155
           +    K + +L    K IHRD+   NILL  +  +K+CDFG++  +       R    R 
Sbjct: 145 SFQVAKGMEFLASR-KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARL 203
Query: 156 --PYMAPERI 163
              +MAPE I
Sbjct: 204 PLKWMAPETI 213

>pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359

Iteration: 1
 Score = 42.4 bits (98), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 23/70 (32%), Positives = 34/70 (48%), Gaps = 4/70 (5%)
Query: 97  TVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTRDAGCR- 155
           +    K + +L    K IHRD+   NILL  +  +K+CDFG++  +       R    R 
Sbjct: 199 SFQVAKGMEFLASR-KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARL 257
Query: 156 --PYMAPERI 163
              +MAPE I
Sbjct: 258 PLKWMAPETI 267

>pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366

Iteration: 1
 Score = 42.4 bits (98), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 23/70 (32%), Positives = 34/70 (48%), Gaps = 4/70 (5%)
Query: 97  TVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTRDAGCR- 155
           +    K + +L    K IHRD+   NILL  +  +K+CDFG++  +       R    R 
Sbjct: 204 SFQVAKGMEFLASR-KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARL 262
Query: 156 --PYMAPERI 163
              +MAPE I
Sbjct: 263 PLKWMAPETI 272

>pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301

Iteration: 1
 Score = 42.4 bits (98), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 45/189 (23%), Positives = 80/189 (42%), Gaps = 36/189 (19%)
Query: 8   SGKLKLSPDTVYDFTSEDLQDLGE-IGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQ 66
           S  LK  PD + D  +      G  +G+GGF    ++    +  V A K +  ++  K  
Sbjct: 9   SAPLKEIPDVLVDPRTMKRYMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPH 68
Query: 67  RQLLMDLDV-VMKSNECPYIVQFYGAL----FKEVTVA---------------------- 99
           ++  M  ++ + KS + P++V F+G      F  V +                       
Sbjct: 69  QKEKMSTEIAIHKSLDNPHVVGFHGFFEDDDFVYVVLEICRRRSLLELHKRRKAVTEPEA 128
Query: 100 ------TVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQL-VDSIAKTRDA 152
                 T++ + YL    ++IHRD+K  N+ L+    +K+ DFG++ ++  D   K    
Sbjct: 129 RYFMRQTIQGVQYLHNN-RVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKDLC 187
Query: 153 GCRPYMAPE 161
           G   Y+APE
Sbjct: 188 GTPNYIAPE 196

>pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364

Iteration: 1
 Score = 42.4 bits (98), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 22/51 (43%), Positives = 29/51 (56%)
Query: 113 IIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERI 163
           IIHRD+KPSNI++     +K+ DFG++     S   T     R Y APE I
Sbjct: 147 IIHRDLKPSNIVVKSDXTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVI 197

>pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353

Iteration: 1
 Score = 42.4 bits (98), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 23/70 (32%), Positives = 34/70 (48%), Gaps = 4/70 (5%)
Query: 97  TVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTRDAGCR- 155
           +    K + +L    K IHRD+   NILL  +  +K+CDFG++  +       R    R 
Sbjct: 191 SFQVAKGMEFLASR-KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARL 249
Query: 156 --PYMAPERI 163
              +MAPE I
Sbjct: 250 PLKWMAPETI 259

>pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314

Iteration: 1
 Score = 42.4 bits (98), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 23/70 (32%), Positives = 34/70 (48%), Gaps = 4/70 (5%)
Query: 97  TVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTRDAGCR- 155
           +    K + +L    K IHRD+   NILL  +  +K+CDFG++  +       R    R 
Sbjct: 145 SFQVAKGMEFLASR-KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARL 203
Query: 156 --PYMAPERI 163
              +MAPE I
Sbjct: 204 PLKWMAPETI 213

>pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356

Iteration: 1
 Score = 42.4 bits (98), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 23/70 (32%), Positives = 34/70 (48%), Gaps = 4/70 (5%)
Query: 97  TVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTRDAGCR- 155
           +    K + +L    K IHRD+   NILL  +  +K+CDFG++  +       R    R 
Sbjct: 197 SFQVAKGMEFLASR-KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARL 255
Query: 156 --PYMAPERI 163
              +MAPE I
Sbjct: 256 PLKWMAPETI 265

>pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349

Iteration: 1
 Score = 42.4 bits (98), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 44/169 (26%), Positives = 73/169 (43%), Gaps = 40/169 (23%)
Query: 9   GKLKLSPDTVYDFTSEDLQDLGEIGRGGFGTVNKMIHRSSD-TVMAVKRIRSTVDEKDQR 67
           G+LK          S++  +   +GRGGFG V K   R +D T++AVKR++    +  + 
Sbjct: 23  GQLKRFSLRELQVASDNFSNKNILGRGGFGKVYK--GRLADGTLVAVKRLKEERXQGGEL 80
Query: 68  QLLMDLDVV---------------MKSNE----CPYIVQ-FYGALFKE------------ 95
           Q   +++++               M   E     PY+      +  +E            
Sbjct: 81  QFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPK 140
Query: 96  ---VTVATVKALNYLKEEL--KIIHRDVKPSNILLDRRGAIKLCDFGIS 139
              + + + + L YL +    KIIHRDVK +NILLD      + DFG++
Sbjct: 141 RQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLA 189

>pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353

Iteration: 1
 Score = 42.4 bits (98), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 23/62 (37%), Positives = 36/62 (58%), Gaps = 2/62 (3%)
Query: 101 VKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQ-LVDSIAKTRDAGCRPYMA 159
           + AL +L ++  II+RD+K  N+LLD  G  KL DFG+  + + + +      G   Y+A
Sbjct: 134 ISALMFLHDK-GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTTATFCGTPDYIA 192
Query: 160 PE 161
           PE
Sbjct: 193 PE 194

>pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316

Iteration: 1
 Score = 42.4 bits (98), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 23/70 (32%), Positives = 34/70 (48%), Gaps = 4/70 (5%)
Query: 97  TVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTRDAGCR- 155
           +    K + +L    K IHRD+   NILL  +  +K+CDFG++  +       R    R 
Sbjct: 154 SFQVAKGMEFLASR-KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARL 212
Query: 156 --PYMAPERI 163
              +MAPE I
Sbjct: 213 PLKWMAPETI 222

>pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353

Iteration: 1
 Score = 42.4 bits (98), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 22/51 (43%), Positives = 29/51 (56%)
Query: 113 IIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERI 163
           IIHRD+KPSNI++     +K+ DFG++     S   T     R Y APE I
Sbjct: 147 IIHRDLKPSNIVVKSDXTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVI 197

>pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318

Iteration: 1
 Score = 42.4 bits (98), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 23/70 (32%), Positives = 34/70 (48%), Gaps = 4/70 (5%)
Query: 97  TVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTRDAGCR- 155
           +    K + +L    K IHRD+   NILL  +  +K+CDFG++  +       R    R 
Sbjct: 156 SFQVAKGMEFLASR-KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARL 214
Query: 156 --PYMAPERI 163
              +MAPE I
Sbjct: 215 PLKWMAPETI 224

>pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317

Iteration: 1
 Score = 42.4 bits (98), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 46/189 (24%), Positives = 80/189 (42%), Gaps = 36/189 (19%)
Query: 8   SGKLKLSPDTVYDFTSEDLQDLGE-IGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQ 66
           S  LK  PD + D  +      G  +G+GGF    ++    +  V A K +  ++  K  
Sbjct: 25  SAPLKEIPDVLVDPRTMKRYMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPH 84
Query: 67  RQLLMDLDV-VMKSNECPYIVQFYGAL------------------------FKEVTVA-- 99
           ++  M  ++ + KS + P++V F+G                           K VT    
Sbjct: 85  QKEKMSTEIAIHKSLDNPHVVGFHGFFEDDDFVYVVLEICRRRSLLELHKRRKAVTEPEA 144
Query: 100 ------TVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQL-VDSIAKTRDA 152
                 T++ + YL    ++IHRD+K  N+ L+    +K+ DFG++ ++  D   K    
Sbjct: 145 RYFMRQTIQGVQYLHNN-RVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKDLC 203
Query: 153 GCRPYMAPE 161
           G   Y+APE
Sbjct: 204 GTPNYIAPE 212

>pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356

Iteration: 1
 Score = 42.4 bits (98), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 22/51 (43%), Positives = 29/51 (56%)
Query: 113 IIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERI 163
           IIHRD+KPSNI++     +K+ DFG++     S   T     R Y APE I
Sbjct: 140 IIHRDLKPSNIVVKSDXTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVI 190

>pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360

Iteration: 1
 Score = 42.0 bits (97), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 21/55 (38%), Positives = 29/55 (52%), Gaps = 3/55 (5%)
Query: 112 KIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTRDAGCR---PYMAPERI 163
           K IHRD+   NILL     +K+CDFG++  +  +    R    R    +MAPE I
Sbjct: 219 KCIHRDLAARNILLSENNVVKICDFGLARDIYKNPDYVRKGDTRLPLKWMAPESI 273

>pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317

Iteration: 1
 Score = 42.0 bits (97), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 39/162 (24%), Positives = 69/162 (42%), Gaps = 32/162 (19%)
Query: 31  EIGRGGFGTVNKMIHRSSDTVMAVKRIR--STVDEKDQRQLLMDL-----------DVVM 77
           +IG G FG    M  + ++ ++AVK I     +DE  +R+++              +V++
Sbjct: 26  DIGAGNFGVARLMRDKQANELVAVKYIERGEKIDENVKREIINHRSLRHPNIVRFKEVIL 85
Query: 78  KSNECPYIVQFY--GALFKEVTVA--------------TVKALNYLKEELKIIHRDVKPS 121
                  ++++   G LF+ +  A               +  ++Y    +++ HRD+K  
Sbjct: 86  TPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSY-AHAMQVAHRDLKLE 144
Query: 122 NILLDRRGA--IKLCDFGISGQLVDSIAKTRDAGCRPYMAPE 161
           N LLD   A  +K+ DFG S   V         G   Y+APE
Sbjct: 145 NTLLDGSPAPRLKIADFGYSKASVLHSQPKSAVGTPAYIAPE 186

>pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326

Iteration: 1
 Score = 42.0 bits (97), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 31/105 (29%), Positives = 48/105 (45%), Gaps = 15/105 (14%)
Query: 84  YIVQFYGALFKEVTVATVKALNYLKEEL-------KIIHRDVKPSNILLDRRGAIKLCDF 136
           Y V   G +  ++ ++T   L +L  E+        I HRD+K  NIL+ + G   + D 
Sbjct: 121 YTVTVEGMI--KLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADL 178
Query: 137 GI-----SGQLVDSIAKTRDAGCRPYMAPERI-DPLRARGYPSFK 175
           G+     S      IA     G + YMAPE + D +  + + SFK
Sbjct: 179 GLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFK 223

>pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331

Iteration: 1
 Score = 42.0 bits (97), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 36/147 (24%), Positives = 61/147 (41%), Gaps = 38/147 (25%)
Query: 32  IGRGGFGTVNKMIH----RSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQ 87
           +G G FGTV K +           +A+K +R     K  +++L D   VM S + P++ +
Sbjct: 27  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEIL-DEAYVMASVDNPHVCR 85
Query: 88  F-----------------YGALFKEV---------------TVATVKALNYLKEELKIIH 115
                             +G L   V                V   K +NYL E+ +++H
Sbjct: 86  LLGICLTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYL-EDRRLVH 144
Query: 116 RDVKPSNILLDRRGAIKLCDFGISGQL 142
           RD+   N+L+     +K+ DFG++  L
Sbjct: 145 RDLAARNVLVKTPQHVKITDFGLAKLL 171

>pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309

Iteration: 1
 Score = 42.0 bits (97), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 31/105 (29%), Positives = 48/105 (45%), Gaps = 15/105 (14%)
Query: 84  YIVQFYGALFKEVTVATVKALNYLKEEL-------KIIHRDVKPSNILLDRRGAIKLCDF 136
           Y V   G +  ++ ++T   L +L  E+        I HRD+K  NIL+ + G   + D 
Sbjct: 101 YTVTVEGMI--KLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADL 158
Query: 137 GI-----SGQLVDSIAKTRDAGCRPYMAPERI-DPLRARGYPSFK 175
           G+     S      IA     G + YMAPE + D +  + + SFK
Sbjct: 159 GLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFK 203

>pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342

Iteration: 1
 Score = 42.0 bits (97), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 31/105 (29%), Positives = 48/105 (45%), Gaps = 15/105 (14%)
Query: 84  YIVQFYGALFKEVTVATVKALNYLKEEL-------KIIHRDVKPSNILLDRRGAIKLCDF 136
           Y V   G +  ++ ++T   L +L  E+        I HRD+K  NIL+ + G   + D 
Sbjct: 134 YTVTVEGMI--KLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADL 191
Query: 137 GI-----SGQLVDSIAKTRDAGCRPYMAPERI-DPLRARGYPSFK 175
           G+     S      IA     G + YMAPE + D +  + + SFK
Sbjct: 192 GLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFK 236

>pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313

Iteration: 1
 Score = 42.0 bits (97), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 22/54 (40%), Positives = 30/54 (55%), Gaps = 4/54 (7%)
Query: 113 IIHRDVKPSNILLDRRGAIKLCDFGISGQL---VDSIAKTRDAGCRPYMAPERI 163
           I+H D+KP+N L+   G +KL DFGI+ Q+      + K    G   YM PE I
Sbjct: 148 IVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDXXXVVKDSQVGTVNYMPPEAI 200

>pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330

Iteration: 1
 Score = 41.6 bits (96), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 36/147 (24%), Positives = 61/147 (41%), Gaps = 38/147 (25%)
Query: 32  IGRGGFGTVNKMIH----RSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQ 87
           +G G FGTV K +           +A+K +R     K  +++L D   VM S + P++ +
Sbjct: 26  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEIL-DEAYVMASVDNPHVCR 84
Query: 88  F-----------------YGALFKEV---------------TVATVKALNYLKEELKIIH 115
                             +G L   V                V   K +NYL E+ +++H
Sbjct: 85  LLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYL-EDRRLVH 143
Query: 116 RDVKPSNILLDRRGAIKLCDFGISGQL 142
           RD+   N+L+     +K+ DFG++  L
Sbjct: 144 RDLAARNVLVKTPQHVKITDFGLAKLL 170

>pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286

Iteration: 1
 Score = 41.6 bits (96), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 39/153 (25%), Positives = 65/153 (42%), Gaps = 38/153 (24%)
Query: 25  DLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPY 84
           +L  + EIG G FG V+     + D V A+K I+     +D    + + +V+MK +  P 
Sbjct: 28  ELTFVQEIGSGQFGLVHLGYWLNKDKV-AIKTIKEGSMSEDD--FIEEAEVMMKLSH-PK 83
Query: 85  IVQFYGALFKEVTVATV---------------------------------KALNYLKEEL 111
           +VQ YG   ++  +  V                                 + + YL EE 
Sbjct: 84  LVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYL-EEA 142
Query: 112 KIIHRDVKPSNILLDRRGAIKLCDFGISGQLVD 144
            +IHRD+   N L+     IK+ DFG++  ++D
Sbjct: 143 CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLD 175

>pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328

Iteration: 1
 Score = 41.6 bits (96), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 36/147 (24%), Positives = 61/147 (41%), Gaps = 38/147 (25%)
Query: 32  IGRGGFGTVNKMIH----RSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQ 87
           +G G FGTV K +           +A+K +R     K  +++L D   VM S + P++ +
Sbjct: 24  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEIL-DEAYVMASVDNPHVCR 82
Query: 88  F-----------------YGALFKEV---------------TVATVKALNYLKEELKIIH 115
                             +G L   V                V   K +NYL E+ +++H
Sbjct: 83  LLGICLTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYL-EDRRLVH 141
Query: 116 RDVKPSNILLDRRGAIKLCDFGISGQL 142
           RD+   N+L+     +K+ DFG++  L
Sbjct: 142 RDLAARNVLVKTPQHVKITDFGLAKLL 168

>pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327

Iteration: 1
 Score = 41.6 bits (96), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 36/147 (24%), Positives = 61/147 (41%), Gaps = 38/147 (25%)
Query: 32  IGRGGFGTVNKMIH----RSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQ 87
           +G G FGTV K +           +A+K +R     K  +++L D   VM S + P++ +
Sbjct: 23  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEIL-DEAYVMASVDNPHVCR 81
Query: 88  F-----------------YGALFKEV---------------TVATVKALNYLKEELKIIH 115
                             +G L   V                V   K +NYL E+ +++H
Sbjct: 82  LLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYL-EDRRLVH 140
Query: 116 RDVKPSNILLDRRGAIKLCDFGISGQL 142
           RD+   N+L+     +K+ DFG++  L
Sbjct: 141 RDLAARNVLVKTPQHVKITDFGLAKLL 167

>pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301

Iteration: 1
 Score = 41.6 bits (96), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 31/105 (29%), Positives = 48/105 (45%), Gaps = 15/105 (14%)
Query: 84  YIVQFYGALFKEVTVATVKALNYLKEEL-------KIIHRDVKPSNILLDRRGAIKLCDF 136
           Y V   G +  ++ ++T   L +L  E+        I HRD+K  NIL+ + G   + D 
Sbjct: 96  YTVTVEGMI--KLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADL 153
Query: 137 GI-----SGQLVDSIAKTRDAGCRPYMAPERI-DPLRARGYPSFK 175
           G+     S      IA     G + YMAPE + D +  + + SFK
Sbjct: 154 GLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFK 198

>pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333

Iteration: 1
 Score = 41.6 bits (96), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 36/147 (24%), Positives = 61/147 (41%), Gaps = 38/147 (25%)
Query: 32  IGRGGFGTVNKMIH----RSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQ 87
           +G G FGTV K +           +A+K +R     K  +++L D   VM S + P++ +
Sbjct: 29  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEIL-DEAYVMASVDNPHVCR 87
Query: 88  F-----------------YGALFKEV---------------TVATVKALNYLKEELKIIH 115
                             +G L   V                V   K +NYL E+ +++H
Sbjct: 88  LLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYL-EDRRLVH 146
Query: 116 RDVKPSNILLDRRGAIKLCDFGISGQL 142
           RD+   N+L+     +K+ DFG++  L
Sbjct: 147 RDLAARNVLVKTPQHVKITDFGLAKLL 173

>pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361

Iteration: 1
 Score = 41.6 bits (96), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 48/181 (26%), Positives = 81/181 (44%), Gaps = 40/181 (22%)
Query: 24  EDLQDLGE-IGRGGFGTVNKMIHRSSDTVMAVKRI---------RSTVDEKDQRQ----- 68
           ED  D+GE +G G F  V K   +S+    A K I         R    E+ +R+     
Sbjct: 11  EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILR 70
Query: 69  ------LLMDLDVVMKSNECPYIVQFY--GALF----KEVTVATVKALNYLKEEL----- 111
                 ++   DV     +   I++    G LF    ++ +++  +A +++K+ L     
Sbjct: 71  QVLHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNY 130
Query: 112 ----KIIHRDVKPSNI-LLDRR---GAIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERI 163
               KI H D+KP NI LLD+      IKL DFG++ ++ D +      G   ++APE +
Sbjct: 131 LHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIV 190
Query: 164 D 164
           +
Sbjct: 191 N 191

>pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329

Iteration: 1
 Score = 41.6 bits (96), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 36/147 (24%), Positives = 61/147 (41%), Gaps = 38/147 (25%)
Query: 32  IGRGGFGTVNKMIH----RSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQ 87
           +G G FGTV K +           +A+K +R     K  +++L D   VM S + P++ +
Sbjct: 25  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEIL-DEAYVMASVDNPHVCR 83
Query: 88  F-----------------YGALFKEV---------------TVATVKALNYLKEELKIIH 115
                             +G L   V                V   K +NYL E+ +++H
Sbjct: 84  LLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYL-EDRRLVH 142
Query: 116 RDVKPSNILLDRRGAIKLCDFGISGQL 142
           RD+   N+L+     +K+ DFG++  L
Sbjct: 143 RDLAARNVLVKTPQHVKITDFGLAKLL 169

>pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303

Iteration: 1
 Score = 41.6 bits (96), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 31/105 (29%), Positives = 48/105 (45%), Gaps = 15/105 (14%)
Query: 84  YIVQFYGALFKEVTVATVKALNYLKEEL-------KIIHRDVKPSNILLDRRGAIKLCDF 136
           Y V   G +  ++ ++T   L +L  E+        I HRD+K  NIL+ + G   + D 
Sbjct: 95  YTVTVEGMI--KLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADL 152
Query: 137 GI-----SGQLVDSIAKTRDAGCRPYMAPERI-DPLRARGYPSFK 175
           G+     S      IA     G + YMAPE + D +  + + SFK
Sbjct: 153 GLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFK 197

>pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337

Iteration: 1
 Score = 41.6 bits (96), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 36/147 (24%), Positives = 61/147 (41%), Gaps = 38/147 (25%)
Query: 32  IGRGGFGTVNKMIH----RSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQ 87
           +G G FGTV K +           +A+K +R     K  +++L D   VM S + P++ +
Sbjct: 33  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEIL-DEAYVMASVDNPHVCR 91
Query: 88  F-----------------YGALFKEV---------------TVATVKALNYLKEELKIIH 115
                             +G L   V                V   K +NYL E+ +++H
Sbjct: 92  LLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYL-EDRRLVH 150
Query: 116 RDVKPSNILLDRRGAIKLCDFGISGQL 142
           RD+   N+L+     +K+ DFG++  L
Sbjct: 151 RDLAARNVLVKTPQHVKITDFGLAKLL 177

>pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315

Iteration: 1
 Score = 41.6 bits (96), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 36/147 (24%), Positives = 61/147 (41%), Gaps = 38/147 (25%)
Query: 32  IGRGGFGTVNKMIH----RSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQ 87
           +G G FGTV K +           +A+K +R     K  +++L D   VM S + P++ +
Sbjct: 17  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEIL-DEAYVMASVDNPHVCR 75
Query: 88  F-----------------YGALFKEV---------------TVATVKALNYLKEELKIIH 115
                             +G L   V                V   K +NYL E+ +++H
Sbjct: 76  LLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYL-EDRRLVH 134
Query: 116 RDVKPSNILLDRRGAIKLCDFGISGQL 142
           RD+   N+L+     +K+ DFG++  L
Sbjct: 135 RDLAARNVLVKTPQHVKITDFGLAKLL 161

>pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352

Iteration: 1
 Score = 41.6 bits (96), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 36/147 (24%), Positives = 61/147 (41%), Gaps = 38/147 (25%)
Query: 32  IGRGGFGTVNKMIH----RSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQ 87
           +G G FGTV K +           +A+K +R     K  +++L D   VM S + P++ +
Sbjct: 48  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEIL-DEAYVMASVDNPHVCR 106
Query: 88  F-----------------YGALFKEV---------------TVATVKALNYLKEELKIIH 115
                             +G L   V                V   K +NYL E+ +++H
Sbjct: 107 LLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYL-EDRRLVH 165
Query: 116 RDVKPSNILLDRRGAIKLCDFGISGQL 142
           RD+   N+L+     +K+ DFG++  L
Sbjct: 166 RDLAARNVLVKTPQHVKITDFGLAKLL 192

>pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 41.6 bits (96), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 36/147 (24%), Positives = 61/147 (41%), Gaps = 38/147 (25%)
Query: 32  IGRGGFGTVNKMIH----RSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQ 87
           +G G FGTV K +           +A+K +R     K  +++L D   VM S + P++ +
Sbjct: 26  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEIL-DEAYVMASVDNPHVCR 84
Query: 88  F-----------------YGALFKEV---------------TVATVKALNYLKEELKIIH 115
                             +G L   V                V   K +NYL E+ +++H
Sbjct: 85  LLGICLTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYL-EDRRLVH 143
Query: 116 RDVKPSNILLDRRGAIKLCDFGISGQL 142
           RD+   N+L+     +K+ DFG++  L
Sbjct: 144 RDLAARNVLVKTPQHVKITDFGLAKLL 170

>pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306

Iteration: 1
 Score = 41.6 bits (96), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 31/105 (29%), Positives = 48/105 (45%), Gaps = 15/105 (14%)
Query: 84  YIVQFYGALFKEVTVATVKALNYLKEEL-------KIIHRDVKPSNILLDRRGAIKLCDF 136
           Y V   G +  ++ ++T   L +L  E+        I HRD+K  NIL+ + G   + D 
Sbjct: 98  YTVTVEGMI--KLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADL 155
Query: 137 GI-----SGQLVDSIAKTRDAGCRPYMAPERI-DPLRARGYPSFK 175
           G+     S      IA     G + YMAPE + D +  + + SFK
Sbjct: 156 GLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFK 200

>pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 41.6 bits (96), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 22/51 (43%), Positives = 29/51 (56%)
Query: 113 IIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERI 163
           IIHRD+KPSNI++     +K+ DFG++     S   T     R Y APE I
Sbjct: 147 IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVI 197

>pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330

Iteration: 1
 Score = 41.6 bits (96), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 36/147 (24%), Positives = 61/147 (41%), Gaps = 38/147 (25%)
Query: 32  IGRGGFGTVNKMIH----RSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQ 87
           +G G FGTV K +           +A+K +R     K  +++L D   VM S + P++ +
Sbjct: 26  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEIL-DEAYVMASVDNPHVCR 84
Query: 88  F-----------------YGALFKEV---------------TVATVKALNYLKEELKIIH 115
                             +G L   V                V   K +NYL E+ +++H
Sbjct: 85  LLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYL-EDRRLVH 143
Query: 116 RDVKPSNILLDRRGAIKLCDFGISGQL 142
           RD+   N+L+     +K+ DFG++  L
Sbjct: 144 RDLAARNVLVKTPQHVKITDFGLAKLL 170

>pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329

Iteration: 1
 Score = 41.6 bits (96), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 36/147 (24%), Positives = 61/147 (41%), Gaps = 38/147 (25%)
Query: 32  IGRGGFGTVNKMIH----RSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQ 87
           +G G FGTV K +           +A+K +R     K  +++L D   VM S + P++ +
Sbjct: 25  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEIL-DEAYVMASVDNPHVCR 83
Query: 88  F-----------------YGALFKEV---------------TVATVKALNYLKEELKIIH 115
                             +G L   V                V   K +NYL E+ +++H
Sbjct: 84  LLGICLTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYL-EDRRLVH 142
Query: 116 RDVKPSNILLDRRGAIKLCDFGISGQL 142
           RD+   N+L+     +K+ DFG++  L
Sbjct: 143 RDLAARNVLVKTPQHVKITDFGLAKLL 169

>pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327

Iteration: 1
 Score = 41.6 bits (96), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 36/147 (24%), Positives = 61/147 (41%), Gaps = 38/147 (25%)
Query: 32  IGRGGFGTVNKMIH----RSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQ 87
           +G G FGTV K +           +A+K +R     K  +++L D   VM S + P++ +
Sbjct: 23  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEIL-DEAYVMASVDNPHVCR 81
Query: 88  F-----------------YGALFKEV---------------TVATVKALNYLKEELKIIH 115
                             +G L   V                V   K +NYL E+ +++H
Sbjct: 82  LLGICLTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYL-EDRRLVH 140
Query: 116 RDVKPSNILLDRRGAIKLCDFGISGQL 142
           RD+   N+L+     +K+ DFG++  L
Sbjct: 141 RDLAARNVLVKTPQHVKITDFGLAKLL 167

>pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288

Iteration: 1
 Score = 41.6 bits (96), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 48/181 (26%), Positives = 81/181 (44%), Gaps = 40/181 (22%)
Query: 24  EDLQDLGE-IGRGGFGTVNKMIHRSSDTVMAVKRI---------RSTVDEKDQRQL---- 69
           ED  D+GE +G G F  V K   +S+    A K I         R    E+ +R++    
Sbjct: 11  EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILR 70
Query: 70  -------LMDLDVVMKSNECPYIVQFY--GALF----KEVTVATVKALNYLKEEL----- 111
                  +   DV     +   I++    G LF    ++ +++  +A +++K+ L     
Sbjct: 71  QVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNY 130
Query: 112 ----KIIHRDVKPSNI-LLDRR---GAIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERI 163
               KI H D+KP NI LLD+      IKL DFG++ ++ D +      G   ++APE +
Sbjct: 131 LHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIV 190
Query: 164 D 164
           +
Sbjct: 191 N 191

>pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 41.6 bits (96), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 36/147 (24%), Positives = 61/147 (41%), Gaps = 38/147 (25%)
Query: 32  IGRGGFGTVNKMIH----RSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQ 87
           +G G FGTV K +           +A+K +R     K  +++L D   VM S + P++ +
Sbjct: 26  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEIL-DEAYVMASVDNPHVCR 84
Query: 88  F-----------------YGALFKEV---------------TVATVKALNYLKEELKIIH 115
                             +G L   V                V   K +NYL E+ +++H
Sbjct: 85  LLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYL-EDRRLVH 143
Query: 116 RDVKPSNILLDRRGAIKLCDFGISGQL 142
           RD+   N+L+     +K+ DFG++  L
Sbjct: 144 RDLAARNVLVKTPQHVKITDFGLAKLL 170

>pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362

Iteration: 1
 Score = 41.6 bits (96), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 22/51 (43%), Positives = 29/51 (56%)
Query: 113 IIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERI 163
           IIHRD+KPSNI++     +K+ DFG++     S   T     R Y APE I
Sbjct: 146 IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVI 196

>pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308

Iteration: 1
 Score = 41.6 bits (96), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 23/61 (37%), Positives = 34/61 (55%), Gaps = 1/61 (1%)
Query: 101 VKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTRDAGCRPYMAP 160
           ++ L++L     I+HRD+KP NIL+   G +KL DFG++      +A T       Y AP
Sbjct: 130 LRGLDFLHANC-IVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALTPVVVTLWYRAP 188
Query: 161 E 161
           E
Sbjct: 189 E 189

>pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321

Iteration: 1
 Score = 41.6 bits (96), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 48/181 (26%), Positives = 81/181 (44%), Gaps = 40/181 (22%)
Query: 24  EDLQDLGE-IGRGGFGTVNKMIHRSSDTVMAVKRI---------RSTVDEKDQRQL---- 69
           ED  D+GE +G G F  V K   +S+    A K I         R    E+ +R++    
Sbjct: 11  EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILR 70
Query: 70  -------LMDLDVVMKSNECPYIVQFY--GALF----KEVTVATVKALNYLKEEL----- 111
                  +   DV     +   I++    G LF    ++ +++  +A +++K+ L     
Sbjct: 71  QVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNY 130
Query: 112 ----KIIHRDVKPSNI-LLDRR---GAIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERI 163
               KI H D+KP NI LLD+      IKL DFG++ ++ D +      G   ++APE +
Sbjct: 131 LHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIV 190
Query: 164 D 164
           +
Sbjct: 191 N 191

>pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 41.6 bits (96), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 48/181 (26%), Positives = 81/181 (44%), Gaps = 40/181 (22%)
Query: 24  EDLQDLGE-IGRGGFGTVNKMIHRSSDTVMAVKRI---------RSTVDEKDQRQL---- 69
           ED  D+GE +G G F  V K   +S+    A K I         R    E+ +R++    
Sbjct: 11  EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILR 70
Query: 70  -------LMDLDVVMKSNECPYIVQFY--GALF----KEVTVATVKALNYLKEEL----- 111
                  +   DV     +   I++    G LF    ++ +++  +A +++K+ L     
Sbjct: 71  QVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNY 130
Query: 112 ----KIIHRDVKPSNI-LLDRR---GAIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERI 163
               KI H D+KP NI LLD+      IKL DFG++ ++ D +      G   ++APE +
Sbjct: 131 LHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIV 190
Query: 164 D 164
           +
Sbjct: 191 N 191

>pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334

Iteration: 1
 Score = 41.6 bits (96), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 36/147 (24%), Positives = 61/147 (41%), Gaps = 38/147 (25%)
Query: 32  IGRGGFGTVNKMIH----RSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQ 87
           +G G FGTV K +           +A+K +R     K  +++L D   VM S + P++ +
Sbjct: 30  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEIL-DEAYVMASVDNPHVCR 88
Query: 88  F-----------------YGALFKEV---------------TVATVKALNYLKEELKIIH 115
                             +G L   V                V   K +NYL E+ +++H
Sbjct: 89  LLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYL-EDRRLVH 147
Query: 116 RDVKPSNILLDRRGAIKLCDFGISGQL 142
           RD+   N+L+     +K+ DFG++  L
Sbjct: 148 RDLAARNVLVKTPQHVKITDFGLAKLL 174

>pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364

Iteration: 1
 Score = 41.6 bits (96), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 21/51 (41%), Positives = 29/51 (56%)
Query: 113 IIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERI 163
           IIHRD+KPSNI++     +K+ DFG++     +   T     R Y APE I
Sbjct: 147 IIHRDLKPSNIVVKSDCTLKILDFGLARTACTNFMMTPYVVTRYYRAPEVI 197

>pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423

Iteration: 1
 Score = 41.6 bits (96), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 22/51 (43%), Positives = 29/51 (56%)
Query: 113 IIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERI 163
           IIHRD+KPSNI++     +K+ DFG++     S   T     R Y APE I
Sbjct: 185 IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVI 235

>pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364

Iteration: 1
 Score = 41.6 bits (96), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 22/51 (43%), Positives = 29/51 (56%)
Query: 113 IIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERI 163
           IIHRD+KPSNI++     +K+ DFG++     S   T     R Y APE I
Sbjct: 147 IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVI 197

>pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367

Iteration: 1
 Score = 41.6 bits (96), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 43/181 (23%), Positives = 75/181 (41%), Gaps = 40/181 (22%)
Query: 17  TVYDFTSEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRI----RSTVDEK-DQRQL-- 69
           T+++   E  Q+L  +G G +G+V       +   +AVK++    +S +  K   R+L  
Sbjct: 23  TIWE-VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 81
Query: 70  -----------LMDLDVVMKS----NECPYIVQFYGALFKEVT--------------VAT 100
                      L+D+    +S    N+   +    GA    +                  
Sbjct: 82  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQI 141
Query: 101 VKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTRDAGCRPYMAP 160
           ++ L Y+     IIHRD+KPSN+ ++    +K+ DFG++    D +  T     R Y AP
Sbjct: 142 LRGLKYIHSA-DIIHRDLKPSNLAVNEDCELKILDFGLARHTADEM--TGYVATRWYRAP 198
Query: 161 E 161
           E
Sbjct: 199 E 199

>pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 41.6 bits (96), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 48/181 (26%), Positives = 81/181 (44%), Gaps = 40/181 (22%)
Query: 24  EDLQDLGE-IGRGGFGTVNKMIHRSSDTVMAVKRI---------RSTVDEKDQRQL---- 69
           ED  D+GE +G G F  V K   +S+    A K I         R    E+ +R++    
Sbjct: 11  EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILR 70
Query: 70  -------LMDLDVVMKSNECPYIVQFY--GALF----KEVTVATVKALNYLKEEL----- 111
                  +   DV     +   I++    G LF    ++ +++  +A +++K+ L     
Sbjct: 71  QVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNY 130
Query: 112 ----KIIHRDVKPSNI-LLDRR---GAIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERI 163
               KI H D+KP NI LLD+      IKL DFG++ ++ D +      G   ++APE +
Sbjct: 131 LHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIV 190
Query: 164 D 164
           +
Sbjct: 191 N 191

>pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364

Iteration: 1
 Score = 41.6 bits (96), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 22/51 (43%), Positives = 29/51 (56%)
Query: 113 IIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERI 163
           IIHRD+KPSNI++     +K+ DFG++     S   T     R Y APE I
Sbjct: 148 IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVI 198

>pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363

Iteration: 1
 Score = 41.6 bits (96), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 22/51 (43%), Positives = 29/51 (56%)
Query: 113 IIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERI 163
           IIHRD+KPSNI++     +K+ DFG++     S   T     R Y APE I
Sbjct: 147 IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVI 197

>pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365

Iteration: 1
 Score = 41.6 bits (96), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 22/51 (43%), Positives = 29/51 (56%)
Query: 113 IIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERI 163
           IIHRD+KPSNI++     +K+ DFG++     S   T     R Y APE I
Sbjct: 148 IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVI 198

>pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355

Iteration: 1
 Score = 41.6 bits (96), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 22/51 (43%), Positives = 29/51 (56%)
Query: 113 IIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERI 163
           IIHRD+KPSNI++     +K+ DFG++     S   T     R Y APE I
Sbjct: 140 IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVI 190

>pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 41.6 bits (96), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 22/51 (43%), Positives = 29/51 (56%)
Query: 113 IIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERI 163
           IIHRD+KPSNI++     +K+ DFG++     S   T     R Y APE I
Sbjct: 147 IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVI 197

>pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356

Iteration: 1
 Score = 41.6 bits (96), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 22/51 (43%), Positives = 29/51 (56%)
Query: 113 IIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERI 163
           IIHRD+KPSNI++     +K+ DFG++     S   T     R Y APE I
Sbjct: 141 IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVI 191

>pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327

Iteration: 1
 Score = 41.6 bits (96), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 36/147 (24%), Positives = 61/147 (41%), Gaps = 38/147 (25%)
Query: 32  IGRGGFGTVNKMIH----RSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQ 87
           +G G FGTV K +           +A+K +R     K  +++L D   VM S + P++ +
Sbjct: 23  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEIL-DEAYVMASVDNPHVCR 81
Query: 88  F-----------------YGALFKEV---------------TVATVKALNYLKEELKIIH 115
                             +G L   V                V   K +NYL E+ +++H
Sbjct: 82  LLGICLTSTVQLITQLMPFGXLLDYVREHKDNIGSQYLLNWCVQIAKGMNYL-EDRRLVH 140
Query: 116 RDVKPSNILLDRRGAIKLCDFGISGQL 142
           RD+   N+L+     +K+ DFG++  L
Sbjct: 141 RDLAARNVLVKTPQHVKITDFGLAKLL 167

>pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356

Iteration: 1
 Score = 41.6 bits (96), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 22/51 (43%), Positives = 29/51 (56%)
Query: 113 IIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERI 163
           IIHRD+KPSNI++     +K+ DFG++     S   T     R Y APE I
Sbjct: 141 IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVI 191

>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298

Iteration: 1
 Score = 41.6 bits (96), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 44/184 (23%), Positives = 80/184 (43%), Gaps = 42/184 (22%)
Query: 21  FTSEDLQDLGEIGRGGFGTVNKM----IHRSSDTVMAVKRIRSTVDE--KDQRQLLMDLD 74
           F    L+ L ++G+G FG+V       +  ++  V+AVK+++ + +E  +D  + +  L 
Sbjct: 10  FEERHLKFLRQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILK 69
Query: 75  VVMKSNECPY--------------IVQF--YGAL---------------FKEVTVATVKA 103
            +   N   Y              I++F  YG+L                 + T    K 
Sbjct: 70  SLQHDNIVKYKGVCYSAGRRNLKLIMEFLPYGSLREYLQKHKERIDHIKLLQYTSQICKG 129
Query: 104 LNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVD--SIAKTRDAGCRP--YMA 159
           + YL  + + IHRD+   NIL++    +K+ DFG++  L       K ++ G  P  + A
Sbjct: 130 MEYLGTK-RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYA 188
Query: 160 PERI 163
           PE +
Sbjct: 189 PESL 192

>pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367

Iteration: 1
 Score = 41.6 bits (96), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 22/61 (36%), Positives = 34/61 (55%), Gaps = 3/61 (4%)
Query: 101 VKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTRDAGCRPYMAP 160
           ++ L Y+     IIHRD+KPSN+ ++    +K+ DFG++    D +  T     R Y AP
Sbjct: 142 LRGLKYIHSA-DIIHRDLKPSNLAVNEDCELKILDFGLARHTADEM--TGYVATRWYRAP 198
Query: 161 E 161
           E
Sbjct: 199 E 199

>pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367

Iteration: 1
 Score = 41.6 bits (96), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 22/61 (36%), Positives = 34/61 (55%), Gaps = 3/61 (4%)
Query: 101 VKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTRDAGCRPYMAP 160
           ++ L Y+     IIHRD+KPSN+ ++    +K+ DFG++    D +  T     R Y AP
Sbjct: 142 LRGLKYIHSA-DIIHRDLKPSNLAVNEDCELKILDFGLARHTADEM--TGYVATRWYRAP 198
Query: 161 E 161
           E
Sbjct: 199 E 199

>pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369

Iteration: 1
 Score = 41.6 bits (96), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 22/51 (43%), Positives = 29/51 (56%)
Query: 113 IIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERI 163
           IIHRD+KPSNI++     +K+ DFG++     S   T     R Y APE I
Sbjct: 147 IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVI 197

>pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358

Iteration: 1
 Score = 41.6 bits (96), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 22/51 (43%), Positives = 29/51 (56%)
Query: 113 IIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERI 163
           IIHRD+KPSNI++     +K+ DFG++     S   T     R Y APE I
Sbjct: 141 IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVI 191

>pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327

Iteration: 1
 Score = 41.6 bits (96), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 36/147 (24%), Positives = 61/147 (41%), Gaps = 38/147 (25%)
Query: 32  IGRGGFGTVNKMIH----RSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQ 87
           +G G FGTV K +           +A+K +R     K  +++L D   VM S + P++ +
Sbjct: 23  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEIL-DEAYVMASVDNPHVCR 81
Query: 88  F-----------------YGALFKEV---------------TVATVKALNYLKEELKIIH 115
                             +G L   V                V   K +NYL E+ +++H
Sbjct: 82  LLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYL-EDRRLVH 140
Query: 116 RDVKPSNILLDRRGAIKLCDFGISGQL 142
           RD+   N+L+     +K+ DFG++  L
Sbjct: 141 RDLAARNVLVKTPQHVKITDFGLAKLL 167

>pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361

Iteration: 1
 Score = 41.6 bits (96), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 53/189 (28%), Positives = 81/189 (42%), Gaps = 47/189 (24%)
Query: 20  DFTSEDLQDLGE-IGRGGFGTVNKMIHRSSDTVMAVKRIR----------STVDEKDQRQ 68
           D   ED+ +L E IG+G F  V + I+R +    AVK +           ST D K +  
Sbjct: 21  DVLFEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREAS 80
Query: 69  ----------------------LLMDLDVVMKSNECPYIVQFY--GALFKEVTVA----- 99
                                 L M  + +  ++ C  IV+    G ++ E   +     
Sbjct: 81  ICHMLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQ 140
Query: 100 TVKALNYLKEELKIIHRDVKPSNILL---DRRGAIKLCDFGISGQLVDS--IAKTRDAGC 154
            ++AL Y  +   IIHRDVKP  +LL   +    +KL  FG++ QL +S  +A  R  G 
Sbjct: 141 ILEALRYCHDN-NIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGR-VGT 198
Query: 155 RPYMAPERI 163
             +MAPE +
Sbjct: 199 PHFMAPEVV 207

>pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464

Iteration: 1
 Score = 41.6 bits (96), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 22/51 (43%), Positives = 29/51 (56%)
Query: 113 IIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERI 163
           IIHRD+KPSNI++     +K+ DFG++     S   T     R Y APE I
Sbjct: 185 IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVI 235

>pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321

Iteration: 1
 Score = 41.6 bits (96), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 48/181 (26%), Positives = 81/181 (44%), Gaps = 40/181 (22%)
Query: 24  EDLQDLGE-IGRGGFGTVNKMIHRSSDTVMAVKRI---------RSTVDEKDQRQL---- 69
           ED  D+GE +G G F  V K   +S+    A K I         R    E+ +R++    
Sbjct: 11  EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILR 70
Query: 70  -------LMDLDVVMKSNECPYIVQFY--GALF----KEVTVATVKALNYLKEEL----- 111
                  +   DV     +   I++    G LF    ++ +++  +A +++K+ L     
Sbjct: 71  QVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNY 130
Query: 112 ----KIIHRDVKPSNI-LLDRR---GAIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERI 163
               KI H D+KP NI LLD+      IKL DFG++ ++ D +      G   ++APE +
Sbjct: 131 LHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIV 190
Query: 164 D 164
           +
Sbjct: 191 N 191

>pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328

Iteration: 1
 Score = 41.6 bits (96), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 36/147 (24%), Positives = 61/147 (41%), Gaps = 38/147 (25%)
Query: 32  IGRGGFGTVNKMIH----RSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQ 87
           +G G FGTV K +           +A+K +R     K  +++L D   VM S + P++ +
Sbjct: 24  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEIL-DEAYVMASVDNPHVCR 82
Query: 88  F-----------------YGALFKEV---------------TVATVKALNYLKEELKIIH 115
                             +G L   V                V   K +NYL E+ +++H
Sbjct: 83  LLGICLTSTVQLIMQLMPFGXLLDYVREHKDNIGSQYLLNWCVQIAKGMNYL-EDRRLVH 141
Query: 116 RDVKPSNILLDRRGAIKLCDFGISGQL 142
           RD+   N+L+     +K+ DFG++  L
Sbjct: 142 RDLAARNVLVKTPQHVKITDFGLAKLL 168

>pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371

Iteration: 1
 Score = 41.6 bits (96), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 22/51 (43%), Positives = 29/51 (56%)
Query: 113 IIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERI 163
           IIHRD+KPSNI++     +K+ DFG++     S   T     R Y APE I
Sbjct: 148 IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVI 198

>pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369

Iteration: 1
 Score = 41.2 bits (95), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 22/51 (43%), Positives = 29/51 (56%)
Query: 113 IIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERI 163
           IIHRD+KPSNI++     +K+ DFG++     S   T     R Y APE I
Sbjct: 152 IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVI 202

>pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351

Iteration: 1
 Score = 41.2 bits (95), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 53/189 (28%), Positives = 81/189 (42%), Gaps = 47/189 (24%)
Query: 20  DFTSEDLQDLGE-IGRGGFGTVNKMIHRSSDTVMAVKRIR----------STVDEKDQRQ 68
           D   ED+ +L E IG+G F  V + I+R +    AVK +           ST D K +  
Sbjct: 19  DVLFEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREAS 78
Query: 69  ----------------------LLMDLDVVMKSNECPYIVQFY--GALFKEVTVA----- 99
                                 L M  + +  ++ C  IV+    G ++ E   +     
Sbjct: 79  ICHMLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQ 138
Query: 100 TVKALNYLKEELKIIHRDVKPSNILL---DRRGAIKLCDFGISGQLVDS--IAKTRDAGC 154
            ++AL Y  +   IIHRDVKP  +LL   +    +KL  FG++ QL +S  +A  R  G 
Sbjct: 139 ILEALRYCHDN-NIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGR-VGT 196
Query: 155 RPYMAPERI 163
             +MAPE +
Sbjct: 197 PHFMAPEVV 205

>pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366

Iteration: 1
 Score = 41.2 bits (95), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 22/61 (36%), Positives = 34/61 (55%), Gaps = 3/61 (4%)
Query: 101 VKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTRDAGCRPYMAP 160
           ++ L Y+     IIHRD+KPSN+ ++    +K+ DFG++    D +  T     R Y AP
Sbjct: 141 LRGLKYIHSA-DIIHRDLKPSNLAVNEDSELKILDFGLARHTDDEM--TGYVATRWYRAP 197
Query: 161 E 161
           E
Sbjct: 198 E 198

>pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 41.2 bits (95), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 22/61 (36%), Positives = 34/61 (55%), Gaps = 3/61 (4%)
Query: 101 VKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTRDAGCRPYMAP 160
           ++ L Y+     IIHRD+KPSN+ ++    +K+ DFG++    D +  T     R Y AP
Sbjct: 137 LRGLKYIHSA-DIIHRDLKPSNLAVNEDSELKILDFGLARHTDDEM--TGYVATRWYRAP 193
Query: 161 E 161
           E
Sbjct: 194 E 194

>pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360

Iteration: 1
 Score = 41.2 bits (95), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 21/51 (41%), Positives = 29/51 (56%)
Query: 113 IIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERI 163
           IIHRD+KPSNI++     +K+ DFG++     +   T     R Y APE I
Sbjct: 145 IIHRDLKPSNIVVKSDCTLKILDFGLARTASTNFMMTPYVVTRYYRAPEVI 195

>pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370

Iteration: 1
 Score = 41.2 bits (95), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 21/51 (41%), Positives = 29/51 (56%)
Query: 113 IIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERI 163
           IIHRD+KPSNI++     +K+ DFG++     S     +   R Y APE I
Sbjct: 147 IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMEPEVVTRYYRAPEVI 197

>pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370

Iteration: 1
 Score = 41.2 bits (95), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 21/51 (41%), Positives = 29/51 (56%)
Query: 113 IIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERI 163
           IIHRD+KPSNI++     +K+ DFG++     S     +   R Y APE I
Sbjct: 147 IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMEPEVVTRYYRAPEVI 197

>pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327

Iteration: 1
 Score = 41.2 bits (95), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 25/59 (42%), Positives = 36/59 (61%), Gaps = 6/59 (10%)
Query: 113 IIHRDVKPSNILLDRR---GAIKLCDFGISGQLV-DSIAKTRDAGCRPYMAPE--RIDP 165
           I+HRD+KP N+LL  +    A+KL DFG++ ++  D  A    AG   Y++PE  R DP
Sbjct: 124 IVHRDLKPENLLLASKSKGAAVKLADFGLAIEVQGDQQAWFGFAGTPGYLSPEVLRKDP 182

>pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365

Iteration: 1
 Score = 40.8 bits (94), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 44/181 (24%), Positives = 75/181 (41%), Gaps = 40/181 (22%)
Query: 17  TVYDFTSEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRI----RSTVDEK-DQRQL-- 69
           T+++   E  Q+L  IG G +G+V       +   +AVK++    +S +  K   R+L  
Sbjct: 21  TIWE-VPERYQNLSPIGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 79
Query: 70  -----------LMDLDVVMKS----NECPYIVQFYGALFKEVT--------------VAT 100
                      L+D+    +S    N+   +    GA    +                  
Sbjct: 80  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQI 139
Query: 101 VKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTRDAGCRPYMAP 160
           ++ L Y+     IIHRD+KPSN+ ++    +K+ DFG++    D +  T     R Y AP
Sbjct: 140 LRGLKYIHSA-DIIHRDLKPSNLAVNEDXELKILDFGLARHTDDEM--TGYVATRWYRAP 196
Query: 161 E 161
           E
Sbjct: 197 E 197

>pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348

Iteration: 1
 Score = 40.8 bits (94), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 43/181 (23%), Positives = 75/181 (41%), Gaps = 40/181 (22%)
Query: 17  TVYDFTSEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRI----RSTVDEK-DQRQL-- 69
           T+++   E  Q+L  +G G +G+V       +   +AVK++    +S +  K   R+L  
Sbjct: 12  TIWE-VPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRL 70
Query: 70  -----------LMDLDVVMKS----NECPYIVQFYGALFKEVT--------------VAT 100
                      L+D+    +S    N+   +    GA    +                  
Sbjct: 71  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQI 130
Query: 101 VKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTRDAGCRPYMAP 160
           ++ L Y+     IIHRD+KPSN+ ++    +K+ DFG++    D +A       R Y AP
Sbjct: 131 LRGLKYIHSA-DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMAGF--VATRWYRAP 187
Query: 161 E 161
           E
Sbjct: 188 E 188

>pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354

Iteration: 1
 Score = 40.8 bits (94), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 43/181 (23%), Positives = 75/181 (41%), Gaps = 40/181 (22%)
Query: 17  TVYDFTSEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRI----RSTVDEK-DQRQL-- 69
           T+++   E  Q+L  +G G +G+V       +   +AVK++    +S +  K   R+L  
Sbjct: 16  TIWE-VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 74
Query: 70  -----------LMDLDVVMKS----NECPYIVQFYGALFKEVT--------------VAT 100
                      L+D+    +S    N+   +    GA    +                  
Sbjct: 75  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQI 134
Query: 101 VKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTRDAGCRPYMAP 160
           ++ L Y+     IIHRD+KPSN+ ++    +K+ DFG++    D +  T     R Y AP
Sbjct: 135 LRGLKYIHSA-DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM--TGXVATRWYRAP 191
Query: 161 E 161
           E
Sbjct: 192 E 192

>pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 40.8 bits (94), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 22/61 (36%), Positives = 34/61 (55%), Gaps = 3/61 (4%)
Query: 101 VKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTRDAGCRPYMAP 160
           ++ L Y+     IIHRD+KPSN+ ++    +K+ DFG++    D +  T     R Y AP
Sbjct: 135 LRGLKYIHSA-DIIHRDLKPSNLAVNEDXELKILDFGLARHTDDEM--TGYVATRWYRAP 191
Query: 161 E 161
           E
Sbjct: 192 E 192

>pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360

Iteration: 1
 Score = 40.8 bits (94), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 22/61 (36%), Positives = 34/61 (55%), Gaps = 3/61 (4%)
Query: 101 VKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTRDAGCRPYMAP 160
           ++ L Y+     IIHRD+KPSN+ ++    +K+ DFG++    D +A       R Y AP
Sbjct: 135 LRGLKYIHSA-DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMAGF--VATRWYRAP 191
Query: 161 E 161
           E
Sbjct: 192 E 192

>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295

Iteration: 1
 Score = 40.8 bits (94), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 43/184 (23%), Positives = 80/184 (43%), Gaps = 42/184 (22%)
Query: 21  FTSEDLQDLGEIGRGGFGTVNKM----IHRSSDTVMAVKRIRSTVDE--KDQRQLLMDLD 74
           F    L+ L ++G+G FG+V       +  ++  V+AVK+++ + +E  +D  + +  L 
Sbjct: 7   FEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILK 66
Query: 75  VVMKSNECPY--------------IVQF--YGAL---------------FKEVTVATVKA 103
            +   N   Y              I+++  YG+L                 + T    K 
Sbjct: 67  SLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKG 126
Query: 104 LNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVD--SIAKTRDAGCRP--YMA 159
           + YL  + + IHRD+   NIL++    +K+ DFG++  L       K ++ G  P  + A
Sbjct: 127 MEYLGTK-RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYA 185
Query: 160 PERI 163
           PE +
Sbjct: 186 PESL 189

>pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324

Iteration: 1
 Score = 40.8 bits (94), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 47/189 (24%), Positives = 74/189 (39%), Gaps = 58/189 (30%)
Query: 10  KLKLSPD-TVY---DFTSEDLQDLGEIGRGGFGTVNKMIHRSSDTVM--AVKRIRSTVDE 63
           K+K +PD T+Y   D+     QD+  IG G FG V K   +     M  A+KR++    +
Sbjct: 6   KVKNNPDPTIYPVLDWNDIKFQDV--IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASK 63
Query: 64  KDQRQLLMDLDVVMKSNECPYIVQFYGA------LFKEVTVA------------------ 99
            D R    +L+V+ K    P I+   GA      L+  +  A                  
Sbjct: 64  DDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETD 123
Query: 100 ------------------------TVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCD 135
                                     + ++YL ++ + IHR++   NIL+      K+ D
Sbjct: 124 PAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK-QFIHRNLAARNILVGENYVAKIAD 182
Query: 136 FGIS-GQLV 143
           FG+S GQ V
Sbjct: 183 FGLSRGQEV 191

>pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635

Iteration: 1
 Score = 40.8 bits (94), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 45/170 (26%), Positives = 73/170 (42%), Gaps = 36/170 (21%)
Query: 31  EIGRGGFGTVNKMIHRSSDTVMAVKR--IRSTVDEKDQRQLLMDLDVVMKSNECPYIVQF 88
           E+G G FGTV K  ++    V  V    +++  ++   +  L+    VM+  + PYIV+ 
Sbjct: 376 ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 435
Query: 89  YGALFKE-----VTVATVKALN-YLK------------------------EELKIIHRDV 118
            G    E     + +A +  LN YL+                        EE   +HRD+
Sbjct: 436 IGICEAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDL 495
Query: 119 KPSNILLDRRGAIKLCDFGISGQLV--DSIAKTRDAGCRP--YMAPERID 164
              N+LL  +   K+ DFG+S  L   ++  K +  G  P  + APE I+
Sbjct: 496 AARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECIN 545

>pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279

Iteration: 1
 Score = 40.8 bits (94), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 41/182 (22%), Positives = 81/182 (44%), Gaps = 35/182 (19%)
Query: 16  DTVYDFTSEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVK-------RIRSTVDEKD--- 65
           D  ++   E ++ + ++G G FG V  M + ++ T +AVK        +++ ++E +   
Sbjct: 4   DPAWEIPRESIKLVKKLGAGQFGEV-WMGYYNNSTKVAVKTLKPGTMSVQAFLEEANLMK 62
Query: 66  --QRQLLMDLDVVMKSNECPYIVQFY---GALFK----------------EVTVATVKAL 104
             Q   L+ L  V+   E  YI+  +   G+L                  + +    + +
Sbjct: 63  TLQHDKLVRLYAVVTKEEPIYIITEFMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGM 122
Query: 105 NYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTRDAGCRP--YMAPER 162
            Y+ E    IHRD++ +N+L+      K+ DFG++  + D+    R+    P  + APE 
Sbjct: 123 AYI-ERKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEA 181
Query: 163 ID 164
           I+
Sbjct: 182 IN 183

>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 40.8 bits (94), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 43/182 (23%), Positives = 74/182 (40%), Gaps = 42/182 (23%)
Query: 19  YDFTSEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMK 78
           ++    D+    ++G G FG V + + +     +AVK ++    E ++    +    VMK
Sbjct: 6   WEMERTDITMKHKLGGGQFGEVYEGVWKKYSLTVAVKTLKEDTMEVEE---FLKEAAVMK 62
Query: 79  SNECPYIVQF------------------YGALF--------KEVTVATV--------KAL 104
             + P +VQ                   YG L         +EV+   +         A+
Sbjct: 63  EIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAM 122
Query: 105 NYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTRDAGCR---PYMAPE 161
            YL E+   IHRD+   N L+     +K+ DFG+S +L+     T  AG +    + APE
Sbjct: 123 EYL-EKKNFIHRDLAARNCLVGENHLVKVADFGLS-RLMTGDTXTAHAGAKFPIKWTAPE 180
Query: 162 RI 163
            +
Sbjct: 181 SL 182

>pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283

Iteration: 1
 Score = 40.8 bits (94), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 44/177 (24%), Positives = 76/177 (42%), Gaps = 36/177 (20%)
Query: 18  VYDFTSEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIR------------STVDEKD 65
           V++   E LQ +  +G G FG V  M   + +T +A+K ++            + + +K 
Sbjct: 3   VWEIPRESLQLIKRLGNGQFGEV-WMGTWNGNTKVAIKTLKPGTMSPESFLEEAQIMKKL 61
Query: 66  QRQLLMDLDVVMKSNECPYIVQFY---GALFK----------------EVTVATVKALNY 106
           +   L+ L  V+ S E  YIV  Y   G+L                  ++       + Y
Sbjct: 62  KHDKLVQLYAVV-SEEPIYIVTEYMNKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAY 120
Query: 107 LKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTRDAGCRP--YMAPE 161
           + E +  IHRD++ +NIL+      K+ DFG++  + D+    R     P  + APE
Sbjct: 121 I-ERMNYIHRDLRSANILVGNGLICKIADFGLARLIEDNEXTARQGAKFPIKWTAPE 176

>pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360

Iteration: 1
 Score = 40.8 bits (94), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 22/61 (36%), Positives = 34/61 (55%), Gaps = 3/61 (4%)
Query: 101 VKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTRDAGCRPYMAP 160
           ++ L Y+     IIHRD+KPSN+ ++    +K+ DFG++    D +A       R Y AP
Sbjct: 135 LRGLKYIHSA-DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMAGF--VATRWYRAP 191
Query: 161 E 161
           E
Sbjct: 192 E 192

>pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636

Iteration: 1
 Score = 40.8 bits (94), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 45/170 (26%), Positives = 73/170 (42%), Gaps = 36/170 (21%)
Query: 31  EIGRGGFGTVNKMIHRSSDTVMAVKR--IRSTVDEKDQRQLLMDLDVVMKSNECPYIVQF 88
           E+G G FGTV K  ++    V  V    +++  ++   +  L+    VM+  + PYIV+ 
Sbjct: 377 ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 436
Query: 89  YGALFKE-----VTVATVKALN-YLK------------------------EELKIIHRDV 118
            G    E     + +A +  LN YL+                        EE   +HRD+
Sbjct: 437 IGICEAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDL 496
Query: 119 KPSNILLDRRGAIKLCDFGISGQLV--DSIAKTRDAGCRP--YMAPERID 164
              N+LL  +   K+ DFG+S  L   ++  K +  G  P  + APE I+
Sbjct: 497 AARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECIN 546

>pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370

Iteration: 1
 Score = 40.8 bits (94), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 19/49 (38%), Positives = 30/49 (61%), Gaps = 2/49 (4%)
Query: 113 IIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTRDAGCRPYMAPE 161
           IIHRD+KPSN+ ++    +++ DFG++ Q  + +  T     R Y APE
Sbjct: 152 IIHRDLKPSNVAVNEDSELRILDFGLARQADEEM--TGYVATRWYRAPE 198

>pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301

Iteration: 1
 Score = 40.8 bits (94), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 25/59 (42%), Positives = 36/59 (61%), Gaps = 6/59 (10%)
Query: 113 IIHRDVKPSNILLDRR---GAIKLCDFGISGQLV-DSIAKTRDAGCRPYMAPE--RIDP 165
           I+HRD+KP N+LL  +    A+KL DFG++ ++  D  A    AG   Y++PE  R DP
Sbjct: 124 IVHRDLKPENLLLASKSKGAAVKLADFGLAIEVQGDQQAWFGFAGTPGYLSPEVLRKDP 182

>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293

Iteration: 1
 Score = 40.8 bits (94), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 43/184 (23%), Positives = 80/184 (43%), Gaps = 42/184 (22%)
Query: 21  FTSEDLQDLGEIGRGGFGTVNKM----IHRSSDTVMAVKRIRSTVDE--KDQRQLLMDLD 74
           F    L+ L ++G+G FG+V       +  ++  V+AVK+++ + +E  +D  + +  L 
Sbjct: 6   FEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILK 65
Query: 75  VVMKSNECPY--------------IVQF--YGAL---------------FKEVTVATVKA 103
            +   N   Y              I+++  YG+L                 + T    K 
Sbjct: 66  SLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKG 125
Query: 104 LNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVD--SIAKTRDAGCRP--YMA 159
           + YL  + + IHRD+   NIL++    +K+ DFG++  L       K ++ G  P  + A
Sbjct: 126 MEYLGTK-RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYA 184
Query: 160 PERI 163
           PE +
Sbjct: 185 PESL 188

>pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320

Iteration: 1
 Score = 40.8 bits (94), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 24/74 (32%), Positives = 37/74 (50%), Gaps = 4/74 (5%)
Query: 95  EVTVATVKALNYLKEELKIIHRDVKPSNILLDRR---GAIKLCDFGISGQLVDSIAKTRD 151
           E+  +  +A+ YL   + I HRDVKP N+L   +     +KL DFG + +     + T  
Sbjct: 119 EIMKSIGEAIQYL-HSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTEP 177
Query: 152 AGCRPYMAPERIDP 165
                Y+APE + P
Sbjct: 178 CYTPYYVAPEVLGP 191

>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326

Iteration: 1
 Score = 40.8 bits (94), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 43/184 (23%), Positives = 80/184 (43%), Gaps = 42/184 (22%)
Query: 21  FTSEDLQDLGEIGRGGFGTVNKM----IHRSSDTVMAVKRIRSTVDE--KDQRQLLMDLD 74
           F    L+ L ++G+G FG+V       +  ++  V+AVK+++ + +E  +D  + +  L 
Sbjct: 38  FEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILK 97
Query: 75  VVMKSNECPY--------------IVQF--YGAL---------------FKEVTVATVKA 103
            +   N   Y              I+++  YG+L                 + T    K 
Sbjct: 98  SLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKG 157
Query: 104 LNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVD--SIAKTRDAGCRP--YMA 159
           + YL  + + IHRD+   NIL++    +K+ DFG++  L       K ++ G  P  + A
Sbjct: 158 MEYLGTK-RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYA 216
Query: 160 PERI 163
           PE +
Sbjct: 217 PESL 220

>pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365

Iteration: 1
 Score = 40.8 bits (94), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 22/61 (36%), Positives = 34/61 (55%), Gaps = 3/61 (4%)
Query: 101 VKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTRDAGCRPYMAP 160
           ++ L Y+     IIHRD+KPSN+ ++    +K+ DFG++    D +  T     R Y AP
Sbjct: 140 LRGLKYIHSA-DIIHRDLKPSNLAVNEDXELKILDFGLARHTDDEM--TGYVATRWYRAP 196
Query: 161 E 161
           E
Sbjct: 197 E 197

>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293

Iteration: 1
 Score = 40.8 bits (94), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 43/184 (23%), Positives = 80/184 (43%), Gaps = 42/184 (22%)
Query: 21  FTSEDLQDLGEIGRGGFGTVNKM----IHRSSDTVMAVKRIRSTVDE--KDQRQLLMDLD 74
           F    L+ L ++G+G FG+V       +  ++  V+AVK+++ + +E  +D  + +  L 
Sbjct: 5   FEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILK 64
Query: 75  VVMKSNECPY--------------IVQF--YGAL---------------FKEVTVATVKA 103
            +   N   Y              I+++  YG+L                 + T    K 
Sbjct: 65  SLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKG 124
Query: 104 LNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVD--SIAKTRDAGCRP--YMA 159
           + YL  + + IHRD+   NIL++    +K+ DFG++  L       K ++ G  P  + A
Sbjct: 125 MEYLGTK-RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYA 183
Query: 160 PERI 163
           PE +
Sbjct: 184 PESL 187

>pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371

Iteration: 1
 Score = 40.8 bits (94), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 22/61 (36%), Positives = 34/61 (55%), Gaps = 3/61 (4%)
Query: 101 VKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTRDAGCRPYMAP 160
           ++ L Y+     IIHRD+KPSN+ ++    +K+ DFG++    D +  T     R Y AP
Sbjct: 146 LRGLKYIHSA-DIIHRDLKPSNLAVNEDXELKILDFGLARHTDDEM--TGYVATRWYRAP 202
Query: 161 E 161
           E
Sbjct: 203 E 203

>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300

Iteration: 1
 Score = 40.8 bits (94), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 43/184 (23%), Positives = 80/184 (43%), Gaps = 42/184 (22%)
Query: 21  FTSEDLQDLGEIGRGGFGTVNKM----IHRSSDTVMAVKRIRSTVDE--KDQRQLLMDLD 74
           F    L+ L ++G+G FG+V       +  ++  V+AVK+++ + +E  +D  + +  L 
Sbjct: 12  FEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILK 71
Query: 75  VVMKSNECPY--------------IVQF--YGAL---------------FKEVTVATVKA 103
            +   N   Y              I+++  YG+L                 + T    K 
Sbjct: 72  SLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKG 131
Query: 104 LNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVD--SIAKTRDAGCRP--YMA 159
           + YL  + + IHRD+   NIL++    +K+ DFG++  L       K ++ G  P  + A
Sbjct: 132 MEYLGTK-RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYA 190
Query: 160 PERI 163
           PE +
Sbjct: 191 PESL 194

>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301

Iteration: 1
 Score = 40.8 bits (94), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 43/184 (23%), Positives = 80/184 (43%), Gaps = 42/184 (22%)
Query: 21  FTSEDLQDLGEIGRGGFGTVNKM----IHRSSDTVMAVKRIRSTVDE--KDQRQLLMDLD 74
           F    L+ L ++G+G FG+V       +  ++  V+AVK+++ + +E  +D  + +  L 
Sbjct: 13  FEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILK 72
Query: 75  VVMKSNECPY--------------IVQF--YGAL---------------FKEVTVATVKA 103
            +   N   Y              I+++  YG+L                 + T    K 
Sbjct: 73  SLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKG 132
Query: 104 LNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVD--SIAKTRDAGCRP--YMA 159
           + YL  + + IHRD+   NIL++    +K+ DFG++  L       K ++ G  P  + A
Sbjct: 133 MEYLGTK-RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYA 191
Query: 160 PERI 163
           PE +
Sbjct: 192 PESL 195

>pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313

Iteration: 1
 Score = 40.8 bits (94), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 43/184 (23%), Positives = 80/184 (43%), Gaps = 42/184 (22%)
Query: 21  FTSEDLQDLGEIGRGGFGTVNKM----IHRSSDTVMAVKRIRSTVDE--KDQRQLLMDLD 74
           F    L+ L ++G+G FG+V       +  ++  V+AVK+++ + +E  +D  + +  L 
Sbjct: 25  FEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILK 84
Query: 75  VVMKSNECPY--------------IVQF--YGAL---------------FKEVTVATVKA 103
            +   N   Y              I+++  YG+L                 + T    K 
Sbjct: 85  SLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKG 144
Query: 104 LNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVD--SIAKTRDAGCRP--YMA 159
           + YL  + + IHRD+   NIL++    +K+ DFG++  L       K ++ G  P  + A
Sbjct: 145 MEYLGTK-RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYA 203
Query: 160 PERI 163
           PE +
Sbjct: 204 PESL 207

>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311

Iteration: 1
 Score = 40.8 bits (94), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 43/184 (23%), Positives = 80/184 (43%), Gaps = 42/184 (22%)
Query: 21  FTSEDLQDLGEIGRGGFGTVNKM----IHRSSDTVMAVKRIRSTVDE--KDQRQLLMDLD 74
           F    L+ L ++G+G FG+V       +  ++  V+AVK+++ + +E  +D  + +  L 
Sbjct: 25  FEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILK 84
Query: 75  VVMKSNECPY--------------IVQF--YGAL---------------FKEVTVATVKA 103
            +   N   Y              I+++  YG+L                 + T    K 
Sbjct: 85  SLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKG 144
Query: 104 LNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVD--SIAKTRDAGCRP--YMA 159
           + YL  + + IHRD+   NIL++    +K+ DFG++  L       K ++ G  P  + A
Sbjct: 145 MEYLGTK-RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYA 203
Query: 160 PERI 163
           PE +
Sbjct: 204 PESL 207

>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 40.4 bits (93), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 43/184 (23%), Positives = 80/184 (43%), Gaps = 42/184 (22%)
Query: 21  FTSEDLQDLGEIGRGGFGTVNKM----IHRSSDTVMAVKRIRSTVDE--KDQRQLLMDLD 74
           F    L+ L ++G+G FG+V       +  ++  V+AVK+++ + +E  +D  + +  L 
Sbjct: 14  FEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILK 73
Query: 75  VVMKSNECPY--------------IVQF--YGAL---------------FKEVTVATVKA 103
            +   N   Y              I+++  YG+L                 + T    K 
Sbjct: 74  SLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKG 133
Query: 104 LNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVD--SIAKTRDAGCRP--YMA 159
           + YL  + + IHRD+   NIL++    +K+ DFG++  L       K ++ G  P  + A
Sbjct: 134 MEYLGTK-RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYA 192
Query: 160 PERI 163
           PE +
Sbjct: 193 PESL 196

>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298

Iteration: 1
 Score = 40.4 bits (93), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 43/184 (23%), Positives = 80/184 (43%), Gaps = 42/184 (22%)
Query: 21  FTSEDLQDLGEIGRGGFGTVNKM----IHRSSDTVMAVKRIRSTVDE--KDQRQLLMDLD 74
           F    L+ L ++G+G FG+V       +  ++  V+AVK+++ + +E  +D  + +  L 
Sbjct: 10  FEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILK 69
Query: 75  VVMKSNECPY--------------IVQF--YGAL---------------FKEVTVATVKA 103
            +   N   Y              I+++  YG+L                 + T    K 
Sbjct: 70  SLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQAHAERIDHIKLLQYTSQICKG 129
Query: 104 LNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVD--SIAKTRDAGCRP--YMA 159
           + YL  + + IHRD+   NIL++    +K+ DFG++  L       K ++ G  P  + A
Sbjct: 130 MEYLGTK-RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYA 188
Query: 160 PERI 163
           PE +
Sbjct: 189 PESL 192

>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301

Iteration: 1
 Score = 40.4 bits (93), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 43/184 (23%), Positives = 80/184 (43%), Gaps = 42/184 (22%)
Query: 21  FTSEDLQDLGEIGRGGFGTVNKM----IHRSSDTVMAVKRIRSTVDE--KDQRQLLMDLD 74
           F    L+ L ++G+G FG+V       +  ++  V+AVK+++ + +E  +D  + +  L 
Sbjct: 7   FEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILK 66
Query: 75  VVMKSNECPY--------------IVQF--YGAL---------------FKEVTVATVKA 103
            +   N   Y              I+++  YG+L                 + T    K 
Sbjct: 67  SLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKG 126
Query: 104 LNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVD--SIAKTRDAGCRP--YMA 159
           + YL  + + IHRD+   NIL++    +K+ DFG++  L       K ++ G  P  + A
Sbjct: 127 MEYLGTK-RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYA 185
Query: 160 PERI 163
           PE +
Sbjct: 186 PESL 189

>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295

Iteration: 1
 Score = 40.4 bits (93), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 43/184 (23%), Positives = 80/184 (43%), Gaps = 42/184 (22%)
Query: 21  FTSEDLQDLGEIGRGGFGTVNKM----IHRSSDTVMAVKRIRSTVDE--KDQRQLLMDLD 74
           F    L+ L ++G+G FG+V       +  ++  V+AVK+++ + +E  +D  + +  L 
Sbjct: 7   FEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILK 66
Query: 75  VVMKSNECPY--------------IVQF--YGAL---------------FKEVTVATVKA 103
            +   N   Y              I+++  YG+L                 + T    K 
Sbjct: 67  SLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKG 126
Query: 104 LNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVD--SIAKTRDAGCRP--YMA 159
           + YL  + + IHRD+   NIL++    +K+ DFG++  L       K ++ G  P  + A
Sbjct: 127 MEYLGTK-RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYA 185
Query: 160 PERI 163
           PE +
Sbjct: 186 PESL 189

>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303

Iteration: 1
 Score = 40.4 bits (93), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 43/184 (23%), Positives = 80/184 (43%), Gaps = 42/184 (22%)
Query: 21  FTSEDLQDLGEIGRGGFGTVNKM----IHRSSDTVMAVKRIRSTVDE--KDQRQLLMDLD 74
           F    L+ L ++G+G FG+V       +  ++  V+AVK+++ + +E  +D  + +  L 
Sbjct: 11  FEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILK 70
Query: 75  VVMKSNECPY--------------IVQF--YGAL---------------FKEVTVATVKA 103
            +   N   Y              I+++  YG+L                 + T    K 
Sbjct: 71  SLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKG 130
Query: 104 LNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVD--SIAKTRDAGCRP--YMA 159
           + YL  + + IHRD+   NIL++    +K+ DFG++  L       K ++ G  P  + A
Sbjct: 131 MEYLGTK-RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYA 189
Query: 160 PERI 163
           PE +
Sbjct: 190 PESL 193

>pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334

Iteration: 1
 Score = 40.4 bits (93), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 24/74 (32%), Positives = 37/74 (50%), Gaps = 4/74 (5%)
Query: 95  EVTVATVKALNYLKEELKIIHRDVKPSNILLDRR---GAIKLCDFGISGQLVDSIAKTRD 151
           E+  +  +A+ YL   + I HRDVKP N+L   +     +KL DFG + +     + T  
Sbjct: 135 EIMKSIGEAIQYL-HSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTP 193
Query: 152 AGCRPYMAPERIDP 165
                Y+APE + P
Sbjct: 194 CYTPYYVAPEVLGP 207

>pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370

Iteration: 1
 Score = 40.4 bits (93), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 19/49 (38%), Positives = 30/49 (61%), Gaps = 2/49 (4%)
Query: 113 IIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTRDAGCRPYMAPE 161
           IIHRD+KPSN+ ++    +++ DFG++ Q  + +  T     R Y APE
Sbjct: 152 IIHRDLKPSNVAVNEDSELRILDFGLARQADEEM--TGYVATRWYRAPE 198

>pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329

Iteration: 1
 Score = 40.4 bits (93), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 35/142 (24%), Positives = 58/142 (40%), Gaps = 38/142 (26%)
Query: 32  IGRGGFGTVNKMIH----RSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQ 87
           +G G FGTV K +           +A+K +R     K  +++L D   VM S + P++ +
Sbjct: 25  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEIL-DEAYVMASVDNPHVCR 83
Query: 88  F-----------------YGALFKEV---------------TVATVKALNYLKEELKIIH 115
                             +G L   V                V   K +NYL E+ +++H
Sbjct: 84  LLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYL-EDRRLVH 142
Query: 116 RDVKPSNILLDRRGAIKLCDFG 137
           RD+   N+L+     +K+ DFG
Sbjct: 143 RDLAARNVLVKTPQHVKITDFG 164

>pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326

Iteration: 1
 Score = 40.4 bits (93), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 24/74 (32%), Positives = 37/74 (50%), Gaps = 4/74 (5%)
Query: 95  EVTVATVKALNYLKEELKIIHRDVKPSNILLDRR---GAIKLCDFGISGQLVDSIAKTRD 151
           E+  +  +A+ YL   + I HRDVKP N+L   +     +KL DFG + +     + T  
Sbjct: 127 EIMKSIGEAIQYL-HSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTP 185
Query: 152 AGCRPYMAPERIDP 165
                Y+APE + P
Sbjct: 186 CYTPYYVAPEVLGP 199

>pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329

Iteration: 1
 Score = 40.4 bits (93), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 35/142 (24%), Positives = 58/142 (40%), Gaps = 38/142 (26%)
Query: 32  IGRGGFGTVNKMIH----RSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQ 87
           +G G FGTV K +           +A+K +R     K  +++L D   VM S + P++ +
Sbjct: 25  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEIL-DEAYVMASVDNPHVCR 83
Query: 88  F-----------------YGALFKEV---------------TVATVKALNYLKEELKIIH 115
                             +G L   V                V   K +NYL E+ +++H
Sbjct: 84  LLGICLTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYL-EDRRLVH 142
Query: 116 RDVKPSNILLDRRGAIKLCDFG 137
           RD+   N+L+     +K+ DFG
Sbjct: 143 RDLAARNVLVKTPQHVKITDFG 164

>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298

Iteration: 1
 Score = 40.4 bits (93), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 43/184 (23%), Positives = 80/184 (43%), Gaps = 42/184 (22%)
Query: 21  FTSEDLQDLGEIGRGGFGTVNKM----IHRSSDTVMAVKRIRSTVDE--KDQRQLLMDLD 74
           F    L+ L ++G+G FG+V       +  ++  V+AVK+++ + +E  +D  + +  L 
Sbjct: 10  FEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILK 69
Query: 75  VVMKSNECPY--------------IVQF--YGAL---------------FKEVTVATVKA 103
            +   N   Y              I+++  YG+L                 + T    K 
Sbjct: 70  SLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKG 129
Query: 104 LNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVD--SIAKTRDAGCRP--YMA 159
           + YL  + + IHRD+   NIL++    +K+ DFG++  L       K ++ G  P  + A
Sbjct: 130 MEYLGTK-RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYA 188
Query: 160 PERI 163
           PE +
Sbjct: 189 PESL 192

>pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327

Iteration: 1
 Score = 40.4 bits (93), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 35/142 (24%), Positives = 58/142 (40%), Gaps = 38/142 (26%)
Query: 32  IGRGGFGTVNKMIH----RSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQ 87
           +G G FGTV K +           +A+K +R     K  +++L D   VM S + P++ +
Sbjct: 23  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEIL-DEAYVMASVDNPHVCR 81
Query: 88  F-----------------YGALFKEV---------------TVATVKALNYLKEELKIIH 115
                             +G L   V                V   K +NYL E+ +++H
Sbjct: 82  LLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYL-EDRRLVH 140
Query: 116 RDVKPSNILLDRRGAIKLCDFG 137
           RD+   N+L+     +K+ DFG
Sbjct: 141 RDLAARNVLVKTPQHVKITDFG 162

>pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329

Iteration: 1
 Score = 40.4 bits (93), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 35/142 (24%), Positives = 58/142 (40%), Gaps = 38/142 (26%)
Query: 32  IGRGGFGTVNKMIH----RSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQ 87
           +G G FGTV K +           +A+K +R     K  +++L D   VM S + P++ +
Sbjct: 25  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEIL-DEAYVMASVDNPHVCR 83
Query: 88  F-----------------YGALFKEV---------------TVATVKALNYLKEELKIIH 115
                             +G L   V                V   K +NYL E+ +++H
Sbjct: 84  LLGICLTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYL-EDRRLVH 142
Query: 116 RDVKPSNILLDRRGAIKLCDFG 137
           RD+   N+L+     +K+ DFG
Sbjct: 143 RDLAARNVLVKTPQHVKITDFG 164

>pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325

Iteration: 1
 Score = 40.4 bits (93), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 24/74 (32%), Positives = 37/74 (50%), Gaps = 4/74 (5%)
Query: 95  EVTVATVKALNYLKEELKIIHRDVKPSNILLDRR---GAIKLCDFGISGQLVDSIAKTRD 151
           E+  +  +A+ YL   + I HRDVKP N+L   +     +KL DFG + +     + T  
Sbjct: 126 EIMKSIGEAIQYL-HSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTP 184
Query: 152 AGCRPYMAPERIDP 165
                Y+APE + P
Sbjct: 185 CYTPYYVAPEVLGP 198

>pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287

Iteration: 1
 Score = 40.4 bits (93), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 47/178 (26%), Positives = 77/178 (43%), Gaps = 34/178 (19%)
Query: 19  YDFTSEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKD------------Q 66
           ++   E L+ +  +G G FG V  M + +  T +AVK ++      D            Q
Sbjct: 16  WEVPRETLKLVERLGAGQFGEV-WMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQ 74
Query: 67  RQLLMDLDVVMKSNECPYIVQFY---GAL--FKEVTVATVKALNYLK------------- 108
            Q L+ L  V+ + E  YI+  Y   G+L  F +        +N L              
Sbjct: 75  HQRLVRLYAVV-TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFI 133
Query: 109 EELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTRDAGCRP--YMAPERID 164
           EE   IHRD++ +NIL+    + K+ DFG++  + D+    R+    P  + APE I+
Sbjct: 134 EERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAIN 191

>pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334

Iteration: 1
 Score = 40.4 bits (93), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 35/142 (24%), Positives = 58/142 (40%), Gaps = 38/142 (26%)
Query: 32  IGRGGFGTVNKMIH----RSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQ 87
           +G G FGTV K +           +A+K +R     K  +++L D   VM S + P++ +
Sbjct: 30  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEIL-DEAYVMASVDNPHVCR 88
Query: 88  F-----------------YGALFKEV---------------TVATVKALNYLKEELKIIH 115
                             +G L   V                V   K +NYL E+ +++H
Sbjct: 89  LLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYL-EDRRLVH 147
Query: 116 RDVKPSNILLDRRGAIKLCDFG 137
           RD+   N+L+     +K+ DFG
Sbjct: 148 RDLAARNVLVKTPQHVKITDFG 169

>pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319

Iteration: 1
 Score = 40.4 bits (93), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 24/74 (32%), Positives = 37/74 (50%), Gaps = 4/74 (5%)
Query: 95  EVTVATVKALNYLKEELKIIHRDVKPSNILLDRR---GAIKLCDFGISGQLVDSIAKTRD 151
           E+  +  +A+ YL   + I HRDVKP N+L   +     +KL DFG + +     + T  
Sbjct: 120 EIMKSIGEAIQYL-HSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTP 178
Query: 152 AGCRPYMAPERIDP 165
                Y+APE + P
Sbjct: 179 CYTPYYVAPEVLGP 192

>pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324

Iteration: 1
 Score = 40.4 bits (93), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 24/74 (32%), Positives = 37/74 (50%), Gaps = 4/74 (5%)
Query: 95  EVTVATVKALNYLKEELKIIHRDVKPSNILLDRR---GAIKLCDFGISGQLVDSIAKTRD 151
           E+  +  +A+ YL   + I HRDVKP N+L   +     +KL DFG + +     + T  
Sbjct: 125 EIMKSIGEAIQYL-HSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTP 183
Query: 152 AGCRPYMAPERIDP 165
                Y+APE + P
Sbjct: 184 CYTPYYVAPEVLGP 197

>pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318

Iteration: 1
 Score = 40.4 bits (93), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 24/74 (32%), Positives = 37/74 (50%), Gaps = 4/74 (5%)
Query: 95  EVTVATVKALNYLKEELKIIHRDVKPSNILLDRR---GAIKLCDFGISGQLVDSIAKTRD 151
           E+  +  +A+ YL   + I HRDVKP N+L   +     +KL DFG + +     + T  
Sbjct: 119 EIMKSIGEAIQYL-HSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTP 177
Query: 152 AGCRPYMAPERIDP 165
                Y+APE + P
Sbjct: 178 CYTPYYVAPEVLGP 191

>pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370

Iteration: 1
 Score = 40.4 bits (93), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 43/181 (23%), Positives = 75/181 (41%), Gaps = 40/181 (22%)
Query: 17  TVYDFTSEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRI----RSTVDEK-DQRQL-- 69
           T+++   E  Q+L  +G G +G+V       +   +AVK++    +S +  K   R+L  
Sbjct: 26  TIWE-VPERYQNLAPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRL 84
Query: 70  -----------LMDLDVVMKS----NECPYIVQFYGALFKEVT--------------VAT 100
                      L+D+    +S    N+   +    GA    +                  
Sbjct: 85  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQI 144
Query: 101 VKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTRDAGCRPYMAP 160
           ++ L Y+     IIHRD+KPSN+ ++    +K+ DFG++    D +  T     R Y AP
Sbjct: 145 LRGLKYIHSA-DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM--TGYVATRWYRAP 201
Query: 161 E 161
           E
Sbjct: 202 E 202

>pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327

Iteration: 1
 Score = 40.4 bits (93), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 24/74 (32%), Positives = 37/74 (50%), Gaps = 4/74 (5%)
Query: 95  EVTVATVKALNYLKEELKIIHRDVKPSNILLDRR---GAIKLCDFGISGQLVDSIAKTRD 151
           E+  +  +A+ YL   + I HRDVKP N+L   +     +KL DFG + +     + T  
Sbjct: 121 EIMKSIGEAIQYL-HSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTP 179
Query: 152 AGCRPYMAPERIDP 165
                Y+APE + P
Sbjct: 180 CYTPYYVAPEVLGP 193

>pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331

Iteration: 1
 Score = 40.4 bits (93), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 35/142 (24%), Positives = 58/142 (40%), Gaps = 38/142 (26%)
Query: 32  IGRGGFGTVNKMIH----RSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQ 87
           +G G FGTV K +           +A+K +R     K  +++L D   VM S + P++ +
Sbjct: 27  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEIL-DEAYVMASVDNPHVCR 85
Query: 88  F-----------------YGALFKEV---------------TVATVKALNYLKEELKIIH 115
                             +G L   V                V   K +NYL E+ +++H
Sbjct: 86  LLGICLTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYL-EDRRLVH 144
Query: 116 RDVKPSNILLDRRGAIKLCDFG 137
           RD+   N+L+     +K+ DFG
Sbjct: 145 RDLAARNVLVKTPQHVKITDFG 166

>pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291

Iteration: 1
 Score = 40.4 bits (93), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 45/170 (26%), Positives = 73/170 (42%), Gaps = 36/170 (21%)
Query: 31  EIGRGGFGTVNKMIHRSSDTVMAVKR--IRSTVDEKDQRQLLMDLDVVMKSNECPYIVQF 88
           E+G G FGTV K  ++    V  V    +++  ++   +  L+    VM+  + PYIV+ 
Sbjct: 32  ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 91
Query: 89  YGALFKE-----VTVATVKALN-YLK------------------------EELKIIHRDV 118
            G    E     + +A +  LN YL+                        EE   +HRD+
Sbjct: 92  IGICEAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDL 151
Query: 119 KPSNILLDRRGAIKLCDFGISGQLV--DSIAKTRDAGCRP--YMAPERID 164
              N+LL  +   K+ DFG+S  L   ++  K +  G  P  + APE I+
Sbjct: 152 AARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECIN 201

>pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313

Iteration: 1
 Score = 40.4 bits (93), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 30/118 (25%), Positives = 56/118 (47%), Gaps = 6/118 (5%)
Query: 54  VKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQFYGALFKEVTVATVKALNYLKEELKI 113
           + R+  ++ E+    L+ DL    +  E     ++Y        +  +        ++ +
Sbjct: 83  IVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQMGV 142
Query: 114 IHRDVKPSNILLDRR---GAIKLCDFGISGQLV-DSIAKTRDAGCRPYMAPE--RIDP 165
           +HRD+KP N+LL  +    A+KL DFG++ ++  +  A    AG   Y++PE  R DP
Sbjct: 143 VHRDLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYLSPEVLRKDP 200

>pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324

Iteration: 1
 Score = 40.4 bits (93), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 35/147 (23%), Positives = 61/147 (41%), Gaps = 38/147 (25%)
Query: 32  IGRGGFGTVNKMIH----RSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQ 87
           +G G FGTV K +           +A+K +R     K  +++L D   VM S + P++ +
Sbjct: 20  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEIL-DEAYVMASVDNPHVCR 78
Query: 88  F-----------------YGALFKEV---------------TVATVKALNYLKEELKIIH 115
                             +G L   V                V   + +NYL E+ +++H
Sbjct: 79  LLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAEGMNYL-EDRRLVH 137
Query: 116 RDVKPSNILLDRRGAIKLCDFGISGQL 142
           RD+   N+L+     +K+ DFG++  L
Sbjct: 138 RDLAARNVLVKTPQHVKITDFGLAKLL 164

>pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348

Iteration: 1
 Score = 40.4 bits (93), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 43/181 (23%), Positives = 75/181 (41%), Gaps = 40/181 (22%)
Query: 17  TVYDFTSEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRI----RSTVDEK-DQRQL-- 69
           T+++   E  Q+L  +G G +G+V       +   +AVK++    +S +  K   R+L  
Sbjct: 12  TIWE-VPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRL 70
Query: 70  -----------LMDLDVVMKS----NECPYIVQFYGALFKEVT--------------VAT 100
                      L+D+    +S    N+   +    GA    +                  
Sbjct: 71  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQI 130
Query: 101 VKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTRDAGCRPYMAP 160
           ++ L Y+     IIHRD+KPSN+ ++    +K+ DFG++    D +  T     R Y AP
Sbjct: 131 LRGLKYIHSA-DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM--TGYVATRWYRAP 187
Query: 161 E 161
           E
Sbjct: 188 E 188

>pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348

Iteration: 1
 Score = 40.4 bits (93), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 43/181 (23%), Positives = 75/181 (41%), Gaps = 40/181 (22%)
Query: 17  TVYDFTSEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRI----RSTVDEK-DQRQL-- 69
           T+++   E  Q+L  +G G +G+V       +   +AVK++    +S +  K   R+L  
Sbjct: 12  TIWE-VPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRL 70
Query: 70  -----------LMDLDVVMKS----NECPYIVQFYGALFKEVT--------------VAT 100
                      L+D+    +S    N+   +    GA    +                  
Sbjct: 71  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCAKLTDDHVQFLIYQI 130
Query: 101 VKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTRDAGCRPYMAP 160
           ++ L Y+     IIHRD+KPSN+ ++    +K+ DFG++    D +  T     R Y AP
Sbjct: 131 LRGLKYIHSA-DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM--TGYVATRWYRAP 187
Query: 161 E 161
           E
Sbjct: 188 E 188

>pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293

Iteration: 1
 Score = 40.4 bits (93), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 45/170 (26%), Positives = 73/170 (42%), Gaps = 36/170 (21%)
Query: 31  EIGRGGFGTVNKMIHRSSDTVMAVKR--IRSTVDEKDQRQLLMDLDVVMKSNECPYIVQF 88
           E+G G FGTV K  ++    V  V    +++  ++   +  L+    VM+  + PYIV+ 
Sbjct: 34  ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 93
Query: 89  YGALFKE-----VTVATVKALN-YLK------------------------EELKIIHRDV 118
            G    E     + +A +  LN YL+                        EE   +HRD+
Sbjct: 94  IGICEAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDL 153
Query: 119 KPSNILLDRRGAIKLCDFGISGQLV--DSIAKTRDAGCRP--YMAPERID 164
              N+LL  +   K+ DFG+S  L   ++  K +  G  P  + APE I+
Sbjct: 154 AARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECIN 203

>pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299

Iteration: 1
 Score = 40.4 bits (93), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 45/170 (26%), Positives = 73/170 (42%), Gaps = 36/170 (21%)
Query: 31  EIGRGGFGTVNKMIHRSSDTVMAVKR--IRSTVDEKDQRQLLMDLDVVMKSNECPYIVQF 88
           E+G G FGTV K  ++    V  V    +++  ++   +  L+    VM+  + PYIV+ 
Sbjct: 34  ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 93
Query: 89  YGALFKE-----VTVATVKALN-YLK------------------------EELKIIHRDV 118
            G    E     + +A +  LN YL+                        EE   +HRD+
Sbjct: 94  IGICEAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDL 153
Query: 119 KPSNILLDRRGAIKLCDFGISGQLV--DSIAKTRDAGCRP--YMAPERID 164
              N+LL  +   K+ DFG+S  L   ++  K +  G  P  + APE I+
Sbjct: 154 AARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECIN 203

>pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350

Iteration: 1
 Score = 40.4 bits (93), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 43/181 (23%), Positives = 75/181 (41%), Gaps = 40/181 (22%)
Query: 17  TVYDFTSEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRI----RSTVDEK-DQRQL-- 69
           T+++   E  Q+L  +G G +G+V       +   +AVK++    +S +  K   R+L  
Sbjct: 14  TIWE-VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 72
Query: 70  -----------LMDLDVVMKS----NECPYIVQFYGALFKEVT--------------VAT 100
                      L+D+    +S    N+   +    GA    +                  
Sbjct: 73  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQI 132
Query: 101 VKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTRDAGCRPYMAP 160
           ++ L Y+     IIHRD+KPSN+ ++    +K+ DFG++    D +  T     R Y AP
Sbjct: 133 LRGLKYIHSA-DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM--TGYVATRWYRAP 189
Query: 161 E 161
           E
Sbjct: 190 E 190

>pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285

Iteration: 1
 Score = 40.4 bits (93), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 47/178 (26%), Positives = 77/178 (43%), Gaps = 34/178 (19%)
Query: 19  YDFTSEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKD------------Q 66
           ++   E L+ +  +G G FG V  M + +  T +AVK ++      D            Q
Sbjct: 14  WEVPRETLKLVERLGAGQFGEV-WMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQ 72
Query: 67  RQLLMDLDVVMKSNECPYIVQFY---GAL--FKEVTVATVKALNYLK------------- 108
            Q L+ L  V+ + E  YI+  Y   G+L  F +        +N L              
Sbjct: 73  HQRLVRLYAVV-TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFI 131
Query: 109 EELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTRDAGCRP--YMAPERID 164
           EE   IHRD++ +NIL+    + K+ DFG++  + D+    R+    P  + APE I+
Sbjct: 132 EERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAIN 189

>pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 40.4 bits (93), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 45/170 (26%), Positives = 73/170 (42%), Gaps = 36/170 (21%)
Query: 31  EIGRGGFGTVNKMIHRSSDTVMAVKR--IRSTVDEKDQRQLLMDLDVVMKSNECPYIVQF 88
           E+G G FGTV K  ++    V  V    +++  ++   +  L+    VM+  + PYIV+ 
Sbjct: 18  ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 77
Query: 89  YGALFKE-----VTVATVKALN-YLK------------------------EELKIIHRDV 118
            G    E     + +A +  LN YL+                        EE   +HRD+
Sbjct: 78  IGICEAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDL 137
Query: 119 KPSNILLDRRGAIKLCDFGISGQLV--DSIAKTRDAGCRP--YMAPERID 164
              N+LL  +   K+ DFG+S  L   ++  K +  G  P  + APE I+
Sbjct: 138 AARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECIN 187

>pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 40.4 bits (93), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 17/39 (43%), Positives = 27/39 (69%), Gaps = 1/39 (2%)
Query: 101 VKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGIS 139
           ++ L++L     I+HRD+KP NIL+   G +KL DFG++
Sbjct: 122 LRGLDFLHANC-IVHRDLKPENILVTSGGTVKLADFGLA 159

>pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389

Iteration: 1
 Score = 40.4 bits (93), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 22/61 (36%), Positives = 34/61 (55%), Gaps = 3/61 (4%)
Query: 101 VKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTRDAGCRPYMAP 160
           ++ L Y+     IIHRD+KPSN+ ++    +K+ DFG++    D +  T     R Y AP
Sbjct: 164 LRGLKYIHSA-DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM--TGYVATRWYRAP 220
Query: 161 E 161
           E
Sbjct: 221 E 221

>pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406

Iteration: 1
 Score = 40.4 bits (93), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 24/74 (32%), Positives = 37/74 (50%), Gaps = 4/74 (5%)
Query: 95  EVTVATVKALNYLKEELKIIHRDVKPSNILLDRR---GAIKLCDFGISGQLVDSIAKTRD 151
           E+  +  +A+ YL   + I HRDVKP N+L   +     +KL DFG + +     + T  
Sbjct: 171 EIMKSIGEAIQYL-HSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTP 229
Query: 152 AGCRPYMAPERIDP 165
                Y+APE + P
Sbjct: 230 CYTPYYVAPEVLGP 243

>pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351

Iteration: 1
 Score = 40.4 bits (93), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 43/181 (23%), Positives = 75/181 (41%), Gaps = 40/181 (22%)
Query: 17  TVYDFTSEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRI----RSTVDEK-DQRQL-- 69
           T+++   E  Q+L  +G G +G+V       +   +AVK++    +S +  K   R+L  
Sbjct: 13  TIWE-VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 71
Query: 70  -----------LMDLDVVMKS----NECPYIVQFYGALFKEVT--------------VAT 100
                      L+D+    +S    N+   +    GA    +                  
Sbjct: 72  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQI 131
Query: 101 VKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTRDAGCRPYMAP 160
           ++ L Y+     IIHRD+KPSN+ ++    +K+ DFG++    D +  T     R Y AP
Sbjct: 132 LRGLKYIHSA-DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM--TGYVATRWYRAP 188
Query: 161 E 161
           E
Sbjct: 189 E 189

>pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288

Iteration: 1
 Score = 40.4 bits (93), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 47/178 (26%), Positives = 77/178 (43%), Gaps = 34/178 (19%)
Query: 19  YDFTSEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKD------------Q 66
           ++   E L+ +  +G G FG V  M + +  T +AVK ++      D            Q
Sbjct: 17  WEVPRETLKLVERLGAGQFGEV-WMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQ 75
Query: 67  RQLLMDLDVVMKSNECPYIVQFY---GAL--FKEVTVATVKALNYLK------------- 108
            Q L+ L  V+ + E  YI+  Y   G+L  F +        +N L              
Sbjct: 76  HQRLVRLYAVV-TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFI 134
Query: 109 EELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTRDAGCRP--YMAPERID 164
           EE   IHRD++ +NIL+    + K+ DFG++  + D+    R+    P  + APE I+
Sbjct: 135 EERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAIN 192

>pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400

Iteration: 1
 Score = 40.4 bits (93), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 24/74 (32%), Positives = 37/74 (50%), Gaps = 4/74 (5%)
Query: 95  EVTVATVKALNYLKEELKIIHRDVKPSNILLDRR---GAIKLCDFGISGQLVDSIAKTRD 151
           E+  +  +A+ YL   + I HRDVKP N+L   +     +KL DFG + +     + T  
Sbjct: 165 EIMKSIGEAIQYL-HSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTP 223
Query: 152 AGCRPYMAPERIDP 165
                Y+APE + P
Sbjct: 224 CYTPYYVAPEVLGP 237

>pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348

Iteration: 1
 Score = 40.4 bits (93), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 43/181 (23%), Positives = 75/181 (41%), Gaps = 40/181 (22%)
Query: 17  TVYDFTSEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRI----RSTVDEK-DQRQL-- 69
           T+++   E  Q+L  +G G +G+V       +   +AVK++    +S +  K   R+L  
Sbjct: 12  TIWE-VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 70
Query: 70  -----------LMDLDVVMKS----NECPYIVQFYGALFKEVT--------------VAT 100
                      L+D+    +S    N+   +    GA    +                  
Sbjct: 71  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQI 130
Query: 101 VKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTRDAGCRPYMAP 160
           ++ L Y+     IIHRD+KPSN+ ++    +K+ DFG++    D +  T     R Y AP
Sbjct: 131 LRGLKYIHSA-DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM--TGYVATRWYRAP 187
Query: 161 E 161
           E
Sbjct: 188 E 188

>pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360

Iteration: 1
 Score = 40.4 bits (93), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 22/61 (36%), Positives = 33/61 (54%), Gaps = 3/61 (4%)
Query: 101 VKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTRDAGCRPYMAP 160
           ++ L Y+     IIHRD+KPSN+ ++    +K+ DFG+     D +  T     R Y AP
Sbjct: 135 LRGLKYIHSA-DIIHRDLKPSNLAVNEDSELKILDFGLCRHTDDEM--TGYVATRWYRAP 191
Query: 161 E 161
           E
Sbjct: 192 E 192

>pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 40.4 bits (93), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 22/61 (36%), Positives = 34/61 (55%), Gaps = 3/61 (4%)
Query: 101 VKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTRDAGCRPYMAP 160
           ++ L Y+     IIHRD+KPSN+ ++    +K+ DFG++    D +  T     R Y AP
Sbjct: 135 LRGLKYIHSA-DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM--TGYVATRWYRAP 191
Query: 161 E 161
           E
Sbjct: 192 E 192

>pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 40.0 bits (92), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 17/39 (43%), Positives = 27/39 (69%), Gaps = 1/39 (2%)
Query: 101 VKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGIS 139
           ++ L++L     I+HRD+KP NIL+   G +KL DFG++
Sbjct: 122 LRGLDFLHANC-IVHRDLKPENILVTSGGTVKLADFGLA 159

>pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349

Iteration: 1
 Score = 40.0 bits (92), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 43/181 (23%), Positives = 75/181 (41%), Gaps = 40/181 (22%)
Query: 17  TVYDFTSEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRI----RSTVDEK-DQRQL-- 69
           T+++   E  Q+L  +G G +G+V       +   +AVK++    +S +  K   R+L  
Sbjct: 13  TIWE-VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 71
Query: 70  -----------LMDLDVVMKS----NECPYIVQFYGALFKEVT--------------VAT 100
                      L+D+    +S    N+   +    GA    +                  
Sbjct: 72  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQI 131
Query: 101 VKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTRDAGCRPYMAP 160
           ++ L Y+     IIHRD+KPSN+ ++    +K+ DFG++    D +  T     R Y AP
Sbjct: 132 LRGLKYIHSA-DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM--TGYVATRWYRAP 188
Query: 161 E 161
           E
Sbjct: 189 E 189

>pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 40.0 bits (92), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 17/39 (43%), Positives = 27/39 (69%), Gaps = 1/39 (2%)
Query: 101 VKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGIS 139
           ++ L++L     I+HRD+KP NIL+   G +KL DFG++
Sbjct: 122 LRGLDFLHANC-IVHRDLKPENILVTSGGTVKLADFGLA 159

>pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327

Iteration: 1
 Score = 40.0 bits (92), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 47/187 (25%), Positives = 72/187 (38%), Gaps = 58/187 (31%)
Query: 12  KLSPD-TVY---DFTSEDLQDLGEIGRGGFGTVNKMIHRSSDTVM--AVKRIRSTVDEKD 65
           K +PD T+Y   D+     QD+  IG G FG V K   +     M  A+KR++    + D
Sbjct: 11  KNNPDPTIYPVLDWNDIKFQDV--IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDD 68
Query: 66  QRQLLMDLDVVMKSNECPYIVQFYGA------LFKEVTVA-------------------- 99
            R    +L+V+ K    P I+   GA      L+  +  A                    
Sbjct: 69  HRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPA 128
Query: 100 ----------------------TVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFG 137
                                   + ++YL ++ + IHRD+   NIL+      K+ DFG
Sbjct: 129 FAIANSTASTLSSQQLLHFAADVARGMDYLSQK-QFIHRDLAARNILVGENYVAKIADFG 187
Query: 138 IS-GQLV 143
           +S GQ V
Sbjct: 188 LSRGQEV 194

>pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372

Iteration: 1
 Score = 40.0 bits (92), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 22/61 (36%), Positives = 34/61 (55%), Gaps = 3/61 (4%)
Query: 101 VKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTRDAGCRPYMAP 160
           ++ L Y+     IIHRD+KPSN+ ++    +K+ DFG++    D +  T     R Y AP
Sbjct: 147 LRGLKYIHSA-DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM--TGYVATRWYRAP 203
Query: 161 E 161
           E
Sbjct: 204 E 204

>pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366

Iteration: 1
 Score = 40.0 bits (92), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 22/61 (36%), Positives = 34/61 (55%), Gaps = 3/61 (4%)
Query: 101 VKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTRDAGCRPYMAP 160
           ++ L Y+     IIHRD+KPSN+ ++    +K+ DFG++    D +  T     R Y AP
Sbjct: 141 LRGLKYIHSA-DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM--TGYVATRWYRAP 197
Query: 161 E 161
           E
Sbjct: 198 E 198

>pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372

Iteration: 1
 Score = 40.0 bits (92), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 22/61 (36%), Positives = 34/61 (55%), Gaps = 3/61 (4%)
Query: 101 VKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTRDAGCRPYMAP 160
           ++ L Y+     IIHRD+KPSN+ ++    +K+ DFG++    D +  T     R Y AP
Sbjct: 147 LRGLKYIHSA-DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM--TGYVATRWYRAP 203
Query: 161 E 161
           E
Sbjct: 204 E 204

>pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360

Iteration: 1
 Score = 40.0 bits (92), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 22/61 (36%), Positives = 34/61 (55%), Gaps = 3/61 (4%)
Query: 101 VKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTRDAGCRPYMAP 160
           ++ L Y+     IIHRD+KPSN+ ++    +K+ DFG++    D +  T     R Y AP
Sbjct: 135 LRGLKYIHSA-DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM--TGYVATRWYRAP 191
Query: 161 E 161
           E
Sbjct: 192 E 192

>pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372

Iteration: 1
 Score = 40.0 bits (92), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 22/61 (36%), Positives = 34/61 (55%), Gaps = 3/61 (4%)
Query: 101 VKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTRDAGCRPYMAP 160
           ++ L Y+     IIHRD+KPSN+ ++    +K+ DFG++    D +  T     R Y AP
Sbjct: 147 LRGLKYIHSA-DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM--TGYVATRWYRAP 203
Query: 161 E 161
           E
Sbjct: 204 E 204

>pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366

Iteration: 1
 Score = 40.0 bits (92), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 22/61 (36%), Positives = 34/61 (55%), Gaps = 3/61 (4%)
Query: 101 VKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTRDAGCRPYMAP 160
           ++ L Y+     IIHRD+KPSN+ ++    +K+ DFG++    D +  T     R Y AP
Sbjct: 141 LRGLKYIHSA-DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM--TGYVATRWYRAP 197
Query: 161 E 161
           E
Sbjct: 198 E 198

>pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317

Iteration: 1
 Score = 40.0 bits (92), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 47/187 (25%), Positives = 72/187 (38%), Gaps = 58/187 (31%)
Query: 12  KLSPD-TVY---DFTSEDLQDLGEIGRGGFGTVNKMIHRSSDTVM--AVKRIRSTVDEKD 65
           K +PD T+Y   D+     QD+  IG G FG V K   +     M  A+KR++    + D
Sbjct: 1   KNNPDPTIYPVLDWNDIKFQDV--IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDD 58
Query: 66  QRQLLMDLDVVMKSNECPYIVQFYGA------LFKEVTVA-------------------- 99
            R    +L+V+ K    P I+   GA      L+  +  A                    
Sbjct: 59  HRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPA 118
Query: 100 ----------------------TVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFG 137
                                   + ++YL ++ + IHRD+   NIL+      K+ DFG
Sbjct: 119 FAIANSTASTLSSQQLLHFAADVARGMDYLSQK-QFIHRDLAARNILVGENYVAKIADFG 177
Query: 138 IS-GQLV 143
           +S GQ V
Sbjct: 178 LSRGQEV 184

>pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365

Iteration: 1
 Score = 40.0 bits (92), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 22/61 (36%), Positives = 34/61 (55%), Gaps = 3/61 (4%)
Query: 101 VKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTRDAGCRPYMAP 160
           ++ L Y+     IIHRD+KPSN+ ++    +K+ DFG++    D +  T     R Y AP
Sbjct: 140 LRGLKYIHSA-DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM--TGYVATRWYRAP 196
Query: 161 E 161
           E
Sbjct: 197 E 197

>pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326

Iteration: 1
 Score = 40.0 bits (92), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 43/169 (25%), Positives = 72/169 (42%), Gaps = 40/169 (23%)
Query: 9   GKLKLSPDTVYDFTSEDLQDLGEIGRGGFGTVNKMIHRSSD-TVMAVKRIRSTVDEKDQR 67
           G+LK          S++  +   +GRGGFG V K   R +D  ++AVKR++    +  + 
Sbjct: 15  GQLKRFSLRELQVASDNFXNKNILGRGGFGKVYK--GRLADGXLVAVKRLKEERTQGGEL 72
Query: 68  QLLMDLDVV---------------MKSNE----CPYIVQ-FYGALFKE------------ 95
           Q   +++++               M   E     PY+      +  +E            
Sbjct: 73  QFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPK 132
Query: 96  ---VTVATVKALNYLKEEL--KIIHRDVKPSNILLDRRGAIKLCDFGIS 139
              + + + + L YL +    KIIHRDVK +NILLD      + DFG++
Sbjct: 133 RQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLA 181

>pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360

Iteration: 1
 Score = 40.0 bits (92), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 22/61 (36%), Positives = 34/61 (55%), Gaps = 3/61 (4%)
Query: 101 VKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTRDAGCRPYMAP 160
           ++ L Y+     IIHRD+KPSN+ ++    +K+ DFG++    D +  T     R Y AP
Sbjct: 135 LRGLKYIHSA-DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM--TGYVATRWYRAP 191
Query: 161 E 161
           E
Sbjct: 192 E 192

>pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360

Iteration: 1
 Score = 40.0 bits (92), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 22/61 (36%), Positives = 34/61 (55%), Gaps = 3/61 (4%)
Query: 101 VKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTRDAGCRPYMAP 160
           ++ L Y+     IIHRD+KPSN+ ++    +K+ DFG++    D +  T     R Y AP
Sbjct: 135 LRGLKYIHSA-DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM--TGYVATRWYRAP 191
Query: 161 E 161
           E
Sbjct: 192 E 192

>pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354

Iteration: 1
 Score = 40.0 bits (92), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 43/181 (23%), Positives = 75/181 (41%), Gaps = 40/181 (22%)
Query: 17  TVYDFTSEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRI----RSTVDEK-DQRQL-- 69
           T+++   E  Q+L  +G G +G+V       +   +AVK++    +S +  K   R+L  
Sbjct: 16  TIWE-VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 74
Query: 70  -----------LMDLDVVMKS----NECPYIVQFYGALFKEVT--------------VAT 100
                      L+D+    +S    N+   +    GA    +                  
Sbjct: 75  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQI 134
Query: 101 VKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTRDAGCRPYMAP 160
           ++ L Y+     IIHRD+KPSN+ ++    +K+ DFG++    D +  T     R Y AP
Sbjct: 135 LRGLKYIHSA-DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM--TGYVATRWYRAP 191
Query: 161 E 161
           E
Sbjct: 192 E 192

>pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359

Iteration: 1
 Score = 40.0 bits (92), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 22/61 (36%), Positives = 34/61 (55%), Gaps = 3/61 (4%)
Query: 101 VKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTRDAGCRPYMAP 160
           ++ L Y+     IIHRD+KPSN+ ++    +K+ DFG++    D +  T     R Y AP
Sbjct: 134 LRGLKYIHSA-DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM--TGYVATRWYRAP 190
Query: 161 E 161
           E
Sbjct: 191 E 191

>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278

Iteration: 1
 Score = 40.0 bits (92), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 28/71 (39%), Positives = 36/71 (50%), Gaps = 2/71 (2%)
Query: 113 IIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTRD-AGCRPYMAPERIDPLRARGY 171
           I+HRD+  SN+LL R   IK+ DFG++ QL     K     G   Y++PE I    A G 
Sbjct: 133 ILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTLCGTPNYISPE-IATRSAHGL 191
Query: 172 PSFKTKLGFKF 182
            S    LG  F
Sbjct: 192 ESDVWSLGCMF 202

>pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371

Iteration: 1
 Score = 40.0 bits (92), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 22/61 (36%), Positives = 34/61 (55%), Gaps = 3/61 (4%)
Query: 101 VKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTRDAGCRPYMAP 160
           ++ L Y+     IIHRD+KPSN+ ++    +K+ DFG++    D +  T     R Y AP
Sbjct: 146 LRGLKYIHSA-DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM--TGYVATRWYRAP 202
Query: 161 E 161
           E
Sbjct: 203 E 203

>pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379

Iteration: 1
 Score = 40.0 bits (92), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 43/181 (23%), Positives = 75/181 (41%), Gaps = 40/181 (22%)
Query: 17  TVYDFTSEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRI----RSTVDEK-DQRQL-- 69
           T+++   E  Q+L  +G G +G+V       +   +AVK++    +S +  K   R+L  
Sbjct: 35  TIWE-VPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRL 93
Query: 70  -----------LMDLDVVMKS----NECPYIVQFYGALFKEVT--------------VAT 100
                      L+D+    +S    N+   +    GA    +                  
Sbjct: 94  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQI 153
Query: 101 VKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTRDAGCRPYMAP 160
           ++ L Y+     IIHRD+KPSN+ ++    +K+ DFG++    D +  T     R Y AP
Sbjct: 154 LRGLKYIHSA-DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM--TGYVATRWYRAP 210
Query: 161 E 161
           E
Sbjct: 211 E 211

>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292

Iteration: 1
 Score = 40.0 bits (92), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 24/78 (30%), Positives = 40/78 (51%), Gaps = 16/78 (20%)
Query: 95  EVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTRDAGC 154
           ++   T + ++YL  +  IIHRD+K +NI L     +K+ DFG++ +      K+R +G 
Sbjct: 124 DIARQTARGMDYLHAK-SIIHRDLKSNNIFLHEDNTVKIGDFGLATE------KSRWSGS 176
Query: 155 RP---------YMAPERI 163
                      +MAPE I
Sbjct: 177 HQFEQLSGSILWMAPEVI 194

>pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380

Iteration: 1
 Score = 40.0 bits (92), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 43/181 (23%), Positives = 75/181 (41%), Gaps = 40/181 (22%)
Query: 17  TVYDFTSEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRI----RSTVDEK-DQRQL-- 69
           T+++   E  Q+L  +G G +G+V       +   +AVK++    +S +  K   R+L  
Sbjct: 36  TIWE-VPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRL 94
Query: 70  -----------LMDLDVVMKS----NECPYIVQFYGALFKEVT--------------VAT 100
                      L+D+    +S    N+   +    GA    +                  
Sbjct: 95  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQI 154
Query: 101 VKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTRDAGCRPYMAP 160
           ++ L Y+     IIHRD+KPSN+ ++    +K+ DFG++    D +  T     R Y AP
Sbjct: 155 LRGLKYIHSA-DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM--TGYVATRWYRAP 211
Query: 161 E 161
           E
Sbjct: 212 E 212

>pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345

Iteration: 1
 Score = 40.0 bits (92), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 26/80 (32%), Positives = 39/80 (48%), Gaps = 8/80 (10%)
Query: 92  LFKEVTVATVKALNYLKEELKIIHRDVKPSNILL--DRRGAIKLCDFGISGQLV-----D 144
           L   +      AL+YL  +  I HRD+KP N L   ++   IKL DFG+S +       +
Sbjct: 169 LISNIMRQIFSALHYLHNQ-GICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGE 227
Query: 145 SIAKTRDAGCRPYMAPERID 164
               T  AG   ++APE ++
Sbjct: 228 YYGMTTKAGTPYFVAPEVLN 247

>pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360

Iteration: 1
 Score = 40.0 bits (92), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 22/61 (36%), Positives = 34/61 (55%), Gaps = 3/61 (4%)
Query: 101 VKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTRDAGCRPYMAP 160
           ++ L Y+     IIHRD+KPSN+ ++    +K+ DFG++    D +  T     R Y AP
Sbjct: 135 LRGLKYIHSA-DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM--TGYVATRWYRAP 191
Query: 161 E 161
           E
Sbjct: 192 E 192

>pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360

Iteration: 1
 Score = 40.0 bits (92), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 22/61 (36%), Positives = 34/61 (55%), Gaps = 3/61 (4%)
Query: 101 VKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTRDAGCRPYMAP 160
           ++ L Y+     IIHRD+KPSN+ ++    +K+ DFG++    D +  T     R Y AP
Sbjct: 135 LRGLKYIHSA-DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM--TGYVATRWYRAP 191
Query: 161 E 161
           E
Sbjct: 192 E 192

>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307

Iteration: 1
 Score = 40.0 bits (92), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 25/77 (32%), Positives = 42/77 (54%), Gaps = 6/77 (7%)
Query: 92  LFKEVTVA--TVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGIS---GQLVDSI 146
           +F+ + +A  T + ++YL  +  IIHRD+K +NI L     +K+ DFG++    +   S 
Sbjct: 131 MFQLIDIARQTAQGMDYLHAK-NIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQ 189
Query: 147 AKTRDAGCRPYMAPERI 163
              +  G   +MAPE I
Sbjct: 190 QVEQPTGSVLWMAPEVI 206

>pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360

Iteration: 1
 Score = 40.0 bits (92), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 22/61 (36%), Positives = 34/61 (55%), Gaps = 3/61 (4%)
Query: 101 VKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTRDAGCRPYMAP 160
           ++ L Y+     IIHRD+KPSN+ ++    +K+ DFG++    D +  T     R Y AP
Sbjct: 135 LRGLKYIHSA-DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM--TGYVATRWYRAP 191
Query: 161 E 161
           E
Sbjct: 192 E 192

>pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360

Iteration: 1
 Score = 40.0 bits (92), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 22/61 (36%), Positives = 34/61 (55%), Gaps = 3/61 (4%)
Query: 101 VKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTRDAGCRPYMAP 160
           ++ L Y+     IIHRD+KPSN+ ++    +K+ DFG++    D +  T     R Y AP
Sbjct: 135 LRGLKYIHSA-DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM--TGYVATRWYRAP 191
Query: 161 E 161
           E
Sbjct: 192 E 192

>pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362

Iteration: 1
 Score = 40.0 bits (92), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 22/61 (36%), Positives = 34/61 (55%), Gaps = 3/61 (4%)
Query: 101 VKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTRDAGCRPYMAP 160
           ++ L Y+     IIHRD+KPSN+ ++    +K+ DFG++    D +  T     R Y AP
Sbjct: 137 LRGLKYIHSA-DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM--TGYVATRWYRAP 193
Query: 161 E 161
           E
Sbjct: 194 E 194

>pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360

Iteration: 1
 Score = 40.0 bits (92), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 22/61 (36%), Positives = 34/61 (55%), Gaps = 3/61 (4%)
Query: 101 VKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTRDAGCRPYMAP 160
           ++ L Y+     IIHRD+KPSN+ ++    +K+ DFG++    D +  T     R Y AP
Sbjct: 135 LRGLKYIHSA-DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM--TGYVATRWYRAP 191
Query: 161 E 161
           E
Sbjct: 192 E 192

>pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383

Iteration: 1
 Score = 40.0 bits (92), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 22/61 (36%), Positives = 34/61 (55%), Gaps = 3/61 (4%)
Query: 101 VKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTRDAGCRPYMAP 160
           ++ L Y+     IIHRD+KPSN+ ++    +K+ DFG++    D +  T     R Y AP
Sbjct: 158 LRGLKYIHSA-DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM--TGYVATRWYRAP 214
Query: 161 E 161
           E
Sbjct: 215 E 215

>pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367

Iteration: 1
 Score = 40.0 bits (92), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 22/61 (36%), Positives = 34/61 (55%), Gaps = 3/61 (4%)
Query: 101 VKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTRDAGCRPYMAP 160
           ++ L Y+     IIHRD+KPSN+ ++    +K+ DFG++    D +  T     R Y AP
Sbjct: 142 LRGLKYIHSA-DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM--TGYVATRWYRAP 198
Query: 161 E 161
           E
Sbjct: 199 E 199

>pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366

Iteration: 1
 Score = 40.0 bits (92), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 22/61 (36%), Positives = 34/61 (55%), Gaps = 3/61 (4%)
Query: 101 VKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTRDAGCRPYMAP 160
           ++ L Y+     IIHRD+KPSN+ ++    +K+ DFG++    D +  T     R Y AP
Sbjct: 141 LRGLKYIHSA-DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM--TGYVATRWYRAP 197
Query: 161 E 161
           E
Sbjct: 198 E 198

>pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 40.0 bits (92), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 47/178 (26%), Positives = 77/178 (43%), Gaps = 34/178 (19%)
Query: 19  YDFTSEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKD------------Q 66
           ++   E L+ +  +G G FG V  M + +  T +AVK ++      D            Q
Sbjct: 8   WEVPRETLKLVERLGAGQFGEV-WMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQ 66
Query: 67  RQLLMDLDVVMKSNECPYIVQFY---GAL--FKEVTVATVKALNYLK------------- 108
            Q L+ L  V+ + E  YI+  Y   G+L  F +        +N L              
Sbjct: 67  HQRLVRLYAVV-TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFI 125
Query: 109 EELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTRDAGCRP--YMAPERID 164
           EE   IHRD++ +NIL+    + K+ DFG++  + D+    R+    P  + APE I+
Sbjct: 126 EERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAIN 183

>pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380

Iteration: 1
 Score = 40.0 bits (92), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 43/181 (23%), Positives = 75/181 (41%), Gaps = 40/181 (22%)
Query: 17  TVYDFTSEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRI----RSTVDEK-DQRQL-- 69
           T+++   E  Q+L  +G G +G+V       +   +AVK++    +S +  K   R+L  
Sbjct: 36  TIWE-VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 94
Query: 70  -----------LMDLDVVMKS----NECPYIVQFYGALFKEVT--------------VAT 100
                      L+D+    +S    N+   +    GA    +                  
Sbjct: 95  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQI 154
Query: 101 VKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTRDAGCRPYMAP 160
           ++ L Y+     IIHRD+KPSN+ ++    +K+ DFG++    D +  T     R Y AP
Sbjct: 155 LRGLKYIHSA-DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM--TGYVATRWYRAP 211
Query: 161 E 161
           E
Sbjct: 212 E 212

>pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362

Iteration: 1
 Score = 40.0 bits (92), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 22/61 (36%), Positives = 34/61 (55%), Gaps = 3/61 (4%)
Query: 101 VKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTRDAGCRPYMAP 160
           ++ L Y+     IIHRD+KPSN+ ++    +K+ DFG++    D +  T     R Y AP
Sbjct: 137 LRGLKYIHSA-DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM--TGYVATRWYRAP 193
Query: 161 E 161
           E
Sbjct: 194 E 194

>pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362

Iteration: 1
 Score = 40.0 bits (92), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 22/61 (36%), Positives = 34/61 (55%), Gaps = 3/61 (4%)
Query: 101 VKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTRDAGCRPYMAP 160
           ++ L Y+     IIHRD+KPSN+ ++    +K+ DFG++    D +  T     R Y AP
Sbjct: 137 LRGLKYIHSA-DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM--TGYVATRWYRAP 193
Query: 161 E 161
           E
Sbjct: 194 E 194

>pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379

Iteration: 1
 Score = 40.0 bits (92), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 43/181 (23%), Positives = 75/181 (41%), Gaps = 40/181 (22%)
Query: 17  TVYDFTSEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRI----RSTVDEK-DQRQL-- 69
           T+++   E  Q+L  +G G +G+V       +   +AVK++    +S +  K   R+L  
Sbjct: 35  TIWE-VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 93
Query: 70  -----------LMDLDVVMKS----NECPYIVQFYGALFKEVT--------------VAT 100
                      L+D+    +S    N+   +    GA    +                  
Sbjct: 94  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQI 153
Query: 101 VKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTRDAGCRPYMAP 160
           ++ L Y+     IIHRD+KPSN+ ++    +K+ DFG++    D +  T     R Y AP
Sbjct: 154 LRGLKYIHSA-DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM--TGYVATRWYRAP 210
Query: 161 E 161
           E
Sbjct: 211 E 211

>pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400

Iteration: 1
 Score = 40.0 bits (92), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 24/74 (32%), Positives = 37/74 (50%), Gaps = 4/74 (5%)
Query: 95  EVTVATVKALNYLKEELKIIHRDVKPSNILLDRR---GAIKLCDFGISGQLVDSIAKTRD 151
           E+  +  +A+ YL   + I HRDVKP N+L   +     +KL DFG + +     + T  
Sbjct: 165 EIXKSIGEAIQYL-HSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTP 223
Query: 152 AGCRPYMAPERIDP 165
                Y+APE + P
Sbjct: 224 CYTPYYVAPEVLGP 237

>pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356

Iteration: 1
 Score = 40.0 bits (92), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 24/74 (32%), Positives = 37/74 (50%), Gaps = 4/74 (5%)
Query: 95  EVTVATVKALNYLKEELKIIHRDVKPSNILLDRR---GAIKLCDFGISGQLVDSIAKTRD 151
           E+  +  +A+ YL   + I HRDVKP N+L   +     +KL DFG + +     + T  
Sbjct: 121 EIMKSIGEAIQYL-HSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTP 179
Query: 152 AGCRPYMAPERIDP 165
                Y+APE + P
Sbjct: 180 CYTPYYVAPEVLGP 193

>pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273

Iteration: 1
 Score = 40.0 bits (92), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 45/170 (26%), Positives = 73/170 (42%), Gaps = 36/170 (21%)
Query: 31  EIGRGGFGTVNKMIHRSSDTVMAVKR--IRSTVDEKDQRQLLMDLDVVMKSNECPYIVQF 88
           E+G G FGTV K  ++    V  V    +++  ++   +  L+    VM+  + PYIV+ 
Sbjct: 12  ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 71
Query: 89  YGALFKE-----VTVATVKALN-YLK------------------------EELKIIHRDV 118
            G    E     + +A +  LN YL+                        EE   +HRD+
Sbjct: 72  IGICEAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDL 131
Query: 119 KPSNILLDRRGAIKLCDFGISGQLV--DSIAKTRDAGCRP--YMAPERID 164
              N+LL  +   K+ DFG+S  L   ++  K +  G  P  + APE I+
Sbjct: 132 AARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECIN 181

>pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 40.0 bits (92), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 45/170 (26%), Positives = 73/170 (42%), Gaps = 36/170 (21%)
Query: 31  EIGRGGFGTVNKMIHRSSDTVMAVKR--IRSTVDEKDQRQLLMDLDVVMKSNECPYIVQF 88
           E+G G FGTV K  ++    V  V    +++  ++   +  L+    VM+  + PYIV+ 
Sbjct: 18  ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 77
Query: 89  YGALFKE-----VTVATVKALN-YLK------------------------EELKIIHRDV 118
            G    E     + +A +  LN YL+                        EE   +HRD+
Sbjct: 78  IGICEAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDL 137
Query: 119 KPSNILLDRRGAIKLCDFGISGQLV--DSIAKTRDAGCRP--YMAPERID 164
              N+LL  +   K+ DFG+S  L   ++  K +  G  P  + APE I+
Sbjct: 138 AARNVLLVTQHYAKISDFGLSKALRADENXYKAQTHGKWPVKWYAPECIN 187

>pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274

Iteration: 1
 Score = 40.0 bits (92), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 45/170 (26%), Positives = 73/170 (42%), Gaps = 36/170 (21%)
Query: 31  EIGRGGFGTVNKMIHRSSDTVMAVKR--IRSTVDEKDQRQLLMDLDVVMKSNECPYIVQF 88
           E+G G FGTV K  ++    V  V    +++  ++   +  L+    VM+  + PYIV+ 
Sbjct: 14  ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 73
Query: 89  YGALFKE-----VTVATVKALN-YLK------------------------EELKIIHRDV 118
            G    E     + +A +  LN YL+                        EE   +HRD+
Sbjct: 74  IGICEAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDL 133
Query: 119 KPSNILLDRRGAIKLCDFGISGQLV--DSIAKTRDAGCRP--YMAPERID 164
              N+LL  +   K+ DFG+S  L   ++  K +  G  P  + APE I+
Sbjct: 134 AARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECIN 183

>pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359

Iteration: 1
 Score = 40.0 bits (92), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 22/61 (36%), Positives = 34/61 (55%), Gaps = 3/61 (4%)
Query: 101 VKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTRDAGCRPYMAP 160
           ++ L Y+     IIHRD+KPSN+ ++    +K+ DFG++    D +  T     R Y AP
Sbjct: 140 LRGLKYIHSA-DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM--TGYVATRWYRAP 196
Query: 161 E 161
           E
Sbjct: 197 E 197

>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289

Iteration: 1
 Score = 40.0 bits (92), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 24/78 (30%), Positives = 40/78 (51%), Gaps = 16/78 (20%)
Query: 95  EVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTRDAGC 154
           ++   T + ++YL  +  IIHRD+K +NI L     +K+ DFG++ +      K+R +G 
Sbjct: 124 DIARQTARGMDYLHAK-SIIHRDLKSNNIFLHEDNTVKIGDFGLATE------KSRWSGS 176
Query: 155 RP---------YMAPERI 163
                      +MAPE I
Sbjct: 177 HQFEQLSGSILWMAPEVI 194

>pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271

Iteration: 1
 Score = 40.0 bits (92), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 47/178 (26%), Positives = 77/178 (43%), Gaps = 34/178 (19%)
Query: 19  YDFTSEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKD------------Q 66
           ++   E L+ +  +G G FG V  M + +  T +AVK ++      D            Q
Sbjct: 8   WEVPRETLKLVERLGAGQFGEV-WMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQ 66
Query: 67  RQLLMDLDVVMKSNECPYIVQFY---GAL--FKEVTVATVKALNYLK------------- 108
            Q L+ L  V+ + E  YI+  Y   G+L  F +        +N L              
Sbjct: 67  HQRLVRLYAVV-TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFI 125
Query: 109 EELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTRDAGCRP--YMAPERID 164
           EE   IHRD++ +NIL+    + K+ DFG++  + D+    R+    P  + APE I+
Sbjct: 126 EERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAIN 183

>pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273

Iteration: 1
 Score = 40.0 bits (92), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 47/178 (26%), Positives = 77/178 (43%), Gaps = 34/178 (19%)
Query: 19  YDFTSEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKD------------Q 66
           ++   E L+ +  +G G FG V  M + +  T +AVK ++      D            Q
Sbjct: 10  WEVPRETLKLVERLGAGQFGEV-WMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQ 68
Query: 67  RQLLMDLDVVMKSNECPYIVQFY---GAL--FKEVTVATVKALNYLK------------- 108
            Q L+ L  V+ + E  YI+  Y   G+L  F +        +N L              
Sbjct: 69  HQRLVRLYAVV-TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFI 127
Query: 109 EELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTRDAGCRP--YMAPERID 164
           EE   IHRD++ +NIL+    + K+ DFG++  + D+    R+    P  + APE I+
Sbjct: 128 EERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAIN 185

>pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294

Iteration: 1
 Score = 40.0 bits (92), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 41/171 (23%), Positives = 71/171 (41%), Gaps = 40/171 (23%)
Query: 32  IGRGGFGTVNKMIHRSSDTVMAVKRI-RSTVDEKDQRQLLMDLDVVMKSNECPYIVQFY- 89
           IGRG +G V   + + +    A K+I +  V++ D+ +  ++   +MKS + P I++ Y 
Sbjct: 34  IGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIE---IMKSLDHPNIIRLYE 90
Query: 90  -----------------GALFKEVTVATV--------------KALNYLKEELKIIHRDV 118
                            G LF+ V    V               A+ Y   +L + HRD+
Sbjct: 91  TFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYC-HKLNVAHRDL 149
Query: 119 KPSNILL---DRRGAIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPL 166
           KP N L         +KL DFG++ +           G   Y++P+ ++ L
Sbjct: 150 KPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKVGTPYYVSPQVLEGL 200

>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280

Iteration: 1
 Score = 40.0 bits (92), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 23/72 (31%), Positives = 39/72 (54%), Gaps = 4/72 (5%)
Query: 95  EVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGIS---GQLVDSIAKTRD 151
           ++   T + ++YL  +  IIHRD+K +NI L     +K+ DFG++    +   S    + 
Sbjct: 112 DIARQTARGMDYLHAK-SIIHRDLKSNNIFLHEDNTVKIGDFGLATVKSRWSGSHQFEQL 170
Query: 152 AGCRPYMAPERI 163
           +G   +MAPE I
Sbjct: 171 SGSILWMAPEVI 182

>pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289

Iteration: 1
 Score = 40.0 bits (92), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 47/178 (26%), Positives = 77/178 (43%), Gaps = 34/178 (19%)
Query: 19  YDFTSEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKD------------Q 66
           ++   E L+ +  +G G FG V  M + +  T +AVK ++      D            Q
Sbjct: 18  WEVPRETLKLVERLGAGQFGEV-WMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQ 76
Query: 67  RQLLMDLDVVMKSNECPYIVQFY---GAL--FKEVTVATVKALNYLK------------- 108
            Q L+ L  V+ + E  YI+  Y   G+L  F +        +N L              
Sbjct: 77  HQRLVRLYAVV-TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFI 135
Query: 109 EELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTRDAGCRP--YMAPERID 164
           EE   IHRD++ +NIL+    + K+ DFG++  + D+    R+    P  + APE I+
Sbjct: 136 EERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAIN 193

>pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291

Iteration: 1
 Score = 40.0 bits (92), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 45/170 (26%), Positives = 73/170 (42%), Gaps = 36/170 (21%)
Query: 31  EIGRGGFGTVNKMIHRSSDTVMAVKR--IRSTVDEKDQRQLLMDLDVVMKSNECPYIVQF 88
           E+G G FGTV K  ++    V  V    +++  ++   +  L+    VM+  + PYIV+ 
Sbjct: 24  ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 83
Query: 89  YGALFKE-----VTVATVKALN-YLK------------------------EELKIIHRDV 118
            G    E     + +A +  LN YL+                        EE   +HRD+
Sbjct: 84  IGICEAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDL 143
Query: 119 KPSNILLDRRGAIKLCDFGISGQLV--DSIAKTRDAGCRP--YMAPERID 164
              N+LL  +   K+ DFG+S  L   ++  K +  G  P  + APE I+
Sbjct: 144 AARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECIN 193

>pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316

Iteration: 1
 Score = 40.0 bits (92), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 26/87 (29%), Positives = 40/87 (45%), Gaps = 15/87 (17%)
Query: 93  FKEVTVATV-----KALNYLKEELKIIHRDVKPSNILLDRRG---AIKLCDFGISGQLVD 144
           F E+  + V      AL++L  +  I HRD+KP NIL +       +K+CDFG+   +  
Sbjct: 108 FNELEASVVVQDVASALDFLHNK-GIAHRDLKPENILCEHPNQVSPVKICDFGLGSGI-- 164
Query: 145 SIAKTRDAGCRPYMAPERIDPLRARGY 171
                 +  C P   PE + P  +  Y
Sbjct: 165 ----KLNGDCSPISTPELLTPCGSAEY 187

>pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272

Iteration: 1
 Score = 40.0 bits (92), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 44/179 (24%), Positives = 78/179 (43%), Gaps = 36/179 (20%)
Query: 19  YDFTSEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKD------------Q 66
           ++   E L+ +  +G G FG V  M + +  T +AVK ++      D            Q
Sbjct: 9   WEVPRETLKLVERLGAGQFGEV-WMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQ 67
Query: 67  RQLLMDLDVVMKSNECPYIVQFY---GAL----------------FKEVTVATVKALNYL 107
            Q L+ L  V+ + E  YI+  Y   G+L                  ++     + + ++
Sbjct: 68  HQRLVRLYAVV-TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFI 126
Query: 108 KEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTRDAGCRP--YMAPERID 164
            EE   IHRD++ +NIL+    + K+ DFG++  + D+    R+    P  + APE I+
Sbjct: 127 -EERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAIN 184

>pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295

Iteration: 1
 Score = 40.0 bits (92), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 41/174 (23%), Positives = 83/174 (47%), Gaps = 35/174 (20%)
Query: 23  SEDLQDLGEIGRGGFGTVNKMI-----HRSSDTVMAVKRIRSTVDEKDQRQ-----LLMD 72
           +++ Q   +IG+G F  V + +     H  +  ++  K++ +   +K +R+     LL  
Sbjct: 3   TDEYQLYEDIGKGAFSVVRRCVKLCTGHEYAAKIINTKKLSARDHQKLEREARICRLLKH 62
Query: 73  LDVVMK----SNECPYIVQF----YGALFKEVTV----ATVKALNYLKE---------EL 111
            ++V      S E  + + F     G LF+++      +   A + +++         ++
Sbjct: 63  SNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQM 122
Query: 112 KIIHRDVKPSNILLDRR---GAIKLCDFGISGQLV-DSIAKTRDAGCRPYMAPE 161
            ++HRD+KP N+LL  +    A+KL DFG++ ++  D  A    AG   Y++PE
Sbjct: 123 GVVHRDLKPENLLLASKCKGAAVKLADFGLAIEVQGDQQAWFGFAGTPGYLSPE 176

>pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290

Iteration: 1
 Score = 39.7 bits (91), Expect = 9e-04,   Method: Compositional matrix adjust.
 Identities = 44/169 (26%), Positives = 68/169 (40%), Gaps = 39/169 (23%)
Query: 31  EIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQFYG 90
           EIGRG F TV K +   +   +A   ++     K +RQ   +    +K  + P IV+FY 
Sbjct: 33  EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEXLKGLQHPNIVRFYD 92
Query: 91  AL-------------------------FKEVTVATVKAL-NYLKEELK-----------I 113
           +                           K   V  +K L ++ ++ LK           I
Sbjct: 93  SWESTVKGKKCIVLVTELXTSGTLKTYLKRFKVXKIKVLRSWCRQILKGLQFLHTRTPPI 152
Query: 114 IHRDVKPSNILLDR-RGAIKLCDFGISGQLVDSIAKTRDAGCRPYMAPE 161
           IHRD+K  NI +    G++K+ D G++     S AK    G   + APE
Sbjct: 153 IHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKAV-IGTPEFXAPE 200

>pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277

Iteration: 1
 Score = 39.7 bits (91), Expect = 9e-04,   Method: Compositional matrix adjust.
 Identities = 41/171 (23%), Positives = 71/171 (41%), Gaps = 40/171 (23%)
Query: 32  IGRGGFGTVNKMIHRSSDTVMAVKRI-RSTVDEKDQRQLLMDLDVVMKSNECPYIVQFY- 89
           IGRG +G V   + + +    A K+I +  V++ D+ +  ++   +MKS + P I++ Y 
Sbjct: 17  IGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIE---IMKSLDHPNIIRLYE 73
Query: 90  -----------------GALFKEVTVATV--------------KALNYLKEELKIIHRDV 118
                            G LF+ V    V               A+ Y   +L + HRD+
Sbjct: 74  TFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYC-HKLNVAHRDL 132
Query: 119 KPSNILL---DRRGAIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPL 166
           KP N L         +KL DFG++ +           G   Y++P+ ++ L
Sbjct: 133 KPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKVGTPYYVSPQVLEGL 183

Structure Templates Detected by RPS-BLAST

Original result of RPS-BLAST against PDB70 database

ID	Length	Definition	E-value
Query	187
3aln_A	327	Dual specificity mitogen-activated protein kinase;	1e-89
3fme_A	290	Dual specificity mitogen-activated protein kinase;	7e-85
3an0_A	340	Dual specificity mitogen-activated protein kinase;	1e-83
2dyl_A	318	Dual specificity mitogen-activated protein kinase	7e-83
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	3e-76
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	2e-33
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	3e-33
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	2e-32
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	8e-32
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	2e-31
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	5e-31
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	2e-30
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	2e-30
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	7e-30
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	9e-30
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	2e-28
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	6e-28
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	9e-27
2a19_B	284	Interferon-induced, double-stranded RNA-activated	9e-27
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	1e-26
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	2e-25
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	2e-25
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	2e-25
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	1e-24
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	3e-24
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	2e-23
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	4e-23
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	1e-22
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	2e-22
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	2e-22
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	2e-22
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	2e-22
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	4e-22
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	4e-22
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	5e-22
3q4u_A	301	Activin receptor type-1; structural genomics conso	7e-22
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	1e-21
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	3e-21
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	3e-21
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	4e-21
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	1e-20
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	2e-20
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	2e-20
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	3e-20
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	3e-20
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	6e-20
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	1e-19
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	1e-19
3soc_A	322	Activin receptor type-2A; structural genomics cons	2e-19
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	4e-19
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	6e-19
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	1e-18
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	1e-18
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	1e-18
3pvu_A	695	Beta-adrenergic receptor kinase 1; transferase, se	1e-18
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	2e-18
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	2e-18
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	3e-18
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	3e-18
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	4e-18
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	5e-18
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	6e-18
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	6e-18
1uu3_A	310	HPDK1, 3-phosphoinositide dependent protein kinase	7e-18
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	7e-18
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	1e-17
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	1e-17
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	1e-17
3g51_A	325	Ribosomal protein S6 kinase alpha-3; N-terminal ki	2e-17
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	2e-17
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	2e-17
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	3e-17
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	3e-17
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	3e-17
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	3e-17
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	4e-17
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	5e-17
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	5e-17
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	6e-17
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	6e-17
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	7e-17
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	8e-17
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	8e-17
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	9e-17
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	1e-16
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	2e-16
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	2e-16
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	2e-16
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	2e-16
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	2e-16
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	3e-16
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	3e-16
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	3e-16
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	3e-16
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	3e-16
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	4e-16
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	4e-16
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	4e-16
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	4e-16
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	5e-16
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	6e-16
3bhy_A	283	Death-associated protein kinase 3; death associate	6e-16
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	6e-16
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	7e-16
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	7e-16
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	9e-16
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	1e-15
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	2e-15
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	2e-15
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	4e-15
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	4e-15
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	5e-15
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	5e-15
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	5e-15
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	6e-15
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	6e-15
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	9e-15
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	1e-14
3o0g_A	292	Cell division protein kinase 5; kinase activator c	2e-14
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	4e-14
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	5e-14
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	5e-14
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	5e-14
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	1e-13
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	1e-13
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	1e-13
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	1e-13
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	1e-13
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	1e-13
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	1e-13
3niz_A	311	Rhodanese family protein; structural genomics, str	2e-13
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	3e-13
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	3e-13
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	4e-13
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	4e-13
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	4e-13
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	4e-13
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	6e-13
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	6e-13
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	8e-13
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	2e-06
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	1e-12
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	1e-12
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	2e-12
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	2e-12
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	2e-12
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	5e-12
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	6e-12
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	6e-12
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	7e-12
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	8e-12
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	1e-11
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	1e-11
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	1e-11
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	1e-11
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	1e-11
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	2e-11
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	2e-11
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	2e-11
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	2e-11
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	2e-11
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	2e-11
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	3e-11
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	3e-11
3rp9_A	458	Mitogen-activated protein kinase; structural genom	4e-11
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	5e-11
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	6e-11
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	6e-11
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	8e-11
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	8e-11
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	8e-11
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	8e-11
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	8e-11
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	8e-11
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	8e-11
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	1e-10
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	1e-10
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	1e-10
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	1e-10
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	2e-10
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	2e-10
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	2e-10
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	2e-10
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	2e-10
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	2e-10
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	2e-10
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	2e-10
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	3e-10
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	4e-10
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	5e-10
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	5e-10
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	6e-10
3ork_A	311	Serine/threonine protein kinase; structural genomi	6e-10
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	6e-10
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	7e-10
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	7e-10
3pls_A	298	Macrophage-stimulating protein receptor; protein k	8e-10
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	1e-09
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	1e-09
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	1e-09
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	2e-09
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	2e-09
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	5e-05
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	4e-09
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	5e-09
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	9e-09
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	1e-08
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	1e-08
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	4e-08
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	5e-08
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	5e-08
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	7e-08
3uqc_A	286	Probable conserved transmembrane protein; structur	8e-08
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	1e-07
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	2e-07
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	5e-07
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	7e-07
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	9e-07
4aoj_A	329	High affinity nerve growth factor receptor; transf	1e-06
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	1e-06
3v5q_A	297	NT-3 growth factor receptor; kinase domain, kinase	2e-06
3zzw_A	289	Tyrosine-protein kinase transmembrane receptor RO;	2e-06
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	3e-06
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	3e-06
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	3e-06
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	9e-06
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	3e-05
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	1e-04
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	4e-05
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	5e-05
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	7e-05
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	1e-04
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	3e-04
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	4e-04
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	6e-04
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	9e-04

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327

 Score =  264 bits (677), Expect = 1e-89
 Identities = 134/205 (65%), Positives = 156/205 (76%), Gaps = 37/205 (18%)

Query: 4   SIQSSGKLKLSPDTVYDFTSEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDE 63
           SI+SSGKLK+SP+  +DFT+EDL+DLGEIGRG +G+VNKM+H+ S  +MAVKRIRSTVDE
Sbjct: 2   SIESSGKLKISPEQHWDFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDE 61

Query: 64  KDQRQLLMDLDVVMKSNECPYIVQFYGALFKE---------------------------- 95
           K+Q+QLLMDLDVVM+S++CPYIVQFYGALF+E                            
Sbjct: 62  KEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICMELMSTSFDKFYKYVYSVLDDV 121

Query: 96  --------VTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIA 147
                   +T+ATVKALN+LKE LKIIHRD+KPSNILLDR G IKLCDFGISGQLVDSIA
Sbjct: 122 IPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIA 181

Query: 148 KTRDAGCRPYMAPERIDP-LRARGY 171
           KTRDAGCRPYMAPERIDP    +GY
Sbjct: 182 KTRDAGCRPYMAPERIDPSASRQGY 206

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score =  251 bits (642), Expect = 7e-85
 Identities = 86/189 (45%), Positives = 120/189 (63%), Gaps = 36/189 (19%)

Query: 19  YDFTSEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMK 78
            +  ++DL+ + E+GRG +G V KM H  S  +MAVKRIR+TV+ ++Q++LLMDLD+ M+
Sbjct: 2   MEVKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMR 61

Query: 79  SNECPYIVQFYGALFKE-----------------------------------VTVATVKA 103
           + +CP+ V FYGALF+E                                   + V+ VKA
Sbjct: 62  TVDCPFTVTFYGALFREGDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKA 121

Query: 104 LNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERI 163
           L +L  +L +IHRDVKPSN+L++  G +K+CDFGISG LVD +AK  DAGC+PYMAPERI
Sbjct: 122 LEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAKDIDAGCKPYMAPERI 181

Query: 164 DP-LRARGY 171
           +P L  +GY
Sbjct: 182 NPELNQKGY 190

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score =  246 bits (631), Expect = 7e-83
 Identities = 91/200 (45%), Positives = 117/200 (58%), Gaps = 33/200 (16%)

Query: 3   QSIQSSGKLKLSPDTVYDFTSEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVD 62
            S + +G L +     Y     DL++LGE+G G  G V KM  R +  V+AVK++R + +
Sbjct: 5   SSGKQTGYLTIG-GQRYQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGN 63

Query: 63  EKDQRQLLMDLDVVMKSNECPYIVQFYGALFKE--------------------------- 95
           +++ +++LMDLDVV+KS++CPYIVQ +G                                
Sbjct: 64  KEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAMELMGTCAEKLKKRMQGPIPE 123

Query: 96  -----VTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTR 150
                +TVA VKAL YLKE+  +IHRDVKPSNILLD RG IKLCDFGISG+LVD  AK R
Sbjct: 124 RILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKAKDR 183

Query: 151 DAGCRPYMAPERIDPLRARG 170
            AGC  YMAPERIDP     
Sbjct: 184 SAGCAAYMAPERIDPPDPTK 203

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360

 Score =  231 bits (591), Expect = 3e-76
 Identities = 69/195 (35%), Positives = 99/195 (50%), Gaps = 34/195 (17%)

Query: 3   QSIQSSGKLKLSPDTVYDFTSEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVD 62
           Q  +           V +   +D + + E+G G  G V K+ H+ S  VMA K I   + 
Sbjct: 12  QQRKRLEAFLTQKQKVGELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIK 71

Query: 63  EKDQRQLLMDLDVVMKSNECPYIVQFYGALFKE--------------------------- 95
              + Q++ +L V +     PYIV FYGA + +                           
Sbjct: 72  PAIRNQIIRELQV-LHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPE 130

Query: 96  -----VTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTR 150
                V++A +K L YL+E+ KI+HRDVKPSNIL++ RG IKLCDFG+SGQL+DS+A + 
Sbjct: 131 QILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSF 190

Query: 151 DAGCRPYMAPERIDP 165
             G R YM+PER+  
Sbjct: 191 -VGTRSYMSPERLQG 204

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score =  120 bits (302), Expect = 2e-33
 Identities = 50/193 (25%), Positives = 76/193 (39%), Gaps = 37/193 (19%)

Query: 2   CQSIQSSGKLKLSPDTVYDFTSEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIR-ST 60
            +++QS G     P++ +    +  Q L  +G G +G V K+  +    + AVKR     
Sbjct: 38  SETLQSPGYDPSRPESFFQ---QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPF 94

Query: 61  VDEKDQRQLLMDLDVVMKSNECPYIVQFYGA---------------------------LF 93
              KD+ + L ++    K  + P  V+   A                             
Sbjct: 95  RGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQTELCGPSLQQHCEAWGASL 154

Query: 94  KEVTVAT-----VKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAK 148
            E  V       + AL +L     ++H DVKP+NI L  RG  KL DFG+  +L  + A 
Sbjct: 155 PEAQVWGYLRDTLLALAHL-HSQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAG 213

Query: 149 TRDAGCRPYMAPE 161
               G   YMAPE
Sbjct: 214 EVQEGDPRYMAPE 226

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score =  118 bits (299), Expect = 3e-33
 Identities = 43/173 (24%), Positives = 79/173 (45%), Gaps = 35/173 (20%)

Query: 23  SEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNEC 82
            +      +IG+G  GTV   +  ++   +A++++   + ++ +++L+++  +VM+ N+ 
Sbjct: 19  KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMN--LQQQPKKELIINEILVMRENKN 76

Query: 83  PYIVQFYGALFK--------------------------EVTVATV-----KALNYLKEEL 111
           P IV +  +                             E  +A V     +AL +L    
Sbjct: 77  PNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSN- 135

Query: 112 KIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTRDAGCRPY-MAPERI 163
           ++IHRD+K  NILL   G++KL DFG   Q+    +K       PY MAPE +
Sbjct: 136 QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVV 188

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score =  117 bits (296), Expect = 2e-32
 Identities = 48/173 (27%), Positives = 74/173 (42%), Gaps = 35/173 (20%)

Query: 23  SEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNEC 82
              L    +IG G  G V     + S   +AVK +   + ++ +R+LL +  V+M+  + 
Sbjct: 44  RLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMD--LRKQQRRELLFNEVVIMRDYQH 101

Query: 83  PYIVQFYGALFK--------------------------EVTVATV-----KALNYLKEEL 111
             +V+ Y +                             E  +ATV     +AL YL  + 
Sbjct: 102 FNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQVRLNEEQIATVCEAVLQALAYLHAQ- 160

Query: 112 KIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTRDAGCRPY-MAPERI 163
            +IHRD+K  +ILL   G +KL DFG   Q+   + K +     PY MAPE I
Sbjct: 161 GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVI 213

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303

 Score =  115 bits (290), Expect = 8e-32
 Identities = 51/207 (24%), Positives = 77/207 (37%), Gaps = 52/207 (25%)

Query: 12  KLSPDTVYDFTSEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLM 71
           + S    +    +D +    IG G    V           +A+KRI     +    +LL 
Sbjct: 3   EDSSALPWSINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLK 62

Query: 72  DLDVVMKSNECPYIVQFYGA-----------------------------------LFKEV 96
           ++   M     P IV +Y +                                   +  E 
Sbjct: 63  EIQA-MSQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDES 121

Query: 97  TVATV-----KALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTRD 151
           T+AT+     + L YL +    IHRDVK  NILL   G++++ DFG+S  L      TR+
Sbjct: 122 TIATILREVLEGLEYLHKN-GQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRN 180

Query: 152 AGCR------PY-MAPERIDPLRARGY 171
              R      P  MAPE ++  + RGY
Sbjct: 181 K-VRKTFVGTPCWMAPEVME--QVRGY 204

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302

 Score =  114 bits (287), Expect = 2e-31
 Identities = 47/185 (25%), Positives = 84/185 (45%), Gaps = 39/185 (21%)

Query: 23  SEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNEC 82
           +E  + +GE+G G FG V K  ++ +  + A K I      +++ +  +    ++ + + 
Sbjct: 18  NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVI--ETKSEEELEDYIVEIEILATCDH 75

Query: 83  PYIVQFYGALFK----------------------------EVTVATV-----KALNYLKE 109
           PYIV+  GA +                             E  +  V     +ALN+L  
Sbjct: 76  PYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHS 135

Query: 110 ELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTRDAGCRPY-MAPERI--DPL 166
           + +IIHRD+K  N+L+   G I+L DFG+S + + ++ K       PY MAPE +  + +
Sbjct: 136 K-RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFIGTPYWMAPEVVMCETM 194

Query: 167 RARGY 171
           +   Y
Sbjct: 195 KDTPY 199

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303

 Score =  113 bits (285), Expect = 5e-31
 Identities = 57/192 (29%), Positives = 87/192 (45%), Gaps = 41/192 (21%)

Query: 4   SIQSSGKLKLSPDTVYDFTSEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDE 63
            +     LK  P+ ++         L +IG+G FG V K I   +  V+A+K I     E
Sbjct: 9   GLPGMQNLKADPEELF-------TKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAE 61

Query: 64  KDQRQLLMDLDVVMKSNECPYIVQFYGALFK--------------------------EVT 97
            +   +  ++ V +   + PY+ ++YG+  K                          E  
Sbjct: 62  DEIEDIQQEITV-LSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQ 120

Query: 98  VATV-----KALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTRDA 152
           +AT+     K L+YL  E K IHRD+K +N+LL   G +KL DFG++GQL D+  K    
Sbjct: 121 IATILREILKGLDYLHSE-KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTF 179

Query: 153 GCRPY-MAPERI 163
              P+ MAPE I
Sbjct: 180 VGTPFWMAPEVI 191

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348

 Score =  112 bits (282), Expect = 2e-30
 Identities = 49/185 (26%), Positives = 74/185 (40%), Gaps = 43/185 (23%)

Query: 23  SEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDE-KDQRQLLMDLDVVMKSNE 81
            +   DL EIG G FG V       +  V+A+K++  +  +  ++ Q ++     ++   
Sbjct: 53  EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR 112

Query: 82  CPYIVQFYGALFK---------------------------EVTVATV-----KALNYLKE 109
            P  +Q+ G   +                           EV +A V     + L YL  
Sbjct: 113 HPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHS 172

Query: 110 ELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLV--DSIAKTRDAGCRPY-MAPERIDPL 166
              +IHRDVK  NILL   G +KL DFG +  +   +S   T      PY MAPE I  +
Sbjct: 173 H-NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANSFVGT------PYWMAPEVILAM 225

Query: 167 RARGY 171
               Y
Sbjct: 226 DEGQY 230

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314

 Score =  111 bits (280), Expect = 2e-30
 Identities = 53/175 (30%), Positives = 85/175 (48%), Gaps = 39/175 (22%)

Query: 23  SEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNEC 82
            E    L ++G G +G+V K IH+ +  ++A+K++      +   Q ++    +M+  + 
Sbjct: 28  EEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQV----PVESDLQEIIKEISIMQQCDS 83

Query: 83  PYIVQFYGALFK----------------------------EVTVATV-----KALNYLKE 109
           P++V++YG+ FK                            E  +AT+     K L YL  
Sbjct: 84  PHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHF 143

Query: 110 ELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTRDAGCRPY-MAPERI 163
             + IHRD+K  NILL+  G  KL DFG++GQL D++AK       P+ MAPE I
Sbjct: 144 M-RKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVI 197

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score =  110 bits (278), Expect = 7e-30
 Identities = 47/194 (24%), Positives = 82/194 (42%), Gaps = 50/194 (25%)

Query: 23  SEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNEC 82
           +   + +  +G G +G V K  H  +  + A+K +   V   ++ ++  +++++ K +  
Sbjct: 23  AGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMD--VTGDEEEEIKQEINMLKKYSHH 80

Query: 83  PYIVQFYGALFK-----------------------------------EVTVATV-----K 102
             I  +YGA  K                                   E  +A +     +
Sbjct: 81  RNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILR 140

Query: 103 ALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTRD--AGCRPY-MA 159
            L++L +  K+IHRD+K  N+LL     +KL DFG+S QL  ++ + R+   G  PY MA
Sbjct: 141 GLSHLHQH-KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGR-RNTFIG-TPYWMA 197

Query: 160 PERI--DPLRARGY 171
           PE I  D      Y
Sbjct: 198 PEVIACDENPDATY 211

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389

 Score =  111 bits (279), Expect = 9e-30
 Identities = 34/185 (18%), Positives = 59/185 (31%), Gaps = 45/185 (24%)

Query: 23  SEDLQDLGEIGRG--GFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSN 80
               + L  IG+G     TVN   ++ +   + V+RI       +    L     V K  
Sbjct: 24  GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLF 83

Query: 81  ECPYIVQFYGAL-----------------------------FKEVTVATV-----KALNY 106
             P IV +                                   E+ +A +     KAL+Y
Sbjct: 84  NHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDY 143

Query: 107 LKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTRDAGCR-------PY-M 158
           +      +HR VK S+IL+   G + L     +  ++    + R               +
Sbjct: 144 IHHM-GYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWL 202

Query: 159 APERI 163
           +PE +
Sbjct: 203 SPEVL 207

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score =  107 bits (268), Expect = 2e-28
 Identities = 44/197 (22%), Positives = 63/197 (31%), Gaps = 50/197 (25%)

Query: 14  SPDTVYDFTSEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDL 73
             D  Y      +     +GRG FG V++M  + +    AVK++R  V   ++      L
Sbjct: 48  PVDYEYREEVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFRVEELVACAGL 107

Query: 74  DVVMKSNECPYIVQFYGAL---------------------------FKEVTVATV----- 101
                    P IV  YGA+                             E           
Sbjct: 108 S-------SPRIVPLYGAVREGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQAL 160

Query: 102 KALNYLKEELKIIHRDVKPSNILLDRRGA-IKLCDFGISGQLVDSIAKTRDAGCR----- 155
           + L YL    +I+H DVK  N+LL   G+   LCDFG +  L                  
Sbjct: 161 EGLEYLHTR-RILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGT 219

Query: 156 PY-MAPERIDPLRARGY 171
              MAPE +     +  
Sbjct: 220 ETHMAPEVV---MGKPC 233

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score =  105 bits (265), Expect = 6e-28
 Identities = 47/199 (23%), Positives = 79/199 (39%), Gaps = 38/199 (19%)

Query: 1   MCQSIQSSGKLKLSPDTVYDFTSEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIR-S 59
           M      S  + L  + +Y  + E    L +IG G FG    +          +K I  S
Sbjct: 1   MHHHHHHSSGVDLGTENLYFQSMEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINIS 60

Query: 60  TVDEKDQRQLLMDLDVVMKSNECPYIVQFY-----------------------------G 90
            +  K++ +   ++ V + + + P IVQ+                              G
Sbjct: 61  RMSSKEREESRREVAV-LANMKHPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKG 119

Query: 91  ALFKEVTVA-----TVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDS 145
            LF+E  +         AL ++ +  KI+HRD+K  NI L + G ++L DFGI+  L  +
Sbjct: 120 VLFQEDQILDWFVQICLALKHVHDR-KILHRDIKSQNIFLTKDGTVQLGDFGIARVLNST 178

Query: 146 IAKTRDAGCRP-YMAPERI 163
           +   R     P Y++PE  
Sbjct: 179 VELARACIGTPYYLSPEIC 197

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289

 Score =  102 bits (255), Expect = 9e-27
 Identities = 36/199 (18%), Positives = 71/199 (35%), Gaps = 60/199 (30%)

Query: 21  FTSEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIR-STVDEKDQRQLLMDLDVVMKS 79
             + +  +L +IG G FG+V K + R    + A+KR +       D++  L ++      
Sbjct: 8   RYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVL 67

Query: 80  NECPYIVQFYGA-------------------------------LFKEVTVATV-----KA 103
            +  ++V+++ A                                FKE  +  +     + 
Sbjct: 68  GQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRG 127

Query: 104 LNYLKEELKIIHRDVKPSNILLDRRGAI-------------------KLCDFGISGQLVD 144
           L Y+     ++H D+KPSNI + R                       K+ D G   ++  
Sbjct: 128 LRYIHSM-SLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRI-- 184

Query: 145 SIAKTRDAGCRPYMAPERI 163
           S  +  +   R ++A E +
Sbjct: 185 SSPQVEEGDSR-FLANEVL 202

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score =  101 bits (254), Expect = 9e-27
 Identities = 48/194 (24%), Positives = 73/194 (37%), Gaps = 61/194 (31%)

Query: 22  TSEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQR--QLLMDLDVVMKS 79
              D +++  IG GGFG V K  HR       +KR++   +EK +R  + L  LD     
Sbjct: 9   FGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYN-NEKAEREVKALAKLD----- 62

Query: 80  NECPYIVQFYGA---------------------------------------------LFK 94
                IV + G                                                 
Sbjct: 63  --HVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLD 120

Query: 95  EVTVA-----TVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKT 149
           +V          K ++Y+  + K+I+RD+KPSNI L     +K+ DFG+   L +   +T
Sbjct: 121 KVLALELFEQITKGVDYIHSK-KLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRT 179

Query: 150 RDAGCRPYMAPERI 163
           R  G   YM+PE+I
Sbjct: 180 RSKGTLRYMSPEQI 193

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score =  102 bits (255), Expect = 1e-26
 Identities = 42/192 (21%), Positives = 77/192 (40%), Gaps = 45/192 (23%)

Query: 24  EDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIR--STVDEKDQRQLLMDLDVVMKSNE 81
            + +   +IGRG F  V +         +A+K+++    +D K +   + ++D+ +K   
Sbjct: 32  ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDL-LKQLN 90

Query: 82  CPYIVQFYGA-------------------------------LFKEVTVAT-----VKALN 105
            P ++++Y +                               L  E TV         AL 
Sbjct: 91  HPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALE 150

Query: 106 YLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTRDAGCRP-YMAPERID 164
           ++    +++HRD+KP+N+ +   G +KL D G+                 P YM+PERI 
Sbjct: 151 HMHSR-RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERI- 208

Query: 165 PLRARGYPSFKT 176
                GY +FK+
Sbjct: 209 --HENGY-NFKS 217

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score = 99.0 bits (247), Expect = 2e-25
 Identities = 40/213 (18%), Positives = 68/213 (31%), Gaps = 54/213 (25%)

Query: 3   QSIQSSGKLKLS-PDTVYDFTSEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTV 61
               SSG+  L     +    ++    + ++G GGF  V+ +         A+KRI    
Sbjct: 7   HHHHSSGRENLYFQGHMVIIDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCH- 65

Query: 62  DEKDQRQLLMDLDVVMKSNECPYIVQFY-------------------------------- 89
           +++D+ +   + D+  +    P I++                                  
Sbjct: 66  EQQDREEAQREADM-HRLFNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERL 124

Query: 90  ---GALFKEVTVA-----TVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQ 141
              G    E  +        + L  +  +    HRD+KP+NILL   G   L D G   Q
Sbjct: 125 KDKGNFLTEDQILWLLLGICRGLEAIHAK-GYAHRDLKPTNILLGDEGQPVLMDLGSMNQ 183

Query: 142 LVDSIAKTRDAGCR----------PYMAPERID 164
               +  +R A              Y APE   
Sbjct: 184 ACIHVEGSRQALTLQDWAAQRCTISYRAPELFS 216

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score = 97.7 bits (244), Expect = 2e-25
 Identities = 41/180 (22%), Positives = 74/180 (41%), Gaps = 47/180 (26%)

Query: 29  LGEIGRGGFGTVNKMIHRSSDTVMAVKRIR-STVDEKDQRQLLMDLDVVMKSNECPYIVQ 87
           L  IG G +G   K+  +S   ++  K +   ++ E +++ L+ ++++ ++  + P IV+
Sbjct: 11  LYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNL-LRELKHPNIVR 69

Query: 88  FY---------------------------------GALFKEVTVAT-----VKALNYL-- 107
           +Y                                      E  V         AL     
Sbjct: 70  YYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHR 129

Query: 108 --KEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVD--SIAKTRDAGCRPYMAPERI 163
                  ++HRD+KP+N+ LD +  +KL DFG++  L    S AKT   G   YM+PE++
Sbjct: 130 RSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTF-VGTPYYMSPEQM 188

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295

 Score = 98.1 bits (245), Expect = 2e-25
 Identities = 52/206 (25%), Positives = 88/206 (42%), Gaps = 42/206 (20%)

Query: 4   SIQSSGKLKLSPDTV-YDFTSEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVD 62
           S++S+ +     D + YD+  ++  D   +G+G +G V      S+   +A+K I    D
Sbjct: 1   SMRSTEEGDCESDLLEYDYEYDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPER-D 59

Query: 63  EKDQRQLLMDLDVVMKSNECPYIVQFYGALFK---------------------------- 94
            +  + L  ++ +  K  +   IVQ+ G+  +                            
Sbjct: 60  SRYSQPLHEEIAL-HKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLK 118

Query: 95  --EVTVAT-----VKALNYLKEELKIIHRDVKPSNILLD-RRGAIKLCDFGISGQLVDSI 146
             E T+       ++ L YL +  +I+HRD+K  N+L++   G +K+ DFG S +L    
Sbjct: 119 DNEQTIGFYTKQILEGLKYLHDN-QIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGIN 177

Query: 147 AKTRD-AGCRPYMAPERIDPLRARGY 171
             T    G   YMAPE ID    RGY
Sbjct: 178 PCTETFTGTLQYMAPEIID-KGPRGY 202

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score = 96.2 bits (240), Expect = 1e-24
 Identities = 43/202 (21%), Positives = 74/202 (36%), Gaps = 48/202 (23%)

Query: 7   SSGKLKLSPDTVYDFTSEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQ 66
           + G  +     +      +++   +IG+GGFG V+K       +V+A+K +     E + 
Sbjct: 2   AMGGSEFPKSRLPTLADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGET 61

Query: 67  RQLLMDLD-----VVMKSNECPYIVQFYGALFKE---VT--------------------- 97
             +    +      +M +   P IV+ YG +      V                      
Sbjct: 62  EMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPPRMVMEFVPCGDLYHRLLDKAHPIKW 121

Query: 98  ---------VATVKALNYL-KEELKIIHRDVKPSNILLDRRGA-----IKLCDFGISGQL 142
                    +A    + Y+  +   I+HRD++  NI L           K+ DFG+S Q 
Sbjct: 122 SVKLRLMLDIA--LGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQS 179

Query: 143 VDSIAKTRDAGCRPYMAPERID 164
           V S   +   G   +MAPE I 
Sbjct: 180 VHS--VSGLLGNFQWMAPETIG 199

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score = 95.5 bits (238), Expect = 3e-24
 Identities = 45/174 (25%), Positives = 70/174 (40%), Gaps = 44/174 (25%)

Query: 24  EDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECP 83
           ++++    +GRG FG V K   R+ D  +A+K+I S  + K     L      +     P
Sbjct: 8   KEIEVEEVVGRGAFGVVCKAKWRAKD--VAIKQIESESERKAFIVELR----QLSRVNHP 61

Query: 84  YIVQFYGALFKEVTVAT---------------------------------VKALNYL--K 108
            IV+ YGA    V +                                    + + YL   
Sbjct: 62  NIVKLYGACLNPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSM 121

Query: 109 EELKIIHRDVKPSNILLDRRG-AIKLCDFGISGQLVDSIAKTRDAGCRPYMAPE 161
           +   +IHRD+KP N+LL   G  +K+CDFG +  +      T + G   +MAPE
Sbjct: 122 QPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH--MTNNKGSAAWMAPE 173

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337

 Score = 93.6 bits (233), Expect = 2e-23
 Identities = 49/218 (22%), Positives = 76/218 (34%), Gaps = 53/218 (24%)

Query: 6   QSSGKLKLSPDTVYDFTSEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKD 65
           QSSG     P  V    ++ +Q + +IG+G +G V     R     +AVK   +T +   
Sbjct: 19  QSSGSGSGLPLLVQRTIAKQIQMVKQIGKGRYGEVWMGKWRGEK--VAVKVFFTTEEASW 76

Query: 66  QRQLLMDLDVVMKSNECPYIVQFYGALFKEVTVAT------------------------- 100
            R+  +   V+M+      I+ F  A  K     T                         
Sbjct: 77  FRETEIYQTVLMRH---ENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYLKSTTLDA 133

Query: 101 ----------VKALNYLKEEL-------KIIHRDVKPSNILLDRRGAIKLCDFGIS---- 139
                     V  L +L  E+        I HRD+K  NIL+ + G   + D G++    
Sbjct: 134 KSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFI 193

Query: 140 -GQLVDSIAKTRDAGCRPYMAPERID-PLRARGYPSFK 175
                  I      G + YM PE +D  L    + S+ 
Sbjct: 194 SDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYI 231

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score = 92.8 bits (231), Expect = 4e-23
 Identities = 47/175 (26%), Positives = 74/175 (42%), Gaps = 39/175 (22%)

Query: 24  EDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECP 83
            DL    +IG G FGTV++     SD V AVK +       ++    +    +MK    P
Sbjct: 37  CDLNIKEKIGAGSFGTVHRAEWHGSD-V-AVKILMEQDFHAERVNEFLREVAIMKRLRHP 94

Query: 84  YIVQFYGALFKEVTVATV-----------------------------------KALNYL- 107
            IV F GA+ +   ++ V                                   K +NYL 
Sbjct: 95  NIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLH 154

Query: 108 KEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDS-IAKTRDAGCRPYMAPE 161
                I+HR++K  N+L+D++  +K+CDFG+S     + ++    AG   +MAPE
Sbjct: 155 NRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKSAAGTPEWMAPE 209

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score = 91.2 bits (227), Expect = 1e-22
 Identities = 42/204 (20%), Positives = 78/204 (38%), Gaps = 73/204 (35%)

Query: 23  SEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNEC 82
           + D +++  +G+G FG V K  +       A+K+IR T  E+    +L ++ + + S   
Sbjct: 5   ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT--EEKLSTILSEVML-LASLNH 61

Query: 83  PYIVQFYGA--------------------------------------------------L 92
            Y+V++Y A                                                  L
Sbjct: 62  QYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRL 121

Query: 93  FKEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTRDA 152
           F+++    ++AL+Y+  +  IIHRD+KP NI +D    +K+ DFG++  +  S+   +  
Sbjct: 122 FRQI----LEALSYIHSQ-GIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLD 176

Query: 153 GCRP---------------YMAPE 161
                              Y+A E
Sbjct: 177 SQNLPGSSDNLTSAIGTAMYVATE 200

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score = 91.4 bits (227), Expect = 2e-22
 Identities = 48/218 (22%), Positives = 76/218 (34%), Gaps = 53/218 (24%)

Query: 6   QSSGKLKLSPDTVYDFTSEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKD 65
            +SG     P  V    +  +     IG+G FG V +   R  +  +AVK   S  +   
Sbjct: 24  TTSGSGSGLPLLVQRTIARTIVLQESIGKGRFGEVWRGKWRGEE--VAVKIFSSREERSW 81

Query: 66  QRQLLMDLDVVMKSNECPYIVQFYGALFKEVTVAT------------------------- 100
            R+  +   V+++      I+ F  A  K+    T                         
Sbjct: 82  FREAEIYQTVMLR---HENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTV 138

Query: 101 ----------VKALNYLKEEL-------KIIHRDVKPSNILLDRRGAIKLCDFGIS---- 139
                        L +L  E+        I HRD+K  NIL+ + G   + D G++    
Sbjct: 139 EGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHD 198

Query: 140 -GQLVDSIAKTRDAGCRPYMAPERID-PLRARGYPSFK 175
                  IA     G + YMAPE +D  +  + + SFK
Sbjct: 199 SATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFK 236

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score = 90.5 bits (225), Expect = 2e-22
 Identities = 42/200 (21%), Positives = 75/200 (37%), Gaps = 62/200 (31%)

Query: 24  EDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECP 83
            D + +  +GRGGFG V +  ++  D   A+KRIR    E  + +++ ++   +   E P
Sbjct: 5   TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKA-LAKLEHP 63

Query: 84  YIVQFYGA-----------------------------------------LFKEVTVA--- 99
            IV+++ A                                           +E +V    
Sbjct: 64  GIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHI 123

Query: 100 ---TVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTRDAGCRP 156
                +A+ +L  +  ++HRD+KPSNI       +K+ DFG+   +     +       P
Sbjct: 124 FLQIAEAVEFLHSK-GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMP 182

Query: 157 -------------YMAPERI 163
                        YM+PE+I
Sbjct: 183 AYARHTGQVGTKLYMSPEQI 202

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384

 Score = 91.2 bits (227), Expect = 2e-22
 Identities = 50/173 (28%), Positives = 77/173 (44%), Gaps = 34/173 (19%)

Query: 32  IGRGGFGTVNKMIHRSSDTVMAVKRIR-STVDEKDQRQLLMDLDVVMKSNECPYIVQFYG 90
           IG+G FG V  +    +  + A+K +      E+++ + +     +M+  E P++V  + 
Sbjct: 23  IGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWY 82

Query: 91  A------------------LF----KEV--TVATVK--------ALNYLKEELKIIHRDV 118
           +                  L     + V     TVK        AL+YL +  +IIHRD+
Sbjct: 83  SFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYL-QNQRIIHRDM 141

Query: 119 KPSNILLDRRGAIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPLRARGY 171
           KP NILLD  G + + DF I+  L      T  AG +PYMAPE     +  GY
Sbjct: 142 KPDNILLDEHGHVHITDFNIAAMLPRETQITTMAGTKPYMAPEMFSSRKGAGY 194

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score = 90.9 bits (226), Expect = 2e-22
 Identities = 41/190 (21%), Positives = 72/190 (37%), Gaps = 40/190 (21%)

Query: 29  LGEIGRGGFGTVNKMIHRSSDTVMAVKRI-RSTVDEKDQRQLLMDLDVVMK-SNECPYIV 86
           L +IG GG   V ++++       A+K +     D +       ++  + K       I+
Sbjct: 14  LKQIGSGGSSKVFQVLNEKKQIY-AIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKII 72

Query: 87  QFYGAL--------------------------FKEVTVAT-----VKALNYLKEELKIIH 115
           + Y                                    +     ++A++ + +   I+H
Sbjct: 73  RLYDYEITDQYIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQH-GIVH 131

Query: 116 RDVKPSNILLDRRGAIKLCDFGISGQLVD---SIAKTRDAGCRPYMAPERI-DPLRARGY 171
            D+KP+N L+   G +KL DFGI+ Q+     S+ K    G   YM PE I D   +R  
Sbjct: 132 SDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSREN 190

Query: 172 PSFKTKLGFK 181
              K+K+  K
Sbjct: 191 GKSKSKISPK 200

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score = 90.1 bits (224), Expect = 4e-22
 Identities = 41/190 (21%), Positives = 72/190 (37%), Gaps = 40/190 (21%)

Query: 29  LGEIGRGGFGTVNKMIHRSSDTVMAVKRI-RSTVDEKDQRQLLMDLDVVMK-SNECPYIV 86
           L +IG GG   V ++++       A+K +     D +       ++  + K       I+
Sbjct: 33  LKQIGSGGSSKVFQVLNEKKQIY-AIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKII 91

Query: 87  QFYGAL--------------------------FKEVTVAT-----VKALNYLKEELKIIH 115
           + Y                                    +     ++A++ + +   I+H
Sbjct: 92  RLYDYEITDQYIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQH-GIVH 150

Query: 116 RDVKPSNILLDRRGAIKLCDFGISGQLVD---SIAKTRDAGCRPYMAPERI-DPLRARGY 171
            D+KP+N L+   G +KL DFGI+ Q+     S+ K    G   YM PE I D   +R  
Sbjct: 151 SDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSREN 209

Query: 172 PSFKTKLGFK 181
              K+K+  K
Sbjct: 210 GKSKSKISPK 219

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score = 91.0 bits (226), Expect = 4e-22
 Identities = 41/190 (21%), Positives = 72/190 (37%), Gaps = 40/190 (21%)

Query: 29  LGEIGRGGFGTVNKMIHRSSDTVMAVKRI-RSTVDEKDQRQLLMDLDVVMK-SNECPYIV 86
           L +IG GG   V ++++       A+K +     D +       ++  + K       I+
Sbjct: 61  LKQIGSGGSSKVFQVLNEKKQIY-AIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKII 119

Query: 87  QFYGAL--------------------------FKEVTVAT-----VKALNYLKEELKIIH 115
           + Y                                    +     ++A++ + +   I+H
Sbjct: 120 RLYDYEITDQYIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQH-GIVH 178

Query: 116 RDVKPSNILLDRRGAIKLCDFGISGQLVD---SIAKTRDAGCRPYMAPERI-DPLRARGY 171
            D+KP+N L+   G +KL DFGI+ Q+     S+ K    G   YM PE I D   +R  
Sbjct: 179 SDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSREN 237

Query: 172 PSFKTKLGFK 181
              K+K+  K
Sbjct: 238 GKSKSKISPK 247

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score = 89.8 bits (223), Expect = 5e-22
 Identities = 46/196 (23%), Positives = 71/196 (36%), Gaps = 57/196 (29%)

Query: 32  IGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQFYGA 91
           +  GGF  V +     S    A+KR+ S  +E+  R ++ ++  + K +  P IVQF  A
Sbjct: 36  LAEGGFAFVYEAQDVGSGREYALKRLLSN-EEEKNRAIIQEVCFMKKLSGHPNIVQFCSA 94

Query: 92  -------------------------------------LFKEVTV-----ATVKALNYL-K 108
                                                     TV      T +A+ ++ +
Sbjct: 95  ASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHR 154

Query: 109 EELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTRDAGCR------------- 155
           ++  IIHRD+K  N+LL  +G IKLCDFG +  +      +  A  R             
Sbjct: 155 QKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTP 214

Query: 156 PYMAPERIDPLRARGY 171
            Y  PE ID       
Sbjct: 215 MYRTPEIIDLYSNFPI 230

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score = 89.0 bits (221), Expect = 7e-22
 Identities = 36/189 (19%), Positives = 68/189 (35%), Gaps = 52/189 (27%)

Query: 23  SEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNEC 82
           + D+  L  +G+G +G V +   +  +  +AVK   S  ++   R+  +   V+++    
Sbjct: 7   ARDITLLECVGKGRYGEVWRGSWQGEN--VAVKIFSSRDEKSWFRETELYNTVMLRH--- 61

Query: 83  PYIVQFYGALFKE---------VT--------------------------VATVKALNYL 107
             I+ F  +             +T                          ++    L +L
Sbjct: 62  ENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTTLDTVSCLRIVLSIASGLAHL 121

Query: 108 KEEL-------KIIHRDVKPSNILLDRRGAIKLCDFGIS-----GQLVDSIAKTRDAGCR 155
             E+        I HRD+K  NIL+ + G   + D G++           +      G +
Sbjct: 122 HIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTK 181

Query: 156 PYMAPERID 164
            YMAPE +D
Sbjct: 182 RYMAPEVLD 190

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score = 87.4 bits (217), Expect = 3e-21
 Identities = 43/172 (25%), Positives = 68/172 (39%), Gaps = 39/172 (22%)

Query: 31  EIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQFYG 90
           EIGRG F TV K +   +   +A   ++     K +RQ   +   ++K  + P IV+FY 
Sbjct: 33  EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYD 92

Query: 91  A-------------------------------LFKEVTVATV-----KALNYL-KEELKI 113
           +                               + K   + +      K L +L      I
Sbjct: 93  SWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPI 152

Query: 114 IHRDVKPSNILLDRR-GAIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERID 164
           IHRD+K  NI +    G++K+ D G++     S AK    G   +MAPE  +
Sbjct: 153 IHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKA-VIGTPEFMAPEMYE 203

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score = 87.4 bits (217), Expect = 3e-21
 Identities = 45/188 (23%), Positives = 73/188 (38%), Gaps = 55/188 (29%)

Query: 24  EDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECP 83
            DL     +G+G FG   K+ HR +  VM +K +    DE+ QR  L ++ V M+  E P
Sbjct: 10  SDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRF-DEETQRTFLKEVKV-MRCLEHP 67

Query: 84  YIVQFYGALFKE-----VT------------------------------VATVKALNYLK 108
            +++F G L+K+     +T                              +A    + YL 
Sbjct: 68  NVLKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIA--SGMAYL- 124

Query: 109 EELKIIHRDVKPSNILLDRRGAIKLCDFGIS---------------GQLVDSIAKTRDAG 153
             + IIHRD+   N L+     + + DFG++                +  D   +    G
Sbjct: 125 HSMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVG 184

Query: 154 CRPYMAPE 161
              +MAPE
Sbjct: 185 NPYWMAPE 192

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score = 88.6 bits (220), Expect = 4e-21
 Identities = 43/199 (21%), Positives = 79/199 (39%), Gaps = 42/199 (21%)

Query: 3   QSIQSSGKLKLSPDTVYDFTSEDLQDL----GEIGRGGFGTVNKMIHRSSDTVMAVKRI- 57
           +++   G L+ +P          L ++     ++G G +G V     + +    A+K I 
Sbjct: 12  ENLYFQGDLQATPGMFITSKKGHLSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIR 71

Query: 58  RSTVDEKDQRQLLMDLDVVMKSNECPYIVQFYGA------------------LF------ 93
           +++V      +LL ++ V +K  + P I++ Y                    LF      
Sbjct: 72  KTSVSTSSNSKLLEEVAV-LKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGELFDEIIHR 130

Query: 94  --------KEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRG---AIKLCDFGISGQL 142
                     +    +  + YL  +  I+HRD+KP N+LL+ +     IK+ DFG+S   
Sbjct: 131 MKFNEVDAAVIIKQVLSGVTYL-HKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVF 189

Query: 143 VDSIAKTRDAGCRPYMAPE 161
            +        G   Y+APE
Sbjct: 190 ENQKKMKERLGTAYYIAPE 208

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676

 Score = 87.8 bits (217), Expect = 1e-20
 Identities = 45/176 (25%), Positives = 70/176 (39%), Gaps = 48/176 (27%)

Query: 31  EIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQFY- 89
            +G GGFG V + IH+ +   +A+K+ R  +  K++ +  +++ + MK    P +V    
Sbjct: 21  RLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQI-MKKLNHPNVVSARE 79

Query: 90  -----------------------GALF------------KEVTVAT-----VKALNYLKE 109
                                  G L             KE  + T       AL YL E
Sbjct: 80  VPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHE 139

Query: 110 ELKIIHRDVKPSNILLDRRG---AIKLCDFGISGQLVD-SIAKTRDAGCRPYMAPE 161
             +IIHRD+KP NI+L         K+ D G + +L    +      G   Y+APE
Sbjct: 140 -NRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEF-VGTLQYLAPE 193

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396

 Score = 86.1 bits (213), Expect = 2e-20
 Identities = 35/172 (20%), Positives = 65/172 (37%), Gaps = 45/172 (26%)

Query: 32  IGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQFY-- 89
           +G+G    V +  H+ +  + A+K   +    +     + + +V +K      IV+ +  
Sbjct: 17  LGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEV-LKKLNHKNIVKLFAI 75

Query: 90  ------------------GALF------------KEVTVAT-----VKALNYLKEELKII 114
                             G+L+             E          V  +N+L+E   I+
Sbjct: 76  EEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRE-NGIV 134

Query: 115 HRDVKPSNILL----DRRGAIKLCDFGISGQLVD-SIAKTRDAGCRPYMAPE 161
           HR++KP NI+     D +   KL DFG + +L D     +   G   Y+ P+
Sbjct: 135 HRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSL-YGTEEYLHPD 185

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score = 84.6 bits (210), Expect = 2e-20
 Identities = 47/182 (25%), Positives = 71/182 (39%), Gaps = 48/182 (26%)

Query: 24  EDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLD---VVMKSN 80
            +L     IG GGFG V +      + V AVK  R   DE D  Q + ++     +    
Sbjct: 7   AELTLEEIIGIGGFGKVYRAFWIGDE-V-AVKAARHDPDE-DISQTIENVRQEAKLFAML 63

Query: 81  ECPYIVQFYGALFKEVTVATV-------------------------------KALNYL-- 107
           + P I+   G   KE  +  V                               + +NYL  
Sbjct: 64  KHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLSGKRIPPDILVNWAVQIARGMNYLHD 123

Query: 108 KEELKIIHRDVKPSNILLDRRGA--------IKLCDFGISGQLVDSIAKTRDAGCRPYMA 159
           +  + IIHRD+K SNIL+ ++          +K+ DFG++ +      K   AG   +MA
Sbjct: 124 EAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLA-REWHRTTKMSAAGAYAWMA 182

Query: 160 PE 161
           PE
Sbjct: 183 PE 184

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score = 86.3 bits (214), Expect = 3e-20
 Identities = 44/193 (22%), Positives = 74/193 (38%), Gaps = 43/193 (22%)

Query: 10  KLKLSPDTVYDFTSEDLQDL----GEIGRGGFGTVNKMIHRSSDTVMAVKRI--RSTVDE 63
            L  +P      ++    D       +G+G FG V     + +    AVK I  R    +
Sbjct: 8   HLHATPGMFVQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQK 67

Query: 64  KDQRQLLMDLDVVMKSNECPYIVQFYGA------------------LF------------ 93
            D+  LL ++ + +K  + P I++ Y                    LF            
Sbjct: 68  TDKESLLREVQL-LKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEV 126

Query: 94  --KEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRG---AIKLCDFGISGQLVDSIAK 148
               +    +  + Y+  + KI+HRD+KP N+LL+ +     I++ DFG+S     S   
Sbjct: 127 DAARIIRQVLSGITYM-HKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKM 185

Query: 149 TRDAGCRPYMAPE 161
               G   Y+APE
Sbjct: 186 KDKIGTAYYIAPE 198

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score = 84.3 bits (209), Expect = 3e-20
 Identities = 44/175 (25%), Positives = 66/175 (37%), Gaps = 39/175 (22%)

Query: 24  EDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECP 83
             +     IG G FGTV K        V AVK +  T     Q Q   +   V++     
Sbjct: 24  GQITVGQRIGSGSFGTVYKGKWH--GDV-AVKMLNVTAPTPQQLQAFKNEVGVLRKTRHV 80

Query: 84  YIVQFYGA------------------------------LFKEVTVA--TVKALNYLKEEL 111
            I+ F G                               + K + +A  T + ++YL    
Sbjct: 81  NILLFMGYSTAPQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYL-HAK 139

Query: 112 KIIHRDVKPSNILLDRRGAIKLCDFGISG---QLVDSIAKTRDAGCRPYMAPERI 163
            IIHRD+K +NI L     +K+ DFG++    +   S    + +G   +MAPE I
Sbjct: 140 SIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVI 194

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score = 84.0 bits (208), Expect = 6e-20
 Identities = 39/183 (21%), Positives = 70/183 (38%), Gaps = 46/183 (25%)

Query: 22  TSEDLQDLGE-IGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSN 80
           TS  L  L + +G+G    V +  H+ +  + A+K   +    +     + + +V +K  
Sbjct: 6   TSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEV-LKKL 64

Query: 81  ECPYIVQFY--------------------GALF------------KEVTVAT-----VKA 103
               IV+ +                    G+L+             E          V  
Sbjct: 65  NHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGG 124

Query: 104 LNYLKEELKIIHRDVKPSNILL----DRRGAIKLCDFGISGQLVD-SIAKTRDAGCRPYM 158
           +N+L+E   I+HR++KP NI+     D +   KL DFG + +L D     +   G   Y+
Sbjct: 125 MNHLRE-NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSL-YGTEEYL 182

Query: 159 APE 161
            P+
Sbjct: 183 HPD 185

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336

 Score = 83.7 bits (207), Expect = 1e-19
 Identities = 39/194 (20%), Positives = 62/194 (31%), Gaps = 58/194 (29%)

Query: 24  EDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECP 83
           ++L+ L  IGRG +G V K         +AVK       +    +  +    +M+     
Sbjct: 13  DNLKLLELIGRGRYGAVYKGSLDERP--VAVKVFSFANRQNFINEKNIYRVPLMEH---D 67

Query: 84  YIVQFYGALFKE----------VT--------------------------VATVKALNYL 107
            I +F     +           V                            +  + L YL
Sbjct: 68  NIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHTSDWVSSCRLAHSVTRGLAYL 127

Query: 108 KEEL--------KIIHRDVKPSNILLDRRGAIKLCDFGIS---------GQLVDSIAKTR 150
             EL         I HRD+   N+L+   G   + DFG+S             +  A   
Sbjct: 128 HTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAIS 187

Query: 151 DAGCRPYMAPERID 164
           + G   YMAPE ++
Sbjct: 188 EVGTIRYMAPEVLE 201

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score = 83.1 bits (206), Expect = 1e-19
 Identities = 43/201 (21%), Positives = 80/201 (39%), Gaps = 44/201 (21%)

Query: 4   SIQSSGKLKLSPDTVYDFTSEDLQDL-----GEIGRGGFGTVNKMIHRSSDTVMAVKRIR 58
               S  + L  + +Y  + E+  +       E+GRG F  V + I +S+    A K ++
Sbjct: 4   HHHHSSGVDLGTENLYFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLK 63

Query: 59  -STVDEKDQRQLLMDLDVVMKSNECPYIVQFYGA------------------LF------ 93
                +  + ++L ++ V+  +  CP ++  +                    +F      
Sbjct: 64  KRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSEIILILEYAAGGEIFSLCLPE 123

Query: 94  -------KEVTVAT---VKALNYLKEELKIIHRDVKPSNILLDRR---GAIKLCDFGISG 140
                   +V       ++ + YL +   I+H D+KP NILL      G IK+ DFG+S 
Sbjct: 124 LAEMVSENDVIRLIKQILEGVYYLHQ-NNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSR 182

Query: 141 QLVDSIAKTRDAGCRPYMAPE 161
           ++  +       G   Y+APE
Sbjct: 183 KIGHACELREIMGTPEYLAPE 203

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322

 Score = 82.8 bits (205), Expect = 2e-19
 Identities = 48/217 (22%), Positives = 71/217 (32%), Gaps = 54/217 (24%)

Query: 6   QSSGKLKLSPDTVYDFTSEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKD 65
            SSG    + +  +   S  LQ L    RG FG V K    +    +AVK       +  
Sbjct: 8   HSSGVDLGTENLYFQ--SMPLQLLEVKARGRFGCVWKAQLLNEY--VAVKIFPIQDKQSW 63

Query: 66  QRQLLMDLDVVMKSNECPYIVQFYGALFKEVTVAT------------------------- 100
           Q +  +     MK      I+QF GA  +  +V                           
Sbjct: 64  QNEYEVYSLPGMK---HENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKANVVSW 120

Query: 101 ----------VKALNYLKEEL---------KIIHRDVKPSNILLDRRGAIKLCDFGIS-- 139
                      + L YL E++          I HRD+K  N+LL       + DFG++  
Sbjct: 121 NELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALK 180

Query: 140 -GQLVDSIAKTRDAGCRPYMAPERIDPLRARGYPSFK 175
                 +       G R YMAPE ++        +F 
Sbjct: 181 FEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFL 217

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score = 82.0 bits (203), Expect = 4e-19
 Identities = 37/179 (20%), Positives = 58/179 (32%), Gaps = 44/179 (24%)

Query: 24  EDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECP 83
           E L+    IG+G FG V          V A++ I    D +DQ +      +  +     
Sbjct: 33  EQLEIGELIGKGRFGQVYHGRWH--GEV-AIRLIDIERDNEDQLKAFKREVMAYRQTRHE 89

Query: 84  YIVQFYGALFKEVTVATV---------------------------------KALNYLKEE 110
            +V F GA      +A +                                 K + YL   
Sbjct: 90  NVVLFMGACMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYL-HA 148

Query: 111 LKIIHRDVKPSNILLDRRGAIKLCDFGIS------GQLVDSIAKTRDAGCRPYMAPERI 163
             I+H+D+K  N+  D  G + + DFG+                    G   ++APE I
Sbjct: 149 KGILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEII 206

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504

 Score = 82.4 bits (204), Expect = 6e-19
 Identities = 39/210 (18%), Positives = 75/210 (35%), Gaps = 53/210 (25%)

Query: 3   QSIQSSGKLKLSPDTVYDFTSEDLQDL----GEIGRGGFGTVNKMIHRSSDTVMAVKRIR 58
           +       + ++P          + +      ++G G +G V     ++  +  A+K I+
Sbjct: 11  RENLYFQGIAINPGMYVRKKEGKIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIK 70

Query: 59  ------------STVDEKDQRQLLMDLDVVMKSNECPYIVQFYGA--------------- 91
                       +   EK   ++  ++ + +KS + P I++ +                 
Sbjct: 71  KSQFDKGRYSDDNKNIEKFHEEIYNEISL-LKSLDHPNIIKLFDVFEDKKYFYLVTEFYE 129

Query: 92  ---LF--------------KEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRG---AI 131
              LF                +    +  + YL  +  I+HRD+KP NILL+ +     I
Sbjct: 130 GGELFEQIINRHKFDECDAANIMKQILSGICYL-HKHNIVHRDIKPENILLENKNSLLNI 188

Query: 132 KLCDFGISGQLVDSIAKTRDAGCRPYMAPE 161
           K+ DFG+S             G   Y+APE
Sbjct: 189 KIVDFGLSSFFSKDYKLRDRLGTAYYIAPE 218

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score = 81.7 bits (202), Expect = 1e-18
 Identities = 41/167 (24%), Positives = 69/167 (41%), Gaps = 38/167 (22%)

Query: 31  EIGRGGFGTVNKMIHRSSDTVMAVKRI-RSTVDEKDQRQLLMDLDVVMKSNECPYIVQFY 89
            +G+G FG V K   R +    AVK I +++   KD   +L ++++ +K  + P I++ +
Sbjct: 29  MLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVEL-LKKLDHPNIMKLF 87

Query: 90  GA------------------LF--------------KEVTVATVKALNYLKEELKIIHRD 117
                               LF                +       + Y+  +  I+HRD
Sbjct: 88  EILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYM-HKHNIVHRD 146

Query: 118 VKPSNILLDRRG---AIKLCDFGISGQLVDSIAKTRDAGCRPYMAPE 161
           +KP NILL+ +     IK+ DFG+S     +       G   Y+APE
Sbjct: 147 LKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPE 193

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score = 80.4 bits (199), Expect = 1e-18
 Identities = 49/184 (26%), Positives = 73/184 (39%), Gaps = 44/184 (23%)

Query: 31  EIGRGGFGTVNKMIHRSSDTVMAVKRI-------RSTVDEKDQRQLLMD-LDVVMKSNEC 82
            +GRG    V + IH+ +    AVK I        S  + ++ R+  +  +D++ K +  
Sbjct: 24  ILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGH 83

Query: 83  PYIVQFYGA------------------LF--------------KEVTVATVKALNYLKEE 110
           P I+Q                      LF              +++  A ++ +  L  +
Sbjct: 84  PNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICAL-HK 142

Query: 111 LKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTRDAGCRPYMAPE---RIDPLR 167
           L I+HRD+KP NILLD    IKL DFG S QL          G   Y+APE         
Sbjct: 143 LNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEIIECSMNDN 202

Query: 168 ARGY 171
             GY
Sbjct: 203 HPGY 206

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437

 Score = 81.3 bits (201), Expect = 1e-18
 Identities = 42/195 (21%), Positives = 75/195 (38%), Gaps = 45/195 (23%)

Query: 3   QSIQSSGKLKLSPDTVYDFTSEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIR-STV 61
                  +++L  +   DF       L  IGRG FG V  +  +++D V A+K +    +
Sbjct: 61  PFTSKVKQMRLHRE---DFEI-----LKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEM 112

Query: 62  DEKDQRQLLMDLDVVMKSNECPYIVQFYGA----------------------------LF 93
            ++ +     +   V+ + +  +I   + A                              
Sbjct: 113 LKRAETACFREERDVLVNGDSKWITTLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRL 172

Query: 94  KEVTVA-----TVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAK 148
            E          V A++ +  +L  +HRD+KP NIL+D  G I+L DFG   +L++    
Sbjct: 173 PEEMARFYLAEMVIAIDSV-HQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTV 231

Query: 149 TRDAGC-RP-YMAPE 161
                   P Y++PE
Sbjct: 232 QSSVAVGTPDYISPE 246

>3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695

 Score = 81.5 bits (201), Expect = 1e-18
 Identities = 46/207 (22%), Positives = 77/207 (37%), Gaps = 50/207 (24%)

Query: 2   CQSIQSSGKLKLSPDTVYDFTSEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIR-ST 60
           CQ       + L+ +   DF          IGRGGFG V       +  + A+K +    
Sbjct: 175 CQWKNVELNIHLTMN---DF-----SVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKR 226

Query: 61  VDEKDQRQLLMD----LDVVMKSNECPYIVQFYGA------------------------- 91
           +  K    L ++    L +V  + +CP+IV    A                         
Sbjct: 227 IKMKQGETLALNERIMLSLV-STGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQ 285

Query: 92  --LFKEVTVA-----TVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVD 144
             +F E  +       +  L ++     +++RD+KP+NILLD  G +++ D G++     
Sbjct: 286 HGVFSEADMRFYAAEIILGLEHM-HNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSK 344

Query: 145 SIAKTRDAGCRPYMAPERIDPLRARGY 171
                   G   YMAPE +   +   Y
Sbjct: 345 KKPHAS-VGTHGYMAPEVL--QKGVAY 368

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score = 80.5 bits (199), Expect = 2e-18
 Identities = 43/184 (23%), Positives = 69/184 (37%), Gaps = 44/184 (23%)

Query: 24  EDLQDLG-EIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNEC 82
            D  ++  E+GRG    V +   + +    A+K ++ TVD+K  R  +     V+     
Sbjct: 52  SDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVDKKIVRTEIG----VLLRLSH 107

Query: 83  PYIVQFYGA------------------LF--------------KEVTVATVKALNYLKEE 110
           P I++                      LF               +     ++A+ YL  E
Sbjct: 108 PNIIKLKEIFETPTEISLVLELVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYL-HE 166

Query: 111 LKIIHRDVKPSNILLDRRG---AIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPLR 167
             I+HRD+KP N+L         +K+ DFG+S  +   +      G   Y APE    LR
Sbjct: 167 NGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKTVCGTPGYCAPE---ILR 223

Query: 168 ARGY 171
              Y
Sbjct: 224 GCAY 227

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score = 80.6 bits (199), Expect = 2e-18
 Identities = 40/184 (21%), Positives = 63/184 (34%), Gaps = 51/184 (27%)

Query: 31  EIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQR--QLLMDLDVVMKSNECPYIVQF 88
            +G G  GT+        +  +AVKRI         R  QLL + D      E P ++++
Sbjct: 31  VLGHGAEGTIVYR-GMFDNRDVAVKRILPECFSFADREVQLLRESD------EHPNVIRY 83

Query: 89  Y-----------------GALF---------------KEVTVATVKALNYLKEELKIIHR 116
           +                   L                  +   T   L +L   L I+HR
Sbjct: 84  FCTEKDRQFQYIAIELCAATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHL-HSLNIVHR 142

Query: 117 DVKPSNILLDRRGA-----IKLCDFGISGQLVD---SIAKTRD-AGCRPYMAPERIDPLR 167
           D+KP NIL+    A       + DFG+  +L     S ++     G   ++APE +    
Sbjct: 143 DLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDC 202

Query: 168 ARGY 171
               
Sbjct: 203 KENP 206

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score = 80.5 bits (198), Expect = 3e-18
 Identities = 26/215 (12%), Positives = 56/215 (26%), Gaps = 70/215 (32%)

Query: 32  IGRGGFGTVNKMIHRSSDTVMAVK---------------------------RIRSTVDEK 64
           +G+       +   + +     V                             I++    K
Sbjct: 86  LGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAK 145

Query: 65  DQRQLLMDLDVVMKSNEC-----------PYIVQFY--------------GALFK----- 94
              + +   D+V    +             +++  +                L       
Sbjct: 146 VHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTH 205

Query: 95  ---------EVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDS 145
                    ++T+  ++ L  L     ++H  ++P +I+LD+RG + L  F      V  
Sbjct: 206 KSLVHHARLQLTLQVIRLLASL-HHYGLVHTYLRPVDIVLDQRGGVFLTGFEHL---VRD 261

Query: 146 IAKTRDAGCRPYMAPERIDPLRARGYPSFKTKLGF 180
            A       R +  PE              T + F
Sbjct: 262 GASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTF 296

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score = 79.7 bits (197), Expect = 3e-18
 Identities = 44/194 (22%), Positives = 68/194 (35%), Gaps = 58/194 (29%)

Query: 19  YDFTSEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMK 78
           Y  + + L      G G  G V +  HR +    A+K +    D    RQ   ++D   +
Sbjct: 30  YQLSKQVL------GLGVNGKVLECFHRRTGQKCALKLLY---DSPKARQ---EVDHHWQ 77

Query: 79  SNECPYIVQFY----------------------GALF----------------KEVTVAT 100
           ++  P+IV                         G LF                 E+    
Sbjct: 78  ASGGPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDI 137

Query: 101 VKALNYLKEELKIIHRDVKPSNILL---DRRGAIKLCDFGISGQLVDSIAKTRDAGCRPY 157
             A+ +L     I HRDVKP N+L    ++   +KL DFG + +   +  +T       Y
Sbjct: 138 GTAIQFL-HSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNALQTP-CYTPYY 195

Query: 158 MAPERIDPLRARGY 171
           +APE    L    Y
Sbjct: 196 VAPE---VLGPEKY 206

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score = 79.3 bits (196), Expect = 5e-18
 Identities = 44/208 (21%), Positives = 83/208 (39%), Gaps = 45/208 (21%)

Query: 4   SIQSSGKLKLSPDTVYDFTSEDLQD---LG-EIGRGGFGTVNKMIHRSSDTVMAVKRI-R 58
           +  + G+            S    D   +  E+G+G F  V + +H+++    A K I  
Sbjct: 5   ASMTGGQQMGRGSEFMMNASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINT 64

Query: 59  STVDEKDQRQLLMDLDVVMKSNECPYIVQFYGA------------------LF------- 93
             +  +D ++L  +  +  +  + P IV+ + +                  LF       
Sbjct: 65  KKLSARDFQKLEREARI-CRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVARE 123

Query: 94  -------KEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRG---AIKLCDFGISGQLV 143
                         ++++ Y      I+HR++KP N+LL  +    A+KL DFG++ ++ 
Sbjct: 124 FYSEADASHCIQQILESIAYC-HSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVN 182

Query: 144 DSIAKTRDAGCRPYMAPERIDPLRARGY 171
           DS A    AG   Y++PE    L+   Y
Sbjct: 183 DSEAWHGFAGTPGYLSPE---VLKKDPY 207

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410

 Score = 79.4 bits (196), Expect = 6e-18
 Identities = 48/200 (24%), Positives = 77/200 (38%), Gaps = 57/200 (28%)

Query: 3   QSIQSSGKLKLSPDTVYDFTSEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIR-STV 61
            +I     L++  +        D + +  IGRG FG V  + H+S+  V A+K +    +
Sbjct: 56  DTINKIRDLRMKAE--------DYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEM 107

Query: 62  DEKDQRQLLMDLDVVMKSNECPYIVQ---------------------------------- 87
            ++       +   +M     P++VQ                                  
Sbjct: 108 IKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPE 167

Query: 88  ----FYGALFKEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLV 143
               FY A   EV +A    L+ +   +  IHRDVKP N+LLD+ G +KL DFG   ++ 
Sbjct: 168 KWARFYTA---EVVLA----LDAI-HSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMN 219

Query: 144 DSIAKTRDAGC-RP-YMAPE 161
                  D     P Y++PE
Sbjct: 220 KEGMVRCDTAVGTPDYISPE 239

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score = 78.9 bits (195), Expect = 6e-18
 Identities = 40/178 (22%), Positives = 69/178 (38%), Gaps = 46/178 (25%)

Query: 31  EIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQFYG 90
           +IG G +    + IH++++   AVK I     +K +R    +++++++  + P I+    
Sbjct: 29  DIGVGSYSVCKRCIHKATNMEFAVKII-----DKSKRDPTEEIEILLRYGQHPNIITLKD 83

Query: 91  A------------------LF--------------KEVTVATVKALNYLKEELKIIHRDV 118
                              L                 V     K + YL     ++HRD+
Sbjct: 84  VYDDGKYVYVVTELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYL-HAQGVVHRDL 142

Query: 119 KPSNILL----DRRGAIKLCDFGISGQLVDSIAKTRDA-GCRPYMAPERIDPLRARGY 171
           KPSNIL         +I++CDFG + QL               ++APE    L  +GY
Sbjct: 143 KPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPCYTANFVAPE---VLERQGY 197

>1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310

 Score = 78.4 bits (194), Expect = 7e-18
 Identities = 46/200 (23%), Positives = 70/200 (35%), Gaps = 47/200 (23%)

Query: 3   QSIQSSGKLKLSPDTVYDFTSEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVK--RIRST 60
           +    S +    P        ED +    +G G F TV      ++    A+K    R  
Sbjct: 9   RPGAGSLQHAQPPPQPRKKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHI 68

Query: 61  VDEKDQRQLLMDLDVVMKSNECPYIVQFYGA------------------LFK-------- 94
           + E     +  + DV+ + +  P+ V+ Y                    L K        
Sbjct: 69  IKENKVPYVTRERDVMSRLD-HPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSF 127

Query: 95  ----------EVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVD 144
                     E+  A    L YL     IIHRD+KP NILL+    I++ DFG +  L  
Sbjct: 128 DETCTRFYTAEIVSA----LEYLHG-KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSP 182

Query: 145 SIAKTRDA---GCRPYMAPE 161
              + R     G   Y++PE
Sbjct: 183 ESKQARANSFVGTAQYVSPE 202

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412

 Score = 79.0 bits (195), Expect = 7e-18
 Identities = 45/193 (23%), Positives = 75/193 (38%), Gaps = 45/193 (23%)

Query: 5   IQSSGKLKLSPDTVYDFTSEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIR-STVDE 63
           +    +++L  D   DF       L  IGRG F  V  +  + +  V A+K +    + +
Sbjct: 50  VVRLKEVRLQRD---DFEI-----LKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLK 101

Query: 64  KDQRQLLMDLDVVMKSNECPYIVQFY----------------------------GALFKE 95
           + +     +   V+ + +  +I Q +                            G     
Sbjct: 102 RGEVSCFREERDVLVNGDRRWITQLHFAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPA 161

Query: 96  VTVA-----TVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQL-VDSIAKT 149
                     V A++ +   L  +HRD+KP NILLDR G I+L DFG   +L  D   ++
Sbjct: 162 EMARFYLAEIVMAIDSV-HRLGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRS 220

Query: 150 RDA-GCRPYMAPE 161
             A G   Y++PE
Sbjct: 221 LVAVGTPDYLSPE 233

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score = 77.3 bits (191), Expect = 1e-17
 Identities = 21/175 (12%), Positives = 51/175 (29%), Gaps = 43/175 (24%)

Query: 24  EDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECP 83
           + L  L ++     G + K   + +D  + VK ++       + +   +    ++    P
Sbjct: 10  KQLNFLTKLNENHSGELWKGRWQGND--IVVKVLKVRDWSTRKSRDFNEECPRLRIFSHP 67

Query: 84  YIVQFYGA--------------------LF------KEVTVATVKAL----------NYL 107
            ++   GA                    L+          V   +A+           +L
Sbjct: 68  NVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFL 127

Query: 108 -KEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTRDAGCRPYMAPE 161
              E  I    +   ++++D     ++    +      S           ++APE
Sbjct: 128 HTLEPLIPRHALNSRSVMIDEDMTARISMADVK----FSFQSPGRMYAPAWVAPE 178

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score = 78.2 bits (193), Expect = 1e-17
 Identities = 48/212 (22%), Positives = 75/212 (35%), Gaps = 44/212 (20%)

Query: 3   QSIQSSGKLKLSPDTVYDFTSEDLQDLGE-IGRGGFGTVNKMIHRSSDTVMAVKRIR--- 58
              QS G     PD           D  + IGRG    V + +HR++    AVK +    
Sbjct: 72  LYFQSMGPEDELPDWAAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTA 131

Query: 59  ----STVDEKDQRQLLMDLDVVMKSNECPYIVQFYGA------------------LF--- 93
                   E+ +     +  ++ +    P+I+    +                  LF   
Sbjct: 132 ERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYL 191

Query: 94  -----------KEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQL 142
                      + +  + ++A+++L     I+HRD+KP NILLD    I+L DFG S  L
Sbjct: 192 TEKVALSEKETRSIMRSLLEAVSFL-HANNIVHRDLKPENILLDDNMQIRLSDFGFSCHL 250

Query: 143 VDSIAKTRDAGCRPYMAPE---RIDPLRARGY 171
                     G   Y+APE           GY
Sbjct: 251 EPGEKLRELCGTPGYLAPEILKCSMDETHPGY 282

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score = 77.7 bits (192), Expect = 1e-17
 Identities = 38/179 (21%), Positives = 63/179 (35%), Gaps = 48/179 (26%)

Query: 31  EIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQR--QLLMDLDVVMKSNECPYIVQF 88
            +G G F    K +H+ S+   AVK I   ++   Q+    L   +        P IV+ 
Sbjct: 18  PLGEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQKEITALKLCE------GHPNIVKL 71

Query: 89  YGA------------------LF--------------KEVTVATVKALNYLKEELKIIHR 116
           +                    LF                +    V A++++  ++ ++HR
Sbjct: 72  HEVFHDQLHTFLVMELLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHM-HDVGVVHR 130

Query: 117 DVKPSNILL---DRRGAIKLCDFGISGQLVDSIAKTRDA-GCRPYMAPERIDPLRARGY 171
           D+KP N+L    +    IK+ DFG +          +       Y APE    L   GY
Sbjct: 131 DLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLHYAAPE---LLNQNGY 186

>3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325

 Score = 77.6 bits (192), Expect = 2e-17
 Identities = 64/202 (31%), Positives = 96/202 (47%), Gaps = 50/202 (24%)

Query: 7   SSGKLKLSPDTVYDFTSEDLQDLGEIGRGGFGTV---NKMIHRSSDTVMAVKRIR-STVD 62
             G  K  P     F   +L  L  +G+G FG V    K+    +  + A+K ++ +T+ 
Sbjct: 15  KEGHEKADPS---QF---EL--LKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLK 66

Query: 63  EKDQRQLLMDLDVVMKSNECPYIVQFY------------------GALF----KEV--TV 98
            +D+ +  M+ D++++ N  P+IV+ +                  G LF    KEV  T 
Sbjct: 67  VRDRVRTKMERDILVEVN-HPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTE 125

Query: 99  ATVK--------ALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTR 150
             VK        AL++L   L II+RD+KP NILLD  G IKL DFG+S + +D   K  
Sbjct: 126 EDVKFYLAELALALDHL-HSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAY 184

Query: 151 D-AGCRPYMAPERIDPLRARGY 171
              G   YMAPE +  +  RG+
Sbjct: 185 SFCGTVEYMAPE-V--VNRRGH 203

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373

 Score = 78.1 bits (193), Expect = 2e-17
 Identities = 53/208 (25%), Positives = 91/208 (43%), Gaps = 53/208 (25%)

Query: 6   QSSGKLKLSPDTVYDFTSEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIR--STVDE 63
             S ++ L P +       D   L  IG+G FG V    H++ +   AVK ++  + + +
Sbjct: 20  APSQQINLGPSSNPHAKPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKK 79

Query: 64  KDQRQLLMDLDVVMKSNECPYIVQ------------------------------------ 87
           K+++ ++ + +V++K+ + P++V                                     
Sbjct: 80  KEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEP 139

Query: 88  ---FYGALFKEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVD 144
              FY A   E+  A    L YL   L I++RD+KP NILLD +G I L DFG+  + ++
Sbjct: 140 RARFYAA---EIASA----LGYL-HSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIE 191

Query: 145 SIAKTRD-AGCRPYMAPERIDPLRARGY 171
             + T    G   Y+APE +  L  + Y
Sbjct: 192 HNSTTSTFCGTPEYLAPE-V--LHKQPY 216

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score = 78.2 bits (193), Expect = 2e-17
 Identities = 47/182 (25%), Positives = 71/182 (39%), Gaps = 43/182 (23%)

Query: 31  EIGRGGFGTVNKMIHRSSDTVMAVKRI-RSTVDEKDQRQLLMDLDV-----VMKSNECPY 84
            +G G  G V     R +   +A++ I +        R+    L+V     ++K    P 
Sbjct: 142 TLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPC 201

Query: 85  IVQFY-----------------GALF--------------KEVTVATVKALNYLKEELKI 113
           I++                   G LF              K      + A+ YL  E  I
Sbjct: 202 IIKIKNFFDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYL-HENGI 260

Query: 114 IHRDVKPSNILL---DRRGAIKLCDFGISGQLVD-SIAKTRDAGCRPYMAPERIDPLRAR 169
           IHRD+KP N+LL   +    IK+ DFG S  L + S+ +T   G   Y+APE +  +   
Sbjct: 261 IHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTL-CGTPTYLAPEVLVSVGTA 319

Query: 170 GY 171
           GY
Sbjct: 320 GY 321

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score = 77.4 bits (190), Expect = 3e-17
 Identities = 27/206 (13%), Positives = 54/206 (26%), Gaps = 70/206 (33%)

Query: 32  IGRGGFGTVNKMIHRSSDTVMAVK---------------------------RIRSTVDEK 64
           +G+       +   + +     V                             I++    K
Sbjct: 81  LGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAK 140

Query: 65  DQRQLLMDLDVVMKSNECPYI-------------------------VQFYGALF------ 93
              + +   D+V    +   I                           F   L       
Sbjct: 141 VHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTH 200

Query: 94  --------KEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDS 145
                    ++T+  ++ L  L     ++H  ++P +I+LD+RG + L  F      V  
Sbjct: 201 KSLVHHARLQLTLQVIRLLASL-HHYGLVHTYLRPVDIVLDQRGGVFLTGFEHL---VRD 256

Query: 146 IAKTRDAGCRPYMAPERIDPLRARGY 171
            A+   +  R +  PE         Y
Sbjct: 257 GARVVSSVSRGFEPPELEARRATISY 282

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score = 76.6 bits (189), Expect = 3e-17
 Identities = 47/182 (25%), Positives = 70/182 (38%), Gaps = 43/182 (23%)

Query: 31  EIGRGGFGTVNKMIHRSSDTVMAVKRI-RSTVDEKDQRQLLMDLDV-----VMKSNECPY 84
            +G G  G V     R +   +A+K I +        R+    L+V     ++K    P 
Sbjct: 17  TLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPC 76

Query: 85  IVQFYGA-----------------LF--------------KEVTVATVKALNYLKEELKI 113
           I++                     LF              K      + A+ YL  E  I
Sbjct: 77  IIKIKNFFDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYL-HENGI 135

Query: 114 IHRDVKPSNILLDRRG---AIKLCDFGISGQLVD-SIAKTRDAGCRPYMAPERIDPLRAR 169
           IHRD+KP N+LL  +     IK+ DFG S  L + S+ +T   G   Y+APE +  +   
Sbjct: 136 IHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTL-CGTPTYLAPEVLVSVGTA 194

Query: 170 GY 171
           GY
Sbjct: 195 GY 196

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304

 Score = 76.5 bits (189), Expect = 3e-17
 Identities = 41/178 (23%), Positives = 60/178 (33%), Gaps = 46/178 (25%)

Query: 31  EIGRGGFGTVNKMIHRSSDTVMAVKRI--RSTVDEKDQRQLLMDLDVVMKSNECPYIVQF 88
            +G G F  V  +  R +  + A+K I       +      +     V+K  +   IV  
Sbjct: 16  VLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIA----VLKKIKHENIVTL 71

Query: 89  YGA------------------LF--------------KEVTVATVKALNYLKEELKIIHR 116
                                LF                V    + A+ YL  E  I+HR
Sbjct: 72  EDIYESTTHYYLVMQLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYL-HENGIVHR 130

Query: 117 DVKPSNILLDRRG---AIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPLRARGY 171
           D+KP N+L         I + DFG+S    + I  T   G   Y+APE    L  + Y
Sbjct: 131 DLKPENLLYLTPEENSKIMITDFGLSKMEQNGIMSTA-CGTPGYVAPE---VLAQKPY 184

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score = 76.1 bits (188), Expect = 3e-17
 Identities = 43/189 (22%), Positives = 79/189 (41%), Gaps = 45/189 (23%)

Query: 23  SEDLQD---LG-EIGRGGFGTVNKMIHRSSDTVMAVKRI-RSTVDEKDQRQLLMDLDVVM 77
           S    D   +  E+G+G F  V + +H+++    A K I    +  +D ++L  +  +  
Sbjct: 1   STKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARI-C 59

Query: 78  KSNECPYIVQFYGA------------------LF--------------KEVTVATVKALN 105
           +  + P IV+ + +                  LF                     ++++ 
Sbjct: 60  RKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIA 119

Query: 106 YLKEELKIIHRDVKPSNILLDRRG---AIKLCDFGISGQLVDSIAKTRDAGCRPYMAPER 162
           Y      I+HR++KP N+LL  +    A+KL DFG++ ++ DS A    AG   Y++PE 
Sbjct: 120 YC-HSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPE- 177

Query: 163 IDPLRARGY 171
              L+   Y
Sbjct: 178 --VLKKDPY 184

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score = 77.0 bits (190), Expect = 4e-17
 Identities = 36/177 (20%), Positives = 67/177 (37%), Gaps = 40/177 (22%)

Query: 31  EIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQFYG 90
           E+G+G F  V + +   +    A   I +        Q L     + +  + P IV+ + 
Sbjct: 18  ELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHD 77

Query: 91  A------------------LF--------------KEVTVATVKALNYLKEELKIIHRDV 118
           +                  LF                     ++A+ +   ++ ++HR++
Sbjct: 78  SISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHC-HQMGVVHRNL 136

Query: 119 KPSNILLDRRG---AIKLCDFGISGQLVDSIAKTRD-AGCRPYMAPERIDPLRARGY 171
           KP N+LL  +    A+KL DFG++ ++          AG   Y++PE    LR   Y
Sbjct: 137 KPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYLSPE---VLRKDPY 190

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396

 Score = 76.6 bits (189), Expect = 5e-17
 Identities = 47/182 (25%), Positives = 76/182 (41%), Gaps = 53/182 (29%)

Query: 32  IGRGGFGTVNKMIHRSSDTVMAVKRIR--STVDEKDQRQLLMDLDVVMKSNECPYIVQ-- 87
           IGRG +  V  +  + +D + A++ ++     D++D   +  +  V  +++  P++V   
Sbjct: 60  IGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLH 119

Query: 88  -------------------------------------FYGALFKEVTVATVKALNYLKEE 110
                                                FY A   E+++A    LNYL  E
Sbjct: 120 SCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSA---EISLA----LNYL-HE 171

Query: 111 LKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTRD-AGCRPYMAPERIDPLRAR 169
             II+RD+K  N+LLD  G IKL D+G+  + +     T    G   Y+APE I  LR  
Sbjct: 172 RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPE-I--LRGE 228

Query: 170 GY 171
            Y
Sbjct: 229 DY 230

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345

 Score = 76.1 bits (188), Expect = 5e-17
 Identities = 48/182 (26%), Positives = 76/182 (41%), Gaps = 53/182 (29%)

Query: 32  IGRGGFGTVNKMIHRSSDTVMAVKRIR--STVDEKDQRQLLMDLDVVMKSNECPYIVQ-- 87
           IGRG +  V  +  + +D + A+K ++     D++D   +  +  V  +++  P++V   
Sbjct: 17  IGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLH 76

Query: 88  -------------------------------------FYGALFKEVTVATVKALNYLKEE 110
                                                FY A   E+++A    LNYL  E
Sbjct: 77  SCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSA---EISLA----LNYL-HE 128

Query: 111 LKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTRD-AGCRPYMAPERIDPLRAR 169
             II+RD+K  N+LLD  G IKL D+G+  + +     T    G   Y+APE I  LR  
Sbjct: 129 RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPE-I--LRGE 185

Query: 170 GY 171
            Y
Sbjct: 186 DY 187

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287

 Score = 75.3 bits (186), Expect = 6e-17
 Identities = 41/167 (24%), Positives = 69/167 (41%), Gaps = 38/167 (22%)

Query: 31  EIGRGGFGTVNKMIHRSSDTVMAVKRI-RSTVDEKDQRQLLMDLDVVMKSNECPYIVQFY 89
            +G+G FG V K   R +    AVK I +++   KD   +L ++++ +K  + P I++ +
Sbjct: 29  MLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVEL-LKKLDHPNIMKLF 87

Query: 90  GA------------------LF--------------KEVTVATVKALNYLKEELKIIHRD 117
                               LF                +       + Y+  +  I+HRD
Sbjct: 88  EILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYM-HKHNIVHRD 146

Query: 118 VKPSNILLDRRG---AIKLCDFGISGQLVDSIAKTRDAGCRPYMAPE 161
           +KP NILL+ +     IK+ DFG+S     +       G   Y+APE
Sbjct: 147 LKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPE 193

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score = 75.3 bits (186), Expect = 6e-17
 Identities = 42/173 (24%), Positives = 66/173 (38%), Gaps = 38/173 (21%)

Query: 32  IGRGGFGTVNKMIHRSSDTVMAVKRI-RSTVDEKDQRQLLMDLDVVMKSNECPYIVQFYG 90
           +G+G FG V     + S  ++A+K + ++ +++      L     +      P I++ YG
Sbjct: 17  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 76

Query: 91  AL---------------------------FKEVTVAT-----VKALNYLKEELKIIHRDV 118
                                        F E   AT       AL+Y     ++IHRD+
Sbjct: 77  YFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYC-HSKRVIHRDI 135

Query: 119 KPSNILLDRRGAIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPLRARGY 171
           KP N+LL   G +K+ DFG S     S       G   Y+ PE I     R +
Sbjct: 136 KPENLLLGSAGELKIADFGWSVHAPSSRRTDL-CGTLDYLPPEMI---EGRMH 184

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353

 Score = 76.1 bits (188), Expect = 7e-17
 Identities = 44/208 (21%), Positives = 81/208 (38%), Gaps = 61/208 (29%)

Query: 6   QSSGKLKLSPDTVYDFTSEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIR--STVDE 63
            +  + ++      DF   +   L  +G+G FG V     + +D + AVK ++    + +
Sbjct: 10  NNGNRDRMKLT---DF---NF--LMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQD 61

Query: 64  KDQRQLLMDLDVVMKSNECPYIVQ------------------------------------ 87
            D    +++  V+    + P++ Q                                    
Sbjct: 62  DDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEP 121

Query: 88  ---FYGALFKEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVD 144
              FY A   E+ +     L +L +   II+RD+K  N++LD  G IK+ DFG+  + + 
Sbjct: 122 HAVFYAA---EIAIG----LFFL-QSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIW 173

Query: 145 SIAKTRD-AGCRPYMAPERIDPLRARGY 171
               T+   G   Y+APE I  +  + Y
Sbjct: 174 DGVTTKTFCGTPDYIAPE-I--IAYQPY 198

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446

 Score = 76.3 bits (188), Expect = 8e-17
 Identities = 40/176 (22%), Positives = 73/176 (41%), Gaps = 36/176 (20%)

Query: 21  FTSEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIR--STVDEKDQRQLLMDLDVVMK 78
            T  + + L  +G+G FG V  +  +++    A+K ++    V + +    L +  V+  
Sbjct: 145 VTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQN 204

Query: 79  SNECPYIVQFYGA---------------------------LFKEVTVA-----TVKALNY 106
           S   P++     +                           +F E          V AL+Y
Sbjct: 205 SR-HPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDY 263

Query: 107 LKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTRD-AGCRPYMAPE 161
           L  E  +++RD+K  N++LD+ G IK+ DFG+  + +   A  +   G   Y+APE
Sbjct: 264 LHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPE 319

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score = 76.3 bits (188), Expect = 8e-17
 Identities = 44/210 (20%), Positives = 81/210 (38%), Gaps = 58/210 (27%)

Query: 4   SIQSSGKLKLSPDT-VYDFTSEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVD 62
            ++S  ++K +     Y  TS+       +G G  G V ++ ++ +    A+K ++   D
Sbjct: 47  HVKSGLQIKKNAIIDDYKVTSQ------VLGLGINGKVLQIFNKRTQEKFALKMLQ---D 97

Query: 63  EKDQRQLLMDLDVVMKSNECPYIVQFYGA----------------------LF------- 93
               R+   ++++  ++++CP+IV+                          LF       
Sbjct: 98  CPKARR---EVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRG 154

Query: 94  ---------KEVTVATVKALNYLKEELKIIHRDVKPSNILL---DRRGAIKLCDFGISGQ 141
                     E+  +  +A+ YL   + I HRDVKP N+L         +KL DFG + +
Sbjct: 155 DQAFTEREASEIMKSIGEAIQYL-HSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKE 213

Query: 142 LVDSIAKTRDAGCRPYMAPERIDPLRARGY 171
                + T       Y+APE    L    Y
Sbjct: 214 TTSHNSLTTPCYTPYYVAPE---VLGPEKY 240

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score = 75.5 bits (186), Expect = 9e-17
 Identities = 44/182 (24%), Positives = 74/182 (40%), Gaps = 47/182 (25%)

Query: 31  EIGRGGFGTVNKMIHRSSDTVMAVKRI-RSTVDEKDQRQLLMDLD---VVMK--SNECPY 84
            +G GGFG+V   I  S +  +A+K + +  + +  +      +    V++K  S+    
Sbjct: 50  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 109

Query: 85  IVQFY-------------------GALF---------KEVTVA------TVKALNYLKEE 110
           +++                       LF         +E  +A       ++A+ +    
Sbjct: 110 VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQE-ELARSFFWQVLEAVRHC-HN 167

Query: 111 LKIIHRDVKPSNILLD-RRGAIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPLRAR 169
             ++HRD+K  NIL+D  RG +KL DFG    L D++    D G R Y  PE I   R  
Sbjct: 168 CGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFD-GTRVYSPPEWI---RYH 223

Query: 170 GY 171
            Y
Sbjct: 224 RY 225

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score = 75.0 bits (185), Expect = 1e-16
 Identities = 44/193 (22%), Positives = 70/193 (36%), Gaps = 50/193 (25%)

Query: 24  EDLQDLG-EIGRGGFGTVNKMIHRSSDTVMAVKRIR----STVDEKDQRQLLMDLDVVMK 78
           ED+ +L   IG+G F  V + I+R +    AVK +     ++        L  +  +   
Sbjct: 23  EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASI-CH 81

Query: 79  SNECPYIVQFYGA------------------LF------------------KEVTVATVK 102
             + P+IV+                      L                          ++
Sbjct: 82  MLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILE 141

Query: 103 ALNYLKEELKIIHRDVKPSNILLDRRG---AIKLCDFGISGQLVDSIAKTRD-AGCRPYM 158
           AL Y   +  IIHRDVKP  +LL  +     +KL  FG++ QL +S        G   +M
Sbjct: 142 ALRYC-HDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVGTPHFM 200

Query: 159 APERIDPLRARGY 171
           APE    ++   Y
Sbjct: 201 APE---VVKREPY 210

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350

 Score = 74.6 bits (184), Expect = 2e-16
 Identities = 41/184 (22%), Positives = 74/184 (40%), Gaps = 39/184 (21%)

Query: 21  FTSEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIR-STVDEKDQRQLLMDLDVVMKS 79
              +    +  +G G FG V  + H+ S    A+K +    V +  Q +  ++   ++++
Sbjct: 38  AQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 97

Query: 80  NECPYIVQFYGA---------------------------LFKEVTVA-----TVKALNYL 107
              P++V+   +                            F E          V    YL
Sbjct: 98  VNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYL 157

Query: 108 KEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPLR 167
              L +I+RD+KP N+L+D++G I++ DFG + + V     T   G    +APE I    
Sbjct: 158 -HSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKR-VKGRTWTL-CGTPEALAPEII---L 211

Query: 168 ARGY 171
           ++GY
Sbjct: 212 SKGY 215

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327

 Score = 74.5 bits (184), Expect = 2e-16
 Identities = 51/215 (23%), Positives = 90/215 (41%), Gaps = 66/215 (30%)

Query: 3   QSIQSSGKLKLSPDTVYDFTSEDLQDLGEIGRGGFGTV---NKMIHRSSDTVMAVKRIRS 59
           ++  + G  K+ P+    F   +L  L  +G+GG+G V    K+   ++  + A+K ++ 
Sbjct: 4   ETSVNRGPEKIRPE---CF---EL--LRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKK 55

Query: 60  TV---DEKDQRQLLMDLDVVMKSNECPYIVQ----------------------------- 87
            +   + KD      + +++ +    P+IV                              
Sbjct: 56  AMIVRNAKDTAHTKAERNILEEVK-HPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLER 114

Query: 88  ----------FYGALFKEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFG 137
                     FY A   E+++A    L +L  +  II+RD+KP NI+L+ +G +KL DFG
Sbjct: 115 EGIFMEDTACFYLA---EISMA----LGHL-HQKGIIYRDLKPENIMLNHQGHVKLTDFG 166

Query: 138 ISGQLVDSIAKTRD-AGCRPYMAPERIDPLRARGY 171
           +  + +     T    G   YMAPE I  L   G+
Sbjct: 167 LCKESIHDGTVTHTFCGTIEYMAPE-I--LMRSGH 198

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score = 74.3 bits (183), Expect = 2e-16
 Identities = 45/184 (24%), Positives = 63/184 (34%), Gaps = 49/184 (26%)

Query: 31  EIGRGGFGTVNKMIHRSSDTVMAVK-----RIRSTVDEKDQRQLLMD---LDVVMKSNEC 82
            +G+GGFGTV      +    +A+K     R+       D     ++   L  V      
Sbjct: 38  LLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGH 97

Query: 83  PYIVQFY-------------------GALF---------KEVTVA------TVKALNYLK 108
           P +++                       LF          E   +       V A+ +  
Sbjct: 98  PGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGPLGE-GPSRCFFGQVVAAIQHC- 155

Query: 109 EELKIIHRDVKPSNILLD-RRGAIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPLR 167
               ++HRD+K  NIL+D RRG  KL DFG    L D      D G R Y  PE I    
Sbjct: 156 HSRGVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEPYTDFD-GTRVYSPPEWI---S 211

Query: 168 ARGY 171
              Y
Sbjct: 212 RHQY 215

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543

 Score = 75.2 bits (185), Expect = 2e-16
 Identities = 41/186 (22%), Positives = 70/186 (37%), Gaps = 53/186 (28%)

Query: 21  FTSEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIR-STVDEKDQRQLLMDLDVVMKS 79
              +   D   +GRGGFG V     +++  + A K++    + ++   Q  M    ++  
Sbjct: 182 MGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAK 241

Query: 80  NECPYIVQ-------------------------------------------FYGALFKEV 96
               +IV                                            FY A   ++
Sbjct: 242 VHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTA---QI 298

Query: 97  TVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTRD-AGCR 155
                  L +L  +  II+RD+KP N+LLD  G +++ D G++ +L     KT+  AG  
Sbjct: 299 VSG----LEHL-HQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTP 353

Query: 156 PYMAPE 161
            +MAPE
Sbjct: 354 GFMAPE 359

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score = 74.7 bits (184), Expect = 2e-16
 Identities = 38/172 (22%), Positives = 69/172 (40%), Gaps = 38/172 (22%)

Query: 25  DLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPY 84
            +     +G G FG V+K    ++   +A K I+ T   KD+ ++  ++ V M   +   
Sbjct: 90  TVSKTEILGGGRFGQVHKCEETATGLKLAAKIIK-TRGMKDKEEVKNEISV-MNQLDHAN 147

Query: 85  IVQFYGA------------------LF----------KEVTVAT-----VKALNYLKEEL 111
           ++Q Y A                  LF           E+          + + ++ + +
Sbjct: 148 LIQLYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQ-M 206

Query: 112 KIIHRDVKPSNILLDRRG--AIKLCDFGISGQLVDSIAKTRDAGCRPYMAPE 161
            I+H D+KP NIL   R    IK+ DFG++ +         + G   ++APE
Sbjct: 207 YILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKVNFGTPEFLAPE 258

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score = 73.8 bits (182), Expect = 3e-16
 Identities = 41/180 (22%), Positives = 69/180 (38%), Gaps = 44/180 (24%)

Query: 24  EDLQDLG-EIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDV-----VM 77
           +D  D G E+G G F  V K   +S+    A K I+    +  +R +  + D+     ++
Sbjct: 10  DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSRE-DIEREVSIL 68

Query: 78  KSNECPYIVQFYGA------------------LF---------KEVTVAT-----VKALN 105
           K  + P ++  +                    LF          E          +  + 
Sbjct: 69  KEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVY 128

Query: 106 YLKEELKIIHRDVKPSNILLDRRGA----IKLCDFGISGQLVDSIAKTRDAGCRPYMAPE 161
           YL   L+I H D+KP NI+L  R      IK+ DFG++ ++          G   ++APE
Sbjct: 129 YLHS-LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPE 187

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score = 73.9 bits (182), Expect = 3e-16
 Identities = 35/199 (17%), Positives = 63/199 (31%), Gaps = 53/199 (26%)

Query: 18  VYDFTSEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVM 77
           VY    + L      G G    V   I+  +    AVK I        + ++  +++++ 
Sbjct: 13  VYQLQEDVL------GEGAHARVQTCINLITSQEYAVKII-EKQPGHIRSRVFREVEMLY 65

Query: 78  KSNECPYIVQFYGA------------------LF--------------KEVTVATVKALN 105
           +      +++                      +                 V      AL+
Sbjct: 66  QCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALD 125

Query: 106 YLKEELKIIHRDVKPSNILL---DRRGAIKLCDFGISGQLVDSIAKTRDAGCR------- 155
           +L     I HRD+KP NIL    ++   +K+CDF +   +  +   +  +          
Sbjct: 126 FL-HNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGS 184

Query: 156 -PYMAPE--RIDPLRARGY 171
             YMAPE        A  Y
Sbjct: 185 AEYMAPEVVEAFSEEASIY 203

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355

 Score = 74.2 bits (183), Expect = 3e-16
 Identities = 43/180 (23%), Positives = 70/180 (38%), Gaps = 42/180 (23%)

Query: 32  IGRGGFGTV---NKMIHRSSDTVMAVKRIRSTV---DEKDQRQLLMDLDVVMKSNECPYI 85
           +G G +G V    K+    +  + A+K ++        K       +  V+    + P++
Sbjct: 62  LGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFL 121

Query: 86  VQFY------------------GALF----KEV--TVATVK--------ALNYLKEELKI 113
           V  +                  G LF    +    T   V+        AL +L  +L I
Sbjct: 122 VTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHL-HKLGI 180

Query: 114 IHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTRDAGC--RPYMAPERIDPLRARGY 171
           I+RD+K  NILLD  G + L DFG+S + V    +     C    YMAP+ +      G+
Sbjct: 181 IYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGD-SGH 239

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674

 Score = 74.7 bits (183), Expect = 3e-16
 Identities = 41/183 (22%), Positives = 71/183 (38%), Gaps = 50/183 (27%)

Query: 21  FTSEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIR--STVDEKDQRQLLMDLDVVMK 78
               D   L  +G+G FG V     + +D + AVK ++    + + D    +++  V+  
Sbjct: 338 MKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLAL 397

Query: 79  SNECPYIVQ---------------------------------------FYGALFKEVTVA 99
             + P++ Q                                       FY A   E+ + 
Sbjct: 398 PGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAA---EIAIG 454

Query: 100 TVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTRD-AGCRPYM 158
               L +L +   II+RD+K  N++LD  G IK+ DFG+  + +     T+   G   Y+
Sbjct: 455 ----LFFL-QSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKTFCGTPDYI 509

Query: 159 APE 161
           APE
Sbjct: 510 APE 512

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score = 73.4 bits (181), Expect = 3e-16
 Identities = 39/189 (20%), Positives = 72/189 (38%), Gaps = 50/189 (26%)

Query: 15  PDTVYDFTSEDLQDLGE-IGRGGFGTVNKMIHRSSDTVMAVKRI-RSTVDEKDQR-QLLM 71
           P+ + D  S      G  +G+GGF    ++    +  V A K + +S + +  QR ++ M
Sbjct: 5   PEVLVDPRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSM 64

Query: 72  DLDVVMKSNECPYIVQFYGAL---------------------------FKEVTVAT---- 100
           ++ +  +S    ++V F+G                               E         
Sbjct: 65  EISI-HRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQ 123

Query: 101 -VKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTRDAGCR---- 155
            V    YL    ++IHRD+K  N+ L+    +K+ DFG++ ++        D   +    
Sbjct: 124 IVLGCQYL-HRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKV------EYDGERKKVLC 176

Query: 156 ---PYMAPE 161
               Y+APE
Sbjct: 177 GTPNYIAPE 185

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576

 Score = 74.4 bits (183), Expect = 4e-16
 Identities = 38/176 (21%), Positives = 67/176 (38%), Gaps = 38/176 (21%)

Query: 22  TSEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIR-STVDEKDQRQLLMDLDVVMKSN 80
           T    +    +G+GGFG V     R++  + A K++    + ++    + ++   +++  
Sbjct: 182 TKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKV 241

Query: 81  ECPYIVQFYGA-----------------------------LFKEVTVA-----TVKALNY 106
              ++V    A                              F E             L  
Sbjct: 242 NSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLED 301

Query: 107 LKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVD-SIAKTRDAGCRPYMAPE 161
           L    +I++RD+KP NILLD  G I++ D G++  + +    K R  G   YMAPE
Sbjct: 302 L-HRERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGR-VGTVGYMAPE 355

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284

 Score = 73.0 bits (180), Expect = 4e-16
 Identities = 42/173 (24%), Positives = 69/173 (39%), Gaps = 38/173 (21%)

Query: 32  IGRGGFGTVNKMIHRSSDTVMAVKRI-RSTVDEKDQRQLLMDLDVVMKSNECPYIVQFYG 90
           +G+G FG V     + +  +MA+K + +S ++++     L     +      P I++ Y 
Sbjct: 22  LGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYN 81

Query: 91  AL---------------------------FKEVTVAT-----VKALNYLKEELKIIHRDV 118
                                        F E   AT       AL+Y   E K+IHRD+
Sbjct: 82  YFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYC-HERKVIHRDI 140

Query: 119 KPSNILLDRRGAIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPLRARGY 171
           KP N+L+  +G +K+ DFG S        +T   G   Y+ PE I     + +
Sbjct: 141 KPENLLMGYKGELKIADFGWSVHAPSLRRRTM-CGTLDYLPPEMI---EGKTH 189

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score = 73.0 bits (180), Expect = 4e-16
 Identities = 45/178 (25%), Positives = 69/178 (38%), Gaps = 42/178 (23%)

Query: 24  EDLQDLG-EIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNEC 82
           +DL     ++G G FG V+ +  RSS     +K I     +    Q+  +++V +KS + 
Sbjct: 21  DDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEV-LKSLDH 79

Query: 83  PYIVQFYGA------------------LF-------------KEVTVAT-----VKALNY 106
           P I++ +                    L               E  VA      + AL Y
Sbjct: 80  PNIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAY 139

Query: 107 LKEELKIIHRDVKPSNILLDRR---GAIKLCDFGISGQLVDSIAKTRDAGCRPYMAPE 161
                 ++H+D+KP NIL         IK+ DFG++         T  AG   YMAPE
Sbjct: 140 F-HSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTNAAGTALYMAPE 196

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score = 73.5 bits (181), Expect = 4e-16
 Identities = 40/201 (19%), Positives = 76/201 (37%), Gaps = 50/201 (24%)

Query: 3   QSIQSSGKLKLSPDTVYDFTSEDLQDLGE-IGRGGFGTVNKMIHRSSDTVMAVKRI-RST 60
            +  ++   K  P+ + D  S      G  +G+GGF    ++    +  V A K + +S 
Sbjct: 19  GAPAAAPPAKEIPEVLVDPRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSL 78

Query: 61  VDEKDQR-QLLMDLDVVMKSNECPYIVQFYGAL--------------------------- 92
           + +  QR ++ M++ +  +S    ++V F+G                             
Sbjct: 79  LLKPHQREKMSMEISI-HRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKA 137

Query: 93  FKEVTVAT-----VKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIA 147
             E          V    YL    ++IHRD+K  N+ L+    +K+ DFG++ ++     
Sbjct: 138 LTEPEARYYLRQIVLGCQYL-HRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKV----- 191

Query: 148 KTRDAGCR-------PYMAPE 161
              D   +        Y+APE
Sbjct: 192 -EYDGERKKVLCGTPNYIAPE 211

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353

 Score = 73.8 bits (182), Expect = 5e-16
 Identities = 43/208 (20%), Positives = 78/208 (37%), Gaps = 53/208 (25%)

Query: 6   QSSGKLKLSPDTVYDFTSEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIR--STVDE 63
            S     +  ++      ++ + +  +G+G FG V     + +  + AVK ++    + +
Sbjct: 5   SSKEGNGIGVNSSNRLGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQD 64

Query: 64  KDQRQLLMDLDVVMKSNECPYIVQ------------------------------------ 87
            D    + +  ++  +   P++ Q                                    
Sbjct: 65  DDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEA 124

Query: 88  ---FYGALFKEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVD 144
              FY A   E+  A    L +L  +  II+RD+K  N+LLD  G  KL DFG+  + + 
Sbjct: 125 RARFYAA---EIISA----LMFL-HDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIC 176

Query: 145 SIAKTRD-AGCRPYMAPERIDPLRARGY 171
           +   T    G   Y+APE I  L+   Y
Sbjct: 177 NGVTTATFCGTPDYIAPE-I--LQEMLY 201

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score = 73.5 bits (181), Expect = 6e-16
 Identities = 42/179 (23%), Positives = 69/179 (38%), Gaps = 42/179 (23%)

Query: 24  EDLQDLG-EIGRGGFGTVNKMIHRSSDTVMAVKRIR-STVDEKDQRQLLMDLD---VVMK 78
           ED  D+G E+G G F  V K   +S+    A K I+        +     +++    +++
Sbjct: 11  EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILR 70

Query: 79  SNECPYIVQFYGA------------------LF---------KEVTVAT-----VKALNY 106
               P I+  +                    LF          E    +     +  +NY
Sbjct: 71  QVLHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNY 130

Query: 107 LKEELKIIHRDVKPSNILLDRR----GAIKLCDFGISGQLVDSIAKTRDAGCRPYMAPE 161
           L    KI H D+KP NI+L  +      IKL DFG++ ++ D +      G   ++APE
Sbjct: 131 LHT-KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPE 188

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score = 72.6 bits (179), Expect = 6e-16
 Identities = 39/181 (21%), Positives = 71/181 (39%), Gaps = 46/181 (25%)

Query: 24  EDLQDLG-EIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDV-----VM 77
           ED  ++G E+G G F  V K   + +    A K I+       +R +  + ++     ++
Sbjct: 4   EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSRE-EIEREVNIL 62

Query: 78  KSNECPYIVQFYGA------------------LF---------KEVTVAT-----VKALN 105
           +    P I+  +                    LF          E          +  ++
Sbjct: 63  REIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVH 122

Query: 106 YLKEELKIIHRDVKPSNILLDRRGA----IKLCDFGISGQLVDSIAKTRDAGCRP-YMAP 160
           YL    +I H D+KP NI+L  +      IKL DFGI+   +++  + ++    P ++AP
Sbjct: 123 YLHS-KRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIA-HKIEAGNEFKNIFGTPEFVAP 180

Query: 161 E 161
           E
Sbjct: 181 E 181

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score = 73.7 bits (181), Expect = 6e-16
 Identities = 40/174 (22%), Positives = 66/174 (37%), Gaps = 39/174 (22%)

Query: 24  EDLQDLG-EIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNEC 82
            D  D+  E+G G FG V+++  R++    A K +  T  E D+  +  ++   M     
Sbjct: 156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVM-TPHESDKETVRKEIQ-TMSVLRH 213

Query: 83  PYIVQFYGA------------------LFK----------EVTVAT-----VKALNYLKE 109
           P +V  + A                  LF+          E           K L ++  
Sbjct: 214 PTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMH- 272

Query: 110 ELKIIHRDVKPSNILLDRRG--AIKLCDFGISGQLVDSIAKTRDAGCRPYMAPE 161
           E   +H D+KP NI+   +    +KL DFG++  L    +     G   + APE
Sbjct: 273 ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPE 326

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345

 Score = 73.0 bits (180), Expect = 7e-16
 Identities = 45/198 (22%), Positives = 78/198 (39%), Gaps = 58/198 (29%)

Query: 6   QSSGKLKLSPDTVYDFTSEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIR--STVDE 63
           + S ++KL  +   DF          +G+G FG V     + ++   A+K ++    + +
Sbjct: 7   RPSLQIKLKIE---DFIL-----HKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMD 58

Query: 64  KDQRQLLMDLDVVMKSNECPYIVQ------------------------------------ 87
            D    +++  V+  + E P++                                      
Sbjct: 59  DDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLS 118

Query: 88  ---FYGALFKEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVD 144
              FY A   E+ +     L +L     I++RD+K  NILLD+ G IK+ DFG+  + + 
Sbjct: 119 RATFYAA---EIILG----LQFL-HSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENML 170

Query: 145 SIAKTRD-AGCRPYMAPE 161
             AKT    G   Y+APE
Sbjct: 171 GDAKTNTFCGTPDYIAPE 188

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score = 73.6 bits (181), Expect = 7e-16
 Identities = 37/174 (21%), Positives = 68/174 (39%), Gaps = 39/174 (22%)

Query: 24  EDLQDLG-EIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNEC 82
            D  D+  E+G G FG V++ + +++  V   K I  T    D+  +  ++ + M     
Sbjct: 50  YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFIN-TPYPLDKYTVKNEISI-MNQLHH 107

Query: 83  PYIVQFYGA------------------LF----------KEVTVAT-----VKALNYLKE 109
           P ++  + A                  LF           E  V        + L ++ E
Sbjct: 108 PKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHE 167

Query: 110 ELKIIHRDVKPSNILLDRRG--AIKLCDFGISGQLVDSIAKTRDAGCRPYMAPE 161
              I+H D+KP NI+ + +   ++K+ DFG++ +L              + APE
Sbjct: 168 -HSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPE 220

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score = 72.8 bits (179), Expect = 9e-16
 Identities = 28/61 (45%), Positives = 37/61 (60%), Gaps = 1/61 (1%)

Query: 101 VKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTRDAGCRPYMAP 160
           + + +Y+  E  I HRDVKPSNIL+D+ G +KL DFG S  +VD   K    G   +M P
Sbjct: 161 LNSFSYIHNEKNICHRDVKPSNILMDKNGRVKLSDFGESEYMVDKKIKGS-RGTYEFMPP 219

Query: 161 E 161
           E
Sbjct: 220 E 220

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score = 72.3 bits (178), Expect = 1e-15
 Identities = 33/180 (18%), Positives = 62/180 (34%), Gaps = 52/180 (28%)

Query: 24  EDLQDLG-EIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDV-----VM 77
            +   +  ++GRG FG V++ +  SS      K ++    ++          V     ++
Sbjct: 4   YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQV--------LVKKEISIL 55

Query: 78  KSNECPYIVQFYGA------------------LF----------KEVTVAT-----VKAL 104
                  I+  + +                  +F           E  + +      +AL
Sbjct: 56  NIARHRNILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEAL 115

Query: 105 NYLKEELKIIHRDVKPSNILLDRR--GAIKLCDFGISGQLVDSIAKTRDAGCRP-YMAPE 161
            +L     I H D++P NI+   R    IK+ +FG + + +      R     P Y APE
Sbjct: 116 QFLHS-HNIGHFDIRPENIIYQTRRSSTIKIIEFGQA-RQLKPGDNFRLLFTAPEYYAPE 173

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318

 Score = 71.4 bits (176), Expect = 2e-15
 Identities = 50/183 (27%), Positives = 76/183 (41%), Gaps = 54/183 (29%)

Query: 21  FTSEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIR-STVDEKDQRQLLMDLDVVMKS 79
           ++ +D Q L  +G G FG V+ +  R +    A+K ++   V    Q +   D  +++  
Sbjct: 3   YSLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSI 62

Query: 80  NECPYIVQ---------------------------------------FYGALFKEVTVAT 100
              P+I++                                       FY A   EV +A 
Sbjct: 63  VTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAA---EVCLA- 118

Query: 101 VKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTRDAGC-RP-YM 158
              L YL     II+RD+KP NILLD+ G IK+ DFG + + V  +  T    C  P Y+
Sbjct: 119 ---LEYL-HSKDIIYRDLKPENILLDKNGHIKITDFGFA-KYVPDVTYTL---CGTPDYI 170

Query: 159 APE 161
           APE
Sbjct: 171 APE 173

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score = 71.5 bits (176), Expect = 2e-15
 Identities = 39/189 (20%), Positives = 71/189 (37%), Gaps = 47/189 (24%)

Query: 18  VYDFTSEDLQDL----GEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDL 73
           +  F  + ++D      E+G G F  V K   +S+    A K I+       +R +  + 
Sbjct: 2   MEPFKQQKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSRE- 60

Query: 74  DV-----VMKSNECPYIVQFYGA------------------LF---------KEVTVAT- 100
           ++     +++      ++  +                    LF          E    + 
Sbjct: 61  EIEREVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSF 120

Query: 101 ----VKALNYLKEELKIIHRDVKPSNILLDRR----GAIKLCDFGISGQLVDSIAKTRDA 152
               +  +NYL    KI H D+KP NI+L  +      IKL DFG++ ++ D +      
Sbjct: 121 IKQILDGVNYLHT-KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIF 179

Query: 153 GCRPYMAPE 161
           G   ++APE
Sbjct: 180 GTPEFVAPE 188

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score = 70.3 bits (173), Expect = 4e-15
 Identities = 39/180 (21%), Positives = 67/180 (37%), Gaps = 42/180 (23%)

Query: 21  FTSEDLQD---LG-EIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVV 76
            T  D+     L   IGRG +G V   + + +    A K+I      +D  +   ++++ 
Sbjct: 2   STKGDINQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKI-PKYFVEDVDRFKQEIEI- 59

Query: 77  MKSNECPYIVQFYGA------------------LF--------------KEVTVATVKAL 104
           MKS + P I++ Y                    LF                +    + A+
Sbjct: 60  MKSLDHPNIIRLYETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAV 119

Query: 105 NYLKEELKIIHRDVKPSNILLDRRG---AIKLCDFGISGQLVDSIAKTRDAGCRPYMAPE 161
            Y   +L + HRD+KP N L         +KL DFG++ +           G   Y++P+
Sbjct: 120 AYC-HKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKVGTPYYVSPQ 178

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score = 70.7 bits (174), Expect = 4e-15
 Identities = 39/147 (26%), Positives = 66/147 (44%), Gaps = 35/147 (23%)

Query: 24  EDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQ-------LLMDL--- 73
           E  + +G+IG G +G V K  +R +  ++A+K+   + D+   ++       +L  L   
Sbjct: 3   EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHP 62

Query: 74  ------DVVMKSNECPYIV-----------------QFYGALFKEVTVATVKALNYLKEE 110
                 +V  +     ++V                      L K +T  T++A+N+  + 
Sbjct: 63  NLVNLLEVFRRKRRL-HLVFEYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKH 121

Query: 111 LKIIHRDVKPSNILLDRRGAIKLCDFG 137
              IHRDVKP NIL+ +   IKLCDFG
Sbjct: 122 -NCIHRDVKPENILITKHSVIKLCDFG 147

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score = 70.8 bits (174), Expect = 5e-15
 Identities = 44/173 (25%), Positives = 71/173 (41%), Gaps = 38/173 (21%)

Query: 32  IGRGGFGTVNKMIHRSSDTVMAVKRI-RSTVDEKDQRQLLMDLDVVMKSNECPYIVQFY- 89
           IG+G F  V    H  +   +A+K I ++ ++    ++L  ++ + MK    P IV+ + 
Sbjct: 23  IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRI-MKILNHPNIVKLFE 81

Query: 90  -----------------GALF---------KEVTVAT-----VKALNYLKEELKIIHRDV 118
                            G +F         KE    +     V A+ Y   + +I+HRD+
Sbjct: 82  VIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYC-HQKRIVHRDL 140

Query: 119 KPSNILLDRRGAIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPLRARGY 171
           K  N+LLD    IK+ DFG S +           G  PY APE     + + Y
Sbjct: 141 KAENLLLDADMNIKIADFGFSNEFTVGGKLDAFCGAPPYAAPELF---QGKKY 190

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score = 71.0 bits (174), Expect = 5e-15
 Identities = 37/197 (18%), Positives = 66/197 (33%), Gaps = 63/197 (31%)

Query: 24  EDLQDLGE-IGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNEC 82
           ++L    + +G G  GTV           +AVKR+     +    ++     ++ +S++ 
Sbjct: 14  KNLVVSEKILGYGSSGTV-VFQGSFQGRPVAVKRMLIDFCDIALMEI----KLLTESDDH 68

Query: 83  PYIVQFY-----------------GALF---------------------KEVTVATVKAL 104
           P ++++Y                   L                        +       +
Sbjct: 69  PNVIRYYCSETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGV 128

Query: 105 NYLKEELKIIHRDVKPSNILLDRRGA-------------IKLCDFGISGQLVDSIAKTRD 151
            +L   LKIIHRD+KP NIL+                  I + DFG+  +L    +  R 
Sbjct: 129 AHL-HSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRT 187

Query: 152 AGCRP-----YMAPERI 163
               P     + APE +
Sbjct: 188 NLNNPSGTSGWRAPELL 204

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score = 69.9 bits (172), Expect = 5e-15
 Identities = 35/167 (20%), Positives = 64/167 (38%), Gaps = 40/167 (23%)

Query: 32  IGRGGFGTVNKMIHRSSDTVMAVKRI-RSTVDEKDQR-QLLMDLDVVMKSNECPYIVQFY 89
           +G+G F  V +     +   +A+K I +  + +     ++  ++ +     + P I++ Y
Sbjct: 19  LGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKI-HCQLKHPSILELY 77

Query: 90  ------------------GALFK----------EVTVAT-----VKALNYLKEELKIIHR 116
                             G + +          E          +  + YL     I+HR
Sbjct: 78  NYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHS-HGILHR 136

Query: 117 DVKPSNILLDRRGAIKLCDFGISGQLV--DSIAKTRDAGCRPYMAPE 161
           D+  SN+LL R   IK+ DFG++ QL        T   G   Y++PE
Sbjct: 137 DLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTL-CGTPNYISPE 182

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score = 70.3 bits (173), Expect = 6e-15
 Identities = 36/147 (24%), Positives = 63/147 (42%), Gaps = 35/147 (23%)

Query: 24  EDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQR-------QLLMDL--- 73
           E  ++LG +G G +G V K  ++ +  ++A+K+   + D+K  +       +LL  L   
Sbjct: 25  EKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHE 84

Query: 74  ------DVVMKSNECPYIV-----------------QFYGALFKEVTVATVKALNYLKEE 110
                 +V  K     Y+V                      + ++     +  + +    
Sbjct: 85  NLVNLLEVCKKKKRW-YLVFEFVDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSH 143

Query: 111 LKIIHRDVKPSNILLDRRGAIKLCDFG 137
             IIHRD+KP NIL+ + G +KLCDFG
Sbjct: 144 -NIIHRDIKPENILVSQSGVVKLCDFG 169

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681

 Score = 71.0 bits (174), Expect = 6e-15
 Identities = 40/188 (21%), Positives = 65/188 (34%), Gaps = 61/188 (32%)

Query: 29  LGEIGRGGFGTVNKMIHRSSDTVM-----AVKRIRSTVDEKDQ------RQLLMDL---- 73
            G I  GG G +    + + D  +      +K +  + D + Q      RQ L ++    
Sbjct: 85  KGCIAHGGLGWI----YLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPS 140

Query: 74  -----DVV----MKSNECPYIVQFY--GALFKEV---TVATVKALNYLKEELK------- 112
                + V       +   YIV  Y  G   K      +   +A+ YL E L        
Sbjct: 141 IVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQKLPVAEAIAYLLEILPALSYLHS 200

Query: 113 --IIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTRDA-----GCRPYMAPERIDP 165
             +++ D+KP NI+L     +KL D G             ++     G   + APE    
Sbjct: 201 IGLVYNDLKPENIMLTEEQ-LKLIDLG--------AVSRINSFGYLYGTPGFQAPE---- 247

Query: 166 LRARGYPS 173
              R  P+
Sbjct: 248 -IVRTGPT 254

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337

 Score = 69.9 bits (172), Expect = 9e-15
 Identities = 39/171 (22%), Positives = 69/171 (40%), Gaps = 49/171 (28%)

Query: 32  IGRGGFGTVNKMIHRSSDTVMAVKRIR-STVDEKDQRQLLMDLDVVMKSNECPYIVQ--- 87
           +G+G FG V  +  +++    A+K +R   +  KD+    +    V+++   P++     
Sbjct: 13  LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKY 72

Query: 88  ------------------------------------FYGALFKEVTVATVKALNYLKEEL 111
                                               FYGA   E+  A    L YL    
Sbjct: 73  AFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGA---EIVSA----LEYL-HSR 124

Query: 112 KIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTRD-AGCRPYMAPE 161
            +++RD+K  N++LD+ G IK+ DFG+  + +   A  +   G   Y+APE
Sbjct: 125 DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPE 175

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score = 69.7 bits (171), Expect = 1e-14
 Identities = 46/177 (25%), Positives = 74/177 (41%), Gaps = 47/177 (26%)

Query: 32  IGRGGFGTVNKMIHRSSDTVMAVKRI--RSTVDEKDQRQLLMDLDVVMKSNECPYIVQFY 89
           IG G FG    M  + +  ++AVK I   + +DE  QR++     +  +S   P IV+F 
Sbjct: 28  IGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQREI-----INHRSLRHPNIVRFK 82

Query: 90  ------------------GALFKEVTVAT--------------VKALNYLKEELKIIHRD 117
                             G L++ +  A               +  ++Y    ++I HRD
Sbjct: 83  EVILTPTHLAIIMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYC-HSMQICHRD 141

Query: 118 VKPSNILLD--RRGAIKLCDFGIS-GQLVDSIAKTRDAGCRPYMAPERIDPLRARGY 171
           +K  N LLD      +K+CDFG S   ++ S  K+   G   Y+APE +     + Y
Sbjct: 142 LKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTV-GTPAYIAPEVL---LRQEY 194

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score = 68.7 bits (169), Expect = 2e-14
 Identities = 37/148 (25%), Positives = 64/148 (43%), Gaps = 37/148 (25%)

Query: 24  EDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKD------QR--QLLMDL-- 73
           +  + L +IG G +GTV K  +R +  ++A+KR+R   D+ +       R   LL +L  
Sbjct: 2   QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVR-LDDDDEGVPSSALREICLLKELKH 60

Query: 74  -------DVVMKSNECPYIV-----------------QFYGALFKEVTVATVKALNYLKE 109
                  DV+    +   +V                      + K      +K L +   
Sbjct: 61  KNIVRLHDVLHSDKKL-TLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHS 119

Query: 110 ELKIIHRDVKPSNILLDRRGAIKLCDFG 137
              ++HRD+KP N+L++R G +KL +FG
Sbjct: 120 R-NVLHRDLKPQNLLINRNGELKLANFG 146

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299

 Score = 67.7 bits (166), Expect = 4e-14
 Identities = 35/177 (19%), Positives = 71/177 (40%), Gaps = 55/177 (31%)

Query: 4   SIQSSGKLKLSPDTVYDFTSEDLQDLGE-IGRGGFGTVNKMIHRSSDTVMAVKRIRSTVD 62
            ++S  ++K +         +D +   + +G G  G V ++ ++ +    A+K ++   D
Sbjct: 3   HVKSGLQIKKNAII------DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQ---D 53

Query: 63  EKDQRQLLMDLDVVMKSNECPYIVQFYGA----------------------LF------- 93
               R+   ++++  ++++CP+IV+                          LF       
Sbjct: 54  CPKARR---EVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRG 110

Query: 94  ---------KEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRG---AIKLCDFGI 138
                     E+  +  +A+ YL   + I HRDVKP N+L   +     +KL DFG 
Sbjct: 111 DQAFTEREASEIMKSIGEAIQYL-HSINIAHRDVKPENLLYTSKRPNAILKLTDFGF 166

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score = 68.0 bits (167), Expect = 5e-14
 Identities = 36/145 (24%), Positives = 61/145 (42%), Gaps = 38/145 (26%)

Query: 29  LGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQR----------QLLMDL----- 73
           L  +G G F TV K   ++++ ++A+K+I+     + +           +LL +L     
Sbjct: 15  LDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNI 74

Query: 74  ----DVVMKSNECPYIV-----------------QFYGALFKEVTVATVKALNYLKEELK 112
               D          +V                     +  K   + T++ L YL +   
Sbjct: 75  IGLLDAFG-HKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQH-W 132

Query: 113 IIHRDVKPSNILLDRRGAIKLCDFG 137
           I+HRD+KP+N+LLD  G +KL DFG
Sbjct: 133 ILHRDLKPNNLLLDENGVLKLADFG 157

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score = 68.2 bits (166), Expect = 5e-14
 Identities = 10/78 (12%), Positives = 22/78 (28%), Gaps = 4/78 (5%)

Query: 94  KEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTRDAG 153
             +T   ++    L +   ++H    P N+ +   G + L D            +   + 
Sbjct: 197 HILTAQLIRLAANL-QSKGLVHGHFTPDNLFIMPDGRLMLGDVSAL---WKVGTRGPASS 252

Query: 154 CRPYMAPERIDPLRARGY 171
                AP          +
Sbjct: 253 VPVTYAPREFLNASTATF 270

>2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ... Length = 299

 Score = 67.6 bits (166), Expect = 5e-14
 Identities = 38/150 (25%), Positives = 65/150 (43%), Gaps = 40/150 (26%)

Query: 24  EDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIR---------ST-------------- 60
           E+ Q + +IG G +G V K  ++ +  V+A+K+IR         ST              
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 62

Query: 61  --------VDEKDQRQLLM-----DLDVVMKSNECPYIVQFYGALFKEVTVATVKALNYL 107
                   +  +++  L+      DL   M ++    I      L K      ++ L + 
Sbjct: 63  NIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPL---PLIKSYLFQLLQGLAFC 119

Query: 108 KEELKIIHRDVKPSNILLDRRGAIKLCDFG 137
               +++HRD+KP N+L++  GAIKL DFG
Sbjct: 120 HSH-RVLHRDLKPQNLLINTEGAIKLADFG 148

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score = 66.8 bits (164), Expect = 1e-13
 Identities = 35/150 (23%), Positives = 59/150 (39%), Gaps = 42/150 (28%)

Query: 24  EDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIR---------ST-------------- 60
           E    L +IG G +G V K  +   +T  A+K+IR         ST              
Sbjct: 2   EKYHGLEKIGEGTYGVVYKAQNNYGETF-ALKKIRLEKEDEGIPSTTIREISILKELKHS 60

Query: 61  --------VDEKDQRQLLM-----DLDVVMKSNECPYIVQFYGALFKEVTVATVKALNYL 107
                   +  K +  L+      DL  ++   E            K   +  +  + Y 
Sbjct: 61  NIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGG----LESVTAKSFLLQLLNGIAYC 116

Query: 108 KEELKIIHRDVKPSNILLDRRGAIKLCDFG 137
            +  +++HRD+KP N+L++R G +K+ DFG
Sbjct: 117 HDR-RVLHRDLKPQNLLINREGELKIADFG 145

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score = 66.8 bits (164), Expect = 1e-13
 Identities = 36/155 (23%), Positives = 69/155 (44%), Gaps = 43/155 (27%)

Query: 22  TSEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKD------QR--QLLMDL 73
           +S   + L ++G G + TV K +++++   +A+K ++  +D ++       R   L+ +L
Sbjct: 3   SSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVK--LDSEEGTPSTAIREISLMKEL 60

Query: 74  ---------DVVMKSNECPYIV-----------------QFYGALFKEVTVAT-----VK 102
                    DV+   N+   +V                        +   V       ++
Sbjct: 61  KHENIVRLYDVIHTENKL-TLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQ 119

Query: 103 ALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFG 137
            L +  E  KI+HRD+KP N+L+++RG +KL DFG
Sbjct: 120 GLAFCHEN-KILHRDLKPQNLLINKRGQLKLGDFG 153

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330

 Score = 66.9 bits (164), Expect = 1e-13
 Identities = 33/144 (22%), Positives = 66/144 (45%), Gaps = 31/144 (21%)

Query: 23  SEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQR-----QLLMD----- 72
            +D Q + ++GRG +  V + I+ +++  + VK ++    +K +R     + L       
Sbjct: 35  QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLRGGPNII 94

Query: 73  --LDVVM--KSNECPYIVQF-----YGALFKEVTVATVKALNYLKEELK---------II 114
              D+V    S     + +      +  L++ +T   ++   Y+ E LK         I+
Sbjct: 95  TLADIVKDPVSRTPALVFEHVNNTDFKQLYQTLTDYDIR--FYMYEILKALDYCHSMGIM 152

Query: 115 HRDVKPSNILLDR-RGAIKLCDFG 137
           HRDVKP N+++D     ++L D+G
Sbjct: 153 HRDVKPHNVMIDHEHRKLRLIDWG 176

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score = 66.9 bits (164), Expect = 1e-13
 Identities = 37/148 (25%), Positives = 62/148 (41%), Gaps = 38/148 (25%)

Query: 24  EDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKD------QR--QLLMDL-- 73
           E    L ++G G + TV K   + +D ++A+K IR  ++ ++       R   LL DL  
Sbjct: 2   ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIR--LEHEEGAPCTAIREVSLLKDLKH 59

Query: 74  -------DVVMKSNECPYIV-----------------QFYGALFKEVTVATVKALNYLKE 109
                  D++        +V                        K      ++ L Y   
Sbjct: 60  ANIVTLHDIIHTEKSL-TLVFEYLDKDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHR 118

Query: 110 ELKIIHRDVKPSNILLDRRGAIKLCDFG 137
           + K++HRD+KP N+L++ RG +KL DFG
Sbjct: 119 Q-KVLHRDLKPQNLLINERGELKLADFG 145

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score = 67.4 bits (165), Expect = 1e-13
 Identities = 50/186 (26%), Positives = 70/186 (37%), Gaps = 49/186 (26%)

Query: 27  QDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQR------QLL--MD------ 72
            D   IG G FG V +     S  ++A+K++      +D+R      Q++  +D      
Sbjct: 57  TDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL-----QDKRFKNRELQIMRKLDHCNIVR 111

Query: 73  -LDVVMKSNECP-----YIVQ------------FYGALFKEVTVATVK--------ALNY 106
                  S E        +V              Y    + + V  VK        +L Y
Sbjct: 112 LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 171

Query: 107 LKEELKIIHRDVKPSNILLDRR-GAIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDP 165
           +     I HRD+KP N+LLD     +KLCDFG + QLV           R Y APE I  
Sbjct: 172 IHS-FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELI-- 228

Query: 166 LRARGY 171
             A  Y
Sbjct: 229 FGATDY 234

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score = 66.8 bits (164), Expect = 1e-13
 Identities = 37/158 (23%), Positives = 54/158 (34%), Gaps = 45/158 (28%)

Query: 24  EDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQR----------QLLMDL 73
              + + EIG G +GTV K     S   +A+K +R                    LL  L
Sbjct: 9   SRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRL 68

Query: 74  ------------DVVMKSNECP----YIV------------------QFYGALFKEVTVA 99
                       DV   S         +V                         K++   
Sbjct: 69  EAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMRQ 128

Query: 100 TVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFG 137
            ++ L++L     I+HRD+KP NIL+   G +KL DFG
Sbjct: 129 FLRGLDFLHAN-CIVHRDLKPENILVTSGGTVKLADFG 165

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365

 Score = 66.9 bits (163), Expect = 1e-13
 Identities = 32/225 (14%), Positives = 63/225 (28%), Gaps = 63/225 (28%)

Query: 5   IQSSGKLK-LSPDTVYDFTSEDLQDLGEIGRGGFGTVNKMIHRSSDTV-----MAVKRIR 58
            +   KL  + P T +   S+ +     +G G F  V +      +         +K  +
Sbjct: 45  FEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQK 104

Query: 59  STVDEKDQRQLLMDLDVVMKSNECPYIVQFYGA--------------------------- 91
                  +  +   L   +K +     ++FY A                           
Sbjct: 105 PAN--PWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYK 162

Query: 92  -----LFKEVTVAT-----VKALNYLKEELKIIHRDVKPSNILL-----------DRRGA 130
                +  +  V +     +  +  + +  +IIH D+KP N +L           D    
Sbjct: 163 NTPEKVMPQGLVISFAMRMLYMIEQVHD-CEIIHGDIKPDNFILGNGFLEQDDEDDLSAG 221

Query: 131 IKLCDFGISGQL---VDSIAKTRDAGCRPYMAPERIDPLRARGYP 172
           + L D G S  +         T       +   E    L  + + 
Sbjct: 222 LALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEM---LSNKPWN 263

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score = 66.0 bits (162), Expect = 2e-13
 Identities = 37/150 (24%), Positives = 59/150 (39%), Gaps = 42/150 (28%)

Query: 24  EDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIR---------ST-------------- 60
           E  Q L ++G G +G V K        V A+KRIR         ST              
Sbjct: 21  EKYQKLEKVGEGTYGVVYKAKDSQGRIV-ALKRIRLDAEDEGIPSTAIREISLLKELHHP 79

Query: 61  --------VDEKDQRQLLM-----DLDVVMKSNECPYIVQFYGALFKEVTVATVKALNYL 107
                   +  +    L+      DL  V+  N+         +  K      ++ + + 
Sbjct: 80  NIVSLIDVIHSERCLTLVFEFMEKDLKKVLDENKTG----LQDSQIKIYLYQLLRGVAHC 135

Query: 108 KEELKIIHRDVKPSNILLDRRGAIKLCDFG 137
            +  +I+HRD+KP N+L++  GA+KL DFG
Sbjct: 136 HQH-RILHRDLKPQNLLINSDGALKLADFG 164

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score = 65.7 bits (161), Expect = 3e-13
 Identities = 39/155 (25%), Positives = 64/155 (41%), Gaps = 43/155 (27%)

Query: 24  EDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKD------QR--QLLMDL-- 73
              + L +IG+G FG V K  HR +   +A+K++    +EK+       R  ++L  L  
Sbjct: 17  SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVL-MENEKEGFPITALREIKILQLLKH 75

Query: 74  -------DVVMKSNECP-------YIV-----------------QFYGALFKEVTVATVK 102
                  ++               Y+V                 +F  +  K V    + 
Sbjct: 76  ENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLN 135

Query: 103 ALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFG 137
            L Y+    KI+HRD+K +N+L+ R G +KL DFG
Sbjct: 136 GLYYIHRN-KILHRDMKAANVLITRDGVLKLADFG 169

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377

 Score = 65.7 bits (161), Expect = 3e-13
 Identities = 45/182 (24%), Positives = 68/182 (37%), Gaps = 50/182 (27%)

Query: 24  EDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECP 83
           EDL    +IGRG FG V     R+ +T++AVK  R T+    + + L +   ++K    P
Sbjct: 114 EDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEAR-ILKQYSHP 172

Query: 84  YIVQFYGALFKEVTVATVKA--------------LNYLK--------------------- 108
            IV+  G       V T K               L +L+                     
Sbjct: 173 NIVRLIG-------VCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAG 225

Query: 109 ----EELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTRD-AGCRPY--MAPE 161
               E    IHRD+   N L+  +  +K+ DFG+S +  D +          P    APE
Sbjct: 226 MEYLESKCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWTAPE 285

Query: 162 RI 163
            +
Sbjct: 286 AL 287

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score = 65.5 bits (160), Expect = 4e-13
 Identities = 40/174 (22%), Positives = 57/174 (32%), Gaps = 41/174 (23%)

Query: 28  DLGE-IGRGGFGTVNKMIHRSSDTVMAVKRI-RSTVDEKDQRQLLMDLDV-----VMKSN 80
                +G G FG V   + +  +  + VK I +  V E    +      V     ++   
Sbjct: 27  STMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRV 86

Query: 81  ECPYIVQFY-------------------GALF---------KEVTVAT-----VKALNYL 107
           E   I++                       LF          E   +      V A+ YL
Sbjct: 87  EHANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVGYL 146

Query: 108 KEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTRDAGCRPYMAPE 161
                IIHRD+K  NI++     IKL DFG +  L          G   Y APE
Sbjct: 147 -RLKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFYTFCGTIEYCAPE 199

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score = 65.4 bits (160), Expect = 4e-13
 Identities = 47/190 (24%), Positives = 68/190 (35%), Gaps = 58/190 (30%)

Query: 27  QDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIR---------------------------- 58
            +   IG G FG V +     SD V A+K++                             
Sbjct: 43  TNCKVIGNGSFGVVFQAKLVESDEV-AIKKVLQDKRFKNRELQIMRIVKHPNVVDLKAFF 101

Query: 59  -STVDEKDQRQL-----LMDLDV--VMKSNECPYIVQFYGALFKEVTVATVK-------- 102
            S  D+KD+  L      +   V    +          Y  L + + +  +K        
Sbjct: 102 YSNGDKKDEVFLNLVLEYVPETVYRASRH---------YAKLKQTMPMLLIKLYMYQLLR 152

Query: 103 ALNYLKEELKIIHRDVKPSNILLDRR-GAIKLCDFGISGQLVDSIAKTRDAGCRPYMAPE 161
           +L Y+   + I HRD+KP N+LLD   G +KL DFG +  L+           R Y APE
Sbjct: 153 SLAYIHS-IGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSYICSRYYRAPE 211

Query: 162 RIDPLRARGY 171
            I    A  Y
Sbjct: 212 LI--FGATNY 219

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score = 65.0 bits (159), Expect = 4e-13
 Identities = 45/200 (22%), Positives = 73/200 (36%), Gaps = 62/200 (31%)

Query: 31  EIGRGGFGTVNKMIHRSSDTVMAVK-------------------RIRSTVDEKDQRQLLM 71
           EIG+G +G V    + + +T  A+K                   R          +    
Sbjct: 20  EIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGP 79

Query: 72  DLDV-----VMKSNECPYIVQFY--------------------GALFKEVT-------VA 99
              V     ++K  + P +V+                      G + +  T        A
Sbjct: 80  IEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLKPLSEDQA 139

Query: 100 ------TVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLV--DSIAKTRD 151
                  +K + YL    KIIHRD+KPSN+L+   G IK+ DFG+S +    D++     
Sbjct: 140 RFYFQDLIKGIEYL-HYQKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDALLSNT- 197

Query: 152 AGCRPYMAPERIDPLRARGY 171
            G   +MAPE +   R + +
Sbjct: 198 VGTPAFMAPESLSETR-KIF 216

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327

 Score = 64.9 bits (159), Expect = 4e-13
 Identities = 39/181 (21%), Positives = 71/181 (39%), Gaps = 45/181 (24%)

Query: 24  EDLQDLGEIGRGGFGTVNK----MIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKS 79
            + + +  +G G FGTV K             +A+K +R     K  +++L +  V M S
Sbjct: 15  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYV-MAS 73

Query: 80  NECPYIVQFYGALFKE----VT------------------------------VATVKALN 105
            + P++ +  G         +T                              +A  K +N
Sbjct: 74  VDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIA--KGMN 131

Query: 106 YLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTRDAGCR---PYMAPER 162
           YL E+ +++HRD+   N+L+     +K+ DFG++  L     +    G +    +MA E 
Sbjct: 132 YL-EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALES 190

Query: 163 I 163
           I
Sbjct: 191 I 191

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360

 Score = 65.0 bits (159), Expect = 6e-13
 Identities = 42/187 (22%), Positives = 66/187 (35%), Gaps = 45/187 (24%)

Query: 27  QDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQR--QLLMDL----------- 73
           Q     G+G FGTV     +S+   +A+K++      +  R  Q++ DL           
Sbjct: 26  QVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFR-NRELQIMQDLAVLHHPNIVQL 84

Query: 74  -DVVMKSNE------CPYIVQ------------FYGALFKEVTVATVK--------ALNY 106
                   E         +V              Y           +K        ++  
Sbjct: 85  QSYFYTLGERDRRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGC 144

Query: 107 L-KEELKIIHRDVKPSNILLDRR-GAIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERID 164
           L    + + HRD+KP N+L++   G +KLCDFG + +L  S         R Y APE I 
Sbjct: 145 LHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPNVAYICSRYYRAPELI- 203

Query: 165 PLRARGY 171
               + Y
Sbjct: 204 -FGNQHY 209

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454

 Score = 65.1 bits (159), Expect = 6e-13
 Identities = 41/174 (23%), Positives = 70/174 (40%), Gaps = 38/174 (21%)

Query: 24  EDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECP 83
           E L+   ++G G FG V    +     V AVK ++      +     +    VMK+ +  
Sbjct: 188 ESLKLEKKLGAGQFGEVWMATYNKHTKV-AVKTMKPGSMSVEA---FLAEANVMKTLQHD 243

Query: 84  YIVQFYGALFKE----VT--VATVKALNYLK--------------------------EEL 111
            +V+ +  + KE    +T  +A    L++LK                          E+ 
Sbjct: 244 KLVKLHAVVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQR 303

Query: 112 KIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTRDAGCRPY--MAPERI 163
             IHRD++ +NIL+      K+ DFG++  + D+    R+    P    APE I
Sbjct: 304 NYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAI 357

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score = 64.5 bits (157), Expect = 8e-13
 Identities = 20/74 (27%), Positives = 33/74 (44%), Gaps = 14/74 (18%)

Query: 101 VKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGIS-------------GQLVDSIA 147
            +A+ +L  +  ++HRD+KPSNI       +K+ DFG+                +     
Sbjct: 174 AEAVEFLHSK-GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYAT 232

Query: 148 KTRDAGCRPYMAPE 161
            T   G + YM+PE
Sbjct: 233 HTGQVGTKLYMSPE 246

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score = 46.0 bits (109), Expect = 2e-06
 Identities = 22/112 (19%), Positives = 50/112 (44%), Gaps = 1/112 (0%)

Query: 24  EDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECP 83
            D + +  +GRGGFG V +  ++  D   A+KRIR    E  + +++ ++  + K    P
Sbjct: 6   TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEH-P 64

Query: 84  YIVQFYGALFKEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCD 135
            IV+++ A  +       + ++ +  + +     +   + +      I+  D
Sbjct: 65  GIVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMD 116

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score = 63.8 bits (156), Expect = 1e-12
 Identities = 42/187 (22%), Positives = 74/187 (39%), Gaps = 55/187 (29%)

Query: 28  DLGE-IGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLD------VVMKSN 80
           DL + +G G +G V   ++R ++  +AVK +       D ++ +   +       + K  
Sbjct: 10  DLVQTLGEGAYGEVQLAVNRVTEEAVAVKIV-------DMKRAVDCPENIKKEICINKML 62

Query: 81  ECPYIVQFY------------------GALFKEVTVAT--------------VKALNYLK 108
               +V+FY                  G LF  +                  +  + YL 
Sbjct: 63  NHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYL- 121

Query: 109 EELKIIHRDVKPSNILLDRRGAIKLCDFGIS----GQLVDSIAKTRDAGCRPYMAPERID 164
             + I HRD+KP N+LLD R  +K+ DFG++        + +      G  PY+APE + 
Sbjct: 122 HGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKM-CGTLPYVAPELL- 179

Query: 165 PLRARGY 171
             + R +
Sbjct: 180 --KRREF 184

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309

 Score = 63.8 bits (156), Expect = 1e-12
 Identities = 22/54 (40%), Positives = 25/54 (46%), Gaps = 4/54 (7%)

Query: 113 IIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTRDA---GCRPYMAPERI 163
             HRDVKP NIL+       L DFGI+         T+     G   YMAPER 
Sbjct: 155 ATHRDVKPENILVSADDFAYLVDFGIA-SATTDEKLTQLGNTVGTLYYMAPERF 207

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score = 63.5 bits (155), Expect = 2e-12
 Identities = 42/187 (22%), Positives = 74/187 (39%), Gaps = 55/187 (29%)

Query: 28  DLGE-IGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLD------VVMKSN 80
           DL + +G G +G V   ++R ++  +AVK +       D ++ +   +       + K  
Sbjct: 10  DLVQTLGEGAYGEVQLAVNRVTEEAVAVKIV-------DMKRAVDCPENIKKEICINKML 62

Query: 81  ECPYIVQFY------------------GALFKEVTVAT--------------VKALNYLK 108
               +V+FY                  G LF  +                  +  + YL 
Sbjct: 63  NHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYL- 121

Query: 109 EELKIIHRDVKPSNILLDRRGAIKLCDFGIS----GQLVDSIAKTRDAGCRPYMAPERID 164
             + I HRD+KP N+LLD R  +K+ DFG++        + +      G  PY+APE + 
Sbjct: 122 HGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKM-CGTLPYVAPELL- 179

Query: 165 PLRARGY 171
             + R +
Sbjct: 180 --KRREF 184

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535

 Score = 63.7 bits (155), Expect = 2e-12
 Identities = 40/174 (22%), Positives = 66/174 (37%), Gaps = 38/174 (21%)

Query: 24  EDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECP 83
           E L+   ++G+G FG V       +  V A+K ++      +     +    VMK     
Sbjct: 267 ESLRLEVKLGQGCFGEVWMGTWNGTTRV-AIKTLKPGTMSPEA---FLQEAQVMKKLRHE 322

Query: 84  YIVQFYGALFKE----VTVATVK--ALNYLK--------------------------EEL 111
            +VQ Y  + +E    VT    K   L++LK                          E +
Sbjct: 323 KLVQLYAVVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM 382

Query: 112 KIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTRDAGCRPY--MAPERI 163
             +HRD++ +NIL+      K+ DFG++  + D+    R     P    APE  
Sbjct: 383 NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAA 436

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score = 63.0 bits (154), Expect = 2e-12
 Identities = 30/153 (19%), Positives = 62/153 (40%), Gaps = 43/153 (28%)

Query: 24  EDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQ-------R--QLLMDL- 73
           +  + + ++G G +G V K I   ++  +A+KRIR  ++ +++       R   LL +L 
Sbjct: 34  DRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIR--LEHEEEGVPGTAIREVSLLKELQ 91

Query: 74  --------DVVMKSNECPYIV----------------QFYGALFKEVTVATVKALNYLKE 109
                    V+  ++   +++                     + K      +  +N+   
Sbjct: 92  HRNIIELKSVIHHNHRL-HLIFEYAENDLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHS 150

Query: 110 ELKIIHRDVKPSNILLD-----RRGAIKLCDFG 137
             + +HRD+KP N+LL          +K+ DFG
Sbjct: 151 R-RCLHRDLKPQNLLLSVSDASETPVLKIGDFG 182

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321

 Score = 62.2 bits (152), Expect = 5e-12
 Identities = 26/64 (40%), Positives = 33/64 (51%), Gaps = 6/64 (9%)

Query: 102 KALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAK----TRDAGCRPY 157
           + L+YL     IIHRDVK  NILLD     K+ DFGIS +    + +    T   G   Y
Sbjct: 150 RGLHYLHTR-AIIHRDVKSINILLDENFVPKITDFGIS-KKGTELDQTHLSTVVKGTLGY 207

Query: 158 MAPE 161
           + PE
Sbjct: 208 IDPE 211

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495

 Score = 62.5 bits (152), Expect = 6e-12
 Identities = 36/175 (20%), Positives = 64/175 (36%), Gaps = 38/175 (21%)

Query: 24  EDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECP 83
            D+    ++G G +G V + + +     +AVK ++   D  +  + L +  V MK  + P
Sbjct: 220 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKE--DTMEVEEFLKEAAV-MKEIKHP 276

Query: 84  YIVQFYGALFKEVTVATV-------KALNYLK--------------------------EE 110
            +VQ  G   +E     +         L+YL+                          E+
Sbjct: 277 NLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEK 336

Query: 111 LKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTRDAGCRPY--MAPERI 163
              IHR++   N L+     +K+ DFG+S  +             P    APE +
Sbjct: 337 KNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESL 391

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326

 Score = 61.8 bits (151), Expect = 6e-12
 Identities = 44/182 (24%), Positives = 69/182 (37%), Gaps = 66/182 (36%)

Query: 32  IGRGGFGTVNKMIHR---SSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSN-ECPYIVQ 87
           +GRGGFG V    ++   +  T++AVKR++    +  + Q   +  V M S      +++
Sbjct: 38  LGRGGFGKV----YKGRLADGTLVAVKRLKEERTQGGELQFQTE--VEMISMAVHRNLLR 91

Query: 88  FYG----------------------ALF--------------KEVTVATVKALNYLKEE- 110
             G                       L               + + + + + L YL +  
Sbjct: 92  LRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHC 151

Query: 111 -LKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAK----------TRDAGCRPYMA 159
             KIIHRDVK +NILLD      + DFG        +AK          T   G   ++A
Sbjct: 152 DPKIIHRDVKAANILLDEEFEAVVGDFG--------LAKLMDYKDTHVTTAVRGTIGHIA 203

Query: 160 PE 161
           PE
Sbjct: 204 PE 205

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452

 Score = 62.1 bits (151), Expect = 7e-12
 Identities = 40/174 (22%), Positives = 66/174 (37%), Gaps = 38/174 (21%)

Query: 24  EDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECP 83
           E L+   ++G+G FG V       +  V A+K ++      +     +    VMK     
Sbjct: 184 ESLRLEVKLGQGCFGEVWMGTWNGTTRV-AIKTLKPGTMSPEA---FLQEAQVMKKLRHE 239

Query: 84  YIVQFYGALFKE----VTVATVK--ALNYLK--------------------------EEL 111
            +VQ Y  + +E    VT    K   L++LK                          E +
Sbjct: 240 KLVQLYAVVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM 299

Query: 112 KIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTRDAGCRPY--MAPERI 163
             +HRD++ +NIL+      K+ DFG++  + D+    R     P    APE  
Sbjct: 300 NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAA 353

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325

 Score = 61.5 bits (150), Expect = 8e-12
 Identities = 42/182 (23%), Positives = 66/182 (36%), Gaps = 46/182 (25%)

Query: 24  EDLQDLGEIGRGGFGTVNK---MIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSN 80
             +     IG G  G V      +    D  +A+K +++   E+ +R  L +  + M   
Sbjct: 49  SRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASI-MGQF 107

Query: 81  ECPYIVQFYGALFKE-----VT------------------------------VATVKALN 105
           + P I++  G + +      VT                              V     + 
Sbjct: 108 DHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVG--AGMR 165

Query: 106 YLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSI--AKTRDAGCRPY--MAPE 161
           YL  +L  +HRD+   N+L+D     K+ DFG+S  L D    A T   G  P    APE
Sbjct: 166 YL-SDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPE 224

Query: 162 RI 163
            I
Sbjct: 225 AI 226

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327

 Score = 61.2 bits (149), Expect = 1e-11
 Identities = 40/181 (22%), Positives = 72/181 (39%), Gaps = 45/181 (24%)

Query: 24  EDLQDLGEIGRGGFGTVNK----MIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKS 79
            + + +  +G G FGTV K             +A+K +R     K  +++L +  V M S
Sbjct: 15  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYV-MAS 73

Query: 80  NECPYIVQFYGALFKE----VT------------------------------VATVKALN 105
            + P++ +  G         +T                              +A  K +N
Sbjct: 74  VDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIA--KGMN 131

Query: 106 YLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQL-VDSIAKTRDAGCRP--YMAPER 162
           YL E+ +++HRD+   N+L+     +K+ DFG++  L  +      + G  P  +MA E 
Sbjct: 132 YL-EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALES 190

Query: 163 I 163
           I
Sbjct: 191 I 191

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score = 60.7 bits (148), Expect = 1e-11
 Identities = 47/179 (26%), Positives = 72/179 (40%), Gaps = 40/179 (22%)

Query: 28  DLGE-IGRGGFGTVNKMIHRSSDTVMAVKRI-RSTVDEKDQRQLLMDLDVVMKSNECPYI 85
            LG+ +G G FG V    H+ +   +AVK + R  +   D    +      +K    P+I
Sbjct: 14  VLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHI 73

Query: 86  VQFY------------------GALF---------KEVTVAT-----VKALNYLKEELKI 113
           ++ Y                  G LF         +E+         + A++Y      +
Sbjct: 74  IKLYQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYC-HRHMV 132

Query: 114 IHRDVKPSNILLDRRGAIKLCDFGISGQLVD-SIAKTRDAGCRPYMAPERIDPLRARGY 171
           +HRD+KP N+LLD     K+ DFG+S  + D    +T   G   Y APE I     R Y
Sbjct: 133 VHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTS-CGSPNYAAPEVI---SGRLY 187

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score = 61.1 bits (149), Expect = 1e-11
 Identities = 37/158 (23%), Positives = 61/158 (38%), Gaps = 47/158 (29%)

Query: 24  EDLQDLGEIGRGGFGTVNKMIH-RSSDTVMAVKRIRSTVDEKDQ-------R--QLLMDL 73
           +  + + EIG G +G V K    ++    +A+KR+R  V   ++       R   +L  L
Sbjct: 11  QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVR--VQTGEEGMPLSTIREVAVLRHL 68

Query: 74  ------------DVVMKSNECP----YIV------------------QFYGALFKEVTVA 99
                       DV   S         +V                         K++   
Sbjct: 69  ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQ 128

Query: 100 TVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFG 137
            ++ L++L    +++HRD+KP NIL+   G IKL DFG
Sbjct: 129 LLRGLDFLHSH-RVVHRDLKPQNILVTSSGQIKLADFG 165

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score = 60.8 bits (148), Expect = 1e-11
 Identities = 48/178 (26%), Positives = 71/178 (39%), Gaps = 39/178 (21%)

Query: 28  DLGE-IGRGGFGTVNKMIHRSSDTVMAVKRI-RSTVDEKDQRQLLMDLDVVMKSNECPYI 85
            + E +G G FG V    H  +   +A+K I R  + + D    +      +K    P+I
Sbjct: 12  IIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHI 71

Query: 86  VQFY-----------------GALF---------KEVTVAT-----VKALNYLKEELKII 114
           ++ Y                 G LF          E          + A+ Y     KI+
Sbjct: 72  IKLYDVITTPTDIVMVIEYAGGELFDYIVEKKRMTEDEGRRFFQQIICAIEYC-HRHKIV 130

Query: 115 HRDVKPSNILLDRRGAIKLCDFGISGQLVD-SIAKTRDAGCRPYMAPERIDPLRARGY 171
           HRD+KP N+LLD    +K+ DFG+S  + D +  KT   G   Y APE I     + Y
Sbjct: 131 HRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTS-CGSPNYAAPEVI---NGKLY 184

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281

 Score = 60.3 bits (147), Expect = 2e-11
 Identities = 44/194 (22%), Positives = 77/194 (39%), Gaps = 44/194 (22%)

Query: 9   GKLKLSPDTVYDFTSEDLQDLGEIGRGGFGTVNK---MIHRSSDTVMAVKRIRSTVDEKD 65
           G +  S    Y+   E ++    IG G FG V++   M   +    +A+K  ++   +  
Sbjct: 1   GAMGSSTRD-YEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSV 59

Query: 66  QRQLLMDLDVVMKSNECPYIVQFYGALFKE----VT------------------------ 97
           + + L +    M+  + P+IV+  G + +     +                         
Sbjct: 60  REKFLQEALT-MRQFDHPHIVKLIGVITENPVWIIMELCTLGELRSFLQVRKYSLDLASL 118

Query: 98  ------VATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTRD 151
                 ++   AL YL E  + +HRD+   N+L+     +KL DFG+S  + DS      
Sbjct: 119 ILYAYQLS--TALAYL-ESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKAS 175

Query: 152 AGCRP--YMAPERI 163
            G  P  +MAPE I
Sbjct: 176 KGKLPIKWMAPESI 189

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464

 Score = 60.6 bits (147), Expect = 2e-11
 Identities = 40/181 (22%), Positives = 61/181 (33%), Gaps = 58/181 (32%)

Query: 27  QDLGEIGRGGFGTVNKMIHRSSDTVMAVKRI----RSTVDEKDQRQL------------- 69
           Q+L  IG G  G V        D  +A+K++    ++    K  R               
Sbjct: 65  QNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAK--RAYRELVLMKCVNHKN 122

Query: 70  -------------------------LM--DLDVVMKSNECPYIVQF--YGALFKEVTVAT 100
                                    LM  +L  V++       + +  Y  L        
Sbjct: 123 IISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQML-------- 174

Query: 101 VKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTRDAGCRPYMAP 160
              + +L     IIHRD+KPSNI++     +K+ DFG++     S   T     R Y AP
Sbjct: 175 -CGIKHL-HSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAP 232

Query: 161 E 161
           E
Sbjct: 233 E 233

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281

 Score = 60.3 bits (147), Expect = 2e-11
 Identities = 41/179 (22%), Positives = 71/179 (39%), Gaps = 43/179 (24%)

Query: 24  EDLQDLGEIGRGGFGTVNK---MIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSN 80
           ED+     +G G FG V +     H+     +AVK  +      ++ + + +  + MK+ 
Sbjct: 12  EDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVI-MKNL 70

Query: 81  ECPYIVQFYGALFKE----VT------------------------------VATVKALNY 106
           + P+IV+  G + +E    +                               +   KA+ Y
Sbjct: 71  DHPHIVKLIGIIEEEPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQIC--KAMAY 128

Query: 107 LKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTRDAGCRP--YMAPERI 163
           L E +  +HRD+   NIL+     +KL DFG+S  + D           P  +M+PE I
Sbjct: 129 L-ESINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMSPESI 186

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362

 Score = 60.4 bits (147), Expect = 2e-11
 Identities = 42/192 (21%), Positives = 59/192 (30%), Gaps = 70/192 (36%)

Query: 27  QDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKD-----------QRQL------ 69
                I  G +G V   +      V A+KR+ +TV +             +R L      
Sbjct: 25  TVQRFISSGSYGAVCAGVDSEGIPV-AIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLL 83

Query: 70  -------------------------------LM--DLDVVMKSNECP-------YIVQFY 89
                                          LM  DL  V+             Y +  Y
Sbjct: 84  NHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQVIHDQRIVISPQHIQYFM--Y 141

Query: 90  GALFKEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKT 149
             L           L+ L E   ++HRD+ P NILL     I +CDF ++ +      KT
Sbjct: 142 HIL---------LGLHVLHEA-GVVHRDLHPGNILLADNNDITICDFNLAREDTADANKT 191

Query: 150 RDAGCRPYMAPE 161
                R Y APE
Sbjct: 192 HYVTHRWYRAPE 203

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371

 Score = 60.5 bits (147), Expect = 2e-11
 Identities = 37/179 (20%), Positives = 61/179 (34%), Gaps = 54/179 (30%)

Query: 27  QDLGEIGRGGFGTVNKMIHRSSDTVMAVKRI----------------------------- 57
           Q+L  IG G  G V        +  +A+K++                             
Sbjct: 28  QNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNII 87

Query: 58  ------RSTVDEKDQRQL-----LM--DLDVVMKSNECPYIVQF--YGALFKEVTVATVK 102
                       ++ + +     LM  +L  V++       + +  Y  L          
Sbjct: 88  GLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQML---------C 138

Query: 103 ALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTRDAGCRPYMAPE 161
            + +L     IIHRD+KPSNI++     +K+ DFG++     S   T     R Y APE
Sbjct: 139 GIKHL-HSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPE 196

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656

 Score = 60.6 bits (147), Expect = 2e-11
 Identities = 43/185 (23%), Positives = 76/185 (41%), Gaps = 39/185 (21%)

Query: 16  DTVYDFTSEDLQDLGEIGRGGFGTVNK---MIHRSSDTVMAVKRIRSTVDEKDQRQLLMD 72
              Y+   E ++    IG G FG V++   M   +    +A+K  ++   +  + + L +
Sbjct: 382 TRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQE 441

Query: 73  LDVVMKSNECPYIVQFYGALFKE------------------------VTVATV------- 101
               M+  + P+IV+  G + +                         + +A++       
Sbjct: 442 ALT-MRQFDHPHIVKLIGVITENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQL 500

Query: 102 -KALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTRDAGCRP--YM 158
             AL YL E  + +HRD+   N+L+     +KL DFG+S  + DS       G  P  +M
Sbjct: 501 STALAYL-ESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWM 559

Query: 159 APERI 163
           APE I
Sbjct: 560 APESI 564

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325

 Score = 60.0 bits (146), Expect = 3e-11
 Identities = 37/181 (20%), Positives = 67/181 (37%), Gaps = 45/181 (24%)

Query: 24  EDLQDLGEIGRGGFGTVNK----MIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKS 79
            +L+ L  +G G FGTV+K        S    + +K I      +  + +   +   + S
Sbjct: 13  TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLA-IGS 71

Query: 80  NECPYIVQFYGALFKE----VT------------------------------VATVKALN 105
            +  +IV+  G         VT                              +A  K + 
Sbjct: 72  LDHAHIVRLLGLCPGSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIA--KGMY 129

Query: 106 YLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTRDAGCR---PYMAPER 162
           YL EE  ++HR++   N+LL     +++ DFG++  L     +   +  +    +MA E 
Sbjct: 130 YL-EEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALES 188

Query: 163 I 163
           I
Sbjct: 189 I 189

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294

 Score = 59.6 bits (145), Expect = 3e-11
 Identities = 42/172 (24%), Positives = 75/172 (43%), Gaps = 44/172 (25%)

Query: 29  LGEIGRGGFGTVNKMIHRSSDTVM----AVKRIRS--TVDEKDQRQ---------LLMDL 73
           + ++G GG  TV    + + DT++    A+K I       E+  ++          L   
Sbjct: 16  VDKLGGGGMSTV----YLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQ 71

Query: 74  DVVM-----KSNECPYIVQFY--GALFKEV-----TVATVKALNYLKEELK--------- 112
           ++V      + ++C Y+V  Y  G    E       ++   A+N+  + L          
Sbjct: 72  NIVSMIDVDEEDDCYYLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHDMR 131

Query: 113 IIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTRDA---GCRPYMAPE 161
           I+HRD+KP NIL+D    +K+ DFGI+ + +   + T+     G   Y +PE
Sbjct: 132 IVHRDIKPQNILIDSNKTLKIFDFGIA-KALSETSLTQTNHVLGTVQYFSPE 182

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458

 Score = 59.8 bits (145), Expect = 4e-11
 Identities = 35/150 (23%), Positives = 65/150 (43%), Gaps = 43/150 (28%)

Query: 27  QDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKD--QRQL-------LMD----- 72
           +    IG G +G V +   +    V+A+K+I    ++    +R L        ++     
Sbjct: 56  EIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVV 115

Query: 73  --LDVVMKSNECP----YIVQ-FYGALFKEVTVATVKALNYLKEE------------LK- 112
             LD+V+  +       Y+V     + FK++     +   YL E             +K 
Sbjct: 116 KVLDIVIPKDVEKFDELYVVLEIADSDFKKL----FRTPVYLTELHIKTLLYNLLVGVKY 171

Query: 113 -----IIHRDVKPSNILLDRRGAIKLCDFG 137
                I+HRD+KP+N L+++  ++K+CDFG
Sbjct: 172 VHSAGILHRDLKPANCLVNQDCSVKVCDFG 201

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613

 Score = 59.6 bits (144), Expect = 5e-11
 Identities = 47/171 (27%), Positives = 74/171 (43%), Gaps = 40/171 (23%)

Query: 31  EIGRGGFGTVNKMIHRSSDTVM--AVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQF 88
           E+G G FG+V + ++R     +  A+K ++   ++ D  +++ +  + M   + PYIV+ 
Sbjct: 343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQI-MHQLDNPYIVRL 401

Query: 89  Y-----------------GALFK-------EVTVATV--------KALNYLKEELKIIHR 116
                             G L K       E+ V+ V          + YL EE   +HR
Sbjct: 402 IGVCQAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYL-EEKNFVHR 460

Query: 117 DVKPSNILLDRRGAIKLCDFGISGQLV--DSIAKTRDAGCRPY--MAPERI 163
           ++   N+LL  R   K+ DFG+S  L   DS    R AG  P    APE I
Sbjct: 461 NLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECI 511

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432

 Score = 59.4 bits (144), Expect = 6e-11
 Identities = 40/176 (22%), Positives = 73/176 (41%), Gaps = 48/176 (27%)

Query: 6   QSSGKLKLSPDTVYDFT-SEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRI----RST 60
            SSG+  L    + +    ++      IGRG +G V     ++++  +A+K++       
Sbjct: 7   HSSGRENLYFQGIKNVHVPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDL 66

Query: 61  VDEKDQRQL-------LMD-------LDVVMKSNECP----YIVQ-FYGALFKEVTVATV 101
           +D K  R L        +         D+++  +       YIV     +  K++     
Sbjct: 67  IDCK--RILREITILNRLKSDYIIRLYDLIIPDDLLKFDELYIVLEIADSDLKKL----F 120

Query: 102 KALNYLKEE------------LK------IIHRDVKPSNILLDRRGAIKLCDFGIS 139
           K   +L EE                    IIHRD+KP+N LL++  ++K+CDFG++
Sbjct: 121 KTPIFLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLLNQDCSVKVCDFGLA 176

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267

 Score = 58.8 bits (143), Expect = 6e-11
 Identities = 45/178 (25%), Positives = 70/178 (39%), Gaps = 46/178 (25%)

Query: 24  EDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIR-STVDEKDQRQLLMDLDVVMKSNEC 82
            +L  + EIG G FG V+     + D V A+K IR   + E+D    + + +V M     
Sbjct: 8   SELTFVQEIGSGQFGLVHLGYWLNKDKV-AIKTIREGAMSEED---FIEEAEV-MMKLSH 62

Query: 83  PYIVQFYGALFKE-----VT------------------------------VATVKALNYL 107
           P +VQ YG   ++     VT                              V   + + YL
Sbjct: 63  PKLVQLYGVCLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVC--EGMAYL 120

Query: 108 KEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTRDAGCRPY--MAPERI 163
            EE  +IHRD+   N L+     IK+ DFG++  ++D    +      P    +PE  
Sbjct: 121 -EEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVF 177

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429

 Score = 59.0 bits (143), Expect = 8e-11
 Identities = 40/178 (22%), Positives = 68/178 (38%), Gaps = 51/178 (28%)

Query: 29  LGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECP----- 83
           L  IG+G FG V K         +A+K +R+  +++  RQ   ++ ++    +       
Sbjct: 102 LKVIGKGSFGQVVKAYDHKVHQHVALKMVRN--EKRFHRQAAEEIRILEHLRKQDKDNTM 159

Query: 84  YIVQFYG---------------------------------ALFKEVTVATVKALNYLKEE 110
            ++                                      L ++   + ++ L+ L + 
Sbjct: 160 NVIHMLENFTFRNHICMTFELLSMNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHK- 218

Query: 111 LKIIHRDVKPSNILL--DRRGAIKLCDFG---ISGQLVDSIAKTRDAGCRPYMAPERI 163
            +IIH D+KP NILL    R  IK+ DFG      Q V +  ++R      Y APE I
Sbjct: 219 NRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQRVYTYIQSRF-----YRAPEVI 271

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318

 Score = 58.5 bits (142), Expect = 8e-11
 Identities = 37/206 (17%), Positives = 78/206 (37%), Gaps = 50/206 (24%)

Query: 4   SIQSSGKLKLSPDTVYD---FTSEDLQDLGEIGRGGFGTVNK----MIHRSSDTVMAVKR 56
                G L++      D   F    L+ + ++G G FG V+       +  +  ++AVK 
Sbjct: 8   HHHHHGALEVLFQGPGDPTVFHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKA 67

Query: 57  IRSTVDEKDQRQLLMDLDVVMKSNECPYIVQFYGALFKE-------VT------------ 97
           +++    + +     ++D+ +++    +I+++ G            V             
Sbjct: 68  LKADAGPQHRSGWKQEIDI-LRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYL 126

Query: 98  ----------------VATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQ 141
                           +   + + YL      IHRD+   N+LLD    +K+ DFG++  
Sbjct: 127 PRHSIGLAQLLLFAQQIC--EGMAYL-HAQHYIHRDLAARNVLLDNDRLVKIGDFGLAKA 183

Query: 142 LVDS--IAKTRDAGCRP--YMAPERI 163
           + +     + R+ G  P  + APE +
Sbjct: 184 VPEGHEYYRVREDGDSPVFWYAPECL 209

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score = 59.0 bits (143), Expect = 8e-11
 Identities = 46/179 (25%), Positives = 68/179 (37%), Gaps = 40/179 (22%)

Query: 28  DLGE-IGRGGFGTVNKMIHRSSDTVMAVKRI-RSTVDEKDQRQLLMDLDVVMKSNECPYI 85
            LG+ +G G FG V    H  +   +AVK + R  +   D    +      +K    P+I
Sbjct: 19  ILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHI 78

Query: 86  VQFY------------------GALF---------KEVTVAT-----VKALNYLKEELKI 113
           ++ Y                  G LF          E          +  ++Y      +
Sbjct: 79  IKLYQVISTPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYC-HRHMV 137

Query: 114 IHRDVKPSNILLDRRGAIKLCDFGISGQLVD-SIAKTRDAGCRPYMAPERIDPLRARGY 171
           +HRD+KP N+LLD     K+ DFG+S  + D    +T   G   Y APE I     R Y
Sbjct: 138 VHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTS-CGSPNYAAPEVI---SGRLY 192

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291

 Score = 58.4 bits (142), Expect = 8e-11
 Identities = 45/170 (26%), Positives = 70/170 (41%), Gaps = 38/170 (22%)

Query: 31  EIGRGGFGTVNKMIHRSSDTVM--AVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQF 88
           E+G G FGTV K  ++    V   AVK +++  ++   +  L+    VM+  + PYIV+ 
Sbjct: 24  ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 83

Query: 89  Y-----------------GALF------KEVTVATV--------KALNYLKEELKIIHRD 117
                             G L       + V    +          + YL EE   +HRD
Sbjct: 84  IGICEAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYL-EESNFVHRD 142

Query: 118 VKPSNILLDRRGAIKLCDFGISGQLV--DSIAKTRDAGCRPY--MAPERI 163
           +   N+LL  +   K+ DFG+S  L   ++  K +  G  P    APE I
Sbjct: 143 LAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECI 192

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333

 Score = 58.5 bits (142), Expect = 8e-11
 Identities = 38/181 (20%), Positives = 61/181 (33%), Gaps = 43/181 (23%)

Query: 24  EDLQDLGEIGRGGFGTVNK----MIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKS 79
             +     IG G FG V K          +  +A+K +++   EK +   L +  + M  
Sbjct: 44  SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGI-MGQ 102

Query: 80  NECPYIVQFYGALFKEVTVATV---------------------------------KALNY 106
                I++  G + K   +  +                                   + Y
Sbjct: 103 FSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKY 162

Query: 107 LKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVD--SIAKTRDAGCRPY--MAPER 162
           L   +  +HRD+   NIL++     K+ DFG+S  L D      T   G  P    APE 
Sbjct: 163 L-ANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEA 221

Query: 163 I 163
           I
Sbjct: 222 I 222

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353

 Score = 58.8 bits (143), Expect = 8e-11
 Identities = 42/191 (21%), Positives = 67/191 (35%), Gaps = 68/191 (35%)

Query: 27  QDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKD-QRQL---------------- 69
           Q    +G G +G V    H+ +  ++A+K+I          R L                
Sbjct: 14  QLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIIT 73

Query: 70  ---------------------LM--DLDVVMKSNE-----CPYIVQFYGALFKEVTVATV 101
                                LM  DL  V+ +         Y +  Y  L         
Sbjct: 74  IFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQYFI--YQTL--------- 122

Query: 102 KALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTRDAGC------- 154
           +A+  L     +IHRD+KPSN+L++    +K+CDFG++  + +S A   +          
Sbjct: 123 RAVKVLHGS-NVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVE 181

Query: 155 ----RPYMAPE 161
               R Y APE
Sbjct: 182 FVATRWYRAPE 192

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307

 Score = 58.3 bits (142), Expect = 8e-11
 Identities = 25/63 (39%), Positives = 34/63 (53%), Gaps = 4/63 (6%)

Query: 102 KALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFG---ISGQLVDSIAKTRDAGCRPYM 158
             +N+L E    IHRD+K +NILLD     K+ DFG    S +   ++  +R  G   YM
Sbjct: 144 NGINFLHEN-HHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYM 202

Query: 159 APE 161
           APE
Sbjct: 203 APE 205

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268

 Score = 58.0 bits (141), Expect = 1e-10
 Identities = 44/174 (25%), Positives = 66/174 (37%), Gaps = 38/174 (21%)

Query: 24  EDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECP 83
           E++  L E+G G FG V     +    V AVK I+       + +   +    M     P
Sbjct: 8   EEITLLKELGSGQFGVVKLGKWKGQYDV-AVKMIKE--GSMSEDEFFQEAQT-MMKLSHP 63

Query: 84  YIVQFYGALFKEVTVATV-------KALNYLK-------------------------EEL 111
            +V+FYG   KE  +  V         LNYL+                         E  
Sbjct: 64  KLVKFYGVCSKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESH 123

Query: 112 KIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTRDAGCRPY--MAPERI 163
           + IHRD+   N L+DR   +K+ DFG++  ++D    +      P    APE  
Sbjct: 124 QFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVGTKFPVKWSAPEVF 177

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353

 Score = 58.1 bits (141), Expect = 1e-10
 Identities = 34/179 (18%), Positives = 59/179 (32%), Gaps = 56/179 (31%)

Query: 27  QDLGEIGRGGFGTVNKMIHRSSDTVMAVKRI----------------------------- 57
                +G G +G+V   I + S   +A+K++                             
Sbjct: 27  VSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVI 86

Query: 58  ------RSTVDEKDQRQL-----LM--DLDVVMKSNECPYIVQF--YGALFKEVTVATVK 102
                       ++          M  DL  +M        +Q+  Y  L         K
Sbjct: 87  GLLDVFTPASSLRNFYDFYLVMPFMQTDLQKIMGLKFSEEKIQYLVYQML---------K 137

Query: 103 ALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTRDAGCRPYMAPE 161
            L Y+     ++HRD+KP N+ ++    +K+ DFG++      +  T     R Y APE
Sbjct: 138 GLKYIHSA-GVVHRDLKPGNLAVNEDCELKILDFGLARHADAEM--TGYVVTRWYRAPE 193

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373

 Score = 58.2 bits (141), Expect = 1e-10
 Identities = 33/191 (17%), Positives = 67/191 (35%), Gaps = 63/191 (32%)

Query: 29  LGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNE------- 81
           + ++G G F TV       ++T +A+K +R   D+        ++ ++ + N+       
Sbjct: 24  VRKLGWGHFSTVWLAKDMVNNTHVAMKIVRG--DKVYTEAAEDEIKLLQRVNDADNTKED 81

Query: 82  ---CPYIVQFYGA-----------------------------LFKEVTVATVK------- 102
                +I++                                   + + +  VK       
Sbjct: 82  SMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLL 141

Query: 103 -ALNYLKEELKIIHRDVKPSNILLDR------RGAIKLCDFGIS---GQLVDSIAKTRDA 152
             L+Y+     IIH D+KP N+L++          IK+ D G +    +   +  +T   
Sbjct: 142 LGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQT--- 198

Query: 153 GCRPYMAPERI 163
             R Y +PE +
Sbjct: 199 --REYRSPEVL 207

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388

 Score = 58.2 bits (141), Expect = 1e-10
 Identities = 39/157 (24%), Positives = 64/157 (40%), Gaps = 60/157 (38%)

Query: 27  QDLGEIGRGGFGTVNKMIHRSSDTVMAVKRI----RSTVDEKDQRQL------------- 69
           + + ++G+G +G V K I R +  V+AVK+I    +++ D +  R               
Sbjct: 12  ELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQ--RTFREIMILTELSGHE 69

Query: 70  ----------------------LM--DLDVVMKSNE-----CPYIVQFYGALFKEVTVAT 100
                                  M  DL  V+++N        Y+V  Y  +        
Sbjct: 70  NIVNLLNVLRADNDRDVYLVFDYMETDLHAVIRANILEPVHKQYVV--YQLI-------- 119

Query: 101 VKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFG 137
            K + YL     ++HRD+KPSNILL+    +K+ DFG
Sbjct: 120 -KVIKYLHSG-GLLHRDMKPSNILLNAECHVKVADFG 154

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364

 Score = 58.1 bits (141), Expect = 2e-10
 Identities = 42/184 (22%), Positives = 63/184 (34%), Gaps = 61/184 (33%)

Query: 27  QDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKD-QRQL---------------- 69
            +L  IG G +G V       +   +A+K+I     +   QR L                
Sbjct: 30  TNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIG 89

Query: 70  ---------------------LM--DLDVVMKSNE-----CPYIVQFYGALFKEVTVATV 101
                                LM  DL  ++K+         Y +  Y  L         
Sbjct: 90  INDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFL--YQIL--------- 138

Query: 102 KALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFG----ISGQLVDSIAKTRDAGCRPY 157
           + L Y+     ++HRD+KPSN+LL+    +K+CDFG           +   T     R Y
Sbjct: 139 RGLKYIHSA-NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWY 197

Query: 158 MAPE 161
            APE
Sbjct: 198 RAPE 201

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302

 Score = 57.3 bits (139), Expect = 2e-10
 Identities = 31/188 (16%), Positives = 69/188 (36%), Gaps = 49/188 (26%)

Query: 21  FTSEDLQDLGEIGRGGFGTVNK----MIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVV 76
           F    L+ + ++G G FG V          ++   +AVK ++          L  ++++ 
Sbjct: 18  FEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEI- 76

Query: 77  MKSNECPYIVQFYGALFKE-------VT------------------------------VA 99
           +++     IV++ G   ++       +                               + 
Sbjct: 77  LRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQIC 136

Query: 100 TVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVD--SIAKTRDAGCRP- 156
             K ++YL    + +HRD+   N+L++    +K+ DFG++  +         +D    P 
Sbjct: 137 --KGMDYL-GSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPV 193

Query: 157 -YMAPERI 163
            + APE +
Sbjct: 194 FWYAPECL 201

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279

 Score = 57.2 bits (139), Expect = 2e-10
 Identities = 40/174 (22%), Positives = 70/174 (40%), Gaps = 38/174 (21%)

Query: 24  EDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECP 83
           E L+ +  +G G FG V    +     V AVK ++           L + ++ MK  +  
Sbjct: 13  ETLKLVERLGAGQFGEVWMGYYNGHTKV-AVKSLKQ--GSMSPDAFLAEANL-MKQLQHQ 68

Query: 84  YIVQFYGALFKE----VT--VATVKALNYLK--------------------------EEL 111
            +V+ Y  + +E    +T  +     +++LK                          EE 
Sbjct: 69  RLVRLYAVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER 128

Query: 112 KIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTRDAGCRPY--MAPERI 163
             IHRD++ +NIL+    + K+ DFG++  + D+    R+    P    APE I
Sbjct: 129 NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAI 182

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405

 Score = 57.5 bits (139), Expect = 2e-10
 Identities = 32/150 (21%), Positives = 57/150 (38%), Gaps = 45/150 (30%)

Query: 32  IGRGGFGTVNKMIHRSSDT--VMAVKRIRST-VDEKDQRQ--LLMDL---------DVVM 77
           +GRG +G V K   +        A+K+I  T +     R+  LL +L          V +
Sbjct: 29  VGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVFL 88

Query: 78  -KSNECPYIV-----------------QFYGALFKEVTVATVK--------ALNYLKEEL 111
             ++   +++                         ++    VK         ++YL    
Sbjct: 89  SHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN- 147

Query: 112 KIIHRDVKPSNILL----DRRGAIKLCDFG 137
            ++HRD+KP+NIL+      RG +K+ D G
Sbjct: 148 WVLHRDLKPANILVMGEGPERGRVKIADMG 177

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373

 Score = 57.4 bits (139), Expect = 2e-10
 Identities = 39/180 (21%), Positives = 65/180 (36%), Gaps = 42/180 (23%)

Query: 24  EDLQDLGEIGRGGFGTVNK---MIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSN 80
            ++     +G G FG V      +    +  +A+K ++    EK +R  L +  + M   
Sbjct: 45  TNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASI-MGQF 103

Query: 81  ECPYIVQFYGALFKEVTVATV---------------------------------KALNYL 107
           + P I++  G + K   V  V                                   + YL
Sbjct: 104 DHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYL 163

Query: 108 KEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSI--AKTRDAGCRPY--MAPERI 163
             ++  +HRD+   NIL++     K+ DFG+   L D    A T   G  P    +PE I
Sbjct: 164 -SDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAI 222

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291

 Score = 57.3 bits (139), Expect = 2e-10
 Identities = 40/182 (21%), Positives = 69/182 (37%), Gaps = 45/182 (24%)

Query: 24  EDLQDLGEIGRGGFGTVNK---MIHRSSDTVMAVKRIRS-TVDEKDQRQLLMDLDVVMKS 79
           +DL+ L ++G G FG V +            +AVK ++   + + +     +     M S
Sbjct: 18  KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 77

Query: 80  NECPYIVQFYGALFKE----VT------------------------------VATVKALN 105
            +   +++ YG +       VT                              VA  + + 
Sbjct: 78  LDHRNLIRLYGVVLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVA--EGMG 135

Query: 106 YLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLV--DSIAKTRDAGCRPY--MAPE 161
           YL E  + IHRD+   N+LL  R  +K+ DFG+   L   D     ++    P+   APE
Sbjct: 136 YL-ESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPE 194

Query: 162 RI 163
            +
Sbjct: 195 SL 196

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283

 Score = 56.8 bits (138), Expect = 2e-10
 Identities = 43/174 (24%), Positives = 70/174 (40%), Gaps = 38/174 (21%)

Query: 24  EDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECP 83
           +DL  L E+G G FG V     R    V A+K I+       + + + +  V M +    
Sbjct: 24  KDLTFLKELGTGQFGVVKYGKWRGQYDV-AIKMIKE--GSMSEDEFIEEAKV-MMNLSHE 79

Query: 84  YIVQFYGALFKE-----VT--VATVKALNYLK-------------------------EEL 111
            +VQ YG   K+     +T  +A    LNYL+                         E  
Sbjct: 80  KLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESK 139

Query: 112 KIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTRDAGCRPY--MAPERI 163
           + +HRD+   N L++ +G +K+ DFG+S  ++D    +      P     PE +
Sbjct: 140 QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVL 193

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320

 Score = 57.3 bits (139), Expect = 2e-10
 Identities = 34/183 (18%), Positives = 57/183 (31%), Gaps = 50/183 (27%)

Query: 27  QDLGEIGRGGFGTVNKMIHRSSDTVMAVKRI--RSTVDEKDQRQL-------LMD----- 72
            DL  +G GG G V   +    D  +A+K+I        K    L        +D     
Sbjct: 14  MDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVK--HALREIKIIRRLDHDNIV 71

Query: 73  --LDVVMKSNECPYIVQFYGALFKEVTVAT---------VKALNYLKEE----------- 110
              +++  S                V +           V     L EE           
Sbjct: 72  KVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQGPLLEEHARLFMYQLLR 131

Query: 111 -LK------IIHRDVKPSNILLDRRG-AIKLCDFG----ISGQLVDSIAKTRDAGCRPYM 158
            LK      ++HRD+KP+N+ ++     +K+ DFG    +          +     + Y 
Sbjct: 132 GLKYIHSANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYR 191

Query: 159 APE 161
           +P 
Sbjct: 192 SPR 194

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382

 Score = 57.0 bits (138), Expect = 3e-10
 Identities = 47/181 (25%), Positives = 73/181 (40%), Gaps = 51/181 (28%)

Query: 27  QDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNE----- 81
           +    IG+G FG V K   R     +A+K I++   +    Q  +++ ++   N+     
Sbjct: 57  EIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKN--KKAFLNQAQIEVRLLELMNKHDTEM 114

Query: 82  CPYIVQFYGAL-------------------------FKEVTVATVK--------ALNYLK 108
             YIV                               F+ V++   +        AL +L 
Sbjct: 115 KYYIVHLKRHFMFRNHLCLVFEMLSYNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLA 174

Query: 109 -EELKIIHRDVKPSNILL--DRRGAIKLCDFGIS---GQLVDSIAKTRDAGCRPYMAPER 162
             EL IIH D+KP NILL   +R AIK+ DFG S   GQ +    ++R      Y +PE 
Sbjct: 175 TPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQYIQSRF-----YRSPEV 229

Query: 163 I 163
           +
Sbjct: 230 L 230

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313

 Score = 56.5 bits (137), Expect = 4e-10
 Identities = 42/211 (19%), Positives = 68/211 (32%), Gaps = 61/211 (28%)

Query: 12  KLSPDTVYDFTSEDLQDLGEIGRGGFGTV-----NKMIHRSSDTVMAVKRIRSTVDEKDQ 66
           +L  D  ++F    L     +G G FG V       +I   +   +AVK ++ +    ++
Sbjct: 11  QLPYDHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTER 70

Query: 67  RQLLMDLDVVMKSNEC-PYIVQFYGA---------------------------------- 91
             L+ +L V +        IV   GA                                  
Sbjct: 71  EALMSELKV-LSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSK 129

Query: 92  -----LFKEVTVATVKAL-----------NYLKEELKIIHRDVKPSNILLDRRGAIKLCD 135
                +  +     ++ L            +L      IHRD+   NILL      K+CD
Sbjct: 130 TSPAIMEDDELALDLEDLLSFSYQVAKGMAFL-ASKNCIHRDLAARNILLTHGRITKICD 188

Query: 136 FGISGQLVDSIAKTRDAGCR-PY--MAPERI 163
           FG++  + +          R P   MAPE I
Sbjct: 189 FGLARDIKNDSNYVVKGNARLPVKWMAPESI 219

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298

 Score = 56.1 bits (136), Expect = 5e-10
 Identities = 40/191 (20%), Positives = 65/191 (34%), Gaps = 44/191 (23%)

Query: 15  PDTVYDFTSEDLQDLGEIGRGGFGTVNK---MIHRSSDTVMAVKRIRSTVDEKDQRQLLM 71
              V   +S  +     IGRG FG V     + +       AVK +    D  +  Q L 
Sbjct: 16  QHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLT 75

Query: 72  DLDVVMKSNECPYIVQFYGALFK--------------------------EVTVATV---- 101
           +  + MK    P ++   G   +                            TV  +    
Sbjct: 76  EGII-MKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFG 134

Query: 102 ----KALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDS---IAKTRDAGC 154
               K + YL    K +HRD+   N +LD +  +K+ DFG++  + D        +    
Sbjct: 135 LQVAKGMKYL-ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAK 193

Query: 155 RP--YMAPERI 163
            P  +MA E +
Sbjct: 194 LPVKWMALESL 204

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287

 Score = 56.1 bits (136), Expect = 5e-10
 Identities = 48/171 (28%), Positives = 72/171 (42%), Gaps = 40/171 (23%)

Query: 31  EIGRGGFGTVNK--MIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQF 88
           E+G G FG+V +     R     +A+K ++   ++ D  +++ +  + M   + PYIV+ 
Sbjct: 17  ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQI-MHQLDNPYIVRL 75

Query: 89  Y-----------------GALFK-------EVTVATV--------KALNYLKEELKIIHR 116
                             G L K       E+ V+ V          + YL EE   +HR
Sbjct: 76  IGVCQAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYL-EEKNFVHR 134

Query: 117 DVKPSNILLDRRGAIKLCDFGISGQLV--DSIAKTRDAGCRPY--MAPERI 163
           D+   N+LL  R   K+ DFG+S  L   DS    R AG  P    APE I
Sbjct: 135 DLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECI 185

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373

 Score = 56.3 bits (136), Expect = 6e-10
 Identities = 39/195 (20%), Positives = 67/195 (34%), Gaps = 44/195 (22%)

Query: 11  LKLSPDTVYDFTSEDLQDLGEIGRGGFGTVNK---MIHRSSDTVMAVKRIRSTVDEKDQR 67
           ++     V   +S  +     IGRG FG V     + +       AVK +    D  +  
Sbjct: 76  VQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVS 135

Query: 68  QLLMDLDVVMKSNECPYIVQFYGALFK--------------------------EVTVATV 101
           Q L +  + MK    P ++   G   +                            TV  +
Sbjct: 136 QFLTEGII-MKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDL 194

Query: 102 --------KALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDS---IAKTR 150
                   K + +L    K +HRD+   N +LD +  +K+ DFG++  + D        +
Sbjct: 195 IGFGLQVAKGMKFL-ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNK 253

Query: 151 DAGCRP--YMAPERI 163
                P  +MA E +
Sbjct: 254 TGAKLPVKWMALESL 268

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311

 Score = 56.1 bits (136), Expect = 6e-10
 Identities = 24/53 (45%), Positives = 34/53 (64%), Gaps = 4/53 (7%)

Query: 113 IIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAK-TRDA---GCRPYMAPE 161
           IIHRDVKP+NI++    A+K+ DFGI+  + DS    T+ A   G   Y++PE
Sbjct: 137 IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPE 189

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383

 Score = 56.3 bits (136), Expect = 6e-10
 Identities = 26/71 (36%), Positives = 40/71 (56%), Gaps = 4/71 (5%)

Query: 102 KALNYLKEELKIIHRDVKPSNILLDRR-GAIKLCDFGISGQLVDSIAKTRDAGCRPYMAP 160
           +A+ ++   L I HRD+KP N+L++ +   +KLCDFG + +L+ S         R Y AP
Sbjct: 152 RAVGFIHS-LGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPSVAYICSRFYRAP 210

Query: 161 ERIDPLRARGY 171
           E +  L A  Y
Sbjct: 211 ELM--LGATEY 219

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288

 Score = 55.7 bits (135), Expect = 7e-10
 Identities = 38/178 (21%), Positives = 66/178 (37%), Gaps = 44/178 (24%)

Query: 24  EDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECP 83
            D+    ++G G +G V + + +     +AVK ++   D  +  + L +  V MK  + P
Sbjct: 13  TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKE--DTMEVEEFLKEAAV-MKEIKHP 69

Query: 84  YIVQFYGALFKE-----VT-------------------------------VATVKALNYL 107
            +VQ  G   +E     +T                               ++   A+ YL
Sbjct: 70  NLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQIS--SAMEYL 127

Query: 108 KEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTRDAGCRPY--MAPERI 163
            E+   IHRD+   N L+     +K+ DFG+S  +             P    APE +
Sbjct: 128 -EKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESL 184

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score = 55.7 bits (135), Expect = 7e-10
 Identities = 28/175 (16%), Positives = 59/175 (33%), Gaps = 51/175 (29%)

Query: 32  IGRGGFGTVNKMIHRSSDTVMAVK-----RIRST--VDEKDQRQLLMDLDVVMKSNECPY 84
           +G G +G V +++   +    AVK     ++R     +   ++++      +++      
Sbjct: 13  LGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEI-----QLLRRLRHKN 67

Query: 85  IVQFYGALFKE-----------VTVATVKALNY-----LKEE------------------ 110
           ++Q    L+ E                 + L+                            
Sbjct: 68  VIQLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHS 127

Query: 111 LKIIHRDVKPSNILLDRRGAIKLCDFGIS----GQLVDSIAKTRDAGCRPYMAPE 161
             I+H+D+KP N+LL   G +K+   G++        D   +T   G   +  PE
Sbjct: 128 QGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTS-QGSPAFQPPE 181

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298

 Score = 55.7 bits (135), Expect = 8e-10
 Identities = 34/183 (18%), Positives = 60/183 (32%), Gaps = 44/183 (24%)

Query: 23  SEDLQDLGEIGRGGFGTVNK---MIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKS 79
                    IG+G FG V     +    +    A+K +    + +     L +  + M+ 
Sbjct: 20  RVVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLL-MRG 78

Query: 80  NECPYIVQFYGALFKEVTVA-----------------------TVKAL-----------N 105
              P ++   G +     +                        TVK L            
Sbjct: 79  LNHPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGME 138

Query: 106 YLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDS---IAKTRDAGCRP--YMAP 160
           YL  E K +HRD+   N +LD    +K+ DFG++  ++D      +       P  + A 
Sbjct: 139 YL-AEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTAL 197

Query: 161 ERI 163
           E +
Sbjct: 198 ESL 200

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322

 Score = 55.4 bits (134), Expect = 1e-09
 Identities = 28/163 (17%), Positives = 59/163 (36%), Gaps = 49/163 (30%)

Query: 24  EDLQDLGEIGRGGFGTV-----NKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMK 78
           E +    E+G+G FG V       ++    +T +A+K +      +++ + L +  V MK
Sbjct: 25  EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASV-MK 83

Query: 79  SNECPYIVQFYGALFKE-------------------------------VTVATVKAL--- 104
              C ++V+  G + +                                +   ++  +   
Sbjct: 84  EFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQM 143

Query: 105 --------NYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGIS 139
                    YL    K +HRD+   N ++     +K+ DFG++
Sbjct: 144 AGEIADGMAYL-NANKFVHRDLAARNCMVAEDFTVKIGDFGMT 185

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367

 Score = 55.4 bits (134), Expect = 1e-09
 Identities = 38/182 (20%), Positives = 67/182 (36%), Gaps = 61/182 (33%)

Query: 27  QDLGEIGRGGFGTVNKMIHRSSDTVMAVKRI----------------------------- 57
           Q+L  +G G +G+V       +   +AVK++                             
Sbjct: 32  QNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVI 91

Query: 58  ------RSTVDEKDQRQL-----LM--DLDVVMKSNE-----CPYIVQFYGALFKEVTVA 99
                       ++   +     LM  DL+ ++K  +       +++  Y  L       
Sbjct: 92  GLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI--YQIL------- 142

Query: 100 TVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTRDAGCRPYMA 159
             + L Y+     IIHRD+KPSN+ ++    +K+ DFG++    D +  T     R Y A
Sbjct: 143 --RGLKYIHSA-DIIHRDLKPSNLAVNEDCELKILDFGLARHTADEM--TGYVATRWYRA 197

Query: 160 PE 161
           PE
Sbjct: 198 PE 199

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367

 Score = 55.4 bits (134), Expect = 1e-09
 Identities = 42/195 (21%), Positives = 69/195 (35%), Gaps = 66/195 (33%)

Query: 16  DTVYDFTSEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRI----RSTVDEKDQRQL-- 69
            T ++      +DL  +G G +G V   +   +   +A+K++    +S +  K  R    
Sbjct: 18  KTAWE-VRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAK--RAYRE 74

Query: 70  ------------------------------------LM--DLDVVMKSNE-----CPYIV 86
                                                M  DL  +MK  +       ++V
Sbjct: 75  LRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLV 134

Query: 87  QFYGALFKEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSI 146
             Y  L         K L Y+     IIHRD+KP N+ ++    +K+ DFG++ Q    +
Sbjct: 135 --YQML---------KGLRYIHAA-GIIHRDLKPGNLAVNEDCELKILDFGLARQADSEM 182

Query: 147 AKTRDAGCRPYMAPE 161
             T     R Y APE
Sbjct: 183 --TGYVVTRWYRAPE 195

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326

 Score = 54.7 bits (132), Expect = 2e-09
 Identities = 41/203 (20%), Positives = 80/203 (39%), Gaps = 50/203 (24%)

Query: 6   QSSGKLKLSPDTVYDFTSEDLQDLGEIGRGGFGTVNK----MIHRSSDTVMAVKRIRSTV 61
           Q +            F    L+ L ++G+G FG+V       +  ++  V+AVK+++ + 
Sbjct: 23  QGAMGSAFEDRDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST 82

Query: 62  DEKDQRQLLMDLDVVMKSNECPYIVQFYGALFKE-------VT----------------- 97
            E+  R    ++++ +KS +   IV++ G  +         +                  
Sbjct: 83  -EEHLRDFEREIEI-LKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKE 140

Query: 98  -------------VATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVD 144
                        +   K + YL    + IHRD+   NIL++    +K+ DFG++  L  
Sbjct: 141 RIDHIKLLQYTSQIC--KGMEYL-GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQ 197

Query: 145 S--IAKTRDAGCRP--YMAPERI 163
                K ++ G  P  + APE +
Sbjct: 198 DKEYYKVKEPGESPIFWYAPESL 220

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score = 54.8 bits (132), Expect = 2e-09
 Identities = 25/68 (36%), Positives = 31/68 (45%), Gaps = 8/68 (11%)

Query: 101 VKALNYLKEELKIIHRDVKPSNILLDRRG--AIKLCDFGIS-----GQLVDSIAKTRDAG 153
             AL+YL     I HRD+KP N L        IKL DFG+S         +    T  AG
Sbjct: 178 FSALHYLHN-QGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAG 236

Query: 154 CRPYMAPE 161
              ++APE
Sbjct: 237 TPYFVAPE 244

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score = 41.7 bits (98), Expect = 5e-05
 Identities = 15/66 (22%), Positives = 29/66 (43%), Gaps = 5/66 (7%)

Query: 31 EIGRGGFGTVNKMIHRSSDTVMAVKRIR----STVDEKDQRQLLMDLDVVMKSNECPYIV 86
           IG+G +G V   I   +  + A+K +       ++ KD  ++  ++  +MK    P I 
Sbjct: 33 AIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVR-LMKKLHHPNIA 91

Query: 87 QFYGAL 92
          + Y   
Sbjct: 92 RLYEVY 97

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367

 Score = 53.6 bits (129), Expect = 4e-09
 Identities = 34/163 (20%), Positives = 56/163 (34%), Gaps = 49/163 (30%)

Query: 24  EDLQDLGEIGRGGFGTV-----NKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMK 78
           +++  +  +G G FG V     + M +  S   +AVK +     E+D+   LM+  + + 
Sbjct: 71  KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALI-IS 129

Query: 79  SNECPYIVQFYGALFKE-----VT-----------------------VATVKAL------ 104
                 IV+  G   +      +                           +  L      
Sbjct: 130 KFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARD 189

Query: 105 -----NYLKEELKIIHRDVKPSNILLDRRG---AIKLCDFGIS 139
                 YL EE   IHRD+   N LL   G     K+ DFG++
Sbjct: 190 IACGCQYL-EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMA 231

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278

 Score = 53.4 bits (129), Expect = 5e-09
 Identities = 44/177 (24%), Positives = 69/177 (38%), Gaps = 52/177 (29%)

Query: 24  EDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECP 83
           ++L+ L  IG+G FG V    +R +  V AVK I++    +     L +  V M      
Sbjct: 21  KELKLLQTIGKGEFGDVMLGDYRGN-KV-AVKCIKNDATAQA---FLAEASV-MTQLRHS 74

Query: 84  YIVQFYGALFKE------VT-------------------------------VATVKALNY 106
            +VQ  G + +E      VT                               V   +A+ Y
Sbjct: 75  NLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVC--EAMEY 132

Query: 107 LKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTRDAGCRPY--MAPE 161
           L E    +HRD+   N+L+      K+ DFG++ +     + T+D G  P    APE
Sbjct: 133 L-EGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKE----ASSTQDTGKLPVKWTAPE 184

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327

 Score = 52.7 bits (127), Expect = 9e-09
 Identities = 32/162 (19%), Positives = 57/162 (35%), Gaps = 47/162 (29%)

Query: 24  EDLQDLGEIGRGGFGTV-----NKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMK 78
           +++  +  +G G FG V     + M +  S   +AVK +     E+D+   LM+  + + 
Sbjct: 30  KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALI-IS 88

Query: 79  SNECPYIVQFYGALFKEVTVATV-------KALNYLK----------------------- 108
                 IV+  G   + +    +          ++L+                       
Sbjct: 89  KFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARD 148

Query: 109 --------EELKIIHRDVKPSNILLDRRGA---IKLCDFGIS 139
                   EE   IHRD+   N LL   G     K+ DFG++
Sbjct: 149 IACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMA 190

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295

 Score = 52.3 bits (126), Expect = 1e-08
 Identities = 40/188 (21%), Positives = 78/188 (41%), Gaps = 50/188 (26%)

Query: 21  FTSEDLQDLGEIGRGGFGTVNK----MIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVV 76
           F    L+ L ++G+G FG+V       +  ++  V+AVK+++ + +E   R    ++++ 
Sbjct: 7   FEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEE-HLRDFEREIEI- 64

Query: 77  MKSNECPYIVQFYGALFKE-------VT------------------------------VA 99
           +KS +   IV++ G  +         +                               + 
Sbjct: 65  LKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQIC 124

Query: 100 TVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDS--IAKTRDAGCRP- 156
             K + YL    + IHRD+   NIL++    +K+ DFG++  L       K ++ G  P 
Sbjct: 125 --KGMEYL-GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPI 181

Query: 157 -YMAPERI 163
            + APE +
Sbjct: 182 FWYAPESL 189

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323

 Score = 52.3 bits (126), Expect = 1e-08
 Identities = 35/211 (16%), Positives = 67/211 (31%), Gaps = 52/211 (24%)

Query: 1   MCQSIQSSGKLKLSPDTVYDFTSEDLQDLGEIGRGGFGTVNK---MIHRSSDTVMAVKRI 57
           M  S+  S +LK   +       +       +G+G FG+V +        S   +AVK +
Sbjct: 1   MLDSLGISDELKEKLED-VLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKML 59

Query: 58  RS-TVDEKDQRQLLMDLDVVMKSNECPYIVQFYGALFKEVTVATVKA------------- 103
           ++  +   D  + L +    MK  + P++ +  G   +      +               
Sbjct: 60  KADIIASSDIEEFLREAAC-MKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDL 118

Query: 104 LNYLK------------------------------EELKIIHRDVKPSNILLDRRGAIKL 133
             +L                                    IHRD+   N +L     + +
Sbjct: 119 HAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAEDMTVCV 178

Query: 134 CDFGISGQLVDS-IAKTRDAGCRP--YMAPE 161
            DFG+S ++      +   A   P  ++A E
Sbjct: 179 ADFGLSRKIYSGDYYRQGCASKLPVKWLALE 209

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450

 Score = 51.2 bits (123), Expect = 4e-08
 Identities = 43/171 (25%), Positives = 69/171 (40%), Gaps = 40/171 (23%)

Query: 24  EDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKD---QRQLLMDLD------ 74
           ++L+ L  IG+G FG V    +R +  V AVK I++    +    +  ++  L       
Sbjct: 193 KELKLLQTIGKGEFGDVMLGDYRGN-KV-AVKCIKNDATAQAFLAEASVMTQLRHSNLVQ 250

Query: 75  ---VVMKSNECPYIVQFY---GALF--------KEVTVAT--------VKALNYLKEELK 112
              V+++     YIV  Y   G+L           +             +A+ YL E   
Sbjct: 251 LLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYL-EGNN 309

Query: 113 IIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTRDAGCRPY--MAPE 161
            +HRD+   N+L+      K+ DFG    L    + T+D G  P    APE
Sbjct: 310 FVHRDLAARNVLVSEDNVAKVSDFG----LTKEASSTQDTGKLPVKWTAPE 356

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327

 Score = 50.4 bits (121), Expect = 5e-08
 Identities = 37/188 (19%), Positives = 77/188 (40%), Gaps = 50/188 (26%)

Query: 21  FTSEDLQDLGEIGRGGFGTVNK----MIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVV 76
           F    L+ + ++G+G FG+V       +  ++  ++AVK+++ +  ++ QR    ++ + 
Sbjct: 20  FEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQ-QRDFQREIQI- 77

Query: 77  MKSNECPYIVQFYGALFKE-------VT------------------------------VA 99
           +K+    +IV++ G  +         V                               + 
Sbjct: 78  LKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQIC 137

Query: 100 TVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLV--DSIAKTRDAGCRP- 156
             K + YL    + +HRD+   NIL++    +K+ DFG++  L         R+ G  P 
Sbjct: 138 --KGMEYL-GSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPI 194

Query: 157 -YMAPERI 163
            + APE +
Sbjct: 195 FWYAPESL 202

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360

 Score = 50.4 bits (121), Expect = 5e-08
 Identities = 46/200 (23%), Positives = 68/200 (34%), Gaps = 73/200 (36%)

Query: 29  LGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECP----Y 84
           + ++G G FG V    H  +    AVK +R+   +K  R   ++ D++ K          
Sbjct: 40  IRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI--KKYTRSAKIEADILKKIQNDDINNNN 97

Query: 85  IVQFY---------------------------------GALFKEVTVATVKALNYLKEEL 111
           IV+++                                     K   +  +KALNYL++ +
Sbjct: 98  IVKYHGKFMYYDHMCLIFEPLGPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRK-M 156

Query: 112 KIIHRDVKPSNILL-------------------------DRRGAIKLCDFG---ISGQLV 143
            + H D+KP NILL                          +   IKL DFG         
Sbjct: 157 SLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDYH 216

Query: 144 DSIAKTRDAGCRPYMAPERI 163
            SI  T     R Y APE I
Sbjct: 217 GSIINT-----RQYRAPEVI 231

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333

 Score = 50.0 bits (120), Expect = 7e-08
 Identities = 44/206 (21%), Positives = 71/206 (34%), Gaps = 55/206 (26%)

Query: 12  KLSPDTVYDFTSEDLQDLGEIGRGGFGTV-----NKMIHRSSDTVMAVKRIRSTVDEKDQ 66
           +L  +  ++F   +LQ    +G G FG V       +    +   +AVK ++ST    ++
Sbjct: 34  QLPYNEKWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEK 93

Query: 67  RQLLMDLDVVMKSNEC-PYIVQFYGALFKEVTVATV-------KALNYLK---------- 108
             L+ +L + M        IV   GA      V  +         LN+L+          
Sbjct: 94  EALMSELKI-MSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDP 152

Query: 109 ----------------------------EELKIIHRDVKPSNILLDRRGAIKLCDFGISG 140
                                            IHRDV   N+LL      K+ DFG++ 
Sbjct: 153 AFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLAR 212

Query: 141 QLVDSIAKTRDAGCR-P--YMAPERI 163
            +++          R P  +MAPE I
Sbjct: 213 DIMNDSNYIVKGNARLPVKWMAPESI 238

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286

 Score = 49.7 bits (119), Expect = 8e-08
 Identities = 20/145 (13%), Positives = 42/145 (28%), Gaps = 40/145 (27%)

Query: 29  LGEIGRGGFGTVNKMIHRSSDTVM----AVKRIRS--TVDEKDQRQLLMD---------- 72
           L   G            ++ DT +    A+  +     + +   ++ L            
Sbjct: 36  LIFHGGVPPLQF----WQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKP 91

Query: 73  -----LDVVMKSNECPYIVQFY--GALFKEV---TVATVKALNYLKE---------ELKI 113
                LDVV  +     +V  +  G   +EV   + + V A+  ++             +
Sbjct: 92  GVARVLDVV-HTRAGGLVVAEWIRGGSLQEVADTSPSPVGAIRAMQSLAAAADAAHRAGV 150

Query: 114 IHRDVKPSNILLDRRGAIKLCDFGI 138
                 PS + +   G + L     
Sbjct: 151 ALSIDHPSRVRVSIDGDVVLAYPAT 175

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313

 Score = 49.6 bits (119), Expect = 1e-07
 Identities = 29/187 (15%), Positives = 57/187 (30%), Gaps = 50/187 (26%)

Query: 24  EDLQDLGEIGRGGFGTVNK---MIHRSSDTVMAVKRIRS-TVDEKDQRQLLMDLDVVMKS 79
             L     +G G FG+V +        +   +AVK ++     +++  + L +    MK 
Sbjct: 34  NLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAAC-MKD 92

Query: 80  NECPYIVQFYGALFKEVTVATVKA------------LNYLK------------------- 108
              P +++  G   +  +    K               YL                    
Sbjct: 93  FSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKF 152

Query: 109 -----------EELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDS-IAKTRDAGCRP 156
                           +HRD+   N +L     + + DFG+S ++      +       P
Sbjct: 153 MVDIALGMEYLSNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMP 212

Query: 157 --YMAPE 161
             ++A E
Sbjct: 213 VKWIAIE 219

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289

 Score = 48.4 bits (116), Expect = 2e-07
 Identities = 38/193 (19%), Positives = 60/193 (31%), Gaps = 64/193 (33%)

Query: 24  EDLQDLGEIGRGGFGTVNK-------MIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVV 76
           EDL     +G+G F  + K          +  +T + +K +                 + 
Sbjct: 8   EDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKA-HRNYSESFFEAASM- 65

Query: 77  MKSNECPYIVQFYGALFKE-----VT------------------------------VATV 101
           M      ++V  YG          V                               +A  
Sbjct: 66  MSKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLA-- 123

Query: 102 KALNYLKEELKIIHRDVKPSNILLDRRGA--------IKLCDFGISGQLVDSIAKTRDAG 153
            A+++L EE  +IH +V   NILL R           IKL D GIS  ++          
Sbjct: 124 AAMHFL-EENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLP------KDI 176

Query: 154 CR---PYMAPERI 163
            +   P++ PE I
Sbjct: 177 LQERIPWVPPECI 189

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316

 Score = 47.6 bits (114), Expect = 5e-07
 Identities = 36/170 (21%), Positives = 58/170 (34%), Gaps = 55/170 (32%)

Query: 24  EDLQDLGEIGRGGFGTV-----NKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMK 78
           + L+    +GRG FG V       +   ++   +AVK ++      + R L+ +L + + 
Sbjct: 27  DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKI-LI 85

Query: 79  SNEC-PYIVQFYGALFKE-----VTVATVKA---LNYLKE-------------------- 109
                  +V   GA  K      V V   K      YL+                     
Sbjct: 86  HIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFL 145

Query: 110 --------------------ELKIIHRDVKPSNILLDRRGAIKLCDFGIS 139
                                 K IHRD+   NILL  +  +K+CDFG++
Sbjct: 146 TLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLA 195

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339

 Score = 47.3 bits (113), Expect = 7e-07
 Identities = 37/196 (18%), Positives = 63/196 (32%), Gaps = 69/196 (35%)

Query: 29  LGEIGRGGFGTVNKMI-HRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNE-----C 82
           +  +G G FG V + I H++    +AVK +++   ++       ++ V+   N       
Sbjct: 19  VDTLGEGAFGKVVECIDHKAGGRHVAVKIVKN--VDRYCEAARSEIQVLEHLNTTDPNST 76

Query: 83  PYIVQFY---------------------------------GALFKEVTVATVKALNYLKE 109
              VQ                                       +++     K++N+L  
Sbjct: 77  FRCVQMLEWFEHHGHICIVFELLGLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHS 136

Query: 110 ELKIIHRDVKPSNILLD-------------------RRGAIKLCDFG---ISGQLVDSIA 147
             K+ H D+KP NIL                         IK+ DFG      +   ++ 
Sbjct: 137 -NKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSATYDDEHHSTLV 195

Query: 148 KTRDAGCRPYMAPERI 163
            T     R Y APE I
Sbjct: 196 ST-----RHYRAPEVI 206

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355

 Score = 46.9 bits (112), Expect = 9e-07
 Identities = 38/196 (19%), Positives = 64/196 (32%), Gaps = 69/196 (35%)

Query: 29  LGEIGRGGFGTVNKMI-HRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNE-----C 82
           +G +G G FG V + + H    + +A+K IR+    K +    ++++V+ K  E      
Sbjct: 24  VGNLGEGTFGKVVECLDHARGKSQVALKIIRNV--GKYREAARLEINVLKKIKEKDKENK 81

Query: 83  PYIVQFY---------------------------------GALFKEVTVATVKALNYLKE 109
              V                                        + +      AL +L E
Sbjct: 82  FLCVLMSDWFNFHGHMCIAFELLGKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHE 141

Query: 110 ELKIIHRDVKPSNILL-------------------DRRGAIKLCDFG---ISGQLVDSIA 147
             ++ H D+KP NIL                     +  +I++ DFG      +   +I 
Sbjct: 142 -NQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSATFDHEHHTTIV 200

Query: 148 KTRDAGCRPYMAPERI 163
            T     R Y  PE I
Sbjct: 201 AT-----RHYRPPEVI 211

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329

 Score = 46.5 bits (111), Expect = 1e-06
 Identities = 30/178 (16%), Positives = 61/178 (34%), Gaps = 53/178 (29%)

Query: 13  LSPDTVYDFTSEDLQDLGEIGRGGFGTV-----NKMIHRSSDTVMAVKRIRSTVDEKDQR 67
            S   V+     D+    E+G G FG V     + ++      ++AVK ++    E  ++
Sbjct: 30  FSDACVHHIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA-SESARQ 88

Query: 68  QLLMDLDVVMKSNECPYIVQFYGALFKEVTVATV-------KALNYLK------------ 108
               + ++ +   +  +IV+F+G   +   +  V           +L+            
Sbjct: 89  DFQREAEL-LTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGG 147

Query: 109 ---------------------------EELKIIHRDVKPSNILLDRRGAIKLCDFGIS 139
                                        L  +HRD+   N L+ +   +K+ DFG+S
Sbjct: 148 EDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMS 205

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327

 Score = 46.1 bits (110), Expect = 1e-06
 Identities = 44/209 (21%), Positives = 70/209 (33%), Gaps = 55/209 (26%)

Query: 5   IQSSGKLKLSPDTVYDFTSEDLQDLGEIGRGGFGTVNK-MIHRSSDTVM-AVKRIRSTVD 62
               GK    P         D++    IG G FG V K  I +    +  A+KR++    
Sbjct: 6   HHHHGKNNPDPTIYPVLDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYAS 65

Query: 63  EKDQRQLLMDLDVVMKSNEC-PYIVQFYGALFKE--VTVATVKA-----LNYLK------ 108
           + D R    +L+V +      P I+   GA      + +A   A     L++L+      
Sbjct: 66  KDDHRDFAGELEV-LCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLE 124

Query: 109 ----------------------------------EELKIIHRDVKPSNILLDRRGAIKLC 134
                                              + + IHRD+   NIL+      K+ 
Sbjct: 125 TDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIA 184

Query: 135 DFGISGQLVDSIAKTRDAGCRP--YMAPE 161
           DFG+S      +   +  G  P  +MA E
Sbjct: 185 DFGLSRG--QEVYVKKTMGRLPVRWMAIE 211

>3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297

 Score = 45.7 bits (109), Expect = 2e-06
 Identities = 34/205 (16%), Positives = 60/205 (29%), Gaps = 77/205 (37%)

Query: 24  EDLQDLGEIGRGGFGTV-----NKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMK 78
            D+    E+G G FG V       +       ++AVK ++       ++    + ++ + 
Sbjct: 15  RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKD-PTLAARKDFQREAEL-LT 72

Query: 79  SNECPYIVQFYGALFKEVTVATV-------KALNYLK----------------------- 108
           + +  +IV+FYG       +  V           +L+                       
Sbjct: 73  NLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGL 132

Query: 109 -----------------EELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTRD 151
                                 +HRD+   N L+     +K+ DFG+S          RD
Sbjct: 133 SQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMS----------RD 182

Query: 152 AGCRPY-------------MAPERI 163
                Y             M PE I
Sbjct: 183 VYSTDYYRVGGHTMLPIRWMPPESI 207

>3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289

 Score = 45.7 bits (109), Expect = 2e-06
 Identities = 29/196 (14%), Positives = 59/196 (30%), Gaps = 58/196 (29%)

Query: 24  EDLQDLGEIGRGGFGTV-----NKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMK 78
             ++ + E+G   FG V                +A+K ++   +   + +   +  +   
Sbjct: 9   SAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAML-RA 67

Query: 79  SNECPYIVQFY------------------GAL--------------FKEVTVATVKALN- 105
             + P +V                     G L                +       AL  
Sbjct: 68  RLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEP 127

Query: 106 ---------------YLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDS-IAKT 149
                          YL     ++H+D+   N+L+  +  +K+ D G+  ++  +   K 
Sbjct: 128 PDFVHLVAQIAAGMEYL-SSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKL 186

Query: 150 RDAGCRP--YMAPERI 163
                 P  +MAPE I
Sbjct: 187 LGNSLLPIRWMAPEAI 202

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343

 Score = 45.4 bits (108), Expect = 3e-06
 Identities = 18/95 (18%), Positives = 35/95 (36%), Gaps = 6/95 (6%)

Query: 6   QSSGKLKLSPDTVYDFTSEDLQDLGEIGRGGFGTV-----NKMIHRSSDTVMAVKRIRST 60
           Q    L        ++   +++ + +IG G FG V       ++     T++AVK ++  
Sbjct: 29  QRMPLLLNPKLLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEE 88

Query: 61  VDEKDQRQLLMDLDVVMKSNECPYIVQFYGALFKE 95
                Q     +   +M   + P IV+  G     
Sbjct: 89  ASADMQADFQREAA-LMAEFDNPNIVKLLGVCAVG 122

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314

 Score = 45.3 bits (108), Expect = 3e-06
 Identities = 23/85 (27%), Positives = 42/85 (49%), Gaps = 6/85 (7%)

Query: 12 KLSPDTVYDFTSEDLQDLGEIGRGGFGTV-----NKMIHRSSDTVMAVKRIRSTVDEKDQ 66
          K+  D  ++F  ++L     +G G FG V       +  R+  T +AVK ++      + 
Sbjct: 11 KILEDPKWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSEL 70

Query: 67 RQLLMDLDVVMKSNECPYIVQFYGA 91
          R LL + + V+K    P++++ YGA
Sbjct: 71 RDLLSEFN-VLKQVNHPHVIKLYGA 94

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382

 Score = 45.4 bits (108), Expect = 3e-06
 Identities = 35/193 (18%), Positives = 64/193 (33%), Gaps = 56/193 (29%)

Query: 2   CQSIQSSGKLKLSPDTVYDFTSEDLQDLGEIGRGGFGTV-------NKMIHRSSDTVMAV 54
              +    + +L  D  ++   + L     +G G FG V             +  T +AV
Sbjct: 47  QGMLAGVSEYELPEDPRWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAV 106

Query: 55  KRIRSTVDEKDQRQLLMDLDVVMKSNEC-PYIVQFYGALFKEVTVATV-------KALNY 106
           K ++S   EKD   L+ ++++ MK       I+   GA  ++  +  +           Y
Sbjct: 107 KMLKSDATEKDLSDLISEMEM-MKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREY 165

Query: 107 LKE----------------------------------------ELKIIHRDVKPSNILLD 126
           L+                                           K IHRD+   N+L+ 
Sbjct: 166 LQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVT 225

Query: 127 RRGAIKLCDFGIS 139
               +K+ DFG++
Sbjct: 226 EDNVMKIADFGLA 238

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334

 Score = 43.8 bits (104), Expect = 9e-06
 Identities = 34/190 (17%), Positives = 63/190 (33%), Gaps = 56/190 (29%)

Query: 5   IQSSGKLKLSPDTVYDFTSEDLQDLGEIGRGGFGTV-----NKMIHRSSDTVM--AVKRI 57
           +    + +L  D  ++F  + L     +G G FG V       +        +  AVK +
Sbjct: 16  LAGVSEYELPEDPKWEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKML 75

Query: 58  RSTVDEKDQRQLLMDLDVVMKSNEC-PYIVQFYGALFKEVTVATV-------KALNYLKE 109
           +    EKD   L+ +++ +MK       I+   GA  ++  +  +           YL+ 
Sbjct: 76  KDDATEKDLSDLVSEME-MMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRA 134

Query: 110 ----------------------------------------ELKIIHRDVKPSNILLDRRG 129
                                                     K IHRD+   N+L+    
Sbjct: 135 RRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENN 194

Query: 130 AIKLCDFGIS 139
            +K+ DFG++
Sbjct: 195 VMKIADFGLA 204

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344

 Score = 42.3 bits (100), Expect = 3e-05
 Identities = 20/91 (21%), Positives = 35/91 (38%), Gaps = 7/91 (7%)

Query: 7   SSGKLKLSPDTVYDFTSEDLQDLGEIGRGGFGTV-----NKMIHRSSDTVMAVKRIRSTV 61
                +   D  ++F  E+L+    +G G FG V       +        +AVK ++   
Sbjct: 28  YVDFREYEYDLKWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA 87

Query: 62  DEKDQRQLLMDLDVVMKSNEC-PYIVQFYGA 91
           D  ++  L+ +L  +M        IV   GA
Sbjct: 88  DSSEREALMSELK-MMTQLGSHENIVNLLGA 117

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344

 Score = 40.7 bits (96), Expect = 1e-04
 Identities = 18/61 (29%), Positives = 31/61 (50%), Gaps = 4/61 (6%)

Query: 106 YLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTRDAGCR-P--YMAPER 162
           +L E    +HRD+   N+L+     +K+CDFG++  ++           R P  +MAPE 
Sbjct: 187 FL-EFKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPES 245

Query: 163 I 163
           +
Sbjct: 246 L 246

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 41.8 bits (98), Expect = 4e-05
 Identities = 24/65 (36%), Positives = 33/65 (50%), Gaps = 4/65 (6%)

Query: 102 KALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTRDAGCR-PY--M 158
           K + +L    K IHRD+   NILL  +  +K+CDFG++  +       R    R P   M
Sbjct: 204 KGMEFL-ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWM 262

Query: 159 APERI 163
           APE I
Sbjct: 263 APETI 267

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370

 Score = 42.0 bits (99), Expect = 5e-05
 Identities = 34/191 (17%), Positives = 62/191 (32%), Gaps = 58/191 (30%)

Query: 5   IQSSGKLKLSPDTVYDFTSEDLQDLGEIGRGGFGTV-----NKMIHRSSDTVM--AVKRI 57
           +    + +L  D  ++F  + L     +G G FG V       +        +  AVK +
Sbjct: 62  LAGVSEYELPEDPKWEFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKML 121

Query: 58  RSTVDEKDQRQLLMDLDVVMKSNEC-PYIVQF------------------YGAL------ 92
           +    EKD   L+ ++++ MK       I+                     G L      
Sbjct: 122 KDDATEKDLSDLVSEMEM-MKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRA 180

Query: 93  --------FKEVTVATVKALN----------------YLKEELKIIHRDVKPSNILLDRR 128
                     ++     + +                 YL    K IHRD+   N+L+   
Sbjct: 181 RRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYL-ASQKCIHRDLAARNVLVTEN 239

Query: 129 GAIKLCDFGIS 139
             +K+ DFG++
Sbjct: 240 NVMKIADFGLA 250

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397

 Score = 41.4 bits (97), Expect = 7e-05
 Identities = 14/38 (36%), Positives = 22/38 (57%)

Query: 88  FYGALFKEVTVATVKALNYLKEELKIIHRDVKPSNILL 125
                 K++    ++ L+YL  + +IIH D+KP NILL
Sbjct: 143 LPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILL 180

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345

 Score = 40.5 bits (95), Expect = 1e-04
 Identities = 10/35 (28%), Positives = 20/35 (57%), Gaps = 2/35 (5%)

Query: 113 IIHRDVKPSNILLDRRGA--IKLCDFGISGQLVDS 145
            +H D+K +N+LL  +    + L D+G+S +   +
Sbjct: 172 YVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPN 206

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336

 Score = 39.5 bits (91), Expect = 3e-04
 Identities = 10/38 (26%), Positives = 16/38 (42%)

Query: 100 TVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFG 137
              +L   +  L+  HRD+   N+LL +    KL    
Sbjct: 170 LTASLAVAEASLRFEHRDLHWGNVLLKKTSLKKLHYTL 207

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364

 Score = 39.0 bits (91), Expect = 4e-04
 Identities = 10/35 (28%), Positives = 20/35 (57%), Gaps = 2/35 (5%)

Query: 113 IIHRDVKPSNILLDRRGA--IKLCDFGISGQLVDS 145
            +H D+K SN+LL+ +    + L D+G++ +    
Sbjct: 173 YVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPE 207

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483

 Score = 38.5 bits (89), Expect = 6e-04
 Identities = 26/149 (17%), Positives = 50/149 (33%), Gaps = 39/149 (26%)

Query: 32  IGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQFYGA 91
           IG G FG +    +  ++  +A+K       +    QLL +  +         I      
Sbjct: 15  IGSGSFGEIYLGTNIQTNEEVAIKLENV---KTKHPQLLYESKIYRILQGGTGIPNVRWF 71

Query: 92  --------------------LFKEV----TVATV--------KALNYLKEELKIIHRDVK 119
                               LF       ++ TV          + ++  +   +HRD+K
Sbjct: 72  GVEGDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSK-SFLHRDIK 130

Query: 120 PSNILLDRRG---AIKLCDFGISGQLVDS 145
           P N L+        + + DFG++ +  D+
Sbjct: 131 PDNFLMGLGRRANQVYIIDFGLAKKYRDT 159

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330

 Score = 38.1 bits (89), Expect = 9e-04
 Identities = 14/38 (36%), Positives = 22/38 (57%), Gaps = 5/38 (13%)

Query: 113 IIHRDVKPSNILLDRRGA-----IKLCDFGISGQLVDS 145
           +I+RDVKP N L+ R G      I + DF ++ + +D 
Sbjct: 126 LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDP 163

Structure Templates Detected by HHsearch

Original result of HHsearch against PDB70 database

ID	Length	Definition	Probability
Query	187
4b9d_A	350	Serine/threonine-protein kinase NEK1; transferase,	100.0
4aw0_A	311	HPDK1, 3-phosphoinositide-dependent protein kinase	100.0
3hyh_A	275	Carbon catabolite-derepressing protein kinase; kin	100.0
4fih_A	346	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
3omv_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	100.0
4fie_A	423	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
3fpq_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
3ubd_A	304	Ribosomal protein S6 kinase alpha-3; kinase-inhibi	100.0
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	100.0
4asz_A	299	BDNF/NT-3 growth factors receptor; transferase, TR	100.0
4ase_A	353	Vascular endothelial growth factor receptor 2; tra	100.0
4aoj_A	329	High affinity nerve growth factor receptor; transf	100.0
4gt4_A	308	Tyrosine-protein kinase transmembrane receptor RO;	100.0
4b99_A	398	Mitogen-activated protein kinase 7; transferase, i	100.0
3v5w_A	689	G-protein coupled receptor kinase 2; inhibitor com	100.0
3hmm_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	100.0
4f9c_A	361	Cell division cycle 7-related protein kinase; Ser/	100.0
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	100.0
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	100.0
3rp9_A	458	Mitogen-activated protein kinase; structural genom	100.0
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	100.0
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	100.0
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	100.0
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	100.0
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	100.0
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	100.0
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	100.0
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	100.0
3aln_A	327	Dual specificity mitogen-activated protein kinase;	100.0
3o0g_A	292	Cell division protein kinase 5; kinase activator c	100.0
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	100.0
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	100.0
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	100.0
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	100.0
3niz_A	311	Rhodanese family protein; structural genomics, str	100.0
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	100.0
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	100.0
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	100.0
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	100.0
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	100.0
3fme_A	290	Dual specificity mitogen-activated protein kinase;	100.0
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	100.0
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	100.0
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	100.0
3zgw_A	347	Maternal embryonic leucine zipper kinase; transfer	100.0
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	100.0
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	100.0
3an0_A	340	Dual specificity mitogen-activated protein kinase;	100.0
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	100.0
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	100.0
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	100.0
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	100.0
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	100.0
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	100.0
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	99.98
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	99.98
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	99.98
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	99.98
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	99.98
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	99.98
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	99.98
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	99.98
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	99.98
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	99.98
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	99.98
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	99.98
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	99.98
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	99.98
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	99.98
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	99.98
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	99.98
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	99.98
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	99.98
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	99.98
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	99.98
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	99.98
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	99.98
2dyl_A	318	Dual specificity mitogen-activated protein kinase	99.98
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	99.98
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	99.98
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	99.97
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	99.97
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	99.97
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	99.97
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	99.97
4exu_A	371	Mitogen-activated protein kinase 13; P38 kinase, t	99.97
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	99.97
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	99.97
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	99.97
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	99.97
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	99.97
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	99.97
3ork_A	311	Serine/threonine protein kinase; structural genomi	99.97
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	99.97
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	99.97
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	99.97
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	99.97
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	99.97
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	99.97
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	99.97
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	99.97
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	99.97
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	99.97
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	99.97
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	99.97
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	99.97
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	99.97
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	99.97
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	99.97
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	99.97
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	99.97
3soc_A	322	Activin receptor type-2A; structural genomics cons	99.97
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	99.97
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	99.97
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	99.97
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	99.97
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	99.97
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	99.97
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	99.97
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	99.97
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	99.97
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	99.97
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	99.97
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	99.97
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	99.97
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	99.97
4hcu_A	269	Tyrosine-protein kinase ITK/TSK; transferase-trans	99.97
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	99.97
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	99.97
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	99.97
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	99.97
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	99.97
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	99.97
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	99.97
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	99.97
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	99.97
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	99.97
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	99.97
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	99.97
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	99.97
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	99.97
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	99.97
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	99.97
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	99.97
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	99.97
3q4u_A	301	Activin receptor type-1; structural genomics conso	99.97
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	99.97
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	99.97
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	99.97
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	99.97
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	99.97
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	99.97
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	99.97
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	99.97
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	99.97
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	99.97
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	99.97
3bhy_A	283	Death-associated protein kinase 3; death associate	99.97
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	99.97
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	99.97
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	99.97
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	99.97
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	99.97
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	99.97
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	99.97
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	99.97
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	99.97
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	99.97
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	99.97
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	99.97
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	99.97
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	99.97
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	99.97
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	99.97
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	99.97
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	99.97
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	99.97
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	99.97
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	99.97
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	99.97
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	99.97
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	99.97
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	99.97
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	99.97
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	99.97
4fl3_A	635	Tyrosine-protein kinase SYK; transferase; HET: ANP	99.97
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	99.97
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	99.97
3pls_A	298	Macrophage-stimulating protein receptor; protein k	99.96
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	99.96
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	99.96
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	99.96
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	99.96
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	99.96
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	99.96
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	99.96
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	99.96
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	99.96
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	99.96
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	99.96
2a19_B	284	Interferon-induced, double-stranded RNA-activated	99.96
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	99.96
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	99.96
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	99.96
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	99.96
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	99.96
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	99.96
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	99.96
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	99.96
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	99.96
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	99.96
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	99.96
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	99.96
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	99.96
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	99.96
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	99.96
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	99.96
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	99.96
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	99.96
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	99.96
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	99.96
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	99.96
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	99.96
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	99.96
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	99.96
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	99.96
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	99.96
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	99.96
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	99.96
4hgt_A	296	Casein kinase I isoform delta; CK1D, inhibitor, tr	99.96
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	99.96
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	99.96
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	99.96
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	99.96
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	99.96
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	99.96
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	99.96
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	99.96
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	99.96
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	99.96
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	99.96
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	99.96
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	99.95
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	99.95
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	99.95
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	99.95
3uqc_A	286	Probable conserved transmembrane protein; structur	99.93
4azs_A	569	Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15	99.92
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	99.92
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	99.89
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	99.83
1zth_A	258	RIO1 serine protein kinase; ribosome biogenesis, r	99.73
4gyi_A	397	RIO2 kinase; protein kinase, ADP complex, phosphoa	99.6
3tm0_A	263	Aminoglycoside 3'-phosphotransferase; protein kina	98.43
1nd4_A	264	Aminoglycoside 3'-phosphotransferase; protein kina	98.14
3dxp_A	359	Putative acyl-COA dehydrogenase; protein kinase-li	97.87
3r70_A	320	Aminoglycoside phosphotransferase; structural geno	96.65
4gkh_A	272	Aminoglycoside 3'-phosphotransferase APHA1-IAB; py	96.15
2q83_A	346	YTAA protein; 2635576, structural genomics, joint	95.51
3d1u_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	95.44
3f7w_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	93.97
2pyw_A	420	Uncharacterized protein; 5-methylthioribose kinase	93.15
3sg8_A	304	APH(2'')-ID; antibiotic resistance enzyme, transfe	93.07
3cxl_A	463	N-chimerin; SH2, RHO-GAP, structural genomics cons	92.63
3ovc_A	362	Hygromycin-B 4-O-kinase; aminoglycoside phosphotra	91.69
2ppq_A	322	HSK, HK, homoserine kinase; structural genomics, M	91.68
3csv_A	333	Aminoglycoside phosphotransferase; YP_614837.1, ph	91.36
3ats_A	357	Putative uncharacterized protein; hypothetical pro	91.03
3tdw_A	306	Gentamicin resistance protein; kinase, phosphoryl	90.85
1zyl_A	328	Hypothetical protein YIHE; putative protein kinase	89.35
3c5i_A	369	Choline kinase; choline, kinase, malaria, transfer	89.21
3dxq_A	301	Choline/ethanolamine kinase family protein; NP_106	88.63
3i1a_A	339	Spectinomycin phosphotransferase; protein kinase,	88.18
2qg7_A	458	Ethanolamine kinase PV091845; malaria, SGC, struct	87.95
1nw1_A	429	Choline kinase (49.2 KD); phospholipid synthesis,	87.53
3feg_A	379	Choline/ethanolamine kinase; non-protein kinase, c	87.13
2olc_A	397	MTR kinase, methylthioribose kinase; kinase ADP-2H	87.03
3f2s_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	86.63
3g15_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	85.23
3mes_A	424	Choline kinase; malaria, structural genomics, stru	80.15

>4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A*

Probab=100.00  E-value=1.4e-45  Score=285.34  Aligned_cols=176  Identities=24%  Similarity=0.351  Sum_probs=132.5

Q ss_pred             ccccCCceecCCCccccCCcccccccccccccCceEEEEEEEcCCCcEEEEEEccCccChHHHHHHHHHHHHHHhcCCCC
Q psy14630          4 SIQSSGKLKLSPDTVYDFTSEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECP   83 (187)
Q Consensus         4 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~h~   83 (187)
                      +..+|+.........+--..++|++++.||+|+||+||+|.+..+++.||||++..........+.+.+|..+++.++||
T Consensus         4 ~~~~ssgvd~gten~~f~sme~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~Hp   83 (350)
T 4b9d_A            4 HHHHSSGVDLGTENLYFQSMEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHP   83 (350)
T ss_dssp             CCCC-------CCCCBCSCCCCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCT
T ss_pred             cCCCCCCccCCCcccCCCcccceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCC
Confidence            33444444433333332345799999999999999999999999999999999975544444556677777788899999


Q ss_pred             chhhhhhhHH----------------------------------HHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCC
Q psy14630         84 YIVQFYGALF----------------------------------KEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRG  129 (187)
Q Consensus        84 ~iv~~~~~~~----------------------------------~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~  129 (187)
                      |||++++.+.                                  ..++.|++.||+|||++ +|+||||||+|||++.++
T Consensus        84 nIV~~~~~~~~~~~~yiVmEy~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~-~IiHRDlKp~NILl~~~g  162 (350)
T 4b9d_A           84 NIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDR-KILHRDIKSQNIFLTKDG  162 (350)
T ss_dssp             TBCCEEEEEEETTEEEEEEECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHT-TCEETTCCGGGEEECTTC
T ss_pred             CCCcEEEEEEECCEEEEEEeCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHC-CeeeccCCHHHEEECCCC
Confidence            9999885431                                  12678999999999998 999999999999999999


Q ss_pred             CEEEEeccccccccccc-cccCCCCCcCccCccccCCCccCCCCCCcceeeeEee
Q psy14630        130 AIKLCDFGISGQLVDSI-AKTRDAGCRPYMAPERIDPLRARGYPSFKTKLGFKFN  183 (187)
Q Consensus       130 ~~ki~dfg~a~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi~  183 (187)
                      .+||+|||+|+.+.... .....+||+.|||||++.   +..|+.++||||+||+
T Consensus       163 ~vKl~DFGla~~~~~~~~~~~~~~GT~~YmAPE~l~---~~~y~~~~DiwSlGvi  214 (350)
T 4b9d_A          163 TVQLGDFGIARVLNSTVELARACIGTPYYLSPEICE---NKPYNNKSDIWALGCV  214 (350)
T ss_dssp             CEEECSTTEESCCCHHHHHHHHHHSCCTTCCHHHHT---TCCCCHHHHHHHHHHH
T ss_pred             CEEEcccccceeecCCcccccccCCCccccCHHHHC---CCCCCcHHHHHHHHHH
Confidence            99999999999876532 233457999999999998   6779999999999993

>4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ...

Probab=100.00  E-value=1.6e-45  Score=280.90  Aligned_cols=163  Identities=25%  Similarity=0.340  Sum_probs=135.0

Q ss_pred             ccCCcccccccccccccCceEEEEEEEcCCCcEEEEEEccCcc-ChHHHHHHHHHHHHHHhcCCCCchhhhhhhHHH---
Q psy14630         19 YDFTSEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTV-DEKDQRQLLMDLDVVMKSNECPYIVQFYGALFK---   94 (187)
Q Consensus        19 ~~~~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~---   94 (187)
                      .....++|++.+.||+|+||+||+|.+..+++.||||++.+.. .+....+.+.+|..+++.++||||+++++++.+   
T Consensus        27 ~~~~~~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~  106 (311)
T 4aw0_A           27 RKKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEK  106 (311)
T ss_dssp             CCCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred             CCCCccccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCE
Confidence            3445688999999999999999999999999999999986421 111223556677778889999999999864321   


Q ss_pred             -----------------------------HHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEecccccccccc
Q psy14630         95 -----------------------------EVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDS  145 (187)
Q Consensus        95 -----------------------------~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg~a~~~~~~  145 (187)
                                                   .++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+|+.+...
T Consensus       107 ~yivmEy~~gG~L~~~i~~~~~l~e~~~~~~~~qi~~al~ylH~~-~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~  185 (311)
T 4aw0_A          107 LYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK-GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPE  185 (311)
T ss_dssp             EEEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred             EEEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC-CCccCCCCHHHeEEcCCCCEEEEEcCCceecCCC
Confidence                                         2778999999999998 9999999999999999999999999999987532


Q ss_pred             ---ccccCCCCCcCccCccccCCCccCCCCCCcceeeeEe-eee
Q psy14630        146 ---IAKTRDAGCRPYMAPERIDPLRARGYPSFKTKLGFKF-NYR  185 (187)
Q Consensus       146 ---~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi-~~~  185 (187)
                         ......+||+.|||||++.   +.+|+.++|+||+|| +|.
T Consensus       186 ~~~~~~~~~~GTp~YmAPEvl~---~~~y~~~~DiWSlGvilye  226 (311)
T 4aw0_A          186 SKQARANSFVGTAQYVSPELLT---EKSACKSSDLWALGCIIYQ  226 (311)
T ss_dssp             TTCCCBCCCCSCGGGCCHHHHH---HSCBCHHHHHHHHHHHHHH
T ss_pred             CCcccccCcccCcccCCHHHHc---CCCCCcHHHHHHHHHHHHH
Confidence               2334568999999999998   677999999999999 443

>3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A

Probab=100.00  E-value=4.6e-44  Score=269.16  Aligned_cols=158  Identities=27%  Similarity=0.424  Sum_probs=117.1

Q ss_pred             ccccccccccccCceEEEEEEEcCCCcEEEEEEccCcc-ChHHHHHHHHHHHHHHhcCCCCchhhhhhhHH---------
Q psy14630         24 EDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTV-DEKDQRQLLMDLDVVMKSNECPYIVQFYGALF---------   93 (187)
Q Consensus        24 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~---------   93 (187)
                      ++|++.+.||+|+||+||+|.+..+++.||+|++.... .+....+.+.+|..+++.++||||+++++.+.         
T Consensus        13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm   92 (275)
T 3hyh_A           13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVI   92 (275)
T ss_dssp             -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEE
Confidence            68999999999999999999999999999999986532 22233455667777888899999999986431         


Q ss_pred             ----------------------HHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEeccccccccccccccCC
Q psy14630         94 ----------------------KEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTRD  151 (187)
Q Consensus        94 ----------------------~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg~a~~~~~~~~~~~~  151 (187)
                                            ..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+|+...+.......
T Consensus        93 Ey~~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~-~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~~~~~~  171 (275)
T 3hyh_A           93 EYAGNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRH-KIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTS  171 (275)
T ss_dssp             ECCCEEHHHHHHHSCSCCHHHHHHHHHHHHHHHHHHHHT-TCCCCCCCTTTEEECTTCCEEECCSSCC------------
T ss_pred             eCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC-CcccccCChHHeEECCCCCEEEeecCCCeecCCCCccCCe
Confidence                                  22778999999999998 9999999999999999999999999999887665555567


Q ss_pred             CCCcCccCccccCCCccCCC-CCCcceeeeEe-eee
Q psy14630        152 AGCRPYMAPERIDPLRARGY-PSFKTKLGFKF-NYR  185 (187)
Q Consensus       152 ~~t~~y~aPE~~~~~~~~~~-~~~~D~ws~gi-~~~  185 (187)
                      +||+.|||||++.   ..++ +.++||||+|| +|.
T Consensus       172 ~GT~~Y~APE~~~---~~~y~~~~~DiwSlGvily~  204 (275)
T 3hyh_A          172 CGSPNYAAPEVIS---GKLYAGPEVDVWSCGVILYV  204 (275)
T ss_dssp             ---CTTSCHHHHS---SSSCCCTHHHHHHHHHHHHH
T ss_pred             eECcccCChhhhc---CCCCCCChhhhHHHHHHHHH
Confidence            8999999999998   5555 57999999999 443

>4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A*

Probab=100.00  E-value=2.5e-44  Score=277.97  Aligned_cols=157  Identities=29%  Similarity=0.450  Sum_probs=131.7

Q ss_pred             cccccccccccccCceEEEEEEEcCCCcEEEEEEccCccChHHHHHHHHHHHHHHhcCCCCchhhhhhhHHH--------
Q psy14630         23 SEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQFYGALFK--------   94 (187)
Q Consensus        23 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~--------   94 (187)
                      .+.|++.++||+|+||+||+|.+..+++.||||++......  ..+.+.+|..+++.++|||||++++++..        
T Consensus        73 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~--~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivm  150 (346)
T 4fih_A           73 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQ--RRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVM  150 (346)
T ss_dssp             GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCS--SGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             hHhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchh--HHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence            45699999999999999999999999999999998643221  22345566778888999999999865422        


Q ss_pred             -----------------------HHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEecccccccccc-ccccC
Q psy14630         95 -----------------------EVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDS-IAKTR  150 (187)
Q Consensus        95 -----------------------~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg~a~~~~~~-~~~~~  150 (187)
                                             .++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+|+.+... .....
T Consensus       151 Ey~~gg~L~~~l~~~~l~e~~~~~~~~qi~~aL~ylH~~-~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~  229 (346)
T 4fih_A          151 EFLEGGALTDIVTHTRMNEEQIAAVCLAVLQALSVLHAQ-GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKS  229 (346)
T ss_dssp             CCCTTEEHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSCCBCC
T ss_pred             eCCCCCcHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC-CcccccCCHHHEEECCCCCEEEecCcCceecCCCCCcccc
Confidence                                   2778999999999998 9999999999999999999999999999987543 33455


Q ss_pred             CCCCcCccCccccCCCccCCCCCCcceeeeEe-eee
Q psy14630        151 DAGCRPYMAPERIDPLRARGYPSFKTKLGFKF-NYR  185 (187)
Q Consensus       151 ~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi-~~~  185 (187)
                      .+||+.|||||++.   ..+|+.++||||+|| +|.
T Consensus       230 ~~GTp~YmAPEvl~---~~~y~~~~DiWSlGvilye  262 (346)
T 4fih_A          230 LVGTPYWMAPELIS---RLPYGPEVDIWSLGIMVIE  262 (346)
T ss_dssp             CCSCGGGCCHHHHT---TCCBCTHHHHHHHHHHHHH
T ss_pred             cccCcCcCCHHHHC---CCCCCcHHHHHHHHHHHHH
Confidence            68999999999998   677999999999999 443

>3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens}

Probab=100.00  E-value=2.3e-43  Score=269.19  Aligned_cols=166  Identities=24%  Similarity=0.344  Sum_probs=133.0

Q ss_pred             CccccCCcccccccccccccCceEEEEEEEcCCCcEEEEEEccCccChHHHHHHHHHHHHHHhcCCCCchhhhhhhHHH-
Q psy14630         16 DTVYDFTSEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQFYGALFK-   94 (187)
Q Consensus        16 ~~~~~~~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~-   94 (187)
                      ...|+++.+++.+.+.||+|+||+||+|.+.   ..||||+++.........+.+.++..+++.++|||||++++++.. 
T Consensus        28 ~~~Wei~~~~l~l~~~iG~G~fG~Vy~~~~~---~~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~  104 (307)
T 3omv_A           28 SYYWEIEASEVMLSTRIGSGSFGTVYKGKWH---GDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTKD  104 (307)
T ss_dssp             -CCCBCCTTSCCEEEECCCCSSSEEEEEESS---SEEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSS
T ss_pred             CcCcEEcHHHeEEeeEEeeCCCcEEEEEEEC---CcEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEECC
Confidence            4568899999999999999999999999864   358999997654455556677778888999999999999864311 


Q ss_pred             -------------------------------HHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEecccccccc
Q psy14630         95 -------------------------------EVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLV  143 (187)
Q Consensus        95 -------------------------------~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg~a~~~~  143 (187)
                                                     .++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+|+...
T Consensus       105 ~~~iVmEy~~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH~~-~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~  183 (307)
T 3omv_A          105 NLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAK-NIIHRDMKSNNIFLHEGLTVKIGDFGLATVKS  183 (307)
T ss_dssp             SCEEEEECCSSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHT-TCBCSCCCSSSEEEETTEEEEECCCSSCBC--
T ss_pred             eEEEEEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHC-CccCCccCHHHEEECCCCcEEEeeccCceecc
Confidence                                           2778999999999997 99999999999999999999999999998764


Q ss_pred             cc---ccccCCCCCcCccCccccCCCccCCCCCCcceeeeEeeee
Q psy14630        144 DS---IAKTRDAGCRPYMAPERIDPLRARGYPSFKTKLGFKFNYR  185 (187)
Q Consensus       144 ~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi~~~  185 (187)
                      ..   ......+||+.|||||++.+.....++.++|||||||++|
T Consensus       184 ~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~  228 (307)
T 3omv_A          184 RWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLY  228 (307)
T ss_dssp             ----------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHH
T ss_pred             cCCcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHH
Confidence            32   2233457999999999997443456899999999999543

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A*

Probab=100.00  E-value=2e-43  Score=269.27  Aligned_cols=156  Identities=28%  Similarity=0.482  Sum_probs=121.6

Q ss_pred             cccccccccccccCceEEEEEEEcCCCcEEEEEEccCccChHHHHHHHHHHHHHHhcCCCCchhhhhhhHH---------
Q psy14630         23 SEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQFYGALF---------   93 (187)
Q Consensus        23 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~---------   93 (187)
                      .++|++.+.||+|+||+||+|.+..+++.||||.++.... ....+.+.++..+++.++|||||++++++.         
T Consensus         4 l~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~-~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~   82 (299)
T 4g31_A            4 LTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNR-ELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQ   82 (299)
T ss_dssp             HHHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSS-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC------
T ss_pred             chhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCC-HHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccc
Confidence            3679999999999999999999999999999999864333 233445666777888899999999875421         


Q ss_pred             --------------------------------------HHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEe
Q psy14630         94 --------------------------------------KEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCD  135 (187)
Q Consensus        94 --------------------------------------~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~d  135 (187)
                                                            ..++.|++.||+|||++ +|+||||||+|||++.++.+||+|
T Consensus        83 ~~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~-~IiHRDlKp~NILl~~~~~vKl~D  161 (299)
T 4g31_A           83 PSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSK-GLMHRDLKPSNIFFTMDDVVKVGD  161 (299)
T ss_dssp             ----CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHT-TCCCCCCCGGGEEECTTCCEEECC
T ss_pred             ccCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHC-cCccccCcHHHeEECCCCcEEEcc
Confidence                                                  12667999999999998 999999999999999999999999


Q ss_pred             cccccccccccc-------------ccCCCCCcCccCccccCCCccCCCCCCcceeeeEee
Q psy14630        136 FGISGQLVDSIA-------------KTRDAGCRPYMAPERIDPLRARGYPSFKTKLGFKFN  183 (187)
Q Consensus       136 fg~a~~~~~~~~-------------~~~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi~  183 (187)
                      ||+|+.+.....             ....+||+.|||||++.   ...|+.++||||+||+
T Consensus       162 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~---~~~y~~~~DiwSlGvi  219 (299)
T 4g31_A          162 FGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIH---GNSYSHKVDIFSLGLI  219 (299)
T ss_dssp             CCCC--------------------------CCCTTSCHHHHT---TCCCCTHHHHHHHHHH
T ss_pred             CccceecCCCccccccccccccccccCCcccCccccCHHHHc---CCCCCCHHHHHHHHHH
Confidence            999988753211             12347999999999998   6679999999999993

>4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens}

Probab=100.00  E-value=1.8e-43  Score=279.36  Aligned_cols=157  Identities=29%  Similarity=0.450  Sum_probs=132.2

Q ss_pred             cccccccccccccCceEEEEEEEcCCCcEEEEEEccCccChHHHHHHHHHHHHHHhcCCCCchhhhhhhHHH--------
Q psy14630         23 SEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQFYGALFK--------   94 (187)
Q Consensus        23 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~--------   94 (187)
                      .+.|++.+.||+|+||.||+|.+..+++.||||++......  ..+.+.+|..+++.++|||||++++++..        
T Consensus       150 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~--~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVm  227 (423)
T 4fie_A          150 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQ--RRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVM  227 (423)
T ss_dssp             GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCS--SGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             hHhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchh--HHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEE
Confidence            46699999999999999999999999999999998643221  23345667778888999999999865321        


Q ss_pred             -----------------------HHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEecccccccccc-ccccC
Q psy14630         95 -----------------------EVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDS-IAKTR  150 (187)
Q Consensus        95 -----------------------~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg~a~~~~~~-~~~~~  150 (187)
                                             .++.|++.||+|||++ +|+||||||+|||++.+|.+||+|||+|+.+... .....
T Consensus       228 Ey~~gG~L~~~i~~~~l~e~~~~~~~~qil~aL~ylH~~-~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~  306 (423)
T 4fie_A          228 EFLEGGALTDIVTHTRMNEEQIAAVCLAVLQALSVLHAQ-GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKS  306 (423)
T ss_dssp             ECCTTEEHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCSTTTEEECTTCCEEECCCTTCEECCSSCCCBCC
T ss_pred             eCCCCCcHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHC-CeecccCCHHHEEEcCCCCEEEecCccceECCCCCccccc
Confidence                                   2778999999999998 9999999999999999999999999999987543 33445


Q ss_pred             CCCCcCccCccccCCCccCCCCCCcceeeeEe-eee
Q psy14630        151 DAGCRPYMAPERIDPLRARGYPSFKTKLGFKF-NYR  185 (187)
Q Consensus       151 ~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi-~~~  185 (187)
                      .+||+.|||||++.   ...|+.++||||+|| +|.
T Consensus       307 ~~GTp~YmAPEvl~---~~~y~~~~DiWSlGvilye  339 (423)
T 4fie_A          307 LVGTPYWMAPELIS---RLPYGPEVDIWSLGIMVIE  339 (423)
T ss_dssp             CEECTTTCCHHHHT---TCCBCTHHHHHHHHHHHHH
T ss_pred             cccCcCcCCHHHHC---CCCCCcHHHHHHHHHHHHH
Confidence            68999999999998   677999999999999 443

>3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus}

Probab=100.00  E-value=1.7e-42  Score=262.55  Aligned_cols=152  Identities=28%  Similarity=0.394  Sum_probs=126.4

Q ss_pred             ccccccccccCceEEEEEEEcCCCcEEEEEEccCccChHHHHHHHHHHHHHHhcCCCCchhhhhhhHH------------
Q psy14630         26 LQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQFYGALF------------   93 (187)
Q Consensus        26 ~~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~------------   93 (187)
                      |++.++||+|+||.||+|.+..+++.||+|.+..........+.+.++..+++.++|||||++++++.            
T Consensus        28 ~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lv  107 (290)
T 3fpq_A           28 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV  107 (290)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEE
T ss_pred             EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEE
Confidence            36678899999999999999999999999998654444445566777888899999999999986431            


Q ss_pred             ------------------------HHHHHHHHHHHHHHHhcCC--CeeecCCCCCeEEc-CCCCEEEEeccccccccccc
Q psy14630         94 ------------------------KEVTVATVKALNYLKEELK--IIHRDVKPSNILLD-RRGAIKLCDFGISGQLVDSI  146 (187)
Q Consensus        94 ------------------------~~~~~~~~~~l~~lh~~~~--i~Hrdlk~~nili~-~~~~~ki~dfg~a~~~~~~~  146 (187)
                                              ..++.|++.||+|||++ +  |+||||||+|||++ .++.+||+|||+|+..... 
T Consensus       108 mEy~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~ylH~~-~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~~~-  185 (290)
T 3fpq_A          108 TELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTR-TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS-  185 (290)
T ss_dssp             EECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTS-SSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCCTT-
T ss_pred             EeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC-CCCEEecccChhheeEECCCCCEEEEeCcCCEeCCCC-
Confidence                                    11678999999999997 7  99999999999997 4789999999999865433 


Q ss_pred             cccCCCCCcCccCccccCCCccCCCCCCcceeeeEee
Q psy14630        147 AKTRDAGCRPYMAPERIDPLRARGYPSFKTKLGFKFN  183 (187)
Q Consensus       147 ~~~~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi~  183 (187)
                      .....+||+.|||||++.   + .|+.++|||||||+
T Consensus       186 ~~~~~~GTp~YmAPE~~~---~-~y~~~~DiwSlGvi  218 (290)
T 3fpq_A          186 FAKAVIGTPEFMAPEMYE---E-KYDESVDVYAFGMC  218 (290)
T ss_dssp             SBEESCSSCCCCCGGGGG---T-CCCTHHHHHHHHHH
T ss_pred             ccCCcccCccccCHHHcC---C-CCCcHHHHHHHHHH
Confidence            334468999999999876   3 48999999999993

>3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A*

Probab=100.00  E-value=1.6e-43  Score=269.65  Aligned_cols=159  Identities=28%  Similarity=0.357  Sum_probs=124.2

Q ss_pred             CCcccccccccccccCceEEEEEEEc---CCCcEEEEEEccCccChHHHHHHHHHHHHHHhcCCCCchhhhhhhHHH---
Q psy14630         21 FTSEDLQDLGEIGRGGFGTVNKMIHR---SSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQFYGALFK---   94 (187)
Q Consensus        21 ~~~~~~~~~~~lg~G~fg~V~~~~~~---~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~---   94 (187)
                      ...++|++.+.||+|+||+||+|++.   .+++.||+|+++...........+..+..+++.++|||||++++++..   
T Consensus        21 ~~p~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~  100 (304)
T 3ubd_A           21 ADPSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGK  100 (304)
T ss_dssp             CCGGGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTE
T ss_pred             CCccccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCE
Confidence            45688999999999999999999874   467899999986432111111234445667788999999999864321   


Q ss_pred             -----------------------------HHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEecccccccccc
Q psy14630         95 -----------------------------EVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDS  145 (187)
Q Consensus        95 -----------------------------~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg~a~~~~~~  145 (187)
                                                   .++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+|+...+.
T Consensus       101 ~~ivmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~-~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~  179 (304)
T 3ubd_A          101 LYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSL-GIIYRDLKPENILLDEEGHIKLTDFGLSKESIDH  179 (304)
T ss_dssp             EEEEECCCTTCEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHT-TCCCSSCCGGGEEECTTSCEEEESSEEEEC----
T ss_pred             EEEEEEcCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC-CCcCCCCCHHHeEEcCCCCEEecccccceeccCC
Confidence                                         2778999999999998 9999999999999999999999999999876443


Q ss_pred             -ccccCCCCCcCccCccccCCCccCCCCCCcceeeeEee
Q psy14630        146 -IAKTRDAGCRPYMAPERIDPLRARGYPSFKTKLGFKFN  183 (187)
Q Consensus       146 -~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi~  183 (187)
                       ......+||+.|||||++.   ..+|+.++|+||+||+
T Consensus       180 ~~~~~~~~GT~~YmAPE~~~---~~~y~~~~DiwSlGvi  215 (304)
T 3ubd_A          180 EKKAYSFCGTVEYMAPEVVN---RRGHTQSADWWSFGVL  215 (304)
T ss_dssp             -CCCCSCCCCGGGCCHHHHH---TSCCCTHHHHHHHHHH
T ss_pred             CccccccccCcccCCHHHhc---cCCCCCCCcccchHHH
Confidence             3344568999999999998   6789999999999993

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A*

Probab=100.00  E-value=2e-42  Score=266.61  Aligned_cols=153  Identities=27%  Similarity=0.365  Sum_probs=124.6

Q ss_pred             CcccccccccccccCceEEEEEEEcCCCcEEEEEEccCccChHHHHHHHHHHHHHHhcCCCCchhhhhhhHHH-------
Q psy14630         22 TSEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQFYGALFK-------   94 (187)
Q Consensus        22 ~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~-------   94 (187)
                      ..+.|++.++||+|+||.||+|.+..+++.||||+++.....       .++..+++.++|||||++++++..       
T Consensus        56 ~~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~~-------~~E~~il~~l~HpnIV~l~~~~~~~~~~~iv  128 (336)
T 4g3f_A           56 EVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFR-------VEELVACAGLSSPRIVPLYGAVREGPWVNIF  128 (336)
T ss_dssp             TTTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCC-------THHHHTTTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred             chhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHhH-------HHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence            445688889999999999999999999999999998753221       235567788999999999864321       


Q ss_pred             -------------------------HHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCC-CEEEEecccccccccccc-
Q psy14630         95 -------------------------EVTVATVKALNYLKEELKIIHRDVKPSNILLDRRG-AIKLCDFGISGQLVDSIA-  147 (187)
Q Consensus        95 -------------------------~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~-~~ki~dfg~a~~~~~~~~-  147 (187)
                                               .++.|++.||+|||++ +|+||||||+|||++.++ .+||+|||+|+.+..... 
T Consensus       129 mEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~-~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~~  207 (336)
T 4g3f_A          129 MELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTR-RILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLG  207 (336)
T ss_dssp             ECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTT-TEECSCCCGGGEEECTTSCCEEECCCTTCEEC------
T ss_pred             EeccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC-CceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCcc
Confidence                                     2778999999999998 999999999999999987 699999999998754321 


Q ss_pred             -----ccCCCCCcCccCccccCCCccCCCCCCcceeeeEe-eee
Q psy14630        148 -----KTRDAGCRPYMAPERIDPLRARGYPSFKTKLGFKF-NYR  185 (187)
Q Consensus       148 -----~~~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi-~~~  185 (187)
                           ....+||+.|||||++.   +.+|+.++||||+|| +|+
T Consensus       208 ~~~~~~~~~~GT~~YmAPE~~~---~~~y~~~~DiwSlGvilye  248 (336)
T 4g3f_A          208 KSLLTGDYIPGTETHMAPEVVM---GKPCDAKVDIWSSCCMMLH  248 (336)
T ss_dssp             ------CCCCCCGGGCCHHHHT---TCCCCTHHHHHHHHHHHHH
T ss_pred             cceecCCccccCccccCHHHHC---CCCCCcHHHHHHHHHHHHH
Confidence                 22347999999999998   678999999999999 443

>4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A*

Probab=100.00  E-value=2.7e-42  Score=262.82  Aligned_cols=161  Identities=20%  Similarity=0.306  Sum_probs=129.2

Q ss_pred             ccCCcccccccccccccCceEEEEEEEc-----CCCcEEEEEEccCccChHHHHHHHHHHHHHHhcCCCCchhhhhhhHH
Q psy14630         19 YDFTSEDLQDLGEIGRGGFGTVNKMIHR-----SSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQFYGALF   93 (187)
Q Consensus        19 ~~~~~~~~~~~~~lg~G~fg~V~~~~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~   93 (187)
                      ..+.+++|.+.+.||+|+||.||+|.+.     .+++.||||.++..  .....+.+.+|..+++.++|||||++++.+.
T Consensus         8 ~~I~r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~--~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~   85 (299)
T 4asz_A            8 QHIKRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA--SDNARKDFHREAELLTNLQHEHIVKFYGVCV   85 (299)
T ss_dssp             CBCCGGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC
T ss_pred             cccCHHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCC--ChHHHHHHHHHHHHHHhCCCCCCccEEEEEe
Confidence            3577899999999999999999999864     46788999999753  2334455677777888999999999986431


Q ss_pred             H---------------------------------------------HHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCC
Q psy14630         94 K---------------------------------------------EVTVATVKALNYLKEELKIIHRDVKPSNILLDRR  128 (187)
Q Consensus        94 ~---------------------------------------------~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~  128 (187)
                      .                                             .++.|++.||.|||+. +|+||||||+|||++.+
T Consensus        86 ~~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~-~iiHRDlKp~NILl~~~  164 (299)
T 4asz_A           86 EGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQ-HFVHRDLATRNCLVGEN  164 (299)
T ss_dssp             SSSSEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCSGGGEEECGG
T ss_pred             eCCEEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CcccCccCHhhEEECCC
Confidence            1                                             2677999999999997 99999999999999999


Q ss_pred             CCEEEEecccccccccccc---ccCCCCCcCccCccccCCCccCCCCCCcceeeeEeeee
Q psy14630        129 GAIKLCDFGISGQLVDSIA---KTRDAGCRPYMAPERIDPLRARGYPSFKTKLGFKFNYR  185 (187)
Q Consensus       129 ~~~ki~dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi~~~  185 (187)
                      +.+||+|||+|+.......   .....||+.|||||++.   ...++.++|||||||++|
T Consensus       165 ~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~---~~~~~~k~DVwS~Gvvl~  221 (299)
T 4asz_A          165 LLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIM---YRKFTTESDVWSLGVVLW  221 (299)
T ss_dssp             GCEEECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHH---HCCCCHHHHHHHHHHHHH
T ss_pred             CcEEECCcccceecCCCCceeecCceecChhhcCHHHHc---CCCCCchhhHHHHHHHHH
Confidence            9999999999987654322   12235899999999998   678999999999999554

>4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A*

Probab=100.00  E-value=4.7e-42  Score=266.79  Aligned_cols=165  Identities=26%  Similarity=0.415  Sum_probs=132.2

Q ss_pred             ccccCCcccccccccccccCceEEEEEEEcCC-----CcEEEEEEccCccChHHHHHHHHHHHHHHhcCCCCchhhhhhh
Q psy14630         17 TVYDFTSEDLQDLGEIGRGGFGTVNKMIHRSS-----DTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQFYGA   91 (187)
Q Consensus        17 ~~~~~~~~~~~~~~~lg~G~fg~V~~~~~~~~-----~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~   91 (187)
                      ..|+++.++|++.+.||+|+||.||+|.+..+     ++.||||.++.........+.+.|+..+.+..+|||||+++++
T Consensus        57 ~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~  136 (353)
T 4ase_A           57 SKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGA  136 (353)
T ss_dssp             HHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             cccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEEE
Confidence            45889999999999999999999999987643     3679999997654444444455555555555567999998864


Q ss_pred             HHH-------------------------------------------------HHHHHHHHHHHHHHhcCCCeeecCCCCC
Q psy14630         92 LFK-------------------------------------------------EVTVATVKALNYLKEELKIIHRDVKPSN  122 (187)
Q Consensus        92 ~~~-------------------------------------------------~~~~~~~~~l~~lh~~~~i~Hrdlk~~n  122 (187)
                      +..                                                 .++.|++.||.|||+. +|+||||||+|
T Consensus       137 ~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~-~iiHRDLK~~N  215 (353)
T 4ase_A          137 CTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR-KCIHRDLAARN  215 (353)
T ss_dssp             ECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCSGGG
T ss_pred             EEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhC-CeecCccCccc
Confidence            311                                                 1456899999999998 99999999999


Q ss_pred             eEEcCCCCEEEEeccccccccccc---cccCCCCCcCccCccccCCCccCCCCCCcceeeeEeeee
Q psy14630        123 ILLDRRGAIKLCDFGISGQLVDSI---AKTRDAGCRPYMAPERIDPLRARGYPSFKTKLGFKFNYR  185 (187)
Q Consensus       123 ili~~~~~~ki~dfg~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi~~~  185 (187)
                      ||++.++.+||+|||+|+.+....   ......||+.|||||++.   ...++.++|||||||++|
T Consensus       216 ILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~---~~~y~~ksDVwS~Gv~l~  278 (353)
T 4ase_A          216 ILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIF---DRVYTIQSDVWSFGVLLW  278 (353)
T ss_dssp             EEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHH---HCCCCHHHHHHHHHHHHH
T ss_pred             eeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHh---cCCCCCcccEeehHHHHH
Confidence            999999999999999999764332   223346899999999998   678999999999999554

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens}

Probab=100.00  E-value=1.2e-41  Score=262.52  Aligned_cols=162  Identities=23%  Similarity=0.309  Sum_probs=124.9

Q ss_pred             cccCCcccccccccccccCceEEEEEEEc-----CCCcEEEEEEccCccChHHHHHHHHHHHHHHhcCCCCchhhhhhhH
Q psy14630         18 VYDFTSEDLQDLGEIGRGGFGTVNKMIHR-----SSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQFYGAL   92 (187)
Q Consensus        18 ~~~~~~~~~~~~~~lg~G~fg~V~~~~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~   92 (187)
                      ...+..+++.+.++||+|+||.||+|.+.     .+++.||||.++..  .....+.+.+|..+++.++|||||++++++
T Consensus        35 ~~~i~~~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~--~~~~~~~f~~E~~il~~l~HpnIV~l~g~~  112 (329)
T 4aoj_A           35 VHHIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA--SESARQDFQREAELLTMLQHQHIVRFFGVC  112 (329)
T ss_dssp             SCBCCGGGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCC--SHHHHHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred             hcccCHHHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcC--CHHHHHHHHHHHHHHHhCCCCCCCcEEEEE
Confidence            34567889999999999999999999864     46789999999753  233445567777788899999999998643


Q ss_pred             H-----------------------------------------------HHHHHHHHHHHHHHHhcCCCeeecCCCCCeEE
Q psy14630         93 F-----------------------------------------------KEVTVATVKALNYLKEELKIIHRDVKPSNILL  125 (187)
Q Consensus        93 ~-----------------------------------------------~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili  125 (187)
                      .                                               ..++.|++.||.|||+. +|+||||||+|||+
T Consensus       113 ~~~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~-~iiHRDLKp~NILl  191 (329)
T 4aoj_A          113 TEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGL-HFVHRDLATRNCLV  191 (329)
T ss_dssp             CSSSSEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCCGGGEEE
T ss_pred             EECCEEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcC-CeecccccHhhEEE
Confidence            1                                               12677999999999997 99999999999999


Q ss_pred             cCCCCEEEEeccccccccccc---cccCCCCCcCccCccccCCCccCCCCCCcceeeeEeeee
Q psy14630        126 DRRGAIKLCDFGISGQLVDSI---AKTRDAGCRPYMAPERIDPLRARGYPSFKTKLGFKFNYR  185 (187)
Q Consensus       126 ~~~~~~ki~dfg~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi~~~  185 (187)
                      +.++.+||+|||+++......   ......||+.|||||++.   ...++.++|||||||++|
T Consensus       192 ~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~---~~~~~~~sDvwS~Gvvl~  251 (329)
T 4aoj_A          192 GQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESIL---YRKFTTESDVWSFGVVLW  251 (329)
T ss_dssp             ETTTEEEECCCC----------------CCCCGGGCCHHHHT---TCCCCHHHHHHHHHHHHH
T ss_pred             CCCCcEEEcccccceeccCCCcceecCcccccccccChhhhc---CCCCCccccccchHHHHH
Confidence            999999999999998764332   223457899999999998   677999999999999554

>4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A

Probab=100.00  E-value=5.6e-42  Score=262.07  Aligned_cols=164  Identities=16%  Similarity=0.256  Sum_probs=131.8

Q ss_pred             ccccCCcccccccccccccCceEEEEEEEc-----CCCcEEEEEEccCccChHHHHHHHHHHHHHHhcCCCCchhhhhhh
Q psy14630         17 TVYDFTSEDLQDLGEIGRGGFGTVNKMIHR-----SSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQFYGA   91 (187)
Q Consensus        17 ~~~~~~~~~~~~~~~lg~G~fg~V~~~~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~   91 (187)
                      ...+++.+++++.++||+|+||.||+|...     .+++.||||.++...... ..+.+.++..+++.++|||||+++++
T Consensus        19 ~~~ei~~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~-~~~~f~~E~~il~~l~HpNIV~l~g~   97 (308)
T 4gt4_A           19 KLKEISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGP-LREEFRHEAMLRARLQHPNVVCLLGV   97 (308)
T ss_dssp             CCCBCCGGGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC--CHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             CcccCCHHHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChH-HHHHHHHHHHHHHhCCCCCCCCcceE
Confidence            345678889999999999999999999853     467889999997543332 33456667778888999999999864


Q ss_pred             HH------------------------------------------------HHHHHHHHHHHHHHHhcCCCeeecCCCCCe
Q psy14630         92 LF------------------------------------------------KEVTVATVKALNYLKEELKIIHRDVKPSNI  123 (187)
Q Consensus        92 ~~------------------------------------------------~~~~~~~~~~l~~lh~~~~i~Hrdlk~~ni  123 (187)
                      +.                                                -.++.|++.||.|||+. +|+||||||+||
T Consensus        98 ~~~~~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~-~iiHRDLK~~NI  176 (308)
T 4gt4_A           98 VTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSH-HVVHKDLATRNV  176 (308)
T ss_dssp             ECSSSSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCSGGGE
T ss_pred             EEECCEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC-CCCCCCccccce
Confidence            31                                                12667999999999997 999999999999


Q ss_pred             EEcCCCCEEEEeccccccccccc---cccCCCCCcCccCccccCCCccCCCCCCcceeeeEeeee
Q psy14630        124 LLDRRGAIKLCDFGISGQLVDSI---AKTRDAGCRPYMAPERIDPLRARGYPSFKTKLGFKFNYR  185 (187)
Q Consensus       124 li~~~~~~ki~dfg~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi~~~  185 (187)
                      |++.++.+||+|||+++......   ......||+.|||||++.   ...++.++|||||||++|
T Consensus       177 Ll~~~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~---~~~~s~ksDVwSfGvvl~  238 (308)
T 4gt4_A          177 LVYDKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIM---YGKFSIDSDIWSYGVVLW  238 (308)
T ss_dssp             EECGGGCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHH---HCCCCHHHHHHHHHHHHH
T ss_pred             EECCCCCEEECCcccceeccCCCceeEecccccCCcccCHHHHh---CCCCCccchhhhHHHHHH
Confidence            99999999999999998775432   223457899999999998   677999999999999554

>4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens}

Probab=100.00  E-value=2.5e-41  Score=266.63  Aligned_cols=159  Identities=23%  Similarity=0.355  Sum_probs=131.2

Q ss_pred             ccccccccccccCceEEEEEEEcCCCcEEEEEEccCccChHHHHHHHHHHHHHHhcCCCCchhhhhhhH-----------
Q psy14630         24 EDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQFYGAL-----------   92 (187)
Q Consensus        24 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~-----------   92 (187)
                      ++|++++.||+|+||+||+|.+..+++.||||+++.........+.+.++..+++.++|||||++++.+           
T Consensus        54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~  133 (398)
T 4b99_A           54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKS  133 (398)
T ss_dssp             SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCC
T ss_pred             CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCE
Confidence            579999999999999999999999999999999976544444455566677788889999999987532           


Q ss_pred             --------------------------HHHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEecccccccccc-
Q psy14630         93 --------------------------FKEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDS-  145 (187)
Q Consensus        93 --------------------------~~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg~a~~~~~~-  145 (187)
                                                ...++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+|+.+... 
T Consensus       134 ~~ivmE~~~g~L~~~i~~~~~l~~~~~~~~~~qil~al~ylH~~-~iiHRDlKP~NIl~~~~~~~Ki~DFGla~~~~~~~  212 (398)
T 4b99_A          134 VYVVLDLMESDLHQIIHSSQPLTLEHVRYFLYQLLRGLKYMHSA-QVIHRDLKPSNLLVNENCELKIGDFGMARGLCTSP  212 (398)
T ss_dssp             EEEEEECCSEEHHHHHTSSSCCCHHHHHHHHHHHHHHHHHHHHT-TCBCCCCCGGGEEECTTCCEEECCCTTCBCC----
T ss_pred             EEEEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC-cCcCCCcCccccccCCCCCEEEeecceeeecccCc
Confidence                                      112788999999999998 9999999999999999999999999999876432 


Q ss_pred             ----ccccCCCCCcCccCccccCCCccCCCCCCcceeeeEe-eee
Q psy14630        146 ----IAKTRDAGCRPYMAPERIDPLRARGYPSFKTKLGFKF-NYR  185 (187)
Q Consensus       146 ----~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi-~~~  185 (187)
                          ......+||+.|||||++.+  ...++.++||||+|+ +|.
T Consensus       213 ~~~~~~~~~~~GT~~Y~APEv~~~--~~~~~~~~DiWSlG~il~e  255 (398)
T 4b99_A          213 AEHQYFMTEYVATRWYRAPELMLS--LHEYTQAIDLWSVGCIFGE  255 (398)
T ss_dssp             ---CCCCCSSCCCCTTCCHHHHTT--CSCCCTHHHHHHHHHHHHH
T ss_pred             cccccccccceeChHhcCHHHhcC--CCCCCChhheehhHHHHHH
Confidence                22345689999999999883  335789999999999 443

>3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A

Probab=100.00  E-value=7.5e-40  Score=269.98  Aligned_cols=162  Identities=23%  Similarity=0.397  Sum_probs=129.6

Q ss_pred             cCCcccccccccccccCceEEEEEEEcCCCcEEEEEEccCcc----ChHHHHHHHHHHHHHHhcCCCCchhhhhhhHHH-
Q psy14630         20 DFTSEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTV----DEKDQRQLLMDLDVVMKSNECPYIVQFYGALFK-   94 (187)
Q Consensus        20 ~~~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~-   94 (187)
                      .+..++|++.+.||+|+||.||+|.+..+++.||||++.+..    ...........+..+++.++|||||++++++.. 
T Consensus       185 ~~slddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~  264 (689)
T 3v5w_A          185 HLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTP  264 (689)
T ss_dssp             CCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECS
T ss_pred             CCchHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEEC
Confidence            356789999999999999999999999999999999985321    111111122223445667899999998754321 


Q ss_pred             -------------------------------HHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEecccccccc
Q psy14630         95 -------------------------------EVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLV  143 (187)
Q Consensus        95 -------------------------------~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg~a~~~~  143 (187)
                                                     .++.|++.||.|||+. +|+||||||+|||++.+|.+||+|||+|+.+.
T Consensus       265 ~~lylVmEy~~GGdL~~~l~~~~~l~E~~a~~y~~qIl~aL~yLH~~-gIiHRDLKPeNILld~~G~vKL~DFGlA~~~~  343 (689)
T 3v5w_A          265 DKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNR-FVVYRDLKPANILLDEHGHVRISDLGLACDFS  343 (689)
T ss_dssp             SEEEEEECCCCSCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHTT-TEECCCCSGGGEEECTTSCEEECCCTTCEECS
T ss_pred             CEEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC-CccccCCchHHeEEeCCCCEEecccceeeecC
Confidence                                           2778999999999997 99999999999999999999999999998875


Q ss_pred             ccccccCCCCCcCccCccccCCCccCCCCCCcceeeeEe-eee
Q psy14630        144 DSIAKTRDAGCRPYMAPERIDPLRARGYPSFKTKLGFKF-NYR  185 (187)
Q Consensus       144 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi-~~~  185 (187)
                      ... ....+||+.|||||++.+  ..+|+.++||||+|| +|.
T Consensus       344 ~~~-~~t~~GTp~YmAPEvl~~--~~~y~~~vDiWSLGvilYE  383 (689)
T 3v5w_A          344 KKK-PHASVGTHGYMAPEVLQK--GVAYDSSADWFSLGCMLFK  383 (689)
T ss_dssp             SCC-CCSCCSCGGGCCHHHHST--TCCCCTHHHHHHHHHHHHH
T ss_pred             CCC-CCCccCCcCccCHHHHhC--CCCCCcHHHHHHHHHHHHH
Confidence            543 344689999999999972  457999999999999 554

>3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A*

Probab=100.00  E-value=9.5e-40  Score=249.59  Aligned_cols=156  Identities=24%  Similarity=0.275  Sum_probs=116.5

Q ss_pred             ccccccccccccCceEEEEEEEcCCCcEEEEEEccCccChHHHHHHHHH-HHHHHhcCCCCchhhhhhhHHH--------
Q psy14630         24 EDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMD-LDVVMKSNECPYIVQFYGALFK--------   94 (187)
Q Consensus        24 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~-~~~~~~~~~h~~iv~~~~~~~~--------   94 (187)
                      .+|.+.+.||+|+||.||+|.+  +++.||||+++...    ..+...+ +...+..++||||+++++.+..        
T Consensus         3 r~i~L~~~iG~G~fG~Vy~~~~--~g~~VAvK~l~~~~----~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~   76 (303)
T 3hmm_A            3 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSRE----ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQL   76 (303)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEE--TTEEEEEEEECGGG----HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEE
T ss_pred             cEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccc----hhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEE
Confidence            5688889999999999999987  48899999986421    1222222 3333456799999998764311        


Q ss_pred             ---------------------------HHHHHHHHHHHHHHhc-------CCCeeecCCCCCeEEcCCCCEEEEeccccc
Q psy14630         95 ---------------------------EVTVATVKALNYLKEE-------LKIIHRDVKPSNILLDRRGAIKLCDFGISG  140 (187)
Q Consensus        95 ---------------------------~~~~~~~~~l~~lh~~-------~~i~Hrdlk~~nili~~~~~~ki~dfg~a~  140 (187)
                                                 .+..|++.||+|||++       .+|+||||||+|||++.++.+||+|||+|+
T Consensus        77 ~lV~Ey~~~gsL~~~l~~~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~  156 (303)
T 3hmm_A           77 WLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV  156 (303)
T ss_dssp             EEEEECCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCE
T ss_pred             EEEecCCCCCcHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCc
Confidence                                       2677999999999974       289999999999999999999999999998


Q ss_pred             ccccccc-----ccCCCCCcCccCccccCCCcc---CCCCCCcceeeeEeeee
Q psy14630        141 QLVDSIA-----KTRDAGCRPYMAPERIDPLRA---RGYPSFKTKLGFKFNYR  185 (187)
Q Consensus       141 ~~~~~~~-----~~~~~~t~~y~aPE~~~~~~~---~~~~~~~D~ws~gi~~~  185 (187)
                      .......     ....+||+.|||||++.+..+   ..++.++|||||||++|
T Consensus       157 ~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~  209 (303)
T 3hmm_A          157 RHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFW  209 (303)
T ss_dssp             EEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHH
T ss_pred             cccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHH
Confidence            7654321     123479999999999974211   13567899999999544

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A

Probab=100.00  E-value=6.6e-39  Score=263.29  Aligned_cols=157  Identities=22%  Similarity=0.362  Sum_probs=132.4

Q ss_pred             cccccccccccccCceEEEEEEEcCCCcEEEEEEccCccChHHHHHHHHHHHHHHhcCCCCchhhhhhhHH---------
Q psy14630         23 SEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQFYGALF---------   93 (187)
Q Consensus        23 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~---------   93 (187)
                      .++|++.+.||+|+||.||+|.++.+++.||+|++...  .....+.+.++..+++.++||||+++++++.         
T Consensus       156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~--~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~  233 (573)
T 3uto_A          156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTP--HESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIY  233 (573)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC--SHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEE
T ss_pred             ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEecc--chhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEE
Confidence            46899999999999999999999999999999998643  2233455666777888899999999875431         


Q ss_pred             ------------------------HHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCC--CCEEEEecccccccccccc
Q psy14630         94 ------------------------KEVTVATVKALNYLKEELKIIHRDVKPSNILLDRR--GAIKLCDFGISGQLVDSIA  147 (187)
Q Consensus        94 ------------------------~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~--~~~ki~dfg~a~~~~~~~~  147 (187)
                                              ..++.|++.||.|||++ +|+||||||+|||++.+  +.+||+|||+|+.+.+...
T Consensus       234 E~~~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH~~-~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~~~  312 (573)
T 3uto_A          234 EFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHEN-NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQS  312 (573)
T ss_dssp             ECCCCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHHHT-TEECCCCCGGGEEESSSSCCCEEECCCSSCEECCTTSE
T ss_pred             eecCCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHC-CeeeccCChhhccccCCCCCCEEEeeccceeEccCCCc
Confidence                                    12778999999999998 99999999999999754  8999999999999876655


Q ss_pred             ccCCCCCcCccCccccCCCccCCCCCCcceeeeEe-eee
Q psy14630        148 KTRDAGCRPYMAPERIDPLRARGYPSFKTKLGFKF-NYR  185 (187)
Q Consensus       148 ~~~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi-~~~  185 (187)
                      ....+||+.|||||++.   ..+|+.++|+||+|| +|.
T Consensus       313 ~~~~~GT~~y~APEv~~---~~~y~~~~DiWSlGvilye  348 (573)
T 3uto_A          313 VKVTTGTAEFAAPEVAE---GKPVGYYTDMWSVGVLSYI  348 (573)
T ss_dssp             EEEECSSGGGCCHHHHT---TCCBCHHHHHHHHHHHHHH
T ss_pred             eeeeEECccccCHHHhC---CCCCCcHHHHHHHHHHHHH
Confidence            55668999999999998   677999999999999 443

>4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A*

Probab=100.00  E-value=1.3e-38  Score=248.51  Aligned_cols=157  Identities=23%  Similarity=0.309  Sum_probs=120.2

Q ss_pred             cccccccccccccCceEEEEEEEc---CCCcEEEEEEccCccChHHHHHHHHHHHHHHhcCCCCchhhhhhhH-------
Q psy14630         23 SEDLQDLGEIGRGGFGTVNKMIHR---SSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQFYGAL-------   92 (187)
Q Consensus        23 ~~~~~~~~~lg~G~fg~V~~~~~~---~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~-------   92 (187)
                      .++|++.+.||+|+||+||+|.++   .+++.||+|.+.....   ..+...|+..+....+||||+++++.+       
T Consensus        20 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~---~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~~   96 (361)
T 4f9c_A           20 SNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTSH---PIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHVV   96 (361)
T ss_dssp             GGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTSC---HHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEEE
T ss_pred             cCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccccC---HHHHHHHHHHHHHhcCCCCCceEEEEEEECCEEE
Confidence            367999999999999999999874   4678899998864322   223344444444445799999987543       


Q ss_pred             ----------------------HHHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCC-CCEEEEeccccccccccc---
Q psy14630         93 ----------------------FKEVTVATVKALNYLKEELKIIHRDVKPSNILLDRR-GAIKLCDFGISGQLVDSI---  146 (187)
Q Consensus        93 ----------------------~~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~-~~~ki~dfg~a~~~~~~~---  146 (187)
                                            ...++.|++.||+|||+. +|+||||||+|||++.+ +.+||+|||+|+...+..   
T Consensus        97 lvmE~~~g~~L~~~~~~l~~~~~~~~~~qll~al~ylH~~-gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~~~~~~~~~  175 (361)
T 4f9c_A           97 IAMPYLEHESFLDILNSLSFQEVREYMLNLFKALKRIHQF-GIVHRDVKPSNFLYNRRLKKYALVDFGLAQGTHDTKIEL  175 (361)
T ss_dssp             EEEECCCCCCHHHHHTTCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEEETTTTEEEECCCTTCEECTTCSCGG
T ss_pred             EEEeCCCcccHHHHHcCCCHHHHHHHHHHHHHHHHHHHHC-CeEeCcCCHHHeEEeCCCCeEEECcCCCCcccCCccccc
Confidence                                  223778999999999998 99999999999999876 799999999998653211   


Q ss_pred             --------------------------cccCCCCCcCccCccccCCCccCCCCCCcceeeeEe-eee
Q psy14630        147 --------------------------AKTRDAGCRPYMAPERIDPLRARGYPSFKTKLGFKF-NYR  185 (187)
Q Consensus       147 --------------------------~~~~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi-~~~  185 (187)
                                                .....+||+.|+|||++.+  ...++.++|+||+|+ +|.
T Consensus       176 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~--~~~y~~~~DiWSlG~il~e  239 (361)
T 4f9c_A          176 LKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTK--CPNQTTAIDMWSAGVIFLS  239 (361)
T ss_dssp             GGGC--------------------------CCCCGGGCCHHHHTT--CSCCCTHHHHHHHHHHHHH
T ss_pred             cccccccccccccccccccccccccccccccccCccccCHHHHcC--CCCCCCccchhhhHHHHHH
Confidence                                      1123479999999999984  335889999999999 443

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens}

Probab=100.00  E-value=3.4e-36  Score=236.72  Aligned_cols=166  Identities=30%  Similarity=0.486  Sum_probs=135.7

Q ss_pred             ccccCCcccccccccccccCceEEEEEEEcCCCcEEEEEEccCcc-ChHHHHHHHHHHHHHHhcCCCCchhhhhhhHH--
Q psy14630         17 TVYDFTSEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTV-DEKDQRQLLMDLDVVMKSNECPYIVQFYGALF--   93 (187)
Q Consensus        17 ~~~~~~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~--   93 (187)
                      ...++..++|++.+.||+|+||.||+|.+..+++.||+|++.... ......+.+..+..+++.+.||||+++++.+.  
T Consensus         8 ~~~~v~~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~   87 (384)
T 4fr4_A            8 ENEDVNFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDE   87 (384)
T ss_dssp             CCCCCCGGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECS
T ss_pred             CCCCCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeC
Confidence            345677899999999999999999999999999999999985321 11112344555666778889999999875331  


Q ss_pred             ------------------------------HHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEecccccccc
Q psy14630         94 ------------------------------KEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLV  143 (187)
Q Consensus        94 ------------------------------~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg~a~~~~  143 (187)
                                                    ..++.|++.||.|||+. +|+||||||+||+++.++.+||+|||+++...
T Consensus        88 ~~~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~-givHrDlkp~NIll~~~g~vkL~DFG~a~~~~  166 (384)
T 4fr4_A           88 EDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQNQ-RIIHRDMKPDNILLDEHGHVHITDFNIAAMLP  166 (384)
T ss_dssp             SEEEEEECCCTTEEHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEECTTSCEEECCCTTCEECC
T ss_pred             CEEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC-CceeccCcHHHeEECCCCCEEEeccceeeecc
Confidence                                          12677999999999998 99999999999999999999999999999876


Q ss_pred             ccccccCCCCCcCccCccccCCCccCCCCCCcceeeeEee
Q psy14630        144 DSIAKTRDAGCRPYMAPERIDPLRARGYPSFKTKLGFKFN  183 (187)
Q Consensus       144 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi~  183 (187)
                      ........+||+.|+|||++......+++.++|+||+|++
T Consensus       167 ~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~i  206 (384)
T 4fr4_A          167 RETQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVT  206 (384)
T ss_dssp             TTCCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHH
T ss_pred             CCCceeccCCCccccCCeeeccCCCCCCCccceeechHHH
Confidence            6555566789999999999975444568999999999993

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A*

Probab=100.00  E-value=6e-36  Score=240.60  Aligned_cols=157  Identities=25%  Similarity=0.314  Sum_probs=127.3

Q ss_pred             cccccccccccccCceEEEEEEEcCCCcEEEEEEccCccChHHHHHHHHHHHHHHhcCCCCchhhhhhhH----------
Q psy14630         23 SEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQFYGAL----------   92 (187)
Q Consensus        23 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~----------   92 (187)
                      .++|++.+.||+|+||.||+|.+..+++.||||.+..........+.+.++..+++.++||||+++++.+          
T Consensus        61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~  140 (464)
T 3ttj_A           61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ  140 (464)
T ss_dssp             ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred             cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCC
Confidence            4679999999999999999999999999999999875444444455566667778888999999987543          


Q ss_pred             -------------------------HHHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEecccccccccccc
Q psy14630         93 -------------------------FKEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIA  147 (187)
Q Consensus        93 -------------------------~~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg~a~~~~~~~~  147 (187)
                                               ...++.|++.||.|||+. +|+||||||+||+++.++.+||+|||+++.......
T Consensus       141 ~~~lv~E~~~~~l~~~~~~~l~~~~~~~~~~qil~aL~~lH~~-~iiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~  219 (464)
T 3ttj_A          141 DVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSA-GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFM  219 (464)
T ss_dssp             EEEEEEECCSEEHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHT-TCCCCCCCGGGEEECTTSCEEECCCCCC-----CCC
T ss_pred             eEEEEEeCCCCCHHHHHhhcCCHHHHHHHHHHHHHHHHHHHHC-CcccCCCChHhEEEeCCCCEEEEEEEeeeecCCCcc
Confidence                                     112678999999999998 999999999999999999999999999988766555


Q ss_pred             ccCCCCCcCccCccccCCCccCCCCCCcceeeeEee
Q psy14630        148 KTRDAGCRPYMAPERIDPLRARGYPSFKTKLGFKFN  183 (187)
Q Consensus       148 ~~~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi~  183 (187)
                      .....||+.|+|||++.   ...++.++|+||+|++
T Consensus       220 ~~~~~gt~~y~aPE~~~---~~~~~~~~DiwSlG~i  252 (464)
T 3ttj_A          220 MTPYVVTRYYRAPEVIL---GMGYKENVDIWSVGCI  252 (464)
T ss_dssp             C----CCCTTCCHHHHT---TCCCCTTHHHHHHHHH
T ss_pred             cCCCcccccccCHHHHc---CCCCCHHHHHHHHHHH
Confidence            55568999999999998   5679999999999993

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii}

Probab=100.00  E-value=9.8e-36  Score=238.91  Aligned_cols=158  Identities=21%  Similarity=0.329  Sum_probs=119.0

Q ss_pred             cccccccccccccCceEEEEEEEcCCCcEEEEEEccCccChHHHHHHHHHHHHHHhcCCCCchhhhhhhH----------
Q psy14630         23 SEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQFYGAL----------   92 (187)
Q Consensus        23 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~----------   92 (187)
                      .++|++.+.||+|+||.||+|.+..+++.||||.+..........+.+.++..+++.++||||+++++.+          
T Consensus        52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~  131 (458)
T 3rp9_A           52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDE  131 (458)
T ss_dssp             CTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred             CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCce
Confidence            3789999999999999999999999999999999875544444555566677778888999999987543          


Q ss_pred             --------------------------HHHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEeccccccccccc
Q psy14630         93 --------------------------FKEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSI  146 (187)
Q Consensus        93 --------------------------~~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg~a~~~~~~~  146 (187)
                                                ...++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++......
T Consensus       132 ~~lv~e~~~~~L~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~-~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~  210 (458)
T 3rp9_A          132 LYVVLEIADSDFKKLFRTPVYLTELHIKTLLYNLLVGVKYVHSA-GILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPE  210 (458)
T ss_dssp             EEEEECCCSEEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHT-TCBCCCCCGGGEEECTTCCEEECCCTTCBCTTSCT
T ss_pred             EEEEEeccccchhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhC-CcCCCCCChhhEEECCCCCEeecccccchhccCcc
Confidence                                      112678999999999998 99999999999999999999999999998764221


Q ss_pred             ----------------------------cccCCCCCcCccCccccCCCccCCCCCCcceeeeEee
Q psy14630        147 ----------------------------AKTRDAGCRPYMAPERIDPLRARGYPSFKTKLGFKFN  183 (187)
Q Consensus       147 ----------------------------~~~~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi~  183 (187)
                                                  .....+||+.|+|||++..  ...++.++||||+|++
T Consensus       211 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~--~~~~~~~~DiwSlG~i  273 (458)
T 3rp9_A          211 NGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILL--QENYTEAIDVWSIGCI  273 (458)
T ss_dssp             TCCCCCC---------------------------CCCTTCCHHHHTT--CCCCCTHHHHHHHHHH
T ss_pred             ccccccccCccccccccccccccccccccccCCcccccccChHHhhC--CCCCCcHhHHHHHHHH
Confidence                                        1223468999999998752  4568999999999993

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A

Probab=100.00  E-value=7e-36  Score=230.56  Aligned_cols=159  Identities=27%  Similarity=0.363  Sum_probs=132.6

Q ss_pred             CCcccccccccccccCceEEEEEEEcCCCcEEEEEEccCccChHHHHHHHHHHHHHHhcCCCCchhhhhhhH--------
Q psy14630         21 FTSEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQFYGAL--------   92 (187)
Q Consensus        21 ~~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~--------   92 (187)
                      ...++|++.+.||+|+||.||+|.+..+++.||+|++..........+.+.++..+++.++||||+++++.+        
T Consensus        12 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~l   91 (328)
T 3fe3_A           12 PHIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYL   91 (328)
T ss_dssp             CEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred             CccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEE
Confidence            345789999999999999999999999999999999865444444445566667778888999999987532        


Q ss_pred             ------------------------HHHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEeccccccccccccc
Q psy14630         93 ------------------------FKEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAK  148 (187)
Q Consensus        93 ------------------------~~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg~a~~~~~~~~~  148 (187)
                                              ...++.|++.|+.|||+. +++||||||+||+++.++.+||+|||+++........
T Consensus        92 v~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~-~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~  170 (328)
T 3fe3_A           92 IMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQK-RIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKL  170 (328)
T ss_dssp             EECCCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCCGGGEEECTTSCEEECSTTCCGGGSSSCGG
T ss_pred             EEECCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC-CEeccCCCHHHEEEcCCCCEEEeeccCceecCCCCcc
Confidence                                    112678999999999998 9999999999999999999999999999887655555


Q ss_pred             cCCCCCcCccCccccCCCccCCCC-CCcceeeeEee
Q psy14630        149 TRDAGCRPYMAPERIDPLRARGYP-SFKTKLGFKFN  183 (187)
Q Consensus       149 ~~~~~t~~y~aPE~~~~~~~~~~~-~~~D~ws~gi~  183 (187)
                      ...+||+.|+|||.+.   ...++ .++|+||+|++
T Consensus       171 ~~~~gt~~y~aPE~~~---~~~~~~~~~DiwslG~i  203 (328)
T 3fe3_A          171 DAFCGAPPYAAPELFQ---GKKYDGPEVDVWSLGVI  203 (328)
T ss_dssp             GTTSSSGGGCCHHHHH---TCCCCSHHHHHHHHHHH
T ss_pred             ccccCCcceeCccccc---CCCcCCchhhhhhhHHH
Confidence            5668999999999998   44554 78999999994

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus}

Probab=100.00  E-value=1.3e-35  Score=234.17  Aligned_cols=161  Identities=24%  Similarity=0.379  Sum_probs=127.1

Q ss_pred             ccCCcccccccccccccCceEEEEEEEcCCCcEEEEEEccCccC-hHHHHH-HHHHHHHHHhcCCCCchhhhhhhHH---
Q psy14630         19 YDFTSEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVD-EKDQRQ-LLMDLDVVMKSNECPYIVQFYGALF---   93 (187)
Q Consensus        19 ~~~~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~-~~~~~~~~~~~~~h~~iv~~~~~~~---   93 (187)
                      ..+..++|++.+.||+|+||.||+|.+..+++.||+|+++.... .....+ ...+...+.+..+||||+++++.+.   
T Consensus        47 ~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~  126 (396)
T 4dc2_A           47 SSLGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTES  126 (396)
T ss_dssp             --CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSS
T ss_pred             cCCChhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECC
Confidence            34677899999999999999999999999999999999865322 122222 3333343444558999999875331   


Q ss_pred             -----------------------------HHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEeccccccc-c
Q psy14630         94 -----------------------------KEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQL-V  143 (187)
Q Consensus        94 -----------------------------~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg~a~~~-~  143 (187)
                                                   ..++.|++.||.|||+. +|+||||||+||+++.++.+||+|||+++.. .
T Consensus       127 ~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~-givHrDLKp~NILl~~~g~ikL~DFGla~~~~~  205 (396)
T 4dc2_A          127 RLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHER-GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLR  205 (396)
T ss_dssp             EEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT-TCBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred             EEEEEEEcCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC-CEEeccCCHHHEEECCCCCEEEeecceeeeccc
Confidence                                         12677899999999998 9999999999999999999999999999873 3


Q ss_pred             ccccccCCCCCcCccCccccCCCccCCCCCCcceeeeEee
Q psy14630        144 DSIAKTRDAGCRPYMAPERIDPLRARGYPSFKTKLGFKFN  183 (187)
Q Consensus       144 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi~  183 (187)
                      ........+||+.|+|||++.   ...++.++|+||+|++
T Consensus       206 ~~~~~~~~~gt~~Y~aPE~l~---~~~~~~~~DiwslGvl  242 (396)
T 4dc2_A          206 PGDTTSTFCGTPNYIAPEILR---GEDYGFSVDWWALGVL  242 (396)
T ss_dssp             TTCCBCCCCBCGGGCCHHHHT---TCCBCTHHHHHHHHHH
T ss_pred             CCCccccccCCcccCCchhhc---CCCCChHHHHHHHHHH
Confidence            334445568999999999998   6678999999999993

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A*

Probab=100.00  E-value=1e-35  Score=233.22  Aligned_cols=160  Identities=27%  Similarity=0.450  Sum_probs=124.7

Q ss_pred             cCCcccccccccccccCceEEEEEEEcCCCcEEEEEEccCccC--hHHHHHHHHHHHHHHhcCCCCchhhhhhhHH----
Q psy14630         20 DFTSEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVD--EKDQRQLLMDLDVVMKSNECPYIVQFYGALF----   93 (187)
Q Consensus        20 ~~~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~----   93 (187)
                      ....++|++.+.||+|+||.||+|.+..+++.||+|+++....  .......+.+...+++.++||||+++++.+.    
T Consensus        34 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~  113 (373)
T 2r5t_A           34 HAKPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADK  113 (373)
T ss_dssp             TCCGGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSE
T ss_pred             CCChhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCE
Confidence            4567899999999999999999999999999999999864321  1222333444443456789999998864321    


Q ss_pred             ----------------------------HHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEeccccccccc-
Q psy14630         94 ----------------------------KEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVD-  144 (187)
Q Consensus        94 ----------------------------~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg~a~~~~~-  144 (187)
                                                  ..++.|++.||.|||+. +++||||||+||+++.++.+||+|||+++.... 
T Consensus       114 ~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~-givHrDlkp~NIll~~~g~ikL~DFG~a~~~~~~  192 (373)
T 2r5t_A          114 LYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSL-NIVYRDLKPENILLDSQGHIVLTDFGLCKENIEH  192 (373)
T ss_dssp             EEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT-TCCCCCCCGGGEEECTTSCEEECCCCBCGGGBCC
T ss_pred             EEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC-CceecCCCHHHEEECCCCCEEEeeCccccccccC
Confidence                                        12677899999999997 999999999999999999999999999987432 


Q ss_pred             cccccCCCCCcCccCccccCCCccCCCCCCcceeeeEee
Q psy14630        145 SIAKTRDAGCRPYMAPERIDPLRARGYPSFKTKLGFKFN  183 (187)
Q Consensus       145 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi~  183 (187)
                      .......+||+.|+|||++.   ...++.++|+||+|++
T Consensus       193 ~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwslG~i  228 (373)
T 2r5t_A          193 NSTTSTFCGTPEYLAPEVLH---KQPYDRTVDWWCLGAV  228 (373)
T ss_dssp             CCCCCSBSCCCCCCCHHHHT---TCCCCTHHHHHHHHHH
T ss_pred             CCccccccCCccccCHHHhC---CCCCCchhhhHHHHHH
Confidence            33344568999999999998   6678999999999993

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ...

Probab=100.00  E-value=2e-35  Score=228.76  Aligned_cols=159  Identities=26%  Similarity=0.421  Sum_probs=128.2

Q ss_pred             CCcccccccccccccCceEEEEEEEcCCCcEEEEEEccCccC-hHHHHHHHHHHHHHHhcCCCCchhhhhhhHH------
Q psy14630         21 FTSEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVD-EKDQRQLLMDLDVVMKSNECPYIVQFYGALF------   93 (187)
Q Consensus        21 ~~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~------   93 (187)
                      +..++|++.+.||+|+||.||+|.+..+++.||+|+++.... .....+.+..+..+++.+.||||+++++.+.      
T Consensus         2 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~   81 (337)
T 1o6l_A            2 VTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLC   81 (337)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEE
T ss_pred             CChHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEE
Confidence            356899999999999999999999999999999999864211 1112234455566777889999998864321      


Q ss_pred             --------------------------HHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEeccccccccc-cc
Q psy14630         94 --------------------------KEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVD-SI  146 (187)
Q Consensus        94 --------------------------~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg~a~~~~~-~~  146 (187)
                                                ..++.|++.||.|||+. +++||||||+||+++.++.+||+|||+++.... ..
T Consensus        82 lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~-~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~  160 (337)
T 1o6l_A           82 FVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSR-DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA  160 (337)
T ss_dssp             EEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHT-TCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTTC
T ss_pred             EEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC-CeecCcCCHHHEEECCCCCEEEeeccchhhcccCCC
Confidence                                      12667899999999998 999999999999999999999999999987432 33


Q ss_pred             cccCCCCCcCccCccccCCCccCCCCCCcceeeeEee
Q psy14630        147 AKTRDAGCRPYMAPERIDPLRARGYPSFKTKLGFKFN  183 (187)
Q Consensus       147 ~~~~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi~  183 (187)
                      .....+||+.|+|||++.   ...++.++|+||+|++
T Consensus       161 ~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwslG~i  194 (337)
T 1o6l_A          161 TMKTFCGTPEYLAPEVLE---DNDYGRAVDWWGLGVV  194 (337)
T ss_dssp             CBCCCEECGGGCCGGGGS---SSCBCTTHHHHHHHHH
T ss_pred             cccccccChhhCChhhhc---CCCCCchhhcccchhH
Confidence            344557999999999998   6678999999999993

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens}

Probab=100.00  E-value=3.9e-35  Score=224.64  Aligned_cols=162  Identities=30%  Similarity=0.411  Sum_probs=128.9

Q ss_pred             ccccCCcccccccccccccCceEEEEEEEcCCCcEEEEEEccCcc-ChHHHHHHHHHHHHHHhcCCCCchhhhhhhH---
Q psy14630         17 TVYDFTSEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTV-DEKDQRQLLMDLDVVMKSNECPYIVQFYGAL---   92 (187)
Q Consensus        17 ~~~~~~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~---   92 (187)
                      ...++..++|++.+.||+|+||+||+|.+..+++.||||++.... ......+.+.++..+.+...||||+++++.+   
T Consensus        50 ~~~~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~  129 (311)
T 3p1a_A           50 RPESFFQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEG  129 (311)
T ss_dssp             SSSCHHHHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEET
T ss_pred             CccchhhhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeC
Confidence            333445578999999999999999999999999999999876433 3334455566666666777999999886532   


Q ss_pred             -----------------------------HHHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEecccccccc
Q psy14630         93 -----------------------------FKEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLV  143 (187)
Q Consensus        93 -----------------------------~~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg~a~~~~  143 (187)
                                                   ...++.|++.||.|||+. +++||||||+||+++.++.+||+|||++....
T Consensus       130 ~~~~lv~e~~~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~-~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~  208 (311)
T 3p1a_A          130 GILYLQTELCGPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQ-GLVHLDVKPANIFLGPRGRCKLGDFGLLVELG  208 (311)
T ss_dssp             TEEEEEEECCCCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEECGGGCEEECCCTTCEECC
T ss_pred             CEEEEEEeccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC-CEecCCCCHHHEEECCCCCEEEccceeeeecc
Confidence                                         112678999999999998 99999999999999999999999999998876


Q ss_pred             ccccccCCCCCcCccCccccCCCccCCCCCCcceeeeEee
Q psy14630        144 DSIAKTRDAGCRPYMAPERIDPLRARGYPSFKTKLGFKFN  183 (187)
Q Consensus       144 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi~  183 (187)
                      .........||+.|+|||++.   . .++.++|+||||++
T Consensus       209 ~~~~~~~~~gt~~y~aPE~~~---~-~~~~~~DiwslG~i  244 (311)
T 3p1a_A          209 TAGAGEVQEGDPRYMAPELLQ---G-SYGTAADVFSLGLT  244 (311)
T ss_dssp             ------CCCCCGGGCCGGGGG---T-CCSTHHHHHHHHHH
T ss_pred             cCCCCcccCCCccccCHhHhc---C-CCCchhhHHHHHHH
Confidence            555555567899999999987   3 58899999999994

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens}

Probab=100.00  E-value=6.5e-36  Score=232.88  Aligned_cols=165  Identities=23%  Similarity=0.393  Sum_probs=121.2

Q ss_pred             ccccCCcccccccccccccCceEEEEEEEcCCCcEEEEEEccCccC-hHHHHHHHHHHHHHHhc-CCCCchhhhhhhH--
Q psy14630         17 TVYDFTSEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVD-EKDQRQLLMDLDVVMKS-NECPYIVQFYGAL--   92 (187)
Q Consensus        17 ~~~~~~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~~~~~~~~-~~h~~iv~~~~~~--   92 (187)
                      ....+..++|++.+.||+|+||.||+|.+..+++.||+|+++.... .....+....+..++.. .+||||+++++.+  
T Consensus        16 ~~~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~   95 (353)
T 3txo_A           16 SSNRLGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQT   95 (353)
T ss_dssp             -------CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEEC
T ss_pred             CcCCCchhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEe
Confidence            3345667899999999999999999999999999999999864211 11122333334444444 4899999887532  


Q ss_pred             ------------------------------HHHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEeccccccc
Q psy14630         93 ------------------------------FKEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQL  142 (187)
Q Consensus        93 ------------------------------~~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg~a~~~  142 (187)
                                                    ...++.|++.||.|||+. +|+||||||+||+++.++.+||+|||+++..
T Consensus        96 ~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~-givHrDlkp~NILl~~~g~ikL~DFG~a~~~  174 (353)
T 3txo_A           96 PDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFLHDK-GIIYRDLKLDNVLLDHEGHCKLADFGMCKEG  174 (353)
T ss_dssp             SSEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT-TCBCCCCCGGGEEECTTSCEEECCCTTCBCS
T ss_pred             CCEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC-CCcccCCCHHHEEECCCCCEEEccccceeec
Confidence                                          112678999999999998 9999999999999999999999999999864


Q ss_pred             cc-cccccCCCCCcCccCccccCCCccCCCCCCcceeeeEe-eee
Q psy14630        143 VD-SIAKTRDAGCRPYMAPERIDPLRARGYPSFKTKLGFKF-NYR  185 (187)
Q Consensus       143 ~~-~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi-~~~  185 (187)
                      .. .......+||+.|+|||++.   ...++.++|+||+|+ +|+
T Consensus       175 ~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwslG~il~e  216 (353)
T 3txo_A          175 ICNGVTTATFCGTPDYIAPEILQ---EMLYGPAVDWWAMGVLLYE  216 (353)
T ss_dssp             CC---------CCGGGCCHHHHH---HHHCTTHHHHHHHHHHHHH
T ss_pred             ccCCccccccCCCcCeEChhhcC---CCCcCCccCCCcchHHHHH
Confidence            32 33344557999999999998   667899999999999 443

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A*

Probab=100.00  E-value=7.3e-35  Score=226.31  Aligned_cols=159  Identities=25%  Similarity=0.401  Sum_probs=128.3

Q ss_pred             CCcccccccccccccCceEEEEEEEcCCCcEEEEEEccCcc-ChHHHHHHHHHHHHHHhc-CCCCchhhhhhhHH-----
Q psy14630         21 FTSEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTV-DEKDQRQLLMDLDVVMKS-NECPYIVQFYGALF-----   93 (187)
Q Consensus        21 ~~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~~~~~~~~-~~h~~iv~~~~~~~-----   93 (187)
                      +..++|++.+.||+|+||.||+|.+..+++.||+|+++... ......+.+..+..++.. .+||||+++++.+.     
T Consensus         6 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~   85 (345)
T 3a8x_A            6 LGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRL   85 (345)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEE
T ss_pred             CchhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEE
Confidence            45689999999999999999999999999999999986532 223333444444445544 48999999875321     


Q ss_pred             ---------------------------HHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEecccccccc-cc
Q psy14630         94 ---------------------------KEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLV-DS  145 (187)
Q Consensus        94 ---------------------------~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg~a~~~~-~~  145 (187)
                                                 ..++.|++.||.|||+. +++||||||+||+++.++.+||+|||+++... ..
T Consensus        86 ~lv~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~-~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~~~  164 (345)
T 3a8x_A           86 FFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHER-GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG  164 (345)
T ss_dssp             EEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT-TCBCCCCCGGGEEECTTSCEEECCGGGCBCSCCTT
T ss_pred             EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC-CceecCCCHHHEEECCCCCEEEEeccccccccCCC
Confidence                                       12667899999999998 99999999999999999999999999998643 23


Q ss_pred             ccccCCCCCcCccCccccCCCccCCCCCCcceeeeEee
Q psy14630        146 IAKTRDAGCRPYMAPERIDPLRARGYPSFKTKLGFKFN  183 (187)
Q Consensus       146 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi~  183 (187)
                      ......+||+.|+|||++.   ...++.++|+||+|++
T Consensus       165 ~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwslG~i  199 (345)
T 3a8x_A          165 DTTSTFCGTPNYIAPEILR---GEDYGFSVDWWALGVL  199 (345)
T ss_dssp             CCBCCCCSCGGGCCHHHHT---TCCBCTHHHHHHHHHH
T ss_pred             CcccccCCCccccCccccC---CCCCChHHhHHHHHHH
Confidence            3344568999999999998   6678999999999993

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B

Probab=100.00  E-value=7.2e-35  Score=227.67  Aligned_cols=157  Identities=25%  Similarity=0.389  Sum_probs=131.1

Q ss_pred             cccccccccccccCceEEEEEEEcCCCcEEEEEEccCccChHHHHHHHHHHHHHHhcCCCCchhhhhhhH----------
Q psy14630         23 SEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQFYGAL----------   92 (187)
Q Consensus        23 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~----------   92 (187)
                      .++|++.+.||+|+||.||+|.+..+++.||+|++..........+.+.++..+++.++||||+++++.+          
T Consensus        28 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~  107 (362)
T 2bdw_A           28 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF  107 (362)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             ccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence            4689999999999999999999999999999999875443344445566677788888999999987532          


Q ss_pred             ----------------------HHHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCC---CEEEEecccccccccccc
Q psy14630         93 ----------------------FKEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRG---AIKLCDFGISGQLVDSIA  147 (187)
Q Consensus        93 ----------------------~~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~---~~ki~dfg~a~~~~~~~~  147 (187)
                                            ...++.|++.||.|||+. +++||||||+||+++.++   .+||+|||++........
T Consensus       108 e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~-~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~~~~~  186 (362)
T 2bdw_A          108 DLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSN-GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEA  186 (362)
T ss_dssp             CCCCSCBHHHHHTTCSCCCHHHHHHHHHHHHHHHHHHHHT-TCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCTTCCS
T ss_pred             ecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC-CeEeccCchHHEEEecCCCCCCEEEeecCcceEecCCcc
Confidence                                  112678999999999998 999999999999997654   599999999988766555


Q ss_pred             ccCCCCCcCccCccccCCCccCCCCCCcceeeeEee
Q psy14630        148 KTRDAGCRPYMAPERIDPLRARGYPSFKTKLGFKFN  183 (187)
Q Consensus       148 ~~~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi~  183 (187)
                      .....||+.|+|||++.   ...++.++|+||+|++
T Consensus       187 ~~~~~gt~~y~aPE~~~---~~~~~~~~DiwslG~i  219 (362)
T 2bdw_A          187 WHGFAGTPGYLSPEVLK---KDPYSKPVDIWACGVI  219 (362)
T ss_dssp             CCCSCSCTTTCCHHHHT---TCCCCTHHHHHHHHHH
T ss_pred             cccCCCCccccCHHHHc---cCCCCchhhHHHHHHH
Confidence            55568999999999998   5678999999999994

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A*

Probab=100.00  E-value=5.6e-35  Score=224.87  Aligned_cols=179  Identities=73%  Similarity=1.166  Sum_probs=126.5

Q ss_pred             cccCCceecCCCccccCCcccccccccccccCceEEEEEEEcCCCcEEEEEEccCccChHHHHHHHHHHHHHHhcCCCCc
Q psy14630          5 IQSSGKLKLSPDTVYDFTSEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPY   84 (187)
Q Consensus         5 ~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~   84 (187)
                      ...+......+...|++..++|++.+.||+|+||.||+|.+..+++.||+|.++.........+.+.++..+++.+.|||
T Consensus         3 ~~~~~~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~n   82 (327)
T 3aln_A            3 IESSGKLKISPEQHWDFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPY   82 (327)
T ss_dssp             --CCEEEECCCCEEECCCSCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTT
T ss_pred             ccccCCcCCChHHhcccCHHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCc
Confidence            34556677888899999999999999999999999999999999999999999765555555566666666788899999


Q ss_pred             hhhhhhhH------------------------------------HHHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCC
Q psy14630         85 IVQFYGAL------------------------------------FKEVTVATVKALNYLKEELKIIHRDVKPSNILLDRR  128 (187)
Q Consensus        85 iv~~~~~~------------------------------------~~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~  128 (187)
                      |+++++.+                                    ...+..+++.|+.|||+..+++||||||+||+++.+
T Consensus        83 iv~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~NIll~~~  162 (327)
T 3aln_A           83 IVQFYGALFREGDCWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLDRS  162 (327)
T ss_dssp             BCCEEEEEECSSEEEEEECCCSEEHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHSCCCSCCCGGGEEEETT
T ss_pred             EeeeeeEEEeCCceEEEEeecCCChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCCEeECCCCHHHEEEcCC
Confidence            99987532                                    112677899999999995589999999999999999


Q ss_pred             CCEEEEeccccccccccccccCCCCCcCccCccccCCC-ccCCCCCCcceeeeEee
Q psy14630        129 GAIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPL-RARGYPSFKTKLGFKFN  183 (187)
Q Consensus       129 ~~~ki~dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~~~~D~ws~gi~  183 (187)
                      +.+||+|||+++............||+.|+|||.+... ....++.++|+||+|++
T Consensus       163 ~~~kl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~i  218 (327)
T 3aln_A          163 GNIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGIT  218 (327)
T ss_dssp             TEEEECCCSSSCC------------------------------CCSHHHHHHHHHH
T ss_pred             CCEEEccCCCceecccccccccCCCCccccCceeeccccCcCCCCchhhHHHHHHH
Confidence            99999999999887655444445789999999998421 14458899999999994

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A

Probab=100.00  E-value=7.4e-35  Score=220.97  Aligned_cols=157  Identities=24%  Similarity=0.387  Sum_probs=129.3

Q ss_pred             ccccccccccccCceEEEEEEEcCCCcEEEEEEccCccChHHHHHHHHHHHHHHhcCCCCchhhhhhhH-----------
Q psy14630         24 EDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQFYGAL-----------   92 (187)
Q Consensus        24 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~-----------   92 (187)
                      ++|++.+.||+|+||.||+|.+..+++.||+|.+..........+.+.++..+++.++||||+++++.+           
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   81 (292)
T 3o0g_A            2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE   81 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence            579999999999999999999999999999999875444444445556667778888999999987542           


Q ss_pred             ---------------------HHHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEecccccccccc-ccccC
Q psy14630         93 ---------------------FKEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDS-IAKTR  150 (187)
Q Consensus        93 ---------------------~~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg~a~~~~~~-~~~~~  150 (187)
                                           ...++.|++.||.|||+. +++||||||+||+++.++.+||+|||+++..... .....
T Consensus        82 ~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~-~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~  160 (292)
T 3o0g_A           82 FCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSR-NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSA  160 (292)
T ss_dssp             CCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEECTTSCEEECCCTTCEECCSCCSCCCS
T ss_pred             cCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhC-CeecCCCCHHHEEEcCCCCEEEeecccceecCCccccccC
Confidence                                 122678999999999998 9999999999999999999999999999876533 22334


Q ss_pred             CCCCcCccCccccCCCccCCCCCCcceeeeEee
Q psy14630        151 DAGCRPYMAPERIDPLRARGYPSFKTKLGFKFN  183 (187)
Q Consensus       151 ~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi~  183 (187)
                      ..+|+.|+|||.+.+  ...++.++|+||+|++
T Consensus       161 ~~~t~~y~aPE~~~~--~~~~~~~~DiwslG~i  191 (292)
T 3o0g_A          161 EVVTLWYRPPDVLFG--AKLYSTSIDMWSAGCI  191 (292)
T ss_dssp             CCSCGGGCCHHHHTT--CSCCCTHHHHHHHHHH
T ss_pred             CccccCCcChHHHcC--CCCcCchHHHHHHHHH
Confidence            578999999999873  3347899999999993

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A*

Probab=100.00  E-value=3.7e-35  Score=227.97  Aligned_cols=163  Identities=23%  Similarity=0.378  Sum_probs=125.1

Q ss_pred             ccccCCcccccccccccccCceEEEEEEEcCCCcEEEEEEccCccC--hHHHHHHHHHHHHHHhcCCCCchhhhhhhHH-
Q psy14630         17 TVYDFTSEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVD--EKDQRQLLMDLDVVMKSNECPYIVQFYGALF-   93 (187)
Q Consensus        17 ~~~~~~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~-   93 (187)
                      ....+..++|.+.+.||+|+||.||+|.+..+++.||+|+++....  .........+...+.....||||+++++.+. 
T Consensus        10 ~~~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~   89 (345)
T 1xjd_A           10 LQIKLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQT   89 (345)
T ss_dssp             ------CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred             ccCCCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEe
Confidence            3445677899999999999999999999999999999999864210  1112223334444444459999998875321 


Q ss_pred             -------------------------------HHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEeccccccc
Q psy14630         94 -------------------------------KEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQL  142 (187)
Q Consensus        94 -------------------------------~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg~a~~~  142 (187)
                                                     ..++.|++.||.|||+. +++||||||+||+++.++.+||+|||+++..
T Consensus        90 ~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~-~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~  168 (345)
T 1xjd_A           90 KENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSK-GIVYRDLKLDNILLDKDGHIKIADFGMCKEN  168 (345)
T ss_dssp             SSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT-TCBCCCCCGGGEEECTTSCEEECCCTTCBCC
T ss_pred             CCEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC-CeEeCCCChhhEEECCCCCEEEeEChhhhhc
Confidence                                           12677899999999998 9999999999999999999999999999875


Q ss_pred             cc-cccccCCCCCcCccCccccCCCccCCCCCCcceeeeEee
Q psy14630        143 VD-SIAKTRDAGCRPYMAPERIDPLRARGYPSFKTKLGFKFN  183 (187)
Q Consensus       143 ~~-~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi~  183 (187)
                      .. .......+||+.|+|||++.   ...++.++|+||+|++
T Consensus       169 ~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwslG~i  207 (345)
T 1xjd_A          169 MLGDAKTNTFCGTPDYIAPEILL---GQKYNHSVDWWSFGVL  207 (345)
T ss_dssp             CCTTCCBCCCCSCGGGCCHHHHT---TCCBCTHHHHHHHHHH
T ss_pred             ccCCCcccCCCCCcccCChhhhc---CCCCCChhhhHHHHHH
Confidence            32 23344568999999999998   5678999999999993

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A*

Probab=100.00  E-value=1e-34  Score=231.57  Aligned_cols=158  Identities=23%  Similarity=0.393  Sum_probs=128.5

Q ss_pred             cccccccccccccCceEEEEEEEcCCCcEEEEEEccCccChHHHHHHHHHHHHHHhcCCCCchhhhhhhH----------
Q psy14630         23 SEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQFYGAL----------   92 (187)
Q Consensus        23 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~----------   92 (187)
                      .++|++.+.||+|+||.||+|.+..+++.||||.+..........+.+.++..+++.++||||+++++.+          
T Consensus        25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~  104 (432)
T 3n9x_A           25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDE  104 (432)
T ss_dssp             CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred             cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCe
Confidence            4789999999999999999999999999999999976544444555666677778888999999887432          


Q ss_pred             --------------------------HHHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEeccccccccccc
Q psy14630         93 --------------------------FKEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSI  146 (187)
Q Consensus        93 --------------------------~~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg~a~~~~~~~  146 (187)
                                                ...++.|++.||.|||+. +++||||||+||+++.++.+||+|||+++......
T Consensus       105 ~~lv~e~~~~~L~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~-givHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~  183 (432)
T 3n9x_A          105 LYIVLEIADSDLKKLFKTPIFLTEEHIKTILYNLLLGENFIHES-GIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEK  183 (432)
T ss_dssp             EEEEEECCSEEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCCGGGEEECTTCCEEECCCTTCEEC----
T ss_pred             EEEEEecCCcCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC-CCCCCCCCHHHeEECCCCCEEEccCCCcccccccc
Confidence                                      112778999999999998 99999999999999999999999999998864321


Q ss_pred             -----------------------cccCCCCCcCccCccccCCCccCCCCCCcceeeeEee
Q psy14630        147 -----------------------AKTRDAGCRPYMAPERIDPLRARGYPSFKTKLGFKFN  183 (187)
Q Consensus       147 -----------------------~~~~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi~  183 (187)
                                             .....+||+.|+|||++..  ...++.++|+||+|++
T Consensus       184 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~--~~~~~~~~DiwSlG~i  241 (432)
T 3n9x_A          184 DTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILL--QENYTKSIDIWSTGCI  241 (432)
T ss_dssp             ---------------------------CCCCCTTCCHHHHTT--CSCCCTHHHHHHHHHH
T ss_pred             cccccccccccccccccccchhccccCCCCCccccCHHHHhc--CCCCCcccccchHHHH
Confidence                                   1244578999999999752  4568999999999994

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=7.9e-35  Score=229.13  Aligned_cols=159  Identities=27%  Similarity=0.378  Sum_probs=116.1

Q ss_pred             CcccccccccccccCceEEEEEEEcCCCcEEEEEEccCccChHHHHHHHHHHHHHHhcC-CCCchhhhhhhHH-------
Q psy14630         22 TSEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSN-ECPYIVQFYGALF-------   93 (187)
Q Consensus        22 ~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~-~h~~iv~~~~~~~-------   93 (187)
                      ..++|++.+.||+|+||.||+|.+..+++.||+|.+..........+...++..+++.+ .||||+++++.+.       
T Consensus         7 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~   86 (388)
T 3oz6_A            7 VLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDV   86 (388)
T ss_dssp             HHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCE
T ss_pred             ccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEE
Confidence            35789999999999999999999999999999999865433333333333444444445 5999999875431       


Q ss_pred             -------------------------HHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEecccccccccc---
Q psy14630         94 -------------------------KEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDS---  145 (187)
Q Consensus        94 -------------------------~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg~a~~~~~~---  145 (187)
                                               ..++.|++.||+|||+. +++||||||+||+++.++.+||+|||+++.....   
T Consensus        87 ~lv~e~~~~~L~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~-~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~  165 (388)
T 3oz6_A           87 YLVFDYMETDLHAVIRANILEPVHKQYVVYQLIKVIKYLHSG-GLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRV  165 (388)
T ss_dssp             EEEEECCSEEHHHHHHHTCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCCGGGEEECTTCCEEECCCTTCEESSSCCCC
T ss_pred             EEEecccCcCHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhC-CEEeCCCCHHHeEEcCCCCEEecCCcccccccccccc
Confidence                                     12667999999999998 9999999999999999999999999999875321   


Q ss_pred             -------------------ccccCCCCCcCccCccccCCCccCCCCCCcceeeeEee
Q psy14630        146 -------------------IAKTRDAGCRPYMAPERIDPLRARGYPSFKTKLGFKFN  183 (187)
Q Consensus       146 -------------------~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi~  183 (187)
                                         ......+||+.|+|||++.+  ...++.++|+||+|++
T Consensus       166 ~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~~DiwSlG~i  220 (388)
T 3oz6_A          166 TNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLG--STKYTKGIDMWSLGCI  220 (388)
T ss_dssp             CCCGGGCCC---------------CCCGGGGCCHHHHTT--CCCCCTHHHHHHHHHH
T ss_pred             cccccccccccccccccccccccCCcccCCcCCHHHhcC--CCCCCChhhHHHHHHH
Confidence                               11223478999999999873  3568899999999993

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus}

Probab=100.00  E-value=1.4e-34  Score=222.38  Aligned_cols=156  Identities=28%  Similarity=0.485  Sum_probs=126.7

Q ss_pred             cccccccccccccCceEEEEEEEcCCCcEEEEEEccCccChHHHHHHHHHHHHHHhcCCCCchhhhhhhH----------
Q psy14630         23 SEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQFYGAL----------   92 (187)
Q Consensus        23 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~----------   92 (187)
                      .++|++.+.||+|+||.||+|.+..+++.||||+++..... ...+.+.++..+++.++||||+++++.+          
T Consensus         5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~   83 (332)
T 3qd2_B            5 LTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRE-LAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQE   83 (332)
T ss_dssp             HHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTT-THHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHH
T ss_pred             hhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCch-hHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhh
Confidence            46899999999999999999999999999999998643322 2345566667778888999999886532          


Q ss_pred             --------------------------------------------------------------------------------
Q psy14630         93 --------------------------------------------------------------------------------   92 (187)
Q Consensus        93 --------------------------------------------------------------------------------   92 (187)
                                                                                                      
T Consensus        84 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~  163 (332)
T 3qd2_B           84 EMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREH  163 (332)
T ss_dssp             HHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCH
T ss_pred             hhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhh
Confidence                                                                                            


Q ss_pred             --HHHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEeccccccccccc-------------cccCCCCCcCc
Q psy14630         93 --FKEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSI-------------AKTRDAGCRPY  157 (187)
Q Consensus        93 --~~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg~a~~~~~~~-------------~~~~~~~t~~y  157 (187)
                        ...++.|++.||.|||+. +++||||||+||+++.++.+||+|||+++......             ......||+.|
T Consensus       164 ~~~~~i~~qi~~aL~~LH~~-~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y  242 (332)
T 3qd2_B          164 GVCLHIFIQIAEAVEFLHSK-GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLY  242 (332)
T ss_dssp             HHHHHHHHHHHHHHHHHHHT-TEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGGG
T ss_pred             HHHHHHHHHHHHHHHHHHhC-CeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcCc
Confidence              123678999999999997 99999999999999999999999999998875431             12334689999


Q ss_pred             cCccccCCCccCCCCCCcceeeeEee
Q psy14630        158 MAPERIDPLRARGYPSFKTKLGFKFN  183 (187)
Q Consensus       158 ~aPE~~~~~~~~~~~~~~D~ws~gi~  183 (187)
                      +|||.+.   ...++.++|+||+|++
T Consensus       243 ~aPE~~~---~~~~~~~~Di~slG~i  265 (332)
T 3qd2_B          243 MSPEQIH---GNNYSHKVDIFSLGLI  265 (332)
T ss_dssp             SCHHHHH---CCCCCTHHHHHHHHHH
T ss_pred             cChHHhc---CCCCcchhhHHHHHHH
Confidence            9999998   5678999999999993

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A*

Probab=100.00  E-value=1.3e-34  Score=221.86  Aligned_cols=165  Identities=23%  Similarity=0.365  Sum_probs=126.9

Q ss_pred             CCccccCCcccccccccccccCceEEEEEEEcCCCcEEEEEEccCccChHHHHHHHHHHHHHHhcCCCCchhhhhhhH--
Q psy14630         15 PDTVYDFTSEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQFYGAL--   92 (187)
Q Consensus        15 ~~~~~~~~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~--   92 (187)
                      +....+...++|++.+.||+|+||.||+|.+. +++.||+|.+..........+.+.++..+++.++||||+++++.+  
T Consensus        12 ~~~~~q~l~~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~   90 (311)
T 3niz_A           12 ENLYFQGLMEKYQKLEKVGEGTYGVVYKAKDS-QGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHS   90 (311)
T ss_dssp             ---CEECSSCEEEEEEEEEECSSCEEEEEEET-TSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECC
T ss_pred             cceeecchHhhhHhhhhccCCCCeEEEEEEEC-CCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEcc
Confidence            33444556789999999999999999999985 588999999865433333344555666677888999999987543  


Q ss_pred             ------------------------------HHHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEeccccccc
Q psy14630         93 ------------------------------FKEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQL  142 (187)
Q Consensus        93 ------------------------------~~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg~a~~~  142 (187)
                                                    ...++.|++.||.|||+. +++||||||+||+++.++.+||+|||+++..
T Consensus        91 ~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~-~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~  169 (311)
T 3niz_A           91 ERCLTLVFEFMEKDLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQH-RILHRDLKPQNLLINSDGALKLADFGLARAF  169 (311)
T ss_dssp             SSCEEEEEECCSEEHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCCGGGEEECTTCCEEECCCTTCEET
T ss_pred             CCEEEEEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC-CcccCCCchHhEEECCCCCEEEccCcCceec
Confidence                                          112678999999999998 9999999999999999999999999999876


Q ss_pred             ccc-ccccCCCCCcCccCccccCCCccCCCCCCcceeeeEee
Q psy14630        143 VDS-IAKTRDAGCRPYMAPERIDPLRARGYPSFKTKLGFKFN  183 (187)
Q Consensus       143 ~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi~  183 (187)
                      ... .......+|+.|+|||++.+  ...++.++|+||+|++
T Consensus       170 ~~~~~~~~~~~~t~~y~aPE~~~~--~~~~~~~~DiwslG~i  209 (311)
T 3niz_A          170 GIPVRSYTHEVVTLWYRAPDVLMG--SKKYSTSVDIWSIGCI  209 (311)
T ss_dssp             TSCCC---CCCCCCTTCCHHHHTT--CCSCCTHHHHHHHHHH
T ss_pred             CCCcccccCCcccCCcCCHHHhcC--CCCCCchHHhHHHHHH
Confidence            432 22333468999999999873  3457899999999993

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens}

Probab=100.00  E-value=3.6e-34  Score=218.86  Aligned_cols=158  Identities=27%  Similarity=0.475  Sum_probs=129.6

Q ss_pred             cCCcccccccccccccCceEEEEEEEcCCCcEEEEEEccCccChHHHHHHHHHHHHHHhcCCCCchhhhhhhHH------
Q psy14630         20 DFTSEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQFYGALF------   93 (187)
Q Consensus        20 ~~~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~------   93 (187)
                      .+..++|++.+.||+|+||.||+|.+..+++.||+|.+...  .....+.+.++..+++.++||||+++++.+.      
T Consensus         6 ~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~   83 (310)
T 3s95_A            6 IFRPSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRF--DEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLN   83 (310)
T ss_dssp             EECGGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEE
T ss_pred             eeChhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccC--CHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeE
Confidence            45678999999999999999999999999999999987542  3344555666777788889999999875321      


Q ss_pred             ---------------------------HHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEeccccccccccc
Q psy14630         94 ---------------------------KEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSI  146 (187)
Q Consensus        94 ---------------------------~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg~a~~~~~~~  146 (187)
                                                 ..++.|++.||.|||+. +++||||||+||+++.++.+||+|||+++......
T Consensus        84 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~-~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  162 (310)
T 3s95_A           84 FITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSM-NIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEK  162 (310)
T ss_dssp             EEEECCTTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHHHT-TEECSCCSTTSEEECTTSCEEECCCTTCEECC---
T ss_pred             EEEEecCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC-CccCCCCCcCeEEECCCCCEEEeecccceeccccc
Confidence                                       12678999999999998 99999999999999999999999999998764322


Q ss_pred             cc---------------cCCCCCcCccCccccCCCccCCCCCCcceeeeEee
Q psy14630        147 AK---------------TRDAGCRPYMAPERIDPLRARGYPSFKTKLGFKFN  183 (187)
Q Consensus       147 ~~---------------~~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi~  183 (187)
                      ..               ....||+.|+|||.+.   ...++.++|+||+|++
T Consensus       163 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Di~slG~~  211 (310)
T 3s95_A          163 TQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMIN---GRSYDEKVDVFSFGIV  211 (310)
T ss_dssp             -----------------CCCCSCGGGCCHHHHT---TCCCCTHHHHHHHHHH
T ss_pred             ccccccccccccccccccccCCCcceeCHHHhc---CCCCCcHHHHHHHHHH
Confidence            11               1346899999999998   6678999999999994

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens}

Probab=100.00  E-value=2.4e-34  Score=230.05  Aligned_cols=157  Identities=22%  Similarity=0.308  Sum_probs=129.1

Q ss_pred             cccccccccccccCceEEEEEEEcCCCcEEEEEEccCccChHHHHHHHHHHHHHHhcCCCCchhhhhhhH----------
Q psy14630         23 SEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQFYGAL----------   92 (187)
Q Consensus        23 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~----------   92 (187)
                      .++|++.+.||+|+||.||+|.+..+++.+|+|++..........+.+.++..+++.++||||+++++.+          
T Consensus        10 ~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~   89 (444)
T 3soa_A           10 TEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLIF   89 (444)
T ss_dssp             HHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEEE
T ss_pred             cCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEEE
Confidence            5789999999999999999999999999999999875544444455666777788889999999987532          


Q ss_pred             ----------------------HHHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEc---CCCCEEEEeccccccccccc-
Q psy14630         93 ----------------------FKEVTVATVKALNYLKEELKIIHRDVKPSNILLD---RRGAIKLCDFGISGQLVDSI-  146 (187)
Q Consensus        93 ----------------------~~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~---~~~~~ki~dfg~a~~~~~~~-  146 (187)
                                            ...++.|++.||.|||+. +++||||||+||+++   ..+.+||+|||+++...... 
T Consensus        90 E~~~gg~L~~~i~~~~~~~e~~~~~i~~qil~aL~~lH~~-givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~~~~~  168 (444)
T 3soa_A           90 DLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQM-GVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQ  168 (444)
T ss_dssp             CCCBCCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHT-TCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCCTTCC
T ss_pred             EeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC-CccccCCCHHHEEEeccCCCCcEEEccCceeEEecCCCc
Confidence                                  112678999999999998 999999999999998   46789999999998775432 


Q ss_pred             cccCCCCCcCccCccccCCCccCCCCCCcceeeeEee
Q psy14630        147 AKTRDAGCRPYMAPERIDPLRARGYPSFKTKLGFKFN  183 (187)
Q Consensus       147 ~~~~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi~  183 (187)
                      ......||+.|+|||++.   ...++.++|+||+|++
T Consensus       169 ~~~~~~gt~~Y~APE~l~---~~~~~~~~DIwSlGvi  202 (444)
T 3soa_A          169 AWFGFAGTPGYLSPEVLR---KDPYGKPVDLWACGVI  202 (444)
T ss_dssp             BCCCSCSCGGGCCHHHHT---TCCBCTHHHHHHHHHH
T ss_pred             eeecccCCcccCCHHHhc---CCCCCCccccHHHHHH
Confidence            233457999999999998   5678999999999994

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe}

Probab=100.00  E-value=7.9e-35  Score=225.35  Aligned_cols=157  Identities=25%  Similarity=0.361  Sum_probs=129.3

Q ss_pred             cccccccccccccCceEEEEEEEcCCCcEEEEEEccCccCh-HHHHHHHHHHHHHHhcCCCCchhhhhhhH---------
Q psy14630         23 SEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDE-KDQRQLLMDLDVVMKSNECPYIVQFYGAL---------   92 (187)
Q Consensus        23 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~~~~~~~~~~h~~iv~~~~~~---------   92 (187)
                      .++|++.+.||+|+||.||+|.+..+++.||+|++...... ......+.++..+++.++||||+++++.+         
T Consensus         8 i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv   87 (336)
T 3h4j_B            8 IGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMV   87 (336)
T ss_dssp             ETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             cCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence            47899999999999999999999999999999998532111 11123456667788889999999987532         


Q ss_pred             ----------------------HHHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEeccccccccccccccC
Q psy14630         93 ----------------------FKEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTR  150 (187)
Q Consensus        93 ----------------------~~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg~a~~~~~~~~~~~  150 (187)
                                            ...++.|++.|+.|||+. +++||||||+||+++.++.+||+|||++...........
T Consensus        88 ~E~~~g~l~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~-givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~~~~~~  166 (336)
T 3h4j_B           88 IEYAGGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRH-KIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKT  166 (336)
T ss_dssp             ECCCCEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHH-TCCCCCCSTTTEEECTTCCEEECCSSCTBTTTTSBTTCC
T ss_pred             EECCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC-CeEecCCchhhEEEcCCCCEEEEEeccceeccCCccccc
Confidence                                  112678999999999998 999999999999999999999999999988776655566


Q ss_pred             CCCCcCccCccccCCCccCCC-CCCcceeeeEee
Q psy14630        151 DAGCRPYMAPERIDPLRARGY-PSFKTKLGFKFN  183 (187)
Q Consensus       151 ~~~t~~y~aPE~~~~~~~~~~-~~~~D~ws~gi~  183 (187)
                      .+||+.|+|||++.   ...+ +.++|+||+|++
T Consensus       167 ~~gt~~y~aPE~~~---~~~~~~~~~DiwslG~i  197 (336)
T 3h4j_B          167 SCGSPNYAAPEVIN---GKLYAGPEVDVWSCGIV  197 (336)
T ss_dssp             CTTSTTTSCGGGSC---CSGGGCHHHHHHHHHHH
T ss_pred             ccCCcCcCCHHHHc---CCCCCCCccchhHHHHH
Confidence            68999999999998   4444 578999999994

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A*

Probab=100.00  E-value=1.2e-34  Score=226.23  Aligned_cols=157  Identities=23%  Similarity=0.299  Sum_probs=129.9

Q ss_pred             cccccccccccccCceEEEEEEEcCCCcEEEEEEccCccChH----HHHHHHHHHHHHHhcCCCCchhhhhhhH------
Q psy14630         23 SEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEK----DQRQLLMDLDVVMKSNECPYIVQFYGAL------   92 (187)
Q Consensus        23 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~----~~~~~~~~~~~~~~~~~h~~iv~~~~~~------   92 (187)
                      .++|++.+.||+|+||.||+|.+..+++.||+|+++......    ...+.+..+..+++.+.||||+++++.+      
T Consensus        11 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~   90 (361)
T 2yab_A           11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDV   90 (361)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred             hhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEE
Confidence            467999999999999999999999999999999986432211    1234455666778888999999987543      


Q ss_pred             --------------------------HHHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCC----CEEEEeccccccc
Q psy14630         93 --------------------------FKEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRG----AIKLCDFGISGQL  142 (187)
Q Consensus        93 --------------------------~~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~----~~ki~dfg~a~~~  142 (187)
                                                ...++.|++.||.|||+. +++||||||+||+++..+    .+||+|||+++..
T Consensus        91 ~lv~e~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~-givHrDlkp~NIll~~~~~~~~~vkl~DFG~a~~~  169 (361)
T 2yab_A           91 VLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTK-KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI  169 (361)
T ss_dssp             EEEEECCCSCBHHHHHTTCSCCBHHHHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEESCTTSSSCCEEECCCSSCEEC
T ss_pred             EEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC-CcccCCCCHHHEEEeCCCCCccCEEEEecCCceEc
Confidence                                      112778999999999997 999999999999998776    7999999999987


Q ss_pred             cccccccCCCCCcCccCccccCCCccCCCCCCcceeeeEee
Q psy14630        143 VDSIAKTRDAGCRPYMAPERIDPLRARGYPSFKTKLGFKFN  183 (187)
Q Consensus       143 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi~  183 (187)
                      ..........||+.|+|||++.   ...++.++|+||+|++
T Consensus       170 ~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwslGvi  207 (361)
T 2yab_A          170 EDGVEFKNIFGTPEFVAPEIVN---YEPLGLEADMWSIGVI  207 (361)
T ss_dssp             CTTCCCCCCCSCGGGCCHHHHT---TCCCCTHHHHHHHHHH
T ss_pred             CCCCccccCCCCccEECchHHc---CCCCCccccHHHHHHH
Confidence            6655555668999999999998   6678999999999983

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7

Probab=100.00  E-value=8.8e-35  Score=223.54  Aligned_cols=157  Identities=29%  Similarity=0.486  Sum_probs=128.4

Q ss_pred             CCcccccccccccccCceEEEEEEEcCCCcEEEEEEccCccC-hHHHHHHHHHHHHHHhcCCCCchhhhhhhHH------
Q psy14630         21 FTSEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVD-EKDQRQLLMDLDVVMKSNECPYIVQFYGALF------   93 (187)
Q Consensus        21 ~~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~------   93 (187)
                      +..++|++.+.||+|+||.||+|.+..+++.||+|+++.... .....+.+.++..+++.+.||||+++++.+.      
T Consensus         3 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~   82 (318)
T 1fot_A            3 YSLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIF   82 (318)
T ss_dssp             CCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEE
T ss_pred             CChHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEE
Confidence            356899999999999999999999999999999999863211 1112344555666778889999999875321      


Q ss_pred             --------------------------HHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEecccccccccccc
Q psy14630         94 --------------------------KEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIA  147 (187)
Q Consensus        94 --------------------------~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg~a~~~~~~~~  147 (187)
                                                ..++.|++.||.|||+. +++||||||+||+++.++.+||+|||+++.....  
T Consensus        83 lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~-~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~~--  159 (318)
T 1fot_A           83 MIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSK-DIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV--  159 (318)
T ss_dssp             EEECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTT-TEECCCCCGGGEEECTTSCEEECCCSSCEECSSC--
T ss_pred             EEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC-CccccCCChheEEEcCCCCEEEeecCcceecCCc--
Confidence                                      12667899999999997 9999999999999999999999999999876443  


Q ss_pred             ccCCCCCcCccCccccCCCccCCCCCCcceeeeEee
Q psy14630        148 KTRDAGCRPYMAPERIDPLRARGYPSFKTKLGFKFN  183 (187)
Q Consensus       148 ~~~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi~  183 (187)
                      ....+||+.|+|||++.   ...++.++|+||+|++
T Consensus       160 ~~~~~gt~~y~aPE~~~---~~~~~~~~DiwslG~i  192 (318)
T 1fot_A          160 TYTLCGTPDYIAPEVVS---TKPYNKSIDWWSFGIL  192 (318)
T ss_dssp             BCCCCSCTTTCCHHHHT---TCCBCTTHHHHHHHHH
T ss_pred             cccccCCccccCHhHhc---CCCCCcccchhhhHHH
Confidence            23457999999999998   6678999999999993

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A

Probab=100.00  E-value=2e-34  Score=217.92  Aligned_cols=165  Identities=50%  Similarity=0.927  Sum_probs=123.8

Q ss_pred             ccCCcccccccccccccCceEEEEEEEcCCCcEEEEEEccCccChHHHHHHHHHHHHHHhcCCCCchhhhhhhH------
Q psy14630         19 YDFTSEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQFYGAL------   92 (187)
Q Consensus        19 ~~~~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~------   92 (187)
                      +++..++|++.+.||+|+||.||+|.+..+++.||+|.++.........+.+.++...++...||||+++++.+      
T Consensus         2 ~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~   81 (290)
T 3fme_A            2 MEVKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDV   81 (290)
T ss_dssp             CCCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSE
T ss_pred             CcccHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCE
Confidence            56788999999999999999999999999999999999976555555566677777778889999999887532      


Q ss_pred             -----------------------------HHHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEecccccccc
Q psy14630         93 -----------------------------FKEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLV  143 (187)
Q Consensus        93 -----------------------------~~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg~a~~~~  143 (187)
                                                   ...++.|++.|+.|||+..+++||||||+||+++.++.+||+|||+++...
T Consensus        82 ~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~  161 (290)
T 3fme_A           82 WICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLV  161 (290)
T ss_dssp             EEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSCCCCCCCSGGGCEECTTCCEEBCCC-------
T ss_pred             EEEEehhccchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeecCCccccc
Confidence                                         112678999999999986599999999999999999999999999998876


Q ss_pred             ccccccCCCCCcCccCccccCCC-ccCCCCCCcceeeeEee
Q psy14630        144 DSIAKTRDAGCRPYMAPERIDPL-RARGYPSFKTKLGFKFN  183 (187)
Q Consensus       144 ~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~~~~D~ws~gi~  183 (187)
                      .........+|+.|+|||.+... ....++.++|+||+|++
T Consensus       162 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~i  202 (290)
T 3fme_A          162 DDVAKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGIT  202 (290)
T ss_dssp             --------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHH
T ss_pred             ccccccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHH
Confidence            55545555789999999997321 14567889999999994

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A*

Probab=100.00  E-value=2.1e-35  Score=233.97  Aligned_cols=164  Identities=28%  Similarity=0.432  Sum_probs=129.2

Q ss_pred             ccCCcccccccccccccCceEEEEEEEcCCCcEEEEEEccCccC-hHHHHHHHHHHHHHHhcCCCCchhhhhhhH-----
Q psy14630         19 YDFTSEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVD-EKDQRQLLMDLDVVMKSNECPYIVQFYGAL-----   92 (187)
Q Consensus        19 ~~~~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~-----   92 (187)
                      ..+..++|++.+.||+|+||.||+|.+..+++.||+|+++.... .....+.+.++..++..++||||+++++.+     
T Consensus        64 ~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~  143 (410)
T 3v8s_A           64 LRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRY  143 (410)
T ss_dssp             HSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred             cccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECCE
Confidence            34677899999999999999999999999999999999853110 001122345566677888999999987533     


Q ss_pred             --------------------------HHHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEeccccccccccc
Q psy14630         93 --------------------------FKEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSI  146 (187)
Q Consensus        93 --------------------------~~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg~a~~~~~~~  146 (187)
                                                ...++.|++.||.|||+. +|+||||||+||+++.++.+||+|||+++......
T Consensus       144 ~~lV~E~~~gg~L~~~l~~~~~~e~~~~~~~~qi~~aL~~LH~~-givHrDLKp~NILl~~~g~ikL~DFG~a~~~~~~~  222 (410)
T 3v8s_A          144 LYMVMEYMPGGDLVNLMSNYDVPEKWARFYTAEVVLALDAIHSM-GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEG  222 (410)
T ss_dssp             EEEEECCCTTEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEECTTSCEEECCCTTCEECCTTS
T ss_pred             EEEEEeCCCCCcHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC-CeEeccCCHHHeeECCCCCEEEeccceeEeeccCC
Confidence                                      112678999999999997 99999999999999999999999999998765432


Q ss_pred             --cccCCCCCcCccCccccCCCccCC-CCCCcceeeeEee
Q psy14630        147 --AKTRDAGCRPYMAPERIDPLRARG-YPSFKTKLGFKFN  183 (187)
Q Consensus       147 --~~~~~~~t~~y~aPE~~~~~~~~~-~~~~~D~ws~gi~  183 (187)
                        .....+||+.|+|||++.+....+ ++.++|+||+|++
T Consensus       223 ~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvi  262 (410)
T 3v8s_A          223 MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVF  262 (410)
T ss_dssp             EEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHH
T ss_pred             cccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHH
Confidence              233568999999999998322111 6789999999993

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens}

Probab=100.00  E-value=2.8e-34  Score=219.29  Aligned_cols=161  Identities=25%  Similarity=0.348  Sum_probs=121.9

Q ss_pred             ccCCcccccccccccccCceEEEEEEEcCCCcEEEEEEccCccCh----HHHHHHHHHH--HHHHhcCCCCchhhhhhhH
Q psy14630         19 YDFTSEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDE----KDQRQLLMDL--DVVMKSNECPYIVQFYGAL   92 (187)
Q Consensus        19 ~~~~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~----~~~~~~~~~~--~~~~~~~~h~~iv~~~~~~   92 (187)
                      .++..++|++.+.||+|+||.||+|.+..+++.||+|.+......    ........+.  ...++.+.||||+++++.+
T Consensus         4 g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~   83 (308)
T 3g33_A            4 GSMATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVC   83 (308)
T ss_dssp             ------CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEE
T ss_pred             CcccccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeee
Confidence            445678999999999999999999999999999999998532110    0001111122  2223344699999876432


Q ss_pred             --------------------------------------HHHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEE
Q psy14630         93 --------------------------------------FKEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLC  134 (187)
Q Consensus        93 --------------------------------------~~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~  134 (187)
                                                            ...++.|++.||.|||+. +++||||||+||+++.++.+||+
T Consensus        84 ~~~~~~~~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~-~ivH~Dlkp~Nil~~~~~~~kl~  162 (308)
T 3g33_A           84 ATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHAN-CIVHRDLKPENILVTSGGTVKLA  162 (308)
T ss_dssp             EECCSSSEEEEEEEEECCCCBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCCTTTEEECTTSCEEEC
T ss_pred             eccCCCCceeEEEEehhhhcCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHC-CcccCCCCHHHEEEcCCCCEEEe
Confidence                                                  122678999999999998 99999999999999999999999


Q ss_pred             eccccccccccccccCCCCCcCccCccccCCCccCCCCCCcceeeeEee
Q psy14630        135 DFGISGQLVDSIAKTRDAGCRPYMAPERIDPLRARGYPSFKTKLGFKFN  183 (187)
Q Consensus       135 dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi~  183 (187)
                      |||+++............+|+.|+|||++.   ...++.++|+||+|++
T Consensus       163 Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwslG~i  208 (308)
T 3g33_A          163 DFGLARIYSYQMALTPVVVTLWYRAPEVLL---QSTYATPVDMWSVGCI  208 (308)
T ss_dssp             SCSCTTTSTTCCCSGGGGCCCSSCCHHHHH---TSCCCSTHHHHHHHHH
T ss_pred             eCccccccCCCcccCCccccccccCchHHc---CCCCCchHHHHHHHHH
Confidence            999998876555555567899999999998   5668999999999993

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ...

Probab=100.00  E-value=3.8e-34  Score=224.15  Aligned_cols=158  Identities=24%  Similarity=0.303  Sum_probs=121.8

Q ss_pred             CcccccccccccccCceEEEEEEEcCCCcEEEEEEccCccChHHHHHHHHHHHHHHhcCCCCchhhhhhhH---------
Q psy14630         22 TSEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQFYGAL---------   92 (187)
Q Consensus        22 ~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~---------   92 (187)
                      ..++|++.+.||+|+||.||+|.+..+++.||+|.+..........+.+.++..+++.++||||+++++.+         
T Consensus        23 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~  102 (371)
T 2xrw_A           23 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF  102 (371)
T ss_dssp             EETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTC
T ss_pred             hhhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeeccccccccc
Confidence            35789999999999999999999999999999999875444444455566666778888999999886532         


Q ss_pred             --------------------------HHHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEeccccccccccc
Q psy14630         93 --------------------------FKEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSI  146 (187)
Q Consensus        93 --------------------------~~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg~a~~~~~~~  146 (187)
                                                ...++.|++.||.|||+. +++||||||+||+++.++.+||+|||+++......
T Consensus       103 ~~~~lv~e~~~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~-~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~  181 (371)
T 2xrw_A          103 QDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSA-GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF  181 (371)
T ss_dssp             CEEEEEEECCSEEHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCCGGGEEECTTSCEEECCCCC--------
T ss_pred             cceEEEEEcCCCCHHHHHhhccCHHHHHHHHHHHHHHHHHHHHC-CeecccCCHHHEEEcCCCCEEEEEeeccccccccc
Confidence                                      112678999999999998 99999999999999999999999999998776544


Q ss_pred             cccCCCCCcCccCccccCCCccCCCCCCcceeeeEee
Q psy14630        147 AKTRDAGCRPYMAPERIDPLRARGYPSFKTKLGFKFN  183 (187)
Q Consensus       147 ~~~~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi~  183 (187)
                      ......||+.|+|||++.   ...++.++|+||+|++
T Consensus       182 ~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwslG~i  215 (371)
T 2xrw_A          182 MMTPYVVTRYYRAPEVIL---GMGYKENVDIWSVGCI  215 (371)
T ss_dssp             --------CTTCCHHHHT---TCCCCTTHHHHHHHHH
T ss_pred             ccCCceecCCccCHHHhc---CCCCCchHhHHHHHHH
Confidence            444557899999999998   5678999999999993

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A*

Probab=100.00  E-value=8.1e-34  Score=217.28  Aligned_cols=162  Identities=28%  Similarity=0.423  Sum_probs=122.2

Q ss_pred             CccccCCcccccccccccccCceEEEEEEEcCCCcEEEEEEccCccChHHHHHHHHHHHHHHhcCCCCchhhhhhhHH--
Q psy14630         16 DTVYDFTSEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQFYGALF--   93 (187)
Q Consensus        16 ~~~~~~~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~--   93 (187)
                      +..+++..++|++.+.||+|+||.||+|.+  +++.||+|++..........+.+.++..+++.++||||+++++.+.  
T Consensus        29 ~~~~~i~~~~y~i~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~  106 (309)
T 3p86_A           29 GDDMDIPWCDLNIKEKIGAGSFGTVHRAEW--HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQP  106 (309)
T ss_dssp             ---CBCCGGGEEEEEEEEECSSEEEEEEEE--TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECST
T ss_pred             cccccCChhHceeeeEeecCCCeEEEEEEE--CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEEC
Confidence            566688999999999999999999999987  4788999998765444444455666677788889999998875321  


Q ss_pred             ---------------------------------HHHHHHHHHHHHHHHhcCC--CeeecCCCCCeEEcCCCCEEEEeccc
Q psy14630         94 ---------------------------------KEVTVATVKALNYLKEELK--IIHRDVKPSNILLDRRGAIKLCDFGI  138 (187)
Q Consensus        94 ---------------------------------~~~~~~~~~~l~~lh~~~~--i~Hrdlk~~nili~~~~~~ki~dfg~  138 (187)
                                                       ..++.|++.||.|||+. +  ++||||||+||+++.++.+||+|||+
T Consensus       107 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~-~~~ivH~Dikp~NIll~~~~~~kL~Dfg~  185 (309)
T 3p86_A          107 PNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNR-NPPIVHRNLKSPNLLVDKKYTVKVCDFGL  185 (309)
T ss_dssp             TCCEEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTS-SSCCCCTTCCGGGEEECTTCCEEECCCC-
T ss_pred             CceEEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcC-CCCEECCCCChhhEEEeCCCcEEECCCCC
Confidence                                             12667899999999998 8  99999999999999999999999999


Q ss_pred             cccccccc-cccCCCCCcCccCccccCCCccCCCCCCcceeeeEee
Q psy14630        139 SGQLVDSI-AKTRDAGCRPYMAPERIDPLRARGYPSFKTKLGFKFN  183 (187)
Q Consensus       139 a~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi~  183 (187)
                      ++...... ......||+.|+|||.+.   ...++.++|+||+|++
T Consensus       186 a~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwslG~i  228 (309)
T 3p86_A          186 SRLKASTFLSSKSAAGTPEWMAPEVLR---DEPSNEKSDVYSFGVI  228 (309)
T ss_dssp             ----------------CCTTSCHHHHT---TCCCCTTHHHHHHHHH
T ss_pred             CccccccccccccCCCCccccChhhhc---CCCCCchhhHHHHHHH
Confidence            98654332 223447899999999998   6678899999999994

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A*

Probab=100.00  E-value=2.8e-34  Score=218.65  Aligned_cols=156  Identities=26%  Similarity=0.484  Sum_probs=128.6

Q ss_pred             CcccccccccccccCceEEEEEEEcCCCcEEEEEEccCccChHHHHHHHHHHHHHHhcCCCCchhhhhhhH---------
Q psy14630         22 TSEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQFYGAL---------   92 (187)
Q Consensus        22 ~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~---------   92 (187)
                      ..++|++.+.||+|+||.||+|.+..+++.||+|.+......  ..+.+.++..+++.+.||||+++++.+         
T Consensus        18 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv   95 (297)
T 3fxz_A           18 PKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP--KKELIINEILVMRENKNPNIVNYLDSYLVGDELWVV   95 (297)
T ss_dssp             GGGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCS--CHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred             hhhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeeccccc--HHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEE
Confidence            457899999999999999999999999999999998643222  133455566677888999999987532         


Q ss_pred             ----------------------HHHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEeccccccccccc-ccc
Q psy14630         93 ----------------------FKEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSI-AKT  149 (187)
Q Consensus        93 ----------------------~~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg~a~~~~~~~-~~~  149 (187)
                                            ...++.|++.||.|||+. +++||||||+||+++.++.+||+|||++....... ...
T Consensus        96 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~-~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~  174 (297)
T 3fxz_A           96 MEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSN-QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRS  174 (297)
T ss_dssp             EECCTTCBHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTCCBC
T ss_pred             EECCCCCCHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHhC-CceeCCCCHHHEEECCCCCEEEeeCCCceecCCcccccC
Confidence                                  122678899999999998 99999999999999999999999999998765432 233


Q ss_pred             CCCCCcCccCccccCCCccCCCCCCcceeeeEee
Q psy14630        150 RDAGCRPYMAPERIDPLRARGYPSFKTKLGFKFN  183 (187)
Q Consensus       150 ~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi~  183 (187)
                      ...||+.|+|||.+.   ...++.++|+||+|++
T Consensus       175 ~~~gt~~y~aPE~~~---~~~~~~~~DiwslG~i  205 (297)
T 3fxz_A          175 TMVGTPYWMAPEVVT---RKAYGPKVDIWSLGIM  205 (297)
T ss_dssp             CCCSCGGGCCHHHHH---CSCBCTHHHHHHHHHH
T ss_pred             CccCCcCccChhhhc---CCCCCcHHHHHHHHHH
Confidence            457899999999998   6678999999999993

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=9.9e-34  Score=221.57  Aligned_cols=156  Identities=21%  Similarity=0.299  Sum_probs=123.5

Q ss_pred             cccccccccccccCceEEEEEEEcCCCcEEEEEEccCccChHHHHHHHHHHHHHHhcCCCCchhhhhhhH----------
Q psy14630         23 SEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQFYGAL----------   92 (187)
Q Consensus        23 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~----------   92 (187)
                      .++|++.+.||+|+||.||+|.+..+++.||||.+..........+.+.++..+++.++||||+++++.+          
T Consensus        24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~  103 (367)
T 1cm8_A           24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT  103 (367)
T ss_dssp             BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred             cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCc
Confidence            4789999999999999999999999999999999865444444455566677778888999999876432          


Q ss_pred             --------------------------HHHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEeccccccccccc
Q psy14630         93 --------------------------FKEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSI  146 (187)
Q Consensus        93 --------------------------~~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg~a~~~~~~~  146 (187)
                                                ...++.|++.||.|||+. +++||||||+||+++.++.+||+|||+++..... 
T Consensus       104 ~~~lv~e~~~~~L~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~-~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~-  181 (367)
T 1cm8_A          104 DFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYIHAA-GIIHRDLKPGNLAVNEDCELKILDFGLARQADSE-  181 (367)
T ss_dssp             CCEEEEECCSEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCCGGGEEECTTCCEEECCCTTCEECCSS-
T ss_pred             eEEEEEecCCCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC-CccccCcCHHHEEEcCCCCEEEEeeecccccccc-
Confidence                                      112667999999999998 9999999999999999999999999999876432 


Q ss_pred             cccCCCCCcCccCccccCCCccCCCCCCcceeeeEee
Q psy14630        147 AKTRDAGCRPYMAPERIDPLRARGYPSFKTKLGFKFN  183 (187)
Q Consensus       147 ~~~~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi~  183 (187)
                       .....+|+.|+|||++.+  ...++.++|+||+|++
T Consensus       182 -~~~~~~t~~y~aPE~~~~--~~~~~~~~DiwslG~i  215 (367)
T 1cm8_A          182 -MTGYVVTRWYRAPEVILN--WMRYTQTVDIWSVGCI  215 (367)
T ss_dssp             -CCSSCSCGGGCCTHHHHT--TTCCCTTHHHHHHHHH
T ss_pred             -cCcCcCCCCcCCHHHHhC--CCCCChhhhHHHHHHH
Confidence             234478999999999873  2568899999999993

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A*

Probab=100.00  E-value=1.4e-34  Score=225.30  Aligned_cols=160  Identities=26%  Similarity=0.391  Sum_probs=124.5

Q ss_pred             cCCcccccccccccccCceEEEEEEEcCCCcEEEEEEccCccC-hHHHHHHHHHHHHHHhc-CCCCchhhhhhhH-----
Q psy14630         20 DFTSEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVD-EKDQRQLLMDLDVVMKS-NECPYIVQFYGAL-----   92 (187)
Q Consensus        20 ~~~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~~~~~~~~-~~h~~iv~~~~~~-----   92 (187)
                      .+..++|++.+.||+|+||.||+|.+..+++.||+|+++.... .....+....+..++.. .+||||+++++.+     
T Consensus        16 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~   95 (353)
T 2i0e_A           16 RMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDR   95 (353)
T ss_dssp             ---CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSE
T ss_pred             CCchHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCE
Confidence            4567899999999999999999999999999999999864211 11112233334444544 4899999876432     


Q ss_pred             ---------------------------HHHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEecccccccc-c
Q psy14630         93 ---------------------------FKEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLV-D  144 (187)
Q Consensus        93 ---------------------------~~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg~a~~~~-~  144 (187)
                                                 ...++.|++.||.|||+. +++||||||+||+++.++.+||+|||+++... .
T Consensus        96 ~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~-givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~  174 (353)
T 2i0e_A           96 LYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSK-GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWD  174 (353)
T ss_dssp             EEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT-TCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT
T ss_pred             EEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC-CEEeccCCHHHEEEcCCCcEEEEeCCcccccccC
Confidence                                       112678999999999998 99999999999999999999999999998743 2


Q ss_pred             cccccCCCCCcCccCccccCCCccCCCCCCcceeeeEee
Q psy14630        145 SIAKTRDAGCRPYMAPERIDPLRARGYPSFKTKLGFKFN  183 (187)
Q Consensus       145 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi~  183 (187)
                      .......+||+.|+|||++.   ..+++.++|+||+|++
T Consensus       175 ~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwslG~i  210 (353)
T 2i0e_A          175 GVTTKTFCGTPDYIAPEIIA---YQPYGKSVDWWAFGVL  210 (353)
T ss_dssp             TCCBCCCCSCGGGCCHHHHT---TCCBSTHHHHHHHHHH
T ss_pred             CcccccccCCccccChhhhc---CCCcCCcccccchHHH
Confidence            33344568999999999998   6678999999999993

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A

Probab=100.00  E-value=9.4e-34  Score=221.92  Aligned_cols=164  Identities=26%  Similarity=0.358  Sum_probs=128.1

Q ss_pred             CCccccCCcccccccccccccCceEEEEEEEc-------CCCcEEEEEEccCccChHHHHHHHHHHHHHHhcC-CCCchh
Q psy14630         15 PDTVYDFTSEDLQDLGEIGRGGFGTVNKMIHR-------SSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSN-ECPYIV   86 (187)
Q Consensus        15 ~~~~~~~~~~~~~~~~~lg~G~fg~V~~~~~~-------~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~-~h~~iv   86 (187)
                      +...+++..++|++.+.||+|+||.||+|.+.       .++..||+|.++........ +.+..+..+++.+ +||||+
T Consensus        72 ~~~~~~~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~-~~~~~E~~~l~~l~~hpnIv  150 (370)
T 2psq_A           72 EDPKWEFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDL-SDLVSEMEMMKMIGKHKNII  150 (370)
T ss_dssp             CCTTTBCCGGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHH-HHHHHHHHHHHHSCCCTTBC
T ss_pred             ccccccccHHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHH-HHHHHHHHHHHHhcCCCCEe
Confidence            34456778899999999999999999999864       34567999999765443333 3444555566666 899999


Q ss_pred             hhhhhHH------------------------------------------------HHHHHHHHHHHHHHHhcCCCeeecC
Q psy14630         87 QFYGALF------------------------------------------------KEVTVATVKALNYLKEELKIIHRDV  118 (187)
Q Consensus        87 ~~~~~~~------------------------------------------------~~~~~~~~~~l~~lh~~~~i~Hrdl  118 (187)
                      ++++.+.                                                ..++.|++.||.|||+. +++||||
T Consensus       151 ~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~-~ivHrDl  229 (370)
T 2psq_A          151 NLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ-KCIHRDL  229 (370)
T ss_dssp             CEEEEECSSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHT-TEECSCC
T ss_pred             eEEEEEccCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC-Ceecccc
Confidence            8875320                                                11567899999999998 9999999


Q ss_pred             CCCCeEEcCCCCEEEEeccccccccccc---cccCCCCCcCccCccccCCCccCCCCCCcceeeeEee
Q psy14630        119 KPSNILLDRRGAIKLCDFGISGQLVDSI---AKTRDAGCRPYMAPERIDPLRARGYPSFKTKLGFKFN  183 (187)
Q Consensus       119 k~~nili~~~~~~ki~dfg~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi~  183 (187)
                      ||+||+++.++.+||+|||+++......   ......+|+.|+|||.+.   ...++.++|+||||++
T Consensus       230 kp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~---~~~~~~~~DvwslG~i  294 (370)
T 2psq_A          230 AARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALF---DRVYTHQSDVWSFGVL  294 (370)
T ss_dssp             CGGGEEECTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHH---TCCCCHHHHHHHHHHH
T ss_pred             chhhEEECCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhc---CCCCCcHHHHHHHHHH
Confidence            9999999999999999999998765432   122335678899999998   5678999999999994

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A*

Probab=100.00  E-value=9.5e-34  Score=218.42  Aligned_cols=162  Identities=23%  Similarity=0.341  Sum_probs=120.9

Q ss_pred             cccCCcccccccccccccCceEEEEEEEc---CCCcEEEEEEccCccC--hHHHHHHHHHHHHHHhcCCCCchhhhhhhH
Q psy14630         18 VYDFTSEDLQDLGEIGRGGFGTVNKMIHR---SSDTVMAVKRIRSTVD--EKDQRQLLMDLDVVMKSNECPYIVQFYGAL   92 (187)
Q Consensus        18 ~~~~~~~~~~~~~~lg~G~fg~V~~~~~~---~~~~~vaiK~~~~~~~--~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~   92 (187)
                      ...+..++|++.+.||+|+||.||+|.+.   .+++.||+|+++....  .......+.++..+++.+.||||+++++.+
T Consensus        11 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~   90 (327)
T 3a62_A           11 PEKIRPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAF   90 (327)
T ss_dssp             --CCCGGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEE
T ss_pred             CCCCCHHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEE
Confidence            34567799999999999999999999985   6889999999875321  112233445566677888999999986432


Q ss_pred             --------------------------------HHHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEeccccc
Q psy14630         93 --------------------------------FKEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISG  140 (187)
Q Consensus        93 --------------------------------~~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg~a~  140 (187)
                                                      ...++.|++.||.|||+. +++||||||+||+++.++.+||+|||+++
T Consensus        91 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~-~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~  169 (327)
T 3a62_A           91 QTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLHQK-GIIYRDLKPENIMLNHQGHVKLTDFGLCK  169 (327)
T ss_dssp             ECSSCEEEEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT-TCCCCCCCTTTEEECTTSCEEECCCSCC-
T ss_pred             EcCCEEEEEEeCCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhC-CEEcccCCHHHeEECCCCcEEEEeCCccc
Confidence                                            112667899999999998 99999999999999999999999999998


Q ss_pred             cccc-cccccCCCCCcCccCccccCCCccCCCCCCcceeeeEee
Q psy14630        141 QLVD-SIAKTRDAGCRPYMAPERIDPLRARGYPSFKTKLGFKFN  183 (187)
Q Consensus       141 ~~~~-~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi~  183 (187)
                      .... ........||+.|+|||++.   ...++.++|+||+|++
T Consensus       170 ~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwslG~i  210 (327)
T 3a62_A          170 ESIHDGTVTHTFCGTIEYMAPEILM---RSGHNRAVDWWSLGAL  210 (327)
T ss_dssp             ---------CTTSSCCTTSCHHHHT---TSCCCTHHHHHHHHHH
T ss_pred             ccccCCccccccCCCcCccCHhhCc---CCCCCCcccchhHHHH
Confidence            6533 22333457899999999998   5678999999999994

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=3.1e-34  Score=220.70  Aligned_cols=154  Identities=20%  Similarity=0.266  Sum_probs=128.5

Q ss_pred             cccccccccccccCceEEEEEEEcCCCcEEEEEEccCccChHHHHHHHHHHHHHHhcCCCCchhhhhhhH----------
Q psy14630         23 SEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQFYGAL----------   92 (187)
Q Consensus        23 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~----------   92 (187)
                      .++|++.+.||+|+||.||+|.+..+++.+|+|.+...  . .....+.++..+++.+.||||+++++.+          
T Consensus         4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~--~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~   80 (321)
T 1tki_A            4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK--G-TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIF   80 (321)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC--T-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEE
T ss_pred             hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecC--c-ccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEE
Confidence            47899999999999999999999999999999998642  2 2334456666778888999999987532          


Q ss_pred             -----------------------HHHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcC--CCCEEEEecccccccccccc
Q psy14630         93 -----------------------FKEVTVATVKALNYLKEELKIIHRDVKPSNILLDR--RGAIKLCDFGISGQLVDSIA  147 (187)
Q Consensus        93 -----------------------~~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~--~~~~ki~dfg~a~~~~~~~~  147 (187)
                                             ...++.|++.|+.|||+. +++||||||+||+++.  ++.+||+|||+++.......
T Consensus        81 e~~~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~-givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~  159 (321)
T 1tki_A           81 EFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSH-NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDN  159 (321)
T ss_dssp             CCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTCE
T ss_pred             EeCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC-CCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCCCc
Confidence                                   112678999999999998 9999999999999987  78999999999988765544


Q ss_pred             ccCCCCCcCccCccccCCCccCCCCCCcceeeeEee
Q psy14630        148 KTRDAGCRPYMAPERIDPLRARGYPSFKTKLGFKFN  183 (187)
Q Consensus       148 ~~~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi~  183 (187)
                      .....+|+.|+|||++.   ...++.++|+||+|++
T Consensus       160 ~~~~~gt~~y~aPE~~~---~~~~~~~~DiwslG~i  192 (321)
T 1tki_A          160 FRLLFTAPEYYAPEVHQ---HDVVSTATDMWSLGTL  192 (321)
T ss_dssp             EEEEESCGGGSCHHHHT---TCEECHHHHHHHHHHH
T ss_pred             cccccCChhhcCcHHhc---CCCCCchhhHHHHHHH
Confidence            44557899999999998   5567899999999994

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B*

Probab=100.00  E-value=1.1e-33  Score=222.70  Aligned_cols=167  Identities=20%  Similarity=0.267  Sum_probs=134.9

Q ss_pred             CCccccCCccccccccccccc--CceEEEEEEEcCCCcEEEEEEccCccChHHHHHHHHHHHHHHhcCCCCchhhhhhhH
Q psy14630         15 PDTVYDFTSEDLQDLGEIGRG--GFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQFYGAL   92 (187)
Q Consensus        15 ~~~~~~~~~~~~~~~~~lg~G--~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~   92 (187)
                      ....+....++|++.+.||+|  +||.||+|.+..+++.||+|.+..........+.+.++..+++.++||||+++++.+
T Consensus        16 ~~s~~~~~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~   95 (389)
T 3gni_B           16 GMSSFLPEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATF   95 (389)
T ss_dssp             --CCCCCCGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             hhhcccCCCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEE
Confidence            345556678899999999999  999999999999999999999976544455566777777888899999999987532


Q ss_pred             ----------------------------------HHHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEeccc
Q psy14630         93 ----------------------------------FKEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGI  138 (187)
Q Consensus        93 ----------------------------------~~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg~  138 (187)
                                                        ...++.|++.||.|||+. +++||||||+||+++.++.+||+|||.
T Consensus        96 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~-~ivHrDlkp~NIll~~~~~~kl~dfg~  174 (389)
T 3gni_B           96 IADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHM-GYVHRSVKASHILISVDGKVYLSGLRS  174 (389)
T ss_dssp             EETTEEEEEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEECTTCCEEECCGGG
T ss_pred             EECCEEEEEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhC-CeecCCCCHHHEEEcCCCCEEEccccc
Confidence                                              112677899999999998 999999999999999999999999998


Q ss_pred             ccccccc--------ccccCCCCCcCccCccccCCCccCCCCCCcceeeeEee
Q psy14630        139 SGQLVDS--------IAKTRDAGCRPYMAPERIDPLRARGYPSFKTKLGFKFN  183 (187)
Q Consensus       139 a~~~~~~--------~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi~  183 (187)
                      +......        .......||+.|+|||++.+. ...++.++|+||+|++
T Consensus       175 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~~DiwslG~i  226 (389)
T 3gni_B          175 NLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQN-LQGYDAKSDIYSVGIT  226 (389)
T ss_dssp             CEECEETTEECSCBCCCCTTCTTTGGGSCHHHHSTT-SSCBCTHHHHHHHHHH
T ss_pred             ceeeccccccccccccccccccccccccCHHHHhcc-CCCCCcHhHHHHHHHH
Confidence            8765321        111223688899999999832 2568899999999994

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A*

Probab=99.98  E-value=2.3e-34  Score=235.55  Aligned_cols=159  Identities=23%  Similarity=0.375  Sum_probs=130.5

Q ss_pred             CCcccccccccccccCceEEEEEEEcCCCcEEEEEEccCccC-hHHHHHHHHHHHHHHhcCCCCchhhhhhhHH------
Q psy14630         21 FTSEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVD-EKDQRQLLMDLDVVMKSNECPYIVQFYGALF------   93 (187)
Q Consensus        21 ~~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~------   93 (187)
                      +..++|++.+.||+|+||.||+|.+..+++.||+|++..... .......+..+..+++.++||||+++++.+.      
T Consensus       181 ~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~  260 (576)
T 2acx_A          181 VTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALC  260 (576)
T ss_dssp             CCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             ccccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEE
Confidence            567889999999999999999999999999999999853211 1112234455666777889999998864321      


Q ss_pred             ----------------------------HHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEecccccccccc
Q psy14630         94 ----------------------------KEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDS  145 (187)
Q Consensus        94 ----------------------------~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg~a~~~~~~  145 (187)
                                                  ..++.|++.||.|||+. +|+||||||+||+++.++.+||+|||+++.....
T Consensus       261 lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~-gIvHrDLKPeNILld~~g~vKL~DFGla~~~~~~  339 (576)
T 2acx_A          261 LVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRE-RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEG  339 (576)
T ss_dssp             EEECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCCGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred             EEEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHC-CEeccCCchheEEEeCCCCeEEEecccceecccC
Confidence                                        12667899999999998 9999999999999999999999999999887655


Q ss_pred             ccccCCCCCcCccCccccCCCccCCCCCCcceeeeEee
Q psy14630        146 IAKTRDAGCRPYMAPERIDPLRARGYPSFKTKLGFKFN  183 (187)
Q Consensus       146 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi~  183 (187)
                      ......+||+.|+|||++.   ...++.++|+||+|++
T Consensus       340 ~~~~~~~GT~~Y~APEvl~---~~~~~~~~DiwSLGvi  374 (576)
T 2acx_A          340 QTIKGRVGTVGYMAPEVVK---NERYTFSPDWWALGCL  374 (576)
T ss_dssp             CCEECCCSCGGGCCHHHHT---TCEESSHHHHHHHHHH
T ss_pred             ccccccCCCccccCHHHHc---CCCCCccchHHHHHHH
Confidence            4445568999999999998   5678999999999993

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A*

Probab=99.98  E-value=7.4e-35  Score=232.51  Aligned_cols=163  Identities=25%  Similarity=0.385  Sum_probs=127.8

Q ss_pred             cCCcccccccccccccCceEEEEEEEcCCCcEEEEEEccCccC-hHHHHHHHHHHHHHHhcCCCCchhhhhhhH------
Q psy14630         20 DFTSEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVD-EKDQRQLLMDLDVVMKSNECPYIVQFYGAL------   92 (187)
Q Consensus        20 ~~~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~------   92 (187)
                      .+..++|++.+.||+|+||.||+|.+..+++.||+|+++.... .....+.+.++..++..++||||+++++.+      
T Consensus        70 ~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~  149 (437)
T 4aw2_A           70 RLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDNNL  149 (437)
T ss_dssp             SCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECSSEE
T ss_pred             cCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCEE
Confidence            4567899999999999999999999999999999999853211 001112245566667778999999886432      


Q ss_pred             ---------------------------HHHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEecccccccccc
Q psy14630         93 ---------------------------FKEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDS  145 (187)
Q Consensus        93 ---------------------------~~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg~a~~~~~~  145 (187)
                                                 ...++.|++.||.|||+. +|+||||||+||+++.++.+||+|||+++.....
T Consensus       150 ~lV~Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH~~-giiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~  228 (437)
T 4aw2_A          150 YLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQL-HYVHRDIKPDNILMDMNGHIRLADFGSCLKLMED  228 (437)
T ss_dssp             EEEECCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred             EEEEecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHHhC-CeEecccCHHHeeEcCCCCEEEcchhhhhhcccC
Confidence                                       112678999999999997 9999999999999999999999999999876543


Q ss_pred             c--cccCCCCCcCccCccccCCCc--cCCCCCCcceeeeEee
Q psy14630        146 I--AKTRDAGCRPYMAPERIDPLR--ARGYPSFKTKLGFKFN  183 (187)
Q Consensus       146 ~--~~~~~~~t~~y~aPE~~~~~~--~~~~~~~~D~ws~gi~  183 (187)
                      .  .....+||+.|+|||++....  ...++.++|+||+|++
T Consensus       229 ~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvi  270 (437)
T 4aw2_A          229 GTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVC  270 (437)
T ss_dssp             SCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHH
T ss_pred             CCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHH
Confidence            2  223457999999999986211  2347899999999993

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A*

Probab=99.98  E-value=2.7e-34  Score=229.97  Aligned_cols=162  Identities=24%  Similarity=0.411  Sum_probs=122.6

Q ss_pred             ccCCcccccccccccccCceEEEEEEEcCCCcEEEEEEccCcc-ChHHHHHHHHHHHHHHhcCCCCchhhhhhhH-----
Q psy14630         19 YDFTSEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTV-DEKDQRQLLMDLDVVMKSNECPYIVQFYGAL-----   92 (187)
Q Consensus        19 ~~~~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~-----   92 (187)
                      ..+..++|++.+.||+|+||.||+|.+..+++.||+|+++... ........+..+..+++.+.||||+++++.+     
T Consensus       143 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~  222 (446)
T 4ejn_A          143 HRVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDR  222 (446)
T ss_dssp             -CCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTE
T ss_pred             cCCChHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCE
Confidence            3456789999999999999999999999999999999986421 1122223344555667788999999886432     


Q ss_pred             ---------------------------HHHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEeccccccccc-
Q psy14630         93 ---------------------------FKEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVD-  144 (187)
Q Consensus        93 ---------------------------~~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg~a~~~~~-  144 (187)
                                                 ...++.|++.||+|||+..+|+||||||+||+++.++.+||+|||+++.... 
T Consensus       223 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~  302 (446)
T 4ejn_A          223 LCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKD  302 (446)
T ss_dssp             EEEEECCCSSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCCCGGGEEECSSSCEEECCCCCCCTTCC-
T ss_pred             EEEEEeeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEECCCCHHHEEECCCCCEEEccCCCceeccCC
Confidence                                       1126678999999999833999999999999999999999999999987433 


Q ss_pred             cccccCCCCCcCccCccccCCCccCCCCCCcceeeeEee
Q psy14630        145 SIAKTRDAGCRPYMAPERIDPLRARGYPSFKTKLGFKFN  183 (187)
Q Consensus       145 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi~  183 (187)
                      .......+||+.|+|||++.   ...++.++|+||+|++
T Consensus       303 ~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwslG~i  338 (446)
T 4ejn_A          303 GATMKTFCGTPEYLAPEVLE---DNDYGRAVDWWGLGVV  338 (446)
T ss_dssp             ----CCSSSCGGGCCHHHHH---TSCCCTHHHHHHHHHH
T ss_pred             CcccccccCCccccCHhhcC---CCCCCCccchhhhHHH
Confidence            33334567999999999998   6678999999999994

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens}

Probab=99.98  E-value=8.7e-34  Score=218.56  Aligned_cols=157  Identities=22%  Similarity=0.274  Sum_probs=128.5

Q ss_pred             cccccccccccccCceEEEEEEEcCCCcEEEEEEccCccChH----HHHHHHHHHHHHHhcCCCCchhhhhhhH------
Q psy14630         23 SEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEK----DQRQLLMDLDVVMKSNECPYIVQFYGAL------   92 (187)
Q Consensus        23 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~----~~~~~~~~~~~~~~~~~h~~iv~~~~~~------   92 (187)
                      .+.|++.+.||+|+||.||+|.+..+++.||+|.++......    ...+.+.++..+++.++||||+++++.+      
T Consensus        10 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~   89 (326)
T 2y0a_A           10 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV   89 (326)
T ss_dssp             HHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             ccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence            467999999999999999999999999999999986432211    1234455566677888999999987532      


Q ss_pred             --------------------------HHHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCC----CEEEEeccccccc
Q psy14630         93 --------------------------FKEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRG----AIKLCDFGISGQL  142 (187)
Q Consensus        93 --------------------------~~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~----~~ki~dfg~a~~~  142 (187)
                                                ...++.|++.||.|||+. +++||||||+||+++.++    .+||+|||+++..
T Consensus        90 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~-~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~~  168 (326)
T 2y0a_A           90 ILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSL-QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI  168 (326)
T ss_dssp             EEEEECCCSCBHHHHHTTSSCCBHHHHHHHHHHHHHHHHHHHHT-TEECCCCCGGGEEESCSSSSSCCEEECCCTTCEEC
T ss_pred             EEEEEcCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHHC-CeEcCCCCHHHEEEecCCCCCCCEEEEECCCCeEC
Confidence                                      112778999999999997 999999999999998877    7999999999887


Q ss_pred             cccccccCCCCCcCccCccccCCCccCCCCCCcceeeeEee
Q psy14630        143 VDSIAKTRDAGCRPYMAPERIDPLRARGYPSFKTKLGFKFN  183 (187)
Q Consensus       143 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi~  183 (187)
                      ..........||+.|+|||++.   ...++.++|+||+|++
T Consensus       169 ~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwslG~i  206 (326)
T 2y0a_A          169 DFGNEFKNIFGTPEFVAPEIVN---YEPLGLEADMWSIGVI  206 (326)
T ss_dssp             CTTSCCCCCCSCTTTCCHHHHT---TCCCCTHHHHHHHHHH
T ss_pred             CCCCccccccCCcCcCCceeec---CCCCCcHHHHHHHHHH
Confidence            6544445567999999999998   5678999999999993

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ...

Probab=99.98  E-value=3.7e-34  Score=222.73  Aligned_cols=158  Identities=22%  Similarity=0.369  Sum_probs=128.6

Q ss_pred             cCCcccccccccccccCceEEEEEEEcCCCcEEEEEEccCccC-hHHHHHHHHHHHHHHhcCCCCchhhhhhhH------
Q psy14630         20 DFTSEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVD-EKDQRQLLMDLDVVMKSNECPYIVQFYGAL------   92 (187)
Q Consensus        20 ~~~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~------   92 (187)
                      ....++|++.+.||+|+||.||+|.+..+++.||+|++..... .....+.+.++..+++.++||||+++++.+      
T Consensus        37 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~  116 (350)
T 1rdq_E           37 TAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNL  116 (350)
T ss_dssp             CCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred             CCCHHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEE
Confidence            3456899999999999999999999999999999999853211 111223455566677888999999886432      


Q ss_pred             --------------------------HHHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEeccccccccccc
Q psy14630         93 --------------------------FKEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSI  146 (187)
Q Consensus        93 --------------------------~~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg~a~~~~~~~  146 (187)
                                                ...++.|++.||.|||+. +++||||||+||+++.++.+||+|||+++..... 
T Consensus       117 ~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~-~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~-  194 (350)
T 1rdq_E          117 YMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSL-DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-  194 (350)
T ss_dssp             EEEEECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEECTTSCEEECCCTTCEECSSC-
T ss_pred             EEEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC-CcccccCccceEEECCCCCEEEcccccceeccCC-
Confidence                                      112678999999999997 9999999999999999999999999999876543 


Q ss_pred             cccCCCCCcCccCccccCCCccCCCCCCcceeeeEee
Q psy14630        147 AKTRDAGCRPYMAPERIDPLRARGYPSFKTKLGFKFN  183 (187)
Q Consensus       147 ~~~~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi~  183 (187)
                       ....+||+.|+|||++.   ...++.++|+||+|++
T Consensus       195 -~~~~~gt~~y~aPE~~~---~~~~~~~~DiwslG~i  227 (350)
T 1rdq_E          195 -TWTLCGTPEALAPEIIL---SKGYNKAVDWWALGVL  227 (350)
T ss_dssp             -BCCCEECGGGCCHHHHT---TCCBCTHHHHHHHHHH
T ss_pred             -cccccCCccccCHHHhc---CCCCCCcCCEecccHh
Confidence             23457899999999998   6678999999999993

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A

Probab=99.98  E-value=3.1e-34  Score=217.23  Aligned_cols=156  Identities=23%  Similarity=0.409  Sum_probs=122.2

Q ss_pred             ccccccccccccCceEEEEEEEcCCCcEEEEEEccCccChHHHHHHHHHHHHHHhcCCCCchhhhhhhH-----------
Q psy14630         24 EDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQFYGAL-----------   92 (187)
Q Consensus        24 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~-----------   92 (187)
                      ++|++.+.||+|+||.||+|.+ .+++.||+|.+..........+.+.++..+++.++||||+++++.+           
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   80 (288)
T 1ob3_A            2 EKYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFE   80 (288)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEE-TTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEE
T ss_pred             ccchhhhhcccCCCEEEEEEEc-CCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEE
Confidence            5799999999999999999998 6788999999865433222234455566678888999999987532           


Q ss_pred             ---------------------HHHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEecccccccccc-ccccC
Q psy14630         93 ---------------------FKEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDS-IAKTR  150 (187)
Q Consensus        93 ---------------------~~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg~a~~~~~~-~~~~~  150 (187)
                                           ...++.|++.||.|||+. +++||||||+||+++.++.+||+|||+++..... .....
T Consensus        81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~-~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~  159 (288)
T 1ob3_A           81 HLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDR-RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTH  159 (288)
T ss_dssp             CCSEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-------
T ss_pred             ecCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHC-CeecCCCCHHHEEEcCCCCEEEeECccccccCcccccccc
Confidence                                 112678999999999998 9999999999999999999999999999875432 22233


Q ss_pred             CCCCcCccCccccCCCccCCCCCCcceeeeEee
Q psy14630        151 DAGCRPYMAPERIDPLRARGYPSFKTKLGFKFN  183 (187)
Q Consensus       151 ~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi~  183 (187)
                      ..+|+.|+|||.+.+  ...++.++|+||+|++
T Consensus       160 ~~~t~~y~aPE~~~~--~~~~~~~~DiwslG~i  190 (288)
T 1ob3_A          160 EIVTLWYRAPDVLMG--SKKYSTTIDIWSVGCI  190 (288)
T ss_dssp             --CCCTTCCHHHHTT--CCSCCTHHHHHHHHHH
T ss_pred             ccccccccCchheeC--CCCCCcHHHHHHHHHH
Confidence            468999999999873  3457899999999993

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp}

Probab=99.98  E-value=1.6e-33  Score=214.07  Aligned_cols=160  Identities=20%  Similarity=0.286  Sum_probs=126.3

Q ss_pred             cCCcccccccccccccCceEEEEEEEcCCCcEEEEEEccCcc-ChHHHHHHHHHHHHHHhcCCCCchhhhhhhH------
Q psy14630         20 DFTSEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTV-DEKDQRQLLMDLDVVMKSNECPYIVQFYGAL------   92 (187)
Q Consensus        20 ~~~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~------   92 (187)
                      +...++|++.+.||+|+||.||+|.+..+++.||+|.+.... ......+.+.++...+..+.||||+++++.+      
T Consensus         7 ~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~   86 (294)
T 4eqm_A            7 KIINERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCY   86 (294)
T ss_dssp             SCEETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEE
T ss_pred             hHhhccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeE
Confidence            344688999999999999999999999999999999985432 3334455666777778888999999887532      


Q ss_pred             --------------------------HHHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEeccccccccccc
Q psy14630         93 --------------------------FKEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSI  146 (187)
Q Consensus        93 --------------------------~~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg~a~~~~~~~  146 (187)
                                                ...++.|++.||.|||+. +++||||||+||+++.++.+||+|||+++......
T Consensus        87 ~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~-~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  165 (294)
T 4eqm_A           87 YLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHDM-RIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETS  165 (294)
T ss_dssp             EEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHT-TCCCCCCCGGGEEECTTSCEEECCCSSSTTC----
T ss_pred             EEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC-CcccCCCCHHHEEECCCCCEEEEeCCCcccccccc
Confidence                                      112677999999999998 99999999999999999999999999998765432


Q ss_pred             c--ccCCCCCcCccCccccCCCccCCCCCCcceeeeEee
Q psy14630        147 A--KTRDAGCRPYMAPERIDPLRARGYPSFKTKLGFKFN  183 (187)
Q Consensus       147 ~--~~~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi~  183 (187)
                      .  .....||+.|+|||.+.   ...++.++|+||+|+.
T Consensus       166 ~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Di~slG~~  201 (294)
T 4eqm_A          166 LTQTNHVLGTVQYFSPEQAK---GEATDECTDIYSIGIV  201 (294)
T ss_dssp             ---------CCSSCCHHHHH---TCCCCTTHHHHHHHHH
T ss_pred             ccccCccccCccccCHhHhc---CCCCCchHhHHHHHHH
Confidence            1  22346899999999998   5668899999999993

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens}

Probab=99.98  E-value=1.6e-34  Score=229.10  Aligned_cols=166  Identities=25%  Similarity=0.351  Sum_probs=129.6

Q ss_pred             ccCCcccccccccccccCceEEEEEEEcCCCcEEEEEEccCccC-hHHHHHHHHHHHHHHhcCCCCchhhhhhhH-----
Q psy14630         19 YDFTSEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVD-EKDQRQLLMDLDVVMKSNECPYIVQFYGAL-----   92 (187)
Q Consensus        19 ~~~~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~-----   92 (187)
                      ..+..++|++.+.||+|+||.||+|.+..+++.||+|++++... .....+.+.++..++..++||||+++++.+     
T Consensus        56 ~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~  135 (412)
T 2vd5_A           56 VRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDENY  135 (412)
T ss_dssp             HSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECSSE
T ss_pred             ccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCE
Confidence            35677899999999999999999999999999999999853211 111122345566667778999999886432     


Q ss_pred             ----------------------------HHHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEeccccccccc
Q psy14630         93 ----------------------------FKEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVD  144 (187)
Q Consensus        93 ----------------------------~~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg~a~~~~~  144 (187)
                                                  ...++.|++.||.|||+. +++||||||+||+++.++.+||+|||+++....
T Consensus       136 ~~lVmE~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH~~-giiHrDLKp~NILld~~g~vkL~DFGla~~~~~  214 (412)
T 2vd5_A          136 LYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRL-GYVHRDIKPDNILLDRCGHIRLADFGSCLKLRA  214 (412)
T ss_dssp             EEEEECCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEECTTSCEEECCCTTCEECCT
T ss_pred             EEEEEcCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC-CeeecccCHHHeeecCCCCEEEeechhheeccC
Confidence                                        112667899999999997 999999999999999999999999999987654


Q ss_pred             ccc--ccCCCCCcCccCccccCCCc----cCCCCCCcceeeeEe-eee
Q psy14630        145 SIA--KTRDAGCRPYMAPERIDPLR----ARGYPSFKTKLGFKF-NYR  185 (187)
Q Consensus       145 ~~~--~~~~~~t~~y~aPE~~~~~~----~~~~~~~~D~ws~gi-~~~  185 (187)
                      ...  ....+||+.|+|||++....    ...++.++|+||+|+ +|+
T Consensus       215 ~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilye  262 (412)
T 2vd5_A          215 DGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYE  262 (412)
T ss_dssp             TSCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHH
T ss_pred             CCccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHH
Confidence            322  23457999999999986210    235789999999999 443

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A*

Probab=99.98  E-value=5.9e-34  Score=219.63  Aligned_cols=161  Identities=21%  Similarity=0.337  Sum_probs=120.3

Q ss_pred             cCCcccccccccccccCceEEEEEEEcCCCcEEEEEEccCccChHHHHHHHHHHHHHHhcCCCCchhhhhhhH-------
Q psy14630         20 DFTSEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQFYGAL-------   92 (187)
Q Consensus        20 ~~~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~-------   92 (187)
                      ....++|++.+.||+|+||.||+|.+..+++.||+|+++.........+.+.++..+++.++||||+++++.+       
T Consensus        30 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  109 (329)
T 3gbz_A           30 ATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLH  109 (329)
T ss_dssp             --CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEE
T ss_pred             ccchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEE
Confidence            4567899999999999999999999999999999999975444333444555667778889999999986532       


Q ss_pred             ------------------------HHHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEc-----CCCCEEEEecccccccc
Q psy14630         93 ------------------------FKEVTVATVKALNYLKEELKIIHRDVKPSNILLD-----RRGAIKLCDFGISGQLV  143 (187)
Q Consensus        93 ------------------------~~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~-----~~~~~ki~dfg~a~~~~  143 (187)
                                              ...++.|++.||.|||+. +++||||||+||+++     ..+.+||+|||+++...
T Consensus       110 lv~e~~~~~L~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~-~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~~~  188 (329)
T 3gbz_A          110 LIFEYAENDLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHSR-RCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFG  188 (329)
T ss_dssp             EEEECCSEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCCGGGEEEEC-----CCEEEECCTTHHHHHC
T ss_pred             EEEecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhC-CEECCCCCHHHEEEecCCCCccceEEECcCCCccccC
Confidence                                    122678999999999998 999999999999994     44559999999998764


Q ss_pred             cc-ccccCCCCCcCccCccccCCCccCCCCCCcceeeeEee
Q psy14630        144 DS-IAKTRDAGCRPYMAPERIDPLRARGYPSFKTKLGFKFN  183 (187)
Q Consensus       144 ~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi~  183 (187)
                      .. .......+|+.|+|||++.+  ...++.++|+||+|++
T Consensus       189 ~~~~~~~~~~~t~~y~aPE~~~~--~~~~~~~~DiwslG~i  227 (329)
T 3gbz_A          189 IPIRQFTHEIITLWYRPPEILLG--SRHYSTSVDIWSIACI  227 (329)
T ss_dssp             -----------CCTTCCHHHHTT--CCCCCTHHHHHHHHHH
T ss_pred             CcccccCCCcCCccccCHHHhcC--CCCCCcHHHHHHHHHH
Confidence            32 22233467999999999973  2447899999999994

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ...

Probab=99.98  E-value=2e-33  Score=219.92  Aligned_cols=161  Identities=22%  Similarity=0.343  Sum_probs=117.8

Q ss_pred             ccccCCcccccccccccccCceEEEEEEEcCCCcEEEEEEccCccChHHHHHHHHHHHHHHhcCCCCchhhhhhhHH---
Q psy14630         17 TVYDFTSEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQFYGALF---   93 (187)
Q Consensus        17 ~~~~~~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~---   93 (187)
                      ..|++ .++|++.+.||+|+||.||+|.+..+++.||||.+..........+.+.++..+++.++||||+++++.+.   
T Consensus        23 ~~~~~-~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~  101 (367)
T 2fst_X           23 TIWEV-PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPAR  101 (367)
T ss_dssp             EEEEE-ETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCS
T ss_pred             cccCC-CCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCC
Confidence            33443 37899999999999999999999999999999998654444444455566666788889999998875431   


Q ss_pred             ---------------------------------HHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEeccccc
Q psy14630         94 ---------------------------------KEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISG  140 (187)
Q Consensus        94 ---------------------------------~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg~a~  140 (187)
                                                       ..++.|++.||.|||+. +++||||||+||+++.++.+||+|||+++
T Consensus       102 ~~~~~~~~~lv~e~~~~~L~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~-givH~Dlkp~NIll~~~~~~kL~DFG~a~  180 (367)
T 2fst_X          102 SLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA-DIIHRDLKPSNLAVNEDCELKILDFGLAR  180 (367)
T ss_dssp             SGGGCCCCEEEEECCCEECC-----CCCCHHHHHHHHHHHHHHHHHHHHT-TCCCCCCCGGGEEECTTCCEEECC-----
T ss_pred             ccccCCeEEEEecccCCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC-CeeeCCCCHhhEEECCCCCEEEeeccccc
Confidence                                             12678999999999997 99999999999999999999999999998


Q ss_pred             cccccccccCCCCCcCccCccccCCCccCCCCCCcceeeeEee
Q psy14630        141 QLVDSIAKTRDAGCRPYMAPERIDPLRARGYPSFKTKLGFKFN  183 (187)
Q Consensus       141 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi~  183 (187)
                      .....  .....+|+.|+|||++.+  ...++.++|+||+|++
T Consensus       181 ~~~~~--~~~~~~t~~y~aPE~~~~--~~~~~~~~DiwslG~i  219 (367)
T 2fst_X          181 HTADE--MTGYVATRWYRAPEIMLN--WMHYNQTVDIWSVGCI  219 (367)
T ss_dssp             ------------CCCTTCCHHHHTT--CCSCCTTHHHHHHHHH
T ss_pred             ccccc--CCCcCcCcCccChHHHcC--CcCCCchhhHHHHHHH
Confidence            75433  233478999999999873  2568899999999993

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens}

Probab=99.98  E-value=1.4e-33  Score=220.37  Aligned_cols=163  Identities=17%  Similarity=0.233  Sum_probs=120.9

Q ss_pred             CCccccCCcccccccccccccCceEEEEE-----EEcCCCcEEEEEEccCccChHHHHHHHHHHHHHHhcCCCCchhhhh
Q psy14630         15 PDTVYDFTSEDLQDLGEIGRGGFGTVNKM-----IHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQFY   89 (187)
Q Consensus        15 ~~~~~~~~~~~~~~~~~lg~G~fg~V~~~-----~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~   89 (187)
                      +...+++..++|++.+.||+|+||.||+|     .+..+++.||+|.++....  .......++...+....|+|++.++
T Consensus        56 ~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~e~~~~~~l~~~~~~~iv~~~  133 (365)
T 3e7e_A           56 PKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANP--WEFYIGTQLMERLKPSMQHMFMKFY  133 (365)
T ss_dssp             SSCEEECSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCCH--HHHHHHHHHHHHSCGGGGGGBCCEE
T ss_pred             cceeEEECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCCh--hHHHHHHHHHHHhhhhhhhhhhhhh
Confidence            44556677889999999999999999999     4677889999999865321  1111111111122233488988776


Q ss_pred             hhH-------------------------------------HHHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcC-----
Q psy14630         90 GAL-------------------------------------FKEVTVATVKALNYLKEELKIIHRDVKPSNILLDR-----  127 (187)
Q Consensus        90 ~~~-------------------------------------~~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~-----  127 (187)
                      +.+                                     ...++.|++.||+|||+. +|+||||||+||+++.     
T Consensus       134 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~-~ivHrDiKp~NIll~~~~~~~  212 (365)
T 3e7e_A          134 SAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDC-EIIHGDIKPDNFILGNGFLEQ  212 (365)
T ss_dssp             EEEECSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTT-TEECCCCSGGGEEECGGGTCC
T ss_pred             eeeecCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhC-CeecCCCCHHHEEecccccCc
Confidence            421                                     112678999999999997 9999999999999988     


Q ss_pred             ------CCCEEEEecccccccc---ccccccCCCCCcCccCccccCCCccCCCCCCcceeeeEee
Q psy14630        128 ------RGAIKLCDFGISGQLV---DSIAKTRDAGCRPYMAPERIDPLRARGYPSFKTKLGFKFN  183 (187)
Q Consensus       128 ------~~~~ki~dfg~a~~~~---~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi~  183 (187)
                            .+.+||+|||+++.+.   ........+||+.|+|||++.   ...++.++|+||||++
T Consensus       213 ~~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwslG~i  274 (365)
T 3e7e_A          213 DDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLS---NKPWNYQIDYFGVAAT  274 (365)
T ss_dssp             ------CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHT---TCCBSTHHHHHHHHHH
T ss_pred             cccccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhc---CCCCCccccHHHHHHH
Confidence                  8999999999997653   233334557999999999998   5668999999999994

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A

Probab=99.98  E-value=4.1e-34  Score=222.48  Aligned_cols=158  Identities=26%  Similarity=0.336  Sum_probs=125.9

Q ss_pred             CcccccccccccccCceEEEEEEEcCCCcEEEEEEccCcc---ChHHHHHHHHHHHHHHhcCCCCchhhhhhhH------
Q psy14630         22 TSEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTV---DEKDQRQLLMDLDVVMKSNECPYIVQFYGAL------   92 (187)
Q Consensus        22 ~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~------   92 (187)
                      ..++|++.+.||+|+||.||+|.+..+++.||+|++....   ......+.+.++..+++.++||||+++++.+      
T Consensus        22 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~  101 (351)
T 3c0i_A           22 FEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGML  101 (351)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEE
T ss_pred             cccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence            4578999999999999999999999999999999985311   0001234456666677888999999887432      


Q ss_pred             ------------------------------HHHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCC---EEEEecccc
Q psy14630         93 ------------------------------FKEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGA---IKLCDFGIS  139 (187)
Q Consensus        93 ------------------------------~~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~---~ki~dfg~a  139 (187)
                                                    ...++.|++.||.|||+. +++||||||+||+++.++.   +||+|||++
T Consensus       102 ~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~-~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a  180 (351)
T 3c0i_A          102 YMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDN-NIIHRDVKPHCVLLASKENSAPVKLGGFGVA  180 (351)
T ss_dssp             EEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEECSSSTTCCEEECCCTTC
T ss_pred             EEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHC-CceeccCChHHeEEecCCCCCcEEEecCcce
Confidence                                          112567899999999998 9999999999999976554   999999999


Q ss_pred             cccccccc-ccCCCCCcCccCccccCCCccCCCCCCcceeeeEee
Q psy14630        140 GQLVDSIA-KTRDAGCRPYMAPERIDPLRARGYPSFKTKLGFKFN  183 (187)
Q Consensus       140 ~~~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi~  183 (187)
                      +....... .....||+.|+|||++.   ...++.++|+||+|++
T Consensus       181 ~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwslG~i  222 (351)
T 3c0i_A          181 IQLGESGLVAGGRVGTPHFMAPEVVK---REPYGKPVDVWGCGVI  222 (351)
T ss_dssp             EECCTTSCBCCCCCSCGGGCCHHHHT---TCCBCTHHHHHHHHHH
T ss_pred             eEecCCCeeecCCcCCcCccCHHHHc---CCCCCchHhhHHHHHH
Confidence            88754332 33457999999999998   5668999999999994

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A*

Probab=99.98  E-value=8.7e-34  Score=217.67  Aligned_cols=157  Identities=25%  Similarity=0.403  Sum_probs=112.2

Q ss_pred             cccccccccccccCceEEEEEEEcCCCcEEEEEEccCccChHHHHHHHHHHHHHHhcCCCCchhhhhhhHH---------
Q psy14630         23 SEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQFYGALF---------   93 (187)
Q Consensus        23 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~---------   93 (187)
                      .++|++.+.||+|+||.||+|.+..+++.||+|.++...... ..+.+.++..+++.+.||||+++++.+.         
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   82 (317)
T 2pmi_A            4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEG-TPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVF   82 (317)
T ss_dssp             ---------------CEEEEEECSSSCCEEEEEEEECCSTTC-SCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEE
T ss_pred             ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccc-cHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEE
Confidence            468999999999999999999999999999999986433221 1233445666788889999999875321         


Q ss_pred             ----------------------------HHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEecccccccccc
Q psy14630         94 ----------------------------KEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDS  145 (187)
Q Consensus        94 ----------------------------~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg~a~~~~~~  145 (187)
                                                  ..+..|++.||.|||+. +++||||||+||+++.++.+||+|||+++.....
T Consensus        83 e~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~-~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~  161 (317)
T 2pmi_A           83 EFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHEN-KILHRDLKPQNLLINKRGQLKLGDFGLARAFGIP  161 (317)
T ss_dssp             ECCCCBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCCGGGEEECTTCCEEECCCSSCEETTSC
T ss_pred             EecCCCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHC-CeeeCCCChHHeEEcCCCCEEECcCccceecCCC
Confidence                                        11456899999999997 9999999999999999999999999999876432


Q ss_pred             -ccccCCCCCcCccCccccCCCccCCCCCCcceeeeEee
Q psy14630        146 -IAKTRDAGCRPYMAPERIDPLRARGYPSFKTKLGFKFN  183 (187)
Q Consensus       146 -~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi~  183 (187)
                       .......+|+.|+|||++.+  ...++.++|+||+|++
T Consensus       162 ~~~~~~~~~t~~y~aPE~~~~--~~~~~~~~DiwslG~i  198 (317)
T 2pmi_A          162 VNTFSSEVVTLWYRAPDVLMG--SRTYSTSIDIWSCGCI  198 (317)
T ss_dssp             CCCCCCCCSCCTTCCHHHHTT--CCCCCTHHHHHHHHHH
T ss_pred             cccCCCCcccccccCchHhhC--CCCCCcHHHHHHHHHH
Confidence             22334478999999999873  3457899999999993

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ...

Probab=99.98  E-value=1.7e-33  Score=213.61  Aligned_cols=160  Identities=24%  Similarity=0.412  Sum_probs=125.6

Q ss_pred             ccCCcccccccccccccCceEEEEEE----EcCCCcEEEEEEccCccChHHHHHHHHHHHHHHhcCCCCchhhhhhhHHH
Q psy14630         19 YDFTSEDLQDLGEIGRGGFGTVNKMI----HRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQFYGALFK   94 (187)
Q Consensus        19 ~~~~~~~~~~~~~lg~G~fg~V~~~~----~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~   94 (187)
                      .++..++|++.+.||+|+||.||+|.    +..+++.||+|.+...  .....+.+.++..+++.++||||+++++.+..
T Consensus         5 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~   82 (295)
T 3ugc_A            5 TQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS--TEEHLRDFEREIEILKSLQHDNIVKYKGVCYS   82 (295)
T ss_dssp             -CCCGGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECH
T ss_pred             CcCCHHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccC--CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec
Confidence            46778999999999999999999998    5678899999998743  33334456666777888899999998754311


Q ss_pred             -----------------------------------HHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEecccc
Q psy14630         95 -----------------------------------EVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGIS  139 (187)
Q Consensus        95 -----------------------------------~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg~a  139 (187)
                                                         .++.|++.||.|||+. +++||||||+||+++.++.+||+|||++
T Consensus        83 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~-~ivH~Dikp~Nil~~~~~~~kl~Dfg~~  161 (295)
T 3ugc_A           83 AGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTK-RYIHRDLATRNILVENENRVKIGDFGLT  161 (295)
T ss_dssp             HHHTSCEEEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCSGGGEEEEETTEEEECCCCSC
T ss_pred             CCCCceEEEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHhcC-CcccCCCCHhhEEEcCCCeEEEccCccc
Confidence                                               1667899999999997 9999999999999999999999999999


Q ss_pred             ccccccc----cccCCCCCcCccCccccCCCccCCCCCCcceeeeEeee
Q psy14630        140 GQLVDSI----AKTRDAGCRPYMAPERIDPLRARGYPSFKTKLGFKFNY  184 (187)
Q Consensus       140 ~~~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi~~  184 (187)
                      +......    ......++..|+|||.+.   ...++.++|+||+|+++
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~Di~slG~~l  207 (295)
T 3ugc_A          162 KVLPQDKEFFKVKEPGESPIFWYAPESLT---ESKFSVASDVWSFGVVL  207 (295)
T ss_dssp             C-------------CTTCGGGGCCHHHHH---HCCCCHHHHHHHHHHHH
T ss_pred             ccccCCcceeeeccCCCCccceeCcHHhc---CCCCChHHHHHHHHHHH
Confidence            8764332    122234677799999998   66789999999999943

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A*

Probab=99.98  E-value=3.6e-33  Score=215.29  Aligned_cols=166  Identities=24%  Similarity=0.425  Sum_probs=129.7

Q ss_pred             CCccccCCcccccccccccccCceEEEEEEEcCCCcEEEEEEccCccChHHHHHHHHHHHHHHhcCCCCchhhhhhhH--
Q psy14630         15 PDTVYDFTSEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQFYGAL--   92 (187)
Q Consensus        15 ~~~~~~~~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~--   92 (187)
                      ....+....++|++.+.||+|+||.||+|.+..+++.||+|.+..........+.+.++..+++.+.||||+++++.+  
T Consensus        16 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~   95 (331)
T 4aaa_A           16 TENLYFQSMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKK   95 (331)
T ss_dssp             ---CCCBCGGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE
T ss_pred             cchhhhhhhhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeec
Confidence            344555677899999999999999999999999999999999865555555556666777788888999999987532  


Q ss_pred             ------------------------------HHHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEeccccccc
Q psy14630         93 ------------------------------FKEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQL  142 (187)
Q Consensus        93 ------------------------------~~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg~a~~~  142 (187)
                                                    ...++.|++.|+.|||+. +++||||||+||+++.++.+||+|||+++..
T Consensus        96 ~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~-~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~  174 (331)
T 4aaa_A           96 KKRWYLVFEFVDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSH-NIIHRDIKPENILVSQSGVVKLCDFGFARTL  174 (331)
T ss_dssp             TTEEEEEEECCSEEHHHHHHHSTTCCCHHHHHHHHHHHHHHHHHHHHT-TCCCCCCCGGGEEECTTSCEEECCCTTC---
T ss_pred             CCEEEEEEecCCcchHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHC-CEEccCcChheEEEcCCCcEEEEeCCCceee
Confidence                                          112678999999999998 9999999999999999999999999999876


Q ss_pred             ccc-ccccCCCCCcCccCccccCCCccCCCCCCcceeeeEee
Q psy14630        143 VDS-IAKTRDAGCRPYMAPERIDPLRARGYPSFKTKLGFKFN  183 (187)
Q Consensus       143 ~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi~  183 (187)
                      ... .......+++.|+|||.+.+  ...++.++|+||+|++
T Consensus       175 ~~~~~~~~~~~~t~~y~aPE~~~~--~~~~~~~~Di~slG~i  214 (331)
T 4aaa_A          175 AAPGEVYDDEVATRWYRAPELLVG--DVKYGKAVDVWAIGCL  214 (331)
T ss_dssp             ---------CCCCCTTCCHHHHTT--CTTCCTHHHHHHHHHH
T ss_pred             cCCccccCCCcCCccccCcccccC--CCCcchHHHHHHHHHH
Confidence            432 22334468999999999873  3367899999999994

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A

Probab=99.98  E-value=9.5e-34  Score=236.73  Aligned_cols=162  Identities=26%  Similarity=0.421  Sum_probs=125.3

Q ss_pred             cCCcccccccccccccCceEEEEEEEcCCCcEEEEEEccCcc--ChHHHHHHHHHHHHHHhcCCCCchhhhhhhH-----
Q psy14630         20 DFTSEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTV--DEKDQRQLLMDLDVVMKSNECPYIVQFYGAL-----   92 (187)
Q Consensus        20 ~~~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~-----   92 (187)
                      .+..++|++.+.||+|+||.||+|.+..+++.||||+++...  ..........+...+....+||+|+.+++.+     
T Consensus       337 ~~~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~  416 (674)
T 3pfq_A          337 RMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDR  416 (674)
T ss_dssp             ---CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSE
T ss_pred             cccccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCE
Confidence            345678999999999999999999999999999999986321  1111222333444344445899999876432     


Q ss_pred             ---------------------------HHHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEecccccccc-c
Q psy14630         93 ---------------------------FKEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLV-D  144 (187)
Q Consensus        93 ---------------------------~~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg~a~~~~-~  144 (187)
                                                 ...++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++... .
T Consensus       417 ~~lV~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~-gIiHrDLKp~NILl~~~g~ikL~DFGla~~~~~~  495 (674)
T 3pfq_A          417 LYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSK-GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWD  495 (674)
T ss_dssp             EEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT-SEECCCCCSTTEEECSSSCEEECCCTTCEECCCT
T ss_pred             EEEEEeCcCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC-CeEeccCChhhEEEcCCCcEEEeecceeeccccC
Confidence                                       112678999999999998 99999999999999999999999999998643 3


Q ss_pred             cccccCCCCCcCccCccccCCCccCCCCCCcceeeeEe-eee
Q psy14630        145 SIAKTRDAGCRPYMAPERIDPLRARGYPSFKTKLGFKF-NYR  185 (187)
Q Consensus       145 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi-~~~  185 (187)
                      .......+||+.|+|||++.   ...++.++|+||+|+ +|+
T Consensus       496 ~~~~~~~~GT~~Y~APE~l~---~~~~~~~~DvwSlGvilye  534 (674)
T 3pfq_A          496 GVTTKTFCGTPDYIAPEIIA---YQPYGKSVDWWAFGVLLYE  534 (674)
T ss_dssp             TCCBCCCCSCSSSCCHHHHT---CCCBSTHHHHHHHHHHHHH
T ss_pred             CcccccccCCCcccCHhhhc---CCCCCccceEechHHHHHH
Confidence            33444568999999999998   677999999999999 443

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B

Probab=99.98  E-value=8.8e-34  Score=231.23  Aligned_cols=162  Identities=25%  Similarity=0.365  Sum_probs=129.7

Q ss_pred             cCCcccccccccccccCceEEEEEEEcCCCcEEEEEEccCccCh-HHHHHHHHHHHHHHhcCCCCchhhhhhhH------
Q psy14630         20 DFTSEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDE-KDQRQLLMDLDVVMKSNECPYIVQFYGAL------   92 (187)
Q Consensus        20 ~~~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~~~~~~~~~~h~~iv~~~~~~------   92 (187)
                      .+..++|.+.+.||+|+||.||+|.+..+++.||+|++...... ....+.+..+..+++.++||||+++++.+      
T Consensus       181 ~~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l  260 (543)
T 3c4z_A          181 PMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDL  260 (543)
T ss_dssp             CCCGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             cCChhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEE
Confidence            35668899999999999999999999999999999998532111 11123445556677788999999876432      


Q ss_pred             ------------------------------HHHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEeccccccc
Q psy14630         93 ------------------------------FKEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQL  142 (187)
Q Consensus        93 ------------------------------~~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg~a~~~  142 (187)
                                                    ...++.|++.||.|||+. +|+||||||+||+++.++.+||+|||+++..
T Consensus       261 ~lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~-gIvHrDLKP~NILl~~~g~vkL~DFGla~~~  339 (543)
T 3c4z_A          261 CLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQR-NIIYRDLKPENVLLDDDGNVRISDLGLAVEL  339 (543)
T ss_dssp             EEEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCCGGGEEECTTSCEEECCCTTCEEC
T ss_pred             EEEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHc-CCcccCCChHHEEEeCCCCEEEeecceeeec
Confidence                                          112567999999999997 9999999999999999999999999999887


Q ss_pred             ccccc-ccCCCCCcCccCccccCCCccCCCCCCcceeeeEe-eee
Q psy14630        143 VDSIA-KTRDAGCRPYMAPERIDPLRARGYPSFKTKLGFKF-NYR  185 (187)
Q Consensus       143 ~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi-~~~  185 (187)
                      ..... ....+||+.|+|||++.   ...++.++|+||+|+ +|+
T Consensus       340 ~~~~~~~~~~~GT~~Y~APE~l~---~~~~~~~~DiwSlGvilye  381 (543)
T 3c4z_A          340 KAGQTKTKGYAGTPGFMAPELLL---GEEYDFSVDYFALGVTLYE  381 (543)
T ss_dssp             CTTCCCBCCCCSCTTTSCHHHHT---TCCBCTHHHHHHHHHHHHH
T ss_pred             cCCCcccccccCCccccChhhhc---CCCCChHHhcCcchHHHHH
Confidence            54433 23458999999999998   667899999999999 443

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A*

Probab=99.98  E-value=5.3e-34  Score=223.75  Aligned_cols=165  Identities=27%  Similarity=0.401  Sum_probs=132.7

Q ss_pred             CCccccCCcccccccccccccCceEEEEEEEcCCCcEEEEEEccCccChHHHHHHHHHHHHHHhcCCCCchhhhhhhHH-
Q psy14630         15 PDTVYDFTSEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQFYGALF-   93 (187)
Q Consensus        15 ~~~~~~~~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~-   93 (187)
                      +...|.+..++|.+.+.||+|+||.||+|.+..+++.||+|.++..... ...+.+.++..+++.+.||||+++++.+. 
T Consensus       105 ~~~~~~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~  183 (377)
T 3cbl_A          105 PKDKWVLNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPP-DLKAKFLQEARILKQYSHPNIVRLIGVCTQ  183 (377)
T ss_dssp             CCCTTBCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCH-HHHTTTTHHHHHHTTCCCTTBCCEEEEECS
T ss_pred             cccccEEchHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCH-HHHHHHHHHHHHHHhCCCCCEEEEEEEEec
Confidence            4467788899999999999999999999999889999999998754332 33344556667788899999999875421 


Q ss_pred             --------------------------------HHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEecccccc
Q psy14630         94 --------------------------------KEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQ  141 (187)
Q Consensus        94 --------------------------------~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg~a~~  141 (187)
                                                      ..++.|++.||+|||+. +++||||||+||+++.++.+||+|||+++.
T Consensus       184 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~-~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~  262 (377)
T 3cbl_A          184 KQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESK-CCIHRDLAARNCLVTEKNVLKISDFGMSRE  262 (377)
T ss_dssp             SSSCEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEECTTCCEEECCGGGCEE
T ss_pred             CCCcEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC-CcCCcccCHHHEEEcCCCcEEECcCCCcee
Confidence                                            12667899999999998 999999999999999999999999999987


Q ss_pred             cccccccc---CCCCCcCccCccccCCCccCCCCCCcceeeeEeee
Q psy14630        142 LVDSIAKT---RDAGCRPYMAPERIDPLRARGYPSFKTKLGFKFNY  184 (187)
Q Consensus       142 ~~~~~~~~---~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi~~  184 (187)
                      ........   ...++..|+|||.+.   ...++.++|+||||+++
T Consensus       263 ~~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~DvwslG~il  305 (377)
T 3cbl_A          263 EADGVYAASGGLRQVPVKWTAPEALN---YGRYSSESDVWSFGILL  305 (377)
T ss_dssp             CTTSEEECCSSCCEEEGGGSCHHHHH---HCEEEHHHHHHHHHHHH
T ss_pred             cCCCceeecCCCCCCCcCcCCHhHhc---cCCCCchhhHHHHHHHH
Confidence            54432221   112466799999988   55688999999999944

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A

Probab=99.98  E-value=5.9e-34  Score=222.40  Aligned_cols=158  Identities=25%  Similarity=0.341  Sum_probs=117.4

Q ss_pred             ccCCcccccccccccccCceEEEEEEEcCCCcEEEEEEccCccChHHHHHHHHHHHHHHhcCCCCchhhhhhhH------
Q psy14630         19 YDFTSEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQFYGAL------   92 (187)
Q Consensus        19 ~~~~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~------   92 (187)
                      .....++|++.+.||+|+||.||++.+..+++.||+|.+......   .+.+.++..+++.++||||+++++.+      
T Consensus        15 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~   91 (361)
T 3uc3_A           15 IMHDSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAI---DENVQREIINHRSLRHPNIVRFKEVILTPTHL   91 (361)
T ss_dssp             CCCCTTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTS---CHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             CCCCCCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCccc---cHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEE
Confidence            345668999999999999999999999999999999998643221   12344556677788999999987532      


Q ss_pred             --------------------------HHHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCC--EEEEeccccccccc
Q psy14630         93 --------------------------FKEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGA--IKLCDFGISGQLVD  144 (187)
Q Consensus        93 --------------------------~~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~--~ki~dfg~a~~~~~  144 (187)
                                                ...++.|++.||.|||+. +++||||||+||+++.++.  +||+|||+++....
T Consensus        92 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~-~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~  170 (361)
T 3uc3_A           92 AIIMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCHSM-QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL  170 (361)
T ss_dssp             EEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT-TCCSCCCCGGGEEECSSSSCCEEECCCCCC-----
T ss_pred             EEEEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC-CcccCCCCHHHEEEcCCCCceEEEeecCccccccc
Confidence                                      112678999999999997 9999999999999987665  99999999986544


Q ss_pred             cccccCCCCCcCccCccccCCCccCCCCCC-cceeeeEee
Q psy14630        145 SIAKTRDAGCRPYMAPERIDPLRARGYPSF-KTKLGFKFN  183 (187)
Q Consensus       145 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~-~D~ws~gi~  183 (187)
                      ........||+.|+|||++.   ...++.+ +|+||+|++
T Consensus       171 ~~~~~~~~gt~~y~aPE~~~---~~~~~~~~~DiwslG~i  207 (361)
T 3uc3_A          171 HSQPKSTVGTPAYIAPEVLL---RQEYDGKIADVWSCGVT  207 (361)
T ss_dssp             ----------CTTSCHHHHH---CSSCCHHHHHHHHHHHH
T ss_pred             cCCCCCCcCCCCcCChhhhc---CCCCCCCeeeeehhHHH
Confidence            44444557999999999998   4556544 899999993

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens}

Probab=99.98  E-value=5e-33  Score=218.55  Aligned_cols=171  Identities=25%  Similarity=0.382  Sum_probs=133.1

Q ss_pred             CceecCCCccccCCcccccccccccccCceEEEEEEEcC-------CCcEEEEEEccCccChHHHHHHHHHHHHHHhcC-
Q psy14630          9 GKLKLSPDTVYDFTSEDLQDLGEIGRGGFGTVNKMIHRS-------SDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSN-   80 (187)
Q Consensus         9 ~~~~~~~~~~~~~~~~~~~~~~~lg~G~fg~V~~~~~~~-------~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~-   80 (187)
                      +....++...|++..++|.+.+.||+|+||.||+|.+..       .+..||+|+++.........+...+.. +++.+ 
T Consensus        54 ~~~~~~~~~~~~i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~-~l~~l~  132 (382)
T 3tt0_A           54 SEYELPEDPRWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEME-MMKMIG  132 (382)
T ss_dssp             CCCCCCCCTTTBCCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHH-HHHHHC
T ss_pred             cccccccCcccccchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHH-HHHHhc
Confidence            344556678889999999999999999999999998753       335799999876544444344444444 44444 


Q ss_pred             CCCchhhhhhhH------------------------------------------------HHHHHHHHHHHHHHHHhcCC
Q psy14630         81 ECPYIVQFYGAL------------------------------------------------FKEVTVATVKALNYLKEELK  112 (187)
Q Consensus        81 ~h~~iv~~~~~~------------------------------------------------~~~~~~~~~~~l~~lh~~~~  112 (187)
                      +||||+++++.+                                                ...++.|++.||.|||+. +
T Consensus       133 ~hpnIv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~-~  211 (382)
T 3tt0_A          133 KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK-K  211 (382)
T ss_dssp             CCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHT-T
T ss_pred             CCchhhhheeeeccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC-C
Confidence            999999876421                                                112667899999999998 9


Q ss_pred             CeeecCCCCCeEEcCCCCEEEEeccccccccccc---cccCCCCCcCccCccccCCCccCCCCCCcceeeeEeee
Q psy14630        113 IIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSI---AKTRDAGCRPYMAPERIDPLRARGYPSFKTKLGFKFNY  184 (187)
Q Consensus       113 i~Hrdlk~~nili~~~~~~ki~dfg~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi~~  184 (187)
                      ++||||||+||+++.++.+||+|||+++......   ......+|+.|+|||.+.   ...++.++|+||||+++
T Consensus       212 ivH~Dlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~---~~~~~~~~DiwslG~il  283 (382)
T 3tt0_A          212 CIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALF---DRIYTHQSDVWSFGVLL  283 (382)
T ss_dssp             CCCSCCCGGGEEECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHH---SCCCCHHHHHHHHHHHH
T ss_pred             EecCCCCcceEEEcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhc---CCCCCchhHHHHHHHHH
Confidence            9999999999999999999999999998765432   222335678899999998   66788999999999943

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens}

Probab=99.98  E-value=3.1e-33  Score=213.60  Aligned_cols=158  Identities=27%  Similarity=0.459  Sum_probs=124.8

Q ss_pred             cccccccccccccCceEEEEEEEcCCCcEEEEEEccCccChHHHHHHHHHHHHHHhcCCCCchhhhhhhH----------
Q psy14630         23 SEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQFYGAL----------   92 (187)
Q Consensus        23 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~----------   92 (187)
                      .++|++.+.||+|+||.||+|.+..+++.||+|.+..........+.+.++..+++.++||||+++++.+          
T Consensus         2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   81 (311)
T 4agu_A            2 MEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVF   81 (311)
T ss_dssp             -CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             cccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEE
Confidence            3689999999999999999999999999999999876555555556666777788888999999887532          


Q ss_pred             ----------------------HHHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEecccccccccc-cccc
Q psy14630         93 ----------------------FKEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDS-IAKT  149 (187)
Q Consensus        93 ----------------------~~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg~a~~~~~~-~~~~  149 (187)
                                            ...++.|++.|+.|||+. +++||||||+||+++.++.+||+|||+++..... ....
T Consensus        82 e~~~~~~l~~~~~~~~~~~~~~~~~i~~~l~~~l~~lH~~-~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~  160 (311)
T 4agu_A           82 EYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKH-NCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYD  160 (311)
T ss_dssp             ECCSEEHHHHHHHTSSCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEECTTSCEEECCCTTCEECC-------
T ss_pred             EeCCCchHHHHHhhhcCCCHHHHHHHHHHHHHHHHHHHHC-CCcCCCCChhhEEEcCCCCEEEeeCCCchhccCcccccC
Confidence                                  122677899999999998 9999999999999999999999999999876533 2233


Q ss_pred             CCCCCcCccCccccCCCccCCCCCCcceeeeEee
Q psy14630        150 RDAGCRPYMAPERIDPLRARGYPSFKTKLGFKFN  183 (187)
Q Consensus       150 ~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi~  183 (187)
                      ...+|+.|+|||.+.+  ...++.++|+||+|++
T Consensus       161 ~~~~~~~y~aPE~~~~--~~~~~~~~Di~slG~i  192 (311)
T 4agu_A          161 DEVATRWYRSPELLVG--DTQYGPPVDVWAIGCV  192 (311)
T ss_dssp             -----GGGCCHHHHHT--CSCCCTHHHHHHHHHH
T ss_pred             CCcCCccccChHHHhc--CCCCCcchhhHHHHHH
Confidence            4478999999999873  3567899999999994

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens}

Probab=99.98  E-value=2.4e-33  Score=214.55  Aligned_cols=169  Identities=53%  Similarity=0.868  Sum_probs=122.0

Q ss_pred             CCccccCCcccccccccccccCceEEEEEEEcCCCcEEEEEEccCccChHHHHHHHHHHHHHHhcCCCCchhhhhhhH--
Q psy14630         15 PDTVYDFTSEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQFYGAL--   92 (187)
Q Consensus        15 ~~~~~~~~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~--   92 (187)
                      .+..+....++|++.+.||+|+||.||+|.+..+++.||+|.+..........+.+.++..+++...||||+++++.+  
T Consensus        16 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~   95 (318)
T 2dyl_A           16 GGQRYQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFIT   95 (318)
T ss_dssp             SSSEEECCGGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEEC
T ss_pred             cchhhhhhhccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEec
Confidence            456778888999999999999999999999999999999999976555555556666777778888999999987532  


Q ss_pred             ------------------------------HHHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEeccccccc
Q psy14630         93 ------------------------------FKEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQL  142 (187)
Q Consensus        93 ------------------------------~~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg~a~~~  142 (187)
                                                    ...+..+++.||.|||+..+++|+||||+||+++.++.+||+|||++...
T Consensus        96 ~~~~~lv~e~~~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~  175 (318)
T 2dyl_A           96 NTDVFIAMELMGTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGQIKLCDFGISGRL  175 (318)
T ss_dssp             SSEEEEEECCCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCGGGEEECTTSCEEECCCTTC---
T ss_pred             CCcEEEEEeccCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhhCCEEeCCCCHHHEEECCCCCEEEEECCCchhc
Confidence                                          11267789999999998338999999999999999999999999999877


Q ss_pred             cccccccCCCCCcCccCccccCCC--ccCCCCCCcceeeeEee
Q psy14630        143 VDSIAKTRDAGCRPYMAPERIDPL--RARGYPSFKTKLGFKFN  183 (187)
Q Consensus       143 ~~~~~~~~~~~t~~y~aPE~~~~~--~~~~~~~~~D~ws~gi~  183 (187)
                      ..........+++.|+|||.+...  ....++.++|+||+|++
T Consensus       176 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~i  218 (318)
T 2dyl_A          176 VDDKAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGIS  218 (318)
T ss_dssp             -----------CCTTCCHHHHC--------CCTHHHHHHHHHH
T ss_pred             cCCccccccCCCccccChhhcccccccccCCccccchhhHHHH
Confidence            654444455789999999998531  13457889999999994

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A*

Probab=99.98  E-value=4.2e-33  Score=210.25  Aligned_cols=158  Identities=24%  Similarity=0.376  Sum_probs=131.0

Q ss_pred             CcccccccccccccCceEEEEEEEcCCCcEEEEEEccCccChHHHHHHHHHHHHHHhcCCCCchhhhhhhH---------
Q psy14630         22 TSEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQFYGAL---------   92 (187)
Q Consensus        22 ~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~---------   92 (187)
                      ..++|++.+.||+|+||.||+|.+..+++.||+|++..........+.+.++..+++.++||||+++++.+         
T Consensus         4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v   83 (284)
T 3kk8_A            4 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV   83 (284)
T ss_dssp             TTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hhhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEE
Confidence            35789999999999999999999999999999999865443444445566666777888999999987532         


Q ss_pred             -----------------------HHHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCC---EEEEeccccccccccc
Q psy14630         93 -----------------------FKEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGA---IKLCDFGISGQLVDSI  146 (187)
Q Consensus        93 -----------------------~~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~---~ki~dfg~a~~~~~~~  146 (187)
                                             ...++.|++.|+.|||+. +++||||||+||+++.++.   +||+|||++.......
T Consensus        84 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~-~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~  162 (284)
T 3kk8_A           84 FDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSN-GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSE  162 (284)
T ss_dssp             ECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCCGGGEEESSSSTTCCEEECCCTTCEECCSSC
T ss_pred             EecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC-CcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEcccCc
Confidence                                   112678899999999998 9999999999999976655   9999999998876655


Q ss_pred             cccCCCCCcCccCccccCCCccCCCCCCcceeeeEee
Q psy14630        147 AKTRDAGCRPYMAPERIDPLRARGYPSFKTKLGFKFN  183 (187)
Q Consensus       147 ~~~~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi~  183 (187)
                      ......+|+.|+|||.+.   ...++.++|+||+|++
T Consensus       163 ~~~~~~~~~~y~aPE~~~---~~~~~~~~Di~slG~~  196 (284)
T 3kk8_A          163 AWHGFAGTPGYLSPEVLK---KDPYSKPVDIWACGVI  196 (284)
T ss_dssp             BCCCSCSCGGGCCHHHHT---TCCBCTHHHHHHHHHH
T ss_pred             cccCCCCCcCCcCchhhc---CCCCCcccchHHHHHH
Confidence            555567899999999998   5678899999999994

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus}

Probab=99.98  E-value=7.7e-34  Score=228.76  Aligned_cols=160  Identities=24%  Similarity=0.299  Sum_probs=131.0

Q ss_pred             cCCcccccccccccccCceEEEEEEEcCCCcEEEEEEccCccC-hHHHHHHHHHHHHHHhcCCCCchhhhhhhH------
Q psy14630         20 DFTSEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVD-EKDQRQLLMDLDVVMKSNECPYIVQFYGAL------   92 (187)
Q Consensus        20 ~~~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~------   92 (187)
                      ....++|.+.+.||+|+||.||+|.+..+++.||+|++..... .....+.+.++..+++.++||||+++++.+      
T Consensus        12 ~~~~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~   91 (476)
T 2y94_A           12 RVKIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDI   91 (476)
T ss_dssp             CCEETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred             CceecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence            4456889999999999999999999999999999999863211 111234566667778889999999987532      


Q ss_pred             --------------------------HHHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEeccccccccccc
Q psy14630         93 --------------------------FKEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSI  146 (187)
Q Consensus        93 --------------------------~~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg~a~~~~~~~  146 (187)
                                                ...++.|++.||.|||+. +++||||||+||+++.++.+||+|||+++......
T Consensus        92 ~lv~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~-givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~~  170 (476)
T 2y94_A           92 FMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHRH-MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE  170 (476)
T ss_dssp             EEEEECCSSEEHHHHTTSSSSCCHHHHHHHHHHHHHHHHHHHTT-TEECSCCSGGGEEECTTCCEEECCCSSCEECCTTC
T ss_pred             EEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC-CCCcccccHHHEEEecCCCeEEEeccchhhccccc
Confidence                                      122778999999999997 99999999999999999999999999998876655


Q ss_pred             cccCCCCCcCccCccccCCCccCCC-CCCcceeeeEee
Q psy14630        147 AKTRDAGCRPYMAPERIDPLRARGY-PSFKTKLGFKFN  183 (187)
Q Consensus       147 ~~~~~~~t~~y~aPE~~~~~~~~~~-~~~~D~ws~gi~  183 (187)
                      .....+||+.|+|||++.   ...+ +.++|+||+|++
T Consensus       171 ~~~~~~gt~~y~aPE~~~---~~~~~~~~~DiwSlGvi  205 (476)
T 2y94_A          171 FLRTSCGSPNYAAPEVIS---GRLYAGPEVDIWSSGVI  205 (476)
T ss_dssp             CBCCCCSCSTTCCHHHHT---TCCBCSHHHHHHHHHHH
T ss_pred             cccccCCCcCeEChhhcc---CCCCCCCcceehhhHHH
Confidence            555568999999999998   4444 578999999993

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A*

Probab=99.97  E-value=1.6e-33  Score=218.73  Aligned_cols=159  Identities=25%  Similarity=0.347  Sum_probs=126.7

Q ss_pred             CcccccccccccccCceEEEEEEEcCCCcEEEEEEccCccChHHHHHHHHHHHHHHhcCCCCchhhhhhhH---------
Q psy14630         22 TSEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQFYGAL---------   92 (187)
Q Consensus        22 ~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~---------   92 (187)
                      ..++|++.+.||+|+||.||+|.+..+++.||+|.+............+.++..+++.++||||+++++.+         
T Consensus        15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   94 (351)
T 3mi9_A           15 EVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNR   94 (351)
T ss_dssp             BGGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC------
T ss_pred             cccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeecccccccc
Confidence            45799999999999999999999999999999999864432222223344556677788999999886532         


Q ss_pred             -------------------------------HHHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEecccccc
Q psy14630         93 -------------------------------FKEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQ  141 (187)
Q Consensus        93 -------------------------------~~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg~a~~  141 (187)
                                                     ...++.|++.||.|||+. +++||||||+||+++.++.+||+|||+++.
T Consensus        95 ~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~-~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~  173 (351)
T 3mi9_A           95 CKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRN-KILHRDMKAANVLITRDGVLKLADFGLARA  173 (351)
T ss_dssp             --CEEEEEEECCSEEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred             CCceEEEEEeccCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC-CeeCCCCCHHHEEEcCCCCEEEccchhccc
Confidence                                           112678999999999998 999999999999999999999999999987


Q ss_pred             cccc-----ccccCCCCCcCccCccccCCCccCCCCCCcceeeeEee
Q psy14630        142 LVDS-----IAKTRDAGCRPYMAPERIDPLRARGYPSFKTKLGFKFN  183 (187)
Q Consensus       142 ~~~~-----~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi~  183 (187)
                      ....     .......+|+.|+|||++.+  ...++.++|+||+|++
T Consensus       174 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~~DiwslG~i  218 (351)
T 3mi9_A          174 FSLAKNSQPNRYTNRVVTLWYRPPELLLG--ERDYGPPIDLWGAGCI  218 (351)
T ss_dssp             CCCCSSSSCCCCCSSCSCGGGCCHHHHTT--CCSCCTHHHHHHHHHH
T ss_pred             ccccccccccccCCcccccCccCchhhcC--CCCCCcHhHHHHHHHH
Confidence            6421     22233468999999999873  3457899999999994

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens}

Probab=99.97  E-value=2e-33  Score=213.70  Aligned_cols=162  Identities=25%  Similarity=0.373  Sum_probs=124.6

Q ss_pred             CCcccccccccccccCceEEEEEEEcCCCcEEEEEEccCccChH------------------------HHHHHHHHHHHH
Q psy14630         21 FTSEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEK------------------------DQRQLLMDLDVV   76 (187)
Q Consensus        21 ~~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~------------------------~~~~~~~~~~~~   76 (187)
                      +..++|++.+.||+|+||.||+|.+..+++.||+|++.......                        ...+.+.++..+
T Consensus        10 ~~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~   89 (298)
T 2zv2_A           10 VQLNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAI   89 (298)
T ss_dssp             CEETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHH
T ss_pred             eeecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHH
Confidence            44678999999999999999999999999999999986432110                        112345566677


Q ss_pred             HhcCCCCchhhhhhhHH---------------------------------HHHHHHHHHHHHHHHhcCCCeeecCCCCCe
Q psy14630         77 MKSNECPYIVQFYGALF---------------------------------KEVTVATVKALNYLKEELKIIHRDVKPSNI  123 (187)
Q Consensus        77 ~~~~~h~~iv~~~~~~~---------------------------------~~~~~~~~~~l~~lh~~~~i~Hrdlk~~ni  123 (187)
                      ++.++||||+++++.+.                                 ..++.|++.||.|||+. +++||||||+||
T Consensus        90 l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~-~ivH~Dlkp~Ni  168 (298)
T 2zv2_A           90 LKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLKPLSEDQARFYFQDLIKGIEYLHYQ-KIIHRDIKPSNL  168 (298)
T ss_dssp             HHTCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSCSSCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCCGGGE
T ss_pred             HHhCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHC-CeeccCCCHHHE
Confidence            88889999999876432                                 12678999999999998 999999999999


Q ss_pred             EEcCCCCEEEEeccccccccccc-cccCCCCCcCccCccccCCCccCCCCCCcceeeeEee
Q psy14630        124 LLDRRGAIKLCDFGISGQLVDSI-AKTRDAGCRPYMAPERIDPLRARGYPSFKTKLGFKFN  183 (187)
Q Consensus       124 li~~~~~~ki~dfg~a~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi~  183 (187)
                      +++.++.+||+|||+++...... ......||+.|+|||.+.+.....++.++|+||+|++
T Consensus       169 l~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~  229 (298)
T 2zv2_A          169 LVGEDGHIKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVT  229 (298)
T ss_dssp             EECTTSCEEECCCTTCEECSSSSCEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHH
T ss_pred             EECCCCCEEEecCCCccccccccccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHH
Confidence            99999999999999998765432 2234578999999999884211113678999999994

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7}

Probab=99.97  E-value=5.6e-33  Score=216.30  Aligned_cols=156  Identities=29%  Similarity=0.366  Sum_probs=123.5

Q ss_pred             ccCCcccccccccccccCceEEEEEEEcCCCcEEEEEEccCccChHHHHHHHHHHHHHHhcC-----CCCchhhhhhhH-
Q psy14630         19 YDFTSEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSN-----ECPYIVQFYGAL-   92 (187)
Q Consensus        19 ~~~~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~-----~h~~iv~~~~~~-   92 (187)
                      .+...++|++.+.||+|+||.||+|.+..+++.||+|+++..  . ...+....+..+++.+     .||||+++++.+ 
T Consensus        30 g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~--~-~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~  106 (360)
T 3llt_A           30 GMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI--K-KYTRSAKIEADILKKIQNDDINNNNIVKYHGKFM  106 (360)
T ss_dssp             TCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC--H-HHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEE
T ss_pred             ceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc--h-hhhhhhHHHHHHHHHhcccCCCCCCeecccceee
Confidence            344567899999999999999999999999999999998642  2 2222333344444444     499999887532 


Q ss_pred             --------------------------------HHHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcC-------------
Q psy14630         93 --------------------------------FKEVTVATVKALNYLKEELKIIHRDVKPSNILLDR-------------  127 (187)
Q Consensus        93 --------------------------------~~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~-------------  127 (187)
                                                      ...++.|++.||.|||+. +++||||||+||+++.             
T Consensus       107 ~~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~-~ivHrDlkp~NIll~~~~~~~~~~~~~~~  185 (360)
T 3llt_A          107 YYDHMCLIFEPLGPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKM-SLTHTDLKPENILLDDPYFEKSLITVRRV  185 (360)
T ss_dssp             ETTEEEEEECCCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEESCTTCCEEEEEEECT
T ss_pred             ECCeeEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHC-CeeeCCCCcccEEEccccccccccchhcc
Confidence                                            112678999999999997 9999999999999975             


Q ss_pred             ------------CCCEEEEeccccccccccccccCCCCCcCccCccccCCCccCCCCCCcceeeeEee
Q psy14630        128 ------------RGAIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPLRARGYPSFKTKLGFKFN  183 (187)
Q Consensus       128 ------------~~~~ki~dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi~  183 (187)
                                  .+.+||+|||+++.....  .....||+.|+|||++.   ...++.++|+||+|++
T Consensus       186 ~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~--~~~~~gt~~y~aPE~~~---~~~~~~~~DiwslG~i  248 (360)
T 3llt_A          186 TDGKKIQIYRTKSTGIKLIDFGCATFKSDY--HGSIINTRQYRAPEVIL---NLGWDVSSDMWSFGCV  248 (360)
T ss_dssp             TTCCEEEEEEESCCCEEECCCTTCEETTSC--CCSCCSCGGGCCHHHHT---TCCCCTTHHHHHHHHH
T ss_pred             cccccccccccCCCCEEEEeccCceecCCC--CcCccCcccccCcHHHc---CCCCCCccchHHHHHH
Confidence                        788999999999865432  23457899999999998   6678999999999994

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A*

Probab=99.97  E-value=4.7e-33  Score=216.32  Aligned_cols=157  Identities=28%  Similarity=0.434  Sum_probs=127.6

Q ss_pred             ccccccccccccCceEEEEEEEcCCCcEEEEEEccCcc-ChHHHHHHHHHHHHHHhcCCCCchhhhhhhHH---------
Q psy14630         24 EDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTV-DEKDQRQLLMDLDVVMKSNECPYIVQFYGALF---------   93 (187)
Q Consensus        24 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~---------   93 (187)
                      +.|+..+.||+|+||.||+|.+..+++.||+|.+.... ......+.+.++..+++.+.||||+++++.+.         
T Consensus        54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~  133 (348)
T 1u5q_A           54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM  133 (348)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEE
Confidence            55888999999999999999999999999999986432 22333445566666778889999999875321         


Q ss_pred             -----------------------HHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEeccccccccccccccC
Q psy14630         94 -----------------------KEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTR  150 (187)
Q Consensus        94 -----------------------~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg~a~~~~~~~~~~~  150 (187)
                                             ..++.|++.||.|||+. +++||||||+||+++.++.+||+|||+++.....   ..
T Consensus       134 e~~~g~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~-~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~---~~  209 (348)
T 1u5q_A          134 EYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSH-NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA---NS  209 (348)
T ss_dssp             ECCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHT-TCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB---CC
T ss_pred             ecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC-CeeeCCCCHHHEEECCCCCEEEeeccCceecCCC---Cc
Confidence                                   12677899999999998 9999999999999999999999999999876532   23


Q ss_pred             CCCCcCccCccccCCCccCCCCCCcceeeeEeee
Q psy14630        151 DAGCRPYMAPERIDPLRARGYPSFKTKLGFKFNY  184 (187)
Q Consensus       151 ~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi~~  184 (187)
                      ..||+.|+|||++.+.....++.++|+||||+++
T Consensus       210 ~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il  243 (348)
T 1u5q_A          210 FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITC  243 (348)
T ss_dssp             CCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHH
T ss_pred             ccCCcceeCHhhhccccCCCCCcHHHHHHHHHHH
Confidence            4789999999998643355688999999999943

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7

Probab=99.97  E-value=2.5e-33  Score=220.70  Aligned_cols=155  Identities=20%  Similarity=0.345  Sum_probs=128.0

Q ss_pred             cccccccccccccCceEEEEEEEcCCCcEEEEEEccCccChHHHHHHHHHHHHHHhcCCCCchhhhhhhH----------
Q psy14630         23 SEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQFYGAL----------   92 (187)
Q Consensus        23 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~----------   92 (187)
                      .++|++.+.||+|+||.||+|.+..+++.+|+|.+....  ......+.++..+++.++||||+++++.+          
T Consensus        50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~--~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~  127 (387)
T 1kob_A           50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY--PLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLIL  127 (387)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS--HHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEE
T ss_pred             ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccc--hhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEE
Confidence            467999999999999999999999999999999986432  22334566677788889999999987532          


Q ss_pred             -----------------------HHHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcC--CCCEEEEecccccccccccc
Q psy14630         93 -----------------------FKEVTVATVKALNYLKEELKIIHRDVKPSNILLDR--RGAIKLCDFGISGQLVDSIA  147 (187)
Q Consensus        93 -----------------------~~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~--~~~~ki~dfg~a~~~~~~~~  147 (187)
                                             ...++.|++.||.|||+. +++||||||+||+++.  .+.+||+|||+++.......
T Consensus       128 E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~-givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~~~  206 (387)
T 1kob_A          128 EFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEH-SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEI  206 (387)
T ss_dssp             ECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHT-TEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTSC
T ss_pred             EcCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhC-CeeecccchHHeEEecCCCCceEEEecccceecCCCcc
Confidence                                   112678999999999997 9999999999999974  56799999999988765444


Q ss_pred             ccCCCCCcCccCccccCCCccCCCCCCcceeeeEee
Q psy14630        148 KTRDAGCRPYMAPERIDPLRARGYPSFKTKLGFKFN  183 (187)
Q Consensus       148 ~~~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi~  183 (187)
                      .....||+.|+|||++.   ...++.++|+||+|++
T Consensus       207 ~~~~~gt~~y~aPE~~~---~~~~~~~~DiwSlG~i  239 (387)
T 1kob_A          207 VKVTTATAEFAAPEIVD---REPVGFYTDMWAIGVL  239 (387)
T ss_dssp             EEEECSSGGGCCHHHHT---TCCBCHHHHHHHHHHH
T ss_pred             eeeeccCCCccCchhcc---CCCCCCcccEeeHhHH
Confidence            44457899999999998   5678899999999994

>4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A

Probab=99.97  E-value=9e-33  Score=216.31  Aligned_cols=155  Identities=19%  Similarity=0.305  Sum_probs=125.7

Q ss_pred             ccccccccccccCceEEEEEEEcCCCcEEEEEEccCccChHHHHHHHHHHHHHHhcCCCCchhhhhhhH-----------
Q psy14630         24 EDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQFYGAL-----------   92 (187)
Q Consensus        24 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~-----------   92 (187)
                      ++|.+.+.||+|+||.||+|.+..+++.||+|.+..........+.+.++..+++.++||||+++++.+           
T Consensus        42 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  121 (371)
T 4exu_A           42 KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYD  121 (371)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCCC
T ss_pred             ccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCccccee
Confidence            689999999999999999999999999999999976544444555666677778888999999887532           


Q ss_pred             ------------------------HHHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEeccccccccccccc
Q psy14630         93 ------------------------FKEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAK  148 (187)
Q Consensus        93 ------------------------~~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg~a~~~~~~~~~  148 (187)
                                              ...++.|++.||.|||+. +++||||||+||+++.++.+||+|||+++.....  .
T Consensus       122 ~~lv~e~~~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~-~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~--~  198 (371)
T 4exu_A          122 FYLVMPFMQTDLQKIMGMEFSEEKIQYLVYQMLKGLKYIHSA-GVVHRDLKPGNLAVNEDCELKILDFGLARHADAE--M  198 (371)
T ss_dssp             CEEEEECCCEEHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCCGGGEEECTTCCEEECSTTCC---------
T ss_pred             EEEEEccccccHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHC-CCcCCCcCHHHeEECCCCCEEEEecCcccccccC--c
Confidence                                    112678999999999998 9999999999999999999999999999875433  2


Q ss_pred             cCCCCCcCccCccccCCCccCCCCCCcceeeeEee
Q psy14630        149 TRDAGCRPYMAPERIDPLRARGYPSFKTKLGFKFN  183 (187)
Q Consensus       149 ~~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi~  183 (187)
                      ....+|+.|+|||.+.+  ...++.++|+||+|++
T Consensus       199 ~~~~~t~~y~aPE~~~~--~~~~~~~~DiwslG~i  231 (371)
T 4exu_A          199 TGYVVTRWYRAPEVILS--WMHYNQTVDIWSVGCI  231 (371)
T ss_dssp             -CTTCCCTTSCHHHHSC--CSCCCTTHHHHHHHHH
T ss_pred             CCcccCccccCHHHhcC--CCCCCcHHhHHHHHHH
Confidence            33478999999999883  2568899999999994

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ...

Probab=99.97  E-value=2.1e-33  Score=223.30  Aligned_cols=152  Identities=29%  Similarity=0.340  Sum_probs=122.4

Q ss_pred             cccccccccccccCceEEEEEEEcCCCcEEEEEEccCccChHHHHHHHHHHHHHHhcCCCCchhhhhhhH----------
Q psy14630         23 SEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQFYGAL----------   92 (187)
Q Consensus        23 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~----------   92 (187)
                      ..+|++.+.||+|+||.||+|.+..+++.||||.+......      ..++..+++.++||||+++++.+          
T Consensus        53 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~------~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~  126 (420)
T 1j1b_A           53 EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF------KNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEV  126 (420)
T ss_dssp             EEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTTS------CCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEE
T ss_pred             cceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccchh------HHHHHHHHHHcCCCCccceeeEEeccCCCCcce
Confidence            34799999999999999999999999999999998542211      12345567788999999874322          


Q ss_pred             -------------------------------HHHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCC-CCEEEEeccccc
Q psy14630         93 -------------------------------FKEVTVATVKALNYLKEELKIIHRDVKPSNILLDRR-GAIKLCDFGISG  140 (187)
Q Consensus        93 -------------------------------~~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~-~~~ki~dfg~a~  140 (187)
                                                     ...++.|++.||.|||+. +|+||||||+||+++.+ +.+||+|||+++
T Consensus       127 ~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~-~ivHrDlkp~NILl~~~~~~~kl~DFG~a~  205 (420)
T 1j1b_A          127 YLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF-GICHRDIKPQNLLLDPDTAVLKLCDFGSAK  205 (420)
T ss_dssp             EEEEEEECCCEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT-TEECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred             eEEeehhcccccHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC-CccccCCChhhEEEeCCCCeEEeccchhhh
Confidence                                           112567999999999997 99999999999999965 568999999999


Q ss_pred             cccccccccCCCCCcCccCccccCCCccCCCCCCcceeeeEee
Q psy14630        141 QLVDSIAKTRDAGCRPYMAPERIDPLRARGYPSFKTKLGFKFN  183 (187)
Q Consensus       141 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi~  183 (187)
                      ............+|+.|+|||++.+  ...++.++|+||+|++
T Consensus       206 ~~~~~~~~~~~~~t~~y~aPE~~~~--~~~~~~~~DiwSlG~i  246 (420)
T 1j1b_A          206 QLVRGEPNVSYICSRYYRAPELIFG--ATDYTSSIDVWSAGCV  246 (420)
T ss_dssp             ECCTTCCCCSCCSCTTSCCHHHHTT--CSSCCTHHHHHHHHHH
T ss_pred             hcccCCCceeeeeCCCcCCHHHHcC--CCCCCchhhhHHHHHH
Confidence            8765544555678999999999873  3468899999999993

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A*

Probab=99.97  E-value=8.4e-33  Score=208.98  Aligned_cols=167  Identities=26%  Similarity=0.424  Sum_probs=129.3

Q ss_pred             cCCCccccCCcccccccccccccCceEEEEEEEcCCCcEEEEEEccCccCh--HHHH---HHHHHHHHHHhcCCCCchhh
Q psy14630         13 LSPDTVYDFTSEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDE--KDQR---QLLMDLDVVMKSNECPYIVQ   87 (187)
Q Consensus        13 ~~~~~~~~~~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~---~~~~~~~~~~~~~~h~~iv~   87 (187)
                      .+......+..++|++.+.||+|+||.||+|.+..+++.||+|.+......  ....   +.+.++..+++.++||||++
T Consensus         8 ~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~   87 (287)
T 4f0f_A            8 FPKSRLPTLADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVK   87 (287)
T ss_dssp             ----CCCBCCSTTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCC
T ss_pred             CcchhhhhhhhccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchh
Confidence            334445567789999999999999999999999999999999998643222  1111   45566667788889999999


Q ss_pred             hhhhHH-------------------------------HHHHHHHHHHHHHHHhcCC--CeeecCCCCCeEEcCCCC----
Q psy14630         88 FYGALF-------------------------------KEVTVATVKALNYLKEELK--IIHRDVKPSNILLDRRGA----  130 (187)
Q Consensus        88 ~~~~~~-------------------------------~~~~~~~~~~l~~lh~~~~--i~Hrdlk~~nili~~~~~----  130 (187)
                      +++.+.                               ..++.|++.|+.|||+. +  ++||||||+||+++..+.    
T Consensus        88 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~-~~~ivH~dikp~Nil~~~~~~~~~~  166 (287)
T 4f0f_A           88 LYGLMHNPPRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQ-NPPIVHRDLRSPNIFLQSLDENAPV  166 (287)
T ss_dssp             EEEEETTTTEEEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHTS-SSCCBCSCCSGGGEEESCCCTTCSC
T ss_pred             hheeecCCCeEEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHHhC-CCCeecCCCCcceEEEeccCCCCce
Confidence            875321                               12678999999999997 8  999999999999987776    


Q ss_pred             -EEEEeccccccccccccccCCCCCcCccCccccCCCccCCCCCCcceeeeEee
Q psy14630        131 -IKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPLRARGYPSFKTKLGFKFN  183 (187)
Q Consensus       131 -~ki~dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi~  183 (187)
                       +||+|||+++.....  .....+|+.|+|||.+... ...++.++|+||+|++
T Consensus       167 ~~kl~Dfg~~~~~~~~--~~~~~g~~~y~aPE~~~~~-~~~~~~~~Di~slG~~  217 (287)
T 4f0f_A          167 CAKVADFGLSQQSVHS--VSGLLGNFQWMAPETIGAE-EESYTEKADTYSFAMI  217 (287)
T ss_dssp             CEEECCCTTCBCCSSC--EECCCCCCTTSCGGGSSCS-SCEECHHHHHHHHHHH
T ss_pred             eEEeCCCCcccccccc--ccccCCCccccCchhhccC-CCCcCchhhHHHHHHH
Confidence             999999999865432  2334789999999998421 4457789999999994

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens}

Probab=99.97  E-value=3.2e-33  Score=214.46  Aligned_cols=163  Identities=22%  Similarity=0.303  Sum_probs=129.4

Q ss_pred             cCCcccccccccccccCceEEEEEEEcCCCcEEEEEEccCccChHHHHHHHHHHHHHHhcCCCCchhhhhhhH-------
Q psy14630         20 DFTSEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQFYGAL-------   92 (187)
Q Consensus        20 ~~~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~-------   92 (187)
                      ....++|++.+.||+|+||.||+|.+..+++.||+|++........ .+.+.++..+++.+.||||+++++.+       
T Consensus         5 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~-~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   83 (319)
T 4euu_A            5 STSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRP-VDVQMREFEVLKKLNHKNIVKLFAIEEETTTRH   83 (319)
T ss_dssp             ECSSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSC-HHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCC
T ss_pred             cCCCCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccch-HHHHHHHHHHHHhcCCCCcceEEEEeecCCCce
Confidence            3456889999999999999999999999999999999864322222 23344556677788999999886422       


Q ss_pred             ------------------------------HHHHHHHHHHHHHHHHhcCCCeeecCCCCCeEE----cCCCCEEEEeccc
Q psy14630         93 ------------------------------FKEVTVATVKALNYLKEELKIIHRDVKPSNILL----DRRGAIKLCDFGI  138 (187)
Q Consensus        93 ------------------------------~~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili----~~~~~~ki~dfg~  138 (187)
                                                    ...++.|++.||.|||+. +++||||||+||++    +..+.+||+|||+
T Consensus        84 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~-~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~  162 (319)
T 4euu_A           84 KVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLREN-GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGA  162 (319)
T ss_dssp             EEEEEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEEEECTTSCEEEEECCCTT
T ss_pred             EEEEEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHC-CEecCCCCHHHEEEeccCCCCceEEEccCCC
Confidence                                          112677999999999998 99999999999998    7777899999999


Q ss_pred             cccccccccccCCCCCcCccCccccCCC-----ccCCCCCCcceeeeEeee
Q psy14630        139 SGQLVDSIAKTRDAGCRPYMAPERIDPL-----RARGYPSFKTKLGFKFNY  184 (187)
Q Consensus       139 a~~~~~~~~~~~~~~t~~y~aPE~~~~~-----~~~~~~~~~D~ws~gi~~  184 (187)
                      ++............||+.|+|||++...     ....++.++|+||+|+++
T Consensus       163 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il  213 (319)
T 4euu_A          163 ARELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTF  213 (319)
T ss_dssp             CEECCTTCCBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHH
T ss_pred             ceecCCCCceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHH
Confidence            9887665555556799999999997521     134578999999999943

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B

Probab=99.97  E-value=9.5e-33  Score=221.46  Aligned_cols=161  Identities=20%  Similarity=0.309  Sum_probs=130.4

Q ss_pred             CccccCCcccccccccccccCceEEEEEEEcCCCcEEEEEEccCccChHHHHHHHHHHHHHHhcCCCCchhhhhhhHH--
Q psy14630         16 DTVYDFTSEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQFYGALF--   93 (187)
Q Consensus        16 ~~~~~~~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~--   93 (187)
                      ...|++..++|++.+.||+|+||.||+|.+. ++..||||.++.....   .+.+.++..+++.++||||+++++.+.  
T Consensus       180 ~~~~~i~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~h~~iv~l~~~~~~~  255 (454)
T 1qcf_A          180 KDAWEIPRESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPGSMS---VEAFLAEANVMKTLQHDKLVKLHAVVTKE  255 (454)
T ss_dssp             TTCSBCCGGGEEEEEEEECCSSEEEEEEEET-TTEEEEEEEECTTSBC---HHHHHHHHHHHTTCCCTTBCCEEEEECSS
T ss_pred             ccceeechHHeEEEEEcccCCceEEEEEEEC-CccEEEEEEecCCCcc---HHHHHHHHHHHhhCCCCCEeeEEEEEeCC
Confidence            4667899999999999999999999999985 4678999998753322   344566677888899999998865321  


Q ss_pred             -------------------------------HHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEeccccccc
Q psy14630         94 -------------------------------KEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQL  142 (187)
Q Consensus        94 -------------------------------~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg~a~~~  142 (187)
                                                     ..++.|++.||.|||+. +++||||||+||+++.++.+||+|||+++..
T Consensus       256 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~-~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~  334 (454)
T 1qcf_A          256 PIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQR-NYIHRDLRAANILVSASLVCKIADFGLARVI  334 (454)
T ss_dssp             SCEEEECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHT-TCCCSSCSGGGEEECTTCCEEECSTTGGGGB
T ss_pred             ccEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhC-CccCCCCCHHHEEECCCCcEEEeeCCCceEc
Confidence                                           11667899999999998 9999999999999999999999999999876


Q ss_pred             ccccc--ccCCCCCcCccCccccCCCccCCCCCCcceeeeEeee
Q psy14630        143 VDSIA--KTRDAGCRPYMAPERIDPLRARGYPSFKTKLGFKFNY  184 (187)
Q Consensus       143 ~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi~~  184 (187)
                      .....  .....++..|+|||.+.   ...++.++|+||||+++
T Consensus       335 ~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~DvwslG~~l  375 (454)
T 1qcf_A          335 EDNEYTAREGAKFPIKWTAPEAIN---FGSFTIKSDVWSFGILL  375 (454)
T ss_dssp             CCHHHHTTCSSSSCGGGSCHHHHH---HCCCCHHHHHHHHHHHH
T ss_pred             CCCceeccCCCcccccccCHHHhc---cCCCCcHHHHHhHHHHH
Confidence            54321  12234577899999998   56789999999999944

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A

Probab=99.97  E-value=1.7e-33  Score=223.75  Aligned_cols=160  Identities=26%  Similarity=0.340  Sum_probs=117.8

Q ss_pred             cccccccccccccCceEEEEEEEcCCCcEEEEEEccCccC------hHHHHHHHHHHHHHHhcCCCCchhhhhhhH----
Q psy14630         23 SEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVD------EKDQRQLLMDLDVVMKSNECPYIVQFYGAL----   92 (187)
Q Consensus        23 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~~------~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~----   92 (187)
                      .++|.+.+.||+|+||.||+|.+..+++.||+|++.....      .......+..+..+++.++||||+++++.+    
T Consensus       134 ~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~  213 (419)
T 3i6u_A          134 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAED  213 (419)
T ss_dssp             HTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEESSE
T ss_pred             hccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEecCc
Confidence            4678999999999999999999999999999999864211      111122345566677888999999987532    


Q ss_pred             ---------------------------HHHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCC---CEEEEeccccccc
Q psy14630         93 ---------------------------FKEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRG---AIKLCDFGISGQL  142 (187)
Q Consensus        93 ---------------------------~~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~---~~ki~dfg~a~~~  142 (187)
                                                 ...++.|++.||.|||+. +++||||||+||+++..+   .+||+|||+++..
T Consensus       214 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~-~ivHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~  292 (419)
T 3i6u_A          214 YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHEN-GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL  292 (419)
T ss_dssp             EEEEEECCTTCBGGGGTSSSCCCCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCCGGGEEESSSSSSCCEEECCSSTTTSC
T ss_pred             eEEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC-CccccCCChHhEEEecCCCcceEEEeecccceec
Confidence                                       122778999999999998 999999999999997544   5999999999987


Q ss_pred             cccccccCCCCCcCccCccccCCCccCCCCCCcceeeeEee
Q psy14630        143 VDSIAKTRDAGCRPYMAPERIDPLRARGYPSFKTKLGFKFN  183 (187)
Q Consensus       143 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi~  183 (187)
                      ..........||+.|+|||.+.+.....++.++|+||+|++
T Consensus       293 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~i  333 (419)
T 3i6u_A          293 GETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVI  333 (419)
T ss_dssp             C-----------CTTCCTTTTC----CTTHHHHHHHHHHHH
T ss_pred             CCCccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHH
Confidence            65554555679999999999864334567889999999993

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens}

Probab=99.97  E-value=2.6e-33  Score=217.82  Aligned_cols=155  Identities=23%  Similarity=0.362  Sum_probs=113.0

Q ss_pred             CCcccccccccccccCceEEEEEEEcCCCcEEEEEEccCccChHHHHHHHHHHHHHHhcCCCCchhhhhhhH--------
Q psy14630         21 FTSEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQFYGAL--------   92 (187)
Q Consensus        21 ~~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~--------   92 (187)
                      ...++|++.+.||+|+||.||+|.+..+++.||+|+++...    ..+.+..+..+++.+.||||+++++.+        
T Consensus        50 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l  125 (349)
T 2w4o_A           50 ALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV----DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISL  125 (349)
T ss_dssp             CGGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC--------------CHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred             cccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch----hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEE
Confidence            34467999999999999999999999999999999986432    223445566677788999999887532        


Q ss_pred             ------------------------HHHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcC---CCCEEEEecccccccccc
Q psy14630         93 ------------------------FKEVTVATVKALNYLKEELKIIHRDVKPSNILLDR---RGAIKLCDFGISGQLVDS  145 (187)
Q Consensus        93 ------------------------~~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~---~~~~ki~dfg~a~~~~~~  145 (187)
                                              ...++.|++.||.|||+. +++||||||+||+++.   ++.+||+|||+++.....
T Consensus       126 v~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~-~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~~  204 (349)
T 2w4o_A          126 VLELVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHEN-GIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQ  204 (349)
T ss_dssp             EECCCCSCBHHHHHTTCSSCCHHHHHHHHHHHHHHHHHHHHT-TCCCCCCCGGGEEESSSSTTCCEEECCCC--------
T ss_pred             EEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC-CeEecCCCcccEEEecCCCCCCEEEccCccccccCcc
Confidence                                    122678999999999998 9999999999999975   889999999999877654


Q ss_pred             ccccCCCCCcCccCccccCCCccCCCCCCcceeeeEee
Q psy14630        146 IAKTRDAGCRPYMAPERIDPLRARGYPSFKTKLGFKFN  183 (187)
Q Consensus       146 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi~  183 (187)
                      .......||+.|+|||.+.   ...++.++|+||+|++
T Consensus       205 ~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwslG~i  239 (349)
T 2w4o_A          205 VLMKTVCGTPGYCAPEILR---GCAYGPEVDMWSVGII  239 (349)
T ss_dssp             --------CGGGSCHHHHT---TCCCCTHHHHHHHHHH
T ss_pred             cccccccCCCCccCHHHhc---CCCCCcccchHHHHHH
Confidence            4444557899999999998   5668999999999994

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A*

Probab=99.97  E-value=1.9e-33  Score=215.13  Aligned_cols=157  Identities=25%  Similarity=0.335  Sum_probs=122.2

Q ss_pred             cccccccccccccCceEEEEEEEcCCCcEEEEEEccCcc-ChHHHHHHHHHHHHHHhcCCCCchhhhhhhH---------
Q psy14630         23 SEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTV-DEKDQRQLLMDLDVVMKSNECPYIVQFYGAL---------   92 (187)
Q Consensus        23 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~---------   92 (187)
                      .++|++.+.||+|+||.||+|.+..+++.||+|+++... ........+.++..+++.++||||+++++.+         
T Consensus        11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~   90 (311)
T 3ork_A           11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL   90 (311)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEE
T ss_pred             cCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcc
Confidence            478999999999999999999999999999999987543 2333445566666677888999999886431         


Q ss_pred             ---------------------------HHHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEecccccccccc
Q psy14630         93 ---------------------------FKEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDS  145 (187)
Q Consensus        93 ---------------------------~~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg~a~~~~~~  145 (187)
                                                 ...++.|++.||.|||+. +++||||||+||+++.++.+||+|||+++.....
T Consensus        91 ~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~-~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~  169 (311)
T 3ork_A           91 PYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQN-GIIHRDVKPANIMISATNAVKVMDFGIARAIADS  169 (311)
T ss_dssp             EEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHT-TCCCCCCCGGGEEEETTSCEEECCCSCC------
T ss_pred             cEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC-CCCcCCCCHHHEEEcCCCCEEEeeccCccccccc
Confidence                                       112678899999999998 9999999999999999999999999999876543


Q ss_pred             c----cccCCCCCcCccCccccCCCccCCCCCCcceeeeEee
Q psy14630        146 I----AKTRDAGCRPYMAPERIDPLRARGYPSFKTKLGFKFN  183 (187)
Q Consensus       146 ~----~~~~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi~  183 (187)
                      .    ......||+.|+|||.+.   ...++.++|+||+|++
T Consensus       170 ~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Di~slG~~  208 (311)
T 3ork_A          170 GNSVTQTAAVIGTAQYLSPEQAR---GDSVDARSDVYSLGCV  208 (311)
T ss_dssp             ------------CCTTCCHHHHH---TCCCCHHHHHHHHHHH
T ss_pred             ccccccccccCcCcccCCHHHhc---CCCCCchHhHHHHHHH
Confidence            2    122346899999999998   5678899999999993

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ...

Probab=99.97  E-value=3.5e-33  Score=211.54  Aligned_cols=172  Identities=24%  Similarity=0.325  Sum_probs=122.3

Q ss_pred             CCceecCCCccccCCcccccccccccccCceEEEEEEEcCCCcEEEEEEccCccChHHHHHHHHHHHHHHhcCCCCchhh
Q psy14630          8 SGKLKLSPDTVYDFTSEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQ   87 (187)
Q Consensus         8 ~~~~~~~~~~~~~~~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~   87 (187)
                      .+....+.-..+++..++|++.+.||+|+||.||+|.+.   ..+|+|.++.........+.+.++..+++.+.||||++
T Consensus         8 ~~~~~~~~~~~~ei~~~~y~~~~~lG~G~~g~Vy~~~~~---~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~   84 (289)
T 3og7_A            8 HHHGSRDAADDWEIPDGQITVGQRIGSGSFGTVYKGKWH---GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILL   84 (289)
T ss_dssp             ----------CCBCCTTSCEEEEEEEECSSEEEEEEESS---SEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCC
T ss_pred             cccCCCCCCCCCccCccceeeeeEecCCCCeEEEEEEEc---CceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEE
Confidence            333344445667889999999999999999999999864   35999998765555555566777777888899999998


Q ss_pred             hhhhH--------------------------------HHHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEe
Q psy14630         88 FYGAL--------------------------------FKEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCD  135 (187)
Q Consensus        88 ~~~~~--------------------------------~~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~d  135 (187)
                      +++..                                ...++.|++.||.|||+. +++||||||+||+++.++.++|+|
T Consensus        85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~-~i~H~Dlkp~Nil~~~~~~~kl~D  163 (289)
T 3og7_A           85 FMGYSTAPQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAK-SIIHRDLKSNNIFLHEDNTVKIGD  163 (289)
T ss_dssp             EEEEECSSSCEEEEECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCCGGGEEEETTTEEEECC
T ss_pred             EEeeccCCccEEEEEecCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhC-CcccccCccceEEECCCCCEEEcc
Confidence            76421                                112678999999999998 999999999999999999999999


Q ss_pred             cccccccccc---ccccCCCCCcCccCccccCCCccCCCCCCcceeeeEee
Q psy14630        136 FGISGQLVDS---IAKTRDAGCRPYMAPERIDPLRARGYPSFKTKLGFKFN  183 (187)
Q Consensus       136 fg~a~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi~  183 (187)
                      ||+++.....   .......||+.|+|||.+.......++.++|+||+|++
T Consensus       164 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~i  214 (289)
T 3og7_A          164 FGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIV  214 (289)
T ss_dssp             CC------------------CCCTTCCHHHHC----CCSCHHHHHHHHHHH
T ss_pred             ceeccccccccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHH
Confidence            9999865431   22233468999999999864334567889999999994

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A*

Probab=99.97  E-value=1.4e-33  Score=227.99  Aligned_cols=158  Identities=25%  Similarity=0.397  Sum_probs=125.0

Q ss_pred             CcccccccccccccCceEEEEEEEcCCCcEEEEEEccCccChHHHHHHHHHHHHHHhcCCCCchhhhhhhH---------
Q psy14630         22 TSEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQFYGAL---------   92 (187)
Q Consensus        22 ~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~---------   92 (187)
                      ..++|++.+.||+|+||.||+|.+..+++.||+|++............+.++..+++.++||||+++++.+         
T Consensus        20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv   99 (486)
T 3mwu_A           20 FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIV   99 (486)
T ss_dssp             HHHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hhcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEE
Confidence            35889999999999999999999999999999999853211111234455566677888999999987532         


Q ss_pred             -----------------------HHHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEc---CCCCEEEEeccccccccccc
Q psy14630         93 -----------------------FKEVTVATVKALNYLKEELKIIHRDVKPSNILLD---RRGAIKLCDFGISGQLVDSI  146 (187)
Q Consensus        93 -----------------------~~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~---~~~~~ki~dfg~a~~~~~~~  146 (187)
                                             ...++.|++.||.|||+. +++||||||+||+++   ..+.+||+|||+++......
T Consensus       100 ~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~-~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~  178 (486)
T 3mwu_A          100 GELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKH-NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNT  178 (486)
T ss_dssp             ECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBCCC-
T ss_pred             EEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC-CeEeccCchHHEEEecCCCCCCEEEEECCcCeECCCCC
Confidence                                   112678999999999998 999999999999995   45679999999998876555


Q ss_pred             cccCCCCCcCccCccccCCCccCCCCCCcceeeeEeee
Q psy14630        147 AKTRDAGCRPYMAPERIDPLRARGYPSFKTKLGFKFNY  184 (187)
Q Consensus       147 ~~~~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi~~  184 (187)
                      ......||+.|+|||++.+    .++.++|+||+|+++
T Consensus       179 ~~~~~~gt~~y~aPE~~~~----~~~~~~DiwslG~il  212 (486)
T 3mwu_A          179 KMKDRIGTAYYIAPEVLRG----TYDEKCDVWSAGVIL  212 (486)
T ss_dssp             ---CCTTGGGGCCGGGGGS----CCCHHHHHHHHHHHH
T ss_pred             ccCCCcCCCCCCCHHHhCC----CCCchhhHHHHHHHH
Confidence            5555679999999999873    488999999999943

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II}

Probab=99.97  E-value=4.3e-33  Score=218.94  Aligned_cols=155  Identities=24%  Similarity=0.332  Sum_probs=124.3

Q ss_pred             cCCcccccccccccccCceEEEEEEEcCCCcEEEEEEccCccChHHHHHHHHHHHHHHhcCCCCchhhhhhhH-------
Q psy14630         20 DFTSEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQFYGAL-------   92 (187)
Q Consensus        20 ~~~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~-------   92 (187)
                      +...++|++.+.||+|+||.||+|.+..+++.||+|.+.......      .++..+++.++||||+++++.+       
T Consensus         3 ~~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~~------~~E~~il~~l~hpnIv~l~~~~~~~~~~~   76 (383)
T 3eb0_A            3 ETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRYK------NRELDIMKVLDHVNIIKLVDYFYTTGDEE   76 (383)
T ss_dssp             ---CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTTSC------CHHHHHHTTCCCTTBCCEEEEEEEC----
T ss_pred             ccccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcchH------HHHHHHHHHcCCCCccchhheeeecCccc
Confidence            455688999999999999999999999999999999886432111      1355567888999999876432       


Q ss_pred             ------------------------------------------------------------------HHHHHHHHHHHHHH
Q psy14630         93 ------------------------------------------------------------------FKEVTVATVKALNY  106 (187)
Q Consensus        93 ------------------------------------------------------------------~~~~~~~~~~~l~~  106 (187)
                                                                                        ...++.|++.||.|
T Consensus        77 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~  156 (383)
T 3eb0_A           77 PKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGF  156 (383)
T ss_dssp             ---------------------------------CCEEEEEECCCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHH
T ss_pred             ccccccccccccccccccccccccccccccCCCceEEEEEEecCCccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHH
Confidence                                                                              01156789999999


Q ss_pred             HHhcCCCeeecCCCCCeEEc-CCCCEEEEeccccccccccccccCCCCCcCccCccccCCCccCCCCCCcceeeeEee
Q psy14630        107 LKEELKIIHRDVKPSNILLD-RRGAIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPLRARGYPSFKTKLGFKFN  183 (187)
Q Consensus       107 lh~~~~i~Hrdlk~~nili~-~~~~~ki~dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi~  183 (187)
                      ||+. +++||||||+||+++ .++.+||+|||+++............+|+.|+|||.+.+  ...++.++|+||+|++
T Consensus       157 LH~~-gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~--~~~~~~~~DiwslG~i  231 (383)
T 3eb0_A          157 IHSL-GICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPSVAYICSRFYRAPELMLG--ATEYTPSIDLWSIGCV  231 (383)
T ss_dssp             HHTT-TEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSCCCCCCCCSSCCCHHHHTT--CSSCCTHHHHHHHHHH
T ss_pred             HHHC-cCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCCCcCcccCCCccCHHHhcC--CCCCCcchhhhhHHHH
Confidence            9997 999999999999997 688999999999998766555556678999999999873  3448899999999993

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens}

Probab=99.97  E-value=4.5e-34  Score=221.00  Aligned_cols=157  Identities=23%  Similarity=0.289  Sum_probs=126.5

Q ss_pred             cccccccccccccCceEEEEEEEcCCCcEEEEEEccCccChH------HHHHHHHHHHHHHhcCCCCchhhhhhhH----
Q psy14630         23 SEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEK------DQRQLLMDLDVVMKSNECPYIVQFYGAL----   92 (187)
Q Consensus        23 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~------~~~~~~~~~~~~~~~~~h~~iv~~~~~~----   92 (187)
                      .++|++.+.||+|+||.||+|.+..+++.||+|+++......      ...+.+..+..+++.++||||+++++.+    
T Consensus        23 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~  102 (335)
T 3dls_A           23 SQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQG  102 (335)
T ss_dssp             HHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECSS
T ss_pred             ccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeCC
Confidence            468999999999999999999999999999999986432110      0112233455677788999999987532    


Q ss_pred             -----------------------------HHHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEecccccccc
Q psy14630         93 -----------------------------FKEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLV  143 (187)
Q Consensus        93 -----------------------------~~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg~a~~~~  143 (187)
                                                   ...++.|++.||.|||+. +++||||||+||+++.++.+||+|||+++...
T Consensus       103 ~~~lv~e~~~~g~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~-~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~  181 (335)
T 3dls_A          103 FFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVGYLRLK-DIIHRDIKDENIVIAEDFTIKLIDFGSAAYLE  181 (335)
T ss_dssp             EEEEEEECCTTSCBHHHHHHTCCCCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEECTTSCEEECCCTTCEECC
T ss_pred             EEEEEEEeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC-CeEEeccCHHHEEEcCCCcEEEeecccceECC
Confidence                                         112678999999999998 99999999999999999999999999998876


Q ss_pred             ccccccCCCCCcCccCccccCCCccCCC-CCCcceeeeEee
Q psy14630        144 DSIAKTRDAGCRPYMAPERIDPLRARGY-PSFKTKLGFKFN  183 (187)
Q Consensus       144 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~-~~~~D~ws~gi~  183 (187)
                      .........||+.|+|||.+.   ...+ +.++|+||+|++
T Consensus       182 ~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~~DiwslG~i  219 (335)
T 3dls_A          182 RGKLFYTFCGTIEYCAPEVLM---GNPYRGPELEMWSLGVT  219 (335)
T ss_dssp             TTCCBCEECSCGGGCCHHHHT---TCCBCSHHHHHHHHHHH
T ss_pred             CCCceeccCCCccccChhhhc---CCCCCCCcccchhHHHH
Confidence            554445557899999999998   4444 688999999993

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C

Probab=99.97  E-value=5.6e-33  Score=219.58  Aligned_cols=150  Identities=23%  Similarity=0.382  Sum_probs=114.4

Q ss_pred             cccccc-ccccccCceEEEEEEEcCCCcEEEEEEccCccChHHHHHHHHHHHHHHhcCCCCchhhhhhhH----------
Q psy14630         24 EDLQDL-GEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQFYGAL----------   92 (187)
Q Consensus        24 ~~~~~~-~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~----------   92 (187)
                      ++|.+. +.||+|+||.||+|.+..+++.||||+++..      .....+...+.+..+||||+++++.+          
T Consensus        61 ~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~------~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~  134 (400)
T 1nxk_A           61 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC------PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL  134 (400)
T ss_dssp             GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred             ccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc------hhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEE
Confidence            456665 6899999999999999999999999998632      12223344445667899999876432          


Q ss_pred             ----------------------------HHHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcC---CCCEEEEecccccc
Q psy14630         93 ----------------------------FKEVTVATVKALNYLKEELKIIHRDVKPSNILLDR---RGAIKLCDFGISGQ  141 (187)
Q Consensus        93 ----------------------------~~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~---~~~~ki~dfg~a~~  141 (187)
                                                  ...++.|++.||.|||+. +|+||||||+||+++.   ++.+||+|||+++.
T Consensus       135 ~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~-~ivHrDlkp~Nill~~~~~~~~~kl~DFG~a~~  213 (400)
T 1nxk_A          135 LIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI-NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKE  213 (400)
T ss_dssp             EEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHT-TEECCCCCGGGEEESSSSTTCCEEECCCTTCEE
T ss_pred             EEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHC-CccccCcCcceEEEecCCCCccEEEEecccccc
Confidence                                        112678899999999997 9999999999999987   78899999999987


Q ss_pred             ccccccccCCCCCcCccCccccCCCccCCCCCCcceeeeEee
Q psy14630        142 LVDSIAKTRDAGCRPYMAPERIDPLRARGYPSFKTKLGFKFN  183 (187)
Q Consensus       142 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi~  183 (187)
                      ..........+||+.|+|||++.   ...++.++||||+|++
T Consensus       214 ~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwslG~i  252 (400)
T 1nxk_A          214 TTSHNSLTTPCYTPYYVAPEVLG---PEKYDKSCDMWSLGVI  252 (400)
T ss_dssp             CC-----------CTTCCGGGSC---CCCSSSHHHHHHHHHH
T ss_pred             cCCCCccccCCCCCCccCHhhcC---CCCCCCcccHHHHHHH
Confidence            66544445567899999999997   6678999999999993

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A*

Probab=99.97  E-value=1.8e-33  Score=216.56  Aligned_cols=156  Identities=26%  Similarity=0.400  Sum_probs=124.4

Q ss_pred             cccccccccccccCceEEEEEEEcCCCcEEEEEEccCccChHHHHHHHHHHHHHHhcCCCCchhhhhhhH----------
Q psy14630         23 SEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQFYGAL----------   92 (187)
Q Consensus        23 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~----------   92 (187)
                      .++|++.+.||+|+||.||+|.+..+++.||+|++...... ...+.+.++..+++.+.||||+++++.+          
T Consensus         6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~   84 (323)
T 3tki_A            6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV-DCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFL   84 (323)
T ss_dssp             TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC--------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEccccc-chHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEE
Confidence            47899999999999999999999999999999998643222 2234455666677888999999987532          


Q ss_pred             ----------------------HHHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEecccccccccc---cc
Q psy14630         93 ----------------------FKEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDS---IA  147 (187)
Q Consensus        93 ----------------------~~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg~a~~~~~~---~~  147 (187)
                                            ...++.|++.||.|||+. +++||||||+||+++.++.+||+|||+++.+...   ..
T Consensus        85 e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~-givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~  163 (323)
T 3tki_A           85 EYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI-GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERL  163 (323)
T ss_dssp             ECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEECC
T ss_pred             EcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHC-CccccccchHHEEEeCCCCEEEEEeeccceeccCCcccc
Confidence                                  223778999999999997 9999999999999999999999999999876432   22


Q ss_pred             ccCCCCCcCccCccccCCCccCCC-CCCcceeeeEee
Q psy14630        148 KTRDAGCRPYMAPERIDPLRARGY-PSFKTKLGFKFN  183 (187)
Q Consensus       148 ~~~~~~t~~y~aPE~~~~~~~~~~-~~~~D~ws~gi~  183 (187)
                      .....||+.|+|||++.   ...+ +.++|+||+|++
T Consensus       164 ~~~~~gt~~y~aPE~~~---~~~~~~~~~DiwslG~i  197 (323)
T 3tki_A          164 LNKMCGTLPYVAPELLK---RREFHAEPVDVWSCGIV  197 (323)
T ss_dssp             BCSCCSCGGGSCHHHHH---CSSBCHHHHHHHHHHHH
T ss_pred             cCCCccCcCccCcHHhc---cCCCCCCcccHHHHHHH
Confidence            23457899999999997   3443 678999999993

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A*

Probab=99.97  E-value=4.2e-33  Score=225.65  Aligned_cols=156  Identities=26%  Similarity=0.425  Sum_probs=123.1

Q ss_pred             ccccccccccccCceEEEEEEEcCCCcEEEEEEccCccChHHHHHHHHHHHHHHhcCCCCchhhhhhhH-----------
Q psy14630         24 EDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQFYGAL-----------   92 (187)
Q Consensus        24 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~-----------   92 (187)
                      ++|++.+.||+|+||.||+|.+..++..+|+|++............+.++..+++.++||||+++++.+           
T Consensus        37 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e  116 (494)
T 3lij_A           37 EMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVME  116 (494)
T ss_dssp             HHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             cCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEe
Confidence            469999999999999999999999999999999865432222234556677788889999999987532           


Q ss_pred             ---------------------HHHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCC---CCEEEEeccccccccccccc
Q psy14630         93 ---------------------FKEVTVATVKALNYLKEELKIIHRDVKPSNILLDRR---GAIKLCDFGISGQLVDSIAK  148 (187)
Q Consensus        93 ---------------------~~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~---~~~ki~dfg~a~~~~~~~~~  148 (187)
                                           ...++.|++.||.|||+. +++||||||+||+++..   +.+||+|||+++........
T Consensus       117 ~~~~g~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~-~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~~~~~  195 (494)
T 3lij_A          117 CYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKH-NIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKM  195 (494)
T ss_dssp             CCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEESCSSTTCCEEECCCTTCEECBTTBCB
T ss_pred             cCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC-CceeccCChhhEEEeCCCCCCcEEEEECCCCeECCCCccc
Confidence                                 112678999999999998 99999999999999764   45999999999887665555


Q ss_pred             cCCCCCcCccCccccCCCccCCCCCCcceeeeEeee
Q psy14630        149 TRDAGCRPYMAPERIDPLRARGYPSFKTKLGFKFNY  184 (187)
Q Consensus       149 ~~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi~~  184 (187)
                      ....||+.|+|||++.    ..++.++|+||+|+++
T Consensus       196 ~~~~gt~~y~aPE~l~----~~~~~~~DiwslG~il  227 (494)
T 3lij_A          196 KERLGTAYYIAPEVLR----KKYDEKCDVWSIGVIL  227 (494)
T ss_dssp             CCCCSCTTTCCHHHHT----TCBCTHHHHHHHHHHH
T ss_pred             cccCCCcCeeCHHHHc----ccCCCchhHHHHHHHH
Confidence            5668999999999976    2488999999999943

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens}

Probab=99.97  E-value=3.6e-33  Score=218.39  Aligned_cols=162  Identities=22%  Similarity=0.311  Sum_probs=125.0

Q ss_pred             ccccCCcccccccccccccCceEEEEEE-----EcCCCcEEEEEEccCccChHHHHHHHHHHHHHHhcCCCCchhhhhhh
Q psy14630         17 TVYDFTSEDLQDLGEIGRGGFGTVNKMI-----HRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQFYGA   91 (187)
Q Consensus        17 ~~~~~~~~~~~~~~~lg~G~fg~V~~~~-----~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~   91 (187)
                      ...++..++|++.+.||+|+||.||+|.     +..+++.||+|.++.........+ +..+..+++.++||||+++++.
T Consensus        64 ~~~~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~-~~~E~~~l~~l~hpnIv~~~~~  142 (367)
T 3l9p_A           64 DLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELD-FLMEALIISKFNHQNIVRCIGV  142 (367)
T ss_dssp             GSCBCCGGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHH-HHHHHHHHHHCCCTTBCCEEEE
T ss_pred             chhhcCHhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHH-HHHHHHHHHhCCCCCCCeEEEE
Confidence            3446778999999999999999999998     456778999999875444433333 4445556777899999988653


Q ss_pred             HH---------------------------------------HHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCC---
Q psy14630         92 LF---------------------------------------KEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRG---  129 (187)
Q Consensus        92 ~~---------------------------------------~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~---  129 (187)
                      +.                                       ..++.|++.||.|||+. +++||||||+||+++.++   
T Consensus       143 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~-~ivHrDlkp~NIll~~~~~~~  221 (367)
T 3l9p_A          143 SLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN-HFIHRDIAARNCLLTCPGPGR  221 (367)
T ss_dssp             ECSSSSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCCGGGEEESCSSTTC
T ss_pred             EecCCCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhC-CeeCCCCChhhEEEecCCCCc
Confidence            21                                       12667899999999998 999999999999998555   


Q ss_pred             CEEEEeccccccccccc---cccCCCCCcCccCccccCCCccCCCCCCcceeeeEee
Q psy14630        130 AIKLCDFGISGQLVDSI---AKTRDAGCRPYMAPERIDPLRARGYPSFKTKLGFKFN  183 (187)
Q Consensus       130 ~~ki~dfg~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi~  183 (187)
                      .+||+|||+++......   ......+|+.|+|||.+.   ...++.++|+||||++
T Consensus       222 ~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~---~~~~~~~~DvwslG~i  275 (367)
T 3l9p_A          222 VAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFM---EGIFTSKTDTWSFGVL  275 (367)
T ss_dssp             CEEECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHH---HCCCCHHHHHHHHHHH
T ss_pred             eEEECCCccccccccccccccCCCcCCcccEECHHHhc---CCCCCcHHHHHHHHHH
Confidence            59999999998653321   122335788999999998   6678999999999994

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens}

Probab=99.97  E-value=6.1e-33  Score=213.73  Aligned_cols=162  Identities=23%  Similarity=0.322  Sum_probs=126.9

Q ss_pred             cccCCcccccccccccccCceEEEEEEEcCCCc---EEEEEEccCccChHHHHHHHHHHHHHHhcCCCCchhhhhhhHHH
Q psy14630         18 VYDFTSEDLQDLGEIGRGGFGTVNKMIHRSSDT---VMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQFYGALFK   94 (187)
Q Consensus        18 ~~~~~~~~~~~~~~lg~G~fg~V~~~~~~~~~~---~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~   94 (187)
                      ..++..++|++.+.||+|+||.||+|.+..++.   .||||.++...... ..+.+.++..+++.++||||+++++.+..
T Consensus        43 ~~~~~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~E~~~l~~l~h~~iv~~~~~~~~  121 (325)
T 3kul_A           43 TREIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTER-QRRDFLSEASIMGQFDHPNIIRLEGVVTR  121 (325)
T ss_dssp             CCBCCGGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHH-HHHHHHHHHHHHTTCCCTTBCCEEEEECG
T ss_pred             ccccChhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHH-HHHHHHHHHHHHHhCCCCCCCcEEEEEEe
Confidence            346778899999999999999999999875554   59999987543333 34455566667888899999998754311


Q ss_pred             ---------------------------------HHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEecccccc
Q psy14630         95 ---------------------------------EVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQ  141 (187)
Q Consensus        95 ---------------------------------~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg~a~~  141 (187)
                                                       .++.+++.||.|||+. +++||||||+||+++.++.+||+|||+++.
T Consensus       122 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~-~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~  200 (325)
T 3kul_A          122 GRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDL-GYVHRDLAARNVLVDSNLVCKVSDFGLSRV  200 (325)
T ss_dssp             GGCCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEECTTCCEEECCCSSCEE
T ss_pred             CCccEEEeeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHC-CeeCCCCCcceEEECCCCCEEECCCCcccc
Confidence                                             2677899999999998 999999999999999999999999999987


Q ss_pred             ccccc----cccCCCCCcCccCccccCCCccCCCCCCcceeeeEeee
Q psy14630        142 LVDSI----AKTRDAGCRPYMAPERIDPLRARGYPSFKTKLGFKFNY  184 (187)
Q Consensus       142 ~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi~~  184 (187)
                      .....    ......+|+.|+|||.+.   ...++.++|+||+|+++
T Consensus       201 ~~~~~~~~~~~~~~~~t~~y~aPE~~~---~~~~~~~~Di~slG~il  244 (325)
T 3kul_A          201 LEDDPDAAYTTTGGKIPIRWTAPEAIA---FRTFSSASDVWSFGVVM  244 (325)
T ss_dssp             CC----CCEECC---CCGGGSCHHHHH---HCEECHHHHHHHHHHHH
T ss_pred             cccCccceeeccCCCCcccccCHhHhc---CCCCCcHHHHHHHHHHH
Confidence            65432    112234577899999997   56688999999999943

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ...

Probab=99.97  E-value=2.2e-32  Score=213.57  Aligned_cols=165  Identities=22%  Similarity=0.344  Sum_probs=130.2

Q ss_pred             CCCccccCCcccccccccccccCceEEEEEEEcCCCcEEEEEEccCccChHHHHHHHHHHHHHHhcCCCCchhhhhhhH-
Q psy14630         14 SPDTVYDFTSEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQFYGAL-   92 (187)
Q Consensus        14 ~~~~~~~~~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~-   92 (187)
                      ..+..+++ .++|++.+.||+|+||.||+|.+..+++.||+|.+...... ...+.+.++..+++.+.||||+++++.+ 
T Consensus        18 ~~g~~~~~-~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~   95 (364)
T 3qyz_A           18 VRGQVFDV-GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQ-TYCQRTLREIKILLRFRHENIIGINDIIR   95 (364)
T ss_dssp             CC-CBCCC-TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCH-HHHHHHHHHHHHHHHCCCTTBCCCCEEEC
T ss_pred             EccEeccc-cccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCc-HHHHHHHHHHHHHHhcCCCCCccceeEEe
Confidence            33444443 36899999999999999999999999999999998753333 3334455666677788999999876432 


Q ss_pred             ----------------------------------HHHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEeccc
Q psy14630         93 ----------------------------------FKEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGI  138 (187)
Q Consensus        93 ----------------------------------~~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg~  138 (187)
                                                        ...++.|++.||.|||+. +++||||||+||+++.++.+||+|||+
T Consensus        96 ~~~~~~~~~~~iv~e~~~~~L~~~l~~~~~~~~~~~~i~~qi~~aL~~LH~~-~ivH~Dikp~NIl~~~~~~~kl~Dfg~  174 (364)
T 3qyz_A           96 APTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSA-NVLHRDLKPSNLLLNTTCDLKICDFGL  174 (364)
T ss_dssp             CSSTTTCCCEEEEEECCSEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCCGGGEEECTTCCEEECCCTT
T ss_pred             cCCccccceEEEEEcccCcCHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHC-CeecCCCChHhEEECCCCCEEEEeCcc
Confidence                                              112678999999999998 999999999999999999999999999


Q ss_pred             ccccccccc----ccCCCCCcCccCccccCCCccCCCCCCcceeeeEee
Q psy14630        139 SGQLVDSIA----KTRDAGCRPYMAPERIDPLRARGYPSFKTKLGFKFN  183 (187)
Q Consensus       139 a~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi~  183 (187)
                      ++.......    .....||+.|+|||++.+  ...++.++|+||+|++
T Consensus       175 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~~DiwslG~i  221 (364)
T 3qyz_A          175 ARVADPDHDHTGFLTEYVATRWYRAPEIMLN--SKGYTKSIDIWSVGCI  221 (364)
T ss_dssp             CEECCGGGCBCCTTCCCCSCGGGCCHHHHHT--BCSCSTHHHHHHHHHH
T ss_pred             eEecCCCCCccccccccccccCCCCCHHhcC--CCCCCcchhHHHHHHH
Confidence            987654322    233478999999998763  4458899999999994

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A*

Probab=99.97  E-value=3e-33  Score=217.58  Aligned_cols=164  Identities=26%  Similarity=0.426  Sum_probs=129.1

Q ss_pred             CccccCCcccccccccccccCceEEEEEE-----EcCCCcEEEEEEccCccChHHHHHHHHHHHHHHhcCCCCchhhhhh
Q psy14630         16 DTVYDFTSEDLQDLGEIGRGGFGTVNKMI-----HRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQFYG   90 (187)
Q Consensus        16 ~~~~~~~~~~~~~~~~lg~G~fg~V~~~~-----~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~   90 (187)
                      ...|++..++|++.+.||+|+||.||+|.     +..+++.||+|.++.............+...+.+..+||||+++++
T Consensus        14 ~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~   93 (359)
T 3vhe_A           14 ASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLG   93 (359)
T ss_dssp             HHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred             cccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeeeee
Confidence            46788999999999999999999999998     5567789999999765444444444455554444448999998874


Q ss_pred             hHH-----------------------------------------------------------------------------
Q psy14630         91 ALF-----------------------------------------------------------------------------   93 (187)
Q Consensus        91 ~~~-----------------------------------------------------------------------------   93 (187)
                      .+.                                                                             
T Consensus        94 ~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  173 (359)
T 3vhe_A           94 ACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSL  173 (359)
T ss_dssp             EECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC--------------------------------------------
T ss_pred             eeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCcccccccccccccccc
Confidence            310                                                                             


Q ss_pred             ----------------------HHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEeccccccccccc---cc
Q psy14630         94 ----------------------KEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSI---AK  148 (187)
Q Consensus        94 ----------------------~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg~a~~~~~~~---~~  148 (187)
                                            ..++.|++.||.|||+. +++||||||+||+++.++.+||+|||+++......   ..
T Consensus       174 ~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~-~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~  252 (359)
T 3vhe_A          174 SDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR-KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRK  252 (359)
T ss_dssp             ----------CTTTTCBCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTCEEC
T ss_pred             chhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHC-CcccCCCChhhEEEcCCCcEEEEeccceeeecccccchhc
Confidence                                  11456899999999998 99999999999999999999999999998764321   22


Q ss_pred             cCCCCCcCccCccccCCCccCCCCCCcceeeeEee
Q psy14630        149 TRDAGCRPYMAPERIDPLRARGYPSFKTKLGFKFN  183 (187)
Q Consensus       149 ~~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi~  183 (187)
                      ....+|+.|+|||++.   ...++.++|+||+|++
T Consensus       253 ~~~~~t~~y~aPE~~~---~~~~~~~~Di~slG~i  284 (359)
T 3vhe_A          253 GDARLPLKWMAPETIF---DRVYTIQSDVWSFGVL  284 (359)
T ss_dssp             --CEECGGGCCHHHHH---HCCCCHHHHHHHHHHH
T ss_pred             cccCCCceeEChhhhc---CCCCCchhhhhhHHHH
Confidence            3345788899999998   6678999999999993

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens}

Probab=99.97  E-value=6.5e-33  Score=213.49  Aligned_cols=166  Identities=27%  Similarity=0.363  Sum_probs=115.2

Q ss_pred             CccccCCcccccccccccccCceEEEEEEEcCCCcEEEEEEccCccChHHHHHHHHHHHHHHhcCCCCchhhhhhhH---
Q psy14630         16 DTVYDFTSEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQFYGAL---   92 (187)
Q Consensus        16 ~~~~~~~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~---   92 (187)
                      +..+++...+|++.+.||+|+||.||+|.+..+++.||+|.+... ..........+...+.+...||||+++++.+   
T Consensus        20 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~   98 (337)
T 3ll6_A           20 GQTVELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSN-EEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIG   98 (337)
T ss_dssp             TCEEEETTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEES-SHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEEC
T ss_pred             cceeeccCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCC-chHHHHHHHHHHHHHHHhccCCChhhcccccccc
Confidence            456677888999999999999999999999999999999988532 2222233334444344334599999885432   


Q ss_pred             ---------------------------------------HHHHHHHHHHHHHHHHhcCC--CeeecCCCCCeEEcCCCCE
Q psy14630         93 ---------------------------------------FKEVTVATVKALNYLKEELK--IIHRDVKPSNILLDRRGAI  131 (187)
Q Consensus        93 ---------------------------------------~~~~~~~~~~~l~~lh~~~~--i~Hrdlk~~nili~~~~~~  131 (187)
                                                             ...++.|++.||.|||+. +  ++||||||+||+++.++.+
T Consensus        99 ~~~~~~~~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~-~~~ivH~Dikp~NIl~~~~~~~  177 (337)
T 3ll6_A           99 KEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQ-KPPIIHRDLKVENLLLSNQGTI  177 (337)
T ss_dssp             TTTSTTSSEEEEEEEECCSEEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTS-SSCCBCCCCCGGGCEECTTSCE
T ss_pred             ccccccCCceEEEEEEecCCCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhC-CCCEEEccCCcccEEECCCCCE
Confidence                                                   112677899999999997 8  9999999999999999999


Q ss_pred             EEEeccccccccccccc-------------cCCCCCcCccCccccCCCccCCCCCCcceeeeEee
Q psy14630        132 KLCDFGISGQLVDSIAK-------------TRDAGCRPYMAPERIDPLRARGYPSFKTKLGFKFN  183 (187)
Q Consensus       132 ki~dfg~a~~~~~~~~~-------------~~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi~  183 (187)
                      ||+|||+++........             ....+|+.|+|||++.......++.++|+||+|++
T Consensus       178 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~i  242 (337)
T 3ll6_A          178 KLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCI  242 (337)
T ss_dssp             EBCCCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHH
T ss_pred             EEecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHH
Confidence            99999999876532211             13358899999999853335668899999999994

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A*

Probab=99.97  E-value=6.8e-33  Score=218.44  Aligned_cols=163  Identities=21%  Similarity=0.323  Sum_probs=121.1

Q ss_pred             cccCCcccccccccccccCceEEEEEEEcCCCcEEEEEEccCccChHHHHHHHHHHHHHHhcCC--CCchhhhhhhH---
Q psy14630         18 VYDFTSEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNE--CPYIVQFYGAL---   92 (187)
Q Consensus        18 ~~~~~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~--h~~iv~~~~~~---   92 (187)
                      ...+...+|++.+.||+|+||.||+|.+.. ++.||||++..........+.+.++..+++.+.  ||||+++++.+   
T Consensus        50 ~~~~~~~~y~~~~~LG~G~fg~Vy~~~~~~-~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~  128 (390)
T 2zmd_A           50 CISVKGRIYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITD  128 (390)
T ss_dssp             CEEETTEEEEEEEEEECCSSEEEEEEECTT-CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECS
T ss_pred             cccccCCceEEEEEEccCCCeEEEEEEcCC-CCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecC
Confidence            334555679999999999999999999865 889999998654433334444455555555543  69999887432   


Q ss_pred             ----------------------------HHHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEeccccccccc
Q psy14630         93 ----------------------------FKEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVD  144 (187)
Q Consensus        93 ----------------------------~~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg~a~~~~~  144 (187)
                                                  ...++.|++.||.|||+. +|+||||||+||+++ ++.+||+|||+++....
T Consensus       129 ~~~~lv~E~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~-~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~  206 (390)
T 2zmd_A          129 QYIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQH-GIVHSDLKPANFLIV-DGMLKLIDFGIANQMQP  206 (390)
T ss_dssp             SEEEEEEECCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHTT-TCCCCCCCGGGEEES-SSCEEECCCSSSCCC--
T ss_pred             CEEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC-CeeecCCCHHHEEEE-CCeEEEEecCccccccC
Confidence                                        112678999999999998 999999999999995 58999999999988754


Q ss_pred             cc---cccCCCCCcCccCccccCCCc--------cCCCCCCcceeeeEee
Q psy14630        145 SI---AKTRDAGCRPYMAPERIDPLR--------ARGYPSFKTKLGFKFN  183 (187)
Q Consensus       145 ~~---~~~~~~~t~~y~aPE~~~~~~--------~~~~~~~~D~ws~gi~  183 (187)
                      ..   ......||+.|+|||++.+..        ...++.++||||||++
T Consensus       207 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvi  256 (390)
T 2zmd_A          207 DTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCI  256 (390)
T ss_dssp             -------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHH
T ss_pred             CCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHH
Confidence            32   223457999999999986321        1357889999999994

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7

Probab=99.97  E-value=9.1e-33  Score=214.35  Aligned_cols=159  Identities=28%  Similarity=0.417  Sum_probs=121.4

Q ss_pred             CcccccccccccccCceEEEEEEEcCCCcEEEEEEccCccChH---HHHHHHHHHHHHHhcCCCCchhhhhhhH------
Q psy14630         22 TSEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEK---DQRQLLMDLDVVMKSNECPYIVQFYGAL------   92 (187)
Q Consensus        22 ~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~---~~~~~~~~~~~~~~~~~h~~iv~~~~~~------   92 (187)
                      ..++|++.+.||+|+||.||+|.+..+++.||+|.+.......   ...+.+.++..+++.+.||||+++++.+      
T Consensus         8 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   87 (346)
T 1ua2_A            8 RAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNI   87 (346)
T ss_dssp             -----CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCC
T ss_pred             HhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCce
Confidence            3578999999999999999999999999999999986432111   1123345566677788999999987543      


Q ss_pred             --------------------------HHHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEecccccccccc-
Q psy14630         93 --------------------------FKEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDS-  145 (187)
Q Consensus        93 --------------------------~~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg~a~~~~~~-  145 (187)
                                                ...++.|++.||.|||+. +++||||||+||+++.++.+||+|||+++..... 
T Consensus        88 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~-~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~  166 (346)
T 1ua2_A           88 SLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQH-WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPN  166 (346)
T ss_dssp             EEEEECCSEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHT-TCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCC
T ss_pred             EEEEEcCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHC-CEECCCCCHHHEEEcCCCCEEEEecccceeccCCc
Confidence                                      122778999999999998 9999999999999999999999999999876433 


Q ss_pred             ccccCCCCCcCccCccccCCCccCCCCCCcceeeeEee
Q psy14630        146 IAKTRDAGCRPYMAPERIDPLRARGYPSFKTKLGFKFN  183 (187)
Q Consensus       146 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi~  183 (187)
                      .......+|+.|+|||.+.+  ...++.++|+||+|++
T Consensus       167 ~~~~~~~~t~~y~aPE~~~~--~~~~~~~~DiwslG~i  202 (346)
T 1ua2_A          167 RAYTHQVVTRWYRAPELLFG--ARMYGVGVDMWAVGCI  202 (346)
T ss_dssp             CCCCCSCCCCTTCCHHHHTT--CSCCCHHHHHHHHHHH
T ss_pred             ccCCcccccccccCchHhhC--CCCCCchhhhHhHHHH
Confidence            23334578999999999873  3457889999999993

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A*

Probab=99.97  E-value=1.4e-32  Score=215.18  Aligned_cols=160  Identities=13%  Similarity=0.127  Sum_probs=115.7

Q ss_pred             ccCCcccccccccccccCceEEEEEEEcCCCcEEEEEEccCccC-hHHHHHHHHHHH---HHHhcCCCCchhhhhhhH--
Q psy14630         19 YDFTSEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVD-EKDQRQLLMDLD---VVMKSNECPYIVQFYGAL--   92 (187)
Q Consensus        19 ~~~~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~~~---~~~~~~~h~~iv~~~~~~--   92 (187)
                      +.....+|++.+.||+|+||.||+|.+..+++.||+|++..... .....+.+.++.   ..++. .||||++++..+  
T Consensus        57 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~-~hp~iv~~~~~~~~  135 (371)
T 3q60_A           57 LSQGERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLG-ESPEEARDRRRLLL  135 (371)
T ss_dssp             TTCCEEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC-----------CBCC
T ss_pred             CCCCceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcc-cChhhhhhceeEEe
Confidence            34445679999999999999999999999999999999976432 333444455543   33444 799976532100  


Q ss_pred             ------------------------------------------H------------------HHHHHHHHHHHHHHHhcCC
Q psy14630         93 ------------------------------------------F------------------KEVTVATVKALNYLKEELK  112 (187)
Q Consensus        93 ------------------------------------------~------------------~~~~~~~~~~l~~lh~~~~  112 (187)
                                                                .                  ..++.|++.||+|||+. +
T Consensus       136 p~d~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~-~  214 (371)
T 3q60_A          136 PSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSK-G  214 (371)
T ss_dssp             CCEEEEETTSCSSSBCSCC---CCEEEEEEEECCCSEEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHT-T
T ss_pred             eehheecCCCCCeeeccCCcccceeeeEEEEecCCCCCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHHHC-C
Confidence                                                      0                  12347999999999997 9


Q ss_pred             CeeecCCCCCeEEcCCCCEEEEeccccccccccccccCCCCCcCccCccccCCCccCCCCCCcceeeeEee
Q psy14630        113 IIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPLRARGYPSFKTKLGFKFN  183 (187)
Q Consensus       113 i~Hrdlk~~nili~~~~~~ki~dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi~  183 (187)
                      ++||||||+||+++.++.+||+|||+++.......  ...+|+.|+|||.+.+. ...++.++|+||+|++
T Consensus       215 ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~~~~--~~~~t~~y~aPE~~~~~-~~~~~~~~DiwSlG~i  282 (371)
T 3q60_A          215 LVHGHFTPDNLFIMPDGRLMLGDVSALWKVGTRGP--ASSVPVTYAPREFLNAS-TATFTHALNAWQLGLS  282 (371)
T ss_dssp             EEETTCSGGGEEECTTSCEEECCGGGEEETTCEEE--GGGSCGGGCCHHHHTCS-EEECCHHHHHHHHHHH
T ss_pred             CccCcCCHHHEEECCCCCEEEEecceeeecCCCcc--CccCCcCCcChhhccCC-CCCcCccccHHHHHHH
Confidence            99999999999999999999999999987654322  23566999999999731 2568999999999993

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A*

Probab=99.97  E-value=1.3e-32  Score=210.34  Aligned_cols=165  Identities=19%  Similarity=0.249  Sum_probs=123.1

Q ss_pred             CCccccCCcccccccccccccCceEEEEEEEcC---CCcEEEEEEccCccChHHHHHHHHHHHHHHhcCCCCchhhhhhh
Q psy14630         15 PDTVYDFTSEDLQDLGEIGRGGFGTVNKMIHRS---SDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQFYGA   91 (187)
Q Consensus        15 ~~~~~~~~~~~~~~~~~lg~G~fg~V~~~~~~~---~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~   91 (187)
                      ....+.+..++|.+.+.||+|+||.||+|.+..   +++.||+|.++.........+.+.++..+++.++||||+++++.
T Consensus        25 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~  104 (313)
T 3brb_A           25 KLEDVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGV  104 (313)
T ss_dssp             CTTTTBCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEE
T ss_pred             hHHhcccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEE
Confidence            345557788999999999999999999998754   55689999987544444444556666777888899999988653


Q ss_pred             HH-------------------------------------------HHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCC
Q psy14630         92 LF-------------------------------------------KEVTVATVKALNYLKEELKIIHRDVKPSNILLDRR  128 (187)
Q Consensus        92 ~~-------------------------------------------~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~  128 (187)
                      +.                                           ..++.|++.||.|||+. +++||||||+||+++.+
T Consensus       105 ~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~-~ivH~dikp~NIli~~~  183 (313)
T 3brb_A          105 CIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNR-NFLHRDLAARNCMLRDD  183 (313)
T ss_dssp             EEC-------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTT-TCCCCCCSGGGEEECTT
T ss_pred             EeeccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhC-CcccCCCCcceEEEcCC
Confidence            21                                           11667899999999998 99999999999999999


Q ss_pred             CCEEEEeccccccccccc---cccCCCCCcCccCccccCCCccCCCCCCcceeeeEee
Q psy14630        129 GAIKLCDFGISGQLVDSI---AKTRDAGCRPYMAPERIDPLRARGYPSFKTKLGFKFN  183 (187)
Q Consensus       129 ~~~ki~dfg~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi~  183 (187)
                      +.+||+|||+++......   ......+++.|+|||.+.   ...++.++|+||+|++
T Consensus       184 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~Di~slG~i  238 (313)
T 3brb_A          184 MTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLA---DRVYTSKSDVWAFGVT  238 (313)
T ss_dssp             SCEEECSCSCC----------------CCGGGSCHHHHH---SSCCCHHHHHHHHHHH
T ss_pred             CcEEEeecCcceecccccccCcccccCCCccccCchhhc---CCCccchhhhHHHHHH
Confidence            999999999998764332   112235677899999998   6678899999999993

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A

Probab=99.97  E-value=5.8e-33  Score=224.90  Aligned_cols=161  Identities=20%  Similarity=0.334  Sum_probs=131.3

Q ss_pred             ccccCCcccccccccccccCceEEEEEEEcCCCcEEEEEEccCccChHHHHHHHHHHHHHHhcCCCCchhhhhhhHH---
Q psy14630         17 TVYDFTSEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQFYGALF---   93 (187)
Q Consensus        17 ~~~~~~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~---   93 (187)
                      ..|++..++|++.+.||+|+||.||+|.+..++..||||.++.....   .+.+.++..+++.++||||+++++.+.   
T Consensus       213 ~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~hpniv~l~~~~~~~~  289 (495)
T 1opk_A          213 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME---VEEFLKEAAVMKEIKHPNLVQLLGVCTREP  289 (495)
T ss_dssp             SCCBCCGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSSC---HHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred             cccccCHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcccc---hHHHHHHHHHHHhcCCCCEeeEEEEEecCC
Confidence            45788899999999999999999999999988999999998754322   334556666788889999999875421   


Q ss_pred             -------------------------------HHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEeccccccc
Q psy14630         94 -------------------------------KEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQL  142 (187)
Q Consensus        94 -------------------------------~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg~a~~~  142 (187)
                                                     ..++.|++.||.|||+. +++||||||+||+++.++.+||+|||+++..
T Consensus       290 ~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~-~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~  368 (495)
T 1opk_A          290 PFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK-NFIHRNLAARNCLVGENHLVKVADFGLSRLM  368 (495)
T ss_dssp             SCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEECGGGCEEECCTTCEECC
T ss_pred             cEEEEEEccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhC-CcccCCCChhhEEECCCCcEEEeecccceec
Confidence                                           12567999999999998 9999999999999999999999999999876


Q ss_pred             ccccc--ccCCCCCcCccCccccCCCccCCCCCCcceeeeEeee
Q psy14630        143 VDSIA--KTRDAGCRPYMAPERIDPLRARGYPSFKTKLGFKFNY  184 (187)
Q Consensus       143 ~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi~~  184 (187)
                      .....  .....++..|+|||++.   ...++.++|+||||+++
T Consensus       369 ~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~sDvwSlG~~l  409 (495)
T 1opk_A          369 TGDTYTAHAGAKFPIKWTAPESLA---YNKFSIKSDVWAFGVLL  409 (495)
T ss_dssp             TTCCEECCTTCCCCGGGCCHHHHH---HCEECHHHHHHHHHHHH
T ss_pred             cCCceeecCCCcCCcceeCHhHHh---cCCCCcHHhHHhHHHHH
Confidence            54321  12234567899999998   56688999999999944

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens}

Probab=99.97  E-value=1.1e-32  Score=216.09  Aligned_cols=149  Identities=21%  Similarity=0.274  Sum_probs=118.1

Q ss_pred             cccccccCceEEEEEEEcCCCcEEEEEEccCccChHHHHHHHHHHHHHHhcCCCCchhhhhhhHH---------------
Q psy14630         29 LGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQFYGALF---------------   93 (187)
Q Consensus        29 ~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~---------------   93 (187)
                      .+.||+|+||.||+|.+..+++.||+|+++...  ....+.+.++..+++.++||||+++++.+.               
T Consensus        94 ~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~  171 (373)
T 2x4f_A           94 TEILGGGRFGQVHKCEETATGLKLAAKIIKTRG--MKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGG  171 (373)
T ss_dssp             EEECC-----CEEEEEETTTCCEEEEEEEECCS--HHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTC
T ss_pred             ceEEecCcCEEEEEEEEcCCCcEEEEEEEcccc--cccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCC
Confidence            567999999999999999999999999987532  223445666777888899999998875321               


Q ss_pred             ------------------HHHHHHHHHHHHHHHhcCCCeeecCCCCCeEE--cCCCCEEEEeccccccccccccccCCCC
Q psy14630         94 ------------------KEVTVATVKALNYLKEELKIIHRDVKPSNILL--DRRGAIKLCDFGISGQLVDSIAKTRDAG  153 (187)
Q Consensus        94 ------------------~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili--~~~~~~ki~dfg~a~~~~~~~~~~~~~~  153 (187)
                                        ..++.|++.||.|||+. +++||||||+||++  +..+.+||+|||+++............|
T Consensus       172 ~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~-~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~~~~~~g  250 (373)
T 2x4f_A          172 ELFDRIIDESYNLTELDTILFMKQICEGIRHMHQM-YILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKVNFG  250 (373)
T ss_dssp             EEHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCBCCCCCS
T ss_pred             cHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC-CcccccCCHHHEEEecCCCCcEEEEeCCCceecCCccccccccC
Confidence                              11567999999999997 99999999999999  5677899999999998766555555679


Q ss_pred             CcCccCccccCCCccCCCCCCcceeeeEee
Q psy14630        154 CRPYMAPERIDPLRARGYPSFKTKLGFKFN  183 (187)
Q Consensus       154 t~~y~aPE~~~~~~~~~~~~~~D~ws~gi~  183 (187)
                      |+.|+|||++.   ...++.++|+||+|++
T Consensus       251 t~~y~aPE~~~---~~~~~~~~DiwslG~i  277 (373)
T 2x4f_A          251 TPEFLAPEVVN---YDFVSFPTDMWSVGVI  277 (373)
T ss_dssp             SCTTCCHHHHT---TCBCCHHHHHHHHHHH
T ss_pred             CCcEeChhhcc---CCCCCcHHhHHHHHHH
Confidence            99999999987   5668899999999994

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A*

Probab=99.97  E-value=2.4e-33  Score=215.69  Aligned_cols=173  Identities=25%  Similarity=0.233  Sum_probs=128.0

Q ss_pred             cCCceecCCCccccCCcccccccccccccCceEEEEEEEcCCCcEEEEEEccCccChHHHHHHHHHHHHHHhcCCCCchh
Q psy14630          7 SSGKLKLSPDTVYDFTSEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIV   86 (187)
Q Consensus         7 ~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv   86 (187)
                      +.++..-.+...+.+..++|++.+.||+|+||.||+|.+.  ++.||+|+++...   ........+..++..++||||+
T Consensus         7 ~~~~~~~~~~~n~~~~~~~y~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~hpniv   81 (322)
T 3soc_A            7 HHSSGVDLGTENLYFQSMPLQLLEVKARGRFGCVWKAQLL--NEYVAVKIFPIQD---KQSWQNEYEVYSLPGMKHENIL   81 (322)
T ss_dssp             -------CCCCCEEETTEEEEEEEEEECSTTCEEEEEEET--TEEEEEEEECGGG---HHHHHHHHHHHTSTTCCCTTBC
T ss_pred             ccccccccCccccccchhhchhhheecccCceEEEEEEEC--CCEEEEEEeecCc---hHHHHHHHHHHHHhcCCCCCch
Confidence            4455556667778889999999999999999999999875  7899999986422   1222223344566778999999


Q ss_pred             hhhhhHH-----------------------------------HHHHHHHHHHHHHHHhcC---------CCeeecCCCCC
Q psy14630         87 QFYGALF-----------------------------------KEVTVATVKALNYLKEEL---------KIIHRDVKPSN  122 (187)
Q Consensus        87 ~~~~~~~-----------------------------------~~~~~~~~~~l~~lh~~~---------~i~Hrdlk~~n  122 (187)
                      ++++.+.                                   ..++.|++.||.|||+..         +++||||||+|
T Consensus        82 ~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~N  161 (322)
T 3soc_A           82 QFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKANVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKN  161 (322)
T ss_dssp             CEEEEEEEECSSSEEEEEEEECCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGG
T ss_pred             hhcceeccCCCCCceEEEEEecCCCCCHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHh
Confidence            9875321                                   126778999999999742         89999999999


Q ss_pred             eEEcCCCCEEEEecccccccccccc---ccCCCCCcCccCccccCCCcc--CCCCCCcceeeeEeee
Q psy14630        123 ILLDRRGAIKLCDFGISGQLVDSIA---KTRDAGCRPYMAPERIDPLRA--RGYPSFKTKLGFKFNY  184 (187)
Q Consensus       123 ili~~~~~~ki~dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~--~~~~~~~D~ws~gi~~  184 (187)
                      |+++.++.+||+|||+++.......   .....||+.|+|||++.+...  ..++.++|+||||+++
T Consensus       162 ill~~~~~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il  228 (322)
T 3soc_A          162 VLLKNNLTACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVL  228 (322)
T ss_dssp             EEECTTCCEEECCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHH
T ss_pred             EEECCCCeEEEccCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHH
Confidence            9999999999999999987654322   223468999999999884211  2345678999999943

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens}

Probab=99.97  E-value=7.6e-33  Score=214.55  Aligned_cols=163  Identities=21%  Similarity=0.316  Sum_probs=121.6

Q ss_pred             cccCCcccccccccccccCceEEEEEEEcCCCcEEEEEEccCccChHHHHHHHHHHHHHHhcCCC--CchhhhhhhH---
Q psy14630         18 VYDFTSEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNEC--PYIVQFYGAL---   92 (187)
Q Consensus        18 ~~~~~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~h--~~iv~~~~~~---   92 (187)
                      .+++..++|++.+.||+|+||.||++.+ .+++.||+|.+..........+.+.++..+++.+.|  +||+++++.+   
T Consensus         3 ~i~~~~~~y~i~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~   81 (343)
T 3dbq_A            3 CISVKGRIYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITD   81 (343)
T ss_dssp             CEESSSCEEEEEEEESCCSSEEEEEEEC-TTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECS
T ss_pred             eeeeecCEEEEEEEEecCCCeEEEEEEe-CCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeC
Confidence            4456778899999999999999999988 468899999986544444444455555555655554  9999887532   


Q ss_pred             ----------------------------HHHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEeccccccccc
Q psy14630         93 ----------------------------FKEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVD  144 (187)
Q Consensus        93 ----------------------------~~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg~a~~~~~  144 (187)
                                                  ...++.|++.||.|||+. +++||||||+||+++ ++.+||+|||+++....
T Consensus        82 ~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~-~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~  159 (343)
T 3dbq_A           82 QYIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQH-GIVHSDLKPANFLIV-DGMLKLIDFGIANQMQP  159 (343)
T ss_dssp             SEEEEEECCCSEEHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHT-TCCCCCCCGGGEEEE-TTEEEECCCSSSCCC--
T ss_pred             CEEEEEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC-CeecCCCCcceEEEE-CCcEEEeecccccccCc
Confidence                                        112678999999999998 999999999999997 57899999999988754


Q ss_pred             ccc---ccCCCCCcCccCccccCCCc--------cCCCCCCcceeeeEee
Q psy14630        145 SIA---KTRDAGCRPYMAPERIDPLR--------ARGYPSFKTKLGFKFN  183 (187)
Q Consensus       145 ~~~---~~~~~~t~~y~aPE~~~~~~--------~~~~~~~~D~ws~gi~  183 (187)
                      ...   .....||+.|+|||.+.+..        ...++.++|+||+|++
T Consensus       160 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~i  209 (343)
T 3dbq_A          160 DTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCI  209 (343)
T ss_dssp             ----------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHH
T ss_pred             ccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHH
Confidence            322   23457899999999986210        1457889999999994

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A

Probab=99.97  E-value=7.4e-33  Score=217.19  Aligned_cols=157  Identities=13%  Similarity=0.086  Sum_probs=121.6

Q ss_pred             cCCcccccccccccccCceEEEEEEEcCCCcEEEEEEccCcc-ChHHHHHHHHHHH---HHHhcCCCCchhhhhhhH---
Q psy14630         20 DFTSEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTV-DEKDQRQLLMDLD---VVMKSNECPYIVQFYGAL---   92 (187)
Q Consensus        20 ~~~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~~~---~~~~~~~h~~iv~~~~~~---   92 (187)
                      ....++|++.+.||+|+||.||+|.+..+++.||||++.... ......+.+.++.   ..++.+.||||+++++.+   
T Consensus        69 ~~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~  148 (377)
T 3byv_A           69 GERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFP  148 (377)
T ss_dssp             SCCCEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCC
T ss_pred             CCCCceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhh
Confidence            344678999999999999999999998899999999986321 1222334444454   344556899999876210   


Q ss_pred             -----------------------------------------------------------HHHHHHHHHHHHHHHHhcCCC
Q psy14630         93 -----------------------------------------------------------FKEVTVATVKALNYLKEELKI  113 (187)
Q Consensus        93 -----------------------------------------------------------~~~~~~~~~~~l~~lh~~~~i  113 (187)
                                                                                 ...++.|++.||+|||+. ++
T Consensus       149 ~~~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~-~i  227 (377)
T 3byv_A          149 FDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY-GL  227 (377)
T ss_dssp             SEEEECTTSCSEEEC------CEEESEEEEEECCSEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHT-TE
T ss_pred             hhhhhccCCccccccccCCCceEEEEEEEEEeccCCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhC-Ce
Confidence                                                                       012667899999999998 99


Q ss_pred             eeecCCCCCeEEcCCCCEEEEeccccccccccccccCCCCCcCccCccccCCCccC-----------CCCCCcceeeeEe
Q psy14630        114 IHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPLRAR-----------GYPSFKTKLGFKF  182 (187)
Q Consensus       114 ~Hrdlk~~nili~~~~~~ki~dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~-----------~~~~~~D~ws~gi  182 (187)
                      +||||||+||+++.++.+||+|||+++.....  .....| +.|+|||.+.   ..           .++.++|+||||+
T Consensus       228 vHrDikp~NIll~~~~~~kL~DFG~a~~~~~~--~~~~~g-~~y~aPE~~~---~~~~~~~~~~~~~~~~~~~DvwSlG~  301 (377)
T 3byv_A          228 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAR--VVSSVS-RGFEPPELEA---RRATISYHRDRRTLMTFSFDAWALGL  301 (377)
T ss_dssp             ECSCCCGGGEEECTTCCEEECCGGGCEETTCE--EECCCC-TTCCCHHHHH---HHTSTHHHHCCEEECCHHHHHHHHHH
T ss_pred             ecCCCCHHHEEEcCCCCEEEEechhheecCCc--ccCCCC-cCccChhhhc---ccccccccccccccCChhhhHHHHHH
Confidence            99999999999999999999999999864432  233467 8999999998   44           6889999999999


Q ss_pred             e
Q psy14630        183 N  183 (187)
Q Consensus       183 ~  183 (187)
                      +
T Consensus       302 i  302 (377)
T 3byv_A          302 V  302 (377)
T ss_dssp             H
T ss_pred             H
Confidence            4

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A*

Probab=99.97  E-value=2.7e-32  Score=210.86  Aligned_cols=159  Identities=21%  Similarity=0.281  Sum_probs=130.8

Q ss_pred             CCcccccccccccccCceEEEEEEEcCCCcEEEEEEccCcc-ChHHHHHHHHHHHHHHhcCCCCchhhhhhhH-------
Q psy14630         21 FTSEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTV-DEKDQRQLLMDLDVVMKSNECPYIVQFYGAL-------   92 (187)
Q Consensus        21 ~~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~-------   92 (187)
                      ...++|.+.+.||+|+||.||++.+..+++.+|+|++.... ......+.+.++..+++.+.||||+++++.+       
T Consensus        38 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  117 (335)
T 2owb_A           38 RSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVF  117 (335)
T ss_dssp             TTTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred             ccCCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEE
Confidence            45678999999999999999999999999999999986432 2334455566677778888999999987532       


Q ss_pred             -------------------------HHHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEecccccccccc-c
Q psy14630         93 -------------------------FKEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDS-I  146 (187)
Q Consensus        93 -------------------------~~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg~a~~~~~~-~  146 (187)
                                               ...+..|++.||.|||+. +++||||||+||+++.++.+||+|||+++..... .
T Consensus       118 lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~-~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~  196 (335)
T 2owb_A          118 VVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRN-RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGE  196 (335)
T ss_dssp             EEECCCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCCGGGEEECTTCCEEECCCTTCEECCSTTC
T ss_pred             EEEecCCCCCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC-CCEecCCCchhEEEcCCCCEEEeeccCceecccCcc
Confidence                                     112678999999999998 9999999999999999999999999999876532 2


Q ss_pred             cccCCCCCcCccCccccCCCccCCCCCCcceeeeEee
Q psy14630        147 AKTRDAGCRPYMAPERIDPLRARGYPSFKTKLGFKFN  183 (187)
Q Consensus       147 ~~~~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi~  183 (187)
                      ......+++.|+|||.+.   ...++.++|+||+|++
T Consensus       197 ~~~~~~gt~~y~aPE~~~---~~~~~~~~Di~slG~i  230 (335)
T 2owb_A          197 RKKVLCGTPNYIAPEVLS---KKGHSFEVDVWSIGCI  230 (335)
T ss_dssp             CBCCCCSCCSSCCHHHHH---TSCBCTHHHHHHHHHH
T ss_pred             cccccCCCccccCHHHhc---cCCCCchhhHHHHHHH
Confidence            333457899999999998   5668899999999994

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens}

Probab=99.97  E-value=4.5e-32  Score=210.84  Aligned_cols=156  Identities=19%  Similarity=0.304  Sum_probs=125.9

Q ss_pred             cccccccccccccCceEEEEEEEcCCCcEEEEEEccCccChHHHHHHHHHHHHHHhcCCCCchhhhhhhH----------
Q psy14630         23 SEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQFYGAL----------   92 (187)
Q Consensus        23 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~----------   92 (187)
                      .++|.+.+.||+|+||.||+|.+..+++.||+|.+..........+.+.++..+++.++||||+++++.+          
T Consensus        23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  102 (353)
T 3coi_A           23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY  102 (353)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred             CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccce
Confidence            3689999999999999999999999999999999875444444455566666778888999999886532          


Q ss_pred             -------------------------HHHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEecccccccccccc
Q psy14630         93 -------------------------FKEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIA  147 (187)
Q Consensus        93 -------------------------~~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg~a~~~~~~~~  147 (187)
                                               ...++.|++.||.|||+. +++||||||+||+++.++.+||+|||+++.....  
T Consensus       103 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~-~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~--  179 (353)
T 3coi_A          103 DFYLVMPFMQTDLQKIMGLKFSEEKIQYLVYQMLKGLKYIHSA-GVVHRDLKPGNLAVNEDCELKILDFGLARHADAE--  179 (353)
T ss_dssp             CCEEEEECCSEEGGGTTTSCCCHHHHHHHHHHHHHHHHHHHHT-TCCCSSCCGGGEEECTTCCEEECSTTCTTC------
T ss_pred             eEEEEeccccCCHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC-CcccCCCCHHHEeECCCCcEEEeecccccCCCCC--
Confidence                                     122678999999999998 9999999999999999999999999999875433  


Q ss_pred             ccCCCCCcCccCccccCCCccCCCCCCcceeeeEee
Q psy14630        148 KTRDAGCRPYMAPERIDPLRARGYPSFKTKLGFKFN  183 (187)
Q Consensus       148 ~~~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi~  183 (187)
                      .....+|+.|+|||.+.+  ...++.++|+||+|++
T Consensus       180 ~~~~~~t~~y~aPE~~~~--~~~~~~~~Di~slG~i  213 (353)
T 3coi_A          180 MTGYVVTRWYRAPEVILS--WMHYNQTVDIWSVGCI  213 (353)
T ss_dssp             ----CCSBCCSCHHHHSC--CSCCCTTHHHHHHHHH
T ss_pred             ccccccCcCcCCHHHHhC--cCCCCchhhHHHHHHH
Confidence            223468999999999873  2568899999999993

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A

Probab=99.97  E-value=1.5e-32  Score=211.05  Aligned_cols=157  Identities=22%  Similarity=0.284  Sum_probs=128.5

Q ss_pred             cccccccccccccCceEEEEEEEcCCCcEEEEEEccCccChH----HHHHHHHHHHHHHhcCCCCchhhhhhhH------
Q psy14630         23 SEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEK----DQRQLLMDLDVVMKSNECPYIVQFYGAL------   92 (187)
Q Consensus        23 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~----~~~~~~~~~~~~~~~~~h~~iv~~~~~~------   92 (187)
                      .++|++.+.||+|+||.||+|.+..+++.||+|.++......    ...+.+.++..+++.+.||||+++++.+      
T Consensus        11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   90 (321)
T 2a2a_A           11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDV   90 (321)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEE
Confidence            578999999999999999999999999999999986432211    1234455566677788999999886532      


Q ss_pred             --------------------------HHHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCC----CEEEEeccccccc
Q psy14630         93 --------------------------FKEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRG----AIKLCDFGISGQL  142 (187)
Q Consensus        93 --------------------------~~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~----~~ki~dfg~a~~~  142 (187)
                                                ...++.|++.||.|||+. +++||||||+||+++.++    .+||+|||+++..
T Consensus        91 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~-~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~~~~  169 (321)
T 2a2a_A           91 VLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTK-KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI  169 (321)
T ss_dssp             EEEECCCCSCBHHHHHHTCSCEEHHHHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEESCTTSSSCCEEECCCTTCEEC
T ss_pred             EEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC-CeecCCCChHHEEEecCCCCcCCEEEccCccceec
Confidence                                      112678999999999998 999999999999999887    7999999999887


Q ss_pred             cccccccCCCCCcCccCccccCCCccCCCCCCcceeeeEee
Q psy14630        143 VDSIAKTRDAGCRPYMAPERIDPLRARGYPSFKTKLGFKFN  183 (187)
Q Consensus       143 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi~  183 (187)
                      ..........||+.|+|||.+.   ...++.++|+||+|++
T Consensus       170 ~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Di~slG~i  207 (321)
T 2a2a_A          170 EDGVEFKNIFGTPEFVAPEIVN---YEPLGLEADMWSIGVI  207 (321)
T ss_dssp             CTTCCCCCCCSCGGGCCHHHHT---TCCCCTHHHHHHHHHH
T ss_pred             CccccccccCCCCCccCccccc---CCCCCCccccHHHHHH
Confidence            6654445557899999999998   5678899999999993

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ...

Probab=99.97  E-value=2e-32  Score=211.35  Aligned_cols=170  Identities=25%  Similarity=0.373  Sum_probs=129.9

Q ss_pred             CceecCCCccccCCcccccccccccccCceEEEEEEEc-------CCCcEEEEEEccCccChHHHHHHHHHHHHHHhcC-
Q psy14630          9 GKLKLSPDTVYDFTSEDLQDLGEIGRGGFGTVNKMIHR-------SSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSN-   80 (187)
Q Consensus         9 ~~~~~~~~~~~~~~~~~~~~~~~lg~G~fg~V~~~~~~-------~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~-   80 (187)
                      ++...+....|++..++|++.+.||+|+||.||+|.+.       .+++.||+|+++............ ++..+++.+ 
T Consensus        20 s~~~~~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~-~E~~~l~~l~   98 (334)
T 2pvf_A           20 SEYELPEDPKWEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLV-SEMEMMKMIG   98 (334)
T ss_dssp             ---CCCCCTTTBCCGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHH-HHHHHHHHHC
T ss_pred             ccccCCCCccccCCHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHH-HHHHHHHHhh
Confidence            44556677889999999999999999999999999875       456789999987554443333444 444455555 


Q ss_pred             CCCchhhhhhhHH------------------------------------------------HHHHHHHHHHHHHHHhcCC
Q psy14630         81 ECPYIVQFYGALF------------------------------------------------KEVTVATVKALNYLKEELK  112 (187)
Q Consensus        81 ~h~~iv~~~~~~~------------------------------------------------~~~~~~~~~~l~~lh~~~~  112 (187)
                      .||||+++++.+.                                                ..++.|++.||.|||+. +
T Consensus        99 ~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~-~  177 (334)
T 2pvf_A           99 KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ-K  177 (334)
T ss_dssp             CCTTBCCEEEEECSSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHT-T
T ss_pred             cCCCEeeEEEEEccCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC-C
Confidence            8999998764210                                                12567899999999998 9


Q ss_pred             CeeecCCCCCeEEcCCCCEEEEeccccccccccc---cccCCCCCcCccCccccCCCccCCCCCCcceeeeEee
Q psy14630        113 IIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSI---AKTRDAGCRPYMAPERIDPLRARGYPSFKTKLGFKFN  183 (187)
Q Consensus       113 i~Hrdlk~~nili~~~~~~ki~dfg~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi~  183 (187)
                      ++||||||+||+++.++.+||+|||+++......   ......+++.|+|||.+.   ...++.++|+||+|++
T Consensus       178 ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~Di~slG~i  248 (334)
T 2pvf_A          178 CIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALF---DRVYTHQSDVWSFGVL  248 (334)
T ss_dssp             EECSCCSGGGEEECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHH---HCEECHHHHHHHHHHH
T ss_pred             eeCCCCccceEEEcCCCCEEEccccccccccccccccccCCCCcccceeChHHhc---CCCcChHHHHHHHHHH
Confidence            9999999999999999999999999998765432   122335678899999987   5568899999999994

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ...

Probab=99.97  E-value=1.7e-32  Score=206.65  Aligned_cols=160  Identities=26%  Similarity=0.373  Sum_probs=126.3

Q ss_pred             ccCCcccccccccccccCceEEEEEEEcCCCcEEEEEEccCccC-hHHHHHHHHHHHHHHhcCCCCchhhhhhhH-----
Q psy14630         19 YDFTSEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVD-EKDQRQLLMDLDVVMKSNECPYIVQFYGAL-----   92 (187)
Q Consensus        19 ~~~~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~-----   92 (187)
                      ..+..++|++.+.||+|+||.||+|.+..+++.||+|.+..... .......+.++..+++.+.||||+++++.+     
T Consensus         4 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   83 (279)
T 3fdn_A            4 RQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATR   83 (279)
T ss_dssp             CCCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred             ceeecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCE
Confidence            34567899999999999999999999999999999999853211 111234456667778888999999887532     


Q ss_pred             ---------------------------HHHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEecccccccccc
Q psy14630         93 ---------------------------FKEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDS  145 (187)
Q Consensus        93 ---------------------------~~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg~a~~~~~~  145 (187)
                                                 ...+..|++.|+.|||+. +++||||||+||+++.++.++|+|||++......
T Consensus        84 ~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~-~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~~  162 (279)
T 3fdn_A           84 VYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSK-RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS  162 (279)
T ss_dssp             EEEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTT-TCEECCCCGGGEEECTTSCEEECSCCEESCC---
T ss_pred             EEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC-CEecccCChHhEEEcCCCCEEEEeccccccCCcc
Confidence                                       112678899999999997 9999999999999999999999999998665433


Q ss_pred             ccccCCCCCcCccCccccCCCccCCCCCCcceeeeEee
Q psy14630        146 IAKTRDAGCRPYMAPERIDPLRARGYPSFKTKLGFKFN  183 (187)
Q Consensus       146 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi~  183 (187)
                      . .....+++.|+|||.+.   ...++.++|+||+|++
T Consensus       163 ~-~~~~~~~~~y~aPE~~~---~~~~~~~~Di~slG~i  196 (279)
T 3fdn_A          163 R-RTDLCGTLDYLPPEMIE---GRMHDEKVDLWSLGVL  196 (279)
T ss_dssp             ------CCCCTTCCHHHHT---TCCCCTTHHHHHHHHH
T ss_pred             c-ccccCCCCCccCHhHhc---cCCCCccchhHhHHHH
Confidence            2 23347899999999998   5668899999999994

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A

Probab=99.97  E-value=2.5e-32  Score=213.23  Aligned_cols=160  Identities=18%  Similarity=0.229  Sum_probs=121.5

Q ss_pred             cCCcccccccccccccCceEEEEEEEcCC-----CcEEEEEEccCccChHH-HHH--------HHHHHHHHHhcCCCCch
Q psy14630         20 DFTSEDLQDLGEIGRGGFGTVNKMIHRSS-----DTVMAVKRIRSTVDEKD-QRQ--------LLMDLDVVMKSNECPYI   85 (187)
Q Consensus        20 ~~~~~~~~~~~~lg~G~fg~V~~~~~~~~-----~~~vaiK~~~~~~~~~~-~~~--------~~~~~~~~~~~~~h~~i   85 (187)
                      +...++|++.+.||+|+||.||+|.+..+     ++.||+|++........ ..+        ....+...+..+.||||
T Consensus        31 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~i  110 (364)
T 3op5_A           31 DMAAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGV  110 (364)
T ss_dssp             CTTCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCS
T ss_pred             ccCCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCC
Confidence            46677999999999999999999998664     57899999864321111 011        11122334567789999


Q ss_pred             hhhhhhHH------------------------------------HHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEc--C
Q psy14630         86 VQFYGALF------------------------------------KEVTVATVKALNYLKEELKIIHRDVKPSNILLD--R  127 (187)
Q Consensus        86 v~~~~~~~------------------------------------~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~--~  127 (187)
                      +++++.+.                                    ..++.|++.||.|||+. +++||||||+||+++  .
T Consensus       111 v~~~~~~~~~~~~~~~~~lv~e~~g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~-~iiHrDlkp~Nill~~~~  189 (364)
T 3op5_A          111 PKYWGSGLHDKNGKSYRFMIMDRFGSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEH-EYVHGDIKASNLLLNYKN  189 (364)
T ss_dssp             CCEEEEEEEEETTEEEEEEEEECEEEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCCGGGEEEESSC
T ss_pred             CeEEeeeeeccCCcceEEEEEeCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC-CeEEecCCHHHEEEecCC
Confidence            98865321                                    12678999999999998 999999999999998  8


Q ss_pred             CCCEEEEeccccccccccccc--------cCCCCCcCccCccccCCCccCCCCCCcceeeeEee
Q psy14630        128 RGAIKLCDFGISGQLVDSIAK--------TRDAGCRPYMAPERIDPLRARGYPSFKTKLGFKFN  183 (187)
Q Consensus       128 ~~~~ki~dfg~a~~~~~~~~~--------~~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi~  183 (187)
                      ++.+||+|||+++.+......        ....||+.|+|||.+.   ...++.++|+||||++
T Consensus       190 ~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Di~slG~~  250 (364)
T 3op5_A          190 PDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHN---GVAPSRRGDLEILGYC  250 (364)
T ss_dssp             TTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHT---TCCCCHHHHHHHHHHH
T ss_pred             CCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhC---CCCCCchhhHHHHHHH
Confidence            899999999999876543211        2335899999999998   5668999999999994

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A

Probab=99.97  E-value=2.8e-32  Score=205.69  Aligned_cols=165  Identities=24%  Similarity=0.339  Sum_probs=126.6

Q ss_pred             eecCCCccccCCcccccccccccccCceEEEEEEEcCCCcEEEEEEccCccChHHHHHHHHHHHHHHhcCCCCchhhhhh
Q psy14630         11 LKLSPDTVYDFTSEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQFYG   90 (187)
Q Consensus        11 ~~~~~~~~~~~~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~   90 (187)
                      ........|++..++|++.+.||+|+||.||+|.+. ++..||+|.++......   +.+.++..+++.+.||||+++++
T Consensus        11 ~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~---~~~~~E~~~l~~l~h~~i~~~~~   86 (283)
T 3gen_A           11 TAGLGYGSWEIDPKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMSE---DEFIEEAKVMMNLSHEKLVQLYG   86 (283)
T ss_dssp             -----CCTTBCCGGGEEEEEECC---CEEEEEEEET-TTEEEEEEEECTTSBCH---HHHHHHHHHHHTCCCTTBCCEEE
T ss_pred             ccCCCCCCccCCHHHHHhHhhcCCCCCceEEEEEEc-CCCeEEEEEecCCCCCH---HHHHHHHHHHhcCCCCCEeeEEE
Confidence            333445778899999999999999999999999885 67789999987543322   23455666777889999998875


Q ss_pred             hH---------------------------------HHHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEecc
Q psy14630         91 AL---------------------------------FKEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFG  137 (187)
Q Consensus        91 ~~---------------------------------~~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg  137 (187)
                      .+                                 ...++.|++.|+.|||+. +++||||||+||+++.++.++|+|||
T Consensus        87 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~-~i~H~dikp~Nili~~~~~~kl~Dfg  165 (283)
T 3gen_A           87 VCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESK-QFLHRDLAARNCLVNDQGVVKVSDFG  165 (283)
T ss_dssp             EECSSSSEEEEECCCTTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHHHT-TCCCSSCSGGGEEECTTSCEEECSTT
T ss_pred             EEecCCCeEEEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHC-CccCCCCccceEEEcCCCCEEEcccc
Confidence            32                                 112678999999999998 99999999999999999999999999


Q ss_pred             cccccccccc--ccCCCCCcCccCccccCCCccCCCCCCcceeeeEee
Q psy14630        138 ISGQLVDSIA--KTRDAGCRPYMAPERIDPLRARGYPSFKTKLGFKFN  183 (187)
Q Consensus       138 ~a~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi~  183 (187)
                      +++.......  .....+|+.|+|||.+.   ...++.++|+||+|++
T Consensus       166 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~Dv~slG~~  210 (283)
T 3gen_A          166 LSRYVLDDEYTSSVGSKFPVRWSPPEVLM---YSKFSSKSDIWAFGVL  210 (283)
T ss_dssp             GGGGBCCHHHHSTTSTTSCGGGCCHHHHH---HCCCSHHHHHHHHHHH
T ss_pred             ccccccccccccccCCccCcccCCHHHhc---cCCCCchhhHHHHHHH
Confidence            9987654321  22234677899999998   5678899999999994

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus}

Probab=99.97  E-value=1e-32  Score=211.84  Aligned_cols=164  Identities=18%  Similarity=0.271  Sum_probs=115.0

Q ss_pred             CccccCCcccccccccccccCceEEEEEEEcCCCc---EEEEEEccCccChHHHHHHHHHHHHHHhcCCCCchhhhhhhH
Q psy14630         16 DTVYDFTSEDLQDLGEIGRGGFGTVNKMIHRSSDT---VMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQFYGAL   92 (187)
Q Consensus        16 ~~~~~~~~~~~~~~~~lg~G~fg~V~~~~~~~~~~---~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~   92 (187)
                      ...+.+..++|++.+.||+|+||.||+|.+..++.   .||+|.++.........+.+.++..+++.++||||+++++.+
T Consensus        15 ~~~~~i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~   94 (323)
T 3qup_A           15 LEDVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVS   94 (323)
T ss_dssp             -CTTBCC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEE
T ss_pred             hhhcccChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhcee
Confidence            34456788899999999999999999999876664   799999875433333445566667778888999999876421


Q ss_pred             --------------------------------------------HHHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCC
Q psy14630         93 --------------------------------------------FKEVTVATVKALNYLKEELKIIHRDVKPSNILLDRR  128 (187)
Q Consensus        93 --------------------------------------------~~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~  128 (187)
                                                                  ...++.|++.||.|||+. +++||||||+||+++.+
T Consensus        95 ~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~-~ivH~Dikp~NIli~~~  173 (323)
T 3qup_A           95 LRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSR-NFIHRDLAARNCMLAED  173 (323)
T ss_dssp             ECC-------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCSGGGEEECTT
T ss_pred             eccccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcC-CcccCCCCcceEEEcCC
Confidence                                                        012567899999999998 99999999999999999


Q ss_pred             CCEEEEeccccccccccccc---cCCCCCcCccCccccCCCccCCCCCCcceeeeEee
Q psy14630        129 GAIKLCDFGISGQLVDSIAK---TRDAGCRPYMAPERIDPLRARGYPSFKTKLGFKFN  183 (187)
Q Consensus       129 ~~~ki~dfg~a~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi~  183 (187)
                      +.+||+|||+++........   ....+++.|+|||.+.   ...++.++|+||+|++
T Consensus       174 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~Di~slG~i  228 (323)
T 3qup_A          174 MTVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLA---DNLYTVHSDVWAFGVT  228 (323)
T ss_dssp             SCEEECCCCC-----------------CCGGGCCHHHHH---HCCCCHHHHHHHHHHH
T ss_pred             CCEEEeeccccccccccccccccccccCcccccCchhhc---CCCCCCccchhhHHHH
Confidence            99999999999876443221   2234677899999998   6678999999999993

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A*

Probab=99.97  E-value=2.2e-32  Score=208.85  Aligned_cols=169  Identities=25%  Similarity=0.355  Sum_probs=132.8

Q ss_pred             ceecCCCccccCCcccccccccccccCceEEEEEEE-----cCCCcEEEEEEccCccChHHHHHHHHHHHHHHhcC-CCC
Q psy14630         10 KLKLSPDTVYDFTSEDLQDLGEIGRGGFGTVNKMIH-----RSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSN-ECP   83 (187)
Q Consensus        10 ~~~~~~~~~~~~~~~~~~~~~~lg~G~fg~V~~~~~-----~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~-~h~   83 (187)
                      +...+....|++..++|++.+.||+|+||.||+|.+     ..+++.||+|.++....... .+.+.++..+++.+ .||
T Consensus         9 ~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~-~~~~~~E~~~l~~l~~h~   87 (313)
T 1t46_A            9 PTQLPYDHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTE-REALMSELKVLSYLGNHM   87 (313)
T ss_dssp             TTTSCCCGGGBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHH-HHHHHHHHHHHHHHCCCT
T ss_pred             cccCCCccccccChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHH-HHHHHHHHHHHhhcccCC
Confidence            344566788999999999999999999999999984     45778999999875433333 34444555555566 899


Q ss_pred             chhhhhhhH--------------------------------------------------HHHHHHHHHHHHHHHHhcCCC
Q psy14630         84 YIVQFYGAL--------------------------------------------------FKEVTVATVKALNYLKEELKI  113 (187)
Q Consensus        84 ~iv~~~~~~--------------------------------------------------~~~~~~~~~~~l~~lh~~~~i  113 (187)
                      ||+++++.+                                                  ...++.|++.||.|||+. ++
T Consensus        88 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~-~i  166 (313)
T 1t46_A           88 NIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK-NC  166 (313)
T ss_dssp             TBCCEEEEECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT-TC
T ss_pred             CeeeEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHC-Ce
Confidence            999876421                                                  012567899999999998 99


Q ss_pred             eeecCCCCCeEEcCCCCEEEEecccccccccccc---ccCCCCCcCccCccccCCCccCCCCCCcceeeeEee
Q psy14630        114 IHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIA---KTRDAGCRPYMAPERIDPLRARGYPSFKTKLGFKFN  183 (187)
Q Consensus       114 ~Hrdlk~~nili~~~~~~ki~dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi~  183 (187)
                      +||||||+||+++.++.+||+|||+++.......   .....+++.|+|||.+.   ...++.++|+||+|++
T Consensus       167 ~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~Di~slG~i  236 (313)
T 1t46_A          167 IHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIF---NCVYTFESDVWSYGIF  236 (313)
T ss_dssp             CCSCCSGGGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHH---HCCCCHHHHHHHHHHH
T ss_pred             ecCCCccceEEEcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhc---CCCCChHHHHHHHHHH
Confidence            9999999999999999999999999987654322   22334677899999987   5678899999999993

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A*

Probab=99.97  E-value=1.2e-32  Score=207.71  Aligned_cols=163  Identities=26%  Similarity=0.405  Sum_probs=119.3

Q ss_pred             CccccCCcccccccccccccCceEEEEEEEcCC---CcEEEEEEccCccChHHHHHHHHHHHHHHhcCCCCchhhhhhhH
Q psy14630         16 DTVYDFTSEDLQDLGEIGRGGFGTVNKMIHRSS---DTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQFYGAL   92 (187)
Q Consensus        16 ~~~~~~~~~~~~~~~~lg~G~fg~V~~~~~~~~---~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~   92 (187)
                      ...+++..++|++.+.||+|+||.||+|.+..+   +..||+|.++..... ...+.+.++...++.++||||+++++.+
T Consensus         7 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~   85 (281)
T 1mp8_A            7 TRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSD-SVREKFLQEALTMRQFDHPHIVKLIGVI   85 (281)
T ss_dssp             --CCBCCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSH-HHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred             ccceEEehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCH-HHHHHHHHHHHHHHhCCCCccceEEEEE
Confidence            345788899999999999999999999998643   456999998754333 3344556666677888999999887532


Q ss_pred             H--------------------------------HHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEeccccc
Q psy14630         93 F--------------------------------KEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISG  140 (187)
Q Consensus        93 ~--------------------------------~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg~a~  140 (187)
                      .                                ..++.|++.||.|||+. +++||||||+||+++.++.+||+|||+++
T Consensus        86 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~-~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~  164 (281)
T 1mp8_A           86 TENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESK-RFVHRDIAARNVLVSSNDCVKLGDFGLSR  164 (281)
T ss_dssp             CSSSCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCSGGGEEEEETTEEEECC-----
T ss_pred             ccCccEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC-CeecccccHHHEEECCCCCEEECcccccc
Confidence            1                                12567899999999998 99999999999999999999999999998


Q ss_pred             cccccccc--cCCCCCcCccCccccCCCccCCCCCCcceeeeEee
Q psy14630        141 QLVDSIAK--TRDAGCRPYMAPERIDPLRARGYPSFKTKLGFKFN  183 (187)
Q Consensus       141 ~~~~~~~~--~~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi~  183 (187)
                      ........  ....+++.|+|||.+.   ...++.++|+||+|++
T Consensus       165 ~~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~Di~slG~~  206 (281)
T 1mp8_A          165 YMEDSTYYKASKGKLPIKWMAPESIN---FRRFTSASDVWMFGVC  206 (281)
T ss_dssp             --------------CCGGGCCHHHHH---HCCCSHHHHHHHHHHH
T ss_pred             ccCcccccccccCCCcccccChhhcc---cCCCCCccCchHHHHH
Confidence            76543221  2234677899999998   6678899999999983

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A*

Probab=99.97  E-value=5.6e-32  Score=205.18  Aligned_cols=160  Identities=21%  Similarity=0.278  Sum_probs=131.3

Q ss_pred             cCCcccccccccccccCceEEEEEEEcCCCcEEEEEEccCcc-ChHHHHHHHHHHHHHHhcCCCCchhhhhhhH------
Q psy14630         20 DFTSEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTV-DEKDQRQLLMDLDVVMKSNECPYIVQFYGAL------   92 (187)
Q Consensus        20 ~~~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~------   92 (187)
                      ....++|.+.+.||+|+||.||+|.+..+++.+|+|++.... ......+.+.++..+++.+.||||+++++.+      
T Consensus        11 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~   90 (294)
T 2rku_A           11 PRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFV   90 (294)
T ss_dssp             TTTTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEE
T ss_pred             CCcccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEE
Confidence            356689999999999999999999999999999999986432 2334455566667778888999999987532      


Q ss_pred             --------------------------HHHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEecccccccccc-
Q psy14630         93 --------------------------FKEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDS-  145 (187)
Q Consensus        93 --------------------------~~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg~a~~~~~~-  145 (187)
                                                ...+..|++.|+.|||+. +++||||||+||+++.++.+||+|||++...... 
T Consensus        91 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~-~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~  169 (294)
T 2rku_A           91 FVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRN-RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDG  169 (294)
T ss_dssp             EEEEECCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCCGGGEEECTTCCEEECCCTTCEECCSTT
T ss_pred             EEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC-CccccCCChHhEEEcCCCCEEEEeccCceecccCc
Confidence                                      112677899999999998 9999999999999999999999999999876432 


Q ss_pred             ccccCCCCCcCccCccccCCCccCCCCCCcceeeeEee
Q psy14630        146 IAKTRDAGCRPYMAPERIDPLRARGYPSFKTKLGFKFN  183 (187)
Q Consensus       146 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi~  183 (187)
                      .......+++.|+|||.+.   ...++.++|+||+|+.
T Consensus       170 ~~~~~~~~~~~y~aPE~~~---~~~~~~~~Di~slG~~  204 (294)
T 2rku_A          170 ERKKVLCGTPNYIAPEVLS---KKGHSFEVDVWSIGCI  204 (294)
T ss_dssp             CCBCCCCSCCSSCCHHHHT---TSCBCTHHHHHHHHHH
T ss_pred             cccccccCCCCcCCcchhc---cCCCCchhhHHHHHHH
Confidence            2233456899999999998   5668899999999993

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A*

Probab=99.97  E-value=5.5e-33  Score=224.31  Aligned_cols=160  Identities=24%  Similarity=0.411  Sum_probs=129.5

Q ss_pred             cCCcccccccccccccCceEEEEEEEcCCCcEEEEEEccCcc-ChHHHHHHHHHHHHHHhcCCCCchhhhhhhH------
Q psy14630         20 DFTSEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTV-DEKDQRQLLMDLDVVMKSNECPYIVQFYGAL------   92 (187)
Q Consensus        20 ~~~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~------   92 (187)
                      ....++|++.+.||+|+||.||+|.+..+++.||+|++.... ......+.+.++..+++.++||||+++++.+      
T Consensus        22 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~  101 (484)
T 3nyv_A           22 AIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYF  101 (484)
T ss_dssp             CCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred             CcccCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence            344678999999999999999999999999999999985432 1122334555666678888999999987532      


Q ss_pred             --------------------------HHHHHHHHHHHHHHHHhcCCCeeecCCCCCeEE---cCCCCEEEEecccccccc
Q psy14630         93 --------------------------FKEVTVATVKALNYLKEELKIIHRDVKPSNILL---DRRGAIKLCDFGISGQLV  143 (187)
Q Consensus        93 --------------------------~~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili---~~~~~~ki~dfg~a~~~~  143 (187)
                                                ...++.|++.||.|||+. +++||||||+||++   +.++.+||+|||+++...
T Consensus       102 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~-~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~  180 (484)
T 3nyv_A          102 YLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKN-KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFE  180 (484)
T ss_dssp             EEEECCCCSCBHHHHHHTCSCCBHHHHHHHHHHHHHHHHHHHHT-TCCCSCCCGGGEEESSSSTTCCEEECCTTHHHHBC
T ss_pred             EEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC-CeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEcc
Confidence                                      112778999999999998 99999999999999   467889999999998876


Q ss_pred             ccccccCCCCCcCccCccccCCCccCCCCCCcceeeeEeee
Q psy14630        144 DSIAKTRDAGCRPYMAPERIDPLRARGYPSFKTKLGFKFNY  184 (187)
Q Consensus       144 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi~~  184 (187)
                      .........||+.|+|||++.   . .++.++|+||+|+++
T Consensus       181 ~~~~~~~~~gt~~y~aPE~~~---~-~~~~~~DiwslG~il  217 (484)
T 3nyv_A          181 ASKKMKDKIGTAYYIAPEVLH---G-TYDEKCDVWSTGVIL  217 (484)
T ss_dssp             CCCSHHHHTTGGGTCCHHHHH---T-CCCTHHHHHHHHHHH
T ss_pred             cccccccCCCCccccCceeec---C-CCCCcceeHHHHHHH
Confidence            554444457999999999987   3 488999999999943

>4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=99.97  E-value=1.9e-32  Score=205.32  Aligned_cols=159  Identities=25%  Similarity=0.370  Sum_probs=127.4

Q ss_pred             ccccCCcccccccccccccCceEEEEEEEcCCCcEEEEEEccCccChHHHHHHHHHHHHHHhcCCCCchhhhhhhHH---
Q psy14630         17 TVYDFTSEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQFYGALF---   93 (187)
Q Consensus        17 ~~~~~~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~---   93 (187)
                      ..|.+..++|++.+.||+|+||.||+|.+. +++.||+|.+.......   +.+.++..+++.++||||+++++.+.   
T Consensus         3 ~~~~i~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~---~~~~~E~~~l~~l~h~~i~~~~~~~~~~~   78 (269)
T 4hcu_A            3 GKWVIDPSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMSE---EDFIEEAEVMMKLSHPKLVQLYGVCLEQA   78 (269)
T ss_dssp             --CBCCGGGEEEEEEEEECSSCEEEEEEET-TTEEEEEEEECTTSBCH---HHHHHHHHHHHTCCCTTBCCEEEEECSSS
T ss_pred             ccEEeChhhceeeheecCCCccEEEEEEec-CCCeEEEEEecccccCH---HHHHHHHHHHHhCCCCCEeeEEEEEecCC
Confidence            457888999999999999999999999986 46789999987543322   33555666777889999999875321   


Q ss_pred             ------------------------------HHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEecccccccc
Q psy14630         94 ------------------------------KEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLV  143 (187)
Q Consensus        94 ------------------------------~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg~a~~~~  143 (187)
                                                    ..+..|++.|+.|||+. +++||||||+||+++.++.++|+|||+++...
T Consensus        79 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~-~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~  157 (269)
T 4hcu_A           79 PICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEA-CVIHRDLAARNCLVGENQVIKVSDFGMTRFVL  157 (269)
T ss_dssp             SEEEEEECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCCGGGEEECGGGCEEECCTTGGGGBC
T ss_pred             ceEEEEEeCCCCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHHhC-CeecCCcchheEEEcCCCCEEecccccccccc
Confidence                                          12667899999999998 99999999999999999999999999998765


Q ss_pred             ccc--cccCCCCCcCccCccccCCCccCCCCCCcceeeeEee
Q psy14630        144 DSI--AKTRDAGCRPYMAPERIDPLRARGYPSFKTKLGFKFN  183 (187)
Q Consensus       144 ~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi~  183 (187)
                      ...  ......+++.|+|||.+.   ...++.++|+||+|+.
T Consensus       158 ~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~Di~slG~~  196 (269)
T 4hcu_A          158 DDQYTSSTGTKFPVKWASPEVFS---FSRYSSKSDVWSFGVL  196 (269)
T ss_dssp             CHHHHSTTSTTCCGGGCCHHHHH---HCCCCHHHHHHHHHHH
T ss_pred             ccccccccCcccccccCCHHHhc---CCCCCchhhhHHHHHH
Confidence            432  222335677899999997   6678999999999993

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A*

Probab=99.97  E-value=2.1e-32  Score=210.39  Aligned_cols=153  Identities=29%  Similarity=0.442  Sum_probs=124.8

Q ss_pred             cccccccccccCceEEEEEEEcCCCcEEEEEEccCccChHHHHHHHHHHHHHHhcCCCCchhhhhhhH------------
Q psy14630         25 DLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQFYGAL------------   92 (187)
Q Consensus        25 ~~~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~------------   92 (187)
                      .|+..+.||+|+||.||+|.+..+++.||||++......  ..+.+.++..+++.++||||+++++.+            
T Consensus        46 ~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  123 (321)
T 2c30_A           46 LLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQ--RRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEF  123 (321)
T ss_dssp             HEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCC--SHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred             hhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchh--HHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEec
Confidence            366678999999999999999889999999998643222  233455666678888999999887532            


Q ss_pred             -------------------HHHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEeccccccccccc-cccCCC
Q psy14630         93 -------------------FKEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSI-AKTRDA  152 (187)
Q Consensus        93 -------------------~~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg~a~~~~~~~-~~~~~~  152 (187)
                                         ...+..|++.||.|||+. +++||||||+||+++.++.+||+|||+++...... ......
T Consensus       124 ~~~~~L~~~l~~~~l~~~~~~~i~~qi~~~L~~LH~~-~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~  202 (321)
T 2c30_A          124 LQGGALTDIVSQVRLNEEQIATVCEAVLQALAYLHAQ-GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLV  202 (321)
T ss_dssp             CCSCBHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSCCBCCCC
T ss_pred             CCCCCHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHC-CeecCCCCHHHEEECCCCcEEEeeeeeeeecccCcccccccc
Confidence                               122678999999999997 99999999999999999999999999998765432 233457


Q ss_pred             CCcCccCccccCCCccCCCCCCcceeeeEee
Q psy14630        153 GCRPYMAPERIDPLRARGYPSFKTKLGFKFN  183 (187)
Q Consensus       153 ~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi~  183 (187)
                      ||+.|+|||.+.   ...++.++|+||+|++
T Consensus       203 gt~~y~aPE~~~---~~~~~~~~Dv~slG~i  230 (321)
T 2c30_A          203 GTPYWMAPEVIS---RSLYATEVDIWSLGIM  230 (321)
T ss_dssp             SCGGGCCHHHHT---TCCBCTHHHHHHHHHH
T ss_pred             CCccccCHhhhc---CCCCCchhhHHHHHHH
Confidence            899999999998   5678899999999994

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A*

Probab=99.97  E-value=1e-32  Score=212.60  Aligned_cols=153  Identities=20%  Similarity=0.234  Sum_probs=121.5

Q ss_pred             cccccccccccccCceEEEEEEEcCCCcEEEEEEccCccChHHHHHHHHHHHHHHhcC-CCCchhhhhhhH---------
Q psy14630         23 SEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSN-ECPYIVQFYGAL---------   92 (187)
Q Consensus        23 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~-~h~~iv~~~~~~---------   92 (187)
                      .++|++.+.||+|+||.||+|.+..+++.||+|++.......    .+..+..+++.+ +||||+++++.+         
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~----~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv   83 (330)
T 2izr_A            8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAP----QLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMV   83 (330)
T ss_dssp             TTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCSSC----CHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEE
T ss_pred             cCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccchH----HHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEE
Confidence            478999999999999999999999999999999986432211    233344445555 899999876421         


Q ss_pred             -----------------------HHHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCC-----EEEEeccccccccc
Q psy14630         93 -----------------------FKEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGA-----IKLCDFGISGQLVD  144 (187)
Q Consensus        93 -----------------------~~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~-----~ki~dfg~a~~~~~  144 (187)
                                             ...++.|++.||.|||+. +++||||||+||+++.++.     +||+|||+++....
T Consensus        84 ~e~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~-~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~~~  162 (330)
T 2izr_A           84 LELLGPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSK-NLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYID  162 (330)
T ss_dssp             EECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEESBC
T ss_pred             EEeCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhC-CeeccCCCHHHeeeccCCCCCCceEEEEEcccceeeec
Confidence                                   112678999999999998 9999999999999998877     99999999987654


Q ss_pred             ccc--------ccCCCCCcCccCccccCCCccCCCCCCcceeeeEee
Q psy14630        145 SIA--------KTRDAGCRPYMAPERIDPLRARGYPSFKTKLGFKFN  183 (187)
Q Consensus       145 ~~~--------~~~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi~  183 (187)
                      ...        .....||+.|+|||.+.   ...++.++|+||||++
T Consensus       163 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Di~slG~i  206 (330)
T 2izr_A          163 PETKKHIPYREHKSLTGTARYMSINTHL---GKEQSRRDDLEALGHM  206 (330)
T ss_dssp             TTTCCBCCCCCCCCCCSCTTTCCHHHHT---TCCCCHHHHHHHHHHH
T ss_pred             CCCCccccccccCCcCCCccccChHHHc---CCCCCchhHHHHHHHH
Confidence            322        23457899999999998   6678999999999994

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A*

Probab=99.97  E-value=3.2e-32  Score=217.04  Aligned_cols=153  Identities=25%  Similarity=0.340  Sum_probs=119.4

Q ss_pred             cccccccccccccCceEEEEEEEcCCCcEEEEEEccCccChHHHHHHHHHHHHHHhc------CCCCchhhhhhhH----
Q psy14630         23 SEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKS------NECPYIVQFYGAL----   92 (187)
Q Consensus        23 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~------~~h~~iv~~~~~~----   92 (187)
                      ..+|++.+.||+|+||.||+|.+..+++.||+|+++..   ....+...++..+++.      ..|+||+++++.+    
T Consensus        96 ~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~---~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~  172 (429)
T 3kvw_A           96 AYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE---KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRN  172 (429)
T ss_dssp             TTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC---HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETT
T ss_pred             cCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc---cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCC
Confidence            45799999999999999999999999999999998742   1222222222222222      3678998876422    


Q ss_pred             -----------------------------HHHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCC--EEEEecccccc
Q psy14630         93 -----------------------------FKEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGA--IKLCDFGISGQ  141 (187)
Q Consensus        93 -----------------------------~~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~--~ki~dfg~a~~  141 (187)
                                                   ...++.|++.||.|||+. +++||||||+||+++.++.  +||+|||++..
T Consensus       173 ~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~-~ivHrDlKp~NILl~~~~~~~vkL~DFG~a~~  251 (429)
T 3kvw_A          173 HICMTFELLSMNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKN-RIIHCDLKPENILLKQQGRSGIKVIDFGSSCY  251 (429)
T ss_dssp             EEEEEECCCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHH-TEECSCCSGGGEEESSTTSCCEEECCCTTCEE
T ss_pred             eEEEEEeccCCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC-CeecCCCCHHHeEEccCCCcceEEeeccccee
Confidence                                         123778999999999998 9999999999999999887  99999999976


Q ss_pred             ccccccccCCCCCcCccCccccCCCccCCCCCCcceeeeEeee
Q psy14630        142 LVDSIAKTRDAGCRPYMAPERIDPLRARGYPSFKTKLGFKFNY  184 (187)
Q Consensus       142 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi~~  184 (187)
                      ....  .....+|+.|+|||++.   ...++.++|+||||+++
T Consensus       252 ~~~~--~~~~~gt~~y~aPE~~~---~~~~~~~~DiwSlG~il  289 (429)
T 3kvw_A          252 EHQR--VYTYIQSRFYRAPEVIL---GARYGMPIDMWSLGCIL  289 (429)
T ss_dssp             TTCC--CCSSCSCGGGCCHHHHH---TBCCCTHHHHHHHHHHH
T ss_pred             cCCc--ccccCCCCCccChHHHh---CCCCCchHHHHhHHHHH
Confidence            5432  23347899999999998   56689999999999943

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ...

Probab=99.97  E-value=4.2e-33  Score=214.69  Aligned_cols=159  Identities=23%  Similarity=0.387  Sum_probs=119.6

Q ss_pred             cCCcccccccccccccCceEEEEEEEcCCCcE----EEEEEccCccChHHHHHHHHHHHHHHhcCCCCchhhhhhhH---
Q psy14630         20 DFTSEDLQDLGEIGRGGFGTVNKMIHRSSDTV----MAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQFYGAL---   92 (187)
Q Consensus        20 ~~~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~----vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~---   92 (187)
                      .+..++|++.+.||+|+||.||+|.+..+++.    ||+|.++..... ...+.+.++..+++.++||||+++++.+   
T Consensus        11 ~l~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~   89 (327)
T 3poz_A           11 ILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSP-KANKEILDEAYVMASVDNPHVCRLLGICLTS   89 (327)
T ss_dssp             ECCGGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC--------CHHHHHHHHHHHHHCCBTTBCCEEEEEESS
T ss_pred             hcCHHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCH-HHHHHHHHHHHHHHhCCCCCEeEEEEEEecC
Confidence            45678999999999999999999998777765    477776533222 2234455566677888999999887532   


Q ss_pred             -----------------------------HHHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEecccccccc
Q psy14630         93 -----------------------------FKEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLV  143 (187)
Q Consensus        93 -----------------------------~~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg~a~~~~  143 (187)
                                                   ...++.|++.||.|||+. +++||||||+||+++.++.+||+|||+++...
T Consensus        90 ~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~-~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~  168 (327)
T 3poz_A           90 TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR-RLVHRDLAARNVLVKTPQHVKITDFGLAKLLG  168 (327)
T ss_dssp             SEEEEEECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCCGGGEEEEETTEEEECCTTHHHHHT
T ss_pred             CeEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhC-CeeCCCCChheEEECCCCCEEEccCcceeEcc
Confidence                                         112678999999999998 99999999999999999999999999998764


Q ss_pred             ccccc---cCCCCCcCccCccccCCCccCCCCCCcceeeeEee
Q psy14630        144 DSIAK---TRDAGCRPYMAPERIDPLRARGYPSFKTKLGFKFN  183 (187)
Q Consensus       144 ~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi~  183 (187)
                      .....   ....+|+.|+|||.+.   ...++.++|+||||++
T Consensus       169 ~~~~~~~~~~~~~t~~y~aPE~~~---~~~~~~~~Di~slG~i  208 (327)
T 3poz_A          169 AEEKEYHAEGGKVPIKWMALESIL---HRIYTHQSDVWSYGVT  208 (327)
T ss_dssp             TTCC-------CCCGGGSCHHHHH---HCCCCHHHHHHHHHHH
T ss_pred             CCcccccccCCCccccccChHHhc---cCCCCchhhhhhhHHH
Confidence            33221   2234677899999998   6678999999999994

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A*

Probab=99.97  E-value=9.1e-33  Score=210.08  Aligned_cols=169  Identities=20%  Similarity=0.290  Sum_probs=130.8

Q ss_pred             ceecCCCccccCCcccccccccccccCceEEEEEE----EcCCCcEEEEEEccCccChHHHHHHHHHHHHHHhcCCCCch
Q psy14630         10 KLKLSPDTVYDFTSEDLQDLGEIGRGGFGTVNKMI----HRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYI   85 (187)
Q Consensus        10 ~~~~~~~~~~~~~~~~~~~~~~lg~G~fg~V~~~~----~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i   85 (187)
                      .....+.....+..+.|++.+.||+|+||.||+|.    +..+++.||+|.++...... ..+.+.++..+++.++||||
T Consensus         7 ~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~E~~~l~~l~h~~i   85 (302)
T 4e5w_A            7 KKPATEVDPTHFEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGN-HIADLKKEIEILRNLYHENI   85 (302)
T ss_dssp             CCCCCCCCTTBCCGGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----C-CHHHHHHHHHHHHTCCCTTB
T ss_pred             cCcceecChhhhhhhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccch-hHHHHHHHHHHHHhCCCCCe
Confidence            33334455556778899999999999999999998    56789999999987432221 22445556667788899999


Q ss_pred             hhhhhhHH-----------------------------------HHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCC
Q psy14630         86 VQFYGALF-----------------------------------KEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGA  130 (187)
Q Consensus        86 v~~~~~~~-----------------------------------~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~  130 (187)
                      +++++.+.                                   ..++.|++.||.|||+. +++||||||+||+++.++.
T Consensus        86 ~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~-~i~H~dikp~Nil~~~~~~  164 (302)
T 4e5w_A           86 VKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSR-QYVHRDLAARNVLVESEHQ  164 (302)
T ss_dssp             CCEEEEEEC---CCEEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEEEETTE
T ss_pred             eeeeeEEecCCCceEEEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhhcC-CcccCCCchheEEEcCCCC
Confidence            98864321                                   11667899999999998 9999999999999999999


Q ss_pred             EEEEeccccccccccc----cccCCCCCcCccCccccCCCccCCCCCCcceeeeEee
Q psy14630        131 IKLCDFGISGQLVDSI----AKTRDAGCRPYMAPERIDPLRARGYPSFKTKLGFKFN  183 (187)
Q Consensus       131 ~ki~dfg~a~~~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi~  183 (187)
                      ++|+|||++.......    ......+|..|+|||.+.   ...++.++|+||+|++
T Consensus       165 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~Di~slG~i  218 (302)
T 4e5w_A          165 VKIGDFGLTKAIETDKEYYTVKDDRDSPVFWYAPECLM---QSKFYIASDVWSFGVT  218 (302)
T ss_dssp             EEECCCTTCEECCTTCCEEECCCCTTCCGGGCCHHHHH---HCEEEHHHHHHHHHHH
T ss_pred             EEECcccccccccCCCcceeccCCCCCCccccCCeeec---CCCCCcchhHHHHHHH
Confidence            9999999998765432    223345788899999997   5567889999999993

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis}

Probab=99.97  E-value=1e-32  Score=217.69  Aligned_cols=154  Identities=27%  Similarity=0.333  Sum_probs=122.6

Q ss_pred             cCCcccccccccccccCceEEEEEEEcCCCcEEEEEEccCccChHHHHHHHHHHHHHHhcCCCCchhhhhhhH-------
Q psy14630         20 DFTSEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQFYGAL-------   92 (187)
Q Consensus        20 ~~~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~-------   92 (187)
                      +....+|++.+.||+|+||.||+|.+..++. +|+|.+......      ..++..+++.++||||+++++.+       
T Consensus        36 ~~~~~~Y~~~~~lG~G~~g~V~~a~~~~~~~-~aikk~~~~~~~------~~~E~~il~~l~h~niv~l~~~~~~~~~~~  108 (394)
T 4e7w_A           36 EQREIAYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQDKRF------KNRELQIMRIVKHPNVVDLKAFFYSNGDKK  108 (394)
T ss_dssp             CEEEEEEEEEEEEEEETTEEEEEEEETTTEE-EEEEEEECCTTS------CCHHHHHHHTCCCTTBCCEEEEEEEESSSS
T ss_pred             CcccceEEEeEEEeeCCCeEEEEEEECCCCe-EEEEEEecCcch------HHHHHHHHHhCCCCCcceEEEEEEecCCCC
Confidence            3345679999999999999999999977665 788876432111      11345567788999999875432       


Q ss_pred             ----------------------------------HHHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEc-CCCCEEEEecc
Q psy14630         93 ----------------------------------FKEVTVATVKALNYLKEELKIIHRDVKPSNILLD-RRGAIKLCDFG  137 (187)
Q Consensus        93 ----------------------------------~~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~-~~~~~ki~dfg  137 (187)
                                                        ...++.|++.||.|||+. +++||||||+||+++ .++.+||+|||
T Consensus       109 ~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~-~ivHrDlkp~Nill~~~~~~~kL~DFG  187 (394)
T 4e7w_A          109 DEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSI-GICHRDIKPQNLLLDPPSGVLKLIDFG  187 (394)
T ss_dssp             SCEEEEEEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEEETTTTEEEECCCT
T ss_pred             CceEEEEEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHC-CccCCCCCHHHEEEcCCCCcEEEeeCC
Confidence                                              112567999999999998 999999999999998 78999999999


Q ss_pred             ccccccccccccCCCCCcCccCccccCCCccCCCCCCcceeeeEee
Q psy14630        138 ISGQLVDSIAKTRDAGCRPYMAPERIDPLRARGYPSFKTKLGFKFN  183 (187)
Q Consensus       138 ~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi~  183 (187)
                      +++............+|+.|+|||++.+  ...++.++|+||+|++
T Consensus       188 ~a~~~~~~~~~~~~~~t~~y~aPE~~~~--~~~~~~~~DiwSlG~i  231 (394)
T 4e7w_A          188 SAKILIAGEPNVSYICSRYYRAPELIFG--ATNYTTNIDIWSTGCV  231 (394)
T ss_dssp             TCEECCTTCCCCSSCSCGGGCCHHHHTT--CSSCCTHHHHHHHHHH
T ss_pred             CcccccCCCCCcccccCcCccCHHHHcC--CCCCCcHHHHHHHHHH
Confidence            9998766555556678999999999873  3458899999999993

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major}

Probab=99.97  E-value=3.9e-33  Score=216.99  Aligned_cols=160  Identities=24%  Similarity=0.344  Sum_probs=115.3

Q ss_pred             ccCCcccccccccccccCceEEEEEEEcCCCcEEEEEEccCccChHHHHHHHHHHHHHHhcCCCCchhhhhhhH------
Q psy14630         19 YDFTSEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQFYGAL------   92 (187)
Q Consensus        19 ~~~~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~------   92 (187)
                      .....++|++.+.||+|+||.||+|.+..+++.||+|.+.......   ....++...+..++||||+++++.+      
T Consensus        18 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~---~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~   94 (360)
T 3e3p_A           18 SRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFR---NRELQIMQDLAVLHHPNIVQLQSYFYTLGER   94 (360)
T ss_dssp             HHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCTTCC---CHHHHHHHHHHHHCCTTBCCEEEEEEEECSS
T ss_pred             chhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCcccc---HHHHHHHHHHHhcCCCCcccHHHhhhccccc
Confidence            3445678999999999999999999999999999999885432111   1122233334556899999875432      


Q ss_pred             ------------------------------------HHHHHHHHHHHHHHHH--hcCCCeeecCCCCCeEEcC-CCCEEE
Q psy14630         93 ------------------------------------FKEVTVATVKALNYLK--EELKIIHRDVKPSNILLDR-RGAIKL  133 (187)
Q Consensus        93 ------------------------------------~~~~~~~~~~~l~~lh--~~~~i~Hrdlk~~nili~~-~~~~ki  133 (187)
                                                          ...+..|++.|+.|||  +. +++||||||+||+++. ++.+||
T Consensus        95 ~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~-~ivH~Dlkp~NIll~~~~~~~kl  173 (360)
T 3e3p_A           95 DRRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSV-NVCHRDIKPHNVLVNEADGTLKL  173 (360)
T ss_dssp             CTTCEEEEEEEECCSCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTT-CCBCSCCCGGGEEEETTTTEEEE
T ss_pred             cccceeEEEEeecccccHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCC-CeecCcCCHHHEEEeCCCCcEEE
Confidence                                                1126678999999999  86 9999999999999986 899999


Q ss_pred             EeccccccccccccccCCCCCcCccCccccCCCccCCCCCCcceeeeEeee
Q psy14630        134 CDFGISGQLVDSIAKTRDAGCRPYMAPERIDPLRARGYPSFKTKLGFKFNY  184 (187)
Q Consensus       134 ~dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi~~  184 (187)
                      +|||+++............||+.|+|||++.+  ...++.++|+||+|+++
T Consensus       174 ~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~~Di~slG~il  222 (360)
T 3e3p_A          174 CDFGSAKKLSPSEPNVAYICSRYYRAPELIFG--NQHYTTAVDIWSVGCIF  222 (360)
T ss_dssp             CCCTTCBCCCTTSCCCSTTSCGGGCCHHHHTT--CSSCCTHHHHHHHHHHH
T ss_pred             eeCCCceecCCCCCcccccCCcceeCHHHHcC--CCCCCcHHHHHHHHHHH
Confidence            99999998776555556678999999999873  34478999999999943

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A

Probab=99.97  E-value=2.7e-32  Score=218.63  Aligned_cols=156  Identities=22%  Similarity=0.381  Sum_probs=125.7

Q ss_pred             ccccCCcccccccccccccCceEEEEEEEcCCCcEEEEEEccCccChHHHHHHHHHHHHHHhcCCCCchhhhhhhHH---
Q psy14630         17 TVYDFTSEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQFYGALF---   93 (187)
Q Consensus        17 ~~~~~~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~---   93 (187)
                      ..|++..++|++.+.||+|+||.||+|.+.  ++.||||.++...    ..+.+.++..+++.++||||+++++.+.   
T Consensus       186 ~~~~i~~~~~~~~~~lG~G~fg~V~~~~~~--~~~vavK~~~~~~----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~  259 (450)
T 1k9a_A          186 SGWALNMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEK  259 (450)
T ss_dssp             TTCBCCGGGEEEEEEEEECSSEEEEEEEET--TEEEEEEEESSCT----TSHHHHHHHHHHHTCCCTTBCCEEEEEECTT
T ss_pred             cccccChHHeEEEeeecCcCCeeEEEEEec--CCeEEEEEeCCch----HHHHHHHHHHHHHhccCCCEEEEEEEEEcCC
Confidence            456788899999999999999999999875  6799999987532    2234556666788889999999875321   


Q ss_pred             --------------------------------HHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEecccccc
Q psy14630         94 --------------------------------KEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQ  141 (187)
Q Consensus        94 --------------------------------~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg~a~~  141 (187)
                                                      ..++.|++.||.|||+. +++||||||+||+++.++.+||+|||+++.
T Consensus       260 ~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~-~ivHrDlkp~Nill~~~~~~kl~DfG~a~~  338 (450)
T 1k9a_A          260 GGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN-NFVHRDLAARNVLVSEDNVAKVSDFGLTKE  338 (450)
T ss_dssp             SCEEEEEECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCCGGGEEECTTSCEEECCCTTCEE
T ss_pred             CceEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC-CeeCCCCCHhhEEECCCCCEEEeeCCCccc
Confidence                                            12667899999999998 999999999999999999999999999986


Q ss_pred             ccccccccCCCCCcCccCccccCCCccCCCCCCcceeeeEeee
Q psy14630        142 LVDSIAKTRDAGCRPYMAPERIDPLRARGYPSFKTKLGFKFNY  184 (187)
Q Consensus       142 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi~~  184 (187)
                      .....  ....++..|+|||.+.   ...++.++|+||||+++
T Consensus       339 ~~~~~--~~~~~~~~y~aPE~~~---~~~~~~~sDvwslG~~l  376 (450)
T 1k9a_A          339 ASSTQ--DTGKLPVKWTAPEALR---EKKFSTKSDVWSFGILL  376 (450)
T ss_dssp             CC--------CCCTTTSCHHHHH---SSCCCHHHHHHHHHHHH
T ss_pred             ccccc--cCCCCCcceeCHHHhc---CCCCCcHHHHHHHHHHH
Confidence            54322  2225678899999998   66789999999999944

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei}

Probab=99.97  E-value=3.2e-32  Score=220.97  Aligned_cols=157  Identities=24%  Similarity=0.423  Sum_probs=124.8

Q ss_pred             cccccccccccccCceEEEEEEEcCCCcEEEEEEccCccChH-----------HHHHHHHHHHHHHhcCCCCchhhhhhh
Q psy14630         23 SEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEK-----------DQRQLLMDLDVVMKSNECPYIVQFYGA   91 (187)
Q Consensus        23 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~-----------~~~~~~~~~~~~~~~~~h~~iv~~~~~   91 (187)
                      .++|++.+.||+|+||.||+|.+..+++.||+|++.......           ...+.+..+..+++.+.||||+++++.
T Consensus        35 ~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~  114 (504)
T 3q5i_A           35 GESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDV  114 (504)
T ss_dssp             GGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred             ccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEEE
Confidence            467999999999999999999999999999999986432111           123445566677888899999998753


Q ss_pred             H--------------------------------HHHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCC---CEEEEec
Q psy14630         92 L--------------------------------FKEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRG---AIKLCDF  136 (187)
Q Consensus        92 ~--------------------------------~~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~---~~ki~df  136 (187)
                      +                                ...++.|++.||.|||+. +++||||||+||+++..+   .+||+||
T Consensus       115 ~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~-~ivH~Dlkp~Nil~~~~~~~~~~kl~Df  193 (504)
T 3q5i_A          115 FEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQILSGICYLHKH-NIVHRDIKPENILLENKNSLLNIKIVDF  193 (504)
T ss_dssp             EECSSEEEEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEESSTTCCSSEEECCC
T ss_pred             EEcCCEEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC-CeEeCCCcHHHEEEecCCCCccEEEEEC
Confidence            2                                112678999999999998 999999999999998776   6999999


Q ss_pred             cccccccccccccCCCCCcCccCccccCCCccCCCCCCcceeeeEeee
Q psy14630        137 GISGQLVDSIAKTRDAGCRPYMAPERIDPLRARGYPSFKTKLGFKFNY  184 (187)
Q Consensus       137 g~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi~~  184 (187)
                      |+++............||+.|+|||++.    ..++.++|+||+|+++
T Consensus       194 g~a~~~~~~~~~~~~~gt~~y~aPE~~~----~~~~~~~DiwslG~il  237 (504)
T 3q5i_A          194 GLSSFFSKDYKLRDRLGTAYYIAPEVLK----KKYNEKCDVWSCGVIM  237 (504)
T ss_dssp             TTCEECCTTSCBCCCCSCTTTCCHHHHT----TCBCTHHHHHHHHHHH
T ss_pred             CCCEEcCCCCccccccCCcCCCCHHHhc----cCCCchHHHHHHHHHH
Confidence            9998876655555568999999999976    2488999999999943

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ...

Probab=99.97  E-value=2.1e-32  Score=214.46  Aligned_cols=160  Identities=21%  Similarity=0.331  Sum_probs=118.0

Q ss_pred             cCCcccccccccccccCceEEEEEEEc---CCCcEEEEEEccCccChHHHHHHHHHHHHHHhcCCCCchhhhhhhHH---
Q psy14630         20 DFTSEDLQDLGEIGRGGFGTVNKMIHR---SSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQFYGALF---   93 (187)
Q Consensus        20 ~~~~~~~~~~~~lg~G~fg~V~~~~~~---~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~---   93 (187)
                      ++..++|++.+.||+|+||.||+|.+.   .++..||||.++..... ...+.+.++..+++.++||||+++++.+.   
T Consensus        41 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~  119 (373)
T 2qol_A           41 ELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTE-KQRRDFLGEASIMGQFDHPNIIRLEGVVTKSK  119 (373)
T ss_dssp             BCCGGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCH-HHHHHHHHHHHHHTTCCCTTBCCEEEEECSSS
T ss_pred             hcCHhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCH-HHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCC
Confidence            566778999999999999999999876   46778999998754333 33455666677788889999999875321   


Q ss_pred             ------------------------------HHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEecccccccc
Q psy14630         94 ------------------------------KEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLV  143 (187)
Q Consensus        94 ------------------------------~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg~a~~~~  143 (187)
                                                    ..++.|++.||.|||+. +++||||||+||+++.++.+||+|||+++...
T Consensus       120 ~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~-~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~  198 (373)
T 2qol_A          120 PVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDM-GYVHRDLAARNILINSNLVCKVSDFGLGRVLE  198 (373)
T ss_dssp             SCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred             ceEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHC-CeeCCCCCcceEEEcCCCCEEECcCccccccc
Confidence                                          12678899999999997 99999999999999999999999999998765


Q ss_pred             ccccc----cCCCCCcCccCccccCCCccCCCCCCcceeeeEeee
Q psy14630        144 DSIAK----TRDAGCRPYMAPERIDPLRARGYPSFKTKLGFKFNY  184 (187)
Q Consensus       144 ~~~~~----~~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi~~  184 (187)
                      .....    ....+++.|+|||.+.   ...++.++|+||||+++
T Consensus       199 ~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~Dv~SlG~il  240 (373)
T 2qol_A          199 DDPEAAYTTRGGKIPIRWTSPEAIA---YRKFTSASDVWSYGIVL  240 (373)
T ss_dssp             ---------------CTTSCHHHHH---HCCCCHHHHHHHHHHHH
T ss_pred             cCCccceeccCCCcCCCccChhhhc---cCCcCchhcHHHHHHHH
Confidence            43211    1223467899999998   66789999999999943

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ...

Probab=99.97  E-value=3.3e-32  Score=209.47  Aligned_cols=154  Identities=20%  Similarity=0.313  Sum_probs=123.6

Q ss_pred             CcccccccccccccCceEEEEEEEcCCCcEEEEEEccCccChHHHHHHHHHHHHHHhcC-CCCchhhhhhhHH-------
Q psy14630         22 TSEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSN-ECPYIVQFYGALF-------   93 (187)
Q Consensus        22 ~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~-~h~~iv~~~~~~~-------   93 (187)
                      ..++|++.+.||+|+||.||+|.+..+++.||+|+++....     +.+.++..+++.+ +||||+++++.+.       
T Consensus        34 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-----~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~  108 (330)
T 3nsz_A           34 NQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKK-----KKIKREIKILENLRGGPNIITLADIVKDPVSRTP  108 (330)
T ss_dssp             EGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCCH-----HHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCE
T ss_pred             CCCceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccch-----HHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCce
Confidence            35679999999999999999999999999999999864221     2233344444444 5999998865321       


Q ss_pred             ------------------------HHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCC-CEEEEeccccccccccccc
Q psy14630         94 ------------------------KEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRG-AIKLCDFGISGQLVDSIAK  148 (187)
Q Consensus        94 ------------------------~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~-~~ki~dfg~a~~~~~~~~~  148 (187)
                                              ..++.|++.||.|||+. +++||||||+||+++.++ .+||+|||+++........
T Consensus       109 ~lv~e~~~~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~-~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~~  187 (330)
T 3nsz_A          109 ALVFEHVNNTDFKQLYQTLTDYDIRFYMYEILKALDYCHSM-GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEY  187 (330)
T ss_dssp             EEEEECCCCCCHHHHGGGCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEEETTTTEEEECCCTTCEECCTTCCC
T ss_pred             EEEEeccCchhHHHHHHhCCHHHHHHHHHHHHHHHHHHHhC-CeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCCCCcc
Confidence                                    12678999999999998 999999999999999777 8999999999887655555


Q ss_pred             cCCCCCcCccCccccCCCccCCCCCCcceeeeEee
Q psy14630        149 TRDAGCRPYMAPERIDPLRARGYPSFKTKLGFKFN  183 (187)
Q Consensus       149 ~~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi~  183 (187)
                      ....+++.|+|||.+.+  ...++.++|+||+|++
T Consensus       188 ~~~~~~~~y~aPE~~~~--~~~~~~~~DiwslG~i  220 (330)
T 3nsz_A          188 NVRVASRYFKGPELLVD--YQMYDYSLDMWSLGCM  220 (330)
T ss_dssp             CSCCSCGGGCCHHHHTT--CCCCCTHHHHHHHHHH
T ss_pred             ccccccccccChhhhcC--CCcCCchhhHHHHHHH
Confidence            55678999999999873  2568899999999993

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A*

Probab=99.97  E-value=2.8e-32  Score=210.18  Aligned_cols=168  Identities=24%  Similarity=0.345  Sum_probs=131.1

Q ss_pred             eecCCCccccCCcccccccccccccCceEEEEEEEcCCCc-----EEEEEEccCccChHHHHHHHHHHHHHHhcC-CCCc
Q psy14630         11 LKLSPDTVYDFTSEDLQDLGEIGRGGFGTVNKMIHRSSDT-----VMAVKRIRSTVDEKDQRQLLMDLDVVMKSN-ECPY   84 (187)
Q Consensus        11 ~~~~~~~~~~~~~~~~~~~~~lg~G~fg~V~~~~~~~~~~-----~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~-~h~~   84 (187)
                      ...+....+++..++|++.+.||+|+||.||+|.+..++.     .||+|.+........ .+.+..+..+++.+ .|||
T Consensus        33 ~~~~~~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~-~~~~~~E~~~l~~l~~h~~  111 (333)
T 2i1m_A           33 TQLPYNEKWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADE-KEALMSELKIMSHLGQHEN  111 (333)
T ss_dssp             TSSCCCGGGBCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHH-HHHHHHHHHHHHHHCCCTT
T ss_pred             ccccccccccCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHH-HHHHHHHHHHHHhhcCCCC
Confidence            3444566788999999999999999999999999876654     799999875443333 34444555556666 8999


Q ss_pred             hhhhhhhHH----------------------------------------------HHHHHHHHHHHHHHHhcCCCeeecC
Q psy14630         85 IVQFYGALF----------------------------------------------KEVTVATVKALNYLKEELKIIHRDV  118 (187)
Q Consensus        85 iv~~~~~~~----------------------------------------------~~~~~~~~~~l~~lh~~~~i~Hrdl  118 (187)
                      |+++++.+.                                              ..++.|++.||.|||+. +++||||
T Consensus       112 iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~-~ivH~Dl  190 (333)
T 2i1m_A          112 IVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASK-NCIHRDV  190 (333)
T ss_dssp             BCCEEEEECSSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHT-TEECSCC
T ss_pred             eeeEEEEEecCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcC-CcccCCc
Confidence            998864320                                              11456899999999998 9999999


Q ss_pred             CCCCeEEcCCCCEEEEecccccccccccc---ccCCCCCcCccCccccCCCccCCCCCCcceeeeEee
Q psy14630        119 KPSNILLDRRGAIKLCDFGISGQLVDSIA---KTRDAGCRPYMAPERIDPLRARGYPSFKTKLGFKFN  183 (187)
Q Consensus       119 k~~nili~~~~~~ki~dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi~  183 (187)
                      ||+||+++.++.+||+|||+++.......   .....+++.|+|||.+.   ...++.++|+||+|++
T Consensus       191 kp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~Di~slG~i  255 (333)
T 2i1m_A          191 AARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIF---DCVYTVQSDVWSYGIL  255 (333)
T ss_dssp             SGGGCEEEGGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHH---HCCCCHHHHHHHHHHH
T ss_pred             ccceEEECCCCeEEECccccccccccccceeecCCCCCCccccCHHHhc---cCCCChHHHHHHHHHH
Confidence            99999999999999999999987643321   22334677899999988   5678899999999994

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A*

Probab=99.97  E-value=5.9e-32  Score=209.81  Aligned_cols=160  Identities=24%  Similarity=0.346  Sum_probs=126.3

Q ss_pred             cCCcccccccccccccCceEEEEEEEcCCCcEEEEEEccCccChHHHHHHHHHHHHHHhcCCCCchhhhhhhH-------
Q psy14630         20 DFTSEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQFYGAL-------   92 (187)
Q Consensus        20 ~~~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~-------   92 (187)
                      ....++|++.+.||+|+||.||+|.+..+++.||+|.+...... .....+.++..+++.++||||+++++.+       
T Consensus         7 ~~i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   85 (353)
T 2b9h_A            7 YNISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKP-LFALRTLREIKILKHFKHENIITIFNIQRPDSFEN   85 (353)
T ss_dssp             CCSCTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSH-HHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTT
T ss_pred             cccccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccc-hHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCc
Confidence            33458999999999999999999999999999999998653333 3334445566677788999999886421       


Q ss_pred             ----------------------------HHHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEeccccccccc
Q psy14630         93 ----------------------------FKEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVD  144 (187)
Q Consensus        93 ----------------------------~~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg~a~~~~~  144 (187)
                                                  ...++.|++.||.|||+. +++||||||+||+++.++.+||+|||+++....
T Consensus        86 ~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~-~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~  164 (353)
T 2b9h_A           86 FNEVYIIQELMQTDLHRVISTQMLSDDHIQYFIYQTLRAVKVLHGS-NVIHRDLKPSNLLINSNCDLKVCDFGLARIIDE  164 (353)
T ss_dssp             CCCEEEEECCCSEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCCGGGEEECTTCCEEECCCTTCEECC-
T ss_pred             cceEEEEEeccCccHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHC-CeecCCCCHHHeEEcCCCcEEEEeccccccccc
Confidence                                        112678999999999998 999999999999999999999999999987643


Q ss_pred             ccc-----------ccCCCCCcCccCccccCCCccCCCCCCcceeeeEee
Q psy14630        145 SIA-----------KTRDAGCRPYMAPERIDPLRARGYPSFKTKLGFKFN  183 (187)
Q Consensus       145 ~~~-----------~~~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi~  183 (187)
                      ...           .....||+.|+|||++.+  ...++.++|+||+|++
T Consensus       165 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~~Di~slG~i  212 (353)
T 2b9h_A          165 SAADNSEPTGQQSGMVEFVATRWYRAPEVMLT--SAKYSRAMDVWSCGCI  212 (353)
T ss_dssp             ---------------CCCCCCGGGCCHHHHHS--CCCCCHHHHHHHHHHH
T ss_pred             ccccccCccccccchhhccccccccCCeeecc--CCCccchhhHHHHHHH
Confidence            211           122468999999998762  3568899999999994

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ...

Probab=99.97  E-value=2e-32  Score=213.30  Aligned_cols=162  Identities=41%  Similarity=0.712  Sum_probs=131.3

Q ss_pred             ccccCCcccccccccccccCceEEEEEEEcCCCcEEEEEEccCccChHHHHHHHHHHHHHHhcCCCCchhhhhhhH----
Q psy14630         17 TVYDFTSEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQFYGAL----   92 (187)
Q Consensus        17 ~~~~~~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~----   92 (187)
                      ...++..++|++.+.||+|+||.||+|.+..+++.||+|++..... ....+.+.++..+++.++||||+++++.+    
T Consensus        26 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~  104 (360)
T 3eqc_A           26 KVGELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIK-PAIRNQIIRELQVLHECNSPYIVGFYGAFYSDG  104 (360)
T ss_dssp             TCCCCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCC-HHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETT
T ss_pred             cccccccccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccC-HHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECC
Confidence            3456778899999999999999999999999999999999875433 33445566666677888999999987532    


Q ss_pred             ----------------------------HHHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEeccccccccc
Q psy14630         93 ----------------------------FKEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVD  144 (187)
Q Consensus        93 ----------------------------~~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg~a~~~~~  144 (187)
                                                  ...+..+++.|+.|||+..+++||||||+||+++.++.++|+|||++.....
T Consensus       105 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  184 (360)
T 3eqc_A          105 EISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID  184 (360)
T ss_dssp             EEEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHH
T ss_pred             EEEEEEECCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHhCCEEcCCccHHHEEECCCCCEEEEECCCCccccc
Confidence                                        1126778999999999844899999999999999999999999999976643


Q ss_pred             cccccCCCCCcCccCccccCCCccCCCCCCcceeeeEee
Q psy14630        145 SIAKTRDAGCRPYMAPERIDPLRARGYPSFKTKLGFKFN  183 (187)
Q Consensus       145 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi~  183 (187)
                      .. .....||+.|+|||.+.   ...++.++|+||+|++
T Consensus       185 ~~-~~~~~gt~~y~aPE~~~---~~~~~~~~Di~slG~i  219 (360)
T 3eqc_A          185 SM-ANSFVGTRSYMSPERLQ---GTHYSVQSDIWSMGLS  219 (360)
T ss_dssp             HC-----CCCCTTCCHHHHT---TCCCSHHHHHHHHHHH
T ss_pred             cc-ccCCCCCCCeECHHHHc---CCCCCchhhHHHHHHH
Confidence            32 23347899999999998   5678899999999993

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens}

Probab=99.97  E-value=4.9e-33  Score=214.09  Aligned_cols=156  Identities=24%  Similarity=0.370  Sum_probs=118.0

Q ss_pred             ccccccccccccCceEEEEEEEcCCCcEEEEEEccCccChHHHHHHHHHHHHHHhcCCCCchhhhhhhH-----------
Q psy14630         24 EDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQFYGAL-----------   92 (187)
Q Consensus        24 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~-----------   92 (187)
                      ++|++.+.||+|+||.||+|.+..+++.||+|.+....... ....+.++..+++.+.||||+++++.+           
T Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   80 (324)
T 3mtl_A            2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEG-APCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFE   80 (324)
T ss_dssp             CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC-------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEE
T ss_pred             CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccc-cchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEec
Confidence            57999999999999999999999999999999986432211 111222355567788999999887532           


Q ss_pred             ---------------------HHHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEecccccccccc-ccccC
Q psy14630         93 ---------------------FKEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDS-IAKTR  150 (187)
Q Consensus        93 ---------------------~~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg~a~~~~~~-~~~~~  150 (187)
                                           ...++.|++.||.|||+. +++||||||+||+++.++.+||+|||+++..... .....
T Consensus        81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~-~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~  159 (324)
T 3mtl_A           81 YLDKDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQ-KVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDN  159 (324)
T ss_dssp             CCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHT-TEEESSCCGGGEEECTTCCEEECSSSEEECC---------
T ss_pred             ccccCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC-CccCCCcCHHHEEECCCCCEEEccCcccccccCCcccccc
Confidence                                 112667999999999997 9999999999999999999999999999875432 22233


Q ss_pred             CCCCcCccCccccCCCccCCCCCCcceeeeEee
Q psy14630        151 DAGCRPYMAPERIDPLRARGYPSFKTKLGFKFN  183 (187)
Q Consensus       151 ~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi~  183 (187)
                      ..+|+.|+|||.+.+  ...++.++|+||+|++
T Consensus       160 ~~~t~~y~aPE~~~~--~~~~~~~~DiwslG~i  190 (324)
T 3mtl_A          160 EVVTLWYRPPDILLG--STDYSTQIDMWGVGCI  190 (324)
T ss_dssp             ---CGGGCCHHHHTT--CCCCCTHHHHHHHHHH
T ss_pred             ccCcccccChhhhcC--CCCCCcHHHHHHHHHH
Confidence            467999999999873  3557899999999993

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens}

Probab=99.97  E-value=8e-33  Score=218.35  Aligned_cols=162  Identities=22%  Similarity=0.290  Sum_probs=128.4

Q ss_pred             cCCcccccccccccccCceEEEEEEEcCCCcEEEEEEccCccChHHHHHHHHHHHHHHhcCCCCchhhhhhhH-------
Q psy14630         20 DFTSEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQFYGAL-------   92 (187)
Q Consensus        20 ~~~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~-------   92 (187)
                      +...++|++.+.||+|+||.||+|.+..+++.||+|++....... ..+.+.++..+++.+.||||+++++.+       
T Consensus         5 ~~~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~   83 (396)
T 4eut_A            5 STSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLR-PVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRH   83 (396)
T ss_dssp             ECSSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGS-CHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCC
T ss_pred             CCCCCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccc-hHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCe
Confidence            345688999999999999999999999999999999986432222 123344566677788999999886432       


Q ss_pred             ------------------------------HHHHHHHHHHHHHHHHhcCCCeeecCCCCCeEE----cCCCCEEEEeccc
Q psy14630         93 ------------------------------FKEVTVATVKALNYLKEELKIIHRDVKPSNILL----DRRGAIKLCDFGI  138 (187)
Q Consensus        93 ------------------------------~~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili----~~~~~~ki~dfg~  138 (187)
                                                    ...++.|++.||.|||+. +++||||||+||++    +..+.+||+|||+
T Consensus        84 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~-~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~  162 (396)
T 4eut_A           84 KVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLREN-GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGA  162 (396)
T ss_dssp             EEEEECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCCGGGEEEEECTTSCEEEEECCGGG
T ss_pred             eEEEEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHC-CEEECCcCHHHEEEeecCCCceeEEEecCCC
Confidence                                          112678999999999998 99999999999998    6777899999999


Q ss_pred             cccccccccccCCCCCcCccCccccCCCc-----cCCCCCCcceeeeEee
Q psy14630        139 SGQLVDSIAKTRDAGCRPYMAPERIDPLR-----ARGYPSFKTKLGFKFN  183 (187)
Q Consensus       139 a~~~~~~~~~~~~~~t~~y~aPE~~~~~~-----~~~~~~~~D~ws~gi~  183 (187)
                      ++............||+.|+|||++.+..     ...++.++|+||||++
T Consensus       163 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~i  212 (396)
T 4eut_A          163 ARELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVT  212 (396)
T ss_dssp             CEECCCGGGSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHH
T ss_pred             ceEccCCCccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHH
Confidence            99876655555667999999999986210     1346789999999994

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A

Probab=99.97  E-value=1.6e-31  Score=202.38  Aligned_cols=158  Identities=27%  Similarity=0.385  Sum_probs=128.7

Q ss_pred             cCCcccccccccccccCceEEEEEEEcCCCcEEEEEEccCccChHHHHHHHHHHHHHHhcCCCCchhhhhhhH-------
Q psy14630         20 DFTSEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQFYGAL-------   92 (187)
Q Consensus        20 ~~~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~-------   92 (187)
                      ......|++.+.||+|+||.||+|.+..++..||+|.+..........+.+.++..+++.+.||||+++++.+       
T Consensus        22 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~  101 (290)
T 1t4h_A           22 SNDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGK  101 (290)
T ss_dssp             CTTSCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSC
T ss_pred             ccCceeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCC
Confidence            4455668889999999999999999999999999999875544445556677777788889999999887532       


Q ss_pred             -----------------------------HHHHHHHHHHHHHHHHhcCC--CeeecCCCCCeEEc-CCCCEEEEeccccc
Q psy14630         93 -----------------------------FKEVTVATVKALNYLKEELK--IIHRDVKPSNILLD-RRGAIKLCDFGISG  140 (187)
Q Consensus        93 -----------------------------~~~~~~~~~~~l~~lh~~~~--i~Hrdlk~~nili~-~~~~~ki~dfg~a~  140 (187)
                                                   ...++.+++.||.|||+. +  ++|+||||+||+++ .++.+||+|||++.
T Consensus       102 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~-~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~  180 (290)
T 1t4h_A          102 KCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTR-TPPIIHRDLKCDNIFITGPTGSVKIGDLGLAT  180 (290)
T ss_dssp             EEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTS-SSCCCCSCCCGGGEEESSTTSCEEECCTTGGG
T ss_pred             ceEEEEEEecCCCCHHHHHHHccCCCHHHHHHHHHHHHHHHHHHHcC-CCCEEECCCCHHHEEEECCCCCEEEeeCCCcc
Confidence                                         112677899999999997 8  99999999999997 78999999999997


Q ss_pred             cccccccccCCCCCcCccCccccCCCccCCCCCCcceeeeEee
Q psy14630        141 QLVDSIAKTRDAGCRPYMAPERIDPLRARGYPSFKTKLGFKFN  183 (187)
Q Consensus       141 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi~  183 (187)
                      ...... .....||+.|+|||.+.   . .++.++|+||+|++
T Consensus       181 ~~~~~~-~~~~~~t~~y~aPE~~~---~-~~~~~~Di~slG~~  218 (290)
T 1t4h_A          181 LKRASF-AKAVIGTPEFMAPEMYE---E-KYDESVDVYAFGMC  218 (290)
T ss_dssp             GCCTTS-BEESCSSCCCCCGGGGG---T-CCCTHHHHHHHHHH
T ss_pred             cccccc-cccccCCcCcCCHHHHh---c-cCCCcchHHHHHHH
Confidence            654332 23346899999999876   2 48899999999993

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A*

Probab=99.97  E-value=1.3e-32  Score=211.36  Aligned_cols=160  Identities=26%  Similarity=0.344  Sum_probs=123.8

Q ss_pred             cccccccccccccCceEEEEEEEcCCCcEEEEEEccCccC------hHHHHHHHHHHHHHHhcCCCCchhhhhhhH----
Q psy14630         23 SEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVD------EKDQRQLLMDLDVVMKSNECPYIVQFYGAL----   92 (187)
Q Consensus        23 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~~------~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~----   92 (187)
                      .++|++.+.||+|+||.||+|.+..+++.||+|++.....      .......+.++..+++.+.||||+++++.+    
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~   88 (322)
T 2ycf_A            9 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAED   88 (322)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESSS
T ss_pred             hhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCCc
Confidence            4789999999999999999999999999999999864321      111223355566677888999999886432    


Q ss_pred             ---------------------------HHHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCC---EEEEeccccccc
Q psy14630         93 ---------------------------FKEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGA---IKLCDFGISGQL  142 (187)
Q Consensus        93 ---------------------------~~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~---~ki~dfg~a~~~  142 (187)
                                                 ...++.|++.||.|||+. +++||||||+||+++.++.   +||+|||+++..
T Consensus        89 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~-~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~  167 (322)
T 2ycf_A           89 YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHEN-GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL  167 (322)
T ss_dssp             EEEEEECCTTEETHHHHSTTCCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEESSSSSSCCEEECCCTTCEEC
T ss_pred             eEEEEecCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC-CeeccCCCHHHEEEecCCCCCeEEEccCccceec
Confidence                                       112678999999999997 9999999999999987654   999999999876


Q ss_pred             cccccccCCCCCcCccCccccCCCccCCCCCCcceeeeEee
Q psy14630        143 VDSIAKTRDAGCRPYMAPERIDPLRARGYPSFKTKLGFKFN  183 (187)
Q Consensus       143 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi~  183 (187)
                      ..........||+.|+|||.+.......++.++|+||+|++
T Consensus       168 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~i  208 (322)
T 2ycf_A          168 GETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVI  208 (322)
T ss_dssp             CCCHHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHH
T ss_pred             ccccccccccCCcCccCchhhccCCCCCCCchhhHHHHHHH
Confidence            54433334468999999999743224568899999999994

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A*

Probab=99.97  E-value=1.9e-32  Score=208.16  Aligned_cols=158  Identities=22%  Similarity=0.292  Sum_probs=118.0

Q ss_pred             cCCcccccccccccccCceEEEEEEEcCCCcEEEEEEccCccChHHHHHHHHHHHH-HHhcCCCCchhhhhhhH------
Q psy14630         20 DFTSEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDV-VMKSNECPYIVQFYGAL------   92 (187)
Q Consensus        20 ~~~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~-~~~~~~h~~iv~~~~~~------   92 (187)
                      ....++|++.+.||+|+||.||+|.+  +++.||+|++....    ......+... ....+.||||+++++.+      
T Consensus         4 ~~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~----~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~   77 (301)
T 3q4u_A            4 RTVARDITLLECVGKGRYGEVWRGSW--QGENVAVKIFSSRD----EKSWFRETELYNTVMLRHENILGFIASDMTSRHS   77 (301)
T ss_dssp             CCCGGGCEEEEEEEECSSEEEEEEEE--TTEEEEEEEECGGG----HHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETT
T ss_pred             ccccCcEEEEEeeccCCCcEEEEEEE--CCEEEEEEEecccc----chhhHHHHHHHHHhhccCcCeeeEEEeeccccCC
Confidence            34578999999999999999999987  58899999986421    1222222222 22237899999986431      


Q ss_pred             -----------------------------HHHHHHHHHHHHHHHH--------hcCCCeeecCCCCCeEEcCCCCEEEEe
Q psy14630         93 -----------------------------FKEVTVATVKALNYLK--------EELKIIHRDVKPSNILLDRRGAIKLCD  135 (187)
Q Consensus        93 -----------------------------~~~~~~~~~~~l~~lh--------~~~~i~Hrdlk~~nili~~~~~~ki~d  135 (187)
                                                   ...++.|++.||.|||        +. +++||||||+||+++.++.+||+|
T Consensus        78 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~-~ivH~Dlkp~Nill~~~~~~kl~D  156 (301)
T 3q4u_A           78 STQLWLITHYHEMGSLYDYLQLTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKP-AIAHRDLKSKNILVKKNGQCCIAD  156 (301)
T ss_dssp             EEEEEEEECCCTTCBHHHHHTTCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBC-EEECSCCCGGGEEECTTSCEEECC
T ss_pred             CceeEEehhhccCCCHHHHHhhcccCHHHHHHHHHHHHHHHHHHHHhhhhccCCC-CeecCCCChHhEEEcCCCCEEEee
Confidence                                         1126789999999999        76 999999999999999999999999


Q ss_pred             cccccccccccc-----ccCCCCCcCccCccccCCCccC---CCCCCcceeeeEeee
Q psy14630        136 FGISGQLVDSIA-----KTRDAGCRPYMAPERIDPLRAR---GYPSFKTKLGFKFNY  184 (187)
Q Consensus       136 fg~a~~~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~---~~~~~~D~ws~gi~~  184 (187)
                      ||+++.......     .....||+.|+|||.+.+....   .++.++|+||||+++
T Consensus       157 fg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il  213 (301)
T 3q4u_A          157 LGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVL  213 (301)
T ss_dssp             CTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHH
T ss_pred             CCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHH
Confidence            999977543221     2234789999999999842111   234689999999943

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A*

Probab=99.97  E-value=4.1e-32  Score=207.41  Aligned_cols=170  Identities=24%  Similarity=0.369  Sum_probs=131.6

Q ss_pred             CceecCCCccccCCcccccccccccccCceEEEEEEEc-----CCCcEEEEEEccCccChHHHHHHHHHHHHHHhcCCCC
Q psy14630          9 GKLKLSPDTVYDFTSEDLQDLGEIGRGGFGTVNKMIHR-----SSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECP   83 (187)
Q Consensus         9 ~~~~~~~~~~~~~~~~~~~~~~~lg~G~fg~V~~~~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~h~   83 (187)
                      +.........+++..++|.+.+.||+|+||.||+|.+.     .++..||+|.++..... ...+.+.++..+++.++||
T Consensus         8 ~~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~hp   86 (314)
T 2ivs_A            8 DAFKILEDPKWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASP-SELRDLLSEFNVLKQVNHP   86 (314)
T ss_dssp             ------CCTTTBCCGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCH-HHHHHHHHHHHHHTTCCCT
T ss_pred             cceeccCCcccccchhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCH-HHHHHHHHHHHHHhhCCCC
Confidence            34445556788999999999999999999999999873     45588999998754333 3344556666678888999


Q ss_pred             chhhhhhhH--------------------------------------------------------HHHHHHHHHHHHHHH
Q psy14630         84 YIVQFYGAL--------------------------------------------------------FKEVTVATVKALNYL  107 (187)
Q Consensus        84 ~iv~~~~~~--------------------------------------------------------~~~~~~~~~~~l~~l  107 (187)
                      ||+++++.+                                                        ...++.|++.||.||
T Consensus        87 ~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~l  166 (314)
T 2ivs_A           87 HVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYL  166 (314)
T ss_dssp             TBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHH
T ss_pred             ceeeEEEEEecCCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHH
Confidence            999876421                                                        012567899999999


Q ss_pred             HhcCCCeeecCCCCCeEEcCCCCEEEEeccccccccccc---cccCCCCCcCccCccccCCCccCCCCCCcceeeeEee
Q psy14630        108 KEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSI---AKTRDAGCRPYMAPERIDPLRARGYPSFKTKLGFKFN  183 (187)
Q Consensus       108 h~~~~i~Hrdlk~~nili~~~~~~ki~dfg~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi~  183 (187)
                      |+. +++||||||+||+++.++.+||+|||+++......   ......+++.|+|||.+.   ...++.++|+||+|++
T Consensus       167 H~~-~ivH~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~Di~slG~i  241 (314)
T 2ivs_A          167 AEM-KLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLF---DHIYTTQSDVWSFGVL  241 (314)
T ss_dssp             HHT-TEECCCCSGGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHH---HCEECHHHHHHHHHHH
T ss_pred             HHC-CCcccccchheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhc---CCCcCchhhHHHHHHH
Confidence            997 99999999999999999999999999998764322   122335678899999998   5668899999999993

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ...

Probab=99.97  E-value=2.1e-32  Score=206.77  Aligned_cols=161  Identities=20%  Similarity=0.329  Sum_probs=131.1

Q ss_pred             CccccCCcccccccccccccCceEEEEEEEcCCCcEEEEEEccCccChHHHHHHHHHHHHHHhcCCCCchhhhhhhHH--
Q psy14630         16 DTVYDFTSEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQFYGALF--   93 (187)
Q Consensus        16 ~~~~~~~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~--   93 (187)
                      -..|++..++|++.+.||+|+||.||+|.+..++..||+|.+.....   ..+.+..+..+++.++||||+++++.+.  
T Consensus         5 ~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~   81 (288)
T 3kfa_A            5 YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM---EVEEFLKEAAVMKEIKHPNLVQLLGVCTRE   81 (288)
T ss_dssp             CCTTBCCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCST---HHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             hhcccccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCHH---HHHHHHHHHHHHHhCCCCCEeeEEEEEccC
Confidence            35788899999999999999999999999999999999999874322   2334555666777889999998865321  


Q ss_pred             --------------------------------HHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEecccccc
Q psy14630         94 --------------------------------KEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQ  141 (187)
Q Consensus        94 --------------------------------~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg~a~~  141 (187)
                                                      ..++.+++.||.|||+. +++|+||||+||+++.++.++|+|||++..
T Consensus        82 ~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~-~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~  160 (288)
T 3kfa_A           82 PPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK-NFIHRDLAARNCLVGENHLVKVADFGLSRL  160 (288)
T ss_dssp             SSEEEEEECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHH-TCCCSCCSGGGEEECGGGCEEECCCCGGGT
T ss_pred             CCEEEEEEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHC-CccCCCCCcceEEEcCCCCEEEccCcccee
Confidence                                            12567899999999998 999999999999999999999999999987


Q ss_pred             cccccc--ccCCCCCcCccCccccCCCccCCCCCCcceeeeEee
Q psy14630        142 LVDSIA--KTRDAGCRPYMAPERIDPLRARGYPSFKTKLGFKFN  183 (187)
Q Consensus       142 ~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi~  183 (187)
                      ......  .....+++.|+|||.+.   ...++.++|+||+|++
T Consensus       161 ~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~Di~slG~i  201 (288)
T 3kfa_A          161 MTGDTYTAHAGAKFPIKWTAPESLA---YNKFSIKSDVWAFGVL  201 (288)
T ss_dssp             SCSSSSEEETTEEECGGGCCHHHHH---HCCCCHHHHHHHHHHH
T ss_pred             ccCCccccccCCccccCcCChhhhc---cCCCCchhhHHHHHHH
Confidence            653321  12234677899999998   5678899999999994

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A*

Probab=99.97  E-value=2.8e-32  Score=214.32  Aligned_cols=156  Identities=24%  Similarity=0.346  Sum_probs=122.0

Q ss_pred             cCCcccccccccccccCceEEEEEEEcCCCcEEEEEEccCccChHHHHHHHHHHHHHHhcCC--------CCchhhhhhh
Q psy14630         20 DFTSEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNE--------CPYIVQFYGA   91 (187)
Q Consensus        20 ~~~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~--------h~~iv~~~~~   91 (187)
                      +...++|++.+.||+|+||.||+|.+..+++.||+|+++..   ....+.+.++..+++.+.        |+||+++++.
T Consensus        33 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~  109 (397)
T 1wak_A           33 DLFNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA---EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDD  109 (397)
T ss_dssp             CEETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC---HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEE
T ss_pred             hhcCCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC---CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecc
Confidence            44467899999999999999999999999999999998642   222233333443444332        7788887653


Q ss_pred             H-------------------------------------HHHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCC-----
Q psy14630         92 L-------------------------------------FKEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRG-----  129 (187)
Q Consensus        92 ~-------------------------------------~~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~-----  129 (187)
                      +                                     ...++.|++.||.|||+..+++||||||+||+++.++     
T Consensus       110 ~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~givHrDikp~NIll~~~~~~~~~  189 (397)
T 1wak_A          110 FKISGVNGTHICMVFEVLGHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRR  189 (397)
T ss_dssp             EEEEETTEEEEEEEECCCCCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECCCCSGGGEEECCCHHHHHH
T ss_pred             eeecCCCCceEEEEEeccCccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHeeEeccchhhhh
Confidence            2                                     1227789999999999854899999999999998765     


Q ss_pred             --------------------------------------------CEEEEeccccccccccccccCCCCCcCccCccccCC
Q psy14630        130 --------------------------------------------AIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDP  165 (187)
Q Consensus       130 --------------------------------------------~~ki~dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~  165 (187)
                                                                  .+||+|||++......  .....||+.|+|||++. 
T Consensus       190 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~--~~~~~gt~~y~aPE~~~-  266 (397)
T 1wak_A          190 LAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH--FTEDIQTRQYRSLEVLI-  266 (397)
T ss_dssp             HHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC--SCSCCSCGGGCCHHHHH-
T ss_pred             hhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc--CccCCCCCcccCChhhc-
Confidence                                                        7999999999876543  23347899999999998 


Q ss_pred             CccCCCCCCcceeeeEee
Q psy14630        166 LRARGYPSFKTKLGFKFN  183 (187)
Q Consensus       166 ~~~~~~~~~~D~ws~gi~  183 (187)
                        ...++.++|+||+|++
T Consensus       267 --~~~~~~~~DiwslG~i  282 (397)
T 1wak_A          267 --GSGYNTPADIWSTACM  282 (397)
T ss_dssp             --TSCCCTHHHHHHHHHH
T ss_pred             --CCCCCcHHHHHHHHHH
Confidence              5668999999999994

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A*

Probab=99.97  E-value=8.5e-32  Score=202.50  Aligned_cols=154  Identities=22%  Similarity=0.359  Sum_probs=127.0

Q ss_pred             cccccccccccccCceEEEEEEEcCCCcEEEEEEccCccChHHHHHHHHHHHHHHhcCCCCchhhhhhhH----------
Q psy14630         23 SEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQFYGAL----------   92 (187)
Q Consensus        23 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~----------   92 (187)
                      .++|++.+.||+|+||.||+|.+..++..+|+|.+......  ..+.+.++..+++.++||||+++++.+          
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~--~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   85 (277)
T 3f3z_A            8 NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVE--DVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVM   85 (277)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCS--CHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccc--hHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEE
Confidence            46899999999999999999999999999999998643222  133455566677888999999887532          


Q ss_pred             ----------------------HHHHHHHHHHHHHHHHhcCCCeeecCCCCCeEE---cCCCCEEEEecccccccccccc
Q psy14630         93 ----------------------FKEVTVATVKALNYLKEELKIIHRDVKPSNILL---DRRGAIKLCDFGISGQLVDSIA  147 (187)
Q Consensus        93 ----------------------~~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili---~~~~~~ki~dfg~a~~~~~~~~  147 (187)
                                            ...++.|++.|+.|||+. +++||||||+||++   +.++.++|+|||++........
T Consensus        86 e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~-~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~~~~  164 (277)
T 3f3z_A           86 ELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKL-NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKM  164 (277)
T ss_dssp             ECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEESSSSTTCCEEECCCTTCEECCTTSC
T ss_pred             eccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC-CccCCCCCHHHEEEecCCCCCcEEEEecccceeccCccc
Confidence                                  112678999999999998 99999999999999   7888999999999988766555


Q ss_pred             ccCCCCCcCccCccccCCCccCCCCCCcceeeeEee
Q psy14630        148 KTRDAGCRPYMAPERIDPLRARGYPSFKTKLGFKFN  183 (187)
Q Consensus       148 ~~~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi~  183 (187)
                      .....+|+.|+|||.+.+    .++.++|+||+|++
T Consensus       165 ~~~~~~t~~y~aPE~~~~----~~~~~~Di~slG~~  196 (277)
T 3f3z_A          165 MRTKVGTPYYVSPQVLEG----LYGPECDEWSAGVM  196 (277)
T ss_dssp             BCCCCSCTTTCCHHHHTT----CBCTTHHHHHHHHH
T ss_pred             hhccCCCCCccChHHhcc----cCCchhhehhHHHH
Confidence            555679999999999873    37899999999993

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A*

Probab=99.97  E-value=1.2e-32  Score=211.92  Aligned_cols=159  Identities=23%  Similarity=0.339  Sum_probs=121.3

Q ss_pred             cCCcccccccccccccCceEEEEEEEcCCCcE----EEEEEccCccChHHHHHHHHHHHHHHhcCCCCchhhhhhhHH--
Q psy14630         20 DFTSEDLQDLGEIGRGGFGTVNKMIHRSSDTV----MAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQFYGALF--   93 (187)
Q Consensus        20 ~~~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~----vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~--   93 (187)
                      .+..++|++.+.||+|+||.||+|.+..+++.    ||+|.+....... ..+.+.++..+++.+.||||+++++.+.  
T Consensus         9 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~-~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~   87 (325)
T 3kex_A            9 IFKETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQ-SFQAVTDHMLAIGSLDHAHIVRLLGLCPGS   87 (325)
T ss_dssp             BCCTTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCS-CBCSCCHHHHHHHTCCCTTBCCEEEEECBS
T ss_pred             hcCHhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHH-HHHHHHHHHHHHhcCCCCCcCeEEEEEcCC
Confidence            35678999999999999999999999887776    6777764322111 1112233444567789999999875321  


Q ss_pred             ------------------------------HHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEecccccccc
Q psy14630         94 ------------------------------KEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLV  143 (187)
Q Consensus        94 ------------------------------~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg~a~~~~  143 (187)
                                                    ..++.|++.||.|||+. +++||||||+||+++.++.+||+|||+++...
T Consensus        88 ~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~-~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~  166 (325)
T 3kex_A           88 SLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEH-GMVHRNLAARNVLLKSPSQVQVADFGVADLLP  166 (325)
T ss_dssp             SEEEEEECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHHHT-TCCCSCCSSTTEEESSSSCEEECSCSGGGGSC
T ss_pred             ccEEEEEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHHhC-CCCCCccchheEEECCCCeEEECCCCcccccC
Confidence                                          12678999999999998 99999999999999999999999999998865


Q ss_pred             cccc---ccCCCCCcCccCccccCCCccCCCCCCcceeeeEee
Q psy14630        144 DSIA---KTRDAGCRPYMAPERIDPLRARGYPSFKTKLGFKFN  183 (187)
Q Consensus       144 ~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi~  183 (187)
                      ....   .....++..|+|||.+.   ...++.++|+||+|++
T Consensus       167 ~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~Di~slG~~  206 (325)
T 3kex_A          167 PDDKQLLYSEAKTPIKWMALESIH---FGKYTHQSDVWSYGVT  206 (325)
T ss_dssp             CCTTCCC-----CCTTTSCHHHHH---HCCCCHHHHHHHHHHH
T ss_pred             cccccccccCCCCcccccChHHhc---cCCCChhhHhHHhHHH
Confidence            4321   22345777899999998   5678999999999993

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A

Probab=99.97  E-value=4.7e-32  Score=209.45  Aligned_cols=152  Identities=19%  Similarity=0.231  Sum_probs=116.5

Q ss_pred             cCCcccccccccccccCceEEEEEEEcCCCcEEEEEEccCccCh------HHHHHHHHHHHHHHhcCC------------
Q psy14630         20 DFTSEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDE------KDQRQLLMDLDVVMKSNE------------   81 (187)
Q Consensus        20 ~~~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~------~~~~~~~~~~~~~~~~~~------------   81 (187)
                      .+..++|++.+.||+|+||.||+|.+  +++.||||.++.....      ....+.+.++..+++.+.            
T Consensus        16 ~~~~~~y~~~~~lG~G~~g~V~~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~n   93 (336)
T 2vuw_A           16 CLPTEKLQRCEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEG   93 (336)
T ss_dssp             HSCHHHHHTCEEEEEETTEEEEEEEE--TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCC
T ss_pred             hcccccchheeeecccCceEEEEEEe--CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCc
Confidence            35678999999999999999999998  6799999998643211      111122223333333322            


Q ss_pred             --------------CCchhhhhhhHHH-------------H-------------------------------HHHHHHHH
Q psy14630         82 --------------CPYIVQFYGALFK-------------E-------------------------------VTVATVKA  103 (187)
Q Consensus        82 --------------h~~iv~~~~~~~~-------------~-------------------------------~~~~~~~~  103 (187)
                                    ||||+++++.+..             .                               ++.|++.|
T Consensus        94 iv~l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~~~~~~~~~~~i~~qi~~a  173 (336)
T 2vuw_A           94 FIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTAS  173 (336)
T ss_dssp             BCCEEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTTTCCCHHHHHHHHHHHHHH
T ss_pred             hhhhcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHhcCCCHHHHHHHHHHHHHH
Confidence                          7888888776654             2                               77899999


Q ss_pred             HHHHH-hcCCCeeecCCCCCeEEcCCC--------------------CEEEEeccccccccccccccCCCCCcCccCccc
Q psy14630        104 LNYLK-EELKIIHRDVKPSNILLDRRG--------------------AIKLCDFGISGQLVDSIAKTRDAGCRPYMAPER  162 (187)
Q Consensus       104 l~~lh-~~~~i~Hrdlk~~nili~~~~--------------------~~ki~dfg~a~~~~~~~~~~~~~~t~~y~aPE~  162 (187)
                      |.||| +. +|+||||||+|||++.++                    .+||+|||+|+.....    ...||+.|+|||+
T Consensus       174 L~~lH~~~-~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~----~~~gt~~y~aPE~  248 (336)
T 2vuw_A          174 LAVAEASL-RFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG----IVVFCDVSMDEDL  248 (336)
T ss_dssp             HHHHHHHH-CCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT----EEECCCCTTCSGG
T ss_pred             HHHHHHhC-CEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC----cEEEeecccChhh
Confidence            99999 77 999999999999999887                    8999999999876543    2378999999999


Q ss_pred             cCCCccCCCCCCcceeeeEe
Q psy14630        163 IDPLRARGYPSFKTKLGFKF  182 (187)
Q Consensus       163 ~~~~~~~~~~~~~D~ws~gi  182 (187)
                      +.+   .. +.++||||++.
T Consensus       249 ~~g---~~-~~~~Diwsl~~  264 (336)
T 2vuw_A          249 FTG---DG-DYQFDIYRLMK  264 (336)
T ss_dssp             GCC---CS-SHHHHHHHHHH
T ss_pred             hcC---CC-ccceehhhhhC
Confidence            983   33 78999999855

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A*

Probab=99.97  E-value=1e-31  Score=206.22  Aligned_cols=155  Identities=26%  Similarity=0.316  Sum_probs=124.7

Q ss_pred             CcccccccccccccCceEEEEEEEcCCCcEEEEEEccCccChHHHHHHHHHHHHHHhcCCCCchhhhhhhH---------
Q psy14630         22 TSEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQFYGAL---------   92 (187)
Q Consensus        22 ~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~---------   92 (187)
                      ..++|++.+.||+|+||.||+|.+ .+++.||+|.+......  ..+.+.++..+++.++||||+++++.+         
T Consensus        37 ~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv  113 (321)
T 2qkw_B           37 ATNNFDHKFLIGHGVFGKVYKGVL-RDGAKVALKRRTPESSQ--GIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILI  113 (321)
T ss_dssp             CCCCCSCCCCSCBCSSSEEEEEEC-TTCCEEEEEECCSCCSS--HHHHHHHHHHGGGSCCCTTBCCEEEECCCTTCCEEE
T ss_pred             HHhccCccceeecCCCeeEEEEEE-CCCCEEEEEEecccChH--HHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEE
Confidence            457899999999999999999996 46889999988654322  234456666678888999999887532         


Q ss_pred             ---------------------------HHHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEecccccccccc
Q psy14630         93 ---------------------------FKEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDS  145 (187)
Q Consensus        93 ---------------------------~~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg~a~~~~~~  145 (187)
                                                 ...+..|++.||.|||+. +++||||||+||+++.++.+||+|||+++.....
T Consensus       114 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~-~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  192 (321)
T 2qkw_B          114 YKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTR-AIIHRDVKSINILLDENFVPKITDFGISKKGTEL  192 (321)
T ss_dssp             EECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCCSTTEEECTTCCEEECCCTTCEECSSS
T ss_pred             EEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCC-CeecCCCCHHHEEECCCCCEEEeecccccccccc
Confidence                                       112678899999999997 9999999999999999999999999999865422


Q ss_pred             ---ccccCCCCCcCccCccccCCCccCCCCCCcceeeeEee
Q psy14630        146 ---IAKTRDAGCRPYMAPERIDPLRARGYPSFKTKLGFKFN  183 (187)
Q Consensus       146 ---~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi~  183 (187)
                         .......||+.|+|||.+.   ...++.++|+||+|++
T Consensus       193 ~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Di~slG~i  230 (321)
T 2qkw_B          193 DQTHLSTVVKGTLGYIDPEYFI---KGRLTEKSDVYSFGVV  230 (321)
T ss_dssp             SCCCCBCCCEEETTTCCHHHHH---HCBCCTHHHHHHHHHH
T ss_pred             cccccccccCCCccccCHHHhc---CCCCCcccchHhHHHH
Confidence               1122335789999999987   5668999999999994

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A*

Probab=99.97  E-value=6.1e-32  Score=203.70  Aligned_cols=155  Identities=21%  Similarity=0.420  Sum_probs=121.1

Q ss_pred             cccccccccccccCceEEEEEEEcCCCcEEEEEEccCccC-hHHHHHHHHHHHHHHhcCCCCchhhhhhhH---------
Q psy14630         23 SEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVD-EKDQRQLLMDLDVVMKSNECPYIVQFYGAL---------   92 (187)
Q Consensus        23 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~---------   92 (187)
                      .++|++.+.||+|+||.||+|.+..+++.||+|.++.... .....+.+.++..+.....||||+++++.+         
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~lv   89 (289)
T 1x8b_A           10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQ   89 (289)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEEE
T ss_pred             cchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEE
Confidence            4789999999999999999999999999999999875433 233344455555444444999999886432         


Q ss_pred             ---------------------------HHHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcC------------------
Q psy14630         93 ---------------------------FKEVTVATVKALNYLKEELKIIHRDVKPSNILLDR------------------  127 (187)
Q Consensus        93 ---------------------------~~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~------------------  127 (187)
                                                 ...++.|++.||.|||+. +++||||||+||+++.                  
T Consensus        90 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~-~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~~~  168 (289)
T 1x8b_A           90 NEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSM-SLVHMDIKPSNIFISRTSIPNAASEEGDEDDWAS  168 (289)
T ss_dssp             EECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEEC-------------------
T ss_pred             EEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhC-CEeecCCCHHHEEEcCCCCCcccccccccccccC
Confidence                                       112677899999999998 9999999999999984                  


Q ss_pred             -CCCEEEEeccccccccccccccCCCCCcCccCccccCCCccCCCCCCcceeeeEee
Q psy14630        128 -RGAIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPLRARGYPSFKTKLGFKFN  183 (187)
Q Consensus       128 -~~~~ki~dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi~  183 (187)
                       ...++|+|||++.......   ...+|+.|+|||.+.+  ...++.++|+||+|++
T Consensus       169 ~~~~~kl~Dfg~~~~~~~~~---~~~gt~~y~aPE~~~~--~~~~~~~~Di~slG~i  220 (289)
T 1x8b_A          169 NKVMFKIGDLGHVTRISSPQ---VEEGDSRFLANEVLQE--NYTHLPKADIFALALT  220 (289)
T ss_dssp             -CCCEEECCCTTCEETTCSC---CCCCCGGGCCHHHHTT--CCTTHHHHHHHHHHHH
T ss_pred             CceEEEEcccccccccCCcc---ccCCCccccChhHhcC--CCCCCchhhHHHHHHH
Confidence             4479999999998765432   2358999999999873  2345679999999994

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens}

Probab=99.97  E-value=3.6e-32  Score=208.20  Aligned_cols=165  Identities=19%  Similarity=0.222  Sum_probs=128.6

Q ss_pred             CccccCCcccccccccccccCceEEEEEEEcCCCcEEEEEEccCccChHHHHHHHHHHHHHHhcCCCCchhhhhhhHH--
Q psy14630         16 DTVYDFTSEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQFYGALF--   93 (187)
Q Consensus        16 ~~~~~~~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~--   93 (187)
                      +..+.+..++|++.+.||+|+||.||+|.+..+++.||+|.+...  .....+.+.++..+++.+.||||+++++.+.  
T Consensus        21 g~~~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~   98 (317)
T 2buj_A           21 GHMVIIDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCH--EQQDREEAQREADMHRLFNHPNILRLVAYCLRE   98 (317)
T ss_dssp             EEEEEETTEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEES--SHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEE
T ss_pred             ccEEEECCeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecC--CHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEec
Confidence            455567889999999999999999999999999999999988542  2334455666677788889999998865321  


Q ss_pred             --------------------------------------HHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEe
Q psy14630         94 --------------------------------------KEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCD  135 (187)
Q Consensus        94 --------------------------------------~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~d  135 (187)
                                                            ..++.|++.||.|||+. +++||||||+||+++.++.++|+|
T Consensus        99 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~-~ivH~dlkp~NIl~~~~~~~kl~d  177 (317)
T 2buj_A           99 RGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAK-GYAHRDLKPTNILLGDEGQPVLMD  177 (317)
T ss_dssp             ETTEEEEEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCCGGGEEECTTSCEEECC
T ss_pred             cCCCceeEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC-CcccCCCCHHHEEEcCCCCEEEEe
Confidence                                                  11667899999999998 999999999999999999999999


Q ss_pred             cccccccccccc----------ccCCCCCcCccCccccCCCccCCCCCCcceeeeEee
Q psy14630        136 FGISGQLVDSIA----------KTRDAGCRPYMAPERIDPLRARGYPSFKTKLGFKFN  183 (187)
Q Consensus       136 fg~a~~~~~~~~----------~~~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi~  183 (187)
                      ||++........          .....||+.|+|||.+.+.....++.++|+||+|++
T Consensus       178 fg~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~i  235 (317)
T 2buj_A          178 LGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCV  235 (317)
T ss_dssp             CSSCEESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHH
T ss_pred             cCcchhcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHH
Confidence            999876532111          112346899999999874323346889999999994

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A*

Probab=99.97  E-value=3.1e-32  Score=209.89  Aligned_cols=158  Identities=23%  Similarity=0.397  Sum_probs=121.1

Q ss_pred             Cccccccc-ccccccCceEEEEEEEcCCCcEEEEEEccCccChH-HHHHHHHHHHHHHhcCCCCchhhhhhhH-------
Q psy14630         22 TSEDLQDL-GEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEK-DQRQLLMDLDVVMKSNECPYIVQFYGAL-------   92 (187)
Q Consensus        22 ~~~~~~~~-~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~~~~~~~~~~h~~iv~~~~~~-------   92 (187)
                      ..+.|.+. +.||+|+||.||+|.+..+++.||+|+++...... .......+...+....+||||+++++.+       
T Consensus        26 ~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~~~~  105 (327)
T 3lm5_A           26 FNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSEII  105 (327)
T ss_dssp             HHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred             hhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeCCeEE
Confidence            34667776 88999999999999999999999999986543222 2234444445444455779999876432       


Q ss_pred             ---------------------------HHHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcC---CCCEEEEeccccccc
Q psy14630         93 ---------------------------FKEVTVATVKALNYLKEELKIIHRDVKPSNILLDR---RGAIKLCDFGISGQL  142 (187)
Q Consensus        93 ---------------------------~~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~---~~~~ki~dfg~a~~~  142 (187)
                                                 ...++.|++.||.|||+. +++||||||+||+++.   .+.+||+|||+++..
T Consensus       106 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~-givH~Dikp~NIl~~~~~~~~~~kL~Dfg~a~~~  184 (327)
T 3lm5_A          106 LILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQN-NIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKI  184 (327)
T ss_dssp             EEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCCGGGEEESCBTTBCCEEECCGGGCEEC
T ss_pred             EEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHC-CeecCcCChHHEEEecCCCCCcEEEeeCcccccc
Confidence                                       123778999999999998 9999999999999987   789999999999887


Q ss_pred             cccccccCCCCCcCccCccccCCCccCCCCCCcceeeeEee
Q psy14630        143 VDSIAKTRDAGCRPYMAPERIDPLRARGYPSFKTKLGFKFN  183 (187)
Q Consensus       143 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi~  183 (187)
                      ..........||+.|+|||.+.   ...++.++|+||+|++
T Consensus       185 ~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwslG~i  222 (327)
T 3lm5_A          185 GHACELREIMGTPEYLAPEILN---YDPITTATDMWNIGII  222 (327)
T ss_dssp             ---------CCCGGGCCHHHHT---TCCCCTHHHHHHHHHH
T ss_pred             CCccccccccCCcCccCCeeec---CCCCCchhhHHHHHHH
Confidence            6554445567999999999998   6678999999999994

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ...

Probab=99.97  E-value=6.6e-32  Score=203.59  Aligned_cols=157  Identities=21%  Similarity=0.289  Sum_probs=123.4

Q ss_pred             cccccccccccccCceEEEEEEEcCCCcEEEEEEccCccChH----HHHHHHHHHHHHHhcCCCCchhhhhhhH------
Q psy14630         23 SEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEK----DQRQLLMDLDVVMKSNECPYIVQFYGAL------   92 (187)
Q Consensus        23 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~----~~~~~~~~~~~~~~~~~h~~iv~~~~~~------   92 (187)
                      .++|++.+.||+|+||.||+|.+..+++.||+|.++......    ...+.+.++..+++.+.||||+++++.+      
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~   83 (283)
T 3bhy_A            4 EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDV   83 (283)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             hhhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeE
Confidence            468999999999999999999999999999999986432111    1234455566677788999999886532      


Q ss_pred             --------------------------HHHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCC----CEEEEeccccccc
Q psy14630         93 --------------------------FKEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRG----AIKLCDFGISGQL  142 (187)
Q Consensus        93 --------------------------~~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~----~~ki~dfg~a~~~  142 (187)
                                                ...++.|++.||.|||+. +++||||||+||+++.++    .++|+|||++...
T Consensus        84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~-~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~~~  162 (283)
T 3bhy_A           84 VLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHSK-RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKI  162 (283)
T ss_dssp             EEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEESCSSSSSCCEEECCCTTCEEC
T ss_pred             EEEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC-CccCCCCChHHEEEecCCCCCCceEEEecccceec
Confidence                                      112678899999999998 999999999999998877    7999999999887


Q ss_pred             cccccccCCCCCcCccCccccCCCccCCCCCCcceeeeEee
Q psy14630        143 VDSIAKTRDAGCRPYMAPERIDPLRARGYPSFKTKLGFKFN  183 (187)
Q Consensus       143 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi~  183 (187)
                      ..........+++.|+|||.+.   ...++.++|+||+|++
T Consensus       163 ~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~Di~slG~i  200 (283)
T 3bhy_A          163 EAGNEFKNIFGTPEFVAPEIVN---YEPLGLEADMWSIGVI  200 (283)
T ss_dssp             C--------CCCGGGCCHHHHT---TCCCCTHHHHHHHHHH
T ss_pred             cCCCcccccCCCcCccCcceec---CCCCCcchhhhhHHHH
Confidence            6544444557899999999998   5678899999999984

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ...

Probab=99.97  E-value=8.7e-32  Score=215.79  Aligned_cols=161  Identities=20%  Similarity=0.292  Sum_probs=124.9

Q ss_pred             CccccCCcccccccccccccCceEEEEEEEcCCCcEEEEEEccCccChHHHHHHHHHHHHHHhcCCCCchhhhhhhHH--
Q psy14630         16 DTVYDFTSEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQFYGALF--   93 (187)
Q Consensus        16 ~~~~~~~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~--   93 (187)
                      ...|++..++|++.+.||+|+||.||+|.+.. +..||||.++.....   .+.+.++..+++.++||||+++++.+.  
T Consensus       176 ~~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~hp~iv~~~~~~~~~  251 (452)
T 1fmk_A          176 KDAWEIPRESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTMS---PEAFLQEAQVMKKLRHEKLVQLYAVVSEE  251 (452)
T ss_dssp             TTCSBCCGGGEEEEEEEEECSSCEEEEEEETT-TEEEEEEECCTTSSC---HHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             ccccccChhHceeeeeecCCCCeEEEEEEECC-CceEEEEEeccCCCC---HHHHHHHHHHHHhCCCCCEeeEEEEEcCC
Confidence            45688899999999999999999999999864 467999998753322   234556667788889999998875321  


Q ss_pred             -------------------------------HHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEeccccccc
Q psy14630         94 -------------------------------KEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQL  142 (187)
Q Consensus        94 -------------------------------~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg~a~~~  142 (187)
                                                     ..++.|++.||.|||+. +++||||||+||+++.++.+||+|||+++..
T Consensus       252 ~~~iv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~-~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~  330 (452)
T 1fmk_A          252 PIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM-NYVHRDLRAANILVGENLVCKVADFGLARLI  330 (452)
T ss_dssp             SCEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCSGGGEEECGGGCEEECCCCTTC--
T ss_pred             ceEEEehhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC-CeeCCCCChhhEEECCCCCEEECCCccceec
Confidence                                           12667899999999997 9999999999999999999999999999876


Q ss_pred             cccccc--cCCCCCcCccCccccCCCccCCCCCCcceeeeEeee
Q psy14630        143 VDSIAK--TRDAGCRPYMAPERIDPLRARGYPSFKTKLGFKFNY  184 (187)
Q Consensus       143 ~~~~~~--~~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi~~  184 (187)
                      ......  ....++..|+|||.+.   ...++.++|+||||+++
T Consensus       331 ~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~sDvwslG~~l  371 (452)
T 1fmk_A          331 EDNEYTARQGAKFPIKWTAPEAAL---YGRFTIKSDVWSFGILL  371 (452)
T ss_dssp             ------------CCGGGSCHHHHH---HCCCCHHHHHHHHHHHH
T ss_pred             CCCceecccCCcccccccCHhHHh---cCCCCccccHHhHHHHH
Confidence            543221  2234677899999998   56789999999999943

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7

Probab=99.97  E-value=1e-31  Score=207.59  Aligned_cols=161  Identities=24%  Similarity=0.380  Sum_probs=128.5

Q ss_pred             cccCCcccccccccccccCceEEEEEEEc-----CCCcEEEEEEccCccChHHHHHHHHHHHHHHhcCCCCchhhhhhhH
Q psy14630         18 VYDFTSEDLQDLGEIGRGGFGTVNKMIHR-----SSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQFYGAL   92 (187)
Q Consensus        18 ~~~~~~~~~~~~~~lg~G~fg~V~~~~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~   92 (187)
                      .+++..++|++.+.||+|+||.||+|.+.     .+++.||+|.++..... ...+.+.++..+++.++||||+++++.+
T Consensus        41 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~  119 (343)
T 1luf_A           41 SLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASA-DMQADFQREAALMAEFDNPNIVKLLGVC  119 (343)
T ss_dssp             HTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCH-HHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred             eeEecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCH-HHHHHHHHHHHHHHhCCCCCEEEEEEEE
Confidence            45778899999999999999999999986     35588999998754333 3345566666778888999999886421


Q ss_pred             ---------------------H-----------------------------------HHHHHHHHHHHHHHHhcCCCeee
Q psy14630         93 ---------------------F-----------------------------------KEVTVATVKALNYLKEELKIIHR  116 (187)
Q Consensus        93 ---------------------~-----------------------------------~~~~~~~~~~l~~lh~~~~i~Hr  116 (187)
                                           .                                   ..++.|++.||.|||+. +++||
T Consensus       120 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~-~ivH~  198 (343)
T 1luf_A          120 AVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER-KFVHR  198 (343)
T ss_dssp             CSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT-TCCCS
T ss_pred             ccCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhC-CeecC
Confidence                                 1                                   11567899999999998 99999


Q ss_pred             cCCCCCeEEcCCCCEEEEeccccccccccc---cccCCCCCcCccCccccCCCccCCCCCCcceeeeEee
Q psy14630        117 DVKPSNILLDRRGAIKLCDFGISGQLVDSI---AKTRDAGCRPYMAPERIDPLRARGYPSFKTKLGFKFN  183 (187)
Q Consensus       117 dlk~~nili~~~~~~ki~dfg~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi~  183 (187)
                      ||||+||+++.++.+||+|||+++......   ......+|+.|+|||.+.   ...++.++|+||||++
T Consensus       199 Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~---~~~~~~~~Di~slG~i  265 (343)
T 1luf_A          199 DLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIF---YNRYTTESDVWAYGVV  265 (343)
T ss_dssp             CCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHH---HCCCCHHHHHHHHHHH
T ss_pred             CCCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhc---cCCcCcccccHHHHHH
Confidence            999999999999999999999998764332   122345788899999988   5668999999999994

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A

Probab=99.97  E-value=5.3e-32  Score=208.52  Aligned_cols=151  Identities=23%  Similarity=0.317  Sum_probs=101.3

Q ss_pred             cccccc---ccccccCceEEEEEEEcCCCcEEEEEEccCccChHHHHHHHHHHHHHHhcC-CCCchhhhhhhH-------
Q psy14630         24 EDLQDL---GEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSN-ECPYIVQFYGAL-------   92 (187)
Q Consensus        24 ~~~~~~---~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~-~h~~iv~~~~~~-------   92 (187)
                      ++|++.   +.||+|+||.||+|.+..+++.||+|++...    ..... .++...++.+ +||||+++++.+       
T Consensus         8 ~~y~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~-~~e~~~l~~l~~h~niv~~~~~~~~~~~~~   82 (325)
T 3kn6_A            8 QHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKR----MEANT-QKEITALKLCEGHPNIVKLHEVFHDQLHTF   82 (325)
T ss_dssp             HHEEECTTSCCSEEETTEEEEEEEETTTCCEEEEEEEEGG----GHHHH-HHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred             hccccccCCCccccCCCeEEEEEEECCCCCEEEEEEEChh----hhhhH-HHHHHHHHHhcCCCCeeEEEEEEEcCCEEE
Confidence            455553   7899999999999999999999999998632    11222 3333344444 599999987532       


Q ss_pred             -------------------------HHHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCC---CEEEEeccccccccc
Q psy14630         93 -------------------------FKEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRG---AIKLCDFGISGQLVD  144 (187)
Q Consensus        93 -------------------------~~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~---~~ki~dfg~a~~~~~  144 (187)
                                               ...++.|++.||.|||+. +++||||||+||+++..+   .+||+|||+++....
T Consensus        83 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~-~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~  161 (325)
T 3kn6_A           83 LVMELLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHMHDV-GVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPP  161 (325)
T ss_dssp             EEECCCCSCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCCGGGEEEEC----CEEEECCCTTCEECCC
T ss_pred             EEEEccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC-CCeecCCCHHHEEEecCCCcccEEEeccccceecCC
Confidence                                     112678999999999998 999999999999997665   799999999986543


Q ss_pred             c-ccccCCCCCcCccCccccCCCccCCCCCCcceeeeEee
Q psy14630        145 S-IAKTRDAGCRPYMAPERIDPLRARGYPSFKTKLGFKFN  183 (187)
Q Consensus       145 ~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi~  183 (187)
                      . .......+|+.|+|||.+.   ...++.++|+||+|++
T Consensus       162 ~~~~~~~~~~t~~y~aPE~~~---~~~~~~~~DiwslG~i  198 (325)
T 3kn6_A          162 DNQPLKTPCFTLHYAAPELLN---QNGYDESCDLWSLGVI  198 (325)
T ss_dssp             -------------------------CCCCHHHHHHHHHHH
T ss_pred             CCCcccccCCCcCccCHHHhc---CCCCCCccchHHHHHH
Confidence            2 2223446899999999998   6678999999999993

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ...

Probab=99.97  E-value=9.5e-32  Score=206.24  Aligned_cols=164  Identities=20%  Similarity=0.406  Sum_probs=130.5

Q ss_pred             CCccccCCcccccccccccccCceEEEEEEEc-----CCCcEEEEEEccCccChHHHHHHHHHHHHHHhcCCCCchhhhh
Q psy14630         15 PDTVYDFTSEDLQDLGEIGRGGFGTVNKMIHR-----SSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQFY   89 (187)
Q Consensus        15 ~~~~~~~~~~~~~~~~~lg~G~fg~V~~~~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~   89 (187)
                      ....|++..++|++.+.||+|+||.||+|.+.     .+++.||+|.+....... ....+.++..+++.+.||||++++
T Consensus        16 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~   94 (322)
T 1p4o_A           16 VPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMR-ERIEFLNEASVMKEFNCHHVVRLL   94 (322)
T ss_dssp             CCCTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHH-HHHHHHHHHHHGGGCCCTTBCCEE
T ss_pred             ChhhhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHH-HHHHHHHHHHHHHhcCCCCEeeeE
Confidence            34577888899999999999999999999875     457889999987543332 334455666778889999999876


Q ss_pred             hhH---------------------H---------------------HHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcC
Q psy14630         90 GAL---------------------F---------------------KEVTVATVKALNYLKEELKIIHRDVKPSNILLDR  127 (187)
Q Consensus        90 ~~~---------------------~---------------------~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~  127 (187)
                      +.+                     .                     ..++.|++.||.|||+. +++||||||+||+++.
T Consensus        95 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~-~i~H~dikp~NIli~~  173 (322)
T 1p4o_A           95 GVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN-KFVHRDLAARNCMVAE  173 (322)
T ss_dssp             EEECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT-TCBCSCCSGGGEEECT
T ss_pred             EEEccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHC-CCccCCCccceEEEcC
Confidence            421                     0                     11567899999999998 9999999999999999


Q ss_pred             CCCEEEEeccccccccccc---cccCCCCCcCccCccccCCCccCCCCCCcceeeeEee
Q psy14630        128 RGAIKLCDFGISGQLVDSI---AKTRDAGCRPYMAPERIDPLRARGYPSFKTKLGFKFN  183 (187)
Q Consensus       128 ~~~~ki~dfg~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi~  183 (187)
                      ++.+||+|||+++......   ......+++.|+|||.+.   ...++.++|+||+|++
T Consensus       174 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~Di~slG~i  229 (322)
T 1p4o_A          174 DFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLK---DGVFTTYSDVWSFGVV  229 (322)
T ss_dssp             TCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHH---HCCCCHHHHHHHHHHH
T ss_pred             CCeEEECcCccccccccccccccccCCCCCCCccChhhhc---cCCCCchhhHHHHHHH
Confidence            9999999999998764332   122335678899999987   5668899999999993

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis}

Probab=99.97  E-value=2.8e-31  Score=203.00  Aligned_cols=158  Identities=23%  Similarity=0.246  Sum_probs=118.8

Q ss_pred             CcccccccccccccCceEEEEEEEcCCCcEEEEEEccCcc-ChHHHHHHHHHHHHHHhcCCCCchhhhhhhH--------
Q psy14630         22 TSEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTV-DEKDQRQLLMDLDVVMKSNECPYIVQFYGAL--------   92 (187)
Q Consensus        22 ~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~--------   92 (187)
                      ..++|++.+.||+|+||.||+|.+..+++.||+|++.... ......+.+.++..+++.+.||||+++++.+        
T Consensus        32 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~l  111 (309)
T 2h34_A           32 QFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYV  111 (309)
T ss_dssp             --CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEE
T ss_pred             EeccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEE
Confidence            4578999999999999999999999999999999986542 2233445666677778888999999886532        


Q ss_pred             ------------------------HHHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEeccccccccccc--
Q psy14630         93 ------------------------FKEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSI--  146 (187)
Q Consensus        93 ------------------------~~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg~a~~~~~~~--  146 (187)
                                              ...++.+++.|+.|||+. +++||||||+||+++.++.+||+|||++.......  
T Consensus       112 v~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~-~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~  190 (309)
T 2h34_A          112 DMRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAHAA-GATHRDVKPENILVSADDFAYLVDFGIASATTDEKLT  190 (309)
T ss_dssp             EEECCCCEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCCGGGEEECTTSCEEECSCCC----------
T ss_pred             EEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC-cCCcCCCChHHEEEcCCCCEEEecCccCccccccccc
Confidence                                    112678899999999998 99999999999999999999999999988765432  


Q ss_pred             cccCCCCCcCccCccccCCCccCCCCCCcceeeeEee
Q psy14630        147 AKTRDAGCRPYMAPERIDPLRARGYPSFKTKLGFKFN  183 (187)
Q Consensus       147 ~~~~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi~  183 (187)
                      ......+++.|+|||.+.   ...++.++|+||+|+.
T Consensus       191 ~~~~~~~~~~y~aPE~~~---~~~~~~~~Di~slG~i  224 (309)
T 2h34_A          191 QLGNTVGTLYYMAPERFS---ESHATYRADIYALTCV  224 (309)
T ss_dssp             ------CCGGGCCGGGTC---C----CCCHHHHHHHH
T ss_pred             cccccCCCcCccCHHHHc---CCCCCchHhHHHHHHH
Confidence            122346889999999998   5678899999999993

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7

Probab=99.97  E-value=6.5e-32  Score=208.99  Aligned_cols=163  Identities=23%  Similarity=0.373  Sum_probs=125.4

Q ss_pred             CccccCCcccccccccccccCceEEEEEEEc-----CCCcEEEEEEccCccChHHHHHHHHHHHHHHhcC-CCCchhhhh
Q psy14630         16 DTVYDFTSEDLQDLGEIGRGGFGTVNKMIHR-----SSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSN-ECPYIVQFY   89 (187)
Q Consensus        16 ~~~~~~~~~~~~~~~~lg~G~fg~V~~~~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~-~h~~iv~~~   89 (187)
                      ...|+++.++|++.+.||+|+||.||+|.+.     .++..||+|.++...... ..+.+..+..+++.+ .||||++++
T Consensus        37 ~~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~E~~~l~~l~~hp~iv~~~  115 (344)
T 1rjb_A           37 DLKWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSS-EREALMSELKMMTQLGSHENIVNLL  115 (344)
T ss_dssp             CGGGBCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC-------CHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred             CcCcccCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHH-HHHHHHHHHHHHHhhcCCCCeeeEE
Confidence            4567889999999999999999999999973     456789999987533222 233444455555566 899999876


Q ss_pred             hhH-------------------------------------------------------HHHHHHHHHHHHHHHHhcCCCe
Q psy14630         90 GAL-------------------------------------------------------FKEVTVATVKALNYLKEELKII  114 (187)
Q Consensus        90 ~~~-------------------------------------------------------~~~~~~~~~~~l~~lh~~~~i~  114 (187)
                      +.+                                                       ...++.|++.||.|||+. +++
T Consensus       116 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~-~iv  194 (344)
T 1rjb_A          116 GACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK-SCV  194 (344)
T ss_dssp             EEECSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT-TEE
T ss_pred             EEEeeCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhC-Ccc
Confidence            421                                                       012567899999999998 999


Q ss_pred             eecCCCCCeEEcCCCCEEEEecccccccccccc---ccCCCCCcCccCccccCCCccCCCCCCcceeeeEee
Q psy14630        115 HRDVKPSNILLDRRGAIKLCDFGISGQLVDSIA---KTRDAGCRPYMAPERIDPLRARGYPSFKTKLGFKFN  183 (187)
Q Consensus       115 Hrdlk~~nili~~~~~~ki~dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi~  183 (187)
                      ||||||+||+++.++.+||+|||++........   .....+|+.|+|||.+.   ...++.++|+||||++
T Consensus       195 H~Dikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~---~~~~~~~~Di~slG~i  263 (344)
T 1rjb_A          195 HRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLF---EGIYTIKSDVWSYGIL  263 (344)
T ss_dssp             ETTCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHH---HCCCCHHHHHHHHHHH
T ss_pred             cCCCChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhc---cCCCChhHhHHHHHHH
Confidence            999999999999999999999999987643321   22234677899999987   5678899999999994

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A*

Probab=99.97  E-value=9e-32  Score=209.62  Aligned_cols=160  Identities=21%  Similarity=0.302  Sum_probs=119.5

Q ss_pred             cCCcccccccccccccCceEEEEEEEcCCCcEEEEEEccCcc---------ChHHHHHHHHHHHHHHhcCCCCchhhhhh
Q psy14630         20 DFTSEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTV---------DEKDQRQLLMDLDVVMKSNECPYIVQFYG   90 (187)
Q Consensus        20 ~~~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~---------~~~~~~~~~~~~~~~~~~~~h~~iv~~~~   90 (187)
                      ....++|++.+.||+|+||.||+|.+.. ++.||+|.+....         ......+.+.++..+++.++||||+++++
T Consensus        18 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~   96 (362)
T 3pg1_A           18 HAMQSPYTVQRFISSGSYGAVCAGVDSE-GIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRD   96 (362)
T ss_dssp             HHTTCSCEEEEEEEEETTEEEEEEECTT-SCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSE
T ss_pred             HHhccceEEeEEeccCCCEEEEEEECCC-CCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccceee
Confidence            3456889999999999999999999854 8899999985321         12223355666677788889999998865


Q ss_pred             hH-------------------------------------HHHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEE
Q psy14630         91 AL-------------------------------------FKEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKL  133 (187)
Q Consensus        91 ~~-------------------------------------~~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki  133 (187)
                      .+                                     ...++.|++.||.|||+. +++||||||+||+++.++.+||
T Consensus        97 ~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~-~ivH~Dlkp~NIl~~~~~~~kl  175 (362)
T 3pg1_A           97 IFVHFEEPAMHKLYLVTELMRTDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEA-GVVHRDLHPGNILLADNNDITI  175 (362)
T ss_dssp             EEEECCTTTCCEEEEEEECCSEEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHT-TCCCCCCCGGGEEECTTCCEEE
T ss_pred             eEEeccCCCcceEEEEEccCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHC-cCEecCCChHHEEEcCCCCEEE
Confidence            43                                     112678999999999998 9999999999999999999999


Q ss_pred             EeccccccccccccccCCCCCcCccCccccCCCccCCCCCCcceeeeEee
Q psy14630        134 CDFGISGQLVDSIAKTRDAGCRPYMAPERIDPLRARGYPSFKTKLGFKFN  183 (187)
Q Consensus       134 ~dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi~  183 (187)
                      +|||+++............+|+.|+|||.+.+  ...++.++|+||+|++
T Consensus       176 ~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~--~~~~~~~~DiwslG~i  223 (362)
T 3pg1_A          176 CDFNLAREDTADANKTHYVTHRWYRAPELVMQ--FKGFTKLVDMWSAGCV  223 (362)
T ss_dssp             CCTTC---------------CGGGCCHHHHTT--CTTCCTHHHHHHHHHH
T ss_pred             EecCcccccccccccceecccceecCcHHhcC--CCCCCcHhHHHhHHHH
Confidence            99999987655544555678999999999873  2568899999999994

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ...

Probab=99.97  E-value=4.4e-32  Score=207.41  Aligned_cols=164  Identities=26%  Similarity=0.423  Sum_probs=127.9

Q ss_pred             CccccCCcccccccccccccCceEEEEEEE-----cCCCcEEEEEEccCccChHHHHHHHHHHHHHHhcCCCCchhhhhh
Q psy14630         16 DTVYDFTSEDLQDLGEIGRGGFGTVNKMIH-----RSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQFYG   90 (187)
Q Consensus        16 ~~~~~~~~~~~~~~~~lg~G~fg~V~~~~~-----~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~   90 (187)
                      ...|++..++|++.+.||+|+||.||+|.+     ..+++.||+|.++.............+...+.+..+||||+++++
T Consensus        19 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~   98 (316)
T 2xir_A           19 ASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLG   98 (316)
T ss_dssp             HHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred             ccceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEEE
Confidence            356788999999999999999999999985     356789999998765444433444444444444448999998764


Q ss_pred             hHH-------------------------------------------------HHHHHHHHHHHHHHHhcCCCeeecCCCC
Q psy14630         91 ALF-------------------------------------------------KEVTVATVKALNYLKEELKIIHRDVKPS  121 (187)
Q Consensus        91 ~~~-------------------------------------------------~~~~~~~~~~l~~lh~~~~i~Hrdlk~~  121 (187)
                      .+.                                                 ..++.|++.||.|||+. +++||||||+
T Consensus        99 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~-~i~H~dikp~  177 (316)
T 2xir_A           99 ACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR-KCIHRDLAAR  177 (316)
T ss_dssp             EECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHT-TCCCSCCSGG
T ss_pred             EEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhC-CcccccCccc
Confidence            321                                                 11556899999999998 9999999999


Q ss_pred             CeEEcCCCCEEEEeccccccccccc---cccCCCCCcCccCccccCCCccCCCCCCcceeeeEee
Q psy14630        122 NILLDRRGAIKLCDFGISGQLVDSI---AKTRDAGCRPYMAPERIDPLRARGYPSFKTKLGFKFN  183 (187)
Q Consensus       122 nili~~~~~~ki~dfg~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi~  183 (187)
                      ||+++.++.+||+|||+++......   ......+|+.|+|||.+.   ...++.++|+||+|++
T Consensus       178 Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~---~~~~~~~~Di~slG~i  239 (316)
T 2xir_A          178 NILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIF---DRVYTIQSDVWSFGVL  239 (316)
T ss_dssp             GEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHH---HCCCCHHHHHHHHHHH
T ss_pred             eEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhc---cccccchhHHHHHHHH
Confidence            9999999999999999998764322   122335678899999997   6678899999999993

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A

Probab=99.97  E-value=1.5e-31  Score=209.06  Aligned_cols=159  Identities=26%  Similarity=0.395  Sum_probs=125.4

Q ss_pred             ccccccccccccCceEEEEEEEcCCCcEEEEEEccCccC---h---HHHHHHHHHHHHHHhcC-CCCchhhhhhhH----
Q psy14630         24 EDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVD---E---KDQRQLLMDLDVVMKSN-ECPYIVQFYGAL----   92 (187)
Q Consensus        24 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~~---~---~~~~~~~~~~~~~~~~~-~h~~iv~~~~~~----   92 (187)
                      ++|++.+.||+|+||.||+|.+..+++.||||++.....   .   ....+.+..+..+++.+ .||||+++++.+    
T Consensus        94 ~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~  173 (365)
T 2y7j_A           94 QKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSS  173 (365)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEBSS
T ss_pred             hhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEeeCC
Confidence            568888999999999999999988999999999864321   1   11233444455555555 899999876432    


Q ss_pred             ----------------------------HHHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEeccccccccc
Q psy14630         93 ----------------------------FKEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVD  144 (187)
Q Consensus        93 ----------------------------~~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg~a~~~~~  144 (187)
                                                  ...++.|++.||.|||+. +++|+||||+||+++.++.++|+|||++..+..
T Consensus       174 ~~~lv~e~~~g~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~-gi~H~Dlkp~NIl~~~~~~ikl~DfG~~~~~~~  252 (365)
T 2y7j_A          174 FMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHAN-NIVHRDLKPENILLDDNMQIRLSDFGFSCHLEP  252 (365)
T ss_dssp             EEEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEECTTCCEEECCCTTCEECCT
T ss_pred             EEEEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC-CeecCCCCHHHEEECCCCCEEEEecCcccccCC
Confidence                                        112677999999999998 999999999999999999999999999988766


Q ss_pred             cccccCCCCCcCccCccccCCC---ccCCCCCCcceeeeEee
Q psy14630        145 SIAKTRDAGCRPYMAPERIDPL---RARGYPSFKTKLGFKFN  183 (187)
Q Consensus       145 ~~~~~~~~~t~~y~aPE~~~~~---~~~~~~~~~D~ws~gi~  183 (187)
                      ........||+.|+|||.+.+.   ....++.++|+||+|++
T Consensus       253 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~i  294 (365)
T 2y7j_A          253 GEKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVI  294 (365)
T ss_dssp             TCCBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHH
T ss_pred             CcccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHH
Confidence            5555556899999999998532   12357889999999994

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A*

Probab=99.97  E-value=6.2e-32  Score=202.36  Aligned_cols=157  Identities=25%  Similarity=0.374  Sum_probs=125.3

Q ss_pred             ccCCcccccccccccccCceEEEEEEEcCCCcEEEEEEccCccChHHHHHHHHHHHHHHhcCCCCchhhhhhhH------
Q psy14630         19 YDFTSEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQFYGAL------   92 (187)
Q Consensus        19 ~~~~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~------   92 (187)
                      +++..++|++.+.||+|+||.||+|.+. ++..||+|.++......   +.+.++..+++.+.||||+++++.+      
T Consensus         3 ~~l~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~---~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~   78 (268)
T 3sxs_A            3 MELKREEITLLKELGSGQFGVVKLGKWK-GQYDVAVKMIKEGSMSE---DEFFQEAQTMMKLSHPKLVKFYGVCSKEYPI   78 (268)
T ss_dssp             TBCCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECBTTBCH---HHHHHHHHHHHHCCCTTBCCEEEEECSSSSE
T ss_pred             eEechhheeeeeeeccCCCceEEEEEec-CceeEEEEEeccCCCcH---HHHHHHHHHHHhCCCCCEeeEEEEEccCCce
Confidence            5678899999999999999999999875 56789999987543222   2344555667778999999887532      


Q ss_pred             ---------------------------HHHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEecccccccccc
Q psy14630         93 ---------------------------FKEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDS  145 (187)
Q Consensus        93 ---------------------------~~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg~a~~~~~~  145 (187)
                                                 ...++.|++.|+.|||+. +++||||||+||+++.++.++|+|||++......
T Consensus        79 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~-~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~  157 (268)
T 3sxs_A           79 YIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESH-QFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDD  157 (268)
T ss_dssp             EEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHT-TEEESSCSGGGEEECTTCCEEECCTTCEEECCTT
T ss_pred             EEEEEccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHC-CeecCCcCcceEEECCCCCEEEccCccceecchh
Confidence                                       112677899999999998 9999999999999999999999999999876543


Q ss_pred             cc--ccCCCCCcCccCccccCCCccCCCCCCcceeeeEee
Q psy14630        146 IA--KTRDAGCRPYMAPERIDPLRARGYPSFKTKLGFKFN  183 (187)
Q Consensus       146 ~~--~~~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi~  183 (187)
                      ..  .....+++.|+|||.+.   ...++.++|+||+|++
T Consensus       158 ~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~Di~slG~i  194 (268)
T 3sxs_A          158 QYVSSVGTKFPVKWSAPEVFH---YFKYSSKSDVWAFGIL  194 (268)
T ss_dssp             CEEECCSCCCCGGGCCHHHHH---HSEEETTHHHHHHHHH
T ss_pred             hhhcccCCCcCcccCCHHHHh---ccCCchhhhhHHHHHH
Confidence            22  22234567899999998   5668899999999993

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A

Probab=99.97  E-value=2.4e-32  Score=211.91  Aligned_cols=153  Identities=24%  Similarity=0.445  Sum_probs=120.6

Q ss_pred             CcccccccccccccCceEEEEEEEcCCCcEEEEEEccCccChHHHHHHHHHHHHHHhcCCCCchhhhhhhHH--------
Q psy14630         22 TSEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQFYGALF--------   93 (187)
Q Consensus        22 ~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~--------   93 (187)
                      ..++|++.+.||+|+||.||+|.+..+++.||+|++.......     ..+...+.+...||||+++++.+.        
T Consensus        20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~-----~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv   94 (342)
T 2qr7_A           20 FTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDP-----TEEIEILLRYGQHPNIITLKDVYDDGKYVYVV   94 (342)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTCCC-----HHHHHHHHHHTTSTTBCCEEEEEECSSEEEEE
T ss_pred             ccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccCCh-----HHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEE
Confidence            3578999999999999999999999999999999986533221     123333445558999999875321        


Q ss_pred             ------------------------HHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCC----CCEEEEecccccccccc
Q psy14630         94 ------------------------KEVTVATVKALNYLKEELKIIHRDVKPSNILLDRR----GAIKLCDFGISGQLVDS  145 (187)
Q Consensus        94 ------------------------~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~----~~~ki~dfg~a~~~~~~  145 (187)
                                              ..++.|++.||.|||+. +++||||||+||++...    +.+||+|||+++.....
T Consensus        95 ~E~~~gg~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~-givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~~~  173 (342)
T 2qr7_A           95 TELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQ-GVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAE  173 (342)
T ss_dssp             ECCCCSCBHHHHHHTCTTCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCCGGGEEESSSSCSGGGEEECCCTTCEECBCT
T ss_pred             EeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC-CcEeccCCHHHEEEecCCCCcCeEEEEECCCcccCcCC
Confidence                                    12678899999999998 99999999999998433    35999999999876543


Q ss_pred             -ccccCCCCCcCccCccccCCCccCCCCCCcceeeeEee
Q psy14630        146 -IAKTRDAGCRPYMAPERIDPLRARGYPSFKTKLGFKFN  183 (187)
Q Consensus       146 -~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi~  183 (187)
                       ......++|+.|+|||++.   ...++.++|+||+|++
T Consensus       174 ~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwslG~i  209 (342)
T 2qr7_A          174 NGLLMTPCYTANFVAPEVLE---RQGYDAACDIWSLGVL  209 (342)
T ss_dssp             TCCBCCSSCCSSCCCHHHHH---HHHHHHHHHHHHHHHH
T ss_pred             CCceeccCCCccccCHHHhc---CCCCCCccCeeeHhHH
Confidence             2233457899999999988   5568889999999993

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii}

Probab=99.97  E-value=7.7e-32  Score=203.85  Aligned_cols=155  Identities=26%  Similarity=0.384  Sum_probs=119.9

Q ss_pred             cccccccccccccCceEEEEEEEcCCCcEEEEEEccCccChHHHHHHHHHHHHHHhcCCCCchhhhhhhH----------
Q psy14630         23 SEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQFYGAL----------   92 (187)
Q Consensus        23 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~----------   92 (187)
                      .++|++.+.||+|+||.||+|.+..++..+|+|.+....... ..+.+..+..+++.+.||||+++++.+          
T Consensus        21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   99 (285)
T 3is5_A           21 DDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQV-PMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVM   99 (285)
T ss_dssp             HHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCS-CHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccch-hHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEE
Confidence            378999999999999999999999999999999986433221 233455566677888999999886432          


Q ss_pred             --------------------------HHHHHHHHHHHHHHHHhcCCCeeecCCCCCeEE---cCCCCEEEEecccccccc
Q psy14630         93 --------------------------FKEVTVATVKALNYLKEELKIIHRDVKPSNILL---DRRGAIKLCDFGISGQLV  143 (187)
Q Consensus        93 --------------------------~~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili---~~~~~~ki~dfg~a~~~~  143 (187)
                                                ...++.|++.||.|||+. +++||||||+||++   +..+.+||+|||++....
T Consensus       100 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~-~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~  178 (285)
T 3is5_A          100 ETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQ-HVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFK  178 (285)
T ss_dssp             CCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHT-TCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC--
T ss_pred             EeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhC-CEEECCCCHHHEEEecCCCCCCEEEEeeecceecC
Confidence                                      112667899999999998 99999999999999   456789999999998776


Q ss_pred             ccccccCCCCCcCccCccccCCCccCCCCCCcceeeeEee
Q psy14630        144 DSIAKTRDAGCRPYMAPERIDPLRARGYPSFKTKLGFKFN  183 (187)
Q Consensus       144 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi~  183 (187)
                      .........+|+.|+|||.+.    ..++.++|+||+|++
T Consensus       179 ~~~~~~~~~~t~~y~aPE~~~----~~~~~~~Di~slG~i  214 (285)
T 3is5_A          179 SDEHSTNAAGTALYMAPEVFK----RDVTFKCDIWSAGVV  214 (285)
T ss_dssp             --------CTTGGGCCHHHHT----TCCCHHHHHHHHHHH
T ss_pred             CcccCcCcccccCcCChHHhc----cCCCcccCeehHHHH
Confidence            554455567899999999976    247889999999994

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens}

Probab=99.97  E-value=7.8e-32  Score=202.82  Aligned_cols=158  Identities=22%  Similarity=0.284  Sum_probs=108.0

Q ss_pred             CcccccccccccccCceEEEEEEEcCCCcEEEEEEccCccC-hHHHHHHHHHHHHHHhcCCCCchhhhhhhH--------
Q psy14630         22 TSEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVD-EKDQRQLLMDLDVVMKSNECPYIVQFYGAL--------   92 (187)
Q Consensus        22 ~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~--------   92 (187)
                      ..++|++.+.||+|+||.||+|.+..+++.||+|.+..... .....+.+.++..+++.+.||||+++++.+        
T Consensus         9 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   88 (278)
T 3cok_A            9 KIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYL   88 (278)
T ss_dssp             SGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEE
T ss_pred             ccccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEE
Confidence            34789999999999999999999999999999999853211 111124456666678888999999886532        


Q ss_pred             -------------------------HHHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEecccccccccc-c
Q psy14630         93 -------------------------FKEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDS-I  146 (187)
Q Consensus        93 -------------------------~~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg~a~~~~~~-~  146 (187)
                                               ...++.|++.|+.|||+. +++||||||+||+++.++.++|+|||++...... .
T Consensus        89 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~-~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~  167 (278)
T 3cok_A           89 VLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSH-GILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHE  167 (278)
T ss_dssp             EEECCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHHHT-TEECSSCCGGGEEECTTCCEEECCCTTCEECC----
T ss_pred             EEecCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC-CeecCCCCHHHEEEcCCCCEEEEeecceeeccCCCC
Confidence                                     112678999999999998 9999999999999999999999999999876532 2


Q ss_pred             cccCCCCCcCccCccccCCCccCCCCCCcceeeeEee
Q psy14630        147 AKTRDAGCRPYMAPERIDPLRARGYPSFKTKLGFKFN  183 (187)
Q Consensus       147 ~~~~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi~  183 (187)
                      ......+++.|+|||.+.   ...++.++|+||+|++
T Consensus       168 ~~~~~~~~~~y~aPE~~~---~~~~~~~~Di~slG~i  201 (278)
T 3cok_A          168 KHYTLCGTPNYISPEIAT---RSAHGLESDVWSLGCM  201 (278)
T ss_dssp             ---------------------------CTHHHHHHHH
T ss_pred             cceeccCCCCcCCcchhc---CCCCCchhhHHHHHHH
Confidence            223346899999999988   5668899999999993

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens}

Probab=99.97  E-value=3.6e-32  Score=209.60  Aligned_cols=159  Identities=24%  Similarity=0.389  Sum_probs=119.2

Q ss_pred             cCCcccccccccccccCceEEEEEEEcCCCcEE----EEEEccCccChHHHHHHHHHHHHHHhcCCCCchhhhhhhH---
Q psy14630         20 DFTSEDLQDLGEIGRGGFGTVNKMIHRSSDTVM----AVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQFYGAL---   92 (187)
Q Consensus        20 ~~~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~v----aiK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~---   92 (187)
                      .+..++|++.+.||+|+||.||+|.+..+++.+    |+|.+....... ..+.+.++..+++.++||||+++++.+   
T Consensus        11 ~l~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~-~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~   89 (327)
T 3lzb_A           11 ILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPK-ANKEILDEAYVMASVDNPHVCRLLGICLTS   89 (327)
T ss_dssp             ECCTTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCC-CHHHHHHHHHHHTTCCBTTBCCCCEEEESS
T ss_pred             ccCHhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHH-HHHHHHHHHHHHHhCCCCCeeEEEEEEecC
Confidence            356789999999999999999999998877765    666664332222 234455566678888999999887532   


Q ss_pred             -----------------------------HHHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEecccccccc
Q psy14630         93 -----------------------------FKEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLV  143 (187)
Q Consensus        93 -----------------------------~~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg~a~~~~  143 (187)
                                                   ...++.|++.||.|||+. +++||||||+||+++.++.+||+|||+++...
T Consensus        90 ~~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~-~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~  168 (327)
T 3lzb_A           90 TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR-RLVHRDLAARNVLVKTPQHVKITDFGLAKLLG  168 (327)
T ss_dssp             SEEEEECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCCGGGEEEEETTEEEECCTTC-----
T ss_pred             CceEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhC-CCcCCCCCHHHEEEcCCCCEEEccCcceeEcc
Confidence                                         112678999999999998 99999999999999999999999999998764


Q ss_pred             cccc---ccCCCCCcCccCccccCCCccCCCCCCcceeeeEee
Q psy14630        144 DSIA---KTRDAGCRPYMAPERIDPLRARGYPSFKTKLGFKFN  183 (187)
Q Consensus       144 ~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi~  183 (187)
                      ....   .....+|+.|+|||.+.   ...++.++|+||+|++
T Consensus       169 ~~~~~~~~~~~~~t~~y~aPE~~~---~~~~~~~~Di~slG~i  208 (327)
T 3lzb_A          169 AEEKEYHAEGGKVPIKWMALESIL---HRIYTHQSDVWSYGVT  208 (327)
T ss_dssp             -----------CCCGGGSCHHHHH---HCCCCHHHHHHHHHHH
T ss_pred             CccccccccCCCccccccCHHHHc---CCCCChHHHHHHHHHH
Confidence            3322   12234677899999998   6678999999999993

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A*

Probab=99.97  E-value=2.2e-31  Score=202.06  Aligned_cols=167  Identities=28%  Similarity=0.330  Sum_probs=126.5

Q ss_pred             CccccCCcccccccccccccCceEEEEEEEcCCCcEEEEEEccCcc----Ch---HHHHHHHHHHHHHHhcC-CCCchhh
Q psy14630         16 DTVYDFTSEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTV----DE---KDQRQLLMDLDVVMKSN-ECPYIVQ   87 (187)
Q Consensus        16 ~~~~~~~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~----~~---~~~~~~~~~~~~~~~~~-~h~~iv~   87 (187)
                      ........++|++.+.||+|+||.||+|.+..+++.||+|+++...    ..   ....+.+..+..+++.+ .||||++
T Consensus         9 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~   88 (298)
T 1phk_A            9 SHSTHGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQ   88 (298)
T ss_dssp             ------CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCC
T ss_pred             ccCCcchhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEee
Confidence            3444456789999999999999999999999999999999986432    11   12233344444455555 5999998


Q ss_pred             hhhhH--------------------------------HHHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEe
Q psy14630         88 FYGAL--------------------------------FKEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCD  135 (187)
Q Consensus        88 ~~~~~--------------------------------~~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~d  135 (187)
                      +++.+                                ...+..|++.||.|||+. +++|+||+|+||+++.++.+||+|
T Consensus        89 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~-~i~H~dl~p~Nil~~~~~~~kl~d  167 (298)
T 1phk_A           89 LKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKL-NIVHRDLKPENILLDDDMNIKLTD  167 (298)
T ss_dssp             EEEEEECSSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEECTTCCEEECC
T ss_pred             eeeeeccCCeEEEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC-CcccCCCCcceEEEcCCCcEEEec
Confidence            86432                                112678899999999997 999999999999999999999999


Q ss_pred             ccccccccccccccCCCCCcCccCccccCCC---ccCCCCCCcceeeeEee
Q psy14630        136 FGISGQLVDSIAKTRDAGCRPYMAPERIDPL---RARGYPSFKTKLGFKFN  183 (187)
Q Consensus       136 fg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~---~~~~~~~~~D~ws~gi~  183 (187)
                      ||++.............+++.|+|||.+.+.   ....++.++|+||+|++
T Consensus       168 fg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~  218 (298)
T 1phk_A          168 FGFSCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVI  218 (298)
T ss_dssp             CTTCEECCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHH
T ss_pred             ccchhhcCCCcccccccCCccccCHHHhccccccccccCCcccccHhHHHH
Confidence            9999887655445556789999999997421   13457889999999994

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens}

Probab=99.97  E-value=1.3e-31  Score=213.68  Aligned_cols=176  Identities=19%  Similarity=0.186  Sum_probs=115.2

Q ss_pred             CccccccCCceecCCCccccCCcccccccccccccCceEEEEEEEcCCCcEEEEEEccCccChHHHHHHHHHHHHHHhcC
Q psy14630          1 MCQSIQSSGKLKLSPDTVYDFTSEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSN   80 (187)
Q Consensus         1 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~   80 (187)
                      |+++.+.+..........+.+...+|...+.||+|+||+|+. ....+++.||||.+.......     ..++..+++.+
T Consensus         1 M~ss~s~~~~~~~~~~~~~~i~~~~y~~~~~LG~G~~G~V~~-~~~~~~~~vAvK~~~~~~~~~-----~~~E~~~l~~l   74 (432)
T 3p23_A            1 MGSSPSLEQDDGDEETSVVIVGKISFCPKDVLGHGAEGTIVY-RGMFDNRDVAVKRILPECFSF-----ADREVQLLRES   74 (432)
T ss_dssp             -----------------CEEETTEEEEEEEEEEECGGGCEEE-EEESSSSEEEEEEECTTTEEE-----CHHHHHHHHHS
T ss_pred             CCCCcccccCcCcccCCcEEEccEEEecCCeeecCcCEEEEE-EEEeCCeEEEEEEECHHHHHH-----HHHHHHHHHhc
Confidence            454544444444444556677788899999999999999763 334578899999986432211     12233344444


Q ss_pred             -CCCchhhhhhhHH--------------------------------HHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcC
Q psy14630         81 -ECPYIVQFYGALF--------------------------------KEVTVATVKALNYLKEELKIIHRDVKPSNILLDR  127 (187)
Q Consensus        81 -~h~~iv~~~~~~~--------------------------------~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~  127 (187)
                       .||||+++++.+.                                ..++.|++.||.|||+. +|+||||||+||+++.
T Consensus        75 ~~HpnIv~l~~~~~~~~~~~lv~E~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~-~ivHrDlKp~NIll~~  153 (432)
T 3p23_A           75 DEHPNVIRYFCTEKDRQFQYIAIELCAATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSL-NIVHRDLKPHNILISM  153 (432)
T ss_dssp             CCCTTBCCEEEEEEETTEEEEEEECCSEEHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHHHT-TCCCCCCSTTSEEECC
T ss_pred             cCCCCcCeEEEEEecCCEEEEEEECCCCCHHHHHHhcCCCccchhHHHHHHHHHHHHHHHHHC-cCEeCCCCHHHEEEec
Confidence             8999999875321                                13778999999999998 9999999999999953


Q ss_pred             -----CCCEEEEeccccccccccc----cccCCCCCcCccCccccCCCccCCCCCCcceeeeEee
Q psy14630        128 -----RGAIKLCDFGISGQLVDSI----AKTRDAGCRPYMAPERIDPLRARGYPSFKTKLGFKFN  183 (187)
Q Consensus       128 -----~~~~ki~dfg~a~~~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi~  183 (187)
                           ...+||+|||+++......    ......||+.|+|||++.+.....++.++||||+|++
T Consensus       154 ~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~i  218 (432)
T 3p23_A          154 PNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCV  218 (432)
T ss_dssp             CBTTTBCCEEECCTTEEECC------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHH
T ss_pred             CCCCCceeEEEecccceeeccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHH
Confidence                 2358899999998765331    2234578999999999975434557789999999983

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ...

Probab=99.97  E-value=1.3e-31  Score=202.34  Aligned_cols=159  Identities=25%  Similarity=0.360  Sum_probs=128.1

Q ss_pred             cCCcccccccccccccCceEEEEEEEcCCCcEEEEEEccCccC-hHHHHHHHHHHHHHHhcCCCCchhhhhhhH------
Q psy14630         20 DFTSEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVD-EKDQRQLLMDLDVVMKSNECPYIVQFYGAL------   92 (187)
Q Consensus        20 ~~~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~------   92 (187)
                      .+..++|++.+.||+|+||.||+|.+..+++.||+|.+..... .....+.+.++..+++.++||||+++++.+      
T Consensus        10 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   89 (284)
T 2vgo_A           10 KFTIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRI   89 (284)
T ss_dssp             CCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEE
T ss_pred             chhhhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEE
Confidence            4567899999999999999999999999999999999853211 111234456666678888999999886532      


Q ss_pred             --------------------------HHHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEeccccccccccc
Q psy14630         93 --------------------------FKEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSI  146 (187)
Q Consensus        93 --------------------------~~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg~a~~~~~~~  146 (187)
                                                ...++.|++.|+.|||+. +++||||||+||+++.++.++|+|||++...... 
T Consensus        90 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~-~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~-  167 (284)
T 2vgo_A           90 YLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHER-KVIHRDIKPENLLMGYKGELKIADFGWSVHAPSL-  167 (284)
T ss_dssp             EEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTT-TEECCCCSGGGEEECTTCCEEECCCTTCEECSSS-
T ss_pred             EEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC-CceecCCCHHHEEEcCCCCEEEecccccccCccc-
Confidence                                      112677899999999997 9999999999999999999999999998765432 


Q ss_pred             cccCCCCCcCccCccccCCCccCCCCCCcceeeeEee
Q psy14630        147 AKTRDAGCRPYMAPERIDPLRARGYPSFKTKLGFKFN  183 (187)
Q Consensus       147 ~~~~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi~  183 (187)
                      ......+++.|+|||.+.   ...++.++|+||+|++
T Consensus       168 ~~~~~~~~~~y~aPE~~~---~~~~~~~~Di~slG~i  201 (284)
T 2vgo_A          168 RRRTMCGTLDYLPPEMIE---GKTHDEKVDLWCAGVL  201 (284)
T ss_dssp             CBCCCCSCGGGCCHHHHT---TCCBCTTHHHHHHHHH
T ss_pred             ccccccCCCCcCCHHHhc---cCCCCcccchhhHHHH
Confidence            223457899999999998   5668899999999994

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens}

Probab=99.97  E-value=2.7e-31  Score=210.06  Aligned_cols=154  Identities=23%  Similarity=0.323  Sum_probs=109.8

Q ss_pred             cccccc-cccccccCceEEEEEEEc--CCCcEEEEEEccCccChHHHHHHHHHHHHHHhcCCCCchhhhhhhH-------
Q psy14630         23 SEDLQD-LGEIGRGGFGTVNKMIHR--SSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQFYGAL-------   92 (187)
Q Consensus        23 ~~~~~~-~~~lg~G~fg~V~~~~~~--~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~-------   92 (187)
                      .+.|.+ .++||+|+||.||+|.+.  .+++.||+|.+.......    .+.++..+++.+.||||+++++.+       
T Consensus        19 ~~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~~~----~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~   94 (405)
T 3rgf_A           19 EDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISM----SACREIALLRELKHPNVISLQKVFLSHADRK   94 (405)
T ss_dssp             HHHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSCCH----HHHHHHHHHHHCCCTTBCCCCEEEEETTTTE
T ss_pred             hhhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCCCH----HHHHHHHHHHhcCCCCeeeEeeEEecCCCCe
Confidence            345666 458999999999999965  568899999987543222    234455677788999999886543       


Q ss_pred             -----------------------------------HHHHHHHHHHHHHHHHhcCCCeeecCCCCCeEE----cCCCCEEE
Q psy14630         93 -----------------------------------FKEVTVATVKALNYLKEELKIIHRDVKPSNILL----DRRGAIKL  133 (187)
Q Consensus        93 -----------------------------------~~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili----~~~~~~ki  133 (187)
                                                         ...++.|++.||.|||+. +|+||||||+||++    +..+.+||
T Consensus        95 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~-~ivH~Dlkp~NIll~~~~~~~~~~kl  173 (405)
T 3rgf_A           95 VWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN-WVLHRDLKPANILVMGEGPERGRVKI  173 (405)
T ss_dssp             EEEEEECCSEEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHT-TCCCCCCCGGGEEECCSSTTTTCEEE
T ss_pred             EEEEEeCCCCCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhC-CEeCCCcCHHHeEEecCCCCCCcEEE
Confidence                                               112567899999999998 99999999999999    67789999


Q ss_pred             Eecccccccccc----ccccCCCCCcCccCccccCCCccCCCCCCcceeeeEee
Q psy14630        134 CDFGISGQLVDS----IAKTRDAGCRPYMAPERIDPLRARGYPSFKTKLGFKFN  183 (187)
Q Consensus       134 ~dfg~a~~~~~~----~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi~  183 (187)
                      +|||+++.....    .......||+.|+|||++.+  ...++.++||||+|++
T Consensus       174 ~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~~DiwSlG~i  225 (405)
T 3rgf_A          174 ADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLG--ARHYTKAIDIWAIGCI  225 (405)
T ss_dssp             CCTTCCC----------------CCCTTCCHHHHTT--CCSCCHHHHHHHHHHH
T ss_pred             EECCCceecCCCCcccccCCCceecCcccCchhhcC--CCcccchhhhHHHHHH
Confidence            999999876532    22234578999999999983  2348899999999994

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A*

Probab=99.97  E-value=2.9e-31  Score=202.03  Aligned_cols=158  Identities=33%  Similarity=0.546  Sum_probs=128.5

Q ss_pred             CCcccccccccccccCceEEEEEEEcCCCcEEEEEEccCccChHHHHHHHHHHHHHHhcCCCCchhhhhhhH--------
Q psy14630         21 FTSEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQFYGAL--------   92 (187)
Q Consensus        21 ~~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~--------   92 (187)
                      ...+.|++.+.||+|+||.||+|.+..+++.||+|++....... ..+.+.++..+++.+.||||+++++.+        
T Consensus        19 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   97 (303)
T 3a7i_A           19 DPEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAED-EIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWI   97 (303)
T ss_dssp             CGGGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCST-THHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred             ChHHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHH-HHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEE
Confidence            35577999999999999999999999999999999986543222 234455566677788999999887532        


Q ss_pred             -----------------------HHHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEeccccccccccc-cc
Q psy14630         93 -----------------------FKEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSI-AK  148 (187)
Q Consensus        93 -----------------------~~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg~a~~~~~~~-~~  148 (187)
                                             ...+..|++.||.|||+. +++|+||||+||+++.++.++|+|||++....... ..
T Consensus        98 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~-~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~  176 (303)
T 3a7i_A           98 IMEYLGGGSALDLLEPGPLDETQIATILREILKGLDYLHSE-KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKR  176 (303)
T ss_dssp             EEECCTTEEHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEECTTSCEEECCCTTCEECBTTBCCB
T ss_pred             EEEeCCCCcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC-CCccCCCChheEEECCCCCEEEeecccceecCcccccc
Confidence                                   112678999999999998 99999999999999999999999999998765432 22


Q ss_pred             cCCCCCcCccCccccCCCccCCCCCCcceeeeEee
Q psy14630        149 TRDAGCRPYMAPERIDPLRARGYPSFKTKLGFKFN  183 (187)
Q Consensus       149 ~~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi~  183 (187)
                      ....+++.|+|||.+.   ...++.++|+||+|++
T Consensus       177 ~~~~~~~~y~aPE~~~---~~~~~~~~Di~slG~i  208 (303)
T 3a7i_A          177 NTFVGTPFWMAPEVIK---QSAYDSKADIWSLGIT  208 (303)
T ss_dssp             CCCCSCGGGCCHHHHT---TCCBCTHHHHHHHHHH
T ss_pred             CccCCCcCccCHHHHh---cCCCCchhhhHHHHHH
Confidence            3456899999999998   5678899999999994

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B

Probab=99.97  E-value=5.6e-32  Score=207.73  Aligned_cols=157  Identities=25%  Similarity=0.420  Sum_probs=121.9

Q ss_pred             cccccccccccccCceEEEEEEEc-CCCcEEEEEEccCccChHH-HHHHHHHHH--HHHhcCCCCchhhhhhhHH-----
Q psy14630         23 SEDLQDLGEIGRGGFGTVNKMIHR-SSDTVMAVKRIRSTVDEKD-QRQLLMDLD--VVMKSNECPYIVQFYGALF-----   93 (187)
Q Consensus        23 ~~~~~~~~~lg~G~fg~V~~~~~~-~~~~~vaiK~~~~~~~~~~-~~~~~~~~~--~~~~~~~h~~iv~~~~~~~-----   93 (187)
                      .++|++.+.||+|+||.||+|.+. .+++.||+|+++....... ......+..  ..+..+.||||+++++.+.     
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~   89 (326)
T 1blx_A           10 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD   89 (326)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred             hhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecccC
Confidence            478999999999999999999995 6788999999853221111 011111222  2223458999998865321     


Q ss_pred             ---------------------------------HHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEeccccc
Q psy14630         94 ---------------------------------KEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISG  140 (187)
Q Consensus        94 ---------------------------------~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg~a~  140 (187)
                                                       ..++.|++.||.|||+. +++||||||+||+++.++.+||+|||+++
T Consensus        90 ~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~-gi~H~dlkp~Nili~~~~~~kl~Dfg~~~  168 (326)
T 1blx_A           90 RETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSH-RVVHRDLKPQNILVTSSGQIKLADFGLAR  168 (326)
T ss_dssp             SEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHT-TCCCCCCCGGGEEECTTCCEEECSCCSCC
T ss_pred             CCceEEEEEecCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHC-CceeccCCHHHeEEcCCCCEEEecCcccc
Confidence                                             11667899999999998 99999999999999999999999999998


Q ss_pred             cccccccccCCCCCcCccCccccCCCccCCCCCCcceeeeEee
Q psy14630        141 QLVDSIAKTRDAGCRPYMAPERIDPLRARGYPSFKTKLGFKFN  183 (187)
Q Consensus       141 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi~  183 (187)
                      ............+++.|+|||.+.   ...++.++|+||+|++
T Consensus       169 ~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~Di~slG~i  208 (326)
T 1blx_A          169 IYSFQMALTSVVVTLWYRAPEVLL---QSSYATPVDLWSVGCI  208 (326)
T ss_dssp             CCCGGGGGCCCCCCCTTCCHHHHT---TCCCCTHHHHHHHHHH
T ss_pred             cccCCCCccccccccceeCHHHHh---cCCCCcchhHHHHHHH
Confidence            876554455567899999999998   5668899999999994

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A*

Probab=99.97  E-value=7.3e-32  Score=202.94  Aligned_cols=158  Identities=25%  Similarity=0.425  Sum_probs=126.6

Q ss_pred             CcccccccccccccCceEEEEEEEcCCCcEEEEEEccCccChHHHHHHHHHHHHHHhcCCCCchhhhhhhHH--------
Q psy14630         22 TSEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQFYGALF--------   93 (187)
Q Consensus        22 ~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~--------   93 (187)
                      ..++|++.+.||+|+||.||+|.+..+++.||+|.+..........+.+.++..+++.++||||+++++.+.        
T Consensus         4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~   83 (279)
T 2w5a_A            4 RAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLY   83 (279)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEE
T ss_pred             chhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEE
Confidence            357899999999999999999999999999999998754444445556666777788889999999875321        


Q ss_pred             ------------------------------HHHHHHHHHHHHHHHhcCC-----CeeecCCCCCeEEcCCCCEEEEeccc
Q psy14630         94 ------------------------------KEVTVATVKALNYLKEELK-----IIHRDVKPSNILLDRRGAIKLCDFGI  138 (187)
Q Consensus        94 ------------------------------~~~~~~~~~~l~~lh~~~~-----i~Hrdlk~~nili~~~~~~ki~dfg~  138 (187)
                                                    ..++.|++.||.|||+. +     ++||||||+||+++.++.+||+|||+
T Consensus        84 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~-~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~  162 (279)
T 2w5a_A           84 IVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRR-SDGGHTVLHRDLKPANVFLDGKQNVKLGDFGL  162 (279)
T ss_dssp             EEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHH-C------CCCCCSGGGEEECSSSCEEECCCCH
T ss_pred             EEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcc-cCCCCeeEEeccchhhEEEcCCCCEEEecCch
Confidence                                          11567899999999998 7     99999999999999999999999999


Q ss_pred             cccccccc-cccCCCCCcCccCccccCCCccCCCCCCcceeeeEee
Q psy14630        139 SGQLVDSI-AKTRDAGCRPYMAPERIDPLRARGYPSFKTKLGFKFN  183 (187)
Q Consensus       139 a~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi~  183 (187)
                      ++...... ......+++.|+|||.+.   ...++.++|+||+|++
T Consensus       163 ~~~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~Di~slG~i  205 (279)
T 2w5a_A          163 ARILNHDTSFAKTFVGTPYYMSPEQMN---RMSYNEKSDIWSLGCL  205 (279)
T ss_dssp             HHHC---CHHHHHHHSCCTTCCHHHHH---CC-CCHHHHHHHHHHH
T ss_pred             heeeccccccccccCCCccccChHHhc---cCCCCchhhHHHHHHH
Confidence            98764322 112236889999999998   5568899999999994

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II}

Probab=99.97  E-value=1.6e-31  Score=206.71  Aligned_cols=161  Identities=25%  Similarity=0.387  Sum_probs=124.6

Q ss_pred             CcccccccccccccCceEEEEEEEcCCCcEEEEEEccCcc---ChHHHHHHHHHHHHHHhcCCCCchhhhhhhH------
Q psy14630         22 TSEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTV---DEKDQRQLLMDLDVVMKSNECPYIVQFYGAL------   92 (187)
Q Consensus        22 ~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~------   92 (187)
                      ..++|++.+.||+|+||.||+|.+..++..||+|++....   ......+.+.++..+++.++||||+++++.+      
T Consensus        24 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~  103 (345)
T 3hko_A           24 LQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYI  103 (345)
T ss_dssp             HHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             hhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccCCeE
Confidence            4578999999999999999999999999999999985321   1122334566666677888999999876422      


Q ss_pred             ------------------------------------------------------------------HHHHHHHHHHHHHH
Q psy14630         93 ------------------------------------------------------------------FKEVTVATVKALNY  106 (187)
Q Consensus        93 ------------------------------------------------------------------~~~~~~~~~~~l~~  106 (187)
                                                                                        ...++.|++.||.|
T Consensus       104 ~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~  183 (345)
T 3hko_A          104 CLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHY  183 (345)
T ss_dssp             EEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHHHH
T ss_pred             EEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHH
Confidence                                                                              11267799999999


Q ss_pred             HHhcCCCeeecCCCCCeEEcCCC--CEEEEeccccccccccc-----cccCCCCCcCccCccccCCCccCCCCCCcceee
Q psy14630        107 LKEELKIIHRDVKPSNILLDRRG--AIKLCDFGISGQLVDSI-----AKTRDAGCRPYMAPERIDPLRARGYPSFKTKLG  179 (187)
Q Consensus       107 lh~~~~i~Hrdlk~~nili~~~~--~~ki~dfg~a~~~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws  179 (187)
                      ||+. +++||||||+||+++.++  .+||+|||+++.+....     ......||+.|+|||.+.+. ...++.++|+||
T Consensus       184 LH~~-~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~~Diws  261 (345)
T 3hko_A          184 LHNQ-GICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTT-NESYGPKCDAWS  261 (345)
T ss_dssp             HHHT-TEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCS-SSCCCTHHHHHH
T ss_pred             HHHC-CccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccC-CCCCCcHHHHHH
Confidence            9998 999999999999998766  89999999998764321     12344689999999998732 356889999999


Q ss_pred             eEeee
Q psy14630        180 FKFNY  184 (187)
Q Consensus       180 ~gi~~  184 (187)
                      +|+++
T Consensus       262 lG~il  266 (345)
T 3hko_A          262 AGVLL  266 (345)
T ss_dssp             HHHHH
T ss_pred             HHHHH
Confidence            99943

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7

Probab=99.97  E-value=8.1e-32  Score=220.01  Aligned_cols=161  Identities=20%  Similarity=0.297  Sum_probs=129.7

Q ss_pred             CccccCCcccccccccccccCceEEEEEEEcCCCcEEEEEEccCccChHHHHHHHHHHHHHHhcCCCCchhhhhhhHH--
Q psy14630         16 DTVYDFTSEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQFYGALF--   93 (187)
Q Consensus        16 ~~~~~~~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~--   93 (187)
                      ...|++..++|++.+.||+|+||.||+|.+.. +..||||+++.....   .+.+.++..+++.++||||+++++.+.  
T Consensus       259 ~~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~hpniv~~~~~~~~~  334 (535)
T 2h8h_A          259 KDAWEIPRESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTMS---PEAFLQEAQVMKKLRHEKLVQLYAVVSEE  334 (535)
T ss_dssp             TTCSBCCGGGEEEEEEEEECSSEEEEEEEETT-TEEEEEEEECTTSSC---HHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             ccceecchhhhhhheecccCCCeEEEEEEECC-CceEEEEEeCCCCCC---HHHHHHHHHHHHhCCCCCEeeEEEEEeec
Confidence            45688999999999999999999999999864 467999998753322   234556667788889999998875321  


Q ss_pred             -------------------------------HHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEeccccccc
Q psy14630         94 -------------------------------KEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQL  142 (187)
Q Consensus        94 -------------------------------~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg~a~~~  142 (187)
                                                     ..++.|++.||.|||+. +++||||||+||+++.++.+||+|||+++..
T Consensus       335 ~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~-~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~  413 (535)
T 2h8h_A          335 PIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM-NYVHRDLRAANILVGENLVCKVADFGLARLI  413 (535)
T ss_dssp             SCEEEECCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCSGGGEEECGGGCEEECCTTSTTTC
T ss_pred             cceEeeehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhC-CeeCCCCCHhhEEEcCCCcEEEcccccceec
Confidence                                           12667899999999997 9999999999999999999999999999876


Q ss_pred             ccccc--ccCCCCCcCccCccccCCCccCCCCCCcceeeeEeee
Q psy14630        143 VDSIA--KTRDAGCRPYMAPERIDPLRARGYPSFKTKLGFKFNY  184 (187)
Q Consensus       143 ~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi~~  184 (187)
                      .....  .....++..|+|||.+.   ...++.++||||||+++
T Consensus       414 ~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~sDvwSlGv~l  454 (535)
T 2h8h_A          414 EDNEYTARQGAKFPIKWTAPEAAL---YGRFTIKSDVWSFGILL  454 (535)
T ss_dssp             CCHHHHTTCSTTSCGGGSCHHHHH---HCCCCHHHHHHHHHHHH
T ss_pred             CCCceecccCCcCcccccCHHHhc---cCCCCchhhHHHHHHHH
Confidence            54321  12234677899999998   56789999999999944

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A*

Probab=99.97  E-value=4.1e-31  Score=201.80  Aligned_cols=159  Identities=23%  Similarity=0.383  Sum_probs=117.6

Q ss_pred             CCcccccccccccccCceEEEEEEEcCCCcEEEEEEccCc-cChHHHHHHHHHHHHHHhcCCCCchhhhhhhH-------
Q psy14630         21 FTSEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRST-VDEKDQRQLLMDLDVVMKSNECPYIVQFYGAL-------   92 (187)
Q Consensus        21 ~~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~-------   92 (187)
                      ...++|++.+.||+|+||.||+|.+..+++.||+|.++.. .......+.+.++..+++.++||||+++++.+       
T Consensus        29 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~  108 (310)
T 2wqm_A           29 NTLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELN  108 (310)
T ss_dssp             SSGGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEE
T ss_pred             ccccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEE
Confidence            4567899999999999999999999999999999998642 22333445556666777888999999886432       


Q ss_pred             -----------------------------HHHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEecccccccc
Q psy14630         93 -----------------------------FKEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLV  143 (187)
Q Consensus        93 -----------------------------~~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg~a~~~~  143 (187)
                                                   ...++.+++.||.|||+. +++|+||||+||+++.++.++|+|||++....
T Consensus       109 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~-~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~  187 (310)
T 2wqm_A          109 IVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSR-RVMHRDIKPANVFITATGVVKLGDLGLGRFFS  187 (310)
T ss_dssp             EEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT-TCCCCCCCGGGEEECTTSCEEECCC-------
T ss_pred             EEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhC-CeeCCCCcHHHEEEcCCCCEEEEeccceeeec
Confidence                                         112667899999999998 99999999999999999999999999988764


Q ss_pred             ccc-cccCCCCCcCccCccccCCCccCCCCCCcceeeeEee
Q psy14630        144 DSI-AKTRDAGCRPYMAPERIDPLRARGYPSFKTKLGFKFN  183 (187)
Q Consensus       144 ~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi~  183 (187)
                      ... ......+++.|+|||.+.   ...++.++|+||||++
T Consensus       188 ~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~Dv~slG~i  225 (310)
T 2wqm_A          188 SKTTAAHSLVGTPYYMSPERIH---ENGYNFKSDIWSLGCL  225 (310)
T ss_dssp             -----------CCSSCCHHHHT---TCCCCHHHHHHHHHHH
T ss_pred             CCCccccccCCCeeEeChHHhC---CCCCCchhhHHHHHHH
Confidence            432 223346889999999998   5678899999999994

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A*

Probab=99.97  E-value=1e-31  Score=202.50  Aligned_cols=163  Identities=26%  Similarity=0.367  Sum_probs=126.1

Q ss_pred             CccccCCcccccccccccccCceEEEEEEEcC---CCcEEEEEEccCccChHHHHHHHHHHHHHHhcCCCCchhhhhhhH
Q psy14630         16 DTVYDFTSEDLQDLGEIGRGGFGTVNKMIHRS---SDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQFYGAL   92 (187)
Q Consensus        16 ~~~~~~~~~~~~~~~~lg~G~fg~V~~~~~~~---~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~   92 (187)
                      +..+.+..++|++.+.||+|+||.||+|.+..   ++..||+|.+...... ...+.+.++..+++.++||||+++++.+
T Consensus         4 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~   82 (281)
T 3cc6_A            4 GPQYGIAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTL-DNKEKFMSEAVIMKNLDHPHIVKLIGII   82 (281)
T ss_dssp             CCCCSCCGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCH-HHHHHHHHHHHHHHHHCCTTBCCEEEEE
T ss_pred             CccceecccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCc-hHHHHHHHHHHHHHhCCCCCcceEEEEE
Confidence            34567888999999999999999999998643   3456999998754333 2344555566667777999999887532


Q ss_pred             H--------------------------------HHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEeccccc
Q psy14630         93 F--------------------------------KEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISG  140 (187)
Q Consensus        93 ~--------------------------------~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg~a~  140 (187)
                      .                                ..+..|++.|+.|||+. +++||||||+||+++.++.+||+|||++.
T Consensus        83 ~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~-~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~  161 (281)
T 3cc6_A           83 EEEPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESI-NCVHRDIAVRNILVASPECVKLGDFGLSR  161 (281)
T ss_dssp             CSSSCEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHT-TCCCCCCSGGGEEEEETTEEEECCCCGGG
T ss_pred             cCCCCEEEEecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHHC-CcccCCCccceEEECCCCcEEeCccCCCc
Confidence            1                                11567899999999997 99999999999999999999999999998


Q ss_pred             ccccccc--ccCCCCCcCccCccccCCCccCCCCCCcceeeeEee
Q psy14630        141 QLVDSIA--KTRDAGCRPYMAPERIDPLRARGYPSFKTKLGFKFN  183 (187)
Q Consensus       141 ~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi~  183 (187)
                      .......  .....+++.|+|||.+.   ...++.++|+||+|++
T Consensus       162 ~~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~Di~slG~i  203 (281)
T 3cc6_A          162 YIEDEDYYKASVTRLPIKWMSPESIN---FRRFTTASDVWMFAVC  203 (281)
T ss_dssp             CC---------CCCCCGGGCCHHHHH---HCCCCHHHHHHHHHHH
T ss_pred             ccccccccccccCCCCcceeCchhhc---cCCCCchhccHHHHHH
Confidence            7654321  22335677899999987   6678899999999993

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A*

Probab=99.97  E-value=4.6e-32  Score=205.00  Aligned_cols=156  Identities=26%  Similarity=0.337  Sum_probs=124.8

Q ss_pred             cCCcccccccccccccCceEEEEEEEcCCC-------cEEEEEEccCccChHHHHHHHHHHHHHHhcCCCCchhhhhhhH
Q psy14630         20 DFTSEDLQDLGEIGRGGFGTVNKMIHRSSD-------TVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQFYGAL   92 (187)
Q Consensus        20 ~~~~~~~~~~~~lg~G~fg~V~~~~~~~~~-------~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~   92 (187)
                      ++..++|++.+.||+|+||.||+|.+..++       ..||+|.+....  ....+.+.++..+++.++||||+++++.+
T Consensus         4 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~   81 (289)
T 4fvq_A            4 KIRNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAH--RNYSESFFEAASMMSKLSHKHLVLNYGVC   81 (289)
T ss_dssp             BCCGGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGG--GGGHHHHHHHHHHHHTSCCTTBCCEEEEE
T ss_pred             EechhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhccccc--HHHHHHHHHHHHHHHhCCCCCEeEEEEEE
Confidence            467889999999999999999999988776       469999986432  22334556666778888999999887532


Q ss_pred             H---------------------------------HHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCC--------E
Q psy14630         93 F---------------------------------KEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGA--------I  131 (187)
Q Consensus        93 ~---------------------------------~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~--------~  131 (187)
                      .                                 ..++.|++.||.|||+. +++||||||+||+++.++.        +
T Consensus        82 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~-~ivH~Dlkp~NIll~~~~~~~~~~~~~~  160 (289)
T 4fvq_A           82 VCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEEN-TLIHGNVCAKNILLIREEDRKTGNPPFI  160 (289)
T ss_dssp             CCTTCCEEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHT-TCCCCCCCGGGEEEEECCBGGGTBCCEE
T ss_pred             EeCCCCEEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHhhC-CeECCCcCcceEEEecCCccccccccee
Confidence            1                                 12677999999999998 9999999999999988876        9


Q ss_pred             EEEeccccccccccccccCCCCCcCccCccccCCCccCCCCCCcceeeeEee
Q psy14630        132 KLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPLRARGYPSFKTKLGFKFN  183 (187)
Q Consensus       132 ki~dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi~  183 (187)
                      ||+|||++........   ..+++.|+|||.+.+  ...++.++|+||+|++
T Consensus       161 kl~Dfg~~~~~~~~~~---~~~~~~y~aPE~~~~--~~~~~~~~DiwslG~i  207 (289)
T 4fvq_A          161 KLSDPGISITVLPKDI---LQERIPWVPPECIEN--PKNLNLATDKWSFGTT  207 (289)
T ss_dssp             EECCCCSCTTTSCHHH---HHHTTTTSCHHHHHC--GGGCCHHHHHHHHHHH
T ss_pred             eeccCcccccccCccc---cCCcCcccCHHHhCC--CCCCCchhHHHHHHHH
Confidence            9999999877644321   246888999999883  2558899999999994

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A

Probab=99.97  E-value=3.3e-31  Score=201.09  Aligned_cols=155  Identities=26%  Similarity=0.475  Sum_probs=120.8

Q ss_pred             cccccccccccccCceEEEEEEEcCCCcEEEEEEccCccChHHHHHHHHHHHHHHhcCCCCchhhhhhhH----------
Q psy14630         23 SEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQFYGAL----------   92 (187)
Q Consensus        23 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~----------   92 (187)
                      .++|++.+.||+|+||.||+|.+..+++.||+|.+..   .....+.+.++..+++.+.||||+++++.+          
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~---~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   81 (303)
T 1zy4_A            5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRH---TEEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPM   81 (303)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEE---EHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC--
T ss_pred             cccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEec---cHHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhh
Confidence            4689999999999999999999999999999999853   223345556666778888999999875421          


Q ss_pred             ------------------------------------HHHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEec
Q psy14630         93 ------------------------------------FKEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDF  136 (187)
Q Consensus        93 ------------------------------------~~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~df  136 (187)
                                                          ...++.|++.|+.|||+. +++||||||+||+++.++.+||+||
T Consensus        82 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~-~i~H~dlkp~Nil~~~~~~~kl~df  160 (303)
T 1zy4_A           82 TAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQ-GIIHRDLKPMNIFIDESRNVKIGDF  160 (303)
T ss_dssp             ----CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCCGGGEEECTTSCEEECCC
T ss_pred             cccccCCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHHhC-CeecccCCHHhEEEcCCCCEEEeeC
Confidence                                                011667899999999998 9999999999999999999999999


Q ss_pred             ccccccccc---------------ccccCCCCCcCccCccccCCCccCCCCCCcceeeeEee
Q psy14630        137 GISGQLVDS---------------IAKTRDAGCRPYMAPERIDPLRARGYPSFKTKLGFKFN  183 (187)
Q Consensus       137 g~a~~~~~~---------------~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi~  183 (187)
                      |+++.....               .......+++.|+|||.+.+  ...++.++|+||+|++
T Consensus       161 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~~Di~slG~i  220 (303)
T 1zy4_A          161 GLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDG--TGHYNEKIDMYSLGII  220 (303)
T ss_dssp             CCCSCTTC-------------------------CTTSCHHHHTS--CSCCCTHHHHHHHHHH
T ss_pred             cchhhcccccchhccccccccccccccccCCCcccccCcccccC--CCCCcchhhHHHHHHH
Confidence            999876421               11223468899999999873  2357899999999993

>4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A*

Probab=99.97  E-value=5.9e-32  Score=224.60  Aligned_cols=159  Identities=27%  Similarity=0.378  Sum_probs=120.7

Q ss_pred             Cccccccc-ccccccCceEEEEEEE--cCCCcEEEEEEccCccChHHHHHHHHHHHHHHhcCCCCchhhhhhhH------
Q psy14630         22 TSEDLQDL-GEIGRGGFGTVNKMIH--RSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQFYGAL------   92 (187)
Q Consensus        22 ~~~~~~~~-~~lg~G~fg~V~~~~~--~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~------   92 (187)
                      ....+.+. +.||+|+||.||+|.+  ..+++.||||+++.........+.+.++..+++.++||||+++++.+      
T Consensus       366 ~~~~~~l~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~  445 (635)
T 4fl3_A          366 DRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAESWM  445 (635)
T ss_dssp             CGGGEEEEEEEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEESSSEE
T ss_pred             cchhccccCCEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEE
Confidence            33444433 4799999999999954  45678899999975443333345566677778888999999987532      


Q ss_pred             -------------------------HHHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEecccccccccccc
Q psy14630         93 -------------------------FKEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIA  147 (187)
Q Consensus        93 -------------------------~~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg~a~~~~~~~~  147 (187)
                                               ...++.|++.||.|||+. +|+||||||+||+++.++.+||+|||+++.+.....
T Consensus       446 lv~E~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~-~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~  524 (635)
T 4fl3_A          446 LVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEES-NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADEN  524 (635)
T ss_dssp             EEEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC---
T ss_pred             EEEEccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHC-CEeCCCCChHhEEEeCCCCEEEEEcCCccccccCcc
Confidence                                     112678999999999998 999999999999999999999999999987654321


Q ss_pred             ----ccCCCCCcCccCccccCCCccCCCCCCcceeeeEeee
Q psy14630        148 ----KTRDAGCRPYMAPERIDPLRARGYPSFKTKLGFKFNY  184 (187)
Q Consensus       148 ----~~~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi~~  184 (187)
                          .....+|+.|+|||++.   ...++.++||||||+++
T Consensus       525 ~~~~~~~~~~t~~y~APE~~~---~~~~~~~sDvwSlGv~l  562 (635)
T 4fl3_A          525 YYKAQTHGKWPVKWYAPECIN---YYKFSSKSDVWSFGVLM  562 (635)
T ss_dssp             ----------CGGGSCHHHHH---HCCCCHHHHHHHHHHHH
T ss_pred             ccccccCCCCceeeeChhhhc---CCCCCcHHHHHHHHHHH
Confidence                12234677899999998   66789999999999943

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A*

Probab=99.97  E-value=5.5e-32  Score=205.07  Aligned_cols=163  Identities=26%  Similarity=0.364  Sum_probs=125.6

Q ss_pred             ccccCCcccccccc-cccccCceEEEEEEE--cCCCcEEEEEEccCccChHHHHHHHHHHHHHHhcCCCCchhhhhhhH-
Q psy14630         17 TVYDFTSEDLQDLG-EIGRGGFGTVNKMIH--RSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQFYGAL-   92 (187)
Q Consensus        17 ~~~~~~~~~~~~~~-~lg~G~fg~V~~~~~--~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~-   92 (187)
                      ..+.+..++|.+.+ .||+|+||.||+|.+  ..+++.||+|+++.........+.+..+..+++.+.||||+++++.+ 
T Consensus         9 ~~~~~~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~   88 (291)
T 1xbb_A            9 KEVYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICE   88 (291)
T ss_dssp             --CBCCGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEE
T ss_pred             ceeeecchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEC
Confidence            45567788999988 999999999999954  56778999999875443334455666677778888999999987532 


Q ss_pred             ------------------------------HHHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEeccccccc
Q psy14630         93 ------------------------------FKEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQL  142 (187)
Q Consensus        93 ------------------------------~~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg~a~~~  142 (187)
                                                    ...++.|++.||.|||+. +++||||||+||+++.++.+||+|||++...
T Consensus        89 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~-~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~  167 (291)
T 1xbb_A           89 AESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEES-NFVHRDLAARNVLLVTQHYAKISDFGLSKAL  167 (291)
T ss_dssp             SSSEEEEEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred             CCCcEEEEEeCCCCCHHHHHHhCcCCCHHHHHHHHHHHHHHHHHHHhC-CeEcCCCCcceEEEeCCCcEEEccCCcceee
Confidence                                          112678999999999998 9999999999999999999999999999876


Q ss_pred             ccccc----ccCCCCCcCccCccccCCCccCCCCCCcceeeeEee
Q psy14630        143 VDSIA----KTRDAGCRPYMAPERIDPLRARGYPSFKTKLGFKFN  183 (187)
Q Consensus       143 ~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi~  183 (187)
                      .....    .....+++.|+|||.+.   ...++.++|+||+|++
T Consensus       168 ~~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~Di~slG~i  209 (291)
T 1xbb_A          168 RADENYYKAQTHGKWPVKWYAPECIN---YYKFSSKSDVWSFGVL  209 (291)
T ss_dssp             CTTCSEEEC----CCCGGGCCHHHHH---HCEEEHHHHHHHHHHH
T ss_pred             ccCCCcccccccCCCCceeeChHHhc---cCCCChhhhHHHHHHH
Confidence            43321    12224567899999997   5567889999999993

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A

Probab=99.97  E-value=1.2e-31  Score=205.16  Aligned_cols=160  Identities=21%  Similarity=0.328  Sum_probs=117.0

Q ss_pred             Cccccccc-ccccccCceEEEEEEEcCCCcEEEEEEccCccChHHHHHHHHHHHHHHhcCCCCchhhhhhhHH-------
Q psy14630         22 TSEDLQDL-GEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQFYGALF-------   93 (187)
Q Consensus        22 ~~~~~~~~-~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~-------   93 (187)
                      ..+.|++. +.||+|+||.||+|.+..+++.||+|++...... .......+...+.+...||||+++++.+.       
T Consensus        10 ~~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~l   88 (316)
T 2ac3_A           10 FEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGH-IRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYL   88 (316)
T ss_dssp             TTTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSC-CHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred             cceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcch-hHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEE
Confidence            34678885 7899999999999999999999999998654222 22334444444444468999998875321       


Q ss_pred             -------------------------HHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCC---EEEEecccccccccc
Q psy14630         94 -------------------------KEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGA---IKLCDFGISGQLVDS  145 (187)
Q Consensus        94 -------------------------~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~---~ki~dfg~a~~~~~~  145 (187)
                                               ..++.|++.||.|||+. +++||||||+||+++.++.   +||+|||+++.....
T Consensus        89 v~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~-~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~  167 (316)
T 2ac3_A           89 VFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNK-GIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLN  167 (316)
T ss_dssp             EEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT-TCCCCCCCGGGEEESCSSSSCSEEECCTTCCC-----
T ss_pred             EEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC-CceeCCCCHHHEEEccCCCcCceEEEEccCccccccC
Confidence                                     12678899999999998 9999999999999987765   999999998875421


Q ss_pred             c--------cccCCCCCcCccCccccCCCc--cCCCCCCcceeeeEee
Q psy14630        146 I--------AKTRDAGCRPYMAPERIDPLR--ARGYPSFKTKLGFKFN  183 (187)
Q Consensus       146 ~--------~~~~~~~t~~y~aPE~~~~~~--~~~~~~~~D~ws~gi~  183 (187)
                      .        ......||+.|+|||.+.+..  ...++.++|+||+|++
T Consensus       168 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~i  215 (316)
T 2ac3_A          168 GDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVI  215 (316)
T ss_dssp             --------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHH
T ss_pred             CccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHH
Confidence            1        112335899999999986211  1347889999999993

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7

Probab=99.96  E-value=2.9e-31  Score=201.29  Aligned_cols=154  Identities=19%  Similarity=0.335  Sum_probs=121.4

Q ss_pred             cccccccccccCceEEEEEEEcCCCc---EEEEEEccCccChHHHHHHHHHHHHHHhcCCCCchhhhhhhHH--------
Q psy14630         25 DLQDLGEIGRGGFGTVNKMIHRSSDT---VMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQFYGALF--------   93 (187)
Q Consensus        25 ~~~~~~~lg~G~fg~V~~~~~~~~~~---~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~--------   93 (187)
                      .|+..+.||+|+||.||+|.+..++.   .+|+|.+...... ...+.+.++..+++.++||||+++++.+.        
T Consensus        22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~  100 (298)
T 3pls_A           22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEM-QQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHV  100 (298)
T ss_dssp             EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSH-HHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEE
T ss_pred             EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccH-HHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEE
Confidence            45566999999999999998755444   7999998754333 33445556666778889999999875431        


Q ss_pred             --------------------------HHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEeccccccccccc-
Q psy14630         94 --------------------------KEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSI-  146 (187)
Q Consensus        94 --------------------------~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg~a~~~~~~~-  146 (187)
                                                ..+..|++.||.|||+. +++||||||+||+++.++.+||+|||+++...... 
T Consensus       101 v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~-~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~  179 (298)
T 3pls_A          101 LLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQ-KFVHRDLAARNCMLDESFTVKVADFGLARDILDREY  179 (298)
T ss_dssp             EECCCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHT-TCCCSCCSGGGEEECTTCCEEECCTTSSCTTTTGGG
T ss_pred             EEecccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhC-CcccCCCCcceEEEcCCCcEEeCcCCCcccccCCcc
Confidence                                      12667899999999998 99999999999999999999999999998764322 


Q ss_pred             ----cccCCCCCcCccCccccCCCccCCCCCCcceeeeEee
Q psy14630        147 ----AKTRDAGCRPYMAPERIDPLRARGYPSFKTKLGFKFN  183 (187)
Q Consensus       147 ----~~~~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi~  183 (187)
                          ......+++.|+|||.+.   ...++.++|+||+|++
T Consensus       180 ~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~Di~slG~i  217 (298)
T 3pls_A          180 YSVQQHRHARLPVKWTALESLQ---TYRFTTKSDVWSFGVL  217 (298)
T ss_dssp             GCSCCSSCTTCGGGGSCHHHHT---TCCCCHHHHHHHHHHH
T ss_pred             cccccCcCCCCCccccChhhhc---cCCCChhhchhhHHHH
Confidence                122335678899999998   6678899999999993

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens}

Probab=99.96  E-value=4.9e-31  Score=201.51  Aligned_cols=152  Identities=28%  Similarity=0.512  Sum_probs=116.0

Q ss_pred             cCCcccccccccccccCceEEEEEEEcCCCcEEEEEEccCccChHHHHHHHHHHHHHHhcCCCCchhhhhhhHHH-----
Q psy14630         20 DFTSEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQFYGALFK-----   94 (187)
Q Consensus        20 ~~~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~-----   94 (187)
                      .+..++|++.+.||+|+||.||+|.+.  ++.||+|.+...   . ..+.+..+..+++.++||||+++++.+..     
T Consensus         4 ~i~~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~---~-~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~lv   77 (307)
T 2eva_A            4 MIDYKEIEVEEVVGRGAFGVVCKAKWR--AKDVAIKQIESE---S-ERKAFIVELRQLSRVNHPNIVKLYGACLNPVCLV   77 (307)
T ss_dssp             BCCGGGEEEEEEEECCSSSEEEEEEET--TEEEEEEECSST---T-HHHHHHHHHHHHHHCCCTTBCCEEEBCTTTTEEE
T ss_pred             cCCHhHeeeeeEeecCCCceEEEEEEC--CeeEEEEEecCh---h-HHHHHHHHHHHHhcCCCCCcCeEEEEEcCCcEEE
Confidence            356789999999999999999999874  678999998632   1 23345555666777899999998754211     


Q ss_pred             ----------------------------HHHHHHHHHHHHHHh---cCCCeeecCCCCCeEEcCCCC-EEEEeccccccc
Q psy14630         95 ----------------------------EVTVATVKALNYLKE---ELKIIHRDVKPSNILLDRRGA-IKLCDFGISGQL  142 (187)
Q Consensus        95 ----------------------------~~~~~~~~~l~~lh~---~~~i~Hrdlk~~nili~~~~~-~ki~dfg~a~~~  142 (187)
                                                  .+..|++.|+.|||+   . +++||||||+||+++.++. +||+|||++...
T Consensus        78 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~-~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~  156 (307)
T 2eva_A           78 MEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPK-ALIHRDLKPPNLLLVAGGTVLKICDFGTACDI  156 (307)
T ss_dssp             EECCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSS-CCCCCCCSGGGEEEETTTTEEEECCCCC----
T ss_pred             EEcCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCC-CeecCCCChhHEEEeCCCCEEEEccccccccc
Confidence                                        155789999999999   5 8999999999999988886 799999999765


Q ss_pred             cccccccCCCCCcCccCccccCCCccCCCCCCcceeeeEee
Q psy14630        143 VDSIAKTRDAGCRPYMAPERIDPLRARGYPSFKTKLGFKFN  183 (187)
Q Consensus       143 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi~  183 (187)
                      ....  ....||+.|+|||.+.   ...++.++|+||||++
T Consensus       157 ~~~~--~~~~gt~~y~aPE~~~---~~~~~~~~Di~slG~i  192 (307)
T 2eva_A          157 QTHM--TNNKGSAAWMAPEVFE---GSNYSEKCDVFSWGII  192 (307)
T ss_dssp             ----------CCTTSSCHHHHT---CCCCCTHHHHHHHHHH
T ss_pred             cccc--ccCCCCCceEChhhhC---CCCCCcHHHHHHHHHH
Confidence            4332  2336899999999998   5678899999999993

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A*

Probab=99.96  E-value=1.1e-31  Score=203.73  Aligned_cols=157  Identities=20%  Similarity=0.243  Sum_probs=120.4

Q ss_pred             cCCcccccccccccccCceEEEEEEEcCCCcEEEEEEccCccChHHHHHHHHHHHHHHhcCCCCchhhhhhhH-------
Q psy14630         20 DFTSEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQFYGAL-------   92 (187)
Q Consensus        20 ~~~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~-------   92 (187)
                      ++..++|++.+.||+|+||.||+|.+..+++.||+|++.......   ....+...+....+|+|++.+++.+       
T Consensus         6 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~---~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~   82 (298)
T 1csn_A            6 NVVGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAP---QLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNV   82 (298)
T ss_dssp             CEETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTSC---CHHHHHHHHHHTTTCTTCCCEEEEEEETTEEE
T ss_pred             cccccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCccH---HHHHHHHHHHHHhcCCCCCeEEeecCCCceeE
Confidence            344678999999999999999999999999999999986432221   1222233333333788877665321       


Q ss_pred             -------------------------HHHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCC-----EEEEeccccccc
Q psy14630         93 -------------------------FKEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGA-----IKLCDFGISGQL  142 (187)
Q Consensus        93 -------------------------~~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~-----~ki~dfg~a~~~  142 (187)
                                               ...++.|++.||.|||+. +++||||||+||+++.++.     +||+|||+++..
T Consensus        83 lv~e~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~-~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~  161 (298)
T 1csn_A           83 LVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEK-SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFY  161 (298)
T ss_dssp             EEEECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTT-TEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEES
T ss_pred             EEEEecCCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhC-CEecCCCCHHHEEeccCCCCCCCeEEEEECcccccc
Confidence                                     122778999999999997 9999999999999987765     999999999876


Q ss_pred             ccccc--------ccCCCCCcCccCccccCCCccCCCCCCcceeeeEee
Q psy14630        143 VDSIA--------KTRDAGCRPYMAPERIDPLRARGYPSFKTKLGFKFN  183 (187)
Q Consensus       143 ~~~~~--------~~~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi~  183 (187)
                      .....        .....||+.|+|||.+.   ...++.++|+||+|++
T Consensus       162 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Di~slG~i  207 (298)
T 1csn_A          162 RDPVTKQHIPYREKKNLSGTARYMSINTHL---GREQSRRDDLEALGHV  207 (298)
T ss_dssp             BCTTTCCBCCCCCCCCCCSCTTTCCHHHHT---TCCCCHHHHHHHHHHH
T ss_pred             ccccccccccccCccCCCCCcccCCchhhc---CCCCChHHHHHHHHHH
Confidence            54322        23446899999999988   5668999999999993

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7

Probab=99.96  E-value=6e-32  Score=210.55  Aligned_cols=162  Identities=24%  Similarity=0.303  Sum_probs=119.2

Q ss_pred             cCCcccccccccccccCceEEEEEEEc---CCCcEEEEEEccCccC--hHHHHHHHHHHHHHHhcC-CCCchhhhhhhH-
Q psy14630         20 DFTSEDLQDLGEIGRGGFGTVNKMIHR---SSDTVMAVKRIRSTVD--EKDQRQLLMDLDVVMKSN-ECPYIVQFYGAL-   92 (187)
Q Consensus        20 ~~~~~~~~~~~~lg~G~fg~V~~~~~~---~~~~~vaiK~~~~~~~--~~~~~~~~~~~~~~~~~~-~h~~iv~~~~~~-   92 (187)
                      .+..++|++.+.||+|+||.||+|.+.   .+++.||+|+++....  .....+.+..+..+++.+ +||||+++++.+ 
T Consensus        50 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~  129 (355)
T 1vzo_A           50 KVGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQ  129 (355)
T ss_dssp             CCCGGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEE
T ss_pred             cccccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEe
Confidence            455689999999999999999999984   5889999999864211  001111122233333333 799999876422 


Q ss_pred             -------------------------------HHHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEecccccc
Q psy14630         93 -------------------------------FKEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQ  141 (187)
Q Consensus        93 -------------------------------~~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg~a~~  141 (187)
                                                     ...++.|++.||.|||+. +++||||||+||+++.++.+||+|||+++.
T Consensus       130 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~-~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~  208 (355)
T 1vzo_A          130 TETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKL-GIIYRDIKLENILLDSNGHVVLTDFGLSKE  208 (355)
T ss_dssp             ETTEEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHT-TCCCCCCCGGGEEECTTSCEEESCSSEEEE
T ss_pred             eCceEEEEeecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC-CcccCCCCHHHEEECCCCcEEEeeCCCCee
Confidence                                           112667899999999997 999999999999999999999999999987


Q ss_pred             ccccc--cccCCCCCcCccCccccCCCccCCCCCCcceeeeEee
Q psy14630        142 LVDSI--AKTRDAGCRPYMAPERIDPLRARGYPSFKTKLGFKFN  183 (187)
Q Consensus       142 ~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi~  183 (187)
                      .....  ......||+.|+|||.+.+. ...++.++|+||||++
T Consensus       209 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~~DvwslG~i  251 (355)
T 1vzo_A          209 FVADETERAYDFCGTIEYMAPDIVRGG-DSGHDKAVDWWSLGVL  251 (355)
T ss_dssp             CCGGGGGGGCGGGSCCTTCCHHHHTTC-C---CTHHHHHHHHHH
T ss_pred             cccCCCCcccCcccCcCccChhhhcCC-CCCCCchhhHHHHHHH
Confidence            64322  22334789999999998842 2347889999999994

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ...

Probab=99.96  E-value=1.6e-31  Score=201.24  Aligned_cols=160  Identities=21%  Similarity=0.343  Sum_probs=128.6

Q ss_pred             CccccCCcccccccccccccCceEEEEEEEcCCCcEEEEEEccCccChHHHHHHHHHHHHHHhcCCCCchhhhhhhH---
Q psy14630         16 DTVYDFTSEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQFYGAL---   92 (187)
Q Consensus        16 ~~~~~~~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~---   92 (187)
                      ...|++..++|++.+.||+|+||.||+|.+. ++..||+|.+......   .+.+..+..+++.++||||+++++.+   
T Consensus         5 ~~~~~v~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~h~~i~~~~~~~~~~   80 (279)
T 1qpc_A            5 EDEWEVPRETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSMS---PDAFLAEANLMKQLQHQRLVRLYAVVTQE   80 (279)
T ss_dssp             TCTTBCCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTSSC---HHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             hhhcccCHHhhhheeeecCCCCeEEEEEEEc-CCcEEEEEEecCCccc---HHHHHHHHHHHHhCCCcCcceEEEEEcCC
Confidence            4578889999999999999999999999974 5678999998653322   23455566677788999999887532   


Q ss_pred             ------------------------------HHHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEeccccccc
Q psy14630         93 ------------------------------FKEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQL  142 (187)
Q Consensus        93 ------------------------------~~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg~a~~~  142 (187)
                                                    ...++.|++.||.|||+. +++||||||+||+++.++.+||+|||++...
T Consensus        81 ~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~-~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~  159 (279)
T 1qpc_A           81 PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER-NYIHRDLRAANILVSDTLSCKIADFGLARLI  159 (279)
T ss_dssp             SCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred             CcEEEEecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHC-CeeccCCCHhhEEEcCCCCEEECCCcccccc
Confidence                                          112678899999999997 9999999999999999999999999999876


Q ss_pred             ccccc--ccCCCCCcCccCccccCCCccCCCCCCcceeeeEee
Q psy14630        143 VDSIA--KTRDAGCRPYMAPERIDPLRARGYPSFKTKLGFKFN  183 (187)
Q Consensus       143 ~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi~  183 (187)
                      .....  .....++..|+|||.+.   ...++.++|+||+|++
T Consensus       160 ~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~Di~slG~i  199 (279)
T 1qpc_A          160 EDNEYTAREGAKFPIKWTAPEAIN---YGTFTIKSDVWSFGIL  199 (279)
T ss_dssp             SSSCEECCTTCCCCTTTSCHHHHH---HCEECHHHHHHHHHHH
T ss_pred             cCcccccccCCCCccCccChhhhc---cCCCCchhhhHHHHHH
Confidence            54322  22334677899999987   5568899999999994

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A*

Probab=99.96  E-value=1.1e-31  Score=201.59  Aligned_cols=160  Identities=24%  Similarity=0.310  Sum_probs=119.4

Q ss_pred             cCCcccccccccccccCceEEEEEEEcCCCcEEEEEEccCccC-hHHHHHHHHHHHHHHhcCCCCchhhhhhhH------
Q psy14630         20 DFTSEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVD-EKDQRQLLMDLDVVMKSNECPYIVQFYGAL------   92 (187)
Q Consensus        20 ~~~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~------   92 (187)
                      .+..++|++.+.||+|+||.||+|.+..+++.||+|.+..... .....+.+.++...++.+.||||+++++.+      
T Consensus         7 ~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   86 (276)
T 2h6d_A            7 RVKIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDF   86 (276)
T ss_dssp             CCEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEE
T ss_pred             cceeccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeE
Confidence            4456899999999999999999999998999999999853211 111233455566677788999999886532      


Q ss_pred             --------------------------HHHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEeccccccccccc
Q psy14630         93 --------------------------FKEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSI  146 (187)
Q Consensus        93 --------------------------~~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg~a~~~~~~~  146 (187)
                                                ...+..|++.|+.|||+. +++|+||||+||+++.++.++|+|||++.......
T Consensus        87 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~-~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~  165 (276)
T 2h6d_A           87 FMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRH-MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE  165 (276)
T ss_dssp             EEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHH-CSSCCCCCGGGEEECTTSCEEECCCCGGGCCCC--
T ss_pred             EEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC-CCccCCCChhhEEECCCCCEEEeecccccccCCCc
Confidence                                      112677899999999998 99999999999999999999999999998876544


Q ss_pred             cccCCCCCcCccCccccCCCccCCC-CCCcceeeeEee
Q psy14630        147 AKTRDAGCRPYMAPERIDPLRARGY-PSFKTKLGFKFN  183 (187)
Q Consensus       147 ~~~~~~~t~~y~aPE~~~~~~~~~~-~~~~D~ws~gi~  183 (187)
                      ......+++.|+|||.+.   ...+ +.++|+||+|++
T Consensus       166 ~~~~~~~~~~y~aPE~~~---~~~~~~~~~Di~slG~~  200 (276)
T 2h6d_A          166 FLRTSCGSPNYAAPEVIS---GRLYAGPEVDIWSCGVI  200 (276)
T ss_dssp             -----------CCTGGGT---TSCCCHHHHHHHHHHHH
T ss_pred             ceecccCCccccCHHHHc---CCCCCCccchHHHHHHH
Confidence            444557899999999988   4444 578999999983

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A*

Probab=99.96  E-value=1.2e-31  Score=206.28  Aligned_cols=157  Identities=22%  Similarity=0.406  Sum_probs=127.5

Q ss_pred             CCcccccccccccccCceEEEEEE----EcCCCcEEEEEEccCccChHHHHHHHHHHHHHHhcCCCCchhhhhhhHH---
Q psy14630         21 FTSEDLQDLGEIGRGGFGTVNKMI----HRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQFYGALF---   93 (187)
Q Consensus        21 ~~~~~~~~~~~lg~G~fg~V~~~~----~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~---   93 (187)
                      +..++|++.+.||+|+||.||+|.    +..+++.||+|.+...  .....+.+.++..+++.++||||+++++.+.   
T Consensus        20 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~   97 (327)
T 3lxl_A           20 FEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHS--GPDQQRDFQREIQILKALHSDFIVKYRGVSYGPG   97 (327)
T ss_dssp             CCGGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSS
T ss_pred             hchhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccC--CHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCC
Confidence            577899999999999999999998    5678899999998753  2334455666777788889999998864321   


Q ss_pred             --------------------------------HHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEecccccc
Q psy14630         94 --------------------------------KEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQ  141 (187)
Q Consensus        94 --------------------------------~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg~a~~  141 (187)
                                                      ..++.|++.||.|||+. +++||||||+||+++.++.+||+|||+++.
T Consensus        98 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~-~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~  176 (327)
T 3lxl_A           98 RQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSR-RCVHRDLAARNILVESEAHVKIADFGLAKL  176 (327)
T ss_dssp             SCEEEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEEEETTEEEECCGGGCEE
T ss_pred             CceEEEEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhC-CccCCCCChhhEEECCCCCEEEccccccee
Confidence                                            11667899999999997 999999999999999999999999999987


Q ss_pred             ccccc----cccCCCCCcCccCccccCCCccCCCCCCcceeeeEee
Q psy14630        142 LVDSI----AKTRDAGCRPYMAPERIDPLRARGYPSFKTKLGFKFN  183 (187)
Q Consensus       142 ~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi~  183 (187)
                      .....    ......+++.|+|||.+.   ...++.++|+||+|++
T Consensus       177 ~~~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~Di~slG~i  219 (327)
T 3lxl_A          177 LPLDKDYYVVREPGQSPIFWYAPESLS---DNIFSRQSDVWSFGVV  219 (327)
T ss_dssp             CCTTCSEEECSSCCCSCGGGSCHHHHH---HCEEEHHHHHHHHHHH
T ss_pred             cccCCccceeeccCCccccccCHHHhc---cCCCChHHhHHHHHHH
Confidence            64322    222335788899999987   5567899999999993

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A

Probab=99.96  E-value=2.9e-31  Score=202.27  Aligned_cols=154  Identities=24%  Similarity=0.347  Sum_probs=122.9

Q ss_pred             cccccccccccccCceEEEEEEEcCCCcEEEEEEccCccChHHHHHHHHHHHHHHhcCCCCchhhhhhhH----------
Q psy14630         23 SEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQFYGAL----------   92 (187)
Q Consensus        23 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~----------   92 (187)
                      .++|++.+.||+|+||.||+|.+..+++.||+|.++....  ...+.+.++..+++.+.||||+++++.+          
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   85 (304)
T 2jam_A            8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPA--FRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVM   85 (304)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC--------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccc--cchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEE
Confidence            4789999999999999999999999999999999874321  2233455566677788999999876432          


Q ss_pred             ----------------------HHHHHHHHHHHHHHHHhcCCCeeecCCCCCeEE---cCCCCEEEEecccccccccccc
Q psy14630         93 ----------------------FKEVTVATVKALNYLKEELKIIHRDVKPSNILL---DRRGAIKLCDFGISGQLVDSIA  147 (187)
Q Consensus        93 ----------------------~~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili---~~~~~~ki~dfg~a~~~~~~~~  147 (187)
                                            ...+..|++.|+.|||+. +++||||||+||++   +..+.++|+|||+++..... .
T Consensus        86 e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~-~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~-~  163 (304)
T 2jam_A           86 QLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHEN-GIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNG-I  163 (304)
T ss_dssp             CCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHT-TCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCCB-T
T ss_pred             EcCCCccHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC-CccccCCCHHHEEEecCCCCCCEEEccCCcceecCCC-c
Confidence                                  112667899999999998 99999999999999   77889999999998765432 2


Q ss_pred             ccCCCCCcCccCccccCCCccCCCCCCcceeeeEee
Q psy14630        148 KTRDAGCRPYMAPERIDPLRARGYPSFKTKLGFKFN  183 (187)
Q Consensus       148 ~~~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi~  183 (187)
                      .....+++.|+|||.+.   ...++.++|+||+|++
T Consensus       164 ~~~~~~~~~y~aPE~~~---~~~~~~~~Di~slG~i  196 (304)
T 2jam_A          164 MSTACGTPGYVAPEVLA---QKPYSKAVDCWSIGVI  196 (304)
T ss_dssp             THHHHSCCCBCCTTTBS---SCSCCHHHHHHHHHHH
T ss_pred             cccccCCCCccChHHhc---cCCCCchhhHHHHHHH
Confidence            22236899999999998   5678899999999994

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ...

Probab=99.96  E-value=2.1e-31  Score=202.24  Aligned_cols=158  Identities=23%  Similarity=0.334  Sum_probs=122.1

Q ss_pred             CCcccccccccccccCceEEEEEEEcCC---CcEEEEEEccCccChHHHHHHHHHHHHHHhcCCCCchhhhhhhHH----
Q psy14630         21 FTSEDLQDLGEIGRGGFGTVNKMIHRSS---DTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQFYGALF----   93 (187)
Q Consensus        21 ~~~~~~~~~~~lg~G~fg~V~~~~~~~~---~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~----   93 (187)
                      ....+|++.+.||+|+||.||+|.+..+   ...+|+|.+...... ...+.+.++..+++.++||||+++++.+.    
T Consensus        22 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~  100 (298)
T 3f66_A           22 PSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDI-GEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEG  100 (298)
T ss_dssp             GGGEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSH-HHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSS
T ss_pred             ccceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCH-HHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCC
Confidence            3445788899999999999999986533   345899998754333 33444556666778889999999876421    


Q ss_pred             ------------------------------HHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEecccccccc
Q psy14630         94 ------------------------------KEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLV  143 (187)
Q Consensus        94 ------------------------------~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg~a~~~~  143 (187)
                                                    ..++.|++.||.|||+. +++||||||+||+++.++.+||+|||+++...
T Consensus       101 ~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~-~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~  179 (298)
T 3f66_A          101 SPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASK-KFVHRDLAARNCMLDEKFTVKVADFGLARDMY  179 (298)
T ss_dssp             CCEEEEECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCSGGGEEECTTCCEEECSCGGGCCCS
T ss_pred             ceEEEEeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhC-CccCCCCchheEEECCCCCEEECccccccccc
Confidence                                          11667899999999998 99999999999999999999999999998765


Q ss_pred             cccc-----ccCCCCCcCccCccccCCCccCCCCCCcceeeeEee
Q psy14630        144 DSIA-----KTRDAGCRPYMAPERIDPLRARGYPSFKTKLGFKFN  183 (187)
Q Consensus       144 ~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi~  183 (187)
                      ....     .....+|+.|+|||.+.   ...++.++|+||+|++
T Consensus       180 ~~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~Di~slG~i  221 (298)
T 3f66_A          180 DKEYYSVHNKTGAKLPVKWMALESLQ---TQKFTTKSDVWSFGVL  221 (298)
T ss_dssp             CGGGCBC-----CCBCGGGSCHHHHH---HCCCCHHHHHHHHHHH
T ss_pred             ccchhccccccCCCCCccccChHHhc---CCCCChHHHHHHHHHH
Confidence            4321     22335678899999997   6678899999999993

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=99.96  E-value=2.9e-31  Score=198.36  Aligned_cols=158  Identities=25%  Similarity=0.375  Sum_probs=126.6

Q ss_pred             cccCCcccccccccccccCceEEEEEEEcCCCcEEEEEEccCccChHHHHHHHHHHHHHHhcCCCCchhhhhhhHH----
Q psy14630         18 VYDFTSEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQFYGALF----   93 (187)
Q Consensus        18 ~~~~~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~----   93 (187)
                      .|.+..++|++.+.||+|+||.||+|.+. ++..||+|.+.......   +.+.++..+++.++||||+++++.+.    
T Consensus         2 ~~~i~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~---~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   77 (267)
T 3t9t_A            2 KWVIDPSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMSE---EDFIEEAEVMMKLSHPKLVQLYGVCLEQAP   77 (267)
T ss_dssp             -CBCCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTTBCH---HHHHHHHHHHHTCCCTTBCCEEEEECSSSS
T ss_pred             ceEEchhheeeeeEecCCCceeEEEEEec-CCCeEEEEEccccCCCH---HHHHHHHHHHHhCCCCCEeeEEEEEccCCC
Confidence            46778899999999999999999999985 57789999987543322   34555666777889999998865321    


Q ss_pred             -----------------------------HHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEeccccccccc
Q psy14630         94 -----------------------------KEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVD  144 (187)
Q Consensus        94 -----------------------------~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg~a~~~~~  144 (187)
                                                   ..+..|++.|+.|||+. +++|+||||+||+++.++.++|+|||+++....
T Consensus        78 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~-~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~  156 (267)
T 3t9t_A           78 ICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEA-CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLD  156 (267)
T ss_dssp             CEEEECCCTTCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHT-TCCCSSCCGGGEEECGGGCEEECCTTGGGGBCC
T ss_pred             eEEEEeCCCCCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHHhC-CcccCCCchheEEECCCCCEEEccccccccccc
Confidence                                         12667899999999998 999999999999999999999999999987643


Q ss_pred             cc--cccCCCCCcCccCccccCCCccCCCCCCcceeeeEee
Q psy14630        145 SI--AKTRDAGCRPYMAPERIDPLRARGYPSFKTKLGFKFN  183 (187)
Q Consensus       145 ~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi~  183 (187)
                      ..  ......++..|+|||.+.   ...++.++|+||+|++
T Consensus       157 ~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~Di~slG~i  194 (267)
T 3t9t_A          157 DQYTSSTGTKFPVKWASPEVFS---FSRYSSKSDVWSFGVL  194 (267)
T ss_dssp             HHHHSTTSTTCCGGGCCHHHHH---HCCCCHHHHHHHHHHH
T ss_pred             ccccccccccccccccChhhhc---CCCccchhchhhhHHH
Confidence            22  122335677899999997   5678899999999993

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ...

Probab=99.96  E-value=3e-31  Score=199.19  Aligned_cols=156  Identities=25%  Similarity=0.391  Sum_probs=125.6

Q ss_pred             cccccccccccccCceEEEEEEEcCCCcEEEEEEccCccChHHHHHHHHHHHHHHhcCCCCchhhhhhhH----------
Q psy14630         23 SEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQFYGAL----------   92 (187)
Q Consensus        23 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~----------   92 (187)
                      .++|++.+.||+|+||.||+|.+..+++.||+|.+....... ..+.+.++..+++.++||||+++++.+          
T Consensus         6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   84 (276)
T 2yex_A            6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVD-CPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFL   84 (276)
T ss_dssp             HHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTT-HHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             ecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchh-hhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEE
Confidence            478999999999999999999999999999999986433222 334555666677888999999887532          


Q ss_pred             ----------------------HHHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEecccccccccc---cc
Q psy14630         93 ----------------------FKEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDS---IA  147 (187)
Q Consensus        93 ----------------------~~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg~a~~~~~~---~~  147 (187)
                                            ...+..|++.||.|||+. +++|+||||+||+++.++.++|+|||++......   ..
T Consensus        85 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~-~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~  163 (276)
T 2yex_A           85 EYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI-GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERL  163 (276)
T ss_dssp             ECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEECC
T ss_pred             EecCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhC-CeeccCCChHHEEEccCCCEEEeeCCCccccCCCcchhc
Confidence                                  122778999999999997 9999999999999999999999999999876432   12


Q ss_pred             ccCCCCCcCccCccccCCCccCCC-CCCcceeeeEee
Q psy14630        148 KTRDAGCRPYMAPERIDPLRARGY-PSFKTKLGFKFN  183 (187)
Q Consensus       148 ~~~~~~t~~y~aPE~~~~~~~~~~-~~~~D~ws~gi~  183 (187)
                      .....+++.|+|||.+.   ...+ +.++|+||+|++
T Consensus       164 ~~~~~~~~~y~aPE~~~---~~~~~~~~~Di~slG~i  197 (276)
T 2yex_A          164 LNKMCGTLPYVAPELLK---RREFHAEPVDVWSCGIV  197 (276)
T ss_dssp             BCCCCSCGGGCCGGGGT---CSSBCHHHHHHHHHHHH
T ss_pred             ccCCccccCccChHHHh---cCCCCCCcchHHHHHHH
Confidence            23456899999999988   3343 578999999993

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens}

Probab=99.96  E-value=3e-31  Score=205.72  Aligned_cols=160  Identities=18%  Similarity=0.245  Sum_probs=119.3

Q ss_pred             cCCcccccccccccccCceEEEEEEEcC---CCcEEEEEEccCccChHHH-H--------HHHHHHHHHHhcCCCCchhh
Q psy14630         20 DFTSEDLQDLGEIGRGGFGTVNKMIHRS---SDTVMAVKRIRSTVDEKDQ-R--------QLLMDLDVVMKSNECPYIVQ   87 (187)
Q Consensus        20 ~~~~~~~~~~~~lg~G~fg~V~~~~~~~---~~~~vaiK~~~~~~~~~~~-~--------~~~~~~~~~~~~~~h~~iv~   87 (187)
                      ++..++|++.+.||+|+||.||+|.+..   ++..+|+|........... .        ..+.++...++.+.||||++
T Consensus        33 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~  112 (345)
T 2v62_A           33 DMEGNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPL  112 (345)
T ss_dssp             CTTSCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCC
T ss_pred             cccCceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcce
Confidence            5677899999999999999999999976   7888999998643221111 1        11333445667789999998


Q ss_pred             hhhhHHH-----------------------------------HHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCC--C
Q psy14630         88 FYGALFK-----------------------------------EVTVATVKALNYLKEELKIIHRDVKPSNILLDRRG--A  130 (187)
Q Consensus        88 ~~~~~~~-----------------------------------~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~--~  130 (187)
                      +++.+..                                   .++.|++.||.|||+. +++||||||+||+++.++  .
T Consensus       113 ~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~-~ivH~Dlkp~NIll~~~~~~~  191 (345)
T 2v62_A          113 FYGSGLTEFKGRSYRFMVMERLGIDLQKISGQNGTFKKSTVLQLGIRMLDVLEYIHEN-EYVHGDIKAANLLLGYKNPDQ  191 (345)
T ss_dssp             EEEEEEEESSSCEEEEEEEECEEEEHHHHCBGGGBCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEEESSSTTS
T ss_pred             eecccccccCCCcEEEEEEeccCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC-CeeCCCcCHHHEEEccCCCCc
Confidence            8754221                                   2778999999999998 999999999999998877  9


Q ss_pred             EEEEecccccccccccc--------ccCCCCCcCccCccccCCCccCCCCCCcceeeeEee
Q psy14630        131 IKLCDFGISGQLVDSIA--------KTRDAGCRPYMAPERIDPLRARGYPSFKTKLGFKFN  183 (187)
Q Consensus       131 ~ki~dfg~a~~~~~~~~--------~~~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi~  183 (187)
                      +||+|||+++.+.....        .....||+.|+|||.+.   ...++.++|+||||++
T Consensus       192 ~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Di~slG~i  249 (345)
T 2v62_A          192 VYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHK---GVALSRRSDVEILGYC  249 (345)
T ss_dssp             EEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHH---TCCCCHHHHHHHHHHH
T ss_pred             EEEEeCCCceecccccccccchhccccccCCCccccCHHHhc---CCCCCchhhHHHHHHH
Confidence            99999999987643221        13346899999999988   5568999999999993

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B*

Probab=99.96  E-value=1.8e-31  Score=200.99  Aligned_cols=152  Identities=28%  Similarity=0.452  Sum_probs=125.1

Q ss_pred             CcccccccccccccCceEEEEEEEcCCCcEEEEEEccCccChHHHHHHHHHHHHHHhcCCCCchhhhhhhH---------
Q psy14630         22 TSEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQFYGAL---------   92 (187)
Q Consensus        22 ~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~---------   92 (187)
                      ...+|++.+.||+|+||.||+|.+..+++.||+|.++....      .+.++..+++.+.||||+++++.+         
T Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~------~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~   82 (284)
T 2a19_B            9 FGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNE------KAEREVKALAKLDHVNIVHYNGCWDGFDYDPET   82 (284)
T ss_dssp             HHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCSG------GGHHHHHHHHHCCCTTBCCEEEEEEEEEEC---
T ss_pred             hccccceeeeeccCCceEEEEEEEcCCCeEEEEEEeccccH------HHHHHHHHHHhCCCCCEEEEeeeEeccccCccc
Confidence            34789999999999999999999998999999999864321      223445566778999999875421         


Q ss_pred             -----------------------------------------HHHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCE
Q psy14630         93 -----------------------------------------FKEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAI  131 (187)
Q Consensus        93 -----------------------------------------~~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~  131 (187)
                                                               ...+..|++.||.|||+. +++|+||||+||+++.++.+
T Consensus        83 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~-~i~H~dlkp~Nil~~~~~~~  161 (284)
T 2a19_B           83 SSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSK-KLINRDLKPSNIFLVDTKQV  161 (284)
T ss_dssp             ------CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEEEETTEE
T ss_pred             ccccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhC-CeeeccCCHHHEEEcCCCCE
Confidence                                                     011667899999999998 99999999999999999999


Q ss_pred             EEEeccccccccccccccCCCCCcCccCccccCCCccCCCCCCcceeeeEee
Q psy14630        132 KLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPLRARGYPSFKTKLGFKFN  183 (187)
Q Consensus       132 ki~dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi~  183 (187)
                      ||+|||+++............+++.|+|||.+.   ...++.++|+||+|++
T Consensus       162 kl~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~Di~slG~i  210 (284)
T 2a19_B          162 KIGDFGLVTSLKNDGKRTRSKGTLRYMSPEQIS---SQDYGKEVDLYALGLI  210 (284)
T ss_dssp             EECCCTTCEESSCCSCCCCCCSCCTTSCHHHHH---CSCCCTHHHHHHHHHH
T ss_pred             EECcchhheeccccccccccCCcccccChhhhc---cCCCcchhhhHHHHHH
Confidence            999999998876554445557899999999998   5678899999999994

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A*

Probab=99.96  E-value=2.6e-31  Score=198.84  Aligned_cols=159  Identities=10%  Similarity=0.106  Sum_probs=126.5

Q ss_pred             cccCCcccccccccccccCceEEEEEEEcCCCcEEEEEEccCccChHHHHHHHHHHHHHHhcCCCCchhhhhhhHH----
Q psy14630         18 VYDFTSEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQFYGALF----   93 (187)
Q Consensus        18 ~~~~~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~----   93 (187)
                      .+.+..++|++.+.||+|+||.||+|.+.  ++.+|+|.++.........+.+.++..+++.++||||+++++.+.    
T Consensus         4 ~~~i~~~~y~~~~~lg~G~~g~V~~~~~~--~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   81 (271)
T 3kmu_A            4 HSGIDFKQLNFLTKLNENHSGELWKGRWQ--GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPA   81 (271)
T ss_dssp             CCCCCGGGCEEEEEEEEETTEEEEEEEET--TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTS
T ss_pred             cCCCCHHHhHHHHHhcCCCcceEEEEEEC--CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCC
Confidence            45677899999999999999999999984  788999998765444444555666777788889999999875421    


Q ss_pred             --------------------------------HHHHHHHHHHHHHHHhcCC--CeeecCCCCCeEEcCCCCEEEEecccc
Q psy14630         94 --------------------------------KEVTVATVKALNYLKEELK--IIHRDVKPSNILLDRRGAIKLCDFGIS  139 (187)
Q Consensus        94 --------------------------------~~~~~~~~~~l~~lh~~~~--i~Hrdlk~~nili~~~~~~ki~dfg~a  139 (187)
                                                      ..+..|++.||.|||+. +  ++||||||+||+++.++.+++.|||++
T Consensus        82 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~-~~~i~H~dikp~Nil~~~~~~~~l~~~~~~  160 (271)
T 3kmu_A           82 PHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTL-EPLIPRHALNSRSVMIDEDMTARISMADVK  160 (271)
T ss_dssp             SSCEEEEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTS-SSCCTTCCCSGGGEEECTTSCEEEEGGGSC
T ss_pred             CCeEeeecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcC-CCceecCCCccceEEEcCCcceeEEeccce
Confidence                                            12678999999999997 8  999999999999999999999999887


Q ss_pred             ccccccccccCCCCCcCccCccccCCCccCCCCCCcceeeeEee
Q psy14630        140 GQLVDSIAKTRDAGCRPYMAPERIDPLRARGYPSFKTKLGFKFN  183 (187)
Q Consensus       140 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi~  183 (187)
                      .....    ....+|+.|+|||.+.+.....++.++|+||+|++
T Consensus       161 ~~~~~----~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~i  200 (271)
T 3kmu_A          161 FSFQS----PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVL  200 (271)
T ss_dssp             CTTSC----TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHH
T ss_pred             eeecc----cCccCCccccChhhhccCCCCCCCchhhHHHHHHH
Confidence            65332    23467899999999984322233347999999994

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii}

Probab=99.96  E-value=7.4e-31  Score=208.22  Aligned_cols=158  Identities=14%  Similarity=0.097  Sum_probs=114.6

Q ss_pred             CcccccccccccccCceEEEEEEEcCCCcEEEEEEccCccCh-HHHHHHHHHHHHHHhcCCC-Cchhhh-----------
Q psy14630         22 TSEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDE-KDQRQLLMDLDVVMKSNEC-PYIVQF-----------   88 (187)
Q Consensus        22 ~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~~~~~~~~~~h-~~iv~~-----------   88 (187)
                      ....|...+.||+|+||.||+|.+..+++.||||++...... ....+.+.++..+++.+.| .|....           
T Consensus        76 ~~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~  155 (413)
T 3dzo_A           76 RPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFD  155 (413)
T ss_dssp             CCEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCE
T ss_pred             CceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchh
Confidence            345688889999999999999999999999999998733221 1123345555555566655 211100           


Q ss_pred             ---------------------------------------hhh--------------HHHHHHHHHHHHHHHHHhcCCCee
Q psy14630         89 ---------------------------------------YGA--------------LFKEVTVATVKALNYLKEELKIIH  115 (187)
Q Consensus        89 ---------------------------------------~~~--------------~~~~~~~~~~~~l~~lh~~~~i~H  115 (187)
                                                             ...              ....++.|++.||+|||+. +|+|
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~-~iiH  234 (413)
T 3dzo_A          156 LVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY-GLVH  234 (413)
T ss_dssp             EEECCC---------------CCSEEEEEECCSEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT-TEEC
T ss_pred             hcccCCCCccccccCCCccccccceEEEeehhcCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhC-Cccc
Confidence                                                   000              0112457999999999997 9999


Q ss_pred             ecCCCCCeEEcCCCCEEEEeccccccccccccccCCCCCcCccCccccCCC-------ccCCCCCCcceeeeEee
Q psy14630        116 RDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPL-------RARGYPSFKTKLGFKFN  183 (187)
Q Consensus       116 rdlk~~nili~~~~~~ki~dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~-------~~~~~~~~~D~ws~gi~  183 (187)
                      |||||+||+++.++.+||+|||+++.....  .....| +.|+|||++...       ....++.++|+||||++
T Consensus       235 rDiKp~NILl~~~~~~kL~DFG~a~~~~~~--~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvi  306 (413)
T 3dzo_A          235 TYLRPVDIVLDQRGGVFLTGFEHLVRDGAS--AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLA  306 (413)
T ss_dssp             SCCCGGGEEECTTCCEEECCGGGCEETTEE--ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHH
T ss_pred             CCcccceEEEecCCeEEEEeccceeecCCc--cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHH
Confidence            999999999999999999999998876544  333467 899999998311       14457789999999994

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0

Probab=99.96  E-value=1.9e-31  Score=199.90  Aligned_cols=157  Identities=28%  Similarity=0.410  Sum_probs=116.4

Q ss_pred             cCCcccccccccccccCceEEEEEEEcCCCcEEEEEEccCccChH--HHHHHHHHHHHHHhcCCCCchhhhhhhH-----
Q psy14630         20 DFTSEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEK--DQRQLLMDLDVVMKSNECPYIVQFYGAL-----   92 (187)
Q Consensus        20 ~~~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~~~~~~~~~~~h~~iv~~~~~~-----   92 (187)
                      ++..++|++.+.||+|+||.||+|.+.  ++.+|+|+++......  ...+.+.++..+++.++||||+++++.+     
T Consensus         3 ~~~~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   80 (271)
T 3dtc_A            3 EIDFAELTLEEIIGIGGFGKVYRAFWI--GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPN   80 (271)
T ss_dssp             BCCTTSEEEEEEEEEETTEEEEEEEET--TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--
T ss_pred             ccchhheeeeeeeccCCCeEEEEEEEc--CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCc
Confidence            567789999999999999999999974  7889999986432221  2234556666778888999999987532     


Q ss_pred             --------------------------HHHHHHHHHHHHHHHHhcCC---CeeecCCCCCeEEcC--------CCCEEEEe
Q psy14630         93 --------------------------FKEVTVATVKALNYLKEELK---IIHRDVKPSNILLDR--------RGAIKLCD  135 (187)
Q Consensus        93 --------------------------~~~~~~~~~~~l~~lh~~~~---i~Hrdlk~~nili~~--------~~~~ki~d  135 (187)
                                                ...+..|++.|+.|||+. +   ++||||||+||+++.        .+.+||+|
T Consensus        81 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~i~~~l~~~l~~lH~~-~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~D  159 (271)
T 3dtc_A           81 LCLVMEFARGGPLNRVLSGKRIPPDILVNWAVQIARGMNYLHDE-AIVPIIHRDLKSSNILILQKVENGDLSNKILKITD  159 (271)
T ss_dssp             CEEEEECCTTEEHHHHHTSSCCCHHHHHHHHHHHHHHHHHHHHS-SSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECC
T ss_pred             eEEEEEcCCCCCHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhC-CCCceeecCCchHHEEEecccccccccCcceEEcc
Confidence                                      122678999999999997 7   899999999999986        67899999


Q ss_pred             ccccccccccccccCCCCCcCccCccccCCCccCCCCCCcceeeeEee
Q psy14630        136 FGISGQLVDSIAKTRDAGCRPYMAPERIDPLRARGYPSFKTKLGFKFN  183 (187)
Q Consensus       136 fg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi~  183 (187)
                      ||+++....... ....+++.|+|||.+.   ...++.++|+||+|+.
T Consensus       160 fg~~~~~~~~~~-~~~~~~~~y~aPE~~~---~~~~~~~~Di~slG~~  203 (271)
T 3dtc_A          160 FGLAREWHRTTK-MSAAGAYAWMAPEVIR---ASMFSKGSDVWSYGVL  203 (271)
T ss_dssp             CCC--------------CCGGGSCHHHHH---HCCCSHHHHHHHHHHH
T ss_pred             CCcccccccccc-cCCCCccceeCHHHhc---cCCCCchhhHHHHHHH
Confidence            999987654332 2347899999999988   6678899999999993

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A*

Probab=99.96  E-value=4.1e-31  Score=198.98  Aligned_cols=155  Identities=23%  Similarity=0.387  Sum_probs=118.8

Q ss_pred             ccccCCcccccccccccccCceEEEEEEEcCCCcEEEEEEccCccChHHHHHHHHHHHHHHhcCCCCchhhhhhhH----
Q psy14630         17 TVYDFTSEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQFYGAL----   92 (187)
Q Consensus        17 ~~~~~~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~----   92 (187)
                      ..|.+..++|++.+.||+|+||.||++.+.  ++.||+|.++...    ..+.+.++..+++.++||||+++++.+    
T Consensus        14 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~----~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~   87 (278)
T 1byg_A           14 SGWALNMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEK   87 (278)
T ss_dssp             -CCBCCGGGEEEEEEEEECSSCEEEEEEET--TEEEEEEECCCCC------HHHHHTHHHHTTCCCTTBCCEEEEECCC-
T ss_pred             ccccCChhhceEEeEEecCCCceEEEEEEc--CCEEEEEEecchh----HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCC
Confidence            456778899999999999999999999874  7899999986432    233455566677888999999886532    


Q ss_pred             -------------------------------HHHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEecccccc
Q psy14630         93 -------------------------------FKEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQ  141 (187)
Q Consensus        93 -------------------------------~~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg~a~~  141 (187)
                                                     ...+..+++.|+.|||+. +++||||||+||+++.++.++|+|||++..
T Consensus        88 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~-~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~  166 (278)
T 1byg_A           88 GGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN-NFVHRDLAARNVLVSEDNVAKVSDFGLTKE  166 (278)
T ss_dssp             -CCEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCSGGGEEECTTSCEEECCCCC---
T ss_pred             CceEEEEecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhC-CccccCCCcceEEEeCCCcEEEeecccccc
Confidence                                           112567899999999998 999999999999999999999999999886


Q ss_pred             ccccccccCCCCCcCccCccccCCCccCCCCCCcceeeeEee
Q psy14630        142 LVDSIAKTRDAGCRPYMAPERIDPLRARGYPSFKTKLGFKFN  183 (187)
Q Consensus       142 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi~  183 (187)
                      .....  ....+++.|+|||.+.   ...++.++|+||+|++
T Consensus       167 ~~~~~--~~~~~~~~y~aPE~~~---~~~~~~~~Di~slG~i  203 (278)
T 1byg_A          167 ASSTQ--DTGKLPVKWTAPEALR---EKKFSTKSDVWSFGIL  203 (278)
T ss_dssp             -----------CCTTTSCHHHHH---HCCCCHHHHHHHHHHH
T ss_pred             ccccc--cCCCccccccCHHHhC---CCCCCchhcHHHHHHH
Confidence            54332  2235678899999987   6678899999999993

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens}

Probab=99.96  E-value=2.7e-31  Score=204.36  Aligned_cols=161  Identities=24%  Similarity=0.402  Sum_probs=127.0

Q ss_pred             ccccCCcccccccccccccCceEEEEEE----EcCCCcEEEEEEccCccChHHHHHHHHHHHHHHhcCCCCchhhhhhhH
Q psy14630         17 TVYDFTSEDLQDLGEIGRGGFGTVNKMI----HRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQFYGAL   92 (187)
Q Consensus        17 ~~~~~~~~~~~~~~~lg~G~fg~V~~~~----~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~   92 (187)
                      ....+..++|++.+.||+|+||.||+|.    +..+++.||+|.+....  ....+.+.++..+++.++||||+++++.+
T Consensus        34 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~  111 (326)
T 2w1i_A           34 DPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST--EEHLRDFEREIEILKSLQHDNIVKYKGVC  111 (326)
T ss_dssp             ---CCCGGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCC--SHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred             CccccCHHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCC--HHHHHHHHHHHHHHHhCCCCCeeeEEEEE
Confidence            3446678889999999999999999998    46788999999987532  23344566666777888999999876432


Q ss_pred             H-----------------------------------HHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEecc
Q psy14630         93 F-----------------------------------KEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFG  137 (187)
Q Consensus        93 ~-----------------------------------~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg  137 (187)
                      .                                   ..++.|++.||.|||+. +++||||||+||+++.++.+||+|||
T Consensus       112 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~-~ivH~dikp~NIli~~~~~~kL~Dfg  190 (326)
T 2w1i_A          112 YSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTK-RYIHRDLATRNILVENENRVKIGDFG  190 (326)
T ss_dssp             CC----CCEEEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHHHT-TEECSCCCGGGEEEEETTEEEECCCT
T ss_pred             EecCCCceEEEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhC-CEeccCCCcceEEEcCCCcEEEecCc
Confidence            1                                   11567899999999997 99999999999999999999999999


Q ss_pred             cccccccccc----ccCCCCCcCccCccccCCCccCCCCCCcceeeeEee
Q psy14630        138 ISGQLVDSIA----KTRDAGCRPYMAPERIDPLRARGYPSFKTKLGFKFN  183 (187)
Q Consensus       138 ~a~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi~  183 (187)
                      +++.......    .....++..|+|||.+.   ...++.++|+||+|++
T Consensus       191 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~Di~slG~i  237 (326)
T 2w1i_A          191 LTKVLPQDKEYYKVKEPGESPIFWYAPESLT---ESKFSVASDVWSFGVV  237 (326)
T ss_dssp             TCEECCSSCSEEECSSCCSCCGGGCCHHHHH---HCEEEHHHHHHHHHHH
T ss_pred             chhhccccccccccccCCCCceeEECchhhc---CCCCCchhhHHHHHHH
Confidence            9987654321    22235677899999988   5567899999999994

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A*

Probab=99.96  E-value=1.6e-31  Score=205.04  Aligned_cols=170  Identities=19%  Similarity=0.314  Sum_probs=125.9

Q ss_pred             CceecCCCccccCCcccccccccccccCceEEEEEE----EcCCCcEEEEEEccCccChHHHHHHHHHHHHHHhcCCCCc
Q psy14630          9 GKLKLSPDTVYDFTSEDLQDLGEIGRGGFGTVNKMI----HRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPY   84 (187)
Q Consensus         9 ~~~~~~~~~~~~~~~~~~~~~~~lg~G~fg~V~~~~----~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~   84 (187)
                      +.....|+....+....|++.+.||+|+||.||++.    +..+++.||+|+++..... ...+.+.++..+++.+.|||
T Consensus        16 ~~~~~~pg~~~~~~~r~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~h~~   94 (318)
T 3lxp_A           16 EVLFQGPGDPTVFHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGP-QHRSGWKQEIDILRTLYHEH   94 (318)
T ss_dssp             --------CCCBCCGGGEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCH-HHHHHHHHHHHHHHHCCCTT
T ss_pred             eeeecCCCCCceecHHHHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccCh-HHHHHHHHHHHHHHhCCCcc
Confidence            334444555555565556999999999999998875    3457889999999764333 33445566666778889999


Q ss_pred             hhhhhhhHH---------------------------------HHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCE
Q psy14630         85 IVQFYGALF---------------------------------KEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAI  131 (187)
Q Consensus        85 iv~~~~~~~---------------------------------~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~  131 (187)
                      |+++++.+.                                 ..++.+++.+|.|||+. +++||||||+||+++.++.+
T Consensus        95 iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~i~~~l~~~l~~LH~~-~ivH~Dikp~Nil~~~~~~~  173 (318)
T 3lxp_A           95 IIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHSIGLAQLLLFAQQICEGMAYLHAQ-HYIHRDLAARNVLLDNDRLV  173 (318)
T ss_dssp             BCCEEEEEEETTTTEEEEEECCCTTCBHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEECTTCCE
T ss_pred             hhhEEEEEecCCCceEEEEEecccCCcHHHHHhhCCCCHHHHHHHHHHHHHHHHHHHhC-CccCCCCchheEEEcCCCCE
Confidence            998865321                                 12678999999999998 99999999999999999999


Q ss_pred             EEEeccccccccccc----cccCCCCCcCccCccccCCCccCCCCCCcceeeeEee
Q psy14630        132 KLCDFGISGQLVDSI----AKTRDAGCRPYMAPERIDPLRARGYPSFKTKLGFKFN  183 (187)
Q Consensus       132 ki~dfg~a~~~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi~  183 (187)
                      ||+|||+++......    ......++..|+|||.+.   ...++.++|+||+|++
T Consensus       174 kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~Di~slG~i  226 (318)
T 3lxp_A          174 KIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLK---EYKFYYASDVWSFGVT  226 (318)
T ss_dssp             EECCGGGCEECCTTCSEEEC---CCCCGGGCCHHHHH---HCEEEHHHHHHHHHHH
T ss_pred             EECCccccccccccccccccccCCCCCceeeChHHhc---CCCCCcHHHHHHHHHH
Confidence            999999998875432    122335778899999998   5567889999999993

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=99.96  E-value=5.9e-31  Score=203.21  Aligned_cols=160  Identities=24%  Similarity=0.343  Sum_probs=119.4

Q ss_pred             ccCCcccccccccccccCceEEEEEEEcCCC----cEEEEEEccCccChHHHHHHHHHHHHHHhcCCCCchhhhhhhH--
Q psy14630         19 YDFTSEDLQDLGEIGRGGFGTVNKMIHRSSD----TVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQFYGAL--   92 (187)
Q Consensus        19 ~~~~~~~~~~~~~lg~G~fg~V~~~~~~~~~----~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~--   92 (187)
                      .++..++|++.+.||+|+||.||+|.+..++    ..||+|.++...... ....+.++..+++.+.||||+++++.+  
T Consensus        39 ~~i~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~E~~~l~~l~h~~iv~~~~~~~~  117 (333)
T 1mqb_A           39 TEIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEK-QRVDFLGEAGIMGQFSHHNIIRLEGVISK  117 (333)
T ss_dssp             CBCCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHH-HHHHHHHHHHHHHTCCCTTBCCEEEEECS
T ss_pred             ccCChHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHH-HHHHHHHHHHHHHhCCCCCCCcEEEEEec
Confidence            3667788999999999999999999876543    459999987543333 334455666677888999999886532  


Q ss_pred             -------------------------------HHHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEecccccc
Q psy14630         93 -------------------------------FKEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQ  141 (187)
Q Consensus        93 -------------------------------~~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg~a~~  141 (187)
                                                     ...++.|++.||.|||+. +++||||||+||+++.++.+||+|||+++.
T Consensus       118 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~-~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~  196 (333)
T 1mqb_A          118 YKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANM-NYVHRDLAARNILVNSNLVCKVSDFGLSRV  196 (333)
T ss_dssp             SSSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCCGGGEEECTTCCEEECCCCC---
T ss_pred             CCCcEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhC-CeeCCCCChheEEECCCCcEEECCCCcchh
Confidence                                           112677899999999998 999999999999999999999999999987


Q ss_pred             cccccc----ccCCCCCcCccCccccCCCccCCCCCCcceeeeEee
Q psy14630        142 LVDSIA----KTRDAGCRPYMAPERIDPLRARGYPSFKTKLGFKFN  183 (187)
Q Consensus       142 ~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi~  183 (187)
                      ......    .....+++.|+|||.+.   ...++.++|+||+|++
T Consensus       197 ~~~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~Di~slG~i  239 (333)
T 1mqb_A          197 LEDDPEATYTTSGGKIPIRWTAPEAIS---YRKFTSASDVWSFGIV  239 (333)
T ss_dssp             --------------CCCGGGSCHHHHH---SCCCCHHHHHHHHHHH
T ss_pred             hccccccccccCCCCccccccCchhcc---cCCCCchhhhHHHHHH
Confidence            653221    11224577899999997   5678899999999994

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens}

Probab=99.96  E-value=1.2e-30  Score=199.37  Aligned_cols=159  Identities=31%  Similarity=0.572  Sum_probs=120.1

Q ss_pred             ccccCCcccccccccccccCceEEEEEEEcCCCcEEEEEEccCccChHHHHHHHHHHHHHHhcCCCCchhhhhhhH----
Q psy14630         17 TVYDFTSEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQFYGAL----   92 (187)
Q Consensus        17 ~~~~~~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~----   92 (187)
                      .......++|++.+.||+|+||.||+|.+..+++.||+|.+......    +.+.++..+++.+.||||+++++.+    
T Consensus        22 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   97 (314)
T 3com_A           22 SLTKQPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESDL----QEIIKEISIMQQCDSPHVVKYYGSYFKNT   97 (314)
T ss_dssp             --------CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTSCC----HHHHHHHHHHHTCCCTTBCCEEEEEEETT
T ss_pred             hhhhcchhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchHHH----HHHHHHHHHHHhCCCCCCccEEEEEEeCC
Confidence            33455677899999999999999999999999999999998653221    2344455667778999999887532    


Q ss_pred             -----------------------------HHHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEecccccccc
Q psy14630         93 -----------------------------FKEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLV  143 (187)
Q Consensus        93 -----------------------------~~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg~a~~~~  143 (187)
                                                   ...++.+++.|+.|||+. +++|+||+|+||+++.++.++|+|||++....
T Consensus        98 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~-~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~  176 (314)
T 3com_A           98 DLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFM-RKIHRDIKAGNILLNTEGHAKLADFGVAGQLT  176 (314)
T ss_dssp             EEEEEEECCTTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEECTTCCEEECCCTTCEECB
T ss_pred             EEEEEeecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC-CCcCCCcCHHHEEECCCCCEEEeecccchhhh
Confidence                                         112677899999999997 99999999999999999999999999998765


Q ss_pred             ccc-cccCCCCCcCccCccccCCCccCCCCCCcceeeeEee
Q psy14630        144 DSI-AKTRDAGCRPYMAPERIDPLRARGYPSFKTKLGFKFN  183 (187)
Q Consensus       144 ~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi~  183 (187)
                      ... ......+++.|+|||.+.   ...++.++|+||+|++
T Consensus       177 ~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~Di~slG~i  214 (314)
T 3com_A          177 DTMAKRNTVIGTPFWMAPEVIQ---EIGYNCVADIWSLGIT  214 (314)
T ss_dssp             TTBSCBCCCCSCGGGCCHHHHS---SSCBCTTHHHHHHHHH
T ss_pred             hhccccCccCCCCCccChhhcC---CCCCCccccHHHHHHH
Confidence            432 223446899999999998   5678899999999993

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens}

Probab=99.96  E-value=3.4e-31  Score=201.66  Aligned_cols=159  Identities=18%  Similarity=0.258  Sum_probs=125.2

Q ss_pred             cccccccccccccCceEEEEEEEcCCCcEEEEEEccCccCh--HHHHHHHHHHHHHHhcCCCCchhhhhhhHH-------
Q psy14630         23 SEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDE--KDQRQLLMDLDVVMKSNECPYIVQFYGALF-------   93 (187)
Q Consensus        23 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~-------   93 (187)
                      .++|++.+.||+|+||.||+|.+..+++.+|+|+++.....  ....+.+.++..+++.++||||+++++.+.       
T Consensus         4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~   83 (305)
T 2wtk_C            4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKM   83 (305)
T ss_dssp             -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CE
T ss_pred             ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeE
Confidence            46899999999999999999999999999999998642111  123345666677788889999999876431       


Q ss_pred             ----------------------------HHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEecccccccccc
Q psy14630         94 ----------------------------KEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDS  145 (187)
Q Consensus        94 ----------------------------~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg~a~~~~~~  145 (187)
                                                  ..++.|++.||.|||+. +++||||||+||+++.++.++|+|||++......
T Consensus        84 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~-~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~~~~  162 (305)
T 2wtk_C           84 YMVMEYCVCGMQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQ-GIVHKDIKPGNLLLTTGGTLKISALGVAEALHPF  162 (305)
T ss_dssp             EEEEECCSEEHHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEECTTCCEEECCCTTCEECCTT
T ss_pred             EEEehhccCCHHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHC-CeeecCCCcccEEEcCCCcEEeeccccccccCcc
Confidence                                        11667899999999998 9999999999999999999999999999876432


Q ss_pred             ---ccccCCCCCcCccCccccCCCccCCCCCCcceeeeEee
Q psy14630        146 ---IAKTRDAGCRPYMAPERIDPLRARGYPSFKTKLGFKFN  183 (187)
Q Consensus       146 ---~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi~  183 (187)
                         .......+++.|+|||.+.+. ...++.++|+||+|++
T Consensus       163 ~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~~Di~slG~i  202 (305)
T 2wtk_C          163 AADDTCRTSQGSPAFQPPEIANGL-DTFSGFKVDIWSAGVT  202 (305)
T ss_dssp             CSSCEECCCCSCGGGCCHHHHTCC-SCEESHHHHHHHHHHH
T ss_pred             ccccccccCCCCCCCcChhhccCc-ccCCcchhhHHHHHHH
Confidence               222344689999999998732 1223678999999993

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens}

Probab=99.96  E-value=1.3e-31  Score=206.54  Aligned_cols=161  Identities=25%  Similarity=0.290  Sum_probs=117.6

Q ss_pred             cccCCcccccccccccccCceEEEEEEEcCCCcEEEEEEccCccChHHHHHHHHHHHHHHhcCCCCchhhhhhhH-----
Q psy14630         18 VYDFTSEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQFYGAL-----   92 (187)
Q Consensus        18 ~~~~~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~-----   92 (187)
                      ...+..++|++.+.||+|+||.||+|.+  +++.||+|++.....   .......+......+.||||+++++.+     
T Consensus         7 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~---~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~   81 (336)
T 3g2f_A            7 EPSLDLDNLKLLELIGRGRYGAVYKGSL--DERPVAVKVFSFANR---QNFINEKNIYRVPLMEHDNIARFIVGDERVTA   81 (336)
T ss_dssp             --CCCTTSEEEEEEEEECSSEEEEEEEE--TTEEEEEEEEEGGGH---HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECT
T ss_pred             CCCcChHHhheeeecccCCCeEEEEEEE--CCeEEEEEEeeccch---hhHHHHHHHHHHHhccCcchhhheeccccccc
Confidence            4456789999999999999999999976  578999999863211   111111122223357999999886310     


Q ss_pred             -------------------------------HHHHHHHHHHHHHHHHhcC--------CCeeecCCCCCeEEcCCCCEEE
Q psy14630         93 -------------------------------FKEVTVATVKALNYLKEEL--------KIIHRDVKPSNILLDRRGAIKL  133 (187)
Q Consensus        93 -------------------------------~~~~~~~~~~~l~~lh~~~--------~i~Hrdlk~~nili~~~~~~ki  133 (187)
                                                     ...++.|++.||.|||+..        +++||||||+||+++.++.+||
T Consensus        82 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL  161 (336)
T 3g2f_A           82 DGRMEYLLVMEYYPNGSLXKYLSLHTSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVI  161 (336)
T ss_dssp             TSCEEEEEEECCCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCEEE
T ss_pred             CCCceEEEEEecCCCCcHHHHHhhcccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcEEE
Confidence                                           1126779999999999842        8999999999999999999999


Q ss_pred             Eecccccccccc---------ccccCCCCCcCccCccccCCCcc----CCCCCCcceeeeEee
Q psy14630        134 CDFGISGQLVDS---------IAKTRDAGCRPYMAPERIDPLRA----RGYPSFKTKLGFKFN  183 (187)
Q Consensus       134 ~dfg~a~~~~~~---------~~~~~~~~t~~y~aPE~~~~~~~----~~~~~~~D~ws~gi~  183 (187)
                      +|||+++.+...         .......||+.|+|||++.+...    ..++.++|+||||++
T Consensus       162 ~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~i  224 (336)
T 3g2f_A          162 SDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLI  224 (336)
T ss_dssp             CCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHH
T ss_pred             eeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHH
Confidence            999999876432         11223468999999999874211    235578999999994

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens}

Probab=99.96  E-value=3.1e-31  Score=219.63  Aligned_cols=159  Identities=25%  Similarity=0.414  Sum_probs=120.0

Q ss_pred             CCcccccccc-cccccCceEEEEEEEc--CCCcEEEEEEccCccChHHHHHHHHHHHHHHhcCCCCchhhhhhhHH----
Q psy14630         21 FTSEDLQDLG-EIGRGGFGTVNKMIHR--SSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQFYGALF----   93 (187)
Q Consensus        21 ~~~~~~~~~~-~lg~G~fg~V~~~~~~--~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~----   93 (187)
                      +..+++.+.+ .||+|+||.||+|.+.  .++..||||+++...... ..+.+.++..+++.++||||+++++.+.    
T Consensus       332 ~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~-~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~  410 (613)
T 2ozo_A          332 LKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKA-DTEEMMREAQIMHQLDNPYIVRLIGVCQAEAL  410 (613)
T ss_dssp             CCTTSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSST-THHHHHHHHHHHTTCCCTTBCCEEEEEESSSE
T ss_pred             ccccceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChH-HHHHHHHHHHHHHhCCCCCEeeEEEEeccCCe
Confidence            3444555555 7999999999999875  456679999997543322 2344556666788889999999875431    


Q ss_pred             ----------------------------HHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEecccccccccc
Q psy14630         94 ----------------------------KEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDS  145 (187)
Q Consensus        94 ----------------------------~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg~a~~~~~~  145 (187)
                                                  ..++.|++.||.|||+. +++||||||+||+++.++.+||+|||+++.....
T Consensus       411 ~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~-~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~  489 (613)
T 2ozo_A          411 MLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEK-NFVHRNLAARNVLLVNRHYAKISDFGLSKALGAD  489 (613)
T ss_dssp             EEEEECCTTCBHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCSGGGEEEEETTEEEECCCSTTTTCC--
T ss_pred             EEEEEeCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC-CEEcCcCCHHHEEEcCCCcEEEeeccCcccccCC
Confidence                                        12678999999999998 9999999999999999999999999999876432


Q ss_pred             cc----ccCCCCCcCccCccccCCCccCCCCCCcceeeeEeee
Q psy14630        146 IA----KTRDAGCRPYMAPERIDPLRARGYPSFKTKLGFKFNY  184 (187)
Q Consensus       146 ~~----~~~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi~~  184 (187)
                      ..    .....+++.|+|||++.   ...++.++||||||+++
T Consensus       490 ~~~~~~~~~~~~~~~y~APE~~~---~~~~~~~sDvwSlGv~l  529 (613)
T 2ozo_A          490 DSYYTARSAGKWPLKWYAPECIN---FRKFSSRSDVWSYGVTM  529 (613)
T ss_dssp             ------------CCTTSCHHHHH---HCCCCHHHHHHHHHHHH
T ss_pred             CceeeeccCCCCccceeCHhhhc---CCCCCcHHHHHHHHHHH
Confidence            21    11223567899999998   66789999999999943

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=99.96  E-value=4.8e-31  Score=199.53  Aligned_cols=162  Identities=25%  Similarity=0.405  Sum_probs=127.8

Q ss_pred             ccccCCcccccccc-cccccCceEEEEEEEc--CCCcEEEEEEccCccChHHHHHHHHHHHHHHhcCCCCchhhhhhhH-
Q psy14630         17 TVYDFTSEDLQDLG-EIGRGGFGTVNKMIHR--SSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQFYGAL-   92 (187)
Q Consensus        17 ~~~~~~~~~~~~~~-~lg~G~fg~V~~~~~~--~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~-   92 (187)
                      +.+.+..++|.+.+ .||+|+||.||+|.+.  .++..||+|.++..... ...+.+.++..+++.+.||||+++++.+ 
T Consensus         2 ~~~~~~~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~   80 (287)
T 1u59_A            2 KKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEK-ADTEEMMREAQIMHQLDNPYIVRLIGVCQ   80 (287)
T ss_dssp             CCCBCCGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCH-HHHHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred             CcccccHHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccch-hHHHHHHHHHHHHHhCCCCCEeEEEEEec
Confidence            45667888998887 9999999999999853  46788999999764333 3344555666677778999999886532 


Q ss_pred             -------------------------------HHHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEecccccc
Q psy14630         93 -------------------------------FKEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQ  141 (187)
Q Consensus        93 -------------------------------~~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg~a~~  141 (187)
                                                     ...++.|++.||.|||+. +++||||||+||+++.++.++|+|||+++.
T Consensus        81 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~-~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~  159 (287)
T 1u59_A           81 AEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEK-NFVHRDLAARNVLLVNRHYAKISDFGLSKA  159 (287)
T ss_dssp             SSSEEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEEEETTEEEECCCTTCEE
T ss_pred             CCCcEEEEEeCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHHHC-CEeeCCCchheEEEcCCCCEEECcccceee
Confidence                                           112678999999999998 999999999999999999999999999987


Q ss_pred             cccccc----ccCCCCCcCccCccccCCCccCCCCCCcceeeeEee
Q psy14630        142 LVDSIA----KTRDAGCRPYMAPERIDPLRARGYPSFKTKLGFKFN  183 (187)
Q Consensus       142 ~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi~  183 (187)
                      ......    .....+|+.|+|||.+.   ...++.++|+||+|++
T Consensus       160 ~~~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~Di~slG~i  202 (287)
T 1u59_A          160 LGADDSYYTARSAGKWPLKWYAPECIN---FRKFSSRSDVWSYGVT  202 (287)
T ss_dssp             CTTCSCEECCCCSSCCCGGGCCHHHHH---HCEECHHHHHHHHHHH
T ss_pred             eccCcceeeccccccccccccCHHHhc---cCCCCchhhHHHHHHH
Confidence            643221    12234678899999987   5668899999999993

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A*

Probab=99.96  E-value=1.4e-31  Score=205.76  Aligned_cols=163  Identities=25%  Similarity=0.353  Sum_probs=126.9

Q ss_pred             CccccCCcccccccccccccCceEEEEEEEcCCCcEEEEEEccCccChHHHHHHHHHHHHHHhcCCCCchhhhhhhH---
Q psy14630         16 DTVYDFTSEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQFYGAL---   92 (187)
Q Consensus        16 ~~~~~~~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~---   92 (187)
                      ........++|++.+.||+|+||.||+|.+ .+++.||+|.+........ ...+..+..+++.+.||||+++++.+   
T Consensus        22 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~-~~~~~~e~~~l~~l~h~~iv~~~~~~~~~   99 (326)
T 3uim_A           22 LRELQVASDNFSNKNILGRGGFGKVYKGRL-ADGTLVAVKRLKEERTQGG-ELQFQTEVEMISMAVHRNLLRLRGFCMTP   99 (326)
T ss_dssp             THHHHTTTTSSCSTTEEECCSSSEEEEECC-SSSCCEEEEECCC-----C-CCHHHHHHHGGGTCCCTTBCCCCEEECCS
T ss_pred             HHHHHHHhhccccceeEecCCCcEEEEEEe-cCCCEEEEEEeccccCchH-HHHHHHHHHHHHhccCCCccceEEEEecC
Confidence            345567778999999999999999999985 4688999999864322111 11345556677888999999887532   


Q ss_pred             ---------------------------------HHHHHHHHHHHHHHHHhcC--CCeeecCCCCCeEEcCCCCEEEEecc
Q psy14630         93 ---------------------------------FKEVTVATVKALNYLKEEL--KIIHRDVKPSNILLDRRGAIKLCDFG  137 (187)
Q Consensus        93 ---------------------------------~~~~~~~~~~~l~~lh~~~--~i~Hrdlk~~nili~~~~~~ki~dfg  137 (187)
                                                       ...++.|++.||.|||+..  +++||||||+||+++.++.+||+|||
T Consensus       100 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg  179 (326)
T 3uim_A          100 TERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFG  179 (326)
T ss_dssp             SCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEECCCS
T ss_pred             CceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEeccCc
Confidence                                             1226788999999999853  89999999999999999999999999


Q ss_pred             cccccccc--ccccCCCCCcCccCccccCCCccCCCCCCcceeeeEee
Q psy14630        138 ISGQLVDS--IAKTRDAGCRPYMAPERIDPLRARGYPSFKTKLGFKFN  183 (187)
Q Consensus       138 ~a~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi~  183 (187)
                      +++.....  .......||+.|+|||.+.   ...++.++|+||+|++
T Consensus       180 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Di~slG~i  224 (326)
T 3uim_A          180 LAKLMDYKDTHVTTAVRGTIGHIAPEYLS---TGKSSEKTDVFGYGVM  224 (326)
T ss_dssp             SCEECCSSSSCEECCCCSCGGGCCHHHHH---HSEECHHHHHHHHHHH
T ss_pred             cccccCcccccccccccCCcCccCHHHhc---cCCCCccccchhHHHH
Confidence            99876432  2223345899999999997   5568899999999994

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens}

Probab=99.96  E-value=4.8e-31  Score=199.85  Aligned_cols=163  Identities=29%  Similarity=0.427  Sum_probs=125.5

Q ss_pred             ccccCCcccccccccccccCceEEEEEEEcCCCcEEEEEEccCccChHHHHHHHHHHHHHHhcCCCCchhhhhhhH----
Q psy14630         17 TVYDFTSEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQFYGAL----   92 (187)
Q Consensus        17 ~~~~~~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~----   92 (187)
                      ..+.+..++|.....||+|+||.||+|.+..+++.||+|.+.....  ...+.+.++..+++.+.||||+++++.+    
T Consensus        15 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~   92 (295)
T 2clq_A           15 LEYDYEYDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDS--RYSQPLHEEIALHKHLKHKNIVQYLGSFSENG   92 (295)
T ss_dssp             CCEEECBCTTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC-----HHHHHHHHHHHTCCCTTBCCEEEEEEETT
T ss_pred             ccccccccCCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCch--HHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCC
Confidence            4445556667667799999999999999999999999999865322  2344566667778888999999886432    


Q ss_pred             -------------------------------HHHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcC-CCCEEEEeccccc
Q psy14630         93 -------------------------------FKEVTVATVKALNYLKEELKIIHRDVKPSNILLDR-RGAIKLCDFGISG  140 (187)
Q Consensus        93 -------------------------------~~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~-~~~~ki~dfg~a~  140 (187)
                                                     ...+..|++.||.|||+. +++|+||||+||+++. ++.+||+|||++.
T Consensus        93 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~-~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~  171 (295)
T 2clq_A           93 FIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDN-QIVHRDIKGDNVLINTYSGVLKISDFGTSK  171 (295)
T ss_dssp             EEEEEEECCSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEEETTTCCEEECCTTTCE
T ss_pred             cEEEEEEeCCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhC-CEEccCCChhhEEEECCCCCEEEeeccccc
Confidence                                           111567899999999998 9999999999999987 8999999999998


Q ss_pred             cccccc-cccCCCCCcCccCccccCCCccCCCCCCcceeeeEee
Q psy14630        141 QLVDSI-AKTRDAGCRPYMAPERIDPLRARGYPSFKTKLGFKFN  183 (187)
Q Consensus       141 ~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi~  183 (187)
                      ...... ......+++.|+|||.+.+. ...++.++|+||+|+.
T Consensus       172 ~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~~Di~slG~i  214 (295)
T 2clq_A          172 RLAGINPCTETFTGTLQYMAPEIIDKG-PRGYGKAADIWSLGCT  214 (295)
T ss_dssp             ESCC-----CCCCCCGGGCCHHHHHHG-GGGCSHHHHHHHHHHH
T ss_pred             ccCCCCCcccccCCCccccChhhhcCC-CCCCCcHHHHHHHHHH
Confidence            765422 22344689999999998732 1237889999999994

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A*

Probab=99.96  E-value=4.6e-31  Score=203.09  Aligned_cols=164  Identities=21%  Similarity=0.283  Sum_probs=122.2

Q ss_pred             CCccccCCcccccccccccccCceEEEEEE-----EcCCCcEEEEEEccCccChHHHHHHHHHHHHHHhcCCCCchhhhh
Q psy14630         15 PDTVYDFTSEDLQDLGEIGRGGFGTVNKMI-----HRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQFY   89 (187)
Q Consensus        15 ~~~~~~~~~~~~~~~~~lg~G~fg~V~~~~-----~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~   89 (187)
                      .....++..++|++.+.||+|+||.||+|.     +..+++.||+|.+.......... .+..+..+++.+.||||++++
T Consensus        21 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~-~~~~E~~~l~~l~h~~iv~~~   99 (327)
T 2yfx_A           21 ISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDEL-DFLMEALIISKFNHQNIVRCI   99 (327)
T ss_dssp             GGGSCBCCGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHH-HHHHHHHHHHHCCCTTBCCEE
T ss_pred             hhhcccCChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHH-HHHHHHHHHhhCCCCCCCeEE
Confidence            345557788999999999999999999998     55678899999987543333333 444555567778999999886


Q ss_pred             hhH---------------------------------------HHHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcC---
Q psy14630         90 GAL---------------------------------------FKEVTVATVKALNYLKEELKIIHRDVKPSNILLDR---  127 (187)
Q Consensus        90 ~~~---------------------------------------~~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~---  127 (187)
                      +.+                                       ...++.|++.||.|||+. +++||||||+||+++.   
T Consensus       100 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~-~i~H~dlkp~NIli~~~~~  178 (327)
T 2yfx_A          100 GVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN-HFIHRDIAARNCLLTCPGP  178 (327)
T ss_dssp             EEECSSSSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCCGGGEEESCSST
T ss_pred             EEEcCCCCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhC-CeecCcCCHhHEEEecCCC
Confidence            432                                       112567899999999998 9999999999999984   


Q ss_pred             CCCEEEEeccccccccccc---cccCCCCCcCccCccccCCCccCCCCCCcceeeeEee
Q psy14630        128 RGAIKLCDFGISGQLVDSI---AKTRDAGCRPYMAPERIDPLRARGYPSFKTKLGFKFN  183 (187)
Q Consensus       128 ~~~~ki~dfg~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi~  183 (187)
                      ...++|+|||+++......   ......+++.|+|||.+.   ...++.++|+||+|++
T Consensus       179 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~Di~slG~i  234 (327)
T 2yfx_A          179 GRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFM---EGIFTSKTDTWSFGVL  234 (327)
T ss_dssp             TCCEEECCCHHHHHHHC------CCGGGSCGGGCCHHHHH---HCCCCHHHHHHHHHHH
T ss_pred             cceEEECccccccccccccccccCCCcCCCcceeCHhHhc---CCCCCchhhHHHHHHH
Confidence            4469999999987653321   112235788999999987   5678899999999993

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7

Probab=99.96  E-value=3.7e-31  Score=207.43  Aligned_cols=156  Identities=23%  Similarity=0.339  Sum_probs=113.4

Q ss_pred             ccccccccccccCceEEEEEEEcCCC---cEEEEEEccCccChHHHHHHHHHHHHHHhcCCCCchhhhhhhHH-------
Q psy14630         24 EDLQDLGEIGRGGFGTVNKMIHRSSD---TVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQFYGALF-------   93 (187)
Q Consensus        24 ~~~~~~~~lg~G~fg~V~~~~~~~~~---~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~-------   93 (187)
                      ..|++.+.||+|+||.||+|.+..++   ..||+|.++...... ..+.+.++..+++.+.||||+++++.+.       
T Consensus        89 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~  167 (373)
T 3c1x_A           89 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIG-EVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPL  167 (373)
T ss_dssp             EEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSH-HHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCE
T ss_pred             ceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHH-HHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeE
Confidence            35677899999999999999875332   468999986543333 3444555666778889999999876421       


Q ss_pred             ---------------------------HHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEeccccccccccc
Q psy14630         94 ---------------------------KEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSI  146 (187)
Q Consensus        94 ---------------------------~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg~a~~~~~~~  146 (187)
                                                 ..+..|++.||.|||+. +++||||||+||+++.++.+||+|||+++......
T Consensus       168 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~-~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~  246 (373)
T 3c1x_A          168 VVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASK-KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKE  246 (373)
T ss_dssp             EEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHT-TCCCSCCCGGGEEECTTCCEEECCC----------
T ss_pred             EEEECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHC-CEecCccchheEEECCCCCEEEeeccccccccccc
Confidence                                       11567899999999998 99999999999999999999999999998764322


Q ss_pred             c-----ccCCCCCcCccCccccCCCccCCCCCCcceeeeEeee
Q psy14630        147 A-----KTRDAGCRPYMAPERIDPLRARGYPSFKTKLGFKFNY  184 (187)
Q Consensus       147 ~-----~~~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi~~  184 (187)
                      .     .....+++.|+|||.+.   ...++.++|+||||+++
T Consensus       247 ~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~DvwSlG~il  286 (373)
T 3c1x_A          247 FDSVHNKTGAKLPVKWMALESLQ---TQKFTTKSDVWSFGVLL  286 (373)
T ss_dssp             -----------CCGGGSCHHHHH---HCCCCHHHHHHHHHHHH
T ss_pred             cccccccCCCCCcccccChHHhc---CCCCCcHHHHHHHHHHH
Confidence            1     12235677899999998   66788999999999943

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A*

Probab=99.96  E-value=2e-31  Score=205.10  Aligned_cols=159  Identities=23%  Similarity=0.326  Sum_probs=121.6

Q ss_pred             cCCcccccccccccccCceEEEEEEEcCCCcEE--EEEEccCccChHHHHHHHHHHHHHHhcC-CCCchhhhhhhH----
Q psy14630         20 DFTSEDLQDLGEIGRGGFGTVNKMIHRSSDTVM--AVKRIRSTVDEKDQRQLLMDLDVVMKSN-ECPYIVQFYGAL----   92 (187)
Q Consensus        20 ~~~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~v--aiK~~~~~~~~~~~~~~~~~~~~~~~~~-~h~~iv~~~~~~----   92 (187)
                      .+..++|++.+.||+|+||.||+|.+..++..+  |+|.++...... ..+.+..+..+++.+ +||||+++++.+    
T Consensus        21 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~-~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~   99 (327)
T 1fvr_A           21 VLDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKD-DHRDFAGELEVLCKLGHHPNIINLLGACEHRG   99 (327)
T ss_dssp             BCCGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC-------CHHHHHHHHHTTCCCCTTBCCEEEEEEETT
T ss_pred             cccHHHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchH-HHHHHHHHHHHHHhccCCCchhhhceeeeeCC
Confidence            356789999999999999999999998888765  999886433222 233344555566666 899999876421    


Q ss_pred             --------------------------------------------HHHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCC
Q psy14630         93 --------------------------------------------FKEVTVATVKALNYLKEELKIIHRDVKPSNILLDRR  128 (187)
Q Consensus        93 --------------------------------------------~~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~  128 (187)
                                                                  ...++.|++.||.|||+. +++||||||+||+++.+
T Consensus       100 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~-~ivH~dlkp~NIl~~~~  178 (327)
T 1fvr_A          100 YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK-QFIHRDLAARNILVGEN  178 (327)
T ss_dssp             EEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEECGG
T ss_pred             ceEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC-CccCCCCccceEEEcCC
Confidence                                                        012667899999999997 99999999999999999


Q ss_pred             CCEEEEeccccccccccccccCCCCCcCccCccccCCCccCCCCCCcceeeeEee
Q psy14630        129 GAIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPLRARGYPSFKTKLGFKFN  183 (187)
Q Consensus       129 ~~~ki~dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi~  183 (187)
                      +.+||+|||+++............+++.|+|||.+.   ...++.++|+||+|++
T Consensus       179 ~~~kL~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~Di~slG~i  230 (327)
T 1fvr_A          179 YVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLN---YSVYTTNSDVWSYGVL  230 (327)
T ss_dssp             GCEEECCTTCEESSCEECCC----CCTTTCCHHHHH---HCEECHHHHHHHHHHH
T ss_pred             CeEEEcccCcCccccccccccCCCCCccccChhhhc---cccCCchhcchHHHHH
Confidence            999999999998654433333445678899999987   5568899999999993

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens}

Probab=99.96  E-value=5.1e-31  Score=204.86  Aligned_cols=160  Identities=17%  Similarity=0.226  Sum_probs=122.6

Q ss_pred             cCCCccc-cCCcccccccccccccCceEEEEEEEcCC--------CcEEEEEEccCccChHHHHHHHHHHHHHHhcCCCC
Q psy14630         13 LSPDTVY-DFTSEDLQDLGEIGRGGFGTVNKMIHRSS--------DTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECP   83 (187)
Q Consensus        13 ~~~~~~~-~~~~~~~~~~~~lg~G~fg~V~~~~~~~~--------~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~h~   83 (187)
                      .+++... +...++|++.+.||+|+||.||+|.+..+        ++.||+|.+...       +.+.++..+++.+.||
T Consensus        30 l~~g~~i~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-------~~~~~E~~~l~~l~h~  102 (352)
T 2jii_A           30 LPTGTVLTDKSGRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-------GRLFNEQNFFQRAAKP  102 (352)
T ss_dssp             CCTTCEEECTTSCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-------STHHHHHHHHHHHCCH
T ss_pred             CCCCceeecccCCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-------chHHHHHHHHHHhccc
Confidence            3444444 45578999999999999999999999774        789999998643       1233445556667889


Q ss_pred             chhhhhhhH-------------------------------------------------HHHHHHHHHHHHHHHHhcCCCe
Q psy14630         84 YIVQFYGAL-------------------------------------------------FKEVTVATVKALNYLKEELKII  114 (187)
Q Consensus        84 ~iv~~~~~~-------------------------------------------------~~~~~~~~~~~l~~lh~~~~i~  114 (187)
                      ||+++++.+                                                 ...++.|++.||.|||+. +++
T Consensus       103 niv~~~~~~~~~~~~~i~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~-~iv  181 (352)
T 2jii_A          103 LQVNKWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSLGRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHEN-EYV  181 (352)
T ss_dssp             HHHHHHHHHTTCTTCSCCCCCEEEEETTTEEEEEEECCCEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHT-TCB
T ss_pred             chhhhhhhhccCCccCccchhhccccCCcEEEEEecCCCcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhC-Ccc
Confidence            988743211                                                 112678999999999998 999


Q ss_pred             eecCCCCCeEEcCCC--CEEEEecccccccccccc--------ccCCCCCcCccCccccCCCccCCCCCCcceeeeEee
Q psy14630        115 HRDVKPSNILLDRRG--AIKLCDFGISGQLVDSIA--------KTRDAGCRPYMAPERIDPLRARGYPSFKTKLGFKFN  183 (187)
Q Consensus       115 Hrdlk~~nili~~~~--~~ki~dfg~a~~~~~~~~--------~~~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi~  183 (187)
                      ||||||+||+++.++  .+||+|||+++.......        .....||+.|+|||.+.   ...++.++|+||||++
T Consensus       182 H~Dikp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Di~slG~i  257 (352)
T 2jii_A          182 HGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHK---GCGPSRRSDLQSLGYC  257 (352)
T ss_dssp             CSCCCGGGEEEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHT---TCCCCHHHHHHHHHHH
T ss_pred             CCCCCHHHEEEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHc---cCCCCchhhHHHHHHH
Confidence            999999999999988  899999999987654321        12347899999999998   5568899999999994

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A*

Probab=99.96  E-value=9.4e-31  Score=218.09  Aligned_cols=163  Identities=26%  Similarity=0.407  Sum_probs=127.2

Q ss_pred             CccccCCcccccccccccccCceEEEEEEEcCC---CcEEEEEEccCccChHHHHHHHHHHHHHHhcCCCCchhhhhhhH
Q psy14630         16 DTVYDFTSEDLQDLGEIGRGGFGTVNKMIHRSS---DTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQFYGAL   92 (187)
Q Consensus        16 ~~~~~~~~~~~~~~~~lg~G~fg~V~~~~~~~~---~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~   92 (187)
                      ...+++..++|++.+.||+|+||.||+|.+..+   +..||+|.++..... ...+.+.++..+++.++||||+++++.+
T Consensus       382 ~~~~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~l~~~~  460 (656)
T 2j0j_A          382 TRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSD-SVREKFLQEALTMRQFDHPHIVKLIGVI  460 (656)
T ss_dssp             GGGTBCCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCH-HHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             ccccccccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCH-HHHHHHHHHHHHHHhCCCCCCCeEEEEE
Confidence            445677788999999999999999999988543   467999998654333 3345566666678888999999987542


Q ss_pred             H--------------------------------HHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEeccccc
Q psy14630         93 F--------------------------------KEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISG  140 (187)
Q Consensus        93 ~--------------------------------~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg~a~  140 (187)
                      .                                ..++.|++.||.|||+. +++||||||+||+++.++.+||+|||+++
T Consensus       461 ~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~-givHrDikp~NILl~~~~~vkL~DFG~a~  539 (656)
T 2j0j_A          461 TENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESK-RFVHRDIAARNVLVSSNDCVKLGDFGLSR  539 (656)
T ss_dssp             CSSSCEEEEECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCSGGGEEEEETTEEEECCCCCCC
T ss_pred             ecCceEEEEEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC-CccccccchHhEEEeCCCCEEEEecCCCe
Confidence            1                                12567899999999998 99999999999999999999999999998


Q ss_pred             cccccccc--cCCCCCcCccCccccCCCccCCCCCCcceeeeEee
Q psy14630        141 QLVDSIAK--TRDAGCRPYMAPERIDPLRARGYPSFKTKLGFKFN  183 (187)
Q Consensus       141 ~~~~~~~~--~~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi~  183 (187)
                      ........  ....+++.|+|||.+.   ...++.++|+||||++
T Consensus       540 ~~~~~~~~~~~~~~~t~~y~aPE~~~---~~~~~~~~DiwSlG~i  581 (656)
T 2j0j_A          540 YMEDSTYYKASKGKLPIKWMAPESIN---FRRFTSASDVWMFGVC  581 (656)
T ss_dssp             SCCC----------CCGGGCCHHHHH---HCCCCHHHHHHHHHHH
T ss_pred             ecCCCcceeccCCCCCcceeCHHHhc---CCCCCchhhHHHHHHH
Confidence            87543222  2234677899999997   5678999999999984

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A*

Probab=99.96  E-value=3.6e-31  Score=200.21  Aligned_cols=157  Identities=25%  Similarity=0.400  Sum_probs=124.4

Q ss_pred             CcccccccccccccCceEEEEEEEcCCCcEEEEEEccCccChHHHHHHHHHHHHHHhcCCCCchhhhhhhH---------
Q psy14630         22 TSEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQFYGAL---------   92 (187)
Q Consensus        22 ~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~---------   92 (187)
                      ..++|++.+.||+|+||.||+|.+..+++.||+|++..........+.+.++..+++.++||||+++++.+         
T Consensus        20 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   99 (287)
T 2wei_A           20 FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIV   99 (287)
T ss_dssp             HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             HhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEEE
Confidence            35789999999999999999999998999999999864332222234455566677788999999886532         


Q ss_pred             -----------------------HHHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCC---CCEEEEeccccccccccc
Q psy14630         93 -----------------------FKEVTVATVKALNYLKEELKIIHRDVKPSNILLDRR---GAIKLCDFGISGQLVDSI  146 (187)
Q Consensus        93 -----------------------~~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~---~~~ki~dfg~a~~~~~~~  146 (187)
                                             ...++.|++.||.|||+. +++|+||||+||+++..   +.+||+|||++.......
T Consensus       100 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~-~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~~~~  178 (287)
T 2wei_A          100 GELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKH-NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNT  178 (287)
T ss_dssp             ECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBCCCS
T ss_pred             EEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC-CeeccCCChhhEEEecCCCcccEEEeccCcceeecCCC
Confidence                                   112678899999999998 99999999999999754   469999999998765443


Q ss_pred             cccCCCCCcCccCccccCCCccCCCCCCcceeeeEee
Q psy14630        147 AKTRDAGCRPYMAPERIDPLRARGYPSFKTKLGFKFN  183 (187)
Q Consensus       147 ~~~~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi~  183 (187)
                      ......+++.|+|||.+.+    .++.++|+||+|+.
T Consensus       179 ~~~~~~~~~~y~aPE~~~~----~~~~~~Di~slG~~  211 (287)
T 2wei_A          179 KMKDRIGTAYYIAPEVLRG----TYDEKCDVWSAGVI  211 (287)
T ss_dssp             SCSCHHHHHTTCCHHHHTT----CCCTHHHHHHHHHH
T ss_pred             ccccccCcccccChHHhcC----CCCCchhhHhHHHH
Confidence            3333457889999999873    37899999999994

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7

Probab=99.96  E-value=4.5e-31  Score=203.47  Aligned_cols=156  Identities=23%  Similarity=0.360  Sum_probs=115.2

Q ss_pred             ccCCcccccccccccccCceEEEEEEEcCCCcEEEEEEccCccChHHHHHHHHHHHH-HHhcCCCCchhhhhhhH-----
Q psy14630         19 YDFTSEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDV-VMKSNECPYIVQFYGAL-----   92 (187)
Q Consensus        19 ~~~~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~-~~~~~~h~~iv~~~~~~-----   92 (187)
                      .....++|++.+.||+|+||.||+|.+.  ++.||+|++....    ......+... ....+.||||+++++.+     
T Consensus        32 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~----~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~  105 (337)
T 3mdy_A           32 QRTIAKQIQMVKQIGKGRYGEVWMGKWR--GEKVAVKVFFTTE----EASWFRETEIYQTVLMRHENILGFIAADIKGTG  105 (337)
T ss_dssp             HTTHHHHCEEEEEEEEETTEEEEEEEET--TEEEEEEEEEGGG----HHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCG
T ss_pred             ccccccceEEEeEeecCCCeEEEEEEEC--CceEEEEEEeccc----cchhhhHHHHHHHHhhcCCCeeeEEEEEccCCC
Confidence            3445689999999999999999999874  8899999985321    1222222222 22235899999886431     


Q ss_pred             ------------------------------HHHHHHHHHHHHHHHHhcC-------CCeeecCCCCCeEEcCCCCEEEEe
Q psy14630         93 ------------------------------FKEVTVATVKALNYLKEEL-------KIIHRDVKPSNILLDRRGAIKLCD  135 (187)
Q Consensus        93 ------------------------------~~~~~~~~~~~l~~lh~~~-------~i~Hrdlk~~nili~~~~~~ki~d  135 (187)
                                                    ...+..|++.||.|||+..       +++||||||+||+++.++.+||+|
T Consensus       106 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl~D  185 (337)
T 3mdy_A          106 SWTQLYLITDYHENGSLYDYLKSTTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIAD  185 (337)
T ss_dssp             GGCEEEEEECCCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEEECC
T ss_pred             CCCceEEEEeccCCCcHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEEEEe
Confidence                                          1126778999999999742       899999999999999999999999


Q ss_pred             ccccccccccccc-----cCCCCCcCccCccccCCCccCCCCCC------cceeeeEee
Q psy14630        136 FGISGQLVDSIAK-----TRDAGCRPYMAPERIDPLRARGYPSF------KTKLGFKFN  183 (187)
Q Consensus       136 fg~a~~~~~~~~~-----~~~~~t~~y~aPE~~~~~~~~~~~~~------~D~ws~gi~  183 (187)
                      ||+++........     ....||+.|+|||.+.   .......      +|+||||++
T Consensus       186 fg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~~~~~~~DiwslG~i  241 (337)
T 3mdy_A          186 LGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLD---ESLNRNHFQSYIMADMYSFGLI  241 (337)
T ss_dssp             CTTCEECC---------CCSSCSCGGGCCHHHHT---TCCCTTCTHHHHHHHHHHHHHH
T ss_pred             CCCceeeccccccccCCCCCCccCcceeChhhcc---cccCCccccCccccchHHHHHH
Confidence            9999876433221     2347899999999998   3444444      999999994

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A

Probab=99.96  E-value=5e-31  Score=205.89  Aligned_cols=156  Identities=21%  Similarity=0.266  Sum_probs=119.3

Q ss_pred             cCCcccccccccccccCceEEEEEEEcCCCcEEEEEEccCccChHHHHHHHHHHHHHHhcC-----------CCCchhhh
Q psy14630         20 DFTSEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSN-----------ECPYIVQF   88 (187)
Q Consensus        20 ~~~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~-----------~h~~iv~~   88 (187)
                      .+..++|++.+.||+|+||.||+|.+..+++.||+|++...   ....+.+.++..+++.+           .|+||+++
T Consensus        15 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~   91 (373)
T 1q8y_A           15 PYKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD---KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKL   91 (373)
T ss_dssp             EETTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC---HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCC
T ss_pred             cccCCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCC---ccchhhhhHHHHHHHHhhcccccchhccccchHHHH
Confidence            34567899999999999999999999999999999998642   11222233333333332           27888877


Q ss_pred             hhhH-------------------------------------HHHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEc-----
Q psy14630         89 YGAL-------------------------------------FKEVTVATVKALNYLKEELKIIHRDVKPSNILLD-----  126 (187)
Q Consensus        89 ~~~~-------------------------------------~~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~-----  126 (187)
                      ++.+                                     ...++.|++.||.|||+..+++||||||+||+++     
T Consensus        92 ~~~~~~~~~~~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~ivH~Dikp~NIll~~~~~~  171 (373)
T 1q8y_A           92 LDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSP  171 (373)
T ss_dssp             CEEEEEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETT
T ss_pred             HHHhhccCCCCceEEEEEecCCCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCCEEecCCChHHeEEeccCCC
Confidence            5421                                     1126789999999999954899999999999994     


Q ss_pred             -CCCCEEEEeccccccccccccccCCCCCcCccCccccCCCccCCCCCCcceeeeEee
Q psy14630        127 -RRGAIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPLRARGYPSFKTKLGFKFN  183 (187)
Q Consensus       127 -~~~~~ki~dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi~  183 (187)
                       ..+.+||+|||++......  .....+|+.|+|||++.   ...++.++|+||+|++
T Consensus       172 ~~~~~~kl~Dfg~a~~~~~~--~~~~~~t~~y~aPE~~~---~~~~~~~~Di~slG~i  224 (373)
T 1q8y_A          172 ENLIQIKIADLGNACWYDEH--YTNSIQTREYRSPEVLL---GAPWGCGADIWSTACL  224 (373)
T ss_dssp             TTEEEEEECCCTTCEETTBC--CCSCCSCGGGCCHHHHH---TCCCCTHHHHHHHHHH
T ss_pred             cCcceEEEcccccccccCCC--CCCCCCCccccCcHHHh---CCCCCchHhHHHHHHH
Confidence             3447999999999876543  23347899999999998   5668999999999994

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens}

Probab=99.96  E-value=2.8e-31  Score=202.93  Aligned_cols=162  Identities=25%  Similarity=0.249  Sum_probs=116.6

Q ss_pred             ccccCCcccccccccccccCceEEEEEEEcCCCcEEEEEEccCccChH----HHHHHHHHHHHHHhcC----CCCchhhh
Q psy14630         17 TVYDFTSEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEK----DQRQLLMDLDVVMKSN----ECPYIVQF   88 (187)
Q Consensus        17 ~~~~~~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~----~~~~~~~~~~~~~~~~----~h~~iv~~   88 (187)
                      ...+...++|++.+.||+|+||.||+|.+..+++.||+|.+.......    .....+..+...+..+    .||||+++
T Consensus        24 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~  103 (312)
T 2iwi_A           24 KDREAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRL  103 (312)
T ss_dssp             ---------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCE
T ss_pred             cchhhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeE
Confidence            444566789999999999999999999999999999999986432211    0111112223333333    89999988


Q ss_pred             hhhHHH---------------------------------HHHHHHHHHHHHHHhcCCCeeecCCCCCeEEc-CCCCEEEE
Q psy14630         89 YGALFK---------------------------------EVTVATVKALNYLKEELKIIHRDVKPSNILLD-RRGAIKLC  134 (187)
Q Consensus        89 ~~~~~~---------------------------------~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~-~~~~~ki~  134 (187)
                      ++.+..                                 .++.|++.||.|||+. +++||||||+||+++ .++.+||+
T Consensus       104 ~~~~~~~~~~~~v~e~~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~-~i~H~dlkp~Nil~~~~~~~~kl~  182 (312)
T 2iwi_A          104 LDWFETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQHCHSR-GVVHRDIKDENILIDLRRGCAKLI  182 (312)
T ss_dssp             EEEC-----CEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHH-TEECCCCSGGGEEEETTTTEEEEC
T ss_pred             EEEEecCCeEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC-CeeecCCChhhEEEeCCCCeEEEE
Confidence            754321                                 1677899999999998 999999999999998 78999999


Q ss_pred             eccccccccccccccCCCCCcCccCccccCCCccCCCC-CCcceeeeEee
Q psy14630        135 DFGISGQLVDSIAKTRDAGCRPYMAPERIDPLRARGYP-SFKTKLGFKFN  183 (187)
Q Consensus       135 dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~-~~~D~ws~gi~  183 (187)
                      |||+++...... .....++..|+|||.+.   ...+. .++|+||+|++
T Consensus       183 dfg~~~~~~~~~-~~~~~~~~~y~aPE~~~---~~~~~~~~~Di~slG~i  228 (312)
T 2iwi_A          183 DFGSGALLHDEP-YTDFDGTRVYSPPEWIS---RHQYHALPATVWSLGIL  228 (312)
T ss_dssp             CCSSCEECCSSC-BCCCCSCTTTSCHHHHH---HSCBCHHHHHHHHHHHH
T ss_pred             EcchhhhcccCc-ccccCCcccccCceeee---cCCCCCccchHHHHHHH
Confidence            999998765432 33446899999999987   34443 58999999994

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens}

Probab=99.96  E-value=1.5e-30  Score=198.92  Aligned_cols=156  Identities=19%  Similarity=0.317  Sum_probs=118.4

Q ss_pred             cccccccccccccCceEEEEEEEcCCCcEEEEEEccCccChHHHHHHHHHHHHHHhcCCCCchhhhhhhH----------
Q psy14630         23 SEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQFYGAL----------   92 (187)
Q Consensus        23 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~----------   92 (187)
                      .++|++.+.||+|+||.||+|.+..+++.||+|.+...  .....+.+.++..+++.++||||+++++.+          
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   87 (320)
T 2i6l_A           10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLT--DPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDD   87 (320)
T ss_dssp             TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECC--SHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC-
T ss_pred             CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecC--ChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccc
Confidence            47899999999999999999999999999999988643  233344555666678888999999986431          


Q ss_pred             ----------------------------------HHHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEc-CCCCEEEEecc
Q psy14630         93 ----------------------------------FKEVTVATVKALNYLKEELKIIHRDVKPSNILLD-RRGAIKLCDFG  137 (187)
Q Consensus        93 ----------------------------------~~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~-~~~~~ki~dfg  137 (187)
                                                        ...++.|++.||.|||+. +++||||||+||+++ .++.+||+|||
T Consensus        88 ~~~~~~~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~-~i~H~dlkp~Nil~~~~~~~~kl~Dfg  166 (320)
T 2i6l_A           88 VGSLTELNSVYIVQEYMETDLANVLEQGPLLEEHARLFMYQLLRGLKYIHSA-NVLHRDLKPANLFINTEDLVLKIGDFG  166 (320)
T ss_dssp             ---CCSCSEEEEEEECCSEEHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT-TCBCCCCSGGGEEEETTTTEEEECCCT
T ss_pred             cccccccCceeEEeeccCCCHHHHhhcCCccHHHHHHHHHHHHHHHHHHHhC-CEecCCCCHHHEEEcCCCCeEEEccCc
Confidence                                              112678999999999998 999999999999997 56789999999


Q ss_pred             cccccccc----ccccCCCCCcCccCccccCCCccCCCCCCcceeeeEee
Q psy14630        138 ISGQLVDS----IAKTRDAGCRPYMAPERIDPLRARGYPSFKTKLGFKFN  183 (187)
Q Consensus       138 ~a~~~~~~----~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi~  183 (187)
                      +++.....    .......++..|+|||.+.+  ...++.++|+||+|++
T Consensus       167 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~~Di~slG~i  214 (320)
T 2i6l_A          167 LARIMDPHYSHKGHLSEGLVTKWYRSPRLLLS--PNNYTKAIDMWAAGCI  214 (320)
T ss_dssp             TCBCC--------CCCGGGSCCTTCCHHHHHC--TTCCCHHHHHHHHHHH
T ss_pred             cccccCCCcccccccccccccccccCcHHhcC--cccCCchhhhHhHHHH
Confidence            99876432    11223356888999999863  3568899999999993

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A*

Probab=99.96  E-value=1.3e-31  Score=203.47  Aligned_cols=164  Identities=26%  Similarity=0.411  Sum_probs=109.5

Q ss_pred             CccccCCcccccccccccccCceEEEEEEEcCCCcEEEEEEccCccChHHHHHHHHHHHHHHhcCCCCchhhhhhhH---
Q psy14630         16 DTVYDFTSEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQFYGAL---   92 (187)
Q Consensus        16 ~~~~~~~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~---   92 (187)
                      ...+.+..++|++.+.||+|+||.||+|.+..+++.||+|.+...... ...+.+.++...++.+.||||+++++.+   
T Consensus         7 ~~p~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~   85 (303)
T 2vwi_A            7 ALPWSINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQ-TSMDELLKEIQAMSQCHHPNIVSYYTSFVVK   85 (303)
T ss_dssp             ------CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC-----------------CCCCCCCTTBCCEEEEEESS
T ss_pred             ccccccchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcc-hhHHHHHHHHHHHhhcCCCCEeeEEEEEeec
Confidence            344677889999999999999999999999889999999988643222 2233445555667778999999876421   


Q ss_pred             -------------------------------------HHHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEe
Q psy14630         93 -------------------------------------FKEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCD  135 (187)
Q Consensus        93 -------------------------------------~~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~d  135 (187)
                                                           ...++.|++.|+.|||+. +++||||||+||+++.++.+||+|
T Consensus        86 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~-~i~H~dl~p~Nil~~~~~~~kl~d  164 (303)
T 2vwi_A           86 DELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKN-GQIHRDVKAGNILLGEDGSVQIAD  164 (303)
T ss_dssp             SCEEEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHT-TCCCCCCSGGGEEECTTCCEEECC
T ss_pred             CCcEEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhC-CCCCCCCChhhEEEcCCCCEEEEe
Confidence                                                 112567899999999998 999999999999999999999999


Q ss_pred             ccccccccccc------cccCCCCCcCccCccccCCCccCCCCCCcceeeeEee
Q psy14630        136 FGISGQLVDSI------AKTRDAGCRPYMAPERIDPLRARGYPSFKTKLGFKFN  183 (187)
Q Consensus       136 fg~a~~~~~~~------~~~~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi~  183 (187)
                      ||++.......      ......+|+.|+|||.+.+  ...++.++|+||+|++
T Consensus       165 fg~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~~Di~slG~i  216 (303)
T 2vwi_A          165 FGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQ--VRGYDFKADIWSFGIT  216 (303)
T ss_dssp             CHHHHHCC---------------CCCTTCCHHHHHH--HHCCCTHHHHHHHHHH
T ss_pred             ccchheeccCCCccchhhhcccCCCccccCHHHhcc--ccCCCchhhHHHHHHH
Confidence            99987654321      1223468999999999862  2457899999999994

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ...

Probab=99.96  E-value=7.9e-32  Score=207.02  Aligned_cols=169  Identities=25%  Similarity=0.323  Sum_probs=120.1

Q ss_pred             ceecCCCccccCCcccccccccccccCceEEEEEEEcCCCcEEEEEEccCccChH----HHHHHHHHHHHHHhcC--CCC
Q psy14630         10 KLKLSPDTVYDFTSEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEK----DQRQLLMDLDVVMKSN--ECP   83 (187)
Q Consensus        10 ~~~~~~~~~~~~~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~----~~~~~~~~~~~~~~~~--~h~   83 (187)
                      .....+....+...++|++.+.||+|+||.||+|.+..+++.||+|.+.......    ...+.+..+..+++.+  .|+
T Consensus        29 ~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~  108 (320)
T 3a99_A           29 ATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFS  108 (320)
T ss_dssp             -----------CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSC
T ss_pred             hhccCcccccCCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCC
Confidence            3445556667777889999999999999999999999999999999985432110    0011112223333333  469


Q ss_pred             chhhhhhhH---------------------------------HHHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEc-CCC
Q psy14630         84 YIVQFYGAL---------------------------------FKEVTVATVKALNYLKEELKIIHRDVKPSNILLD-RRG  129 (187)
Q Consensus        84 ~iv~~~~~~---------------------------------~~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~-~~~  129 (187)
                      ||+++++.+                                 ...++.|++.||.|||+. +++||||||+||+++ .++
T Consensus       109 ~i~~~~~~~~~~~~~~lv~e~~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~-~ivH~Dlkp~NIll~~~~~  187 (320)
T 3a99_A          109 GVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNC-GVLHRDIKDENILIDLNRG  187 (320)
T ss_dssp             SBCCEEEEEECSSEEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEEETTTT
T ss_pred             CceEEEEEEecCCcEEEEEEcCCCCccHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC-CcEeCCCCHHHEEEeCCCC
Confidence            999876432                                 112667999999999997 999999999999998 788


Q ss_pred             CEEEEeccccccccccccccCCCCCcCccCccccCCCccCCC-CCCcceeeeEee
Q psy14630        130 AIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPLRARGY-PSFKTKLGFKFN  183 (187)
Q Consensus       130 ~~ki~dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~-~~~~D~ws~gi~  183 (187)
                      .+||+|||+++...... .....||+.|+|||.+.   ...+ +.++|+||||++
T Consensus       188 ~~kL~Dfg~~~~~~~~~-~~~~~gt~~y~aPE~~~---~~~~~~~~~Di~slG~i  238 (320)
T 3a99_A          188 ELKLIDFGSGALLKDTV-YTDFDGTRVYSPPEWIR---YHRYHGRSAAVWSLGIL  238 (320)
T ss_dssp             EEEECCCTTCEECCSSC-BCCCCSCGGGSCHHHHH---HSCBCHHHHHHHHHHHH
T ss_pred             CEEEeeCcccccccccc-ccCCCCCccCCChHHhc---cCCCCCccchHHhHHHH
Confidence            99999999998765432 23347899999999987   4444 578999999994

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A

Probab=99.96  E-value=1.2e-30  Score=197.79  Aligned_cols=153  Identities=16%  Similarity=0.194  Sum_probs=118.6

Q ss_pred             cccccccccccccCceEEEEEEEcCCCcEEEEEEccCccChHHHHHHHHHHHHHHhcCCCCchhhhhhh-----------
Q psy14630         23 SEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQFYGA-----------   91 (187)
Q Consensus        23 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~-----------   91 (187)
                      .++|++.+.||+|+||.||+|.+..+++.||+|++.......    .+..+..+++.+.|++++..+..           
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~----~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv   83 (296)
T 3uzp_A            8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHP----QLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMV   83 (296)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSSCC----HHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEE
T ss_pred             ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcchh----HHHHHHHHHHHhhcCCCCCccccccCCCCceEEE
Confidence            478999999999999999999999999999999986433222    23334445555566665433211           


Q ss_pred             ----------------------HHHHHHHHHHHHHHHHHhcCCCeeecCCCCCeEE---cCCCCEEEEeccccccccccc
Q psy14630         92 ----------------------LFKEVTVATVKALNYLKEELKIIHRDVKPSNILL---DRRGAIKLCDFGISGQLVDSI  146 (187)
Q Consensus        92 ----------------------~~~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili---~~~~~~ki~dfg~a~~~~~~~  146 (187)
                                            ....++.|++.||.|||+. +++||||||+||++   +.++.+||+|||+++......
T Consensus        84 ~e~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~-~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~  162 (296)
T 3uzp_A           84 MELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSK-NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDAR  162 (296)
T ss_dssp             EECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCCGGGEEECCGGGTTCEEECCCTTCEECBCTT
T ss_pred             EEecCCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhC-CeeeCCCCHHHeEEecCCCCCeEEEeeCCCcccccccc
Confidence                                  0122678999999999998 99999999999999   478899999999998765432


Q ss_pred             c--------ccCCCCCcCccCccccCCCccCCCCCCcceeeeEee
Q psy14630        147 A--------KTRDAGCRPYMAPERIDPLRARGYPSFKTKLGFKFN  183 (187)
Q Consensus       147 ~--------~~~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi~  183 (187)
                      .        .....||+.|+|||.+.   ...++.++|+||+|++
T Consensus       163 ~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Di~slG~i  204 (296)
T 3uzp_A          163 THQHIPYRENKNLTGTARYASINTHL---GIEQSRRDDLESLGYV  204 (296)
T ss_dssp             TCCBCCCCCSCCCCSCTTTCCHHHHT---TCCCCHHHHHHHHHHH
T ss_pred             cccccccccccccccccccCChhhhc---CCCCCcchhhHHHHHH
Confidence            2        23447899999999998   5668899999999994

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A*

Probab=99.96  E-value=4.7e-31  Score=200.59  Aligned_cols=160  Identities=28%  Similarity=0.453  Sum_probs=121.2

Q ss_pred             CCcccccccccccccCceEEEEEEEcCCCcEEEEEEccCccChHHHHHHHHHHHHHHhcCCCCchhhhhhhH--------
Q psy14630         21 FTSEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQFYGAL--------   92 (187)
Q Consensus        21 ~~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~--------   92 (187)
                      -..++|++.+.||+|+||.||+|.+..+++.||+|.+......  ..+.+..+..+++.+.||||+++++.+        
T Consensus        16 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   93 (302)
T 2j7t_A           16 DPNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEE--ELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWI   93 (302)
T ss_dssp             CGGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----C--CHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEE
T ss_pred             CCccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHH--HHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEE
Confidence            3567899999999999999999999999999999998643211  223344455567778999999987532        


Q ss_pred             -------------------------HHHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEecccccccccc-c
Q psy14630         93 -------------------------FKEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDS-I  146 (187)
Q Consensus        93 -------------------------~~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg~a~~~~~~-~  146 (187)
                                               ...+..+++.|+.|||+. +++||||||+||+++.++.+||+|||++...... .
T Consensus        94 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~-~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  172 (302)
T 2j7t_A           94 MIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSK-RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQ  172 (302)
T ss_dssp             EEECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHT-TCCCCCCSGGGEEECTTSCEEECCCHHHHHHHHHHH
T ss_pred             EEEeCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhcC-CcccCCCCHHHEEECCCCCEEEEECCCCcccccccc
Confidence                                     112677899999999998 9999999999999999999999999987654322 2


Q ss_pred             cccCCCCCcCccCccccCCC--ccCCCCCCcceeeeEee
Q psy14630        147 AKTRDAGCRPYMAPERIDPL--RARGYPSFKTKLGFKFN  183 (187)
Q Consensus       147 ~~~~~~~t~~y~aPE~~~~~--~~~~~~~~~D~ws~gi~  183 (187)
                      ......+++.|+|||.+...  ....++.++|+||+|++
T Consensus       173 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~i  211 (302)
T 2j7t_A          173 KRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGIT  211 (302)
T ss_dssp             C-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHH
T ss_pred             ccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHH
Confidence            22334689999999998310  14557899999999994

>4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A

Probab=99.96  E-value=4.8e-31  Score=199.83  Aligned_cols=153  Identities=16%  Similarity=0.194  Sum_probs=115.1

Q ss_pred             cccccccccccccCceEEEEEEEcCCCcEEEEEEccCccChHHHHHHHHHHHHHHhcCCCCchhhhhhh-----------
Q psy14630         23 SEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQFYGA-----------   91 (187)
Q Consensus        23 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~-----------   91 (187)
                      .++|++.+.||+|+||.||+|.+..+++.||+|++.......    .+..+..+++.+.|++++..+..           
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~----~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv   83 (296)
T 4hgt_A            8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHP----QLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMV   83 (296)
T ss_dssp             ---CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC---CC----CHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEE
T ss_pred             CCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccccch----HHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEE
Confidence            478999999999999999999999999999999865322111    12333444555566665543211           


Q ss_pred             ----------------------HHHHHHHHHHHHHHHHHhcCCCeeecCCCCCeEE---cCCCCEEEEeccccccccccc
Q psy14630         92 ----------------------LFKEVTVATVKALNYLKEELKIIHRDVKPSNILL---DRRGAIKLCDFGISGQLVDSI  146 (187)
Q Consensus        92 ----------------------~~~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili---~~~~~~ki~dfg~a~~~~~~~  146 (187)
                                            ....++.|++.||.|||+. +++||||||+||++   +..+.+||+|||+++......
T Consensus        84 ~e~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~-~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~~  162 (296)
T 4hgt_A           84 MELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSK-NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDAR  162 (296)
T ss_dssp             EECCCCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEECCGGGTTCEEECCCTTCEECBCTT
T ss_pred             EEccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC-CeecCCCCHHHeeeeccCCCCeEEEecCccceeccCcc
Confidence                                  1122678999999999998 99999999999999   788999999999998765432


Q ss_pred             c--------ccCCCCCcCccCccccCCCccCCCCCCcceeeeEee
Q psy14630        147 A--------KTRDAGCRPYMAPERIDPLRARGYPSFKTKLGFKFN  183 (187)
Q Consensus       147 ~--------~~~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi~  183 (187)
                      .        .....||+.|+|||.+.   ...++.++|+||+|++
T Consensus       163 ~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Di~slG~i  204 (296)
T 4hgt_A          163 THQHIPYRENKNLTGTARYASINTHL---GIEQSRRDDLESLGYV  204 (296)
T ss_dssp             TCCBCCCCCSCCCCSCGGGCCHHHHT---TCCCCHHHHHHHHHHH
T ss_pred             cCccCCCCcccccCCCccccchHHhc---CCCCCchhHHHHHHHH
Confidence            1        22447899999999998   5668899999999994

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A*

Probab=99.96  E-value=1.2e-30  Score=200.91  Aligned_cols=155  Identities=25%  Similarity=0.325  Sum_probs=117.4

Q ss_pred             cCCcccccccccccccCceEEEEEEE-cCCCcEEEEEEccCccChHHHHHHHHHHHHHHhcC------CCCchhhhhhhH
Q psy14630         20 DFTSEDLQDLGEIGRGGFGTVNKMIH-RSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSN------ECPYIVQFYGAL   92 (187)
Q Consensus        20 ~~~~~~~~~~~~lg~G~fg~V~~~~~-~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~------~h~~iv~~~~~~   92 (187)
                      +...++|++.+.||+|+||.||+|.+ ..+++.||+|+++..   ....+.+..+..+++.+      .|++++++++.+
T Consensus        10 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~   86 (339)
T 1z57_A           10 DVLSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV---DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWF   86 (339)
T ss_dssp             CEETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS---HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEE
T ss_pred             CCccCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC---CchhHHHHHHHHHHHHhhhcCCCCceeeEeeeccc
Confidence            34467999999999999999999998 568899999998642   12222333333333333      334566654321


Q ss_pred             ---------------------------------HHHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcC------------
Q psy14630         93 ---------------------------------FKEVTVATVKALNYLKEELKIIHRDVKPSNILLDR------------  127 (187)
Q Consensus        93 ---------------------------------~~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~------------  127 (187)
                                                       ...++.|++.||.|||+. +++||||||+||+++.            
T Consensus        87 ~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~-~ivH~Dlkp~Nil~~~~~~~~~~~~~~~  165 (339)
T 1z57_A           87 EHHGHICIVFELLGLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSN-KLTHTDLKPENILFVQSDYTEAYNPKIK  165 (339)
T ss_dssp             EETTEEEEEEECCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCCGGGEEESCCCEEEEEC----
T ss_pred             ccCCcEEEEEcCCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHC-CCcCCCCCHHHEEEeccccccccCCccc
Confidence                                             123778999999999998 9999999999999987            


Q ss_pred             -------CCCEEEEeccccccccccccccCCCCCcCccCccccCCCccCCCCCCcceeeeEee
Q psy14630        128 -------RGAIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPLRARGYPSFKTKLGFKFN  183 (187)
Q Consensus       128 -------~~~~ki~dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi~  183 (187)
                             ++.+||+|||+++.....  .....||+.|+|||++.   ...++.++|+||+|++
T Consensus       166 ~~~~~~~~~~~kl~Dfg~~~~~~~~--~~~~~gt~~y~aPE~~~---~~~~~~~~Di~slG~i  223 (339)
T 1z57_A          166 RDERTLINPDIKVVDFGSATYDDEH--HSTLVSTRHYRAPEVIL---ALGWSQPCDVWSIGCI  223 (339)
T ss_dssp             CEEEEESCCCEEECCCSSCEETTSC--CCSSCSCGGGCCHHHHT---TSCCCTHHHHHHHHHH
T ss_pred             cccccccCCCceEeeCcccccCccc--cccccCCccccChHHhh---CCCCCcchhhHHHHHH
Confidence                   668999999999875432  23447899999999998   6678999999999994

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens}

Probab=99.96  E-value=2.2e-30  Score=198.92  Aligned_cols=161  Identities=26%  Similarity=0.406  Sum_probs=116.9

Q ss_pred             cCCcccccccccccccCceEEEEEEEcCCCcEEEEEEccCccChHHHHHHHHHHHHHHhcCCCCchhhhhhhHH------
Q psy14630         20 DFTSEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQFYGALF------   93 (187)
Q Consensus        20 ~~~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~------   93 (187)
                      ....++|++.+.||+|+||.||+|.+..+++.||+|++......  ......+...+.+..+||||+++++.+.      
T Consensus        20 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~--~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~   97 (326)
T 2x7f_A           20 RDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDE--EEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPG   97 (326)
T ss_dssp             CCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSST--THHHHHHHHHHHHHCCSTTBCCEEEEEEECC--C
T ss_pred             cCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCccc--HHHHHHHHHHHHhccCCCCeeeeeeEEeeccCcc
Confidence            34668899999999999999999999999999999998643222  1223333343334448999998764321      


Q ss_pred             ----------------------------------HHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEecccc
Q psy14630         94 ----------------------------------KEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGIS  139 (187)
Q Consensus        94 ----------------------------------~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg~a  139 (187)
                                                        ..+..|++.||.|||+. +++|+||||+||+++.++.+||+|||++
T Consensus        98 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~-~ivH~dlkp~NIl~~~~~~~kl~Dfg~~  176 (326)
T 2x7f_A           98 MDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQH-KVIHRDIKGQNVLLTENAEVKLVDFGVS  176 (326)
T ss_dssp             CCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHT-TCCCCCCSGGGEEECTTCCEEECCCTTT
T ss_pred             ccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHC-CccccCCcHHHEEEcCCCCEEEeeCcCc
Confidence                                              11667899999999998 9999999999999999999999999999


Q ss_pred             ccccccc-cccCCCCCcCccCccccCCCc--cCCCCCCcceeeeEee
Q psy14630        140 GQLVDSI-AKTRDAGCRPYMAPERIDPLR--ARGYPSFKTKLGFKFN  183 (187)
Q Consensus       140 ~~~~~~~-~~~~~~~t~~y~aPE~~~~~~--~~~~~~~~D~ws~gi~  183 (187)
                      ....... ......+++.|+|||.+....  ...++.++|+||+|++
T Consensus       177 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~i  223 (326)
T 2x7f_A          177 AQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGIT  223 (326)
T ss_dssp             C-------------CCGGGCCHHHHC--------CCTTHHHHHHHHH
T ss_pred             eecCcCccccccccCCccccChhhhccccccCcCCCccchHHHHHHH
Confidence            8764322 223346899999999986321  3457899999999993

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A*

Probab=99.96  E-value=2.9e-30  Score=202.75  Aligned_cols=153  Identities=28%  Similarity=0.310  Sum_probs=114.5

Q ss_pred             cccccccccccccCceEEEEEEEcCCCcEEEEEEccCccChHHHHHHHHHHHHHHhcC-CCCc-----hhhhhhhH----
Q psy14630         23 SEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSN-ECPY-----IVQFYGAL----   92 (187)
Q Consensus        23 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~-~h~~-----iv~~~~~~----   92 (187)
                      .++|++.+.||+|+||.||+|.+..+++.||||+++..  . ...+....+..+++.+ +|++     ++.+++.+    
T Consensus        53 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~--~-~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~  129 (382)
T 2vx3_A           53 MDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK--K-AFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRN  129 (382)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS--H-HHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETT
T ss_pred             eeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc--H-HHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCC
Confidence            57899999999999999999999999999999998742  2 1122222222222222 3443     55443211    


Q ss_pred             -----------------------------HHHHHHHHHHHHHHHHh-cCCCeeecCCCCCeEEc--CCCCEEEEeccccc
Q psy14630         93 -----------------------------FKEVTVATVKALNYLKE-ELKIIHRDVKPSNILLD--RRGAIKLCDFGISG  140 (187)
Q Consensus        93 -----------------------------~~~~~~~~~~~l~~lh~-~~~i~Hrdlk~~nili~--~~~~~ki~dfg~a~  140 (187)
                                                   ...++.|++.||.|||. ..+|+||||||+||+++  .++.+||+|||+++
T Consensus       130 ~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~~~~~~~kL~DFG~a~  209 (382)
T 2vx3_A          130 HLCLVFEMLSYNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSC  209 (382)
T ss_dssp             EEEEEEECCCCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESSTTSCCEEECCCTTCE
T ss_pred             ceEEEEecCCCCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEecCCCCcEEEEeccCce
Confidence                                         12377899999999994 24899999999999994  47789999999998


Q ss_pred             cccccccccCCCCCcCccCccccCCCccCCCCCCcceeeeEee
Q psy14630        141 QLVDSIAKTRDAGCRPYMAPERIDPLRARGYPSFKTKLGFKFN  183 (187)
Q Consensus       141 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi~  183 (187)
                      .....  .....+|+.|+|||++.   ...++.++|+||+|++
T Consensus       210 ~~~~~--~~~~~~t~~y~aPE~~~---~~~~~~~~DiwSlG~i  247 (382)
T 2vx3_A          210 QLGQR--IYQYIQSRFYRSPEVLL---GMPYDLAIDMWSLGCI  247 (382)
T ss_dssp             ETTCC--CCSSCSCGGGCCHHHHT---TCCCCTHHHHHHHHHH
T ss_pred             ecccc--cccccCCccccChHHHc---CCCCCcHHHHHHHHHH
Confidence            76433  23457899999999998   5678999999999994

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A*

Probab=99.96  E-value=8.7e-31  Score=202.55  Aligned_cols=153  Identities=24%  Similarity=0.313  Sum_probs=104.4

Q ss_pred             cCCcccccccc-cccccCceEEEEEEEcCCCcEEEEEEccCccChHHHHHHHHHHHHHHhcCCCCchhhhhhhH------
Q psy14630         20 DFTSEDLQDLG-EIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQFYGAL------   92 (187)
Q Consensus        20 ~~~~~~~~~~~-~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~------   92 (187)
                      ....++|++.+ .||+|+||.||+|.+..+++.||+|++...  .    ....+.....+...||||+++++.+      
T Consensus        24 ~~~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~--~----~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~   97 (336)
T 3fhr_A           24 YAVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDS--P----KARQEVDHHWQASGGPHIVCILDVYENMHHG   97 (336)
T ss_dssp             SCGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESS--H----HHHHHHHHHHHHTTSTTBCCEEEEEEEEETT
T ss_pred             ccccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCc--H----HHHHHHHHHHHhcCCCChHHHHHHHhhccCC
Confidence            34568899865 699999999999999999999999998642  1    1222334445667899999876432      


Q ss_pred             --------------------------------HHHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcC---CCCEEEEecc
Q psy14630         93 --------------------------------FKEVTVATVKALNYLKEELKIIHRDVKPSNILLDR---RGAIKLCDFG  137 (187)
Q Consensus        93 --------------------------------~~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~---~~~~ki~dfg  137 (187)
                                                      ...++.|++.||.|||+. +++||||||+||+++.   .+.+||+|||
T Consensus        98 ~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~-~ivH~dlkp~NIll~~~~~~~~~kl~Dfg  176 (336)
T 3fhr_A           98 KRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSH-NIAHRDVKPENLLYTSKEKDAVLKLTDFG  176 (336)
T ss_dssp             EEEEEEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEESCSSTTCCEEECCCT
T ss_pred             CceEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC-CeecCCCCHHHEEEEecCCCceEEEeccc
Confidence                                            112678999999999998 9999999999999976   4559999999


Q ss_pred             ccccccccccccCCCCCcCccCccccCCCccCCCCCCcceeeeEee
Q psy14630        138 ISGQLVDSIAKTRDAGCRPYMAPERIDPLRARGYPSFKTKLGFKFN  183 (187)
Q Consensus       138 ~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi~  183 (187)
                      +++...... .....+|+.|+|||.+.   ...++.++|+||+|++
T Consensus       177 ~~~~~~~~~-~~~~~~t~~y~aPE~~~---~~~~~~~~Di~slG~i  218 (336)
T 3fhr_A          177 FAKETTQNA-LQTPCYTPYYVAPEVLG---PEKYDKSCDMWSLGVI  218 (336)
T ss_dssp             TCEEC--------------------------CHHHHHHHHHHHHHH
T ss_pred             cceeccccc-cccCCCCcCccChhhhC---CCCCCchhhHHHHHHH
Confidence            998765432 23346799999999987   5567889999999994

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A*

Probab=99.96  E-value=1.7e-30  Score=201.33  Aligned_cols=156  Identities=24%  Similarity=0.319  Sum_probs=116.9

Q ss_pred             ccCCcccccccccccccCceEEEEEEEcCCC-cEEEEEEccCccChHHHHHHHHHHHHHHhcCCCCc------hhhhhhh
Q psy14630         19 YDFTSEDLQDLGEIGRGGFGTVNKMIHRSSD-TVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPY------IVQFYGA   91 (187)
Q Consensus        19 ~~~~~~~~~~~~~lg~G~fg~V~~~~~~~~~-~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~------iv~~~~~   91 (187)
                      .+...++|++.+.||+|+||.||+|.+..++ +.||+|+++..   ....+.+..+..+++.+.|++      ++.+++.
T Consensus        14 g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~   90 (355)
T 2eu9_A           14 GDWLQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV---GKYREAARLEINVLKKIKEKDKENKFLCVLMSDW   90 (355)
T ss_dssp             TCEETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC---HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEE
T ss_pred             CceecccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc---ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeee
Confidence            3444689999999999999999999997776 78999998642   122233333333344333332      5443321


Q ss_pred             ---------------------------------HHHHHHHHHHHHHHHHHhcCCCeeecCCCCCeEE-------------
Q psy14630         92 ---------------------------------LFKEVTVATVKALNYLKEELKIIHRDVKPSNILL-------------  125 (187)
Q Consensus        92 ---------------------------------~~~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili-------------  125 (187)
                                                       ....++.|++.||.|||+. +++||||||+||++             
T Consensus        91 ~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~-~ivH~Dlkp~NIll~~~~~~~~~~~~~  169 (355)
T 2eu9_A           91 FNFHGHMCIAFELLGKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHEN-QLTHTDLKPENILFVNSEFETLYNEHK  169 (355)
T ss_dssp             EEETTEEEEEEECCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTT-TEECCCCCGGGEEESCCCEEEEECCC-
T ss_pred             eeeCCeEEEEEeccCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC-CcccCCCCHHHEEEecccccccccccc
Confidence                                             1223778999999999998 99999999999999             


Q ss_pred             ------cCCCCEEEEeccccccccccccccCCCCCcCccCccccCCCccCCCCCCcceeeeEee
Q psy14630        126 ------DRRGAIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPLRARGYPSFKTKLGFKFN  183 (187)
Q Consensus       126 ------~~~~~~ki~dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi~  183 (187)
                            +..+.+||+|||+++.....  .....||+.|+|||++.   ...++.++|+||+|++
T Consensus       170 ~~~~~~~~~~~~kl~Dfg~~~~~~~~--~~~~~gt~~y~aPE~~~---~~~~~~~~Di~slG~i  228 (355)
T 2eu9_A          170 SCEEKSVKNTSIRVADFGSATFDHEH--HTTIVATRHYRPPEVIL---ELGWAQPCDVWSIGCI  228 (355)
T ss_dssp             CCCEEEESCCCEEECCCTTCEETTSC--CCSSCSCGGGCCHHHHT---TCCCCTHHHHHHHHHH
T ss_pred             cccccccCCCcEEEeecCcccccccc--ccCCcCCCcccCCeeee---cCCCCCccchHHHHHH
Confidence                  56788999999999865432  23447899999999998   6678999999999994

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B*

Probab=99.96  E-value=4.8e-31  Score=199.49  Aligned_cols=162  Identities=23%  Similarity=0.402  Sum_probs=116.6

Q ss_pred             cccCCcccccccccccccCceEEEEEEEcC-CC--cEEEEEEccCcc-ChHHHHHHHHHHHHHHhcCCCCchhhhhhhH-
Q psy14630         18 VYDFTSEDLQDLGEIGRGGFGTVNKMIHRS-SD--TVMAVKRIRSTV-DEKDQRQLLMDLDVVMKSNECPYIVQFYGAL-   92 (187)
Q Consensus        18 ~~~~~~~~~~~~~~lg~G~fg~V~~~~~~~-~~--~~vaiK~~~~~~-~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~-   92 (187)
                      ...+..++|++.+.||+|+||.||+|.+.. ++  ..||+|+++... ......+.+.++..+++.++||||+++++.+ 
T Consensus        12 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~   91 (291)
T 1u46_A           12 TCLIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVL   91 (291)
T ss_dssp             CEECCGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             ccccchhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEc
Confidence            345678899999999999999999998633 33  368999986432 1223344556666677788999999887532 


Q ss_pred             -------------------------------HHHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEecccccc
Q psy14630         93 -------------------------------FKEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQ  141 (187)
Q Consensus        93 -------------------------------~~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg~a~~  141 (187)
                                                     ...++.|++.||.|||+. +++|+||||+||+++.++.+||+|||++..
T Consensus        92 ~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~-~i~H~dikp~Nili~~~~~~kl~Dfg~~~~  170 (291)
T 1u46_A           92 TPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESK-RFIHRDLAARNLLLATRDLVKIGDFGLMRA  170 (291)
T ss_dssp             SSSCEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHT-TEECSCCCGGGEEEEETTEEEECCCTTCEE
T ss_pred             cCCceeeEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHHhC-CcccCCCchheEEEcCCCCEEEcccccccc
Confidence                                           112667899999999998 999999999999999999999999999987


Q ss_pred             cccccc----ccCCCCCcCccCccccCCCccCCCCCCcceeeeEee
Q psy14630        142 LVDSIA----KTRDAGCRPYMAPERIDPLRARGYPSFKTKLGFKFN  183 (187)
Q Consensus       142 ~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi~  183 (187)
                      ......    .....++..|+|||.+.   ...++.++|+||+|++
T Consensus       171 ~~~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~Di~slG~i  213 (291)
T 1u46_A          171 LPQNDDHYVMQEHRKVPFAWCAPESLK---TRTFSHASDTWMFGVT  213 (291)
T ss_dssp             CCC-CCEEEC-----CCGGGCCHHHHH---HCEEEHHHHHHHHHHH
T ss_pred             ccccccchhhhccCCCCceeeCchhhc---CCCCCchhhHHHHHHH
Confidence            654321    12335677899999987   5567899999999993

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group}

Probab=99.96  E-value=2.8e-30  Score=208.38  Aligned_cols=154  Identities=15%  Similarity=0.234  Sum_probs=116.7

Q ss_pred             cccccccccccccCceEEEEEEEcCCCcEEEEEEccCccChHHHHHHHHHHHHHHhcCCCCchh-hhh------------
Q psy14630         23 SEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIV-QFY------------   89 (187)
Q Consensus        23 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv-~~~------------   89 (187)
                      .++|++.+.||+|+||.||+|.+..+++.||||++.......   + +..+..+++.+.|++.+ .+.            
T Consensus         6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~---~-~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lv   81 (483)
T 3sv0_A            6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHP---Q-LLYESKIYRILQGGTGIPNVRWFGVEGDYNVLV   81 (483)
T ss_dssp             TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSSC---C-HHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEE
T ss_pred             CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccccH---H-HHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEE
Confidence            478999999999999999999999999999999875432221   1 22333344445553332 221            


Q ss_pred             ---------hh-----------HHHHHHHHHHHHHHHHHhcCCCeeecCCCCCeEE---cCCCCEEEEeccccccccccc
Q psy14630         90 ---------GA-----------LFKEVTVATVKALNYLKEELKIIHRDVKPSNILL---DRRGAIKLCDFGISGQLVDSI  146 (187)
Q Consensus        90 ---------~~-----------~~~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili---~~~~~~ki~dfg~a~~~~~~~  146 (187)
                               +.           ....++.|++.||.|||+. +|+||||||+|||+   +..+.+||+|||+++......
T Consensus        82 me~~g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH~~-gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~  160 (483)
T 3sv0_A           82 MDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSK-SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTS  160 (483)
T ss_dssp             EECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCCGGGEEECCGGGTTCEEECCCTTCEECBCTT
T ss_pred             EECCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHC-CEeecccCcceEEEecCCCCCeEEEEeCCcceeccCCc
Confidence                     00           1123778999999999998 99999999999999   578999999999998875432


Q ss_pred             c--------ccCCCCCcCccCccccCCCccCCCCCCcceeeeEeee
Q psy14630        147 A--------KTRDAGCRPYMAPERIDPLRARGYPSFKTKLGFKFNY  184 (187)
Q Consensus       147 ~--------~~~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi~~  184 (187)
                      .        .....||+.|+|||.+.   ...++.++||||||+++
T Consensus       161 ~~~~~~~~~~~~~~gt~~Y~aPE~~~---~~~~s~~sDvwSlGvil  203 (483)
T 3sv0_A          161 THQHIPYRENKNLTGTARYASVNTHL---GIEQSRRDDLESLGYVL  203 (483)
T ss_dssp             TCCBCCCCCCCCCCSCTTTCCHHHHT---TCCCCHHHHHHHHHHHH
T ss_pred             cccccccccccccCCCccccCHHHhc---CCCCChHHHHHHHHHHH
Confidence            2        12457899999999998   56788999999999943

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A*

Probab=99.96  E-value=2.3e-30  Score=197.96  Aligned_cols=164  Identities=21%  Similarity=0.319  Sum_probs=119.5

Q ss_pred             ccccCCcccccccccccccCceEEEEEEEcCCCcEEEEEEccCccChHHHHHHHHHHHHHHhcCC--CCchhhhhhhH--
Q psy14630         17 TVYDFTSEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNE--CPYIVQFYGAL--   92 (187)
Q Consensus        17 ~~~~~~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~--h~~iv~~~~~~--   92 (187)
                      ...++..++|++.+.||+|+||.||+|.+. +++.||+|.+..........+.+.++..+++.+.  |+||+++++.+  
T Consensus        21 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~   99 (313)
T 3cek_A           21 QSMSVKGRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEIT   99 (313)
T ss_dssp             CEEEETTEEEEEEEEEECCSSEEEEEEECT-TCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEEC
T ss_pred             eeeeeccceEEEEEEecCCCCEEEEEEEcC-CCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeec
Confidence            344567788999999999999999999985 5888999998654333334444455555555444  69999887432  


Q ss_pred             -----------------------------HHHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEecccccccc
Q psy14630         93 -----------------------------FKEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLV  143 (187)
Q Consensus        93 -----------------------------~~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg~a~~~~  143 (187)
                                                   ...++.|++.||.|||+. +++||||||+||+++. +.+||+|||+++...
T Consensus       100 ~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~-~ivH~dlkp~NIl~~~-~~~kL~Dfg~~~~~~  177 (313)
T 3cek_A          100 DQYIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQH-GIVHSDLKPANFLIVD-GMLKLIDFGIANQMQ  177 (313)
T ss_dssp             SSEEEEEECCCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHHT-TCCCCCCCGGGEEEET-TEEEECCCSSSCC--
T ss_pred             CCEEEEEEecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC-CceecCCCcccEEEEC-CeEEEeecccccccc
Confidence                                         112678999999999998 9999999999999964 899999999998765


Q ss_pred             cccc---ccCCCCCcCccCccccCCCc--------cCCCCCCcceeeeEee
Q psy14630        144 DSIA---KTRDAGCRPYMAPERIDPLR--------ARGYPSFKTKLGFKFN  183 (187)
Q Consensus       144 ~~~~---~~~~~~t~~y~aPE~~~~~~--------~~~~~~~~D~ws~gi~  183 (187)
                      ....   .....|++.|+|||.+.+..        ...++.++|+||+|++
T Consensus       178 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~i  228 (313)
T 3cek_A          178 PDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCI  228 (313)
T ss_dssp             ------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHH
T ss_pred             CccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHH
Confidence            4321   22346899999999987321        1357789999999994

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis}

Probab=99.96  E-value=3.6e-30  Score=215.56  Aligned_cols=154  Identities=21%  Similarity=0.307  Sum_probs=124.5

Q ss_pred             CCcccccccccccccCceEEEEEEEcC-CCcEEEEEEccCccChHHHHHHHHHHHHHHhcCCCCchhhhhhhH-------
Q psy14630         21 FTSEDLQDLGEIGRGGFGTVNKMIHRS-SDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQFYGAL-------   92 (187)
Q Consensus        21 ~~~~~~~~~~~lg~G~fg~V~~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~-------   92 (187)
                      ...++|++.+.||+|+||.||+|.+.. +++.||||.+..... ....+.+..+..+++.+.||||+++++.+       
T Consensus        77 ~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~  155 (681)
T 2pzi_A           77 IVAGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGD-AEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHG  155 (681)
T ss_dssp             EETTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCC-HHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTS
T ss_pred             EeCCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCC-HHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCC
Confidence            345789999999999999999999975 789999999865333 33344556666678888999999887532       


Q ss_pred             ----------------------------HHHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEeccccccccc
Q psy14630         93 ----------------------------FKEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVD  144 (187)
Q Consensus        93 ----------------------------~~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg~a~~~~~  144 (187)
                                                  ...+..|++.+|.|||+. +|+||||||+||+++.+ .+||+|||+++....
T Consensus       156 ~~~~~lv~E~~~g~~L~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~-giiHrDlkp~NIll~~~-~~kl~DFG~a~~~~~  233 (681)
T 2pzi_A          156 DPVGYIVMEYVGGQSLKRSKGQKLPVAEAIAYLLEILPALSYLHSI-GLVYNDLKPENIMLTEE-QLKLIDLGAVSRINS  233 (681)
T ss_dssp             CEEEEEEEECCCCEECC----CCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEECSS-CEEECCCTTCEETTC
T ss_pred             CceeEEEEEeCCCCcHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHC-CCeecccChHHeEEeCC-cEEEEecccchhccc
Confidence                                        112678999999999998 99999999999999875 899999999987654


Q ss_pred             cccccCCCCCcCccCccccCCCccCCCCCCcceeeeEeee
Q psy14630        145 SIAKTRDAGCRPYMAPERIDPLRARGYPSFKTKLGFKFNY  184 (187)
Q Consensus       145 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi~~  184 (187)
                      .   ....||+.|+|||++.   . .++.++||||||+++
T Consensus       234 ~---~~~~gt~~y~aPE~~~---~-~~~~~sDi~slG~~l  266 (681)
T 2pzi_A          234 F---GYLYGTPGFQAPEIVR---T-GPTVATDIYTVGRTL  266 (681)
T ss_dssp             C---SCCCCCTTTSCTTHHH---H-CSCHHHHHHHHHHHH
T ss_pred             C---CccCCCccccCHHHHc---C-CCCCceehhhhHHHH
Confidence            3   3446899999999987   3 247899999999943

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A*

Probab=99.96  E-value=8.8e-30  Score=211.00  Aligned_cols=156  Identities=28%  Similarity=0.383  Sum_probs=126.4

Q ss_pred             cccccccccccccCceEEEEEEEcCCCcEEEEEEccCccChHHHHHHHHHHHHHHhcCCCCchhhhhhhHH---------
Q psy14630         23 SEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQFYGALF---------   93 (187)
Q Consensus        23 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~---------   93 (187)
                      .++|++.+.||+|+||.||+|.+..+++.||+|++...... ...+.+..+..+++.++||||+++++.+.         
T Consensus        13 ~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~-~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~   91 (676)
T 3qa8_A           13 CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSP-KNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPND   91 (676)
T ss_dssp             ----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCH-HHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTS
T ss_pred             CCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCH-HHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCC
Confidence            37899999999999999999999999999999998754333 33445556666778889999998754321         


Q ss_pred             --------------------------------HHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCC---EEEEeccc
Q psy14630         94 --------------------------------KEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGA---IKLCDFGI  138 (187)
Q Consensus        94 --------------------------------~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~---~ki~dfg~  138 (187)
                                                      ..++.+++.|+.|||+. +++||||||+||+++.++.   +||+|||+
T Consensus        92 ~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~-gIVHrDLKP~NILl~~~g~~~~vKL~DFG~  170 (676)
T 3qa8_A           92 LPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHEN-RIIHRDLKPENIVLQPGPQRLIHKIIDLGY  170 (676)
T ss_dssp             SCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHT-TBCCCCCCSTTEEEECCSSSCEEEECSCCC
T ss_pred             eEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHC-CCccCCCCHHHeEeecCCCceeEEEccccc
Confidence                                            12678899999999997 9999999999999987665   99999999


Q ss_pred             cccccccccccCCCCCcCccCccccCCCccCCCCCCcceeeeEee
Q psy14630        139 SGQLVDSIAKTRDAGCRPYMAPERIDPLRARGYPSFKTKLGFKFN  183 (187)
Q Consensus       139 a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi~  183 (187)
                      +.............||+.|+|||.+.   ...++.++|+||+|++
T Consensus       171 a~~~~~~~~~~~~~gt~~Y~APE~l~---~~~~s~ksDIwSLGvi  212 (676)
T 3qa8_A          171 AKELDQGELCTEFVGTLQYLAPELLE---QKKYTVTVDYWSFGTL  212 (676)
T ss_dssp             CCBTTSCCCCCCCCSCCTTCSSCSSC---CSCCSTTHHHHHHHHH
T ss_pred             ccccccccccccccCCcccCChHHhc---cCCCCchhHHHHHHHH
Confidence            99876655555668999999999998   6678999999999994

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens}

Probab=99.96  E-value=8.2e-31  Score=200.69  Aligned_cols=165  Identities=23%  Similarity=0.302  Sum_probs=122.0

Q ss_pred             CCCccccCCcccccccccccccCceEEEEEEEcCCCcEEEEEEccCccChHHHHHHHHHHHHHHhcCCCCchhhhhhhH-
Q psy14630         14 SPDTVYDFTSEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQFYGAL-   92 (187)
Q Consensus        14 ~~~~~~~~~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~-   92 (187)
                      .....|++..++|++.+.||+|+||.||+|.+..   .+|+|.++.........+.+.++..+++.++||||+++++.+ 
T Consensus        23 ~~~~~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~---~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~   99 (319)
T 2y4i_B           23 IFLQEWDIPFEQLEIGELIGKGRFGQVYHGRWHG---EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACM   99 (319)
T ss_dssp             CCGGGSSSCCSCEECCCBCCCSSSSEEEEEEESS---SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEE
T ss_pred             cccccccCCHHHeEEeeEeccCCceEEEEEEEcC---eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEe
Confidence            3457788999999999999999999999998853   489999864322222222334455567778999999887532 


Q ss_pred             --------------------------------HHHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEeccccc
Q psy14630         93 --------------------------------FKEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISG  140 (187)
Q Consensus        93 --------------------------------~~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg~a~  140 (187)
                                                      ...++.|++.||.|||+. +++||||||+||+++ ++.++|+|||+++
T Consensus       100 ~~~~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~-~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~  177 (319)
T 2y4i_B          100 SPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAK-GILHKDLKSKNVFYD-NGKVVITDFGLFS  177 (319)
T ss_dssp             CSSCEEEECBCCCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHHHT-TCCCCCCCSTTEEEC---CCEECCCSCCC
T ss_pred             cCCceEEEeecccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC-CccccCCChhhEEEe-CCCEEEeecCCcc
Confidence                                            122778999999999998 999999999999998 6899999999987


Q ss_pred             ccccc------ccccCCCCCcCccCccccCCCc------cCCCCCCcceeeeEee
Q psy14630        141 QLVDS------IAKTRDAGCRPYMAPERIDPLR------ARGYPSFKTKLGFKFN  183 (187)
Q Consensus       141 ~~~~~------~~~~~~~~t~~y~aPE~~~~~~------~~~~~~~~D~ws~gi~  183 (187)
                      .....      .......|++.|+|||.+.+..      ...++.++|+||||++
T Consensus       178 ~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~i  232 (319)
T 2y4i_B          178 ISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTI  232 (319)
T ss_dssp             ----------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHH
T ss_pred             ccccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHH
Confidence            65321      1122335888999999987421      2346789999999993

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A*

Probab=99.95  E-value=1.8e-30  Score=200.58  Aligned_cols=156  Identities=23%  Similarity=0.317  Sum_probs=117.3

Q ss_pred             cCCcccccccccccccCceEEEEEEEcCCCcEEEEEEccCccChHHHHHHHHHHHHHHhc--CCCCchhhhhhhH-----
Q psy14630         20 DFTSEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKS--NECPYIVQFYGAL-----   92 (187)
Q Consensus        20 ~~~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~--~~h~~iv~~~~~~-----   92 (187)
                      +...++|++.+.||+|+||.||+|.+  +++.||+|++....    ......+.. ++..  +.||||+++++.+     
T Consensus        38 ~~~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~----~~~~~~e~~-~~~~~~l~h~ni~~~~~~~~~~~~  110 (342)
T 1b6c_B           38 RTIARTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSRE----ERSWFREAE-IYQTVMLRHENILGFIAADNKDNG  110 (342)
T ss_dssp             HHHHHHCEEEEEEEEETTEEEEEEEE--TTEEEEEEEECGGG----HHHHHHHHH-HHHHSCCCCTTBCCEEEEEECCCS
T ss_pred             ccccccEEEEeeecCCCCcEEEEEEE--cCccEEEEEeCchh----HHHHHHHHH-HHHHhhcCCCcEEEEEeeecccCC
Confidence            34457899999999999999999987  48899999986321    222333333 3333  7899999876432     


Q ss_pred             ------------------------------HHHHHHHHHHHHHHHH--------hcCCCeeecCCCCCeEEcCCCCEEEE
Q psy14630         93 ------------------------------FKEVTVATVKALNYLK--------EELKIIHRDVKPSNILLDRRGAIKLC  134 (187)
Q Consensus        93 ------------------------------~~~~~~~~~~~l~~lh--------~~~~i~Hrdlk~~nili~~~~~~ki~  134 (187)
                                                    ...++.|++.||.|||        +. +++||||||+||+++.++.+||+
T Consensus       111 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~-~ivH~Dlkp~NIll~~~~~~kL~  189 (342)
T 1b6c_B          111 TWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKP-AIAHRDLKSKNILVKKNGTCCIA  189 (342)
T ss_dssp             SCCCEEEEECCCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBC-EEECSCCSGGGEEECTTSCEEEC
T ss_pred             ccceeEEEEeecCCCcHHHHHhccCccHHHHHHHHHHHHHHHHHHHHHHhhhcccC-CeeeCCCCHHHEEECCCCCEEEE
Confidence                                          1126778999999999        65 99999999999999999999999


Q ss_pred             eccccccccccc-----cccCCCCCcCccCccccCCCccC---CCCCCcceeeeEee
Q psy14630        135 DFGISGQLVDSI-----AKTRDAGCRPYMAPERIDPLRAR---GYPSFKTKLGFKFN  183 (187)
Q Consensus       135 dfg~a~~~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~---~~~~~~D~ws~gi~  183 (187)
                      |||+++......     ......||+.|+|||.+.+....   .++.++|+||||++
T Consensus       190 Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~i  246 (342)
T 1b6c_B          190 DLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLV  246 (342)
T ss_dssp             CCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHH
T ss_pred             ECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHH
Confidence            999998765432     22344789999999998742111   12368999999993

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A*

Probab=99.95  E-value=1.3e-29  Score=193.16  Aligned_cols=151  Identities=28%  Similarity=0.402  Sum_probs=118.3

Q ss_pred             ccccccccccCceEEEEEEEcCCCcEEEEEEccCcc--ChHHHHHHHHHHHHHHhcCCCCchhhhhhhHH----------
Q psy14630         26 LQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTV--DEKDQRQLLMDLDVVMKSNECPYIVQFYGALF----------   93 (187)
Q Consensus        26 ~~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~----------   93 (187)
                      |...+.||+|+||.||+|.+  +++.||+|.+....  ......+.+.++..+++.++||||+++++.+.          
T Consensus        33 ~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e  110 (307)
T 2nru_A           33 SVGGNKMGEGGFGVVYKGYV--NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYV  110 (307)
T ss_dssp             TTTCCEEEECSSEEEEEEES--SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred             cccCCccccCCCeEEEEEEE--CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCCeEEEEEEEecCCceEEEEE
Confidence            33458899999999999986  57889999986432  22234455666677788889999998864321          


Q ss_pred             -------------------------HHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEeccccccccccc--
Q psy14630         94 -------------------------KEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSI--  146 (187)
Q Consensus        94 -------------------------~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg~a~~~~~~~--  146 (187)
                                               ..++.+++.||.|||+. +++||||||+||+++.++.+||+|||+++......  
T Consensus       111 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~-~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~  189 (307)
T 2nru_A          111 YMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHEN-HHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQT  189 (307)
T ss_dssp             CCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCCGGGEEECTTCCEEECCCTTCEECCSCSSC
T ss_pred             ecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcC-CeecCCCCHHHEEEcCCCcEEEeeccccccccccccc
Confidence                                     12677899999999997 99999999999999999999999999988764321  


Q ss_pred             -cccCCCCCcCccCccccCCCccCCCCCCcceeeeEee
Q psy14630        147 -AKTRDAGCRPYMAPERIDPLRARGYPSFKTKLGFKFN  183 (187)
Q Consensus       147 -~~~~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi~  183 (187)
                       ......||+.|+|||.+.+    .++.++|+||+|++
T Consensus       190 ~~~~~~~g~~~y~aPE~~~~----~~~~~~Dv~slG~i  223 (307)
T 2nru_A          190 VMTSRIVGTTAYMAPEALRG----EITPKSDIYSFGVV  223 (307)
T ss_dssp             EECSSCCSCGGGCCHHHHTT----EECTHHHHHHHHHH
T ss_pred             ccccccCCCcCcCChHHhcC----CCCccchhHHHHHH
Confidence             2233468999999999873    37889999999994

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X*

Probab=99.95  E-value=3.5e-30  Score=199.49  Aligned_cols=157  Identities=24%  Similarity=0.382  Sum_probs=123.5

Q ss_pred             CCcccccccccccccCceEEEEEEEcCCCcEEEEEEccCccChH---------------HHHHHHHHHHHHHhcCCCCch
Q psy14630         21 FTSEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEK---------------DQRQLLMDLDVVMKSNECPYI   85 (187)
Q Consensus        21 ~~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~---------------~~~~~~~~~~~~~~~~~h~~i   85 (187)
                      ...++|++.+.||+|+||.||+|.+  +++.||+|.+.......               ...+.+.++..+++.++||||
T Consensus        28 ~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i  105 (348)
T 2pml_X           28 KYINDYRIIRTLNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYC  105 (348)
T ss_dssp             EEETTEEEEEEEECCSSCCEEEEEE--TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTB
T ss_pred             cccCceEEEEEEcCCCCeEEEEEEc--CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCc
Confidence            4467999999999999999999998  78999999985321100               001455666667888899999


Q ss_pred             hhhhhhH----------------------------------------HHHHHHHHHHHHHHHHh-cCCCeeecCCCCCeE
Q psy14630         86 VQFYGAL----------------------------------------FKEVTVATVKALNYLKE-ELKIIHRDVKPSNIL  124 (187)
Q Consensus        86 v~~~~~~----------------------------------------~~~~~~~~~~~l~~lh~-~~~i~Hrdlk~~nil  124 (187)
                      +++++.+                                        ...++.|++.|+.|||+ . +++|+||+|+||+
T Consensus       106 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~-~i~H~dl~p~Nil  184 (348)
T 2pml_X          106 LTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEK-NICHRDVKPSNIL  184 (348)
T ss_dssp             CCCSEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTS-CEECCCCCGGGEE
T ss_pred             ceEEEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccC-CEeecCCChHhEE
Confidence            9876431                                        11267899999999998 6 9999999999999


Q ss_pred             EcCCCCEEEEeccccccccccccccCCCCCcCccCccccCCCccCCCCC-CcceeeeEee
Q psy14630        125 LDRRGAIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPLRARGYPS-FKTKLGFKFN  183 (187)
Q Consensus       125 i~~~~~~ki~dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~-~~D~ws~gi~  183 (187)
                      ++.++.++|+|||++...... ......+++.|+|||.+.+  ...++. ++|+||+|++
T Consensus       185 ~~~~~~~kl~dfg~~~~~~~~-~~~~~~~~~~y~aPE~~~~--~~~~~~~~~Di~slG~i  241 (348)
T 2pml_X          185 MDKNGRVKLSDFGESEYMVDK-KIKGSRGTYEFMPPEFFSN--ESSYNGAKVDIWSLGIC  241 (348)
T ss_dssp             ECTTSCEEECCCTTCEECBTT-EECSSCSCGGGCCGGGGSS--CCCEEHHHHHHHHHHHH
T ss_pred             EcCCCcEEEeccccccccccc-cccCCCCCcCccCchhhcC--CCCCCcchhhHHHHHHH
Confidence            999999999999999876543 2334578999999999983  214555 9999999993

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A*

Probab=99.95  E-value=1.8e-29  Score=201.45  Aligned_cols=154  Identities=23%  Similarity=0.311  Sum_probs=110.6

Q ss_pred             ccccccccccccCceEEEEEEEcCCCcEEEEEEccCccChHHHHHHHHHHHHHHhcCCCCchhhhhhhHH----------
Q psy14630         24 EDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQFYGALF----------   93 (187)
Q Consensus        24 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~----------   93 (187)
                      +.|...+.||+|+||+||.+. ..+++.||||.+....    ......|...+.+..+||||+++++.+.          
T Consensus        15 ~~~~~~~~LG~G~~g~V~~~~-~~~g~~vAvK~~~~~~----~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E   89 (434)
T 2rio_A           15 NLVVSEKILGYGSSGTVVFQG-SFQGRPVAVKRMLIDF----CDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALE   89 (434)
T ss_dssp             SCEEEEEEEEECSTTCEEEEE-ESSSSEEEEEEEEGGG----HHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEEC
T ss_pred             heeeccCeEeeCCCeEEEEEE-EECCeEEEEEEEcHHH----HHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEe
Confidence            445556889999999998654 4678999999875321    1223334444444568999999874310          


Q ss_pred             ----------------------------HHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCC-------------CCEE
Q psy14630         94 ----------------------------KEVTVATVKALNYLKEELKIIHRDVKPSNILLDRR-------------GAIK  132 (187)
Q Consensus        94 ----------------------------~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~-------------~~~k  132 (187)
                                                  ..++.|++.||.|||+. +++||||||+||+++..             +.+|
T Consensus        90 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~-~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~k  168 (434)
T 2rio_A           90 LCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSL-KIIHRDLKPQNILVSTSSRFTADQQTGAENLRIL  168 (434)
T ss_dssp             CCSEEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEEECCHHHHSCCTTCCCSCEEE
T ss_pred             cCCCCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHC-CccccCCChHhEEEecCcccccccccCCCceEEE
Confidence                                        12678999999999998 99999999999999654             4799


Q ss_pred             EEecccccccccccc-----ccCCCCCcCccCccccCCCc----cCCCCCCcceeeeEee
Q psy14630        133 LCDFGISGQLVDSIA-----KTRDAGCRPYMAPERIDPLR----ARGYPSFKTKLGFKFN  183 (187)
Q Consensus       133 i~dfg~a~~~~~~~~-----~~~~~~t~~y~aPE~~~~~~----~~~~~~~~D~ws~gi~  183 (187)
                      |+|||+++.......     .....||+.|+|||++.+..    ...++.++|+||+|++
T Consensus       169 L~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~i  228 (434)
T 2rio_A          169 ISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCV  228 (434)
T ss_dssp             ECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHH
T ss_pred             EcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHH
Confidence            999999988754321     12346899999999997421    2568899999999993

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A

Probab=99.93  E-value=4.9e-27  Score=177.86  Aligned_cols=133  Identities=11%  Similarity=0.007  Sum_probs=106.4

Q ss_pred             CCcccccccccccccCceEEEEEEEcCCCcEEEEEEccCccC-hHHHHHHHHHHHHHHhcCCCCchhhhhhhHH------
Q psy14630         21 FTSEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVD-EKDQRQLLMDLDVVMKSNECPYIVQFYGALF------   93 (187)
Q Consensus        21 ~~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~------   93 (187)
                      +..++|++.+.||+|+||.||+|.+..+++.||+|++..... .....+.+.++...+..+.||||+++++.+.      
T Consensus        28 ~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~  107 (286)
T 3uqc_A           28 IANGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGL  107 (286)
T ss_dssp             ETTTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEE
T ss_pred             EecCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEE
Confidence            344789999999999999999999999999999999975432 2334445555666678889999999875321      


Q ss_pred             ------------------------HHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEecccccccccccccc
Q psy14630         94 ------------------------KEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKT  149 (187)
Q Consensus        94 ------------------------~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg~a~~~~~~~~~~  149 (187)
                                              ..+..|++.||.|||+. +++||||||+||+++.++.+||++++            
T Consensus       108 lv~e~~~g~~L~~~l~~~~~~~~~~~i~~ql~~aL~~lH~~-givH~Dikp~NIll~~~g~~kl~~~~------------  174 (286)
T 3uqc_A          108 VVAEWIRGGSLQEVADTSPSPVGAIRAMQSLAAAADAAHRA-GVALSIDHPSRVRVSIDGDVVLAYPA------------  174 (286)
T ss_dssp             EEEECCCEEEHHHHHTTCCCHHHHHHHHHHHHHHHHHHHHT-TCCCCCCSGGGEEEETTSCEEECSCC------------
T ss_pred             EEEEecCCCCHHHHHhcCCChHHHHHHHHHHHHHHHHHHHC-CCccCCCCcccEEEcCCCCEEEEecc------------
Confidence                                    12678999999999998 99999999999999999999987433            


Q ss_pred             CCCCCcCccCccccCCCccCCCCCCcceeeeEee
Q psy14630        150 RDAGCRPYMAPERIDPLRARGYPSFKTKLGFKFN  183 (187)
Q Consensus       150 ~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi~  183 (187)
                             |++|          ++.++|+||+|++
T Consensus       175 -------~~~~----------~~~~~Di~slG~i  191 (286)
T 3uqc_A          175 -------TMPD----------ANPQDDIRGIGAS  191 (286)
T ss_dssp             -------CCTT----------CCHHHHHHHHHHH
T ss_pred             -------ccCC----------CCchhHHHHHHHH
Confidence                   3332          5689999999994

>4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A*

Probab=99.92  E-value=4.3e-27  Score=193.17  Aligned_cols=149  Identities=12%  Similarity=-0.015  Sum_probs=94.0

Q ss_pred             cccccccCceEEEEEEEcCCCcEEEEEEccCcc-----Ch---HHHHHHHHHHHHHHhcC-CCCchhhhhhhHH------
Q psy14630         29 LGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTV-----DE---KDQRQLLMDLDVVMKSN-ECPYIVQFYGALF------   93 (187)
Q Consensus        29 ~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~-----~~---~~~~~~~~~~~~~~~~~-~h~~iv~~~~~~~------   93 (187)
                      ....+.|++|.+..++....++.+|+|++....     ..   ....+.+.++..+++.+ .|+||+++++++.      
T Consensus       239 ~~~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~y  318 (569)
T 4azs_A          239 QNQPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGW  318 (569)
T ss_dssp             ECC-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEE
T ss_pred             hhccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEE
Confidence            356778888888777777788999999985431     11   11223345555555554 7999999886431      


Q ss_pred             -----------------------HHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEecccccccccc-cccc
Q psy14630         94 -----------------------KEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDS-IAKT  149 (187)
Q Consensus        94 -----------------------~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg~a~~~~~~-~~~~  149 (187)
                                             ..++.|++.||+|+|++ ||+||||||+|||++.+|.+||+|||+|+..... ....
T Consensus       319 LVMEyv~G~~L~d~i~~~~~l~~~~I~~QIl~AL~ylH~~-GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~~~~~~  397 (569)
T 4azs_A          319 LVMEKLPGRLLSDMLAAGEEIDREKILGSLLRSLAALEKQ-GFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQDCSWPT  397 (569)
T ss_dssp             EEEECCCSEEHHHHHHTTCCCCHHHHHHHHHHHHHHHHHT-TCEESCCCGGGEEECTTSCEEECCCTTEESCC---CCSH
T ss_pred             EEEecCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHC-CceeccCchHhEEECCCCCEEEeecccCeeCCCCCcccc
Confidence                                   23888999999999998 9999999999999999999999999999877543 2233


Q ss_pred             CCCCCcCccCccccCCCccCCCCCCcceeeeEe
Q psy14630        150 RDAGCRPYMAPERIDPLRARGYPSFKTKLGFKF  182 (187)
Q Consensus       150 ~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi  182 (187)
                      ..+||+.|||||++.+    .+..++|+|++|+
T Consensus       398 t~vGTp~YmAPE~l~g----~~~~~~d~~s~g~  426 (569)
T 4azs_A          398 NLVQSFFVFVNELFAE----NKSWNGFWRSAPV  426 (569)
T ss_dssp             HHHHHHHHHHHHHC-------------------
T ss_pred             CceechhhccHHHhCC----CCCCccccccccc
Confidence            4479999999999883    2567899999998

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A*

Probab=99.92  E-value=7.3e-26  Score=172.11  Aligned_cols=130  Identities=23%  Similarity=0.396  Sum_probs=102.8

Q ss_pred             ccccccc-ccccccCceEEEEEEEcCCCcEEEEEEccCccChHHHHHHHHHHHHHHhcCCCCchhhhhhhHH--------
Q psy14630         23 SEDLQDL-GEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQFYGALF--------   93 (187)
Q Consensus        23 ~~~~~~~-~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~--------   93 (187)
                      .++|.+. +.||+|+||.||+|.+..+++.||+|.++..      .....+...+.+..+||||+++++.+.        
T Consensus        16 ~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~   89 (299)
T 3m2w_A           16 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC------PKARREVELHWRASQCPHIVRIVDVYENLYAGRKC   89 (299)
T ss_dssp             GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEE
T ss_pred             ccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc------HHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCce
Confidence            4677777 7799999999999999999999999998632      122333444456779999998764321        


Q ss_pred             ------------------------------HHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcC---CCCEEEEeccccc
Q psy14630         94 ------------------------------KEVTVATVKALNYLKEELKIIHRDVKPSNILLDR---RGAIKLCDFGISG  140 (187)
Q Consensus        94 ------------------------------~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~---~~~~ki~dfg~a~  140 (187)
                                                    ..++.|++.||.|||+. +++||||||+||+++.   ++.+||+|||++.
T Consensus        90 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~-~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a~  168 (299)
T 3m2w_A           90 LLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI-NIAHRDVKPENLLYTSKRPNAILKLTDFGFAK  168 (299)
T ss_dssp             EEEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEESSSSTTCCEEECCCTTCE
T ss_pred             EEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhC-CcccCCCCHHHEEEecCCCCCcEEEecccccc
Confidence                                          12678899999999998 9999999999999988   7889999999885


Q ss_pred             cccccccccCCCCCcCccCccccCCCccCCCCCCcceeeeEee
Q psy14630        141 QLVDSIAKTRDAGCRPYMAPERIDPLRARGYPSFKTKLGFKFN  183 (187)
Q Consensus       141 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi~  183 (187)
                      ...                        ...++.++|+||+|++
T Consensus       169 ~~~------------------------~~~~~~~~DiwslG~i  187 (299)
T 3m2w_A          169 ETT------------------------GEKYDKSCDMWSLGVI  187 (299)
T ss_dssp             ECT------------------------TCGGGGHHHHHHHHHH
T ss_pred             ccc------------------------cccCCchhhHHHHHHH
Confidence            432                        1235678999999994

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A*

Probab=99.89  E-value=1.3e-24  Score=177.46  Aligned_cols=148  Identities=15%  Similarity=0.131  Sum_probs=105.7

Q ss_pred             cccccccCceEEEEEEEcCCCcEEEEEEccCcc-C-h----HHHHHHHHHHHHHHhcCCCCchh--hhhhh---------
Q psy14630         29 LGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTV-D-E----KDQRQLLMDLDVVMKSNECPYIV--QFYGA---------   91 (187)
Q Consensus        29 ~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~-~-~----~~~~~~~~~~~~~~~~~~h~~iv--~~~~~---------   91 (187)
                      .+.||+|+||.||+|.  ..+..+++|...... . .    ....+.+.++..+++.++||||+  .+++.         
T Consensus       341 ~~~LG~G~fg~Vy~~~--~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lVm  418 (540)
T 3en9_A          341 EHLIGKGAEADIKRDS--YLDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIMM  418 (540)
T ss_dssp             -------CCEEEEEEE--CSSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEEE
T ss_pred             CCEEeeCCCEEEEEEE--ECCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEEE
Confidence            4689999999999994  346788999864321 1 1    11234456677778888999999  43321         


Q ss_pred             -------H------HHHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEecccccccccccc--------ccC
Q psy14630         92 -------L------FKEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIA--------KTR  150 (187)
Q Consensus        92 -------~------~~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg~a~~~~~~~~--------~~~  150 (187)
                             +      ...+..|++.+|.|||+. +|+||||||+||+++.  .+||+|||+++.......        ...
T Consensus       419 E~~~ggsL~~~l~~~~~i~~qi~~aL~~LH~~-gIiHrDiKp~NILl~~--~~kL~DFGla~~~~~~~~~~~~~~~~~~~  495 (540)
T 3en9_A          419 SYINGKLAKDVIEDNLDIAYKIGEIVGKLHKN-DVIHNDLTTSNFIFDK--DLYIIDFGLGKISNLDEDKAVDLIVFKKA  495 (540)
T ss_dssp             ECCCSEEHHHHSTTCTHHHHHHHHHHHHHHHT-TEECTTCCTTSEEESS--SEEECCCTTCEECCCHHHHHHHHHHHHHH
T ss_pred             ECCCCCCHHHHHHHHHHHHHHHHHHHHHHHHC-cCccCCCCHHHEEECC--eEEEEECccCEECCCccccccchhhhhhh
Confidence                   1      124788999999999998 9999999999999998  999999999998765322        124


Q ss_pred             CCCCcCccCccccCCCccCCCCCCcceeeeEe
Q psy14630        151 DAGCRPYMAPERIDPLRARGYPSFKTKLGFKF  182 (187)
Q Consensus       151 ~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi  182 (187)
                      ..||+.|||||++... ..+|+..+|+|+.++
T Consensus       496 ~~GT~~y~APEv~~~~-~~~Y~~~~d~ws~vl  526 (540)
T 3en9_A          496 VLSTHHEKFDEIWERF-LEGYKSVYDRWEIIL  526 (540)
T ss_dssp             HHHHCGGGHHHHHHHH-HHHHHHHCTTHHHHH
T ss_pred             hcCCCCcCCHHHHHHH-HHHHHHHHhHHHHHH
Confidence            5789999999999832 256788899998654

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A*

Probab=99.83  E-value=5.2e-21  Score=144.51  Aligned_cols=120  Identities=15%  Similarity=0.057  Sum_probs=88.3

Q ss_pred             ccccccCceEEEEEEEcCCCcEEEEEEccCccChH----------------HHHHHHHHHHHHHhcCCCCchhhhhh---
Q psy14630         30 GEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEK----------------DQRQLLMDLDVVMKSNECPYIVQFYG---   90 (187)
Q Consensus        30 ~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~----------------~~~~~~~~~~~~~~~~~h~~iv~~~~---   90 (187)
                      +.||+|+||.||+|.+ .+++.||+|.++......                .....+..+..+++.++|+++...++   
T Consensus        96 ~~iG~G~~g~Vy~~~~-~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~~~~v~~~~~~~~  174 (282)
T 1zar_A           96 KLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAWEG  174 (282)
T ss_dssp             EEEEECSSEEEEEEEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEEET
T ss_pred             CEeccCCCceEEEEEe-CCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhccCCCcCeEEeccc
Confidence            9999999999999999 889999999986321110                12333445555555555444443321   


Q ss_pred             -----------h-------HHHHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEeccccccccccccccCCC
Q psy14630         91 -----------A-------LFKEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTRDA  152 (187)
Q Consensus        91 -----------~-------~~~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg~a~~~~~~~~~~~~~  152 (187)
                                 .       ....+..|++.|+.|||+. +++||||||+||+++ ++.+||+|||+++.           
T Consensus       175 ~~lvmE~~~g~~L~~l~~~~~~~i~~qi~~~l~~lH~~-giiHrDlkp~NILl~-~~~vkl~DFG~a~~-----------  241 (282)
T 1zar_A          175 NAVLMELIDAKELYRVRVENPDEVLDMILEEVAKFYHR-GIVHGDLSQYNVLVS-EEGIWIIDFPQSVE-----------  241 (282)
T ss_dssp             TEEEEECCCCEEGGGCCCSCHHHHHHHHHHHHHHHHHT-TEECSCCSTTSEEEE-TTEEEECCCTTCEE-----------
T ss_pred             eEEEEEecCCCcHHHcchhhHHHHHHHHHHHHHHHHHC-CCEeCCCCHHHEEEE-CCcEEEEECCCCeE-----------
Confidence                       0       1234788999999999997 999999999999999 99999999999864           


Q ss_pred             CCcCccCccccC
Q psy14630        153 GCRPYMAPERID  164 (187)
Q Consensus       153 ~t~~y~aPE~~~  164 (187)
                       +..++|||.+.
T Consensus       242 -~~~~~a~e~l~  252 (282)
T 1zar_A          242 -VGEEGWREILE  252 (282)
T ss_dssp             -TTSTTHHHHHH
T ss_pred             -CCCCCHHHHHH
Confidence             34567888775

>1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A*

Probab=99.73  E-value=2e-17  Score=123.33  Aligned_cols=115  Identities=20%  Similarity=0.131  Sum_probs=79.6

Q ss_pred             ccccccccccCceEEEEEEEcCCCcE--EEEEEccCccCh----------------------HHHHHHHHHHHHHHhcCC
Q psy14630         26 LQDLGEIGRGGFGTVNKMIHRSSDTV--MAVKRIRSTVDE----------------------KDQRQLLMDLDVVMKSNE   81 (187)
Q Consensus        26 ~~~~~~lg~G~fg~V~~~~~~~~~~~--vaiK~~~~~~~~----------------------~~~~~~~~~~~~~~~~~~   81 (187)
                      |.+.+.||+|+||.||+|.+..+++.  ||||+++.....                      ......+..+...+..+.
T Consensus        49 ~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~  128 (258)
T 1zth_A           49 TAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAK  128 (258)
T ss_dssp             EEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHH
T ss_pred             hhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHH
Confidence            56778999999999999998778888  999987532110                      011123333433443333


Q ss_pred             C-----Cchhh---------hhh-------h-----------HHHHHHHHHHHHHHHHH-hcCCCeeecCCCCCeEEcCC
Q psy14630         82 C-----PYIVQ---------FYG-------A-----------LFKEVTVATVKALNYLK-EELKIIHRDVKPSNILLDRR  128 (187)
Q Consensus        82 h-----~~iv~---------~~~-------~-----------~~~~~~~~~~~~l~~lh-~~~~i~Hrdlk~~nili~~~  128 (187)
                      |     |.++.         +.+       .           ....+..|++.++.||| +. +++||||||+|||++. 
T Consensus       129 ~~~i~~p~~~~~~~~~lVmE~~g~~g~~~~~L~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~-givHrDlkp~NILl~~-  206 (258)
T 1zth_A          129 EAGVSVPQPYTYMKNVLLMEFIGEDELPAPTLVELGRELKELDVEGIFNDVVENVKRLYQEA-ELVHADLSEYNIMYID-  206 (258)
T ss_dssp             HTTCCCCCEEEEETTEEEEECCEETTEECCBHHHHGGGGGGSCHHHHHHHHHHHHHHHHHTS-CEECSSCSTTSEEESS-
T ss_pred             hCCCCCCeEEEcCCCEEEEEecCCCCCccccHHHHhhccChHHHHHHHHHHHHHHHHHHHHC-CEEeCCCCHHHEEEcC-
Confidence            3     32221         111       1           12246789999999999 76 9999999999999988 


Q ss_pred             CCEEEEecccccccc
Q psy14630        129 GAIKLCDFGISGQLV  143 (187)
Q Consensus       129 ~~~ki~dfg~a~~~~  143 (187)
                       .++|+|||+|....
T Consensus       207 -~~~liDFG~a~~~~  220 (258)
T 1zth_A          207 -KVYFIDMGQAVTLR  220 (258)
T ss_dssp             -SEEECCCTTCEETT
T ss_pred             -cEEEEECcccccCC
Confidence             99999999997653

>4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A

Probab=99.60  E-value=3.7e-16  Score=122.11  Aligned_cols=115  Identities=12%  Similarity=0.088  Sum_probs=73.6

Q ss_pred             ccccccccccCceEEEEEEEcCCCcEEEEEEccCccC-------------hHHHHHH--------HHHHHHHHhc----C
Q psy14630         26 LQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVD-------------EKDQRQL--------LMDLDVVMKS----N   80 (187)
Q Consensus        26 ~~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~~-------------~~~~~~~--------~~~~~~~~~~----~   80 (187)
                      |++...||+|+||.||+|.+ .+|+.||||+++....             ......+        ..+...+.+.    .
T Consensus        97 Y~I~~~IG~Gk~a~VY~a~d-~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv  175 (397)
T 4gyi_A           97 YSVGSRIGVGKESDIMIVAD-EKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGF  175 (397)
T ss_dssp             SEEEEEEEECSSEEEEEEEC-TTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred             EEecCEeeeCCceEEEEEEC-CCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCC
Confidence            66788999999999999998 4689999998753110             0000011        1111111111    1


Q ss_pred             CCCchh---------hhhh----------hHHHHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCC----------CE
Q psy14630         81 ECPYIV---------QFYG----------ALFKEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRG----------AI  131 (187)
Q Consensus        81 ~h~~iv---------~~~~----------~~~~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~----------~~  131 (187)
                      ..|..+         .+.+          .-...+..|++.++.+||+. +++||||||.|||++.++          .+
T Consensus       176 ~vp~p~~~~~~~LVME~i~G~~L~~l~~~~~~~~l~~qll~~l~~lH~~-gIVHrDLKp~NILl~~dgd~~d~~~~~~~~  254 (397)
T 4gyi_A          176 PVPEPIAQSRHTIVMSLVDALPMRQVSSVPDPASLYADLIALILRLAKH-GLIHGDFNEFNILIREEKDAEDPSSITLTP  254 (397)
T ss_dssp             SCCCEEEEETTEEEEECCSCEEGGGCCCCSCHHHHHHHHHHHHHHHHHT-TEECSCCSTTSEEEEEEECSSCTTSEEEEE
T ss_pred             CCCeeeeccCceEEEEecCCccHhhhcccHHHHHHHHHHHHHHHHHHHC-CCcCCCCCHHHEEEeCCCCcccccccccce
Confidence            111100         0000          01234778999999999997 999999999999998766          38


Q ss_pred             EEEeccccccc
Q psy14630        132 KLCDFGISGQL  142 (187)
Q Consensus       132 ki~dfg~a~~~  142 (187)
                      .|+||+-+...
T Consensus       255 ~iID~~Q~V~~  265 (397)
T 4gyi_A          255 IIIXFPQMVSM  265 (397)
T ss_dssp             EECCCTTCEET
T ss_pred             EEEEeCCcccC
Confidence            99999976543

>3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A*

Probab=98.43  E-value=2.1e-07  Score=68.74  Aligned_cols=114  Identities=14%  Similarity=0.087  Sum_probs=71.4

Q ss_pred             ccccccccccccCceEEEEEEEcCCCcEEEEEEccCccChHHHHHHHHHHHHHHhcC-CCCchhhhhhh-----------
Q psy14630         24 EDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSN-ECPYIVQFYGA-----------   91 (187)
Q Consensus        24 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~-~h~~iv~~~~~-----------   91 (187)
                      .+|++...++.|+.+.||++...  +..+++|.........  ...+..+...++.+ .+..+.++++.           
T Consensus        14 ~~~~~~~~~~g~s~~~v~~~~~~--~~~~vlK~~~~~~~~~--~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~   89 (263)
T 3tm0_A           14 EKYRCVKDTEGMSPAKVYKLVGE--NENLYLKMTDSRYKGT--TYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLM   89 (263)
T ss_dssp             TTSEEEECCSCCSSSEEEEEECS--SCEEEEEEECGGGTTS--TTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEE
T ss_pred             ccceeEeeccCCCCCeEEEEECC--CCcEEEEeCCcccCCC--HHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEE
Confidence            46778888888999999998753  5789999975321000  01122222222222 12233222210           


Q ss_pred             -------H---------HHHHHHHHHHHHHHHHhc---------------------------------------------
Q psy14630         92 -------L---------FKEVTVATVKALNYLKEE---------------------------------------------  110 (187)
Q Consensus        92 -------~---------~~~~~~~~~~~l~~lh~~---------------------------------------------  110 (187)
                             +         ...+..++..++..||+.                                             
T Consensus        90 e~i~G~~l~~~~~~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  169 (263)
T 3tm0_A           90 SEADGVLCSEEYEDEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDPRE  169 (263)
T ss_dssp             ECCSSEEHHHHCCTTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTCSSSSHHH
T ss_pred             EecCCeehhhccCCcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccccccCCCHHH
Confidence                   0         113567788889999971                                             


Q ss_pred             -------------CCCeeecCCCCCeEEcCCCCEEEEecccccc
Q psy14630        111 -------------LKIIHRDVKPSNILLDRRGAIKLCDFGISGQ  141 (187)
Q Consensus       111 -------------~~i~Hrdlk~~nili~~~~~~ki~dfg~a~~  141 (187)
                                   ..++|+|+++.||+++..+.+.|+||+.+..
T Consensus       170 l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~~  213 (263)
T 3tm0_A          170 LYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR  213 (263)
T ss_dssp             HHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCEE
T ss_pred             HHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhccc
Confidence                         1489999999999998755567999998765

>1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6

Probab=98.14  E-value=1e-05  Score=59.21  Aligned_cols=30  Identities=23%  Similarity=0.297  Sum_probs=25.8

Q ss_pred             CeeecCCCCCeEEcCCCCEEEEeccccccc
Q psy14630        113 IIHRDVKPSNILLDRRGAIKLCDFGISGQL  142 (187)
Q Consensus       113 i~Hrdlk~~nili~~~~~~ki~dfg~a~~~  142 (187)
                      ++|+|++|.||+++..+.+.++||+.+...
T Consensus       186 l~HgDl~~~Nil~~~~~~~~liD~~~a~~g  215 (264)
T 1nd4_A          186 VTHGDACLPNIMVENGRFSGFIDCGRLGVA  215 (264)
T ss_dssp             EECSSCCGGGEEEETTEEEEECCCTTCEEE
T ss_pred             EECCCCCCCcEEEECCcEEEEEcchhcccC
Confidence            899999999999987666679999987653

>3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134}

Probab=97.87  E-value=1.9e-05  Score=60.95  Aligned_cols=31  Identities=19%  Similarity=0.378  Sum_probs=26.3

Q ss_pred             CCeeecCCCCCeEEcCCCC--EEEEeccccccc
Q psy14630        112 KIIHRDVKPSNILLDRRGA--IKLCDFGISGQL  142 (187)
Q Consensus       112 ~i~Hrdlk~~nili~~~~~--~ki~dfg~a~~~  142 (187)
                      .++|+|+++.||+++.++.  +.++||+.+..-
T Consensus       217 ~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~g  249 (359)
T 3dxp_A          217 SIVHGDYRLDNLMFHPTEPRVLAVLDWELSTLG  249 (359)
T ss_dssp             EEECSSCSGGGEEECSSSSCEEEECCCTTCEEE
T ss_pred             eEEeCCCCCCcEEEeCCCCcEEEEECccccccC
Confidence            5899999999999987653  689999988753

>4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A*

Probab=96.15  E-value=0.013  Score=42.88  Aligned_cols=29  Identities=28%  Similarity=0.424  Sum_probs=25.6

Q ss_pred             CeeecCCCCCeEEcCCCCEEEEecccccc
Q psy14630        113 IIHRDVKPSNILLDRRGAIKLCDFGISGQ  141 (187)
Q Consensus       113 i~Hrdlk~~nili~~~~~~ki~dfg~a~~  141 (187)
                      ++|+|+.+.|++++..+.+-|+||+.+..
T Consensus       195 l~HGDl~~~Nil~~~~~~~~viDwe~a~~  223 (272)
T 4gkh_A          195 VTHGDFSLDNLIFDEGKLIGCIDVGRVGI  223 (272)
T ss_dssp             EECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred             EEcCCCCCCeEEEECCeEEEEEECccccc
Confidence            78999999999999877677999998765

>2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis}

Probab=95.51  E-value=0.018  Score=43.53  Aligned_cols=31  Identities=23%  Similarity=0.280  Sum_probs=27.5

Q ss_pred             CCCeeecCCCCCeEEcCCCCEEEEecccccc
Q psy14630        111 LKIIHRDVKPSNILLDRRGAIKLCDFGISGQ  141 (187)
Q Consensus       111 ~~i~Hrdlk~~nili~~~~~~ki~dfg~a~~  141 (187)
                      ..++|+|+.+.|++++..+.+.++||+.+..
T Consensus       222 ~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~~  252 (346)
T 2q83_A          222 PNLCHQDYGTGNTLLGENEQIWVIDLDTVSF  252 (346)
T ss_dssp             CCEECSSCSTTSEEECGGGCEEECCCTTCEE
T ss_pred             CceecCCCCcccEEEeCCCcEEEEehhhccc
Confidence            4799999999999998778899999998754

>3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX}

Probab=93.97  E-value=0.051  Score=40.26  Aligned_cols=33  Identities=15%  Similarity=0.152  Sum_probs=26.0

Q ss_pred             ccccccccccCceEEEEEEEcCCCcEEEEEEccC
Q psy14630         26 LQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRS   59 (187)
Q Consensus        26 ~~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~   59 (187)
                      ..-.+.+|.|..+.||+... .+|+.+.+|+...
T Consensus        17 v~~v~~~g~G~~~~vyrv~l-~DG~~~~vK~~~~   49 (288)
T 3f7w_A           17 VAAVAERGHSHRWHLYRVEL-ADGTPLFVKALPD   49 (288)
T ss_dssp             EEEEEEEEEETTEEEEEEEE-TTSCEEEEEECCT
T ss_pred             eEEEEecCCCCCeEEEEEEE-CCCCEEEEEEeCC
Confidence            34457789999999999876 5678899998653

>2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana}

Probab=93.15  E-value=0.034  Score=43.68  Aligned_cols=30  Identities=17%  Similarity=0.255  Sum_probs=26.4

Q ss_pred             CCeeecCCCCCeEEcCCCCEEEEeccccccc
Q psy14630        112 KIIHRDVKPSNILLDRRGAIKLCDFGISGQL  142 (187)
Q Consensus       112 ~i~Hrdlk~~nili~~~~~~ki~dfg~a~~~  142 (187)
                      .++|+|+++.||+++.++ +.++||+.+..-
T Consensus       233 ~liHGDl~~~Nil~~~~~-~~lID~e~a~~G  262 (420)
T 2pyw_A          233 ALIHGDLHTGSVMVTQDS-TQVIDPEFSFYG  262 (420)
T ss_dssp             EEECSCCSGGGEEECSSC-EEECCCTTCEEE
T ss_pred             eEEecCCCCCcEEEeCCC-CEEEeCcccccC
Confidence            689999999999998776 999999887653

>3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A

Probab=93.07  E-value=0.025  Score=42.30  Aligned_cols=31  Identities=29%  Similarity=0.451  Sum_probs=26.1

Q ss_pred             CCeeecCCCCCeEEcC--CCCEEEEeccccccc
Q psy14630        112 KIIHRDVKPSNILLDR--RGAIKLCDFGISGQL  142 (187)
Q Consensus       112 ~i~Hrdlk~~nili~~--~~~~ki~dfg~a~~~  142 (187)
                      .++|+|+++.|++++.  ...+.++||+.+..-
T Consensus       192 ~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~  224 (304)
T 3sg8_A          192 CLIHNDFSSDHILFDTEKNTICGIIDFGDAAIS  224 (304)
T ss_dssp             EEECSCCCGGGEEEETTTTEEEEECCCTTCEEE
T ss_pred             eeEeCCCCcccEEEeCCCCCEEEEEeCCCCccC
Confidence            3799999999999987  456789999987653

>3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A

Probab=92.63  E-value=0.008  Score=48.09  Aligned_cols=60  Identities=8%  Similarity=0.070  Sum_probs=14.9

Q ss_pred             ccccccccCceEEEEEEEcCCCcEEEE------EEccCccChHHHHHHHHHHHHHHhcCCCCchhhhhh
Q psy14630         28 DLGEIGRGGFGTVNKMIHRSSDTVMAV------KRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQFYG   90 (187)
Q Consensus        28 ~~~~lg~G~fg~V~~~~~~~~~~~vai------K~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~   90 (187)
                      +.+.||   ||.||++.......+||+      |..+...........+..+..+++..+|||+++.++
T Consensus       146 l~~~lG---fG~v~~g~~~~~~~~Vav~~~~~~K~~~~~~~~~e~~~~~~rea~l~~~~~H~niv~~h~  211 (463)
T 3cxl_A          146 IYEHVG---YTTLNREPAYKKHMPVLKETHDERDSTGQDGVSEKRLTSLVRRATLKENEQIPKYEKIHN  211 (463)
T ss_dssp             STTTSS---BCCC---------CCBGGGC-----------------------------------CBCCC
T ss_pred             ccccCC---chhhhcccccccCCchhhhhccCccccccccccccccccccccccccccccccccCCCcc
Confidence            345666   999999988655567888      665432222222233444555667778999988764

>2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6

Probab=91.68  E-value=0.047  Score=40.95  Aligned_cols=30  Identities=23%  Similarity=0.302  Sum_probs=25.6

Q ss_pred             CCeeecCCCCCeEEcCCCCEEEEecccccc
Q psy14630        112 KIIHRDVKPSNILLDRRGAIKLCDFGISGQ  141 (187)
Q Consensus       112 ~i~Hrdlk~~nili~~~~~~ki~dfg~a~~  141 (187)
                      +++|+|+.+.|++++.++.+.++||+.+..
T Consensus       188 ~liHgDl~~~Nil~~~~~~~~lIDf~~a~~  217 (322)
T 2ppq_A          188 GVIHADLFQDNVFFLGDELSGLIDFYFACN  217 (322)
T ss_dssp             EEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             ccCCCCCCccCEEEeCCceEEEecchhccC
Confidence            589999999999998766568999987754

>3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP}

Probab=91.36  E-value=0.067  Score=40.42  Aligned_cols=30  Identities=23%  Similarity=0.360  Sum_probs=26.3

Q ss_pred             CCeeecCCCCCeEEcCC----CCEEEEecccccc
Q psy14630        112 KIIHRDVKPSNILLDRR----GAIKLCDFGISGQ  141 (187)
Q Consensus       112 ~i~Hrdlk~~nili~~~----~~~ki~dfg~a~~  141 (187)
                      .++|+|+.+.|++++.+    +.+.++||+.+..
T Consensus       184 ~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~  217 (333)
T 3csv_A          184 VFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL  217 (333)
T ss_dssp             EEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred             eeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence            68999999999999874    6799999998765

>3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A*

Probab=91.03  E-value=0.057  Score=41.17  Aligned_cols=30  Identities=13%  Similarity=0.285  Sum_probs=25.4

Q ss_pred             CCeeecCCCCCeEEcCCCCEEEEecccccc
Q psy14630        112 KIIHRDVKPSNILLDRRGAIKLCDFGISGQ  141 (187)
Q Consensus       112 ~i~Hrdlk~~nili~~~~~~ki~dfg~a~~  141 (187)
                      .++|+|+.+.|++++....+.|+||+.+..
T Consensus       223 ~l~HgDl~~~Nil~~~~~~~~vIDwe~a~~  252 (357)
T 3ats_A          223 VLLWGDARVGNVLYRDFQPVAVLDWEMVAL  252 (357)
T ss_dssp             EEECSSCSGGGEEEETTEEEEECCGGGCEE
T ss_pred             eEEeCCCCCCeEEEeCCcEEEEEccccccc
Confidence            689999999999998644578999998765

>3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A*

Probab=90.85  E-value=0.085  Score=39.52  Aligned_cols=31  Identities=26%  Similarity=0.505  Sum_probs=25.4

Q ss_pred             CCeeecCCCCCeEEcC---CCC-EEEEeccccccc
Q psy14630        112 KIIHRDVKPSNILLDR---RGA-IKLCDFGISGQL  142 (187)
Q Consensus       112 ~i~Hrdlk~~nili~~---~~~-~ki~dfg~a~~~  142 (187)
                      .++|+|+++.|++++.   .+. +.|+||+.+..-
T Consensus       191 ~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~g  225 (306)
T 3tdw_A          191 RLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAIS  225 (306)
T ss_dssp             EEECSCCSGGGEEECTTCSSCCEEEECCCTTCEEE
T ss_pred             eeEeCCCCcccEEEecCCCCCceEEEEehhhcCCC
Confidence            4699999999999987   455 479999977653

>1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6

Probab=89.35  E-value=0.13  Score=38.62  Aligned_cols=28  Identities=21%  Similarity=0.265  Sum_probs=24.3

Q ss_pred             CCeeecCCCCCeEEcCCCCEEEEecccccc
Q psy14630        112 KIIHRDVKPSNILLDRRGAIKLCDFGISGQ  141 (187)
Q Consensus       112 ~i~Hrdlk~~nili~~~~~~ki~dfg~a~~  141 (187)
                      .++|+|+++.|++++ + .+.++||+.+..
T Consensus       196 ~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~  223 (328)
T 1zyl_A          196 LRLHGDCHAGNILWR-D-GPMFVDLDDARN  223 (328)
T ss_dssp             EECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred             eeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence            478999999999998 4 899999987654

>3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A*

Probab=89.21  E-value=0.15  Score=39.12  Aligned_cols=29  Identities=31%  Similarity=0.533  Sum_probs=24.2

Q ss_pred             CCeeecCCCCCeEEcCCCCEEEEecccccc
Q psy14630        112 KIIHRDVKPSNILLDRRGAIKLCDFGISGQ  141 (187)
Q Consensus       112 ~i~Hrdlk~~nili~~~~~~ki~dfg~a~~  141 (187)
                      .++|+|+.+.|++++..+ +.++||..+..
T Consensus       213 ~l~HgDl~~~Nil~~~~~-~~lID~e~a~~  241 (369)
T 3c5i_A          213 VFCHNDLQENNIINTNKC-LRLIDFEYSGF  241 (369)
T ss_dssp             EEECSCCCGGGEEECC-C-EEECCCTTCEE
T ss_pred             EEEeCCCCcccEEecCCc-EEEEEecCCCC
Confidence            589999999999997654 89999987764

>3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti}

Probab=88.63  E-value=0.16  Score=37.81  Aligned_cols=29  Identities=28%  Similarity=0.308  Sum_probs=24.7

Q ss_pred             CCeeecCCCCCeEEcCCCCEEEEecccccc
Q psy14630        112 KIIHRDVKPSNILLDRRGAIKLCDFGISGQ  141 (187)
Q Consensus       112 ~i~Hrdlk~~nili~~~~~~ki~dfg~a~~  141 (187)
                      .++|+|+.+.|++ ..++.+.++||..+..
T Consensus       174 ~l~HgDl~~~Nil-~~~~~~~lID~e~a~~  202 (301)
T 3dxq_A          174 AACHCDPLCENFL-DTGERMWIVDWEYSGM  202 (301)
T ss_dssp             EEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred             eeeccCCCcCCEE-ECCCCEEEEecccccC
Confidence            3799999999999 5667889999987764

>3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A*

Probab=88.18  E-value=0.14  Score=38.90  Aligned_cols=31  Identities=19%  Similarity=0.347  Sum_probs=27.2

Q ss_pred             CCeeecCCCCCeEEcCCCCEEEEeccccccc
Q psy14630        112 KIIHRDVKPSNILLDRRGAIKLCDFGISGQL  142 (187)
Q Consensus       112 ~i~Hrdlk~~nili~~~~~~ki~dfg~a~~~  142 (187)
                      .++|+|+.+.|++++.++.+.++||+.+..-
T Consensus       207 ~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~~  237 (339)
T 3i1a_A          207 VLCHSDIHAGNVLVGNEESIYIIDWDEPMLA  237 (339)
T ss_dssp             EEECSCCCGGGEEECGGGCEEECCCSSCEEE
T ss_pred             eeEeCCCCcCCEEEeCCCeEEEEECCCCeeC
Confidence            5899999999999988788999999877653

>2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax}

Probab=87.95  E-value=0.22  Score=39.67  Aligned_cols=30  Identities=30%  Similarity=0.381  Sum_probs=25.7

Q ss_pred             CCeeecCCCCCeEEc-------------------------------------CCCCEEEEecccccc
Q psy14630        112 KIIHRDVKPSNILLD-------------------------------------RRGAIKLCDFGISGQ  141 (187)
Q Consensus       112 ~i~Hrdlk~~nili~-------------------------------------~~~~~ki~dfg~a~~  141 (187)
                      .++|+|+.+.||+++                                     ..+.+.++||..|..
T Consensus       291 v~cHnDl~~gNIL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~lIDfEya~~  357 (458)
T 2qg7_A          291 VLCHCDLLSSNIINTVGGGEAGELGEAGETGEGGETGEGGETGEGGETGEGGEGDSISFIDFEYSCP  357 (458)
T ss_dssp             EEECSCCCGGGEEECCC-----------------------------------CCCCEEECCCTTCEE
T ss_pred             eEEecCCCCCcEEeecccccccccccccccccccccccccccccccccccCCCCCeEEEEeecCCCC
Confidence            479999999999998                                     466799999987765

>1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8

Probab=87.53  E-value=0.17  Score=39.96  Aligned_cols=30  Identities=30%  Similarity=0.481  Sum_probs=24.7

Q ss_pred             CCeeecCCCCCeEEcCC----------------------------CCEEEEecccccc
Q psy14630        112 KIIHRDVKPSNILLDRR----------------------------GAIKLCDFGISGQ  141 (187)
Q Consensus       112 ~i~Hrdlk~~nili~~~----------------------------~~~ki~dfg~a~~  141 (187)
                      .++|+|+.+.||+++.+                            +.+.++||..+..
T Consensus       250 v~~H~Dl~~gNiL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lIDfEya~~  307 (429)
T 1nw1_A          250 TFCHNDLQEGNILLPKASSGNIRMPSLSDETQALGNSLSAFNPADPRLVLIDFEYASY  307 (429)
T ss_dssp             EEECSCCCGGGEEEEC------------------------------CCEECCCTTCEE
T ss_pred             EEEeCCCCCCeEEeeCCccccccccccccccccccccccccccCCCeEEEEecccCCc
Confidence            47999999999999875                            6789999987765

>3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A*

Probab=87.13  E-value=0.24  Score=38.45  Aligned_cols=30  Identities=33%  Similarity=0.483  Sum_probs=26.5

Q ss_pred             CCeeecCCCCCeEEcCC----CCEEEEecccccc
Q psy14630        112 KIIHRDVKPSNILLDRR----GAIKLCDFGISGQ  141 (187)
Q Consensus       112 ~i~Hrdlk~~nili~~~----~~~ki~dfg~a~~  141 (187)
                      .++|+|+.+.|++++.+    +.+.++||..+..
T Consensus       221 ~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~  254 (379)
T 3feg_A          221 VFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY  254 (379)
T ss_dssp             EEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred             EEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence            47999999999999876    7899999998765

>2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A*

Probab=87.03  E-value=0.25  Score=38.27  Aligned_cols=29  Identities=21%  Similarity=0.292  Sum_probs=24.6

Q ss_pred             CCeeecCCCCCeEEcCCCCEEEEecccccc
Q psy14630        112 KIIHRDVKPSNILLDRRGAIKLCDFGISGQ  141 (187)
Q Consensus       112 ~i~Hrdlk~~nili~~~~~~ki~dfg~a~~  141 (187)
                      .++|+|+.+.|++++.+ .+.++||..+..
T Consensus       228 ~L~HGDl~~~Nil~~~~-~~~lID~e~a~~  256 (397)
T 2olc_A          228 TLIHGDLHTGSIFASEH-ETKVIDPEFAFY  256 (397)
T ss_dssp             EEECSCCSGGGEEECSS-CEEECCCTTCEE
T ss_pred             ceeeCCCCcCcEEEeCC-CeEEEeCccccc
Confidence            58999999999999765 489999987654

>3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A*

Probab=85.23  E-value=0.37  Score=37.55  Aligned_cols=29  Identities=34%  Similarity=0.526  Sum_probs=24.9

Q ss_pred             CeeecCCCCCeEE------cCCCCEEEEecccccc
Q psy14630        113 IIHRDVKPSNILL------DRRGAIKLCDFGISGQ  141 (187)
Q Consensus       113 i~Hrdlk~~nili------~~~~~~ki~dfg~a~~  141 (187)
                      ++|+|+.+.||++      +....+.++||..|..
T Consensus       246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~  280 (401)
T 3g15_A          246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY  280 (401)
T ss_dssp             EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred             eEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence            6799999999999      3467799999998875

>3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum}

Probab=80.15  E-value=0.64  Score=36.67  Aligned_cols=29  Identities=24%  Similarity=0.502  Sum_probs=25.8

Q ss_pred             CCeeecCCCCCeEEcCCCCEEEEecccccc
Q psy14630        112 KIIHRDVKPSNILLDRRGAIKLCDFGISGQ  141 (187)
Q Consensus       112 ~i~Hrdlk~~nili~~~~~~ki~dfg~a~~  141 (187)
                      .++|+|+.+.|++ +..+.+.++||..+..
T Consensus       263 ~~~H~D~~~~N~l-~~~~~~~~IDwe~a~~  291 (424)
T 3mes_A          263 VFAHNDLQENNLL-QTQNNIRMIDYEYSAI  291 (424)
T ss_dssp             EEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred             eEECCCCCcccee-cCCCcEEEEecccCCc
Confidence            4799999999999 7788899999998875

---

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST

Original result of RPS-BLAST against SCOP70(version1.75) database

ID	Length	Definition	E-value
Query	187
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	2e-36
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	4e-29
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	1e-28
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	3e-27
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	7e-27
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	2e-26
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	6e-26
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	8e-26
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	5e-25
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	2e-24
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	8e-24
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	1e-23
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	3e-23
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	5e-23
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	1e-22
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	3e-22
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	5e-22
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	6e-22
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	1e-21
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	1e-21
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	1e-21
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	1e-21
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	2e-21
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	2e-21
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	2e-21
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	3e-21
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	4e-21
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	7e-21
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	8e-21
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	9e-21
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	1e-20
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	2e-20
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	3e-20
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	3e-20
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	4e-20
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	5e-20
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	1e-19
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	2e-19
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	2e-19
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	3e-19
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	5e-19
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	6e-19
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	7e-19
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	1e-18
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	2e-18
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	2e-18
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	3e-18
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	4e-18
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	5e-18
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	3e-17
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	3e-17
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	5e-17
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	6e-17
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	9e-17
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	1e-16
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	1e-16
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	1e-16
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	4e-16
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	1e-15
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	3e-15
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	3e-14
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	3e-14
d1zara2	191	d.144.1.9 (A:91-281) Rio2 serine protein kinase C-	1e-08

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  126 bits (318), Expect = 2e-36
 Identities = 67/172 (38%), Positives = 95/172 (55%), Gaps = 34/172 (19%)

Query: 24  EDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECP 83
           +D + + E+G G  G V K+ H+ S  VMA K I   +    + Q++ +L V +     P
Sbjct: 6   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQV-LHECNSP 64

Query: 84  YIVQFYGALF--------------------------------KEVTVATVKALNYLKEEL 111
           YIV FYGA +                                 +V++A +K L YL+E+ 
Sbjct: 65  YIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKH 124

Query: 112 KIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERI 163
           KI+HRDVKPSNIL++ RG IKLCDFG+SGQL+DS+A +   G R YM+PER+
Sbjct: 125 KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSF-VGTRSYMSPERL 175

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  106 bits (266), Expect = 4e-29
 Identities = 44/176 (25%), Positives = 68/176 (38%), Gaps = 35/176 (19%)

Query: 21  FTSEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIR-STVDEKDQRQLLMDLDVVMKS 79
           +  ED +    +G+G FG V     + S  ++A+K +  + +++      L     +   
Sbjct: 3   WALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSH 62

Query: 80  NECPYIVQFYGAL---------------------------FKEVTVAT-----VKALNYL 107
              P I++ YG                             F E   AT       AL+Y 
Sbjct: 63  LRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYC 122

Query: 108 KEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERI 163
               ++IHRD+KP N+LL   G +K+ DFG S     S   T   G   Y+ PE I
Sbjct: 123 -HSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTL-CGTLDYLPPEMI 176

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  105 bits (264), Expect = 1e-28
 Identities = 53/197 (26%), Positives = 86/197 (43%), Gaps = 44/197 (22%)

Query: 10  KLKLSPDTVYDFTSEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQL 69
              L+P+  ++        +GE+G G FG V K  ++ +  + A K I +   E++    
Sbjct: 5   TRDLNPEDFWEI-------IGELGDGAFGKVYKAQNKETSVLAAAKVIDTK-SEEELEDY 56

Query: 70  LMDLDVVMKSNECPYIVQFYGALFKE---------------------------------V 96
           ++++D+ + S + P IV+   A + E                                 V
Sbjct: 57  MVEIDI-LASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVV 115

Query: 97  TVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTRD-AGCR 155
              T+ ALNYL  + KIIHRD+K  NIL    G IKL DFG+S +   +I +     G  
Sbjct: 116 CKQTLDALNYL-HDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTP 174

Query: 156 PYMAPERIDPLRARGYP 172
            +MAPE +    ++  P
Sbjct: 175 YWMAPEVVMCETSKDRP 191

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  102 bits (255), Expect = 3e-27
 Identities = 48/195 (24%), Positives = 74/195 (37%), Gaps = 43/195 (22%)

Query: 15  PDTVYDFTSEDL----QDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIR--STVDEKDQRQ 68
           PD    F  +D      DL EIG G FG V       +  V+A+K++        +  + 
Sbjct: 2   PDVAELFFKDDPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQD 61

Query: 69  LLMDLDVVMKSNECPYIVQFYGALFKE--------------------------------V 96
           ++ ++   ++    P  +Q+ G   +E                                V
Sbjct: 62  IIKEVRF-LQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAV 120

Query: 97  TVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTRDAGCRP 156
           T   ++ L YL     +IHRDVK  NILL   G +KL DFG +  +  +       G   
Sbjct: 121 THGALQGLAYL-HSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA---NSFVGTPY 176

Query: 157 YMAPERIDPLRARGY 171
           +MAPE I  +    Y
Sbjct: 177 WMAPEVILAMDEGQY 191

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  100 bits (250), Expect = 7e-27
 Identities = 38/184 (20%), Positives = 72/184 (39%), Gaps = 43/184 (23%)

Query: 24  EDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECP 83
           ED + L  IG G +G   K+  +S   ++  K +      + ++Q+L+    +++  + P
Sbjct: 4   EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 63

Query: 84  YIVQFYGALFKE--------------------------------------VTVATVKALN 105
            IV++Y  +                                         V      AL 
Sbjct: 64  NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 123

Query: 106 YL----KEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTRDAGCRP-YMAP 160
                      ++HRD+KP+N+ LD +  +KL DFG++  L    +  +     P YM+P
Sbjct: 124 ECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAFVGTPYYMSP 183

Query: 161 ERID 164
           E+++
Sbjct: 184 EQMN 187

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  100 bits (250), Expect = 2e-26
 Identities = 43/175 (24%), Positives = 71/175 (40%), Gaps = 34/175 (19%)

Query: 21  FTSEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIR-STVDEKDQRQLLMDLDVVMKS 79
           ++ +D Q L  +G G FG V+ +  R +    A+K ++   V    Q +   D  +++  
Sbjct: 1   YSLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSI 60

Query: 80  NECPYIVQFYGALFKEVTVATVK----------------------ALNYLKE-------- 109
              P+I++ +G       +  +                       A  Y  E        
Sbjct: 61  VTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYL 120

Query: 110 -ELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERI 163
               II+RD+KP NILLD+ G IK+ DFG +  + D        G   Y+APE +
Sbjct: 121 HSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVT--YTLCGTPDYIAPEVV 173

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 98.2 bits (244), Expect = 6e-26
 Identities = 39/185 (21%), Positives = 67/185 (36%), Gaps = 37/185 (20%)

Query: 24  EDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECP 83
           ED   +  +G G +G V   ++R ++  +AVK +           +  ++ +  K     
Sbjct: 5   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICI-NKMLNHE 63

Query: 84  YIVQFYGALF--------------------------------KEVTVATVKALNYLKEEL 111
            +V+FYG                                   +      +  + YL   +
Sbjct: 64  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYL-HGI 122

Query: 112 KIIHRDVKPSNILLDRRGAIKLCDFGISGQLV---DSIAKTRDAGCRPYMAPERIDPLRA 168
            I HRD+KP N+LLD R  +K+ DFG++             +  G  PY+APE +     
Sbjct: 123 GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 182

Query: 169 RGYPS 173
              P 
Sbjct: 183 HAEPV 187

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 97.8 bits (243), Expect = 8e-26
 Identities = 42/172 (24%), Positives = 67/172 (38%), Gaps = 39/172 (22%)

Query: 31  EIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQFYG 90
           EIGRG F TV K +   +   +A   ++     K +RQ   +   ++K  + P IV+FY 
Sbjct: 16  EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYD 75

Query: 91  A------------------------------------LFKEVTVATVKALNYLKEE-LKI 113
           +                                    + +      +K L +L      I
Sbjct: 76  SWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPI 135

Query: 114 IHRDVKPSNILLDRR-GAIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERID 164
           IHRD+K  NI +    G++K+ D G++     S AK    G   +MAPE  +
Sbjct: 136 IHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKAV-IGTPEFMAPEMYE 186

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 96.2 bits (239), Expect = 5e-25
 Identities = 39/173 (22%), Positives = 78/173 (45%), Gaps = 35/173 (20%)

Query: 23  SEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNEC 82
            +      +IG+G  GTV   +  ++   +A++++   + ++ +++L+++  +VM+ N+ 
Sbjct: 19  KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMN--LQQQPKKELIINEILVMRENKN 76

Query: 83  PYIVQFYGALF-------------------------------KEVTVATVKALNYLKEEL 111
           P IV +  +                                   V    ++AL +L    
Sbjct: 77  PNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFL-HSN 135

Query: 112 KIIHRDVKPSNILLDRRGAIKLCDFGISGQL-VDSIAKTRDAGCRPYMAPERI 163
           ++IHRD+K  NILL   G++KL DFG   Q+  +   ++   G   +MAPE +
Sbjct: 136 QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVV 188

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score = 94.4 bits (234), Expect = 2e-24
 Identities = 51/194 (26%), Positives = 80/194 (41%), Gaps = 41/194 (21%)

Query: 24  EDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTV--------DEKDQRQLLMDLDV 75
           E+ +    +GRG    V + IH+ +    AVK I  T          ++ +   L ++D+
Sbjct: 3   ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 62

Query: 76  VMKSNECPYIVQFY------------------GALF--------------KEVTVATVKA 103
           + K +  P I+Q                    G LF              +++  A ++ 
Sbjct: 63  LRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEV 122

Query: 104 LNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERI 163
           +  L  +L I+HRD+KP NILLD    IKL DFG S QL          G   Y+APE I
Sbjct: 123 ICAL-HKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEII 181

Query: 164 DPLRARGYPSFKTK 177
           +      +P +  +
Sbjct: 182 ECSMNDNHPGYGKE 195

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score = 94.0 bits (233), Expect = 8e-24
 Identities = 37/181 (20%), Positives = 64/181 (35%), Gaps = 38/181 (20%)

Query: 19  YDFTSEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMK 78
           +D   +      E+G G FG V+++  R++    A K + +   E D+  +  ++   M 
Sbjct: 21  HDHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTP-HESDKETVRKEIQT-MS 78

Query: 79  SNECPYIVQFYGALF---------------------------------KEVTVATVKALN 105
               P +V  + A                                    E      K L 
Sbjct: 79  VLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLC 138

Query: 106 YLKEELKIIHRDVKPSNILL--DRRGAIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERI 163
           ++  E   +H D+KP NI+    R   +KL DFG++  L    +     G   + APE  
Sbjct: 139 HM-HENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVA 197

Query: 164 D 164
           +
Sbjct: 198 E 198

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 92.0 bits (228), Expect = 1e-23
 Identities = 43/188 (22%), Positives = 67/188 (35%), Gaps = 39/188 (20%)

Query: 19  YDFTSEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMK 78
           ++     +     IG G FGTV K        V AVK +  T     Q Q   +   V++
Sbjct: 3   WEIPDGQITVGQRIGSGSFGTVYKGKWH--GDV-AVKMLNVTAPTPQQLQAFKNEVGVLR 59

Query: 79  SNECPYIVQFYGA-----------------LFK---------------EVTVATVKALNY 106
                 I+ F G                  L+                ++   T + ++Y
Sbjct: 60  KTRHVNILLFMGYSTAPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDY 119

Query: 107 LKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAK---TRDAGCRPYMAPERI 163
           L  +  IIHRD+K +NI L     +K+ DFG++             + +G   +MAPE I
Sbjct: 120 LHAK-SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVI 178

Query: 164 DPLRARGY 171
                  Y
Sbjct: 179 RMQDKNPY 186

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 91.2 bits (226), Expect = 3e-23
 Identities = 39/175 (22%), Positives = 67/175 (38%), Gaps = 35/175 (20%)

Query: 24  EDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIR-STVDEKDQRQLLMDLDVVMKSNEC 82
           ED +    +G G F TV      ++    A+K +    + ++++   +     VM   + 
Sbjct: 8   EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 67

Query: 83  PYIVQFYGAL---------------------------FKEVTVA--TVKALNYLKE--EL 111
           P+ V+ Y                              F E      T + ++ L+     
Sbjct: 68  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 127

Query: 112 KIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTRD---AGCRPYMAPERI 163
            IIHRD+KP NILL+    I++ DFG +  L     + R     G   Y++PE +
Sbjct: 128 GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELL 182

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 91.3 bits (226), Expect = 5e-23
 Identities = 37/175 (21%), Positives = 68/175 (38%), Gaps = 36/175 (20%)

Query: 24  EDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIR--STVDEKDQRQLLMDLDVVMKSNE 81
           ED      +G+G FG V     + ++   A+K ++    + + D    +++  V+  + E
Sbjct: 2   EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 61

Query: 82  CPYIVQFYGALFKE--------------------------------VTVATVKALNYLKE 109
            P++   +     +                                     +  L +L  
Sbjct: 62  HPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHS 121

Query: 110 ELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAK-TRDAGCRPYMAPERI 163
              I++RD+K  NILLD+ G IK+ DFG+  + +   AK     G   Y+APE +
Sbjct: 122 -KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEIL 175

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 90.3 bits (223), Expect = 1e-22
 Identities = 44/187 (23%), Positives = 73/187 (39%), Gaps = 38/187 (20%)

Query: 24  EDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECP 83
           E+ Q + +IG G +G V K  ++ +  V+A+K+IR   + +      +    ++K    P
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61

Query: 84  YIVQFYGA---------------------------------LFKEVTVATVKALNYLKEE 110
            IV+                                     L K      ++ L +    
Sbjct: 62  NIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 121

Query: 111 LKIIHRDVKPSNILLDRRGAIKLCDFGISGQL-VDSIAKTRDAGCRPYMAPERIDPLRAR 169
            +++HRD+KP N+L++  GAIKL DFG++    V     T +     Y APE    L   
Sbjct: 122 -RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPE---ILLGC 177

Query: 170 GYPSFKT 176
            Y S   
Sbjct: 178 KYYSTAV 184

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 88.6 bits (219), Expect = 3e-22
 Identities = 36/180 (20%), Positives = 69/180 (38%), Gaps = 40/180 (22%)

Query: 19  YDFTSEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMK 78
           ++   E L+ +  +G G FG V    +     V AVK ++           L + ++ MK
Sbjct: 8   WEVPRETLKLVERLGAGQFGEVWMGYYNGHTKV-AVKSLKQ--GSMSPDAFLAEANL-MK 63

Query: 79  SNECPYIVQFYGALFKE---------------------------------VTVATVKALN 105
             +   +V+ Y  + +E                                 +     + + 
Sbjct: 64  QLQHQRLVRLYAVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMA 123

Query: 106 YLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDS--IAKTRDAGCRPYMAPERI 163
           ++ EE   IHRD++ +NIL+    + K+ DFG++  + D+   A+        + APE I
Sbjct: 124 FI-EERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAI 182

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score = 89.0 bits (220), Expect = 5e-22
 Identities = 38/178 (21%), Positives = 64/178 (35%), Gaps = 38/178 (21%)

Query: 22  TSEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDV----VM 77
           T  D      IGRGGFG V       +  + A+K +     +  Q + L   +     ++
Sbjct: 2   TMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLV 61

Query: 78  KSNECPYIVQFYGALFKE--------------------------------VTVATVKALN 105
            + +CP+IV    A                                         +  L 
Sbjct: 62  STGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLE 121

Query: 106 YLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERI 163
           ++     +++RD+KP+NILLD  G +++ D G++             G   YMAPE +
Sbjct: 122 HM-HNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP-HASVGTHGYMAPEVL 177

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 87.8 bits (217), Expect = 6e-22
 Identities = 37/183 (20%), Positives = 67/183 (36%), Gaps = 41/183 (22%)

Query: 13  LSPDTVYDFTSEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMD 72
           L+ D  ++   E L+   ++G+G FG V       +  V A+K ++           L +
Sbjct: 7   LAKD-AWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRV-AIKTLKP--GTMSPEAFLQE 62

Query: 73  LDVVMKSNECPYIVQFYGALFKE---------------------------------VTVA 99
             V MK      +VQ Y  + +E                                 +   
Sbjct: 63  AQV-MKKLRHEKLVQLYAVVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQ 121

Query: 100 TVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTRDAGCRP--Y 157
               + Y+ E +  +HRD++ +NIL+      K+ DFG++  + D+    R     P  +
Sbjct: 122 IASGMAYV-ERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKW 180

Query: 158 MAP 160
            AP
Sbjct: 181 TAP 183

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score = 87.5 bits (216), Expect = 1e-21
 Identities = 35/180 (19%), Positives = 64/180 (35%), Gaps = 38/180 (21%)

Query: 19  YDFTSEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMK 78
           ++    D+    ++G G +G V + + +     +AVK ++   D  +  + L +   VMK
Sbjct: 12  WEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKE--DTMEVEEFLKEAA-VMK 68

Query: 79  SNECPYIVQFYGALFKE------------------------VTVATVKALNYLKE----- 109
             + P +VQ  G   +E                          V+ V  L    +     
Sbjct: 69  EIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAM 128

Query: 110 ----ELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAK--TRDAGCRPYMAPERI 163
               +   IHRD+   N L+     +K+ DFG+S  +                + APE +
Sbjct: 129 EYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESL 188

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 88.0 bits (217), Expect = 1e-21
 Identities = 33/176 (18%), Positives = 61/176 (34%), Gaps = 41/176 (23%)

Query: 27  QDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIV 86
            +L  IG G +G V       +   +A+K+I     +   ++ L ++ + +       I+
Sbjct: 11  TNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKI-LLRFRHENII 69

Query: 87  QFYGALF-----------------------------------KEVTVATVKALNYLKEEL 111
                +                                           ++ L Y+    
Sbjct: 70  GINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLKYIHSA- 128

Query: 112 KIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAK----TRDAGCRPYMAPERI 163
            ++HRD+KPSN+LL+    +K+CDFG++             T     R Y APE +
Sbjct: 129 NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIM 184

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 87.5 bits (216), Expect = 1e-21
 Identities = 37/182 (20%), Positives = 69/182 (37%), Gaps = 41/182 (22%)

Query: 21  FTSEDLQDLGEIGRGGFGTVNKMIHRSSDTV----MAVKRIRSTVDEKDQRQLLMDLDVV 76
               + + +  +G G FGTV K +           +A+K +R     K  +++L +  V 
Sbjct: 6   LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYV- 64

Query: 77  MKSNECPYIVQFYGA--------------------------------LFKEVTVATVKAL 104
           M S + P++ +  G                                       V   K +
Sbjct: 65  MASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGM 124

Query: 105 NYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTRDAGCR---PYMAPE 161
           NYL++  +++HRD+   N+L+     +K+ DFG++  L     +    G +    +MA E
Sbjct: 125 NYLEDR-RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALE 183

Query: 162 RI 163
            I
Sbjct: 184 SI 185

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 86.7 bits (214), Expect = 1e-21
 Identities = 51/192 (26%), Positives = 79/192 (41%), Gaps = 47/192 (24%)

Query: 10  KLKLSPDTVYDFTSEDLQDLGEIGRGGFGTVNKMIHRSSDT--VMAVKRIRSTVDEKDQR 67
           KL L  D   +    D+    E+G G FG+V + ++R       +A+K ++   ++ D  
Sbjct: 2   KLFLKRD---NLLIADI----ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTE 54

Query: 68  QLLMDLDVVMKSNECPYIVQFYGA-----------------LFK---------------E 95
           +++ +  + M   + PYIV+  G                  L K               E
Sbjct: 55  EMMREAQI-MHQLDNPYIVRLIGVCQAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAE 113

Query: 96  VTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQL--VDSIAKTRDAG 153
           +       + YL EE   +HRD+   N+LL  R   K+ DFG+S  L   DS    R AG
Sbjct: 114 LLHQVSMGMKYL-EEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAG 172

Query: 154 CRP--YMAPERI 163
             P  + APE I
Sbjct: 173 KWPLKWYAPECI 184

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 87.2 bits (215), Expect = 2e-21
 Identities = 39/190 (20%), Positives = 62/190 (32%), Gaps = 51/190 (26%)

Query: 24  EDLQDLGEIGRGGFGTVNKMIHRSSDT--VMAVKRIRSTVDEKDQRQLLMDLDVVMKSNE 81
            D++    IG G FG V K   +        A+KR++    + D R    +L+V+ K   
Sbjct: 10  NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 69

Query: 82  CPYIVQFYGALFKE---------------------------------------------- 95
            P I+   GA                                                  
Sbjct: 70  HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 129

Query: 96  --VTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTRDAG 153
                   + ++YL +  + IHRD+   NIL+      K+ DFG+S      + KT    
Sbjct: 130 LHFAADVARGMDYLSQ-KQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRL 188

Query: 154 CRPYMAPERI 163
              +MA E +
Sbjct: 189 PVRWMAIESL 198

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 86.2 bits (213), Expect = 2e-21
 Identities = 36/175 (20%), Positives = 66/175 (37%), Gaps = 44/175 (25%)

Query: 24  EDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECP 83
           ++L+ L  IG+G FG V    +R     +AVK I+   ++   +  L +  V M      
Sbjct: 7   KELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIK---NDATAQAFLAEASV-MTQLRHS 60

Query: 84  YIVQFYGALFKE-----------------------------------VTVATVKALNYLK 108
            +VQ  G + +E                                    ++   +A+ YL 
Sbjct: 61  NLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYL- 119

Query: 109 EELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERI 163
           E    +HRD+   N+L+      K+ DFG++ +   +  +        + APE +
Sbjct: 120 EGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST--QDTGKLPVKWTAPEAL 172

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 85.9 bits (212), Expect = 2e-21
 Identities = 39/183 (21%), Positives = 70/183 (38%), Gaps = 42/183 (22%)

Query: 31  EIGRGGFGTVNKMIHRSSDTVMAVKRIR-----STVDEKDQRQLLMDLDVVMK-SNECPY 84
            +G GGFG+V   I  S +  +A+K +         +  +  ++ M++ ++ K S+    
Sbjct: 11  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 70

Query: 85  IVQFYGALF---------------------------------KEVTVATVKALNYLKEEL 111
           +++                                       +      ++A+ +     
Sbjct: 71  VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHN-C 129

Query: 112 KIIHRDVKPSNILLDR-RGAIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPLRARG 170
            ++HRD+K  NIL+D  RG +KL DFG    L D++      G R Y  PE I   R  G
Sbjct: 130 GVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDF-DGTRVYSPPEWIRYHRYHG 188

Query: 171 YPS 173
             +
Sbjct: 189 RSA 191

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score = 86.7 bits (214), Expect = 3e-21
 Identities = 34/172 (19%), Positives = 66/172 (38%), Gaps = 38/172 (22%)

Query: 29  LGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQF 88
           L E+G G FG V++ + +++  V   K I +     D+  +  ++  +M     P ++  
Sbjct: 34  LEELGSGAFGVVHRCVEKATGRVFVAKFINTP-YPLDKYTVKNEIS-IMNQLHHPKLINL 91

Query: 89  YGA------------------LF---------------KEVTVATVKALNYLKEELKIIH 115
           + A                  LF                       + L ++  E  I+H
Sbjct: 92  HDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHM-HEHSIVH 150

Query: 116 RDVKPSNILLD--RRGAIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDP 165
            D+KP NI+ +  +  ++K+ DFG++ +L              + APE +D 
Sbjct: 151 LDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIVDR 202

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 85.5 bits (211), Expect = 4e-21
 Identities = 41/170 (24%), Positives = 66/170 (38%), Gaps = 38/170 (22%)

Query: 31  EIGRGGFGTVNKMIHRSSDT--VMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQF 88
           E+G G FGTV K  ++       +AVK +++  ++   +  L+    VM+  + PYIV+ 
Sbjct: 14  ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 73

Query: 89  YGALFKE-------------------------------VTVATVKALNYLKEELKIIHRD 117
            G    E                               +       + YL+E    +HRD
Sbjct: 74  IGICEAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEES-NFVHRD 132

Query: 118 VKPSNILLDRRGAIKLCDFGISGQLVDSI----AKTRDAGCRPYMAPERI 163
           +   N+LL  +   K+ DFG+S  L        A+T       + APE I
Sbjct: 133 LAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECI 182

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 84.7 bits (209), Expect = 7e-21
 Identities = 40/175 (22%), Positives = 67/175 (38%), Gaps = 40/175 (22%)

Query: 24  EDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECP 83
            +L  + EIG G FG V+     + D V A+K IR       +   + + +V M     P
Sbjct: 5   SELTFVQEIGSGQFGLVHLGYWLNKDKV-AIKTIRE--GAMSEEDFIEEAEV-MMKLSHP 60

Query: 84  YIVQFYGALFKEVTVATV---------------------------------KALNYLKEE 110
            +VQ YG   ++  +  V                                 + + YL+E 
Sbjct: 61  KLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEA 120

Query: 111 LKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTRDAGCRP--YMAPERI 163
             +IHRD+   N L+     IK+ DFG++  ++D    +      P  + +PE  
Sbjct: 121 -CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVF 174

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 85.0 bits (209), Expect = 8e-21
 Identities = 35/169 (20%), Positives = 68/169 (40%), Gaps = 33/169 (19%)

Query: 24  EDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECP 83
           +  + L +IG G +GTV K  +R +  ++A+KR+R   D++      +    ++K  +  
Sbjct: 2   QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHK 61

Query: 84  YIVQFYGALFKEVTVATV--------------------------------KALNYLKEEL 111
            IV+ +  L  +  +  V                                K L +     
Sbjct: 62  NIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSR- 120

Query: 112 KIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTRDAGCRPYMAP 160
            ++HRD+KP N+L++R G +KL +FG++      +          +  P
Sbjct: 121 NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRP 169

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 85.6 bits (211), Expect = 9e-21
 Identities = 39/175 (22%), Positives = 71/175 (40%), Gaps = 33/175 (18%)

Query: 22  TSEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIR-STVDEKDQRQLLMDLDVVMKSN 80
           T  D   L  +G+G FG V  +  +++    A+K +R   +  KD+    +    V+++ 
Sbjct: 3   TMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNT 62

Query: 81  ECPYIVQFYGA----------------------LFKEVTVATVKALNYLKE--------- 109
             P++     A                      L +E      +A  Y  E         
Sbjct: 63  RHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLH 122

Query: 110 ELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTRD-AGCRPYMAPERI 163
              +++RD+K  N++LD+ G IK+ DFG+  + +   A  +   G   Y+APE +
Sbjct: 123 SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVL 177

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 84.0 bits (207), Expect = 1e-20
 Identities = 44/183 (24%), Positives = 73/183 (39%), Gaps = 39/183 (21%)

Query: 19  YDFTSEDLQDLGEIGRGGFGTVNKMIHRSSD---TVMAVKRIRSTVDEKDQRQLLMDLDV 75
           Y+   E ++    IG G FG V++ I+ S +     +A+K  ++   +  + + L +   
Sbjct: 2   YEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALT 61

Query: 76  VMKSNECPYIVQFYG--------------------------------ALFKEVTVATVKA 103
            M+  + P+IV+  G                                A           A
Sbjct: 62  -MRQFDHPHIVKLIGVITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTA 120

Query: 104 LNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTRDAGCRP--YMAPE 161
           L YL E  + +HRD+   N+L+     +KL DFG+S  + DS       G  P  +MAPE
Sbjct: 121 LAYL-ESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPE 179

Query: 162 RID 164
            I+
Sbjct: 180 SIN 182

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 84.4 bits (208), Expect = 2e-20
 Identities = 41/197 (20%), Positives = 80/197 (40%), Gaps = 53/197 (26%)

Query: 11  LKLSPDTVYDFTSEDLQDLGE-IGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQL 69
           L++  + + D    D +   + +G G  G V ++ ++ +    A+K +      +D  + 
Sbjct: 2   LQIKKNAIID----DYKVTSQVLGLGINGKVLQIFNKRTQEKFALKML------QDCPKA 51

Query: 70  LMDLDVVMKSNECPYIVQFY----------------------GALF-------------- 93
             ++++  ++++CP+IV+                        G LF              
Sbjct: 52  RREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTER 111

Query: 94  --KEVTVATVKALNYLKEELKIIHRDVKPSNILLDRR---GAIKLCDFGISGQLVDSIAK 148
              E+  +  +A+ YL   + I HRDVKP N+L   +     +KL DFG + +     + 
Sbjct: 112 EASEIMKSIGEAIQYLHS-INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSL 170

Query: 149 TRDAGCRPYMAPERIDP 165
           T       Y+APE + P
Sbjct: 171 TTPCYTPYYVAPEVLGP 187

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score = 84.1 bits (207), Expect = 3e-20
 Identities = 35/173 (20%), Positives = 68/173 (39%), Gaps = 36/173 (20%)

Query: 24  EDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIR-STVDEKDQRQLLMDLDVVMKSNEC 82
           +    +  +G G FG V  + H+ S    A+K +    V +  Q +  ++   ++++   
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100

Query: 83  PYIVQFYGALF--------------------------------KEVTVATVKALNYLKEE 110
           P++V+   +                                  +      V    YL   
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYL-HS 159

Query: 111 LKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERI 163
           L +I+RD+KP N+L+D++G I++ DFG + ++          G    +APE I
Sbjct: 160 LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWTLC--GTPEALAPEII 210

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 83.4 bits (205), Expect = 3e-20
 Identities = 40/194 (20%), Positives = 63/194 (32%), Gaps = 52/194 (26%)

Query: 31  EIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQFYG 90
            IG+G FG V +   R     +AVK   S  +    R+  +             I+ F  
Sbjct: 10  SIGKGRFGEVWRGKWR--GEEVAVKIFSSREERSWFREAEIY---QTVMLRHENILGFIA 64

Query: 91  ALFKE-----------------------------------VTVATVKALNYL-------K 108
           A  K+                                   + ++T   L +L       +
Sbjct: 65  ADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQ 124

Query: 109 EELKIIHRDVKPSNILLDRRGAIKLCDFGI-----SGQLVDSIAKTRDAGCRPYMAPERI 163
            +  I HRD+K  NIL+ + G   + D G+     S      IA     G + YMAPE +
Sbjct: 125 GKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVL 184

Query: 164 DPLRARGYPSFKTK 177
           D      +     +
Sbjct: 185 DDSINMKHFESFKR 198

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 83.0 bits (204), Expect = 4e-20
 Identities = 36/172 (20%), Positives = 63/172 (36%), Gaps = 41/172 (23%)

Query: 32  IGRGGFGTVNKMIHRSSD----TVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQ 87
           IG G FG V K + ++S       +A+K +++   EK +   L +  + M       I++
Sbjct: 15  IGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGI-MGQFSHHNIIR 73

Query: 88  FYGALFKEVTVATV-----------------------KALNYLKE---------ELKIIH 115
             G + K   +  +                       + +  L+           +  +H
Sbjct: 74  LEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVH 133

Query: 116 RDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKT----RDAGCRPYMAPERI 163
           RD+   NIL++     K+ DFG+S  L D    T           + APE I
Sbjct: 134 RDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAI 185

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 83.0 bits (204), Expect = 5e-20
 Identities = 44/182 (24%), Positives = 74/182 (40%), Gaps = 39/182 (21%)

Query: 29  LGEIGRGGFGTVNKMIHRSSDTVMAVKRIR----STVDEKDQRQLLMDLDVVMKSNECPY 84
           L  +G G F TV K   ++++ ++A+K+I+    S   +   R  L ++ + ++    P 
Sbjct: 3   LDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKL-LQELSHPN 61

Query: 85  IVQFYG--------------------------------ALFKEVTVATVKALNYLKEELK 112
           I+                                    +  K   + T++ L YL +   
Sbjct: 62  IIGLLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQH-W 120

Query: 113 IIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAK-TRDAGCRPYMAPERIDPLRARGY 171
           I+HRD+KP+N+LLD  G +KL DFG++          T     R Y APE +   R  G 
Sbjct: 121 ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFGARMYGV 180

Query: 172 PS 173
             
Sbjct: 181 GV 182

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 82.0 bits (202), Expect = 1e-19
 Identities = 39/180 (21%), Positives = 66/180 (36%), Gaps = 41/180 (22%)

Query: 23  SEDLQD----LGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMK 78
           +ED++D       +G G F  V     + +  ++A+K I     E  +  +  ++ V + 
Sbjct: 4   AEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAV-LH 62

Query: 79  SNECPYIVQFYGA------------------LF--------------KEVTVATVKALNY 106
             + P IV                       LF                +    + A+ Y
Sbjct: 63  KIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKY 122

Query: 107 LKEELKIIHRDVKPSNILL---DRRGAIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERI 163
           L +   I+HRD+KP N+L    D    I + DFG+S         +   G   Y+APE +
Sbjct: 123 LHDL-GIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEVL 181

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 80.9 bits (199), Expect = 2e-19
 Identities = 40/175 (22%), Positives = 68/175 (38%), Gaps = 40/175 (22%)

Query: 24  EDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECP 83
           +DL  L E+G G FG V     R    V A+K I+       + + + +  V M +    
Sbjct: 4   KDLTFLKELGTGQFGVVKYGKWRGQYDV-AIKMIKE--GSMSEDEFIEEAKV-MMNLSHE 59

Query: 84  YIVQFYGALFKE---------------------------------VTVATVKALNYLKEE 110
            +VQ YG   K+                                 +     +A+ YL E 
Sbjct: 60  KLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYL-ES 118

Query: 111 LKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTRDAGCRP--YMAPERI 163
            + +HRD+   N L++ +G +K+ DFG+S  ++D    +      P  +  PE +
Sbjct: 119 KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVL 173

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score = 81.7 bits (201), Expect = 2e-19
 Identities = 37/185 (20%), Positives = 65/185 (35%), Gaps = 40/185 (21%)

Query: 18  VYDFTSE----DLQDLGEIGRGGFGTVNKMIHRSSD---TVMAVKRIRSTVDEKDQRQLL 70
           V +F  E     ++    IG G FG V     +        +A+K ++S   EK +R  L
Sbjct: 16  VREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFL 75

Query: 71  MDLDVVMKSNECPYIVQFYGALFKEVTVATV-----------------------KALNYL 107
            +  + M   + P ++   G + K   V  +                       + +  L
Sbjct: 76  SEASI-MGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGML 134

Query: 108 KE---------ELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTRDAGCRPYM 158
           +          ++  +HRD+   NIL++     K+ DFG+S  L D  +           
Sbjct: 135 RGIAAGMKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGK 194

Query: 159 APERI 163
            P R 
Sbjct: 195 IPIRW 199

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 81.0 bits (199), Expect = 3e-19
 Identities = 41/210 (19%), Positives = 67/210 (31%), Gaps = 59/210 (28%)

Query: 12  KLSPDTVYDFTSEDLQDLGEIGRGGFGTV-----NKMIHRSSDTVMAVKRIRSTVDEKDQ 66
           +L  D  ++F    L     +G G FG V       +I   +   +AVK ++ +    ++
Sbjct: 11  QLPYDHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTER 70

Query: 67  RQLLMDLDVVMKSNECPYIVQFYGALFKEVTVATV------------------------- 101
             L+ +L V+        IV   GA         +                         
Sbjct: 71  EALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKT 130

Query: 102 -------------------------KALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDF 136
                                    K + +L      IHRD+   NILL      K+CDF
Sbjct: 131 SPAIMEDDELALDLEDLLSFSYQVAKGMAFL-ASKNCIHRDLAARNILLTHGRITKICDF 189

Query: 137 GISGQLVDS---IAKTRDAGCRPYMAPERI 163
           G++  + +    + K        +MAPE I
Sbjct: 190 GLARDIKNDSNYVVKGNARLPVKWMAPESI 219

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 80.6 bits (198), Expect = 5e-19
 Identities = 41/233 (17%), Positives = 74/233 (31%), Gaps = 71/233 (30%)

Query: 1   MCQSIQSSG-------KLKLSPDTVYDFTSEDLQDLGEIGRGGFGTVNKMIHRSSD---- 49
           M Q   SS          +   D  ++F  E+L+    +G G FG V             
Sbjct: 7   MVQVTGSSDNEYFYVDFREYEYDLKWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGV 66

Query: 50  -TVMAVKRIRSTVDEKDQRQLLMDLDVVMK---------------SNECPYIVQFY---G 90
              +AVK ++   D  ++  L+ +L ++ +                +   Y++  Y   G
Sbjct: 67  SIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYG 126

Query: 91  ALFK-------------------------------------EVTVATVKALNYLKEELKI 113
            L                                              K + +L E    
Sbjct: 127 DLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFL-EFKSC 185

Query: 114 IHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTRDAGCR---PYMAPERI 163
           +HRD+   N+L+     +K+CDFG++  ++           R    +MAPE +
Sbjct: 186 VHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESL 238

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score = 79.9 bits (196), Expect = 6e-19
 Identities = 36/183 (19%), Positives = 70/183 (38%), Gaps = 35/183 (19%)

Query: 24  EDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECP 83
           E    L +IG G +G V K  +   +T  A+K+IR   +++      +    ++K  +  
Sbjct: 2   EKYHGLEKIGEGTYGVVYKAQNNYGETF-ALKKIRLEKEDEGIPSTTIREISILKELKHS 60

Query: 84  YIVQFYGALFKEVTVATV--------------------------------KALNYLKEEL 111
            IV+ Y  +  +  +  V                                  + Y   + 
Sbjct: 61  NIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYC-HDR 119

Query: 112 KIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTRDAGCRP-YMAPERIDPLRARG 170
           +++HRD+KP N+L++R G +K+ DFG++      + K         Y AP+ +   +   
Sbjct: 120 RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKYS 179

Query: 171 YPS 173
              
Sbjct: 180 TTI 182

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score = 79.9 bits (196), Expect = 7e-19
 Identities = 33/177 (18%), Positives = 55/177 (31%), Gaps = 43/177 (24%)

Query: 29  LGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQF 88
              IG G FG + +  +  ++  +A+K      D    R       ++      P +  F
Sbjct: 10  GRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTGIPNVYYF 69

Query: 89  Y------------------------GALFKEVTVATV-----KALNYLKEELKIIHRDVK 119
                                    G  F   TVA         +  +  E  +++RD+K
Sbjct: 70  GQEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSI-HEKSLVYRDIK 128

Query: 120 PSNILLDR-----RGAIKLCDFGISGQLVDSIAKTRD--------AGCRPYMAPERI 163
           P N L+ R        I + DFG+     D + K           +G   YM+    
Sbjct: 129 PDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTH 185

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 79.6 bits (195), Expect = 1e-18
 Identities = 38/189 (20%), Positives = 66/189 (34%), Gaps = 44/189 (23%)

Query: 29  LGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQF 88
           L +IG+G FG V K  HR +   +A+K++    +++      +    +++  +   +V  
Sbjct: 15  LAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNL 74

Query: 89  YGAL-------------------------------------FKEVTVATVKALNYLKE-- 109
                                                      E+       LN L    
Sbjct: 75  IEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIH 134

Query: 110 ELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTRD-----AGCRPYMAPERID 164
             KI+HRD+K +N+L+ R G +KL DFG++     +     +          Y  PE + 
Sbjct: 135 RNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLL 194

Query: 165 PLRARGYPS 173
             R  G P 
Sbjct: 195 GERDYGPPI 203

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score = 79.1 bits (194), Expect = 2e-18
 Identities = 32/182 (17%), Positives = 73/182 (40%), Gaps = 37/182 (20%)

Query: 24  EDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECP 83
           +D Q + ++GRG +  V + I+ +++  + VK ++       ++++  ++ ++      P
Sbjct: 35  DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILK----PVKKKKIKREIKILENLRGGP 90

Query: 84  YIVQFYGA-----------------------LFKEVTVATVK--------ALNYLKEELK 112
            I+                            L++ +T   ++        AL+Y    + 
Sbjct: 91  NIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQTLTDYDIRFYMYEILKALDYCHS-MG 149

Query: 113 IIHRDVKPSNILLDRRGA-IKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPLRARGY 171
           I+HRDVKP N+++D     ++L D+G++               R +  PE +   +   Y
Sbjct: 150 IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDY 209

Query: 172 PS 173
             
Sbjct: 210 SL 211

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 78.8 bits (193), Expect = 2e-18
 Identities = 41/182 (22%), Positives = 75/182 (41%), Gaps = 43/182 (23%)

Query: 24  EDLQDLGEIGRGGFGTVNKMIHRSSD-TVMAVKRIR-STVDEKDQRQLLMDLDVV--MKS 79
           +  + + EIG G +G V K     +    +A+KR+R  T +E      + ++ V+  +++
Sbjct: 7   QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLET 66

Query: 80  NECPYIVQFYGA--------------------------------------LFKEVTVATV 101
            E P +V+ +                                          K++    +
Sbjct: 67  FEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLL 126

Query: 102 KALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTRDAGCRPYMAPE 161
           + L++L    +++HRD+KP NIL+   G IKL DFG++      +A T       Y APE
Sbjct: 127 RGLDFL-HSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWYRAPE 185

Query: 162 RI 163
            +
Sbjct: 186 VL 187

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 77.9 bits (191), Expect = 3e-18
 Identities = 39/186 (20%), Positives = 70/186 (37%), Gaps = 43/186 (23%)

Query: 21  FTSEDLQD----LGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDV- 75
           F  E++ D      E+G G F  V K   +S+    A K I+    +  +R +  +    
Sbjct: 3   FRQENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIER 62

Query: 76  ---VMKSNECPYIVQFYGALFKEVTVATV----------------------KALNYLKEE 110
              ++K  + P ++  +     +  V  +                      +A  +LK+ 
Sbjct: 63  EVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQI 122

Query: 111 LK---------IIHRDVKPSNILLDRRGA----IKLCDFGISGQLVDSIAKTRDAGCRPY 157
           L          I H D+KP NI+L  R      IK+ DFG++ ++          G   +
Sbjct: 123 LNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEF 182

Query: 158 MAPERI 163
           +APE +
Sbjct: 183 VAPEIV 188

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 77.6 bits (190), Expect = 4e-18
 Identities = 42/202 (20%), Positives = 70/202 (34%), Gaps = 58/202 (28%)

Query: 19  YDFTSEDLQDLGEIGRGGFGTVNKMIHRSSD-----TVMAVKRIRSTVDEKDQRQLLMDL 73
           ++F  + L+    +GRG FG V +      D       +AVK ++      + R L+ +L
Sbjct: 8   WEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSEL 67

Query: 74  DVVMKSNECPYIVQFYGALFKE-------------------------------------- 95
            +++       +V   GA  K                                       
Sbjct: 68  KILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLY 127

Query: 96  -----------VTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQL-- 142
                       +    K + +L    K IHRD+   NILL  +  +K+CDFG++  +  
Sbjct: 128 KDFLTLEHLICYSFQVAKGMEFL-ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYK 186

Query: 143 -VDSIAKTRDAGCRPYMAPERI 163
             D + K        +MAPE I
Sbjct: 187 DPDYVRKGDARLPLKWMAPETI 208

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 77.8 bits (191), Expect = 5e-18
 Identities = 35/173 (20%), Positives = 60/173 (34%), Gaps = 39/173 (22%)

Query: 24  EDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECP 83
           E      ++GRG FG V++ +  SS      K ++  V   DQ  +  ++ + +      
Sbjct: 5   EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVK--VKGTDQVLVKKEISI-LNIARHR 61

Query: 84  YIVQFYGA------------------LF---------------KEVTVATVKALNYLKEE 110
            I+  + +                  +F                       +AL +L   
Sbjct: 62  NILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFL-HS 120

Query: 111 LKIIHRDVKPSNILLDRRGA--IKLCDFGISGQLVDSIAKTRDAGCRPYMAPE 161
             I H D++P NI+   R +  IK+ +FG + QL              Y APE
Sbjct: 121 HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPE 173

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 76.0 bits (186), Expect = 3e-17
 Identities = 45/181 (24%), Positives = 66/181 (36%), Gaps = 49/181 (27%)

Query: 25  DLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPY 84
              D   IG G FG V +     S  ++A+K++      +D+R    +L + M+  +   
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL-----QDKRFKNRELQI-MRKLDHCN 74

Query: 85  IVQFYGALF-----------------------------------------KEVTVATVKA 103
           IV+     +                                         K       ++
Sbjct: 75  IVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRS 134

Query: 104 LNYLKEELKIIHRDVKPSNILLDRRGAI-KLCDFGISGQLVDSIAKTRDAGCRPYMAPER 162
           L Y+     I HRD+KP N+LLD   A+ KLCDFG + QLV           R Y APE 
Sbjct: 135 LAYI-HSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPEL 193

Query: 163 I 163
           I
Sbjct: 194 I 194

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 75.6 bits (185), Expect = 3e-17
 Identities = 34/200 (17%), Positives = 65/200 (32%), Gaps = 40/200 (20%)

Query: 16  DTVYDFTSEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDV 75
            T ++      +DL  +G G +G V   +   +   +A+K++      +   +       
Sbjct: 11  KTAWEV-RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELR 69

Query: 76  VMKSNECPYIVQFYGALF------------------------------------KEVTVA 99
           ++K      ++                                           + +   
Sbjct: 70  LLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQ 129

Query: 100 TVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTRDAGCRPYMA 159
            +K L Y+     IIHRD+KP N+ ++    +K+ DFG++ Q    +  T     R Y A
Sbjct: 130 MLKGLRYI-HAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSEM--TGYVVTRWYRA 186

Query: 160 PERIDPLRARGYPSFKTKLG 179
           PE I              +G
Sbjct: 187 PEVILNWMRYTQTVDIWSVG 206

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 75.4 bits (184), Expect = 5e-17
 Identities = 41/172 (23%), Positives = 61/172 (35%), Gaps = 36/172 (20%)

Query: 27  QDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIV 86
           Q+L  IG G  G V        D  +A+K++      +   +      V+MK      I+
Sbjct: 20  QNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNII 79

Query: 87  QFYGALFKEVTVATVKALNYLKEEL----------------------------------- 111
                   + T+   + + YL  EL                                   
Sbjct: 80  SLLNVFTPQKTLEEFQDV-YLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSA 138

Query: 112 KIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERI 163
            IIHRD+KPSNI++     +K+ DFG++     S   T     R Y APE I
Sbjct: 139 GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVI 190

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 74.8 bits (183), Expect = 6e-17
 Identities = 36/174 (20%), Positives = 58/174 (33%), Gaps = 44/174 (25%)

Query: 32  IGRGGFGTVNKMIHRSSD---TVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQF 88
           IGRG FG V       +D      AVK +    D  +  Q L +  + MK    P ++  
Sbjct: 35  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGII-MKDFSHPNVLSL 93

Query: 89  YGALFKE----------------------------------VTVATVKALNYLKEELKII 114
            G   +                                     +   K + +     K +
Sbjct: 94  LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKF-LASKKFV 152

Query: 115 HRDVKPSNILLDRRGAIKLCDFGISGQLVDSIA-----KTRDAGCRPYMAPERI 163
           HRD+   N +LD +  +K+ DFG++  + D        KT       +MA E +
Sbjct: 153 HRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESL 206

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 74.1 bits (181), Expect = 9e-17
 Identities = 36/208 (17%), Positives = 67/208 (32%), Gaps = 64/208 (30%)

Query: 19  YDFTSEDLQDLGEIGRGGFGTVNK-----MIHRSSDTVMAVKRIRSTVDEKDQRQLLMDL 73
            ++   +++ + +IG G FG V +     ++     T++AVK ++       Q     + 
Sbjct: 8   LEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREA 67

Query: 74  DV--------------VMKSNECPYIVQFY---GALFK---------------------- 94
            +              V    +   ++  Y   G L +                      
Sbjct: 68  ALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRA 127

Query: 95  ----------------EVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGI 138
                            +       + YL E  K +HRD+   N L+     +K+ DFG+
Sbjct: 128 RVSSPGPPPLSCAEQLCIARQVAAGMAYLSER-KFVHRDLATRNCLVGENMVVKIADFGL 186

Query: 139 SGQLVDS---IAKTRDAGCRPYMAPERI 163
           S  +  +    A   DA    +M PE I
Sbjct: 187 SRNIYSADYYKADGNDAIPIRWMPPESI 214

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 73.6 bits (180), Expect = 1e-16
 Identities = 36/181 (19%), Positives = 67/181 (37%), Gaps = 43/181 (23%)

Query: 24  EDLQDLGEIGRGGFGTVNKMIHRSSD---TVMAVKRIRSTV--DEKDQRQLLMDLDVVMK 78
           +DL+ L ++G G FG V +    +       +AVK ++  V    +     + +++  M 
Sbjct: 8   KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNA-MH 66

Query: 79  SNECPYIVQFYGA--------------------------------LFKEVTVATVKALNY 106
           S +   +++ YG                                       V   + + Y
Sbjct: 67  SLDHRNLIRLYGVVLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGY 126

Query: 107 LKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDS----IAKTRDAGCRPYMAPER 162
           L E  + IHRD+   N+LL  R  +K+ DFG+   L  +    + +        + APE 
Sbjct: 127 L-ESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPES 185

Query: 163 I 163
           +
Sbjct: 186 L 186

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 73.7 bits (180), Expect = 1e-16
 Identities = 34/206 (16%), Positives = 71/206 (34%), Gaps = 57/206 (27%)

Query: 13  LSPDTVYD-----FTSEDLQDLGEIGRGGFGTVNKMIHRS-----SDTVMAVKRIRSTVD 62
            S   VY         E +    E+G+G FG V + + +       +T +A+K +     
Sbjct: 4   FSAADVYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAAS 63

Query: 63  EKDQRQLLMDLDVVMKSNECPYIVQFYGALFKE--------------------------- 95
            +++ + L +   VMK   C ++V+  G + +                            
Sbjct: 64  MRERIEFLNEAS-VMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMA 122

Query: 96  ---------------VTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISG 140
                          +       + YL    K +HRD+   N ++     +K+ DFG++ 
Sbjct: 123 NNPVLAPPSLSKMIQMAGEIADGMAYLNAN-KFVHRDLAARNCMVAEDFTVKIGDFGMTR 181

Query: 141 QLVDS---IAKTRDAGCRPYMAPERI 163
            + ++       +      +M+PE +
Sbjct: 182 DIYETDYYRKGGKGLLPVRWMSPESL 207

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score = 73.2 bits (179), Expect = 1e-16
 Identities = 41/183 (22%), Positives = 65/183 (35%), Gaps = 44/183 (24%)

Query: 23  SEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTV--DEKDQRQLLMDLDVVMKSN 80
           S+  +    +G GG   V+          +AVK +R+ +  D     +   +      + 
Sbjct: 6   SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQN-AAAL 64

Query: 81  ECPYIVQFYGALF------------------------------------KEVTVATVKAL 104
             P IV  Y                                         EV     +AL
Sbjct: 65  NHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQAL 124

Query: 105 NYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAK----TRDAGCRPYMAP 160
           N+  +   IIHRDVKP+NI++    A+K+ DFGI+  + DS           G   Y++P
Sbjct: 125 NFSHQ-NGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSP 183

Query: 161 ERI 163
           E+ 
Sbjct: 184 EQA 186

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 72.2 bits (176), Expect = 4e-16
 Identities = 38/209 (18%), Positives = 66/209 (31%), Gaps = 59/209 (28%)

Query: 13  LSPDTVYDFTSEDLQDLGEIGRGGFGTVNKMIHRSSD-------TVMAVKRIRSTVDEKD 65
           L  D  ++   + L     +G G FG V        D       T +AVK ++S   EKD
Sbjct: 2   LPEDPRWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKD 61

Query: 66  QRQLLMDLDVVMKSNECPYIVQFYG----------------------------------- 90
              L+ +++++    +   I+   G                                   
Sbjct: 62  LSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYS 121

Query: 91  -------------ALFKEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFG 137
                                   + + YL    K IHRD+   N+L+     +K+ DFG
Sbjct: 122 YNPSHNPEEQLSSKDLVSCAYQVARGMEYL-ASKKCIHRDLAARNVLVTEDNVMKIADFG 180

Query: 138 ISGQLVDSIAKTRDAGCR---PYMAPERI 163
           ++  +       +    R    +MAPE +
Sbjct: 181 LARDIHHIDYYKKTTNGRLPVKWMAPEAL 209

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 71.0 bits (173), Expect = 1e-15
 Identities = 42/180 (23%), Positives = 69/180 (38%), Gaps = 41/180 (22%)

Query: 24  EDLQDLGEIGRGGFGTV---NKMIHRSSDTVMAVKRIRSTV---DEKDQRQLLMDLDVVM 77
           E+ + L  +G G +G V    K+    +  + A+K ++        K       +  V+ 
Sbjct: 24  ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 83

Query: 78  KSNECPYIVQFYGALFKEVTV--------------------------------ATVKALN 105
              + P++V  + A   E  +                                  V AL 
Sbjct: 84  HIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALE 143

Query: 106 YLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAK--TRDAGCRPYMAPERI 163
           +L  +L II+RD+K  NILLD  G + L DFG+S + V    +      G   YMAP+ +
Sbjct: 144 HL-HKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIV 202

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 70.3 bits (171), Expect = 3e-15
 Identities = 33/182 (18%), Positives = 63/182 (34%), Gaps = 40/182 (21%)

Query: 16  DTVYDFTSEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDV 75
            T+++   E  Q+L  +G G +G+V       +   +AVK++          +       
Sbjct: 11  KTIWEVP-ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELR 69

Query: 76  VMKSNECPYIVQFYGALFKEVTVAT----------------------------------- 100
           ++K  +   ++          ++                                     
Sbjct: 70  LLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQ 129

Query: 101 -VKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTRDAGCRPYMA 159
            ++ L Y+     IIHRD+KPSN+ ++    +K+ DFG++         T     R Y A
Sbjct: 130 ILRGLKYI-HSADIIHRDLKPSNLAVNEDCELKILDFGLARHT--DDEMTGYVATRWYRA 186

Query: 160 PE 161
           PE
Sbjct: 187 PE 188

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score = 67.4 bits (163), Expect = 3e-14
 Identities = 30/186 (16%), Positives = 63/186 (33%), Gaps = 53/186 (28%)

Query: 29  LGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQ--------RQLLMDLDVVMKSN 80
           + ++G G F TV       ++T +A+K +R      +         +++    +    S 
Sbjct: 18  VRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSM 77

Query: 81  ECPYIVQFYG-------------------------------------ALFKEVTVATVKA 103
              +I++                                           K+++   +  
Sbjct: 78  GANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLG 137

Query: 104 LNYLKEELKIIHRDVKPSNILLDRRGA------IKLCDFGISGQLVDSIAKTRDAGCRPY 157
           L+Y+     IIH D+KP N+L++   +      IK+ D G +    +    +     R Y
Sbjct: 138 LDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSI--QTREY 195

Query: 158 MAPERI 163
            +PE +
Sbjct: 196 RSPEVL 201

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 66.8 bits (162), Expect = 3e-14
 Identities = 27/178 (15%), Positives = 48/178 (26%), Gaps = 47/178 (26%)

Query: 29  LGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQF 88
             +IG G FG +      ++   +A+K       +    QL ++  +         I   
Sbjct: 12  GRKIGSGSFGDIYLGTDIAAGEEVAIKLECV---KTKHPQLHIESKIYKMMQGGVGIPTI 68

Query: 89  YGALFKEVTVATV--------------------------------KALNYLKEELKIIHR 116
                +      V                                  + Y+      IHR
Sbjct: 69  RWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYI-HSKNFIHR 127

Query: 117 DVKPSNILLDRRGA---IKLCDFGISGQLVDS--------IAKTRDAGCRPYMAPERI 163
           DVKP N L+        + + DFG++ +  D+               G   Y +    
Sbjct: 128 DVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTH 185

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

 Score = 50.2 bits (119), Expect = 1e-08
 Identities = 20/149 (13%), Positives = 40/149 (26%), Gaps = 40/149 (26%)

Query: 31  EIGRGGFGTVNKMIHRSSDTVMAVKRIR-STVDEKDQRQLLMDLDV-------------- 75
            +G G    V             VK  +      K  ++     D+              
Sbjct: 7   LMGEGKESAVFNCYSEKFGEC-VVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEF 65

Query: 76  -VMKSNECPYIVQFYGA---------------------LFKEVTVATVKALNYLKEELKI 113
             ++  +   + + Y                          EV    ++ +        I
Sbjct: 66  RALQKLQGLAVPKVYAWEGNAVLMELIDAKELYRVRVENPDEVLDMILEEVAKFYHR-GI 124

Query: 114 IHRDVKPSNILLDRRGAIKLCDFGISGQL 142
           +H D+   N+L+   G I + DF  S ++
Sbjct: 125 VHGDLSQYNVLVSEEG-IWIIDFPQSVEV 152

Homologous Domains Detected by HHsearch

Original result of HHsearch against SCOP70(version1.75) database

ID	Length	Definition	Probability
Query	187
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	100.0
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	100.0
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	100.0
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	100.0
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	100.0
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	100.0
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	100.0
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	100.0
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	100.0
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	100.0
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	100.0
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	100.0
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	100.0
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	100.0
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	100.0
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	100.0
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	100.0
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	100.0
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	100.0
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	100.0
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	100.0
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	100.0
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	100.0
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	100.0
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	100.0
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	100.0
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	100.0
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	100.0
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	100.0
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	100.0
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	100.0
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	100.0
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	100.0
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	100.0
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	100.0
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	100.0
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	100.0
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	100.0
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	100.0
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	100.0
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	100.0
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	100.0
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	100.0
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	100.0
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	100.0
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	100.0
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	100.0
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	100.0
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	100.0
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	100.0
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	100.0
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	100.0
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	100.0
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	100.0
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	100.0
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	100.0
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	100.0
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	100.0
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	100.0
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	99.97
d1zara2	191	Rio2 serine protein kinase C-terminal domain {Arch	99.86
d2pula1	392	Methylthioribose kinase MtnK {Bacillus subtilis [T	94.86
d2ppqa1	316	Homoserine kinase ThrB {Agrobacterium tumefaciens	93.8
d1j7la_	263	Type IIIa 3',5"-aminoglycoside phosphotransferase	92.98
d1nd4a_	255	Aminoglycoside 3'-phosphotransferase IIa (Kanamyci	91.9
d1nw1a_	395	Choline kinase {Caenorhabditis elegans [TaxId: 623	89.06
d1zyla1	325	RdoA {Escherichia coli [TaxId: 562]}	81.87

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-42  Score=259.54  Aligned_cols=158  Identities=25%  Similarity=0.426  Sum_probs=123.3

Q ss_pred             cccccccccccccCceEEEEEEEcCCCcEEEEEEccCccChHHHHHHHHHHHHHHhcCCCCchhhhhhhHHH--------
Q psy14630         23 SEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQFYGALFK--------   94 (187)
Q Consensus        23 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~--------   94 (187)
                      .++|++.+.||+|+||.||+|.++.+++.||+|.+..........+.+.++..+++.++||||+++++.+.+        
T Consensus         3 ~edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~i   82 (269)
T d2java1           3 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI   82 (269)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEE
T ss_pred             chhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEE
Confidence            578999999999999999999999999999999987654444455667777778889999999998764321        


Q ss_pred             ------------------------------HHHHHHHHHHHHHHhcC----CCeeecCCCCCeEEcCCCCEEEEeccccc
Q psy14630         95 ------------------------------EVTVATVKALNYLKEEL----KIIHRDVKPSNILLDRRGAIKLCDFGISG  140 (187)
Q Consensus        95 ------------------------------~~~~~~~~~l~~lh~~~----~i~Hrdlk~~nili~~~~~~ki~dfg~a~  140 (187)
                                                    .++.|++.||.|||+..    +|+||||||+||+++.++.+||+|||+|+
T Consensus        83 vmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~  162 (269)
T d2java1          83 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR  162 (269)
T ss_dssp             EEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHH
T ss_pred             EEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeecccee
Confidence                                          16779999999999861    39999999999999999999999999999


Q ss_pred             cccccc-cccCCCCCcCccCccccCCCccCCCCCCcceeeeEee
Q psy14630        141 QLVDSI-AKTRDAGCRPYMAPERIDPLRARGYPSFKTKLGFKFN  183 (187)
Q Consensus       141 ~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi~  183 (187)
                      .+.... ......||+.|+|||++.   ...++.++||||+|++
T Consensus       163 ~~~~~~~~~~~~~gt~~Y~APE~l~---~~~~~~~~DIwSlGvi  203 (269)
T d2java1         163 ILNHDTSFAKAFVGTPYYMSPEQMN---RMSYNEKSDIWSLGCL  203 (269)
T ss_dssp             HC-----------CCCSCCCHHHHT---TCCCCHHHHHHHHHHH
T ss_pred             ecccCCCccccCCCCcccCCHHHHc---CCCCChHHHHHhhCHH
Confidence            875432 334467999999999998   6678999999999993

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.2e-43  Score=266.58  Aligned_cols=159  Identities=42%  Similarity=0.733  Sum_probs=131.8

Q ss_pred             cCCcccccccccccccCceEEEEEEEcCCCcEEEEEEccCccChHHHHHHHHHHHHHHhcCCCCchhhhhhhHH------
Q psy14630         20 DFTSEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQFYGALF------   93 (187)
Q Consensus        20 ~~~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~------   93 (187)
                      ++..++|++.+.||+|+||.||+|.+..+++.||+|.++...... ..+.+.++..+++.++||||+++++.+.      
T Consensus         2 el~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~-~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~   80 (322)
T d1s9ja_           2 ELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPA-IRNQIIRELQVLHECNSPYIVGFYGAFYSDGEIS   80 (322)
T ss_dssp             CCCGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTT-HHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEE
T ss_pred             CCCccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHH-HHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence            456789999999999999999999999999999999987543333 3345566666788899999999986431      


Q ss_pred             --------------------------HHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEecccccccccccc
Q psy14630         94 --------------------------KEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIA  147 (187)
Q Consensus        94 --------------------------~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg~a~~~~~~~~  147 (187)
                                                ..++.|++.||.|||+..+|+||||||+|||++.++.+||+|||+|+...+.. 
T Consensus        81 iVmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~-  159 (322)
T d1s9ja_          81 ICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM-  159 (322)
T ss_dssp             EEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHHT-
T ss_pred             EEEEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCEEccccCHHHeeECCCCCEEEeeCCCccccCCCc-
Confidence                                      22778999999999974389999999999999999999999999999765443 


Q ss_pred             ccCCCCCcCccCccccCCCccCCCCCCcceeeeEee
Q psy14630        148 KTRDAGCRPYMAPERIDPLRARGYPSFKTKLGFKFN  183 (187)
Q Consensus       148 ~~~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi~  183 (187)
                      ....+||+.|+|||++.   +..++.++||||+|++
T Consensus       160 ~~~~~GT~~Y~APEvl~---~~~y~~~~DiWSlGvi  192 (322)
T d1s9ja_         160 ANSFVGTRSYMSPERLQ---GTHYSVQSDIWSMGLS  192 (322)
T ss_dssp             C---CCSSCCCCHHHHH---CSCCCTTHHHHHHHHH
T ss_pred             cccccCCccccCchHHc---CCCCCcHHHHHHHHHH
Confidence            33458999999999998   6679999999999993

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.9e-42  Score=259.65  Aligned_cols=156  Identities=26%  Similarity=0.486  Sum_probs=131.0

Q ss_pred             CcccccccccccccCceEEEEEEEcCCCcEEEEEEccCccChHHHHHHHHHHHHHHhcCCCCchhhhhhhHH--------
Q psy14630         22 TSEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQFYGALF--------   93 (187)
Q Consensus        22 ~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~--------   93 (187)
                      +.++|++.+.||+|+||+||+|.+..+++.||+|+++.....  ..+.+.++..+++.++||||+++++.+.        
T Consensus        18 p~~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~--~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv   95 (293)
T d1yhwa1          18 PKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP--KKELIINEILVMRENKNPNIVNYLDSYLVGDELWVV   95 (293)
T ss_dssp             TTTTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCS--CHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred             cccccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccCh--HHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEE
Confidence            356899999999999999999999999999999998643222  2344566677888899999999986431        


Q ss_pred             -----------------------HHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEecccccccccc-cccc
Q psy14630         94 -----------------------KEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDS-IAKT  149 (187)
Q Consensus        94 -----------------------~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg~a~~~~~~-~~~~  149 (187)
                                             ..++.|++.||.|||++ +|+||||||+|||++.++.+||+|||+|+.+... ....
T Consensus        96 mEy~~gg~L~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~-~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~  174 (293)
T d1yhwa1          96 MEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSN-QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRS  174 (293)
T ss_dssp             EECCTTCBHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTCCBC
T ss_pred             EEecCCCcHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHC-CCcccCCcHHHeEECCCCcEeeccchhheeecccccccc
Confidence                                   22778999999999997 9999999999999999999999999999987543 3334


Q ss_pred             CCCCCcCccCccccCCCccCCCCCCcceeeeEee
Q psy14630        150 RDAGCRPYMAPERIDPLRARGYPSFKTKLGFKFN  183 (187)
Q Consensus       150 ~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi~  183 (187)
                      ..+||+.|+|||++.   ...++.++||||+||.
T Consensus       175 ~~~gt~~Y~aPE~~~---~~~~~~~~DiwSlGvi  205 (293)
T d1yhwa1         175 TMVGTPYWMAPEVVT---RKAYGPKVDIWSLGIM  205 (293)
T ss_dssp             CCCSCGGGCCHHHHS---SSCBCTHHHHHHHHHH
T ss_pred             ccccCCCccChhhhc---CCCCCchhceehHhHH
Confidence            557999999999998   6678999999999993

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.7e-42  Score=258.00  Aligned_cols=157  Identities=26%  Similarity=0.395  Sum_probs=130.6

Q ss_pred             CcccccccccccccCceEEEEEEEcCCCcEEEEEEccCcc-ChHHHHHHHHHHHHHHhcCCCCchhhhhhhHHH------
Q psy14630         22 TSEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTV-DEKDQRQLLMDLDVVMKSNECPYIVQFYGALFK------   94 (187)
Q Consensus        22 ~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~------   94 (187)
                      ..++|++.+.||+|+||.||+|.++.+++.||+|++.... .+....+.+.++..+++.++||||+++++.+..      
T Consensus         4 ~l~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i   83 (263)
T d2j4za1           4 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYL   83 (263)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred             chhHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEE
Confidence            4578999999999999999999999999999999985321 111223455666778888999999999864321      


Q ss_pred             --------------------------HHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEeccccccccccccc
Q psy14630         95 --------------------------EVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAK  148 (187)
Q Consensus        95 --------------------------~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg~a~~~~~~~~~  148 (187)
                                                .++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+|+...... .
T Consensus        84 vmEy~~~g~L~~~l~~~~~l~e~~~~~i~~qi~~al~~lH~~-~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~~-~  161 (263)
T d2j4za1          84 ILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSK-RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR-R  161 (263)
T ss_dssp             EEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT-TCCCCCCCGGGEEECTTSCEEECCCCSCSCCCCCC-C
T ss_pred             EEeecCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHC-CeeeeeeccccceecCCCCEeecccceeeecCCCc-c
Confidence                                      2778999999999997 99999999999999999999999999998765433 3


Q ss_pred             cCCCCCcCccCccccCCCccCCCCCCcceeeeEee
Q psy14630        149 TRDAGCRPYMAPERIDPLRARGYPSFKTKLGFKFN  183 (187)
Q Consensus       149 ~~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi~  183 (187)
                      ....||+.|+|||++.   +.+++.++||||+|++
T Consensus       162 ~~~~Gt~~Y~APE~~~---~~~~~~~~DiwSlGvi  193 (263)
T d2j4za1         162 TTLCGTLDYLPPEMIE---GRMHDEKVDLWSLGVL  193 (263)
T ss_dssp             EETTEEGGGCCHHHHT---TCCCCTTHHHHHHHHH
T ss_pred             cccCCCCcccCHHHHc---CCCCCchhhhhhHhHH
Confidence            3457999999999998   6678999999999993

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=1.3e-42  Score=261.84  Aligned_cols=161  Identities=21%  Similarity=0.349  Sum_probs=134.4

Q ss_pred             ccccCCcccccccccccccCceEEEEEEEcCCCcEEEEEEccCccChHHHHHHHHHHHHHHhcCCCCchhhhhhhHHH--
Q psy14630         17 TVYDFTSEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQFYGALFK--   94 (187)
Q Consensus        17 ~~~~~~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~--   94 (187)
                      ..|+++.++|++.+.||+|+||.||+|.+..+++.||||.++.....   .+.+.++..+++.++||||+++++.+..  
T Consensus        10 ~~wei~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~---~~~~~~E~~il~~l~HpnIv~~~~~~~~~~   86 (287)
T d1opja_          10 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME---VEEFLKEAAVMKEIKHPNLVQLLGVCTREP   86 (287)
T ss_dssp             CTTBCCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCSC---HHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred             cccEecHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccch---HHHHHHHHHHHHhCCCCCEecCCccEeeCC
Confidence            56899999999999999999999999999999999999998754332   2335556677888999999999864321  


Q ss_pred             --------------------------------HHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEeccccccc
Q psy14630         95 --------------------------------EVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQL  142 (187)
Q Consensus        95 --------------------------------~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg~a~~~  142 (187)
                                                      .++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+|+..
T Consensus        87 ~~~iv~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~-~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~  165 (287)
T d1opja_          87 PFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK-NFIHRDLAARNCLVGENHLVKVADFGLSRLM  165 (287)
T ss_dssp             SCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCSGGGEEECGGGCEEECCCCCTTTC
T ss_pred             eeEEEeecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHC-CcccCccccCeEEECCCCcEEEccccceeec
Confidence                                            1667999999999997 9999999999999999999999999999886


Q ss_pred             ccccc--ccCCCCCcCccCccccCCCccCCCCCCcceeeeEeee
Q psy14630        143 VDSIA--KTRDAGCRPYMAPERIDPLRARGYPSFKTKLGFKFNY  184 (187)
Q Consensus       143 ~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi~~  184 (187)
                      .....  .....|++.|+|||.+.   ...++.++||||||+++
T Consensus       166 ~~~~~~~~~~~~g~~~y~aPE~~~---~~~~~~k~DiwS~Gv~l  206 (287)
T d1opja_         166 TGDTYTAHAGAKFPIKWTAPESLA---YNKFSIKSDVWAFGVLL  206 (287)
T ss_dssp             CSSSSEEETTEEECGGGCCHHHHH---HCCCSHHHHHHHHHHHH
T ss_pred             CCCCceeeccccccccccChHHHc---CCCCCchhhhhhHHHHH
Confidence            54322  22235788999999998   67799999999999944

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=6.8e-42  Score=260.14  Aligned_cols=156  Identities=28%  Similarity=0.445  Sum_probs=130.7

Q ss_pred             ccccccccccccCceEEEEEEEcCCCcEEEEEEccCcc-ChHHHHHHHHHHHHHHhcCCCCchhhhhhhHHH--------
Q psy14630         24 EDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTV-DEKDQRQLLMDLDVVMKSNECPYIVQFYGALFK--------   94 (187)
Q Consensus        24 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~--------   94 (187)
                      +.|+.++.||+|+||.||+|.+..+++.||||.+.... ......+.+.++..+++.++||||+++++++..        
T Consensus        15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~   94 (309)
T d1u5ra_          15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM   94 (309)
T ss_dssp             HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             HhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEE
Confidence            45999999999999999999999999999999986543 333444556667778888999999999865322        


Q ss_pred             ------------------------HHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEeccccccccccccccC
Q psy14630         95 ------------------------EVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAKTR  150 (187)
Q Consensus        95 ------------------------~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg~a~~~~~~~~~~~  150 (187)
                                              .++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+|+.....   ..
T Consensus        95 E~~~~g~l~~~~~~~~~l~e~~~~~i~~qi~~aL~yLH~~-~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~~---~~  170 (309)
T d1u5ra_          95 EYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSH-NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA---NS  170 (309)
T ss_dssp             ECCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHT-TCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB---CC
T ss_pred             EecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhC-CEeccCCCcceEEECCCCCEEEeecccccccCCC---Cc
Confidence                                    2778999999999998 9999999999999999999999999999876543   33


Q ss_pred             CCCCcCccCccccCCCccCCCCCCcceeeeEee
Q psy14630        151 DAGCRPYMAPERIDPLRARGYPSFKTKLGFKFN  183 (187)
Q Consensus       151 ~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi~  183 (187)
                      ..||+.|||||++.+.....++.++||||+||.
T Consensus       171 ~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvi  203 (309)
T d1u5ra_         171 FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGIT  203 (309)
T ss_dssp             CCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHH
T ss_pred             cccCccccCHHHHhccCCCCcCchhhhhhHHHH
Confidence            579999999999975434568899999999993

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.8e-42  Score=257.82  Aligned_cols=156  Identities=25%  Similarity=0.389  Sum_probs=126.9

Q ss_pred             cccccccccccccCceEEEEEEEcCCCcEEEEEEccCccChHHHHHHHHHHHHHHhcCCCCchhhhhhhHH---------
Q psy14630         23 SEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQFYGALF---------   93 (187)
Q Consensus        23 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~---------   93 (187)
                      .++|++.+.||+|+||+||+|.++.+++.||||++....... ..+.+.++..+++.++||||+++++.+.         
T Consensus         4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~-~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivm   82 (271)
T d1nvra_           4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVD-CPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFL   82 (271)
T ss_dssp             TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC--------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             CcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcch-HHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEE
Confidence            468999999999999999999999999999999986532222 2344566667888899999999986432         


Q ss_pred             -----------------------HHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEecccccccccc---cc
Q psy14630         94 -----------------------KEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDS---IA  147 (187)
Q Consensus        94 -----------------------~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg~a~~~~~~---~~  147 (187)
                                             ..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+|+.....   ..
T Consensus        83 Ey~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~al~ylH~~-~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~~~~  161 (271)
T d1nvra_          83 EYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI-GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERL  161 (271)
T ss_dssp             ECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCCGGGEEECTTCCEEECCCTTCEECEETTEECC
T ss_pred             eccCCCcHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHc-CCccCcccHHHEEECCCCCEEEccchhheeeccCCcccc
Confidence                                   22788999999999997 9999999999999999999999999999987532   22


Q ss_pred             ccCCCCCcCccCccccCCCccCCC-CCCcceeeeEee
Q psy14630        148 KTRDAGCRPYMAPERIDPLRARGY-PSFKTKLGFKFN  183 (187)
Q Consensus       148 ~~~~~~t~~y~aPE~~~~~~~~~~-~~~~D~ws~gi~  183 (187)
                      ....+||+.|||||++.   ...+ +.++||||+||+
T Consensus       162 ~~~~~GT~~Y~APE~~~---~~~~~~~~~DiwSlGvi  195 (271)
T d1nvra_         162 LNKMCGTLPYVAPELLK---RREFHAEPVDVWSCGIV  195 (271)
T ss_dssp             BCCCCSCGGGSCTHHHH---CSSBCHHHHHHHHHHHH
T ss_pred             ccceeeCcCccCHhHhc---CCCCCCCceeeeHhHHH
Confidence            34457999999999998   4555 578999999993

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.3e-42  Score=256.66  Aligned_cols=164  Identities=26%  Similarity=0.322  Sum_probs=130.1

Q ss_pred             cccCCcccccccccccccCceEEEEEEEcCCCcEEEEEEccCccChHHHHHHHHHHHHHHhcCCCCchhhhhhhHH----
Q psy14630         18 VYDFTSEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQFYGALF----   93 (187)
Q Consensus        18 ~~~~~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~----   93 (187)
                      .|+++.++|++.+.||+|+||.||+|...   ..||||+++.........+.+.++..++..++||||+++++.+.    
T Consensus         2 dwei~~~~~~~~~~lG~G~fg~Vy~~~~~---~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~   78 (276)
T d1uwha_           2 DWEIPDGQITVGQRIGSGSFGTVYKGKWH---GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTAPQL   78 (276)
T ss_dssp             CCBCCTTCCCCCSEEEECSSCEEEEEESS---SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSC
T ss_pred             CcccccccEEEEEEEeeCCCcEEEEEEEC---CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEeccEE
Confidence            47889999999999999999999999753   35999999755444444556677777888899999999876421    


Q ss_pred             ----------------------------HHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEecccccccccc
Q psy14630         94 ----------------------------KEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDS  145 (187)
Q Consensus        94 ----------------------------~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg~a~~~~~~  145 (187)
                                                  ..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+|+.....
T Consensus        79 ~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~~-~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~  157 (276)
T d1uwha_          79 AIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAK-SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRW  157 (276)
T ss_dssp             EEEEECCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCCGGGEEEETTSSEEECCCCCSCC----
T ss_pred             EEEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHhcC-CEeccccCHHHEEEcCCCCEEEccccceeecccc
Confidence                                        12778999999999997 9999999999999999999999999999876432


Q ss_pred             ---ccccCCCCCcCccCccccCCCccCCCCCCcceeeeEeeee
Q psy14630        146 ---IAKTRDAGCRPYMAPERIDPLRARGYPSFKTKLGFKFNYR  185 (187)
Q Consensus       146 ---~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi~~~  185 (187)
                         .......||+.|||||++.+.....++.++|||||||++|
T Consensus       158 ~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~  200 (276)
T d1uwha_         158 SGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLY  200 (276)
T ss_dssp             --------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHH
T ss_pred             CCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHH
Confidence               2223457899999999997543456889999999999543

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-41  Score=261.41  Aligned_cols=161  Identities=26%  Similarity=0.432  Sum_probs=132.6

Q ss_pred             CCcccccccccccccCceEEEEEEEcCCCcEEEEEEccCcc-ChHHHHHHHHHHHHHHhcCCCCchhhhhhhHH------
Q psy14630         21 FTSEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTV-DEKDQRQLLMDLDVVMKSNECPYIVQFYGALF------   93 (187)
Q Consensus        21 ~~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~------   93 (187)
                      +..++|++.+.||+|+||.||+|+++.+++.||||++++.. ......+.+..+..+++.++||||+++++++.      
T Consensus         2 i~l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~   81 (337)
T d1o6la_           2 VTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLC   81 (337)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEE
T ss_pred             CchHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccc
Confidence            35689999999999999999999999999999999986421 11112344555666788899999999875431      


Q ss_pred             --------------------------HHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEeccccccccc-cc
Q psy14630         94 --------------------------KEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVD-SI  146 (187)
Q Consensus        94 --------------------------~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg~a~~~~~-~~  146 (187)
                                                ..++.|++.||+|||++ +|+||||||+|||++.+|.+||+|||+|+.... ..
T Consensus        82 iv~ey~~gg~L~~~~~~~~~~~e~~~~~~~~qil~al~ylH~~-~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~~~  160 (337)
T d1o6la_          82 FVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSR-DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA  160 (337)
T ss_dssp             EEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHT-TCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTTC
T ss_pred             cceeccCCCchhhhhhcccCCcHHHHHHHHHHHhhhhhhhhhc-CccccccCHHHeEecCCCCEEEeecccccccccCCc
Confidence                                      12678999999999998 999999999999999999999999999997644 33


Q ss_pred             cccCCCCCcCccCccccCCCccCCCCCCcceeeeEe-eee
Q psy14630        147 AKTRDAGCRPYMAPERIDPLRARGYPSFKTKLGFKF-NYR  185 (187)
Q Consensus       147 ~~~~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi-~~~  185 (187)
                      .....+||+.|+|||++.   +.+++.++|+||+|| +|.
T Consensus       161 ~~~~~~GT~~Y~aPE~~~---~~~y~~~~DiwSlGvilye  197 (337)
T d1o6la_         161 TMKTFCGTPEYLAPEVLE---DNDYGRAVDWWGLGVVMYE  197 (337)
T ss_dssp             CBCCCEECGGGCCGGGGS---SSCBCTTHHHHHHHHHHHH
T ss_pred             ccccceeCHHHhhhhhcc---CCCCChhhcccchhhHHHH
Confidence            444568999999999998   678999999999999 443

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=7.2e-42  Score=260.80  Aligned_cols=158  Identities=30%  Similarity=0.488  Sum_probs=131.7

Q ss_pred             CcccccccccccccCceEEEEEEEcCCCcEEEEEEccCcc-ChHHHHHHHHHHHHHHhcCCCCchhhhhhhHH-------
Q psy14630         22 TSEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTV-DEKDQRQLLMDLDVVMKSNECPYIVQFYGALF-------   93 (187)
Q Consensus        22 ~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~-------   93 (187)
                      ..++|++.+.||+|+||+||+|+++.+++.||||+++... ......+.+.++..+++.++||||+++++.+.       
T Consensus         2 sl~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~i   81 (316)
T d1fota_           2 SLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFM   81 (316)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEE
T ss_pred             chhHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeee
Confidence            4578999999999999999999999999999999986321 11122345666777888899999999986432       


Q ss_pred             -------------------------HHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEeccccccccccccc
Q psy14630         94 -------------------------KEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAK  148 (187)
Q Consensus        94 -------------------------~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg~a~~~~~~~~~  148 (187)
                                               ..++.|++.|+.|||+. +|+||||||+|||++.++.+||+|||+|+......  
T Consensus        82 vmE~~~gg~l~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~-~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~~--  158 (316)
T d1fota_          82 IMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSK-DIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVT--  158 (316)
T ss_dssp             EECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTT-TEECCCCCGGGEEECTTSCEEECCCSSCEECSSCB--
T ss_pred             EeeecCCccccccccccccccccHHHHHHHHHHHhhhhhccC-cEEccccCchheeEcCCCCEEEecCccceEecccc--
Confidence                                     12678999999999997 99999999999999999999999999998875432  


Q ss_pred             cCCCCCcCccCccccCCCccCCCCCCcceeeeEe-eee
Q psy14630        149 TRDAGCRPYMAPERIDPLRARGYPSFKTKLGFKF-NYR  185 (187)
Q Consensus       149 ~~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi-~~~  185 (187)
                      ...+||+.|+|||++.   ...++.++|+||+|| +|+
T Consensus       159 ~~~~Gt~~Y~APE~l~---~~~y~~~~DiwSlGvilye  193 (316)
T d1fota_         159 YTLCGTPDYIAPEVVS---TKPYNKSIDWWSFGILIYE  193 (316)
T ss_dssp             CCCCSCTTTCCHHHHT---TCCBCTTHHHHHHHHHHHH
T ss_pred             ccccCcccccCHHHHc---CCCCCchhhccccchhHHH
Confidence            3458999999999998   667899999999999 443

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.9e-42  Score=257.77  Aligned_cols=159  Identities=26%  Similarity=0.359  Sum_probs=128.6

Q ss_pred             cccccccccccccCceEEEEEEEcCCCcEEEEEEccCcc-ChHHHHHHHHHHHHHHhcCCCCchhhhhhhHHH-------
Q psy14630         23 SEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTV-DEKDQRQLLMDLDVVMKSNECPYIVQFYGALFK-------   94 (187)
Q Consensus        23 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~-------   94 (187)
                      .++|++.+.||+|+||+||+|.+..+++.||||++.... ......+.+.++..+++.++||||+++++.+..       
T Consensus         7 p~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~iv   86 (288)
T d1uu3a_           7 PEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFG   86 (288)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEE
T ss_pred             CCCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEE
Confidence            478999999999999999999999999999999986321 111223456667777888999999998864311       


Q ss_pred             -------------------------HHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEecccccccccc---c
Q psy14630         95 -------------------------EVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDS---I  146 (187)
Q Consensus        95 -------------------------~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg~a~~~~~~---~  146 (187)
                                               .++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+|+.+...   .
T Consensus        87 mEy~~gg~L~~~~~~~~~l~e~~~~~~~~qi~~al~ylH~~-~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~~~~  165 (288)
T d1uu3a_          87 LSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK-GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQA  165 (288)
T ss_dssp             ECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEECTTSCEEECCCTTCEECC------
T ss_pred             EEccCCCCHHHhhhccCCCCHHHHHHHHHHHHHHHHhhccc-cEEcCcCCccccccCCCceEEecccccceecccCCccc
Confidence                                     2678999999999998 9999999999999999999999999999887532   2


Q ss_pred             cccCCCCCcCccCccccCCCccCCCCCCcceeeeEe-eee
Q psy14630        147 AKTRDAGCRPYMAPERIDPLRARGYPSFKTKLGFKF-NYR  185 (187)
Q Consensus       147 ~~~~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi-~~~  185 (187)
                      .....+||+.|+|||++.   +..++.++||||+|| +|+
T Consensus       166 ~~~~~~GT~~Y~APE~~~---~~~~~~~~DiwSlGvilye  202 (288)
T d1uu3a_         166 RANSFVGTAQYVSPELLT---EKSACKSSDLWALGCIIYQ  202 (288)
T ss_dssp             ----CCCCGGGCCHHHHH---TCCCCHHHHHHHHHHHHHH
T ss_pred             ccccccCCccccCceeec---cCCCCcccceehhhHHHHH
Confidence            233457999999999998   667899999999999 443

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-41  Score=256.58  Aligned_cols=158  Identities=32%  Similarity=0.467  Sum_probs=128.1

Q ss_pred             cccccccccccccCceEEEEEEEcCCCcEEEEEEccCccChHHHHHHHHHHHHHHhcCCCCchhhhhhhHH---------
Q psy14630         23 SEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQFYGALF---------   93 (187)
Q Consensus        23 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~---------   93 (187)
                      .+.|++.+.||+|+||.||+|.+..+++.||+|+++.....  ..+.+.++..+++.++||||+++++.+.         
T Consensus        11 ~d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~--~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvm   88 (288)
T d2jfla1          11 EDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEE--ELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILI   88 (288)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSG--GGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             ccCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHH--HHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEE
Confidence            35689999999999999999999999999999998643222  2234455666778899999999986431         


Q ss_pred             ------------------------HHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEecccccccccc-ccc
Q psy14630         94 ------------------------KEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDS-IAK  148 (187)
Q Consensus        94 ------------------------~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg~a~~~~~~-~~~  148 (187)
                                              ..++.|++.||.|||++ +|+||||||+||+++.++.+||+|||+|+..... ...
T Consensus        89 Ey~~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~~-~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~~~~  167 (288)
T d2jfla1          89 EFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDN-KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRR  167 (288)
T ss_dssp             ECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEECTTSCEEECCCTTCEECHHHHHHH
T ss_pred             ecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC-CEEEeecChhheeECCCCCEEEEechhhhccCCCcccc
Confidence                                    12778999999999998 9999999999999999999999999999876543 223


Q ss_pred             cCCCCCcCccCccccCCC--ccCCCCCCcceeeeEee
Q psy14630        149 TRDAGCRPYMAPERIDPL--RARGYPSFKTKLGFKFN  183 (187)
Q Consensus       149 ~~~~~t~~y~aPE~~~~~--~~~~~~~~~D~ws~gi~  183 (187)
                      ....||+.|+|||++...  ...+++.++||||+||.
T Consensus       168 ~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvi  204 (288)
T d2jfla1         168 DSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGIT  204 (288)
T ss_dssp             TCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHH
T ss_pred             cccccccccCCHHHHhhcccCCCCCChhhhHHHHHHH
Confidence            345799999999998532  24568899999999994

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.3e-41  Score=253.24  Aligned_cols=163  Identities=21%  Similarity=0.334  Sum_probs=134.1

Q ss_pred             CCccccCCcccccccccccccCceEEEEEEEcCCCcEEEEEEccCccChHHHHHHHHHHHHHHhcCCCCchhhhhhhHHH
Q psy14630         15 PDTVYDFTSEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQFYGALFK   94 (187)
Q Consensus        15 ~~~~~~~~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~   94 (187)
                      ....|+++.++|++.+.||+|+||.||+|.+. +++.||||.++.....   .+.+.++..++..++||||+++++.+.+
T Consensus         4 ~~~~wei~~~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~---~~~~~~E~~~l~~l~HpnIv~~~g~~~~   79 (272)
T d1qpca_           4 WEDEWEVPRETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSMS---PDAFLAEANLMKQLQHQRLVRLYAVVTQ   79 (272)
T ss_dssp             TTCTTBCCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTSSC---HHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             CCCCeecCHHHeEEeEEEecCCCcEEEEEEEC-CCCEEEEEEEccCcCC---HHHHHHHHHHHHhCCCCCEeEEEeeecc
Confidence            35678999999999999999999999999984 6788999998754332   2345566667788899999999864311


Q ss_pred             ---------------------------------HHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEecccccc
Q psy14630         95 ---------------------------------EVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQ  141 (187)
Q Consensus        95 ---------------------------------~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg~a~~  141 (187)
                                                       .++.|++.||.|||+. +|+||||||+||+++.++.+||+|||+|+.
T Consensus        80 ~~~~iv~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~-~ivHrDiKp~NIll~~~~~~Kl~DFGla~~  158 (272)
T d1qpca_          80 EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER-NYIHRDLRAANILVSDTLSCKIADFGLARL  158 (272)
T ss_dssp             SSCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred             CCeEEEEEeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhC-CcccCccchhheeeecccceeeccccceEE
Confidence                                             2678999999999997 999999999999999999999999999998


Q ss_pred             ccccc--cccCCCCCcCccCccccCCCccCCCCCCcceeeeEeeee
Q psy14630        142 LVDSI--AKTRDAGCRPYMAPERIDPLRARGYPSFKTKLGFKFNYR  185 (187)
Q Consensus       142 ~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi~~~  185 (187)
                      ..+..  ......||+.|+|||++.   ...++.++||||||+++|
T Consensus       159 ~~~~~~~~~~~~~gt~~y~APE~~~---~~~~~~~sDvwS~Gvvl~  201 (272)
T d1qpca_         159 IEDNEYTAREGAKFPIKWTAPEAIN---YGTFTIKSDVWSFGILLT  201 (272)
T ss_dssp             CSSSCEECCTTCCCCTTTSCHHHHH---HCEECHHHHHHHHHHHHH
T ss_pred             ccCCccccccccCCcccccChHHHh---CCCCCchhhhhhhHHHHH
Confidence            75432  223446889999999998   566899999999999443

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-40  Score=248.23  Aligned_cols=152  Identities=28%  Similarity=0.401  Sum_probs=125.5

Q ss_pred             ccccccccccCceEEEEEEEcCCCcEEEEEEccCccChHHHHHHHHHHHHHHhcCCCCchhhhhhhHH------------
Q psy14630         26 LQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQFYGALF------------   93 (187)
Q Consensus        26 ~~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~------------   93 (187)
                      |++.++||+|+||+||+|.+..+++.||+|.+..........+.+.++..+++.++||||+++++.+.            
T Consensus        11 ~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~iv   90 (270)
T d1t4ha_          11 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV   90 (270)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEE
T ss_pred             EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEE
Confidence            46677899999999999999999999999998654434444556777778889999999999876431            


Q ss_pred             ------------------------HHHHHHHHHHHHHHHhcCC--CeeecCCCCCeEEc-CCCCEEEEeccccccccccc
Q psy14630         94 ------------------------KEVTVATVKALNYLKEELK--IIHRDVKPSNILLD-RRGAIKLCDFGISGQLVDSI  146 (187)
Q Consensus        94 ------------------------~~~~~~~~~~l~~lh~~~~--i~Hrdlk~~nili~-~~~~~ki~dfg~a~~~~~~~  146 (187)
                                              ..++.|++.||+|||++ +  |+||||||+|||++ .++.+||+|||+|+......
T Consensus        91 mE~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~gl~yLH~~-~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~~~~  169 (270)
T d1t4ha_          91 TELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTR-TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASF  169 (270)
T ss_dssp             EECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTS-SSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCTTS
T ss_pred             EeCCCCCcHHHHHhccccccHHHHHHHHHHHHHHHHHHHHC-CCCEEeCCcChhhceeeCCCCCEEEeecCcceeccCCc
Confidence                                    12678999999999997 7  99999999999996 57899999999998654432


Q ss_pred             cccCCCCCcCccCccccCCCccCCCCCCcceeeeEee
Q psy14630        147 AKTRDAGCRPYMAPERIDPLRARGYPSFKTKLGFKFN  183 (187)
Q Consensus       147 ~~~~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi~  183 (187)
                       ....+||+.|+|||++.   + .++.++||||+|+.
T Consensus       170 -~~~~~GT~~Y~aPE~~~---~-~~~~~~DIwSlGvi  201 (270)
T d1t4ha_         170 -AKAVIGTPEFMAPEMYE---E-KYDESVDVYAFGMC  201 (270)
T ss_dssp             -BEESCSSCCCCCGGGGG---T-CCCTHHHHHHHHHH
T ss_pred             -cCCcccCccccCHHHhC---C-CCCCcCchhhHHHH
Confidence             33458999999999986   3 48999999999993

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=3.7e-41  Score=260.11  Aligned_cols=156  Identities=22%  Similarity=0.377  Sum_probs=129.7

Q ss_pred             CcccccccccccccCceEEEEEEEcCCCcEEEEEEccCcc-ChHHHHHHHHHHHHHHhcCCCCchhhhhhhH--------
Q psy14630         22 TSEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTV-DEKDQRQLLMDLDVVMKSNECPYIVQFYGAL--------   92 (187)
Q Consensus        22 ~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~--------   92 (187)
                      ..++|++++.||+|+||.||+|.+..+++.||||++.... .+....+.+..+..+++.++||||+++++.+        
T Consensus        39 ~ld~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~  118 (350)
T d1rdqe_          39 QLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYM  118 (350)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred             CccCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccc
Confidence            3578999999999999999999999999999999985321 1111234455666788889999999987543        


Q ss_pred             ------------------------HHHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEeccccccccccccc
Q psy14630         93 ------------------------FKEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAK  148 (187)
Q Consensus        93 ------------------------~~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg~a~~~~~~~~~  148 (187)
                                              ...++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+|+......  
T Consensus       119 v~e~~~~g~l~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~-~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~~--  195 (350)
T d1rdqe_         119 VMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSL-DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT--  195 (350)
T ss_dssp             EEECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEECTTSCEEECCCTTCEECSSCB--
T ss_pred             ccccccccchhhhHhhcCCCCHHHHHHHHHHHHHHHHHHHhC-CEecCcCCHHHcccCCCCCEEeeeceeeeeccccc--
Confidence                                    122778999999999997 99999999999999999999999999999875432  


Q ss_pred             cCCCCCcCccCccccCCCccCCCCCCcceeeeEee
Q psy14630        149 TRDAGCRPYMAPERIDPLRARGYPSFKTKLGFKFN  183 (187)
Q Consensus       149 ~~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi~  183 (187)
                      ....||+.|||||++.   +.+++.++|+||+||+
T Consensus       196 ~~~~Gt~~Y~APE~~~---~~~~~~~~DiwSlGvi  227 (350)
T d1rdqe_         196 WTLCGTPEALAPEIIL---SKGYNKAVDWWALGVL  227 (350)
T ss_dssp             CCCEECGGGCCHHHHT---TCCBCTHHHHHHHHHH
T ss_pred             ccccCccccCCHHHHc---CCCCCccccccchhHH
Confidence            3457999999999998   6778999999999993

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=5e-41  Score=255.17  Aligned_cols=156  Identities=22%  Similarity=0.304  Sum_probs=113.5

Q ss_pred             cccccccccccccCceEEEEEEEcCCCcEEEEEEccCccChHHHHHHHHHHHHHHhcCCCCchhhhhhhHH---------
Q psy14630         23 SEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQFYGALF---------   93 (187)
Q Consensus        23 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~---------   93 (187)
                      .+.|++.+.||+|+||+||+|.+..+++.||+|++........ .+.+.++..+++.++||||+++++.+.         
T Consensus         8 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~-~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvm   86 (307)
T d1a06a_           8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGK-EGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIM   86 (307)
T ss_dssp             GGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC-----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             ccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhH-HHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence            4669999999999999999999999999999999865432222 234555667788899999999886431         


Q ss_pred             -----------------------HHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEc---CCCCEEEEecccccccccccc
Q psy14630         94 -----------------------KEVTVATVKALNYLKEELKIIHRDVKPSNILLD---RRGAIKLCDFGISGQLVDSIA  147 (187)
Q Consensus        94 -----------------------~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~---~~~~~ki~dfg~a~~~~~~~~  147 (187)
                                             ..++.|++.||.|||+. +++||||||+||++.   .++.+||+|||+++.......
T Consensus        87 E~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~-~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~~~~  165 (307)
T d1a06a_          87 QLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDL-GIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSV  165 (307)
T ss_dssp             CCCCSCBHHHHHHTCSCCCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCCGGGEEESSSSTTCCEEECCC-----------
T ss_pred             eccCCCcHHHhhhcccCCCHHHHHHHHHHHHHHHHhhhhc-eeeeEEecccceeecccCCCceEEEeccceeEEccCCCe
Confidence                                   12778999999999997 999999999999994   578999999999988765555


Q ss_pred             ccCCCCCcCccCccccCCCccCCCCCCcceeeeEee
Q psy14630        148 KTRDAGCRPYMAPERIDPLRARGYPSFKTKLGFKFN  183 (187)
Q Consensus       148 ~~~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi~  183 (187)
                      ....+||+.|+|||++.   ...++.++||||+||+
T Consensus       166 ~~~~~GT~~y~APE~~~---~~~~~~~~DiwSlGvi  198 (307)
T d1a06a_         166 LSTACGTPGYVAPEVLA---QKPYSKAVDCWSIGVI  198 (307)
T ss_dssp             -------CTTSCHHHHT---TCCCCTHHHHHHHHHH
T ss_pred             eeeeeeCccccCcHHHc---CCCCCcHHHhhhhhHH
Confidence            55568999999999998   6678999999999993

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-40  Score=254.80  Aligned_cols=168  Identities=21%  Similarity=0.362  Sum_probs=129.5

Q ss_pred             CCCccccCCcccccccccccccCceEEEEEEEcCCCc-----EEEEEEccCccChHHHHHHHHHHHHHHhcCCCCchhhh
Q psy14630         14 SPDTVYDFTSEDLQDLGEIGRGGFGTVNKMIHRSSDT-----VMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQF   88 (187)
Q Consensus        14 ~~~~~~~~~~~~~~~~~~lg~G~fg~V~~~~~~~~~~-----~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~   88 (187)
                      .....|+++.++|++.+.||+|+||+||+|.+..+++     .||+|.+..............|+..+.+..+|||||++
T Consensus        27 ~~~~kwei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l  106 (325)
T d1rjba_          27 EYDLKWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNL  106 (325)
T ss_dssp             CCCGGGBCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCE
T ss_pred             CCCccccCCHHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEE
Confidence            3356688999999999999999999999999865543     68999986543333333444555545455589999998


Q ss_pred             hhhHH-------------------------------------------------------HHHHHHHHHHHHHHHhcCCC
Q psy14630         89 YGALF-------------------------------------------------------KEVTVATVKALNYLKEELKI  113 (187)
Q Consensus        89 ~~~~~-------------------------------------------------------~~~~~~~~~~l~~lh~~~~i  113 (187)
                      ++++.                                                       ..++.|++.||+|||++ +|
T Consensus       107 ~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~-~I  185 (325)
T d1rjba_         107 LGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK-SC  185 (325)
T ss_dssp             EEEECSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT-TE
T ss_pred             EEEEeeCCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC-Ce
Confidence            75321                                                       11567999999999998 99


Q ss_pred             eeecCCCCCeEEcCCCCEEEEecccccccccccc---ccCCCCCcCccCccccCCCccCCCCCCcceeeeEeeee
Q psy14630        114 IHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIA---KTRDAGCRPYMAPERIDPLRARGYPSFKTKLGFKFNYR  185 (187)
Q Consensus       114 ~Hrdlk~~nili~~~~~~ki~dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi~~~  185 (187)
                      +||||||+||+++.++.+||+|||+|+.......   .....||+.|||||++.   ...++.++|||||||++|
T Consensus       186 iHRDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~---~~~~~~~~DiwS~Gvil~  257 (325)
T d1rjba_         186 VHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLF---EGIYTIKSDVWSYGILLW  257 (325)
T ss_dssp             EETTCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHH---HCCCCHHHHHHHHHHHHH
T ss_pred             eeccCchhccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHc---CCCCCcceeccchhHHHH
Confidence            9999999999999999999999999987654322   22345789999999998   677999999999999443

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=100.00  E-value=2.4e-40  Score=255.42  Aligned_cols=155  Identities=21%  Similarity=0.335  Sum_probs=131.0

Q ss_pred             cccccccccccccCceEEEEEEEcCCCcEEEEEEccCccChHHHHHHHHHHHHHHhcCCCCchhhhhhhHH---------
Q psy14630         23 SEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQFYGALF---------   93 (187)
Q Consensus        23 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~---------   93 (187)
                      .++|++.+.||+|+||.||+|.+..+++.||||.+....  ....+.+.++..+++.++||||+++++++.         
T Consensus        25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~--~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm  102 (350)
T d1koaa2          25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPH--ESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIY  102 (350)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCS--HHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEE
T ss_pred             ccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccc--hhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence            468999999999999999999999999999999986432  233455666777888899999999886431         


Q ss_pred             ------------------------HHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcC--CCCEEEEecccccccccccc
Q psy14630         94 ------------------------KEVTVATVKALNYLKEELKIIHRDVKPSNILLDR--RGAIKLCDFGISGQLVDSIA  147 (187)
Q Consensus        94 ------------------------~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~--~~~~ki~dfg~a~~~~~~~~  147 (187)
                                              ..++.|++.||.|||+. +++||||||+||+++.  ++.+||+|||+++.+.....
T Consensus       103 E~~~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~~-~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~~~  181 (350)
T d1koaa2         103 EFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHEN-NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQS  181 (350)
T ss_dssp             CCCCSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHHT-TEECCCCCGGGEEESSTTSCCEEECCCTTCEECCTTSC
T ss_pred             EcCCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhc-CCeeeeechhHeeeccCCCCeEEEeecchheecccccc
Confidence                                    12778999999999998 9999999999999954  57899999999998776555


Q ss_pred             ccCCCCCcCccCccccCCCccCCCCCCcceeeeEee
Q psy14630        148 KTRDAGCRPYMAPERIDPLRARGYPSFKTKLGFKFN  183 (187)
Q Consensus       148 ~~~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi~  183 (187)
                      .....||+.|||||++.   ...++.++||||+|++
T Consensus       182 ~~~~~gT~~Y~aPEv~~---~~~~~~~~DiwSlGvi  214 (350)
T d1koaa2         182 VKVTTGTAEFAAPEVAE---GKPVGYYTDMWSVGVL  214 (350)
T ss_dssp             EEEECSCTTTCCHHHHH---TCCBCHHHHHHHHHHH
T ss_pred             cceecCcccccCHHHHc---CCCCChhHhhhhhhHH
Confidence            55568999999999998   6678999999999993

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3e-40  Score=248.43  Aligned_cols=161  Identities=24%  Similarity=0.339  Sum_probs=122.7

Q ss_pred             cCCcccccccccccccCceEEEEEEEcCCC----cEEEEEEccCccChHHHHHHHHHHHHHHhcCCCCchhhhhhhHHH-
Q psy14630         20 DFTSEDLQDLGEIGRGGFGTVNKMIHRSSD----TVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQFYGALFK-   94 (187)
Q Consensus        20 ~~~~~~~~~~~~lg~G~fg~V~~~~~~~~~----~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~-   94 (187)
                      ++..++|++.+.||+|+||.||+|.+..++    ..||||.+........ ...+.++..+++.++||||+++++.+.. 
T Consensus         3 ei~~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~-~~~~~~E~~il~~l~H~nIv~~~g~~~~~   81 (283)
T d1mqba_           3 EIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQ-RVDFLGEAGIMGQFSHHNIIRLEGVISKY   81 (283)
T ss_dssp             BCCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHH-HHHHHHHHHHHHTCCCTTBCCEEEEECSS
T ss_pred             cCCHHHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHH-HHHHHHHHHHHHhcCCCCEeeeeEEEecC
Confidence            456678999999999999999999876544    4699999875444433 3345556667888899999999865421 


Q ss_pred             --------------------------------HHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEeccccccc
Q psy14630         95 --------------------------------EVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQL  142 (187)
Q Consensus        95 --------------------------------~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg~a~~~  142 (187)
                                                      .++.|++.|+.|||+. +|+||||||+|||++.++.+||+|||+++.+
T Consensus        82 ~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~~-~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~  160 (283)
T d1mqba_          82 KPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANM-NYVHRDLAARNILVNSNLVCKVSDFGLSRVL  160 (283)
T ss_dssp             SSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCCGGGEEECTTCCEEECCCCC----
T ss_pred             CceEEEEEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhcccc-ccccCccccceEEECCCCeEEEcccchhhcc
Confidence                                            2778999999999997 9999999999999999999999999999886


Q ss_pred             cccc----cccCCCCCcCccCccccCCCccCCCCCCcceeeeEeeee
Q psy14630        143 VDSI----AKTRDAGCRPYMAPERIDPLRARGYPSFKTKLGFKFNYR  185 (187)
Q Consensus       143 ~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi~~~  185 (187)
                      ....    ......||+.|+|||.+.   ...++.++||||||+++|
T Consensus       161 ~~~~~~~~~~~~~~gt~~Y~APE~l~---~~~~~~~sDI~S~Gvil~  204 (283)
T d1mqba_         161 EDDPEATYTTSGGKIPIRWTAPEAIS---YRKFTSASDVWSFGIVMW  204 (283)
T ss_dssp             -------------CCCGGGSCHHHHH---SCCCCHHHHHHHHHHHHH
T ss_pred             cCCCccceEeccCCCCccccCHHHHc---cCCCCCcccccccHHHHH
Confidence            5432    222346789999999998   667999999999999544

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=100.00  E-value=2.5e-40  Score=255.51  Aligned_cols=157  Identities=20%  Similarity=0.363  Sum_probs=132.3

Q ss_pred             cccccccccccccCceEEEEEEEcCCCcEEEEEEccCccChHHHHHHHHHHHHHHhcCCCCchhhhhhhHHH--------
Q psy14630         23 SEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQFYGALFK--------   94 (187)
Q Consensus        23 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~--------   94 (187)
                      .++|++.+.||+|+||.||+|.+..+++.||||+++...  ....+.+.++..+++.++||||+++++++..        
T Consensus        28 ~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~--~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm  105 (352)
T d1koba_          28 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY--PLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLIL  105 (352)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS--HHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEE
T ss_pred             ccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcc--hhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence            367999999999999999999999999999999986532  2233455667778888999999999865321        


Q ss_pred             -------------------------HHHHHHHHHHHHHHhcCCCeeecCCCCCeEEc--CCCCEEEEecccccccccccc
Q psy14630         95 -------------------------EVTVATVKALNYLKEELKIIHRDVKPSNILLD--RRGAIKLCDFGISGQLVDSIA  147 (187)
Q Consensus        95 -------------------------~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~--~~~~~ki~dfg~a~~~~~~~~  147 (187)
                                               .++.|++.||.|||+. +|+||||||+|||++  ..+.+||+|||+|+.+.....
T Consensus       106 E~~~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~-~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~~~  184 (352)
T d1koba_         106 EFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEH-SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEI  184 (352)
T ss_dssp             ECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHT-TEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTSC
T ss_pred             EcCCCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC-CeeecccccccccccccCCCeEEEeecccceecCCCCc
Confidence                                     2778999999999997 999999999999997  578999999999998876655


Q ss_pred             ccCCCCCcCccCccccCCCccCCCCCCcceeeeEe-eee
Q psy14630        148 KTRDAGCRPYMAPERIDPLRARGYPSFKTKLGFKF-NYR  185 (187)
Q Consensus       148 ~~~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi-~~~  185 (187)
                      .....||+.|+|||++.   ...++.++||||+|+ +|+
T Consensus       185 ~~~~~gt~~y~aPE~~~---~~~~~~~~DiwSlGvilye  220 (352)
T d1koba_         185 VKVTTATAEFAAPEIVD---REPVGFYTDMWAIGVLGYV  220 (352)
T ss_dssp             EEEECSSGGGCCHHHHT---TCCBCHHHHHHHHHHHHHH
T ss_pred             eeeccCcccccCHHHHc---CCCCCCccchHHHHHHHHH
Confidence            55568999999999998   667999999999999 443

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.6e-40  Score=248.06  Aligned_cols=156  Identities=22%  Similarity=0.270  Sum_probs=130.0

Q ss_pred             ccccccccccccCceEEEEEEEcCCCcEEEEEEccCccCh----HHHHHHHHHHHHHHhcCCCCchhhhhhhHHH-----
Q psy14630         24 EDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDE----KDQRQLLMDLDVVMKSNECPYIVQFYGALFK-----   94 (187)
Q Consensus        24 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~----~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~-----   94 (187)
                      ++|++.+.||+|+||+||+|.+..+++.||||+++.....    ....+.+.++..+++.++||||+++++++..     
T Consensus        10 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~   89 (293)
T d1jksa_          10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI   89 (293)
T ss_dssp             GTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             cCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence            5699999999999999999999999999999998543211    1123455666677888899999999864321     


Q ss_pred             ---------------------------HHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCC----CEEEEecccccccc
Q psy14630         95 ---------------------------EVTVATVKALNYLKEELKIIHRDVKPSNILLDRRG----AIKLCDFGISGQLV  143 (187)
Q Consensus        95 ---------------------------~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~----~~ki~dfg~a~~~~  143 (187)
                                                 .++.|++.||+|||+. +++||||||+||+++.++    .+|++|||+++...
T Consensus        90 iv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~qi~~al~yLH~~-~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a~~~~  168 (293)
T d1jksa_          90 LILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSL-QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKID  168 (293)
T ss_dssp             EEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEESCSSSSSCCEEECCCTTCEECT
T ss_pred             EEEEcCCCccccchhccccccchhHHHHHHHHHHHHHHhhhhc-ceeecccccceEEEecCCCcccceEecchhhhhhcC
Confidence                                       2778999999999998 999999999999998776    49999999999887


Q ss_pred             ccccccCCCCCcCccCccccCCCccCCCCCCcceeeeEee
Q psy14630        144 DSIAKTRDAGCRPYMAPERIDPLRARGYPSFKTKLGFKFN  183 (187)
Q Consensus       144 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi~  183 (187)
                      .........+|+.|+|||++.   ...++.++||||+||+
T Consensus       169 ~~~~~~~~~~t~~y~APE~~~---~~~~~~~~DiwSlGvi  205 (293)
T d1jksa_         169 FGNEFKNIFGTPEFVAPEIVN---YEPLGLEADMWSIGVI  205 (293)
T ss_dssp             TSCBCSCCCCCGGGCCHHHHT---TCCBCTHHHHHHHHHH
T ss_pred             CCccccccCCCCcccCHHHHc---CCCCCCcccchhhhHH
Confidence            655555668999999999998   6678999999999993

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=100.00  E-value=7.2e-40  Score=254.04  Aligned_cols=160  Identities=24%  Similarity=0.397  Sum_probs=126.7

Q ss_pred             CcccccccccccccCceEEEEEEEcCCCcEEEEEEccCccCh----HHHHHHHHHHHHHHhcCCCCchhhhhhhHH----
Q psy14630         22 TSEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDE----KDQRQLLMDLDVVMKSNECPYIVQFYGALF----   93 (187)
Q Consensus        22 ~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~----~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~----   93 (187)
                      ..++|++.+.||+|+||.||+|++..+++.||||++......    .........+..+++.++||||+++++++.    
T Consensus         2 slddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~   81 (364)
T d1omwa3           2 TMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDK   81 (364)
T ss_dssp             CSTTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSE
T ss_pred             CHHhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCE
Confidence            467899999999999999999999999999999998532111    111111222344566778999999875431    


Q ss_pred             ----------------------------HHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEecccccccccc
Q psy14630         94 ----------------------------KEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDS  145 (187)
Q Consensus        94 ----------------------------~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg~a~~~~~~  145 (187)
                                                  ..++.|++.||.|||+. +++||||||+|||++.++.+||+|||+|+.+...
T Consensus        82 ~~ivmE~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~ylH~~-~iiHrDlKP~NILl~~~g~iKl~DFGla~~~~~~  160 (364)
T d1omwa3          82 LSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNR-FVVYRDLKPANILLDEHGHVRISDLGLACDFSKK  160 (364)
T ss_dssp             EEEEECCCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEECSSSCEEECCCTTCEECSSS
T ss_pred             EEEEEEecCCCcHHHHHHhcccccHHHHHHHHHHHHHHHHHHHHC-CccceeeccceeEEcCCCcEEEeeeceeeecCCC
Confidence                                        12678999999999998 9999999999999999999999999999877654


Q ss_pred             ccccCCCCCcCccCccccCCCccCCCCCCcceeeeEe-eee
Q psy14630        146 IAKTRDAGCRPYMAPERIDPLRARGYPSFKTKLGFKF-NYR  185 (187)
Q Consensus       146 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi-~~~  185 (187)
                      . .....||+.|+|||++..  ...++.++||||+|| +|+
T Consensus       161 ~-~~~~~GT~~y~APE~~~~--~~~~~~~~DiwSlGvilye  198 (364)
T d1omwa3         161 K-PHASVGTHGYMAPEVLQK--GVAYDSSADWFSLGCMLFK  198 (364)
T ss_dssp             C-CCSCCSCGGGCCHHHHST--TCCCCTHHHHHHHHHHHHH
T ss_pred             c-ccccccccccchhHHhhc--CCCCCcccchhHHHHHHHH
Confidence            3 334579999999999873  456889999999999 443

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.8e-40  Score=249.03  Aligned_cols=164  Identities=26%  Similarity=0.425  Sum_probs=125.5

Q ss_pred             ccccCCcccccccccccccCceEEEEEEEcC-----CCcEEEEEEccCccChHHHHHHHHHHHHHHhcCCCCchhhhhhh
Q psy14630         17 TVYDFTSEDLQDLGEIGRGGFGTVNKMIHRS-----SDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQFYGA   91 (187)
Q Consensus        17 ~~~~~~~~~~~~~~~lg~G~fg~V~~~~~~~-----~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~   91 (187)
                      ..|+++.++|++.+.||+|+||.||+|.+..     +++.||||.++...........+.++..+.+..+|+||+.+++.
T Consensus         6 ~~wei~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~   85 (299)
T d1ywna1           6 SKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGA   85 (299)
T ss_dssp             HHHBCCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             ccccccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeee
Confidence            5688999999999999999999999998754     44689999987655555555666677777777889999876532


Q ss_pred             H-------------------------------------------------HHHHHHHHHHHHHHHHhcCCCeeecCCCCC
Q psy14630         92 L-------------------------------------------------FKEVTVATVKALNYLKEELKIIHRDVKPSN  122 (187)
Q Consensus        92 ~-------------------------------------------------~~~~~~~~~~~l~~lh~~~~i~Hrdlk~~n  122 (187)
                      +                                                 ...++.|++.||.|||+. +|+||||||+|
T Consensus        86 ~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~-~ivHrDlKp~N  164 (299)
T d1ywna1          86 CTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR-KCIHRDLAARN  164 (299)
T ss_dssp             ECSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCCGGG
T ss_pred             eccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhC-CCcCCcCCccc
Confidence            1                                                 112567899999999997 99999999999


Q ss_pred             eEEcCCCCEEEEeccccccccccc---cccCCCCCcCccCccccCCCccCCCCCCcceeeeEeee
Q psy14630        123 ILLDRRGAIKLCDFGISGQLVDSI---AKTRDAGCRPYMAPERIDPLRARGYPSFKTKLGFKFNY  184 (187)
Q Consensus       123 ili~~~~~~ki~dfg~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi~~  184 (187)
                      ||++.++.+||+|||+|+......   ......||+.|+|||.+.   ...++.++||||||+++
T Consensus       165 ILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~---~~~~~~~sDiwS~Gvil  226 (299)
T d1ywna1         165 ILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIF---DRVYTIQSDVWSFGVLL  226 (299)
T ss_dssp             EEECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHH---HCCCCHHHHHHHHHHHH
T ss_pred             eeECCCCcEEEccCcchhhccccccccccCceeeCccccchhHhh---cCCCCcccceeehHHHH
Confidence            999999999999999998764332   223457899999999998   67789999999999943

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.1e-40  Score=246.82  Aligned_cols=156  Identities=26%  Similarity=0.373  Sum_probs=118.8

Q ss_pred             CcccccccccccccCceEEEEEEEcCCCcEEEEEEccCccChHHHHHHHHHHHHHHhcCCCCchhhhhhhHHH-------
Q psy14630         22 TSEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQFYGALFK-------   94 (187)
Q Consensus        22 ~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~-------   94 (187)
                      ..++|++.+.||+|+||.||+|.+. +++.||||.++.....   .+.+.++..+++.++||||+++++.+..       
T Consensus         3 dp~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~---~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv   78 (263)
T d1sm2a_           3 DPSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMS---EEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLV   78 (263)
T ss_dssp             CCSCEEEEEEEECCSSCCEEEEEET-TTEEEEEEECCSSSSC---HHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEE
T ss_pred             ChHHcEEEEEEeeCCCeEEEEEEEC-CCCEEEEEEECCCcCc---HHHHHHHHHHHHhcCCCCcccccceeccCCceEEE
Confidence            4678999999999999999999985 5678999998753332   2345566667888899999999875421       


Q ss_pred             --------------------------HHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEeccccccccccccc
Q psy14630         95 --------------------------EVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAK  148 (187)
Q Consensus        95 --------------------------~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg~a~~~~~~~~~  148 (187)
                                                .++.|++.||.|||+. +++||||||+||+++.++.+||+|||+++........
T Consensus        79 ~E~~~~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~~-~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~  157 (263)
T d1sm2a_          79 FEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEA-CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT  157 (263)
T ss_dssp             EECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHT-TCCCTTCSGGGEEECGGGCEEECSCC-----------
T ss_pred             EEecCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhhcc-ceeecccchhheeecCCCCeEecccchheeccCCCce
Confidence                                      2778999999999997 9999999999999999999999999999877543222


Q ss_pred             --cCCCCCcCccCccccCCCccCCCCCCcceeeeEeeee
Q psy14630        149 --TRDAGCRPYMAPERIDPLRARGYPSFKTKLGFKFNYR  185 (187)
Q Consensus       149 --~~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi~~~  185 (187)
                        ....||+.|+|||.+.   ...++.++||||||+.+|
T Consensus       158 ~~~~~~gt~~y~aPE~l~---~~~~~~k~DVwS~Gvil~  193 (263)
T d1sm2a_         158 SSTGTKFPVKWASPEVFS---FSRYSSKSDVWSFGVLMW  193 (263)
T ss_dssp             -------CTTSCCHHHHT---TCCCCHHHHHHHHHHHHH
T ss_pred             eecceecCcccCChHHhc---CCCCCchhhhcchHHHHH
Confidence              2346889999999998   667999999999999543

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.2e-40  Score=246.68  Aligned_cols=163  Identities=20%  Similarity=0.313  Sum_probs=129.1

Q ss_pred             CCccccCCcccccccccccccCceEEEEEEEcCCCcEEEEEEccCccChHHHHHHHHHHHHHHhcCCCCchhhhhhhHHH
Q psy14630         15 PDTVYDFTSEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQFYGALFK   94 (187)
Q Consensus        15 ~~~~~~~~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~   94 (187)
                      +-..|+++.++|++.+.||+|+||+||+|.+..+ +.||||.++......   +.+.++..+++.++|||||++++.+..
T Consensus         8 ~~~~~~i~~~~~~i~~~iG~G~fg~Vy~~~~~~~-~~vAiK~l~~~~~~~---~~~~~E~~~l~~l~h~nIv~~~g~~~~   83 (285)
T d1fmka3           8 AKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMSP---EAFLQEAQVMKKLRHEKLVQLYAVVSE   83 (285)
T ss_dssp             STTCSBCCGGGEEEEEEEEECSSCEEEEEEETTT-EEEEEEECCTTSSCH---HHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             CCcceEcCHHHEEEeeEEeeCCCeEEEEEEECCC-CEEEEEEECcccCCH---HHHHHHHHHHHhcccCCEeEEEEEEec
Confidence            4567899999999999999999999999998655 579999997543332   345666677888999999999864311


Q ss_pred             ---------------------------------HHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEecccccc
Q psy14630         95 ---------------------------------EVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQ  141 (187)
Q Consensus        95 ---------------------------------~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg~a~~  141 (187)
                                                       .++.+++.||+|||+. +++||||||+||+++.++.+||+|||+++.
T Consensus        84 ~~~~lv~Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~-~ivH~DlKp~NIll~~~~~~kl~DfGla~~  162 (285)
T d1fmka3          84 EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM-NYVHRDLRAANILVGENLVCKVADFGLARL  162 (285)
T ss_dssp             SSCEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCSGGGEEECGGGCEEECCCCTTC-
T ss_pred             CCeEEEEEecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhh-heecccccceEEEECCCCcEEEcccchhhh
Confidence                                             1778999999999998 999999999999999999999999999987


Q ss_pred             ccccc--cccCCCCCcCccCccccCCCccCCCCCCcceeeeEeeee
Q psy14630        142 LVDSI--AKTRDAGCRPYMAPERIDPLRARGYPSFKTKLGFKFNYR  185 (187)
Q Consensus       142 ~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi~~~  185 (187)
                      .....  ......+|+.|+|||.+.   ...++.++||||||+++|
T Consensus       163 ~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~ksDI~S~Giil~  205 (285)
T d1fmka3         163 IEDNEYTARQGAKFPIKWTAPEAAL---YGRFTIKSDVWSFGILLT  205 (285)
T ss_dssp             -------------CCGGGSCHHHHH---HCCCCHHHHHHHHHHHHH
T ss_pred             ccCCCceeeccccccccccChHHHh---CCCCCcHHhhhcchHHHH
Confidence            65432  222346889999999998   677899999999999443

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=1.2e-39  Score=246.71  Aligned_cols=161  Identities=24%  Similarity=0.340  Sum_probs=119.1

Q ss_pred             cCCcccccccccccccCceEEEEEEEcCCCc---EEEEEEccCccChHHHHHHHHHHHHHHhcCCCCchhhhhhhHHH--
Q psy14630         20 DFTSEDLQDLGEIGRGGFGTVNKMIHRSSDT---VMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQFYGALFK--   94 (187)
Q Consensus        20 ~~~~~~~~~~~~lg~G~fg~V~~~~~~~~~~---~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~--   94 (187)
                      ++..++|++.+.||+|+||+||+|.+..+++   .||||.+....... ..+.+.++..+++.++||||+++++++..  
T Consensus        22 ~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~  100 (299)
T d1jpaa_          22 EIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEK-QRRDFLSEASIMGQFDHPNVIHLEGVVTKST  100 (299)
T ss_dssp             BCCGGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHH-HHHHHHHHHHHHTTCCCTTBCCEEEEECSSS
T ss_pred             hhChhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHH-HHHHHHHHHHHHHhCCCCCCccEEEEEeeCC
Confidence            4567889999999999999999999876654   58999886544443 34455666777888999999999865421  


Q ss_pred             -------------------------------HHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEecccccccc
Q psy14630         95 -------------------------------EVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLV  143 (187)
Q Consensus        95 -------------------------------~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg~a~~~~  143 (187)
                                                     .++.|++.||.|||+. +++||||||+|||++.++.+||+|||+++.+.
T Consensus       101 ~~~iv~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~-~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~  179 (299)
T d1jpaa_         101 PVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADM-NYVHRDLAARNILVNSNLVCKVSDFGLSRFLE  179 (299)
T ss_dssp             SCEEEEECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred             EEEEEEEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHhhC-CCccCccccceEEECCCCcEEECCcccceEcc
Confidence                                           2778999999999997 99999999999999999999999999998875


Q ss_pred             ccccc------cCCCCCcCccCccccCCCccCCCCCCcceeeeEeeee
Q psy14630        144 DSIAK------TRDAGCRPYMAPERIDPLRARGYPSFKTKLGFKFNYR  185 (187)
Q Consensus       144 ~~~~~------~~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi~~~  185 (187)
                      +....      ....+|+.|+|||.+.   ...++.++|||||||++|
T Consensus       180 ~~~~~~~~~~~~~~~~t~~y~aPE~~~---~~~~~~~sDvwS~Gvvl~  224 (299)
T d1jpaa_         180 DDTSDPTYTSALGGKIPIRWTAPEAIQ---YRKFTSASDVWSYGIVMW  224 (299)
T ss_dssp             ----------------CGGGSCHHHHH---SCCCCHHHHHHHHHHHHH
T ss_pred             CCCCcceeeecccccCCccccCHHHHh---cCCCCcccccccchHHHH
Confidence            43211      1234688999999998   667899999999999543

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7e-40  Score=248.05  Aligned_cols=157  Identities=25%  Similarity=0.414  Sum_probs=127.2

Q ss_pred             ccccccccccccCceEEEEEEEcCCCcEEEEEEccCccChHHHHHHHHHHHHHHhcCCCCchhhhhhhHH----------
Q psy14630         24 EDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQFYGALF----------   93 (187)
Q Consensus        24 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~----------   93 (187)
                      ++|++.+.||+|+||.||+|.+..+++.||+|+++.........+.+.++..+++.++||||+++++++.          
T Consensus         2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e   81 (298)
T d1gz8a_           2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE   81 (298)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence            6899999999999999999999999999999998654333233445666777888999999999986432          


Q ss_pred             -----------------------HHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEecccccccccc-cccc
Q psy14630         94 -----------------------KEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDS-IAKT  149 (187)
Q Consensus        94 -----------------------~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg~a~~~~~~-~~~~  149 (187)
                                             ..++.|++.||+|||+. +|+||||||+||+++.++.+|++|||+|+..... ....
T Consensus        82 ~~~~~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~-~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~~~~~  160 (298)
T d1gz8a_          82 FLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH-RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYT  160 (298)
T ss_dssp             CCSEEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCSBCTT
T ss_pred             ecCCchhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcC-CEEccccCchheeecccCcceeccCCcceeccCCcccce
Confidence                                   22778999999999997 9999999999999999999999999999876543 3334


Q ss_pred             CCCCCcCccCccccCCCccCCCCCCcceeeeEee
Q psy14630        150 RDAGCRPYMAPERIDPLRARGYPSFKTKLGFKFN  183 (187)
Q Consensus       150 ~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi~  183 (187)
                      ...||+.|+|||.+..  ...++.++|+||+||+
T Consensus       161 ~~~gt~~y~apE~~~~--~~~~~~~~DiwSlGvi  192 (298)
T d1gz8a_         161 HEVVTLWYRAPEILLG--CKYYSTAVDIWSLGCI  192 (298)
T ss_dssp             CCBCCCTTCCHHHHTT--CSSCCTHHHHHHHHHH
T ss_pred             eecccceeeehhhhcc--ccCCCccccccccchh
Confidence            4578999999999873  3345789999999993

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.8e-40  Score=249.61  Aligned_cols=156  Identities=24%  Similarity=0.400  Sum_probs=128.6

Q ss_pred             ccccccccccccCceEEEEEEEcCCCcEEEEEEccCcc--ChHHHHHHHHHHHHHHhcCCCCchhhhhhhHH--------
Q psy14630         24 EDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTV--DEKDQRQLLMDLDVVMKSNECPYIVQFYGALF--------   93 (187)
Q Consensus        24 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~--------   93 (187)
                      ++|.+.+.||+|+||+||+|.+..+++.||||++++..  .+......+.++..+.+.++||||+++++++.        
T Consensus         2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv   81 (320)
T d1xjda_           2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV   81 (320)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred             CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence            68999999999999999999999999999999986321  11122344555555666789999999986431        


Q ss_pred             ------------------------HHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEecccccccccc-ccc
Q psy14630         94 ------------------------KEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDS-IAK  148 (187)
Q Consensus        94 ------------------------~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg~a~~~~~~-~~~  148 (187)
                                              ..++.|++.||+|||+. +++||||||+|||++..+.+|++|||+++..... ...
T Consensus        82 mEy~~~g~L~~~i~~~~~~~e~~~~~~~~qi~~al~ylH~~-~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~~~~~  160 (320)
T d1xjda_          82 MEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSK-GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKT  160 (320)
T ss_dssp             EECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT-TCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTTCCB
T ss_pred             EeecCCCcHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhC-CeeeccCcccceeecCCCceeccccchhhhcccccccc
Confidence                                    22778999999999998 9999999999999999999999999999876532 333


Q ss_pred             cCCCCCcCccCccccCCCccCCCCCCcceeeeEee
Q psy14630        149 TRDAGCRPYMAPERIDPLRARGYPSFKTKLGFKFN  183 (187)
Q Consensus       149 ~~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi~  183 (187)
                      ....||+.|+|||++.   ...++.++||||+|++
T Consensus       161 ~~~~gt~~y~aPE~~~---~~~~~~~~DiwSlGvi  192 (320)
T d1xjda_         161 NTFCGTPDYIAPEILL---GQKYNHSVDWWSFGVL  192 (320)
T ss_dssp             CCCCSCGGGCCHHHHT---TCCBCTHHHHHHHHHH
T ss_pred             cccCCCCCcCCHHHHc---CCCCCchhhhhhhhHH
Confidence            4457999999999999   6679999999999994

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.6e-40  Score=248.80  Aligned_cols=157  Identities=25%  Similarity=0.426  Sum_probs=124.8

Q ss_pred             cccccccccccccCceEEEEEEEcCC-CcEEEEEEccCccChHH-HHHHHHHHH--HHHhcCCCCchhhhhhhH------
Q psy14630         23 SEDLQDLGEIGRGGFGTVNKMIHRSS-DTVMAVKRIRSTVDEKD-QRQLLMDLD--VVMKSNECPYIVQFYGAL------   92 (187)
Q Consensus        23 ~~~~~~~~~lg~G~fg~V~~~~~~~~-~~~vaiK~~~~~~~~~~-~~~~~~~~~--~~~~~~~h~~iv~~~~~~------   92 (187)
                      .++|++++.||+|+||+||+|.+..+ ++.||||+++....... ......|+.  ..++..+||||+++++.+      
T Consensus         6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~   85 (305)
T d1blxa_           6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD   85 (305)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred             cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence            47899999999999999999999655 66799999854321111 111222222  223446899999987543      


Q ss_pred             --------------------------------HHHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEeccccc
Q psy14630         93 --------------------------------FKEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISG  140 (187)
Q Consensus        93 --------------------------------~~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg~a~  140 (187)
                                                      ...++.|++.||+|||+. +|+||||||+|||++..+.+||+|||+++
T Consensus        86 ~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~-~ivHrDiKp~NILi~~~~~~kl~dfg~~~  164 (305)
T d1blxa_          86 RETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSH-RVVHRDLKPQNILVTSSGQIKLADFGLAR  164 (305)
T ss_dssp             SEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHT-TCCCCCCCGGGEEECTTCCEEECSCCSCC
T ss_pred             cCceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhC-CEEecCCCccEEEEcCCCCeeecchhhhh
Confidence                                            112778999999999997 99999999999999999999999999998


Q ss_pred             cccccccccCCCCCcCccCccccCCCccCCCCCCcceeeeEee
Q psy14630        141 QLVDSIAKTRDAGCRPYMAPERIDPLRARGYPSFKTKLGFKFN  183 (187)
Q Consensus       141 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi~  183 (187)
                      ............||+.|+|||++.   ...++.++||||+|++
T Consensus       165 ~~~~~~~~~~~~gT~~Y~APE~~~---~~~y~~~~DiwSlG~i  204 (305)
T d1blxa_         165 IYSFQMALTSVVVTLWYRAPEVLL---QSSYATPVDLWSVGCI  204 (305)
T ss_dssp             CCCGGGGGCCCCCCCTTCCHHHHT---TCCCCTHHHHHHHHHH
T ss_pred             hhcccccCCCcccChhhcCcchhc---CCCCChhehhhchHHH
Confidence            876666666678999999999998   6779999999999993

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2e-39  Score=242.70  Aligned_cols=161  Identities=27%  Similarity=0.436  Sum_probs=121.6

Q ss_pred             ccCCcccccccccccccCceEEEEEEEcCCC---cEEEEEEccCccChHHHHHHHHHHHHHHhcCCCCchhhhhhhHHH-
Q psy14630         19 YDFTSEDLQDLGEIGRGGFGTVNKMIHRSSD---TVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQFYGALFK-   94 (187)
Q Consensus        19 ~~~~~~~~~~~~~lg~G~fg~V~~~~~~~~~---~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~-   94 (187)
                      |+++.++|++.+.||+|+||.||+|.+..++   ..||||.++..... ...+.+.++..+++.++||||+++++.+.. 
T Consensus         2 ~ei~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~   80 (273)
T d1mp8a_           2 YEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSD-SVREKFLQEALTMRQFDHPHIVKLIGVITEN   80 (273)
T ss_dssp             CBCCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSH-HHHHHHHHHHHHHHTCCCTTBCCEEEEECSS
T ss_pred             CCcCHHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCH-HHHHHHHHHHHHHHhCCCCCEeeEEEEEecC
Confidence            7889999999999999999999999886543   56899988654333 344556667777888999999999865421 


Q ss_pred             -------------------------------HHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEecccccccc
Q psy14630         95 -------------------------------EVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLV  143 (187)
Q Consensus        95 -------------------------------~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg~a~~~~  143 (187)
                                                     .++.|++.||.|||+. +++||||||+||+++.++.+||+|||+++...
T Consensus        81 ~~~iv~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~-~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~  159 (273)
T d1mp8a_          81 PVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESK-RFVHRDIAARNVLVSSNDCVKLGDFGLSRYME  159 (273)
T ss_dssp             SCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCSGGGEEEEETTEEEECC--------
T ss_pred             eEEEEEEeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhccc-CeeccccchhheeecCCCcEEEccchhheecc
Confidence                                           1678999999999998 99999999999999999999999999998865


Q ss_pred             ccc--cccCCCCCcCccCccccCCCccCCCCCCcceeeeEeee
Q psy14630        144 DSI--AKTRDAGCRPYMAPERIDPLRARGYPSFKTKLGFKFNY  184 (187)
Q Consensus       144 ~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi~~  184 (187)
                      ...  ......||+.|+|||++.   ...++.++|||||||.+
T Consensus       160 ~~~~~~~~~~~gt~~y~apE~l~---~~~~~~~~DiwSlGvil  199 (273)
T d1mp8a_         160 DSTYYKASKGKLPIKWMAPESIN---FRRFTSASDVWMFGVCM  199 (273)
T ss_dssp             -----------CCGGGCCHHHHH---HCCCSHHHHHHHHHHHH
T ss_pred             CCcceeccceecCcccchhhHhc---cCCCCCccccccchHHH
Confidence            432  223346789999999998   67799999999999943

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.7e-39  Score=244.11  Aligned_cols=153  Identities=29%  Similarity=0.411  Sum_probs=121.7

Q ss_pred             ccccccccCceEEEEEEEcCCCcEEEEEEccCccChH---HHHHHHHHHHHHHhcCCCCchhhhhhhHH-----------
Q psy14630         28 DLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEK---DQRQLLMDLDVVMKSNECPYIVQFYGALF-----------   93 (187)
Q Consensus        28 ~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~---~~~~~~~~~~~~~~~~~h~~iv~~~~~~~-----------   93 (187)
                      .++.||+|+||+||+|.+..+++.||||+++......   ...+.+.++..+++.++||||+++++.+.           
T Consensus         2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~   81 (299)
T d1ua2a_           2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDF   81 (299)
T ss_dssp             EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEEC
T ss_pred             cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhh
Confidence            4578999999999999999999999999986432211   12234556667788899999999986542           


Q ss_pred             ---------------------HHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEeccccccccccc-cccCC
Q psy14630         94 ---------------------KEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSI-AKTRD  151 (187)
Q Consensus        94 ---------------------~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg~a~~~~~~~-~~~~~  151 (187)
                                           ..++.|++.||+|||+. +++||||||+||+++.++.+||+|||+++...... .....
T Consensus        82 ~~~~~~~~~~~~~~~l~~~~~~~~~~qil~aL~~lH~~-~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~~~~~~  160 (299)
T d1ua2a_          82 METDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQH-WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQ  160 (299)
T ss_dssp             CSEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHT-TCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCCCCCCS
T ss_pred             hcchHHhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcc-ceecccCCcceEEecCCCccccccCccccccCCCcccccce
Confidence                                 22778999999999997 99999999999999999999999999998765432 33345


Q ss_pred             CCCcCccCccccCCCccCCCCCCcceeeeEee
Q psy14630        152 AGCRPYMAPERIDPLRARGYPSFKTKLGFKFN  183 (187)
Q Consensus       152 ~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi~  183 (187)
                      +||+.|+|||++.+  ...++.++||||+|++
T Consensus       161 ~gt~~y~aPE~~~~--~~~~~~~~DiwSlGvi  190 (299)
T d1ua2a_         161 VVTRWYRAPELLFG--ARMYGVGVDMWAVGCI  190 (299)
T ss_dssp             CCCCTTCCHHHHTT--CSCCCHHHHHHHHHHH
T ss_pred             ecChhhccHHHHcc--CCCCChhhhhhhcchH
Confidence            78999999999873  4457899999999993

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.9e-39  Score=239.91  Aligned_cols=155  Identities=25%  Similarity=0.366  Sum_probs=128.2

Q ss_pred             CcccccccccccccCceEEEEEEEcCCCcEEEEEEccCccChHHHHHHHHHHHHHHhcCCCCchhhhhhhHHH-------
Q psy14630         22 TSEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQFYGALFK-------   94 (187)
Q Consensus        22 ~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~-------   94 (187)
                      ..++|++.++||+|+||.||+|++ .+++.||||.++......   +.+.++..++..++||||+++++.+..       
T Consensus         2 ~~~~~~~~~~iG~G~fg~Vy~~~~-~~~~~vAvK~l~~~~~~~---~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv   77 (258)
T d1k2pa_           2 DPKDLTFLKELGTGQFGVVKYGKW-RGQYDVAIKMIKEGSMSE---DEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFII   77 (258)
T ss_dssp             CCCCCCCCCCCCEETTEEEEEEEE-TTTEEEEEEEEESSSSCH---HHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEE
T ss_pred             ChHHCEEeEEEecCCCeEEEEEEE-CCCCEEEEEEECcCcCCH---HHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEE
Confidence            457899999999999999999998 477899999987543332   335566677888899999999875422       


Q ss_pred             --------------------------HHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEecccccccccccc-
Q psy14630         95 --------------------------EVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIA-  147 (187)
Q Consensus        95 --------------------------~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg~a~~~~~~~~-  147 (187)
                                                .+..|++.||+|||+. +|+||||||+||+++.++.+||+|||+++....... 
T Consensus        78 ~Ey~~~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~-~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~  156 (258)
T d1k2pa_          78 TEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESK-QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYT  156 (258)
T ss_dssp             EECCTTEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHT-TBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCC
T ss_pred             EEccCCCcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHhhc-CcccccccceeEEEcCCCcEEECcchhheeccCCCce
Confidence                                      2678999999999997 999999999999999999999999999987654322 


Q ss_pred             -ccCCCCCcCccCccccCCCccCCCCCCcceeeeEeee
Q psy14630        148 -KTRDAGCRPYMAPERIDPLRARGYPSFKTKLGFKFNY  184 (187)
Q Consensus       148 -~~~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi~~  184 (187)
                       .....+|+.|+|||.+.   ...++.++||||||+.+
T Consensus       157 ~~~~~~~t~~y~aPE~~~---~~~~~~ksDiwS~G~~l  191 (258)
T d1k2pa_         157 SSVGSKFPVRWSPPEVLM---YSKFSSKSDIWAFGVLM  191 (258)
T ss_dssp             CCCCSCCCGGGCCHHHHH---HCCCCHHHHHHHHHHHH
T ss_pred             eecccCCCCCcCCcHHhc---CCCCCcceeecccchhh
Confidence             22346889999999998   66789999999999944

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-39  Score=248.68  Aligned_cols=159  Identities=24%  Similarity=0.392  Sum_probs=122.7

Q ss_pred             CcccccccccccccCceEEEEEEEcCCCc----EEEEEEccCccChHHHHHHHHHHHHHHhcCCCCchhhhhhhHHH---
Q psy14630         22 TSEDLQDLGEIGRGGFGTVNKMIHRSSDT----VMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQFYGALFK---   94 (187)
Q Consensus        22 ~~~~~~~~~~lg~G~fg~V~~~~~~~~~~----~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~---   94 (187)
                      ..++|++.+.||+|+||.||+|.+..+++    .||+|.++...... ..+.+.++..+++.++||||+++++.+..   
T Consensus         7 k~~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~   85 (317)
T d1xkka_           7 KETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPK-ANKEILDEAYVMASVDNPHVCRLLGICLTSTV   85 (317)
T ss_dssp             CTTTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----C-THHHHHHHHHHHHHCCCTTBCCEEEEEESSSE
T ss_pred             CHHHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHH-HHHHHHHHHHHHHhCCCCCEeeEEEEEecCCe
Confidence            44689999999999999999999887776    57888876432222 23445566667788899999999865321   


Q ss_pred             -----------------------------HHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEecccccccccc
Q psy14630         95 -----------------------------EVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDS  145 (187)
Q Consensus        95 -----------------------------~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg~a~~~~~~  145 (187)
                                                   .++.|++.||.|||+. +|+||||||+||+++.++.+||+|||+++.....
T Consensus        86 ~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~-~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~~  164 (317)
T d1xkka_          86 QLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR-RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE  164 (317)
T ss_dssp             EEEEECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCCGGGEEEEETTEEEECCCSHHHHTTTT
T ss_pred             eEEEEeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHHHc-CcccCcchhhcceeCCCCCeEeeccccceecccc
Confidence                                         2678999999999997 9999999999999999999999999999887543


Q ss_pred             cc---ccCCCCCcCccCccccCCCccCCCCCCcceeeeEeeee
Q psy14630        146 IA---KTRDAGCRPYMAPERIDPLRARGYPSFKTKLGFKFNYR  185 (187)
Q Consensus       146 ~~---~~~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi~~~  185 (187)
                      ..   .....||+.|+|||.+.   ...++.++||||||+.+|
T Consensus       165 ~~~~~~~~~~gt~~y~APE~l~---~~~~~~~sDvwS~Gvil~  204 (317)
T d1xkka_         165 EKEYHAEGGKVPIKWMALESIL---HRIYTHQSDVWSYGVTVW  204 (317)
T ss_dssp             CC--------CCTTTSCHHHHH---HCCCCHHHHHHHHHHHHH
T ss_pred             cccccccccccCccccChHHHh---cCCCChhhhhhhHHHHHH
Confidence            22   22335899999999998   667999999999999543

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=3.2e-39  Score=244.75  Aligned_cols=164  Identities=23%  Similarity=0.359  Sum_probs=131.8

Q ss_pred             ccccCCcccccccccccccCceEEEEEEEc-----CCCcEEEEEEccCccChHHHHHHHHHHHHHHhcCCCCchhhhhhh
Q psy14630         17 TVYDFTSEDLQDLGEIGRGGFGTVNKMIHR-----SSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQFYGA   91 (187)
Q Consensus        17 ~~~~~~~~~~~~~~~lg~G~fg~V~~~~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~   91 (187)
                      ..+++++++|++.+.||+|+||.||+|+..     .+++.||||.++..... ...+.+.++..+++.++||||+++++.
T Consensus         6 ~~~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~-~~~~~~~~E~~il~~l~h~niv~~~~~   84 (301)
T d1lufa_           6 LSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASA-DMQADFQREAALMAEFDNPNIVKLLGV   84 (301)
T ss_dssp             HHTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCH-HHHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred             hhccCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcCh-HHHHHHHHHHHHHHhcCCCCcccceee
Confidence            346889999999999999999999999875     35678999998754333 344555666677888999999998754


Q ss_pred             HHH--------------------------------------------------------HHHHHHHHHHHHHHhcCCCee
Q psy14630         92 LFK--------------------------------------------------------EVTVATVKALNYLKEELKIIH  115 (187)
Q Consensus        92 ~~~--------------------------------------------------------~~~~~~~~~l~~lh~~~~i~H  115 (187)
                      +..                                                        .++.|++.||+|||+. +++|
T Consensus        85 ~~~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~-~ivH  163 (301)
T d1lufa_          85 CAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER-KFVH  163 (301)
T ss_dssp             ECSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT-TCCC
T ss_pred             eccCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccC-CeEe
Confidence            211                                                        1577899999999997 9999


Q ss_pred             ecCCCCCeEEcCCCCEEEEeccccccccccc---cccCCCCCcCccCccccCCCccCCCCCCcceeeeEeeee
Q psy14630        116 RDVKPSNILLDRRGAIKLCDFGISGQLVDSI---AKTRDAGCRPYMAPERIDPLRARGYPSFKTKLGFKFNYR  185 (187)
Q Consensus       116 rdlk~~nili~~~~~~ki~dfg~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi~~~  185 (187)
                      |||||+||+++.++.+||+|||+++...+..   ......+++.|+|||.+.   ...++.++|||||||++|
T Consensus       164 rDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~t~ksDVwS~Gvvl~  233 (301)
T d1lufa_         164 RDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIF---YNRYTTESDVWAYGVVLW  233 (301)
T ss_dssp             SCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHH---HCCCCHHHHHHHHHHHHH
T ss_pred             eEEcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHc---cCCCChhhhhccchhhHH
Confidence            9999999999999999999999998764432   223346788999999998   677999999999999543

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.3e-39  Score=241.95  Aligned_cols=168  Identities=25%  Similarity=0.381  Sum_probs=132.2

Q ss_pred             cCCCccccCCcccccccccccccCceEEEEEEEcCCC-------cEEEEEEccCccChHHHHHHHHHHHHHHhcCCCCch
Q psy14630         13 LSPDTVYDFTSEDLQDLGEIGRGGFGTVNKMIHRSSD-------TVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYI   85 (187)
Q Consensus        13 ~~~~~~~~~~~~~~~~~~~lg~G~fg~V~~~~~~~~~-------~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i   85 (187)
                      .|..+.|+++.++|.+.+.||+|+||.||+|.+..++       ..||||.++.........+...++..+.+..+||||
T Consensus         2 ~~~~~~~~i~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnI   81 (299)
T d1fgka_           2 LPEDPRWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNI   81 (299)
T ss_dssp             CCCCTTTBCCGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTB
T ss_pred             cCcCCcCcccHHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeE
Confidence            3456679999999999999999999999999876544       479999997665555556666666666666689999


Q ss_pred             hhhhhhHHH------------------------------------------------HHHHHHHHHHHHHHhcCCCeeec
Q psy14630         86 VQFYGALFK------------------------------------------------EVTVATVKALNYLKEELKIIHRD  117 (187)
Q Consensus        86 v~~~~~~~~------------------------------------------------~~~~~~~~~l~~lh~~~~i~Hrd  117 (187)
                      +++++++.+                                                .++.|++.||+|||+. +++|||
T Consensus        82 v~~~~~~~~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~-~ivHrD  160 (299)
T d1fgka_          82 INLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK-KCIHRD  160 (299)
T ss_dssp             CCEEEEECSSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHT-TCCCSC
T ss_pred             EecccccccCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhC-CEEeee
Confidence            998764311                                                2667999999999998 999999


Q ss_pred             CCCCCeEEcCCCCEEEEeccccccccccc---cccCCCCCcCccCccccCCCccCCCCCCcceeeeEeee
Q psy14630        118 VKPSNILLDRRGAIKLCDFGISGQLVDSI---AKTRDAGCRPYMAPERIDPLRARGYPSFKTKLGFKFNY  184 (187)
Q Consensus       118 lk~~nili~~~~~~ki~dfg~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi~~  184 (187)
                      |||+|||++.++.+||+|||+++......   ......+++.|+|||.+.   +..++.++||||||+++
T Consensus       161 iKp~NiLl~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~---~~~y~~k~DiwS~Gvvl  227 (299)
T d1fgka_         161 LAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALF---DRIYTHQSDVWSFGVLL  227 (299)
T ss_dssp             CSGGGEEECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHH---HCCCCHHHHHHHHHHHH
T ss_pred             ecccceeecCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhc---CCCCCchhhhHHhHHHH
Confidence            99999999999999999999999875432   223356888999999998   67899999999999943

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2e-38  Score=244.53  Aligned_cols=159  Identities=21%  Similarity=0.308  Sum_probs=127.0

Q ss_pred             ccCCcccccccccccccCceEEEEEEEcCCCcEEEEEEccCccChHHHHHHHHHHHHHHhcCCCCchhhhhhhH------
Q psy14630         19 YDFTSEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQFYGAL------   92 (187)
Q Consensus        19 ~~~~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~------   92 (187)
                      |++ .++|++.+.||+|+||+||+|.+..+++.||||+++.........+...++..+++.++||||+++++.+      
T Consensus        14 ~~~-~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~   92 (346)
T d1cm8a_          14 WEV-RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETL   92 (346)
T ss_dssp             ECC-BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSST
T ss_pred             eec-CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccc
Confidence            454 5799999999999999999999999999999999976544444555666677788889999999987543      


Q ss_pred             ------------------------------HHHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEeccccccc
Q psy14630         93 ------------------------------FKEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQL  142 (187)
Q Consensus        93 ------------------------------~~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg~a~~~  142 (187)
                                                    ...++.|++.||.|||+. +|+||||||+|||++.++.+|++|||+|+..
T Consensus        93 ~~~~~~~lv~e~~~~~l~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~-~IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~~  171 (346)
T d1cm8a_          93 DDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYIHAA-GIIHRDLKPGNLAVNEDCELKILDFGLARQA  171 (346)
T ss_dssp             TTCCCCEEEEECCSEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred             cccceEEEEEecccccHHHHHHhccccHHHHHHHHHHHHHHHHHHHhC-CCcccccCcchhhcccccccccccccceecc
Confidence                                          112778999999999997 9999999999999999999999999999876


Q ss_pred             cccccccCCCCCcCccCccccCCCccCCCCCCcceeeeEee
Q psy14630        143 VDSIAKTRDAGCRPYMAPERIDPLRARGYPSFKTKLGFKFN  183 (187)
Q Consensus       143 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi~  183 (187)
                      ...  .....+|+.|+|||++.+  ...++.++|+||+|++
T Consensus       172 ~~~--~~~~~~t~~y~aPE~~~~--~~~~~~~~DiwSlGvi  208 (346)
T d1cm8a_         172 DSE--MTGYVVTRWYRAPEVILN--WMRYTQTVDIWSVGCI  208 (346)
T ss_dssp             CSS--CCSSCSCGGGCCTHHHHT--TTCCCTTHHHHHHHHH
T ss_pred             CCc--cccccccccccCHHHHcC--CCCCCccchhhcchHH
Confidence            543  234578999999999873  3456899999999993

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=100.00  E-value=9.3e-39  Score=239.53  Aligned_cols=157  Identities=25%  Similarity=0.338  Sum_probs=124.1

Q ss_pred             cccccccccccccCceEEEEEEEcCCCcEEEEEEccCcc-ChHHHHHHHHHHHHHHhcCCCCchhhhhhhH---------
Q psy14630         23 SEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTV-DEKDQRQLLMDLDVVMKSNECPYIVQFYGAL---------   92 (187)
Q Consensus        23 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~---------   92 (187)
                      .++|++.+.||+|+||.||+|.+..+++.||||+++... .+....+.+.++..+++.++||||+++++.+         
T Consensus         6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~   85 (277)
T d1o6ya_           6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL   85 (277)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred             cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCce
Confidence            367999999999999999999999999999999997543 3344455666777788889999999987532         


Q ss_pred             ---------------------------HHHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEecccccccccc
Q psy14630         93 ---------------------------FKEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDS  145 (187)
Q Consensus        93 ---------------------------~~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg~a~~~~~~  145 (187)
                                                 ...++.|++.||.|||+. +++||||||+||+++.++..+++|||.+......
T Consensus        86 ~~lvmE~~~g~~L~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~-~iiHrDiKP~NIll~~~~~~~l~d~~~~~~~~~~  164 (277)
T d1o6ya_          86 PYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQN-GIIHRDVKPANIMISATNAVKVMDFGIARAIADS  164 (277)
T ss_dssp             EEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEEETTSCEEECCCTTCEECC--
T ss_pred             EEEEEECCCCCEehhhhcccCCCCHHHHHHHHHHHHHHHHHHHhC-CccCccccCcccccCccccceeehhhhhhhhccc
Confidence                                       112778999999999997 9999999999999999999999999998765432


Q ss_pred             ----ccccCCCCCcCccCccccCCCccCCCCCCcceeeeEee
Q psy14630        146 ----IAKTRDAGCRPYMAPERIDPLRARGYPSFKTKLGFKFN  183 (187)
Q Consensus       146 ----~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi~  183 (187)
                          ......+||+.|+|||++.   ...++.++|+||+|++
T Consensus       165 ~~~~~~~~~~~Gt~~Y~aPE~~~---~~~~~~~~DiwSlGvi  203 (277)
T d1o6ya_         165 GNSVTQTAAVIGTAQYLSPEQAR---GDSVDARSDVYSLGCV  203 (277)
T ss_dssp             --------------TTCCHHHHT---TCCCCHHHHHHHHHHH
T ss_pred             cccccccccccCcccccCHHHHc---CCCCCcceecccchHH
Confidence                2233457999999999998   6678999999999993

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.8e-39  Score=241.04  Aligned_cols=162  Identities=25%  Similarity=0.386  Sum_probs=129.0

Q ss_pred             ccCCccccccccc-ccccCceEEEEEEEcC--CCcEEEEEEccCccChHHHHHHHHHHHHHHhcCCCCchhhhhhhHHH-
Q psy14630         19 YDFTSEDLQDLGE-IGRGGFGTVNKMIHRS--SDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQFYGALFK-   94 (187)
Q Consensus        19 ~~~~~~~~~~~~~-lg~G~fg~V~~~~~~~--~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~-   94 (187)
                      +-+..++|.+.+. ||+|+||.||+|.+..  ++..||||.++...... ..+.+.++..+++.++||||+++++.+.. 
T Consensus         3 l~l~~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~-~~~~~~~E~~il~~l~HpnIv~l~g~~~~~   81 (285)
T d1u59a_           3 LFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKA-DTEEMMREAQIMHQLDNPYIVRLIGVCQAE   81 (285)
T ss_dssp             CBCCGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHH-HHHHHHHHHHHHHHCCCTTBCCEEEEEESS
T ss_pred             eeecccCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHH-HHHHHHHHHHHHHhCCCCCEeeEeeeeccC
Confidence            3456788888884 9999999999998753  45579999997654433 34455666677888899999999864321 


Q ss_pred             -------------------------------HHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEecccccccc
Q psy14630         95 -------------------------------EVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLV  143 (187)
Q Consensus        95 -------------------------------~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg~a~~~~  143 (187)
                                                     .++.|++.||+|||+. +++||||||+||+++.++.+||+|||+++.+.
T Consensus        82 ~~~lvmE~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~~-~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~  160 (285)
T d1u59a_          82 ALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEK-NFVHRDLAARNVLLVNRHYAKISDFGLSKALG  160 (285)
T ss_dssp             SEEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEEEETTEEEECCCTTCEECT
T ss_pred             eEEEEEEeCCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHhC-CeecCcCchhheeeccCCceeeccchhhhccc
Confidence                                           2778999999999997 99999999999999999999999999998865


Q ss_pred             ccc----cccCCCCCcCccCccccCCCccCCCCCCcceeeeEeeee
Q psy14630        144 DSI----AKTRDAGCRPYMAPERIDPLRARGYPSFKTKLGFKFNYR  185 (187)
Q Consensus       144 ~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi~~~  185 (187)
                      ...    ......||+.|+|||++.   ...++.++||||||+..|
T Consensus       161 ~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~ksDVwS~Gv~l~  203 (285)
T d1u59a_         161 ADDSYYTARSAGKWPLKWYAPECIN---FRKFSSRSDVWSYGVTMW  203 (285)
T ss_dssp             TCSCEECCCCSSCCCGGGCCHHHHH---HCEECHHHHHHHHHHHHH
T ss_pred             ccccccccccccccCccccChHHHh---CCCCCccchhhcchHHHH
Confidence            322    222346788999999998   667899999999999443

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-38  Score=244.27  Aligned_cols=153  Identities=24%  Similarity=0.383  Sum_probs=125.1

Q ss_pred             cccccccc-cccccCceEEEEEEEcCCCcEEEEEEccCccChHHHHHHHHHHHHHHhcCCCCchhhhhhhHH--------
Q psy14630         23 SEDLQDLG-EIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQFYGALF--------   93 (187)
Q Consensus        23 ~~~~~~~~-~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~--------   93 (187)
                      .++|.+.. .||+|+||+||+|.+..+++.||||+++..      .....|...+.+..+||||+++++.+.        
T Consensus        10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~------~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~   83 (335)
T d2ozaa1          10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC------PKARREVELHWRASQCPHIVRIVDVYENLYAGRKC   83 (335)
T ss_dssp             GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEE
T ss_pred             ccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc------HHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCE
Confidence            36898875 599999999999999999999999998632      112234444456679999999865431        


Q ss_pred             ------------------------------HHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcC---CCCEEEEeccccc
Q psy14630         94 ------------------------------KEVTVATVKALNYLKEELKIIHRDVKPSNILLDR---RGAIKLCDFGISG  140 (187)
Q Consensus        94 ------------------------------~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~---~~~~ki~dfg~a~  140 (187)
                                                    ..++.|++.||+|||+. +|+||||||+||+++.   .+.+||+|||+|+
T Consensus        84 ~~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~-~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a~  162 (335)
T d2ozaa1          84 LLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI-NIAHRDVKPENLLYTSKRPNAILKLTDFGFAK  162 (335)
T ss_dssp             EEEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEESCSSTTCCEEECCCTTCE
T ss_pred             EEEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHc-CCccccccccccccccccccccccccccceee
Confidence                                          12778999999999998 9999999999999975   5679999999999


Q ss_pred             cccccccccCCCCCcCccCccccCCCccCCCCCCcceeeeEe-eee
Q psy14630        141 QLVDSIAKTRDAGCRPYMAPERIDPLRARGYPSFKTKLGFKF-NYR  185 (187)
Q Consensus       141 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi-~~~  185 (187)
                      ............||+.|+|||++.   ...++.++|+||+|+ +|+
T Consensus       163 ~~~~~~~~~~~~gt~~y~aPE~~~---~~~y~~~~DiwSlGvily~  205 (335)
T d2ozaa1         163 ETTSHNSLTTPCYTPYYVAPEVLG---PEKYDKSCDMWSLGVIMYI  205 (335)
T ss_dssp             ECCCCCCCCCCSCCCSSCCCCCCC---GGGGSHHHHHHHHHHHHHH
T ss_pred             eccCCCccccccCCcccCCcHHHc---CCCCCHHHHHHhhchhHHH
Confidence            877665566678999999999998   667899999999999 443

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.5e-39  Score=244.26  Aligned_cols=156  Identities=21%  Similarity=0.261  Sum_probs=129.6

Q ss_pred             cccccccccccccCceEEEEEEEcCCCcEEEEEEccCccChHHHHHHHHHHHHHHhcCCCCchhhhhhhHH---------
Q psy14630         23 SEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQFYGALF---------   93 (187)
Q Consensus        23 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~---------   93 (187)
                      .++|++.+.||+|+||+||+|.+..+++.||+|.++....   ....+.++..+++.++||||+++++.+.         
T Consensus         4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~---~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvm   80 (321)
T d1tkia_           4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGT---DQVLVKKEISILNIARHRNILHLHESFESMEELVMIF   80 (321)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTH---HHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEE
T ss_pred             ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCcc---cHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEE
Confidence            4789999999999999999999999999999999975322   2334556667788899999999986432         


Q ss_pred             ------------------------HHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcC--CCCEEEEecccccccccccc
Q psy14630         94 ------------------------KEVTVATVKALNYLKEELKIIHRDVKPSNILLDR--RGAIKLCDFGISGQLVDSIA  147 (187)
Q Consensus        94 ------------------------~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~--~~~~ki~dfg~a~~~~~~~~  147 (187)
                                              ..++.|++.||+|||+. +|+||||||+||+++.  ...+||+|||+++.......
T Consensus        81 E~~~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~~-~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~~~  159 (321)
T d1tkia_          81 EFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSH-NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDN  159 (321)
T ss_dssp             CCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTCE
T ss_pred             ecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHc-CCCcccccccceeecCCCceEEEEcccchhhccccCCc
Confidence                                    12778999999999997 9999999999999975  45799999999998765554


Q ss_pred             ccCCCCCcCccCccccCCCccCCCCCCcceeeeEe-eee
Q psy14630        148 KTRDAGCRPYMAPERIDPLRARGYPSFKTKLGFKF-NYR  185 (187)
Q Consensus       148 ~~~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi-~~~  185 (187)
                      .....+|+.|+|||.+.   ...++.++|+||+|+ +|.
T Consensus       160 ~~~~~~t~~y~ape~~~---~~~~~~~~DiWSlGvily~  195 (321)
T d1tkia_         160 FRLLFTAPEYYAPEVHQ---HDVVSTATDMWSLGTLVYV  195 (321)
T ss_dssp             EEEEESCGGGSCHHHHT---TCEECHHHHHHHHHHHHHH
T ss_pred             ccccccccccccchhcc---CCCCCchhhcccHHHHHHH
Confidence            55557899999999998   667899999999999 443

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.3e-38  Score=240.98  Aligned_cols=174  Identities=24%  Similarity=0.352  Sum_probs=138.8

Q ss_pred             CCceecCCCccccCCcccccccccccccCceEEEEEEEc-----CCCcEEEEEEccCccChHHHHHHHHHHHHHHhcCCC
Q psy14630          8 SGKLKLSPDTVYDFTSEDLQDLGEIGRGGFGTVNKMIHR-----SSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNEC   82 (187)
Q Consensus         8 ~~~~~~~~~~~~~~~~~~~~~~~~lg~G~fg~V~~~~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~h   82 (187)
                      ..+..+++...|+++.++|++.+.||+|+||.||+|.+.     .+++.||||.++.........+...|...+.+..+|
T Consensus         7 ~~~~~~~~~~~~~~~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~H   86 (311)
T d1t46a_           7 IDPTQLPYDHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNH   86 (311)
T ss_dssp             CCTTTSCCCGGGBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCC
T ss_pred             eCcccCCCcccccCCHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCC
Confidence            355667778899999999999999999999999999753     566789999997654444444444444444444479


Q ss_pred             CchhhhhhhHHH--------------------------------------------------HHHHHHHHHHHHHHhcCC
Q psy14630         83 PYIVQFYGALFK--------------------------------------------------EVTVATVKALNYLKEELK  112 (187)
Q Consensus        83 ~~iv~~~~~~~~--------------------------------------------------~~~~~~~~~l~~lh~~~~  112 (187)
                      |||+++++.+..                                                  .++.|++.|++|||++ +
T Consensus        87 pnIv~~~g~~~~~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~-~  165 (311)
T d1t46a_          87 MNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK-N  165 (311)
T ss_dssp             TTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT-T
T ss_pred             CCEEEEEEEEeeCCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC-C
Confidence            999998764211                                                  1678999999999998 9


Q ss_pred             CeeecCCCCCeEEcCCCCEEEEecccccccccc---ccccCCCCCcCccCccccCCCccCCCCCCcceeeeEeeee
Q psy14630        113 IIHRDVKPSNILLDRRGAIKLCDFGISGQLVDS---IAKTRDAGCRPYMAPERIDPLRARGYPSFKTKLGFKFNYR  185 (187)
Q Consensus       113 i~Hrdlk~~nili~~~~~~ki~dfg~a~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi~~~  185 (187)
                      ++||||||+||+++.++.+|++|||+++.....   .......||+.|+|||.+.   ...++.++||||||+++|
T Consensus       166 ivHrDLKp~NIl~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DIwS~G~~l~  238 (311)
T d1t46a_         166 CIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIF---NCVYTFESDVWSYGIFLW  238 (311)
T ss_dssp             CCCSCCSGGGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHH---HCCCCHHHHHHHHHHHHH
T ss_pred             eeecccccccccccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhc---CCCCCCcccccchHHHHH
Confidence            999999999999999999999999999986542   2223456899999999998   677899999999999543

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.7e-39  Score=241.11  Aligned_cols=152  Identities=28%  Similarity=0.401  Sum_probs=119.3

Q ss_pred             ccccccCceEEEEEEEc--CCCcEEEEEEccCccChHHHHHHHHHHHHHHhcCCCCchhhhhhhHHH-------------
Q psy14630         30 GEIGRGGFGTVNKMIHR--SSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQFYGALFK-------------   94 (187)
Q Consensus        30 ~~lg~G~fg~V~~~~~~--~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~-------------   94 (187)
                      ++||+|+||.||+|.+.  .+++.||||+++....+....+.+.++..+++.++||||+++++.+..             
T Consensus        13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~~~~~lvmE~~~~g   92 (277)
T d1xbba_          13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAESWMLVMEMAELG   92 (277)
T ss_dssp             EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEESSSEEEEEECCTTE
T ss_pred             CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEeccCCEEEEEEcCCCC
Confidence            46999999999999764  455789999987544444445566677778888999999999865411             


Q ss_pred             ------------------HHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEeccccccccccc----cccCCC
Q psy14630         95 ------------------EVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSI----AKTRDA  152 (187)
Q Consensus        95 ------------------~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg~a~~~~~~~----~~~~~~  152 (187)
                                        .++.|++.||+|||+. +++||||||+||+++.++.+|++|||+++.+....    ......
T Consensus        93 ~L~~~l~~~~~l~~~~~~~i~~qi~~gl~ylH~~-~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~  171 (277)
T d1xbba_          93 PLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEES-NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGK  171 (277)
T ss_dssp             EHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC----C
T ss_pred             cHHHHHhhccCCCHHHHHHHHHHHHHHHhhHHhC-CcccCCCcchhhcccccCcccccchhhhhhccccccccccccccC
Confidence                              2778999999999997 99999999999999999999999999998764322    122346


Q ss_pred             CCcCccCccccCCCccCCCCCCcceeeeEeeee
Q psy14630        153 GCRPYMAPERIDPLRARGYPSFKTKLGFKFNYR  185 (187)
Q Consensus       153 ~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi~~~  185 (187)
                      ||+.|+|||.+.   ...++.++||||||+++|
T Consensus       172 gt~~y~APE~l~---~~~~~~~sDiwS~Gv~l~  201 (277)
T d1xbba_         172 WPVKWYAPECIN---YYKFSSKSDVWSFGVLMW  201 (277)
T ss_dssp             CCGGGCCHHHHH---HCEEEHHHHHHHHHHHHH
T ss_pred             CCceecCchhhc---CCCCCchhhhccchhhhh
Confidence            889999999998   667889999999999443

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-37  Score=240.24  Aligned_cols=161  Identities=23%  Similarity=0.356  Sum_probs=126.8

Q ss_pred             cccCCcccccccccccccCceEEEEEEEcCCCcEEEEEEccCccChHHHHHHHHHHHHHHhcCCCCchhhhhhhH-----
Q psy14630         18 VYDFTSEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQFYGAL-----   92 (187)
Q Consensus        18 ~~~~~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~-----   92 (187)
                      .+++. ++|++++.||+|+||+||+|.+..+++.||||+++..... ...+.+.++..+++.++||||+++++.+     
T Consensus         3 ~~~i~-~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~-~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~   80 (345)
T d1pmea_           3 VFDVG-PRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQ-TYCQRTLREIKILLRFRHENIIGINDIIRAPTI   80 (345)
T ss_dssp             CCCCC-TTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCH-HHHHHHHHHHHHHHHCCCTTBCCCCEEECCSST
T ss_pred             ccCcC-CCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcCh-HHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccc
Confidence            34443 4699999999999999999999999999999998754333 3344455666678889999999876432     


Q ss_pred             ------------------------------HHHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEeccccccc
Q psy14630         93 ------------------------------FKEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQL  142 (187)
Q Consensus        93 ------------------------------~~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg~a~~~  142 (187)
                                                    ...++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++..
T Consensus        81 ~~~~~~~l~~~~~~g~L~~~l~~~~l~~~~i~~i~~qil~al~yLH~~-~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~  159 (345)
T d1pmea_          81 EQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLKYIHSA-NVLHRDLKPSNLLLNTTCDLKICDFGLARVA  159 (345)
T ss_dssp             TTCCCEEEEEECCCEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred             cccceEEEEEeecCCchhhhhhcCCCCHHHHHHHHHHHHHHHHHHHHC-CCcCCCCCcceEEECCCCCEEEcccCceeec
Confidence                                          122788999999999997 9999999999999999999999999999876


Q ss_pred             ccccc----ccCCCCCcCccCccccCCCccCCCCCCcceeeeEee
Q psy14630        143 VDSIA----KTRDAGCRPYMAPERIDPLRARGYPSFKTKLGFKFN  183 (187)
Q Consensus       143 ~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi~  183 (187)
                      .....    .....||+.|+|||++..  ...++.++|+||+|++
T Consensus       160 ~~~~~~~~~~~~~~gt~~y~aPE~l~~--~~~~~~~~DiwSlG~i  202 (345)
T d1pmea_         160 DPDHDHTGFLTEYVATRWYRAPEIMLN--SKGYTKSIDIWSVGCI  202 (345)
T ss_dssp             CGGGCBCCTTCCCCSCGGGCCGGGTTT--BCSCSTHHHHHHHHHH
T ss_pred             cCCCccceeeccccccceechHHHhhc--CCCCCchhhhhccCce
Confidence            54322    234468999999999863  4457899999999993

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.2e-38  Score=240.75  Aligned_cols=158  Identities=25%  Similarity=0.351  Sum_probs=125.3

Q ss_pred             cccccccccccccCceEEEEEEEcCCCcEEEEEEccCccChHHHHHHHHHHHHHHhcCCCCchhhhhhhH----------
Q psy14630         23 SEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQFYGAL----------   92 (187)
Q Consensus        23 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~----------   92 (187)
                      .++|++.+.||+|+||+||+|++..+++.||||++............+.++..+++.++|||++++++.+          
T Consensus         9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~   88 (318)
T d3blha1           9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC   88 (318)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--------
T ss_pred             cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeeccccccccc
Confidence            5899999999999999999999999999999999864332222223344556677888999999876432          


Q ss_pred             ------------------------------HHHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEeccccccc
Q psy14630         93 ------------------------------FKEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQL  142 (187)
Q Consensus        93 ------------------------------~~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg~a~~~  142 (187)
                                                    ...++.|++.||.|||+. +|+||||||+||+++.++.+|++|||+++..
T Consensus        89 ~~~~~iv~e~~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~l~~lH~~-~ivHrDlKp~NILl~~~~~~kl~dfg~~~~~  167 (318)
T d3blha1          89 KGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRN-KILHRDMKAANVLITRDGVLKLADFGLARAF  167 (318)
T ss_dssp             --CEEEEEECCCEEHHHHHTCTTCCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCCGGGEEECTTSCEEECCCTTCEEC
T ss_pred             CceEEEEEeccCCCccchhhhcccccccHHHHHHHHHHHHHHHHhccC-CEEecCcCchheeecCCCcEEeeecceeeec
Confidence                                          112778999999999997 9999999999999999999999999999876


Q ss_pred             cccc-----cccCCCCCcCccCccccCCCccCCCCCCcceeeeEee
Q psy14630        143 VDSI-----AKTRDAGCRPYMAPERIDPLRARGYPSFKTKLGFKFN  183 (187)
Q Consensus       143 ~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi~  183 (187)
                      ....     .....+||+.|+|||++.+  ...++.++|+||+|++
T Consensus       168 ~~~~~~~~~~~~~~~gT~~Y~aPE~~~~--~~~~~~k~DiwSlGvi  211 (318)
T d3blha1         168 SLAKNSQPNRYTNRVVTLWYRPPELLLG--ERDYGPPIDLWGAGCI  211 (318)
T ss_dssp             CC-----CCCCCSCCSCGGGCCHHHHTT--CSSCCTHHHHHHHHHH
T ss_pred             ccccccccccccceecCHHHhhHHHHcC--CCCCCcHHHcccCCce
Confidence            5321     2223468999999999874  3468899999999993

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=100.00  E-value=7.4e-38  Score=234.48  Aligned_cols=160  Identities=29%  Similarity=0.358  Sum_probs=128.4

Q ss_pred             cccccccccccccCceEEEEEEEcCCCcEEEEEEccCccCh-------HHHHHHHHHHHHHHhcC-CCCchhhhhhhHH-
Q psy14630         23 SEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDE-------KDQRQLLMDLDVVMKSN-ECPYIVQFYGALF-   93 (187)
Q Consensus        23 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~-------~~~~~~~~~~~~~~~~~-~h~~iv~~~~~~~-   93 (187)
                      .++|++.+.||+|+||+||+|++..+++.||||+++.....       +...+.+.++..+++.+ .||||+++++.+. 
T Consensus         2 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~   81 (277)
T d1phka_           2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET   81 (277)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred             cccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeeccc
Confidence            57899999999999999999999999999999998643211       12233444555556555 4999999875431 


Q ss_pred             -------------------------------HHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEeccccccc
Q psy14630         94 -------------------------------KEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQL  142 (187)
Q Consensus        94 -------------------------------~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg~a~~~  142 (187)
                                                     ..++.|++.||+|||+. +++||||||+||+++.++.+||+|||+++..
T Consensus        82 ~~~~~ivmE~~~~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~~lH~~-~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~  160 (277)
T d1phka_          82 NTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKL-NIVHRDLKPENILLDDDMNIKLTDFGFSCQL  160 (277)
T ss_dssp             SSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred             CcceEEEEEcCCCchHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHc-CCcccccccceEEEcCCCCeEEccchheeEc
Confidence                                           12778999999999997 9999999999999999999999999999987


Q ss_pred             cccccccCCCCCcCccCccccCCC---ccCCCCCCcceeeeEee
Q psy14630        143 VDSIAKTRDAGCRPYMAPERIDPL---RARGYPSFKTKLGFKFN  183 (187)
Q Consensus       143 ~~~~~~~~~~~t~~y~aPE~~~~~---~~~~~~~~~D~ws~gi~  183 (187)
                      .+........||+.|+|||.+.+.   ....++.++||||+|++
T Consensus       161 ~~~~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvi  204 (277)
T d1phka_         161 DPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVI  204 (277)
T ss_dssp             CTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHH
T ss_pred             cCCCceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchh
Confidence            665555556899999999998532   13346789999999993

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=100.00  E-value=2e-38  Score=238.68  Aligned_cols=156  Identities=23%  Similarity=0.424  Sum_probs=124.7

Q ss_pred             ccccccccccccCceEEEEEEEcCCCcEEEEEEccCccChHHHHHHHHHHHHHHhcCCCCchhhhhhhHH----------
Q psy14630         24 EDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQFYGALF----------   93 (187)
Q Consensus        24 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~----------   93 (187)
                      ++|++.+.||+|+||.||+|.+. +++.||||.++.........+.+.++..+++.++||||+++++.+.          
T Consensus         2 ~~Y~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e   80 (286)
T d1ob3a_           2 EKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFE   80 (286)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEET-TSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEE
T ss_pred             CCceeccEEecCCCcEEEEEEeC-CCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEE
Confidence            68999999999999999999985 7789999998654333333445666777888899999999886432          


Q ss_pred             ----------------------HHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEeccccccccccc-cccC
Q psy14630         94 ----------------------KEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSI-AKTR  150 (187)
Q Consensus        94 ----------------------~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg~a~~~~~~~-~~~~  150 (187)
                                            ..++.|++.||+|||+. +|+||||||+||+++.++.+|++|||.+....... ....
T Consensus        81 ~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~-~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~  159 (286)
T d1ob3a_          81 HLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDR-RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTH  159 (286)
T ss_dssp             CCSEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-------
T ss_pred             eehhhhHHHHHhhcCCcchhhhHHHHHHHHHHHHHhccC-cEEecCCCCceeeEcCCCCEEecccccceecccCccccce
Confidence                                  22788999999999997 99999999999999999999999999998765432 2334


Q ss_pred             CCCCcCccCccccCCCccCCCCCCcceeeeEee
Q psy14630        151 DAGCRPYMAPERIDPLRARGYPSFKTKLGFKFN  183 (187)
Q Consensus       151 ~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi~  183 (187)
                      ..+++.|+|||.+.+  ...++.++|+||+|++
T Consensus       160 ~~~~~~y~~pE~~~~--~~~~~~~~DiwslGv~  190 (286)
T d1ob3a_         160 EIVTLWYRAPDVLMG--SKKYSTTIDIWSVGCI  190 (286)
T ss_dssp             --CCCTTCCHHHHTT--CCSCCTHHHHHHHHHH
T ss_pred             ecccchhhhHHHHhC--CCCCCcceeehhcCcH
Confidence            468899999999873  3457899999999994

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.3e-37  Score=239.33  Aligned_cols=156  Identities=25%  Similarity=0.312  Sum_probs=122.1

Q ss_pred             ccccccccccccCceEEEEEEEcCCCcEEEEEEccCccChHHHHHHHHHHHHHHhcCCCCchhhhhhhHH----------
Q psy14630         24 EDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQFYGALF----------   93 (187)
Q Consensus        24 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~----------   93 (187)
                      ++|++.+.||+|+||+||+|++..+++.||||+++....+......+.++..+++.++||||+++++++.          
T Consensus        17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~   96 (355)
T d2b1pa1          17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD   96 (355)
T ss_dssp             TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred             CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCce
Confidence            6799999999999999999999999999999999765545555556666777788889999999876541          


Q ss_pred             -------------------------HHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEeccccccccccccc
Q psy14630         94 -------------------------KEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIAK  148 (187)
Q Consensus        94 -------------------------~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg~a~~~~~~~~~  148 (187)
                                               ..++.|++.||.|||+. ||+||||||+||+++.++.++++|||+++........
T Consensus        97 ~~iv~Ey~~~~l~~~~~~~~~~~~i~~~~~qil~gl~~LH~~-giiHrDlKP~Nil~~~~~~~kl~df~~~~~~~~~~~~  175 (355)
T d2b1pa1          97 VYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSA-GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMM  175 (355)
T ss_dssp             EEEEEECCSEEHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCCGGGEEECTTCCEEECCCCC----------
T ss_pred             eEEEEeccchHHHHhhhcCCCHHHHHHHHHHHHHHHHHhhhc-ccccccCCccccccccccceeeechhhhhcccccccc
Confidence                                     12778999999999998 9999999999999999999999999999887766666


Q ss_pred             cCCCCCcCccCccccCCCccCCCCCCcceeeeEee
Q psy14630        149 TRDAGCRPYMAPERIDPLRARGYPSFKTKLGFKFN  183 (187)
Q Consensus       149 ~~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi~  183 (187)
                      ....+|+.|+|||++.   +..++.++|+||+|++
T Consensus       176 ~~~~~t~~y~aPE~l~---~~~~~~~~DiwSlG~~  207 (355)
T d2b1pa1         176 TPYVVTRYYRAPEVIL---GMGYKENVDIWSVGCI  207 (355)
T ss_dssp             -----CCTTCCHHHHT---TCCCCTTHHHHHHHHH
T ss_pred             ccccccccccChhhhc---CCCCCCCcccccccch
Confidence            6668999999999998   6678999999999993

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.1e-37  Score=233.40  Aligned_cols=157  Identities=24%  Similarity=0.398  Sum_probs=129.3

Q ss_pred             ccccccccccccCceEEEEEEEcCCCcEEEEEEccCccChHHHHHHHHHHHHHHhcCCCCchhhhhhhH-----------
Q psy14630         24 EDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQFYGAL-----------   92 (187)
Q Consensus        24 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~-----------   92 (187)
                      ++|++++.||+|+||+||+|++..+++.||||+++.........+.+.++..+++.++||||+++++.+           
T Consensus         2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~   81 (292)
T d1unla_           2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE   81 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence            589999999999999999999999999999999865444434455566677778889999999987533           


Q ss_pred             ---------------------HHHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEeccccccccccc-cccC
Q psy14630         93 ---------------------FKEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSI-AKTR  150 (187)
Q Consensus        93 ---------------------~~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg~a~~~~~~~-~~~~  150 (187)
                                           ...++.|++.||+|||+. +|+||||||+||+++..+.+|++|||.++...... ....
T Consensus        82 ~~~~~~l~~~~~~~~~~~~~~~~~~~~q~~~aL~~lH~~-~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~~~~~~  160 (292)
T d1unla_          82 FCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSR-NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSA  160 (292)
T ss_dssp             CCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEECTTCCEEECCCTTCEECCSCCSCCCS
T ss_pred             eccccccccccccccccchhHHHHHHHHHHHHHHHhhcC-CEeeecccCcccccccCCceeeeecchhhcccCCCcccee
Confidence                                 223778999999999997 99999999999999999999999999998875433 2333


Q ss_pred             CCCCcCccCccccCCCccCCCCCCcceeeeEee
Q psy14630        151 DAGCRPYMAPERIDPLRARGYPSFKTKLGFKFN  183 (187)
Q Consensus       151 ~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi~  183 (187)
                      ..+++.|+|||.+..  ...++.++|+||+|++
T Consensus       161 ~~~~~~~~~pe~~~~--~~~~~~~~DiwSlG~i  191 (292)
T d1unla_         161 EVVTLWYRPPDVLFG--AKLYSTSIDMWSAGCI  191 (292)
T ss_dssp             CCSCGGGCCHHHHTT--CSCCCTHHHHHHHHHH
T ss_pred             eccccchhhhhHhcc--CCCCCchhhccccchH
Confidence            456788999999873  3346899999999994

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=100.00  E-value=2.1e-37  Score=237.15  Aligned_cols=154  Identities=20%  Similarity=0.335  Sum_probs=125.9

Q ss_pred             CcccccccccccccCceEEEEEEEcCCCcEEEEEEccCccChHHHHHHHHHHHHHHhcC-CCCchhhhhhhH--------
Q psy14630         22 TSEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSN-ECPYIVQFYGAL--------   92 (187)
Q Consensus        22 ~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~-~h~~iv~~~~~~--------   92 (187)
                      ..++|++.+.||+|+||+||+|++..+++.||||+++...    ..+ +.++..+++.+ .||||+++++.+        
T Consensus        33 ~~d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~----~~~-~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~  107 (328)
T d3bqca1          33 NQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK----KKK-IKREIKILENLRGGPNIITLADIVKDPVSRTP  107 (328)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC----HHH-HHHHHHHHHHHTTSTTBCCEEEEEECTTTCSE
T ss_pred             CCcCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHH----HHH-HHHHHHHHHhccCCCCCcEEEEEEEecCCCce
Confidence            5578999999999999999999999999999999986421    122 33344445544 699999987543        


Q ss_pred             -----------------------HHHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCC-CEEEEeccccccccccccc
Q psy14630         93 -----------------------FKEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRG-AIKLCDFGISGQLVDSIAK  148 (187)
Q Consensus        93 -----------------------~~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~-~~ki~dfg~a~~~~~~~~~  148 (187)
                                             ...++.|++.||+|||+. +|+||||||+|||++.++ .+|++|||+|+...+....
T Consensus       108 ~~v~e~~~~~~L~~~~~~l~e~~i~~i~~qil~aL~~LH~~-gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~~~~  186 (328)
T d3bqca1         108 ALVFEHVNNTDFKQLYQTLTDYDIRFYMYEILKALDYCHSM-GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEY  186 (328)
T ss_dssp             EEEEECCCSCBGGGTTTSCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEEETTTTEEEECCGGGCEECCTTCCC
T ss_pred             eEEEeecCCCcHHHHhcCCCHHHHHHHHHHHHHHHHHHhhc-ccccccccccceEEcCCCCeeeecccccceeccCCCcc
Confidence                                   222788999999999997 999999999999998765 5899999999988766666


Q ss_pred             cCCCCCcCccCccccCCCccCCCCCCcceeeeEee
Q psy14630        149 TRDAGCRPYMAPERIDPLRARGYPSFKTKLGFKFN  183 (187)
Q Consensus       149 ~~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi~  183 (187)
                      ....+|+.|+|||.+.+  ...++.++|+||+|+.
T Consensus       187 ~~~~~t~~y~aPE~~~~--~~~~~~~~DiwslG~~  219 (328)
T d3bqca1         187 NVRVASRYFKGPELLVD--YQMYDYSLDMWSLGCM  219 (328)
T ss_dssp             CSCCSCGGGCCHHHHTT--CCCCCTHHHHHHHHHH
T ss_pred             cccccCccccCcccccC--CCCCCcccchhhhhhh
Confidence            66789999999999874  3457899999999993

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.1e-38  Score=232.54  Aligned_cols=155  Identities=23%  Similarity=0.411  Sum_probs=122.5

Q ss_pred             ccCCcccccccccccccCceEEEEEEEcCCCcEEEEEEccCccChHHHHHHHHHHHHHHhcCCCCchhhhhhhHHH----
Q psy14630         19 YDFTSEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQFYGALFK----   94 (187)
Q Consensus        19 ~~~~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~----   94 (187)
                      |++..++|++.+.||+|+||.||+|.+.  ++.||||.++...    ..+.+.++..+++.++||||+++++++..    
T Consensus         2 w~i~~~~~~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~i~~~~----~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~   75 (262)
T d1byga_           2 WALNMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGG   75 (262)
T ss_dssp             CBCCGGGEEEEEEEEECSSCEEEEEEET--TEEEEEEECCCCC------HHHHHTHHHHTTCCCTTBCCEEEEECCC--C
T ss_pred             CccCHHHeEEeEEEecCCCeEEEEEEEC--CeEEEEEEECcHH----HHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCc
Confidence            7889999999999999999999999984  6789999997432    22345556667888899999999875421    


Q ss_pred             -------------------------------HHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEecccccccc
Q psy14630         95 -------------------------------EVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLV  143 (187)
Q Consensus        95 -------------------------------~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg~a~~~~  143 (187)
                                                     .++.|++.|+.|||+. +++||||||+||+++.++.+|++|||+++...
T Consensus        76 ~~lv~ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~-~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~  154 (262)
T d1byga_          76 LYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN-NFVHRDLAARNVLVSEDNVAKVSDFGLTKEAS  154 (262)
T ss_dssp             CEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCSGGGEEECTTSCEEECCCCC-----
T ss_pred             EEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccC-ceeccccchHhheecCCCCEeecccccceecC
Confidence                                           1678999999999997 99999999999999999999999999998754


Q ss_pred             ccccccCCCCCcCccCccccCCCccCCCCCCcceeeeEe-eee
Q psy14630        144 DSIAKTRDAGCRPYMAPERIDPLRARGYPSFKTKLGFKF-NYR  185 (187)
Q Consensus       144 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi-~~~  185 (187)
                      ..  .....++..|+|||.+.   ...++.++||||||+ +|+
T Consensus       155 ~~--~~~~~~~~~y~aPE~l~---~~~~t~~sDIwSfG~il~e  192 (262)
T d1byga_         155 ST--QDTGKLPVKWTAPEALR---EKKFSTKSDVWSFGILLWE  192 (262)
T ss_dssp             ---------CCTTTSCHHHHH---HCCCCHHHHHHHHHHHHHH
T ss_pred             CC--CccccccccCCChHHHh---CCCCChHHHHHhHHHHHHH
Confidence            43  22346788999999998   667899999999999 544

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-37  Score=239.83  Aligned_cols=151  Identities=29%  Similarity=0.338  Sum_probs=124.3

Q ss_pred             ccccccccccccCceEEEEEEEcCCCcEEEEEEccCccChHHHHHHHHHHHHHHhcCCCCchhhhhhhH-----------
Q psy14630         24 EDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQFYGAL-----------   92 (187)
Q Consensus        24 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~-----------   92 (187)
                      -+|+..++||+|+||+||+|++..+++.||||++......      ..++..+++.++||||+++++.+           
T Consensus        20 ~~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~------~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~   93 (350)
T d1q5ka_          20 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF------KNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVY   93 (350)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSS------CCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCE
T ss_pred             CCcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccchH------HHHHHHHHHhcCCCCCCcEEEEEEecCccCCceE
Confidence            3789999999999999999999999999999998643211      11345567778999999875432           


Q ss_pred             ------------------------------HHHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCC-CEEEEecccccc
Q psy14630         93 ------------------------------FKEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRG-AIKLCDFGISGQ  141 (187)
Q Consensus        93 ------------------------------~~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~-~~ki~dfg~a~~  141 (187)
                                                    ...++.|++.||+|||+. +|+||||||+|||++.++ .+||+|||+++.
T Consensus        94 ~~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~-~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~  172 (350)
T d1q5ka_          94 LNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF-GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQ  172 (350)
T ss_dssp             EEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT-TEECCCCCGGGEEECTTTCCEEECCCTTCEE
T ss_pred             EEEEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhc-CCcccCCCcceEEEecCCCceeEecccchhh
Confidence                                          112678999999999997 999999999999999775 899999999998


Q ss_pred             ccccccccCCCCCcCccCccccCCCccCCCCCCcceeeeEee
Q psy14630        142 LVDSIAKTRDAGCRPYMAPERIDPLRARGYPSFKTKLGFKFN  183 (187)
Q Consensus       142 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi~  183 (187)
                      ...........||+.|+|||.+.+  ...++.++||||+|++
T Consensus       173 ~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~~DIwSlG~i  212 (350)
T d1q5ka_         173 LVRGEPNVSYICSRYYRAPELIFG--ATDYTSSIDVWSAGCV  212 (350)
T ss_dssp             CCTTSCCCSCCSCTTSCCHHHHTT--CSSCCTHHHHHHHHHH
T ss_pred             ccCCcccccccccccccChHHhhc--ccCCCcceeecccceE
Confidence            776655666689999999999873  4568999999999993

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.3e-37  Score=235.16  Aligned_cols=161  Identities=20%  Similarity=0.409  Sum_probs=132.0

Q ss_pred             cccCCcccccccccccccCceEEEEEEEc-----CCCcEEEEEEccCccChHHHHHHHHHHHHHHhcCCCCchhhhhhhH
Q psy14630         18 VYDFTSEDLQDLGEIGRGGFGTVNKMIHR-----SSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQFYGAL   92 (187)
Q Consensus        18 ~~~~~~~~~~~~~~lg~G~fg~V~~~~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~   92 (187)
                      .|+++.++|.+.+.||+|+||.||+|.+.     .+++.||||.++...... ....+.++..+++.++||||+++++.+
T Consensus        14 ~~ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~-~~~~~~~E~~il~~l~h~nIv~~~~~~   92 (308)
T d1p4oa_          14 EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMR-ERIEFLNEASVMKEFNCHHVVRLLGVV   92 (308)
T ss_dssp             TTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHH-HHHHHHHHHHHGGGCCCTTBCCEEEEE
T ss_pred             ceeecHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChH-HHHHHHHHHHHHHHcCCCCEeeeeeEE
Confidence            58899999999999999999999999874     235789999997544333 344556667778889999999987532


Q ss_pred             H------------------------------------------HHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCC
Q psy14630         93 F------------------------------------------KEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGA  130 (187)
Q Consensus        93 ~------------------------------------------~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~  130 (187)
                      .                                          ..++.+++.||.|||+. +|+||||||+|||++.++.
T Consensus        93 ~~~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~-~ivHrDlk~~NiLld~~~~  171 (308)
T d1p4oa_          93 SQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN-KFVHRDLAARNCMVAEDFT  171 (308)
T ss_dssp             CSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT-TCBCSCCSGGGEEECTTCC
T ss_pred             ecCCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhC-CeeeceEcCCceeecCCce
Confidence            1                                          12677899999999997 9999999999999999999


Q ss_pred             EEEEeccccccccccc---cccCCCCCcCccCccccCCCccCCCCCCcceeeeEee
Q psy14630        131 IKLCDFGISGQLVDSI---AKTRDAGCRPYMAPERIDPLRARGYPSFKTKLGFKFN  183 (187)
Q Consensus       131 ~ki~dfg~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi~  183 (187)
                      +||+|||+++......   ......+|+.|+|||.+.   ...++.++|+||||++
T Consensus       172 ~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~---~~~~~~~~Dv~S~G~i  224 (308)
T d1p4oa_         172 VKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLK---DGVFTTYSDVWSFGVV  224 (308)
T ss_dssp             EEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHH---HCCCCHHHHHHHHHHH
T ss_pred             EEEeecccceeccCCcceeeccceecccccCCHHHHc---cCCCCcccccccHHHH
Confidence            9999999998775432   223346889999999998   6778899999999984

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.6e-39  Score=239.26  Aligned_cols=156  Identities=25%  Similarity=0.324  Sum_probs=119.0

Q ss_pred             cccccccccccccCceEEEEEEEcCCCcEEEEEEccCccChH----HHHHHHHHHHHHHhcC--CCCchhhhhhhHH---
Q psy14630         23 SEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEK----DQRQLLMDLDVVMKSN--ECPYIVQFYGALF---   93 (187)
Q Consensus        23 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~----~~~~~~~~~~~~~~~~--~h~~iv~~~~~~~---   93 (187)
                      .++|++.+.||+|+||.||+|.+..+++.||||.++......    .....+..+..+++.+  .||||+++++.+.   
T Consensus         3 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~   82 (273)
T d1xwsa_           3 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPD   82 (273)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSS
T ss_pred             CCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCC
Confidence            367999999999999999999999999999999985321110    0011122233344443  4899999876431   


Q ss_pred             ------------------------------HHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcC-CCCEEEEeccccccc
Q psy14630         94 ------------------------------KEVTVATVKALNYLKEELKIIHRDVKPSNILLDR-RGAIKLCDFGISGQL  142 (187)
Q Consensus        94 ------------------------------~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~-~~~~ki~dfg~a~~~  142 (187)
                                                    ..++.|++.||.|||+. +++||||||+||+++. .+.+||+|||+|+..
T Consensus        83 ~~~lv~e~~~~~~~l~~~~~~~~~l~e~~~~~~~~qi~~al~~lH~~-~iiHrDiKp~NIll~~~~~~vkl~DFG~a~~~  161 (273)
T d1xwsa_          83 SFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNC-GVLHRDIKDENILIDLNRGELKLIDFGSGALL  161 (273)
T ss_dssp             EEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred             eEEEEEEeccCcchHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC-CCccccCcccceEEecCCCeEEECccccceec
Confidence                                          12778999999999998 9999999999999985 478999999999876


Q ss_pred             cccccccCCCCCcCccCccccCCCccCCC-CCCcceeeeEee
Q psy14630        143 VDSIAKTRDAGCRPYMAPERIDPLRARGY-PSFKTKLGFKFN  183 (187)
Q Consensus       143 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~-~~~~D~ws~gi~  183 (187)
                      .... .....||+.|+|||++.   ...+ +.++|+||+|++
T Consensus       162 ~~~~-~~~~~GT~~y~aPE~~~---~~~~~~~~~DiwSlGvi  199 (273)
T d1xwsa_         162 KDTV-YTDFDGTRVYSPPEWIR---YHRYHGRSAAVWSLGIL  199 (273)
T ss_dssp             CSSC-BCCCCSCGGGSCHHHHH---HSCBCHHHHHHHHHHHH
T ss_pred             cccc-ccccccCCCcCCHHHHc---CCCCCCcccccccceee
Confidence            5433 33457999999999987   4444 577999999993

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.2e-38  Score=234.51  Aligned_cols=160  Identities=24%  Similarity=0.417  Sum_probs=117.8

Q ss_pred             CCcccccccccccccCceEEEEEEEcC-CC--cEEEEEEccCcc-ChHHHHHHHHHHHHHHhcCCCCchhhhhhhHHH--
Q psy14630         21 FTSEDLQDLGEIGRGGFGTVNKMIHRS-SD--TVMAVKRIRSTV-DEKDQRQLLMDLDVVMKSNECPYIVQFYGALFK--   94 (187)
Q Consensus        21 ~~~~~~~~~~~lg~G~fg~V~~~~~~~-~~--~~vaiK~~~~~~-~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~--   94 (187)
                      +..++|++.+.||+|+||.||+|.+.. ++  ..||||.++... ......+.+.++..+++.++||||+++++++.+  
T Consensus         5 i~~~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~~~   84 (273)
T d1u46a_           5 IGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP   84 (273)
T ss_dssp             CCGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred             EchHHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeecc
Confidence            457889999999999999999998643 22  468999986432 222333445566677888899999999875421  


Q ss_pred             ------------------------------HHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEeccccccccc
Q psy14630         95 ------------------------------EVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVD  144 (187)
Q Consensus        95 ------------------------------~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg~a~~~~~  144 (187)
                                                    .+..|++.||.|||+. +++||||||+||+++.++.+|++|||+++....
T Consensus        85 ~~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~-~iiHrDikp~NIll~~~~~vkl~DfGl~~~~~~  163 (273)
T d1u46a_          85 MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESK-RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQ  163 (273)
T ss_dssp             CEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHT-TEECSCCCGGGEEEEETTEEEECCCTTCEECCC
T ss_pred             hheeeeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhhhC-CEeeeeecHHHhccccccceeeccchhhhhccc
Confidence                                          2678999999999997 999999999999999999999999999998754


Q ss_pred             ccc----ccCCCCCcCccCccccCCCccCCCCCCcceeeeEeee
Q psy14630        145 SIA----KTRDAGCRPYMAPERIDPLRARGYPSFKTKLGFKFNY  184 (187)
Q Consensus       145 ~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi~~  184 (187)
                      ...    .....++..|+|||.+.   ...++.++||||||+..
T Consensus       164 ~~~~~~~~~~~~~~~~~~aPE~~~---~~~~~~~~Di~S~Gvil  204 (273)
T d1u46a_         164 NDDHYVMQEHRKVPFAWCAPESLK---TRTFSHASDTWMFGVTL  204 (273)
T ss_dssp             -CCEEEC-----CCGGGCCHHHHH---HCEEEHHHHHHHHHHHH
T ss_pred             CCCcceecCccccCcccCCHHHHh---CCCCCcchhhhhhHHHH
Confidence            322    22235678899999998   66788999999999943

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-37  Score=236.27  Aligned_cols=159  Identities=23%  Similarity=0.323  Sum_probs=123.7

Q ss_pred             CCcccccccccccccCceEEEEEEEcCCCcE--EEEEEccCccChHHHHHHHHHHHHHHhcC-CCCchhhhhhhHHH---
Q psy14630         21 FTSEDLQDLGEIGRGGFGTVNKMIHRSSDTV--MAVKRIRSTVDEKDQRQLLMDLDVVMKSN-ECPYIVQFYGALFK---   94 (187)
Q Consensus        21 ~~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~--vaiK~~~~~~~~~~~~~~~~~~~~~~~~~-~h~~iv~~~~~~~~---   94 (187)
                      +..++|++.+.||+|+||.||+|.+..++..  ||||.++....+.. .+.+.++..++..+ +||||+++++++..   
T Consensus         7 i~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~-~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~   85 (309)
T d1fvra_           7 LDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDD-HRDFAGELEVLCKLGHHPNIINLLGACEHRGY   85 (309)
T ss_dssp             CCGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC-------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTE
T ss_pred             cCHHHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHH-HHHHHHHHHHHHhccCCCCEeeEEEEEecCCe
Confidence            4678999999999999999999999888764  67787754333333 33344455566665 79999999864311   


Q ss_pred             ---------------------------------------------HHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCC
Q psy14630         95 ---------------------------------------------EVTVATVKALNYLKEELKIIHRDVKPSNILLDRRG  129 (187)
Q Consensus        95 ---------------------------------------------~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~  129 (187)
                                                                   .++.|++.|+.|+|+. +++||||||+|||++.++
T Consensus        86 ~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~-~iiHrDlkp~NIL~~~~~  164 (309)
T d1fvra_          86 LYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK-QFIHRDLAARNILVGENY  164 (309)
T ss_dssp             EEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEECGGG
T ss_pred             eEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcC-CccccccccceEEEcCCC
Confidence                                                         1567999999999997 999999999999999999


Q ss_pred             CEEEEeccccccccccccccCCCCCcCccCccccCCCccCCCCCCcceeeeEeee
Q psy14630        130 AIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPLRARGYPSFKTKLGFKFNY  184 (187)
Q Consensus       130 ~~ki~dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi~~  184 (187)
                      .+||+|||+++............+|..|+|||.+.   ...++.++||||||+.+
T Consensus       165 ~~kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~l~---~~~~~~~sDvwSfGvil  216 (309)
T d1fvra_         165 VAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLN---YSVYTTNSDVWSYGVLL  216 (309)
T ss_dssp             CEEECCTTCEESSCEECCC----CCTTTCCHHHHH---HCEECHHHHHHHHHHHH
T ss_pred             ceEEccccccccccccccccceecCCcccchHHhc---cCCCCccceeehhHHHH
Confidence            99999999998876655555557899999999998   66789999999999944

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-36  Score=234.19  Aligned_cols=163  Identities=21%  Similarity=0.335  Sum_probs=129.3

Q ss_pred             ccccCCcccccccccccccCceEEEEEEEcCCCcEEEEEEccCccChHHHHHHHHHHHHHHhcCCCCchhhhhhhH----
Q psy14630         17 TVYDFTSEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQFYGAL----   92 (187)
Q Consensus        17 ~~~~~~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~----   92 (187)
                      +.|++ .++|++++.||+|+||+||+|++..+++.||||+++.........+.+.++..+++.++|||++++++.+    
T Consensus        12 ~~~~~-~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~   90 (348)
T d2gfsa1          12 TIWEV-PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPAR   90 (348)
T ss_dssp             SEEEE-ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCS
T ss_pred             ccccC-CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeecc
Confidence            34554 4789999999999999999999999999999999976544444455566677788889999999876532    


Q ss_pred             --------------------------------HHHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEeccccc
Q psy14630         93 --------------------------------FKEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISG  140 (187)
Q Consensus        93 --------------------------------~~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg~a~  140 (187)
                                                      ...++.|++.||+|||+. +|+||||||+||+++.++.+|++|||++.
T Consensus        91 ~~~~~~~~~i~~~~~gg~L~~~~~~~~l~e~~~~~i~~qil~aL~~LH~~-giiHrDiKp~NILi~~~~~~kl~dfg~a~  169 (348)
T d2gfsa1          91 SLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA-DIIHRDLKPSNLAVNEDCELKILDFGLAR  169 (348)
T ss_dssp             STTTCCCCEEEEECCSEEHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT-TCCCCCCCGGGEEECTTCCEEECCC----
T ss_pred             ccccCceEEEEEeecCCchhhhcccccccHHHHHHHHHHHHHHHHHHHhC-CCcccccCCccccccccccccccccchhc
Confidence                                            122778999999999998 99999999999999999999999999997


Q ss_pred             cccccccccCCCCCcCccCccccCCCccCCCCCCcceeeeEe-eee
Q psy14630        141 QLVDSIAKTRDAGCRPYMAPERIDPLRARGYPSFKTKLGFKF-NYR  185 (187)
Q Consensus       141 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi-~~~  185 (187)
                      .....  .....|++.|+|||.+.+  ...++.++|+||+|+ +|+
T Consensus       170 ~~~~~--~~~~~g~~~y~apE~~~~--~~~~~~~~DiwSlGv~l~~  211 (348)
T d2gfsa1         170 HTDDE--MTGYVATRWYRAPEIMLN--WMHYNQTVDIWSVGCIMAE  211 (348)
T ss_dssp             CCTGG--GSSSCHHHHTSCHHHHTT--CSCCCTTHHHHHHHHHHHH
T ss_pred             ccCcc--cccccccccccCchhhcC--CccCCcccchhhhhHHHHH
Confidence            76443  233478899999999873  344679999999999 443

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.6e-36  Score=228.82  Aligned_cols=156  Identities=24%  Similarity=0.284  Sum_probs=116.8

Q ss_pred             ccccccccccccCceEEEEEEEcCCCcEEEEEEccCccChHHHHHHHHH-HHHHHhcCCCCchhhhhhhHHH--------
Q psy14630         24 EDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMD-LDVVMKSNECPYIVQFYGALFK--------   94 (187)
Q Consensus        24 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~-~~~~~~~~~h~~iv~~~~~~~~--------   94 (187)
                      ++|.+.+.||+|+||.||+|++  +++.||||.++...    ..+...+ +...+..++||||+++++.+..        
T Consensus         3 ~~~~l~~~iG~G~fg~Vy~~~~--~g~~vAvK~~~~~~----~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~   76 (303)
T d1vjya_           3 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSRE----ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQL   76 (303)
T ss_dssp             GGEEEEEEEECCSSSEEEEEEE--TTEEEEEEEECGGG----HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEE
T ss_pred             cEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccc----hhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEE
Confidence            6788889999999999999986  57899999986321    1222222 2333446789999998764321        


Q ss_pred             ---------------------------HHHHHHHHHHHHHHhc-------CCCeeecCCCCCeEEcCCCCEEEEeccccc
Q psy14630         95 ---------------------------EVTVATVKALNYLKEE-------LKIIHRDVKPSNILLDRRGAIKLCDFGISG  140 (187)
Q Consensus        95 ---------------------------~~~~~~~~~l~~lh~~-------~~i~Hrdlk~~nili~~~~~~ki~dfg~a~  140 (187)
                                                 .+..+++.|+.|+|+.       .+|+||||||+||+++.++.+||+|||+++
T Consensus        77 ~lv~Ey~~~g~L~~~l~~~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~  156 (303)
T d1vjya_          77 WLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV  156 (303)
T ss_dssp             EEEEECCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCE
T ss_pred             EEEEecccCCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCccc
Confidence                                       2678899999999962       489999999999999999999999999998


Q ss_pred             cccccc-----cccCCCCCcCccCccccCCCccC---CCCCCcceeeeEeeee
Q psy14630        141 QLVDSI-----AKTRDAGCRPYMAPERIDPLRAR---GYPSFKTKLGFKFNYR  185 (187)
Q Consensus       141 ~~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~---~~~~~~D~ws~gi~~~  185 (187)
                      ......     ......||+.|+|||.+.+....   .++.++||||||+++|
T Consensus       157 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~  209 (303)
T d1vjya_         157 RHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFW  209 (303)
T ss_dssp             EEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHH
T ss_pred             cccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHH
Confidence            874422     22345799999999998743111   2567899999999543

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=100.00  E-value=3.6e-36  Score=227.07  Aligned_cols=153  Identities=20%  Similarity=0.230  Sum_probs=117.7

Q ss_pred             cccccccccccccCceEEEEEEEcCCCcEEEEEEccCccChHHHHHHHHHHHHHHhcC-CCCchhhhhhhH---------
Q psy14630         23 SEDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSN-ECPYIVQFYGAL---------   92 (187)
Q Consensus        23 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~-~h~~iv~~~~~~---------   92 (187)
                      .++|++.+.||+|+||+||+|.+..+++.||||++.........    .++...++.+ +|+|++.+++.+         
T Consensus         4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~~~----~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~v   79 (293)
T d1csna_           4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQL----RDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLV   79 (293)
T ss_dssp             TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTSCCH----HHHHHHHHHTTTCTTCCCEEEEEEETTEEEEE
T ss_pred             CCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccCcHHH----HHHHHHHHHhcCCCCCCEEEEEeecCCccEEE
Confidence            46899999999999999999999999999999998543322221    2222233333 457777654321         


Q ss_pred             -----------------------HHHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcC-----CCCEEEEeccccccccc
Q psy14630         93 -----------------------FKEVTVATVKALNYLKEELKIIHRDVKPSNILLDR-----RGAIKLCDFGISGQLVD  144 (187)
Q Consensus        93 -----------------------~~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~-----~~~~ki~dfg~a~~~~~  144 (187)
                                             ...++.|++.||.|||+. +++||||||+||+++.     .+.+||+|||+|+....
T Consensus        80 me~~~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH~~-giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~~  158 (293)
T d1csna_          80 IDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEK-SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRD  158 (293)
T ss_dssp             EECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTT-TEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBC
T ss_pred             EEecCCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHHHC-CceeccCCccceeecCcccccCCceEEcccceeEEccc
Confidence                                   112778999999999998 9999999999999964     57899999999988653


Q ss_pred             cc--------cccCCCCCcCccCccccCCCccCCCCCCcceeeeEee
Q psy14630        145 SI--------AKTRDAGCRPYMAPERIDPLRARGYPSFKTKLGFKFN  183 (187)
Q Consensus       145 ~~--------~~~~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi~  183 (187)
                      ..        ......||+.|||||.+.   +..++.++|+||+|++
T Consensus       159 ~~~~~~~~~~~~~~~~GT~~y~aPE~~~---~~~~~~~~DiwSlG~~  202 (293)
T d1csna_         159 PVTKQHIPYREKKNLSGTARYMSINTHL---GREQSRRDDLEALGHV  202 (293)
T ss_dssp             TTTCCBCCCCCCCCCCSCTTTCCHHHHT---TCCCCHHHHHHHHHHH
T ss_pred             CccccceeecccCceEEchhhcCHHHhc---CCCCChHHHHHHhhHH
Confidence            21        123447999999999998   6779999999999993

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=5.9e-36  Score=226.42  Aligned_cols=152  Identities=16%  Similarity=0.181  Sum_probs=118.3

Q ss_pred             ccccccccccccCceEEEEEEEcCCCcEEEEEEccCccChHHHHHHHHHHHHHHhcCCCCchhhhhhh------------
Q psy14630         24 EDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQFYGA------------   91 (187)
Q Consensus        24 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~------------   91 (187)
                      ++|++.+.||+|+||.||+|.+..+++.||||++.......    .+..+..+++.+.|+|++..+..            
T Consensus         7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~----~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivm   82 (299)
T d1ckia_           7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHP----QLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM   82 (299)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTTSC----CHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEE
T ss_pred             CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhccCH----HHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEE
Confidence            46999999999999999999999999999999876432221    23344556666766665544321            


Q ss_pred             ---------------------HHHHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcC---CCCEEEEeccccccccccc-
Q psy14630         92 ---------------------LFKEVTVATVKALNYLKEELKIIHRDVKPSNILLDR---RGAIKLCDFGISGQLVDSI-  146 (187)
Q Consensus        92 ---------------------~~~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~---~~~~ki~dfg~a~~~~~~~-  146 (187)
                                           ....++.|++.||+|||++ +|+||||||+||+++.   ...++++|||+|+.+.... 
T Consensus        83 e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~-~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~~~  161 (299)
T d1ckia_          83 ELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSK-NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDART  161 (299)
T ss_dssp             ECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCTTT
T ss_pred             EEcCCchhhhhhhccCCCcHHHHHHHHHHHHHHHHHHHHC-CeeeccCCHhhccccccCCCceeeeeccCcceecccccc
Confidence                                 1122778999999999998 9999999999999864   4579999999999875432 


Q ss_pred             -------cccCCCCCcCccCccccCCCccCCCCCCcceeeeEee
Q psy14630        147 -------AKTRDAGCRPYMAPERIDPLRARGYPSFKTKLGFKFN  183 (187)
Q Consensus       147 -------~~~~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi~  183 (187)
                             ......||+.|+|||.+.   +.+++.++||||||+.
T Consensus       162 ~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwSlG~~  202 (299)
T d1ckia_         162 HQHIPYRENKNLTGTARYASINTHL---GIEQSRRDDLESLGYV  202 (299)
T ss_dssp             CCBCCCCBCCSCCCCSSSCCHHHHT---TBCCCHHHHHHHHHHH
T ss_pred             ccceeccccCCcCCCccccCHHHHh---CCCCCChhhEEecCHH
Confidence                   123447999999999998   6678999999999993

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2e-35  Score=224.54  Aligned_cols=151  Identities=24%  Similarity=0.379  Sum_probs=120.2

Q ss_pred             cccccccCceEEEEEEEcCCC---cEEEEEEccCccChHHHHHHHHHHHHHHhcCCCCchhhhhhhHHH-----------
Q psy14630         29 LGEIGRGGFGTVNKMIHRSSD---TVMAVKRIRSTVDEKDQRQLLMDLDVVMKSNECPYIVQFYGALFK-----------   94 (187)
Q Consensus        29 ~~~lg~G~fg~V~~~~~~~~~---~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~-----------   94 (187)
                      .++||+|+||+||+|.+..++   ..||||.++...... ..+.+.++..++..++||||+++++.+..           
T Consensus        32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~-~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~  110 (311)
T d1r0pa_          32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIG-EVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPY  110 (311)
T ss_dssp             EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHH-HHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEEC
T ss_pred             ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHH-HHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEE
Confidence            578999999999999975543   468999987543333 34455666667788899999999865321           


Q ss_pred             -----------------------HHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEecccccccccccc----
Q psy14630         95 -----------------------EVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLVDSIA----  147 (187)
Q Consensus        95 -----------------------~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg~a~~~~~~~~----  147 (187)
                                             .++.|++.||.|+|+. +++||||||+|||++.++.+||+|||+++.......    
T Consensus       111 ~~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~~-~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~~~~  189 (311)
T d1r0pa_         111 MKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASK-KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVH  189 (311)
T ss_dssp             CTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHT-TCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCCCTT
T ss_pred             eecCchhhhhccccccchHHHHHHHHHHHHHhhhhhccc-CcccCCccHHhEeECCCCCEEEecccchhhccccccccce
Confidence                                   1678999999999997 999999999999999999999999999988654322    


Q ss_pred             -ccCCCCCcCccCccccCCCccCCCCCCcceeeeEeee
Q psy14630        148 -KTRDAGCRPYMAPERIDPLRARGYPSFKTKLGFKFNY  184 (187)
Q Consensus       148 -~~~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi~~  184 (187)
                       .....||+.|+|||.+.   ...++.++||||||+.+
T Consensus       190 ~~~~~~gt~~y~aPE~~~---~~~~~~ksDI~SfGivl  224 (311)
T d1r0pa_         190 NKTGAKLPVKWMALESLQ---TQKFTTKSDVWSFGVLL  224 (311)
T ss_dssp             CTTCSSCCGGGSCHHHHH---HCCCCHHHHHHHHHHHH
T ss_pred             ecccccccccccChHHHh---cCCCCChhHhhhhHHHH
Confidence             12235788999999988   66789999999999943

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-35  Score=226.46  Aligned_cols=163  Identities=25%  Similarity=0.334  Sum_probs=121.9

Q ss_pred             CCcccccccccccccCceEEEEEEE---cCCCcEEEEEEccCcc--ChHHHHHHHHHHHHHHhcC-CCCchhhhhhhH--
Q psy14630         21 FTSEDLQDLGEIGRGGFGTVNKMIH---RSSDTVMAVKRIRSTV--DEKDQRQLLMDLDVVMKSN-ECPYIVQFYGAL--   92 (187)
Q Consensus        21 ~~~~~~~~~~~lg~G~fg~V~~~~~---~~~~~~vaiK~~~~~~--~~~~~~~~~~~~~~~~~~~-~h~~iv~~~~~~--   92 (187)
                      +..++|++.+.||+|+||+||+|.+   ..+++.||+|+++...  .+....+.+.++..+++.+ +||||+++++.+  
T Consensus        21 ~~l~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~  100 (322)
T d1vzoa_          21 VGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQT  100 (322)
T ss_dssp             CCGGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEE
T ss_pred             cchhceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeecc
Confidence            4568999999999999999999987   4478999999986422  1111122233344444544 558999886532  


Q ss_pred             ------------------------------HHHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEeccccccc
Q psy14630         93 ------------------------------FKEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQL  142 (187)
Q Consensus        93 ------------------------------~~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg~a~~~  142 (187)
                                                    ...++.|++.|+.|+|+. +++||||||+||+++.++.+||+|||+++.+
T Consensus       101 ~~~~~~v~e~~~~~~L~~~i~~~~~~~e~~~~~~~~Qi~~al~~lH~~-~ivHrDiKp~Nill~~~~~vkL~DFG~a~~~  179 (322)
T d1vzoa_         101 ETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKL-GIIYRDIKLENILLDSNGHVVLTDFGLSKEF  179 (322)
T ss_dssp             TTEEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHT-TCCCCCCCGGGEEECTTSCEEESCSSEEEEC
T ss_pred             CCceeeeeecccccHHHHHHHhcccccHHHHHHHHHHHHHHHHHhhcC-CEEeccCCccceeecCCCCEEEeeccchhhh
Confidence                                          112677999999999997 9999999999999999999999999999876


Q ss_pred             ccc--ccccCCCCCcCccCccccCCCccCCCCCCcceeeeEe-eee
Q psy14630        143 VDS--IAKTRDAGCRPYMAPERIDPLRARGYPSFKTKLGFKF-NYR  185 (187)
Q Consensus       143 ~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi-~~~  185 (187)
                      ...  .......|++.|+|||.+.+. ...++.++||||+|+ +|+
T Consensus       180 ~~~~~~~~~~~~g~~~~~~pe~~~~~-~~~~~~ksDIWSlG~iLye  224 (322)
T d1vzoa_         180 VADETERAYDFCGTIEYMAPDIVRGG-DSGHDKAVDWWSLGVLMYE  224 (322)
T ss_dssp             CGGGGGGGCGGGSCCTTCCHHHHTTC-C---CTHHHHHHHHHHHHH
T ss_pred             cccccccccccccccccchhHHhhcC-CcCCCchhhhHHHHHHHHH
Confidence            433  223345789999999999742 335778999999999 443

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=99.97  E-value=6.8e-33  Score=214.34  Aligned_cols=153  Identities=20%  Similarity=0.256  Sum_probs=117.8

Q ss_pred             ccccccccccccCceEEEEEEEcCCCcEEEEEEccCccChHHHHHHHHHHHHHHhcC-----------CCCchhhhhhhH
Q psy14630         24 EDLQDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVDEKDQRQLLMDLDVVMKSN-----------ECPYIVQFYGAL   92 (187)
Q Consensus        24 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~-----------~h~~iv~~~~~~   92 (187)
                      .+|++.++||+|+||+||+|++..+++.||||+++...   ...+...++..+++.+           .|+||+++++.+
T Consensus        13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~---~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~   89 (362)
T d1q8ya_          13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK---VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHF   89 (362)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH---HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEE
T ss_pred             CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccc---cchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEe
Confidence            45999999999999999999999999999999987432   1222223333333322           457777765321


Q ss_pred             -------------------------------------HHHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCC-----
Q psy14630         93 -------------------------------------FKEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGA-----  130 (187)
Q Consensus        93 -------------------------------------~~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~-----  130 (187)
                                                           ...++.|++.|++|||+..+|+||||||+|||++..+.     
T Consensus        90 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~IvHrDlKp~NIll~~~~~~~~~~  169 (362)
T d1q8ya_          90 NHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLI  169 (362)
T ss_dssp             EEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTTTEE
T ss_pred             eeccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcCcccccCChhHeeeeccCcccccc
Confidence                                                 23378899999999998559999999999999976543     


Q ss_pred             -EEEEeccccccccccccccCCCCCcCccCccccCCCccCCCCCCcceeeeEeee
Q psy14630        131 -IKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPLRARGYPSFKTKLGFKFNY  184 (187)
Q Consensus       131 -~ki~dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~D~ws~gi~~  184 (187)
                       ++++|||.+......  ....+||+.|+|||.+.   ...++.++|+||+|+.+
T Consensus       170 ~~kl~dfg~s~~~~~~--~~~~~gt~~y~aPE~~~---~~~~~~~~DiwSlG~il  219 (362)
T d1q8ya_         170 QIKIADLGNACWYDEH--YTNSIQTREYRSPEVLL---GAPWGCGADIWSTACLI  219 (362)
T ss_dssp             EEEECCCTTCEETTBC--CCSCCSCGGGCCHHHHH---TCCCCTHHHHHHHHHHH
T ss_pred             eeeEeecccccccccc--cccccccccccChhhcc---ccCCCccccccchHHHH
Confidence             899999998865443  23457999999999998   66789999999999943

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=99.86  E-value=1.1e-21  Score=138.53  Aligned_cols=114  Identities=15%  Similarity=0.047  Sum_probs=82.2

Q ss_pred             cccccccccCceEEEEEEEcCCCcEEEEEEccCccC-------h---------HHHHHHHHHHHHHHhcCCCCchhhhhh
Q psy14630         27 QDLGEIGRGGFGTVNKMIHRSSDTVMAVKRIRSTVD-------E---------KDQRQLLMDLDVVMKSNECPYIVQFYG   90 (187)
Q Consensus        27 ~~~~~lg~G~fg~V~~~~~~~~~~~vaiK~~~~~~~-------~---------~~~~~~~~~~~~~~~~~~h~~iv~~~~   90 (187)
                      .+.+.||+|+||.||+|.+ .+++.||||+++....       .         .........+...+..+.|++++..++
T Consensus         3 ~vg~~IG~G~~g~Vy~a~~-~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~   81 (191)
T d1zara2           3 AIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYA   81 (191)
T ss_dssp             EEEEEEEECSSEEEEEEEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEE
T ss_pred             hhCCEeeeCcceEEEEEEC-CCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEE
Confidence            4678999999999999998 4688999998752110       0         001111222334455567777776542


Q ss_pred             h---------------------HHHHHHHHHHHHHHHHHhcCCCeeecCCCCCeEEcCCCCEEEEecccccccc
Q psy14630         91 A---------------------LFKEVTVATVKALNYLKEELKIIHRDVKPSNILLDRRGAIKLCDFGISGQLV  143 (187)
Q Consensus        91 ~---------------------~~~~~~~~~~~~l~~lh~~~~i~Hrdlk~~nili~~~~~~ki~dfg~a~~~~  143 (187)
                      .                     ....+..|++.++.|||+. +++||||||+|||+++. .++++|||+|....
T Consensus        82 ~~~~~lvme~~~~~~~~~l~~~~~~~i~~ql~~~l~~lH~~-giiHrDiKP~NILv~~~-~~~liDFG~a~~~~  153 (191)
T d1zara2          82 WEGNAVLMELIDAKELYRVRVENPDEVLDMILEEVAKFYHR-GIVHGDLSQYNVLVSEE-GIWIIDFPQSVEVG  153 (191)
T ss_dssp             EETTEEEEECCCCEEGGGCCCSCHHHHHHHHHHHHHHHHHT-TEECSCCSTTSEEEETT-EEEECCCTTCEETT
T ss_pred             ecCCEEEEEeeccccccchhhHHHHHHHHHHHHHHHHHhhC-CEEEccCChhheeeeCC-CEEEEECCCcccCC
Confidence            1                     1334788999999999997 99999999999999865 48999999987654

>d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Methylthioribose kinase MtnK
species: Bacillus subtilis [TaxId: 1423]

Probab=94.86  E-value=0.051  Score=40.50  Aligned_cols=29  Identities=21%  Similarity=0.292  Sum_probs=24.8

Q ss_pred             CCeeecCCCCCeEEcCCCCEEEEecccccc
Q psy14630        112 KIIHRDVKPSNILLDRRGAIKLCDFGISGQ  141 (187)
Q Consensus       112 ~i~Hrdlk~~nili~~~~~~ki~dfg~a~~  141 (187)
                      .++|+|+.+.|+|++++ .++++||..+..
T Consensus       224 ~LiHGDl~~gNIlv~~~-~~~vID~E~a~~  252 (392)
T d2pula1         224 TLIHGDLHTGSIFASEH-ETKVIDPEFAFY  252 (392)
T ss_dssp             EEECSCCCGGGEEECSS-CEEECCCTTCEE
T ss_pred             ceeccCCcCCceeEcCC-ceEEechhhccc
Confidence            48999999999999865 489999987754

>d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Homoserine kinase ThrB
species: Agrobacterium tumefaciens [TaxId: 358]

Probab=93.80  E-value=0.0065  Score=43.92  Aligned_cols=30  Identities=23%  Similarity=0.302  Sum_probs=26.6

Q ss_pred             CCeeecCCCCCeEEcCCCCEEEEecccccc
Q psy14630        112 KIIHRDVKPSNILLDRRGAIKLCDFGISGQ  141 (187)
Q Consensus       112 ~i~Hrdlk~~nili~~~~~~ki~dfg~a~~  141 (187)
                      +++|+|+.+.|++++.+...-++||+.+..
T Consensus       184 giIHgDl~~dNvl~~~~~v~gvIDF~~~~~  213 (316)
T d2ppqa1         184 GVIHADLFQDNVFFLGDELSGLIDFYFACN  213 (316)
T ss_dssp             EEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             ccccCCcchhhhhcccccceeEeccccccc
Confidence            689999999999999887778999997754

>d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Type IIIa 3',5"-aminoglycoside phosphotransferase
species: Enterococcus faecalis [TaxId: 1351]

Probab=92.98  E-value=0.017  Score=40.17  Aligned_cols=29  Identities=31%  Similarity=0.462  Sum_probs=25.4

Q ss_pred             CeeecCCCCCeEEcCCCCEEEEecccccc
Q psy14630        113 IIHRDVKPSNILLDRRGAIKLCDFGISGQ  141 (187)
Q Consensus       113 i~Hrdlk~~nili~~~~~~ki~dfg~a~~  141 (187)
                      ++|+|+.+.|+++++.+.+.++||+.+..
T Consensus       185 l~HgD~~~~Nil~~~~~~~~lIDwe~a~~  213 (263)
T d1j7la_         185 FSHGDLGDSNIFVKDGKVSGFIDLGRSGR  213 (263)
T ss_dssp             EECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred             EEEeeccCcceeecCCceEEEeechhccc
Confidence            78999999999999766677999998765

>d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase)
species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]

Probab=91.90  E-value=0.021  Score=39.58  Aligned_cols=29  Identities=24%  Similarity=0.321  Sum_probs=25.4

Q ss_pred             CeeecCCCCCeEEcCCCCEEEEecccccc
Q psy14630        113 IIHRDVKPSNILLDRRGAIKLCDFGISGQ  141 (187)
Q Consensus       113 i~Hrdlk~~nili~~~~~~ki~dfg~a~~  141 (187)
                      ++|+|+.|.|++++....+-|+||+.+..
T Consensus       177 liHgD~~~~Nvl~~~~~~~~iID~~~~~~  205 (255)
T d1nd4a_         177 VTHGDACLPNIMVENGRFSGFIDCGRLGV  205 (255)
T ss_dssp             EECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             EEeCCCCCcceEEeCCceEEEEEchhccc
Confidence            79999999999998876678999998765

>d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Choline kinase
domain: Choline kinase
species: Caenorhabditis elegans [TaxId: 6239]

Probab=89.06  E-value=2.4  Score=30.88  Aligned_cols=36  Identities=11%  Similarity=-0.042  Sum_probs=23.1

Q ss_pred             CcccccccccccccCceEEEEEEEcC-------CCcEEEEEEcc
Q psy14630         22 TSEDLQDLGEIGRGGFGTVNKMIHRS-------SDTVMAVKRIR   58 (187)
Q Consensus        22 ~~~~~~~~~~lg~G~fg~V~~~~~~~-------~~~~vaiK~~~   58 (187)
                      +.+++++ +.|+-|---.+|++....       ....|.+++..
T Consensus        41 ~~~~l~v-~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g   83 (395)
T d1nw1a_          41 PLEHLRI-SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYF   83 (395)
T ss_dssp             CGGGEEE-EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEEC
T ss_pred             CccceEE-EEcCCccccceEEEEeCCCCccccCCCCcEEEEecC
Confidence            3344443 567778888999987643       23557777764

>d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: RdoA
species: Escherichia coli [TaxId: 562]

Probab=81.87  E-value=0.21  Score=35.94  Aligned_cols=28  Identities=25%  Similarity=0.337  Sum_probs=22.7

Q ss_pred             CCeeecCCCCCeEEcCCCCEEEEecccccc
Q psy14630        112 KIIHRDVKPSNILLDRRGAIKLCDFGISGQ  141 (187)
Q Consensus       112 ~i~Hrdlk~~nili~~~~~~ki~dfg~a~~  141 (187)
                      +++|+|+.+.|++++. + ..++||+-+..
T Consensus       193 ~liHgDlh~~NvL~~~-~-~~~IDFdd~~~  220 (325)
T d1zyla1         193 LRLHGDCHAGNILWRD-G-PMFVDLDDARN  220 (325)
T ss_dssp             EECCSSCSGGGEEESS-S-EEECCCTTCCE
T ss_pred             eeecCCCCcccEEEeC-C-ceEEechhccc
Confidence            5799999999999974 3 45899987654